PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Araki, R; Uda, M; Hoki, Y; Sunayama, M; Nakamura, M; Ando, S; Sugiura, M; Ideno, H; Shimada, A; Nifuji, A; Abe, M				Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira; Abe, Masumi			Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells	NATURE			English	Article							GROUND-STATE; C-MYC; MICE; GENERATION; FIBROBLASTS	The advantages of using induced pluripotent stem cells (iPSCs) instead of embryonic stem (ES) cells in regenerative medicine centre around circumventing concerns about the ethics of using ES cells and the likelihood of immune rejection of ES-cell-derived tissues(1,2). However, partial reprogramming and genetic instabilities in iPSCs(3-6) could elicit immune responses in transplant recipients even when iPSC-derived differentiated cells are transplanted. iPSCs are first differentiated into specific types of cells in vitro for subsequent transplantation. Although model transplantation experiments have been conducted using various iPSC-derived differentiated tissues(7-10) and immune rejections have not been observed, careful investigation of the immunogenicity of iPSC-derived tissue is becoming increasingly critical, especially as this has not been the focus of most studies done so far. A recent study reported immunogenicity of iPSC- but not ES-cell-derived teratomas(11) and implicated several causative genes. Nevertheless, some controversy has arisen regarding these findings(12). Here we examine the immunogenicity of differentiated skin and bone marrow tissues derived from mouse iPSCs. To ensure optimal comparison of iPSCs and ES cells, we established ten integration-free iPSC and seven ES-cell lines using an inbred mouse strain, C57BL/6. We observed no differences in the rate of success of transplantation when skin and bone marrow cells derived from iPSCs were compared with ES-cell-derived tissues. Moreover, we observed limited or no immune responses, including T-cell infiltration, for tissues derived from either iPSCs or ES cells, and no increase in the expression of the immunogenicity-causing Zg16 and Hormad1 genes in regressing skin and teratoma tissues. Our findings suggest limited immunogenicity of transplanted cells differentiated from iPSCs and ES cells.	[Araki, Ryoko; Uda, Masahiro; Hoki, Yuko; Sunayama, Misato; Nakamura, Miki; Ando, Shunsuke; Sugiura, Mayumi; Ideno, Hisashi; Nifuji, Akira; Abe, Masumi] Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan; [Araki, Ryoko] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Ideno, Hisashi; Shimada, Akemi; Nifuji, Akira] Tsurumi Univ, Sch Dent Med, Dept Pharmacol, Yokohama, Kanagawa 2308501, Japan	National Institutes for Quantum Science & Technology; Japan Science & Technology Agency (JST); Tsurumi University	Abe, M (corresponding author), Natl Inst Radiol Sci, Transcriptome Res Grp, Chiba 2638555, Japan.	abemasum@nirs.go.jp	Nifuji, Akira/AAX-7907-2021	Nifuji, Akira/0000-0002-8182-4380; Abe, Masumi/0000-0003-1550-2006	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [22592053, 23592784] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Yamanaka for providing the 2A plasmid vectors; K. Ito, N. Nakajima and K. Kawabata for technical advice on the transplantation experiments; H. Yoshida, K. Nishikawa, A. Ishibashi, R. Watanabe, M. Nakamura and T. Maeda for technical assistance. This work was partially funded by a research grant from Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency.	Araki R, 2011, STEM CELLS, V29, P1362, DOI 10.1002/stem.685; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bubnic SJ, 2005, HEMATOLOGY, V10, P289, DOI 10.1080/10245330500093468; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chen Yao-Tseng, 2005, Cancer Immun, V5, P9; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jincho Y, 2010, J BIOL CHEM, V285, P26384, DOI 10.1074/jbc.M110.115915; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kiskinis E, 2010, J CLIN INVEST, V120, P51, DOI 10.1172/JCI40553; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Martins-Taylor K, 2012, STEM CELLS, V30, P22, DOI 10.1002/stem.705; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2011, CIRC RES, V109, P720, DOI 10.1161/RES.0b013e318232e187; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Puri MC, 2012, STEM CELLS, V30, P10, DOI 10.1002/stem.788; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Tucker BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018992; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	30	350	371	2	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					100	104		10.1038/nature11807	http://dx.doi.org/10.1038/nature11807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23302801				2022-12-28	WOS:000314741200042
J	van Nood, E; Vrieze, A; Nieuwdorp, M; Fuentes, S; Zoetendal, EG; de Vos, WM; Visser, CE; Kuijper, EJ; Bartelsman, JFWM; Tijssen, JGP; Speelman, P; Dijkgraaf, MGW; Keller, JJ				van Nood, Els; Vrieze, Anne; Nieuwdorp, Max; Fuentes, Susana; Zoetendal, Erwin G.; de Vos, Willem M.; Visser, Caroline E.; Kuijper, Ed J.; Bartelsman, Joep F. W. M.; Tijssen, Jan G. P.; Speelman, Peter; Dijkgraaf, Marcel G. W.; Keller, Josbert J.			Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTESTINAL MICROBIOTA; VANCOMYCIN; INFECTION; ANTIBODY; COLITIS; DISEASE; PROTECTION; DIVERSITY; ADJUNCT	Background Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection. Methods We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a solution of donor feces through a nasoduodenal tube; a standard vancomycin regimen (500 mg orally four times per day for 14 days); or a standard vancomycin regimen with bowel lavage. The primary end point was the resolution of diarrhea associated with C. difficile infection without relapse after 10 weeks. Results The study was stopped after an interim analysis. Of 16 patients in the infusion group, 13 (81%) had resolution of C. difficile-associated diarrhea after the first infusion. The 3 remaining patients received a second infusion with feces from a different donor, with resolution in 2 patients. Resolution of C. difficile infection occurred in 4 of 13 patients (31%) receiving vancomycin alone and in 3 of 13 patients (23%) receiving vancomycin with bowel lavage (P< 0.001 for both comparisons with the infusion group). No significant differences in adverse events among the three study groups were observed except for mild diarrhea and abdominal cramping in the infusion group on the infusion day. After donor-feces infusion, patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species. Conclusions The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin. (Funded by the Netherlands Organization for Health Research and Development and the Netherlands Organization for Scientific Research; Netherlands Trial Register number, NTR1177.)	[van Nood, Els; Vrieze, Anne; Nieuwdorp, Max; Speelman, Peter] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [Visser, Caroline E.] Univ Amsterdam, Acad Med Ctr, Dept Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Bartelsman, Joep F. W. M.; Keller, Josbert J.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Tijssen, Jan G. P.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Dijkgraaf, Marcel G. W.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Fuentes, Susana; Zoetendal, Erwin G.; de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands; [Kuijper, Ed J.] Leiden Univ, Dept Expt & Med Microbiol, Med Ctr, Leiden, Netherlands; [Keller, Josbert J.] Hagaziekenhuis, Dept Gastroenterol, The Hague, Netherlands; [de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Fac Med, Helsinki, Finland	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Haga Hospital; University of Helsinki	Keller, JJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	keller@hagaziekenhuis.nl	Kuijper, ed/AAB-7853-2022; Dijkgraaf, Marcel GW/G-6663-2011	Kuijper, ed/0000-0001-5726-2405; 	Netherlands Organization for Health Research and Development (ZonMW) [170881001]; VENI [016096044]; Netherlands Organization for Scientific Research	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); VENI(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Supported by grants from the Netherlands Organization for Health Research and Development (ZonMW, 170881001; VENI grant, MN: 016096044) and a Spinoza Award ( to Dr. de Vos) from the Netherlands Organization for Scientific Research.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Bakken JS, 2009, ANAEROBE, V15, P285, DOI 10.1016/j.anaerobe.2009.09.007; Bartlett JG, 2008, CLIN INFECT DIS, V46, P1489, DOI 10.1086/587654; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borody TJ, 2000, AM J GASTROENTEROL, V95, P3028; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; EISEMAN B, 1958, SURGERY, V44, P854; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Liacouras CA, 1996, J CLIN GASTROENTEROL, V22, P186, DOI 10.1097/00004836-199604000-00007; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Manges AR, 2010, J INFECT DIS, V202, P1877, DOI 10.1086/657319; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V272, P518; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nieuwdorp M, 2008, Ned Tijdschr Geneeskd, V152, P1927; Paltansing S, 2007, CLIN MICROBIOL INFEC, V13, P1058, DOI 10.1111/j.1469-0691.2007.01793.x; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Speelman P, 2009, EURO SURVEILL, V14; WALTERS BAJ, 1983, GUT, V24, P206, DOI 10.1136/gut.24.3.206; You DM, 2008, ANN INTERN MED, V148, P632, DOI 10.7326/0003-4819-148-8-200804150-00024; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	33	2314	2436	14	368	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					407	415		10.1056/NEJMoa1205037	http://dx.doi.org/10.1056/NEJMoa1205037			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	080BE	23323867	Bronze			2022-12-28	WOS:000314215400005
J	Booth, GH; Gruneis, A; Kresse, G; Alavi, A				Booth, George H.; Grueneis, Andreas; Kresse, Georg; Alavi, Ali			Towards an exact description of electronic wavefunctions in real solids	NATURE			English	Article							NOBEL LECTURE; SYSTEMS; APPROXIMATION; MODELS	The properties of all materials arise largely from the quantum mechanics of their constituent electrons under the influence of the electric field of the nuclei. The solution of the underlying many-electron Schrodinger equation is a 'non-polynomial hard' problem, owing to the complex interplay of kinetic energy, electron-electron repulsion and the Pauli exclusion principle. The dominant computational method for describing such systems has been density functional theory. Quantum-chemical methods-based on an explicit ansatz for the many-electron wavefunctions and, hence, potentially more accurate-have not been fully explored in the solid state owing to their computational complexity, which ranges from strongly exponential to high-order polynomial in system size. Here we report the application of an exact technique, full configuration interaction quantum Monte Carlo to a variety of real solids, providing reference many-electron energies that are used to rigorously benchmark the standard hierarchy of quantum-chemical techniques, up to the 'gold standard' coupled-cluster ansatz, including single, double and perturbative triple particle-hole excitation operators. We show the errors in cohesive energies predicted by this method to be small, indicating the potential of this computationally polynomial scaling technique to tackle current solid-state problems.	[Booth, George H.; Grueneis, Andreas; Alavi, Ali] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Grueneis, Andreas; Kresse, Georg] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Grueneis, Andreas; Kresse, Georg] Ctr Computat Mat Sci, A-1090 Vienna, Austria	University of Cambridge; University of Vienna	Booth, GH (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	ghb24@cam.ac.uk; andreas.grueneis@univie.ac.at	Booth, George/B-9029-2012; Kresse, Georg/X-2531-2018; Grüneis, Andreas/F-6607-2012	Kresse, Georg/0000-0001-9102-4259; Grüneis, Andreas/0000-0002-4984-7785	Trinity College, Cambridge; Austrian Academy of Sciences; Austrian Science fund (FWF) within the SFB ViCoM [F41]; EPSRC [EP/I014624/1, EP/J003867/1]; Engineering and Physical Sciences Research Council [EP/I014624/1, EP/J003867/1] Funding Source: researchfish	Trinity College, Cambridge; Austrian Academy of Sciences; Austrian Science fund (FWF) within the SFB ViCoM(Austrian Science Fund (FWF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	G.H.B. acknowledges support from Trinity College, Cambridge. A.G. acknowledges an APART fellowship from the Austrian Academy of Sciences. G.K. acknowledges support from the Austrian Science fund (FWF) within the SFB ViCoM (F41). A.A. acknowledges the support of the EPSRC through grants EP/I014624/1 and EP/J003867/1. The authors thank J. Spencer and A. Thom for technical contributions and discussions. Computer time on the Vienna Scientific Cluster (VSC) and HECToR (under the DEISA Extreme Computing Initiative) are acknowledged.	Al-Saidi WA, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770707; Ayala PY, 2001, J CHEM PHYS, V115, P9698, DOI 10.1063/1.1414369; Binnie SJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.165431; Booth GH, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3624383; Booth GH, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3407895; Booth GH, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3193710; Casassa S, 2007, THEOR CHEM ACC, V117, P781, DOI 10.1007/s00214-006-0198-x; CIZEK J, 1966, J CHEM PHYS, V45, P4256; Cleland DM, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3525712; Cleland D, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3302277; Cohen AJ, 2012, CHEM REV, V112, P289, DOI 10.1021/cr200107z; Cora F., 2004, DENSITY FUNCTIONAL T, P171; Csonka GI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.155107; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Gruneis A, 2011, J CHEM THEORY COMPUT, V7, P2780, DOI 10.1021/ct200263g; Gruneis A, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3466765; Hattig C, 2012, CHEM REV, V112, P4, DOI 10.1021/cr200168z; HUTCHINGS MT, 1972, PHYS REV B-SOLID ST, V6, P3447, DOI 10.1103/PhysRevB.6.3447; KNOWLES PJ, 1984, CHEM PHYS LETT, V111, P315, DOI 10.1016/0009-2614(84)85513-X; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; Kwee H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.126404; Larsen H, 2000, J CHEM PHYS, V113, P6677, DOI 10.1063/1.1311294; Manby FR, 2012, J CHEM THEORY COMPUT, V8, P2564, DOI 10.1021/ct300544e; Marsman M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3126249; Maschio L, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075101; Moller C, 1934, PHYS REV, V46, P0618, DOI 10.1103/PhysRev.46.618; Morales MA, 2012, J CHEM THEORY COMPUT, V8, P2181, DOI 10.1021/ct3003404; Muller C, 2012, PHYS CHEM CHEM PHYS, V14, P7605, DOI 10.1039/c2cp24020c; Nemec N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3288054; Nolan SJ, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/7/074201; Nolan SJ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165109; Ohnishi YY, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3455717; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pople JA, 1999, REV MOD PHYS, V71, P1267, DOI 10.1103/RevModPhys.71.1267; RAGHAVACHARI K, 1989, CHEM PHYS LETT, V157, P479, DOI 10.1016/S0009-2614(89)87395-6; Rios PL, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066701; Schimka L, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3524336; Shepherd JJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081103; Shiozaki T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3396079; Spencer JS, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3681396; Stoll H, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3687003; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Usvyat D, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3595514	44	372	375	4	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					365	370		10.1038/nature11770	http://dx.doi.org/10.1038/nature11770			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23254929	Bronze			2022-12-28	WOS:000313615900043
J	Volk, LJ; Bachman, JL; Johnson, R; Yu, YL; Huganir, RL				Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.			PKM-zeta is not required for hippocampal synaptic plasticity, learning and memory	NATURE			English	Article							PROTEIN-KINASE-M; LONG-TERM POTENTIATION; C-ZETA; ZIP; MAINTENANCE; INHIBITOR; MECHANISM; ERASURE; CELLS	Long-term potentiation (LTP), a well-characterized form of synaptic plasticity, has long been postulated as a cellular correlate of learning and memory. Although LTP can persist for long periods of time(1), the mechanisms underlying LTP maintenance, in the midst of ongoing protein turnover and synaptic activity, remain elusive. Sustained activation of the brain-specific protein kinase C (PKC) isoform protein kinase M-zeta (PKM-zeta) has been reported to be necessary for both LTP maintenance and long-term memory(2). Inhibiting PKM-zeta activity using a synthetic zeta inhibitory peptide (ZIP) based on the PKC-zeta pseudosubstrate sequence reverses established LTP in vitro and in vivo(3,4). More notably, infusion of ZIP eliminates memories for a growing list of experience-dependent behaviours, including active place avoidance(4), conditioned taste aversion(5), fear conditioning and spatial learning(6). However, most of the evidence supporting a role for PKM-zeta in LTP and memory relies heavily on pharmacological inhibition of PKM-zeta by ZIP. To further investigate the involvement of PKM-zeta in the maintenance of LTP and memory, we generated transgenic mice lacking PKC-zeta and PKM-zeta. We find that both conventional and conditional PKC zeta/PKM-zeta knockout mice show normal synaptic transmission and LTP at Schaffer collateral-CA1 synapses, and have no deficits in several hippocampal-dependent learning and memory tasks. Notably, ZIP still reverses LTP in PKC-zeta/PKM-zeta knockout mice, indicating that the effects of ZIP are independent of PKM-zeta.	[Volk, Lenora J.; Bachman, Julia L.; Johnson, Richard; Yu, Yilin; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu		Volk, Lenora/0000-0002-9074-4091	National Institute of Health [NS36715, T32MH15330]; Howard Hughes Medical Institute; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH015330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715, P30NS050274] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. Schutz for providing the CaMKII Cre-ER<SUP>T2</SUP> mice, M. Gallagher and D. Smith for advice on behaviour and M. Coulter for technical support. We also thank all members of the Huganir lab for discussion and support. This work was supported by grants from the National Institute of Health (NS36715) and the Howard Hughes Medical Institute (to R. L. H.). L.J.V. is supported by a training grant from the National Institute of Health (T32MH15330).	Abraham WC, 2002, J NEUROSCI, V22, P9626; DENNY JB, 1990, BRAIN RES, V534, P201, DOI 10.1016/0006-8993(90)90130-4; Erdmann G, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hirai T, 2003, NEUROSCI LETT, V348, P151, DOI 10.1016/S0304-3940(03)00780-8; Huang Y Y, 1994, Learn Mem, V1, P74; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Krotova K, 2006, BRIT J PHARMACOL, V148, P732, DOI 10.1038/sj.bjp.0706777; Kwapis JL, 2009, BEHAV NEUROSCI, V123, P844, DOI 10.1037/a0016343; Lim S, 2008, LIFE SCI, V82, P733, DOI 10.1016/j.lfs.2008.01.005; Ling DSF, 2006, HIPPOCAMPUS, V16, P443, DOI 10.1002/hipo.20171; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Makuch L, 2011, NEURON, V71, P1022, DOI 10.1016/j.neuron.2011.08.017; McEchron MD, 1998, HIPPOCAMPUS, V8, P638, DOI 10.1002/(SICI)1098-1063(1998)8:6<638::AID-HIPO6>3.0.CO;2-Q; Mei F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021568; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sacktor TC, 2012, HIPPOCAMPUS, V22, P645, DOI 10.1002/hipo.20978; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Sajikumar S, 2005, J NEUROSCI, V25, P5750, DOI 10.1523/JNEUROSCI.1104-05.2005; Sajikumar S, 2011, P NATL ACAD SCI USA, V108, P2551, DOI 10.1073/pnas.1016849108; Serrano P, 2005, J NEUROSCI, V25, P1979, DOI 10.1523/JNEUROSCI.5132-04.2005; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shema R, 2011, SCIENCE, V331, P1207, DOI 10.1126/science.1200215; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	28	218	223	0	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					420	U169		10.1038/nature11802	http://dx.doi.org/10.1038/nature11802			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283174	Green Accepted			2022-12-28	WOS:000313615900055
J	Di Meglio, T; Kratochwil, CF; Vilain, N; Loche, A; Vitobello, A; Yonehara, K; Hrycaj, SM; Roska, B; Peters, AHFM; Eichmann, A; Wellik, D; Ducret, S; Rijli, FM				Di Meglio, Thomas; Kratochwil, Claudius F.; Vilain, Nathalie; Loche, Alberto; Vitobello, Antonio; Yonehara, Keisuke; Hrycaj, Steven M.; Roska, Botond; Peters, Antoine H. F. M.; Eichmann, Anne; Wellik, Deneen; Ducret, Sebastien; Rijli, Filippo M.			Ezh2 Orchestrates Topographic Migration and Connectivity of Mouse Precerebellar Neurons	SCIENCE			English	Article							GUIDANCE; COMPLEX	We investigated the role of histone methyltransferase Ezh2 in tangential migration of mouse precerebellar pontine nuclei, the main relay between neocortex and cerebellum. By counteracting the sonic hedgehog pathway, Ezh2 represses Netrin1 in dorsal hindbrain, which allows normal pontine neuron migration. In Ezh2 mutants, ectopic Netrin1 derepression results in abnormal migration and supernumerary nuclei integrating in brain circuitry. Moreover, intrinsic topographic organization of pontine nuclei according to rostrocaudal progenitor origin is maintained throughout migration and correlates with patterned cortical input. Ezh2 maintains spatially restricted Hox expression, which, in turn, regulates differential expression of the repulsive receptor Unc5b in migrating neurons; together, they generate subsets with distinct responsiveness to environmental Netrin1. Thus, Ezh2-dependent epigenetic regulation of intrinsic and extrinsic transcriptional programs controls topographic neuronal guidance and connectivity in the cortico-ponto-cerebellar pathway.	[Di Meglio, Thomas; Kratochwil, Claudius F.; Vilain, Nathalie; Loche, Alberto; Vitobello, Antonio; Yonehara, Keisuke; Roska, Botond; Peters, Antoine H. F. M.; Ducret, Sebastien; Rijli, Filippo M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; [Kratochwil, Claudius F.; Loche, Alberto; Vitobello, Antonio; Roska, Botond; Peters, Antoine H. F. M.; Rijli, Filippo M.] Univ Basel, CH-4056 Basel, Switzerland; [Hrycaj, Steven M.; Eichmann, Anne] Yale Univ, Sch Med, Dept Internal Med, Yale Cardiovasc Res Ctr, New Haven, CT 06511 USA; [Eichmann, Anne] INSERM, CIRB, U1050, F-75005 Paris, France; [Wellik, Deneen] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	Friedrich Miescher Institute for Biomedical Research; University of Basel; Yale University; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Michigan System; University of Michigan	Rijli, FM (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	filippo.rijli@fmi.ch	Vitobello, Antonio/ABC-2970-2021; Kratochwil, Claudius F/B-1294-2013; Roska, Botond/AAD-7268-2021; Peters, Antoine/ABA-6283-2020; RIJLI, Filippo/AAP-2516-2020	Vitobello, Antonio/0000-0003-3717-8374; Kratochwil, Claudius F/0000-0002-5646-3114; RIJLI, Filippo/0000-0003-0515-0182; Peters, Antoine/0000-0002-0311-1887; Yonehara, Keisuke/0000-0001-9541-6671; Loche, Alberto/0000-0001-5974-6008	European Molecular Biology Organization Long-Term Fellowship; Swiss National Science Foundation [Sinergia CRSI33_127440]; Association pour la Recherche sur la Sclerose en Plaques; Novartis Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061402] Funding Source: NIH RePORTER	European Molecular Biology Organization Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Association pour la Recherche sur la Sclerose en Plaques; Novartis Research Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank K. Balint, F. Boukhtouche, Y.-Y. Lee, C.-Y. Liang, D. Kraus, T. Mathivet, F. Santagati, J. F. Spetz, and A. Yallowitz for technical support and discussion. We are grateful to M. Tessier-Lavigne, S. H. Orkin, E. Callaway, V. Castellani, P. Mehlen, O. Nyabi, and J. Haigh for gifts of mouse lines, probes, or reagents. The mouse transgenic lines r5-6::Cre, Hoxa2::Cre, r5post::Cre, r7post::Cre, MafB::CreERT2, Hoxa5::Cre, ROSA26::(lox-STOPlox) Hoxa2-IRES-EGFP generated in this research and their respective DNA constructs are available from F. M. R. under a material transfer agreement with the Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland. The SAD G-eGFP and SAD G-mCherry G-deleted rabies viruses used in this research are available from E. M. Callaway under a material transfer agreement with Salk Institute for Biological Studies, La Jolla, CA, USA. T. D. is the recipient of a European Molecular Biology Organization Long-Term Fellowship. Work in F.M.R.'s laboratory is supported by the Swiss National Science Foundation (Sinergia CRSI33_127440), Association pour la Recherche sur la Sclerose en Plaques, and the Novartis Research Foundation.	ALTMAN J, 1987, J COMP NEUROL, V257, P529, DOI 10.1002/cne.902570405; Bloch-Gallego E, 1999, J NEUROSCI, V19, P4407; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Leergaard TB, 2007, FRONT NEUROSCI-SWITZ, V1, P211, DOI 10.3389/neuro.01.1.1.016.2007; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Nobrega-Pereira S, 2009, CEREB CORTEX, V19, pI107, DOI 10.1093/cercor/bhp044; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Yee KT, 1999, NEURON, V24, P607, DOI 10.1016/S0896-6273(00)81116-2	16	83	84	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					204	207		10.1126/science.1229326	http://dx.doi.org/10.1126/science.1229326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307742	Green Accepted			2022-12-28	WOS:000313328200044
J	Greer, DM; Robbins, GK; Lijewski, V; Gonzales, RG; McGuone, D				Greer, David M.; Robbins, Gregory K.; Lijewski, Virginia; Gonzales, R. Gilberto; McGuone, Declan			Case 1-2013: A 63-Year-Old Man with Paresthesias and Difficulty Swallowing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN RABIES; MANAGEMENT; DIAGNOSIS; INDUCTION; BOTULISM; HUMANS; COMA		[Greer, David M.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Robbins, Gregory K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Gonzales, R. Gilberto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [McGuone, Declan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Robbins, Gregory K.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Gonzales, R. Gilberto] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [McGuone, Declan] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lijewski, Virginia] Massachusetts Dept Publ Hlth, Div Epidemiol & Immunizat, Boston, MA USA	Yale University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Department of Public Health	Greer, DM (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.			Robbins, Gregory/0000-0001-7545-5817; Greer, David/0000-0002-2026-8333				ANDERSON LJ, 1984, ANN INTERN MED, V100, P728, DOI 10.7326/0003-4819-100-5-728; Brathen G, 1999, EUR J NEUROL, V6, P697, DOI 10.1046/j.1468-1331.1999.660697.x; BRYCESON AD, 1975, J INFECT DIS, V131, P71, DOI 10.1093/infdis/131.1.71; Gibbons RV, 2002, ANN EMERG MED, V39, P528, DOI 10.1067/mem.2002.121521; HAALAND KY, 1980, ARCH NEUROL-CHICAGO, V37, P657, DOI 10.1001/archneur.1980.00500590081014; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hu WT, 2007, NEW ENGL J MED, V357, P945, DOI 10.1056/NEJMc062479; HUGHES JM, 1981, ANN INTERN MED, V95, P442, DOI 10.7326/0003-4819-95-4-442; Human rabies - Indiana and California, 2006, MMWR MORB MORTAL WKL, V56, P361; Jackson AC, 2003, CLIN INFECT DIS, V36, P60, DOI 10.1086/344905; JACKSON AC, 2007, RABIES, P309; Kiroglu Y, 2006, NEURORADIOLOGY, V48, P875, DOI 10.1007/s00234-006-0143-7; KURDI A, 1979, J NEUROL SCI, V42, P243, DOI 10.1016/0022-510X(79)90055-8; Laothamatas J, 2011, ADV VIRUS RES, V79, P309, DOI 10.1016/B978-0-12-387040-7.00014-7; Mani CS, 2006, PEDIATR REV, V27, P129, DOI 10.1542/pir.27-4-129; UDWADIA FE, 1992, Q J MED, V83, P449; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382; 2008, MMWR RECOMM REP, V57, P1	19	13	13	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					172	180		10.1056/NEJMcpc1209935	http://dx.doi.org/10.1056/NEJMcpc1209935			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301735				2022-12-28	WOS:000313238100009
J	Balbus, JM; Barouki, R; Birnbaum, LS; Etzel, RA; Gluckman, PD; Grandjean, P; Hancock, C; Hanson, MA; Heindel, JJ; Hoffman, K; Jensen, GK; Keeling, A; Neira, M; Rabadan-Diehl, C; Ralston, J; Tang, KC				Balbus, John M.; Barouki, Robert; Birnbaum, Linda S.; Etzel, Ruth A.; Gluckman, Peter D.; Grandjean, Philippe; Hancock, Christine; Hanson, Mark A.; Heindel, Jerrold J.; Hoffman, Kate; Jensen, Genon K.; Keeling, Ann; Neira, Maria; Rabadan-Diehl, Cristina; Ralston, Johanna; Tang, Kwok-Cho			Early-life prevention of non-communicable diseases	LANCET			English	Editorial Material							CHILDHOOD; HEALTH		[Balbus, John M.] NIEHS, NIH, Bethesda, MD 20892 USA; [Barouki, Robert] Univ Paris 05, Paris, France; [Birnbaum, Linda S.] NIEHS, Natl Technol Program, Res Triangle Pk, NC 27709 USA; [Heindel, Jerrold J.] NIEHS, Div Extramural Res & Training, Res Triangle Pk, NC 27709 USA; [Etzel, Ruth A.] Univ Wisconsin, Joseph J Zilber Sch Publ Hlth, Madison, WI 53706 USA; [Gluckman, Peter D.] Univ Auckland, Auckland 1, New Zealand; [Grandjean, Philippe] Univ So Denmark, Odense, Denmark; [Hancock, Christine] C3 Collaborating Hlth, London, England; [Hanson, Mark A.] Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England; [Hoffman, Kate] Social & Sci Syst, Durham, NC USA; [Hoffman, Kate] Univ N Carolina, Chapel Hill, NC USA; [Jensen, Genon K.] Hlth & Environm Alliance, Brussels, Belgium; [Keeling, Ann] Int Diabet Federat, Brussels, Belgium; [Neira, Maria; Tang, Kwok-Cho] WHO, CH-1211 Geneva, Switzerland; [Rabadan-Diehl, Cristina] NHLBI, NIH, Bethesda, MD 20892 USA; [Ralston, Johanna] World Heart Federat, Geneva, Switzerland	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Wisconsin System; University of Wisconsin Madison; University of Auckland; University of Southern Denmark; University of Southampton; Social & Scientific Systems; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Balbus, JM (corresponding author), NIEHS, NIH, 31 Ctr Dr,Room B1CO2, Bethesda, MD 20892 USA.	john.balbus@nih.gov	Etzel, Ruth A./N-5700-2019; Hanson, Mark/AAE-8236-2019; Grandjean, Philippe/I-2962-2014	Etzel, Ruth A./0000-0002-5236-3976; Hanson, Mark/0000-0002-6907-613X; hoffman, kate/0000-0001-8029-7710; Birnbaum, Linda/0000-0001-5429-5658; Grandjean, Philippe/0000-0003-4046-9658	NIEHS NIH HHS [R01 ES012199, T32 ES007018] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007018, R01ES012199] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barouki R, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-42; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Gale CR, 2006, ARTERIOSCL THROM VAS, V26, P1877, DOI 10.1161/01.ATV.0000228819.13039.b8; Godfrey KM, 1998, EUR J OBSTET GYN R B, V78, P141, DOI 10.1016/S0301-2115(98)00060-8; Hou LF, 2012, INT J EPIDEMIOL, V41, P79, DOI 10.1093/ije/dyr154; Perera F, 2011, REPROD TOXICOL, V31, P363, DOI 10.1016/j.reprotox.2010.12.055; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Skinner MK, 2011, REPROD TOXICOL, V31, P337, DOI 10.1016/j.reprotox.2010.10.012; UN,, 2012, ARES66288 UN; United Nations, 2011, MILL DEV GOALS REP 2; United Nations, 2011, NCDS MDGS SUCC SYN; WHO, 2010, GLOB STAT REP NONC D	12	108	110	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					3	4		10.1016/S0140-6736(12)61609-2	http://dx.doi.org/10.1016/S0140-6736(12)61609-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	064AW	23290956	Green Accepted, Green Submitted			2022-12-28	WOS:000313044300004
J	Flegal, KM; Kit, BK; Orpana, H; Graubard, BI				Flegal, Katherine M.; Kit, Brian K.; Orpana, Heather; Graubard, Barry I.			Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index Categories A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-ARTERY-DISEASE; LONG-TERM MORTALITY; SELF-REPORTED WEIGHT; LIFE-STYLE; RISK-FACTORS; FOLLOW-UP; CARDIOVASCULAR-DISEASE; PROSPECTIVE COHORT; CARDIORESPIRATORY FITNESS; WAIST CIRCUMFERENCE	Importance Estimates of the relative mortality risks associated with normal weight, overweight, and obesity may help to inform decision making in the clinical setting. Objective To perform a systematic review of reported hazard ratios (HRs) of all-cause mortality for overweight and obesity relative to normal weight in the general population. Data Sources PubMed and EMBASE electronic databases were searched through September 30, 2012, without language restrictions. Study Selection Articles that reported HRs for all-cause mortality using standard body mass index (BMI) categories from prospective studies of general populations of adults were selected by consensus among multiple reviewers. Studies were excluded that used nonstandard categories or that were limited to adolescents or to those with specific medical conditions or to those undergoing specific procedures. PubMed searches yielded 7034 articles, of which 141 (2.0%) were eligible. An EMBASE search yielded 2 additional articles. After eliminating overlap, 97 studies were retained for analysis, providing a combined sample size of more than 2.88 million individuals and more than 270 000 deaths. Data Extraction Data were extracted by 1 reviewer and then reviewed by 3 independent reviewers. We selected the most complex model available for the full sample and used a variety of sensitivity analyses to address issues of possible overadjustment (adjusted for factors in causal pathway) or underadjustment (not adjusted for at least age, sex, and smoking). Results Random-effects summary all-cause mortality HRs for overweight (BMI of 25-<30), obesity (BMI of >= 30), grade 1 obesity (BMI of 30-<35), and grades 2 and 3 obesity (BMI of >= 35) were calculated relative to normal weight (BMI of 18.5-<25). The summary HRs were 0.94 (95% CI, 0.91-0.96) for overweight, 1.18 (95% CI, 1.12-1.25) for obesity (all grades combined), 0.95 (95% CI, 0.88-1.01) for grade 1 obesity, and 1.29 (95% CI, 1.18-1.41) for grades 2 and 3 obesity. These findings persisted when limited to studies with measured weight and height that were considered to be adequately adjusted. The HRs tended to be higher when weight and height were self-reported rather than measured. Conclusions and Relevance Relative to normal weight, both obesity (all grades) and grades 2 and 3 obesity were associated with significantly higher all-cause mortality. Grade 1 obesity overall was not associated with higher mortality, and overweight was associated with significantly lower all-cause mortality. The use of predefined standard BMI groupings can facilitate between-study comparisons.	[Flegal, Katherine M.; Kit, Brian K.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Orpana, Heather] Univ Ottawa, Sch Psychol, Ottawa, ON K1N 6N5, Canada; [Graubard, Barry I.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of Ottawa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4336, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013; alzahrani, saud hamed/C-2014-2012; Orpana, Heather/A-2215-2008	Orpana, Heather/0000-0001-9982-981X; Flegal, Katherine/0000-0002-0838-469X	Intramural CDC HHS [CC999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIACP010181] Funding Source: NIH RePORTER	Intramural CDC HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Al Snih S, 2007, ARCH INTERN MED, V167, P774, DOI 10.1001/archinte.167.8.774; Arndt V, 2007, J OCCUP ENVIRON MED, V49, P913, DOI 10.1097/JOM.0b013e31814544fe; Arnlov J, 2010, CIRCULATION, V121, P230, DOI 10.1161/CIRCULATIONAHA.109.887521; Atlantis E, 2010, AGE AGEING, V39, P643, DOI 10.1093/ageing/afq073; Auyeung TW, 2010, J GERONTOL A-BIOL, V65, P99, DOI 10.1093/gerona/glp099; Baldinger Beatrice, 2006, J Insur Med, V38, P44; Batty GD, 2006, HEART, V92, P886, DOI 10.1136/hrt.2005.072637; Bellocco R, 2010, EUR J EPIDEMIOL, V25, P777, DOI 10.1007/s10654-010-9497-6; Bessonova L, 2011, INT J CANCER, V129, P2492, DOI 10.1002/ijc.25905; Bevilacqua MR, 2011, CAD SAUDE PUBLICA, V27, P1986, DOI 10.1590/S0102-311X2011001000012; Blain H, 2010, J NUTR HEALTH AGING, V14, P595, DOI 10.1007/s12603-010-0111-0; Boggs DA, 2011, NEW ENGL J MED, V365, P901, DOI 10.1056/NEJMoa1104119; Cabrera Marcos A. S., 2005, Cad. Saúde Pública, V21, P767, DOI 10.1590/S0102-311X2005000300010; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carlsson S, 2011, EPIDEMIOLOGY, V22, P98, DOI 10.1097/EDE.0b013e3181fce2a2; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chang VW, 2010, JAMA-J AM MED ASSOC, V303, P1274, DOI 10.1001/jama.2010.339; Chiolero A, 2007, OBES REV, V8, P373, DOI 10.1111/j.1467-789X.2007.00375.x; Cohen SS, 2012, AM J EPIDEMIOL, V176, P431, DOI 10.1093/aje/kws032; Corrada MM, 2006, AM J EPIDEMIOL, V163, P938, DOI 10.1093/aje/kwj114; Crespo CJ, 2002, ANN EPIDEMIOL, V12, P543, DOI 10.1016/S1047-2797(01)00296-4; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Faeh D, 2011, EUR J EPIDEMIOL, V26, P647, DOI 10.1007/s10654-011-9593-2; Fang Xianghua, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P28; Farrell SW, 2002, OBES RES, V10, P417, DOI 10.1038/oby.2002.58; Ferrie JE, 2009, HEART, V95, P1250, DOI 10.1136/hrt.2008.164251; Flegal KM, 2007, AM J EPIDEMIOL, V166, P975, DOI 10.1093/aje/kwm152; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flicker L, 2010, J AM GERIATR SOC, V58, P234, DOI 10.1111/j.1532-5415.2009.02677.x; Fontaine KR, 2012, INT J OBESITY, V36, P1121, DOI 10.1038/ijo.2011.194; Ford J, 2008, AGE AGEING, V37, P194, DOI 10.1093/ageing/afm171; Freedman DM, 2006, AM J PREV MED, V31, P355, DOI 10.1016/j.amepre.2006.07.022; Froslie KF, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-103; Fujino Y, 2007, ASIAN PAC J CANCER P, V8, P105; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Gelber RP, 2007, INT J OBESITY, V31, P1240, DOI 10.1038/sj.ijo.0803564; Gillum RF, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-27; Gray L, 2010, EUR J CARDIOV PREV R, V17, P106, DOI 10.1097/HJR.0b013e3283348ed9; Greenberg JA, 2007, INT J OBESITY, V31, P1449, DOI 10.1038/sj.ijo.0803615; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Haapanen-Niemi N, 2000, INT J OBESITY, V24, P1465, DOI 10.1038/sj.ijo.0801426; Hahn S, 2000, STAT MED, V19, P3325, DOI 10.1002/1097-0258(20001230)19:24<3325::AID-SIM827>3.0.CO;2-D; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hastie CE, 2010, EUR HEART J, V31, P222, DOI 10.1093/eurheartj/ehp317; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Heir T, 2011, PREV MED, V52, P223, DOI 10.1016/j.ypmed.2011.01.010; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hjartaker A, 2005, EUR J EPIDEMIOL, V20, P747, DOI 10.1007/s10654-005-2145-x; Hotchkiss JW, 2011, INT J OBESITY, V35, P838, DOI 10.1038/ijo.2010.207; Hu G, 2005, INT J OBESITY, V29, P894, DOI 10.1038/sj.ijo.0802870; Ioachimescu AG, 2010, OBESITY, V18, P1836, DOI 10.1038/oby.2009.453; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Iribarren C, 2005, SOC SCI MED, V60, P471, DOI 10.1016/j.socscimed.2004.06.007; Iversen L, 2010, BRIT J GEN PRACT, V60, P563, DOI 10.3399/bjgp10X515052; Jacobs EJ, 2010, ARCH INTERN MED, V170, P1293, DOI 10.1001/archinternmed.2010.201; Janssen I, 2007, OBES REV, V8, P41, DOI 10.1111/j.1467-789X.2006.00248.x; Janssen I, 2008, OBESITY, V16, P2504, DOI 10.1038/oby.2008.400; Janssen I, 2007, OBESITY, V15, P1827, DOI 10.1038/oby.2007.217; Jee SH, 2006, NEW ENGL J MED, V355, P779, DOI 10.1056/NEJMoa054017; Jerant A, 2012, J AM BOARD FAM MED, V25, P422, DOI 10.3122/jabfm.2012.04.110289; Jonsson S, 2002, INT J OBESITY, V26, P1046, DOI 10.1038/sj.ijo.0802060; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Katzmarzyk PT, 2001, J CLIN EPIDEMIOL, V54, P916, DOI 10.1016/S0895-4356(01)00356-0; Keller HH, 2005, J NUTR HEALTH AGING, V9, P316; Klenk J, 2009, EUR J EPIDEMIOL, V24, P83, DOI 10.1007/s10654-009-9312-4; Krueger PM, 2004, RES AGING, V26, P82, DOI 10.1177/0164027503258518; Lahmann PH, 2002, OBES RES, V10, P361, DOI 10.1038/oby.2002.50; Lainscak M, 2012, J CACHEXIA SARCOPENI, V3, P1, DOI 10.1007/s13539-012-0059-5; Lakoski SG, 2011, J CLIN ENDOCR METAB, V96, P1805, DOI 10.1210/jc.2010-3055; Lang IA, 2008, J AM GERIATR SOC, V56, P1474, DOI 10.1111/j.1532-5415.2008.01813.x; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; Lawlor DA, 2006, OBESITY, V14, P2294, DOI 10.1038/oby.2006.269; Leitzmann MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018582; Lisko I, 2011, J GERONTOL A-BIOL, V66, P1244, DOI 10.1093/gerona/glr147; Locher JL, 2007, J GERONTOL A-BIOL, V62, P1389, DOI 10.1093/gerona/62.12.1389; Lubin F, 2003, J NUTR, V133, P1180, DOI 10.1093/jn/133.4.1180; Luchsinger JA, 2008, J NUTR HEALTH AGING, V12, P127, DOI 10.1007/BF02982565; Ma JM, 2011, AM J EPIDEMIOL, V174, P934, DOI 10.1093/aje/kwr169; Majer IM, 2011, OBESITY, V19, P1451, DOI 10.1038/oby.2011.46; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; McAuley PA, 2010, MAYO CLIN PROC, V85, P115, DOI 10.4065/mcp.2009.0562; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; Mehta NK, 2009, DEMOGRAPHY, V46, P851, DOI 10.1353/dem.0.0077; Miller MD, 2002, J AM GERIATR SOC, V50, P1272, DOI 10.1046/j.1532-5415.2002.50316.x; Monteverde M, 2010, DEMOGRAPHY, V47, P79, DOI 10.1353/dem.0.0085; Nagai M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000940; National Health Service Information Centre, HLTH SURV ENGL 2010; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; Niedhammer I, 2011, EUR J EPIDEMIOL, V26, P1, DOI 10.1007/s10654-010-9506-9; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Oreopoulos A, 2009, EUR HEART J, V30, P2584, DOI 10.1093/eurheartj/ehp288; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Osler M, 2001, J EPIDEMIOL COMMUN H, V55, P399, DOI 10.1136/jech.55.6.399; Patsopoulos NA, 2008, INT J EPIDEMIOL, V37, P1148, DOI 10.1093/ije/dyn065; Pednekar MS, 2008, INT J EPIDEMIOL, V37, P524, DOI 10.1093/ije/dyn001; Petursson H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026621; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Plankey MW, 1997, OBES RES, V5, P308, DOI 10.1002/j.1550-8528.1997.tb00556.x; Public Health Agency of Canada and the Canadian Institute for Health Information, OB CAN JOINT REP PUB; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Schenkeveld L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000535; Seccareccia F, 1998, J EPIDEMIOL COMMUN H, V52, P20, DOI 10.1136/jech.52.1.20; Seidell JC, 1996, ARCH INTERN MED, V156, P958, DOI 10.1001/archinte.156.9.958; Simpson JA, 2007, OBESITY, V15, P994, DOI 10.1038/oby.2007.622; Sonestedt E, 2011, INT J OBESITY, V35, P1041, DOI 10.1038/ijo.2010.263; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Steinberg BA, 2007, AM J CARDIOL, V100, P1331, DOI 10.1016/j.amjcard.2007.06.019; Stessman J, 2009, J AM GERIATR SOC, V57, P2232, DOI 10.1111/j.1532-5415.2009.02567.x; Stevens J, 2000, J AM DIET ASSOC, V100, P825, DOI 10.1016/S0002-8223(00)00238-8; Strawbridge WJ, 2000, AM J PUBLIC HEALTH, V90, P340, DOI 10.2105/AJPH.90.3.340; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Suadicani P, 2009, METAB SYNDR RELAT D, V7, P97, DOI 10.1089/met.2008.0041; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Takata Y, 2007, J AM GERIATR SOC, V55, P913, DOI 10.1111/j.1532-5415.2007.01170.x; Taylor DH, 2001, J AM GERIATR SOC, V49, P1319, DOI 10.1046/j.1532-5415.2001.49259.x; Tice JA, 2006, ARCH INTERN MED, V166, P2469, DOI 10.1001/archinte.166.22.2469; Tsai SP, 2008, DIABETES RES CLIN PR, V82, P148, DOI 10.1016/j.diabres.2008.07.016; Tsai SP, 2006, J OCCUP ENVIRON MED, V48, P22, DOI 10.1097/01.jom.0000184866.49000.e5; Uretsky S, 2010, J NUCL CARDIOL, V17, P390, DOI 10.1007/s12350-010-9214-6; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Zunzunegui MV, 2012, J AGING HEALTH, V24, P29, DOI 10.1177/0898264311408419; Visscher TLS, 2004, ARCH INTERN MED, V164, P1413, DOI 10.1001/archinte.164.13.1413; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Wandell PE, 2009, INT J OBESITY, V33, P577, DOI 10.1038/ijo.2009.36; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wannamethee SG, 2007, AM J CLIN NUTR, V86, P1339, DOI 10.1093/ajcn/86.5.1339; Weitoft GR, 2008, SCAND J PUBLIC HEALT, V36, P169, DOI 10.1177/1403494807085080; Welch HG, 2005, CAN MED ASSOC J, V172, P891, DOI 10.1503/cmaj.1041310; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	138	2393	2479	17	382	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					71	82		10.1001/jama.2012.113905	http://dx.doi.org/10.1001/jama.2012.113905			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	146TB	23280227	Green Accepted, Bronze			2022-12-28	WOS:000319113000029
J	Weeks, WB; Rauh, SS; Wadsworth, EB; Weinstein, JN				Weeks, William B.; Rauh, Stephen S.; Wadsworth, Eric B.; Weinstein, James N.			The Unintended Consequences of Bundled Payments	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICARE; CARE	Consensus is building that episode-based bundled payments can produce substantial Medicare savings, and the Center for Medicare & Medicaid Innovation's Bundled Payment Initiative endorses this concept. The program generates potential cost savings by reducing the historic cost of time-defined episodes of care, provided through a discount. Although bundled payments can reduce waste primarily in the postacute care setting, concerns arise that, in an effort to maintain income levels that are necessary to cover fixed costs, providers may change their behaviors to increase the volume of episodes. Such actions would mitigate the savings that Medicare might have accrued and may perpetuate the fee-for-service payment mechanism, with episodes of care becoming the new service. Although bundled payments have some advantages over the current reimbursement system, true cost-savings to Medicare will be realized only when the federal government addresses the use issue that underlies much of the waste inherent in the system and provides ample incentives to eliminate capacity and move toward capitation. Ann Intern Med. 2013;158:62-64.	[Weeks, William B.] Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, Lebanon, NH 03766 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA; Stephen Rauh Consulting, Montpelier, VT USA	Dartmouth College; Dartmouth College	Weeks, WB (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, 35 Centerra Pkwy,Room 213, Lebanon, NH 03766 USA.	wbw@dartmouth.edu	Weeks, WB/G-7436-2014					American Institutes for Research, 2012, BUNDL PAYM CAR IMPR; Cutler DM, 2012, NEW ENGL J MED, V366, P1075, DOI 10.1056/NEJMp1113361; Guram JS, 2012, NEW ENGL J MED, V366, P1177, DOI 10.1056/NEJMp1114019; Hussey PS, 2009, NEW ENGL J MED, V361, P2109, DOI 10.1056/NEJMp0910315; Joynt KE, 2012, NEW ENGL J MED, V366, P1366, DOI 10.1056/NEJMp1201598; Nguyen NX, 1997, HEALTH SERV RES, V32, P283; Rauh Stephen S, 2011, N Engl J Med, V365, pe48, DOI 10.1056/NEJMp1111662; Weinberger Stanley, 2004, J Health Care Finance, V31, P53; Welch H, 2011, OVERDIAGNOSED MAKING; Wennberg JE, 2007, HEALTH AFFAIR, V26, P1575, DOI 10.1377/hlthaff.26.6.1575	10	48	48	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					62	U136		10.7326/0003-4819-158-1-201301010-00012	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277901				2022-12-28	WOS:000313119900010
J	Tucker, ME				Tucker, Miriam E.			US drug shortages: a disappearing problem?	BRITISH MEDICAL JOURNAL			English	Editorial Material												miriametucker@aol.com						American Society of Anesthesiologists, 2012, 2012 ASA DRUG SHORT; FDA, IMP AM SHUTD REC DRU; Generic Pharmaceutical Association, DRUG SHORT; Government Accountability Office, 2011, DRUG SHORT FDAS AB R; Silverman E, 2012, PHARMALOT       1211	5	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 21	2012	345								e8551	10.1136/bmj.e8551	http://dx.doi.org/10.1136/bmj.e8551			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23261759				2022-12-28	WOS:000312701700024
J	Muraskin, W				Muraskin, William			Polio eradication was an ideological project	BRITISH MEDICAL JOURNAL			English	Editorial Material									CUNY Queens Coll, Dept Urban Studies, Flushing, NY 11367 USA	City University of New York (CUNY) System; Queens College NY (CUNY)	Muraskin, W (corresponding author), CUNY Queens Coll, Dept Urban Studies, Flushing, NY 11367 USA.	william.muraskin@qc.cuny.edu						Muraskin William, 2012, POLIO ERADICATION IT	1	3	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8545	10.1136/bmj.e8545	http://dx.doi.org/10.1136/bmj.e8545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255583				2022-12-28	WOS:000312700100009
J	Zhou, HH; Sun, LT; Yang, XL; Schimmel, P				Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul			ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase	NATURE			English	Article							HALOFUGINONE; ADENYLATE; ASSAYS	Febrifugine is the active component of the Chinese herb Chang Shan (Dichroa febrifuga Lour.)(1,2), which has been used for treating malaria-induced fever for about 2,000 years. Halofuginone (HF), the halogenated derivative of febrifugine, has been tested in clinical trials for potential therapeutic applications in cancer and fibrotic disease(3-6). Recently, HF was reported to inhibit T(H)17 cell differentiation by activating the amino acid response pathway(7), through inhibiting human prolyl-transfer RNA synthetase (ProRS) to cause intracellular accumulation of uncharged tRNA(8,9). Curiously, inhibition requires the presence of unhydrolysed ATP. Here we report an unusual 2.0 angstrom structure showing that ATP directly locks onto and orients two parts of HF onto human ProRS, so that one part of HF mimics bound proline and the other mimics the 3' end of bound tRNA. Thus, HF is a new type of ATP-dependent inhibitor that simultaneously occupies two different substrate binding sites on ProRS. Moreover, our structure indicates a possible similar mechanism of action for febrifugine in malaria treatment. Finally, the elucidation here of a two-site modular targeting activity of HF raises the possibility that substrate-directed capture of similar inhibitors might be a general mechanism that could be applied to other synthetases.	[Zhou, Huihao; Sun, Litao; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	ZHOU, HUIHAO/L-6133-2016; Yang, Xiang-Lei/AAR-7107-2020	ZHOU, HUIHAO/0000-0002-9675-5007; SUN, LITAO/0000-0002-8415-989X; Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM15539, GM23562, GM88278]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088278, R01GM015539, R37GM015539, R01GM023562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Musier-Forsyth for providing the ProRS gene plasmid and Pro-SA, staff at beamline 7-1 of Stanford Synchrotron Radiation Lightsource for assistance in X-ray diffraction data collection, and M. Guo for comments. This work was supported by National Institutes of Health grants GM15539, GM23562 and GM88278 and by a fellowship from the National Foundation for Cancer Research.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Beebe K, 2007, ANAL BIOCHEM, V368, P111, DOI 10.1016/j.ab.2007.05.013; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Coatney G. R., 1950, Journal of the National Malaria Society, V9, P183; de Jonge MJA, 2006, EUR J CANCER, V42, P1768, DOI 10.1016/j.ejca.2005.12.027; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hill JM, 1998, U. S. Patent, Patent No. [5,824,657, 5824657]; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kilberg MS, 2005, ANNU REV NUTR, V25, P59, DOI 10.1146/annurev.nutr.24.012003.132145; KOEPFLI JB, 1947, J AM CHEM SOC, V69, P1837, DOI 10.1021/ja01199a513; Koon HB, 2011, JAIDS-J ACQ IMM DEF, V56, P64, DOI 10.1097/QAI.0b013e3181fc0141; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pines A, 2003, BIOL BLOOD MARROW TR, V9, P417, DOI 10.1016/S1083-8791(03)00151-4; Pines M, 1998, GEN PHARMACOL, V30, P445, DOI 10.1016/S0306-3623(97)00307-8; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Sankaranarayanan R, 1999, CELL, V97, P371, DOI 10.1016/S0092-8674(00)80746-1; Schimmel P, 1998, FASEB J, V12, P1599, DOI 10.1096/fasebj.12.15.1599; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Yaremchuk A, 2001, J MOL BIOL, V309, P989, DOI 10.1006/jmbi.2001.4712; Zhu SR, 2009, BIOORGAN MED CHEM, V17, P4496, DOI 10.1016/j.bmc.2009.05.011	21	105	116	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 7	2013	494	7435					121	124		10.1038/nature11774	http://dx.doi.org/10.1038/nature11774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	087DJ	23263184	Green Accepted			2022-12-28	WOS:000314741200046
J	Guiver, MD; Lee, YM				Guiver, Michael D.; Lee, Young Moo			Polymer Rigidity Improves Microporous Membranes	SCIENCE			English	Editorial Material							INTRINSIC MICROPOROSITY; GAS SEPARATION		[Guiver, Michael D.] Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada; [Guiver, Michael D.; Lee, Young Moo] Hanyang Univ, Dept Energy Engn, WCU, Seoul 133791, South Korea	National Research Council Canada; Hanyang University	Guiver, MD (corresponding author), Natl Res Council Canada, Ottawa, ON K1A 0R6, Canada.	michael.guiver@nrc-cnrc.gc.ca; ymlee@hanyang.ac.kr	Lee, Young Moo/G-5920-2015; Guiver, Michael/I-3248-2016	Lee, Young Moo/0000-0002-5047-3143; Guiver, Michael/0000-0003-2619-6809				Bezzu CG, 2012, ADV MATER, V24, P5930, DOI 10.1002/adma.201202393; Budd PM, 2004, CHEM COMMUN, P230, DOI 10.1039/b311764b; Budd PM, 2004, ADV MATER, V16, P456, DOI 10.1002/adma.200306053; Carta M, 2013, SCIENCE, V339, P303, DOI 10.1126/science.1228032; Dawson R, 2012, PROG POLYM SCI, V37, P530, DOI 10.1016/j.progpolymsci.2011.09.002; Du NY, 2012, ENERG ENVIRON SCI, V5, P7306, DOI [10.1039/c1ee02668b, 10.1039/C1EE02668B]; Du NY, 2011, NAT MATER, V10, P372, DOI [10.1038/NMAT2989, 10.1038/nmat2989]; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Freeman BD, 1999, MACROMOLECULES, V32, P375, DOI 10.1021/ma9814548; Heuchel M, 2008, J MEMBRANE SCI, V318, P84, DOI 10.1016/j.memsci.2008.02.038; McKeown NB, 2010, MACROMOLECULES, V43, P5163, DOI 10.1021/ma1006396; Nagai K, 2001, PROG POLYM SCI, V26, P721, DOI 10.1016/S0079-6700(01)00008-9; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030	14	176	178	7	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					284	285		10.1126/science.1232714	http://dx.doi.org/10.1126/science.1232714			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329040	Green Submitted			2022-12-28	WOS:000313622000034
J	Kohwi, M; Lupton, JR; Lai, SL; Miller, MR; Doe, CQ				Kohwi, Minoree; Lupton, Joshua R.; Lai, Sen-Lin; Miller, Michael R.; Doe, Chris Q.			Developmentally Regulated Subnuclear Genome Reorganization Restricts Neural Progenitor Competence in Drosophila	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; NUCLEAR LAMINA INTERACTIONS; CELL-FATE DETERMINATION; DNA-BINDING PROTEINS; TEMPORAL IDENTITY; NEUROBLAST COMPETENCE; DISTAL-ANTENNA; TRANSCRIPTION FACTORS; CEREBRAL-CORTEX; HUNCHBACK	Stem and/or progenitor cells often generate distinct cell types in a stereotyped birth order and over time lose competence to specify earlier-born fates by unknown mechanisms. In Drosophila, the Hunchback transcription factor acts in neural progenitors (neuroblasts) to specify early-born neurons, in part by indirectly inducing the neuronal transcription of its target genes, including the hunchback gene. We used in vivo immuno-DNA FISH and found that the hunchback gene moves to the neuroblast nuclear periphery, a repressive subnuclear compartment, precisely when competence to specify early-born fate is lost and several hours and cell divisions after termination of its transcription. hunchback movement to the lamina correlated with downregulation of the neuroblast nuclear protein, Distal antenna (Dan). Either prolonging Dan expression or disrupting lamina interfered with hunchback repositioning and extended neuroblast competence. We propose that neuroblasts undergo a developmentally regulated subnuclear genome reorganization to permanently silence Hunchback target genes that results in loss of progenitor competence.	[Kohwi, Minoree; Lupton, Joshua R.; Lai, Sen-Lin; Miller, Michael R.; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Inst Neurosci, Eugene, OR 97403 USA	Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Howard Hughes Med Inst, Inst Mol Biol, Inst Neurosci, Eugene, OR 97403 USA.	cdoe@uoneuro.uoregon.edu		Lai, Sen-Lin/0000-0002-7531-283X	Leukemia & Lymphoma Society; NICHD [HD072035]; NIH [HD27056]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD027056, K99HD072035, R00HD072035] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058899] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Hui Zong, Rui Galvao, Chong Liu, Eric Selker, Mike Cleary, and Doe laboratory members for discussion and comments on the manuscript, Keiko Hirono for blind scoring of the hb FISH data, Fre'de'ric Bantignies for technical advice, Jennifer Curtiss for antibody and fly stocks, and Josh Udovich for technical assistance. We thank Janet Hanawalt and Marina Hirsch for copy editing. This work was supported by a Leukemia & Lymphoma Society career development award and a K99/R00 NIH grant from NICHD (HD072035) to M.K. and funding from the NIH (HD27056) and HHMI to C.Q.D.	Bantignies F, 2011, CELL, V144, P214, DOI 10.1016/j.cell.2010.12.026; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Benito-Sipos J, 2011, DEVELOPMENT, V138, P5311, DOI 10.1242/dev.070946; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Carney TD, 2012, DEV BIOL, V361, P137, DOI 10.1016/j.ydbio.2011.10.020; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cleary MD, 2006, GENE DEV, V20, P429, DOI 10.1101/gad.1382206; Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006; DOE CQ, 1992, DEVELOPMENT, V116, P855; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246; Kanai MI, 2005, DEV CELL, V8, P203, DOI 10.1016/j.devcel.2004.12.014; Kao CF, 2012, NEURON, V73, P677, DOI 10.1016/j.neuron.2011.12.018; Karlsson D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000368; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kohwi M, 2011, DEVELOPMENT, V138, P1727, DOI 10.1242/dev.061499; Kwan KY, 2012, DEVELOPMENT, V139, P1535, DOI 10.1242/dev.069963; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Luan HJ, 2006, NEURON, V52, P425, DOI 10.1016/j.neuron.2006.08.028; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; MCCONNELL SK, 1989, TRENDS NEUROSCI, V12, P342, DOI 10.1016/0166-2236(89)90041-6; Meister P, 2010, GENE DEV, V24, P766, DOI 10.1101/gad.559610; Mettler U, 2006, DEVELOPMENT, V133, P429, DOI 10.1242/dev.02229; Novotny T, 2002, DEVELOPMENT, V129, P1027; Okano H, 2009, CURR OPIN NEUROBIOL, V19, P112, DOI 10.1016/j.conb.2009.04.003; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910; Peric-Hupkes D, 2010, COLD SH Q B, V75, P517, DOI 10.1101/sqb.2010.75.014; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Schmid A, 1999, DEVELOPMENT, V126, P4653; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shevelyov YY, 2012, CURR ISSUES MOL BIOL, V14, P27; Siegmund T, 2002, DEV GENES EVOL, V212, P152, DOI 10.1007/s00427-002-0219-2; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; Touma JJ, 2012, DEVELOPMENT, V139, P657, DOI 10.1242/dev.071589; Towbin BD, 2010, COLD SH Q B, V75, P555, DOI 10.1101/sqb.2010.75.041; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349; Trimarchi JM, 2007, J COMP NEUROL, V502, P1047, DOI 10.1002/cne.21368; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Wimmer EA, 2000, SCIENCE, V287, P2476, DOI 10.1126/science.287.5462.2476; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007; Zullo JM, 2012, CELL, V149, P1474, DOI 10.1016/j.cell.2012.04.035	61	118	122	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					97	108		10.1016/j.cell.2012.11.049	http://dx.doi.org/10.1016/j.cell.2012.11.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332748	Bronze, Green Accepted			2022-12-28	WOS:000313719800009
J	Sepkowitz, KA				Sepkowitz, Kent A.			Energy Drinks and Caffeine-Related Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FATALITIES		[Sepkowitz, Kent A.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, New York, NY 10065 USA; [Sepkowitz, Kent A.] Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Sepkowitz, KA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, 1275 York Ave, New York, NY 10065 USA.	sepkowik@mskcc.org						BENJAMIN LT, 1991, J HIST BEHAV SCI, V27, P42, DOI 10.1002/1520-6696(199101)27:1<42::AID-JHBS2300270105>3.0.CO;2-1; Holmgren P, 2004, FORENSIC SCI INT, V139, P71, DOI 10.1016/j.forsciint.2003.09.019; Meier B, 2012, NY TIMES; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Thelander G, 2010, CLIN TOXICOL, V48, P354, DOI 10.3109/15563650903586752; Toblin Robin L., 2012, Morbidity and Mortality Weekly Report, V61, P895; Wolk BJ, 2012, CURR OPIN PEDIATR, V24, P243, DOI 10.1097/MOP.0b013e3283506827; YOUNG JH, 1983, J SOUTHERN HIST, V49, P3, DOI 10.2307/2209304	8	80	84	0	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					243	244		10.1001/jama.2012.173526	http://dx.doi.org/10.1001/jama.2012.173526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23330171				2022-12-28	WOS:000313546800022
J	Chatterjee, S				Chatterjee, Saurav			A 13-item score based on readily available risk factors predicted risk for 3-year mortality in heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chatterjee, Saurav] Brown Univ, Providence, RI 02912 USA; [Chatterjee, Saurav] Providence VAMC, Providence, RI USA	Brown University	Chatterjee, S (corresponding author), Brown Univ, Providence, RI 02912 USA.							Aronow WS, 1997, AM J CARDIOL, V80, P207, DOI 10.1016/S0002-9149(97)00320-2; Hori M, 2005, J CARD FAIL, V11, P542, DOI 10.1016/j.cardfail.2005.04.003; Pocock SJ, 2006, EUR HEART J, V27, P65, DOI 10.1093/eurheartj/ehi555; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC13	10.7326/0003-4819-158-2-201301150-02013	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318335				2022-12-28	WOS:000314029400012
J	Stanbrook, MB				Stanbrook, Matthew B.			Physician-, biomarker-, and symptom-based adjustment of inhaled corticosteroids for asthma had similar effects	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC6	10.7326/0003-4819-158-2-201301150-02006	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318340				2022-12-28	WOS:000314029400005
J	Ghosh, J				Ghosh, Jayati			Should rich countries stop sending development aid to India? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Jawaharlal Nehru Univ, Sch Social Sci, Ctr Econ Studies & Planning, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Ghosh, J (corresponding author), Jawaharlal Nehru Univ, Sch Social Sci, Ctr Econ Studies & Planning, New Delhi 110067, India.	jayatijnu@gmail.com						Desai R M., 2012, INDIAN EXPRESS; Doane D., 2012, GUARDIAN; Gilligan A., 2012, TELEGRAPH; Government of India Institute of Applied Manpower Research and Planning Commission, IND HUM DEV REP 2011; Government of India Ministry of Finance, 2011, IND EC SURV 2011 12; Krishnanv Simha R, 2012, RUSSIA INDIA REPORT; PROVOST CLAIRE, 2011, GUARDIAN; United Nations Development Programme, 2008, CHIN HUM DEV REP	8	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2013	346								f78	10.1136/bmj.f78	http://dx.doi.org/10.1136/bmj.f78			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZV	23305941				2022-12-28	WOS:000313555300009
J	Carr, LD				Carr, Lincoln D.			Negative Temperatures?	SCIENCE			English	Editorial Material									Colorado Sch Mines, Dept Phys, Boulder, CO 80401 USA	Colorado School of Mines	Carr, LD (corresponding author), Colorado Sch Mines, Dept Phys, Boulder, CO 80401 USA.	lcarr@mines.edu	Carr, Lincoln/E-3819-2016	Carr, Lincoln/0000-0002-4848-7941	Division Of Physics [1067973] Funding Source: National Science Foundation	Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Braun S, 2013, SCIENCE, V339, P52, DOI 10.1126/science.1227831; Calabrese P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.227203; Carr LD, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.063602; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Carr Lincoln D., 2010, UNDERSTANDING QUANTU; Cassidy AC, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.140405; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Khaykovich L, 2002, SCIENCE, V296, P1290, DOI 10.1126/science.1071021; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Pollack SE, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.090402; Rigol M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.050405; Stockton JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.133001; Tabor M, 1989, CHAOS INTEGRABILITY	15	18	18	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					42	43		10.1126/science.1232558	http://dx.doi.org/10.1126/science.1232558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288530				2022-12-28	WOS:000312985800043
J	Rodriguez, NA; Ascaso, FJ				Rodriguez, Nelson A.; Ascaso, Francisco J.			Corneal-Flap Dehiscence after Screwdriver Trauma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rodriguez, Nelson A.] Hosp Navarra, Pamplona, Spain; [Ascaso, Francisco J.] Lozano Blesa Univ Clin Hosp, Zaragoza, Spain	Servicio Navarro de Salud - Osasunbidea; Lozano Blesa University Clinical Hospital	Rodriguez, NA (corresponding author), Hosp Navarra, Pamplona, Spain.	jascaso@gmail.com	PUYUELO, FCO. JAVIER ASCASO/I-8426-2019						0	3	3	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					E1	E1		10.1056/NEJMicm1204137	http://dx.doi.org/10.1056/NEJMicm1204137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23282001				2022-12-28	WOS:000312930600007
J	Stavert, RR; Lott, JP				Stavert, Robert R.; Lott, Jason P.			The Bystander Effect in Medical Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INTERVENTION; EMERGENCIES		[Stavert, Robert R.; Lott, Jason P.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Lott, Jason P.] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT USA	Yale University; Robert Wood Johnson Foundation (RWJF); Yale University	Stavert, RR (corresponding author), Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA.			Lott, Jason/0000-0002-4097-7225				Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Fischer P, 2011, PSYCHOL BULL, V137, P517, DOI 10.1037/a0023304; Greenberg J., 1981, NY TIMES, pC1; LATANE B, 1968, J PERS SOC PSYCHOL, V10, P215, DOI 10.1037/h0026570; Levine M, 2008, J PERS SOC PSYCHOL, V95, P1429, DOI 10.1037/a0012634	5	25	25	1	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					8	9		10.1056/NEJMp1210501	http://dx.doi.org/10.1056/NEJMp1210501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23281972				2022-12-28	WOS:000312930600016
J	Gammon, K				Gammon, Katharine			MATHEMATICAL MODELLING Forecasting cancer	NATURE			English	Editorial Material																		Basanta D, 2012, MOL PHARMACEUT, V9, P914, DOI 10.1021/mp200458e; Chmielecki J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002356; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399	3	8	8	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S66	S67		10.1038/491S66a	http://dx.doi.org/10.1038/491S66a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320294	Bronze			2022-12-28	WOS:000311339800010
J	Agee, CB; Wilson, NV; McCubbin, FM; Ziegler, K; Polyak, VJ; Sharp, ZD; Asmerom, Y; Nunn, MH; Shaheen, R; Thiemens, MH; Steele, A; Fogel, ML; Bowden, R; Glamoclija, M; Zhang, ZS; Elardo, SM				Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela; Zhang, Zhisheng; Elardo, Stephen M.			Unique Meteorite from Early Amazonian Mars: Water-Rich Basaltic Breccia Northwest Africa 7034	SCIENCE			English	Article							OXYGEN-ISOTOPIC COMPOSITION; CHASSIGNY METEORITE; DIFFERENTIATION PROCESSES; MARTIAN METEORITES; UPPER-MANTLE; RB-SR; CONSTRAINTS; PETROGENESIS; SURFACE; ATMOSPHERE	We report data on the martian meteorite Northwest Africa (NWA) 7034, which shares some petrologic and geochemical characteristics with known martian meteorites of the SNC (i.e., shergottite, nakhlite, and chassignite) group, but also has some unique characteristics that would exclude it from that group. NWA 7034 is a geochemically enriched crustal rock compositionally similar to basalts and average martian crust measured by recent Rover and Orbiter missions. It formed 2.089 +/- 0.081 billion years ago, during the early Amazonian epoch in Mars' geologic history. NWA 7034 has an order of magnitude more indigenous water than most SNC meteorites, with up to 6000 parts per million extraterrestrial H2O released during stepped heating. It also has bulk oxygen isotope values of Delta O-17 = 0.58 +/- 0.05 per mil and a heat-released water oxygen isotope average value of Delta O-17 = 0.330 +/- 0.011 per mil, suggesting the existence of multiple oxygen reservoirs on Mars.	[Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Ziegler, Karen; Elardo, Stephen M.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA; [Agee, Carl B.; Wilson, Nicole V.; McCubbin, Francis M.; Polyak, Victor J.; Sharp, Zachary D.; Asmerom, Yemane; Elardo, Stephen M.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Nunn, Morgan H.; Shaheen, Robina; Thiemens, Mark H.; Zhang, Zhisheng] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Steele, Andrew; Fogel, Marilyn L.; Bowden, Roxane; Glamoclija, Mihaela] Carnegie Inst Sci, Geophys Lab, Washington, DC 20005 USA; [Zhang, Zhisheng] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China	University of New Mexico; University of New Mexico; University of California System; University of California San Diego; Carnegie Institution for Science; Sun Yat Sen University	Agee, CB (corresponding author), Univ New Mexico, Inst Meteorit, Albuquerque, NM 87131 USA.	agee@unm.edu	Steele, Andrew/A-3573-2013; Glamoclija, Mihaela/GWQ-3360-2022; Zhang, Zhisheng/W-5138-2019; Fogel, Marilyn L/M-2395-2015; McCubbin, Francis/AAG-1095-2020; McCubbin, Francis/D-1698-2009; Elardo, Stephen M/E-5865-2010	Steele, Andrew/0000-0001-9643-2841; Glamoclija, Mihaela/0000-0003-4327-6480; Zhang, Zhisheng/0000-0002-3742-0880; Fogel, Marilyn L/0000-0002-1176-3818; Elardo, Stephen M/0000-0001-5730-8485	NASA Cosmochemistry Program [NNX11AH16G, NNX11AG76G]; New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship [NNX12AO15H]; NASA [NNX10AI77G]; NSF [ATM0960594]	NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA)); New Mexico Space Grant Consortium; NASA Earth and Space Science Fellowship; NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We thank J. Piatek for acquiring the NWA 7034 specimen and for his generous donation to the UNM Meteorite Museum, which has enabled this research and sample allocations for future research on NWA 7034. We also thank M. Spilde, V. Atudorei, and J. Connolly at the University of New Mexico for assistance with data collection. Supported by NASA Cosmochemistry Program grants NNX11AH16G (C. B. A.) and NNX11AG76G (F. M. M.). S. M. E. acknowledges support from the New Mexico Space Grant Consortium, NASA Earth and Space Science Fellowship NNX12AO15H, and NASA Cosmochemistry grant NNX10AI77G to Charles K. Shearer. M. H. T. and R. S. acknowledge NSF award ATM0960594, which allowed the development of an analytical technique to measure oxygen triple isotopic composition of small (<1 mu M) sulfate samples.	Aoudjehane HC, 2012, SCIENCE, V338, P785, DOI 10.1126/science.1224514; Borg L, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002402; Borg LE, 1997, GEOCHIM COSMOCHIM AC, V61, P4915, DOI 10.1016/S0016-7037(97)00276-7; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Borg LE, 2003, GEOCHIM COSMOCHIM AC, V67, P3519, DOI 10.1016/S0016-7037(03)00094-2; Borg LE, 2002, GEOCHIM COSMOCHIM AC, V66, P2037, DOI 10.1016/S0016-7037(02)00835-9; Boynton WV, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002887; CLAYTON RN, 1983, EARTH PLANET SC LETT, V62, P1, DOI 10.1016/0012-821X(83)90066-3; Day JMD, 2006, METEORIT PLANET SCI, V41, P581, DOI 10.1111/j.1945-5100.2006.tb00484.x; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; Farquhar J, 2000, J GEOPHYS RES-PLANET, V105, P11991, DOI 10.1029/1999JE001194; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; Filiberto J, 2008, GEOCHIM COSMOCHIM AC, V72, P690, DOI 10.1016/j.gca.2007.11.007; Gellert R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002555; Grady MM., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Hartmann WK, 2001, SPACE SCI REV, V96, P165, DOI 10.1023/A:1011945222010; Herd CDK, 2003, METEORIT PLANET SCI, V38, P1793, DOI 10.1111/j.1945-5100.2003.tb00015.x; Herd CDK, 2002, GEOCHIM COSMOCHIM AC, V66, P2025, DOI 10.1016/S0016-7037(02)00828-1; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; Leshin LA, 1996, GEOCHIM COSMOCHIM AC, V60, P2635, DOI 10.1016/0016-7037(96)00122-6; Lodders K., 1998, PLANETARY SCI COMPAN; McCubbin FM, 2008, AM MINERAL, V93, P676, DOI 10.2138/am.2008.2558; McCubbin FM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051711; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McCubbin FM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003165; McSween HY, 2009, SCIENCE, V324, P736, DOI 10.1126/science.1165871; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; MING DW, 2008, J GEOPHYS RES-PLANET, V113, DOI DOI 10.1029/2008JE003195; Mittlefehldt DW, 2008, REV MINERAL GEOCHEM, V68, P399, DOI 10.2138/rmg.2008.68.14; Nekvasil H, 2009, METEORIT PLANET SCI, V44, P853, DOI 10.1111/j.1945-5100.2009.tb00773.x; Nimmo F, 2008, NATURE, V453, P1220, DOI 10.1038/nature07025; Nittler LR, 2011, SCIENCE, V333, P1847, DOI 10.1126/science.1211567; Norman MD, 1999, METEORIT PLANET SCI, V34, P439, DOI 10.1111/j.1945-5100.1999.tb01352.x; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Papike JJ, 2009, GEOCHIM COSMOCHIM AC, V73, P7443, DOI 10.1016/j.gca.2009.09.008; Reese CC, 2006, ICARUS, V184, P102, DOI 10.1016/j.icarus.2006.04.008; Riner MA, 2010, ICARUS, V209, P301, DOI 10.1016/j.icarus.2010.05.018; Romanek CS, 1998, METEORIT PLANET SCI, V33, P775, DOI 10.1111/j.1945-5100.1998.tb01683.x; Rumble D., 2009, P 40 LUN PLAN SCI C, V40, P2293; Sarbadhikari AB, 2011, GEOCHIM COSMOCHIM AC, V75, P6803, DOI 10.1016/j.gca.2011.09.001; Sarbadhikari AB, 2009, GEOCHIM COSMOCHIM AC, V73, P2190, DOI 10.1016/j.gca.2009.01.012; Sharp ZD, 2001, CHEM GEOL, V178, P197, DOI 10.1016/S0009-2541(01)00262-5; Shearer CK, 2011, AM MINERAL, V96, P1418, DOI 10.2138/am.2011.3860; SNYDER GA, 1992, GEOCHIM COSMOCHIM AC, V56, P3809, DOI 10.1016/0016-7037(92)90172-F; SNYDER GA, 1994, GEOCHIM COSMOCHIM AC, V58, P4795, DOI 10.1016/0016-7037(94)90209-7; Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Till CB, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009044; Treiman AH, 2000, PLANET SPACE SCI, V48, P1213, DOI 10.1016/S0032-0633(00)00105-7; Wadwa M., 2004, ANTARCT METEORITE RE, V17, P97; WARREN PH, 1979, REV GEOPHYS, V17, P73, DOI 10.1029/RG017i001p00073; Wright SP, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003785; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Yung Y.L., 1999, PHOTOCHEMISTRY PLANE; Zipfel J, 2011, METEORIT PLANET SCI, V46, P1, DOI 10.1111/j.1945-5100.2010.01127.x	55	290	294	7	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					780	785		10.1126/science.1228858	http://dx.doi.org/10.1126/science.1228858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287721				2022-12-28	WOS:000314874400038
J	Hu, B; Margolin, W; Molineux, IJ; Liu, J				Hu, Bo; Margolin, William; Molineux, Ian J.; Liu, Jun			The Bacteriophage T7 Virion Undergoes Extensive Structural Remodeling During Infection	SCIENCE			English	Article							ESCHERICHIA-COLI; DNA EJECTION; TAIL FIBERS; INITIATION; MECHANISM; MACHINES; DELIVERY; PROTEIN	Adsorption and genome ejection are fundamental to the bacteriophage life cycle, yet their molecular mechanisms are not well understood. We used cryo-electron tomography to capture T7 virions at successive stages of infection of Escherichia coli minicells at similar to 4-nm resolution. The six phage tail fibers were folded against the capsid, extending and orienting symmetrically only after productive adsorption to the host cell surface. Receptor binding by the tail triggered conformational changes resulting in the insertion of an extended tail, which functions as the DNA ejection conduit into the cell cytoplasm. After ejection, the extended phage tail collapsed or disassembled, which allowed resealing of the infected cell membrane. These structural studies provide a detailed series of intermediates during phage infection.	[Hu, Bo; Liu, Jun] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Margolin, William] Univ Texas Med Sch Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Molineux, Ian J.] Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Austin	Molineux, IJ (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Austin, TX 78712 USA.	molineux@austin.utexas.edu; jun.liu.1@uth.tmc.edu			National Institute on Allergy and Infection, NIH [R01AI087946]; Welch Foundation [AU-1714]; NIH [R01GM61074]; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110243, R01GM061074] Funding Source: NIH RePORTER	National Institute on Allergy and Infection, NIH; Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Leiman, S. Norris, and Y. W. Yin for comments. B. H. and J.L. were supported in part by grants R01AI087946 from the National Institute on Allergy and Infection, NIH, and AU-1714 from the Welch Foundation. W. M. was supported by NIH grant R01GM61074 and a grant from the Human Frontier Science Program. EM maps have been deposited in the EM Data Bank (www.ebi.ac.uk/pdbe/emdb/) with accession nos. EMD-5534, 5535, 5536, and 5537. J.L. and I.J.M. designed research; B. H. and W. M. constructed the E. coli mutants; B. H. and J. L. collected and analyzed data; and B. H., W. M., J. L., and I. J. M. wrote the paper.	Adam G., 1968, STRUCTURAL CHEM MOL, P198; Agirrezabala X, 2005, EMBO J, V24, P3820, DOI 10.1038/sj.emboj.7600840; Casjens SR, 2012, ADV EXP MED BIOL, V726, P143, DOI 10.1007/978-1-4614-0980-9_7; Chang CY, 2010, VIROLOGY, V398, P176, DOI 10.1016/j.virol.2009.12.002; Garcia LR, 1996, J BACTERIOL, V178, P6921, DOI 10.1128/jb.178.23.6921-6929.1996; Garcia-Doval C, 2012, P NATL ACAD SCI USA, V109, P9390, DOI 10.1073/pnas.1119719109; Johnson JE, 2007, CURR OPIN STRUC BIOL, V17, P237, DOI 10.1016/j.sbi.2007.03.011; Kemp P, 2005, VIROLOGY, V340, P307, DOI 10.1016/j.virol.2005.06.039; Kemp P, 2004, MOL MICROBIOL, V53, P1251, DOI 10.1111/j.1365-2958.2004.04204.x; Leiman PG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-355; Liu J, 2012, P NATL ACAD SCI USA, V109, pE1481, DOI 10.1073/pnas.1200781109; Liu XA, 2010, NAT STRUCT MOL BIOL, V17, P830, DOI 10.1038/nsmb.1823; Moak M, 2004, MOL MICROBIOL, V51, P1169, DOI 10.1046/j.1365-2958.2003.03894.x; Moak M, 2000, MOL MICROBIOL, V37, P345, DOI 10.1046/j.1365-2958.2000.01995.x; Molineux IJ, 2001, MOL MICROBIOL, V40, P1, DOI 10.1046/j.1365-2958.2001.02357.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Rothenberg E, 2011, BIOPHYS J, V100, P2875, DOI 10.1016/j.bpj.2011.05.014; STEVEN AC, 1988, J MOL BIOL, V200, P351, DOI 10.1016/0022-2836(88)90246-X; Struthers-Schlinke JS, 2000, J MOL BIOL, V301, P35, DOI 10.1006/jmbi.2000.3940; ZIMKUS A Z, 1986, Molekulyarnaya Biologiya (Moscow), V20, P185	20	150	157	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					576	579		10.1126/science.1231887	http://dx.doi.org/10.1126/science.1231887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23306440	Green Accepted			2022-12-28	WOS:000314270000058
J	Gallimore, AM; Godkin, A				Gallimore, Awen M.; Godkin, Andrew			Epithelial Barriers, Microbiota, and Colorectal Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gallimore, Awen M.; Godkin, Andrew] Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales; [Godkin, Andrew] Univ Wales Hosp, Cardiff CF4 4XW, S Glam, Wales	Cardiff University; Cardiff University	Gallimore, AM (corresponding author), Cardiff Univ, Sch Med, Cardiff CF10 3AX, S Glam, Wales.			Gallimore, Awen/0000-0001-6675-7004; Godkin, Andrew/0000-0002-1910-7567				Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907	5	33	40	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					282	284		10.1056/NEJMcibr1212341	http://dx.doi.org/10.1056/NEJMcibr1212341			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323906				2022-12-28	WOS:000313549900016
J	Gholkar, N; Lehman, D				Gholkar, Neil; Lehman, Deborah			Borrelia hermsii (Relapsing Fever)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gholkar, Neil] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Lehman, Deborah] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center	Gholkar, N (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	ngholkar@mednet.ucla.edu							0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					266	266		10.1056/NEJMicm1204145	http://dx.doi.org/10.1056/NEJMicm1204145			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323903				2022-12-28	WOS:000313549900011
J	Wu, B; Peisley, A; Richards, C; Yao, H; Zeng, XH; Lin, C; Chu, FX; Walz, T; Hur, S				Wu, Bin; Peisley, Alys; Richards, Claire; Yao, Hui; Zeng, Xiaohui; Lin, Cecilie; Chu, Feixia; Walz, Thomas; Hur, Sun			Structural Basis for dsRNA Recognition, Filament Formation, and Antiviral Signal Activation by MDA5	CELL			English	Article							RIG-I HELICASE; RNA-RECOGNITION; PATTERN-RECOGNITION; SENSOR; MECHANISM; INSIGHTS; SYSTEM; DOMAIN; LGP2	MDA5, a viral double-stranded RNA (dsRNA) receptor, shares sequence similarity and signaling pathways with RIG-I yet plays essential functions in antiviral immunity through distinct specificity for viral RNA. Revealing the molecular basis for the functional divergence, we report here the crystal structure of MDA5 bound to dsRNA, which shows how, using the same domain architecture, MDA5 recognizes the internal duplex structure, whereas RIG-I recognizes the terminus of dsRNA. We further show that MDA5 uses direct protein-protein contacts to stack along dsRNA in a head-to-tail arrangement, and that the signaling domain (tandem CARD), which decorates the outside of the core MDA5 filament, also has an intrinsic propensity to oligomerize into an elongated structure that activates the signaling adaptor, MAVS. These data support a model in which MDA5 uses long dsRNA as a signaling platform to cooperatively assemble the core filament, which in turn promotes stochastic assembly of the tandem CARD oligomers for signaling.	[Wu, Bin; Peisley, Alys; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lin, Cecilie; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wu, Bin; Peisley, Alys; Richards, Claire; Hur, Sun] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yao, Hui] Nankai Univ, Dept Biochem & Mol Biol, Tianjin 300071, Peoples R China; [Zeng, Xiaohui; Chu, Feixia] Univ New Hampshire, Dept Mol Cellular & Biomed Sci, Durham, NH 03824 USA; [Walz, Thomas] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Nankai University; University System Of New Hampshire; University of New Hampshire; Howard Hughes Medical Institute	Hur, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	hur@idi.harvard.edu	Wu, Bin/C-4715-2015	Wu, Bin/0000-0002-0883-8006; Peisley, Alys/0000-0002-8999-5440; Walz, Thomas/0000-0003-2606-2835	NIFA/USDA [H00567]; UNH Karabelis Fund; Pew Scholarship	NIFA/USDA(United States Department of Agriculture (USDA)); UNH Karabelis Fund; Pew Scholarship	The authors thank the NE-CAT beamline scientists for their assistance during data collection. F.C. acknowledges NIFA/USDA H00567 and UNH Karabelis Fund. T.W. is an Investigator in the Howard Hughes Medical Institute. S.H. is the recipient of a Pew Scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Peisley A, 2012, P NATL ACAD SCI USA, V109, pE3340, DOI 10.1073/pnas.1208618109; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takahasi K, 2009, J BIOL CHEM, V284, P17465, DOI 10.1074/jbc.M109.007179; Triantafilou K., 2012, J CELL SCI; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	25	357	362	1	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					276	289		10.1016/j.cell.2012.11.048	http://dx.doi.org/10.1016/j.cell.2012.11.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273991	Bronze			2022-12-28	WOS:000313719800023
J	Reid, RO; Deb, P; Howell, BL; Shrank, WH				Reid, Rachel O.; Deb, Partha; Howell, Benjamin L.; Shrank, William H.			Association Between Medicare Advantage Plan Star Ratings and Enrollment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHOICE SET SIZE; DECISION-MAKING; QUALITY INFORMATION; HEALTH-INSURANCE; REPORT CARDS; LESSONS; PROGRAM; FUTURE; MARKET	Importance The US Centers for Medicare & Medicaid Services publishes star ratings reflecting Medicare Advantage plan quality to inform enrollment decisions. Objective To assess the association between publicly reported Medicare Advantage plan quality ratings and enrollment. Design, Setting, and Participants Cross-sectional study of 2011 Medicare Advantage enrollments among 952 352 first-time enrollees and 322 699 enrollees switching plans. Main Outcome Measure Association between star ratings and enrollment was modeled using conditional logit regression, controlling for beneficiary and plan characteristics. Results Among the 952 352 included first-time enrollees, a 1-star higher rating was associated with a 9.5 (95% CI, 9.3-9.6) percentage-point increase in likelihood to enroll. The highest rating available to a beneficiary was associated with a 1.9 (95% CI, 1.8-2.1) percentage-point increase in likelihood to enroll. Among the 322 699 enrollees switching plans, a 1-star higher rating was associated with a 4.4 (95% CI, 4.24.7) percentage-point increase in likelihood to enroll. A rating at least as high as a beneficiary's prior plan was associated with a 6.3 (95% CI, 6.0-6.6) percentage-point increase in likelihood to enroll. Star ratings were less strongly associated with enrollment for black, rural, low-income, and the youngest beneficiaries. Conclusion and Relevance Medicare's 5-star rating program for Medicare Advantage is associated with beneficiaries' enrollment decisions. JAMA. 2013;309(3):267-274 www.jama.com	[Shrank, William H.] Ctr Medicare Serv, Ctr Medicare & Medicaid Innovat, Rapid Cycle Evaluat Grp, Baltimore, MD USA; Ctr Medicaid Serv, Ctr Medicare & Medicaid Innovat, Rapid Cycle Evaluat Grp, Baltimore, MD USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Shrank, WH (corresponding author), Ctr Medicare Serv, Ctr Medicare & Medicaid Innovat, Rapid Cycle Evaluat Grp, 7500 Secur Blvd,Mailstop WB 06-05, Baltimore, MD USA.	william.shrank@cms.hhs.gov		Deb, Partha/0000-0003-1876-8678	CVS Caremark; Aetna; Express Scripts	CVS Caremark; Aetna; Express Scripts	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shrank reported serving as a consultant to United Healthcare; and receiving grant support from CVS Caremark, Aetna, and Express Scripts. The other authors did not report any disclosures.	Atherly A, 2004, HEALTH SERV RES, V39, P847, DOI 10.1111/j.1475-6773.2004.00261.x; Biles B, 2004, HLTH AFF MILWOOD, V23, pW4, DOI [10.1377/hlthaff.w4.586, DOI 10.1377/HLTHAFF.W4.586]; Bundorf MK, 2010, MED DECIS MAKING, V30, P582, DOI 10.1177/0272989X09357793; Carroll J, 2010, MANAG CARE, V19, P14; Centers for Medicare and Medicaid Services, CHOOS HIGH QUAL BETT; Centers for Medicare & Medicaid Services, MAN CAR MARK; Centers for Medicare & Medicaid Services, PART D PERF DAT; Centers for Medicare & Medicaid Services, PLAN CROSSW; Centers for Medicare & Medicaid Services, DET SYST REC 09 70 0; Centers for Medicare & Medicaid Services, 2012, CMS INT DAT REP IDR; Cosgrove JC, GAO 12 409R QUALITY; Dafny L, 2008, RAND J ECON, V39, P790, DOI 10.1111/j.1756-2171.2008.00039.x; Diamond Frank, 2010, Manag Care, V19, P34; EdgmanLevitan S, 1996, HEALTH AFFAIR, V15, P42, DOI 10.1377/hlthaff.15.4.42; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Faber M, 2009, MED CARE, V47, P1, DOI 10.1097/MLR.0b013e3181808bb5; Gold M, 2012, NEW ENGL J MED, V366, P1174, DOI 10.1056/NEJMp1200156; Goldstein E, 2001, HEALTH CARE FINANC R, V23, P5; Goldstein E, 2001, HEALTH SERV RES, V36, P477; Grabowski DC, 2011, HEALTH SERV RES, V46, P1698, DOI 10.1111/j.1475-6773.2011.01298.x; Hackbarth GM, MEDPAC COMMENTS CMS; Hanoch Y, 2011, HEALTH PSYCHOL, V30, P719, DOI 10.1037/a0023951; Harris Interactive, MED STAR QUAL RAT SY; Kolstad JT, 2009, MED CARE RES REV, V66, p28S, DOI 10.1177/1077558708325887; McWilliams JM, 2011, HEALTH AFFAIR, V30, P1786, DOI 10.1377/hlthaff.2011.0132; MECHANIC D, 1989, HEALTH AFFAIR, V8, P138, DOI 10.1377/hlthaff.8.1.138; Pereira AG, 2003, ARCH INTERN MED, V163, P909, DOI 10.1001/archinte.163.8.909; Pope GC, 2011, EVALUATION CMS HCC R; Scanlon DP, 1997, ANNU REV PUBL HEALTH, V18, P507, DOI 10.1146/annurev.publhealth.18.1.507; Shimada SL, 2009, MED CARE, V47, P517, DOI 10.1097/MLR.0b013e318195f86e; Sorensen Alan T, 2006, Rand J Econ, V37, P1; Weaver C, CHASING STARS INSURE; Werner RM, 2012, J HEALTH ECON, V31, P50, DOI 10.1016/j.jhealeco.2012.01.001	33	69	69	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					267	274		10.1001/jama.2012.173925	http://dx.doi.org/10.1001/jama.2012.173925			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070XG	23321765	Bronze			2022-12-28	WOS:000313546800027
J	Abakka, S; Elhalouat, H; Khoummane, N; Achaaban, M; ElAmrani, S; Bargach, S; Yousfi, M				Abakka, Sanae; Elhalouat, Hatim; Khoummane, Nadia; Achaaban, Mouad; ElAmrani, Sabah; Bargach, Samir; Yousfi, Mounia			Uterine leiomyosarcoma and Leser-Trelat sign	LANCET			English	Editorial Material									[Abakka, Sanae; Elhalouat, Hatim; Khoummane, Nadia; Achaaban, Mouad; ElAmrani, Sabah; Bargach, Samir; Yousfi, Mounia] Univ Teaching Hosp Ibn Sina Rabat, Matern Hosp Souissi, Dept Obstet & Gynaecol Oncol & High Risk Pregnanc, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Abakka, S (corresponding author), 23 Ave Princesses, Rabat 10170, Morocco.	sanaeabakka@gmail.com						Hassini A, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P348; Hendrickson MR, 2003, TUMOURS BREAST FEMAL; Kebria MM, 2006, GYNECOL ONCOL, V101, P353, DOI 10.1016/j.ygyno.2005.12.024; KURZROCK R, 1995, AM J MED, V99, P662, DOI 10.1016/S0002-9343(99)80254-X; Schwartz RA, 1996, J AM ACAD DERMATOL, V35, P88, DOI 10.1016/S0190-9622(96)90502-2	5	6	7	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 5	2013	381	9860					88	88		10.1016/S0140-6736(12)61805-4	http://dx.doi.org/10.1016/S0140-6736(12)61805-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	064AW	23290965				2022-12-28	WOS:000313044300030
J	Grumbine, RE; Pandit, MK				Grumbine, R. Edward; Pandit, Maharaj K.			Threats from India's Himalaya Dams	SCIENCE			English	Editorial Material									[Grumbine, R. Edward] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China; [Pandit, Maharaj K.] Univ Delhi, Dept Environm Studies, Ctr Interdisciplinary Studies Mt & Hill Environm, Delhi 110007, India	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; University of Delhi	Grumbine, RE (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming 650204, Peoples R China.	ed.grumbine@gmail.com	Pandit, Maharaj K/A-4065-2014	Pandit, Maharaj K/0000-0001-6611-560X				[Anonymous], 2012, BP EN OUTL 2030; Centre for Interdisciplinary Studies of Mountain & Hill Environment, 2007, CARR CAP STUD TEEST; Choudhury Nirmalya, 2010, SUSTAINABLE DAM DEV; Dharmadikhary S., 2008, MOUNTAINS CONCRETE D; DYNESIUS M, 1994, SCIENCE, V266, P753, DOI 10.1126/science.266.5186.753; Ebinger Charles K., 2011, ENERGY SECURITY S AS; Hennig T., 2012, HYDROPOWER PRACTICE, P293; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; Mehta M. C., 2009, ECON POLIT WEEKLY, V2; Ministry of Water Resources Draft National Water Policy, 2012, NAT WAT POL IN PRESS; Nandimath O.V., 2009, OXFORD HDB ENV DECIS; Negi NS, 2011, 103 U BIEL CTR MIGR; Pandit MK, 2007, BIODIVERS CONSERV, V16, P153, DOI 10.1007/s10531-006-9038-5; Pandit MK, 2012, CONSERV BIOL, V26, P1061, DOI 10.1111/j.1523-1739.2012.01918.x; Press Information Bureau Government of India, 2012, 3 M NAT GANG RIV BAS; Rajaram T, 2011, J ENVIRON MANAGE, V92, P140, DOI 10.1016/j.jenvman.2010.08.024; Richter B. D., 2010, WATER ALTERN, V3, P14, DOI DOI 10.1007/S11195-009-9131-2; Sharma T., 2012, MEGA DAMS CAMPAIGNIN; Singh JS, 2006, CURR SCI INDIA, V90, P784; Sreedharan P, 2011, ELECT GRID EVOLUTION; Subramanian A., 2012, CAN INDIAS POWER PRO; Tollefson J, 2011, NATURE, V474, P430, DOI 10.1038/474430a; Wildlife Institute of India, 2012, ASS CUM IMP HYDR PRO; World Wildlife Fund, 2007, CLIM SOL WWFS VIS 20	24	138	142	5	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					36	37		10.1126/science.1227211	http://dx.doi.org/10.1126/science.1227211			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288526				2022-12-28	WOS:000312985800039
J	Khajetoorians, AA; Baxevanis, B; Hubner, C; Schlenk, T; Krause, S; Wehling, TO; Lounis, S; Lichtenstein, A; Pfannkuche, D; Wiebe, J; Wiesendanger, R				Khajetoorians, Alexander Ako; Baxevanis, Benjamin; Huebner, Christoph; Schlenk, Tobias; Krause, Stefan; Wehling, Tim Oliver; Lounis, Samir; Lichtenstein, Alexander; Pfannkuche, Daniela; Wiebe, Jens; Wiesendanger, Roland			Current-Driven Spin Dynamics of Artificially Constructed Quantum Magnets	SCIENCE			English	Article							GIANT MAGNETORESISTANCE; MULTILAYER; EXCITATION	The future of nanoscale spin-based technologies hinges on a fundamental understanding and dynamic control of atomic-scale magnets. The role of the substrate conduction electrons on the dynamics of supported atomic magnets is still a question of interest lacking experimental insight. We characterized the temperature-dependent dynamical response of artificially constructed magnets, composed of a few exchange-coupled atomic spins adsorbed on a metallic substrate, to spin-polarized currents driven and read out by a magnetic scanning tunneling microscope tip. The dynamics, reflected by two-state spin noise, is quantified by a model that considers the interplay between quantum tunneling and sequential spin transitions driven by electron spin-flip processes and accounts for an observed spin-transfer torque effect.	[Khajetoorians, Alexander Ako; Schlenk, Tobias; Krause, Stefan; Wiebe, Jens; Wiesendanger, Roland] Univ Hamburg, Inst Appl Phys, D-20355 Hamburg, Germany; [Baxevanis, Benjamin; Huebner, Christoph; Lichtenstein, Alexander; Pfannkuche, Daniela] Univ Hamburg, Inst Theoret Phys 1, D-20355 Hamburg, Germany; [Wehling, Tim Oliver] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany; [Wehling, Tim Oliver] Univ Bremen, Bremen Ctr Computat Mat Sci, D-28359 Bremen, Germany; [Lounis, Samir] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Lounis, Samir] Forschungszentrum Julich, Inst Adv Simulat, D-52425 Julich, Germany; [Lounis, Samir] JARA Julich Aachen Res Alliance, D-52425 Julich, Germany	University of Hamburg; University of Hamburg; University of Bremen; University of Bremen; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Khajetoorians, AA (corresponding author), Univ Hamburg, Inst Appl Phys, Jungiusstr 11, D-20355 Hamburg, Germany.	akhajeto@physnet.uni-hamburg.de; jwiebe@physnet.uni-hamburg.de	Krause, Stefan/M-6384-2019; Krause, Stefan/C-8491-2009; Lichtenstein, Alexander/K-8730-2012; Wehling, Tim/O-4642-2014; Lounis, Samir/G-1875-2010; Wiesendanger, Roland/P-9726-2016; Wiebe, Jens/C-7580-2018; Khajetoorians, Alexander A/F-9698-2015	Krause, Stefan/0000-0002-0677-8468; Lichtenstein, Alexander/0000-0003-0152-7122; Wehling, Tim/0000-0002-5579-2231; Lounis, Samir/0000-0003-2573-2841; Wiesendanger, Roland/0000-0002-0472-4183; Wiebe, Jens/0000-0003-1668-6142; 	European Research Council (ERC) Advanced Grant "FURORE"; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft [SFB668, SPP 1285, FOR1346, Graduiertenkolleg 1286]; Cluster of Excellence "Nanospintronics"; Forschungs-und Wissenschaftsstiftung Hamburg; HGF-YIG Programme [VH-NG-717 (]	European Research Council (ERC) Advanced Grant "FURORE"(European Research Council (ERC)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Nanospintronics"; Forschungs-und Wissenschaftsstiftung Hamburg; HGF-YIG Programme	Financial support from the European Research Council (ERC) Advanced Grant "FURORE"; Bundesministerium fur Bildung und Forschung; the Deutsche Forschungsgemeinschaft via the SFB668, SPP 1285 (B. B.), FOR1346, and the Graduiertenkolleg 1286 "Functional Metal-Semiconductor Hybrid Systems"; the Cluster of Excellence "Nanospintronics" funded by the Forschungs-und Wissenschaftsstiftung Hamburg; and HGF-YIG Programme VH-NG-717 (Functional nanoscale structure probe and simulation laboratory-Funsilab, S. L.) is gratefully acknowledged.	BAIBICH MN, 1988, PHYS REV LETT, V61, P2472, DOI 10.1103/PhysRevLett.61.2472; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Bergman A, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.224425; Brataas A, 2012, NAT MATER, V11, P372, DOI [10.1038/NMAT3311, 10.1038/nmat3311]; Delgado F, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.026601; DIENY B, 1991, PHYS REV B, V43, P1297, DOI 10.1103/PhysRevB.43.1297; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Fransson J, 2009, NANO LETT, V9, P2414, DOI 10.1021/nl901066a; Gatteschi D, 2006, MESOSCOPIC PHYS NANO, P1; Gawronski H, 2008, SCIENCE, V319, P930, DOI 10.1126/science.1152473; Gilbert TL, 2004, IEEE T MAGN, V40, P3443, DOI 10.1109/TMAG.2004.836740; Hirjibehedin CF, 2006, SCIENCE, V312, P1021, DOI 10.1126/science.1125398; Khajetoorians AA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.037205; Khajetoorians AA, 2012, NAT PHYS, V8, P497, DOI [10.1038/nphys2299, 10.1038/NPHYS2299]; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Krause S, 2007, SCIENCE, V317, P1537, DOI 10.1126/science.1145336; Lorente N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.176601; Loth S, 2012, SCIENCE, V335, P196, DOI 10.1126/science.1214131; Loth S, 2010, NAT PHYS, V6, P340, DOI 10.1038/NPHYS1616; Meier F, 2008, SCIENCE, V320, P82, DOI 10.1126/science.1154415; MILLS DL, 1967, PHYS REV, V160, P590, DOI 10.1103/PhysRev.160.590; Misiorny M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.054448; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Ralph DC, 2008, J MAGN MAGN MATER, V320, P1190, DOI 10.1016/j.jmmm.2007.12.019; Schuh T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104401; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tsoi M, 2000, NATURE, V406, P46, DOI 10.1038/35017512; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Wernsdorfer W, 1999, SCIENCE, V284, P133, DOI 10.1126/science.284.5411.133	30	173	174	3	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					55	59		10.1126/science.1228519	http://dx.doi.org/10.1126/science.1228519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288534				2022-12-28	WOS:000312985800049
J	Kamerow, D				Kamerow, Douglas			Does gay marriage improve health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INSURANCE		RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				Buffie WC, 2011, AM J PUBLIC HEALTH, V101, P986, DOI 10.2105/AJPH.2010.300112; Halkitis PN, 2012, AM J PUBLIC HEALTH, V102, P1628, DOI 10.2105/AJPH.2012.300940; Hatzenbuehler ML, 2012, AM J PUBLIC HEALTH, V102, P285, DOI 10.2105/AJPH.2011.300382; Parker-Pope Tara, 2010, NY TIMES MAGAZINE; Ponce NA, 2010, HEALTH AFFAIR, V29, P1539, DOI 10.1377/hlthaff.2009.0583; Wight RG, 2012, AM J PUBLIC HEALTH, V102, P503, DOI 10.2105/AJPH.2011.300384; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	7	1	1	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2012	345								e8586	10.1136/bmj.e8586	http://dx.doi.org/10.1136/bmj.e8586			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23262572				2022-12-28	WOS:000312701700003
J	Kharazmi, E; Fallah, M; Sundquist, K; Hemminki, K				Kharazmi, E.; Fallah, M.; Sundquist, K.; Hemminki, K.			Familial risk of early and late onset cancer: nationwide prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIETARY FACTORS; LIFE-STYLE; UK; FRACTION; DATABASE; DISEASE	Objective To determine whether familial risk of cancer is limited to early onset cases. Design Nationwide prospective cohort study. Setting Nationwide Swedish Family-Cancer Database. Participants All Swedes born after 1931 and their biological parents, totalling >12.2 million individuals, including >1.1 million cases of first primary cancer. Main outcome measures Familial risks of the concordant cancers by age at diagnosis. Results The highest familial risk was seen for offspring whose parents were diagnosed at an early age. Familial risks were significantly increased for colorectal, lung, breast, prostate, and urinary bladder cancer and melanoma, skin squamous cell carcinoma, and non-Hodgkin's lymphoma, even when parents were diagnosed at age 70-79 or 80-89. When parents were diagnosed at more advanced ages (>= 90), the risk of concordant cancer in offspring was still significantly increased for skin squamous cell carcinoma (hazard ratio 1.9, 95% confidence interval 1.4 to 2.7), colorectal (1.6, 1.2 to 2.0), breast (1.3, 1.0 to 1.6), and prostate cancer (1.3, 1.1 to 1.6). For offspring with a cancer diagnosed at ages 60-76 whose parents were affected at age <50, familial risks were not significantly increased for nearly all cancers. Conclusion Though the highest familial risks of cancer are seen in offspring whose parents received a diagnosis of a concordant cancer at earlier ages, increased risks exist even in cancers of advanced ages. Familial cancers might not be early onset in people whose family members were affected at older ages and so familial cancers might have distinct early and late onset components.	[Kharazmi, E.; Fallah, M.; Hemminki, K.] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Sundquist, K.; Hemminki, K.] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, K.] Stanford Univ, Sch Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Lund University; Stanford University	Kharazmi, E (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany.	E.Kharazmi@dkfz.de	Fallah, Mahdi/A-8745-2008	Fallah, Mahdi/0000-0002-6639-065X; Kharazmi, Elham/0000-0003-4919-6641	Swedish Council for Working Life and Social Research; German Cancer Aid (Deutsche Krebshilfe)	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	This study was supported by the Swedish Council for Working Life and Social Research and the German Cancer Aid (Deutsche Krebshilfe).	Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bergstrom A, 2001, INT J CANCER, V91, P421, DOI 10.1002/1097-0215(200002)9999:9999&lt;::AID-IJC1053&gt;3.0.CO;2-T; Brandt A, 2008, ANN ONCOL, V19, P2084, DOI 10.1093/annonc/mdn527; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Engholm G, 2012, NORDCAN CANC INCIDEN; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Hampel H, 2004, J MED GENET, V41, P81, DOI 10.1136/jmg.2003.010918; Hemminki K, 2003, INT J CANCER, V103, P105, DOI 10.1002/ijc.10764; Hemminki K, 2002, INT J CANCER, V98, P316, DOI 10.1002/ijc.10195; Hemminki K, 2009, INT J CANCER, V124, P2250, DOI 10.1002/ijc.24301; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Hemminki K, 2001, ACTA ONCOL, V40, P772; Hemminki K, 2005, HERED CANCER CLIN PR, V3, P7, DOI 10.1186/1897-4287-3-1-7; Hopper John L, 2011, Epidemiol Perspect Innov, V8, P2, DOI 10.1186/1742-5573-8-2; Kerber RA, 2005, CANCER-AM CANCER SOC, V103, P1906, DOI 10.1002/cncr.20989; Leu M, 2008, J NATL CANCER I, V100, P1318, DOI 10.1093/jnci/djn290; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Parkin DM, 2011, BRIT J CANCER, V105, pS27, DOI 10.1038/bjc.2011.479; Parkin DM, 2011, BRIT J CANCER, V105, pS24, DOI 10.1038/bjc.2011.478; Parkin DM, 2011, BRIT J CANCER, V105, pS2, DOI 10.1038/bjc.2011.474; Peto J, 2001, NATURE, V411, P390, DOI 10.1038/35077256; Pisani P, 1997, CANCER EPIDEM BIOMAR, V6, P387; Sundquist K, 2011, AM HEART J, V162, P317, DOI 10.1016/j.ahj.2011.05.013; The National Board of Health and Welfare, 2007, CANC INC SWED 2006; zur Hausen H, 1999, EUR J CANCER, V35, P1878, DOI 10.1016/S0959-8049(99)00291-9	28	46	48	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2012	345								e8076	10.1136/bmj.e8076	http://dx.doi.org/10.1136/bmj.e8076			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059JI	23257063	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000312700600001
J	Agus, DB; Gell-Mann, M				Agus, David B.; Gell-Mann, Murray			PERSPECTIVE Meeting of minds	NATURE			English	Editorial Material									[Agus, David B.] Univ So Calif, Ctr Appl Mol Med, Beverly Hills, CA USA; [Gell-Mann, Murray] Santa Fe Inst, Santa Fe, NM USA	University of Southern California; The Santa Fe Institute	Agus, DB (corresponding author), Univ So Calif, Ctr Appl Mol Med, Beverly Hills, CA USA.	agus@usc.edu							0	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S61	S61		10.1038/491S61a	http://dx.doi.org/10.1038/491S61a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320291	Bronze			2022-12-28	WOS:000311339800007
J	Summers, DM; Johnson, RJ; Hudson, A; Collett, D; Watson, CJ; Bradley, JA				Summers, Dominic M.; Johnson, Rachel J.; Hudson, Alex; Collett, David; Watson, Christopher J.; Bradley, J. Andrew			Effect of donor age and cold storage time on outcome in recipients of kidneys donated after circulatory death in the UK: a cohort study	LANCET			English	Article							CARDIAC DEATH; MACHINE PERFUSION; ORGAN DONATION; TRANSPLANTATION; MULTICENTER; ALLOCATION; SURVIVAL; ISCHEMIA	Background Use of kidneys donated after controlled circulatory death has increased the number of transplants undertaken in the UK but there remains reluctance to use kidneys from older circulatory-death donors and concern that kidneys from circulatory-death donors are particularly susceptible to cold ischaemic injury. We aimed to compare the effect of donor age and cold ischaemic time on transplant outcome in kidneys donated after circulatory death versus brain death. Methods We used the UK transplant registry to select a cohort of first-time recipients (aged >= 18 years) of deceaseddonor kidneys for transplantations done between Jan 1, 2005, and Nov 1, 2010. We did univariate comparisons of transplants from brain-death donors versus circulatory-death donors with chi(2) tests for categorical data and Wilcoxon tests for non-parametric continuous data. We used Kaplan-Meier curves to show graft survival. We used Cox proportional hazards regression to adjust for donor and recipient factors associated with graft-survival with tests for interaction effects to establish the relative effect of donor age and cold ischaemia on kidneys from circulatory-death and brain-death donors. Findings 6490 deceased-donor kidney transplants were done at 23 centres. 3 year graft survival showed no difference between circulatory-death (n=1768) and brain-death (n=4127) groups (HR 1.14, 95% CI 0.95-1.36, p=0.16). Donor age older than 60 years (compared with <40 years) was associated with an increased risk of graft loss for all deceaseddonor kidneys (2.35, 1.85-3.00, p<0.0001) but there was no increased risk of graft loss for circulatory-death donors older than 60 years compared with brain-death donors in the same age group (p=0.30). Prolonged cold ischaemic time (>24 h vs <12 h) was not associated with decreased graft survival for all deceased-donor kidneys but was associated with poorer graft survival for kidneys from circulatory-death donors than for those from brain-death donors (2.36, 1.39-4.02, p for interaction=0.004). Interpretation Kidneys from older circulatory-death donors have equivalent graft survival to kidneys from brain-death donors in the same age group, and are acceptable for transplantation. However, circulatory-death donor kidneys tolerate cold storage less well than do brain-death donor kidneys and this finding should be considered when developing organ allocation policy.	[Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Univ Cambridge, Sch Clin Med, Dept Surg, Cambridge, England; [Summers, Dominic M.; Watson, Christopher J.; Bradley, J. Andrew] Cambridge Natl Inst Hlth Res, Biomed Res Ctr, Cambridge, England; [Summers, Dominic M.; Johnson, Rachel J.; Hudson, Alex; Collett, David] Natl Hlth Serv Blood & Transplant, Bristol, Avon, England	University of Cambridge; University of Cambridge; NHS Blood & Transplant (NHSBT)	Summers, DM (corresponding author), Addenbrookes Hosp, Univ Dept Surg, Box 202, Cambridge CB2 0QQ, England.	dms39@cam.ac.uk	Summers, D. M./H-8678-2019	Summers, D. M./0000-0003-3360-0726; Collett, David/0000-0003-4861-7627; Johnson, Rachel/0000-0001-9199-3455	Astellas; Novartis; Roche; Wyeth; Organ Recovery Systems; UK National Health Service Blood and Transplant; Cambridge National Institute for Health Research Biomedical Research Centre	Astellas(Astellas Pharmaceuticals); Novartis(Novartis); Roche(Roche Holding); Wyeth(Wyeth); Organ Recovery Systems; UK National Health Service Blood and Transplant; Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR))	Funding UK National Health Service Blood and Transplant; Cambridge National Institute for Health Research Biomedical Research Centre.; JAB is trustee of the Roche Organ Transplant Foundation; his department has received grants from pharmaceutical companies that market immunosuppressive therapy, notably Astellas, Novartis, Roche, and Wyeth, and from machine preservation manufacturers Organ Recovery Systems; and he has received travel and accommodation costs from Astellas to attend a training course. CJW has received research grants and honoraria for travel, accommodation, and registration to transplant conferences from Astellas, Novartis, Roche, and Wyeth; and research grants from Organ Recovery Systems. All other authors declare that they have no conflicts of interest.	De Fijter JW, 2001, J AM SOC NEPHROL, V12, P1538, DOI 10.1681/ASN.V1271538; Gomez MP, 2012, TRANSPL P, V44, P1592, DOI 10.1016/j.transproceed.2012.04.005; Jochmans I, 2010, ANN SURG, V252, P756, DOI 10.1097/SLA.0b013e3181ffc256; Johnson RJ, 2010, TRANSPLANTATION, V89, P387, DOI 10.1097/TP.0b013e3181c9029d; Johnson RJ, 2010, TRANSPLANTATION, V89, P379, DOI 10.1097/TP.0b013e3181c90287; Kayler LK, 2011, AM J TRANSPLANT, V11, P2657, DOI 10.1111/j.1600-6143.2011.03817.x; Kayler LK, 2011, AM J TRANSPLANT, V11, P2647, DOI 10.1111/j.1600-6143.2011.03741.x; Klein AS, 2010, AM J TRANSPLANT, V10, P973, DOI 10.1111/j.1600-6143.2009.03008.x; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Locke JE, 2007, AM J TRANSPLANT, V7, P1797, DOI 10.1111/j.1600-6143.2007.01852.x; Moreso F, 1999, NEPHROL DIAL TRANSPL, V14, P930, DOI 10.1093/ndt/14.4.930; NHSBT, TRANSPL AT UK ACT RE; NHSBT, MED WAIT TIM KIDN TR; Opelz G, 2007, TRANSPLANTATION, V83, P247, DOI 10.1097/01.tp.0000251781.36117.27; Rao PS, 2009, CLIN J AM SOC NEPHRO, V4, P1827, DOI 10.2215/CJN.02270409; Rao PS, 2009, TRANSPLANTATION, V88, P231, DOI 10.1097/TP.0b013e3181ac620b; Snoeijs MGJ, 2010, TRANSPLANTATION, V90, P1106, DOI 10.1097/TP.0b013e3181f83b0b; Summers DM, 2010, LANCET, V376, P1303, DOI 10.1016/S0140-6736(10)60827-6; van der Vliet JA, 2011, CLIN TRANSPLANT, V25, pE612, DOI 10.1111/j.1399-0012.2011.01510.x; Watson CJE, 2010, AM J TRANSPLANT, V10, P1991, DOI 10.1111/j.1600-6143.2010.03165.x; Watson CJE, 2012, TRANSPLANTATION, V93, P314, DOI 10.1097/TP.0b013e31823f14d4	21	174	175	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					727	734		10.1016/S0140-6736(12)61685-7	http://dx.doi.org/10.1016/S0140-6736(12)61685-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098TC	23261146				2022-12-28	WOS:000315570900026
J	Lamb, SE; Gates, S; Williams, MA; Williamson, EM; Mt-Isa, S; Withers, EJ; Castelnuovo, E; Smith, J; Ashby, D; Cooke, MW; Petrou, S; Underwood, MR				Lamb, Sarah E.; Gates, Simon; Williams, Mark A.; Williamson, Esther M.; Mt-Isa, Shahrul; Withers, Emma J.; Castelnuovo, Emanuela; Smith, Jessica; Ashby, Deborah; Cooke, Matthew W.; Petrou, Stavros; Underwood, Martin R.		Managing Injuries Neck Trial MINT	Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trial	LANCET			English	Article							2000-2010 TASK-FORCE; MANAGING INJURIES; EARLY MANAGEMENT; NECK PAIN; DISORDERS; INTERVENTION; GUIDELINES; MINT; RECOVERY; IMPROVE	Background Little is known about the effectiveness of treatments for acute whiplash injury. We aimed to estimate whether training of staff in emergency departments to provide active management consultations was more effective than usual consultations (Step 1) and to estimate whether a physiotherapy package was more effective than one additional physiotherapy advice session in patients with persisting symptoms (Step 2). Methods Step 1 was a pragmatic, cluster randomised trial of 12 NHS Trust hospitals including 15 emergency departments who treated patients with acute whiplash associated disorder of grades I-III. The hospitals were randomised by clusters to either active management or usual care consultations. In Step 2, we used a nested individually randomised trial. Patients were randomly assigned to receive either a package of up to six physiotherapy sessions or a single advice session. Randomisation in Step 2 was stratified by centre. Investigator-masked outcomes were obtained at 4, 8, and 12 months. Masking of clinicians and patients was not possible in all steps of the trial. The primary outcome was the Neck Disability Index (NDI). Analysis was intention to treat, and included an economic evaluation. The study is registered ISRCTN33302125. Findings Recruitment ran from Dec 5, 2005 to Nov 30, 2007. Follow-up was completed on Dec 19, 2008. In Step 1, 12 NHS Trusts were randomised, and 3851 of 6952 eligible patients agreed to participate (1598 patients were assigned to usual care and 2253 patients were assigned to active management). 2704 (70%) of 3851 patients provided data at 12 months. NDI score did not differ between active management and usual care consultations (difference at 12 months 0.5, 95% CI -1.5 to 2.5). In Step 2, 599 patients were randomly assigned to receive either advice (299 patients) or a physiotherapy package (300 patients). 479 (80%) patients provided data at 12 months. The physiotherapy package at 4 months showed a modest benefit compared to advice (NDI difference -3.7, -6.1 to -1.3), but not at 8 or 12 months. Active management consultations and the physiotherapy package were more expensive than usual care and single advice session. No treatment-related serious adverse events or deaths were noted. Interpretation Provision of active management consultation did not show additional benefit. A package of physiotherapy gave a modest acceleration to early recovery of persisting symptoms but was not cost effective from a UK NHS perspective. Usual consultations in emergency departments and a single physiotherapy advice session for persistent symptoms are recommended.	[Lamb, Sarah E.; Gates, Simon; Williams, Mark A.; Williamson, Esther M.; Withers, Emma J.; Castelnuovo, Emanuela; Smith, Jessica; Cooke, Matthew W.; Petrou, Stavros; Underwood, Martin R.] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Lamb, Sarah E.] John Radcliff Hosp, Kadoorie Crit Care Res Ctr, Oxford, England; [Mt-Isa, Shahrul; Ashby, Deborah] Univ London Imperial Coll Sci Technol & Med, London, England	University of Warwick; Imperial College London	Lamb, SE (corresponding author), Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England.	s.lamb@warwick.ac.uk	Mt-Isa, Shahrul/F-1275-2010; Sterling, Michele/F-1679-2010; Petrou, Stavros/ABD-8323-2021; Underwood, Martin/D-6364-2015; Williams, Mark/J-5347-2013	Mt-Isa, Shahrul/0000-0002-7163-8402; Sterling, Michele/0000-0003-1772-2248; Petrou, Stavros/0000-0003-3121-6050; Underwood, Martin/0000-0002-0309-1708; Williams, Mark/0000-0002-3488-847X; Lamb, Sarah/0000-0003-4349-7195; Williamson, Esther/0000-0003-0638-0406	NIHR Health Technology Assessment programme [02/35/02]; Birmingham Science; Advantage West Midlands; National Institute for Health Research [02/35/02, NF-SI-0512-10103] Funding Source: researchfish	NIHR Health Technology Assessment programme(National Institute for Health Research (NIHR)); Birmingham Science; Advantage West Midlands(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	MINT was funded by the NIHR Health Technology Assessment Programme, project number 02/35/02. This project benefitted from facilities funded through Birmingham Science. City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West Midlands.	[Anonymous], 2002, BC MED J; Carroll LJ, 2008, SPINE, V33, pS83, DOI 10.1097/BRS.0b013e3181643eb8; Ferrari R, 2005, ACAD EMERG MED, V12, P699, DOI 10.1197/j.aem.2005.03.531; Gargan M, 1997, J BONE JOINT SURG BR, V79B, P523, DOI 10.1302/0301-620X.79B4.6940; Gates S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-44; GRIMSHAW JM, 1993, LANCET, V342, P1317, DOI 10.1016/0140-6736(93)92244-N; Hurwitz EL, 2008, SPINE, V33, pS123, DOI 10.1097/BRS.0b013e3181644b1d; Kongsted A, 2008, SPINE, V33, pE843, DOI 10.1097/BRS.0b013e318182bee2; Lamb SE, 2009, EMERG MED J, V26, P644, DOI 10.1136/emj.2008.065276; Lamb SE, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-7; Mayou R, 1996, INJURY, V27, P617, DOI 10.1016/S0020-1383(96)00114-3; McClune T, 2003, EMERG MED J, V20, P514, DOI 10.1136/emj.20.6.514; National Centre for Social Research and University of College London. Department of Epidemiology and Public Health HSfE, 1991, HLTH SURV ENGL 2006; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; PENNIE B, 1991, INJURY, V22, P57, DOI 10.1016/0020-1383(91)90166-C; Pietrobon B, 2002, SPINE, V27, P515, DOI 10.1097/00007632-200203010-00012; Provinciali L, 1996, SCAND J REHABIL MED, V28, P105; Rasbash J, 2009, MLWIN VERSION 21; Rosenfeld M, 2003, SPINE, V28, P2491, DOI 10.1097/01.BRS.0000090822.96814.13; Rushton A, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000265; Savigny P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1805; SPITZER WO, 1995, SPINE, V20, pS1; Torgerson DJ, 2001, BMJ-BRIT MED J, V322, P355, DOI 10.1136/bmj.322.7282.355; Underwood M, 2002, FAM PRACT, V19, P511, DOI 10.1093/fampra/19.5.511; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Verhagen A, 2007, COCHRANE DB SYST REV, V2; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Waddell G, 2005, WHIPLASH BOOK; WILLIAMS A., 1995, MEASUREMENT VALUATIO; Williamson E, 2009, PHYSIOTHERAPY, V95, P15, DOI 10.1016/j.physio.2008.11.001	30	84	86	0	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					546	556		10.1016/S0140-6736(12)61304-X	http://dx.doi.org/10.1016/S0140-6736(12)61304-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23260167				2022-12-28	WOS:000314927500029
J	Mozaffarian, D; Hemenway, D; Ludwig, DS				Mozaffarian, Dariush; Hemenway, David; Ludwig, David S.			Curbing Gun Violence Lessons From Public Health Successes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POISON PREVENTION		[Mozaffarian, Dariush] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Hemenway, David] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cook PJ, 2006, J PUBLIC ECON, V90, P379, DOI 10.1016/j.jpubeco.2005.02.003; Gallop Politics, STOP SHOOT AM FOC PO; Hemenway D, 2001, J PUBLIC HEALTH POL, V22, P381, DOI 10.2307/3343157; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; *I MED COMM RED TO, 2007, END TOB PROBL BLUEPR; King Brian, 2011, Morbidity and Mortality Weekly Report, V60, P1207; LOVEJOY FH, 1994, PEDIATRICS, V94, P220; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; WALTON WW, 1982, PEDIATRICS, V69, P363	9	32	33	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					551	552		10.1001/jama.2013.38	http://dx.doi.org/10.1001/jama.2013.38			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087PH	23295618	Bronze			2022-12-28	WOS:000314773700024
J	Zhang, GJ; Cowled, C; Shi, ZL; Huang, ZY; Bishop-Lilly, KA; Fang, XD; Wynne, JW; Xiong, ZQ; Baker, ML; Zhao, W; Tachedjian, M; Zhu, YB; Zhou, P; Jiang, XT; Ng, J; Yang, L; Wu, LJ; Xiao, J; Feng, Y; Chen, YX; Sun, XQ; Zhang, Y; Marsh, GA; Crameri, G; Broder, CC; Frey, KG; Wang, LF; Wang, J				Zhang, Guojie; Cowled, Christopher; Shi, Zhengli; Huang, Zhiyong; Bishop-Lilly, Kimberly A.; Fang, Xiaodong; Wynne, James W.; Xiong, Zhiqiang; Baker, Michelle L.; Zhao, Wei; Tachedjian, Mary; Zhu, Yabing; Zhou, Peng; Jiang, Xuanting; Ng, Justin; Yang, Lan; Wu, Lijun; Xiao, Jin; Feng, Yue; Chen, Yuanxin; Sun, Xiaoqing; Zhang, Yong; Marsh, Glenn A.; Crameri, Gary; Broder, Christopher C.; Frey, Kenneth G.; Wang, Lin-Fa; Wang, Jun			Comparative Analysis of Bat Genomes Provides Insight into the Evolution of Flight and Immunity	SCIENCE			English	Article							DNA-DAMAGE; PHYLOGENY; ACTIVATION; PATHWAYS; VIRUSES; PROTEIN; STRESS; FAMILY; P53	Bats are the only mammals capable of sustained flight and are notorious reservoir hosts for some of the world's most highly pathogenic viruses, including Nipah, Hendra, Ebola, and severe acute respiratory syndrome (SARS). To identify genetic changes associated with the development of bat-specific traits, we performed whole-genome sequencing and comparative analyses of two distantly related species, fruit bat Pteropus alecto and insectivorous bat Myotis davidii. We discovered an unexpected concentration of positively selected genes in the DNA damage checkpoint and nuclear factor kappa B pathways that may be related to the origin of flight, as well as expansion and contraction of important gene families. Comparison of bat genomes with other mammalian species has provided new insights into bat biology and evolution.	[Zhang, Guojie; Huang, Zhiyong; Fang, Xiaodong; Xiong, Zhiqiang; Zhao, Wei; Zhu, Yabing; Jiang, Xuanting; Yang, Lan; Xiao, Jin; Feng, Yue; Chen, Yuanxin; Sun, Xiaoqing; Zhang, Yong; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Zhang, Guojie] Univ Copenhagen, Dept Biol, Ctr Social Evolut, DK-2100 Copenhagen, Denmark; [Cowled, Christopher; Wynne, James W.; Baker, Michelle L.; Tachedjian, Mary; Zhou, Peng; Ng, Justin; Marsh, Glenn A.; Crameri, Gary; Wang, Lin-Fa] CSIRO, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia; [Shi, Zhengli; Zhou, Peng; Wu, Lijun] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China; [Bishop-Lilly, Kimberly A.; Frey, Kenneth G.] USN, Med Res Ctr, Frederick, MD 21702 USA; [Bishop-Lilly, Kimberly A.; Frey, Kenneth G.] Henry M Jackson Fdn, Frederick, MD 21702 USA; [Broder, Christopher C.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Wang, Lin-Fa] Duke Natl Univ Singapore Grad Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Beijing Genomics Institute (BGI); University of Copenhagen; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; United States Department of Defense; United States Navy; Uniformed Services University of the Health Sciences - USA; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Zhang, GJ (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	zhanggj@genomics.org.cn; linfa.wang@csiro.au; wangj@genomics.org.cn	Crameri, Gary/H-8441-2013; Baker, Michelle L/C-9694-2013; Broder, Christopher/E-1169-2013; Wang, Jun/A-7261-2013; Cowled, Christopher JE/H-5308-2013; wang, lin/GSE-3040-2022; Fang, Xiaodong/K-6743-2018; Baker, Michelle/AAX-9171-2020; Zhang, Guojie/J-7273-2019; Marsh, Glenn A/A-5418-2013; Wynne, James W/H-7957-2013; Zhou, Peng/I-8578-2015; Zhang, Guojie/B-6188-2014; Shi, Zheng-Li/A-1013-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016; Tachedjian, Mary/H-4572-2013	Baker, Michelle L/0000-0002-7993-9971; Cowled, Christopher JE/0000-0002-1969-9371; Fang, Xiaodong/0000-0001-7061-3337; Baker, Michelle/0000-0002-7993-9971; Zhang, Guojie/0000-0001-6860-1521; Marsh, Glenn A/0000-0002-3469-1837; Wynne, James W/0000-0001-6846-757X; Zhou, Peng/0000-0003-1938-8255; Zhang, Guojie/0000-0001-6860-1521; Shi, Zheng-Li/0000-0001-8089-163X; Wang, Jun/0000-0002-8540-8931; Wang, Lin-Fa/0000-0003-2752-0535; Wang, Jun/0000-0002-2113-5874; Tachedjian, Mary/0000-0002-8936-6564	China National Genebank at Shenzhen; CSIRO; Australian Research Council [FT110100234]; State Key Program for Basic Research [2011CB504701]; National Natural Science Foundation of China [81290341]; Defense Threat Reduction Agency of the USA	China National Genebank at Shenzhen; CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council(Australian Research Council); State Key Program for Basic Research(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Defense Threat Reduction Agency of the USA(United States Department of DefenseDefense Threat Reduction Agency)	We thank H. Field, C. Smith, and M. Yu for helping source genomic DNA; K. Itahana and J. J. Boomsma for constructive discussion; and M. Cowled for graphics assistance. We acknowledge financial support from the China National Genebank at Shenzhen, CSIRO (Office of the Chief Executive Science Leaders Award, Julius Award), The Australian Research Council (FT110100234), State Key Program for Basic Research (2011CB504701), National Natural Science Foundation of China (81290341), and the Defense Threat Reduction Agency of the USA. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U. S. government. K. A. B.-L. and K. G. F. are contractors for the U. S. government. This work was prepared as part of their official duties. Title 17 U. S. C. 105 provides that "Copyright protection under this title is not available for any work of the United States Government." Title 17 U. S. C. 101 defines a U. S. government work as a work prepared by a military service member or employee of the U. S. government as part of that person's official duties. P. alecto and M. davidii genomes have been deposited at DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank under the accession nos. ALWS01000000 and ALWT01000000. Short-read data have been deposited into the Short Read Archive under accession nos. SRA056924 and SRA056925. Raw transcriptome data have been deposited in Gene Expression Omnibus as GSE39933. Tree files and alignments have been submitted to TreeBASE under Study Accession URL: http://purl.org/phylo/treebase/phylows/study/TB2:S13654. We also thank the editor and two anonymous reviewers for their helpful comments and suggestions. Author contributions: J.W., L.-F.W., G.Z., C. C. B., and K. A. B.-L. conceived the study. M. T., M. L. B., G. A. M., G. C., L. W., and Z.S. prepared the samples. G.Z., Z. H., X. F., Z. X., W. Z., Y. Zhu, X.J., L. Y., J.X., Y. F., Y. C., X. S., Y. Zhang, K. G. F., K. A. B.-L., and J.W. performed genome sequencing, assembly, and annotation. G. Z. and J.W. supervised genome sequencing, assembly, and annotation. G. Z., C. C., Z. H., X. F., J.W. W., Z. X., J.N., W. Z., P. Z., Y. Zhu, M. T., and M. L. B. performed genome analyses. G. Z., Z. H., C. C., and J.W. W. carried out genetic analyses. G. Z., C. C., Z. H., X. F., P. Z., J.N., M. T., J.W. W., M. L. B., and L.-F.W. discussed the data. All authors contributed to data interpretation. C. C. and J.W. W. wrote the paper with significant contributions from G. Z., Z. H., P. Z., J.N., M. T., M. L. B., and L.-F.W. and input from all authors. The authors declare no competing financial interests. Requests for materials should be addressed to the authors for correspondence.	Barzilai A, 2002, DNA REPAIR, V1, P3, DOI 10.1016/S1568-7864(01)00007-6; Brunet-Rossinni AK, 2004, BIOGERONTOLOGY, V5, P211, DOI 10.1023/B:BGEN.0000038022.65024.d8; Brzoska K, 2009, MUTAGENESIS, V24, P1, DOI 10.1093/mutage/gen056; Cocchi F, 2012, P NATL ACAD SCI USA, V109, P5411, DOI 10.1073/pnas.1202240109; Cridland JA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-140; De Siervi A, 2009, CELL CYCLE, V8, P2093, DOI 10.4161/cc.8.13.8926; Gilmore Thomas D, 2011, Genes Cancer, V2, P695, DOI 10.1177/1947601911421925; Kenneth NS, 2010, EMBO J, V29, P2966, DOI 10.1038/emboj.2010.171; Li G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000900; Nery MF, 2012, MOL PHYLOGENET EVOL, V64, P685, DOI 10.1016/j.ympev.2012.04.012; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; O'Keefe K, 2003, MOL CELL BIOL, V23, P6396, DOI 10.1128/MCB.23.18.6396-6405.2003; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; Pritham EJ, 2007, P NATL ACAD SCI USA, V104, P1895, DOI 10.1073/pnas.0609601104; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; Sambrook JG, 2007, CURR OPIN IMMUNOL, V19, P553, DOI 10.1016/j.coi.2007.08.002; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Smith JDL, 2009, BIOL LETTERS, V5, P347, DOI 10.1098/rsbl.2009.0016; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Turnell AS, 2012, J GEN VIROL, V93, P2076, DOI 10.1099/vir.0.044412-0; Wang LF, 2011, CURR OPIN VIROL, V1, P649, DOI 10.1016/j.coviro.2011.10.013	23	372	388	9	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					456	460		10.1126/science.1230835	http://dx.doi.org/10.1126/science.1230835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23258410	Green Accepted			2022-12-28	WOS:000313960700046
J	Coussens, LM; Zitvogel, L; Palucka, AK				Coussens, Lisa M.; Zitvogel, Laurence; Palucka, A. Karolina			Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?	SCIENCE			English	Review							CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; CANCER; IMMUNITY; MACROPHAGES; STROMA; RISK; CLASSIFICATION; IMMUNOTHERAPY	There have been substantial advances in cancer diagnostics and therapies in the past decade. Besides chemotherapeutic agents and radiation therapy, approaches now include targeting cancer cell-intrinsic mediators linked to genetic aberrations in cancer cells, in addition to cancer cell-extrinsic pathways, especially those regulating vascular programming of solid tumors. More recently, immunotherapeutics have entered the clinic largely on the basis of the recognition that several immune cell subsets, when chronically activated, foster tumor development. Here, we discuss clinical and experimental studies delineating protumorigenic roles for immune cell subsets that are players in cancer-associated inflammation. Some of these cells can be targeted to reprogram their function, leading to resolution, or at least neutralization, of cancer-promoting chronic inflammation, thereby facilitating cancer rejection.	[Coussens, Lisa M.] Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell & Dev Biol, Portland, OR 97239 USA; [Zitvogel, Laurence] Univ Paris 11, Inst Gustave Roussy, CICBT507, INSERM,U1015, F-94805 Paris, France; [Palucka, A. Karolina] BIIR, Dallas, TX 75204 USA; [Palucka, A. Karolina] Mt Sinai Sch Med, Dept Oncol Sci, New York, NY 10029 USA	Oregon Health & Science University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Icahn School of Medicine at Mount Sinai	Coussens, LM (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Dept Cell & Dev Biol, 3181 SW Sam Jackson Pk Rd,Mail Code L215,Room 550, Portland, OR 97239 USA.	coussenl@ohsu.edu	Coussens, Lisa/ABH-9834-2020	ZITVOGEL, laurence/0000-0003-1596-0998	NIH/National Cancer Institute (NCI); Department of Defense; Susan B. Komen Foundation; Breast Cancer Research Foundation; LIGUE Francaise Contre le Cancer; Fondation pour la Recherche Medicale; Institut National du Cancer (SIRIC); Fondation Gustave Roussy; BIIR; Baylor University Medical Center foundations; Cancer Prevention Research Institute of Texas; NIH/NCI; NATIONAL CANCER INSTITUTE [U54CA163123, R01CA155331] Funding Source: NIH RePORTER	NIH/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)National Research Council of Science & Technology (NST), Republic of Korea); Department of Defense(United States Department of Defense); Susan B. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; LIGUE Francaise Contre le Cancer; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut National du Cancer (SIRIC); Fondation Gustave Roussy; BIIR; Baylor University Medical Center foundations; Cancer Prevention Research Institute of Texas; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank members of their laboratories for critical discussions on content and specifically A. Gunderson and B. Ruffell for critical reading of the manuscript. L. M. C. acknowledges support from the NIH/National Cancer Institute (NCI), a Department of Defense Breast Cancer Research Program Era of Hope Scholar Scholar Expansion Award, Susan B. Komen Foundation, and the Breast Cancer Research Foundation. L.Z. is supported by LIGUE Francaise Contre le Cancer, Fondation pour la Recherche Medicale, Institut National du Cancer (SIRIC), and Fondation Gustave Roussy. A.K.P. acknowledges the support from the BIIR and Baylor University Medical Center foundations, Susan B. Komen Foundation, Cancer Prevention Research Institute of Texas, and NIH/NCI.	Adams S, 2012, CLIN CANCER RES, V18, P6748, DOI 10.1158/1078-0432.CCR-12-1149; Ammirante M, 2010, NATURE, V464, P302, DOI 10.1038/nature08782; Andreu P, 2010, CANCER CELL, V17, P121, DOI 10.1016/j.ccr.2009.12.019; Anglesio MS, 2011, CLIN CANCER RES, V17, P2538, DOI 10.1158/1078-0432.CCR-10-3314; Aspord C, 2007, J EXP MED, V204, P1037, DOI 10.1084/jem.20061120; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Beck AH, 2009, CLIN CANCER RES, V15, P778, DOI 10.1158/1078-0432.CCR-08-1283; Bickels J, 2002, ISRAEL MED ASSOC J, V4, P471; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Monte L, 2011, J EXP MED, V208, P469, DOI 10.1084/jem.20101876; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Demehri S, 2012, CANCER CELL, V22, P494, DOI 10.1016/j.ccr.2012.08.017; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Di Piazza M, 2012, CANCER CELL, V22, P479, DOI 10.1016/j.ccr.2012.08.016; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205; Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-1; Geborek P, 2005, ANN RHEUM DIS, V64, P699, DOI 10.1136/ard.2004.030528; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasan A, 2011, EXPERT OPIN THER TAR, V15, P1211, DOI 10.1517/14728222.2011.613826; Heber G, 2009, J DTSCH DERMATOL GES, V7, P534, DOI 10.1111/j.1610-0387.2009.07038.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Horikawa M, 2011, J CLIN INVEST, V121, P4268, DOI 10.1172/JCI59266; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kessel A, 2008, CLIN REV ALLERG IMMU, V34, P74, DOI 10.1007/s12016-008-8074-1; Kido M, 2010, INFECT IMMUN, V78, P108, DOI 10.1128/IAI.00762-09; Kozin SV, 2010, CANCER RES, V70, P5679, DOI 10.1158/0008-5472.CAN-09-4446; Kristensen VN, 2012, P NATL ACAD SCI USA, V109, P2802, DOI 10.1073/pnas.1108781108; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Pedroza-Gonzalez A, 2011, J EXP MED, V208, P479, DOI 10.1084/jem.20102131; Pillai S, 2011, CURR OPIN IMMUNOL, V23, P721, DOI 10.1016/j.coi.2011.10.007; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Qian DZ, 2010, PROSTATE, V70, P433, DOI 10.1002/pros.21077; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sakthivel P, 2012, REV RECENT CLIN TRIA, V7, P10, DOI 10.2174/157488712799363262; Schioppa T, 2011, P NATL ACAD SCI USA, V108, P10662, DOI 10.1073/pnas.1100994108; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Skinnider BF, 2002, BLOOD, V99, P4283, DOI 10.1182/blood-2002-01-0099; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tan TT, 2007, CURR OPIN IMMUNOL, V19, P209, DOI 10.1016/j.coi.2007.01.001; Tanchot C, 2013, CANCER MICROENVIRON, V6, P147, DOI 10.1007/s12307-012-0122-y; Terabe M, 2004, CANCER IMMUNOL IMMUN, V53, P79, DOI 10.1007/s00262-003-0445-0; Thun Michael J, 2004, Novartis Found Symp, V256, P6; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Wang SDA, 2011, CURR TOP MICROBIOL, V344, P245, DOI 10.1007/82_2010_81; Wei EK, 2010, J CLIN ONCOL, V28, P4052, DOI 10.1200/JCO.2009.26.9324; Wei S, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19440; Welford AF, 2011, J CLIN INVEST, V121, P1969, DOI 10.1172/JCI44562; Wooster R, 2010, CURR OPIN GENET DEV, V20, P336, DOI 10.1016/j.gde.2010.03.007; ZBAR B, 1971, SCIENCE, V172, P271, DOI 10.1126/science.172.3980.271; Zhang WJ, 2008, CYTOKINE, V42, P39, DOI 10.1016/j.cyto.2008.01.016	73	744	780	5	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					286	291		10.1126/science.1232227	http://dx.doi.org/10.1126/science.1232227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329041	Green Accepted			2022-12-28	WOS:000313622000035
J	Narayan, ARH; Sherman, DH				Narayan, Alison R. H.; Sherman, David H.			Re-Engineering Nature's Catalysts	SCIENCE			English	Editorial Material							CONVERSION; PROTEIN		[Narayan, Alison R. H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Narayan, ARH (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	davidhs@umich.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078553] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1205646] Funding Source: National Science Foundation; NIGMS NIH HHS [R01 GM078553] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Breslow R, 2009, J BIOL CHEM, V284, P1337, DOI 10.1074/jbc.X800011200; Bulger PG, 2008, NAT PROD REP, V25, P254, DOI 10.1039/b705909b; Coelho PS, 2013, SCIENCE, V339, P307, DOI 10.1126/science.1231434; Doukyu N, 2010, BIOCHEM ENG J, V48, P270, DOI 10.1016/j.bej.2009.09.009; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P7745, DOI 10.1002/anie.200602795; Reetz MT, 2011, ANGEW CHEM INT EDIT, V50, P138, DOI 10.1002/anie.201000826; Sundar VC, 2003, NATURE, V424, P899, DOI 10.1038/424899a; WILSON ME, 1978, J AM CHEM SOC, V100, P306, DOI 10.1021/ja00469a064; Zhang KD, 2012, J AM CHEM SOC, V134, P18695, DOI 10.1021/ja3073462	12	12	12	1	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					283	284		10.1126/science.1233324	http://dx.doi.org/10.1126/science.1233324			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329039				2022-12-28	WOS:000313622000033
J	Ostuni, R; Piccolo, V; Barozzi, I; Polletti, S; Termanini, A; Bonifacio, S; Curina, A; Prosperini, E; Ghisletti, S; Natoli, G				Ostuni, Renato; Piccolo, Viviana; Barozzi, Iros; Polletti, Sara; Termanini, Alberto; Bonifacio, Silvia; Curina, Alessia; Prosperini, Elena; Ghisletti, Serena; Natoli, Gioacchino			Latent Enhancers Activated by Stimulation in Differentiated Cells	CELL			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTORS; REGULATORY ELEMENTS; CHROMATIN IMMUNOPRECIPITATION; GENE-EXPRESSION; MACROPHAGE; DYNAMICS; METHYLATIONS; PATHWAYS; DISTINCT	According to current models, once the cell has reached terminal differentiation, the enhancer repertoire is completely established and maintained by cooperatively acting lineage-specific transcription factors (TFs). TFs activated by extracellular stimuli operate within this predetermined repertoire, landing close to where master regulators are constitutively bound. Here, we describe latent enhancers, defined as regions of the genome that in terminally differentiated cells are unbound by TFs and lack the histone marks characteristic of enhancers but acquire these features in response to stimulation. Macrophage stimulation caused sequential binding of stimulus-activated and lineage-determining TFs to these regions, enabling deposition of enhancer marks. Once unveiled, many of these enhancers did not return to a latent state when stimulation ceased; instead, they persisted and mediated a faster and stronger response upon restimulation. We suggest that stimulus-specific expansion of the cis-regulatory repertoire provides an epigenomic memory of the exposure to environmental agents.	[Ostuni, Renato; Piccolo, Viviana; Barozzi, Iros; Polletti, Sara; Termanini, Alberto; Bonifacio, Silvia; Curina, Alessia; Prosperini, Elena; Ghisletti, Serena; Natoli, Gioacchino] European Inst Oncol IEO, Dept Expt Oncol, I-20139 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Ostuni, R (corresponding author), European Inst Oncol IEO, Dept Expt Oncol, Via Adamello 16, I-20139 Milan, Italy.	renato.ostuni@ieo.eu; gioacchino.natoli@ieo.eu	Barozzi, Iros/GLQ-8907-2022; Ghisletti, Serena/AAO-6437-2021; Termanini, Alberto/AAB-9934-2019; PROSPERINI, ELENA/AAB-1952-2021; Natoli, gioacchino/ABB-8679-2020; Ostuni, Renato/AAB-8832-2022; Natoli, gioacchino/J-2100-2018; Polletti, Sara/AAA-9543-2021; Polletti, Sara/K-3948-2018	Barozzi, Iros/0000-0003-0690-3473; Termanini, Alberto/0000-0002-9697-906X; Ostuni, Renato/0000-0003-0460-3426; Polletti, Sara/0000-0002-5433-0502; Polletti, Sara/0000-0002-5433-0502; Ghisletti, Serena/0000-0002-7087-5553; Natoli, Gioacchino/0000-0003-0711-2411	EMBO fellowship [ASTF 210-2012]; European Research Council [268757-NORM]	EMBO fellowship(European Molecular Biology Organization (EMBO)); European Research Council(European Research Council (ERC)European Commission)	We thank D. Voehringer and A. Planas for the generous gift of Stat6- and Stat1-deficient bone marrows, respectively; B. Amati for critical comments to the manuscript; I. Amit (Weizmann Institute, Rehovot) for training in the HT-ChIP protocol; L. Rotta, M. Riboni, S. Minardi (Cogentech, Milan), and S. Bianchi (IIT@SEMM) for the preparation and processing of sequencing libraries; K. Ferrari and D. Pasini (IEO) for sharing reagents. Sequence data in fastq format were prepared by H. Muller and the Computational Research Unit of the Center for Genomic Sciences of IIT@SEMM and hosted on the IIT@SEMM computational infrastructure. Training in HT-ChIP was supported by a short-term EMBO fellowship (ASTF 210-2012) to R.O. This study was supported by the European Research Council (advanced grant 268757-NORM to G.N.). R.O. and S.P. carried out the ChIP-seq and RNA-Seq experiments, their validation and functional assays with the help of S.B., A.C., E.P., and S.G. V.P. and I. B. analyzed data with the help of A.T. G.N. designed the study with the help of R.O. and S.G. and wrote the paper.	Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Barozzi I, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-51; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Liu H, 2002, MOL CELL BIOL, V22, P6471, DOI 10.1128/MCB.22.18.6471-6479.2002; Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Natoli G, 2011, GENE DEV, V25, P101, DOI 10.1101/gad.2018811; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Siersbaek R, 2011, EMBO J, V30, P1459, DOI 10.1038/emboj.2011.65; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Valouev A, 2011, NATURE, V474, P516, DOI 10.1038/nature10002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106	57	521	536	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					157	171		10.1016/j.cell.2012.12.018	http://dx.doi.org/10.1016/j.cell.2012.12.018			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332752	Bronze			2022-12-28	WOS:000313719800014
J	Peters, SE; Kelly, DC; Fraass, AJ				Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.			Oceanographic controls on the diversity and extinction of planktonic foraminifera	NATURE			English	Article							GLOBAL DISTRIBUTION; SPECIES-DIVERSITY; ORIGINATION; MACROSTRATIGRAPHY; HISTORY; TRENDS; RECORD	Understanding the links between long-term biological evolution, the ocean-atmosphere system and plate tectonics is a central goal of Earth science. Although environmental perturbations of many different kinds are known to have affected long-term biological evolution, particularly during major mass extinction events(1,2), the relative importance of physical environmental factors versus biological interactions in governing rates of extinction and origination through geological time remains unknown(2). Here we use macrostratigraphic data from the Atlantic Ocean basin to show that changes in global species diversity and rates of extinction among planktonic foraminifera have been linked to tectonically and climatically forced changes in ocean circulation and chemistry from the Jurassic period to the present. Transient environmental perturbations, such as those that occurred after the asteroid impact at the end of the Cretaceous period(1) approximately 66 million years ago, and the Eocene/Oligocene greenhouse-icehouse transition(3,4) approximately 34 million years ago, are superimposed on this general long-term relationship. Rates of species origination, by contrast, are not correlated with corresponding macrostratigraphic quantities, indicating that physiochemical changes in the ocean-atmosphere system affect evolution principally by driving the synchronous extinction of lineages that originated owing to more protracted and complex interactions between biological and environmental factors.	[Peters, Shanan E.; Kelly, Daniel C.; Fraass, Andrew J.] Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Peters, SE (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI 53706 USA.	peters@geology.wisc.edu	Peters, Shanan E/A-5620-2013	Peters, Shanan E/0000-0002-3346-4317; Fraass, Andrew/0000-0002-2007-3616; Kelly, Clay/0000-0002-3241-1635	National Science Foundation Division of Earth Sciences (NSF EAR) [EAR 0819931]; NSF [EAR 0628719]	National Science Foundation Division of Earth Sciences (NSF EAR); NSF(National Science Foundation (NSF))	We thank M. Foote and B. Wilkinson for feedback on our analyses and this manuscript, and N. A. Heim for help in drafting the maps herein. This work was partially supported by National Science Foundation Division of Earth Sciences (NSF EAR) EAR 0819931 to S.E.P. and NSF EAR 0628719 subcontract to D.C.K.	Adrain JM, 2000, SCIENCE, V289, P110, DOI 10.1126/science.289.5476.110; Be A. W. H., 1971, MICROPALEONTOLOGY OC, P1025; Be A.W.H., 1977, OCEANIC MICROPALEONT, P1; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; BERGGREN WA, 1977, TECTONOPHYSICS, V38, P11, DOI 10.1016/0040-1951(77)90199-8; CIFELLI R, 1969, SYST ZOOL, V18, P154, DOI 10.2307/2412601; CLIMAP Project Members, 1976, Science, V191, P1131; CLIMAP Project Members, 1994, CLIMAP 18K DAT; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; D'Hondt S, 1998, PALEOBIOLOGY, V24, P512, DOI 10.1017/S0094837300020133; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 1999, PALEOCEANOGRAPHY, V14, P3, DOI 10.1029/1998PA900002; Foote M, 2005, PALEOBIOLOGY, V31, P6, DOI 10.1666/0094-8373(2005)031<0006:POAEIT>2.0.CO;2; Foote M, 2003, J GEOL, V111, P125, DOI 10.1086/345841; Georgescu MD, 2008, J FORAMIN RES, V38, P157, DOI 10.2113/gsjfr.38.2.157; HALLOCK P, 1991, PALAEOGEOGR PALAEOCL, V83, P49, DOI 10.1016/0031-0182(91)90075-3; Hannisdal B, 2011, SCIENCE, V334, P1121, DOI 10.1126/science.1210695; Hannisdal B, 2010, J GEOL, V118, P111, DOI 10.1086/650180; HAQ BU, 1977, J GEOPHYS RES-OC ATM, V82, P3861, DOI 10.1029/JC082i027p03861; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; HOLLAND SM, 1995, PALEOBIOLOGY, V21, P92, DOI 10.1017/S0094837300013099; Holland SM, 2000, PALEOBIOLOGY, V26, P148, DOI 10.1666/0094-8373(2000)26[148:TQOTFR]2.0.CO;2; Huber B.T., 2006, MESOZOIC PLANKTONIC; Kauffman E.G., 1993, 39 GEOL ASS CAN, P1; KELLER G, 1987, GEOLOGY, V15, P199, DOI 10.1130/0091-7613(1987)15<199:GDOLPH>2.0.CO;2; Kennett J.P., 1983, NEOGENE PLANKTONIC F; LIPPS JH, 1970, EVOLUTION, V24, P1, DOI 10.1111/j.1558-5646.1970.tb01737.x; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle M., 1995, 1995 P OC DRILL PROG, V138, DOI [DOI 10.2973/0DP.PR0C.SR.138.157.1995, 10.2973/odp.proc.sr.138.157.1995]; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Milliman J. D., 1974, RECENT SEDIMENTARY C; Moore Jr T. C., 1978, MICROPALEONTOL SP PU, V3, P113; Muller RD, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001743; Norris RD, 2001, GEOL SOC SPEC PUBL, V183, P23, DOI 10.1144/GSL.SP.2001.183.01.02; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; Ogg J.G., 2004, GEOLOGIC TIME SCALE, P344; Olsson R. K., 1999, ATLAS PALEOCENE PLAN; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Pearson P.N., 2006, CUSHMAN FDN FORAMINI, V41; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2006, PALEOBIOLOGY, V32, P387, DOI 10.1666/05081.1; Peters SE, 2011, GEOLOGY, V39, P259, DOI 10.1130/G31442.1; Peters SE, 2006, J GEOL, V114, P391, DOI 10.1086/504176; PROTHERO DR, 1980, SYST ZOOL, V29, P119, DOI 10.2307/2412642; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; Saito T, 1981, SYSTEMATIC INDEX REC; Schiebel R, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001459; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Stewart D. R. M., 2000, PLANKRANGE DATABASE; Sverdrup H.U., 1942, OCEANS THEIR PHYS CH, P1065; Thierstein H. R., 1979, DEEP DRILLING RESULT, P249; Thunell R., 1986, TERMINAL EOCENE EVEN, P363, DOI [10.1016/s0920-5446(08)70140-7, DOI 10.1016/S0920-5446(08)70140-7]; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Vincent E., 1981, OCEAN LITHOSPHERE SE, V7, P1025; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	56	31	32	0	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					398	U140		10.1038/nature11815	http://dx.doi.org/10.1038/nature11815			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23302802				2022-12-28	WOS:000313615900050
J	Rai, AK; Rai, A; Ramaiya, AJ; Jha, R; Mallik, R				Rai, Arpan K.; Rai, Ashim; Ramaiya, Avin J.; Jha, Rupam; Mallik, Roop			Molecular Adaptations Allow Dynein to Generate Large Collective Forces inside Cells	CELL			English	Article							TUG-OF-WAR; CYTOPLASMIC DYNEIN; CARGO TRANSPORT; OPTICAL TRAPS; PHAGOSOMES; MOTORS; PROCESSIVITY; ENDOSOMES; MOVEMENT; PROTEOME	Many cellular processes require large forces that are generated collectively by multiple cytoskeletal motor proteins. Understanding how motors generate force as a team is therefore fundamentally important but is poorly understood. Here, we demonstrate optical trapping at single-molecule resolution inside cells to quantify force generation by motor teams driving single phagosomes. In remarkable paradox, strong kinesins fail to work collectively, whereas weak and detachment-prone dyneins team up to generate large forces that tune linearly in strength and persistence with dynein number. Based on experimental evidence, we propose that leading dyneins in a load-carrying team take short steps, whereas trailing dyneins take larger steps. Dyneins in such a team bunch close together and therefore share load better to overcome low/intermediate loads. Up against higher load, dyneins "catch bond'' tenaciously to the microtubule, but kinesins detach rapidly. Dynein therefore appears uniquely adapted to work in large teams, which may explain how this motor executes bewilderingly diverse cellular processes.	[Rai, Arpan K.; Rai, Ashim; Ramaiya, Avin J.; Jha, Rupam; Mallik, Roop] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Mallik, R (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.	roop@tifr.res.in		mallik, roop/0000-0001-6820-6556; Jha, Rupam/0000-0003-0332-2542	Wellcome Trust, UK [WT079214MA]	Wellcome Trust, UK(Wellcome Trust)	R.M. thanks S. Gross and S. Cermelli for help with animal cell culture. We thank G. Griffiths and E. Hoffman for help with phagosome isolation. P. Barak, V. Soppina, A. Dubey, N. Buwa, and D. Choudhury are thanked for help with experiments. S. Nair, M. Gopalakrishnan, R. Vale, and S.J. King are thanked for comments on the manuscript. S.J. King is acknowledged for help with purification of kinesin-1 and dynein. We thank the following for sharing reagents: T. Schroer (CC1); K. Verhey (kinesin-1 antibodies); A. Bershadsky (EB1-GFP). R.M. acknowledges funding through an International Senior Research Fellowship from the Wellcome Trust, UK (grant WT079214MA).	Al-Haddad AH, 2001, MOL BIOL CELL, V12, P2742, DOI 10.1091/mbc.12.9.2742; Bhat D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/046003; Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113; Capitanio M, 2002, REV SCI INSTRUM, V73, P1687, DOI 10.1063/1.1460929; Carter AP, 2011, SCIENCE, V331, P1159, DOI 10.1126/science.1202393; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Desjardins M, 2003, CURR OPIN CELL BIOL, V15, P498, DOI 10.1016/S0955-0674(03)00083-8; DeWitt MA, 2012, SCIENCE, V335, P221, DOI 10.1126/science.1215804; Driver JW, 2011, BIOPHYS J, V101, P386, DOI 10.1016/j.bpj.2011.05.067; Duclos S, 2000, J CELL SCI, V113, P3531; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gross SP, 2003, METHOD ENZYMOL, V361, P162; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hirakawa E, 2000, P NATL ACAD SCI USA, V97, P2533, DOI 10.1073/pnas.050585297; Jamison DK, 2010, BIOPHYS J, V99, P2967, DOI 10.1016/j.bpj.2010.08.025; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kunwar A, 2011, P NATL ACAD SCI USA, V108, P18960, DOI 10.1073/pnas.1107841108; Leidel C, 2012, BIOPHYS J, V103, P492, DOI 10.1016/j.bpj.2012.06.038; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Nan XL, 2008, CHEMPHYSCHEM, V9, P707, DOI 10.1002/cphc.200700839; Petrov DY, 2007, BIOPHYS J, V92, P2953, DOI 10.1529/biophysj.106.097253; Qiu WH, 2012, NAT STRUCT MOL BIOL, V19, P193, DOI 10.1038/nsmb.2205; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice SE, 2003, METHOD ENZYMOL, V361, P112; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Sims PA, 2009, CHEMPHYSCHEM, V10, P1511, DOI 10.1002/cphc.200900113; Singh MP, 2005, P NATL ACAD SCI USA, V102, P12059, DOI 10.1073/pnas.0501570102; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Soppina V, 2009, BIOTECHNIQUES, V46, P543, DOI 10.2144/000113124; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Toba S, 2006, P NATL ACAD SCI USA, V103, P5741, DOI 10.1073/pnas.0508511103; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; Vershinin M, 2007, P NATL ACAD SCI USA, V104, P87, DOI 10.1073/pnas.0607919104; Viana NB, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021914; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Walter WJ, 2012, P NATL ACAD SCI USA, V109, P5289, DOI 10.1073/pnas.1116315109; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wu MS, 2005, EMBO J, V24, P1491, DOI 10.1038/sj.emboj.7600643	51	193	195	1	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					172	182		10.1016/j.cell.2012.11.044	http://dx.doi.org/10.1016/j.cell.2012.11.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332753	Bronze			2022-12-28	WOS:000313719800015
J	Rockey, S				Rockey, Sally			Two years of blogging the NIH	NATURE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Rockey, S (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	sally.rockey@nih.gov			Intramural NIH HHS [Z99 OD999999] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Berg JM, 2012, NATURE, V489, P203, DOI 10.1038/489203a	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					298	299		10.1038/493298a	http://dx.doi.org/10.1038/493298a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TA	23325193	Bronze			2022-12-28	WOS:000313615900014
J	Stefanini, GG; Holmes, DR				Stefanini, Giulio G.; Holmes, David R., Jr.			Drug-Eluting Coronary-Artery Stents	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BARE-METAL STENTS; DUAL-ANTIPLATELET THERAPY; ACUTE MYOCARDIAL-INFARCTION; COLLABORATIVE NETWORK METAANALYSIS; OPTICAL COHERENCE TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM OUTCOMES; 3-YEAR FOLLOW-UP; BIODEGRADABLE POLYMER; BYPASS-SURGERY		[Stefanini, Giulio G.] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Holmes, David R., Jr.] Mayo Clin, Div Cardiovasc Dis & Internal Med, Rochester, MN USA	University of Bern; University Hospital of Bern; Mayo Clinic	Stefanini, GG (corresponding author), Univ Hosp Bern, Dept Cardiol, Freiburgstr 4, CH-3010 Bern, Switzerland.	giulio.stefanini@insel.ch	Stefanini, Giulio G/K-7406-2016; Stefanini, Giulio/GZG-4754-2022	Stefanini, Giulio G/0000-0002-3558-6967; Stefanini, Giulio/0000-0002-3558-6967				Amin AP, 2012, AM J CARDIOL, V110, P765, DOI 10.1016/j.amjcard.2012.05.006; Amin AP, 2012, ARCH INTERN MED, V172, P1145, DOI 10.1001/archinternmed.2012.3093; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Berry C, 2007, J AM COLL CARDIOL, V49, P643, DOI 10.1016/j.jacc.2006.09.045; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; Dewilde W, 2012, EUR SOC CARD ESC C M; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Grines CL, 2007, J AM COLL CARDIOL, V49, P734, DOI 10.1016/j.jacc.2007.01.003; Guo N, 2010, CIRCULATION, V122, P1077, DOI 10.1161/CIRCULATIONAHA.109.906040; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Holmes DR, 2010, J AM COLL CARDIOL, V56, P1357, DOI 10.1016/j.jacc.2010.07.016; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2010, NEW ENGL J MED, V363, P2310, DOI 10.1056/NEJMoa1009406; Kalesan B, 2012, EUR HEART J, V33, P977, DOI 10.1093/eurheartj/ehs036; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P1119, DOI 10.1016/j.jcin.2011.06.017; Kappetein AP, 2011, EUR HEART J, V32, P2125, DOI 10.1093/eurheartj/ehr213; Kapur A, 2010, J AM COLL CARDIOL, V55, P432, DOI 10.1016/j.jacc.2009.10.014; Kastrati A, 2001, CIRCULATION, V103, P2816; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kedhi E, 2012, EUROINTERVENTION, V8, P599, DOI 10.4244/EIJV8I5A92; Kedhi E, 2010, LANCET, V375, P201, DOI 10.1016/S0140-6736(09)62127-9; Kim JS, 2012, AM HEART J, V163, P601, DOI 10.1016/j.ahj.2011.10.016; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mohr F, 2012, EUR SOC CARD ESC C M; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park SJ, 2011, NEW ENGL J MED, V364, P1718, DOI 10.1056/NEJMoa1100452; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Raber L, 2012, JACC-CARDIOVASC INTE, V5, P946, DOI 10.1016/j.jcin.2012.05.012; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Schafer PE, 2011, CIRC-CARDIOVASC QUAL, V4, P408, DOI 10.1161/CIRCOUTCOMES.110.960187; Serruys PW, 2011, J AM COLL CARDIOL, V58, P1578, DOI 10.1016/j.jacc.2011.05.050; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Serruys PW, 2001, NEW ENGL J MED, V344, P1117, DOI 10.1056/NEJM200104123441502; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Smits PC, 2012, EUR SOC CARD ESC C M; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stettler C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1331; Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2011, CIRCULATION, V124, P893, DOI 10.1161/CIRCULATIONAHA.111.031070; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690; Venkitachalam L, 2011, CIRCULATION, V124, P1028, DOI 10.1161/CIRCULATIONAHA.110.978593; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P1716	76	512	529	11	129	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					254	265		10.1056/NEJMra1210816	http://dx.doi.org/10.1056/NEJMra1210816			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323902	Green Published			2022-12-28	WOS:000313549900010
J	Hasegawa, K; Hiraide, A; Chang, YC; Brown, DFM				Hasegawa, Kohei; Hiraide, Atsushi; Chang, Yuchiao; Brown, David F. M.			Association of Prehospital Advanced Airway Management With Neurologic Outcome and Survival in Patients With Out-of-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; HEALTH-CARE PROFESSIONALS; CARDIOPULMONARY-RESUSCITATION; ENDOTRACHEAL INTUBATION; LIFE-SUPPORT; TASK-FORCE; RECOMMENDED GUIDELINES; STROKE-FOUNDATION; UTSTEIN STYLE	Importance It is unclear whether advanced airway management such as endotracheal intubation or use of supraglottic airway devices in the prehospital setting improves outcomes following out-of-hospital cardiac arrest (OHCA) compared with conventional bag-valve-mask ventilation. Objective To test the hypothesis that prehospital advanced airway management is associated with favorable outcome after adult OHCA. Design, Setting, and Participants Prospective, nationwide, population-based study (All-Japan Utstein Registry) involving 649 654 consecutive adult patients in Japan who had an OHCA and in whom resuscitation was attempted by emergency responders with subsequent transport to medical institutions from January 2005 through December 2010. Main Outcome Measures Favorable neurological outcome 1 month after an OHCA, defined as cerebral performance category 1 or 2. Results Of the eligible 649 359 patients with OHCA, 367 837 (57%) underwent bag-valve-mask ventilation and 281 522 (43%) advanced airway management, including 41 972 (6%) with endotracheal intubation and 239 550 (37%) with use of supraglottic airways. In the full cohort, the advanced airway group incurred a lower rate of favorable neurological outcome compared with the bag-valve-mask group (1.1% vs 2.9%; odds ratio [OR], 0.38; 95% CI, 0.36-0.39). In multivariable logistic regression, advanced airway management had an OR for favorable neurological outcome of 0.38 (95% CI, 0.37-0.40) after adjusting for age, sex, etiology of arrest, first documented rhythm, witnessed status, type of bystander cardiopulmonary resuscitation, use of public access automated external defibrillator, epinephrine administration, and time intervals. Similarly, the odds of neurologically favorable survival were significantly lower both for endotracheal intubation (adjusted OR, 0.41; 95% CI, 0.37-0.45) and for supraglottic airways (adjusted OR, 0.38; 95% CI, 0.36-0.40). In a propensity score-matched cohort (357 228 patients), the adjusted odds of neurologically favorable survival were significantly lower both for endotracheal intubation (adjusted OR, 0.45; 95% CI, 0.37-0.55) and for use of supraglottic airways (adjusted OR, 0.36; 95% CI, 0.33-0.39). Both endotracheal intubation and use of supraglottic airways were similarly associated with decreased odds of neurologically favorable survival. Conclusion and Relevance Among adult patients with OHCA, any type of advanced airway management was independently associated with decreased odds of neurologically favorable survival compared with conventional bag-valve-mask ventilation. JAMA. 2013;309(3):257-266 www.jama.com	[Hasegawa, Kohei] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Hasegawa, Kohei; Brown, David F. M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Chang, Yuchiao] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Hiraide, Atsushi] Kinki Univ, Fac Med, Dept Acute Med, Osaka, Japan	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Kindai University (Kinki University)	Hasegawa, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Emergency Med, 326 Cambridge St,Ste 410, Boston, MA 02114 USA.	khasegawa1@partners.org			Fire and Disaster Management Agency	Fire and Disaster Management Agency	This study was supported by a grant to Dr Hiraide for emergency management scientific research from the Fire and Disaster Management Agency.	Abo BN, 2007, RESUSCITATION, V72, P234, DOI 10.1016/j.resuscitation.2006.06.028; Ambulance Service Planning Office of Fire and Disaster Management Agency of Japan, AIRW MAN END INT EM; Ambulance Service Planning Office of Fire and Disaster Management Agency of Japan, 2004, AIRW MAN END INT EM; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; [Anonymous], 2010, JAP GUID EM CAR CARD; [Anonymous], 2011, 2010 POP CENS JAP; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Berg RA, 2010, CIRCULATION, V122, pS685; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; Do Shin S, 2012, RESUSCITATION, V83, P313, DOI 10.1016/j.resuscitation.2011.10.028; Egly J, 2011, PREHOSP EMERG CARE, V15, P44, DOI 10.3109/10903127.2010.514090; Ferguson LP, 2012, CIRCULATION, V126, P335, DOI 10.1161/CIRCULATIONAHA.111.085100; Field JM, 2010, CIRCULATION, V122, pS640; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Hagihara A, 2012, JAMA-J AM MED ASSOC, V307, P1161, DOI 10.1001/jama.2012.294; Hanif MA, 2010, ACAD EMERG MED, V17, P926, DOI 10.1111/j.1553-2712.2010.00829.x; Hoyle JD, 2007, PREHOSP EMERG CARE, V11, P330, DOI 10.1080/10903120701205083; Institute of Healthcare Development Training Requirement for Endotracheal Intubation: Joint Recommendation From AETAG/JRCALC Airway Group, 2008, JOINT REC AETAG JRCA; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nagao T, 2012, J EMERG MED, V42, P162, DOI 10.1016/j.jemermed.2011.02.020; National Highway Traffic Safety Administration, EM MED TECHN PAR NAT; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nickel EA, 2008, RESUSCITATION, V79, P212, DOI 10.1016/j.resuscitation.2008.06.020; Parsons LS, REDUCING BIAS PROPER; Pitts S, 2004, LANCET, V364, P313, DOI 10.1016/S0140-6736(04)16740-8; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Studnek JR, 2010, ACAD EMERG MED, V17, P918, DOI 10.1111/j.1553-2712.2010.00827.x; Thomas MJC, 2011, RESUSCITATION, V82, P367, DOI 10.1016/j.resuscitation.2011.02.001; Wang HE, 2006, ACAD EMERG MED, V13, P372, DOI 10.1197/j.aem.2005.11.001; Wang HE, 2006, HEALTH AFFAIR, V25, P501, DOI 10.1377/hlthaff.25.2.501; Wang HE, 2006, ANN EMERG MED, V47, P532, DOI 10.1016/j.annemergmed.2006.01.016; Wang HE, 2012, RESUSCITATION, V83, P1061, DOI 10.1016/j.resuscitation.2012.05.018; Wang HE, 2010, ANN EMERG MED, V55, P527, DOI 10.1016/j.annemergmed.2009.12.020; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006	40	255	266	1	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					257	266		10.1001/jama.2012.187612	http://dx.doi.org/10.1001/jama.2012.187612			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321764				2022-12-28	WOS:000313546800026
J	Lim, LS				Lim, Lionel S.			Review: General health checks in adults do not reduce all-cause, cardiovascular, or cancer mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Griffin Hosp, Derby, CT USA		Lim, LS (corresponding author), Griffin Hosp, Derby, CT USA.			Lim, Lionel/0000-0002-0730-8767				Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; MacAuley D, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7775; US Preventive Services Task Force, TOOLS US REC PRIM CA	3	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC2	10.7326/0003-4819-158-2-201301150-02002	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318336				2022-12-28	WOS:000314029400001
J	Fitzharris, L				Fitzharris, Lindsey			The art of medicine Mangling the dead: dissection, past and present	LANCET			English	Editorial Material									Univ London, Sch Hist, London E1 4NS, England	University of London	Fitzharris, L (corresponding author), Univ London, Sch Hist, London E1 4NS, England.	l.a.fitzharris@qmul.ac.uk						Burch D, 2008, DIGGING DEAD UNCOVER; Cunningham Andrew, 2010, ANATOMIST ANATOMISD; Payne Lynda, 2007, WORDS KNIVES LEARNIN; Richardson R., 2000, DEATH DISSECTION DES	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					108	109		10.1016/S0140-6736(13)60037-9	http://dx.doi.org/10.1016/S0140-6736(13)60037-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069FO	23320282				2022-12-28	WOS:000313420900013
J	Helliwell, JR				Helliwell, John R.			How to Solve Protein Structures with an X-ray Laser	SCIENCE			English	Editorial Material							SYNCHROTRON RADIATION; CRYSTALLOGRAPHY; DIFFRACTION		Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England	University of Manchester	Helliwell, JR (corresponding author), Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England.	john.helliwell@manchester.ac.uk	Helliwell, John R/C-4587-2014	Helliwell, John R/0000-0002-0520-7540				ANDREWS SJ, 1988, ACTA CRYSTALLOGR B, V44, P73, DOI 10.1107/S0108768187009820; Evans G, 2011, CRYSTALLOGR REV, V17, P105, DOI 10.1080/0889311X.2010.527964; Hau-Riege SP, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042511; HEDMAN B, 1985, P NATL ACAD SCI USA, V82, P7604, DOI 10.1073/pnas.82.22.7604; Helliwell JR, 2004, J SYNCHROTRON RADIAT, V11, P1, DOI 10.1107/S0909049503024099; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Podobnik M, 1997, J MOL BIOL, V271, P774, DOI 10.1006/jmbi.1997.1218; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Schotte F, 2012, P NATL ACAD SCI USA, V109, P19256, DOI 10.1073/pnas.1210938109; Tanley SWM, 2012, ACTA CRYSTALLOGR F, V68, P1300, DOI 10.1107/S1744309112042005	10	14	14	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					146	147		10.1126/science.1233209	http://dx.doi.org/10.1126/science.1233209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307725				2022-12-28	WOS:000313328200026
J	Sakata, Y; Furukawa, S; Kondo, M; Hirai, K; Horike, N; Takashima, Y; Uehara, H; Louvain, N; Meilikhov, M; Tsuruoka, T; Isoda, S; Kosaka, W; Sakata, O; Kitagawa, S				Sakata, Yoko; Furukawa, Shuhei; Kondo, Mio; Hirai, Kenji; Horike, Nao; Takashima, Yohei; Uehara, Hiromitsu; Louvain, Nicolas; Meilikhov, Mikhail; Tsuruoka, Takaaki; Isoda, Seiji; Kosaka, Wataru; Sakata, Osami; Kitagawa, Susumu			Shape-Memory Nanopores Induced in Coordination Frameworks by Crystal Downsizing	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; ADSORPTION; NANOCRYSTALS; POLYMER; TRANSFORMATION; SURFACE	Flexible porous coordination polymers change their structure in response to molecular incorporation but recover their original configuration after the guest has been removed. We demonstrated that the crystal downsizing of twofold interpenetrated frameworks of [Cu-2(dicarboxylate)(2)(amine)](n) regulates the structural flexibility and induces a shape-memory effect in the coordination frameworks. In addition to the two structures that contribute to the sorption process (that is, a nonporous closed phase and a guest-included open phase), we isolated an unusual, metastable open dried phase when downsizing the crystals to the mesoscale, and the closed phase was recovered by thermal treatment. Crystal downsizing suppressed the structural mobility and stabilized the open dried phase. The successful isolation of two interconvertible empty phases, the closed phase and the open dried phase, provided switchable sorption properties with or without gate-opening behavior.	[Sakata, Yoko; Furukawa, Shuhei; Kondo, Mio; Louvain, Nicolas; Isoda, Seiji; Kitagawa, Susumu] Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, World Premier Int Res Initiat, Sakyo Ku, Kyoto 6068501, Japan; [Sakata, Yoko; Furukawa, Shuhei; Kondo, Mio; Horike, Nao; Takashima, Yohei; Uehara, Hiromitsu; Louvain, Nicolas; Meilikhov, Mikhail; Tsuruoka, Takaaki; Kosaka, Wataru; Kitagawa, Susumu] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO Kitagawa Integr, Shimogyo Ku, Kyoto 6008815, Japan; [Hirai, Kenji; Kitagawa, Susumu] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Nishikyo Ku, Kyoto 6158510, Japan; [Sakata, Osami] Natl Inst Mat Sci NIMS, Synchrotron Xray Stn SPring 8, Sayo, Hyogo 6795148, Japan; [Tsuruoka, Takaaki] Konan Univ, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; Konan University	Furukawa, S (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci WPI ICeMS, World Premier Int Res Initiat, Sakyo Ku, Kyoto 6068501, Japan.	shuhei.furukawa@icems.kyoto-u.ac.jp; kitagawa@icems.kyoto-u.ac.jp	SAKATA, Osami/H-2621-2011; Kondo, Mio/I-4532-2015; Hirai, Kenji/D-9008-2017; Tsuruoka, Takaaki/U-7225-2019; Kosaka, Wataru/P-6119-2014; Kitagawa, Susumu/AAB-1753-2019; Furukawa, Shuhei/D-9681-2012; Louvain, Nicolas/AAF-5720-2019	SAKATA, Osami/0000-0003-2626-0161; Kondo, Mio/0000-0001-9627-2331; Hirai, Kenji/0000-0003-3307-3970; Kosaka, Wataru/0000-0002-2445-5099; Kitagawa, Susumu/0000-0001-6956-9543; Furukawa, Shuhei/0000-0003-3849-8038; Tsuruoka, Takaaki/0000-0003-4457-5925	Japan Society for the Promotion of Science; World Premier International Research Initiative (WPI); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Grants-in-Aid for Scientific Research [10J02257] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); World Premier International Research Initiative (WPI); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Y.S. is grateful to the Japan Society for the Promotion of Science Research Fellowships for Young Scientists. The Institute for Integrated Cell-Material Sciences (iCeMS) is supported by World Premier International Research Initiative (WPI); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The synchrotron x-ray experiments were performed at BL13XU in the SPring-8 under the Priority Nanotechnology Support Program administered by the Japan Synchrotron Radiation Research Institute (JASRI) (proposal no. 2011B1671). We also thank T. Asai and M. Maeda (TA Instruments, Japan) for the differential scanning calorimetry measurements. Crystallographic data for 1 superset of ethanol, 1 superset of methanol, 1 superset of DMF, 1, and 2 superset of ethanol have been deposited with the Cambridge Crystallographic Data Centre under reference nos. CCDC 863312 to 863316, respectively. These data can be obtained free of charge via www.ccdc.cam.ac.uk.	Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Behl M, 2010, ADV MATER, V22, P3388, DOI 10.1002/adma.200904447; Chen BL, 2006, ANGEW CHEM INT EDIT, V45, P1390, DOI 10.1002/anie.200502844; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; Chen CC, 1997, SCIENCE, V276, P398, DOI 10.1126/science.276.5311.398; CHEN IW, 1985, ACTA METALL MATER, V33, P1827, DOI 10.1016/0001-6160(85)90006-9; Diring S, 2010, CHEM MATER, V22, P4531, DOI 10.1021/cm101778g; Ferey G, 2009, CHEM SOC REV, V38, P1380, DOI 10.1039/b804302g; Horike S, 2009, NAT CHEM, V1, P695, DOI [10.1038/NCHEM.444, 10.1038/nchem.444]; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; Mohideen MIH, 2011, NAT CHEM, V3, P304, DOI 10.1038/NCHEM.1003; Navrotsky A, 2008, SCIENCE, V319, P1635, DOI 10.1126/science.1148614; Ni Z, 2006, J AM CHEM SOC, V128, P12394, DOI 10.1021/ja0635231; Qiu LG, 2008, CHEM COMMUN, P3642, DOI 10.1039/b804126a; Seki K, 2002, PHYS CHEM CHEM PHYS, V4, P1968, DOI 10.1039/b110899a; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Takashima Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1170; Tanaka D, 2010, NAT CHEM, V2, P410, DOI [10.1038/NCHEM.627, 10.1038/nchem.627]; Triguero C, 2011, J PHYS CHEM LETT, V2, P2033, DOI 10.1021/jz2008769; Tsuruoka T, 2009, ANGEW CHEM INT EDIT, V48, P4739, DOI 10.1002/anie.200901177; Waitz T, 2009, MRS BULL, V34, P814, DOI 10.1557/mrs2009.231; Watanabe S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3122988; Xiao B, 2009, NAT CHEM, V1, P289, DOI 10.1038/NCHEM.254; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	25	389	402	28	712	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					193	196		10.1126/science.1231451	http://dx.doi.org/10.1126/science.1231451			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307740				2022-12-28	WOS:000313328200041
J	DiFonzo, N				DiFonzo, Nicholas			Rumour research can douse digital wildfires	NATURE			English	Editorial Material									Rochester Inst Technol, Rochester, NY 14627 USA	Rochester Institute of Technology	DiFonzo, N (corresponding author), Rochester Inst Technol, Rochester, NY 14627 USA.	nick@profnick.com							0	11	14	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					135	135		10.1038/493135a	http://dx.doi.org/10.1038/493135a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066YY	23302823	Bronze			2022-12-28	WOS:000313259600004
J	McAlindon, T; LaValley, M; Schneider, E; Nuite, M; Lee, JY; Price, LL; Lo, G; Dawson-Hughes, B				McAlindon, Timothy; LaValley, Michael; Schneider, Erica; Nuite, Melynn; Lee, Ji Yeon; Price, Lori Lyn; Lo, Grace; Dawson-Hughes, Bess			Effect of Vitamin D Supplementation on Progression of Knee Pain and Cartilage Volume Loss in Patients With Symptomatic Osteoarthritis A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BONE-MINERAL DENSITY; THERAPY; RISK; INCIDENT; DAMAGE; WOMEN; HIP	Importance Knee osteoarthritis (OA), a disorder of cartilage and periarticular bone, is a public health problem without effective medical treatments. Some studies have suggested that vitamin D may protect against structural progression. Objective To determine whether vitamin D supplementation reduces symptom and structural progression of knee OA. Design, Setting, and Patients A 2-year randomized, placebo-controlled, double-blind, clinical trial involving 146 participants with symptomatic knee OA (mean age, 62.4 years [SD, 8.5]; 57 women [61%], 115 white race [79%]). Patients were enrolled at Tufts Medical Center in Boston between March 2006 and June 2009. Intervention Participants were randomized to receive either placebo or oral cholecalciferol, 2000 IU/d, with dose escalation to elevate serum levels to more than 36 ng/mL. Main Outcome Measures Primary outcomes were knee pain severity (Western Ontario and McMaster Universities [WOMAC] pain scale, 0-20: 0, no pain; 20, extreme pain), and cartilage volume loss measured by magnetic resonance imaging. Secondary end points included physical function, knee function (WOMAC function scale, 0-68: 0, no difficulty; 68, extreme difficulty), cartilage thickness, bone marrow lesions, and radiographic joint space width. Results Eighty-five percent of the participants completed the study. Serum 25-hydroxyvitamin D levels increased by a mean 16.1 ng/mL (95% CI, 13.7 to 18.6) in the treatment group and by a mean 2.1 mg/mL (95% CI, 0.5 to 3.7) (P < .001) in the placebo group. Baseline knee pain was slightly worse in the treatment group (mean, 6.9; 95% CI, 6.0 to 7.7) than in the placebo group (mean, 5.8; 95% CI, 5.0 to 6.6) (P=.08). Baseline knee function was significantly worse in the treatment group (mean, 22.7; 95% CI, 19.8 to 25.6) than in the placebo group (mean, 18.5; 95% CI, 15.8 to 21.2) (P=.04). Knee pain decreased in both groups by a mean -2.31 (95% CI, -3.24 to -1.38) in the treatment group and -1.46 (95% CI, -2.33 to -0.60) in the placebo group, with no significant differences at any time. The percentage of cartilage volume decreased by the same extent in both groups (mean, -4.30; 95% CI, -5.48 to -3.12 vs mean, -4.25; 95% CI, -6.12 to -2.39) (P=.96). There were no differences in any of the secondary clinical end points. Conclusion and Relevance Vitamin D supplementation for 2 years at a dose sufficient to elevate 25-hydroxyvitamin D plasma levels to higher than 36 ng/mL, when compared with placebo, did not reduce knee pain or cartilage volume loss in patients with symptomatic knee OA.	[McAlindon, Timothy; Nuite, Melynn; Lee, Ji Yeon] Tufts Med Ctr, Div Rheumatol, Boston, MA 02111 USA; [LaValley, Michael] Boston Univ, Sch Publ Hlth, Crosstown Ctr, Boston, MA USA; [Schneider, Erica] Cleveland Clin Fdn, Imaging Inst, Cleveland, OH 44195 USA; [Price, Lori Lyn] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Biostat Res Ctr, Boston, MA 02111 USA; [Lo, Grace] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Lo, Grace] Baylor Coll Med, Houston VA Hlth Serv, Res & Dev Ctr Excellence, Houston, TX 77030 USA; [Lo, Grace] Baylor Coll Med, Dept Med, Sect Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Dawson-Hughes, Bess] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Tufts Medical Center; Boston University; Cleveland Clinic Foundation; Tufts Medical Center; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Tufts University; United States Department of Agriculture (USDA)	McAlindon, T (corresponding author), Tufts Med Ctr, Div Rheumatol, Box 406,800 Washington St, Boston, MA 02111 USA.	tmcalindon@tuftsmedicalcenter.org	LaValley, Michael/AAA-2030-2020	LaValley, Michael/0000-0002-8488-5170	National Institutes of Health, NIAMS [R01 AR51361]; Office of Dietary Supplements; National Center for Research Resources [UL1RR025752]; Houston Veterans Affairs Health Services Research and Development Service [HFP90-020]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051361] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Houston Veterans Affairs Health Services Research and Development Service; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was funded by grant R01 AR51361 from the National Institutes of Health, NIAMS, and the Office of Dietary Supplements, grant UL1RR025752 from the National Center for Research Resources, and grant HFP90-020 from the Houston Veterans Affairs Health Services Research and Development Service.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; [Anonymous], 1995, INC PREV DAT PROC, P592; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bergink AP, 2009, JCR-J CLIN RHEUMATOL, V15, P230, DOI 10.1097/RHU.0b013e3181b08f20; Buckland-Wright JC, 1999, J RHEUMATOL, V26, P2664; Burr DB, 2004, J RHEUMATOL, V31, P77; Cicuttini FM, 2001, ANN RHEUM DIS, V60, P977, DOI 10.1136/ard.60.10.977; CLARK JM, 1990, J BONE JOINT SURG BR, V72, P866, DOI 10.1302/0301-620X.72B5.2211774; Conaghan PG, 2011, OSTEOARTHR CARTILAGE, V19, P606, DOI 10.1016/j.joca.2011.02.018; DAWSONHUGHES B, 1991, ANN INTERN MED, V115, P505, DOI 10.7326/0003-4819-115-7-505; DIEPPE P, 1993, ANN RHEUM DIS, V52, P557, DOI 10.1136/ard.52.8.557; Driban JB, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-217; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P129, DOI 10.1002/art.22292; Fransen M, 2001, J RHEUMATOL, V28, P156; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Guermazi A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3488; Heidari B, 2011, INT ORTHOP, V35, P1627, DOI 10.1007/s00264-010-1186-2; HOSHINO A, 1987, J BONE JOINT SURG BR, V69, P807, DOI 10.1302/0301-620X.69B5.3680348; Kellgren JH, 1962, EPIDEMIOLOGY CHRONIC; Kirkwood BR, 2003, ESSENTIAL MED STAT, P361; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Kraus VB, 2005, ARTHRITIS RHEUM, V52, P1730, DOI 10.1002/art.21100; Lane NE, 1999, ARTHRITIS RHEUM-US, V42, P854, DOI 10.1002/1529-0131(199905)42:5&lt;854::AID-ANR3&gt;3.0.CO;2-I; Lo GH, 2005, ARTHRITIS RHEUM-US, V52, P2814, DOI 10.1002/art.21290; McAlindon TE, 1996, ANN INTERN MED, V125, P353, DOI 10.7326/0003-4819-125-5-199609010-00001; Murphy L, 2008, ARTHRIT RHEUM-ARTHR, V59, P1207, DOI 10.1002/art.24021; Neumann G, 2009, OSTEOARTHR CARTILAGE, V17, P761, DOI 10.1016/j.joca.2008.11.001; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; RADIN E L, 1984, Journal of Orthopaedic Research, V2, P221, DOI 10.1002/jor.1100020303; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Raynauld JP, 2009, ANN RHEUM DIS, V68, P938, DOI 10.1136/ard.2008.088732; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stratford PW, 2007, OSTEOARTHR CARTILAGE, V15, P266, DOI 10.1016/j.joca.2006.09.005; Verbeke G, 2000, LINEAR MIXED MODELS; Wirth W, 2009, OSTEOARTHR CARTILAGE, V17, P291, DOI 10.1016/j.joca.2008.07.008; Wluka A, 2001, ANN RHEUM DIS, V60, P332, DOI 10.1136/ard.60.4.332; Zhang YQ, 2000, J RHEUMATOL, V27, P1032; Zhang YQ, 2010, ARTHRIT CARE RES, V62, P1527, DOI 10.1002/acr.20287	39	167	172	4	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					155	162		10.1001/jama.2012.164487	http://dx.doi.org/10.1001/jama.2012.164487			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299607	Green Accepted, Bronze			2022-12-28	WOS:000313517000024
J	Gane, EJ; Stedman, CA; Hyland, RH; Ding, X; Svarovskaia, E; Symonds, WT; Hindes, RG; Berrey, MM				Gane, Edward J.; Stedman, Catherine A.; Hyland, Robert H.; Ding, Xiao; Svarovskaia, Evguenia; Symonds, William T.; Hindes, Robert G.; Berrey, M. Michelle			Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT-NAIVE PATIENTS; REPLICON RNA-SYNTHESIS; VIRUS-INFECTION; GENOTYPE 1; PSI-7977; COMBINATION; RESISTANCE; PROTEASE; THERAPY; REPLICATION	BACKGROUND The standard treatment for hepatitis C virus (HCV) infection is interferon, which is administered subcutaneously and can have troublesome side effects. We evaluated sofosbuvir, an oral nucleotide inhibitor of HCV polymerase, in interferon-sparing and interferon-free regimens for the treatment of HCV infection. METHODS We provided open-label treatment to eight groups of patients. A total of 40 previously untreated patients with HCV genotype 2 or 3 infection were randomly assigned to four groups; all four groups received sofosbuvir (at a dose of 400 mg once daily) plus ribavirin for 12 weeks. Three of these groups also received peginterferon alfa-2a for 4, 8, or 12 weeks. Two additional groups of previously untreated patients with HCV genotype 2 or 3 infection received sofosbuvir monotherapy for 12 weeks or sofosbuvir plus peginterferon alfa-2a and ribavirin for 8 weeks. Two groups of patients with HCV genotype 1 infection received sofosbuvir and ribavirin for 12 weeks: 10 patients with no response to prior treatment and 25 with no previous treatment. We report the rate of sustained virologic response 24 weeks after therapy. RESULTS Of the 40 patients who underwent randomization, all 10 (100%) who received sofosbuvir plus ribavirin without interferon and all 30 (100%) who received sofosbuvir plus ribavirin for 12 weeks and interferon for 4, 8, or 12 weeks had a sustained virologic response at 24 weeks. For the other patients with HCV genotype 2 or 3 infection, all 10 (100%) who received sofosbuvir plus peginterferon alfa-2a and ribavirin for 8 weeks had a sustained virologic response at 24 weeks, as did 6 of 10 (60%) who received sofosbuvir monotherapy. Among patients with HCV genotype 1 infection, 21 of 25 previously untreated patients (84%) and 1 of 10 with no response to previous therapy (10%) had a sustained virologic response at 24 weeks. The most common adverse events were headache, fatigue, insomnia, nausea, rash, and anemia. CONCLUSIONS Sofosbuvir plus ribavirin for 12 weeks may be effective in previously untreated patients with HCV genotype 1, 2, or 3 infection. (Funded by Pharmasset and Gilead Sciences; ClinicalTrials.gov number, NCT01260350.)	[Gane, Edward J.] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland, New Zealand; [Stedman, Catherine A.] Christchurch Hosp, Dept Gastroenterol, Christchurch, New Zealand; [Stedman, Catherine A.] Univ Otago, Christchurch, New Zealand; [Hyland, Robert H.; Symonds, William T.; Hindes, Robert G.; Berrey, M. Michelle] Pharmasset, Princeton, NJ USA; [Hyland, Robert H.; Ding, Xiao; Svarovskaia, Evguenia; Symonds, William T.] Gilead Sci, Foster City, CA USA	Auckland City Hospital; Christchurch Hospital New Zealand; University of Otago; Gilead Sciences	Gane, EJ (corresponding author), Auckland City Hosp, New Zealand Liver Transplant Unit, Private Bag 1142, Auckland, New Zealand.	edgane@adhb.govt.nz	Cheng, Yushao/E-6256-2011		Pharmasset; Gilead Sciences	Pharmasset; Gilead Sciences(Gilead Sciences)	Supported by Pharmasset and Gilead Sciences.	Bourliere Marc, 2011, Clin Res Hepatol Gastroenterol, V35 Suppl 2, pS84, DOI 10.1016/S2210-7401(11)70013-4; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chung RT, 2012, NEW ENGL J MED, V366, P273, DOI 10.1056/NEJMe1113272; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Gane EJ, 2010, LANCET, V376, P1467, DOI 10.1016/S0140-6736(10)61384-0; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Kuntzen T, 2008, HEPATOLOGY, V48, P1769, DOI 10.1002/hep.22549; Lalezari J, 2011, J HEPATOL, V54, pS28, DOI 10.1016/S0168-8278(11)60063-9; Lam AM, 2011, ANTIMICROB AGENTS CH, V55, P2566, DOI 10.1128/AAC.00032-11; Lam AM, 2010, ANTIMICROB AGENTS CH, V54, P3187, DOI 10.1128/AAC.00399-10; Lawitz E, 2011, J HEPATOL, V54, pS543, DOI 10.1016/S0168-8278(11)61372-X; Lawitz E, 2011, HEPATOLOGY, V54, p472A; Le Pogam S, 2010, J INFECT DIS, V202, P1510, DOI 10.1086/656774; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Muir AJ, 2002, J CLIN GASTROENTEROL, V34, P268, DOI 10.1097/00004836-200203000-00015; Murakami E, 2008, ANTIMICROB AGENTS CH, V52, P458, DOI 10.1128/AAC.01184-07; National Institute of Allergy and Infectious Diseases, 2004, DIV AIDS DAIDS TABL; Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Soriano V, 2012, EXPERT OPIN PHARMACO, V13, P313, DOI 10.1517/14656566.2012.653341; Stuyver Lieven J., 2006, Antiviral Chemistry & Chemotherapy, V17, P79; Sulkowski M, 2012, 47 ANN M EUR ASS STU; Thomas E, 2012, ANTIVIR CHEM CHEMOTH; Wohnsland A, 2007, CLIN MICROBIOL REV, V20, P23, DOI 10.1128/CMR.00010-06	26	585	605	4	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					34	44		10.1056/NEJMoa1208953	http://dx.doi.org/10.1056/NEJMoa1208953			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281974				2022-12-28	WOS:000312930600003
J	Sarewitz, D				Sarewitz, Daniel			Science must be seen to bridge the political divide	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	daniel.sarewitz@asu.edu							0	3	3	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					7	7		10.1038/493007a	http://dx.doi.org/10.1038/493007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062QC	23282339	Bronze			2022-12-28	WOS:000312933800003
J	Villanueva, C; Colomo, A; Bosch, A; Concepcion, M; Hernandez-Gea, V; Aracil, C; Graupera, I; Poca, M; Alvarez-Urturi, C; Gordillo, J; Guarner-Argente, C; Santalo, M; Muniz, E; Guarner, C				Villanueva, Candid; Colomo, Alan; Bosch, Alba; Concepcion, Mar; Hernandez-Gea, Virginia; Aracil, Carles; Graupera, Isabel; Poca, Maria; Alvarez-Urturi, Cristina; Gordillo, Jordi; Guarner-Argente, Carlos; Santalo, Miquel; Muniz, Eduardo; Guarner, Carlos			Transfusion Strategies for Acute Upper Gastrointestinal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-CELL TRANSFUSION; CONSENSUS RECOMMENDATIONS; PORTAL-HYPERTENSION; HEMORRHAGE; METHODOLOGY; MANAGEMENT; MORTALITY; PRESSURE; WORKSHOP; OUTCOMES	BACKGROUND The hemoglobin threshold for transfusion of red cells in patients with acute gastrointestinal bleeding is controversial. We compared the efficacy and safety of a restrictive transfusion strategy with those of a liberal transfusion strategy. METHODS We enrolled 921 patients with severe acute upper gastrointestinal bleeding and randomly assigned 461 of them to a restrictive strategy (transfusion when the hemoglobin level fell below 7 g per deciliter) and 460 to a liberal strategy (transfusion when the hemoglobin fell below 9 g per deciliter). Randomization was stratified according to the presence or absence of liver cirrhosis. RESULTS A total of 225 patients assigned to the restrictive strategy (51%), as compared with 65 assigned to the liberal strategy (15%), did not receive transfusions (P<0.001). The probability of survival at 6 weeks was higher in the restrictive-strategy group than in the liberal-strategy group (95% vs. 91%; hazard ratio for death with restrictive strategy, 0.55; 95% confidence interval [CI], 0.33 to 0.92; P = 0.02). Further bleeding occurred in 10% of the patients in the restrictive-strategy group as compared with 16% of the patients in the liberal-strategy group (P = 0.01), and adverse events occurred in 40% as compared with 48% (P = 0.02). The probability of survival was slightly higher with the restrictive strategy than with the liberal strategy in the subgroup of patients who had bleeding associated with a peptic ulcer (hazard ratio, 0.70; 95% CI, 0.26 to 1.25) and was significantly higher in the subgroup of patients with cirrhosis and Child-Pugh class A or B disease (hazard ratio, 0.30; 95% CI, 0.11 to 0.85), but not in those with cirrhosis and Child-Pugh class C disease (hazard ratio, 1.04; 95% CI, 0.45 to 2.37). Within the first 5 days, the portal-pressure gradient increased significantly in patients assigned to the liberal strategy (P = 0.03) but not in those assigned to the restrictive strategy. CONCLUSIONS As compared with a liberal transfusion strategy, a restrictive strategy significantly improved outcomes in patients with acute upper gastrointestinal bleeding. (Funded by Fundacio Investigacio Sant Pau; ClinicalTrials.govnumber, NCT00414713.)	[Villanueva, Candid; Colomo, Alan; Concepcion, Mar; Hernandez-Gea, Virginia; Aracil, Carles; Graupera, Isabel; Poca, Maria; Alvarez-Urturi, Cristina; Gordillo, Jordi; Guarner-Argente, Carlos; Guarner, Carlos] Autonomous Univ Barcelona, Hosp St Pau, Gastrointestinal Bleeding Unit, Dept Gastroenterol, Barcelona, Spain; [Bosch, Alba; Muniz, Eduardo] Autonomous Univ Barcelona, Hosp St Pau, Blood & Tissue Bank, Barcelona, Spain; [Santalo, Miquel] Autonomous Univ Barcelona, Hosp St Pau, Semicrit Unit, Barcelona, Spain; [Villanueva, Candid; Colomo, Alan; Graupera, Isabel; Guarner, Carlos] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Fundacio Banc Sang Teixits de les Illes Balears; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Villanueva, C (corresponding author), Hosp Santa Creu & Sant Pau, Serv Patol Digest, Mas Casanovas 90, Barcelona 08025, Spain.	cvillanueva@santpau.cat	Hernandez-Gea, Virginia/E-9485-2017; Guarner-Argente, Carlos/M-7616-2019; Callahan, Charles D/L-1641-2013	Hernandez-Gea, Virginia/0000-0001-7937-984X; Guarner-Argente, Carlos/0000-0002-8180-1488; Poca Sans, Maria/0000-0002-0235-1395; Graupera, Isabel/0000-0001-9170-9784; Guarner, Carlos/0000-0001-5957-9481	Fundacio Investigacio Sant Pau; Sequana Medical	Fundacio Investigacio Sant Pau; Sequana Medical	Supported in part by the Fundacio Investigacio Sant Pau.; Dr. Guarner reports receiving consulting fees from Sequana Medical. No other potential conflict of interest relevant to this article was reported.	Barkun A, 2003, ANN INTERN MED, V139, P843, DOI 10.7326/0003-4819-139-10-200311180-00012; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; BLAIR SD, 1986, BRIT J SURG, V73, P783, DOI 10.1002/bjs.1800731007; British Society of Gastroenterology, UK UPP GI BLEED AUD; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Castaneda B, 2001, HEPATOLOGY, V33, P821, DOI 10.1053/jhep.2001.23437; Crooks C, 2011, GASTROENTEROLOGY, V141, P62, DOI 10.1053/j.gastro.2011.03.048; de Franchis R, 2000, J HEPATOL, V33, P846; de Franchis R, 2010, J HEPATOL, V53, P762, DOI 10.1016/j.jhep.2010.06.004; Duggan JM, 2001, ALIMENT PHARM THERAP, V15, P1109, DOI 10.1046/j.1365-2036.2001.01013.x; Gralnek IM, 2008, NEW ENGL J MED, V359, P928, DOI 10.1056/NEJMra0706113; Halland M, 2010, DIGEST DIS SCI, V55, P3430, DOI 10.1007/s10620-010-1223-4; Hearnshaw SA, 2010, ALIMENT PHARM THER, V32, P215, DOI 10.1111/j.1365-2036.2010.04348.x; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1999, NEW ENGL J MED, V340, P1056; Jairath V, 2010, COCHRANE DB SYST REV, V9; Kanias T, 2012, TRANSFUSION, V52, P1388, DOI 10.1111/j.1537-2995.2012.03748.x; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; KRAVETZ D, 1986, GASTROENTEROLOGY, V90, P1232, DOI 10.1016/0016-5085(86)90390-2; Lacroix J, 2007, NEW ENGL J MED, V356, P1609, DOI 10.1056/NEJMoa066240; Malone DL, 2003, J TRAUMA, V54, P898, DOI 10.1097/01.TA.0000060261.10597.5C; Marik PE, 2008, CRIT CARE MED, V36, P2667, DOI 10.1097/CCM.0b013e3181844677; MCCORMICK PA, 1995, GUT, V36, P100, DOI 10.1136/gut.36.1.100; Palmer KR, 2002, GUT, V51, P1; Roberts I, 2001, LANCET, V357, P385, DOI 10.1016/S0140-6736(00)03653-9; Robinson WP, 2005, J TRAUMA, V58, P437, DOI 10.1097/01.TA.0000153935.18997.14; Vamvakas EC, 2007, BLOOD REV, V21, P327, DOI 10.1016/j.blre.2007.07.003; Villanueva C, 2001, GASTROENTEROLOGY, V121, P110, DOI 10.1053/gast.2001.25536; Villarejo F., 1999, Acta Gastroenterologica Latinoamericana, V29, P261	29	940	984	7	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					11	21		10.1056/NEJMoa1211801	http://dx.doi.org/10.1056/NEJMoa1211801			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281973				2022-12-28	WOS:000312930600001
J	Metzger, ML; Billett, A; Link, MP				Metzger, Monika L.; Billett, Amy; Link, Michael P.			The Impact of Drug Shortages on Children with Cancer - The Example of Mechlorethamine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Metzger, Monika L.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Metzger, Monika L.] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Billett, Amy] Dana Farber Canc Inst, Boston, MA 02115 USA; [Billett, Amy] Boston Childrens Hosp, Boston, MA USA; [Link, Michael P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Link, Michael P.] Lucile Packard Childrens Hosp, Stanford, CA USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Stanford University; Lucile Packard Children's Hospital (LPCH)	Metzger, ML (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.							Chabner BA, 2011, NEW ENGL J MED, V365, P2147, DOI 10.1056/NEJMp1112633; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Link MP, 2012, J CLIN ONCOL, V30, P692, DOI 10.1200/JCO.2011.41.0936	3	61	61	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2461	2463		10.1056/NEJMp1212468	http://dx.doi.org/10.1056/NEJMp1212468			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268661				2022-12-28	WOS:000312714200001
J	Ponting, CP				Ponting, Chris P.			Loaded Dice for Human Genome Mutation	CELL			English	Editorial Material								Not all bases in the human genome are equally prone to chance mutations. Michaelson et al. show that individuals can acquire clusters of de novo DNA changes and propose that the likelihood of single base pair change differs across three orders of magnitude.	Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3PT, England	University of Oxford	Ponting, CP (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, S Parks Rd, Oxford OX1 3PT, England.	chris.ponting@dpag.ox.ac.uk	Ponting, Chris/AAV-2621-2021	Ponting, Chris/0000-0003-0202-7816	Parkinson&apos;s UK [J-0901] Funding Source: Medline; Parkinson&quot;s UK [J-0901] Funding Source: researchfish	Parkinson&apos;s UK(Parkinson&apos;s UK); Parkinson&quot;s UK(Parkinson&apos;s UK)		Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Michaelson J.J., 2012, CELL, V151, P1431; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241	9	3	3	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1399	1400		10.1016/j.cell.2012.12.002	http://dx.doi.org/10.1016/j.cell.2012.12.002			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260131	Bronze			2022-12-28	WOS:000312890300005
J	Dennedy, MC; Dunne, F				Dennedy, Michael Conall; Dunne, Fidelma			Macrosomia: defining the problem worldwide	LANCET			English	Editorial Material							BIRTH-WEIGHT; FETAL; ASSOCIATION; CRITERIA; OUTCOMES; OBESITY; DIP		[Dennedy, Michael Conall; Dunne, Fidelma] Natl Univ Ireland, Dept Med, Inst Clin Sci, Galway, Ireland; [Dennedy, Michael Conall] Addenbrookes Univ Hosp, Metab Res Labs, Inst Metab Sci, Cambridge, England	Ollscoil na Gaillimhe-University of Galway; University of Cambridge	Dennedy, MC (corresponding author), Natl Univ Ireland, Dept Med, Inst Clin Sci, Galway, Ireland.	cdennedy@me.com		Dennedy, Michael/0000-0001-9325-6520				Chatfield J, 2001, AM FAM PHYSICIAN, V64, P169; Cohen B, 2006, TECHNOL SOC, V28, P63, DOI 10.1016/j.techsoc.2005.10.005; Cresswell JA, 2012, LANCET, V380, P1325, DOI 10.1016/S0140-6736(12)60869-1; Dennedy MC, 2012, J CLIN ENDOCR METAB, V97, pE608, DOI 10.1210/jc.2011-2674; Dennedy MC, 2010, BEST PRACT RES CL EN, V24, P573, DOI 10.1016/j.beem.2010.06.001; Gardosi J, 2004, SEMIN PERINATOL, V28, P33, DOI 10.1053/j.semperi.2003.12.002; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Koyanagi A., 2013, LANCET; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; O'Sullivan EP, 2011, DIABETOLOGIA, V54, P1670, DOI 10.1007/s00125-011-2150-4; Rios LP, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-11; Sparano S, 2012, MATERN CHILD HLTH J; Uchimura H, 2009, IDE-JETRO SER, P1, DOI 10.1057/9780230250772; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	15	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					435	436		10.1016/S0140-6736(12)62090-X	http://dx.doi.org/10.1016/S0140-6736(12)62090-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	088CH	23290492				2022-12-28	WOS:000314810900011
J	Arnon, TI; Horton, RM; Grigorova, IL; Cyster, JG				Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.			Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress	NATURE			English	Article							IMMUNE-COMPLEXES; LYMPHOCYTES; ANTIGEN; ABSENCE; ACTIVATION; EXPRESSION; RETENTION; TRANSPORT; SELECTION; CD19	The splenic marginal zone is a unique microenvironment where resident immune cells are exposed to the open blood circulation(1,2). Even though it has an important role in responses against bloodborne antigens, lymphocyte migration in the marginal zone has not been intravitally visualized due to challenges associated with achieving adequate imaging depth in this abdominal organ. Here we develop a two-photon microscopy procedure to study marginal zone and follicular B-cell movement in the live mouse spleen. We show that marginal zone B cells are highly motile and exhibit long membrane extensions. Marginal zone B cells shuttle between the marginal zone and follicles with at least one-fifth of the cells exchanging between compartments per hour, a behaviour that explains their ability to deliver antigens rapidly from the open blood circulation to the secluded follicles. Follicular B cells also transit from follicles to the marginal zone, but unlike marginal zone B cells, they fail to undergo integrin-mediated adhesion, become caught in fluid flow and are carried into the red pulp. Follicular B-cell egress via the marginal zone is sphingosine-1-phosphate receptor-1 (S1PR1)-dependent. This study shows that marginal zone B cells migrate continually between marginal zone and follicles and establishes the marginal zone as a site of S1PR1-dependent B-cell exit from follicles. The results also show how adhesive differences of similar cells critically influence their behaviour in the same microenvironment.	[Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Arnon, Tal I.; Horton, Robert M.; Grigorova, Irina L.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	Jason.Cyster@ucsf.edu	Grigorova, Irina/AAR-8795-2020	Grigorova, Irina/0000-0002-4963-7403; Arnon, Tal/0000-0003-4629-5820	Jane Coffin Child's fellowship; National Institutes of Health [AI74847]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Jane Coffin Child's fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Miller for help with the microscope stage mount, T. Phan for advice regarding mouse surgery, J. An for technical assistance and O. M Bannard, J. R. Muppidi, M. Barnes and A. Reboldi for comments on the manuscript. T. I. A. was supported by a Jane Coffin Child's fellowship and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health grant AI74847.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnon TI, 2011, SCIENCE, V333, P1898, DOI 10.1126/science.1208248; Barral P, 2012, EMBO J, V31, P2378, DOI 10.1038/emboj.2012.87; Boscacci RT, 2010, BLOOD, V116, P915, DOI 10.1182/blood-2009-11-254334; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Green JA, 2012, IMMUNOL REV, V247, P36, DOI 10.1111/j.1600-065X.2012.01114.x; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Hao ZY, 2001, J EXP MED, V194, P1151, DOI 10.1084/jem.194.8.1151; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; KRAAL G, 1995, AM J PATHOL, V147, P763; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; KUMARARATNE DS, 1981, EUR J IMMUNOL, V11, P865, DOI 10.1002/eji.1830111104; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; MACLENNAN ICM, 1982, IMMUNOL TODAY, V3, P305, DOI 10.1016/0167-5699(82)90032-9; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Molina H, 1996, P NATL ACAD SCI USA, V93, P3357, DOI 10.1073/pnas.93.8.3357; Morris MA, 2005, EUR J IMMUNOL, V35, P3570, DOI 10.1002/eji.200526218; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; SCHMIDT EE, 1993, SCANNING MICROSCOPY, V7, P613; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Suzuki K, 2009, J EXP MED, V206, P1485, DOI 10.1084/jem.20090209; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; You YY, 2009, J IMMUNOL, V182, P7343, DOI 10.4049/jimmunol.0804295	36	142	143	2	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					684	+		10.1038/nature11738	http://dx.doi.org/10.1038/nature11738			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263181	Green Accepted, Green Submitted			2022-12-28	WOS:000314219600059
J	Service, RF				Service, Robert F.			SOLAR ENERGY Performance of Nanowire Solar Cells on the Rise	SCIENCE			English	News Item																			0	21	21	2	135	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					263	263		10.1126/science.339.6117.263	http://dx.doi.org/10.1126/science.339.6117.263			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329026				2022-12-28	WOS:000313622000015
J	Serganov, A; Nudler, E				Serganov, Alexander; Nudler, Evgeny			A Decade of Riboswitches	CELL			English	Review							CANDIDATE STRUCTURED RNAS; CONTROLS GENE-EXPRESSION; SAM-II RIBOSWITCH; MESSENGER-RNA; S-ADENOSYLMETHIONINE; GLYCINE RIBOSWITCH; SENSING RIBOSWITCH; BACILLUS-SUBTILIS; LIGAND-BINDING; GLMS RIBOZYME	Riboswitches were discovered in 2002 in bacteria as RNA-based intracellular sensors of vitamin derivatives. During the last decade, naturally occurring RNA sensor elements have been found to bind a range of small metabolites and ions and to exert regulatory control of transcription, translation, splicing, and RNA stability. Extensive biochemical, structural, and genetic studies have established the basic principles underpinning riboswitch function in all three kingdoms of life with implications for developing antibiotics, designing new molecular sensors, and integrating riboswitches into synthetic circuits.	[Serganov, Alexander; Nudler, Evgeny] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	New York University	Serganov, A (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	alexander.serganov@nyumc.org; evgeny.nudler@nyumc.org		Serganov, Alexander/0000-0001-8328-9310; Nudler, Evgeny/0000-0002-8811-3071	NIH; New York University Medical Center funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Medical Center funds; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the NIH (E.N.) and by New York University Medical Center funds (A.S. and E.N.).	Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Bocobza S, 2007, GENE DEV, V21, P2874, DOI 10.1101/gad.443907; Breaker RR, 2006, COLD SPRING HARB MON, V43, P89; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Butler EB, 2011, CHEM BIOL, V18, P293, DOI 10.1016/j.chembiol.2011.01.013; Chen AGY, 2011, RNA, V17, P1967, DOI 10.1261/rna.2757311; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Collins JA, 2007, GENE DEV, V21, P3356, DOI 10.1101/gad.1605307; Corbino KA, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r70; Croft MT, 2007, P NATL ACAD SCI USA, V104, P20770, DOI 10.1073/pnas.0705786105; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Dixon N, 2012, ANGEW CHEM INT EDIT, V51, P3620, DOI 10.1002/anie.201109106; Dixon N, 2010, P NATL ACAD SCI USA, V107, P2830, DOI 10.1073/pnas.0911209107; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Epshtein V, 2003, P NATL ACAD SCI USA, V100, P5052, DOI 10.1073/pnas.0531307100; Fox KA, 2009, P NATL ACAD SCI USA, V106, P4435, DOI 10.1073/pnas.0812194106; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gelfand MS, 1999, TRENDS GENET, V15, P439, DOI 10.1016/S0168-9525(99)01856-9; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GRALLA J, 1974, NATURE, V248, P204, DOI 10.1038/248204a0; GRUNDY FJ, 1993, CELL, V74, P475, DOI 10.1016/0092-8674(93)80049-K; Haller A, 2011, NAT CHEM BIOL, V7, P393, DOI [10.1038/NCHEMBIO.562, 10.1038/nchembio.562]; Huang LL, 2011, P NATL ACAD SCI USA, V108, P14801, DOI 10.1073/pnas.1111701108; Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026; Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911; Johnson JE, 2012, NATURE, V492, P133, DOI 10.1038/nature11607; Kladwang W, 2012, J AM CHEM SOC, V134, P1404, DOI 10.1021/ja2093508; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Kwon MY, 2008, RNA, V14, P25, DOI 10.1261/rna.771608; Lee ER, 2010, SCIENCE, V329, P845, DOI 10.1126/science.1190713; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Lilley David M. J., 2008, P1; Loh E, 2009, CELL, V139, P770, DOI 10.1016/j.cell.2009.08.046; Lu C, 2008, NAT STRUCT MOL BIOL, V15, P1076, DOI 10.1038/nsmb.1494; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; McDaniel BAM, 2003, P NATL ACAD SCI USA, V100, P3083, DOI 10.1073/pnas.0630422100; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; Mironov AS, 2002, CELL, V111, P747, DOI 10.1016/S0092-8674(02)01134-0; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nechooshtan G, 2009, GENE DEV, V23, P2650, DOI 10.1101/gad.552209; Nou XW, 1998, J BACTERIOL, V180, P6719, DOI 10.1128/JB.180.24.6719-6728.1998; Nou XW, 2000, P NATL ACAD SCI USA, V97, P7190, DOI 10.1073/pnas.130013897; Perkins JB, 2002, BACILLUS SUBTILIS IT, P271, DOI DOI 10.1128/9781555817992.CH20; Peselis A, 2012, NAT STRUCT MOL BIOL, V19, P1182, DOI 10.1038/nsmb.2405; Pikovskaya O, 2011, NAT CHEM BIOL, V7, P748, DOI [10.1038/NCHEMBIO.631, 10.1038/nchembio.631]; Ravnum S, 2001, MOL MICROBIOL, V39, P1585, DOI 10.1046/j.1365-2958.2001.02346.x; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Ren AM, 2012, NATURE, V486, P85, DOI 10.1038/nature11152; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2008, NATURE, V455, P1263, DOI 10.1038/nature07326; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; Stormo GD, 2001, P NATL ACAD SCI USA, V98, P9465, DOI 10.1073/pnas.181334498; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Suess B, 2004, NUCLEIC ACIDS RES, V32, P1610, DOI 10.1093/nar/gkh321; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tomsic J, 2008, J BACTERIOL, V190, P823, DOI 10.1128/JB.01034-07; Trausch JJ, 2011, STRUCTURE, V19, P1413, DOI 10.1016/j.str.2011.06.019; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Verhounig A, 2010, P NATL ACAD SCI USA, V107, P6204, DOI 10.1073/pnas.0914423107; Vu MMK, 2012, CHEM BIOL, V19, P1247, DOI 10.1016/j.chembiol.2012.08.010; Wachter A, 2007, PLANT CELL, V19, P3437, DOI 10.1105/tpc.107.053645; Watson PY, 2012, NAT CHEM BIOL, V8, P963, DOI [10.1038/nchembio.1095, 10.1038/NCHEMBIO.1095]; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Winkler WC, 2003, NAT STRUCT BIOL, V10, P701, DOI 10.1038/nsb967; YANOFSKY C, 1981, NATURE, V289, P751, DOI 10.1038/289751a0	79	661	687	19	380	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					17	24		10.1016/j.cell.2012.12.024	http://dx.doi.org/10.1016/j.cell.2012.12.024			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332744	Bronze, Green Accepted			2022-12-28	WOS:000313719800003
J	Ioannidis, JPA				Ioannidis, John P. A.			Mega-Trials for Blockbusters	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE		[Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford Prevent Res Ctr, Med Sch Off Bldg,Room X306,1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011					[Anonymous], 2011, US PHARM SAL 2011; Bohlius J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007303.pub2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Eisenstein EL, 2008, CLIN TRIALS, V5, P75, DOI 10.1177/1740774507087551; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rizos EC, 2011, J CLIN EPIDEMIOL, V64, P830, DOI 10.1016/j.jclinepi.2010.11.017; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	9	32	34	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					239	240		10.1001/jama.2012.168095	http://dx.doi.org/10.1001/jama.2012.168095			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321760				2022-12-28	WOS:000313546800020
J	O'Shea, JJ; Holland, SM; Staudt, LM				O'Shea, John J.; Holland, Steven M.; Staudt, Louis M.			MECHANISMS OF DISEASE JAKs and STATs in Immunity, Immunodeficiency, and Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; HYPER-IGE SYNDROME; PLACEBO-CONTROLLED TRIAL; JANUS KINASE INHIBITOR; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; ACTIVATING MUTATION; HEMATOPOIETIC STEM; INBORN-ERRORS		[O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Holland, Steven M.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Staudt, Louis M.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, 10 Ctr Dr,Rm 13C103C, Bethesda, MD 20892 USA.	osheajo@mail.nih.gov	Staudt, Louis/AAC-5324-2019		Intramural NIH HHS [Z01 SC004024, ZIA AR041106] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZIAAR041167, ZIAAR041106] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asnafi V, 2010, BRIT J HAEMATOL, V148, P179, DOI 10.1111/j.1365-2141.2009.07912.x; Bandaranayake RM, 2012, NAT STRUCT MOL BIOL, V19, P754, DOI 10.1038/nsmb.2348; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bellucci R, 2012, J CLIN INVEST, V122, P2369, DOI 10.1172/JCI58457; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Boisson-Dupuis S, 2012, CURR OPIN IMMUNOL, V24, P364, DOI 10.1016/j.coi.2012.04.011; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Casanova JL, 2012, IMMUNITY, V36, P515, DOI 10.1016/j.immuni.2012.03.016; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Chapgier A, 2009, J CLIN INVEST, V119, P1502, DOI 10.1172/JCI37083; Chen E, 2012, IMMUNITY, V36, P529, DOI 10.1016/j.immuni.2012.03.017; Cho JH, 2011, NEW ENGL J MED, V365, P1612, DOI 10.1056/NEJMra1100030; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Ding BB, 2008, BLOOD, V111, P1515, DOI 10.1182/blood-2007-04-087734; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Elliott NE, 2011, BLOOD, V118, P3911, DOI 10.1182/blood-2010-12-319467; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Funakoshi-Tago M, 2010, J BIOL CHEM, V285, P5296, DOI 10.1074/jbc.M109.040733; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Granada M, 2012, J ALLERGY CLIN IMMUN, V129, P840, DOI 10.1016/j.jaci.2011.09.029; Grimbacher B, 1999, NEW ENGL J MED, V340, P692, DOI 10.1056/NEJM199903043400904; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; Hernandez-Ilizaliturri FJ, 2011, CANCER-AM CANCER SOC, V117, P5058, DOI 10.1002/cncr.26135; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Hunter MG, 2000, BLOOD, V95, P2132, DOI 10.1182/blood.V95.6.2132; Imada K, 1998, J EXP MED, V188, P2067, DOI 10.1084/jem.188.11.2067; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kearney L, 2009, BLOOD, V113, P646, DOI 10.1182/blood-2008-08-170928; Kilic SS, 2012, J PEDIATR-US, V160, P1055, DOI 10.1016/j.jpeds.2012.01.056; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926; Koo GC, 2012, CANCER DISCOV, V2, P591, DOI 10.1158/2159-8290.CD-12-0028; Koskela HLM, 2012, NEW ENGL J MED, V366, P1905, DOI 10.1056/NEJMoa1114885; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lam LT, 2008, BLOOD, V111, P3701, DOI 10.1182/blood-2007-09-111948; Landgren O, 2008, BLOOD, V112, P2199, DOI 10.1182/blood-2008-03-143602; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Li JA, 2010, BLOOD, V116, P1528, DOI 10.1182/blood-2009-12-259747; Liu LY, 2011, J EXP MED, V208, P1635, DOI 10.1084/jem.20110958; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; MIGONE TS, 1995, SCIENCE, V269, P79, DOI 10.1126/science.7604283; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Montesinos-Rongen M, 2011, ACTA NEUROPATHOL, V122, P791, DOI 10.1007/s00401-011-0891-2; Mullally A, 2010, CANCER CELL, V17, P584, DOI 10.1016/j.ccr.2010.05.015; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Nelson EA, 2011, ONCOTARGET, V2, P518; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; O'Shea J. J., 2011, RHEUMATOLOGY, P91; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Rui LX, 2010, CANCER CELL, V18, P590, DOI 10.1016/j.ccr.2010.11.013; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Sampaio EP, 2012, J CLIN IMMUNOL, V32, P681, DOI 10.1007/s10875-012-9659-2; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scuto A, 2011, LEUKEMIA, V25, P538, DOI 10.1038/leu.2010.289; Shochat C, 2011, J EXP MED, V208, P1333, DOI 10.1084/jem.201105802011512c; Siegel AM, 2011, IMMUNITY, V35, P806, DOI 10.1016/j.immuni.2011.09.016; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Turkson J, 2000, ONCOGENE, V19, P6613, DOI 10.1038/sj.onc.1204086; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; van de Veerdonk FL, 2011, NEW ENGL J MED, V365, P54, DOI 10.1056/NEJMoa1100102; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557; Verstovsek S, 2010, NEW ENGL J MED, V363, P1117, DOI 10.1056/NEJMoa1002028; Walz C, 2012, BLOOD, V119, P3550, DOI 10.1182/blood-2011-12-397554; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Xiang ZF, 2008, BLOOD, V111, P4809, DOI 10.1182/blood-2007-05-090308; Yan DQ, 2012, BLOOD, V119, P3539, DOI 10.1182/blood-2011-03-345215; Yan QG, 2012, HAEMATOL-HEMATOL J, V97, P595, DOI 10.3324/haematol.2011.054080; Yang YB, 2012, CANCER CELL, V21, P723, DOI 10.1016/j.ccr.2012.05.024; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yoda A, 2010, P NATL ACAD SCI USA, V107, P252, DOI 10.1073/pnas.0911726107; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	99	521	558	5	114	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					161	170		10.1056/NEJMra1202117	http://dx.doi.org/10.1056/NEJMra1202117			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301733	Green Accepted			2022-12-28	WOS:000313238100006
J	Papasaikas, P; Valcarcel, J				Papasaikas, Panagiotis; Valcarcel, Juan			Splicing in 4D	SCIENCE			English	Editorial Material							PROTEIN-INTERACTION NETWORKS		[Papasaikas, Panagiotis; Valcarcel, Juan] Ctr Regulacio Genom, Barcelona 08003, Spain; [Papasaikas, Panagiotis; Valcarcel, Juan] Univ Pompeu Fabra, Barcelona 08003, Spain; [Valcarcel, Juan] Inst Catalana Recerca & Estudis Avancats, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Papasaikas, P (corresponding author), Ctr Regulacio Genom, Barcelona 08003, Spain.	juan.valcarcel@crg.eu	Papasaikas, Panagiotis/J-8581-2015; Valcarcel, Juan/O-9814-2014	Papasaikas, Panagiotis/0000-0002-1640-7636; Valcarcel, Juan/0000-0001-5398-3571	ICREA Funding Source: Custom	ICREA(ICREA)		Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; GILBERT W, 1978, NATURE, V271, P501, DOI 10.1038/271501a0; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009	12	11	11	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1547	1548		10.1126/science.1233219	http://dx.doi.org/10.1126/science.1233219			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258879				2022-12-28	WOS:000312533100035
J	Hosgood, SA; Nicholson, ML				Hosgood, Sarah A.; Nicholson, Michael L.			Age and cold storage in kidneys from circulatory-death donors	LANCET			English	Editorial Material							DELAYED GRAFT FUNCTION; CARDIAC DEATH; MACHINE PERFUSION; TRANSPLANTATION; DONATION		[Hosgood, Sarah A.; Nicholson, Michael L.] Univ Leicester, Leicester Gen Hosp, Transplant Grp, Dept Infect Immun & Inflammat, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester	Hosgood, SA (corresponding author), Univ Leicester, Leicester Gen Hosp, Transplant Grp, Dept Infect Immun & Inflammat, Leicester LE5 4PW, Leics, England.	sah76@le.ac.uk		Hosgood, Sarah/0000-0002-8039-143X				Cantafio AW, 2011, CLIN TRANSPLANT, V25, pE530, DOI 10.1111/j.1399-0012.2011.01477.x; Hosgood SA, 2011, TRANSPLANTATION, V92, P735, DOI 10.1097/TP.0b013e31822d4e04; Locke JE, 2007, AM J TRANSPLANT, V7, P1797, DOI 10.1111/j.1600-6143.2007.01852.x; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Siedlecki A, 2011, AM J TRANSPLANT, V11, P2279, DOI 10.1111/j.1600-6143.2011.03754.x; Singh RP, 2011, CLIN TRANSPLANT, V25, P255, DOI 10.1111/j.1399-0012.2010.01241.x; Snoeijs MGJ, 2010, TRANSPLANTATION, V90, P1106, DOI 10.1097/TP.0b013e3181f83b0b; Summers DM, 2012, LANCET; van der Vliet JA, 2011, CLIN TRANSPLANT, V25, pE612, DOI 10.1111/j.1399-0012.2011.01510.x; Watson CJE, 2010, AM J TRANSPLANT, V10, P1991, DOI 10.1111/j.1600-6143.2010.03165.x	10	5	5	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					703	704		10.1016/S0140-6736(12)61779-6	http://dx.doi.org/10.1016/S0140-6736(12)61779-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23261145				2022-12-28	WOS:000315570900005
J	Carta, M; Malpass-Evans, R; Croad, M; Rogan, Y; Jansen, JC; Bernardo, P; Bazzarelli, F; McKeown, NB				Carta, Mariolino; Malpass-Evans, Richard; Croad, Matthew; Rogan, Yulia; Jansen, Johannes C.; Bernardo, Paola; Bazzarelli, Fabio; McKeown, Neil B.			An Efficient Polymer Molecular Sieve for Membrane Gas Separations	SCIENCE			English	Article							INTRINSIC MICROPOROSITY; TROGERS BASE; PERMEATION PARAMETERS; FREE-VOLUME; PERMEABILITY; PERFORMANCE; TRANSPORT; MONOMERS; NITROGEN; ANALOGS	Microporous polymers of extreme rigidity are required for gas-separation membranes that combine high permeability with selectivity. We report a shape-persistent ladder polymer consisting of benzene rings fused together by inflexible bridged bicyclic units. The polymer's contorted shape ensures both microporosity-with an internal surface area greater than 1000 square meters per gram-and solubility so that it is readily cast from solution into robust films. These films demonstrate exceptional performance as molecular sieves with high gas permeabilities and good selectivities for smaller gas molecules, such as hydrogen and oxygen, over larger molecules, such as nitrogen and methane. Hence, this polymer has excellent potential for making membranes suitable for large-scale gas separations of commercial and environmental relevance.	[Carta, Mariolino; Malpass-Evans, Richard; Croad, Matthew; Rogan, Yulia; McKeown, Neil B.] Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales; [Jansen, Johannes C.; Bernardo, Paola; Bazzarelli, Fabio] Univ Calabria, ITM CNR, Consiglio Nazl Ric, Inst Membrane Technol, I-87030 Arcavacata Di Rende, CS, Italy	Cardiff University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Tecnologia delle Membrane (ITM-CNR); University of Calabria	McKeown, NB (corresponding author), Cardiff Univ, Sch Chem, Cardiff CF10 3AT, S Glam, Wales.	mckeownnb@cardiff.ac.uk	Jansen, Johannes Carolus/D-2118-2012; McKeown, Neil/U-8963-2019; Bernardo, Paola/H-6799-2012; McKeown, Neil B/A-2451-2011; BAZZARELLI, FABIO/AAX-9440-2020; Malpass-Evans, Richard/G-8164-2014; Carta, Mariolino/J-7476-2012	Jansen, Johannes Carolus/0000-0003-4538-6851; McKeown, Neil/0000-0002-6027-261X; Bernardo, Paola/0000-0003-0370-6319; McKeown, Neil B/0000-0002-6027-261X; BAZZARELLI, FABIO/0000-0002-5611-5574; Malpass-Evans, Richard/0000-0002-6375-6273; Carta, Mariolino/0000-0003-0718-6971	European Community [NMP3-SL-2009-228631]; Engineering and Physical Sciences Research Council [EP/G01244X, EP/G062129/1]; EPSRC [EP/G01244X/1, EP/G062129/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G01244X/1] Funding Source: researchfish	European Community(European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of the work leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement NMP3-SL-2009-228631, project DoubleNanoMem. We also thank the Engineering and Physical Sciences Research Council for funding (grants EP/G01244X and EP/G062129/1). K. Pilnacek and G. Clarizia are gratefully acknowledged for their help in the data elaboration and the performance of mixed-gas permeation measurements. We thank G. Hutchings (Cardiff University) for reading the manuscript and making helpful suggestions. A patent has been filed through Cardiff University on the polymer synthesis presented in this report (UK patent application PCT/GB2011/051703; WO 2012/035327 (2010).	Abdolmaleki A, 2011, J APPL POLYM SCI, V122, P282, DOI 10.1002/app.34033; Bernardo P, 2009, IND ENG CHEM RES, V48, P4638, DOI 10.1021/ie8019032; Bezzu CG, 2012, ADV MATER, V24, P5930, DOI 10.1002/adma.201202393; Budd PM, 2010, POLYM CHEM-UK, V1, P63, DOI 10.1039/b9py00319c; Budd PM, 2008, J MEMBRANE SCI, V325, P851, DOI 10.1016/j.memsci.2008.09.010; Calle M, 2010, MACROMOLECULES, V43, P2268, DOI 10.1021/ma901943j; Carta M, 2008, ORG LETT, V10, P2641, DOI 10.1021/ol800573m; Didier D, 2008, TETRAHEDRON, V64, P6252, DOI 10.1016/j.tet.2008.04.111; Dolensky B, 2012, CHEM SOC REV, V41, P3839, DOI 10.1039/c2cs15307f; Dorkenoo KD, 2000, MACROMOLECULES, V33, P3747, DOI 10.1021/ma9921145; Du NY, 2012, ENERG ENVIRON SCI, V5, P7306, DOI [10.1039/c1ee02668b, 10.1039/C1EE02668B]; Du NY, 2011, NAT MATER, V10, P372, DOI [10.1038/NMAT2989, 10.1038/nmat2989]; Du NY, 2010, MACROMOLECULES, V43, P8580, DOI 10.1021/ma101930x; Du NY, 2009, MACROMOLECULES, V42, P6023, DOI 10.1021/ma900898m; Du NY, 2009, MACROMOLECULES, V42, P6038, DOI 10.1021/ma9009017; Du N, 2009, MACROMOL RAPID COMM, V30, P584, DOI 10.1002/marc.200800795; Du NY, 2008, MACROMOLECULES, V41, P9656, DOI 10.1021/ma801858d; Du X, 2010, CHEM COMMUN, V46, P970, DOI 10.1039/b920113k; Freeman BD, 1999, MACROMOLECULES, V32, P375, DOI 10.1021/ma9814548; Fritsch D, 2011, MACROMOL CHEM PHYS, V212, P1137, DOI 10.1002/macp.201100089; Ghanem BS, 2008, MACROMOLECULES, V41, P1640, DOI 10.1021/ma071846r; Ghanem BS, 2009, MACROMOLECULES, V42, P7881, DOI 10.1021/ma901430q; Gringolts M, 2010, MACROMOLECULES, V43, P7165, DOI 10.1021/ma100656e; Heuchel M, 2008, J MEMBRANE SCI, V318, P84, DOI 10.1016/j.memsci.2008.02.038; Hu Y, 2008, MACROMOLECULES, V41, P8525, DOI 10.1021/ma801845g; Jiang S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1207; McCaig MS, 2000, POLYMER, V41, P629, DOI 10.1016/S0032-3861(99)00172-X; McKeown N. B., 2010, UK Patent Appl., Patent No. [PCT/GB2011/051703, 2011051703, PCT/GB2011/051703; WO 2012/ 035327]; Merkel TC, 2012, J MEMBRANE SCI, V389, P441, DOI 10.1016/j.memsci.2011.11.012; NAGAI K, 1995, J POLYM SCI POL PHYS, V33, P289, DOI 10.1002/polb.1995.090330214; Park HB, 2007, SCIENCE, V318, P254, DOI 10.1126/science.1146744; Poli E, 2011, J PHYS CHEM C, V115, P7573, DOI 10.1021/jp2002854; Prelog V, 1944, HELV CHIM ACTA, V27, P1127, DOI 10.1002/hlca.194402701143; Robeson LM, 2008, J MEMBRANE SCI, V320, P390, DOI 10.1016/j.memsci.2008.04.030; ROBESON LM, 1991, J MEMBRANE SCI, V62, P165, DOI 10.1016/0376-7388(91)80060-J; Rowe BW, 2010, J MEMBRANE SCI, V360, P58, DOI 10.1016/j.memsci.2010.04.047; Schneider MW, 2012, CHEM-EUR J, V18, P836, DOI 10.1002/chem.201102857; Sergeyev S, 2009, HELV CHIM ACTA, V92, P415, DOI 10.1002/hlca.200800329; Short R, 2011, CHEM COMMUN, V47, P6822, DOI 10.1039/c1cc11717c; Troger J., 1887, J PRAKT CHEM, V36, P227; Yampolskii Y, 2012, MACROMOLECULES, V45, P3298, DOI 10.1021/ma300213b	41	695	718	53	1054	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					303	307		10.1126/science.1228032	http://dx.doi.org/10.1126/science.1228032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329042				2022-12-28	WOS:000313622000039
J	Wearn, OR; Reuman, DC; Ewers, RM				Wearn, Oliver R.; Reuman, Daniel C.; Ewers, Robert M.			Response to Comment on "Extinction Debt and Windows of Conservation Opportunity in the Brazilian Amazon"	SCIENCE			English	Editorial Material														Wearn, Oliver/0000-0001-8258-3534					0	4	4	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					271	271		10.1126/science.1231618	http://dx.doi.org/10.1126/science.1231618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329034				2022-12-28	WOS:000313622000023
J	Dhatariya, K				Dhatariya, Ketan			Should inpatient hyperglycaemia be treated?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTENSIVE INSULIN THERAPY; MYOCARDIAL-INFARCTION; MORTALITY; MANAGEMENT; INFUSION		Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust	Dhatariya, K (corresponding author), Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Norwich NR4 7UY, Norfolk, England.	ketan.dhatariya@nnuh.nhs.uk						Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P3079, DOI 10.1210/jc.2012-1112; Dhatariya K, 2011, MANAGEMENT ADULTS DI; Dungan KM, 2009, LANCET, V373, P1798, DOI 10.1016/S0140-6736(09)60553-5; Evans NR, 2012, CLIN MED, V12, P137, DOI 10.7861/clinmedicine.12-2-137; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Fowler D., 2010, SAFE EFFECTIVE USE I; Frisch A, 2010, DIABETES CARE, V33, P1783, DOI 10.2337/dc10-0304; Gandhi GY, 2008, MAYO CLIN PROC, V83, P418, DOI 10.4065/83.4.418; George JT, 2011, QJM-INT J MED, V104, P761, DOI 10.1093/qjmed/hcr046; Hirsch IB, 2009, JAMA-J AM MED ASSOC, V301, P213, DOI 10.1001/jama.2008.943; Joint British Diabetes Societies for Inpatient Care Group, 2012, MAN HYP HYP STAT HHS; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; NHS Information Centre, 2012, NAT DIAB INP AUD; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Sampson MJ, 2007, DIABETES RES CLIN PR, V77, P92, DOI 10.1016/j.diabres.2006.10.004; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Walid M Sami, 2010, J Hosp Med, V5, pE10, DOI 10.1002/jhm.541	24	24	24	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2013	346								f134	10.1136/bmj.f134	http://dx.doi.org/10.1136/bmj.f134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FP	23328031				2022-12-28	WOS:000313869500001
J	Kottemann, MC; Smogorzewska, A				Kottemann, Molly C.; Smogorzewska, Agata			Fanconi anaemia and the repair of Watson and Crick DNA crosslinks	NATURE			English	Review							STRUCTURE-SPECIFIC ENDONUCLEASES; HOLLIDAY JUNCTION RESOLVASE; CANCER SUSCEPTIBILITY GENE; BREAK REPAIR; HOMOLOGOUS RECOMBINATION; MONOUBIQUITINATED FANCD2; HEMATOPOIETIC STEM; CELLS DEFICIENT; HELICASE BRIP1; OVARIAN-CANCER	The function of Fanconi anaemia proteins is to maintain genomic stability. Their main role is in the repair of DNA interstrand crosslinks, which, by covalently binding the Watson and the Crick strands of DNA, impede replication and transcription. Inappropriate repair of interstrand crosslinks causes genomic instability, leading to cancer; conversely, the toxicity of crosslinking agents makes them a powerful chemotherapeutic. Fanconi anaemia proteins can promote stem-cell function, prevent tumorigenesis, stabilize replication forks and inhibit inaccurate repair. Recent advances have identified endogenous aldehydes as possible culprits of DNA damage that may induce the phenotypes seen in patients with Fanconi anaemia.	[Kottemann, Molly C.; Smogorzewska, Agata] Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA	Rockefeller University	Smogorzewska, A (corresponding author), Rockefeller Univ, Lab Genome Maintenance, New York, NY 10065 USA.	asmogorzewska@rockefeller.edu		Smogorzewska, Agata/0000-0001-6285-1562	Burroughs Wellcome Fund Career Award for Medical Scientists; Starr Center Consortium; National Center for Research Resources [8 UL1 TR000043]; National Center for Advancing Translational Sciences (NCATS), National Institutes of Health; Doris Duke Clinical Scientist Development Award; American Cancer Society; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Career Award for Medical Scientists(Burroughs Wellcome Fund); Starr Center Consortium; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank A. Auerbach, S. Gregg, E. Garner, Y. Kim, S. Thongthip and A. Wang for their comments. Work in our laboratory is supported by the Burroughs Wellcome Fund Career Award for Medical Scientists, the Starr Center Consortium grant, and by grant number 8 UL1 TR000043 from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health. A.S. is a Rita Allen Foundation, Irma T. Hirschl, Alexandrine and Alexander Sinsheimer Foundation scholar, and is a recipient of the Doris Duke Clinical Scientist Development Award. M.C.K. is supported by an American Cancer Society-J.T.Tai postdoctoral fellowship.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Berwick M, 2007, CANCER RES, V67, P9591, DOI 10.1158/0008-5472.CAN-07-1501; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Ceccaldi R, 2012, CELL STEM CELL, V11, P36, DOI 10.1016/j.stem.2012.05.013; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Enoiu M, 2012, NUCLEIC ACIDS RES, V40, P8953, DOI 10.1093/nar/gks670; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Hadjur S, 2001, BLOOD, V98, P1003, DOI 10.1182/blood.V98.4.1003; Houghtaling S, 2005, HUM MOL GENET, V14, P3027, DOI 10.1093/hmg/ddi334; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Karanam K, 2012, MOL CELL, V47, P320, DOI 10.1016/j.molcel.2012.05.052; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Kim YC, 2012, BLOOD, DOI 10.1182/blood-2011-09-377895; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Marietta C, 2009, MUTAT RES-FUND MOL M, V664, P77, DOI 10.1016/j.mrfmmm.2009.03.011; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Muller LUW, 2012, BLOOD, V119, P5449, DOI 10.1182/blood-2012-02-408674; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pang QS, 2009, MUTAT RES-FUND MOL M, V668, P42, DOI 10.1016/j.mrfmmm.2009.03.013; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Ridpath JR, 2007, CANCER RES, V67, P11117, DOI 10.1158/0008-5472.CAN-07-3028; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Rosenberg PS, 2011, AM J MED GENET A, V155A, P1877, DOI 10.1002/ajmg.a.34087; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Sato K, 2012, NUCLEIC ACIDS RES, V40, P4553, DOI 10.1093/nar/gks053; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shen X, 2009, MOL CELL, V35, P716, DOI 10.1016/j.molcel.2009.06.034; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Tischkowitz M, 2007, P NATL ACAD SCI USA, V104, P6788, DOI 10.1073/pnas.0701724104; Tulpule A, 2010, BLOOD, V115, P3453, DOI 10.1182/blood-2009-10-246694; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Vinciguerra P, 2010, J CLIN INVEST, V120, P3834, DOI 10.1172/JCI43391; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Wang X, 2001, MOL CELL BIOL, V21, P713, DOI 10.1128/MCB.21.3.713-720.2001; Wang YB, 2009, P NATL ACAD SCI USA, V106, P12430, DOI 10.1073/pnas.0903362106; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Williams SA, 2011, HUM MOL GENET, V20, P4395, DOI 10.1093/hmg/ddr366; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Youds JL, 2009, MUTAT RES-FUND MOL M, V668, P103, DOI 10.1016/j.mrfmmm.2008.11.007; Zhou WB, 2012, NAT GENET, V44, P910, DOI 10.1038/ng.2347	75	409	420	4	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					356	363		10.1038/nature11863	http://dx.doi.org/10.1038/nature11863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325218	Green Accepted			2022-12-28	WOS:000313615900042
J	Xue, YC; Ouyang, KF; Huang, J; Zhou, Y; Ouyang, H; Li, HR; Wang, G; Wu, QJ; Wei, CL; Bi, YZ; Jiang, L; Cai, ZQ; Sun, H; Zhang, K; Zhang, Y; Chen, J; Fu, XD				Xue, Yuanchao; Ouyang, Kunfu; Huang, Jie; Zhou, Yu; Ouyang, Hong; Li, Hairi; Wang, Gang; Wu, Qijia; Wei, Chaoliang; Bi, Yanzhen; Jiang, Li; Cai, Zhiqiang; Sun, Hui; Zhang, Kang; Zhang, Yi; Chen, Ju; Fu, Xiang-Dong			Direct Conversion of Fibroblasts to Neurons by Reprogramming PTB-Regulated MicroRNA Circuits	CELL			English	Article							TRACT-BINDING PROTEIN; MESSENGER-RNA STABILITY; ADULT NEUROGENESIS; FUNCTIONAL-NEURONS; MOUSE; CELLS; REST; DIFFERENTIATION; PATHWAY; EXPRESSION	The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.	[Xue, Yuanchao; Huang, Jie; Zhou, Yu; Wu, Qijia; Bi, Yanzhen; Jiang, Li; Cai, Zhiqiang; Sun, Hui; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Xue, Yuanchao; Zhou, Yu; Li, Hairi; Wei, Chaoliang; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ouyang, Kunfu; Wang, Gang; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ouyang, Hong; Zhang, Kang; Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Zhang, Kang/Y-2740-2019; Wei, Chaoliang/A-9008-2013; Chen, Ju/E-5579-2011; Zhou, Yu/AAP-9964-2021; ouyang, kunfu/B-3073-2011	Zhang, Kang/0000-0002-4549-1697; ouyang, kunfu/0000-0003-0292-375X; Huang, Jie/0000-0003-3842-6181; Zhang, Yi/0000-0003-1035-6134; Zhou, Yu/0000-0002-2102-9377; Ouyang, Hong/0000-0002-7622-7733; XUE, YUANCHAO/0000-0002-8113-2333	China 973 program [2011CB811300, 2012CB910800]; Chinese 111 program [B06018]; NIH [GM049369, GM052872, HG004659]; NIH Director's Transformative RO1 Program [EY021374]; NATIONAL EYE INSTITUTE [R01EY021374] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052872, R01GM049369] Funding Source: NIH RePORTER	China 973 program(National Basic Research Program of China); Chinese 111 program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Transformative RO1 Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful to Drs. Gordon Gill, Dongxian Zhang, and Wei Xiong for insightful advice during the course of this investigation and to Drs. Gordon Gill, Amy Pasquinelli, Bruce Hamilton, and Larry Goldstein for critical reading of the manuscript. We thank Drs. Douglas Black, Robert Darnell, Samuel Pfaff, Alysson Muotri, and Geoff Rosenfeld for generous gifts of antibodies and Drs. Zhiping Pang and Marius Wernig for sharing detailed experimental protocols. This work was supported by the China 973 program (2011CB811300, 2012CB910800), the Chinese 111 program grant (B06018), and grants from NIH (GM049369, GM052872, HG004659). H.O. and K.Z. were supported by NIH Director's Transformative RO1 Program (EY021374).	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baudet ML, 2012, NAT NEUROSCI, V15, P29, DOI 10.1038/nn.2979; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coutinho-Mansfield GC, 2007, GENE DEV, V21, P1573, DOI 10.1101/gad.1575607; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Hakamata Y, 2001, BIOCHEM BIOPH RES CO, V286, P779, DOI 10.1006/bbrc.2001.5452; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim J, 2011, P NATL ACAD SCI USA, V108, P7838, DOI 10.1073/pnas.1103113108; Knoch KP, 2004, NAT CELL BIOL, V6, P207, DOI 10.1038/ncb1099; Kosinski PA, 2003, J IMMUNOL, V170, P979, DOI 10.4049/jimmunol.170.2.979; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Pautz A, 2006, J BIOL CHEM, V281, P32294, DOI 10.1074/jbc.M603915200; Porter JF, 2008, J IMMUNOL, V181, P3336, DOI 10.4049/jimmunol.181.5.3336; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Raj B, 2011, MOL CELL, V43, P843, DOI 10.1016/j.molcel.2011.08.014; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tillmar L, 2002, MOL MED, V8, P263, DOI 10.1007/BF03402152; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Watanabe Y, 2004, GENE DEV, V18, P889, DOI 10.1101/gad.1179004; Woo KC, 2009, NUCLEIC ACIDS RES, V37, P26, DOI 10.1093/nar/gkn893; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yang N, 2011, CELL STEM CELL, V9, P517, DOI 10.1016/j.stem.2011.11.015; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564; Zheng S, 2012, NAT NEUROSCI, V15, P381, DOI 10.1038/nn.3026; Zibetti C, 2010, J NEUROSCI, V30, P2521, DOI 10.1523/JNEUROSCI.5500-09.2010	50	364	390	3	126	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					82	96		10.1016/j.cell.2012.11.045	http://dx.doi.org/10.1016/j.cell.2012.11.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23313552	Bronze, Green Accepted			2022-12-28	WOS:000313719800008
J	Howland, J; Rohsenow, DJ				Howland, Jonathan; Rohsenow, Damaris J.			Risks of Energy Drinks Mixed With Alcohol	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLEGE-STUDENTS; CONSUMPTION; CONSEQUENCES; IMPAIRMENT		[Howland, Jonathan] Boston Univ, Dept Emergency Med, Boston, MA 02118 USA; [Rohsenow, Damaris J.] Brown Univ, Ctr Alcohol & Addict Studies, Providence, RI 02912 USA; [Rohsenow, Damaris J.] VA Med Ctr, Providence, RI USA	Boston University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Howland, J (corresponding author), Boston Univ, Dept Emergency Med, 1 Boston Med Ctr Pl,Dowling 1 S, Boston, MA 02118 USA.	jhowl@bu.edu		Howland, Jonathan/0000-0001-8079-1188				Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Fillmore MT, 2002, J STUD ALCOHOL, V63, P745, DOI 10.15288/jsa.2002.63.745; Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4; Malinauskas BM, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-35; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; Peacock A, 2012, ALCOHOL CLIN EXP RES, V36, P2008, DOI 10.1111/j.1530-0277.2012.01820.x; Thombs DL, 2010, ADDICT BEHAV, V35, P325, DOI 10.1016/j.addbeh.2009.11.004; Woolsey C, 2010, J APPL SPORT PSYCHOL, V22, P65, DOI 10.1080/10413200903403224	8	52	52	1	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					245	246		10.1001/jama.2012.187978	http://dx.doi.org/10.1001/jama.2012.187978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070XG	23330172				2022-12-28	WOS:000313546800023
J	Bellman, M; Byrne, O; Sege, R				Bellman, Martin; Byrne, Orlaith; Sege, Robert			Developmental assessment of children	BMJ-BRITISH MEDICAL JOURNAL			English	Review							YOUNG-CHILDREN; ACCURACY; OUTCOMES; AUTISM; HEALTH		[Bellman, Martin] Royal Free Hosp, Dept Paediat, London NW3 2QG, England; [Byrne, Orlaith] Birmingham Community Healthcare NHS Trust, Dept Child Hlth, Birmingham, W Midlands, England; [Sege, Robert] Boston Univ, Dept Pediat, Boston, MA 02215 USA	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Boston University	Bellman, M (corresponding author), Royal Free Hosp, Dept Paediat, Pond St, London NW3 2QG, England.	m.bellman@nhs.net		Sege, Robert/0000-0003-1260-4787				Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; BAX M, 1987, DEV MED CHILD NEUROL, V29, P40; Bellman M, 1997, SCHEDULE GROWING SKI; BELLMAN MH, 1985, CHILD CARE HLTH DEV, V11, P309, DOI 10.1111/j.1365-2214.1985.tb00472.x; Blanchard LT, 2006, PEDIATRICS, V117, pE1202, DOI 10.1542/peds.2005-2606; COCHRANE AL, 1971, BRIT MED BULL, V27, P3, DOI 10.1093/oxfordjournals.bmb.a070810; Department of Health, 2009, HLTH CHILD PROGR; Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231; Engle PL, 2011, LANCET, V378, P1339, DOI 10.1016/S0140-6736(11)60889-1; Glascoe F. P., 1999, AMBULATORY CHILD HLT, V5, P197; Glascoe FP, 2000, CHILD CARE HLTH DEV, V26, P137, DOI 10.1046/j.1365-2214.2000.00173.x; GLASCOE FP, 1993, J EARLY INTERVENTION, V17, P368, DOI 10.1177/105381519301700403; GLASCOE FP, 1992, PEDIATRICS, V89, P1221; Glascoe FP, 1997, PEDIATRICS, V99, P522, DOI 10.1542/peds.99.4.522; Gomby DS, 1995, FUTURE CHILD, V5, P6, DOI 10.2307/1602365; Guralnik MJ, 1997, EFFECTIVENESS EARLY; Hagan JF, 2008, BRIGHT FUTURES GUIDE; Heckman JJ, 2007, REV AGR ECON, V29, P446, DOI 10.1111/j.1467-9353.2007.00359.x; Horridge KA, 2011, ARCH DIS CHILDHOOD-E, V96, P9, DOI 10.1136/adc.2009.182436; Kelly Y, 2006, DEV MED CHILD NEUROL, V48, P825, DOI 10.1017/S0012162206001770; Klamer A, 2005, ACTA PAEDIATR, V94, P1327, DOI 10.1080/08035250510042825; Kohler L, 2003, CHILD CARE HLTH DEV, V29, P551, DOI 10.1046/j.1365-2214.2003.00375.x; KPMG, 2011, REV EV EFF EARL CHIL; Lake A, 2011, LANCET, V378, P1277, DOI 10.1016/S0140-6736(11)61450-5; McCain M, 1999, REVERSING REAL BRAIN; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Perry B, 2002, BRAIN MIND, V3, P79, DOI DOI 10.1023/A:1016557824657; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Sharma A, 2011, ARCH DIS CHILDHOOD-E, V96, P162, DOI 10.1136/adc.2009.175901; Sheridan M, 2007, BIRTH 5 YEARS CHILDR; Sheridan MA, 2012, P NATL ACAD SCI USA, V109, P12927, DOI 10.1073/pnas.1200041109; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Voigt RG, 2007, CLIN PEDIATR, V46, P523, DOI 10.1177/0009922806299100; Williams AN, 2004, DEV MED CHILD NEUROL, V46, P502, DOI 10.1017/S0012162204240828; WILSON JMG, 1968, WHO CHRON, V22, P473; Windsor J, 2011, CHILD DEV, V82, P1040, DOI 10.1111/j.1467-8624.2011.01604.x	37	56	58	4	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								e8687	10.1136/bmj.e8687	http://dx.doi.org/10.1136/bmj.e8687			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075ER	23321410				2022-12-28	WOS:000313867100006
J	Paik, RS; Pepples, D; Hutchinson, MR				Paik, Ronald S.; Pepples, Douglas; Hutchinson, Mark R.			EASILY MISSED? Chronic exertional compartment syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE-INDUCED PAIN; LOWER LEG; ANTERIOR COMPARTMENT; DIAGNOSIS; RELEASE		[Paik, Ronald S.; Pepples, Douglas; Hutchinson, Mark R.] Univ Illinois, Sports Med Serv, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hutchinson, MR (corresponding author), Univ Illinois, Sports Med Serv, Chicago, IL 60612 USA.	mhutch@uic.edu						Aweid O, 2012, CLIN J SPORT MED, V22, P356, DOI 10.1097/JSM.0b013e3182580e1d; CLANTON TO, 1994, CLIN SPORT MED, V13, P743; Edmundsson D, 2011, DIABETIC MED, V28, P81, DOI 10.1111/j.1464-5491.2010.03158.x; Edmundsson D, 2007, ACTA ORTHOP, V78, P136, DOI 10.1080/17453670610013547; Fraipont Michael J, 2003, J Am Acad Orthop Surg, V11, P268; George CA, 2012, CLIN SPORT MED, V31, P307, DOI 10.1016/j.csm.2011.09.013; Glorioso J, 2001, TXB RUNNING MED, P95; Hislop M, 2011, BRIT J SPORT MED, V45, P956, DOI 10.1136/bjsports-2011-090368; Lohrer H, 2007, ARCH ORTHOP TRAUM SU, V127, P827, DOI 10.1007/s00402-006-0269-4; PEDOWITZ RA, 1990, AM J SPORT MED, V18, P35, DOI 10.1177/036354659001800106; Schepsis AA, 2005, AM J SPORT MED, V33, P1040, DOI 10.1177/0363546504271974; Shah Steven N, 2004, Am J Orthop (Belle Mead NJ), V33, P335; STYF J, 1988, AM J SPORT MED, V16, P165, DOI 10.1177/036354658801600214; Tzortziou V, 2006, CLIN J SPORT MED, V16, P209, DOI 10.1097/00042752-200605000-00004; van den Brand JGH, 2005, AM J SPORT MED, V33, P699, DOI 10.1177/0363546504270565; Verleisdonk EJMM, 2004, INT J SPORTS MED, V25, P224, DOI 10.1055/s-2003-45255; Whitesides, 1996, J Am Acad Orthop Surg, V4, P209; Wilder RP, 2010, CLIN SPORT MED, V29, P429, DOI 10.1016/j.csm.2010.03.008; Wittstein J, 2010, AM J SPORT MED, V38, P1661, DOI 10.1177/0363546510363415	19	4	5	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								f33	10.1136/bmj.f33	http://dx.doi.org/10.1136/bmj.f33			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075ER	23321416				2022-12-28	WOS:000313867100024
J	Piwowar, H				Piwowar, Heather			Value all research products	NATURE			English	Editorial Material									[Piwowar, Heather] Duke Univ, Natl Evolutionary Synth Ctr, Durham, NC 27708 USA	Duke University; The National Evolutionary Synthesis Center	Piwowar, H (corresponding author), Duke Univ, Natl Evolutionary Synth Ctr, Durham, NC 27708 USA.	heather@impactstory.org		Piwowar, Heather/0000-0003-1613-5981	Office of Advanced Cyberinfrastructure (OAC) [0830944] Funding Source: National Science Foundation	Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Fausto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050109; Oettl A, 2012, NATURE, V489, P496, DOI 10.1038/489496a; Piwowar H. A, 2011, DRYAD DIGITAL REPOSI; Piwowar HA, 2011, NATURE, V473, P285, DOI 10.1038/473285a; Priem J., 2012, FIGSHARE; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101	6	230	247	1	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					159	159		10.1038/493159a	http://dx.doi.org/10.1038/493159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	066YY	23302843	Green Published, Bronze			2022-12-28	WOS:000313259600014
J	Ibata, RA; Lewis, GF; Conn, AR; Irwin, MJ; McConnachie, AW; Chapman, SC; Collins, ML; Fardal, M; Ferguson, AMN; Ibata, NG; Mackey, AD; Martin, NF; Navarro, J; Rich, RM; Valls-Gabaud, D; Widrow, LM				Ibata, Rodrigo A.; Lewis, Geraint F.; Conn, Anthony R.; Irwin, Michael J.; McConnachie, Alan W.; Chapman, Scott C.; Collins, Michelle L.; Fardal, Mark; Ferguson, Annette M. N.; Ibata, Neil G.; Mackey, A. Dougal; Martin, Nicolas F.; Navarro, Julio; Rich, R. Michael; Valls-Gabaud, David; Widrow, Lawrence M.			A vast, thin plane of corotating dwarf galaxies orbiting the Andromeda galaxy	NATURE			English	Article							RED GIANT BRANCH; SATELLITE GALAXIES; LOCAL GROUP; MILKY-WAY; ANISOTROPIC DISTRIBUTION; GALACTIC SATELLITES; BAYESIAN-APPROACH; M31; TIP; VELOCITY	Dwarf satellite galaxies are thought to be the remnants of the population of primordial structures that coalesced to form giant galaxies like the Milky Way(1). It has previously been suspected(2) that dwarf galaxies may not be isotropically distributed around our Galaxy, because several are correlated with streams of H I emission, and may form coplanar groups(3). These suspicions are supported by recent analyses(4-7). It has been claimed(7) that the apparently planar distribution of satellites is not predicted within standard cosmology(8), and cannot simply represent a memory of past coherent accretion. However, other studies dispute this conclusion(9-11). Here we report the existence of a planar subgroup of satellites in the Andromeda galaxy (M 31), comprising about half of the population. The structure is at least 400 kiloparsecs in diameter, but also extremely thin, with a perpendicular scatter of less than 14.1 kiloparsecs. Radial velocity measurements(12-15) reveal that the satellites in this structure have the same sense of rotation about their host. This shows conclusively that substantial numbers of dwarf satellite galaxies share the same dynamical orbital properties and direction of angular momentum. Intriguingly, the plane we identify is approximately aligned with the pole of the Milky Way's disk and with the vector between the Milky Way and Andromeda.	[Ibata, Rodrigo A.; Martin, Nicolas F.] Observ Astron, F-67000 Strasbourg, France; [Lewis, Geraint F.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Conn, Anthony R.] Macquarie Univ, Dept Phys & Astron, N Ryde, NSW 2109, Australia; [Irwin, Michael J.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [McConnachie, Alan W.] NRC Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Chapman, Scott C.] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 4R2, Canada; [Collins, Michelle L.; Martin, Nicolas F.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Fardal, Mark] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Ferguson, Annette M. N.] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Ibata, Neil G.] Lyce Int Pontonniers, F-67000 Strasbourg, France; [Mackey, A. Dougal] Australian Natl Univ, Mt Stromlo Observ, Weston, ACT 2611, Australia; [Navarro, Julio] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Rich, R. Michael] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Valls-Gabaud, David] Observ Paris, LERMA, CNRS, UMR 8112, F-75014 Paris, France; [Widrow, Lawrence M.] Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada	University of Sydney; Macquarie University; University of Cambridge; National Research Council Canada; Dalhousie University; Max Planck Society; University of Massachusetts System; University of Massachusetts Amherst; University of Edinburgh; Australian National University; University of Victoria; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Queens University - Canada	Ibata, RA (corresponding author), Observ Astron, 11 Rue Univ, F-67000 Strasbourg, France.	rodrigo.ibata@astro.unistra.fr	Lewis, Geraint/F-9069-2015	Lewis, Geraint/0000-0003-3081-9319; Ibata, Rodrigo/0000-0002-3292-9709; McConnachie, Alan/0000-0003-4666-6564; Mackey, Dougal/0000-0002-6529-8093; Navarro, Julio/0000-0003-3862-5076	Agence Nationale de la Recherche; Australian Research Council; W.M. Keck Foundation; Direct For Mathematical & Physical Scien [1009652] Funding Source: National Science Foundation; Science and Technology Facilities Council [PP/C002229/1, ST/J001422/1, ST/H00243X/1, ST/J00541X/1, ST/J000647/1, ST/H004165/1, ST/J001538/1, ST/H004157/1] Funding Source: researchfish; STFC [ST/J001422/1, ST/H004157/1, ST/H004165/1, ST/J001538/1, ST/J000647/1, PP/C002229/1, ST/J00541X/1] Funding Source: UKRI	Agence Nationale de la Recherche(French National Research Agency (ANR)); Australian Research Council(Australian Research Council); W.M. Keck Foundation(W.M. Keck Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the staff of the Canada-France-Hawaii Telescope for taking the PAndAS data, and for their continued support throughout the project. We thank one of our referees, B. Tully, for pointing out that IC 1613 could also be associated to the planar structure. R. A. I. and D. V. G. gratefully acknowledge support from the Agence Nationale de la Recherche though the grant POMMME, and would like to thank B. Famaey for discussions. G. F. L. thanks the Australian Research Council for support through his Future Fellowship and Discovery Project. This work is based on observations obtained with MegaPrime/MegaCam, a joint project of CFHT and CEA/DAPNIA, at the Canada-France-Hawaii Telescope, which is operated by the National Research Council (NRC) of Canada, the Institut National des Sciences de l'Univers of the Centre National de la Recherche Scientifique (CNRS) of France, and the University of Hawaii. Some of the data presented here were obtained at the W. M. Keck Observatory, which is operated as a scientific partnership among the California Institute of Technology, the University of California and the National Aeronautics and Space Administration. The Observatory was made possible by the generous financial support of the W.M. Keck Foundation.	Barnes DG, 2006, PUBL ASTRON SOC AUST, V23, P82, DOI 10.1071/AS06009; Collins M. L., MON NOT R ASTR UNPUB; Collins MLM, 2011, MON NOT R ASTRON SOC, V417, P1170, DOI 10.1111/j.1365-2966.2011.19342.x; Conn AR, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/11; Conn AR, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/69; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Koch A, 2006, ASTRON J, V131, P1405, DOI 10.1086/499534; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; LEE MG, 1993, ASTROPHYS J, V417, P553, DOI 10.1086/173334; Lovell MR, 2011, MON NOT R ASTRON SOC, V413, P3013, DOI 10.1111/j.1365-2966.2011.18377.x; LYNDENBELL D, 1995, MON NOT R ASTRON SOC, V275, P429, DOI 10.1093/mnras/275.2.429; LYNDENBELL D, 1976, MON NOT R ASTRON SOC, V174, P695, DOI 10.1093/mnras/174.3.695; Majewski SR, 2007, ASTROPHYS J, V670, pL9, DOI 10.1086/524033; McConnachie AW, 2009, NATURE, V461, P66, DOI 10.1038/nature08327; McConnachie AW, 2006, MON NOT R ASTRON SOC, V365, P902, DOI 10.1111/j.1365-2966.2005.09771.x; Metz M, 2008, ASTROPHYS J, V680, P287, DOI 10.1086/587833; Metz M, 2007, MON NOT R ASTRON SOC, V374, P1125, DOI 10.1111/j.1365-2966.2006.11228.x; Metz M, 2009, MON NOT R ASTRON SOC, V394, P2223, DOI 10.1111/j.1365-2966.2009.14489.x; Pawlowski MS, 2012, MON NOT R ASTRON SOC, V423, P1109, DOI 10.1111/j.1365-2966.2012.20937.x; Richardson JC, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/2/76; Tollerud EJ, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/45; van der Marel RP, 2008, ASTROPHYS J, V678, P187, DOI 10.1086/533430; Walker M.G., 2012, DARK MATTER MILKY WA; Wang J, 2012, MON NOT R ASTRON SOC, V424, P2715, DOI 10.1111/j.1365-2966.2012.21357.x; Zentner AR, 2005, ASTROPHYS J, V629, P219, DOI 10.1086/431355	26	370	375	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					62	65		10.1038/nature11717	http://dx.doi.org/10.1038/nature11717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282362	Green Submitted			2022-12-28	WOS:000312933800030
J	Moore, W				Moore, Wendy			PAST CARING Remedy for all the inconveniences of life	BRITISH MEDICAL JOURNAL			English	Editorial Material												wendymoore@ntlworld.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 27	2012	345								e8637	10.1136/bmj.e8637	http://dx.doi.org/10.1136/bmj.e8637			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PL	23271745				2022-12-28	WOS:000312931700012
J	Thorsteinsdottir, H; Saenz, TW				Thorsteinsdottir, Halla; Saenz, Tirso W.			Tackling Meningitis in Africa	SCIENCE			English	Editorial Material									[Thorsteinsdottir, Halla] Small Globe, Toronto, ON, Canada; [Saenz, Tirso W.] Univ Brasilia, Ctr Sustainable Dev, Brasilia, DF, Brazil	Universidade de Brasilia	Thorsteinsdottir, H (corresponding author), Small Globe, Toronto, ON, Canada.	halla@smallglobe.org			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Brautigam D., 2009, DRAGONS GIFT; Centers for Disease Control and Prevention, 2012, MULT FUNG MEN OUTBR; Ferrer M, 2004, NAT BIOTECHNOL, V22, pDC8, DOI 10.1038/nbt1204supp-DC8; Grogg P., 2010, CUBA BRAZIL UNITE AF; IRIN, 2007, AFR FIGHT MEN RAC TI; Kapoor A. K., 2012, S S COLLABORATION HL, P233; Love Patrick, 2012, OECD INSIGHTS; Padron F. Sotolongo, 2007, MEDICC REV, V9, P18; Reid-Henry S. M., 2010, CUBAN CURE; Rezaie R, 2008, NAT BIOTECHNOL, V26, P627, DOI 10.1038/nbt0608-627; Saenz T. W., 2012, S S COLLABORATION HL; Thorsteinsdottir H, 2004, NAT BIOTECHNOL, V22, pDC19, DOI 10.1038/nbt1204supp-DC19; Undesa (Departamento de Asuntos Economicos y Sociales de las Naciones Unidas), 2010, DEV COOP MDGS MAX RE	13	4	5	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1546	1547		10.1126/science.1233318	http://dx.doi.org/10.1126/science.1233318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057AE	23258878				2022-12-28	WOS:000312533100034
J	Kakkar, M				Kakkar, Manish			Dengue fever is massively under-reported in India, hampering our response	BRITISH MEDICAL JOURNAL			English	Editorial Material							THAILAND; BURDEN		Publ Hlth Fdn India, Delhi 110070, India	Public Health Foundation of India	Kakkar, M (corresponding author), Publ Hlth Fdn India, Communicable Dis ISID Campus,4 Inst Area Vasant K, Delhi 110070, India.	manish.kakkar@phfi.org						[Anonymous], DENG CAS DEATHS COUN; Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890; Central Bureau of Health Intelligence, 2012, NAT HLTH PROF 2011; Chakravarti A, 2012, T ROY SOC TROP MED H, V106, P273, DOI 10.1016/j.trstmh.2011.12.007; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Harris G., 2012, NY TIMES; Ministry of Statistics and Programme Implementation Government of India, 2006, MORB HLTH CAR COND A, P507; National Vector Borne Disease Control Programme, 2012, MAL SIT IND; Organization WH, 2010, SIT UPD DENG SEA REG; Sudarshan MK, 2007, INT J INFECT DIS, V11, P29, DOI 10.1016/j.ijid.2005.10.007; The National Vector Borne Disease Control Programme, DISTR DENG DENG HAEM; Wichmann O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000996; World Health Organization, 2009, DENGUE GUIDELINES DI	14	30	32	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8574	10.1136/bmj.e8574	http://dx.doi.org/10.1136/bmj.e8574			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255584				2022-12-28	WOS:000312700100008
J	Das, P; Samarasekera, U				Das, Pamela; Samarasekera, Udani			The story of GBD 2010: a "super-human" effort	LANCET			English	News Item																			0	28	30	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 15	2012	380	9859					2067	2070		10.1016/S0140-6736(12)62174-6	http://dx.doi.org/10.1016/S0140-6736(12)62174-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	055AL	23259158				2022-12-28	WOS:000312387000010
J	DuBois, RM; Vaney, MC; Tortorici, MA; Al Kurdi, R; Barba-Spaeth, G; Krey, T; Rey, FA				DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.			Functional and evolutionary insight from the crystal structure of rubella virus protein E1	NATURE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN; FUSION PROTEIN; GLYCOPROTEIN; RECEPTOR; RESPONSES; SURFACE; DOMAIN; ENTRY; FORM	Little is known about the three-dimensional organization of rubella virus, which causes a relatively mild measles-like disease in children but leads to serious congenital health problems when contracted in utero(1). Although rubella virus belongs to the same family as the mosquito-borne alphaviruses, in many respects it is more similar to other aerosol-transmitted human viruses such as the agents of measles and mumps. Although the use of the triple MMR (measles, mumps and rubella) live vaccine has limited its incidence in western countries, congenital rubella syndrome remains an important health problem in the developing world. Here we report the 1.8 angstrom resolution crystal structure of envelope glycoprotein E1, the main antigen and sole target of neutralizing antibodies against rubella virus. E1 is the main player during entry into target cells owing to its receptor-binding and membrane-fusion functions. The structure reveals the epitope and the neutralization mechanism of an important category of protecting antibodies against rubella infection. It also shows that rubella virus E1 is a class II fusion protein, which had hitherto only been structurally characterized for the arthropod-borne alphaviruses and flaviviruses. In addition, rubella virus E1 has an extensive membrane-fusion surface that includes a metal site, reminiscent of the T-cell immunoglobulin and mucin family of cellular proteins that bind phosphatidylserine lipids at the plasma membrane of cells undergoing apoptosis. Such features have not been seen in any fusion protein crystallized so far. Structural comparisons show that the class II fusion proteins from alphaviruses and flaviviruses, despite belonging to different virus families, are closer to each other than they are to rubella virus E1. This suggests that the constraints on arboviruses imposed by alternating cycles between vertebrates and arthropods resulted in more conservative evolution. By contrast, in the absence of this constraint, the strictly human rubella virus seems to have drifted considerably into a unique niche as sole member of the Rubivirus genus.	[DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [DuBois, Rebecca M.; Vaney, Marie-Christine; Tortorici, M. Alejandra; Al Kurdi, Rana; Barba-Spaeth, Giovanna; Krey, Thomas; Rey, Felix A.] CNRS, URA 3015, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Rey, FA (corresponding author), Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France.	rey@pasteur.fr		DuBois, Rebecca/0000-0003-4185-5673; Barba Spaeth, Giovanna/0000-0003-2069-9501; Rey, Felix/0000-0002-9953-7988; Tortorici, M. Alejandra/0000-0002-2260-2577	'Pasteur-Howard' fellowship; Merck-Serono from the French Government [ANR-10-LABX-62-IBEID];  [ANR-05-MIIM-012-02-Dentry]	'Pasteur-Howard' fellowship; Merck-Serono from the French Government; 	We thank A. Haouz of Institut Pasteur and the PXI beam line staff at the Swiss Light Source and PROXIMA 1 beam line at SOLEIL synchrotron facilities for assistance; C. Vonrhein at Global Phasing for expertise in phase determination; G. Bricogne for input, G. Dupras and J.M. Mallet at Ecole Normale Superieure in Paris for the synthesis of galactose-3-sulphate used in co-crystallization trials; and J. Casasnovas, L. Chernomordik, Y. Gaudin, S. Harrison, F. Heinz, M. Kielian and J. Lepault for discussion. R. M. D. was supported by a 'Pasteur-Howard' fellowship. This work was mainly funded by grant ANR-05-MIIM-012-02-Dentry to F. A. R., who also acknowledges support from Merck-Serono from the French Government's Investissements d'Avenir program: Laboratoire d'Excellence 'Integrative Biology of Emerging Infectious Diseases' (grant no. ANR-10-LABX-62-IBEID).	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Backovic M, 2009, P NATL ACAD SCI USA, V106, P2880, DOI 10.1073/pnas.0810530106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battisti AJ, 2012, J VIROL, V86, P11078, DOI 10.1128/JVI.01390-12; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Bricogne G, 2009, BUSTER VERSION 2 8 0; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Cong HL, 2011, J VIROL, V85, P11038, DOI 10.1128/JVI.05398-11; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibbons DL, 2003, CELL, V114, P573, DOI 10.1016/S0092-8674(03)00683-4; Goldstein D. A., 1990, CLIN METHODS HIST PH, P677; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Hobman T., 2007, FIELDS VIROLOGY, P1069; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2008, NAT STRUCT MOL BIOL, V15, P1024, DOI 10.1038/nsmb.1484; KATOW S, 1988, J GEN VIROL, V69, P2797, DOI 10.1099/0022-1317-69-11-2797; KATOW S, 1985, J CLIN MICROBIOL, V21, P449, DOI 10.1128/JCM.21.3.449-451.1985; Kee SH, 2004, MICROBIOL IMMUNOL, V48, P823, DOI 10.1111/j.1348-0421.2004.tb03614.x; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; MASTROMARINO P, 1990, MED MICROBIOL IMMUN, V179, P105; MITCHELL LA, 1992, J CLIN MICROBIOL, V30, P1841, DOI 10.1128/JCM.30.7.1841-1847.1992; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08; Petruzziello R, 1996, J GEN VIROL, V77, P303, DOI 10.1099/0022-1317-77-2-303; Qiu ZY, 2000, J VIROL, V74, P6637, DOI 10.1128/JVI.74.14.6637-6642.2000; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Roussel A, 2006, STRUCTURE, V14, P75, DOI 10.1016/j.str.2005.09.014; Santiago C, 2007, IMMUNITY, V26, P299, DOI 10.1016/j.immuni.2007.01.014; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Stiasny K, 2004, J VIROL, V78, P3178, DOI 10.1128/JVI.78.6.3178-3183.2004; Stiasny K, 2002, J VIROL, V76, P3784, DOI 10.1128/JVI.76.8.3784-3790.2002; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555; WOLINSKY JS, 1993, J VIROL, V67, P961, DOI 10.1128/JVI.67.2.961-968.1993	41	71	78	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					552	+		10.1038/nature11741	http://dx.doi.org/10.1038/nature11741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23292515				2022-12-28	WOS:000313871400042
J	Halley, JM; Iwasa, Y; Vokou, D				Halley, John M.; Iwasa, Yoh; Vokou, Despoina			Comment on "Extinction Debt and Windows of Conservation Opportunity in the Brazilian Amazon"	SCIENCE			English	Editorial Material							FOREST FRAGMENTS; NEUTRAL THEORY	A paper by Wearn et al. (Reports, 13 July 2012, p. 228) yields new insights on extinction debt. However, it leaves out the area dependence of the relaxation process. We show that this is not warranted on theoretical or observational grounds and that it may lead to erroneous conservation recommendations.	[Halley, John M.] Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece; [Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan; [Vokou, Despoina] Aristotle Univ Thessaloniki, Sch Biol, Dept Ecol, Thessaloniki 54124, Greece	University of Ioannina; Kyushu University; Aristotle University of Thessaloniki	Halley, JM (corresponding author), Univ Ioannina, Dept Biol Applicat & Technol, GR-45110 Ioannina, Greece.	jhalley@cc.uoi.gr	Vokou, Despoina/N-5988-2015; Iwasa, Yoh/G-5368-2010; Halley, John M/AAP-3004-2020	Vokou, Despoina/0000-0002-9734-6707; Iwasa, Yoh/0000-0003-0691-1852; 				Brooks TM, 1999, CONSERV BIOL, V13, P1140, DOI 10.1046/j.1523-1739.1999.98341.x; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Ferraz G, 2003, P NATL ACAD SCI USA, V100, P14069, DOI 10.1073/pnas.2336195100; Gilbert B, 2006, AM NAT, V168, P304, DOI 10.1086/506969; Halley JM, 2011, P NATL ACAD SCI USA, V108, P2316, DOI 10.1073/pnas.1011217108; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013	8	10	10	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					271	+		10.1126/science.1231438	http://dx.doi.org/10.1126/science.1231438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329033				2022-12-28	WOS:000313622000024
J	Pereira, HM; Ferrier, S; Walters, M; Geller, GN; Jongman, RHG; Scholes, RJ; Bruford, MW; Brummitt, N; Butchart, SHM; Cardoso, AC; Coops, NC; Dulloo, E; Faith, DP; Freyhof, J; Gregory, RD; Heip, C; Hoft, R; Hurtt, G; Jetz, W; Karp, DS; McGeoch, MA; Obura, D; Onoda, Y; Pettorelli, N; Reyers, B; Sayre, R; Scharlemann, JPW; Stuart, SN; Turak, E; Walpole, M; Wegmann, M				Pereira, H. M.; Ferrier, S.; Walters, M.; Geller, G. N.; Jongman, R. H. G.; Scholes, R. J.; Bruford, M. W.; Brummitt, N.; Butchart, S. H. M.; Cardoso, A. C.; Coops, N. C.; Dulloo, E.; Faith, D. P.; Freyhof, J.; Gregory, R. D.; Heip, C.; Hoeft, R.; Hurtt, G.; Jetz, W.; Karp, D. S.; McGeoch, M. A.; Obura, D.; Onoda, Y.; Pettorelli, N.; Reyers, B.; Sayre, R.; Scharlemann, J. P. W.; Stuart, S. N.; Turak, E.; Walpole, M.; Wegmann, M.			Essential Biodiversity Variables	SCIENCE			English	Editorial Material							GLOBAL BIODIVERSITY; INDICATORS; SYSTEM; MAP		[Pereira, H. M.] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal; [Geller, G. N.] CALTECH, Jet Prop Lab, Pasadena, CA 91125 USA; [Jongman, R. H. G.] Alterra, Wageningen Ur, Netherlands; [Bruford, M. W.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Coops, N. C.] Univ British Columbia, Dept Forest Resource Management, Vancouver, BC V5Z 1M9, Canada; [Faith, D. P.] Australian Museum, Sydney, NSW 2000, Australia; [Hurtt, G.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Jetz, W.] Yale Univ, New Haven, CT 06520 USA; [Karp, D. S.] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [McGeoch, M. A.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Onoda, Y.] Kyoto Univ, Grad Sch Agr, Kyoto 6068501, Japan; [Pettorelli, N.] Zool Soc London, Inst Zool, London, England; [Sayre, R.] US Geol Survey, Washington, DC USA; [Scharlemann, J. P. W.] Univ Sussex, Sch Life Sci, Brighton BN1 9RH, E Sussex, England; [Turak, E.] Off Environm & Heritage, Sydney, NSW, Australia; [Wegmann, M.] Univ Wurzburg, Dept Geog & Geol, Wurzburg, Germany	Universidade de Lisboa; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Wageningen University & Research; Cardiff University; University of British Columbia; Australian Museum; University System of Maryland; University of Maryland College Park; Yale University; Stanford University; Monash University; Kyoto University; Zoological Society of London; United States Department of the Interior; United States Geological Survey; University of Sussex; Office of Environment & Heritage - New South Wales; University of Wurzburg	Pereira, HM (corresponding author), Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, Lisbon, Portugal.	hpereira@fc.ul.pt	Bruford, Michael/Y-7463-2019; Coops, Nicholas C/J-1543-2012; Ferrier, Simon/C-1490-2009; Butchart, Stuart HM/Y-2711-2018; Bruford, Michael W/D-3750-2009; Pettorelli, Nathalie/AAW-8438-2021; Reyers, Belinda/AAF-6225-2019; Onoda, Yusuke/L-7179-2015; Butchart, Stuart/AAJ-1852-2021; Coops, Nicholas/L-3652-2019; Jetz, Walter/ABF-1517-2020; Hurtt, George/A-8450-2012; McGeoch, Melodie A/F-8353-2011; Pereira, Henrique/B-3975-2009; Scharlemann, Jorn/A-4737-2008; Walters, Michele/AAH-2327-2019	Bruford, Michael/0000-0001-6357-6080; Coops, Nicholas C/0000-0002-0151-9037; Ferrier, Simon/0000-0001-7884-2388; Bruford, Michael W/0000-0001-6357-6080; Reyers, Belinda/0000-0002-2194-8656; Onoda, Yusuke/0000-0001-6245-2342; Butchart, Stuart/0000-0002-1140-4049; Coops, Nicholas/0000-0002-0151-9037; Hurtt, George/0000-0001-7278-202X; McGeoch, Melodie A/0000-0003-3388-2241; Pereira, Henrique/0000-0003-1043-1675; Scharlemann, Jorn/0000-0002-2834-6367; Turak, Eren/0000-0001-7383-9112; Walters, Michele/0000-0001-8302-3408; Obura, David/0000-0003-2256-6649; Jetz, Walter/0000-0002-1971-7277; Gregory, Richard/0000-0002-7419-5053; Wegmann, Martin/0000-0003-0335-9601; Geller, Gary/0000-0002-4490-6002; Scholes, Robert/0000-0001-5537-6935				Bubb P., 2011, NATL INDICATORS MONI; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CBD, 2010, DEC X 2 STRAT PLAN B; Feld CK, 2009, OIKOS, V118, P1862, DOI 10.1111/j.1600-0706.2009.17860.x; Ferrier S, 2011, BIOSCIENCE, V61, P96, DOI 10.1525/bio.2011.61.2.2; GCOS, 2010, IMPL PLAN GLOB OBS S, P180; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Guralnick RP, 2007, ECOL LETT, V10, P663, DOI 10.1111/j.1461-0248.2007.01063.x; IOC, 2011, FRAM OC OBS IN PRESS, V7, P26; Jetz W, 2012, TRENDS ECOL EVOL, V27, P151, DOI 10.1016/j.tree.2011.09.007; Lenzen M, 2012, NATURE, V486, P109, DOI 10.1038/nature11145; Martin LJ, 2012, FRONT ECOL ENVIRON, V10, P195, DOI 10.1890/110154; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pereira HM, 2012, ANNU REV ENV RESOUR, V37, P25, DOI 10.1146/annurev-environ-042911-093511; Scholes RJ, 2012, CURR OPIN ENV SUST, V4, P139, DOI 10.1016/j.cosust.2011.12.005; Secretariat of the CBD, 2011, REP AD HOC TECHN EXP; Tallis H, 2012, BIOSCIENCE, V62, P977, DOI 10.1525/bio.2012.62.11.7; Turner DP, 2011, FRONT ECOL ENVIRON, V9, P111, DOI 10.1890/090171; Wilson EO, 2000, SCIENCE, V289, P2279	19	821	858	27	682	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					277	278		10.1126/science.1229931	http://dx.doi.org/10.1126/science.1229931			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329036	Green Submitted			2022-12-28	WOS:000313622000029
J	Chertow, DS; Memoli, MJ				Chertow, Daniel S.; Memoli, Matthew J.			Bacterial Coinfection in Influenza A Grand Rounds Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY-TRACT COMPLICATIONS; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PNEUMONIAE; PANDEMIC INFLUENZA; ADVISORY-COMMITTEE; GLOBAL MORTALITY; H1N1 INFLUENZA; UNITED-STATES; VIRUS	Bacterial coinfection complicated nearly all influenza deaths in the 1918 influenza pandemic and up to 34% of 2009 pandemic influenza A(H1N1) infections managed in intensive care units worldwide. More than 65 000 deaths attributable to influenza and pneumonia occur annually in the United States. Data from 683 critically ill patients with 2009 pandemic influenza A(H1N1) infection admitted to 35 intensive care units in the United States reveal that bacterial coinfection commonly occurs within the first 6 days of influenza infection, presents similarly to influenza infection occurring alone, and is associated with an increased risk of death. Pathogens that colonize the nasopharynx, including Staphylococcus aureus, Streptococcus pneumoniae, and Streptococcus pyogenes, are most commonly isolated. Complex viral, bacterial, and host factors contribute to the pathogenesis of coinfection. Reductions in morbidity and mortality are dependent on prevention with available vaccines as well as early diagnosis and treatment. JAMA. 2013;309(3):275-282 www.jama.com	[Chertow, Daniel S.] NIH, Dept Crit Care Med, Ctr Clin, Bethesda, MD 20892 USA; [Memoli, Matthew J.] NIAID, Viral Pathogenesis & Evolut Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chertow, DS (corresponding author), NIH, Dept Crit Care Med, Ctr Clin, 10 Ctr Dr,Room 2C145, Bethesda, MD 20892 USA.	chertowd@cc.nih.gov			Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr Memoli is supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Barry MA, 2010, JAMA-J AM MED ASSOC, V304, P671, DOI [10.1001/jama.2010.907, 10.1001/jama.304.6.671]; Blyth CC, 2009, NEW ENGL J MED, V361, P2493, DOI 10.1056/NEJMc0909049; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Christenson B, 2004, EUR RESPIR J, V23, P363, DOI 10.1183/09031936.04.00063504; Cohen D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e458; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Estenssoro E, 2010, AM J RESP CRIT CARE, V182, P41, DOI [10.1164/rccm.201001-0037OC, 10.1164/201001-0037OC]; Farias JA, 2010, INTENS CARE MED, V36, P1015, DOI 10.1007/s00134-010-1853-1; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Gillet Y, 2007, CLIN INFECT DIS, V45, P315, DOI 10.1086/519263; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; HARFORD CG, 1946, J EXP MED, V83, P505, DOI 10.1084/jem.83.6.505; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kash JC, 2011, MBIO, V2, DOI 10.1128/mBio.00172-11; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lee MH, 2010, J INFECT DIS, V201, P508, DOI 10.1086/650204; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; LeVine AM, 2001, J VIROL METHODS, V94, P173, DOI 10.1016/S0166-0934(01)00287-7; Lewis P A, 1931, J Exp Med, V54, P361, DOI 10.1084/jem.54.3.361; Louie J., 2009, Morbidity and Mortality Weekly Report, V58, P1071; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martin-Loeches I, 2011, CHEST, V139, P555, DOI 10.1378/chest.10-1396; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McCullers JA, 2004, J INFECT DIS, V190, P519, DOI 10.1086/421525; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Mori I, 1995, J INFECT DIS, V76, P2869; National Vital Statistics System, 2012, DEATHS FIN DAT 1976; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nuorti J. P., 2010, Morbidity and Mortality Weekly Report, V59, P1102; O'Brien Linda, 2012, Morbidity and Mortality Weekly Report, V61, P289; Okamoto S, 2003, J VIROL, V77, P4104, DOI 10.1128/JVI.77.7.4104-4112.2003; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Peltola VT, 2005, J INFECT DIS, V192, P249, DOI 10.1086/430954; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; PLOTKOWSKI MC, 1986, AM REV RESPIR DIS, V134, P1040, DOI 10.1164/arrd.1986.134.5.1040; Pogue M., 2007, Morbidity and Mortality Weekly Report, V56, P325; Randolph AG, 2011, PEDIATRICS, V128, pE1450, DOI 10.1542/peds.2011-0774; Reed C, 2009, PEDIATR INFECT DIS J, V28, P572, DOI 10.1097/INF.0b013e31819d8b71; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23; SANZEZQUERRO JJ, 1995, J VIROL, V69, P2420, DOI 10.1128/JVI.69.4.2420-2426.1995; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; TASHIRO M, 1987, VIROLOGY, V157, P421, DOI 10.1016/0042-6822(87)90284-4; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Weinberger DM, 2012, J INFECT DIS, V205, P458, DOI 10.1093/infdis/jir749	72	260	282	4	50	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					275	282		10.1001/jama.2012.194139	http://dx.doi.org/10.1001/jama.2012.194139			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321766				2022-12-28	WOS:000313546800028
J	Gorrindo, P; Tedeschi, SK; Powers, AR; Niswender, K				Gorrindo, Phillip; Tedeschi, Sara K.; Powers, Albert R.; Niswender, Kevin			Fulfilling Our Leadership Responsibility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FAST-FOOD; HOSPITALS		[Gorrindo, Phillip; Niswender, Kevin] Vanderbilt Univ, Med Ctr, Nashville, TN 37212 USA; [Tedeschi, Sara K.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Powers, Albert R.] Yale New Haven Med Ctr, Dept Psychiat, New Haven, CT 06504 USA	Vanderbilt University; Harvard University; Brigham & Women's Hospital; Yale University	Gorrindo, P (corresponding author), Vanderbilt Univ, Med Ctr, Nashville, TN 37212 USA.	phillip.gorrindo@vanderbilt.edu	Powers, Albert/AAX-6241-2021	Gorrindo, Phillip/0000-0002-0296-8790	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019961] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Cram P, 2002, JAMA-J AM MED ASSOC, V287, P2945, DOI 10.1001/jama.287.22.2945; Institute of Medicine, 2012, ACC PROGR OB PREV, P478; Lesser LI, 2012, JAMA-J AM MED ASSOC, V308, P983, DOI 10.1001/2012.jama.10427; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228	4	1	1	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					147	148		10.1001/jama.2012.165720	http://dx.doi.org/10.1001/jama.2012.165720			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299605				2022-12-28	WOS:000313517000022
J	Piazza, G				Piazza, Gregory			Submassive Pulmonary Embolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RIGHT-VENTRICULAR ENLARGEMENT; PERCUTANEOUS MECHANICAL THROMBECTOMY; INTENSITY WARFARIN THERAPY; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; LONG-TERM; THROMBOLYTIC THERAPY; UNFRACTIONATED HEPARIN; SECONDARY PREVENTION; ORAL RIVAROXABAN	The US Surgeon General estimates that 100 000 to 180 000 deaths occur annually from acute pulmonary embolism (PE) in the United States. The case of Ms A, a 60-year-old woman with acute PE and right ventricular dysfunction (submassive PE), illustrates the clinical challenge of identifying this high-risk patient population and determining when more aggressive immediate therapy should be pursued in addition to standard anticoagulation. The clinical examination, electrocardiogram, cardiac biomarkers, chest computed tomography, and echocardiography can be used to risk stratify patients with acute PE. Current options for more aggressive intervention in the treatment of patients with acute PE who are at increased risk of an adverse clinical course include systemic fibrinolysis, pharmacomechanical catheter-directed therapy, surgical pulmonary embolectomy, and inferior vena cava filter insertion. Determination of the optimal duration of anticoagulation and lifestyle modification to reduce overall cardiovascular risk are critical components of the long-term therapy of patients with acute PE. JAMA. 2013; 309(2):171-180 www.jama.com	[Piazza, Gregory] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Piazza, Gregory] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Piazza, G (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	gpiazza@partners.org			Daiichi-Sankyo; Eisai; EKOS	Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); EKOS	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Piazza reports receipt of research support from Daiichi-Sankyo, Eisai, and EKOS.	Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; Aklog L, 2002, CIRCULATION, V105, P1416, DOI 10.1161/01.CIR.0000012526.21603.25; Bauer KA, 2011, JAMA-J AM MED ASSOC, V305, P1336, DOI 10.1001/jama.2011.361; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Becattini C, 2010, THROMB RES, V125, pE82, DOI 10.1016/j.thromres.2009.09.017; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Chauhan MS, 2007, CATHETER CARDIO INTE, V70, P121, DOI 10.1002/ccd.20997; Daniels LB, 1997, AM J CARDIOL, V80, P184, DOI 10.1016/S0002-9149(97)00315-9; Decousus H, 1998, NEW ENGL J MED, V338, P409, DOI 10.1056/NEJM199802123380701; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Fanikos J, 2012, J AM COLL CARDIOL, V59, pE2119, DOI 10.1016/S0735-1097(12)62120-2; Fiumara K, 2006, AM J CARDIOL, V97, P127, DOI 10.1016/j.amjcard.2005.07.117; Goldhaber SZ, 2007, CATHETER CARDIO INTE, V70, P807, DOI 10.1002/ccd.21255; Goldhaber SZ, 2007, CHEST, V132, P363, DOI 10.1378/chest.07-0591; Goldhaber SZ, 2011, CIRCULATION, V123, P664, DOI 10.1161/CIRCULATIONAHA.110.970822; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; Goldhaber SZ, 2002, CIRCULATION, V106, P1436, DOI 10.1161/01.CIR.0000031167.64088.F6; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kline JA, 2009, CHEST, V136, P1202, DOI 10.1378/chest.08-2988; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kucher N, 2005, RADIOLOGY, V236, P852, DOI 10.1148/radiol.2363041287; Kucher N, 2005, ARCH INTERN MED, V165, P1777, DOI 10.1001/archinte.165.15.1777; Kucher N, 2007, CHEST, V132, P657, DOI 10.1378/chest.07-0665; Kuo WT, 2009, J VASC INTERV RADIOL, V20, P1431, DOI 10.1016/j.jvir.2009.08.002; Leacche M, 2005, J THORAC CARDIOV SUR, V129, P1018, DOI 10.1016/j.jtcvs.2004.10.023; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Mismetti P, 2007, CHEST, V131, P223, DOI 10.1378/chest.06-0631; Nass N, 1999, AM J CARDIOL, V83, P804, DOI 10.1016/S0002-9149(98)01000-5; PARKER JA, 1995, J NUCL MED, V36, P364; Parkin L, 2012, CIRCULATION, V125, P1897, DOI 10.1161/CIRCULATIONAHA.111.063354; Piazza G, 2011, THROMB HAEMOSTASIS, V106, P1095, DOI 10.1160/TH11-07-0469; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Piazza G, 2010, VASC MED, V15, P419, DOI 10.1177/1358863X10380304; Piazza G, 2010, CIRCULATION, V122, P1124, DOI 10.1161/CIRCULATIONAHA.110.961136; Piazza G, 2010, CIRCULATION, V121, P2146, DOI 10.1161/CIRCULATIONAHA.110.951236; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rogers MAM, 2012, CIRCULATION, V125, P2092, DOI 10.1161/CIRCULATIONAHA.111.084467; Schoepf UJ, 2004, CIRCULATION, V110, P3276, DOI 10.1161/01.CIR.0000147612.59751.4C; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; Schulman S, 2011, INT SOC THROMB HAEM; Schulman S, 2011, AM SOC HEM ANN M DEC; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Sharifi M, 2012, MODERATE PULMONARY E; Sharma GVRK, 2000, VASC MED, V5, P91, DOI 10.1191/135886300666830773; SHARMA GVRK, 1980, NEW ENGL J MED, V303, P842, DOI 10.1056/NEJM198010093031502; Simonneau G, 1997, NEW ENGL J MED, V337, P663, DOI 10.1056/NEJM199709043371002; Sorensen HT, 2007, LANCET, V370, P1773, DOI 10.1016/S0140-6736(07)61745-0; Spencer FA, 2008, J THROMB HAEMOST, V6, P1507, DOI 10.1111/j.1538-7836.2008.03062.x; Stein PD, 2010, AM J CARDIOL, V106, P558, DOI 10.1016/j.amjcard.2010.03.071; Stein PD, 2009, J THROMB THROMBOLYS, V28, P342, DOI 10.1007/s11239-009-0331-5; tenCate JW, 1997, NEW ENGL J MED, V337, P657; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; US Department of Health and Human Services, 2008, SURG GEN CALL ACT PR; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Weitz JI, 2012, CHEST, V141, pE120S, DOI 10.1378/chest.11-2294	62	26	26	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					171	180		10.1001/jama.2012.164493	http://dx.doi.org/10.1001/jama.2012.164493			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299609				2022-12-28	WOS:000313517000026
J	Ransohoff, DF; Pignone, M; Sox, HC				Ransohoff, David F.; Pignone, Michael; Sox, Harold C.			How to Decide Whether a Clinical Practice Guideline Is Trustworthy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY		[Ransohoff, David F.; Pignone, Michael] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC USA; [Sox, Harold C.] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med, W Lebanon, NH 03784 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Dartmouth College	Sox, HC (corresponding author), Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med, 31 Faraway Ln, W Lebanon, NH 03784 USA.	hsox@comcast.net		Pignone, Michael/0000-0002-6657-7342				Brawley O, 2011, JAMA-J AM MED ASSOC, V306, P2495, DOI 10.1001/jama.2011.1800; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Eden J, 2011, FINDING WHAT WORKS IN HEALTH CARE: STANDARDS FOR SYSTEMATIC REVIEWS, P1; Eden J, 2008, KNOWING WHAT WORKS H; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Sox HC, 2012, NEW ENGL J MED, V367, P669, DOI 10.1056/NEJMe1207165	7	110	110	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					139	140		10.1001/jama.2012.156703	http://dx.doi.org/10.1001/jama.2012.156703			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299601				2022-12-28	WOS:000313517000018
J	Downer, NJ; Ali, NJ; Au-Yong, ITH				Downer, Nicola J.; Ali, Nabeel J.; Au-Yong, Iain T. H.			Investigating pleural thickening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIFFERENTIAL-DIAGNOSIS; THORACOSCOPY; CT; DISEASE; MANAGEMENT		[Downer, Nicola J.; Ali, Nabeel J.] Kings Mill Hosp, Dept Resp Med, Mansfield NG17 4JL, Sutton In Ashfi, England; [Au-Yong, Iain T. H.] Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England		Au-Yong, ITH (corresponding author), Kings Mill Hosp, Dept Radiol, Mansfield NG17 4JL, Sutton In Ashfi, England.	iauyong@doctors.org.uk						British Thoracic Society, 2011, PLEUR PLAQ INF HLTH; Duysinx B, 2004, CHEST, V125, P489, DOI 10.1378/chest.125.2.489; Hansell D, 2009, IMAGING DIS CHEST; Hansen M, 1998, RESP MED, V92, P228, DOI 10.1016/S0954-6111(98)90100-7; HARRIS RJ, 1995, CHEST, V107, P845, DOI 10.1378/chest.107.3.845; Hierholzer J, 2000, CHEST, V118, P604, DOI 10.1378/chest.118.3.604; LEUNG AN, 1990, AM J ROENTGENOL, V154, P487, DOI 10.2214/ajr.154.3.2106209; Manhire A, 2003, THORAX, V58, P920, DOI 10.1136/thorax.58.11.920; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; MCLOUD TC, 1991, AM J ROENTGENOL, V156, P1145, DOI 10.2214/ajr.156.6.2028857; Miles Susan E, 2008, J Occup Med Toxicol, V3, P20, DOI 10.1186/1745-6673-3-20; Qureshi NR, 2009, THORAX, V64, P139, DOI 10.1136/thx.2008.100545; Rahman NM, 2007, BRIT MED J, V334, P206, DOI 10.1136/bmj.39061.503866.0B; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Rodriguez-Panadero F, 2006, EUR RESPIR J, V28, P409, DOI 10.1183/09031936.06.00013706; Rusch V W, 1995, Chest, V108, P1122; Sharif S, 2011, INTERACT CARDIOV TH, V12, P806, DOI 10.1510/icvts.2010.255901; Treasure T, 2011, LANCET ONCOL, V12, P763, DOI 10.1016/S1470-2045(11)70149-8; Wiggins J, 2007, THORAX, V62, P1, DOI 10.1136/thx.2007.087619	19	9	9	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 3	2013	346								e8376	10.1136/bmj.e8376	http://dx.doi.org/10.1136/bmj.e8376			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066QZ	23287997				2022-12-28	WOS:000313236600004
J	Lee, EO; Emanuel, EJ				Lee, Emily Oshima; Emanuel, Ezekiel J.			Shared Decision Making to Improve Care and Reduce Costs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Emily Oshima; Emanuel, Ezekiel J.] Ctr Amer Progress, Washington, DC USA; [Emanuel, Ezekiel J.] Perelman Sch Med, Off Provost, Dept Med Eth & Hlth Policy, Philadelphia, PA USA; [Emanuel, Ezekiel J.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Lee, EO (corresponding author), Ctr Amer Progress, Washington, DC USA.							Arterburn D, 2012, HEALTH AFFAIR, V31, P2094, DOI 10.1377/hlthaff.2011.0686; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Covinsky KE, 2000, J AM GERIATR SOC, V48, pS187, DOI 10.1111/j.1532-5415.2000.tb03131.x; Krumholz HM, 2010, JAMA-J AM MED ASSOC, V303, P1190, DOI 10.1001/jama.2010.309; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]	5	498	504	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					6	8		10.1056/NEJMp1209500	http://dx.doi.org/10.1056/NEJMp1209500			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PA	23281971				2022-12-28	WOS:000312930600015
J	Li, XC; Dang, SY; Yan, CY; Gong, XQ; Wang, JW; Shi, YG				Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong			Structure of a presenilin family intramembrane aspartate protease	NATURE			English	Article							GAMMA-SECRETASE REVEALS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CATALYTIC PORE; TRANSMEMBRANE DOMAIN-4; COMPLEX; PROTEOLYSIS; BINDING; PEN-2; MODEL	Presenilin and signal peptide peptidase (SPP) are intramembrane aspartyl proteases that regulate important biological functions in eukaryotes. Mechanistic understanding of presenilin and SPP has been hamperedby lack of relevant structural information. Here we report the crystal structure of a presenilin/SPP homologue (PSH) from the archaeon Methanoculleus marisnigri JR1. The protease, comprising nine transmembrane segments (TMs), adopts a previously unreported protein fold. The amino-terminal domain, consisting of TM1-6, forms a horseshoe-shaped structure, surrounding TM7-9 of the carboxy-terminal domain. The two catalytic aspartate residues are located on the cytoplasmic side of TM6 and TM7, spatially close to each other and approximately 8 angstrom into the lipid membrane surface. Water molecules gain constant access to the catalytic aspartates through a large cavity between the amino-and carboxy-terminal domains. Structural analysis reveals insights into the presenilin/SPP family of intramembrane proteases.	[Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Shi, Yigong] Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Li, Xiaochun; Dang, Shangyu; Yan, Chuangye; Gong, Xinqi; Wang, Jiawei; Shi, Yigong] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Prot Sci, Sch Life Sci,Ctr Struct Biol, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Yan, Chuangye/AAJ-5832-2021; Wang, Jiawei/D-1144-2010	Wang, Jiawei/0000-0001-9893-8539; Li, Xiaochun/0000-0002-0177-0803; Shi, Yigong/0000-0003-2030-168X; Yan, Chuangye/0000-0001-9338-8048; Dang, Shangyu/0000-0001-9141-1865	Ministry of Science and Technology [2009CB918801]; National Natural Science Foundation of China [30888001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank J. He and Q. Wang at Shanghai Synchrotron Radiation Facility beamline BL17U and K. Hasegawa and T. Kumasaka at the SPring-8 beamline BL41XU for assistance. This work was supported by funds from the Ministry of Science and Technology (grant number 2009CB918801), and National Natural Science Foundation of China project 30888001.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cervantes S, 2004, J BIOL CHEM, V279, P36519, DOI 10.1074/jbc.M404832200; Chiang PM, 2012, NEUROBIOL AGING, V33, P277, DOI 10.1016/j.neurobiolaging.2009.12.028; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erez E, 2009, NATURE, V459, P371, DOI 10.1038/nature08146; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu J, 2011, NATURE, V475, P528, DOI 10.1038/nature10218; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kornilova AY, 2003, J BIOL CHEM, V278, P16470, DOI 10.1074/jbc.C300019200; Lazarov VK, 2006, P NATL ACAD SCI USA, V103, P6889, DOI 10.1073/pnas.0602321103; Lemieux MJ, 2007, P NATL ACAD SCI USA, V104, P750, DOI 10.1073/pnas.0609981104; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miyashita H, 2011, J BIOL CHEM, V286, P26188, DOI 10.1074/jbc.M111.260273; Narayanan S, 2007, J BIOL CHEM, V282, P20172, DOI 10.1074/jbc.M701536200; Ogura T, 2006, BIOCHEM BIOPH RES CO, V343, P525, DOI 10.1016/j.bbrc.2006.02.158; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Sato T, 2007, J BIOL CHEM, V282, P33985, DOI 10.1074/jbc.M705248200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Sobhanifar S, 2010, P NATL ACAD SCI USA, V107, P9644, DOI 10.1073/pnas.1000778107; Steiner H, 2000, NAT CELL BIOL, V2, P848, DOI 10.1038/35041097; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takagi S, 2010, J NEUROSCI, V30, P15943, DOI 10.1523/JNEUROSCI.3318-10.2010; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Torres-Arancivia C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013072; Urban S, 2009, NAT REV MICROBIOL, V7, P411, DOI 10.1038/nrmicro2130; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	60	158	160	2	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					56	+		10.1038/nature11801	http://dx.doi.org/10.1038/nature11801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254940				2022-12-28	WOS:000312933800029
J	Pollock, AM				Pollock, Allyson M.			Will expansion of the NHS abroad benefit UK patients? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London, England	University of London	Pollock, AM (corresponding author), Univ London, London, England.	a.pollock@qmul.ac.uk		pollock, allyson/0000-0002-7388-3110				Anon, 2012, INT MED TRAVEL J; [Anonymous], 2012, GUARDIAN; Department of Health, 2012, NHS MAND; Health Industry Task Force, 2004, BETT HLTH PARTN PROG; Kanchanachitra C, 2011, LANCET, V377, P769, DOI 10.1016/S0140-6736(10)62035-1; Lewisham Healthcare NHS Trust SLHT, 2012, TRUST SPEC IN PRESS; National Audit Office Department of Health, 2012, 16 DEP HLTH NAT AUD; Pollock A., 2005, NHS PLC	8	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8496	10.1136/bmj.e8496	http://dx.doi.org/10.1136/bmj.e8496			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284156				2022-12-28	WOS:000313236300012
J	Mick, DU; Dennerlein, S; Wiese, H; Reinhold, R; Pacheu-Grau, D; Lorenzi, I; Sasarman, F; Weraarpachai, W; Shoubridge, EA; Warscheid, B; Rehling, P				Mick, David U.; Dennerlein, Sven; Wiese, Heike; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.; Warscheid, Bettina; Rehling, Peter			MITRAC Links Mitochondrial Protein Translocation to Respiratory-Chain Assembly and Translational Regulation	CELL			English	Article							CYTOCHROME-C-OXIDASE; F1F0-ATP SYNTHASE; COX I; COMPLEX; YEAST; SUPERCOMPLEX; BIOGENESIS; DEFICIENCY; EXPRESSION; MUTATIONS	Mitochondrial respiratory-chain complexes assemble from subunits of dual genetic origin assisted by specialized assembly factors. Whereas core subunits are translated on mitochondrial ribosomes, others are imported after cytosolic translation. How imported subunits are ushered to assembly intermediates containing mitochondria-encoded subunits is unresolved. Here, we report a comprehensive dissection of early cytochrome c oxidase assembly intermediates containing proteins required for normal mitochondrial translation and reveal assembly factors promoting biogenesis of human respiratory-chain complexes. We find that TIM21, a subunit of the inner-membrane presequence translocase, is also present in the major assembly intermediates containing newly mitochondria-synthesized and imported respiratory-chain subunits, which we term MITRAC complexes. Human TIM21 is dispensable for protein import but required for integration of early-assembling, presequence-containing subunits into respiratory-chain intermediates. We establish an unexpected molecular link between the TIM23 transport machinery and assembly of respiratory-chain complexes that regulate mitochondrial protein synthesis in response to their assembly state.	[Mick, David U.; Dennerlein, Sven; Reinhold, Robert; Pacheu-Grau, David; Lorenzi, Isotta; Rehling, Peter] Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany; [Wiese, Heike; Warscheid, Bettina] Univ Freiburg, Fac Biol, Inst Biol 2, D-79104 Freiburg, Germany; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2B4, Canada; [Sasarman, Florin; Weraarpachai, Woranontee; Shoubridge, Eric A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rehling, Peter] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	University of Gottingen; University of Freiburg; McGill University; McGill University; Max Planck Society	Rehling, P (corresponding author), Univ Gottingen, Dept Biochem 2, D-37073 Gottingen, Germany.	peter.rehling@medizin.uni-goettingen.de	Pacheu-Grau, David/A-9074-2017; Mick, David/AAW-3726-2021	Pacheu-Grau, David/0000-0003-2645-3983; Mick, David/0000-0003-1427-9412; Warscheid, Bettina/0000-0001-5096-1975; Wiese, Heike/0000-0002-8941-3762	Deutsche Forschungsgemeinschaft [SFB860]; Excellence Initiative of the German Federal Government [EXC 294 BIOSS]; Excellence Initiative of the German State, Government [EXC 294 BIOSS]; CIHR; Max-Planck-Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State, Government; CIHR(Canadian Institutes of Health Research (CIHR)); Max-Planck-Society(Max Planck Society)	We thank C. Schulz, M. Deckers, and B. Schrul for helpful discussion; J. Melin for critical reading of the manuscript; D. Gorlich for his support; and M. Balleininger, M. Wissel, B. Knapp, and K. Lobenwein for technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft, SFB860, Excellence Initiative of the German Federal & State, Governments (EXC 294 BIOSS) (B.W.), operating grant from the CIHR (E.A.S.), and the Max-Planck-Society (P.R.). E.A.S. is an HHMI international scholar.	Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Barrientos A, 2002, EMBO J, V21, P43, DOI 10.1093/emboj/21.1.43; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; Fontanesi F, 2011, J BIOL CHEM, V286, P555, DOI 10.1074/jbc.M110.188805; Horn D, 2008, MOL CELL BIOL, V28, P4354, DOI 10.1128/MCB.01920-07; Khalimonchuk O, 2007, J BIOL CHEM, V282, P17442, DOI 10.1074/jbc.M702379200; Lazarou M, 2009, FEBS J, V276, P6701, DOI 10.1111/j.1742-4658.2009.07384.x; Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356; Mick DU, 2011, NAT REV MOL CELL BIO, V12, P14, DOI 10.1038/nrm3029; Mick DU, 2010, J CELL BIOL, V191, P141, DOI 10.1083/jcb.201007026; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Peralta S, 2012, J BIOL CHEM, V287, P24174, DOI 10.1074/jbc.M112.343764; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Pierrel F, 2007, EMBO J, V26, P4335, DOI 10.1038/sj.emboj.7601861; Reinhold R, 2011, HUM MOL GENET, V20, P2379, DOI 10.1093/hmg/ddr145; Saddar S, 2008, J BIOL CHEM, V283, P6677, DOI 10.1074/jbc.M708440200; Shoubridge EA, 2001, AM J MED GENET, V106, P46, DOI 10.1002/ajmg.1378; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Soto IC, 2012, BBA-BIOENERGETICS, V1817, P883, DOI 10.1016/j.bbabio.2011.09.005; Strogolova V, 2012, MOL CELL BIOL, V32, P1363, DOI 10.1128/MCB.06369-11; Szklarczyk R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r12; Tiranti V, 2000, HUM MOL GENET, V9, P2733, DOI 10.1093/hmg/9.18.2733; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; Vukotic M, 2012, CELL METAB, V15, P336, DOI 10.1016/j.cmet.2012.01.016; Wagner K, 2009, J MOL BIOL, V392, P855, DOI 10.1016/j.jmb.2009.07.059; Weraarpachai W, 2012, AM J HUM GENET, V90, P142, DOI 10.1016/j.ajhg.2011.11.027; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	32	148	157	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1528	1541		10.1016/j.cell.2012.11.053	http://dx.doi.org/10.1016/j.cell.2012.11.053			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260140	Bronze, Green Submitted			2022-12-28	WOS:000312890300017
J	Stuhl, BK; Hummon, MT; Yeo, M; Quemener, G; Bohn, JL; Ye, J				Stuhl, Benjamin K.; Hummon, Matthew T.; Yeo, Mark; Quemener, Goulven; Bohn, John L.; Ye, Jun			Evaporative cooling of the dipolar hydroxyl radical	NATURE			English	Article							BOSE-EINSTEIN CONDENSATION; POLAR-MOLECULES; ATOMS; GAS	Atomic physics was revolutionized by the development of forced evaporative cooling, which led directly to the observation of Bose-Einstein condensation(1,2), quantum-degenerate Fermi gases(3) and ultracold optical lattice simulations of condensed-matter phenomena(4). More recently, substantial progress has been made in the production of cold molecular gases(5). Their permanent electric dipole moment is expected to generate systems with varied and controllable phases(6-8), dynamics(9-11) and chemistry(12-14). However, although advances have been made(15) in both direct cooling and cold-association techniques, evaporative cooling has not been achieved so far. This is due to unfavourable ratios of elastic to inelastic scattering(13) and impractically slow thermalization rates in the available trapped species. Here we report the observation of microwave-forced evaporative cooling of neutral hydroxyl (OH center dot) molecules loaded from a Stark-decelerated beam into an extremely high-gradient magnetic quadrupole trap. We demonstrate cooling by at least one order of magnitude in temperature, and a corresponding increase in phase-space density by three orders of magnitude, limited only by the low-temperature sensitivity of our spectroscopic thermometry technique. With evaporative cooling and a sufficiently large initial population, much colder temperatures are possible; even a quantum-degenerate gas of this dipolar radical (or anything else it can sympathetically cool) may be within reach.	[Stuhl, Benjamin K.; Hummon, Matthew T.; Yeo, Mark; Quemener, Goulven; Bohn, John L.; Ye, Jun] Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Stuhl, Benjamin K.; Hummon, Matthew T.; Yeo, Mark; Quemener, Goulven; Bohn, John L.; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Ye, J (corresponding author), Univ Colorado, NIST, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	ye@jila.colorado.edu	Ye, Jun/C-3312-2011; Hummon, Matthew Taylor/S-1139-2019	Ye, Jun/0000-0003-0076-2112; Hummon, Matthew Taylor/0000-0002-3020-0500; Quemener, Goulven/0000-0001-9396-7701; Stuhl, Benjamin/0000-0003-0759-3323	NSF Physics Frontier Center; DOE; AFOSR (MURI); DARPA; NIST	NSF Physics Frontier Center(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); AFOSR (MURI)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIST(National Institute of Standards & Technology (NIST) - USA)	We thank E. Cornell for discussions and B. Baxley for artistic contributions. We acknowledge funding from the NSF Physics Frontier Center, DOE, AFOSR (MURI), DARPA and NIST.	ANDERSON MH, 1995, SCIENCE, V269, P198, DOI 10.1126/science.269.5221.198; Avdeenkov AV, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.052718; Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Baranov MA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.043602; Barnett R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.190401; Bochinski JR, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.243001; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Campbell WC, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013003; Carr LD, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055049; Child M S, 1996, MOL COLLISION THEORY, V76; DAVIS KB, 1995, PHYS REV LETT, V75, P3969, DOI 10.1103/PhysRevLett.75.3969; DeMarco B, 1999, SCIENCE, V285, P1703, DOI 10.1126/science.285.5434.1703; Derevianko A, 1999, PHYS REV LETT, V82, P3589, DOI 10.1103/PhysRevLett.82.3589; Doret SC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.103005; Fried DG, 1998, PHYS REV LETT, V81, P3811, DOI 10.1103/PhysRevLett.81.3811; Gorshkov AV, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.115301; Janssen LMC, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.022713; Ketterle W, 1996, ADV ATOM MOL OPT PHY, V37, P181; Lara M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.183201; Lev BL, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.061402; Levinsen J, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013603; Manion JA., NIST STANDARD REFERE; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; Ni KK, 2010, NATURE, V464, P1324, DOI 10.1038/nature08953; Ospelkaus S, 2010, SCIENCE, V327, P853, DOI 10.1126/science.1184121; Parazzoli LP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.193201; Quemener G, 2012, CHEM REV, V112, P4949, DOI 10.1021/cr300092g; Sawyer BC, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203203; Stuhl BK, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.033427; Suleimanov YV, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4733288; Ticknor C, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022709; Zuchowski PS, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062708	33	142	144	2	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					396	+		10.1038/nature11718	http://dx.doi.org/10.1038/nature11718			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257881	Green Submitted			2022-12-28	WOS:000312488200049
J	Bellemain-Appaix, A; O'Connor, SA; Silvain, J; Cucherat, M; Beygui, F; Barthelemy, O; Collet, JP; Jacq, L; Bernasconi, F; Montalescot, G				Bellemain-Appaix, Anne; O'Connor, Stephen A.; Silvain, Johanne; Cucherat, Michel; Beygui, Farzin; Barthelemy, Olivier; Collet, Jean-Philippe; Jacq, Laurent; Bernasconi, Francois; Montalescot, Gilles		ACTION Grp	Association of Clopidogrel Pretreatment With Mortality, Cardiovascular Events, and Major Bleeding Among Patients Undergoing Percutaneous Coronary Intervention A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ELEVATION MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; PLATELET ACTIVATION; TASK-FORCE; IIB/IIIA INHIBITOR; CLINICAL-OUTCOMES; DOSE CLOPIDOGREL; FOCUSED UPDATE; EFFICACY; ASPIRIN	Context Clopidogrel pretreatment is recommended for patients with acute coronary syndromes (ACS) and stable coronary artery disease who are scheduled for percutaneous coronary intervention (PCI), but whether using clopidogrel as a pretreatment for PCI is associated with positive clinical outcomes has not been established. Objective To evaluate the association of clopidogrel pretreatment vs no treatment with mortality and major bleeding after PCI. Data Sources MEDLINE, EMBASE, Cochrane Controlled Trials Register databases, and reference lists of qualifying articles. Study Selection Studies reporting clinical data on mortality and major bleeding were included. Of the 392 titles identified, 15 articles published between August 2001 and September 2012 met the inclusion criteria: 6 randomized controlled trials (RCTs), 2 observational analyses of RCTs, and 7 observational studies. Data Extraction Quality of studies was assessed with the Ottawa Scale and the Jadad Score as appropriate. Results were independently extracted by 2 reviewers. A random-effect model was applied. Pretreatment was defined as the administration of clopidogrel before PCI or catheterization. The main analysis was performed on RCTs and confirmed by observational analyses and observational studies. Prespecified subgroups-clinical presentation and clopidogrel loading dose-were analyzed. The primary efficacy and safety end points were all-cause mortality and major bleeding. Secondary end points included major cardiac events. Results Of the 37 814 patients included in the meta-analysis, 8608 patients had participated in RCTs; 10 945, in observational analyses of RCTs; and 18 261, in observational studies. Analysis of RCTs showed that clopidogrel pretreatment was not associated with a reduction of death (absolute risk, 1.54% vs 1.97%; OR, 0.80; 95% CI, 0.57-1.11; P=.17) but was associated with a lower risk of major cardiac events (9.83% vs 12.35%; OR, 0.77; 95% CI, 0.66-0.89; P<.001). There was no significant association between pretreatment and major bleeding overall (3.57% vs 3.08%; OR, 1.18; 95% CI, 0.93-1.50; P=.18). Analyses from observational analyses of RCTs and observational studies were consistent for all results. Conclusions Among patients scheduled for PCI, clopidogrel pretreatment was not associated with a lower risk of mortality but was associated with a lower risk of major coronary events. JAMA.2012;308(23):2507-2517 www.jama.com	[Montalescot, Gilles] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, INSERM,Inst Cardiol,UMRS937,Bur 2 236, F-75013 Paris, France; [Bellemain-Appaix, Anne; Jacq, Laurent; Bernasconi, Francois] La Fontonne Hosp, Serv Cardiol, Antibes, France; [Cucherat, Michel] Univ Lyon 1, CNRS, UMR 5558, F-69365 Lyon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup	Montalescot, G (corresponding author), Univ Paris 06, Pitie Salpetriere Hosp, AP HP, INSERM,Inst Cardiol,UMRS937,Bur 2 236, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Cucherat, Michel/B-2343-2008; SILVAIN, Johanne/C-7521-2016	Cucherat, Michel/0000-0003-2150-5932; O'Connor, Stephen/0000-0002-6539-0375; SILVAIN, Johanne/0000-0002-1901-2808	Bristol-Myers Squibb; sanofi-aventis; Eli Lilly; Guerbet Medical; Medtronic; Boston Scientific; Cordis; Stago; Centocor; Fondation de France; INSERM; Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Medicines Company; Schering Plough; Merck Sharpe Dohme; GlaxoSmithKline; Daiichi-Sankyo; Brahms; A Menarini; European Society of Cardiology	Bristol-Myers Squibb(Bristol-Myers Squibb); sanofi-aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Guerbet Medical; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Cordis; Stago; Centocor; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Societe Francaise de Cardiologie; Medicines Company; Schering Plough(Merck & CompanySchering Plough Corporation); Merck Sharpe Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Daiichi-Sankyo(Daiichi Sankyo Company Limited); Brahms; A Menarini(Menarini Group); European Society of Cardiology	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Montalescot reported that he has received research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Centocor, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from sanofi-aventis, Eli Lilly, Bristol-Myers Squibb, The Medicines Company, and Schering Plough; lectures fees from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Merck Sharpe & Dohme, Cordis, GlaxoSmithKline, and Schering Plough. Dr Collet reported he has received research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Centocor, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from sanofi-aventis, Eli Lilly, and Bristol-Myers Squibb; and lecture fees from Bristol-Myers Squibb, sanofi-aventis, and Eli Lilly. Dr Bellemain-Appaix reported that she had received research grants from Daiichi-Sankyo, Eli Lilly, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie and lecture fees from AstraZeneca. Dr Silvain reported that he has received research grants from sanofi-aventis, Daiichi-Sankyo, Eli Lilly, Brahms, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from Daiichi-Sankyo, Eli Lilly; and speaker honoraria from AstraZeneca, Daiichi Sankyo, Eli Lilly, Iroko Cardio and Servier. Dr O'Connor reported that he has received grants from A Menarini and the European Society of Cardiology. M Cucherat has received research grants from Bristol-Myers Squibb, AstraZeneca, Bayer, and Haute Autorite de Sante; consulting fees from Bayer, Bristol-Myers Squibb; and speaker honoraria from Bristol-Myers Squibb. The other authors report no conflicts.	Amin AP, 2011, AM J CARDIOL, V107, P1751, DOI 10.1016/j.amjcard.2011.02.331; Ault KA, 1999, J AM COLL CARDIOL, V33, P634, DOI 10.1016/S0735-1097(98)00635-4; Biancari F, 2012, J THORAC CARDIOV SUR, V143, P665, DOI 10.1016/j.jtcvs.2011.01.069; Chan AW, 2003, J AM COLL CARDIOL, V42, P1188, DOI 10.1016/S0735-1097(03)00944-6; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collet JP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.029; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Cuisset T, 2006, J AM COLL CARDIOL, V48, P1339, DOI 10.1016/j.jacc.2006.06.049; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas G, 2009, J AM COLL CARDIOL, V54, P1438, DOI 10.1016/j.jacc.2009.06.021; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Davlouros PA, 2009, AM HEART J, V158, P585, DOI 10.1016/j.ahj.2009.07.029; Di Sciascio G, 2010, J AM COLL CARDIOL, V56, P550, DOI 10.1016/j.jacc.2010.01.067; Dorler J, 2011, EUR HEART J, V32, P2954, DOI 10.1093/eurheartj/ehr360; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Fefer P, 2009, AM J CARDIOL, V104, P514, DOI 10.1016/j.amjcard.2009.04.013; Feldman DN, 2010, AM J CARDIOL, V105, P323, DOI 10.1016/j.amjcard.2009.09.034; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kushner FG, 2009, J AM COLL CARDIOL, V54, P2205, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Leon MB, 1998, NEW ENGL J MED, V339, P1665, DOI 10.1056/NEJM199812033392303; Lotrionte M, 2007, AM J CARDIOL, V100, P1199, DOI 10.1016/j.amjcard.2007.05.048; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2010, LANCET, V376, P1233, DOI 10.1016/S0140-6736(10)61088-4; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; R Foundation for Statistical Computing, 2012, R LANG ENV STAT COMP; Sabatine MS, 2008, AM HEART J, V155, P910, DOI 10.1016/j.ahj.2007.11.020; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Saw J, 2004, J AM COLL CARDIOL, V44, P1194, DOI 10.1016/j.jacc.2004.06.049; Schomig A, 1996, NEW ENGL J MED, V334, P1084, DOI 10.1056/NEJM199604253341702; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Steinhubl SR, 2006, J AM COLL CARDIOL, V47, P939, DOI 10.1016/j.jacc.2005.10.047; Steinhubl SR, 2001, CIRCULATION, V103, P1403, DOI 10.1161/01.CIR.103.10.1403; Stone GW, 2007, CIRCULATION, V115, P2842, DOI 10.1161/CIRCULATIONAHA.106.687186; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Szuk T, 2007, AM HEART J, V153, P289, DOI 10.1016/j.ahj.2006.10.030; Taggart DP, 2011, HEART, V97, P445, DOI 10.1136/hrt.2010.216135; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Vlaar PJ, 2008, CIRCULATION, V118, P1828, DOI 10.1161/CIRCULATIONAHA.107.749531; Widimsky P, 2008, EUR HEART J, V29, P1495, DOI 10.1093/eurheartj/ehn169; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Wright RS, 2011, CIRCULATION, V123, P2022, DOI 10.1161/CIR.0b013e31820f2f3e; Zeymer U, 2007, CARDIOLOGY, V108, P265, DOI 10.1159/000096988	51	156	165	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2507	2516		10.1001/jama.2012.50788	http://dx.doi.org/10.1001/jama.2012.50788			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23287889				2022-12-28	WOS:000312441400027
J	Bourzac, K				Bourzac, Katherine			NANOTECHNOLOGY Carrying drugs	NATURE			English	Editorial Material																		Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Hrkach J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003651; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; von Maltzahn G, 2011, NAT MATER, V10, P545, DOI [10.1038/nmat3049, 10.1038/NMAT3049]	4	153	157	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S58	S60		10.1038/491S58a	http://dx.doi.org/10.1038/491S58a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320289	Bronze			2022-12-28	WOS:000311339800006
J	GRABHERR, G; GOTTFRIED, M; PAULI, H				GRABHERR, G; GOTTFRIED, M; PAULI, H			CLIMATE EFFECTS ON MOUNTAIN PLANTS	NATURE			English	Letter											GRABHERR, G (corresponding author), UNIV VIENNA,DEPT VEGETAT ECOL & CONSERVAT BIOL,POB 285,A-1091 VIENNA,AUSTRIA.		Wrbka, Thomas/A-5699-2010; Gottfried, Michael/C-2923-2011	Wrbka, Thomas/0000-0002-1451-9108; Pauli, Harald/0000-0002-9842-9934				AUER R, 1992, BESTANDSAUFNAHME ANT; BRAUN J, 1913, VEGETATIONSVERHALTNI, V48, P156; BRAUNBLANQUET J, 1958, OBERSTEN GRENZEN PFL, V6, P119; BRAUNBLANQUET J, 1957, EIN JAHRHUNDERT FLOR; HOFER HR, 1992, BERICHTE GEOBOTANISC, V58, P39; Holten Jarle I., 1993, P84; KLEBELSBERG R, 1913, OSTERR BOT Z JAHRG, P177; KLEBELSBERG R, 1913, OSTERR BOT Z JAHRG, P241; MARKHAM S, 1993, SOME LIKE HOT; NILSON S, 1991, MOUNTAIN WORLD DANGE; REISIGL H, 1958, VEGETATIO, V8, P93, DOI 10.1007/BF00419154; Rubel E., 1911, BOT JB SYSTEMATIK PF, V47, P1	12	716	806	5	287	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					448	448		10.1038/369448a0	http://dx.doi.org/10.1038/369448a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	23320303	Bronze			2022-12-28	WOS:A1994NQ28600036
J	Das Thakur, M; Salangsang, F; Landman, AS; Sellers, WR; Pryer, NK; Levesque, MP; Dummer, R; McMahon, M; Stuart, DD				Das Thakur, Meghna; Salangsang, Fernando; Landman, Allison S.; Sellers, William R.; Pryer, Nancy K.; Levesque, Mitchell P.; Dummer, Reinhard; McMahon, Martin; Stuart, Darrin D.			Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance	NATURE			English	Article							RAF INHIBITOR RESISTANCE; BRAF; BRAF(V600E); SENESCENCE; PATHWAY; CANCER	Mutational activation of BRAF is the most prevalent genetic alteration in human melanoma, with >= 50% of tumours expressing the BRAF(V600E) oncoprotein(1,2). Moreover, the marked tumour regression and improved survival of late-stage BRAF-mutated melanoma patients in response to treatment with vemurafenib demonstrates the essential role of oncogenic BRAF in melanoma maintenance(3,4). However, as most patients relapse with lethal drug-resistant disease, understanding and preventing mechanism(s) of resistance is critical to providing improved therapy(5). Here we investigate the cause and consequences of vemurafenib resistance using two independently derived primary human melanoma xenograft models in which drug resistance is selected by continuous vemurafenib administration. In one of these models, resistant tumours show continued dependency on BRAF(V600E)-> MEK -> ERK signalling owing to elevated BRAF(V600E) expression. Most importantly, we demonstrate that vemurafenib-resistant melanomas become drug dependent for their continued proliferation, such that cessation of drug administration leads to regression of established drug-resistant tumours. We further demonstrate that a discontinuous dosing strategy, which exploits the fitness disadvantage displayed by drug-resistant cells in the absence of the drug, forestalls the onset of lethal drug-resistant disease. These data highlight the concept that drug-resistant cells may also display drug dependency, such that altered dosing may prevent the emergence of lethal drug resistance. Such observations may contribute to sustaining the durability of the vemurafenib response with the ultimate goal of curative therapy for the subset of melanoma patients with BRAF mutations.	[Das Thakur, Meghna; Salangsang, Fernando; Pryer, Nancy K.; Stuart, Darrin D.] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Landman, Allison S.; McMahon, Martin] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Sellers, William R.] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Levesque, Mitchell P.; Dummer, Reinhard] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland	Novartis; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Novartis; University of Zurich; University Zurich Hospital	Stuart, DD (corresponding author), Novartis Inst Biomed Res, Emeryville, CA 94608 USA.	mcmahon@cc.ucsf.edu; darrin.stuart@novartis.com			NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute [R01-CA176839]; National Research Service Award T32 training grant [HL007185]; NATIONAL CANCER INSTITUTE [R01CA176839] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007185] Funding Source: NIH RePORTER	NIBR Presidential Postdoctoral Fellowship; Melanoma Research Alliance; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Research Service Award T32 training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the members of the Novartis Institutes for BioMedical Reseach (NIBR) Pharmacology department for technical support, comments and discussions during the course of this work. We thank C. Voliva, N. Aziz and E. Collisson for discussions. We thank B. Weisburd and the rest of the NIBR Bioinformatics department for assistance with exome sequencing data analysis. We thank S. Kaufman for sharing her knowledge of cell-based assays. We thank V. Marsh, N. Rosen, P. Poulikakos and D. Solit for providing additional advice and reagents. M.D.T. was supported by an NIBR Presidential Postdoctoral Fellowship. M.M. acknowledges support from the Melanoma Research Alliance and the National Cancer Institute (R01-CA176839). A.S.L. was supported by a National Research Service Award T32 training grant HL007185.	Bennett DC, 2008, PIGM CELL MELANOMA R, V21, P27, DOI 10.1111/j.1755-148X.2007.00433.x; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chmielecki J, 2012, J THORAC ONCOL, V7, P434, DOI 10.1097/JTO.0b013e31823c5aee; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Petti C, 2006, CANCER RES, V66, P6503, DOI 10.1158/0008-5472.CAN-05-4671; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Seghers AC, 2012, MELANOMA RES, V22, P466, DOI 10.1097/CMR.0b013e3283541541; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Tap WD, 2010, NEOPLASIA, V12, P637, DOI 10.1593/neo.10414; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wagle N, 2011, J CLIN ONCOL, V29, P3085, DOI 10.1200/JCO.2010.33.2312; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	22	524	535	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					251	255		10.1038/nature11814	http://dx.doi.org/10.1038/nature11814			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23302800	Green Accepted			2022-12-28	WOS:000315137700043
J	Miller, RA; Chu, QW; Xie, JX; Foretz, M; Viollet, B; Birnbaum, MJ				Miller, Russell A.; Chu, Qingwei; Xie, Jianxin; Foretz, Marc; Viollet, Benoit; Birnbaum, Morris J.			Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP	NATURE			English	Article							ADENYLATE-CYCLASE ACTIVITY; DIABETES-MELLITUS; RESPIRATORY-CHAIN; PROTEIN-KINASE; ENERGY-STATE; METFORMIN; ADENOSINE; LIVER; INHIBITION; GLUCOSE	Glucose production by the liver is essential for providing a substrate for the brain during fasting. The inability of insulin to suppress hepatic glucose output is a major aetiological factor in the hyperglycaemia of type-2 diabetes mellitus and other diseases of insulin resistance(1,2). For fifty years, one of the few classes of therapeutics effective in reducing glucose production has been the biguanides, which include phenformim and metformin, the latter the most frequently prescribed drug for type-2 diabetes(3). Nonetheless, the mechanism of action of biguanides remains imperfectly understood. The suggestion a decade ago that metformin reduces glucose synthesis through activation of the enzyme AMP-activated protein kinase (AMPK) has recently been challenged by genetic loss-of-function experiments(4). Here we provide a novel mechanism by which metformin antagonizes the action of glucagon, thus reducing fasting glucose levels. In mouse hepatocytes, metformin leads to the accumulation of AMP and related nucleotides, which inhibit adenylate cyclase, reduce levels of cyclic AMP and protein kinase A (PICA) activity, abrogate phosphorylation of critical protein targets of PICA, and block glucagon-dependent glucose output from hepatocytes. These data support a mechanism of action for metformin involving antagonism of glucagon, and suggest an approach for the development of antidiabetic drugs.	[Miller, Russell A.; Chu, Qingwei; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Xie, Jianxin] Cell Signaling Technol Inc, Danvers, MA 01923 USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, F-75006 Paris, France	University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Birnbaum, MJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA.	birnbaum@mail.med.upenn.edu	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health (NIH) [RO1 DK56886, PO1 DK49210, F32 DK079572]; Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525, P01DK049210, F32DK079572, R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM); Programme National de Recherche sur le Diabete (PNRD); Institut Benjamin Delessert; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) grants RO1 DK56886 and PO1 DK49210 (M.J.B.) and F32 DK079572 (R.A.M.), the Association pour l'Etude des Diabetes et des Maladies Metaboliques (ALFEDIAM) (to M.F.), the Programme National de Recherche sur le Diabete (PNRD) (to M.F. and B.V.) and the Institut Benjamin Delessert (to M.F.). Microscopy was performed in the University of Pennsylvania Cell and Developmental Biology Microscopy Core Facility. The Transgenic/Knockout, Mouse Phenotypipg, Viral Vector and Biomarker Cores of the University of Pennsylvania Diabetes and Endocrinology Research Center (NIH grant P30 DK19525) were instrumental in this work.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; BLUME AJ, 1975, J BIOL CHEM, V250, P5003; D'Alessio D, 2011, DIABETES OBES METAB, V13, P126, DOI 10.1111/j.1463-1326.2011.01449.x; DEFRONZO RA, 1982, DIABETOLOGIA, V23, P313; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; FAIN JN, 1979, MOL CELL BIOCHEM, V25, P143; FAIN JN, 1972, J BIOL CHEM, V247, P6866; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GAWLER DJ, 1989, J ENDOCRINOL, V122, P207, DOI 10.1677/joe.0.1220207; Goodarzi MO, 2005, DIABETES OBES METAB, V7, P654, DOI 10.1111/j.1463-1326.2004.00448.x; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; JOHNSON RA, 1989, MOL PHARMACOL, V35, P681; LONDOS C, 1977, J BIOL CHEM, V252, P5951; MASSON S, 1992, BIOCHEMISTRY-US, V31, P7488, DOI 10.1021/bi00148a008; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Post Sr, 2000, METH MOL B, V136, P363; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; STOLL B, 1992, BIOCHEM J, V287, P217, DOI 10.1042/bj2870217; Torres TP, 2011, J PHARMACOL EXP THER, V337, P610, DOI 10.1124/jpet.110.177899; TUCKER GT, 1981, BRIT J CLIN PHARMACO, V12, P235; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; YU B, 1994, BIOCHEM PHARMACOL, V48, P949, DOI 10.1016/0006-2952(94)90365-4; Zhang TT, 2009, J MOL ENDOCRINOL, V42, P57, DOI 10.1677/JME-08-0130; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	30	571	606	6	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 14	2013	494	7436					256	260		10.1038/nature11808	http://dx.doi.org/10.1038/nature11808			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	092QS	23292513	Green Accepted			2022-12-28	WOS:000315137700044
J	Weber, M; Hauschild, R; Schwarz, J; Moussion, C; de Vries, I; Legler, DF; Luther, SA; Bollenbach, T; Sixt, M				Weber, Michele; Hauschild, Robert; Schwarz, Jan; Moussion, Christine; de Vries, Ingrid; Legler, Daniel F.; Luther, Sanjiv A.; Bollenbach, Tobias; Sixt, Michael			Interstitial Dendritic Cell Guidance by Haptotactic Chemokine Gradients	SCIENCE			English	Article							MIGRATION; CCL21; CHEMOTAXIS; SITES	Directional guidance of cells via gradients of chemokines is considered crucial for embryonic development, cancer dissemination, and immune responses. Nevertheless, the concept still lacks direct experimental confirmation in vivo. Here, we identify endogenous gradients of the chemokine CCL21 within mouse skin and show that they guide dendritic cells toward lymphatic vessels. Quantitative imaging reveals depots of CCL21 within lymphatic endothelial cells and steeply decaying gradients within the perilymphatic interstitium. These gradients match the migratory patterns of the dendritic cells, which directionally approach vessels from a distance of up to 90-micrometers. Interstitial CCL21 is immobilized to heparan sulfates, and its experimental delocalization or swamping the endogenous gradients abolishes directed migration. These findings functionally establish the concept of haptotaxis, directed migration along immobilized gradients, in tissues.	[Weber, Michele; Hauschild, Robert; Schwarz, Jan; Moussion, Christine; de Vries, Ingrid; Bollenbach, Tobias; Sixt, Michael] IST Austria Inst Sci & Technol Austria, A-3400 Klosterneuburg, Austria; [Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau BITg, CH-8280 Kreuzlingen, Switzerland; [Luther, Sanjiv A.] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Institute of Science & Technology - Austria; University of Lausanne	Sixt, M (corresponding author), IST Austria Inst Sci & Technol Austria, Campus 1, A-3400 Klosterneuburg, Austria.	Sixt@ist.ac.at	Bollenbach, Tobias/AAK-3206-2020; Schwarz, Jan Oliver/AAH-7583-2020; Luther, Sanjiv/AAP-6525-2020; Luther, Sanjiv A/B-4380-2016; , Sanjiv/B-4380-2016	Bollenbach, Tobias/0000-0003-4398-476X; Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Sixt, Michael/0000-0002-6620-9179; , Sanjiv/0000-0002-0614-561X; Weber, Michele/0000-0003-2056-3751; Legler, Daniel F./0000-0001-8610-4764	Humboldt Foundation; German Research Foundation [Si1323-1,2]; Human Frontier Science Program [HFSP-RGP0058/2011]; European Research Council [ERC StG 281556]; Swiss National Science Foundation [31003A_127474, 130488]	Humboldt Foundation(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG)); Human Frontier Science Program(Human Frontier Science Program); European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank M. Frank for technical assistance and S. Cremer, P. Schmalhorst, and E. Kiermaier for critical reading of the manuscript. This work was supported by a Humboldt Foundation postdoctoral fellowship (to M. W.), the German Research Foundation (Si1323-1,2 to M. S.), the Human Frontier Science Program (HFSP-RGP0058/2011 to M. S.), the European Research Council (ERC StG 281556 to M. S.), and the Swiss National Science Foundation (31003A_127474 to D.F.L., 130488 to S.A.L.). The authors declare no conflicts of interest. The data reported in the manuscript are tabulated in the main paper and in the supplementary materials.	Alon R, 2010, IMMUNITY, V33, P654, DOI 10.1016/j.immuni.2010.11.012; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Bao XF, 2010, IMMUNITY, V33, P817, DOI 10.1016/j.immuni.2010.10.018; Bax M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006987; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Ehrlich LIR, 2009, IMMUNITY, V31, P986, DOI 10.1016/j.immuni.2009.09.020; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Haessler U, 2011, P NATL ACAD SCI USA, V108, P5614, DOI 10.1073/pnas.1014920108; Hirose J, 2002, BBA-GEN SUBJECTS, V1571, P219, DOI 10.1016/S0304-4165(02)00232-5; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; ROT A, 1993, EUR J IMMUNOL, V23, P303, DOI 10.1002/eji.1830230150; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Schumann K, 2010, IMMUNITY, V32, P703, DOI 10.1016/j.immuni.2010.04.017; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x	29	370	375	4	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					328	332		10.1126/science.1228456	http://dx.doi.org/10.1126/science.1228456			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329049	Green Submitted			2022-12-28	WOS:000313622000047
J	Arriaga, AF; Bader, AM; Wong, JM; Lipsitz, SR; Berry, WR; Ziewacz, JE; Hepner, DL; Boorman, DJ; Pozner, CN; Smink, DS; Gawande, AA				Arriaga, Alexander F.; Bader, Angela M.; Wong, Judith M.; Lipsitz, Stuart R.; Berry, William R.; Ziewacz, John E.; Hepner, David L.; Boorman, Daniel J.; Pozner, Charles N.; Smink, Douglas S.; Gawande, Atul A.			Simulation-Based Trial of Surgical-Crisis Checklists	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESOURCE-MANAGEMENT; SAFETY CHECKLIST; MORTALITY; ASSOCIATION; PERFORMANCE; RETENTION; ACLS	BACKGROUND Operating-room crises (e. g., cardiac arrest and massive hemorrhage) are common events in large hospitals but can be rare for individual clinicians. Successful management is difficult and complex. We sought to evaluate a tool to improve adherence to evidence-based best practices during such events. METHODS Operating-room teams from three institutions (one academic medical center and two community hospitals) participated in a series of surgical-crisis scenarios in a simulated operating room. Each team was randomly assigned to manage half the scenarios with a set of crisis checklists and the remaining scenarios from memory alone. The primary outcome measure was failure to adhere to critical processes of care. Participants were also surveyed regarding their perceptions of the usefulness and clinical relevance of the checklists. RESULTS A total of 17 operating-room teams participated in 106 simulated surgical-crisis scenarios. Failure to adhere to lifesaving processes of care was less common during simulations when checklists were available (6% of steps missed when checklists were available vs. 23% when they were unavailable, P<0.001). The results were similar in a multivariate model that accounted for clustering within teams, with adjustment for institution, scenario, and learning and fatigue effects (adjusted relative risk, 0.28; 95% confidence interval, 0.18 to 0.42; P<0.001). Every team performed better when the crisis checklists were available than when they were not. A total of 97% of the participants reported that if one of these crises occurred while they were undergoing an operation, they would want the checklist used. CONCLUSIONS In a high-fidelity simulation study, checklist use was associated with significant improvement in the management of operating-room crises. These findings suggest that checklists for use during operating-room crises have the potential to improve surgical care. (Funded by the Agency for Healthcare Research and Quality.)	[Arriaga, Alexander F.; Bader, Angela M.; Wong, Judith M.; Lipsitz, Stuart R.; Berry, William R.; Ziewacz, John E.; Smink, Douglas S.; Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Arriaga, Alexander F.; Bader, Angela M.; Wong, Judith M.; Lipsitz, Stuart R.; Berry, William R.; Ziewacz, John E.; Gawande, Atul A.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Arriaga, Alexander F.; Bader, Angela M.; Hepner, David L.] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Med, Boston, MA 02115 USA; [Wong, Judith M.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Pozner, Charles N.; Smink, Douglas S.] Brigham & Womens Hosp, Simulat Training Res & Technol Utilizat Syst STRA, Ctr Med Simulat, Boston, MA 02115 USA; [Arriaga, Alexander F.; Smink, Douglas S.; Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Ziewacz, John E.] Univ Michigan Hlth Syst, Dept Neurosurg, Ann Arbor, MI USA; [Boorman, Daniel J.] Boeing Aircraft, Seattle, WA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Boeing	Gawande, AA (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	agawande@partners.org	Arriaga, Alexander/AAV-2547-2020	Smink, Douglas/0000-0002-8240-9760; Gawande, Atul/0000-0002-1824-9176	Agency for Healthcare Research and Quality [1R18 HS018537-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS018537] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by a grant from the Agency for Healthcare Research and Quality (1R18 HS018537-01).	Agency for Healthcare Research and Quality, 2003, GUID PAT SAF IND; Aircraft accident report: Northwest Airlines Inc., 1988, MCD DOUGL DC 9 82 N3; Aircraft accident report: United Airlines Inc., 1979, MCD DOUGL DC 8 61 N8; [Anonymous], 1924, CURR RES ANESTHE ANA; [Anonymous], MED MED PROGR HOSP O; [Anonymous], MAL HYP PROT POST; Berry WR, 2012, CAN J ANESTH, V59, P522, DOI 10.1007/s12630-012-9697-5; Birkmeyer JD, 2010, NEW ENGL J MED, V363, P1963, DOI 10.1056/NEJMe1009542; Charuluxananan Somrat, 2005, J Med Assoc Thai, V88 Suppl 7, pS14; Chu L, 2011, VISUAL GUIDE CRISIS; Cooper JB, 2004, QUAL SAF HEALTH CARE, V13, P413, DOI 10.1136/qshc.2004.011544; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Gaba DM, 1994, CRISIS MANAGEMENT AN; Gawande Atul, 2010, CHECKLIST MANIFESTO; Ghaferi AA, 2011, MED CARE, V49, P1076, DOI 10.1097/MLR.0b013e3182329b97; Ghaferi AA, 2010, J AM COLL SURGEONS, V211, P325, DOI 10.1016/j.jamcollsurg.2010.04.025; Ghaferi AA, 2009, NEW ENGL J MED, V361, P1368, DOI 10.1056/NEJMsa0903048; GOROVITZ S, 1975, HASTINGS CENT REP, V5, P13, DOI 10.2307/3560992; Harrison TK, 2006, ANESTH ANALG, V103, P551, DOI 10.1213/01.ane.0000229718.02478.c4; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Holzman RS, 1995, J CLIN ANESTH, V7, P675, DOI 10.1016/0952-8180(95)00146-8; Kurrek MM, 1998, CAN J ANAESTH, V45, P130, DOI 10.1007/BF03013250; Moitra VK, 2012, CAN J ANESTH, V59, P586, DOI 10.1007/s12630-012-9699-3; Moorthy K, 2005, BMJ-BRIT MED J, V330, P493, DOI 10.1136/bmj.330.7490.493; National Transportation Safety Board, 2010, AIRCR ACC REP LOSS T; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Neumar, 2011, CIRCULATION, V123, pE236, DOI 10.1161/CIR.0b013e31820ff511; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Rosen MA, 2008, SIMUL HEALTHC, V3, P33, DOI 10.1097/SIH.0b013e3181626276; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P579, DOI 10.1177/0310057X9302100515; Runciman WB, 2005, QUAL SAF HEALTH CARE, V14, P156, DOI 10.1136/qshc.2004.012856; Semeraro F, 2006, RESUSCITATION, V68, P101, DOI 10.1016/j.resuscitation.2005.06.011; Smith GCS, 2003, BRIT MED J, V327, P1459, DOI 10.1136/bmj.327.7429.1459; Smith KK, 2008, RESUSCITATION, V78, P59, DOI 10.1016/j.resuscitation.2008.02.007; van Klei WA, 2012, ANN SURG, V255, P44, DOI 10.1097/SLA.0b013e31823779ae; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; WEBB RK, 1993, ANAESTH INTENS CARE, V21, P520, DOI 10.1177/0310057X9302100507; Ziewacz JE, 2011, J AM COLL SURGEONS, V213; Ziewacz JE, 2012, J AM COLL SURGEONS, V215, P310	40	344	352	2	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					246	253		10.1056/NEJMsa1204720	http://dx.doi.org/10.1056/NEJMsa1204720			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323901	Bronze			2022-12-28	WOS:000313549900009
J	Horowitz, HW				Horowitz, Harold W.			Fever of Unknown Origin or Fever of Too Many Origins?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NYU, Sch Med, Div Infect Dis & Immunol, New York, NY USA	New York University	Horowitz, HW (corresponding author), NYU, Sch Med, Div Infect Dis & Immunol, New York, NY USA.							Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Durack D T, 1991, Curr Clin Top Infect Dis, V11, P35; PETERSDORF R, 1961, MEDICINE, V40, P1, DOI 10.1097/00005792-196102000-00001; Vanderschueren S, 2003, ARCH INTERN MED, V163, P1033, DOI 10.1001/archinte.163.9.1033	4	61	70	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					197	199		10.1056/NEJMp1212725	http://dx.doi.org/10.1056/NEJMp1212725			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YG	23323894				2022-12-28	WOS:000313549900001
J	Masaki, T; Qu, JR; Cholewa-Waclaw, J; Burr, K; Raaum, R; Rambukkana, A				Masaki, Toshihiro; Qu, Jinrong; Cholewa-Waclaw, Justyna; Burr, Karen; Raaum, Ryan; Rambukkana, Anura			Reprogramming Adult Schwann Cells to Stem Cell-like Cells by Leprosy Bacilli Promotes Dissemination of Infection	CELL			English	Article							PERIPHERAL-NERVE REGENERATION; VIABLE MYCOBACTERIUM-LEPRAE; MUSCLE REGENERATION; PULMONARY GRANULOMA; IN-VIVO; DEMYELINATION; PREDILECTION; ACTIVATION; EXPRESSION; RECEPTOR	Differentiated cells possess a remarkable genomic plasticity that can be manipulated to reverse or change developmental commitments. Here, we show that the leprosy bacterium hijacks this property to reprogram adult Schwann cells, its preferred host niche, to a stage of progenitor/stem-like cells (pSLC) of mesenchymal trait by downregulating Schwann cell lineage/differentiation-associated genes and up-regulating genes mostly of mesoderm development. Reprogramming accompanies epigenetic changes and renders infected cells highly plastic, migratory, and immunomodulatory. We provide evidence that acquisition of these properties by pSLC promotes bacterial spread by two distinct mechanisms: direct differentiation to mesenchymal tissues, including skeletal and smooth muscles, and formation of granuloma-like structures and subsequent release of bacteria-laden macrophages. These findings support a model of host cell reprogramming in which a bacterial pathogen uses the plasticity of its cellular niche for promoting dissemination of infection and provide an unexpected link between cellular reprogramming and host-pathogen interaction.	[Masaki, Toshihiro; Cholewa-Waclaw, Justyna; Rambukkana, Anura] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Masaki, Toshihiro; Cholewa-Waclaw, Justyna; Burr, Karen; Rambukkana, Anura] Univ Edinburgh, Ctr Neuroregenerat, Edinburgh EH16 4UU, Midlothian, Scotland; [Rambukkana, Anura] Univ Edinburgh, Ctr Infect Dis, Edinburgh EH16 4UU, Midlothian, Scotland; [Masaki, Toshihiro; Qu, Jinrong; Raaum, Ryan; Rambukkana, Anura] Rockefeller Univ, New York, NY 10065 USA	University of Edinburgh; University of Edinburgh; University of Edinburgh; Rockefeller University	Rambukkana, A (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Little France Campus, Edinburgh EH16 4UU, Midlothian, Scotland.	a.rambuka@ed.ac.uk	Raaum, Ryan L/B-4609-2008	Raaum, Ryan L/0000-0003-4723-5475; rambukkana, anura/0000-0002-6286-9145	American Leprosy Missions; Hospitaler Order of St. Lazarus of Jerusalem; NIAID [AI45816, NS45187]; Order of MALTALEP Foundation; Rockefeller University; University of Edinburgh; Medical Research Council [G0700711B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045187] Funding Source: NIH RePORTER	American Leprosy Missions; Hospitaler Order of St. Lazarus of Jerusalem; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Order of MALTALEP Foundation; Rockefeller University; University of Edinburgh; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ian Wilmut and Emil Gotschlich for critical reading of the manuscript. We are grateful to Emil Gotschlich, Paul Nurse, Michael Young, Vincent Fi-schetti, Thomas Sakmar (Rockefeller University), John Savill, Jonathan Sackl, Nick Hastie (University of Edinburgh), and James Krahenbuhl (National Hansen's Disease Programs; NHDP) for their support during the initial and final phases of this study. Our thanks to Richard Truman (NHDP) for providing Fite's staining of infected mouse tissue sections; members of the core facilities at the Rockefeller University and the University of Edinburgh for their invaluable assistance; Joe Dybaas, Jennifer Smith, Clara Eastby, Paola Basilico, and Maxmilien Grandclaudon (Rambukkana laboratory) for their participation and technical assistance; and members of Genome Exploration and EpigenDx for technical assistance and data analysis. Mycobacterium leprae were provided by The Laboratory Research Branch of NHDP, Baton Rouge, LA with funding from The American Leprosy Missions and the Hospitaler Order of St. Lazarus of Jerusalem. This work was funded in part by grants from NIAID (AI45816) and NINDS (NS45187), The Order of MALTALEP Foundation, The Rockefeller University, and the University of Edinburgh.	Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Buatois V, 2010, J IMMUNOL, V185, P2544, DOI 10.4049/jimmunol.1000182; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chiu BC, 2004, AM J PATHOL, V164, P1021, DOI 10.1016/S0002-9440(10)63189-6; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; FALKOW S, 1991, CELL, V65, P1099, DOI 10.1016/0092-8674(91)90003-H; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; GUPTA JC, 1975, INT J LEPROSY, V43, P348; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hoogduijn MJ, 2010, INT IMMUNOPHARMACOL, V10, P1496, DOI 10.1016/j.intimp.2010.06.019; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; JOB CK, 1989, INT J LEPROSY, V57, P532; Kaur S, 1981, Lepr India, V53, P52; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Lahiri R, 2010, J INFECT DIS, V201, P1736, DOI 10.1086/652499; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee J, 2012, CELL, V151, P547, DOI 10.1016/j.cell.2012.09.034; Li Y, 2009, BLOOD, V113, P2342, DOI 10.1182/blood-2008-07-168138; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MIKO TL, 1993, LANCET, V342, P521, DOI 10.1016/0140-6736(93)91647-5; MODLIN RL, 1988, SPRINGER SEMIN IMMUN, V10, P359, DOI 10.1007/BF02053846; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; Pearson J M, 1970, Lepr Rev, V41, P155; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qiu BQ, 2001, AM J PATHOL, V158, P1503, DOI 10.1016/S0002-9440(10)64101-6; Rambukkana A, 1998, SCIENCE, V282, P2076, DOI 10.1126/science.282.5396.2076; Rambukkana A, 1997, CELL, V88, P811, DOI 10.1016/S0092-8674(00)81927-3; Rambukkana A, 2002, SCIENCE, V296, P927, DOI 10.1126/science.1067631; Rambukkana A, 2010, PROG NEUROBIOL, V91, P102, DOI 10.1016/j.pneurobio.2009.12.002; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; SHETTY VP, 1988, J NEUROL SCI, V88, P115, DOI 10.1016/0022-510X(88)90210-9; Shi DQ, 2004, BLOOD, V104, P290, DOI 10.1182/blood-2003-03-0688; STONER GL, 1979, LANCET, V2, P994; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Tapinos N, 2006, NAT MED, V12, P961, DOI 10.1038/nm1433; Theise ND, 2003, NATURE, V425, P21, DOI 10.1038/425021a; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Truman RW, 2001, INT J LEPROSY, V69, P1; Weider M., 2012, DEV CELL, V23, P193; Werneck LC, 1999, ARQ NEURO-PSIQUIAT, V57, P723, DOI 10.1590/S0004-282X1999000500001; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	50	151	155	2	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					51	67		10.1016/j.cell.2012.12.014	http://dx.doi.org/10.1016/j.cell.2012.12.014			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332746	Bronze, Green Accepted			2022-12-28	WOS:000313719800006
J	Martin, CH; Wainwright, PC				Martin, Christopher H.; Wainwright, Peter C.			Multiple Fitness Peaks on the Adaptive Landscape Drive Adaptive Radiation in the Wild	SCIENCE			English	Article							DISRUPTIVE SELECTION; BODY-SIZE; EVOLUTION; DIVERSIFICATION; DIVERGENCE; FINCHES	The relationship between phenotype and fitness can be visualized as a rugged landscape. Multiple fitness peaks on this landscape are predicted to drive early bursts of niche diversification during adaptive radiation. We measured the adaptive landscape in a nascent adaptive radiation of Cyprinodon pupfishes endemic to San Salvador Island, Bahamas, and found multiple coexisting high-fitness regions driven by increased competition at high densities, supporting the early burst model. Hybrids resembling the generalist phenotype were isolated on a local fitness peak separated by a valley from a higher-fitness region corresponding to trophic specialization. This complex landscape could explain both the rarity of specialists across many similar environments due to stabilizing selection on generalists and the rapid morphological diversification rate of specialists due to their higher fitness.	[Martin, Christopher H.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Martin, CH (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	chmartin@ucdavis.edu	NAME, NO/AAA-3691-2021	Martin, Christopher/0000-0001-7989-9124	NSF [DDIG DEB-1010849]; Gerace Research Centre; Center for Population Biology; Direct For Biological Sciences [0924489] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Gerace Research Centre; Center for Population Biology; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funded by NSF grant DDIG DEB-1010849, the Gerace Research Centre, and the Center for Population Biology. Permits were approved by the Bahamian government and the University of California, Davis. G. Mount and S. Romero assisted with research; T. Schoener, M. Turelli, A. Hendry, D. Nychka, L. Schmitz, and C. Boettiger provided feedback. C. H. M. designed the study, raised funding, performed research, collected and analyzed data, and wrote the paper. P. C. W. contributed materials, discussed design and results, and commented on the manuscript.	Benkman CW, 2003, EVOLUTION, V57, P1176; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Foote M, 1997, ANNU REV ECOL SYST, V28, P129, DOI 10.1146/annurev.ecolsys.28.1.129; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hendry AP, 2009, P ROY SOC B-BIOL SCI, V276, P753, DOI 10.1098/rspb.2008.1321; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Martin CH, 2012, AM NAT, V180, pE90, DOI 10.1086/667586; Martin CH, 2011, EVOLUTION, V65, P2197, DOI 10.1111/j.1558-5646.2011.01294.x; McBride CS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000529; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; SCHLUTER D, 1984, AM NAT, V123, P175, DOI 10.1086/284196; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Svensson E, 2000, EVOLUTION, V54, P1396; Svensson EI, 2012, ADAPTIVE LANDSCAPE IN EVOLUTIONARY BIOLOGY, P1; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356	19	111	111	0	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					208	211		10.1126/science.1227710	http://dx.doi.org/10.1126/science.1227710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307743				2022-12-28	WOS:000313328200045
J	Casassus, S; van der Plas, G; Perez, MS; Dent, WRF; Fomalont, E; Hagelberg, J; Hales, A; Jordan, A; Mawet, D; Menard, F; Wootten, A; Wilner, D; Hughes, AM; Schreiber, MR; Girard, JH; Ercolano, B; Canovas, H; Roman, PE; Salinas, V				Casassus, Simon; van der Plas, Gerrit; Sebastian Perez, M.; Dent, William R. F.; Fomalont, Ed; Hagelberg, Janis; Hales, Antonio; Jordan, Andres; Mawet, Dimitri; Menard, Francois; Wootten, Al; Wilner, David; Hughes, A. Meredith; Schreiber, Matthias R.; Girard, Julien H.; Ercolano, Barbara; Canovas, Hector; Roman, Pablo E.; Salinas, Vachail			Flows of gas through a protoplanetary gap	NATURE			English	Article							DISK SURROUNDING HD-142527; CO FUNDAMENTAL EMISSION; HERBIG AE/BE STARS; T-TAURI; TRANSITIONAL DISKS; PLANET FORMATION; MOLECULAR GAS; AE STARS; SPECTROSCOPY; ACCRETION	The formation of gaseous giant planets is thought to occur in the first few million years after stellar birth. Models(1) predict that the process produces a deep gap in the dust component (shallower in the gas(2-4)). Infrared observations of the disk around the young star HD 142527 (at a distance of about 140 parsecs from Earth) found an inner disk about 10 astronomical units (AU) in radius(5) (1 AU is the Earth-Sun distance), surrounded by a particularly large gap(6) and a disrupted(7) outer disk beyond 140 AU. This disruption is indicative of a perturbing planetary-mass body at about 90 AU. Radio observations(8,9) indicate that the bulk mass is molecular and lies in the outer disk, whose continuum emission has a horseshoe morphology(8). The high stellar accretion rate(10) would deplete the inner disk(11) in less than one year, and to sustain the observed accretion matter must therefore flow from the outer disk and cross the gap. In dynamical models, the putative protoplanets channel outer-disk material into gap-crossing bridges that feed stellar accretion through the inner disk(12). Here we report observations of diffuse CO gas inside the gap, with denser HCO+ gas along gap-crossing filaments. The estimated flow rate of the gas is in the range of 7 x 10(-9) to 2 x 10(-7) solar masses per year, which is sufficient to maintain accretion onto the star at the present rate.	[Casassus, Simon; van der Plas, Gerrit; Sebastian Perez, M.; Menard, Francois; Salinas, Vachail] Univ Chile, Dept Astron, Santiago, Chile; [Dent, William R. F.; Hales, Antonio] Joint ALMA Observ, Santiago 7630355, Chile; [Dent, William R. F.; Mawet, Dimitri; Girard, Julien H.] European So Observ, Santiago 19, Chile; [Fomalont, Ed; Hales, Antonio; Wootten, Al] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Hagelberg, Janis] Univ Geneva, Observ Geneve, CH-1290 Versoix, Switzerland; [Jordan, Andres] Pontificia Univ Catolica Chile, Dept Astron & Astrofis, Santiago, Chile; [Menard, Francois] CNRS INSU France UMI 3386, UMI FCA, Grenoble, France; [Menard, Francois] UJF Grenoble 1, CNRS, UMR 5274, IPAG, F-48041 Grenoble 9, France; [Wilner, David] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Hughes, A. Meredith] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Schreiber, Matthias R.; Canovas, Hector] Univ Valparaiso, Dept Fis & Astron, Valparaiso, Chile; [Ercolano, Barbara] Univ Munich, Univ Observ, D-81679 Munich, Germany; [Roman, Pablo E.] Univ Chile, Ctr Math Modeling, Santiago, Chile	Universidad de Chile; European Southern Observatory; National Radio Astronomy Observatory (NRAO); University of Geneva; Pontificia Universidad Catolica de Chile; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley; Universidad de Valparaiso; University of Munich; Universidad de Chile	Casassus, S (corresponding author), Univ Chile, Dept Astron, Casilla 36-D, Santiago, Chile.	scasassus@u.uchile.cl	Cánovas, Héctor/HCI-1393-2022; Girard, Julien H/GRJ-2731-2022; Roman, Pablo E/G-1960-2011; Girard, Julien/Q-4917-2019; Pérez, Sebastián/AAS-5857-2020; Asenjo, Pablo Roman/AAZ-8486-2021; Casassus, Simon/I-8609-2016; Schreiber, Matthias R./AAQ-1185-2020; Hagelberg, Janis/E-8520-2013	Cánovas, Héctor/0000-0001-7668-8022; Girard, Julien H/0000-0001-8627-0404; Roman, Pablo E/0000-0002-7105-9371; Girard, Julien/0000-0001-8627-0404; Pérez, Sebastián/0000-0003-2953-755X; Asenjo, Pablo Roman/0000-0002-7105-9371; Schreiber, Matthias R./0000-0003-3903-8009; casassus, simon/0000-0002-0433-9840; Wootten, Henry/0000-0001-7026-6099; Jordan, Andres/0000-0002-5389-3944; Hagelberg, Janis/0000-0002-1096-1433; van der Plas, Gerrit/0000-0001-5688-187X; Hughes, A. Meredith/0000-0002-4803-6200; Wilner, David/0000-0003-1526-7587	Millennium Nucleus [P10-022-F]; European Union [FONDECYT 1100221, 284405]	Millennium Nucleus; European Union(European Commission)	This paper makes use of the following ALMA data: ADS/JAO.ALMA#2011.0.00465. S. ALMA is a partnership of the ESO, NSF, NINS, NRC, NSC and ASIAA. The Joint ALMA Observatory is operated by the ESO, AUI/NRAO and NAOJ. This work was also based on observations obtained at the Gemini Observatory. Financial support was provided by Millennium Nucleus P10-022-F (Chilean Ministry of Economy) and additionally by grant FONDECYT 1100221 and grant 284405 from the European Union FP7 programme.	Acke B, 2006, ASTRON ASTROPHYS, V449, P267, DOI 10.1051/0004-6361:20054330; Ayliffe BA, 2012, MON NOT R ASTRON SOC, V423, P1450, DOI 10.1111/j.1365-2966.2012.20967.x; Beck TL, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/72; Carr JS, 2001, ASTROPHYS J, V551, P454, DOI 10.1086/320071; Casassus S, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/2/L31; Dodson-Robinson SE, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/131; Eisner JA, 2010, ASTROPHYS J, V718, P774, DOI 10.1088/0004-637X/718/2/774; Fouchet L, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/200913778; Fujiwara H, 2006, ASTROPHYS J, V644, pL133, DOI 10.1086/505597; Fukagawa M, 2006, ASTROPHYS J, V636, pL153, DOI 10.1086/500128; Kraus S, 2008, ASTRON ASTROPHYS, V489, P1157, DOI 10.1051/0004-6361:200809946; Lopez RG, 2006, ASTRON ASTROPHYS, V459, P837, DOI 10.1051/0004-6361:20065575; Lubow SH, 2006, ASTROPHYS J, V641, P526, DOI 10.1086/500356; Lyo AR, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/151; Mathews GS, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/59; Najita J, 2003, ASTROPHYS J, V589, P931, DOI 10.1086/374809; Oberg KI, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/2/98; Ohashi N, 2008, ASTROPHYS SPACE SCI, V313, P101, DOI 10.1007/s10509-007-9667-5; Pietu V, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015682; Pontoppidan KM, 2008, ASTROPHYS J, V684, P1323, DOI 10.1086/590400; Pontoppidan KM, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/84; Regaly Z, 2012, MON NOT R ASTRON SOC, V419, P1701, DOI 10.1111/j.1365-2966.2011.19834.x; Sacco GG, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/2/142; Salyk C, 2009, ASTROPHYS J, V699, P330, DOI 10.1088/0004-637X/699/1/330; Tatulli E, 2007, ASTRON ASTROPHYS, V464, P55, DOI 10.1051/0004-6361:20065719; van der Plas G, 2008, ASTRON ASTROPHYS, V485, P487, DOI 10.1051/0004-6361:20078867; van der Plas G, 2009, ASTRON ASTROPHYS, V500, P1137, DOI 10.1051/0004-6361/200811148; Verhoeff AP, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201014952	30	288	288	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					191	194		10.1038/nature11769	http://dx.doi.org/10.1038/nature11769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23283173	Green Submitted			2022-12-28	WOS:000313259600033
J	Lapi, F; Azoulay, L; Yin, H; Nessim, SJ; Suissa, S				Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Nessim, Sharon J.; Suissa, Samy			Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE-RENAL-FAILURE; PRACTICE RESEARCH DATABASE; EUROPEAN-SOCIETY; EPIDEMIOLOGY; VALIDITY; COMBINATIONS; PRESCRIPTION; DISEASE; DEATH; BIAS	Objectives To assess whether a double therapy combination consisting of diuretics, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers with addition of non-steroidal anti-inflammatory drugs (NSAIDs) and the triple therapy combination of two of the aforementioned antihypertensive drugs to which NSAIDs are added are associated with an increased risk of acute kidney injury. Design Retrospective cohort study using nested case-control analysis. Setting General practices contributing data to the UK Clinical Practice Research Datalink linked to the Hospital Episodes Statistics database. Participants A cohort of 487 372 users of antihypertensive drugs. Main outcome measures Rate ratios with 95% confidence intervals of acute kidney injury associated with current use of double and triple therapy combinations of antihypertensive drugs with NSAIDs. Results During a mean follow-up of 5.9 (SD 3.4) years, 2215 cases of acute kidney injury were identified (incidence rate 7/10 000 person years). Overall, current use of a double therapy combination containing either diuretics or angiotensin converting enzyme inhibitors or angiotensin receptor blockers with NSAIDs was not associated with an increased rate of acute kidney injury. In contrast, current use of a triple therapy combination was associated with an increased rate of acute kidney injury (rate ratio 1.31, 95% confidence interval 1.12 to 1.53). In secondary analyses, the highest risk was observed in the first 30 days of use (rate ratio 1.82, 1.35 to 2.46). Conclusions A triple therapy combination consisting of diuretics with angiotensin converting enzyme inhibitors or angiotensin receptor blockers and NSAIDs was associated with an increased risk of acute kidney injury. The risk was greatest at the start of treatment. Although antihypertensive drugs have cardiovascular benefits, vigilance may be warranted when they are used concurrently with NSAIDs.	[Lapi, Francesco; Azoulay, Laurent; Yin, Hui; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Lapi, Francesco; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, I-50139 Florence, Italy; [Azoulay, Laurent] McGill Univ, Dept Oncol, Montreal, PQ H3G 1A4, Canada; [Nessim, Sharon J.] McGill Univ, Jewish Gen Hosp, Div Nephrol, Dept Med, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; University of Florence; McGill University; McGill University	Suissa, S (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine, Montreal, PQ H3T 1E2, Canada.	samy.suissa@mcgill.ca	Azoulay, Laurent/Z-4421-2019		Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR); Canada Foundation for Innovation	Drug Safety and Effectiveness Network (DSEN); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This study was funded in part by infrastructure grants from the Drug Safety and Effectiveness Network (DSEN), the Canadian Institute of Health Research (CIHR), and the Canada Foundation for Innovation. The funding sources had no role in the design, analysis, or interpretation of the results, and thus the authors were independent from the funding sources. FL is the recipient of an LDI post-doctoral research award, LA is the recipient of a Chercheur-Boursier career award from the Fonds de recherche en sante du Quebec, and SS is the recipient of the James McGill chair award.	Adhiyaman V, 2001, J ROY SOC MED, V94, P512, DOI 10.1177/014107680109401005; Baraldi A, 1998, NEPHROL DIAL TRANSPL, V13, P25, DOI 10.1093/ndt/13.suppl_7.25; Breslow NE, 1996, J AM STAT ASSOC, V91, P14, DOI 10.2307/2291379; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Feenstra H, 2001, ANN INTERN MED, V134, P569, DOI 10.7326/0003-4819-134-7-200104030-00010; Girman CJ, 2012, DIABETIC MED, V29, P614, DOI 10.1111/j.1464-5491.2011.03498.x; Gislason GH, 2007, CIRCULATION, V116, P737, DOI 10.1161/CIRCULATIONAHA.106.669101; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Han L, 2012, ANN EPIDEMIOL, V22, P9, DOI 10.1016/j.annepidem.2011.10.004; Hernandez-Diaz S, 2001, AM J MED S1, V110, P20, DOI DOI 10.1016/S0002-9343(00)00682-3; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hsu CY, 2007, KIDNEY INT, V72, P208, DOI 10.1038/sj.ki.5002297; Hsu CY, 2009, CLIN J AM SOC NEPHRO, V4, P891, DOI 10.2215/CJN.05571008; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Ishiguro C, 2008, J EPIDEMIOL, V18, P119, DOI 10.2188/jea.JE2007413; Kellum JA, 2002, CRIT CARE MED, V30, P2156, DOI 10.1097/00003246-200209000-00041; Kellum J, 2007, AM FAM PHYSICIAN, V76, P418; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Knauf H, 2006, EUR J CLIN PHARMACOL, V62, P885, DOI 10.1007/s00228-006-0190-3; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; LaCivita C, 2009, J AM PHARM ASSOC, V49, pE110, DOI 10.1331/JAPhA.2009.09005; Lafrance JP, 2009, PHARMACOEPIDEM DR S, V18, P923, DOI 10.1002/pds.1798; LaMarr B, 2010, AM J HEALTH-SYST PH, V67, P290, DOI 10.2146/ajhp090009; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Loboz KK, 2005, BRIT J CLIN PHARMACO, V59, P239, DOI 10.1111/j.0306-5251.2004.2188.x; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; MATHEW TH, 1992, MED J AUSTRALIA, V156, P724, DOI 10.5694/j.1326-5377.1992.tb121517.x; Mazzaglia G, 2009, CIRCULATION, V120, P1598, DOI 10.1161/CIRCULATIONAHA.108.830299; Morabito S, 2012, J NEPHROL, V25, P1098, DOI 10.5301/jn.5000101; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; NHS Information Centre for Health and Social Care, 2012, QOF 2009 10 DAT TABL; Olsen MH, 2010, J HYPERTENS, V28, P1593, DOI 10.1097/HJH.0b013e32833b7b08; Perez Gutthann S, 1996, ARCH INTERN MED, V156, P2433; Psaty BM, 2010, JAMA-J AM MED ASSOC, V304, P897, DOI 10.1001/jama.2010.1205; Quartey G, 2011, PHARM STAT, V10, P539, DOI 10.1002/pst.528; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Remuzzi G, 2002, NEW ENGL J MED, V346, P1145, DOI 10.1056/NEJMcp011773; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Schetz M, 2005, CURR OPIN CRIT CARE, V11, P555, DOI 10.1097/01.ccx.0000184300.68383.95; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; SHUSTERMAN N, 1987, AM J MED, V83, P65, DOI 10.1016/0002-9343(87)90498-0; Smets HLE, 2008, PHARMACOEPIDEM DR S, V17, P1014, DOI 10.1002/pds.1641; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; Taber SS, 2008, EXPERT OPIN DRUG SAF, V7, P679, DOI [10.1517/14740330802410462, 10.1517/14740330802410462 ]; Thomas MC, 2000, MED J AUSTRALIA, V172, P184, DOI 10.5694/j.1326-5377.2000.tb125548.x; Thurman JM, 2008, KIDNEY INT, V73, P379, DOI 10.1038/sj.ki.5002739; Vlasschaert MEO, 2011, AM J KIDNEY DIS, V57, P29, DOI 10.1053/j.ajkd.2010.08.031; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073; World Health Organisation (WHO), DAT; Wu TY, 2010, J ROY SOC MED, V103, P239, DOI 10.1258/jrsm.2010.100113; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	55	189	191	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8525	10.1136/bmj.e8525	http://dx.doi.org/10.1136/bmj.e8525			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299844	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000313553800001
J	Stagno, V; Ojwang, DO; McCammon, CA; Frost, DJ				Stagno, Vincenzo; Ojwang, Dickson O.; McCammon, Catherine A.; Frost, Daniel J.			The oxidation state of the mantle and the extraction of carbon from Earth's interior	NATURE			English	Article							OXYGEN FUGACITY; FERRIC IRON; OLIVINE; GARNET; MELTS; FE3+/SIGMA-FE; PROFILE; BENEATH; PHASES; ALLOYS	Determining the oxygen fugacity of Earth's silicate mantle is of prime importance because it affects the speciation and mobility of volatile elements in the interior and has controlled the character of degassing species from the Earth since the planet's formation(1). Oxygen fugacities recorded by garnet-bearing peridotite xenoliths from Archaean lithosphere are of particular interest, because they provide constraints on the nature of volatile-bearing metasomatic fluids and melts active in the oldest mantle samples, including those in which diamonds are found(2,3). Here we report the results of experiments to test garnet oxythermobarometry equilibria(4,5) under high-pressure conditions relevant to the deepest mantle xenoliths. We present a formulation for the most successful equilibrium and use it to determine an accurate picture of the oxygen fugacity through cratonic lithosphere. The oxygen fugacity of the deepest rocks is found to be at least one order of magnitude more oxidized than previously estimated. At depths where diamonds can form, the oxygen fugacity is not compatible with the stability of either carbonate-or methane-rich liquid but is instead compatible with a metasomatic liquid poor in carbonate and dominated by either water or silicate melt. The equilibrium also indicates that the relative oxygen fugacity of garnet-bearing rocks will increase with decreasing depth during adiabatic decompression. This implies that carbon in the asthenospheric mantle will be hosted as graphite or diamond but will be oxidized to produce carbonatemelt through the reduction of Fe3+ in silicate minerals during upwelling. The depth of carbonate melt formation will depend on the ratio of Fe3+ to total iron in the bulk rock. This 'redox melting' relationship has important implications for the onset of geophysically detectable incipient melting and for the extraction of carbon dioxide from the mantle through decompressive melting.	[Stagno, Vincenzo; Ojwang, Dickson O.; McCammon, Catherine A.; Frost, Daniel J.] Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	Frost, DJ (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	dan.frost@uni-bayreuth.de	McCammon, Catherine/B-4983-2010; Frost, Daniel J/B-7526-2016; Ojwang, Dickson O./AAW-4379-2020	McCammon, Catherine/0000-0001-5680-9106; Frost, Daniel J/0000-0002-4443-8149; Ojwang, Dickson O./0000-0001-9304-8975; Stagno, Vincenzo/0000-0002-8710-0885	European Commission under the Marie Curie Action for Early Stage Training of Researchers within the 6th Framework Programme [MEST-CT-2005-019700]; German Science Foundation [FR1555/5-1]	European Commission under the Marie Curie Action for Early Stage Training of Researchers within the 6th Framework Programme; German Science Foundation(German Research Foundation (DFG))	Financial support was provided to V. S. by the European Commission under the Marie Curie Action for Early Stage Training of Researchers within the 6th Framework Programme (contract number MEST-CT-2005-019700) and by the German Science Foundation (grant FR1555/5-1).	AMTHAUER G, 1976, Z KRISTALLOGR, V143, P14; BALLHAUS C, 1995, EARTH PLANET SC LETT, V132, P75, DOI 10.1016/0012-821X(95)00047-G; BALLHAUS C, 1994, GEOCHIM COSMOCHIM AC, V58, P4931, DOI 10.1016/0016-7037(94)90222-4; Balta JB, 2011, J PETROL, V52, P2079, DOI 10.1093/petrology/egr040; Bezos A, 2005, GEOCHIM COSMOCHIM AC, V69, P711, DOI 10.1016/j.gca.2004.07.026; BLUNDY JD, 1991, NATURE, V349, P321, DOI 10.1038/349321a0; Campbell IH, 2005, ELEMENTS, V1, P265, DOI 10.2113/gselements.1.5.265; Canil D, 1996, J PETROL, V37, P609, DOI 10.1093/petrology/37.3.609; Creighton S, 2010, CONTRIB MINERAL PETR, V159, P645, DOI 10.1007/s00410-009-0446-x; Creighton S, 2009, CONTRIB MINERAL PETR, V157, P491, DOI 10.1007/s00410-008-0348-3; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Eggler DH., 1982, HIGH PRESSURE RES GE, P237, DOI [10.1007/978-94-009-7867-6_19, DOI 10.1007/978-94-009-7867-6_19]; Frost DJ, 2008, ANNU REV EARTH PL SC, V36, P389, DOI 10.1146/annurev.earth.36.031207.124322; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Ganguly J, 1996, CONTRIB MINERAL PETR, V126, P137, DOI 10.1007/s004100050240; Gu YJ, 2005, EARTH PLANET SC LETT, V232, P259, DOI 10.1016/j.epsl.2005.01.019; GUDMUNDSSON G, 1995, CONTRIB MINERAL PETR, V119, P56, DOI 10.1007/BF00310717; Holland TJB, 2011, J METAMORPH GEOL, V29, P333, DOI 10.1111/j.1525-1314.2010.00923.x; KASTING JF, 1993, J GEOL, V101, P245, DOI 10.1086/648219; Lazarov M, 2009, LITHOS, V112, P913, DOI 10.1016/j.lithos.2009.03.035; LUTH RW, 1990, CONTRIB MINERAL PETR, V104, P56, DOI 10.1007/BF00310646; McCammon C, 2004, CONTRIB MINERAL PETR, V148, P55, DOI 10.1007/s00410-004-0583-1; MCCAMMON CA, 1994, HYPERFINE INTERACT, V92, P1235, DOI 10.1007/BF02065761; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; MCKENZIE D, 1985, EARTH PLANET SC LETT, V74, P81, DOI 10.1016/0012-821X(85)90168-2; ONeill H., 1993, GEOPHYS MONOGR SER, V74, P74; ONEILL HS, 1987, J PETROL, V28, P1169, DOI 10.1093/petrology/28.6.1169; ONEILL HSC, 1979, CONTRIB MINERAL PETR, V70, P59, DOI 10.1007/BF00371872; Peslier AH, 2010, NATURE, V467, P78, DOI 10.1038/nature09317; Prescher C, 2012, J APPL CRYSTALLOGR, V45, P329, DOI 10.1107/S0021889812004979; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; SCHWERDTFEGER K, 1968, T METALL SOC AIME, V242, P631; Smith J.F., 1984, B ALLOY PHASE DIAGR, V5, P184, DOI [DOI 10.1007/BF02868724, 10.1007/BF02868958, DOI 10.1007/BF02868958]; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038; WISER NM, 1991, CONTRIB MINERAL PETR, V108, P146, DOI 10.1007/BF00307333; WOOD BJ, 1978, CONTRIB MINERAL PETR, V66, P389, DOI 10.1007/BF00403424; WOOD BJ, 1991, REV MINERAL, V25, P417; Woodland AB, 2003, EARTH PLANET SC LETT, V214, P295, DOI 10.1016/S0012-821X(03)00379-0; WOODLAND AB, 1993, AM MINERAL, V78, P1002; Woodland AB, 1997, GEOCHIM COSMOCHIM AC, V61, P4359, DOI 10.1016/S0016-7037(97)00247-0; Yaxley GM, 2012, LITHOS, V140, P142, DOI 10.1016/j.lithos.2012.01.016	43	310	328	14	323	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					84	+		10.1038/nature11679	http://dx.doi.org/10.1038/nature11679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282365				2022-12-28	WOS:000312933800035
J	Leonard, P				Leonard, Philip			Will expansion of the NHS abroad benefit UK patients? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Ernst & Young, Healthcare, London SE1 2AF, England		Leonard, P (corresponding author), Ernst & Young, Healthcare, London SE1 2AF, England.	pleonard@uk.ey.com							0	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8493	10.1136/bmj.e8493	http://dx.doi.org/10.1136/bmj.e8493			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284155				2022-12-28	WOS:000313236300013
J	Aad, G; Abajyan, T; Abbott, B; Abdallah, J; Khalek, SA; Abdelalim, AA; Abdinov, O; Aben, R; Abi, B; Abolins, M; AbouZeid, OS; Abramowicz, H; Abreu, H; Acharya, BS; Adamczyk, L; Adams, DL; Addy, TN; Adelman, J; Adomeit, S; Adragna, P; Adye, T; Aefsky, S; Aguilar-Saavedra, JA; Agustoni, M; Aharrouche, M; Ahlen, SP; Ahles, F; Ahmad, A; Ahsan, M; Aielli, G; Akdogan, T; Akesson, TPA; Akimoto, G; Akimov, AV; Alam, MS; Alam, MA; Albert, J; Albrand, S; Aleksa, M; Aleksandrov, IN; Alessandria, F; Alexa, C; Alexander, G; Alexandre, G; Alexopoulos, T; Alhroob, M; Aliev, M; Alimonti, G; Alison, J; Allbrooke, BMM; Allport, PP; Allwood-Spiers, SE; Almond, J; Aloisio, A; Alon, R; Alonso, A; Alonso, F; Altheimer, A; Gonzalez, BA; Alviggi, MG; Amako, K; Amelung, C; Ammosov, VV; Dos Santos, SPA; Amorim, A; Amram, N; Anastopoulos, C; Ancu, LS; Andari, N; Andeen, T; Anders, CF; Anders, G; Anderson, KJ; Andreazza, A; Andrei, V; Andrieux, ML; Anduaga, XS; Angelidakis, S; Anger, P; Angerami, A; Anghinolfi, F; Anisenkov, A; Anjos, N; Annovi, A; Antonaki, A; Antonelli, M; Antonov, A; Antos, J; Anulli, F; Aoki, M; Aoun, S; Bella, LA; Apolle, R; Arabidze, G; Aracena, I; Arai, Y; Arce, ATH; Arfaoui, S; Arguin, JF; Arik, E; Arik, M; Armbruster, AJ; Arnaez, O; Arnal, V; Arnault, C; Artamonov, A; Artoni, G; Arutinov, D; Asai, S; Ask, S; Asman, B; Asquith, L; Assamagan, K; Astbury, A; Atkinson, M; Aubert, B; Auge, E; Augsten, K; Aurousseau, M; Avolio, G; Avramidou, R; Axen, D; Azuelos, G; Azuma, Y; Baak, MA; Baccaglioni, G; Bacci, C; Bach, AM; Bachacou, H; Bachas, K; Backes, M; Backhaus, M; Mayes, JB; Badescu, E; Bagnaia, P; Bahinipati, S; Bai, Y; Bailey, DC; Bain, T; Baines, JT; Baker, OK; Baker, MD; Baker, S; Balek, P; Banas, E; Banerjee, P; Banerjee, S; Banfi, D; Bangert, A; Bansal, V; Bansil, HS; Barak, L; Baranov, SP; Galtieri, AB; Barber, T; Barberio, EL; Barberis, D; Barbero, M; Bardin, DY; Barillari, T; Barisonzi, M; Barklow, T; Barlow, N; Barnett, BM; Barnett, RM; Baroncelli, A; Barone, G; Barr, AJ; Barreiro, F; da Costa, JBG; Barrillon, P; Bartoldus, R; Barton, AE; Bartsch, V; Basye, A; Bates, RL; Batkova, L; Batley, JR; Battaglia, A; Battistin, M; Bauer, F; Bawa, HS; Beale, S; Beau, T; Beauchemin, PH; Beccherle, R; Bechtle, P; Beck, HP; Becker, AK; Becker, S; Beckingham, M; Becks, KH; Bedda, AJ; Bedda, A; Bedikian, S; Bednyakov, VA; Bee, CP; Beemster, LJ; Bege, M; Harpaz, SB; Behera, PK; Beimforde, M; Belanger-Champagne, C; Bell, PJ; Bell, WH; Bella, G; Bellagamba, L; Bellomo, M; Belloni, A; Beloborodova, O; Belotskiy, K; Beltramello, O; Benary, O; Benchekroun, D; Bendtz, K; Benekos, N; Benhammou, Y; Noccioli, EB; Garcia, JAB; Benjamin, DP; Benoit, M; Bensinger, JR; Benslama, K; Bentvelsen, S; Berge, D; Kuutmann, EB; Berger, N; Berghaus, F; Berglund, E; Beringer, J; Bernat, P; Bernhard, R; Bernius, C; Bernlochner, FU; Berry, T; Bertella, C; Bertin, A; Bertolucci, F; Besana, MI; Besjes, GJ; Besson, N; Bethke, S; Bhimji, W; Bianchi, RM; Bianco, M; Biebe, O; Bieniek, SP; Bierwagen, K; Biesiada, J; Biglietti, M; Bilokon, H; Bindi, M; Binet, S; Bingul, A; Bini, C; Biscarat, C; Bittner, B; Black, KM; Blair, RE; Blanchard, JB; Blanchot, G; Blazek, T; Bloch, I; Blocker, C; Blocki, J; Blondel, A; Blum, W; Blumenschein, U; Bobbink, GJ; Bobrovnikov, VB; Bocchetta, SS; Bocci, A; Boddy, CR; Boehler, M; Boek, J; Boelaert, N; Bogaerts, JA; Bogdanchikov, A; Bogouch, A; Bohm, C; Bohm, J; Boisvert, V; Bold, T; Boldea, V; Bolnet, NM; Bomben, M; Bona, M; Boonekamp, M; Bordoni, S; Borer, C; Borisov, A; Borissov, G; Borjanovic, I; Borri, M; Borroni, S; Bortolotto, V; Bos, K; Boscherini, D; Bosman, M; Boterenbrood, H; Bouchami, J; Boudreau, J; Bouhova-Thacker, EV; Boumediene, D; Bourdarios, C; Bousson, N; Boveia, A; Boyd, J; Boyko, IR; Bozovic-Jelisavcic, I; Bracinik, J; Branchini, P; Brandenburg, GW; Brandt, A; Brandt, G; Brandt, O; Bratzler, U; Brau, B; Brau, JE; Braun, HM; Brazzale, SF; Brelier, B; Bremer, J; Brendlinger, K; Brenner, R; Bressler, S; Britton, D; Brochu, FM; Brock, I; Brock, R; Broggi, F; Bromberg, C; Bronner, J; Brooijmans, G; Brooks, T; Brooks, WK; Brown, G; Brown, H; de Renstrom, PAB; Bruncko, D; Bruneliere, R; Brunet, S; Bruni, A; Bruni, G; Bruschi, M; Buanes, T; Buat, Q; Bucci, F; Buchanan, J; Buchholz, P; Buckingham, RM; Buckley, AG; Buda, SI; Budagov, IA; Budick, B; Buscher, V; Bugge, L; Bulekov, O; Bundock, AC; Bunse, M; Buran, T; Burckhart, H; Burdin, S; Burgess, T; Burke, S; Busato, E; Bussey, P; Buszello, CP; Butler, B; Butler, JM; Buttar, CM; Butterworth, JM; Buttinger, W; Urban, SC; Caforio, D; Cakir, O; Calafiura, P; Calderini, G; Calfayan, P; Calkins, R; Caloba, LP; Caloi, R; Calvet, D; Calvet, S; Toro, RC; Camarri, P; Cameron, D; Caminada, LM; Armadans, RC; Campana, S; Campanelli, M; Canale, V; Canelli, F; Canepa, A; Cantero, J; Cantrill, R; Capasso, L; Garrido, MDMC; Caprini, I; Caprini, M; Capriotti, D; Capua, M; Caputo, R; Cardarelli, R; Carli, T; Carlino, G; Carminati, L; Caron, B; Caron, S; Carquin, E; Carrillo-Montoya, GD; Carter, AA; Carter, JR; Carvalho, J; Casadei, D; Casado, MP; Cascella, M; Caso, C; Hernandez, AMC; Castaneda-Miranda, E; Gimenez, CV; Castro, NF; Cataldi, G; Catastini, P; Catinaccio, A; Catmore, JR; Cattai, A; Cattani, G; Caughron, S; Cavaliere, V; Cavalleri, P; Cavalli, D; Cavalli-Sforza, M; Cavasinni, V; Ceradini, F; Cerqueira, AS; Cerri, A; Cerrito, L; Cerutti, F; Cetin, SA; Chafaq, A; Chakraborty, D; Chalupkova, I; Chan, K; Chang, P; Chapleau, B; Chapman, JD; Chapman, JW; Chareyre, E; Charlton, DG; Chavda, V; Barajas, CAC; Cheatham, S; Chekanov, S; Chekulaev, SV; Chelkov, GA; Chelstowska, MA; Chen, C; Chen, H; Chen, S; Chen, X; Chen, Y; Cheng, Y; Cheplakov, A; El Moursli, RC; Chernyatin, V; Cheu, E; Cheung, SL; Chevalier, L; Chiefari, G; Chikovani, L; Childers, JT; Chilingarov, A; Chiodini, G; Chisholm, AS; Chislett, RT; Chitan, A; Chizhov, MV; Choudalakis, G; Chouridou, S; Christidi, IA; Christov, A; Chromek-Burckhart, D; Chu, ML; Chudoba, J; Ciapetti, G; Ciftci, AK; Ciftci, R; Cinca, D; Cindro, V; Ciocca, C; Ciocio, A; Cirilli, M; Cirkovic, P; Citron, ZH; Citterio, M; Ciubancan, M; Clark, A; Clark, PJ; Clarke, RN; Cleland, W; Clemens, JC; Clement, B; Clement, C; Coadou, Y; Cobal, M; Coccaro, A; Cochran, J; Coffey, L; Cogan, JG; Coggeshall, J; Cogneras, E; Colas, J; Cole, S; Colijn, AP; Collins, NJ; Collins-Tooth, C; Collot, J; Colombo, T; Colon, G; Compostella, G; Muino, PC; Coniavitis, E; Conidi, MC; Consonni, SM; Consorti, V; Constantinescu, S; Conta, C; Conti, G; Conventi, F; Cooke, M; Cooper, BD; Cooper-Sarkar, AM; Cooper-Smith, NJ; Copic, K; Cornelissen, T; Corradi, M; Corriveau, F; Cortes-Gonzalez, A; Cortiana, G; Costa, G; Costa, MJ; Costanzo, D; Cote, D; Courneyea, L; Cowan, G; Cowden, C; Cox, BE; Cranmer, K; Crescioli, F; Cristinziani, M; Crosetti, G; Crepe-Renaudin, S; Cuciuc, CM; Almenar, CC; Donszelmann, TC; Curatolo, M; Curtis, CJ; Cuthbert, C; Cwetanski, P; Czirr, H; Czodrowski, P; Czyczula, Z; D'Auria, S; D'Onofrio, M; D'Orazio, A; De Sousa, MJDS; Da Via, C; Dabrowski, W; Dafinca, A; Dai, T; Dallapiccola, C; Dam, M; Dameri, M; Damiani, DS; Danielsson, HO; Dao, V; Darbo, G; Darlea, GL; Dassoulas, JA; Davey, W; Davidek, T; Davidson, N; Davidson, R; Davies, E; Davies, M; Davignon, O; Davison, AR; Davygora, Y; Dawe, E; Dawson, I; Daya-Ishmukhametova, RK; De, K; de Asmundis, R; De Castro, S; De Cecco, S; de Graat, J; De Groot, N; de Jong, P; De La Taille, C; De la Torre, H; De Lorenzi, F; de Mora, L; De Nooij, L; De Pedis, D; De Salvo, A; De Sanctis, U; De Santo, A; De Regie, JBD; De Zorzi, G; Dearnaley, WJ; Debbe, R; Debenedetti, C; Dechenaux, B; Dedovich, DV; Degenhardt, J; Del Papa, C; Del Peso, J; Del Prete, T; Delemontex, T; Deliyergiyev, M; Dell'Acqua, A; Dell'Asta, L; Della Pietra, M; della Volpe, D; Delmastro, M; Delpierre, P; Delsart, PA; Deluca, C; Demers, S; Demichev, M; Demirkoz, B; Deng, J; Denisov, SP; Derendarz, D; Derkaoui, JE; Derue, F; Dervan, P; Desch, K; Devetak, E; Deviveiros, PO; Dewhurst, A; DeWilde, B; Dhaliwal, S; Dhullipud, R; Di Ciaccio, A; Di Ciaccio, L; Di Donato, C; Di Girolamo, A; Di Girolamo, B; Di Luise, S; Di Mattia, A; Di Micco, B; Di Nardo, R; Di Simone, A; Di Sipio, R; Diaz, MA; Diehl, EB; Dietrich, J; Dietzsch, TA; Diglio, S; Yagci, KD; Dingfelder, J; Dinut, F; Dionisi, C; Dita, P; Dita, S; Dittus, F; Djama, F; Djobava, T; do Vale, MAB; Wemans, AD; Doan, TKO; Dobbs, M; Dobinson, R; Dobos, D; Dobson, E; Dodd, J; Doglioni, C; Doherty, T; Doi, Y; Dolejsi, J; Dolenc, I; Dolezal, Z; Dolgoshein, BA; Dohmae, T; Donadelli, M; Donini, J; Dopke, J; Doria, A; Dos Anjos, A; Dotti, A; Dova, MT; Dowell, JD; Doxiadis, AD; Doyle, AT; Dressnandt, N; Dris, M; Dubbert, J; Dube, S; Duchovni, E; Duckeck, G; Duda, D; Dudarev, A; Dudziak, F; Duhrssen, M; Duerdoth, IP; Duflot, L; Dufour, MA; Duguid, L; Dunford, M; Yildiz, HD; Duxfield, R; Dwuznik, M; Dydak, F; Duren, M; Ebenstein, WL; Ebke, J; Eckweiler, S; Edmonds, K; Edson, W; Edwards, CA; Edwards, NC; Ehrenfeld, W; Eifert, T; Eigen, G; Einsweiler, K; Eisenhandler, E; Ekelof, T; El Kacimi, M; Ellert, M; Elles, S; Ellinghaus, F; Ellis, K; Ellis, N; Elmsheuser, J; Elsing, M; Emeliyanov, D; Engelmann, R; Engl, R; Epp, B; Erdmann, J; Ereditato, A; Eriksson, D; Ernst, J; Ernst, M; Ernwein, J; Errede, D; Errede, S; Ertel, E; Escalier, M; Esch, H; Escobar, C; Curull, XE; Esposito, B; Etienne, F; Etienvre, AI; Etzion, E; Evangelakou, D; Evans, H; Fabbri, L; Fabre, C; Fakhrutdinov, RM; Falciano, S; Fang, Y; Fanti, M; Farbin, A; Farilla, A; Farley, J; Farooque, T; Farrell, S; Farrington, SM; Farthouat, P; Fassi, F; Fassnacht, P; Fassouliotis, D; Fatholahzadeh, B; Favareto, A; Fayard, L; Fazio, S; Febbraro, R; Federic, P; Fedin, OL; Fedorko, W; Fehling-Kaschek, M; Feligioni, L; Fellmann, D; Feng, C; Feng, EJ; Fenyuk, AB; Ferencei, J; Fernando, W; Ferrag, S; Ferrando, J; Ferrara, V; Ferrari, A; Ferrari, P; Ferrari, R; de Lima, DEF; Ferrer, A; Ferrere, D; Ferretti, C; Parodi, AF; Fiascaris, M; Fiedler, F; Filipcic, A; Filthaut, F; Fincke-Keeler, M; Fiolhais, MCN; Fiorini, L; Firan, A; Fischer, G; Fisher, MJ; Flechl, M; Fleck, I; Fleckner, J; Fleischmann, P; Fleischmann, S; Flick, T; Floderus, A; Castillo, LRC; Flowerdew, MJ; Martin, TF; Formica, A; Forti, A; Fortin, D; Fournier, D; Fowler, AJ; Fox, H; Francavilla, P; Franchini, M; Franchino, S; Francis, D; Frank, T; Franklin, M; Franz, S; Fraternali, M; Fratina, S; French, ST; Friedrich, C; Friedrich, F; Froeschl, R; Froidevaux, D; Frost, JA; Fukunaga, C; Torregrosa, EF; Fulsom, BG; Fuster, J; Gabaldon, C; Gabizon, O; Gadatsch, S; Gadfort, T; Gadomski, S; Gagliardi, G; Gagnon, P; Galea, C; Galhardo, B; Gallas, EJ; Gallo, V; Gallop, BJ; Gallus, P; Gan, KK; Gao, YS; Gaponenko, A; Garberson, F; Garcia-Sciveres, M; Garcia, C; Navarro, JEG; Gardner, RW; Garelli, N; Garitaonandia, H; Garonne, V; Gatti, C; Gaudio, G; Gaur, B; Gauthier, L; Gauzzi, P; Gavrilenko, IL; Gay, C; Gaycken, G; Gazis, EN; Ge, P; Gecse, Z; Gee, CNP; Geerts, DAA; Geich-Gimbel, C; Gellerstedt, K; Gemme, C; Gemmell, A; Genest, MH; Gentile, S; George, M; George, S; Gerlach, P; Gershon, A; Geweniger, C; Ghazlane, H; Ghodbane, N; Giacobbe, B; Giagu, S; Giakoumopoulou, V; Giangiobbe, V; Gianotti, F; Gibbard, B; Gibson, A; Gibson, SM; Gilchriese, M; Gildemeister, O; Gillberg, D; Gillman, AR; Gingrich, DM; Ginzburg, J; Giokaris, N; Giordani, MP; Giordano, R; Giorgi, FM; Giovannini, P; Giraud, PF; Giugn, D; Giunta, M; Giusti, P; Gjelsten, BK; Gladilin, LK; Glasman, C; Glatzer, J; Glazov, A; Glitza, KW; Glonti, GL; Goddard, JR; Godfrey, J; Godlewski, J; Goebel, M; Gopfert, T; Goeringer, C; Gossling, C; Goldfarb, S; Golling, T; Gomes, A; Fajardo, LSG; Goncalo, R; Da Costa, JGPF; Gonella, L; de la Hoz, SG; Parra, GG; Silva, MLG; Gonzalez-Sevilla, S; Goodson, JJ; Goossens, L; Gorbounov, PA; Gordon, HA; Gorelov, I; Gorfine, G; Gorini, B; Gorini, E; Gorisek, E; Gornicki, E; Gosdzik, B; Goshaw, AT; Gosselink, M; Gostkin, MI; Eschrich, IG; Gouighri, M; Goujdami, D; Goulette, MP; Goussiou, AG; Goy, C; Gozpinar, S; Grabowska-Bold, I; Grafstrom, P; Grahn, KJ; Gramstad, E; Grancagnolo, F; Grancagnolo, S; Grassi, V; Gratchev, V; Grau, N; Gray, HM; Gray, JA; Graziani, E; Grebenyuk, OG; Greenshaw, T; Greenwood, ZD; Gregersen, K; Gregor, IM; Grenier, P; Griffiths, J; Grigalashvili, N; Grillo, AA; Grinstein, S; Gris, P; Grishkevich, YV; Grivaz, JF; Gross, E; Grosse-Knetter, J; Groth-Jensen, J; Grybel, K; Guest, D; Guicheney, C; Guillemin, T; Guindon, S; Gul, U; Gunther, J; Guo, B; Guo, J; Gutierrez, P; Guttman, N; Gutzwiller, O; Guyot, C; Gwenlan, C; Gwilliam, CB; Haas, A; Haas, S; Haber, C; Hadavand, HK; Hadley, DR; Haefner, P; Hahn, F; Haider, S; Hajduk, Z; Hakobyan, H; Hall, D; Haller, J; Hamacher, K; Hamal, P; Hamano, K; Hamer, M; Hamilton, A; Hamilton, S; Han, L; Hanagaki, K; Hanawa, K; Hance, M; Handel, C; Hanke, P; Hansen, JR; Hansen, JB; Hansen, JD; Hansen, PH; Hansson, P; Hara, K; Hard, AS; Hare, GA; Harenberg, T; Harkusha, S; Harper, D; Harrington, RD; Harris, OM; Hartert, J; Hartjes, F; Haruyama, T; Harvey, A; Hasegawa, S; Hasegawa, Y; Hassani, S; Haug, S; Hauschild, M; Hauser, R; Havranek, M; Hawkes, CM; Hawkings, RJ; Hawkins, AD; Hayakawa, T; Hayashi, T; Hayden, D; Hays, CP; Hayward, HS; Haywood, SJ; Head, SJ; Hedberg, V; Heelan, L; Heim, S; Heinemann, B; Heisterkamp, S; Helary, L; Heller, C; Heller, M; Hellman, S; Hellmich, D; Helsens, C; Henderson, RCW; Henke, M; Henrichs, A; Correia, AMH; Henrot-Versille, S; Hensel, C; Henss, T; Hernandez, CM; Jimenez, CM; Jimenez, YH; Herrberg, R; Herten, G; Hertenberger, R; Hervas, L; Hesketh, GG; Hessey, NP; Higon-Rodriguez, E; Hill, JC; Hiller, KH; Hillert, S; Hillier, SJ; Hinchliffe, I; Hines, E; Hirose, M; Hirsch, F; Hirschbuehl, D; Hobbs, J; Hod, N; Hodgkinson, MC; Hodgson, P; Hoecker, A; Hoeferkamp, MR; Hoffman, J; Hoffmann, D; Hohlfeld, M; Holder, M; Holmgren, SO; Holy, T; Holzbauer, JL; Hong, TM; van Huysduynen, LH; Horner, S; Hostachy, JY; Hou, S; Hoummada, A; Howard, J; Howarth, J; Hristova, I; Hrivnac, J; Hryn'ova, T; Hsu, PJ; Hsu, SC; Hu, D; Hubacek, Z; Hubaut, F; Huegging, F; Huettmann, A; Huffman, TB; Hughes, EW; Hughes, G; Huhtinen, M; Hurwitz, M; Huseynov, N; Huston, J; Huth, J; Iacobucci, G; Iakovidis, G; Ibbotson, M; Ibragimov, I; Iconomidou-Fayard, L; Idarraga, J; Iengo, P; Igonkina, O; Ikegami, Y; Ikeno, M; Iliadis, D; Ilic, N; Ince, T; Inigo-Golfin, J; Ioannou, P; Iodice, M; Iordanidou, K; Ippolito, V; Quiles, AI; Isaksson, C; Ishino, M; Ishitsuka, M; Ishmukhametov, R; Issever, C; Istin, S; Ivashin, AV; Iwanski, W; Iwasaki, H; Izen, JM; Izzo, V; Jackson, B; Jackson, JN; Jackson, P; Jaekel, MR; Jain, V; Jakobs, K; Jakobsen, S; Jakoubek, T; Jakubek, J; Jamin, DO; Jana, DK; Jansen, E; Jansen, H; Jantsch, A; Janus, M; Jarlskog, G; Jeanty, L; Plante, IJ; Jennens, D; Jenni, P; Loevschall-Jensen, AE; Jez, P; Jezequel, S; Jha, MK; Ji, H; Ji, W; Jia, J; Jiang, Y; Belenguer, MJ; Jin, S; Jinnouchi, O; Joergensen, MD; Joffe, D; Johansen, M; Johansson, KE; Johansson, P; Johnert, S; Johns, KA; Jon-And, K; Jones, G; Jones, RWL; Jones, TJ; Joram, C; Jorge, PM; Joshi, KD; Jovicevic, J; Jovin, T; Ju, X; Jung, CA; Jungst, RM; Juranek, V; Jussel, P; Rozas, AJ; Kabana, S; Kaci, M; Kaczmarska, A; Kadlecik, P; Kado, M; Kagan, H; Kagan, M; Kajomovitz, E; Kalinin, S; Kalinovskaya, LV; Kama, S; Kanaya, N; Kaneda, M; Kaneti, S; Kanno, T; Kantserov, VA; Kanzaki, J; Kaplan, B; Kapliy, A; Kaplon, J; Kar, D; Karagounis, M; Karakostas, K; Karnevskiy, M; Kartvelishvili, V; Karyukhin, AN; Kashif, L; Kasieczka, G; Kass, RD; Kastanas, A; Kataoka, M; Kataoka, Y; Katsoufis, E; Katzy, J; Kaushik, V; Kawagoe, K; Kawamoto, T; Kawamura, G; Kay, MS; Kazama, S; Kazanin, VA; Kazarinov, MY; Keeler, R; Keener, PT; Kehoe, R; Keil, M; Kekelidze, GD; Keller, JS; Kenyon, M; Kepka, O; Kerschen, N; Kersevan, BP; Kersten, S; Kessoku, K; Keung, J; Khalil-zada, F; Khandanyan, H; Khanov, A; Kharchenko, D; Khodinov, A; Khomich, A; Khoo, TJ; Khoriauli, G; Khoroshilov, A; Khovanskiy, V; Khramov, E; Khubua, J; Kim, H; Kim, SH; Kimura, N; Kind, O; King, BT; King, M; King, RSB; Kirk, J; Kiryunin, AE; Kishimoto, T; Kisielewska, D; Kitamura, T; Kittelmann, T; Kiuchi, K; Kladiva, E; Klein, M; Klein, U; Kleinknecht, K; Klemetti, M; Klier, A; Klimek, P; Klimentov, A; Klingenberg, R; Klinger, JA; Klinkby, EB; Klioutchnikova, T; Klok, PF; Klous, S; Kluge, EE; Kluge, T; Kluit, P; Kluth, S; Kneringer, E; Knoops, EBFG; Knue, A; Ko, BR; Kobayashi, T; Kobel, M; Kocian, M; Kodys, P; Koneke, K; Koning, AC; Koenig, S; Kopke, L; Koetsveld, F; Koevesarki, P; Koffas, T; Koffeman, E; Kogan, LA; Kohlmann, S; Kohn, F; Kohout, Z; Kohriki, T; Koi, T; Kolachev, GM; Kolanoski, H; Kolesnikov, V; Koletsou, I; Koll, J; Komar, AA; Komori, Y; Kondo, T; Kono, T; Kononov, AI; Konoplich, R; Konstantinidis, N; Kopeliansky, R; Koperny, S; Korcyl, K; Kordas, K; Korn, A; Korol, A; Korolkov, I; Korolkova, EV; Korotkov, VA; Kortner, O; Kortner, S; Kostyukhin, VV; Kotov, S; Kotov, VM; Kotwal, A; Kourkoumelis, C; Kouskoura, V; Koutsman, A; Kowalewski, R; Kowalski, TZ; Kozanecki, W; Kozhin, AS; Kral, V; Kramarenko, VA; Kramberger, G; Krasny, MW; Krasznahorkay, A; Kraus, JK; Kreiss, S; Krejci, F; Kretzschmar, J; Krieger, N; Krieger, P; Kroeninger, K; Kroha, H; Kroll, J; Kroseberg, J; Krstic, J; Kruchonak, U; Kruger, H; Kruker, T; Krumnack, N; Krumshteyn, ZV; Kruse, A; Kubota, T; Kuday, S; Kuehn, S; Kugel, A; Kuhl, T; Kuhn, D; Kukhtin, V; Kulchitsky, Y; Kuleshov, S; Kummer, C; Kuna, M; Kunkle, J; Kupco, A; Kurashige, H; Kurata, M; Kurochkin, YA; Kus, V; Kuwertz, ES; Kuze, M; Kvita, J; Kwee, R; La Rosa, A; La Rotonda, L; Labarga, L; Labbe, J; Lablak, S; Lacasta, C; Lacava, F; Lacey, J; Lacker, H; Lacour, D; Lacuesta, VR; Ladygin, E; Lafaye, R; Laforge, B; Lagouri, T; Lai, S; Laisne, E; Lamanna, M; Lambourne, L; Lampen, CL; Lampl, W; Lancon, E; Landgraf, U; Landon, MPJ; Lang, VS; Lange, C; Lankford, AJ; Lanni, F; Lantzsch, K; Laplace, S; Lapoire, C; Laporte, JF; Lari, T; Larner, A; Lassnig, M; Laurelli, P; Lavorini, V; Lavrijsen, W; Laycock, P; Lazovich, T; Le Dortz, O; Le Guirriec, E; Le Menedeu, E; LeCompte, T; Ledroit-Guillon, F; Lee, H; Lee, JSH; Lee, SC; Lee, L; Lefebvre, M; Legendre, M; Legger, F; Leggett, C; Lehmacher, M; Miotto, GL; Lei, X; Leite, MAL; Leitner, R; Lellouch, D; Lemmer, B; Lendermann, V; Leney, KJC; Lenz, T; Lenzen, G; Lenzi, B; Leonhardt, K; Leontsinis, S; Lepold, F; Leroy, C; Lessard, JR; Lester, CG; Lester, CM; Leveque, J; Levin, D; Levinson, LJ; Lewis, A; Lewis, GH; Leyko, AM; Leyton, M; Li, B; Li, H; Li, HL; Li, S; Li, X; Liang, Z; Liao, H; Liberti, B; Lichard, P; Lichtnecker, M; Lie, K; Liebig, W; Limbach, C; Limosani, A; Limper, M; Lin, SC; Linde, F; Linnemann, JT; Lipeles, E; Lipniacka, A; Liss, TM; Lissauer, D; Lister, A; Litke, AM; Liu, C; Liu, D; Liu, H; Liu, JB; Liu, K; Liu, L; Liu, M; Liu, Y; Livan, M; Livermore, SSA; Lleres, A; Merino, JL; Lloyd, SL; Lobodzinska, E; Loch, P; Lockman, WS; Loddenkoetter, T; Loebinger, FK; Loginov, A; Loh, CW; Lohse, T; Lohwasser, K; Lokajicek, M; Lombardo, VP; Long, JD; Long, RE; Lopes, L; Mateos, DL; Lorenz, J; Martinez, NL; Losada, M; Loscutoff, P; Lo Sterzo, F; Losty, MJ; Lou, X; Lounis, A; Loureiro, KF; Love, J; Love, PA; Lowe, AJ; Lu, F; Lubatti, HJ; Luci, C; Lucotte, A; Ludwig, A; Ludwig, D; Ludwig, I; Ludwig, J; Luehring, F; Luijckx, G; Lukas, W; Luminari, L; Lund, E; Lund-Jensen, B; Lundberg, B; Lundberg, J; Lundberg, O; Lundquist, J; Lungwitz, M; Lynn, D; Lytken, E; Ma, H; Ma, LL; Maccarrone, G; Macchiolo, A; Macek, B; Miguens, JM; Mackeprang, R; Madaras, RJ; Maddocks, HJ; Mader, WF; Maenner, R; Maeno, T; Mattig, P; Mattig, S; Magnoni, L; Magradze, E; Mahboubi, K; Mahlstedt, J; Mahmoud, S; Mahout, G; Maiani, C; Maidantchik, C; Maio, A; Majewski, S; Makida, Y; Makovec, N; Mal, P; Malaescu, B; Malecki, P; Malecki, P; Maleev, VP; Malek, F; Mallik, U; Malon, D; Malone, C; Maltezos, S; Malyshev, V; Malyukov, S; Mameghani, R; Mamuzic, J; Manabe, A; Mandelli, L; Mandic, I; Mandrysch, R; Maneira, J; Manfredini, A; Mangeard, PS; de Andrade, LM; Ramos, JAM; Mann, A; Manning, PM; Manousakis-Katsikakis, A; Mansoulie, B; Mapelli, A; Mapelli, L; March, L; Marchand, JF; Marchese, F; Marchiori, G; Marcisovsky, M; Marino, CP; Marroquim, F; Marshall, Z; Martens, FK; Marti, LF; Marti-Garcia, S; Martin, B; Martin, B; Martin, JP; Martin, TA; Martin, VJ; dit Latour, BM; Martin-Haugh, S; Martinez, M; Outschoorn, VM; Martyniuk, AC; Marx, M; Marzano, F; Marzin, A; Masetti, L; Mashimo, T; Mashinistov, R; Masik, J; Maslennikov, AL; Massa, I; Massaro, G; Massol, N; Mastrandrea, P; Mastroberardino, A; Masubuchi, T; Matricon, P; Matsunaga, H; Matsushita, T; Mattravers, C; Maurer, J; Maxfield, SJ; Mayne, A; Mazini, R; Mazur, M; Mazzaferro, L; Mazzanti, M; Mc Donald, J; Mc Kee, SP; McCarn, A; McCarthy, RL; McCarthy, TG; McCubbin, NA; McFarlane, KW; Mcfayden, JA; Mchedlidze, G; Mclaughlan, T; McMahon, SJ; McPherson, RA; Meade, A; Mechnich, J; Mechtel, M; Medinnis, M; Meera-Lebbai, R; Meguro, T; Mehdiyev, R; Mehlhase, S; Mehta, A; Meier, K; Meirose, B; Melachrinos, C; Garcia, BRM; Meloni, F; Navas, LM; Meng, Z; Mengarelli, A; Menke, S; Meoni, E; Mercurio, KM; Mermod, P; Merola, L; Meroni, C; Merritt, FS; Merritt, H; Messina, A; Metcalfe, J; Mete, AS; Meyer, C; Meyer, C; Meyer, JP; Meyer, J; Meyer, J; Meyer, TC; Michal, S; Micu, L; Middleton, RP; Migas, S; Mijovic, L; Mikenberg, G; Mikestikova, M; Mikuz, M; Miller, DW; Miller, RJ; Mills, WJ; Mills, C; Milov, A; Milstead, DA; Milstein, D; Minaenko, AA; Moya, MM; Minashvili, IA; Mincer, AI; Mindur, B; Mineev, M; Ming, Y; Mir, LM; Mirabelli, G; Mitrevski, J; Mitsou, VA; Mitsui, S; Miyagawa, PS; Mjornmark, JU; Moa, T; Moeller, V; Monig, K; Moser, N; Mohapatra, S; Mohr, W; Moles-Valls, R; Molfetas, A; Monk, J; Monnier, E; Berlingen, JM; Monticelli, F; Monzani, S; Moore, RW; Moorhead, GF; Herrera, CM; Moraes, A; Morange, N; Morel, J; Morello, G; Moreno, D; Llacer, MM; Morettini, P; Morgenstern, M; Morii, M; Morley, AK; Mornacchi, G; Morris, JD; Morvaj, L; Moser, HG; Mosidze, M; Moss, J; Mount, R; Mountricha, E; Mouraviev, SV; Moyse, EJW; Mueller, F; Mueller, J; Mueller, K; Muller, TA; Mueller, T; Muenstermann, D; Munwes, Y; Murray, WJ; Mussche, I; Musto, E; Myagkov, AG; Myska, M; Nackenhorst, O; Nadal, J; Nagai, K; Nagai, R; Nagano, K; Nagarkar, A; Nagasaka, Y; Nagel, M; Nairz, AM; Nakahama, Y; Nakamura, K; Nakamura, T; Nakano, I; Nanava, G; Napier, A; Narayan, R; Nash, M; Nattermann, T; Naumann, T; Navarro, G; Neal, HA; Nechaeva, PY; Neep, TJ; Negri, A; Negri, G; Negrini, M; Nektarijevic, S; Nelson, A; Nelson, TK; Nemecek, S; Nemethy, P; Nepomuceno, AA; Nessi, M; Neubauer, MS; Neumann, M; Neusiedl, A; Neves, RM; Nevski, P; Newcomer, FM; Newman, PR; Hong, VNT; Nickerson, RB; Nicolaidou, R; Nicquevert, B; Niedercorn, F; Nielsen, J; Nikiforou, N; Nikiforov, A; Nikolaenko, V; Nikolic-Audit, I; Nikolics, K; Nikolopoulos, K; Nilsen, H; Nilsson, P; Ninomiya, Y; Nisati, A; Nisius, R; Nobe, T; Nodulman, L; Nomachi, M; Nomidis, I; Norberg, S; Nordberg, M; Norton, PR; Novakova, J; Nozaki, M; Nozka, L; Nugent, IM; Nuncio-Quiroz, AE; Hanninger, GN; Nunnemann, T; Nurse, E; O'Brien, BJ; O'Neil, DC; O'Shea, V; Oakes, LB; Oakham, FG; Oberlack, H; Ocariz, J; Ochi, A; Oda, S; Odaka, S; Odier, J; Ogren, H; Oh, A; Oh, SH; Ohm, CC; Ohshima, T; Okamura, W; Okawa, H; Okumura, Y; Okuyama, T; Olariu, A; Olchevski, AG; Pino, SAO; Oliveira, M; Damazio, DO; Garcia, EO; Olivito, D; Olszewski, A; Olszowska, J; Onofre, A; Onyisi, PUE; Oram, CJ; Oreglia, MJ; Oren, Y; Orestano, D; Orlando, N; Orlov, I; Barrera, CO; Orr, RS; Osculati, B; Ospanov, R; Osuna, C; Garzon, GOY; Ottersbach, JP; Ouchrif, M; Ouellette, EA; Ould-Saada, F; Ouraou, A; Ouyang, Q; Ovcharova, A; Owen, M; Owen, S; Ozcan, VE; Ozturk, N; Pages, AP; Aranda, CP; Griso, SP; Paganis, E; Pahl, C; Paige, F; Pais, P; Pajchel, K; Palacino, G; Paleari, CP; Palestini, S; Pallin, D; Palma, A; Palmer, JD; Pan, YB; Panagiotopoulou, E; Vazquez, JGP; Pani, P; Panikashvili, N; Panitkin, S; Pantea, D; Papadelis, A; Papadopoulou, TD; Paramonov, A; Hernandez, DP; Park, W; Parker, MA; Parodi, F; Parsons, JA; Parzefall, U; Pashapour, S; Pasqualucci, E; Passaggio, S; Passeri, A; Pastore, F; Pastore, F; Pasztor, G; Pataraia, S; Patel, N; Pater, JR; Patricelli, S; Pauly, T; Pecsy, M; Lopez, SP; Morales, MIP; Peleganchuk, SV; Pelikan, D; Peng, H; Penning, B; Penson, A; Penwell, J; Perantoni, M; Perez, K; Cavalcanti, TP; Codina, EP; Garcia-Estan, MTP; Reale, VP; Perini, L; Pernegger, H; Perrino, R; Perrodo, P; Peshekhonov, VD; Peters, K; Petersen, BA; Petersen, J; Petersen, TC; Petit, E; Petridis, A; Petridou, C; Petrolo, E; Petrucci, F; Petschull, D; Petteni, M; Pezoa, R; Phan, A; Phillips, PW; Piacquadio, G; Picazio, A; Piccaro, E; Piccinini, M; Piec, SM; Piegaia, R; Pignotti, DT; Pilcher, JE; Pilkington, AD; Pina, J; Pinamonti, M; Pinder, A; Pinfold, JL; Pinto, B; Pizio, C; Plamondon, M; Pleier, MA; Plotnikova, E; Poblaguev, A; Poddar, S; Podlyski, F; Poggioli, L; Pohl, D; Pohl, M; Polesello, G; Policicchio, A; Polifka, R; Polini, A; Poll, J; Polychronakos, V; Pomeroy, D; Pommes, K; Pontecorvo, L; Pope, BG; Popeneciu, GA; Popovic, DS; Poppleton, A; Bueso, XP; Pospelov, GE; Pospisil, S; Potrap, IN; Potter, CJ; Potter, CT; Poulard, G; Poveda, J; Pozdnyakov, V; Prabhu, R; Pralavorio, P; Pranko, A; Prasad, S; Pravahan, R; Prell, S; Pretzl, K; Price, D; Price, J; Price, LE; Prieur, D; Primavera, M; Prokofiev, K; Prokoshin, F; Protopopescu, S; Proudfoot, J; Prudent, X; Przybycien, M; Przysiezniak, H; Psoroulas, S; Ptacek, E; Pueschel, E; Purdham, J; Purohit, M; Puzo, P; Pylypchenko, Y; Qian, J; Quadt, A; Quarrie, DR; Quayle, WB; Quinonez, F; Raas, M; Raddum, S; Radeka, V; Radescu, V; Radloff, P; Rador, T; Ragusa, F; Rahal, G; Rahimi, AM; Rahm, D; Rajagopalan, S; Rammensee, M; Rammes, M; Randle-Conde, AS; Randrianarivony, K; Rauscher, F; Rave, TC; Raymond, M; Read, AL; Rebuzzi, DM; Redelbach, A; Redlinger, G; Reece, R; Reeves, K; Reinherz-Aronis, E; Reinsch, A; Reisinger, I; Rembser, C; Ren, ZL; Renaud, A; Rescigno, M; Resconi, S; Resende, B; Reznicek, P; Rezvani, R; Richter, R; Richter-Was, E; Ridel, M; Rijpstra, M; Rijssenbeek, M; Rimoldi, A; Rinaldi, L; Rios, RR; Riu, I; Rivoltella, G; Rizatdinova, F; Rizvi, E; Robertson, SH; Robichaud-Veronneau, A; Robinson, D; Robinson, JEM; Robson, A; de Lima, JGR; Roda, C; Dos Santos, DR; Roe, A; Roe, S; Rohne, O; Rolli, S; Romaniouk, A; Romano, M; Romeo, G; Adam, ER; Rompotis, N; Roos, L; Ros, E; Rosati, S; Rosbach, K; Rose, A; Rose, M; Rosenbaum, GA; Rosenberg, EI; Rosendahl, PL; Rosendahl, O; Rosselet, L; Rossetti, V; Rossi, E; Rossi, LP; Rotaru, M; Roth, I; Rothberg, J; Rousseau, D; Royon, CR; Rozanov, A; Rozen, Y; Ruan, X; Rubbo, F; Rubinskiy, I; Ruckstuhl, N; Rud, VI; Rudolph, C; Rudolph, G; Ruhr, F; Ruiz-Martinez, A; Rumyantsev, L; Rurikova, Z; Rusakovich, NA; Rutherfoord, JP; Ruzicka, P; Ryabov, YF; Rybar, M; Rybkin, G; Ryder, NC; Saavedra, AF; Sadeh, I; Sadrozinski, HFW; Sadykov, R; Tehrani, FS; Sakamoto, H; Salamanna, G; Salamon, A; Saleem, M; Salek, D; Salihagic, D; Salnikov, A; Salt, J; Ferrando, BMS; Salvatore, D; Salvatore, F; Salvucci, A; Salzburger, A; Sampsonidis, D; Samset, BH; Sanchez, A; Martinez, VS; Sandaker, H; Sander, HG; Sanders, MP; Sandhoff, M; Sandoval, T; Sandoval, C; Sandstroem, R; Sankey, DPC; Sansoni, A; Rios, CS; Santoni, C; Santonico, R; Santos, H; Saraiva, JG; Sarangi, T; Sarkisyan-Grinbaum, E; Sarri, F; Sartisohn, G; Sasaki, O; Sasaki, Y; Sasao, N; Satsounkevitch, I; Sauvage, G; Sauvan, E; Sauvan, JB; Savard, P; Savinov, V; Savu, DO; Sawyer, L; Saxon, DH; Saxon, J; Sbarra, C; Sbrizzi, A; Scannicchio, DA; Scarcella, M; Schaarschmidt, J; Schacht, P; Schaefer, D; Schafer, U; Schaelicke, A; Schaepe, S; Schaetzel, S; Schaffer, AC; Schaile, D; Schamberger, RD; Schamov, AG; Scharf, V; Schegelsky, VA; Scheirich, D; Schernau, M; Scherzer, MI; Schiavi, C; Schieck, J; Schioppa, M; Schlenker, S; Schmid, P; Schmidt, E; Schmieden, K; Schmitt, C; Schmitt, S; Schmitz, M; Schneider, B; Schnoor, U; Schoeffel, L; Schoening, A; Schorlemmer, ALS; Schott, M; Schouten, D; Schovancova, J; Schram, M; Schroeder, C; Schroer, N; Schultens, MJ; Schultes, J; Schultz-Coulon, HC; Schulz, H; Schumacher, M; Schumm, BA; Schune, P; Schwanenberger, C; Schwartzman, A; Schwegler, P; Schwemling, P; Schwienhorst, R; Schwierz, R; Schwindling, J; Schwindt, T; Schwoerer, M; Sciolla, G; Scott, WG; Searcy, J; Sedov, G; Sedykh, E; Seidel, SC; Seiden, A; Seifert, F; Seixas, JM; Sekhniaidze, G; Sekula, SJ; Selbach, KE; Seliverstov, DM; Sellden, B; Sellers, G; Seman, M; Semprini-Cesari, N; Serfon, C; Serin, L; Serkin, L; Seuster, R; Severini, H; Sfyrla, A; Shabalina, E; Shamim, M; Shan, LY; Shank, JT; Shao, QT; Shapiro, M; Shatalov, PB; Shaw, K; Sherman, D; Sherwood, P; Shimizu, S; Shimojima, M; Shin, T; Shiyakova, M; Shmeleva, A; Shochet, MJ; Short, D; Shrestha, S; Shulga, E; Shupe, MA; Sicho, P; Sidoti, A; Siegert, F; Sijacki, D; Silbert, O; Silva, J; Silver, Y; Silverstein, D; Silverstein, SB; Simak, V; Simard, O; Simic, L; Simion, S; Simioni, E; Simmons, B; Simoniello, R; Simonyan, M; Sinervo, P; Sinev, NB; Sipica, V; Siragusa, G; Sircar, A; Sisakyan, AN; Sivoklokov, SY; Sjolin, J; Sjursen, TB; Skinnari, LA; Skottowe, HP; Skovpen, K; Skubic, P; Slater, M; Slavicek, T; Sliwa, K; Smakhtin, V; Smart, BH; Smestad, L; Smirnov, SY; Smirnov, Y; Smirnova, LN; Smirnova, O; Smith, BC; Smith, D; Smith, KM; Smizanska, M; Smolek, K; Snesarev, AA; Snow, SW; Snow, J; Snyder, S; Sobie, R; Sodomka, J; Soffer, A; Solans, CA; Solar, M; Solc, J; Soldatov, EY; Soldevila, U; Camillocci, ES; Solodkov, AA; Solovyanov, OV; Solovyev, V; Soni, N; Sopko, V; Sopko, B; Sosebee, M; Soualah, R; Soukharev, A; Spagnolo, S; Spano, F; Spearman, WR; Spighi, R; Spigo, G; Spiwoks, R; Spousta, M; Spreitzer, T; Spurlock, B; St Denis, RD; Stahlman, J; Stamen, R; Stanecka, E; Stanek, RW; Stanescu, C; Stanescu-Bellu, M; Stanitzki, MM; Stapnes, S; Starchenko, EA; Stark, J; Staroba, P; Starovoitov, P; Staszewski, R; Staude, A; Stavina, P; Steele, G; Steinbach, P; Steinberg, P; Stekl, I; Stelzer, B; Stelzer, HJ; Stelzer-Chilton, O; Stenzel, H; Stern, S; Stewart, GA; Stillings, JA; Stockton, MC; Stoerig, K; Stoicea, G; Stonjek, S; Strachota, P; Stradling, AR; Straessner, A; Strandberg, J; Strandberg, S; Strandlie, A; Strang, M; Strauss, E; Strauss, M; Strizenec, P; Strohmer, R; Strom, DM; Strong, JA; Stroynowski, R; Stugu, B; Stumer, I; Stupak, J; Sturm, P; Styles, NA; Soh, DA; Su, D; Subramania, HS; Subramaniam, R; Succurro, A; Sugaya, Y; Suhr, C; Suk, M; Sulin, VV; Sultansoy, S; Sumida, T; Sun, X; Sundermann, JE; Suruliz, K; Susinno, G; Sutton, MR; Suzuki, Y; Suzuki, Y; Svatos, M; Swedish, S; Sykora, I; Sykora, T; Sanchez, J; Ta, D; Tackmann, K; Taffard, A; Tafirout, R; Taiblum, N; Takahashi, Y; Takai, H; Takashima, R; Takeda, H; Takeshita, T; Takubo, Y; Talby, M; Talyshev, A; Tamsett, MC; Tan, KG; Tanaka, J; Tanaka, R; Tanaka, S; Tanaka, S; Tanasijczuk, AJ; Tani, K; Tannoury, N; Tapprogge, S; Tardif, D; Tarem, S; Tarrade, F; Tartarelli, GF; Tas, P; Tasevsky, M; Tassi, E; Tatarkhanov, M; Tayalati, Y; Taylor, C; Taylor, FE; Taylor, GN; Taylor, W; Teinturier, M; Teischinger, FA; Castanheira, MTD; Teixeira-Dias, P; Temming, KK; Ten Kate, H; Teng, PK; Terada, S; Terashi, K; Terron, J; Testa, M; Teuscher, RJ; Therhaag, J; Theveneaux-Pelzer, T; Thoma, S; Thomas, JP; Thompson, EN; Thompson, PD; Thompson, PD; Thompson, AS; Thomsen, LA; Thomson, E; Thomson, M; Thong, WM; Thun, RP; Tian, F; Tibbetts, MJ; Tic, T; Tikhomirov, VO; Tikhonov, YA; Timoshenko, S; Tiouchichine, E; Tipton, P; Tisserant, S; Todorov, T; Todorova-Nova, S; Toggerson, B; Tojo, J; Tokar, S; Tokushuku, K; Tollefson, K; Tomoto, M; Tompkins, L; Toms, K; Tonoyan, A; Topfel, C; Topilin, ND; Torchiani, I; Torrence, E; Torres, H; Pastor, ET; Toth, J; Touchard, F; Tovey, DR; Trefzger, T; Tremblet, L; Tricoli, A; Trigger, IM; Trilling, G; Trincaz-Duvoid, S; Tripiana, MF; Triplett, N; Trischuk, W; Trocme, B; Troncon, C; Trottier-McDonald, M; Trzebinski, M; Trzupek, A; Tsarouchas, C; Tseng, JCL; Tsiakiris, M; Tsiareshka, PV; Tsionou, D; Tsipolitis, G; Tsiskaridze, S; Tsiskaridze, V; Tskhadadze, EG; Tsukerman, II; Tsulaia, V; Tsung, JW; Tsuno, S; Tsybychev, D; Tua, A; Tudorache, A; Tudorache, V; Tuggle, JM; Turala, M; Turecek, D; Cakir, IA; Turlay, E; Turra, R; Tuts, PM; Tykhonov, A; Tylmad, M; Tyndel, M; Tzanakos, G; Uchida, K; Ueda, I; Ueno, R; Ugland, M; Uhlenbrock, M; Uhrmacher, M; Ukegawa, F; Unal, G; Undrus, A; Unel, G; Unno, Y; Urbaniec, D; Urquijo, P; Usai, G; Uslenghi, M; Vacavant, L; Vacek, V; Vachon, B; Vahsen, S; Valenta, J; Valentinetti, S; Valero, A; Valkar, S; Gallego, EV; Vallecorsa, S; Ferrer, JAV; Van Berg, R; Van Der Deijl, PC; van der Geer, R; van der Graaf, H; Van Der Leeuw, R; van der Poel, E; van der Ster, D; van Eldik, N; van Gemmeren, P; van Vulpen, I; Vanadia, M; Vandelli, W; Vanguri, R; Vaniachine, A; Vankov, P; Vannucci, F; Vari, R; Varol, T; Varouchas, D; Vartapetian, A; Varvell, KE; Vassilakopoulos, VI; Vazeille, F; Schroeder, TV; Vegni, G; Veillet, JJ; Veloso, F; Veness, R; Veneziano, S; Ventura, A; Ventura, D; Venturi, M; Venturi, N; Vercesi, V; Verducci, M; Verkerke, W; Vermeulen, JC; Vest, A; Vetterli, MC; Vichou, I; Vickey, T; Boeriu, OEV; Viehhauser, GHA; Viel, S; Villa, M; Perez, MV; Vilucchi, E; Vincter, MG; Vinek, E; Vinogradov, VB; Virchaux, M; Virzi, J; Vitells, O; Viti, M; Vivarelli, I; Vaque, FV; Vlachos, S; Vladoiu, D; Vlasak, M; Vogel, A; Vokac, P; Volpi, G; Volpi, M; Volpini, G; von der Schmitt, H; von Radziewski, H; von Toerne, E; Vorobel, V; Vorwerk, V; Vos, M; Voss, R; Voss, TT; Vossebeld, JH; Vranjes, N; Milosavljevic, MV; Vrba, V; Vreeswijk, M; Anh, TV; Vuillermet, R; Vukotic, I; Wagner, W; Wagner, P; Wahlen, H; Wahrmund, S; Wakabayashi, J; Walch, S; Walder, J; Walker, R; Walkowiak, W; Wall, R; Waller, P; Walsh, B; Wang, C; Wang, F; Wang, H; Wang, H; Wang, J; Wang, J; Wang, R; Wang, SM; Wang, T; Warburton, A; Ward, CP; Wardrope, DR; Warsinsky, M; Washbrook, A; Wasicki, C; Watanabe, I; Watkins, PM; Watson, AT; Watson, IJ; Watson, MF; Watts, G; Watts, S; Waugh, AT; Waugh, BM; Weber, MS; Weber, P; Webster, JS; Weidberg, AR; Weigell, P; Weingarten, J; Weiser, C; Wells, PS; Wenaus, T; Wendland, D; Weng, Z; Wengler, T; Wenig, S; Wermes, N; Werner, M; Werner, P; Werth, M; Wessels, M; Wetter, J; Weydert, C; Whalen, K; Wheeler-Ellis, SJ; White, A; White, MJ; White, S; Whitehead, SR; Whiteson, D; Whittington, D; Wicek, F; Wicke, D; Wickens, FJ; Wiedenmann, W; Wielers, M; Wienemann, P; Wiglesworth, C; Wiik-Fuchs, LAM; Wijeratne, PA; Wildauer, A; Wildt, MA; Wilhelm, I; Wilkens, HG; Will, JZ; Williams, E; Williams, HH; Willis, W; Willocq, S; Wilson, JA; Wilson, MG; Wilson, A; Wingerter-Seez, I; Winkelmann, S; Winklmeier, F; Wittgen, M; Wollstadt, SJ; Wolter, MW; Wolters, H; Wong, WC; Wooden, G; Wosiek, BK; Wotschack, J; Woudstra, MJ; Wozniak, KW; Wraight, K; Wright, M; Wrona, B; Wu, SL; Wu, X; Wu, Y; Wulf, E; Wynne, BM; Xella, S; Xiao, M; Xie, S; Xu, C; Xu, D; Yabsley, B; Yacoob, S; Yamada, M; Yamaguchi, H; Yamaguchi, Y; Yamamoto, A; Yamamoto, K; Yamamoto, S; Yamamura, T; Yamanaka, T; Yamazaki, T; Yamazaki, Y; Yan, Z; Yang, H; Yang, H; Yang, UK; Yang, Y; Yang, Z; Yanush, S; Yao, L; Yao, Y; Yasu, Y; Smit, GVY; Ye, J; Ye, S; Yilmaz, M; Yoosoofmiya, R; Yorita, K; Yoshida, R; Yoshihara, K; Young, C; Young, CJ; Youssef, S; Yu, D; Yu, J; Yu, J; Yuan, L; Yurkewicz, A; Byszewski, M; Zabinski, B; Zaidan, R; Zaitsev, AM; Zajacova, Z; Zanello, L; Zanzi, D; Zaytsev, A; Zeitnitz, C; Zeman, M; Zemla, A; Zendler, C; Zenin, O; Zenis, T; Zinonos, Z; Zerwas, D; della Porta, GZ; Zhang, D; Zhang, H; Zhang, J; Zhang, X; Zhang, Z; Zhao, L; Zhao, Z; Zhemchugov, A; Zhong, J; Zhou, B; Zhou, N; Zhou, Y; Zhu, CG; Zhu, H; Zhu, J; Zhu, Y; Zhuang, X; Zhuravlov, V; Zieminska, D; Zimin, NI; Zimmermann, R; Zimmermann, S; Zimmermann, S; Ziolkowski, M; Zitoun, R; Zivkovic, L; Zmouchko, VV; Zobernig, G; Zoccoli, A; zur Nedden, M; Zutshi, V; Zwalinski, L				Aad, G.; Abajyan, T.; Abbott, B.; Abdallah, J.; Khalek, S. Abdel; Abdelalim, A. A.; Abdinov, O.; Aben, R.; Abi, B.; Abolins, M.; AbouZeid, O. S.; Abramowicz, H.; Abreu, H.; Acharya, B. S.; Adamczyk, L.; Adams, D. L.; Addy, T. N.; Adelman, J.; Adomeit, S.; Adragna, P.; Adye, T.; Aefsky, S.; Aguilar-Saavedra, J. A.; Agustoni, M.; Aharrouche, M.; Ahlen, S. P.; Ahles, F.; Ahmad, A.; Ahsan, M.; Aielli, G.; Akdogan, T.; Akesson, T. P. A.; Akimoto, G.; Akimov, A. V.; Alam, M. S.; Alam, M. A.; Albert, J.; Albrand, S.; Aleksa, M.; Aleksandrov, I. N.; Alessandria, F.; Alexa, C.; Alexander, G.; Alexandre, G.; Alexopoulos, T.; Alhroob, M.; Aliev, M.; Alimonti, G.; Alison, J.; Allbrooke, B. M. M.; Allport, P. P.; Allwood-Spiers, S. E.; Almond, J.; Aloisio, A.; Alon, R.; Alonso, A.; Alonso, F.; Altheimer, A.; Gonzalez, B. Alvarez; Alviggi, M. G.; Amako, K.; Amelung, C.; Ammosov, V. V.; Amor Dos Santos, S. P.; Amorim, A.; Amram, N.; Anastopoulos, C.; Ancu, L. S.; Andari, N.; Andeen, T.; Anders, C. F.; Anders, G.; Anderson, K. J.; Andreazza, A.; Andrei, V.; Andrieux, M. -L.; Anduaga, X. S.; Angelidakis, S.; Anger, P.; Angerami, A.; Anghinolfi, F.; Anisenkov, A.; Anjos, N.; Annovi, A.; Antonaki, A.; Antonelli, M.; Antonov, A.; Antos, J.; Anulli, F.; Aoki, M.; Aoun, S.; Bella, L. Aperio; Apolle, R.; Arabidze, G.; Aracena, I.; Arai, Y.; Arce, A. T. H.; Arfaoui, S.; Arguin, J. -F.; Arik, E.; Arik, M.; Armbruster, A. J.; Arnaez, O.; Arnal, V.; Arnault, C.; Artamonov, A.; Artoni, G.; Arutinov, D.; Asai, S.; Ask, S.; Asman, B.; Asquith, L.; Assamagan, K.; Astbury, A.; Atkinson, M.; Aubert, B.; Auge, E.; Augsten, K.; Aurousseau, M.; Avolio, G.; Avramidou, R.; Axen, D.; Azuelos, G.; Azuma, Y.; Baak, M. A.; Baccaglioni, G.; Bacci, C.; Bach, A. M.; Bachacou, H.; Bachas, K.; Backes, M.; Backhaus, M.; Mayes, J. Backus; Badescu, E.; Bagnaia, P.; Bahinipati, S.; Bai, Y.; Bailey, D. C.; Bain, T.; Baines, J. T.; Baker, O. K.; Baker, M. D.; Baker, S.; Balek, P.; Banas, E.; Banerjee, P.; Banerjee, Sw.; Banfi, D.; Bangert, A.; Bansal, V.; Bansil, H. S.; Barak, L.; Baranov, S. P.; Galtieri, A. Barbaro; Barber, T.; Barberio, E. L.; Barberis, D.; Barbero, M.; Bardin, D. Y.; Barillari, T.; Barisonzi, M.; Barklow, T.; Barlow, N.; Barnett, B. M.; Barnett, R. M.; Baroncelli, A.; Barone, G.; Barr, A. J.; Barreiro, F.; da Costa, J. Barreiro Guimaraes; Barrillon, P.; Bartoldus, R.; Barton, A. E.; Bartsch, V.; Basye, A.; Bates, R. L.; Batkova, L.; Batley, J. R.; Battaglia, A.; Battistin, M.; Bauer, F.; Bawa, H. S.; Beale, S.; Beau, T.; Beauchemin, P. H.; Beccherle, R.; Bechtle, P.; Beck, H. P.; Becker, A. K.; Becker, S.; Beckingham, M.; Becks, K. H.; Bedda, A. J.; Bedda, A.; Bedikian, S.; Bednyakov, V. A.; Bee, C. P.; Beemster, L. J.; Bege, M.; Harpaz, S. Behar; Behera, P. K.; Beimforde, M.; Belanger-Champagne, C.; Bell, P. J.; Bell, W. H.; Bella, G.; Bellagamba, L.; Bellomo, M.; Belloni, A.; Beloborodova, O.; Belotskiy, K.; Beltramello, O.; Benary, O.; Benchekroun, D.; Bendtz, K.; Benekos, N.; Benhammou, Y.; Noccioli, E. Benhar; Garcia, J. A. Benitez; Benjamin, D. P.; Benoit, M.; Bensinger, J. R.; Benslama, K.; Bentvelsen, S.; Berge, D.; Kuutmann, E. Bergeaas; Berger, N.; Berghaus, F.; Berglund, E.; Beringer, J.; Bernat, P.; Bernhard, R.; Bernius, C.; Bernlochner, F. U.; Berry, T.; Bertella, C.; Bertin, A.; Bertolucci, F.; Besana, M. I.; Besjes, G. J.; Besson, N.; Bethke, S.; Bhimji, W.; Bianchi, R. M.; Bianco, M.; Biebe, O.; Bieniek, S. P.; Bierwagen, K.; Biesiada, J.; Biglietti, M.; Bilokon, H.; Bindi, M.; Binet, S.; Bingul, A.; Bini, C.; Biscarat, C.; Bittner, B.; Black, K. M.; Blair, R. E.; Blanchard, J. -B.; Blanchot, G.; Blazek, T.; Bloch, I.; Blocker, C.; Blocki, J.; Blondel, A.; Blum, W.; Blumenschein, U.; Bobbink, G. J.; Bobrovnikov, V. B.; Bocchetta, S. S.; Bocci, A.; Boddy, C. R.; Boehler, M.; Boek, J.; Boelaert, N.; Bogaerts, J. A.; Bogdanchikov, A.; Bogouch, A.; Bohm, C.; Bohm, J.; Boisvert, V.; Bold, T.; Boldea, V.; Bolnet, N. M.; Bomben, M.; Bona, M.; Boonekamp, M.; Bordoni, S.; Borer, C.; Borisov, A.; Borissov, G.; Borjanovic, I.; Borri, M.; Borroni, S.; Bortolotto, V.; Bos, K.; Boscherini, D.; Bosman, M.; Boterenbrood, H.; Bouchami, J.; Boudreau, J.; Bouhova-Thacker, E. V.; Boumediene, D.; Bourdarios, C.; Bousson, N.; Boveia, A.; Boyd, J.; Boyko, I. R.; Bozovic-Jelisavcic, I.; Bracinik, J.; Branchini, P.; Brandenburg, G. W.; Brandt, A.; Brandt, G.; Brandt, O.; Bratzler, U.; Brau, B.; Brau, J. E.; Braun, H. M.; Brazzale, S. F.; Brelier, B.; Bremer, J.; Brendlinger, K.; Brenner, R.; Bressler, S.; Britton, D.; Brochu, F. M.; Brock, I.; Brock, R.; Broggi, F.; Bromberg, C.; Bronner, J.; Brooijmans, G.; Brooks, T.; Brooks, W. K.; Brown, G.; Brown, H.; de Renstrom, P. A. Bruckman; Bruncko, D.; Bruneliere, R.; Brunet, S.; Bruni, A.; Bruni, G.; Bruschi, M.; Buanes, T.; Buat, Q.; Bucci, F.; Buchanan, J.; Buchholz, P.; Buckingham, R. M.; Buckley, A. G.; Buda, S. I.; Budagov, I. A.; Budick, B.; Buescher, V.; Bugge, L.; Bulekov, O.; Bundock, A. C.; Bunse, M.; Buran, T.; Burckhart, H.; Burdin, S.; Burgess, T.; Burke, S.; Busato, E.; Bussey, P.; Buszello, C. P.; Butler, B.; Butler, J. M.; Buttar, C. M.; Butterworth, J. M.; Buttinger, W.; Cabrera Urban, S.; Caforio, D.; Cakir, O.; Calafiura, P.; Calderini, G.; Calfayan, P.; Calkins, R.; Caloba, L. P.; Caloi, R.; Calvet, D.; Calvet, S.; Toro, R. Camacho; Camarri, P.; Cameron, D.; Caminada, L. M.; Caminal Armadans, R.; Campana, S.; Campanelli, M.; Canale, V.; Canelli, F.; Canepa, A.; Cantero, J.; Cantrill, R.; Capasso, L.; Garrido, M. D. M. Capeans; Caprini, I.; Caprini, M.; Capriotti, D.; Capua, M.; Caputo, R.; Cardarelli, R.; Carli, T.; Carlino, G.; Carminati, L.; Caron, B.; Caron, S.; Carquin, E.; Carrillo-Montoya, G. D.; Carter, A. A.; Carter, J. R.; Carvalho, J.; Casadei, D.; Casado, M. P.; Cascella, M.; Caso, C.; Hernandez, A. M. Castaneda; Castaneda-Miranda, E.; Castillo Gimenez, V.; Castro, N. F.; Cataldi, G.; Catastini, P.; Catinaccio, A.; Catmore, J. R.; Cattai, A.; Cattani, G.; Caughron, S.; Cavaliere, V.; Cavalleri, P.; Cavalli, D.; Cavalli-Sforza, M.; Cavasinni, V.; Ceradini, F.; Cerqueira, A. S.; Cerri, A.; Cerrito, L.; Cerutti, F.; Cetin, S. A.; Chafaq, A.; Chakraborty, D.; Chalupkova, I.; Chan, K.; Chang, P.; Chapleau, B.; Chapman, J. D.; Chapman, J. W.; Chareyre, E.; Charlton, D. G.; Chavda, V.; Barajas, C. A. Chavez; Cheatham, S.; Chekanov, S.; Chekulaev, S. V.; Chelkov, G. A.; Chelstowska, M. A.; Chen, C.; Chen, H.; Chen, S.; Chen, X.; Chen, Y.; Cheng, Y.; Cheplakov, A.; Cherkaoui El Moursli, R.; Chernyatin, V.; Cheu, E.; Cheung, S. L.; Chevalier, L.; Chiefari, G.; Chikovani, L.; Childers, J. T.; Chilingarov, A.; Chiodini, G.; Chisholm, A. S.; Chislett, R. T.; Chitan, A.; Chizhov, M. V.; Choudalakis, G.; Chouridou, S.; Christidi, I. A.; Christov, A.; Chromek-Burckhart, D.; Chu, M. L.; Chudoba, J.; Ciapetti, G.; Ciftci, A. K.; Ciftci, R.; Cinca, D.; Cindro, V.; Ciocca, C.; Ciocio, A.; Cirilli, M.; Cirkovic, P.; Citron, Z. H.; Citterio, M.; Ciubancan, M.; Clark, A.; Clark, P. J.; Clarke, R. N.; Cleland, W.; Clemens, J. C.; Clement, B.; Clement, C.; Coadou, Y.; Cobal, M.; Coccaro, A.; Cochran, J.; Coffey, L.; Cogan, J. G.; Coggeshall, J.; Cogneras, E.; Colas, J.; Cole, S.; Colijn, A. P.; Collins, N. J.; Collins-Tooth, C.; Collot, J.; Colombo, T.; Colon, G.; Compostella, G.; Muino, P. Conde; Coniavitis, E.; Conidi, M. C.; Consonni, S. M.; Consorti, V.; Constantinescu, S.; Conta, C.; Conti, G.; Conventi, F.; Cooke, M.; Cooper, B. D.; Cooper-Sarkar, A. M.; Cooper-Smith, N. J.; Copic, K.; Cornelissen, T.; Corradi, M.; Corriveau, F.; Cortes-Gonzalez, A.; Cortiana, G.; Costa, G.; Costa, M. J.; Costanzo, D.; Cote, D.; Courneyea, L.; Cowan, G.; Cowden, C.; Cox, B. E.; Cranmer, K.; Crescioli, F.; Cristinziani, M.; Crosetti, G.; Crepe-Renaudin, S.; Cuciuc, C. -M.; Almenar, C. Cuenca; Donszelmann, T. Cuhadar; Curatolo, M.; Curtis, C. J.; Cuthbert, C.; Cwetanski, P.; Czirr, H.; Czodrowski, P.; Czyczula, Z.; D'Auria, S.; D'Onofrio, M.; D'Orazio, A.; Da Cunha Sargedas De Sousa, M. J.; Da Via, C.; Dabrowski, W.; Dafinca, A.; Dai, T.; Dallapiccola, C.; Dam, M.; Dameri, M.; Damiani, D. S.; Danielsson, H. O.; Dao, V.; Darbo, G.; Darlea, G. L.; Dassoulas, J. A.; Davey, W.; Davidek, T.; Davidson, N.; Davidson, R.; Davies, E.; Davies, M.; Davignon, O.; Davison, A. R.; Davygora, Y.; Dawe, E.; Dawson, I.; Daya-Ishmukhametova, R. K.; De, K.; de Asmundis, R.; De Castro, S.; De Cecco, S.; de Graat, J.; De Groot, N.; de Jong, P.; De La Taille, C.; De la Torre, H.; De Lorenzi, F.; de Mora, L.; De Nooij, L.; De Pedis, D.; De Salvo, A.; De Sanctis, U.; De Santo, A.; De Regie, J. B. De Vivie; De Zorzi, G.; Dearnaley, W. J.; Debbe, R.; Debenedetti, C.; Dechenaux, B.; Dedovich, D. V.; Degenhardt, J.; Del Papa, C.; Del Peso, J.; Del Prete, T.; Delemontex, T.; Deliyergiyev, M.; Dell'Acqua, A.; Dell'Asta, L.; Della Pietra, M.; della Volpe, D.; Delmastro, M.; Delpierre, P.; Delsart, P. A.; Deluca, C.; Demers, S.; Demichev, M.; Demirkoz, B.; Deng, J.; Denisov, S. P.; Derendarz, D.; Derkaoui, J. E.; Derue, F.; Dervan, P.; Desch, K.; Devetak, E.; Deviveiros, P. O.; Dewhurst, A.; DeWilde, B.; Dhaliwal, S.; Dhullipud, R.; Di Ciaccio, A.; Di Ciaccio, L.; Di Donato, C.; Di Girolamo, A.; Di Girolamo, B.; Di Luise, S.; Di Mattia, A.; Di Micco, B.; Di Nardo, R.; Di Simone, A.; Di Sipio, R.; Diaz, M. A.; Diehl, E. B.; Dietrich, J.; Dietzsch, T. A.; Diglio, S.; Yagci, K. Dindar; Dingfelder, J.; Dinut, F.; Dionisi, C.; Dita, P.; Dita, S.; Dittus, F.; Djama, F.; Djobava, T.; do Vale, M. A. B.; Wemans, A. Do Valle; Doan, T. K. O.; Dobbs, M.; Dobinson, R.; Dobos, D.; Dobson, E.; Dodd, J.; Doglioni, C.; Doherty, T.; Doi, Y.; Dolejsi, J.; Dolenc, I.; Dolezal, Z.; Dolgoshein, B. A.; Dohmae, T.; Donadelli, M.; Donini, J.; Dopke, J.; Doria, A.; Dos Anjos, A.; Dotti, A.; Dova, M. T.; Dowell, J. D.; Doxiadis, A. D.; Doyle, A. T.; Dressnandt, N.; Dris, M.; Dubbert, J.; Dube, S.; Duchovni, E.; Duckeck, G.; Duda, D.; Dudarev, A.; Dudziak, F.; Duehrssen, M.; Duerdoth, I. P.; Duflot, L.; Dufour, M. -A.; Duguid, L.; Dunford, M.; Yildiz, H. D.; Duxfield, R.; Dwuznik, M.; Dydak, F.; Dueren, M.; Ebenstein, W. L.; Ebke, J.; Eckweiler, S.; Edmonds, K.; Edson, W.; Edwards, C. A.; Edwards, N. C.; Ehrenfeld, W.; Eifert, T.; Eigen, G.; Einsweiler, K.; Eisenhandler, E.; Ekelof, T.; El Kacimi, M.; Ellert, M.; Elles, S.; Ellinghaus, F.; Ellis, K.; Ellis, N.; Elmsheuser, J.; Elsing, M.; Emeliyanov, D.; Engelmann, R.; Engl, R.; Epp, B.; Erdmann, J.; Ereditato, A.; Eriksson, D.; Ernst, J.; Ernst, M.; Ernwein, J.; Errede, D.; Errede, S.; Ertel, E.; Escalier, M.; Esch, H.; Escobar, C.; Espinal Curull, X.; Esposito, B.; Etienne, F.; Etienvre, A. I.; Etzion, E.; Evangelakou, D.; Evans, H.; Fabbri, L.; Fabre, C.; Fakhrutdinov, R. M.; Falciano, S.; Fang, Y.; Fanti, M.; Farbin, A.; Farilla, A.; Farley, J.; Farooque, T.; Farrell, S.; Farrington, S. M.; Farthouat, P.; Fassi, F.; Fassnacht, P.; Fassouliotis, D.; Fatholahzadeh, B.; Favareto, A.; Fayard, L.; Fazio, S.; Febbraro, R.; Federic, P.; Fedin, O. L.; Fedorko, W.; Fehling-Kaschek, M.; Feligioni, L.; Fellmann, D.; Feng, C.; Feng, E. J.; Fenyuk, A. B.; Ferencei, J.; Fernando, W.; Ferrag, S.; Ferrando, J.; Ferrara, V.; Ferrari, A.; Ferrari, P.; Ferrari, R.; de Lima, D. E. Ferreira; Ferrer, A.; Ferrere, D.; Ferretti, C.; Parodi, A. Ferretto; Fiascaris, M.; Fiedler, F.; Filipcic, A.; Filthaut, F.; Fincke-Keeler, M.; Fiolhais, M. C. N.; Fiorini, L.; Firan, A.; Fischer, G.; Fisher, M. J.; Flechl, M.; Fleck, I.; Fleckner, J.; Fleischmann, P.; Fleischmann, S.; Flick, T.; Floderus, A.; Castillo, L. R. Flores; Flowerdew, M. J.; Martin, T. Fonseca; Formica, A.; Forti, A.; Fortin, D.; Fournier, D.; Fowler, A. J.; Fox, H.; Francavilla, P.; Franchini, M.; Franchino, S.; Francis, D.; Frank, T.; Franklin, M.; Franz, S.; Fraternali, M.; Fratina, S.; French, S. T.; Friedrich, C.; Friedrich, F.; Froeschl, R.; Froidevaux, D.; Frost, J. A.; Fukunaga, C.; Torregrosa, E. Fullana; Fulsom, B. G.; Fuster, J.; Gabaldon, C.; Gabizon, O.; Gadatsch, S.; Gadfort, T.; Gadomski, S.; Gagliardi, G.; Gagnon, P.; Galea, C.; Galhardo, B.; Gallas, E. J.; Gallo, V.; Gallop, B. J.; Gallus, P.; Gan, K. K.; Gao, Y. S.; Gaponenko, A.; Garberson, F.; Garcia-Sciveres, M.; Garcia, C.; Garcia Navarro, J. E.; Gardner, R. W.; Garelli, N.; Garitaonandia, H.; Garonne, V.; Gatti, C.; Gaudio, G.; Gaur, B.; Gauthier, L.; Gauzzi, P.; Gavrilenko, I. L.; Gay, C.; Gaycken, G.; Gazis, E. N.; Ge, P.; Gecse, Z.; Gee, C. N. P.; Geerts, D. A. A.; Geich-Gimbel, C.; Gellerstedt, K.; Gemme, C.; Gemmell, A.; Genest, M. H.; Gentile, S.; George, M.; George, S.; Gerlach, P.; Gershon, A.; Geweniger, C.; Ghazlane, H.; Ghodbane, N.; Giacobbe, B.; Giagu, S.; Giakoumopoulou, V.; Giangiobbe, V.; Gianotti, F.; Gibbard, B.; Gibson, A.; Gibson, S. M.; Gilchriese, M.; Gildemeister, O.; Gillberg, D.; Gillman, A. R.; Gingrich, D. M.; Ginzburg, J.; Giokaris, N.; Giordani, M. P.; Giordano, R.; Giorgi, F. M.; Giovannini, P.; Giraud, P. F.; Giugn, D.; Giunta, M.; Giusti, P.; Gjelsten, B. K.; Gladilin, L. K.; Glasman, C.; Glatzer, J.; Glazov, A.; Glitza, K. W.; Glonti, G. L.; Goddard, J. R.; Godfrey, J.; Godlewski, J.; Goebel, M.; Goepfert, T.; Goeringer, C.; Goessling, C.; Goldfarb, S.; Golling, T.; Gomes, A.; Fajardo, L. S. Gomez; Goncalo, R.; Da Costa, J. Goncalves Pinto Firmino; Gonella, L.; Gonzalez de la Hoz, S.; Gonzalez Parra, G.; Gonzalez Silva, M. L.; Gonzalez-Sevilla, S.; Goodson, J. J.; Goossens, L.; Gorbounov, P. A.; Gordon, H. A.; Gorelov, I.; Gorfine, G.; Gorini, B.; Gorini, E.; Gorisek, E.; Gornicki, E.; Gosdzik, B.; Goshaw, A. T.; Gosselink, M.; Gostkin, M. I.; Eschrich, I. G.; Gouighri, M.; Goujdami, D.; Goulette, M. P.; Goussiou, A. G.; Goy, C.; Gozpinar, S.; Grabowska-Bold, I.; Grafstroem, P.; Grahn, K. J.; Gramstad, E.; Grancagnolo, F.; Grancagnolo, S.; Grassi, V.; Gratchev, V.; Grau, N.; Gray, H. M.; Gray, J. A.; Graziani, E.; Grebenyuk, O. G.; Greenshaw, T.; Greenwood, Z. D.; Gregersen, K.; Gregor, I. M.; Grenier, P.; Griffiths, J.; Grigalashvili, N.; Grillo, A. A.; Grinstein, S.; Gris, Ph.; Grishkevich, Y. V.; Grivaz, J. -F.; Gross, E.; Grosse-Knetter, J.; Groth-Jensen, J.; Grybel, K.; Guest, D.; Guicheney, C.; Guillemin, T.; Guindon, S.; Gul, U.; Gunther, J.; Guo, B.; Guo, J.; Gutierrez, P.; Guttman, N.; Gutzwiller, O.; Guyot, C.; Gwenlan, C.; Gwilliam, C. B.; Haas, A.; Haas, S.; Haber, C.; Hadavand, H. K.; Hadley, D. R.; Haefner, P.; Hahn, F.; Haider, S.; Hajduk, Z.; Hakobyan, H.; Hall, D.; Haller, J.; Hamacher, K.; Hamal, P.; Hamano, K.; Hamer, M.; Hamilton, A.; Hamilton, S.; Han, L.; Hanagaki, K.; Hanawa, K.; Hance, M.; Handel, C.; Hanke, P.; Hansen, J. R.; Hansen, J. B.; Hansen, J. D.; Hansen, P. H.; Hansson, P.; Hara, K.; Hard, A. S.; Hare, G. A.; Harenberg, T.; Harkusha, S.; Harper, D.; Harrington, R. D.; Harris, O. M.; Hartert, J.; Hartjes, F.; Haruyama, T.; Harvey, A.; Hasegawa, S.; Hasegawa, Y.; Hassani, S.; Haug, S.; Hauschild, M.; Hauser, R.; Havranek, M.; Hawkes, C. M.; Hawkings, R. J.; Hawkins, A. D.; Hayakawa, T.; Hayashi, T.; Hayden, D.; Hays, C. P.; Hayward, H. S.; Haywood, S. J.; Head, S. J.; Hedberg, V.; Heelan, L.; Heim, S.; Heinemann, B.; Heisterkamp, S.; Helary, L.; Heller, C.; Heller, M.; Hellman, S.; Hellmich, D.; Helsens, C.; Henderson, R. C. W.; Henke, M.; Henrichs, A.; Correia, A. M. Henriques; Henrot-Versille, S.; Hensel, C.; Henss, T.; Hernandez, C. M.; Jimenez, C. M.; Hernandez Jimenez, Y.; Herrberg, R.; Herten, G.; Hertenberger, R.; Hervas, L.; Hesketh, G. G.; Hessey, N. P.; Higon-Rodriguez, E.; Hill, J. C.; Hiller, K. H.; Hillert, S.; Hillier, S. J.; Hinchliffe, I.; Hines, E.; Hirose, M.; Hirsch, F.; Hirschbuehl, D.; Hobbs, J.; Hod, N.; Hodgkinson, M. C.; Hodgson, P.; Hoecker, A.; Hoeferkamp, M. R.; Hoffman, J.; Hoffmann, D.; Hohlfeld, M.; Holder, M.; Holmgren, S. O.; Holy, T.; Holzbauer, J. L.; Hong, T. M.; van Huysduynen, L. Hooft; Horner, S.; Hostachy, J. -Y.; Hou, S.; Hoummada, A.; Howard, J.; Howarth, J.; Hristova, I.; Hrivnac, J.; Hryn'ova, T.; Hsu, P. J.; Hsu, S. -C.; Hu, D.; Hubacek, Z.; Hubaut, F.; Huegging, F.; Huettmann, A.; Huffman, T. B.; Hughes, E. W.; Hughes, G.; Huhtinen, M.; Hurwitz, M.; Huseynov, N.; Huston, J.; Huth, J.; Iacobucci, G.; Iakovidis, G.; Ibbotson, M.; Ibragimov, I.; Iconomidou-Fayard, L.; Idarraga, J.; Iengo, P.; Igonkina, O.; Ikegami, Y.; Ikeno, L.; Iliadis, D.; Ilic, N.; Ince, T.; Inigo-Golfin, J.; Ioannou, P.; Iodice, M.; Iordanidou, K.; Ippolito, V.; Irles Quiles, A.; Isaksson, C.; Ishino, M.; Ishitsuka, M.; Ishmukhametov, R.; Issever, C.; Istin, S.; Ivashin, A. V.; Iwanski, W.; Iwasaki, H.; Izen, J. M.; Izzo, V.; Jackson, B.; Jackson, J. N.; Jackson, P.; Jaekel, M. R.; Jain, V.; Jakobs, K.; Jakobsen, S.; Jakoubek, T.; Jakubek, J.; Jamin, D. O.; Jana, D. K.; Jansen, E.; Jansen, H.; Jantsch, A.; Janus, M.; Jarlskog, G.; Jeanty, L.; Plante, I. Jen-La; Jennens, D.; Jenni, P.; Loevschall-Jensen, A. E.; Jez, P.; Jezeque, S.; Jha, M. K.; Ji, H.; Ji, W.; Jia, J.; Jiang, Y.; Belenguer, M. Jimenez; Jin, S.; Jinnouchi, O.; Joergensen, M. D.; Joffe, D.; Johansen, M.; Johansson, K. E.; Johansson, P.; Johnert, S.; Johns, K. A.; Jon-And, K.; Jones, G.; Jones, R. W. L.; Jones, T. J.; Joram, C.; Jorge, P. M.; Joshi, K. D.; Jovicevic, J.; Jovin, T.; Ju, X.; Jung, C. A.; Jungst, R. M.; Juranek, V.; Jussel, P.; Juste Rozas, A.; Kabana, S.; Kaci, M.; Kaczmarska, A.; Kadlecik, P.; Kado, M.; Kagan, H.; Kagan, M.; Kajomovitz, E.; Kalinin, S.; Kalinovskaya, L. V.; Kama, S.; Kanaya, N.; Kaneda, M.; Kaneti, S.; Kanno, T.; Kantserov, V. A.; Kanzaki, J.; Kaplan, B.; Kapliy, A.; Kaplon, J.; Kar, D.; Karagounis, M.; Karakostas, K.; Karnevskiy, M.; Kartvelishvili, V.; Karyukhin, A. N.; Kashif, L.; Kasieczka, G.; Kass, R. D.; Kastanas, A.; Kataoka, M.; Kataoka, Y.; Katsoufis, E.; Katzy, J.; Kaushik, V.; Kawagoe, K.; Kawamoto, T.; Kawamura, G.; Kay, M. S.; Kazama, S.; Kazanin, V. A.; Kazarinov, M. Y.; Keeler, R.; Keener, P. T.; Kehoe, R.; Keil, M.; Kekelidze, G. D.; Keller, J. S.; Kenyon, M.; Kepka, O.; Kerschen, N.; Kersevan, B. P.; Kersten, S.; Kessoku, K.; Keung, J.; Khalil-zada, F.; Khandanyan, H.; Khanov, A.; Kharchenko, D.; Khodinov, A.; Khomich, A.; Khoo, T. J.; Khoriauli, G.; Khoroshilov, A.; Khovanskiy, V.; Khramov, E.; Khubua, J.; Kim, H.; Kim, S. H.; Kimura, N.; Kind, O.; King, B. T.; King, M.; King, R. S. B.; Kirk, J.; Kiryunin, A. E.; Kishimoto, T.; Kisielewska, D.; Kitamura, T.; Kittelmann, T.; Kiuchi, K.; Kladiva, E.; Klein, M.; Klein, U.; Kleinknecht, K.; Klemetti, M.; Klier, A.; Klimek, P.; Klimentov, A.; Klingenberg, R.; Klinger, J. A.; Klinkby, E. B.; Klioutchnikova, T.; Klok, P. F.; Klous, S.; Kluge, E. -E.; Kluge, T.; Kluit, P.; Kluth, S.; Kneringer, E.; Knoops, E. B. F. G.; Knue, A.; Ko, B. R.; Kobayashi, T.; Kobel, M.; Kocian, M.; Kodys, P.; Koeneke, K.; Koning, A. C.; Koenig, S.; Koepke, L.; Koetsveld, F.; Koevesarki, P.; Koffas, T.; Koffeman, E.; Kogan, L. A.; Kohlmann, S.; Kohn, F.; Kohout, Z.; Kohriki, T.; Koi, T.; Kolachev, G. M.; Kolanoski, H.; Kolesnikov, V.; Koletsou, I.; Koll, J.; Komar, A. A.; Komori, Y.; Kondo, T.; Kono, T.; Kononov, A. I.; Konoplich, R.; Konstantinidis, N.; Kopeliansky, R.; Koperny, S.; Korcyl, K.; Kordas, K.; Korn, A.; Korol, A.; Korolkov, I.; Korolkova, E. V.; Korotkov, V. A.; Kortner, O.; Kortner, S.; Kostyukhin, V. V.; Kotov, S.; Kotov, V. M.; Kotwal, A.; Kourkoumelis, C.; Kouskoura, V.; Koutsman, A.; Kowalewski, R.; Kowalski, T. Z.; Kozanecki, W.; Kozhin, A. S.; Kral, V.; Kramarenko, V. A.; Kramberger, G.; Krasny, M. W.; Krasznahorkay, A.; Kraus, J. K.; Kreiss, S.; Krejci, F.; Kretzschmar, J.; Krieger, N.; Krieger, P.; Kroeninger, K.; Kroha, H.; Kroll, J.; Kroseberg, J.; Krstic, J.; Kruchonak, U.; Krueger, H.; Kruker, T.; Krumnack, N.; Krumshteyn, Z. V.; Kruse, A.; Kubota, T.; Kuday, S.; Kuehn, S.; Kugel, A.; Kuhl, T.; Kuhn, D.; Kukhtin, V.; Kulchitsky, Y.; Kuleshov, S.; Kummer, C.; Kuna, M.; Kunkle, J.; Kupco, A.; Kurashige, H.; Kurata, M.; Kurochkin, Y. A.; Kus, V.; Kuwertz, E. S.; Kuze, M.; Kvita, J.; Kwee, R.; La Rosa, A.; La Rotonda, L.; Labarga, L.; Labbe, J.; Lablak, S.; Lacasta, C.; Lacava, F.; Lacey, J.; Lacker, H.; Lacour, D.; Lacuesta, V. R.; Ladygin, E.; Lafaye, R.; Laforge, B.; Lagouri, T.; Lai, S.; Laisne, E.; Lamanna, M.; Lambourne, L.; Lampen, C. L.; Lampl, W.; Lancon, E.; Landgraf, U.; Landon, M. P. J.; Lang, V. S.; Lange, C.; Lankford, A. J.; Lanni, F.; Lantzsch, K.; Laplace, S.; Lapoire, C.; Laporte, J. F.; Lari, T.; Larner, A.; Lassnig, M.; Laurelli, P.; Lavorini, V.; Lavrijsen, W.; Laycock, P.; Lazovich, T.; Le Dortz, O.; Le Guirriec, E.; Le Menedeu, E.; LeCompte, T.; Ledroit-Guillon, F.; Lee, H.; Lee, J. S. H.; Lee, S. C.; Lee, L.; Lefebvre, M.; Legendre, M.; Legger, F.; Leggett, C.; Lehmacher, M.; Miotto, G. Lehmann; Lei, X.; Leite, M. A. L.; Leitner, R.; Lellouch, D.; Lemmer, B.; Lendermann, V.; Leney, K. J. C.; Lenz, T.; Lenzen, G.; Lenzi, B.; Leonhardt, K.; Leontsinis, S.; Lepold, F.; Leroy, C.; Lessard, J. -R.; Lester, C. G.; Lester, C. M.; Leveque, J.; Levin, D.; Levinson, L. J.; Lewis, A.; Lewis, G. H.; Leyko, A. M.; Leyton, M.; Li, B.; Li, H.; Li, H. L.; Li, S.; Li, X.; Liang, Z.; Liao, H.; Liberti, B.; Lichard, P.; Lichtnecker, M.; Lie, K.; Liebig, W.; Limbach, C.; Limosani, A.; Limper, M.; Lin, S. C.; Linde, F.; Linnemann, J. T.; Lipeles, E.; Lipniacka, A.; Liss, T. M.; Lissauer, D.; Lister, A.; Litke, A. M.; Liu, C.; Liu, D.; Liu, H.; Liu, J. B.; Liu, K.; Liu, L.; Liu, M.; Liu, Y.; Livan, M.; Livermore, S. S. A.; Lleres, A.; Llorente Merino, J.; Lloyd, S. L.; Lobodzinska, E.; Loch, P.; Lockman, W. S.; Loddenkoetter, T.; Loebinger, F. K.; Loginov, A.; Loh, C. W.; Lohse, T.; Lohwasser, K.; Lokajicek, M.; Lombardo, V. P.; Long, J. D.; Long, R. E.; Lopes, L.; Mateos, D. Lopez; Lorenz, J.; Martinez, N. Lorenzo; Losada, M.; Loscutoff, P.; Lo Sterzo, F.; Losty, M. J.; Lou, X.; Lounis, A.; Loureiro, K. F.; Love, J.; Love, P. A.; Lowe, A. J.; Lu, F.; Lubatti, H. J.; Luci, C.; Lucotte, A.; Ludwig, A.; Ludwig, D.; Ludwig, I.; Ludwig, J.; Luehring, F.; Luijckx, G.; Lukas, W.; Luminari, L.; Lund, E.; Lund-Jensen, B.; Lundberg, B.; Lundberg, J.; Lundberg, O.; Lundquist, J.; Lungwitz, M.; Lynn, D.; Lytken, E.; Ma, H.; Ma, L. L.; Maccarrone, G.; Macchiolo, A.; Macek, B.; Miguens, J. Machado; Mackeprang, R.; Madaras, R. J.; Maddocks, H. J.; Mader, W. F.; Maenner, R.; Maeno, T.; Maettig, P.; Maettig, S.; Magnoni, L.; Magradze, E.; Mahboubi, K.; Mahlstedt, J.; Mahmoud, S.; Mahout, G.; Maiani, C.; Maidantchik, C.; Maio, A.; Majewski, S.; Makida, Y.; Makovec, N.; Mal, P.; Malaescu, B.; Malecki, Pa.; Malecki, P.; Maleev, V. P.; Malek, F.; Mallik, U.; Malon, D.; Malone, C.; Maltezos, S.; Malyshev, V.; Malyukov, S.; Mameghani, R.; Mamuzic, J.; Manabe, A.; Mandelli, L.; Mandic, I.; Mandrysch, R.; Maneira, J.; Manfredini, A.; Mangeard, P. S.; de Andrade Filho, L. Manhaes; Ramos, J. A. M.; Mann, A.; Manning, P. M.; Manousakis-Katsikakis, A.; Mansoulie, B.; Mapelli, A.; Mapelli, L.; March, L.; Marchand, J. F.; Marchese, F.; Marchiori, G.; Marcisovsky, M.; Marino, C. P.; Marroquim, F.; Marshall, Z.; Martens, F. K.; Marti, L. F.; Marti-Garcia, S.; Martin, B.; Martin, B.; Martin, J. P.; Martin, T. A.; Martin, V. J.; dit Latour, B. Martin; Martin-Haugh, S.; Martinez, M.; Outschoorn, V. Martinez; Martyniuk, A. C.; Marx, M.; Marzano, F.; Marzin, A.; Masetti, L.; Mashimo, T.; Mashinistov, R.; Masik, J.; Maslennikov, A. L.; Massa, I.; Massaro, G.; Massol, N.; Mastrandrea, P.; Mastroberardino, A.; Masubuchi, T.; Matricon, P.; Matsunaga, H.; Matsushita, T.; Mattravers, C.; Maurer, J.; Maxfield, S. J.; Mayne, A.; Mazini, R.; Mazur, M.; Mazzaferro, L.; Mazzanti, M.; Mc Donald, J.; Mc Kee, S. P.; McCarn, A.; McCarthy, R. L.; McCarthy, T. G.; McCubbin, N. A.; McFarlane, K. W.; Mcfayden, J. A.; Mchedlidze, G.; Mclaughlan, T.; McMahon, S. J.; McPherson, R. A.; Meade, A.; Mechnich, J.; Mechtel, M.; Medinnis, M.; Meera-Lebbai, R.; Meguro, T.; Mehdiyev, R.; Mehlhase, S.; Mehta, A.; Meier, K.; Meirose, B.; Melachrinos, C.; Garcia, B. R. Mellado; Meloni, F.; Mendoza Navas, L.; Meng, Z.; Mengarelli, A.; Menke, S.; Meoni, E.; Mercurio, K. M.; Mermod, P.; Merola, L.; Meroni, C.; Merritt, F. S.; Merritt, H.; Messina, A.; Metcalfe, J.; Mete, A. S.; Meyer, C.; Meyer, C.; Meyer, J. -P.; Meyer, J.; Meyer, J.; Meyer, T. C.; Michal, S.; Micu, L.; Middleton, R. P.; Migas, S.; Mijovic, L.; Mikenberg, G.; Mikestikova, M.; Mikuz, M.; Miller, D. W.; Miller, R. J.; Mills, W. J.; Mills, C.; Milov, A.; Milstead, D. A.; Milstein, D.; Minaenko, A. A.; Minano Moya, M.; Minashvili, I. A.; Mincer, A. I.; Mindur, B.; Mineev, M.; Ming, Y.; Mir, L. M.; Mirabelli, G.; Mitrevski, J.; Mitsou, V. A.; Mitsui, S.; Miyagawa, P. S.; Mjornmark, J. U.; Moa, T.; Moeller, V.; Moenig, K.; Moeser, N.; Mohapatra, S.; Mohr, W.; Moles-Valls, R.; Molfetas, A.; Monk, J.; Monnier, E.; Montejo Berlingen, J.; Monticelli, F.; Monzani, S.; Moore, R. W.; Moorhead, G. F.; Herrera, C. Mora; Moraes, A.; Morange, N.; Morel, J.; Morello, G.; Moreno, D.; Moreno Llacer, M.; Morettini, P.; Morgenstern, M.; Morii, M.; Morley, A. K.; Mornacchi, G.; Morris, J. D.; Morvaj, L.; Moser, H. G.; Mosidze, M.; Moss, J.; Mount, R.; Mountricha, E.; Mouraviev, S. V.; Moyse, E. J. W.; Mueller, F.; Mueller, J.; Mueller, K.; Mueller, T. A.; Mueller, T.; Muenstermann, D.; Munwes, Y.; Murray, W. J.; Mussche, I.; Musto, E.; Myagkov, A. G.; Myska, M.; Nackenhorst, O.; Nadal, J.; Nagai, K.; Nagai, R.; Nagano, K.; Nagarkar, A.; Nagasaka, Y.; Nagel, M.; Nairz, A. M.; Nakahama, Y.; Nakamura, K.; Nakamura, T.; Nakano, I.; Nanava, G.; Napier, A.; Narayan, R.; Nash, M.; Nattermann, T.; Naumann, T.; Navarro, G.; Neal, H. A.; Nechaeva, P. Yu.; Neep, T. J.; Negri, A.; Negri, G.; Negrini, M.; Nektarijevic, S.; Nelson, A.; Nelson, T. K.; Nemecek, S.; Nemethy, P.; Nepomuceno, A. A.; Nessi, M.; Neubauer, M. S.; Neumann, M.; Neusiedl, A.; Neves, R. M.; Nevski, P.; Newcomer, F. M.; Newman, P. R.; Hong, V. Nguyen Thi; Nickerson, R. B.; Nicolaidou, R.; Nicquevert, B.; Niedercorn, F.; Nielsen, J.; Nikiforou, N.; Nikiforov, A.; Nikolaenko, V.; Nikolic-Audit, I.; Nikolics, K.; Nikolopoulos, K.; Nilsen, H.; Nilsson, P.; Ninomiya, Y.; Nisati, A.; Nisius, R.; Nobe, T.; Nodulman, L.; Nomachi, M.; Nomidis, I.; Norberg, S.; Nordberg, M.; Norton, P. R.; Novakova, J.; Nozaki, M.; Nozka, L.; Nugent, I. M.; Nuncio-Quiroz, A. -E.; Hanninger, G. Nunes; Nunnemann, T.; Nurse, E.; O'Brien, B. J.; O'Neil, D. C.; O'Shea, V.; Oakes, L. B.; Oakham, F. G.; Oberlack, H.; Ocariz, J.; Ochi, A.; Oda, S.; Odaka, S.; Odier, J.; Ogren, H.; Oh, A.; Oh, S. H.; Ohm, C. C.; Ohshima, T.; Okamura, W.; Okawa, H.; Okumura, Y.; Okuyama, T.; Olariu, A.; Olchevski, A. G.; Olivares Pino, S. A.; Oliveira, M.; Damazio, D. Oliveira; Oliver Garcia, E.; Olivito, D.; Olszewski, A.; Olszowska, J.; Onofre, A.; Onyisi, P. U. E.; Oram, C. J.; Oreglia, M. J.; Oren, Y.; Orestano, D.; Orlando, N.; Orlov, I.; Barrera, C. Oropeza; Orr, R. S.; Osculati, B.; Ospanov, R.; Osuna, C.; Otero y Garzon, G.; Ottersbach, J. P.; Ouchrif, M.; Ouellette, E. A.; Ould-Saada, F.; Ouraou, A.; Ouyang, Q.; Ovcharova, A.; Owen, M.; Owen, S.; Ozcan, V. E.; Ozturk, N.; Pacheco Pages, A.; Padilla Aranda, C.; Griso, S. Pagan; Paganis, E.; Pahl, C.; Paige, F.; Pais, P.; Pajchel, K.; Palacino, G.; Paleari, C. P.; Palestini, S.; Pallin, D.; Palma, A.; Palmer, J. D.; Pan, Y. B.; Panagiotopoulou, E.; Vazquez, J. G. Panduro; Pani, P.; Panikashvili, N.; Panitkin, S.; Pantea, D.; Papadelis, A.; Papadopoulou, Th. D.; Paramonov, A.; Hernandez, D. Paredes; Park, W.; Parker, M. A.; Parodi, F.; Parsons, J. A.; Parzefall, U.; Pashapour, S.; Pasqualucci, E.; Passaggio, S.; Passeri, A.; Pastore, F.; Pastore, Fr.; Pasztor, G.; Pataraia, S.; Patel, N.; Pater, J. R.; Patricelli, S.; Pauly, T.; Pecsy, M.; Pedraza Lopez, S.; Morales, M. I. Pedraza; Peleganchuk, S. V.; Pelikan, D.; Peng, H.; Penning, B.; Penson, A.; Penwell, J.; Perantoni, M.; Perez, K.; Cavalcanti, T. Perez; Codina, E. Perez; Perez Garcia-Estan, M. T.; Reale, V. Perez; Perini, L.; Pernegger, H.; Perrino, R.; Perrodo, P.; Peshekhonov, V. D.; Peters, K.; Petersen, B. A.; Petersen, J.; Petersen, T. C.; Petit, E.; Petridis, A.; Petridou, C.; Petrolo, E.; Petrucci, F.; Petschull, D.; Petteni, M.; Pezoa, R.; Phan, A.; Phillips, P. W.; Piacquadio, G.; Picazio, A.; Piccaro, E.; Piccinini, M.; Piec, S. M.; Piegaia, R.; Pignotti, D. T.; Pilcher, J. E.; Pilkington, A. D.; Pina, J.; Pinamonti, M.; Pinder, A.; Pinfold, J. L.; Pinto, B.; Pizio, C.; Plamondon, M.; Pleier, M. -A.; Plotnikova, E.; Poblaguev, A.; Poddar, S.; Podlyski, F.; Poggioli, L.; Pohl, D.; Pohl, M.; Polesello, G.; Policicchio, A.; Polifka, R.; Polini, A.; Poll, J.; Polychronakos, V.; Pomeroy, D.; Pommes, K.; Pontecorvo, L.; Pope, B. G.; Popeneciu, G. A.; Popovic, D. S.; Poppleton, A.; Bueso, X. Portell; Pospelov, G. E.; Pospisil, S.; Potrap, I. N.; Potter, C. J.; Potter, C. T.; Poulard, G.; Poveda, J.; Pozdnyakov, V.; Prabhu, R.; Pralavorio, P.; Pranko, A.; Prasad, S.; Pravahan, R.; Prell, S.; Pretzl, K.; Price, D.; Price, J.; Price, L. E.; Prieur, D.; Primavera, M.; Prokofiev, K.; Prokoshin, F.; Protopopescu, S.; Proudfoot, J.; Prudent, X.; Przybycien, M.; Przysiezniak, H.; Psoroulas, S.; Ptacek, E.; Pueschel, E.; Purdham, J.; Purohit, M.; Puzo, P.; Pylypchenko, Y.; Qian, J.; Quadt, A.; Quarrie, D. R.; Quayle, W. B.; Quinonez, F.; Raas, M.; Raddum, S.; Radeka, V.; Radescu, V.; Radloff, P.; Rador, T.; Ragusa, F.; Rahal, G.; Rahimi, A. M.; Rahm, D.; Rajagopalan, S.; Rammensee, M.; Rammes, M.; Randle-Conde, A. S.; Randrianarivony, K.; Rauscher, F.; Rave, T. C.; Raymond, M.; Read, A. L.; Rebuzzi, D. M.; Redelbach, A.; Redlinger, G.; Reece, R.; Reeves, K.; Reinherz-Aronis, E.; Reinsch, A.; Reisinger, I.; Rembser, C.; Ren, Z. L.; Renaud, A.; Rescigno, M.; Resconi, S.; Resende, B.; Reznicek, P.; Rezvani, R.; Richter, R.; Richter-Was, E.; Ridel, M.; Rijpstra, M.; Rijssenbeek, M.; Rimoldi, A.; Rinaldi, L.; Rios, R. R.; Riu, I.; Rivoltella, G.; Rizatdinova, F.; Rizvi, E.; Robertson, S. H.; Robichaud-Veronneau, A.; Robinson, D.; Robinson, J. E. M.; Robson, A.; de Lima, J. G. Rocha; Roda, C.; Dos Santos, D. Roda; Roe, A.; Roe, S.; Rohne, O.; Rolli, S.; Romaniouk, A.; Romano, M.; Romeo, G.; Romero Adam, E.; Rompotis, N.; Roos, L.; Ros, E.; Rosati, S.; Rosbach, K.; Rose, A.; Rose, M.; Rosenbaum, G. A.; Rosenberg, E. I.; Rosendahl, P. L.; Rosenthal, O.; Rosselet, L.; Rossetti, V.; Rossi, E.; Rossi, L. P.; Rotaru, M.; Roth, I.; Rothberg, J.; Rousseau, D.; Royon, C. R.; Rozanov, A.; Rozen, Y.; Ruan, X.; Rubbo, F.; Rubinskiy, I.; Ruckstuhl, N.; Rud, V. I.; Rudolph, C.; Rudolph, G.; Ruehr, F.; Ruiz-Martinez, A.; Rumyantsev, L.; Rurikova, Z.; Rusakovich, N. A.; Rutherfoord, J. P.; Ruzicka, P.; Ryabov, Y. F.; Rybar, M.; Rybkin, G.; Ryder, N. C.; Saavedra, A. F.; Sadeh, I.; Sadrozinski, H. F. -W.; Sadykov, R.; Tehrani, F. Safai; Sakamoto, H.; Salamanna, G.; Salamon, A.; Saleem, M.; Salek, D.; Salihagic, D.; Salnikov, A.; Salt, J.; Ferrando, B. M. Salvachua; Salvatore, D.; Salvatore, F.; Salvucci, A.; Salzburger, A.; Sampsonidis, D.; Samset, B. H.; Sanchez, A.; Sanchez Martinez, V.; Sandaker, H.; Sander, H. G.; Sanders, M. P.; Sandhoff, M.; Sandoval, T.; Sandoval, C.; Sandstroem, R.; Sankey, D. P. C.; Sansoni, A.; Rios, C. Santamarina; Santoni, C.; Santonico, R.; Santos, H.; Saraiva, J. G.; Sarangi, T.; Sarkisyan-Grinbaum, E.; Sarri, F.; Sartisohn, G.; Sasaki, O.; Sasaki, Y.; Sasao, N.; Satsounkevitch, I.; Sauvage, G.; Sauvan, E.; Sauvan, J. B.; Savard, P.; Savinov, V.; Savu, D. O.; Sawyer, L.; Saxon, D. H.; Saxon, J.; Sbarra, C.; Sbrizzi, A.; Scannicchio, D. A.; Scarcella, M.; Schaarschmidt, J.; Schacht, P.; Schaefer, D.; Schaefer, U.; Schaelicke, A.; Schaepe, S.; Schaetzel, S.; Schaffer, A. C.; Schaile, D.; Schamberger, R. D.; Schamov, A. G.; Scharf, V.; Schegelsky, V. A.; Scheirich, D.; Schernau, M.; Scherzer, M. I.; Schiavi, C.; Schieck, J.; Schioppa, M.; Schlenker, S.; Schmid, P.; Schmidt, E.; Schmieden, K.; Schmitt, C.; Schmitt, S.; Schmitz, M.; Schneider, B.; Schnoor, U.; Schoeffel, L.; Schoening, A.; Schorlemmer, A. L. S.; Schott, M.; Schouten, D.; Schovancova, J.; Schram, M.; Schroeder, C.; Schroer, N.; Schultens, M. J.; Schultes, J.; Schultz-Coulon, H. -C.; Schulz, H.; Schumacher, M.; Schumm, B. A.; Schune, Ph.; Schwanenberger, C.; Schwartzman, A.; Schwegler, Ph.; Schwemling, Ph.; Schwienhorst, R.; Schwierz, R.; Schwindling, J.; Schwindt, T.; Schwoerer, M.; Sciolla, G.; Scott, W. G.; Searcy, J.; Sedov, G.; Sedykh, E.; Seidel, S. C.; Seiden, A.; Seifert, F.; Seixas, J. M.; Sekhniaidze, G.; Sekula, S. J.; Selbach, K. E.; Seliverstov, D. M.; Sellden, B.; Sellers, G.; Seman, M.; Semprini-Cesari, N.; Serfon, C.; Serin, L.; Serkin, L.; Seuster, R.; Severini, H.; Sfyrla, A.; Shabalina, E.; Shamim, M.; Shan, L. Y.; Shank, J. T.; Shao, Q. T.; Shapiro, M.; Shatalov, P. B.; Shaw, K.; Sherman, D.; Sherwood, P.; Shimizu, S.; Shimojima, M.; Shin, T.; Shiyakova, M.; Shmeleva, A.; Shochet, M. J.; Short, D.; Shrestha, S.; Shulga, E.; Shupe, M. A.; Sicho, P.; Sidoti, A.; Siegert, F.; Sijacki, Dj.; Silbert, O.; Silva, J.; Silver, Y.; Silverstein, D.; Silverstein, S. B.; Simak, V.; Simard, O.; Simic, Lj.; Simion, S.; Simioni, E.; Simmons, B.; Simoniello, R.; Simonyan, M.; Sinervo, P.; Sinev, N. B.; Sipica, V.; Siragusa, G.; Sircar, A.; Sisakyan, A. N.; Sivoklokov, S. Yu.; Sjolin, J.; Sjursen, T. B.; Skinnari, L. A.; Skottowe, H. P.; Skovpen, K.; Skubic, P.; Slater, M.; Slavicek, T.; Sliwa, K.; Smakhtin, V.; Smart, B. H.; Smestad, L.; Smirnov, S. Yu.; Smirnov, Y.; Smirnova, L. N.; Smirnova, O.; Smith, B. C.; Smith, D.; Smith, K. M.; Smizanska, M.; Smolek, K.; Snesarev, A. A.; Snow, S. W.; Snow, J.; Snyder, S.; Sobie, R.; Sodomka, J.; Soffer, A.; Solans, C. A.; Solar, M.; Solc, J.; Soldatov, E. Yu.; Soldevila, U.; Camillocci, E. Solfaroli; Solodkov, A. A.; Solovyanov, O. V.; Solovyev, V.; Soni, N.; Sopko, V.; Sopko, B.; Sosebee, M.; Soualah, R.; Soukharev, A.; Spagnolo, S.; Spano, F.; Spearman, W. R.; Spighi, R.; Spigo, G.; Spiwoks, R.; Spousta, M.; Spreitzer, T.; Spurlock, B.; St. Denis, R. D.; Stahlman, J.; Stamen, R.; Stanecka, E.; Stanek, R. W.; Stanescu, C.; Stanescu-Bellu, M.; Stanitzki, M. M.; Stapnes, S.; Starchenko, E. A.; Stark, J.; Staroba, P.; Starovoitov, P.; Staszewski, R.; Staude, A.; Stavina, P.; Steele, G.; Steinbach, P.; Steinberg, P.; Stekl, I.; Stelzer, B.; Stelzer, H. J.; Stelzer-Chilton, O.; Stenzel, H.; Stern, S.; Stewart, G. A.; Stillings, J. A.; Stockton, M. C.; Stoerig, K.; Stoicea, G.; Stonjek, S.; Strachota, P.; Stradling, A. R.; Straessner, A.; Strandberg, J.; Strandberg, S.; Strandlie, A.; Strang, M.; Strauss, E.; Strauss, M.; Strizenec, P.; Stroehmer, R.; Strom, D. M.; Strong, J. A.; Stroynowski, R.; Stugu, B.; Stumer, I.; Stupak, J.; Sturm, P.; Styles, N. A.; Soh, D. A.; Su, D.; Subramania, H. S.; Subramaniam, R.; Succurro, A.; Sugaya, Y.; Suhr, C.; Suk, M.; Sulin, V. V.; Sultansoy, S.; Sumida, T.; Sun, X.; Sundermann, J. E.; Suruliz, K.; Susinno, G.; Sutton, M. R.; Suzuki, Y.; Suzuki, Y.; Svatos, M.; Swedish, S.; Sykora, I.; Sykora, T.; Sanchez, J.; Ta, D.; Tackmann, K.; Taffard, A.; Tafirout, R.; Taiblum, N.; Takahashi, Y.; Takai, H.; Takashima, R.; Takeda, H.; Takeshita, T.; Takubo, Y.; Talby, M.; Talyshev, A.; Tamsett, M. C.; Tan, K. G.; Tanaka, J.; Tanaka, R.; Tanaka, S.; Tanaka, S.; Tanasijczuk, A. J.; Tani, K.; Tannoury, N.; Tapprogge, S.; Tardif, D.; Tarem, S.; Tarrade, F.; Tartarelli, G. F.; Tas, P.; Tasevsky, M.; Tassi, E.; Tatarkhanov, M.; Tayalati, Y.; Taylor, C.; Taylor, F. E.; Taylor, G. N.; Taylor, W.; Teinturier, M.; Teischinger, F. A.; Castanheira, M. Teixeira Dias; Teixeira-Dias, P.; Temming, K. K.; Ten Kate, H.; Teng, P. K.; Terada, S.; Terashi, K.; Terron, J.; Testa, M.; Teuscher, R. J.; Therhaag, J.; Theveneaux-Pelzer, T.; Thoma, S.; Thomas, J. P.; Thompson, E. N.; Thompson, P. D.; Thompson, P. D.; Thompson, A. S.; Thomsen, L. A.; Thomson, E.; Thomson, M.; Thong, W. M.; Thun, R. P.; Tian, F.; Tibbetts, M. J.; Tic, T.; Tikhomirov, V. O.; Tikhonov, Y. A.; Timoshenko, S.; Tiouchichine, E.; Tipton, P.; Tisserant, S.; Todorov, T.; Todorova-Nova, S.; Toggerson, B.; Tojo, J.; Tokar, S.; Tokushuku, K.; Tollefson, K.; Tomoto, M.; Tompkins, L.; Toms, K.; Tonoyan, A.; Topfel, C.; Topilin, N. D.; Torchiani, I.; Torrence, E.; Torres, H.; Torro Pastor, E.; Toth, J.; Touchard, F.; Tovey, D. R.; Trefzger, T.; Tremblet, L.; Tricoli, A.; Trigger, I. M.; Trilling, G.; Trincaz-Duvoid, S.; Tripiana, M. F.; Triplett, N.; Trischuk, W.; Trocme, B.; Troncon, C.; Trottier-McDonald, M.; Trzebinski, M.; Trzupek, A.; Tsarouchas, C.; Tseng, J. C. -L.; Tsiakiris, M.; Tsiareshka, P. V.; Tsionou, D.; Tsipolitis, G.; Tsiskaridze, S.; Tsiskaridze, V.; Tskhadadze, E. G.; Tsukerman, I. I.; Tsulaia, V.; Tsung, J. -W.; Tsuno, S.; Tsybychev, D.; Tua, A.; Tudorache, A.; Tudorache, V.; Tuggle, J. M.; Turala, M.; Turecek, D.; Cakir, I. Turk; Turlay, E.; Turra, R.; Tuts, P. M.; Tykhonov, A.; Tylmad, M.; Tyndel, M.; Tzanakos, G.; Uchida, K.; Ueda, I.; Ueno, R.; Ugland, M.; Uhlenbrock, M.; Uhrmacher, M.; Ukegawa, F.; Unal, G.; Undrus, A.; Unel, G.; Unno, Y.; Urbaniec, D.; Urquijo, P.; Usai, G.; Uslenghi, M.; Vacavant, L.; Vacek, V.; Vachon, B.; Vahsen, S.; Valenta, J.; Valentinetti, S.; Valero, A.; Valkar, S.; Valladolid Gallego, E.; Vallecorsa, S.; Valls Ferrer, J. A.; Van Berg, R.; Van Der Deijl, P. C.; van der Geer, R.; van der Graaf, H.; Van Der Leeuw, R.; van der Poel, E.; van der Ster, D.; van Eldik, N.; van Gemmeren, P.; van Vulpen, I.; Vanadia, M.; Vandelli, W.; Vanguri, R.; Vaniachine, A.; Vankov, P.; Vannucci, F.; Vari, R.; Varol, T.; Varouchas, D.; Vartapetian, A.; Varvell, K. E.; Vassilakopoulos, V. I.; Vazeille, F.; Schroeder, T. Vazquez; Vegni, G.; Veillet, J. J.; Veloso, F.; Veness, R.; Veneziano, S.; Ventura, A.; Ventura, D.; Venturi, M.; Venturi, N.; Vercesi, V.; Verducci, M.; Verkerke, W.; Vermeulen, J. C.; Vest, A.; Vetterli, M. C.; Vichou, I.; Vickey, T.; Boeriu, O. E. Vickey; Viehhauser, G. H. A.; Viel, S.; Villa, M.; Villaplana Perez, M.; Vilucchi, E.; Vincter, M. G.; Vinek, E.; Vinogradov, V. B.; Virchaux, M.; Virzi, J.; Vitells, O.; Viti, M.; Vivarelli, I.; Vaque, F. Vives; Vlachos, S.; Vladoiu, D.; Vlasak, M.; Vogel, A.; Vokac, P.; Volpi, G.; Volpi, M.; Volpini, G.; von der Schmitt, H.; von Radziewski, H.; von Toerne, E.; Vorobel, V.; Vorwerk, V.; Vos, M.; Voss, R.; Voss, T. T.; Vossebeld, J. H.; Vranjes, N.; Milosavljevic, M. Vranjes; Vrba, V.; Vreeswijk, M.; Anh, T. Vu; Vuillermet, R.; Vukotic, I.; Wagner, W.; Wagner, P.; Wahlen, H.; Wahrmund, S.; Wakabayashi, J.; Walch, S.; Walder, J.; Walker, R.; Walkowiak, W.; Wall, R.; Waller, P.; Walsh, B.; Wang, C.; Wang, F.; Wang, H.; Wang, H.; Wang, J.; Wang, J.; Wang, R.; Wang, S. M.; Wang, T.; Warburton, A.; Ward, C. P.; Wardrope, D. R.; Warsinsky, M.; Washbrook, A.; Wasicki, C.; Watanabe, I.; Watkins, P. M.; Watson, A. T.; Watson, I. J.; Watson, M. F.; Watts, G.; Watts, S.; Waugh, A. T.; Waugh, B. M.; Weber, M. S.; Weber, P.; Webster, J. S.; Weidberg, A. R.; Weigell, P.; Weingarten, J.; Weiser, C.; Wells, P. S.; Wenaus, T.; Wendland, D.; Weng, Z.; Wengler, T.; Wenig, S.; Wermes, N.; Werner, M.; Werner, P.; Werth, M.; Wessels, M.; Wetter, J.; Weydert, C.; Whalen, K.; Wheeler-Ellis, S. J.; White, A.; White, M. J.; White, S.; Whitehead, S. R.; Whiteson, D.; Whittington, D.; Wicek, F.; Wicke, D.; Wickens, F. J.; Wiedenmann, W.; Wielers, M.; Wienemann, P.; Wiglesworth, C.; Wiik-Fuchs, L. A. M.; Wijeratne, P. A.; Wildauer, A.; Wildt, M. A.; Wilhelm, I.; Wilkens, H. G.; Will, J. Z.; Williams, E.; Williams, H. H.; Willis, W.; Willocq, S.; Wilson, J. A.; Wilson, M. G.; Wilson, A.; Wingerter-Seez, I.; Winkelmann, S.; Winklmeier, F.; Wittgen, M.; Wollstadt, S. J.; Wolter, M. W.; Wolters, H.; Wong, W. C.; Wooden, G.; Wosiek, B. K.; Wotschack, J.; Woudstra, M. J.; Wozniak, K. W.; Wraight, K.; Wright, M.; Wrona, B.; Wu, S. L.; Wu, X.; Wu, Y.; Wulf, E.; Wynne, B. M.; Xella, S.; Xiao, M.; Xie, S.; Xu, C.; Xu, D.; Yabsley, B.; Yacoob, S.; Yamada, M.; Yamaguchi, H.; Yamaguchi, Y.; Yamamoto, A.; Yamamoto, K.; Yamamoto, S.; Yamamura, T.; Yamanaka, T.; Yamazaki, T.; Yamazaki, Y.; Yan, Z.; Yang, H.; Yang, H.; Yang, U. K.; Yang, Y.; Yang, Z.; Yanush, S.; Yao, L.; Yao, Y.; Yasu, Y.; Smit, G. V. Ybeles; Ye, J.; Ye, S.; Yilmaz, M.; Yoosoofmiya, R.; Yorita, K.; Yoshida, R.; Yoshihara, K.; Young, C.; Young, C. J.; Youssef, S.; Yu, D.; Yu, J.; Yu, J.; Yuan, L.; Yurkewicz, A.; Byszewski, M.; Zabinski, B.; Zaidan, R.; Zaitsev, A. M.; Zajacova, Z.; Zanello, L.; Zanzi, D.; Zaytsev, A.; Zeitnitz, C.; Zeman, M.; Zemla, A.; Zendler, C.; Zenin, O.; Zenis, T.; Zinonos, Z.; Zerwas, D.; della Porta, G. Zevi; Zhang, D.; Zhang, H.; Zhang, J.; Zhang, X.; Zhang, Z.; Zhao, L.; Zhao, Z.; Zhemchugov, A.; Zhong, J.; Zhou, B.; Zhou, N.; Zhou, Y.; Zhu, C. G.; Zhu, H.; Zhu, J.; Zhu, Y.; Zhuang, X.; Zhuravlov, V.; Zieminska, D.; Zimin, N. I.; Zimmermann, R.; Zimmermann, S.; Zimmermann, S.; Ziolkowski, M.; Zitoun, R.; Zivkovic, L.; Zmouchko, V. V.; Zobernig, G.; Zoccoli, A.; zur Nedden, M.; Zutshi, V.; Zwalinski, L.		ATLAS Collaboration	A Particle Consistent with the Higgs Boson Observed with the ATLAS Detector at the Large Hadron Collider	SCIENCE			English	Article							BROKEN SYMMETRIES; GAUGE	Nearly 50 years ago, theoretical physicists proposed that a field permeates the universe and gives energy to the vacuum. This field was required to explain why some, but not all, fundamental particles have mass. Numerous precision measurements during recent decades have provided indirect support for the existence of this field, but one crucial prediction of this theory has remained unconfirmed despite 30 years of experimental searches: the existence of a massive particle, the standard model Higgs boson. The ATLAS experiment at the Large Hadron Collider at CERN has now observed the production of a new particle with a mass of 126 giga-electron volts and decay signatures consistent with those expected for the Higgs particle. This result is strong support for the standard model of particle physics, including the presence of this vacuum field. The existence and properties of the newly discovered particle may also have consequences beyond the standard model itself.	[Jackson, P.; Soni, N.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA, Australia; [Alam, M. S.; Edson, W.; Ernst, J.] SUNY Albany, Dept Phys, Albany, NY 12246 USA; [Bahinipati, S.; Chan, K.; Gingrich, D. M.; Moore, R. W.; Pinfold, J. L.; Subramania, H. S.; Vaque, F. Vives] Univ Alberta, Dept Phys, Edmonton, AB, Canada; [Cakir, O.; Ciftci, A. K.; Ciftci, R.; Yildiz, H. D.; Kuday, S.] Ankara Univ, Dept Phys, Ankara, Turkey; Dumlupinar Univ, Dept Phys, Kutahya, Turkey; [Yilmaz, M.] Gazi Univ, Dept Phys, Ankara, Turkey; [Sultansoy, S.] TOBB Univ Econ & Technol, Div Phys, Ankara, Turkey; [Cakir, I. Turk] Turkish Atom Energy Commiss, Ankara, Turkey; [Bella, L. Aperio; Aubert, B.; Berger, N.; Colas, J.; Delmastro, M.; Di Ciaccio, L.; Doan, T. K. O.; Elles, S.; Goy, C.; Hryn'ova, T.; Jezeque, S.; Kataoka, M.; Labbe, J.; Lafaye, R.; Leveque, J.; Lombardo, V. P.; Massol, N.; Perrodo, P.; Petit, E.; Przysiezniak, H.; Richter-Was, E.; Sauvage, G.; Sauvan, E.; Schwoerer, M.; Todorov, T.; Tsionou, D.; Wingerter-Seez, I.; Zitoun, R.] CNRS, IN2P3, LAPP, Annecy Le Vieux, France; [Bella, L. Aperio; Aubert, B.; Berger, N.; Colas, J.; Delmastro, M.; Di Ciaccio, L.; Doan, T. K. O.; Elles, S.; Goy, C.; Hryn'ova, T.; Jezeque, S.; Kataoka, M.; Labbe, J.; Lafaye, R.; Leveque, J.; Lombardo, V. P.; Massol, N.; Perrodo, P.; Petit, E.; Przysiezniak, H.; Richter-Was, E.; Sauvage, G.; Sauvan, E.; Schwoerer, M.; Todorov, T.; Tsionou, D.; Wingerter-Seez, I.; Zitoun, R.] Univ Savoie, Annecy Le Vieux, France; [Asquith, L.; Blair, R. E.; Chekanov, S.; Fellmann, D.; Feng, E. J.; Fernando, W.; Goshaw, A. T.; LeCompte, T.; Love, J.; Malon, D.; Nodulman, L.; Paramonov, A.; Price, L. E.; Proudfoot, J.; Ferrando, B. M. Salvachua; Stanek, R. W.; van Gemmeren, P.; Vaniachine, A.; Yoshida, R.; Zhang, J.] Argonne Natl Lab, Div High Energy Phys, Argonne, IL 60439 USA; [Cheu, E.; Johns, K. A.; Kaushik, V.; Lampen, C. L.; Lampl, W.; Lei, X.; Loch, P.; Paleari, C. P.; Ruehr, F.; Rutherfoord, J. P.; Shupe, M. A.] Univ Arizona, Dept Phys, Tucson, AZ 85721 USA; [Brandt, A.; Brown, H.; De, K.; Farbin, A.; Griffiths, J.; Hadavand, H. K.; Heelan, L.; Hernandez, C. M.; Nilsson, P.; Ozturk, N.; Sarkisyan-Grinbaum, E.; Sosebee, M.; Spurlock, B.; Stradling, A. R.; Usai, G.; Vartapetian, A.; White, A.; Yu, J.] Univ Texas Arlington, Dept Phys, Arlington, TX 76019 USA; [Angelidakis, S.; Antonaki, A.; Fassouliotis, D.; Gazis, E. N.; Giakoumopoulou, V.; Giokaris, N.; Ioannou, P.; Iordanidou, K.; Kourkoumelis, C.; Manousakis-Katsikakis, A.; Tzanakos, G.] Univ Athens, Dept Phys, Athens, Greece; [Alexopoulos, T.; Avramidou, R.; Dris, M.; Iakovidis, G.; Karakostas, K.; Katsoufis, E.; Leontsinis, S.; Maltezos, S.; Mountricha, E.; Panagiotopoulou, E.; Papadopoulou, Th. D.; Tsipolitis, G.; Vlachos, S.] Natl Tech Univ Athens, Dept Phys, Zografos, Greece; [Abdinov, O.; Huseynov, N.; Khalil-zada, F.] Azerbaijan Acad Sci, Inst Phys, Baku 370143, Azerbaijan; [Abdallah, J.; Bosman, M.; Caminal Armadans, R.; Casado, M. P.; Cavalli-Sforza, M.; Conidi, M. C.; Demirkoz, B.; Espinal Curull, X.; Francavilla, P.; Giangiobbe, V.; Gonzalez Parra, G.; Grinstein, S.; Helsens, C.; Juste Rozas, A.; Korolkov, I.; Le Menedeu, E.; Martinez, M.; Mir, L. M.; Montejo Berlingen, J.; Nadal, J.; Osuna, C.; Pacheco Pages, A.; Padilla Aranda, C.; Riu, I.; Rossetti, V.; Rubbo, F.; Succurro, A.; Tsiskaridze, S.; Vorwerk, V.] Univ Autonoma Barcelona, Inst Fis Altes Energies, E-08193 Barcelona, Spain; [Abdallah, J.; Bosman, M.; Caminal Armadans, R.; Casado, M. P.; Cavalli-Sforza, M.; Conidi, M. C.; Demirkoz, B.; Espinal Curull, X.; Francavilla, P.; Giangiobbe, V.; Gonzalez Parra, G.; Grinstein, S.; Helsens, C.; Juste Rozas, A.; Korolkov, I.; Le Menedeu, E.; Martinez, M.; Mir, L. M.; Montejo Berlingen, J.; Nadal, J.; Osuna, C.; Pacheco Pages, A.; Padilla Aranda, C.; Riu, I.; Rossetti, V.; Rubbo, F.; Succurro, A.; Tsiskaridze, S.; Vorwerk, V.] Univ Autonoma Barcelona, Dept Fis, E-08193 Barcelona, Spain; [Abdallah, J.; Bosman, M.; Caminal Armadans, R.; Casado, M. P.; Cavalli-Sforza, M.; Conidi, M. C.; Demirkoz, B.; Espinal Curull, X.; Francavilla, P.; Giangiobbe, V.; Gonzalez Parra, G.; Grinstein, S.; Helsens, C.; Juste Rozas, A.; Korolkov, I.; Le Menedeu, E.; Mir, L. M.; Montejo Berlingen, J.; Nadal, J.; Osuna, C.; Pacheco Pages, A.; Padilla Aranda, C.; Riu, I.; Rossetti, V.; Rubbo, F.; Succurro, A.; Tsiskaridze, S.; Vorwerk, V.] ICREA, Barcelona, Spain; [Borjanovic, I.; Krstic, J.; Popovic, D. S.; Sijacki, Dj.; Simic, Lj.] Univ Belgrade, Inst Phys, Belgrade, Serbia; [Bozovic-Jelisavcic, I.; Cirkovic, P.; Jovin, T.; Mamuzic, J.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Buanes, T.; Burgess, T.; Eigen, G.; Kastanas, A.; Liebig, W.; Lipniacka, A.; Rosendahl, P. L.; Sandaker, H.; Sjursen, T. B.; Stugu, B.; Tonoyan, A.; Ugland, M.] Univ Bergen, Dept Phys & Technol, Bergen, Norway; [Bach, A. M.; Galtieri, A. Barbaro; Barnett, R. M.; Beringer, J.; Biesiada, J.; Calafiura, P.; Caminada, L. M.; Ciocio, A.; Clarke, R. N.; Cooke, M.; Copic, K.; Dube, S.; Einsweiler, K.; Gaponenko, A.; Garcia-Sciveres, M.; Gilchriese, M.; Haber, C.; Hance, M.; Heinemann, B.; Hinchliffe, I.; Hsu, S. -C.; Hurwitz, M.; Lavrijsen, W.; Leggett, C.; Loscutoff, P.; Madaras, R. J.; Ovcharova, A.; Griso, S. Pagan; Pranko, A.; Quarrie, D. R.; Shapiro, M.; Skinnari, L. A.; Tatarkhanov, M.; Tibbetts, M. J.; Trilling, G.; Tsulaia, V.; Vahsen, S.; Varouchas, D.; Virzi, J.; Yao, Y.] Lawrence Berkeley Natl Lab, Div Phys, Berkeley, CA USA; [Bach, A. M.; Galtieri, A. Barbaro; Barnett, R. M.; Beringer, J.; Biesiada, J.; Calafiura, P.; Caminada, L. M.; Ciocio, A.; Clarke, R. N.; Cooke, M.; Copic, K.; Dube, S.; Einsweiler, K.; Gaponenko, A.; Garcia-Sciveres, M.; Gilchriese, M.; Haber, C.; Hance, M.; Heinemann, B.; Hinchliffe, I.; Hsu, S. -C.; Hurwitz, M.; Lavrijsen, W.; Loscutoff, P.; Madaras, R. J.; Ovcharova, A.; Griso, S. Pagan; Pranko, A.; Quarrie, D. R.; Shapiro, M.; Skinnari, L. A.; Tatarkhanov, M.; Tibbetts, M. J.; Trilling, G.; Tsulaia, V.; Vahsen, S.; Varouchas, D.; Virzi, J.; Yao, Y.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Aliev, M.; Giorgi, F. M.; Grancagnolo, S.; Herrberg, R.; Hristova, I.; Kind, O.; Kolanoski, H.; Kwee, R.; Lacker, H.; Leyton, M.; Lohse, T.; Mandrysch, R.; Nikiforov, A.; Schulz, H.; Wendland, D.; zur Nedden, M.] Humboldt Univ, Dept Phys, Berlin, Germany; [Agustoni, M.; Ancu, L. S.; Battaglia, A.; Beck, H. P.; Borer, C.; Ereditato, A.; Martin, T. Fonseca; Gallo, V.; Haug, S.; Kabana, S.; Kruker, T.; Marti, L. F.; Pretzl, K.; Schneider, B.; Topfel, C.; Weber, M. S.] Univ Bern, Albert Einstein Ctr Fundamental Phys, Bern, Switzerland; [Agustoni, M.; Ancu, L. S.; Battaglia, A.; Beck, H. P.; Borer, C.; Ereditato, A.; Martin, T. Fonseca; Gallo, V.; Haug, S.; Kabana, S.; Kruker, T.; Marti, L. F.; Pretzl, K.; Schneider, B.; Topfel, C.; Weber, M. S.] Univ Bern, High Energy Phys Lab, Bern, Switzerland; [Allbrooke, B. M. M.; Bansil, H. S.; Bracinik, J.; Charlton, D. G.; Chisholm, A. S.; Collins, N. J.; Curtis, C. J.; Dowell, J. D.; Hadley, D. R.; Hawkes, C. M.; Head, S. J.; Hillier, S. J.; Mahout, G.; Martin, T. A.; Mclaughlan, T.; Newman, P. R.; Nikolopoulos, K.; Palmer, J. D.; Slater, M.; Thomas, J. P.; Thompson, P. D.; Watkins, P. M.; Watson, A. T.; Watson, M. F.; Wilson, J. A.] Univ Birmingham, Sch Phys & Astron, Birmingham, W Midlands, England; [Akdogan, T.; Arik, E.; Arik, M.; Istin, S.; Ozcan, V. E.; Rador, T.] Bogazici Univ, Dept Phys, Istanbul, Turkey; [Cetin, S. A.] Dogus Univ, Div Phys, Istanbul, Turkey; [Bedda, A. J.; Bedda, A.; Bingul, A.] Gaziantep Univ, Dept Engn Phys, Gaziantep, Turkey; Istanbul Tech Univ, Dept Phys, Istanbul, Turkey; [Bellagamba, L.; Bertin, A.; Bindi, M.; Boscherini, D.; Bruni, A.; Bruni, G.; Bruschi, M.; Caforio, D.; Ciocca, C.; Corradi, M.; De Castro, S.; Di Sipio, R.; Fabbri, L.; Franchini, M.; Giacobbe, B.; Giusti, P.; Grafstroem, P.; Jha, M. K.; Massa, I.; Mengarelli, A.; Monzani, S.; Negrini, M.; Piccinini, M.; Polini, A.; Rinaldi, L.; Romano, M.; Sbarra, C.; Sbrizzi, A.; Semprini-Cesari, N.; Spighi, R.; Valentinetti, S.; Villa, M.; Zoccoli, A.] Ist Nazl Fis Nucl, Sez Bologna, Bologna, Italy; [Bertin, A.; Bindi, M.; Caforio, D.; Ciocca, C.; De Castro, S.; Di Sipio, R.; Fabbri, L.; Franchini, M.; Grafstroem, P.; Massa, I.; Mengarelli, A.; Monzani, S.; Piccinini, M.; Romano, M.; Sbrizzi, A.; Semprini-Cesari, N.; Valentinetti, S.; Villa, M.; Zoccoli, A.] Univ Bologna, Dipartimento Fis, Bologna, Italy; [Abajyan, T.; Arutinov, D.; Avolio, G.; Backhaus, M.; Barbero, M.; Bechtle, P.; Brock, I.; Cristinziani, M.; Davey, W.; Desch, K.; Dingfelder, J.; Gaycken, G.; Geich-Gimbel, C.; Glatzer, J.; Gonella, L.; Haefner, P.; Havranek, M.; Hellmich, D.; Hillert, S.; Huegging, F.; Karagounis, M.; Khoriauli, G.; Koevesarki, P.; Kostyukhin, V. V.; Kraus, J. K.; Kroseberg, J.; Krueger, H.; Lapoire, C.; Lehmacher, M.; Leyko, A. M.; Limbach, C.; Loddenkoetter, T.; Mazur, M.; Moeser, N.; Mueller, K.; Nanava, G.; Nattermann, T.; Nuncio-Quiroz, A. -E.; Pohl, D.; Psoroulas, S.; Schaepe, S.; Schmieden, K.; Schmitz, M.; Schultens, M. J.; Schwindt, T.; Stillings, J. A.; Therhaag, J.; Tsung, J. -W.; Uchida, K.; Uhlenbrock, M.; Urquijo, P.; Vogel, A.; von Toerne, E.; Wang, T.; Wermes, N.; Wienemann, P.; Zendler, C.; Zimmermann, R.; Zimmermann, S.] Univ Bonn, Inst Phys, Bonn, Germany; [Ahlen, S. P.; Black, K. M.; Butler, J. M.; Dell'Asta, L.; Helary, L.; Shank, J. T.; Yan, Z.; Youssef, S.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Aefsky, S.; Amelung, C.; Bensinger, J. R.; Blocker, C.; Coffey, L.; Daya-Ishmukhametova, R. K.; Gozpinar, S.; Pomeroy, D.; Sciolla, G.] Brandeis Univ, Dept Phys, Waltham, MA USA; [Caloba, L. P.; Maidantchik, C.; Marroquim, F.; Nepomuceno, A. A.; Perantoni, M.; Seixas, J. M.] Fed Univ Rio De Janeiro COPPE EE IF, Rio De Janeiro, Brazil; [Cerqueira, A. S.; de Andrade Filho, L. Manhaes] Fed Univ Juiz de Fora UFJF, Juiz De Fora, Brazil; [do Vale, M. A. B.] Fed Univ Sao Joao del Rei UFSJ, Sao Joao Del Rei, Brazil; [Donadelli, M.; Leite, M. A. L.] Univ Sao Paulo, Inst Fis, BR-01498 Sao Paulo, Brazil; [Adams, D. L.; Assamagan, K.; Baker, M. D.; Bege, M.; Bernius, C.; Chen, H.; Chernyatin, V.; Debbe, R.; Dhullipud, R.; Ernst, M.; Gadfort, T.; Gibbard, B.; Gordon, H. A.; Greenwood, Z. D.; Klimentov, A.; Lanni, F.; Lissauer, D.; Lynn, D.; Ma, H.; Maeno, T.; Majewski, S.; Metcalfe, J.; Nevski, P.; Okawa, H.; Damazio, D. Oliveira; Paige, F.; Panitkin, S.; Park, W.; Pleier, M. -A.; Poblaguev, A.; Polychronakos, V.; Pravahan, R.; Protopopescu, S.; Purohit, M.; Radeka, V.; Rahm, D.; Rajagopalan, S.; Redlinger, G.; Sawyer, L.; Sircar, A.; Snyder, S.; Steinberg, P.; Stumer, I.; Subramaniam, R.; Takai, H.; Tamsett, M. C.; Triplett, N.; Undrus, A.; Wenaus, T.; Ye, S.; Yu, D.; Zaytsev, A.] Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; [Alexa, C.; Badescu, E.; Boldea, V.; Buda, S. I.; Caprini, I.; Caprini, M.; Chitan, A.; Ciubancan, M.; Constantinescu, S.; Cuciuc, C. -M.; Dinut, F.; Dita, P.; Dita, S.; Micu, L.; Olariu, A.; Pantea, D.; Popeneciu, G. A.; Rotaru, M.; Stoicea, G.; Tudorache, A.; Tudorache, V.] Natl Inst Phys & Nucl Engn, Bucharest, Romania; [Darlea, G. L.] Univ Politehn Bucuresti, Bucharest, Romania; West Univ Timisoara, Timisoara, Romania; [Gonzalez Silva, M. L.; Otero y Garzon, G.; Piegaia, R.; Romeo, G.] Univ Buenos Aires, Dept Fis, Buenos Aires, DF, Argentina; [Ask, S.; Barlow, N.; Batley, J. R.; Brochu, F. M.; Buttinger, W.; Carter, J. R.; Chapman, J. D.; Cowden, C.; French, S. T.; Frost, J. A.; Hill, J. C.; Kaneti, S.; Khoo, T. J.; Lester, C. G.; Outschoorn, V. Martinez; Moeller, V.; Parker, M. A.; Robinson, D.; Sandoval, T.; Thomson, M.; Ward, C. P.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Gillberg, D.; Koffas, T.; Lacey, J.; Liu, C.; Marchand, J. F.; McCarthy, T. G.; Oakham, F. G.; Randrianarivony, K.; Tarrade, F.; Ueno, R.; Vincter, M. G.; Whalen, K.] Carleton Univ, Dept Phys, Ottawa, ON K1S 5B6, Canada; [Aleksa, M.; Anastopoulos, C.; Anghinolfi, F.; Baak, M. A.; Bachas, K.; Banfi, D.; Battistin, M.; Bellomo, M.; Beltramello, O.; Berge, D.; Bianchi, R. M.; Blanchot, G.; Bogaerts, J. A.; Boyd, J.; Bremer, J.; Burckhart, H.; Campana, S.; Garrido, M. D. M. Capeans; Carli, T.; Catinaccio, A.; Catmore, J. R.; Cattai, A.; Cerri, A.; Barajas, C. A. Chavez; Childers, J. T.; Chromek-Burckhart, D.; Cote, D.; Danielsson, H. O.; Dell'Acqua, A.; Di Girolamo, A.; Di Girolamo, B.; Di Micco, B.; Dittus, F.; Dobinson, R.; Dobos, D.; Dobson, E.; Dopke, J.; Dudarev, A.; Duehrssen, M.; Dydak, F.; Ellis, N.; Elsing, M.; Fabre, C.; Farthouat, P.; Fassnacht, P.; Francis, D.; Franz, S.; Froeschl, R.; Froidevaux, D.; Torregrosa, E. Fullana; Gabaldon, C.; Garelli, N.; Garonne, V.; Gianotti, F.; Gibson, S. M.; Gildemeister, O.; Godlewski, J.; Goossens, L.; Gorini, B.; Gray, H. M.; Haas, S.; Hahn, F.; Haider, S.; Hauschild, M.; Hawkings, R. J.; Heller, M.; Correia, A. M. Henriques; Hervas, L.; Hoecker, A.; Huhtinen, M.; Inigo-Golfin, J.; Jaekel, M. R.; Jansen, H.; Jenni, P.; Joram, C.; Jungst, R. M.; Kaneda, M.; Kaplon, J.; Kerschen, N.; Klioutchnikova, T.; Koeneke, K.; Lamanna, M.; Lassnig, M.; Miotto, G. Lehmann; Lenzi, B.; Lichard, P.; Malaescu, B.; Malyukov, S.; Mapelli, A.; Mapelli, L.; Marshall, Z.; Martin, B.; Messina, A.; Meyer, T. C.; Michal, S.; Molfetas, A.; Morley, A. K.; Mornacchi, G.; Muenstermann, D.; Nairz, A. M.; Nakahama, Y.; Negri, G.; Nessi, M.; Nicquevert, B.; Nordberg, M.; Ohm, C. C.; Palestini, S.; Pauly, T.; Pernegger, H.; Peters, K.; Petersen, B. A.; Petersen, J.; Piacquadio, G.; Pommes, K.; Poppleton, A.; Bueso, X. Portell; Poulard, G.; Prasad, S.; Raymond, M.; Rembser, C.; Dos Santos, D. Roda; Roe, S.; Salek, D.; Salzburger, A.; Savu, D. O.; Schlenker, S.; Schmid, P.; Schott, M.; Sfyrla, A.; Spigo, G.; Spiwoks, R.; Stewart, G. A.; Teischinger, F. A.; Ten Kate, H.; Torchiani, I.; Tremblet, L.; Tricoli, A.; Tsarouchas, C.; Unal, G.; van der Ster, D.; van Eldik, N.; Vandelli, W.; Veness, R.; Vinek, E.; Voss, R.; Vuillermet, R.; Wells, P. S.; Wengler, T.; Wenig, S.; Werner, P.; Wilkens, H. G.; Winklmeier, F.; Wotschack, J.; Byszewski, M.; Zajacova, Z.; Zwalinski, L.] CERN, Geneva, Switzerland; [Anderson, K. J.; Boveia, A.; Canelli, F.; Cheng, Y.; Choudalakis, G.; Fiascaris, M.; Gardner, R. W.; Plante, I. Jen-La; Kapliy, A.; Li, H. L.; Melachrinos, C.; Merritt, F. S.; Meyer, C.; Miller, D. W.; Okumura, Y.; Onyisi, P. U. E.; Oreglia, M. J.; Penning, B.; Pilcher, J. E.; Shochet, M. J.; Tompkins, L.; Tuggle, J. M.; Vukotic, I.; Webster, J. S.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Diaz, M. A.; Olivares Pino, S. A.; Quinonez, F.] Pontificia Univ Catolica Chile, Dept Fis, Santiago, Chile; [Brooks, W. K.; Canelli, F.; Carquin, E.; Kuleshov, S.; Pezoa, R.; Prokoshin, F.] Univ Tecn Federico Santa Maria, Dept Fis, Valparaiso, Chile; [Bai, Y.; Jin, S.; Lu, F.; Ouyang, Q.; Ruan, X.; Shan, L. Y.; Yao, L.] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Andrieux, M. -L.; Han, L.; Jiang, Y.; Li, S.; Liu, K.; Liu, M.; Liu, Y.; Peng, H.; Wang, H.; Wu, Y.; Xu, C.; Zhang, D.; Zhao, Z.; Zhu, Y.] Univ Sci & Technol China, Dept Modern Phys, Hefei, Anhui, Peoples R China; [Andrieux, M. -L.; Chen, S.] Nanjing Univ, Dept Phys, Nanjing, Jiangsu, Peoples R China; [Andrieux, M. -L.; Feng, C.; Ge, P.; Meng, Z.; Zhang, X.; Zhu, C. G.] Shandong Univ, Sch Phys, Jinan, Shandong, Peoples R China; [Boumediene, D.; Busato, E.; Calvet, D.; Cinca, D.; Donini, J.; Febbraro, R.; Ghodbane, N.; Gris, Ph.; Guicheney, C.; Liao, H.; Pallin, D.; Hernandez, D. Paredes; Podlyski, F.; Santoni, C.; Vazeille, F.] Clermont Univ, Lab Phys Corpusculaire, Clermont Ferrand, France; [Boumediene, D.; Busato, E.; Calvet, D.; Cinca, D.; Donini, J.; Febbraro, R.; Ghodbane, N.; Gris, Ph.; Guicheney, C.; Liao, H.; Pallin, D.; Hernandez, D. Paredes; Podlyski, F.; Santoni, C.; Vazeille, F.] Univ Blaise Pascal, Clermont Ferrand, France; [Boumediene, D.; Busato, E.; Calvet, D.; Calvet, S.; Toro, R. Camacho; Cinca, D.; Donini, J.; Febbraro, R.; Ghodbane, N.; Gris, Ph.; Guicheney, C.; Liao, H.; Pallin, D.; Hernandez, D. Paredes; Podlyski, F.; Santoni, C.; Vazeille, F.] CNRS IN2P3, Clermont Ferrand, France; [Altheimer, A.; Andeen, T.; Angerami, A.; Brooijmans, G.; Chen, Y.; Dodd, J.; Grau, N.; Guo, J.; Hu, D.; Hughes, E. W.; Nikiforou, N.; Parsons, J. A.; Penson, A.; Perez, K.; Reale, V. Perez; Scherzer, M. I.; Spousta, M.; Thompson, E. N.; Tian, F.; Tuts, P. M.; Urbaniec, D.; Williams, E.; Willis, W.; Wulf, E.; Zivkovic, L.] Columbia Univ, Nevis Lab, Irvington, NY USA; [Boelaert, N.; Dam, M.; Gregersen, K.; Hansen, J. R.; Hansen, J. B.; Hansen, J. D.; Hansen, P. H.; Heisterkamp, S.; Jakobsen, S.; Loevschall-Jensen, A. E.; Jez, P.; Joergensen, M. D.; Kadlecik, P.; Klinkby, E. B.; Lundquist, J.; Mackeprang, R.; Mehlhase, S.; Petersen, T. C.; Simonyan, M.; Thomsen, L. A.; Xella, S.] Univ Copenhagen, Niels Bohr Inst, Copenhagen, Denmark; [Capua, M.; Crosetti, G.; Fazio, S.; Lavorini, V.; Mastroberardino, A.; Morello, G.; Policicchio, A.; Salvatore, D.; Schioppa, M.; Susinno, G.; Tassi, E.] Ist Nazl Fis Nucl, Grp Coll Cosenza, Arcavacata Di Rende, Italy; [Capua, M.; Crosetti, G.; Fazio, S.; La Rotonda, L.; Lavorini, V.; Mastroberardino, A.; Morello, G.; Policicchio, A.; Salvatore, D.; Schioppa, M.; Susinno, G.; Tassi, E.] Univ Calabria, Dipartimento Fis, Arcavacata Di Rende, Italy; [Adamczyk, L.; Bold, T.; Dabrowski, W.; Dwuznik, M.; Grabowska-Bold, I.; Ikeno, L.; Kisielewska, D.; Koperny, S.; Kowalski, T. Z.; La Rotonda, L.; Mindur, B.; Przybycien, M.] AGH Univ Sci & Technol, Fac Phys & Appl Comp Sci, Krakow, Poland; [Banas, E.; Blocki, J.; de Renstrom, P. A. Bruckman; Derendarz, D.; Gornicki, E.; Hajduk, Z.; Iwanski, W.; Kaczmarska, A.; Korcyl, K.; Malecki, Pa.; Malecki, P.; Olszewski, A.; Olszowska, J.; Stanecka, E.; Staszewski, R.; Trzebinski, M.; Trzupek, A.; Turala, M.; Wolter, M. W.; Wosiek, B. K.; Wozniak, K. W.; Zabinski, B.; Zemla, A.] Polish Acad Sci, Henryk Niewodniczanski Inst Nucl Phys, Krakow, Poland; [Yagci, K. Dindar; Firan, A.; Hoffman, J.; Joffe, D.; Kama, S.; Kehoe, R.; Randle-Conde, A. S.; Rios, R. R.; Sekula, S. J.; Stroynowski, R.; Ye, J.] So Methodist Univ, Dept Phys, Dallas, TX 75275 USA; [Ahsan, M.; Izen, J. M.; Lou, X.; Reeves, K.; Wong, W. C.] Univ Texas Dallas, Dept Phys, Richardson, TX 75083 USA; [Kuutmann, E. Bergeaas; Bloch, I.; Dassoulas, J. A.; Dietrich, J.; Ehrenfeld, W.; Ferrara, V.; Fischer, G.; Friedrich, C.; Glazov, A.; Goebel, M.; Fajardo, L. S. Gomez; Da Costa, J. Goncalves Pinto Firmino; Gosdzik, B.; Grahn, K. J.; Gregor, I. M.; Hiller, K. H.; Huettmann, A.; Belenguer, M. Jimenez; Johnert, S.; Karnevskiy, M.; Katzy, J.; Kono, T.; Kuhl, T.; Lange, C.; Lobodzinska, E.; Ludwig, D.; Medinnis, M.; Moenig, K.; Naumann, T.; Cavalcanti, T. Perez; Petschull, D.; Piec, S. M.; Radescu, V.; Rubinskiy, I.; Sedov, G.; Stanescu-Bellu, M.; Stanitzki, M. M.; Starovoitov, P.; Styles, N. A.; Tackmann, K.; Vankov, P.; Viti, M.; Wasicki, C.; Wildt, M. A.; Zhu, H.] DESY, Hamburg, Germany; [Kuutmann, E. Bergeaas; Bloch, I.; Dassoulas, J. A.; Dietrich, J.; Ehrenfeld, W.; Ferrara, V.; Fischer, G.; Friedrich, C.; Glazov, A.; Goebel, M.; Fajardo, L. S. Gomez; Da Costa, J. Goncalves Pinto Firmino; Gosdzik, B.; Grahn, K. J.; Gregor, I. M.; Hiller, K. H.; Huettmann, A.; Belenguer, M. Jimenez; Johnert, S.; Karnevskiy, M.; Katzy, J.; Kono, T.; Kuhl, T.; Lange, C.; Lobodzinska, E.; Ludwig, D.; Medinnis, M.; Moenig, K.; Naumann, T.; Cavalcanti, T. Perez; Petschull, D.; Piec, S. M.; Radescu, V.; Rubinskiy, I.; Sedov, G.; Stanescu-Bellu, M.; Stanitzki, M. M.; Starovoitov, P.; Styles, N. A.; Tackmann, K.; Vankov, P.; Viti, M.; Wasicki, C.; Wildt, M. A.; Zhu, H.] DESY, Zeuthen, Germany; [Bunse, M.; Esch, H.; Goessling, C.; Hirsch, F.; Jung, C. A.; Klingenberg, R.; Reisinger, I.] Tech Univ Dortmund, Inst Expt Phys 4, Dortmund, Germany; [Anger, P.; Czodrowski, P.; Friedrich, F.; Goepfert, T.; Kobel, M.; Leonhardt, K.; Ludwig, A.; Mader, W. F.; Morgenstern, M.; Prudent, X.; Rudolph, C.; Schnoor, U.; Schwierz, R.; Seifert, F.; Steinbach, P.; Straessner, A.; Vest, A.; Wahrmund, S.] Tech Univ Dresden, Inst Kern & Teilchenphys, D-01062 Dresden, Germany; [Arce, A. T. H.; Benjamin, D. P.; Bocci, A.; Ebenstein, W. L.; Fowler, A. J.; Ko, B. R.; Kotwal, A.; Oh, S. H.; Wang, C.] Duke Univ, Dept Phys, Durham, NC 27706 USA; [Bhimji, W.; Buckley, A. G.; Clark, P. J.; Debenedetti, C.; Harrington, R. D.; Martin, V. J.; O'Brien, B. J.; Schaelicke, A.; Selbach, K. E.; Smart, B. H.; Washbrook, A.; Wynne, B. M.] Univ Edinburgh, SUPA Sch Phys & Astron, Edinburgh, Midlothian, Scotland; [Annovi, A.; Antonelli, M.; Bilokon, H.; Cerutti, F.; Curatolo, M.; Di Nardo, R.; Esposito, B.; Gatti, C.; Laurelli, P.; Maccarrone, G.; Sansoni, A.; Testa, M.; Vilucchi, E.; Volpi, G.] Ist Nazl Fis Nucl, Nazl Frascati Lab, I-00044 Frascati, Italy; [Aad, G.; Ahles, F.; Barber, T.; Bernhard, R.; Boehler, M.; Bruneliere, R.; Christov, A.; Consorti, V.; Fehling-Kaschek, M.; Flechl, M.; Hartert, J.; Herten, G.; Horner, S.; Jakobs, K.; Janus, M.; Kononov, A. I.; Kuehn, S.; Lai, S.; Landgraf, U.; Lohwasser, K.; Ludwig, I.; Ludwig, J.; Mahboubi, K.; Mohr, W.; Nilsen, H.; Parzefall, U.; Rammensee, M.; Rave, T. C.; Rurikova, Z.; Schmidt, E.; Schumacher, M.; Siegert, F.; Stoerig, K.; Sundermann, J. E.; Temming, K. K.; Thoma, S.; Tsiskaridze, V.; Venturi, M.; Vivarelli, I.; von Radziewski, H.; Anh, T. Vu; Warsinsky, M.; Weiser, C.; Werner, M.; Wiik-Fuchs, L. A. M.; Winkelmann, S.; Xie, S.; Zimmermann, S.] Univ Freiburg, Fak Math & Phys, D-79106 Freiburg, Germany; [Abdelalim, A. A.; Alexandre, G.; Backes, M.; Barone, G.; Bell, P. J.; Bell, W. H.; Noccioli, E. Benhar; Blondel, A.; Bucci, F.; Clark, A.; Dao, V.; Doglioni, C.; Ferrere, D.; Gadomski, S.; Gonzalez-Sevilla, S.; Goulette, M. P.; Iacobucci, G.; La Rosa, A.; Lister, A.; dit Latour, B. Martin; Mermod, P.; Herrera, C. Mora; Nektarijevic, S.; Nessi, M.; Nikolics, K.; Pasztor, G.; Picazio, A.; Pohl, M.; Rosbach, K.; Rosselet, L.; Wu, X.] Univ Geneva, Sect Phys, Geneva, Switzerland; [Barberis, D.; Beccherle, R.; Caso, C.; Dameri, M.; Darbo, G.; Parodi, A. Ferretto; Gagliardi, G.; Gemme, C.; Morettini, P.; Osculati, B.; Parodi, F.; Passaggio, S.; Rossi, L. P.; Schiavi, C.] Ist Nazl Fis Nucl, Sez Genova, Genoa, Italy; [Barberis, D.; Caso, C.; Dameri, M.; Parodi, A. Ferretto; Gagliardi, G.; Osculati, B.; Parodi, F.; Schiavi, C.] Univ Genoa, Dipartimento Fis, Genoa, Italy; [Chikovani, L.; Tskhadadze, E. G.] Iv Javakhishvili Tbilisi State Univ, E Andronikashvili Inst Phys, Tbilisi, Georgia; [Djobava, T.; Khubua, J.; Mchedlidze, G.; Mosidze, M.] Tbilisi State Univ, Inst High Energy Phys, Tbilisi, Georgia; [Doherty, T.; Dueren, M.; Stenzel, H.] Univ Giessen, Inst Phys 2, Giessen, Germany; [Allwood-Spiers, S. E.; Bates, R. L.; Britton, D.; Bussey, P.; Buttar, C. M.; Collins-Tooth, C.; D'Auria, S.; Doyle, A. T.; Edwards, N. C.; Ferrag, S.; Ferrando, J.; de Lima, D. E. Ferreira; Gemmell, A.; Gul, U.; Kar, D.; Kenyon, M.; Moraes, A.; O'Shea, V.; Barrera, C. Oropeza; Robson, A.; Saxon, D. H.; Smith, K. M.; St. Denis, R. D.; Steele, G.; Thompson, A. S.; Wraight, K.; Wright, M.] Univ Glasgow, SUPA Sch Phys & Astron, Glasgow, Lanark, Scotland; [Bierwagen, K.; Blumenschein, U.; Brandt, O.; Erdmann, J.; Evangelakou, D.; George, M.; Grosse-Knetter, J.; Guindon, S.; Haller, J.; Hamer, M.; Henrichs, A.; Hensel, C.; Keil, M.; Knue, A.; Kohn, F.; Krieger, N.; Kroeninger, K.; Lemmer, B.; Magradze, E.; Mann, A.; Meyer, J.; Morel, J.; Nackenhorst, O.; Pashapour, S.; Quadt, A.; Roe, A.; Schorlemmer, A. L. S.; Serkin, L.; Shabalina, E.; Uhrmacher, M.; Schroeder, T. Vazquez; Weber, P.; Weingarten, J.] Univ Gottingen, Inst Phys 2, Gottingen, Germany; [Albrand, S.; Buat, Q.; Clement, B.; Collot, J.; Crepe-Renaudin, S.; Delemontex, T.; Delsart, P. A.; Genest, M. H.; Hostachy, J. -Y.; Laisne, E.; Ledroit-Guillon, F.; Lleres, A.; Lucotte, A.; Malek, F.; Stark, J.; Sun, X.; Trocme, B.; Wang, J.; Weydert, C.] Univ Grenoble 1, Lab Phys Subatom & Cosmol, Grenoble, France; [Albrand, S.; Clement, B.; Collot, J.; Crepe-Renaudin, S.; Delemontex, T.; Delsart, P. A.; Genest, M. H.; Hostachy, J. -Y.; Laisne, E.; Ledroit-Guillon, F.; Lleres, A.; Lucotte, A.; Malek, F.; Stark, J.; Sun, X.; Trocme, B.; Wang, J.; Weydert, C.] CNRS, IN2P3, Grenoble, France; [Albrand, S.; Clement, B.; Collot, J.; Crepe-Renaudin, S.; Delemontex, T.; Delsart, P. A.; Genest, M. H.; Hostachy, J. -Y.; Laisne, E.; Ledroit-Guillon, F.; Lleres, A.; Lucotte, A.; Malek, F.; Stark, J.; Sun, X.; Trocme, B.; Wang, J.; Weydert, C.] Inst Natl Polytech Grenoble, F-38031 Grenoble, France; [Addy, T. N.; Harvey, A.; Lazovich, T.; McFarlane, K. W.; Shin, T.; Vassilakopoulos, V. I.] Hampton Univ, Dept Phys, Hampton, VA 23668 USA; [da Costa, J. Barreiro Guimaraes; Belloni, A.; Brandenburg, G. W.; Catastini, P.; Conti, G.; Franklin, M.; Huth, J.; Jeanty, L.; Kagan, M.; Mateos, D. Lopez; Mercurio, K. M.; Mills, C.; Morii, M.; Skottowe, H. P.; Smith, B. C.; Spearman, W. R.; della Porta, G. Zevi] Harvard Univ, Lab Particle Phys & Cosmol, Cambridge, MA 02138 USA; [Anders, G.; Andrei, V.; Davygora, Y.; Dietzsch, T. A.; Dunford, M.; Geweniger, C.; Hanke, P.; Henke, M.; Khomich, A.; Kluge, E. -E.; Lang, V. S.; Lendermann, V.; Lepold, F.; Meier, K.; Mueller, F.; Poddar, S.; Scharf, V.; Schultz-Coulon, H. -C.; Stamen, R.; Wessels, M.] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Anders, C. F.; Kasieczka, G.; Narayan, R.; Schaetzel, S.; Schmitt, S.; Schoening, A.] Heidelberg Univ, Inst Phys, Heidelberg, Germany; [Kugel, A.; Maenner, R.; Schroer, N.] Heidelberg Univ, ZITI Inst Tech Informat, Mannheim, Germany; [Nagasaka, Y.] Hiroshima Inst Technol, Fac Appl Informat Sci, Hiroshima, Japan; [Brunet, S.; Cwetanski, P.; Evans, H.; Gagnon, P.; Jain, V.; Luehring, F.; Ogren, H.; Penwell, J.; Poveda, J.; Price, D.; Whittington, D.; Zieminska, D.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; [Epp, B.; Jussel, P.; Kneringer, E.; Kuhn, D.; Lukas, W.; Rudolph, G.] Leopold Franzens Univ, Inst Astro & Teilchenphys, Innsbruck, Austria; [Behera, P. K.; Limper, M.; Mallik, U.; Pylypchenko, Y.; Zaidan, R.] Univ Iowa, Iowa City, IA USA; [Chen, C.; Cochran, J.; De Lorenzi, F.; Dudziak, F.; Krumnack, N.; Lorenz, J.; Prell, S.; Rosenberg, E. I.; Ruiz-Martinez, A.; Shrestha, S.; Yamamoto, K.] Iowa State Univ, Dept Phys & Astron, Ames, IA USA; [Aleksandrov, I. N.; Bardin, D. Y.; Bednyakov, V. A.; Boyko, I. R.; Budagov, I. A.; Chelkov, G. A.; Cheplakov, A.; Chizhov, M. V.; Dedovich, D. V.; Demichev, M.; Glonti, G. L.; Gostkin, M. I.; Grigalashvili, N.; Huseynov, N.; Kalinovskaya, L. V.; Kazarinov, M. Y.; Kekelidze, G. D.; Kharchenko, D.; Khramov, E.; Kolesnikov, V.; Kotov, V. M.; Kruchonak, U.; Krumshteyn, Z. V.; Kukhtin, V.; Ladygin, E.; Minashvili, I. A.; Mineev, M.; Olchevski, A. G.; Peshekhonov, V. D.; Plotnikova, E.; Pozdnyakov, V.; Rumyantsev, L.; Rusakovich, N. A.; Sadykov, R.; Shiyakova, M.; Sisakyan, A. N.; Topilin, N. D.; Vinogradov, V. B.; Zhemchugov, A.; Zimin, N. I.] Joint Inst Nucl Res Dubna, Joint Inst Nucl Res, Dubna, Russia; [Amako, K.; Arai, Y.; Doi, Y.; Haruyama, T.; Ikegami, Y.; Iwasaki, H.; Kanzaki, J.; Kohriki, T.; Kondo, T.; Makida, Y.; Manabe, A.; Mitsui, S.; Nagano, K.; Nozaki, M.; Odaka, S.; Sasaki, O.; Suzuki, Y.; Takubo, Y.; Tanaka, S.; Terada, S.; Tokushuku, K.; Tsuno, S.; Unno, Y.; Yamada, M.; Yamamoto, A.; Yasu, Y.] High Energy Accelerator Res Org, KEK, Tsukuba, Ibaraki, Japan; [Hayakawa, T.; King, M.; Kishimoto, T.; Kitamura, T.; Kurashige, H.; Matsushita, T.; Ochi, A.; Suzuki, Y.; Takeda, H.; Tani, K.; Watanabe, I.; Yamazaki, Y.; Yuan, L.] Kobe Univ, Grad Sch Sci, Kobe, Hyogo, Japan; [Ishino, M.; Sasao, N.; Sumida, T.] Kyoto Univ, Fac Sci, Kyoto, Japan; [Takashima, R.] Kyoto Univ Educ, Kyoto, Japan; [Kawagoe, K.; Oda, S.; Tojo, J.] Kyushu Univ, Dept Phys, Fukuoka, Japan; [Alonso, F.; Anduaga, X. S.; Dova, M. T.; Monticelli, F.; Tripiana, M. F.] Univ Nacl La Plata, Inst Fis La Plata, La Plata, Buenos Aires, Argentina; [Alonso, F.; Anduaga, X. S.; Dova, M. T.; Monticelli, F.; Tripiana, M. F.] Consejo Nacl Invest Cient & Tecn, La Plata, Buenos Aires, Argentina; [Barton, A. E.; Borissov, G.; Bouhova-Thacker, E. V.; Chilingarov, A.; Davidson, R.; de Mora, L.; Dearnaley, W. J.; Fox, H.; Henderson, R. C. W.; Hughes, G.; Jones, R. W. L.; Kartvelishvili, V.; Long, R. E.; Love, P. A.; Maddocks, H. J.; Smizanska, M.; Walder, J.] Univ Lancaster, Dept Phys, Lancaster, England; [Bianco, M.; Cataldi, G.; Chiodini, G.; Gorini, E.; Grancagnolo, F.; Orlando, N.; Perrino, R.; Primavera, M.; Spagnolo, S.; Ventura, A.] Ist Nazl Fis Nucl, Sez Lecce, Lecce, Italy; [Bianco, M.; Gorini, E.; Orlando, N.; Spagnolo, S.; Ventura, A.] Univ Salento, Dipartimento Matemat & Fis, Lecce, Italy; [Allport, P. P.; Bundock, A. C.; Burdin, S.; D'Onofrio, M.; Dervan, P.; Greenshaw, T.; Gwilliam, C. B.; Hayward, H. S.; Jackson, J. N.; Jones, T. J.; King, B. T.; Klein, M.; Klein, U.; Kluge, T.; Kretzschmar, J.; Laycock, P.; Mahmoud, S.; Mehta, A.; Migas, S.; Price, J.; Sellers, G.; Vossebeld, J. H.; Waller, P.; Wrona, B.] Univ Liverpool, Oliver Lodge Lab, Liverpool L69 3BX, Merseyside, England; [Cindro, V.; Deliyergiyev, M.; Dolenc, I.; Filipcic, A.; Gorisek, E.; Kersevan, B. P.; Kramberger, G.; Macek, B.; Mandic, I.; Tykhonov, A.] Univ Ljubljana, Ljubljana, Slovenia; [Cindro, V.; Deliyergiyev, M.; Dolenc, I.; Filipcic, A.; Gorisek, E.; Kersevan, B. P.; Kramberger, G.; Macek, B.; Mandic, I.; Mikuz, M.; Tykhonov, A.] Jozef Stefan Inst, Dept Phys, Ljubljana, Slovenia; [Adragna, P.; Bona, M.; Carter, A. A.; Cerrito, L.; Eisenhandler, E.; Ellis, K.; Goddard, J. R.; Landon, M. P. J.; Lloyd, S. L.; Morris, J. D.; Piccaro, E.; Poll, J.; Rizvi, E.; Salamanna, G.; Castanheira, M. Teixeira Dias; Wiglesworth, C.] Queen Mary Univ London, Sch Phys & Astron, London, England; [Alam, M. A.; Berry, T.; Boisvert, V.; Brooks, T.; Cantrill, R.; Cooper-Smith, N. J.; Cowan, G.; Duguid, L.; Edwards, C. A.; George, S.; Goncalo, R.; Hayden, D.; Vazquez, J. G. Panduro; Pastore, Fr.; Rose, M.; Spano, F.; Strong, J. A.; Teixeira-Dias, P.] Royal Holloway Univ London, Dept Phys, Surrey, England; [Baker, S.; Bernat, P.; Bieniek, S. P.; Butterworth, J. M.; Campanelli, M.; Chislett, R. T.; Christidi, I. A.; Cooper, B. D.; Davison, A. R.; Dobson, E.; Hesketh, G. G.; Jansen, E.; Konstantinidis, N.; Lambourne, L.; Monk, J.; Nash, M.; Nurse, E.; Prabhu, R.; Sherwood, P.; Simmons, B.; Taylor, C.; Wardrope, D. R.; Waugh, B. M.; Wijeratne, P. A.] UCL, Dept Phys & Astron, London, England; [Beau, T.; Bomben, M.; Bordoni, S.; Calderini, G.; Cavalleri, P.; Chareyre, E.; Davignon, O.; De Cecco, S.; Derue, F.; Krasny, M. W.; Kuna, M.; Lacour, D.; Laforge, B.; Laplace, S.; Le Dortz, O.; Liu, K.; Marchiori, G.; Maxfield, S. J.; Nikolic-Audit, I.; Ocariz, J.; Ridel, M.; Roos, L.; Schwemling, Ph.; Theveneaux-Pelzer, T.; Torres, H.; Trincaz-Duvoid, S.; Vannucci, F.] UPMC, Lab Phys Nucl & Hautes Energies, Paris, France; [Beau, T.; Bomben, M.; Bordoni, S.; Calderini, G.; Cavalleri, P.; Chareyre, E.; Davignon, O.; De Cecco, S.; Derue, F.; Krasny, M. W.; Lacour, D.; Laforge, B.; Laplace, S.; Le Dortz, O.; Liu, K.; Marchiori, G.; Maxfield, S. J.; Nikolic-Audit, I.; Ocariz, J.; Ridel, M.; Roos, L.; Schwemling, Ph.; Theveneaux-Pelzer, T.; Torres, H.; Trincaz-Duvoid, S.; Vannucci, F.] Univ Paris Diderot, Paris, France; [Beau, T.; Bomben, M.; Bordoni, S.; Calderini, G.; Cavalleri, P.; Chareyre, E.; Davignon, O.; De Cecco, S.; Derue, F.; Krasny, M. W.; Lacour, D.; Laforge, B.; Laplace, S.; Le Dortz, O.; Liu, K.; Marchiori, G.; Maxfield, S. J.; Nikolic-Audit, I.; Ocariz, J.; Ridel, M.; Roos, L.; Schwemling, Ph.; Theveneaux-Pelzer, T.; Torres, H.; Trincaz-Duvoid, S.; Vannucci, F.] CNRS, IN2P3, Paris, France; [Akesson, T. P. A.; Alonso, A.; Bocchetta, S. S.; Floderus, A.; Hawkins, A. D.; Hedberg, V.; Jarlskog, G.; Lundberg, B.; Lytken, E.; Meirose, B.; Mjornmark, J. U.; Smirnova, O.] Lund Univ, Inst Fys, Lund, Sweden; [Arnal, V.; Barreiro, F.; Cantero, J.; De la Torre, H.; Del Peso, J.; Eckweiler, S.; Edmonds, K.; Glasman, C.; Labarga, L.; Llorente Merino, J.; Terron, J.] Univ Autonoma Madrid, Dept Fis Teor C15, Madrid, Spain; [Aharrouche, M.; Arnaez, O.; Blum, W.; Buescher, V.; Caputo, R.; Ellinghaus, F.; Ertel, E.; Fiedler, F.; Fleckner, J.; Goeringer, C.; Handel, C.; Hohlfeld, M.; Hsu, P. J.; Ji, W.; Kawamura, G.; Kleinknecht, K.; Koenig, S.; Koepke, L.; Lungwitz, M.; Maettig, S.; Masetti, L.; Meyer, C.; Moreno, D.; Mueller, T.; Neusiedl, A.; Sander, H. G.; Schaefer, U.; Schmitt, C.; Schroeder, C.; Simioni, E.; Tapprogge, S.; Wollstadt, S. J.] Johannes Gutenberg Univ Mainz, Inst Phys, Mainz, Germany; [Almond, J.; Borri, M.; Brown, G.; Chavda, V.; Cox, B. E.; Da Via, C.; Duerdoth, I. P.; Forti, A.; Howarth, J.; Ibbotson, M.; Joshi, K. D.; Klinger, J. A.; Loebinger, F. K.; Marx, M.; Masik, J.; Neep, T. J.; Oh, A.; Owen, M.; Pater, J. R.; Pilkington, A. D.; Robinson, J. E. M.; Schwanenberger, C.; Snow, S. W.; Watts, S.; Woudstra, M. J.; Yang, U. K.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Aoun, S.; Bee, C. P.; Bertella, C.; Bousson, N.; Clemens, J. C.; Coadou, Y.; Delpierre, P.; Djama, F.; Etienne, F.; Feligioni, L.; Hoffmann, D.; Hubaut, F.; Knoops, E. B. F. G.; Le Guirriec, E.; Li, B.; Li, S.; Maurer, J.; Monnier, E.; Odier, J.; Pralavorio, P.; Rozanov, A.; Talby, M.; Tannoury, N.; Tiouchichine, E.; Tisserant, S.; Toth, J.; Touchard, F.; Vacavant, L.] Aix Marseille Univ, CPPM, Marseille, France; [Aoun, S.; Bee, C. P.; Bertella, C.; Bousson, N.; Clemens, J. C.; Coadou, Y.; Delpierre, P.; Djama, F.; Etienne, F.; Feligioni, L.; Hoffmann, D.; Hubaut, F.; Knoops, E. B. F. G.; Le Guirriec, E.; Li, B.; Li, S.; Maurer, J.; Monnier, E.; Odier, J.; Pralavorio, P.; Rozanov, A.; Talby, M.; Tannoury, N.; Tiouchichine, E.; Tisserant, S.; Toth, J.; Touchard, F.; Vacavant, L.] CNRS, IN2P3, Marseille, France; [Brau, B.; Colon, G.; Dallapiccola, C.; Meade, A.; Moyse, E. J. W.; Pais, P.; Pueschel, E.; Varol, T.; Ventura, D.; Willocq, S.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Belanger-Champagne, C.; Caron, B.; Chapleau, B.; Cheatham, S.; Corriveau, F.; Dobbs, M.; Dufour, M. -A.; Klemetti, M.; Mc Donald, J.; Robertson, S. H.; Rios, C. Santamarina; Schram, M.; Stockton, M. C.; Vachon, B.; Warburton, A.] McGill Univ, Dept Phys, Montreal, PQ, Canada; [Barberio, E. L.; Davidson, N.; Diglio, S.; Hamano, K.; Jennens, D.; Kubota, T.; Limosani, A.; Moorhead, G. F.; Nemecek, S.; Hanninger, G. Nunes; Phan, A.; Shao, Q. T.; Tan, K. G.; Taylor, G. N.; Thong, W. M.; Volpi, M.; White, M. J.] Univ Melbourne, Sch Phys, Melbourne, Vic 3010, Australia; [Armbruster, A. J.; Borroni, S.; Chapman, J. W.; Cirilli, M.; Dai, T.; Diehl, E. B.; Ferretti, C.; Goldfarb, S.; Harper, D.; Levin, D.; Li, X.; Liu, H.; Liu, J. B.; Liu, L.; Long, J. D.; Mc Kee, S. P.; Neal, H. A.; Panikashvili, N.; Purdham, J.; Qian, J.; Scheirich, D.; Thun, R. P.; Walch, S.; Wilson, A.; Wooden, G.; Wu, Y.; Yang, H.; Zhou, B.; Zhu, J.] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Abolins, M.; Gonzalez, B. Alvarez; Arabidze, G.; Brock, R.; Bromberg, C.; Caughron, S.; Fedorko, W.; Hauser, R.; Heim, S.; Holzbauer, J. L.; Huston, J.; Koll, J.; Linnemann, J. T.; Mangeard, P. S.; Martin, B.; Miller, R. J.; Pope, B. G.; Schwienhorst, R.; Stelzer, H. J.; Tollefson, K.; Zhang, H.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Alessandria, F.; Alimonti, G.; Andreazza, A.; Baccaglioni, G.; Besana, M. I.; Broggi, F.; Carminati, L.; Cavalli, D.; Citterio, M.; Consonni, S. M.; Costa, G.; Fanti, M.; Favareto, A.; Giugn, D.; Koletsou, I.; Lari, T.; Mandelli, L.; Mazzanti, M.; Meloni, F.; Meroni, C.; Perini, L.; Pizio, C.; Ragusa, F.; Resconi, S.; Rivoltella, G.; Simoniello, R.; Tartarelli, G. F.; Troncon, C.; Turra, R.; Vegni, G.; Volpini, G.] Ist Nazl Fis Nucl, Sez Milano, Milan, Italy; [Andreazza, A.; Besana, M. I.; Carminati, L.; Consonni, S. M.; Fanti, M.; Favareto, A.; Meloni, F.; Perini, L.; Pizio, C.; Ragusa, F.; Rivoltella, G.; Simoniello, R.; Turra, R.; Vegni, G.] Univ Milan, Dipartimento Fis, Milan, Italy; [Bogouch, A.; Harkusha, S.; Kulchitsky, Y.; Kurochkin, Y. A.; Satsounkevitch, I.; Tsiareshka, P. V.] Natl Acad Sci Belarus, BI Stepanov Phys Inst, Minsk, BELARUS; [Yanush, S.] Natl Sci & Educ Ctr Particle & High Energy Phys, Minsk, BELARUS; [Taylor, F. E.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Arguin, J. -F.; Azuelos, G.; Banerjee, P.; Bouchami, J.; Davies, M.; Giunta, M.; Leroy, C.; Martin, J. P.; Mehdiyev, R.] Univ Montreal, Grp Particle Phys, Montreal, PQ, Canada; [Akimov, A. V.; Baranov, S. P.; Gavrilenko, I. L.; Komar, A. A.; Mashinistov, R.; Mouraviev, S. V.; Nechaeva, P. Yu.; Shmeleva, A.; Snesarev, A. A.; Sulin, V. V.; Tikhomirov, V. O.] Acad Sci, PN Lebedev Phys Inst, Moscow, Russia; [Artamonov, A.; Gorbounov, P. A.; Khovanskiy, V.; Shatalov, P. B.; Tsukerman, I. I.] ITEP, Moscow, Russia; [Antonov, A.; Belotskiy, K.; Bulekov, O.; Dolgoshein, B. A.; Kantserov, V. A.; Khodinov, A.; Romaniouk, A.; Shulga, E.; Smirnov, S. Yu.; Smirnov, Y.; Soldatov, E. Yu.; Timoshenko, S.] MEPhI, Moscow, Russia; [Elmsheuser, J.; Gladilin, L. K.; Grishkevich, Y. V.; Kramarenko, V. A.; Rud, V. I.; Sivoklokov, S. Yu.; Smirnova, L. N.] Moscow MV Lomonosov State Univ, DV Skobeltsyn Inst Nucl Phys, Moscow, Russia; [Adomeit, S.; Beale, S.; Becker, S.; Biebe, O.; Calfayan, P.; de Graat, J.; Duckeck, G.; Ebke, J.; Engl, R.; Galea, C.; Heller, C.; Hertenberger, R.; Kummer, C.; Legger, F.; Lichtnecker, M.; Mameghani, R.; Mueller, T. A.; Nunnemann, T.; Oakes, L. B.; Rauscher, F.; Reznicek, P.; Sanders, M. P.; Schaile, D.; Schieck, J.; Serfon, C.; Staude, A.; Vladoiu, D.; Walker, R.; Will, J. Z.; Zhuang, X.] Univ Munich, Fak Phys, Munich, Germany; [Barillari, T.; Beimforde, M.; Bethke, S.; Bittner, B.; Bronner, J.; Capriotti, D.; Compostella, G.; Cortiana, G.; Dubbert, J.; Flowerdew, M. J.; Giovannini, P.; Ince, T.; Jantsch, A.; Kiryunin, A. E.; Kluth, S.; Kortner, O.; Kortner, S.; Kotov, S.; Kroha, H.; Macchiolo, A.; Manfredini, A.; Menke, S.; Moser, H. G.; Nagel, M.; Nisius, R.; Oberlack, H.; Pahl, C.; Pospelov, G. E.; Potrap, I. N.; Richter, R.; Salihagic, D.; Sandstroem, R.; Schacht, P.; Schwegler, Ph.; Stern, S.; Stonjek, S.; Vanadia, M.; von der Schmitt, H.; Weigell, P.; Wildauer, A.; Zanzi, D.; Zhuravlov, V.] Max Planck Inst Phys & Astrophys, Werner Heisenberg Inst, D-80805 Munich, Germany; [Shimojima, M.] Nagasaki Inst Appl Sci, Nagasaki, Japan; [Aoki, M.; Hasegawa, S.; Morvaj, L.; Ohshima, T.; Shimizu, S.; Takahashi, Y.; Tomoto, M.; Wakabayashi, J.] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Aoki, M.; Hasegawa, S.; Morvaj, L.; Ohshima, T.; Shimizu, S.; Takahashi, Y.; Tomoto, M.; Wakabayashi, J.] Nagoya Univ, Kobayashi Maskawa Inst, Nagoya, Aichi 4648601, Japan; [Aloisio, A.; Alviggi, M. G.; Canale, V.; Capasso, L.; Carlino, G.; Chiefari, G.; Conventi, F.; de Asmundis, R.; Della Pietra, M.; della Volpe, D.; Di Donato, C.; Doria, A.; Giordano, R.; Iengo, P.; Izzo, V.; Merola, L.; Musto, E.; Patricelli, S.; Sanchez, A.; Sekhniaidze, G.] Ist Nazl Fis Nucl, Sez Napoli, Naples, Italy; [Aloisio, A.; Alviggi, M. G.; Canale, V.; Capasso, L.; Chiefari, G.; della Volpe, D.; Di Donato, C.; Giordano, R.; Merola, L.; Musto, E.; Patricelli, S.; Rybkin, G.; Sanchez, A.] Univ Naples Federico II, Dipartimento Sci Fis, Naples, Italy; [Gorelov, I.; Hoeferkamp, M. R.; Seidel, S. C.; Toms, K.; Wang, R.] Univ New Mexico, Dept Phys & Astron, Albuquerque, NM USA; [Besjes, G. J.; Caron, S.; Chelstowska, M. A.; De Groot, N.; Filthaut, F.; Klok, P. F.; Koning, A. C.; Koetsveld, F.; Raas, M.; Salvucci, A.] Radboud Univ Nijmegen Nikhef, Inst Math Astrophys & Particle Phys, Nijmegen, Netherlands; [Aben, R.; Beemster, L. J.; Bentvelsen, S.; Berglund, E.; Bobbink, G. J.; Bos, K.; Boterenbrood, H.; Colijn, A. P.; de Jong, P.; De Nooij, L.; Deluca, C.; Deviveiros, P. O.; Doxiadis, A. D.; Ferrari, P.; Gadatsch, S.; Garitaonandia, H.; Geerts, D. A. A.; Gosselink, M.; Hartjes, F.; Hessey, N. P.; Igonkina, O.; Kay, M. S.; Klous, S.; Kluit, P.; Koffeman, E.; Lee, H.; Lenz, T.; Linde, F.; Luijckx, G.; Mahlstedt, J.; Massaro, G.; Mechnich, J.; Mussche, I.; Ottersbach, J. P.; Pani, P.; Rijpstra, M.; Ruckstuhl, N.; Ta, D.; Tsiakiris, M.; Turlay, E.; Van Der Deijl, P. C.; van der Geer, R.; van der Graaf, H.; Van Der Leeuw, R.; van der Poel, E.; van Vulpen, I.; Verkerke, W.; Vermeulen, J. C.; Milosavljevic, M. Vranjes; Vreeswijk, M.] Nikhef Natl Inst Subatom Phys, Amsterdam, Netherlands; [Aben, R.; Beemster, L. J.; Bentvelsen, S.; Berglund, E.; Bobbink, G. J.; Bos, K.; Boterenbrood, H.; Colijn, A. P.; de Jong, P.; De Nooij, L.; Deluca, C.; Deviveiros, P. O.; Doxiadis, A. D.; Ferrari, P.; Gadatsch, S.; Garitaonandia, H.; Geerts, D. A. A.; Gosselink, M.; Hartjes, F.; Hessey, N. P.; Igonkina, O.; Kay, M. S.; Klous, S.; Kluit, P.; Lee, H.; Lenz, T.; Linde, F.; Mahlstedt, J.; Massaro, G.; Mechnich, J.; Mussche, I.; Ottersbach, J. P.; Pani, P.; Rijpstra, M.; Ruckstuhl, N.; Ta, D.; Tsiakiris, M.; Turlay, E.; Van Der Deijl, P. C.; van der Geer, R.; van der Graaf, H.; Van Der Leeuw, R.; van der Poel, E.; van Vulpen, I.; Verkerke, W.; Vermeulen, J. C.; Milosavljevic, M. Vranjes; Vreeswijk, M.] Univ Amsterdam, Amsterdam, Netherlands; [Calkins, R.; Chakraborty, D.; Cole, S.; de Lima, J. G. Rocha; Suhr, C.; Yurkewicz, A.; Zutshi, V.] No Illinois Univ, Dept Phys, De Kalb, IL USA; [Anisenkov, A.; Beloborodova, O.; Bobrovnikov, V. B.; Bogdanchikov, A.; Kazanin, V. A.; Kolachev, G. M.; Korol, A.; Malyshev, V.; Maslennikov, A. L.; Orlov, I.; Peleganchuk, S. V.; Schamov, A. G.; Skovpen, K.; Soukharev, A.; Talyshev, A.; Tikhonov, Y. A.] SB RAS, Budker Inst Nucl Phys, Novosibirsk, Russia; [Budick, B.; Casadei, D.; Cranmer, K.; van Huysduynen, L. Hooft; Kaplan, B.; Konoplich, R.; Krasznahorkay, A.; Kreiss, S.; Lewis, G. H.; Mincer, A. I.; Nemethy, P.; Neves, R. M.; Prokofiev, K.; Zhao, L.] NYU, Dept Phys, New York, NY 10003 USA; [Fisher, M. J.; Gan, K. K.; Ishmukhametov, R.; Kagan, H.; Merritt, H.; Moss, J.; Nagarkar, A.; Pignotti, D. T.; Rahimi, A. M.; Strang, M.; Yang, Y.] Ohio State Univ, Columbus, OH 43210 USA; [Kass, R. D.; Nakano, I.] Okayama Univ, Fac Sci, Okayama, Japan; [Abbott, B.; Gutierrez, P.; Jana, D. K.; Marzin, A.; Meera-Lebbai, R.; Norberg, S.; Saleem, M.; Severini, H.; Skubic, P.; Snow, J.; Strauss, M.] Univ Oklahoma, Homer L Dodge Dept Phys & Astron, Norman, OK 73019 USA; [Abi, B.; Khanov, A.; Rizatdinova, F.; Yu, J.] Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA; [Hamal, P.; Nozka, L.] Palacky Univ, RCPTM, CR-77147 Olomouc, Czech Republic; [Brau, J. E.; Potter, C. T.; Ptacek, E.; Radloff, P.; Reinsch, A.; Searcy, J.; Shamim, M.; Sinev, N. B.; Strom, D. M.; Torrence, E.] Univ Oregon, Ctr High Energy Phys, Eugene, OR 97403 USA; [Khalek, S. Abdel; Andari, N.; Arnault, C.; Auge, E.; Barrillon, P.; Benoit, M.; Binet, S.; Bourdarios, C.; De La Taille, C.; De Regie, J. B. De Vivie; Duflot, L.; Escalier, M.; Fayard, L.; Fournier, D.; Grivaz, J. -F.; Guillemin, T.; Henrot-Versille, S.; Hrivnac, J.; Iconomidou-Fayard, L.; Idarraga, J.; Kado, M.; Martinez, N. Lorenzo; Lounis, A.; Makovec, N.; Matricon, P.; Niedercorn, F.; Poggioli, L.; Puzo, P.; Renaud, A.; Rousseau, D.; Ruan, X.; Sauvan, J. B.; Schaarschmidt, J.; Schaffer, A. C.; Serin, L.; Simion, S.; Tanaka, R.; Teinturier, M.; Veillet, J. J.; Wicek, F.; Zerwas, D.; Zhang, Z.] Univ Paris 11, LAL, Orsay, France; [Khalek, S. Abdel; Andari, N.; Arnault, C.; Auge, E.; Barrillon, P.; Benoit, M.; Binet, S.; Bourdarios, C.; De La Taille, C.; De Regie, J. B. De Vivie; Duflot, L.; Escalier, M.; Fayard, L.; Grivaz, J. -F.; Guillemin, T.; Henrot-Versille, S.; Hrivnac, J.; Iconomidou-Fayard, L.; Idarraga, J.; Martinez, N. Lorenzo; Lounis, A.; Makovec, N.; Matricon, P.; Niedercorn, F.; Poggioli, L.; Puzo, P.; Renaud, A.; Rousseau, D.; Ruan, X.; Sauvan, J. B.; Schaarschmidt, J.; Schaffer, A. C.; Serin, L.; Simion, S.; Tanaka, R.; Teinturier, M.; Veillet, J. J.; Wicek, F.; Zerwas, D.; Zhang, Z.] CNRS, IN2P3, Orsay, France; [Hanagaki, K.; Hirose, M.; Lee, J. S. H.; Meguro, T.; Nomachi, M.; Okamura, W.; Sugaya, Y.] Osaka Univ, Grad Sch Sci, F-91405 Osaka, Japan; [Bugge, L.; Buran, T.; Cameron, D.; Gjelsten, B. K.; Gramstad, E.; Lund, E.; Ould-Saada, F.; Pajchel, K.; Raddum, S.; Read, A. L.; Rohne, O.; Samset, B. H.; Smestad, L.; Stapnes, S.; Strandlie, A.] Univ Oslo, Dept Phys, Oslo, Norway; [Apolle, R.; Barr, A. J.; Boddy, C. R.; Brandt, G.; Buchanan, J.; Buckingham, R. M.; Cooper-Sarkar, A. M.; Dafinca, A.; Davies, E.; Gallas, E. J.; Gwenlan, C.; Hall, D.; Hays, C. P.; Howard, J.; Huffman, T. B.; Issever, C.; King, R. S. B.; Kogan, L. A.; Korn, A.; Larner, A.; Lewis, A.; Liang, Z.; Livermore, S. S. A.; Mattravers, C.; Nickerson, R. B.; Pinder, A.; Robichaud-Veronneau, A.; Ryder, N. C.; Short, D.; Tseng, J. C. -L.; Vickey, T.; Viehhauser, G. H. A.; Weidberg, A. R.; Whitehead, S. R.; Young, C. J.; Zhong, J.] Univ Oxford, Dept Phys, Oxford, England; [Colombo, T.; Conta, C.; Ferrari, R.; Franchino, S.; Fraternali, M.; Gaudio, G.; Livan, M.; Negri, A.; Polesello, G.; Rebuzzi, D. M.; Rimoldi, A.; Uslenghi, M.; Vercesi, V.] Ist Nazl Fis Nucl, Sez Pavia, Pavia, Italy; [Basye, A.; Colombo, T.; Conta, C.; Franchino, S.; Fraternali, M.; Livan, M.; Negri, A.; Rebuzzi, D. M.; Rimoldi, A.; Uslenghi, M.] Univ Pavia, Dipartimento Fis, I-27100 Pavia, Italy; [Alison, J.; Brendlinger, K.; Degenhardt, J.; Dressnandt, N.; Fratina, S.; Hines, E.; Hong, T. M.; Jackson, B.; Keener, P. T.; Kroll, J.; Kunkle, J.; Lester, C. M.; Lipeles, E.; Newcomer, F. M.; Olivito, D.; Ospanov, R.; Reece, R.; Saxon, J.; Schaefer, D.; Stahlman, J.; Thomson, E.; Van Berg, R.; Vanguri, R.; Wagner, P.; Williams, H. H.] Univ Penn, Dept Phys, Philadelphia, PA 19104 USA; [Fedin, O. L.; Gratchev, V.; Grebenyuk, O. G.; Maleev, V. P.; Ryabov, Y. F.; Schegelsky, V. A.; Sedykh, E.; Seliverstov, D. M.; Solovyev, V.] Petersburg Nucl Phys Inst, Gatchina, Russia; [Bertolucci, F.; Cascella, M.; Cavasinni, V.; Crescioli, F.; Del Prete, T.; Dotti, A.; Roda, C.; Sarri, F.; White, S.; Zinonos, Z.] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Bertolucci, F.; Cascella, M.; Cavasinni, V.; Crescioli, F.; Del Prete, T.; Dotti, A.; Roda, C.; Sarri, F.; White, S.; Zinonos, Z.] Univ Pisa, Dipartimento Fis E Fermi, Pisa, Italy; [Boudreau, J.; Cleland, W.; Escobar, C.; Kittelmann, T.; Mueller, J.; Prieur, D.; Savinov, V.; Yoosoofmiya, R.] Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; [Aguilar-Saavedra, J. A.; Amor Dos Santos, S. P.; Amorim, A.; Anjos, N.; Carvalho, J.; Castro, N. F.; Muino, P. Conde; Da Cunha Sargedas De Sousa, M. J.; Wemans, A. Do Valle; Fiolhais, M. C. N.; Galhardo, B.; Gomes, A.; Jorge, P. M.; Lopes, L.; Maio, A.; Maneira, J.; Oliveira, M.; Onofre, A.; Palma, A.; Pina, J.; Pinto, B.; Santos, H.; Saraiva, J. G.; Silva, J.; Veloso, F.; Wolters, H.] Lab Instrumentacao & Fis Expt Particulas LIP, Lisbon, Portugal; [Aguilar-Saavedra, J. A.; Maio, A.] Univ Granada, Dept Fis Teor & Cosmos, Granada, Spain; [Aguilar-Saavedra, J. A.] Univ Granada, CAFPE, Granada, Spain; [Bohm, J.; Chudoba, J.; Gallus, P.; Gunther, J.; Jakoubek, T.; Juranek, V.; Kepka, O.; Kupco, A.; Kus, V.; Lokajicek, M.; Marcisovsky, M.; Mikestikova, M.; Myska, M.; Ruzicka, P.; Schovancova, J.; Sicho, P.; Staroba, P.; Svatos, M.; Tasevsky, M.; Tic, T.; Valenta, J.; Vrba, V.; Zeman, M.] Acad Sci Czech Republic, Inst Phys, Prague, Czech Republic; [Balek, P.; Chalupkova, I.; Davidek, T.; Dolejsi, J.; Dolezal, Z.; Kodys, P.; Leitner, R.; Novakova, J.; Rybar, M.; Spousta, M.; Strachota, P.; Suk, M.; Sykora, T.; Tas, P.; Valkar, S.; Vorobel, V.; Wilhelm, I.] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Augsten, K.; Holy, T.; Hubacek, Z.; Jakubek, J.; Kohout, Z.; Kral, V.; Krejci, F.; Pospisil, S.; Simak, V.; Slavicek, T.; Smolek, K.; Sodomka, J.; Solar, M.; Solc, J.; Sopko, V.; Sopko, B.; Stekl, I.; Turecek, D.; Vacek, V.; Vlasak, M.; Vokac, P.] Czech Tech Univ, Prague, Czech Republic; [Ammosov, V. V.; Borisov, A.; Denisov, S. P.; Fakhrutdinov, R. M.; Fenyuk, A. B.; Ivashin, A. V.; Karyukhin, A. N.; Korotkov, V. A.; Kozhin, A. S.; Minaenko, A. A.; Myagkov, A. G.; Nikolaenko, V.; Solodkov, A. A.; Solovyanov, O. V.; Starchenko, E. A.; Zaitsev, A. M.; Zenin, O.; Zmouchko, V. V.] State Res Ctr Inst High Energy Phys, Protvino, Russia; [Adye, T.; Apolle, R.; Baines, J. T.; Barnett, B. M.; Burke, S.; Davies, E.; Dewhurst, A.; Emeliyanov, D.; Gallop, B. J.; Gee, C. N. P.; Gillman, A. R.; Haywood, S. J.; Kirk, J.; Mattravers, C.; McCubbin, N. A.; McMahon, S. J.; Middleton, R. P.; Murray, W. J.; Nash, M.; Norton, P. R.; Phillips, P. W.; Sankey, D. P. C.; Scott, W. G.; Tyndel, M.; Wickens, F. J.; Wielers, M.] Rutherford Appleton Lab, Particle Phys Dept, Didcot OX11 0QX, Oxon, England; [Benslama, K.; Smit, G. V. Ybeles] Univ Regina, Dept Phys, Regina, SK S4S 0A2, Canada; [Tanaka, S.] Ritsumeikan Univ, Kusatsu, Shiga, Japan; [Anulli, F.; Artoni, G.; Bagnaia, P.; Bini, C.; Caloi, R.; Ciapetti, G.; D'Orazio, A.; De Pedis, D.; De Salvo, A.; De Zorzi, G.; Dionisi, C.; Falciano, S.; Gauzzi, P.; Gentile, S.; Giagu, S.; Ippolito, V.; Lacava, F.; Lo Sterzo, F.; Luci, C.; Luminari, L.; Marzano, F.; Mirabelli, G.; Nisati, A.; Pasqualucci, E.; Petrolo, E.; Pontecorvo, L.; Rescigno, M.; Rosati, S.; Rossi, E.; Tehrani, F. Safai; Sidoti, A.; Camillocci, E. Solfaroli; Vari, R.; Veneziano, S.; Zanello, L.] Ist Nazl Fis Nucl, Sez Roma 1, Rome, Italy; [Artoni, G.; Bagnaia, P.; Bini, C.; Caloi, R.; Ciapetti, G.; D'Orazio, A.; De Zorzi, G.; Dionisi, C.; Gauzzi, P.; Gentile, S.; Giagu, S.; Ippolito, V.; Lacava, F.; Messina, A.; Rossi, E.; Camillocci, E. Solfaroli; Zanello, L.] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Aielli, G.; Camarri, P.; Cardarelli, R.; Cattani, G.; Di Ciaccio, A.; Di Simone, A.; Liberti, B.; Marchese, F.; Mazzaferro, L.; Salamon, A.; Santonico, R.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, Rome, Italy; [Aielli, G.; Camarri, P.; Cattani, G.; Di Ciaccio, A.; Di Simone, A.; Lo Sterzo, F.; Luci, C.; Marchese, F.; Mazzaferro, L.; Santonico, R.] Univ Roma Tor Vergata, Dipartimento Fis, I-00173 Rome, Italy; [Bacci, C.; Baroncelli, A.; Biglietti, M.; Bortolotto, V.; Branchini, P.; Ceradini, F.; Di Luise, S.; Farilla, A.; Graziani, E.; Iodice, M.; Orestano, D.; Passeri, A.; Pastore, F.; Petrucci, F.; Stanescu, C.] Ist Nazl Fis Nucl, Sez Roma Tre, Rome, Italy; [Bacci, C.; Bortolotto, V.; Ceradini, F.; Di Luise, S.; Orestano, D.; Pastore, F.; Petrucci, F.] Univ Roma Tre, Dipartimento Fis, Rome, Italy; [Benchekroun, D.; Chafaq, A.; Gouighri, M.; Hoummada, A.; Lablak, S.] Reseau Univ Phys Hautes Energies Univ Hassan II, Fac Sci Ain Chock, Casablanca, Morocco; [Ghazlane, H.] Ctr Natl Energie Sci Tech Nucl, Rabat, Morocco; [El Kacimi, M.; Goujdami, D.] Univ Cadi Ayyad, Fac Sci Semlalia, LPHEA, Marrakech, Morocco; [Derkaoui, J. E.; Ouchrif, M.; Tayalati, Y.] Univ Mohamed Premier, Fac Sci, Oujda, Morocco; [Derkaoui, J. E.; Ouchrif, M.; Tayalati, Y.] LFTPM, Oujda, Morocco; [Cherkaoui El Moursli, R.] Univ Mohammed V Agdal, Fac Sci, Rabat, Morocco; [Abreu, H.; Bachacou, H.; Bauer, F.; Besson, N.; Blanchard, J. -B.; Bolnet, N. M.; Boonekamp, M.; Chevalier, L.; Ernwein, J.; Etienvre, A. I.; Formica, A.; Gauthier, L.; Giraud, P. F.; Guyot, C.; Hassani, S.; Kozanecki, W.; Lancon, E.; Laporte, J. F.; Legendre, M.; Maiani, C.; Mal, P.; Ramos, J. A. M.; Mansoulie, B.; Meyer, J. -P.; Mijovic, L.; Morange, N.; Mountricha, E.; Hong, V. Nguyen Thi; Nicolaidou, R.; Ouraou, A.; Resende, B.; Royon, C. R.; Schoeffel, L.; Schune, Ph.; Schwindling, J.; Simard, O.; Virchaux, M.; Vranjes, N.; Xiao, M.; Xu, C.] CEA Saclay Commissariat Energie Atom & Energies A, DSM IRFU Inst Rech Lois Fondamentales Univers, Gif Sur Yvette, France; [Chouridou, S.; Damiani, D. S.; Grillo, A. A.; Hare, G. A.; Litke, A. M.; Lockman, W. S.; Manning, P. M.; Mitrevski, J.; Nielsen, J.; Sadrozinski, H. F. -W.; Schumm, B. A.; Seiden, A.] Univ Calif Santa Cruz, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Beckingham, M.; Coccaro, A.; Goussiou, A. G.; Harris, O. M.; Keller, J. S.; Lubatti, H. J.; Rompotis, N.; Rothberg, J.; Verducci, M.; Watts, G.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Costanzo, D.; Donszelmann, T. Cuhadar; Dawson, I.; Duxfield, R.; Hodgkinson, M. C.; Hodgson, P.; Johansson, P.; Korolkova, E. V.; Mayne, A.; Mcfayden, J. A.; Miyagawa, P. S.; Owen, S.; Paganis, E.; Suruliz, K.; Tovey, D. R.; Tsionou, D.; Tua, A.; Xu, D.] Univ Sheffield, Dept Phys & Astron, Sheffield, S Yorkshire, England; [Hasegawa, Y.; Takeshita, T.] Shinshu Univ, Dept Phys, Nagano, Japan; [Buchholz, P.; Czirr, H.; Fleck, I.; Gaur, B.; Grybel, K.; Holder, M.; Ibragimov, I.; Rammes, M.; Rosenthal, O.; Sipica, V.; Walkowiak, W.; Ziolkowski, M.] Univ Siegen, Fachbereich Phys, D-57068 Siegen, Germany; [Dawe, E.; Godfrey, J.; Kvita, J.; O'Neil, D. C.; Petteni, M.; Stelzer, B.; Tanasijczuk, A. J.; Trottier-McDonald, M.; Vetterli, M. C.] Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada; [Aracena, I.; Mayes, J. Backus; Barklow, T.; Bartoldus, R.; Bawa, H. S.; Butler, B.; Cogan, J. G.; Eifert, T.; Fulsom, B. G.; Gao, Y. S.; Grenier, P.; Haas, A.; Hansson, P.; Kocian, M.; Koi, T.; Lowe, A. J.; Malone, C.; Mount, R.; Nelson, T. K.; Salnikov, A.; Schwartzman, A.; Silverstein, D.; Smith, D.; Strauss, E.; Su, D.; Wilson, M. G.; Wittgen, M.; Young, C.] SLAC Natl Accelerator Lab, Stanford, CA USA; [Batkova, L.; Blazek, T.; Federic, P.; Pecsy, M.; Stavina, P.; Sykora, I.; Tokar, S.; Zenis, T.] Comenius Univ, Fac Math Phys & Informat, Bratislava, Slovakia; [Antos, J.; Bruncko, D.; Ferencei, J.; Kladiva, E.; Seman, M.; Strizenec, P.] Slovak Acad Sci, Inst Expt Phys, Dept Subnucl Phys, Kosice 04353, Slovakia; [Aurousseau, M.] Univ Johannesburg, Dept Phys, Johannesburg, South Africa; [Hamilton, A.; Leney, K. J. C.; Vickey, T.; Boeriu, O. E. Vickey] Univ Witwatersrand, Sch Phys, Johannesburg, South Africa; [Asman, B.; Bendtz, K.; Bohm, C.; Clement, C.; Eriksson, D.; Gellerstedt, K.; Hellman, S.; Holmgren, S. O.; Johansen, M.; Johansson, K. E.; Jon-And, K.; Khandanyan, H.; Kim, H.; Klimek, P.; Lundberg, J.; Lundberg, O.; Milstead, D. A.; Moa, T.; Papadelis, A.; Sellden, B.; Silverstein, S. B.; Sjolin, J.; Strandberg, S.; Tylmad, M.; Yacoob, S.; Yang, Z.] Stockholm Univ, Dept Phys, Stockholm, Sweden; [Asman, B.; Bendtz, K.; Clement, C.; Gellerstedt, K.; Hellman, S.; Johansen, M.; Jon-And, K.; Khandanyan, H.; Kim, H.; Klimek, P.; Lundberg, J.; Lundberg, O.; Milstead, D. A.; Moa, T.; Sjolin, J.; Strandberg, S.; Tylmad, M.; Yang, Z.] Oskar Klein Ctr, Stockholm, Sweden; [Jovicevic, J.; Kuwertz, E. S.; Lund-Jensen, B.; Strandberg, J.] Royal Inst Technol, Dept Phys, S-10044 Stockholm, Sweden; [Ahmad, A.; Arfaoui, S.; Devetak, E.; DeWilde, B.; Engelmann, R.; Farley, J.; Goodson, J. J.; Grassi, V.; Gray, J. A.; Hobbs, J.; Jia, J.; Li, H.; Mastrandrea, P.; McCarthy, R. L.; Mohapatra, S.; Rijssenbeek, M.; Schamberger, R. D.; Stupak, J.; Tsybychev, D.] SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; [Ahmad, A.; Arfaoui, S.; Devetak, E.; DeWilde, B.; Engelmann, R.; Farley, J.; Goodson, J. J.; Grassi, V.; Gray, J. A.; Hobbs, J.; Jia, J.; Li, H.; Mastrandrea, P.; McCarthy, R. L.; Mohapatra, S.; Rijssenbeek, M.; Schamberger, R. D.; Stupak, J.; Tsybychev, D.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Bartsch, V.; De Santo, A.; Martin-Haugh, S.; Potter, C. J.; Rose, A.; Salvatore, F.; Sutton, M. R.] Univ Sussex, Dept Phys & Astron, Brighton, E Sussex, England; [Bangert, A.; Cuthbert, C.; Lee, S. C.; Patel, N.; Saavedra, A. F.; Scarcella, M.; Varvell, K. E.; Watson, I. J.; Waugh, A. T.; Yabsley, B.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Chu, M. L.; Hou, S.; Jamin, D. O.; Lin, S. C.; Liu, D.; Mazini, R.; Meng, Z.; Ren, Z. L.; Soh, D. A.; Teng, P. K.; Wang, H.; Wang, J.; Wang, S. M.; Weng, Z.; Zhang, D.; Zhou, Y.] Acad Sinicaica, Inst Phys, Taipei, Taiwan; [Harpaz, S. Behar; Kajomovitz, E.; Kopeliansky, R.; Rozen, Y.; Tarem, S.; Vallecorsa, S.] Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; [Abramowicz, H.; Alexander, G.; Amram, N.; Bella, G.; Benary, O.; Benhammou, Y.; Etzion, E.; Gershon, A.; Ginzburg, J.; Guttman, N.; Hod, N.; Munwes, Y.; Oren, Y.; Reinherz-Aronis, E.; Sadeh, I.; Silver, Y.; Soffer, A.; Taiblum, N.] Tel Aviv Univ, Raymond & Beverly Sackler Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Kordas, K.; Kouskoura, V.; Nomidis, I.; Petridis, A.; Petridou, C.; Sampsonidis, D.] Aristotle Univ Thessaloniki, Dept Phys, GR-54006 Thessaloniki, Greece; [Akimoto, G.; Asai, S.; Azuma, Y.; Dechenaux, B.; Dohmae, T.; Iliadis, D.; Kanaya, N.; Kataoka, Y.; Kawamoto, T.; Kazama, S.; Kessoku, K.; Kobayashi, T.; Komori, Y.; Mashimo, T.; Masubuchi, T.; Matsunaga, H.; Nakamura, K.; Nakamura, T.; Ninomiya, Y.; Okuyama, T.; Sakamoto, H.; Sasaki, Y.; Tanaka, J.; Terashi, K.; Ueda, I.; Yamaguchi, H.; Yamaguchi, Y.; Yamamoto, S.; Yamamura, T.; Yamanaka, T.; Yoshihara, K.] Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo, Japan; [Akimoto, G.; Asai, S.; Azuma, Y.; Dechenaux, B.; Dohmae, T.; Iliadis, D.; Kanaya, N.; Kataoka, Y.; Kawamoto, T.; Kazama, S.; Kessoku, K.; Kobayashi, T.; Komori, Y.; Mashimo, T.; Masubuchi, T.; Matsunaga, H.; Nakamura, K.; Nakamura, T.; Ninomiya, Y.; Okuyama, T.; Sasaki, Y.; Tanaka, J.; Terashi, K.; Ueda, I.; Yamaguchi, H.; Yamaguchi, Y.; Yamamoto, S.; Yamamura, T.; Yamazaki, T.; Yoshihara, K.] Univ Tokyo, Dept Phys, Tokyo 113, Japan; [Bratzler, U.; Fukunaga, C.] Tokyo Metropolitan Univ, Grad Sch Sci & Technol, Tokyo 158, Japan; [Ishitsuka, M.; Jinnouchi, O.; Kanno, T.; Kuze, M.; Nagai, R.; Nobe, T.] Tokyo Inst Technol, Dept Phys, Tokyo 152, Japan; [AbouZeid, O. S.; Bailey, D. C.; Bain, T.; Brelier, B.; Cheung, S. L.; Dhaliwal, S.; Farooque, T.; Fatholahzadeh, B.; Gibson, A.; Guo, B.; Ilic, N.; Keung, J.; Krieger, P.; Martens, F. K.; Orr, R. S.; Polifka, R.; Rezvani, R.; Rosenbaum, G. A.; Savard, P.; Sinervo, P.; Spreitzer, T.; Tardif, D.; Teuscher, R. J.; Thompson, P. D.; Trischuk, W.; Venturi, N.] Univ Toronto, Dept Phys, Toronto, ON, Canada; [Azuelos, G.; Canepa, A.; Chekulaev, S. V.; Fortin, D.; Gingrich, D. M.; Koutsman, A.; Losty, M. J.; Nugent, I. M.; Oakham, F. G.; Oram, C. J.; Codina, E. Perez; Savard, P.; Schouten, D.; Seuster, R.; Stelzer-Chilton, O.; Tafirout, R.; Trigger, I. M.; Vetterli, M. C.] TRIUMF, Vancouver, BC V6T 2A3, Canada; [Garcia, J. A. Benitez; Palacino, G.; Taylor, W.] York Univ, Dept Phys & Astron, Toronto, ON M3J 2R7, Canada; [Hanawa, K.; Hara, K.; Hayashi, T.; Kim, S. H.; Kiuchi, K.; Kurata, M.; Nagai, K.; Ukegawa, F.] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki, Japan; [Beauchemin, P. H.; Hamilton, S.; Meoni, E.; Napier, A.; Rolli, S.; Sliwa, K.; Todorova-Nova, S.; Wetter, J.] Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA; [Losada, M.; Loureiro, K. F.; Mendoza Navas, L.; Navarro, G.; Sandoval, C.] Univ Antonio Narino, Ctr Invest, Bogota, Colombia; [Avolio, G.; Deng, J.; Farrell, S.; Eschrich, I. G.; Lankford, A. J.; Magnoni, L.; Mete, A. S.; Nelson, A.; Scannicchio, D. A.; Schernau, M.; Taffard, A.; Toggerson, B.; Unel, G.; Werth, M.; Wheeler-Ellis, S. J.; Whiteson, D.; Zhou, N.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA; [Acharya, B. S.; Alhroob, M.; Brazzale, S. F.; Cobal, M.; De Sanctis, U.; Del Papa, C.; Pinamonti, M.; Shaw, K.; Soualah, R.] Ist Nazl Fis Nucl, Grp Coll Udine, Udine, Italy; [Acharya, B. S.] Abdus Salaam Int Ctr Theoret Phys, Trieste, Italy; [Alhroob, M.; Brazzale, S. F.; Cobal, M.; De Sanctis, U.; Del Papa, C.; Giordani, M. P.; Pinamonti, M.; Shaw, K.; Soualah, R.] Univ Udine, Dipartimento Chim Fis & Ambiente, I-33100 Udine, Italy; [Atkinson, M.; Basye, A.; Benekos, N.; Cavaliere, V.; Chang, P.; Coggeshall, J.; Cortes-Gonzalez, A.; Errede, D.; Errede, S.; Lie, K.; Liss, T. M.; McCarn, A.; Neubauer, M. S.; Vichou, I.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Brenner, R.; Buszello, C. P.; Coniavitis, E.; Ekelof, T.; Ellert, M.; Ferrari, A.; Isaksson, C.; Pelikan, D.] Uppsala Univ, Dept Phys & Astron, Uppsala, Sweden; [Cabrera Urban, S.; Castillo Gimenez, V.; Costa, M. J.; Fassi, F.; Ferrer, A.; Fiorini, L.; Fuster, J.; Garcia, C.; Garcia Navarro, J. E.; Gonzalez de la Hoz, S.; Hernandez Jimenez, Y.; Higon-Rodriguez, E.; Irles Quiles, A.; Kaci, M.; Lacasta, C.; Lacuesta, V. R.; March, L.; Marti-Garcia, S.; Minano Moya, M.; Mitsou, V. A.; Moles-Valls, R.; Moreno Llacer, M.; Oliver Garcia, E.; Pedraza Lopez, S.; Perez Garcia-Estan, M. T.; Romero Adam, E.; Ros, E.; Salt, J.; Sanchez Martinez, V.; Solans, C. A.; Soldevila, U.; Sanchez, J.; Torro Pastor, E.; Valero, A.; Valladolid Gallego, E.; Valls Ferrer, J. A.; Villaplana Perez, M.; Vos, M.] Univ Valencia, Inst Fis Corpuscular IFIC, Valencia, Spain; [Cabrera Urban, S.; Castillo Gimenez, V.; Costa, M. J.; Fassi, F.; Ferrer, A.; Fiorini, L.; Fuster, J.; Garcia, C.; Garcia Navarro, J. E.; Gonzalez de la Hoz, S.; Hernandez Jimenez, Y.; Higon-Rodriguez, E.; Irles Quiles, A.; Kaci, M.; Lacasta, C.; Lacuesta, V. R.; March, L.; Marti-Garcia, S.; Minano Moya, M.; Mitsou, V. A.; Moles-Valls, R.; Moreno Llacer, M.; Oliver Garcia, E.; Pedraza Lopez, S.; Perez Garcia-Estan, M. T.; Romero Adam, E.; Ros, E.; Salt, J.; Sanchez Martinez, V.; Solans, C. A.; Soldevila, U.; Sanchez, J.; Torro Pastor, E.; Valero, A.; Valladolid Gallego, E.; Valls Ferrer, J. A.; Villaplana Perez, M.; Vos, M.] Univ Valencia, Dept Fis Atom Mol & Nucl, Valencia, Spain; [Cabrera Urban, S.; Castillo Gimenez, V.; Costa, M. J.; Fassi, F.; Ferrer, A.; Fiorini, L.; Fuster, J.; Garcia, C.; Garcia Navarro, J. E.; Gonzalez de la Hoz, S.; Hernandez Jimenez, Y.; Higon-Rodriguez, E.; Irles Quiles, A.; Kaci, M.; Lacasta, C.; Lacuesta, V. R.; March, L.; Marti-Garcia, S.; Minano Moya, M.; Mitsou, V. A.; Moles-Valls, R.; Moreno Llacer, M.; Oliver Garcia, E.; Pedraza Lopez, S.; Perez Garcia-Estan, M. T.; Romero Adam, E.; Ros, E.; Salt, J.; Sanchez Martinez, V.; Solans, C. A.; Soldevila, U.; Sanchez, J.; Torro Pastor, E.; Valero, A.; Valladolid Gallego, E.; Valls Ferrer, J. A.; Villaplana Perez, M.; Vos, M.] Univ Valencia, Dept Ingn Elect, Valencia, Spain; [Cabrera Urban, S.; Castillo Gimenez, V.; Costa, M. J.; Fassi, F.; Ferrer, A.; Fiorini, L.; Fuster, J.; Garcia, C.; Garcia Navarro, J. E.; Gonzalez de la Hoz, S.; Hernandez Jimenez, Y.; Higon-Rodriguez, E.; Irles Quiles, A.; Kaci, M.; Lacasta, C.; Lacuesta, V. R.; March, L.; Marti-Garcia, S.; Minano Moya, M.; Mitsou, V. A.; Moles-Valls, R.; Moreno Llacer, M.; Oliver Garcia, E.; Pedraza Lopez, S.; Perez Garcia-Estan, M. T.; Romero Adam, E.; Ros, E.; Salt, J.; Sanchez Martinez, V.; Solans, C. A.; Soldevila, U.; Sanchez, J.; Torro Pastor, E.; Valero, A.; Valladolid Gallego, E.; Valls Ferrer, J. A.; Villaplana Perez, M.; Vos, M.] Univ Valencia, Inst Microelect Barcelona IMB CNM, Valencia, Spain; [Cabrera Urban, S.; Castillo Gimenez, V.; Costa, M. J.; Fassi, F.; Ferrer, A.; Fiorini, L.; Fuster, J.; Garcia, C.; Garcia Navarro, J. E.; Gonzalez de la Hoz, S.; Hernandez Jimenez, Y.; Higon-Rodriguez, E.; Irles Quiles, A.; Kaci, M.; Lacasta, C.; Lacuesta, V. R.; March, L.; Marti-Garcia, S.; Minano Moya, M.; Mitsou, V. A.; Moles-Valls, R.; Moreno Llacer, M.; Oliver Garcia, E.; Pedraza Lopez, S.; Perez Garcia-Estan, M. T.; Romero Adam, E.; Ros, E.; Salt, J.; Sanchez Martinez, V.; Solans, C. A.; Soldevila, U.; Sanchez, J.; Torro Pastor, E.; Valero, A.; Valladolid Gallego, E.; Valls Ferrer, J. A.; Villaplana Perez, M.; Vos, M.] CSIC, Valencia, Spain; [Axen, D.; Gay, C.; Gecse, Z.; Loh, C. W.; Martyniuk, A. C.; Mills, W. J.; Swedish, S.; Viel, S.] Univ British Columbia, Dept Phys, Vancouver, BC, Canada; [Albert, J.; Astbury, A.; Bansal, V.; Berghaus, F.; Bernlochner, F. U.; Courneyea, L.; Fincke-Keeler, M.; Keeler, R.; Kowalewski, R.; Lefebvre, M.; Lessard, J. -R.; Marino, C. P.; McPherson, R. A.; Ouellette, E. A.; Plamondon, M.; Sobie, R.] Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; [Farrington, S. M.; Jones, G.] Univ Warwick, Dept Phys, Coventry, W Midlands, England; [Kimura, N.; Yorita, K.] Waseda Univ, Tokyo, Japan; [Alon, R.; Barak, L.; Bressler, S.; Citron, Z. H.; Duchovni, E.; Frank, T.; Gabizon, O.; Gross, E.; Groth-Jensen, J.; Klier, A.; Lellouch, D.; Levinson, L. J.; Mikenberg, G.; Milov, A.; Milstein, D.; Roth, I.; Silbert, O.; Smakhtin, V.; Vitells, O.] Weizmann Inst Sci, Dept Particle Phys, IL-76100 Rehovot, Israel; [Banerjee, Sw.; Carrillo-Montoya, G. D.; Hernandez, A. M. Castaneda; Castaneda-Miranda, E.; Chen, X.; Di Mattia, A.; Dos Anjos, A.; Fang, Y.; Castillo, L. R. Flores; Gutzwiller, O.; Hard, A. S.; Ji, H.; Ju, X.; Kashif, L.; Kruse, A.; Ma, L. L.; Garcia, B. R. Mellado; Ming, Y.; Pan, Y. B.; Morales, M. I. Pedraza; Quayle, W. B.; Sarangi, T.; Wang, F.; Wang, H.; Wiedenmann, W.; Wu, S. L.; Yang, H.; Zobernig, G.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA; [Fleischmann, P.; Meyer, J.; Redelbach, A.; Siragusa, G.; Stroehmer, R.; Trefzger, T.] Univ Wurzburg, Fak Phys & Astron, D-97070 Wurzburg, Germany; [Barisonzi, M.; Becker, A. K.; Becks, K. H.; Braun, H. M.; Cornelissen, T.; Duda, D.; Fleischmann, S.; Flick, T.; Gerlach, P.; Glitza, K. W.; Gorfine, G.; Hamacher, K.; Harenberg, T.; Henss, T.; Hirschbuehl, D.; Kalinin, S.; Kersten, S.; Khoroshilov, A.; Kohlmann, S.; Lantzsch, K.; Lenzen, G.; Maettig, P.; Mechtel, M.; Neumann, M.; Pataraia, S.; Sandhoff, M.; Sartisohn, G.; Schultes, J.; Sturm, P.; Voss, T. T.; Wagner, W.; Wahlen, H.; Wicke, D.; Zeitnitz, C.] Berg Univ Wuppertal, Fachbereich Phys C, Wuppertal, Germany; [Adelman, J.; Baker, O. K.; Bedikian, S.; Boek, J.; Almenar, C. Cuenca; Czyczula, Z.; Demers, S.; Garberson, F.; Golling, T.; Guest, D.; Lagouri, T.; Lee, L.; Loginov, A.; Sherman, D.; Tipton, P.; Wall, R.; Walsh, B.] Yale Univ, Dept Phys, New Haven, CT USA; [Hakobyan, H.] Yerevan Phys Inst, Yerevan, Armenia; [Biscarat, C.; Cogneras, E.; Rahal, G.] Inst Natl Phys Nucl & Phys Particules IN2P3, Ctr Calcul, Villeurbanne, France; [Miguens, J. Machado] Lab Instrumentacao & Fis Expt Particulas LIP, Lisbon, Portugal; [Amorim, A.; Gomes, A.; Pina, J.] Univ Lisbon, Fac Ciencias, Lisbon, Portugal; [Amorim, A.; Gomes, A.; Pina, J.] Univ Lisbon, CFNUL, Lisbon, Portugal; [Bawa, H. S.; Gao, Y. S.] Calif State Univ, Dept Phys, Fresno, CA USA; [Beloborodova, O.; Talyshev, A.; Tikhonov, Y. A.] Novosibirsk State Univ, Novosibirsk, Russia; Fermilab Natl Accelerator Lab, Batavia, IL USA; [Carvalho, J.; Fiolhais, M. C. N.; Oliveira, M.; Wolters, H.] Univ Coimbra, Dept Phys, Coimbra, Portugal; [Hernandez, A. M. Castaneda] UASLP, Dept Phys, San Luis Potosi, Mexico; [Conventi, F.; Della Pietra, M.] Univ Napoli Parthenope, Naples, Italy; [Corriveau, F.; McPherson, R. A.; Robertson, S. H.; Sobie, R.; Teuscher, R. J.] Inst Particle Phys, Toronto, ON, Canada; [Demirkoz, B.] Middle E Tech Univ, Dept Phys, TR-06531 Ankara, Turkey; [Dhullipud, R.; Greenwood, Z. D.; Sawyer, L.] Louisiana Tech Univ, Ruston, LA 71270 USA; [Wemans, A. Do Valle] Univ Nova Lisboa, Dept Fis, Caparica, Portugal; [Wemans, A. Do Valle] Univ Nova Lisboa, CEFITEC, Fac Ciencias & Tecnol, Caparica, Portugal; [Hamilton, A.] Univ Cape Town, Dept Phys, Cape Town, South Africa; [Kono, T.; Wildt, M. A.] Univ Hamburg, Inst Expt Phys, Hamburg, Germany; [Konoplich, R.] Manhattan Coll, New York, NY USA; [Liang, Z.; Soh, D. A.; Weng, Z.] Sun Yat Sen Univ, Sch Phys & Engn, Guangzhou, Peoples R China; [Lin, S. C.] Acad Sinica, Inst Phys, Acad Sinica Grid Comp, Taipei, Taiwan; [Onofre, A.] Univ Minho, Dept Fis, Braga, Portugal; [Park, W.; Purohit, M.] Univ S Carolina, Dept Phys & Astron, Columbia, SC 29208 USA; [Pasztor, G.; Toth, J.] Wigner Res Ctr Phys, Inst Particle & Nucl Phys, Budapest, Hungary; [Perez, K.] CALTECH, Pasadena, CA 91125 USA; [Richter-Was, E.] Jagiellonian Univ, Inst Phys, Krakow, Poland; [Yacoob, S.] Univ KwaZulu Natal, Discipline Phys, Durban, South Africa	University of Adelaide; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of Alberta; Ankara University; Dumlupinar University; Gazi University; TOBB Ekonomi ve Teknoloji University; Gaziantep University; Ministry of Energy & Natural Resources - Turkey; Turkish Energy, Nuclear & Mineral Research Agency (TENMAK); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Universite de Savoie; United States Department of Energy (DOE); Argonne National Laboratory; University of Arizona; University of Texas System; University of Texas Arlington; National & Kapodistrian University of Athens; National Technical University of Athens; Azerbaijan National Academy of Sciences (ANAS); Institute of Physics of the Azerbaijan National Academy of Sciences; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Institute for High Energy Physics (IFAE); Autonomous University of Barcelona; ICREA; University of Belgrade; University of Belgrade; University of Bergen; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Humboldt University of Berlin; University of Bern; University of Bern; University of Birmingham; Bogazici University; Dogus University; Gaziantep University; Istanbul Technical University; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; University of Bonn; Boston University; Brandeis University; Universidade Federal de Juiz de Fora; Universidade Federal de Sao Joao del-Rei; Universidade de Sao Paulo; United States Department of Energy (DOE); Brookhaven National Laboratory; Horia Hulubei National Institute of Physics & Nuclear Engineering; Polytechnic University of Bucharest; West University of Timisoara; University of Buenos Aires; University of Cambridge; Carleton University; European Organization for Nuclear Research (CERN); University of Chicago; Pontificia Universidad Catolica de Chile; Universidad Tecnica Federico Santa Maria; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing University; Shandong University; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Columbia University; University of Copenhagen; Niels Bohr Institute; Istituto Nazionale di Fisica Nucleare (INFN); University of Calabria; AGH University of Science & Technology; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; Southern Methodist University; University of Texas System; University of Texas Dallas; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Dortmund University of Technology; Technische Universitat Dresden; Duke University; University of Edinburgh; Istituto Nazionale di Fisica Nucleare (INFN); University of Freiburg; University of Geneva; Istituto Nazionale di Fisica Nucleare (INFN); University of Genoa; Ivane Javakhishvili Tbilisi State University; Ivane Javakhishvili Tbilisi State University; Justus Liebig University Giessen; University of Glasgow; University of Gottingen; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Hampton University; Harvard University; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Hiroshima Institute of Technology; Indiana University System; Indiana University Bloomington; University of Innsbruck; University of Iowa; Iowa State University; Joint Institute for Nuclear Research - Russia; High Energy Accelerator Research Organization (KEK); Kobe University; Kyoto University; Kyoto University of Education; Kyushu University; National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Lancaster University; Istituto Nazionale di Fisica Nucleare (INFN); University of Salento; University of Liverpool; University of Ljubljana; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of London; Queen Mary University London; University College London; University of London; Royal Holloway University London; University of London; University College London; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Lund University; Autonomous University of Madrid; Johannes Gutenberg University of Mainz; University of Manchester; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); University of Massachusetts System; University of Massachusetts Amherst; McGill University; University of Melbourne; University of Michigan System; University of Michigan; Michigan State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Milan; National Academy of Sciences of Belarus (NASB); B.I. Stepanov Institute of Physics of the National Academy of Sciences of Belarus; Belarusian State University; National Center of Particles & High Energy Physics - Belarus; Massachusetts Institute of Technology (MIT); Universite de Montreal; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; National Research Nuclear University MEPhI (Moscow Engineering Physics Institute); Lomonosov Moscow State University; University of Munich; Max Planck Society; Nagasaki Institute of Applied Science; Nagoya University; Nagoya University; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; University of New Mexico; Radboud University Nijmegen; FOM National Institute for Subatomic Physics; University of Amsterdam; Northern Illinois University; Russian Academy of Sciences; Budker Institute of Nuclear Physics; New York University; University System of Ohio; Ohio State University; Okayama University; University of Oklahoma System; University of Oklahoma - Norman; Oklahoma State University System; Oklahoma State University - Stillwater; Palacky University Olomouc; University of Oregon; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Osaka University; University of Oslo; University of Oxford; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; University of Pennsylvania; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Istituto Nazionale di Fisica Nucleare (INFN); University of Pisa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Laboratorio de Instrumentacao e Fisica Experimental de Particulas; University of Granada; University of Granada; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Charles University Prague; Czech Technical University Prague; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of Regina; Ritsumeikan University; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN); University of Rome Tor Vergata; Istituto Nazionale di Fisica Nucleare (INFN); Roma Tre University; Hassan II University of Casablanca; Cadi Ayyad University of Marrakech; Mohammed First University of Oujda; Mohammed V University in Rabat; CEA; University of California System; University of California Santa Cruz; University of Washington; University of Washington Seattle; University of Sheffield; Shinshu University; Universitat Siegen; Simon Fraser University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Comenius University Bratislava; Slovak Academy of Sciences; University of Johannesburg; University of Witwatersrand; Stockholm University; Oskar Klein Centre; Royal Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Sussex; University of Sydney; Technion Israel Institute of Technology; Tel Aviv University; Aristotle University of Thessaloniki; University of Tokyo; University of Tokyo; Tokyo Metropolitan University; Tokyo Institute of Technology; University of Toronto; University of British Columbia; York University - Canada; University of Tsukuba; Tufts University; Universidad Antonio Narino; University of California System; University of California Irvine; Istituto Nazionale di Fisica Nucleare (INFN); Abdus Salam International Centre for Theoretical Physics (ICTP); University of Udine; University of Illinois System; University of Illinois Urbana-Champaign; Uppsala University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Fisica Corpuscular (IFIC); University of Valencia; University of Valencia; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Microelectronica de Barcelona (IMB-CNM); University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); University of British Columbia; University of Victoria; University of Warwick; Waseda University; Weizmann Institute of Science; University of Wisconsin System; University of Wisconsin Madison; University of Wurzburg; University of Wuppertal; Yale University; Yerevan Physics Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Laboratorio de Instrumentacao e Fisica Experimental de Particulas; Universidade de Lisboa; Universidade de Lisboa; California State University System; California State University Fresno; Novosibirsk State University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; Universidade de Coimbra; Universidad Autonoma de San Luis Potosi; Parthenope University Naples; Middle East Technical University; University of Louisiana System; Louisiana Technical University; Universidade Nova de Lisboa; Universidade Nova de Lisboa; University of Cape Town; University of Hamburg; Manhattan College; Sun Yat Sen University; Academia Sinica - Taiwan; Universidade do Minho; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; California Institute of Technology; Jagiellonian University; University of Kwazulu Natal	Aad, G (corresponding author), Univ Freiburg, Fak Math & Phys, Freiburg, Germany.	atlas.publications@cern.ch	García, Josu Cantero/AAS-9810-2020; Llácer, María Moreno/AAQ-7522-2020; BLOCKI, Jacek/AAP-3256-2021; Berger, N/ABE-4064-2020; Iengo, Paolo/AAR-7518-2020; Řezníček, Pavel/C-1989-2017; Perrino, Roberto/AAA-5752-2022; Busato, Emmanuel/AAS-5459-2020; Gutierrez, Phillip/C-1161-2011; Llácer, María Moreno/AAU-6582-2020; Garcia, Carmen/W-2465-2018; Boyko, Igor R/J-3659-2013; CAKIR, Orhan/L-1893-2015; Coadou, Yann/G-2263-2010; Bachas, Konstantinos/C-8101-2019; della Volpe, Domenico/B-4482-2012; Di Nardo, Roberto/J-4993-2012; Reznicek, Pavel/AGH-4685-2022; Alimonti, Gianluca/AAG-4603-2020; Malecki, Piotr/O-2434-2018; Andreazza, Attilio/E-5642-2011; Sukharev, Andrey/A-6470-2014; Herrera, Maria Clemencia Mora/L-3893-2016; Paganis, Stathes/J-8413-2017; Canelli, Florencia/AAI-1616-2021; Fiorini, Luca/W-6250-2018; Milosavljevic, Marija Vranjes/F-9847-2016; Ozcan, Veysi Erkcan/AAS-4508-2020; Muino, Patricia Conde/F-7696-2011; Annovi, Alberto/G-6028-2012; Klimentov, Alexei A/I-4270-2013; Kodys, Peter/P-2636-2017; Dabrowski, Wladyslaw/AAS-6369-2020; Wozniak, Krzysztof W/P-4475-2017; Grinstein, Sebastian/ABE-1880-2020; de la Hoz, Santiago Gonzalez/AHC-7576-2022; Banaś, Elżbieta A/W-4583-2017; Stoicea, Gabriel/B-6717-2011; Vandelli, Wainer/ABI-8185-2020; de la Torre Perez, Hector/ABG-6942-2020; Cavaliere, Viviana/CAG-2384-2022; Cavaliere, Viviana/CAE-8597-2022; Kuleshov, Sergey V/D-9940-2013; Masik, Jiri/AAE-1203-2021; Donadelli, Marisilvia/H-3710-2016; Chitan, Adrian/AAC-8946-2022; Maneira, Jose/D-8486-2011; Tassi, Enrico/AAJ-9661-2020; Camarri, Paolo/M-7979-2015; Mikestikova, Marcela/H-1996-2014; Smirnov, Sergei Y/F-1014-2011; Yang, Haijun/O-1055-2015; Albert, Justin/J-4152-2017; O'Shea, Val/G-1279-2010; Gonzalez, Barbara Alvarez/ABG-7021-2020; Solfaroli Camillocci, Elena/J-1596-2012; Chekulaev, Sergey V/O-1145-2015; Peleganchuk, Sergey V/J-6722-2014; Evangelos, Gazis/L-3966-2017; Buttar, Craig/AAG-5392-2021; Villaplana Perez, Miguel/B-5772-2014; de Renstrom, Pawel Bruckman/AAG-7725-2021; de Groot, Nicolo/A-2675-2009; Demirköz, Bilge M/C-8179-2014; Negrini, Matteo/C-8906-2014; Laycock, Paul/AAL-8261-2021; Urbán, Susana Cabrera/H-1376-2015; Glasman, Claudia/Y-8858-2019; Wolters, Helmut/M-4154-2013; Torro Pastor, Emma/AAB-5979-2021; Saavedra, Juan Antonio Aguilar/F-1256-2016; Zivkovic, Lidija/HGA-8150-2022; Nechaeva, Polina Y/N-1148-2015; Nevski, Pavel/M-6292-2015; Torregrosa, Esteban Fullana/A-7305-2016; Castillo, Luis Roberto Flores/W-3928-2018; Tudorache, Valentina I/D-2743-2012; Darbo, Giovanni/C-8175-2012; Gavrilenko, Igor/M-8260-2015; Nevski, Pavel/AAH-1839-2019; Coccaro, Andrea/AAB-6990-2021; Snesarev, Andrei/H-5090-2013; Ferrando, James E/A-9192-2012; yang, yang/HGT-7999-2022; Trzebinski, Maciej/W-1748-2018; Orlov, Ilya O/E-6611-2012; Kartvelishvili, Vakhtang G/K-2312-2013; Tsybychev, Dmitri/J-3733-2017; yang, yang/GVT-5210-2022; Benslama, Kamal/AAO-2056-2021; Smirnova, Oxana/A-4401-2013; Passeri, Antonio/AAJ-8429-2020; Rozen, Yoram/H-1880-2017; Santos, Denis R./F-4015-2018; Pina, Joao/C-4391-2012; Petrucci, Fabrizio/G-8348-2012; de la Hoz, Santiago Gonzalez/E-2494-2016; Malek, Fairouz/E-4410-2018; Di Simone, Andrea/K-6609-2013; Ríos, Cibrán Santamarina/K-4686-2014; Kuday, Sinan/CAF-3048-2022; spagnolo, stefania/A-6359-2012; Lee, Jason SH/B-9701-2014; Trzupek, Adam/N-2448-2018; Olshevskiy, Alexander/I-1580-2016; Gonella, Laura/GLR-3838-2022; Castro, Nuno/AAB-3648-2019; Stoicea, Gabriel/L-5602-2019; Górnicki, Edward/C-4075-2019; Klok, Peter/AAF-7393-2019; Kantserov, Vadim/M-9761-2015; Irles, Adrian/AAW-1879-2021; Canelli, Florencia/O-9693-2016; Berge, David/P-2179-2017; Moorhead, Gareth F/B-6634-2009; Fazio, Salvatore/G-5156-2010; Llorente Merino, Javier/AGP-3432-2022; perez, miguel/GXF-5077-2022; Succurro, Antonella/K-3523-2019; Busato, Emmanuel/AAZ-4423-2020; Ciftci, Rena/O-6517-2018; Fuster, Juan/W-6189-2018; Sýkora, Tomáš/Q-3174-2017; Giagu, Stefano/H-6455-2013; Marti-Garcia, Salvador/F-3085-2011; Šolc, Jaroslav/AAC-5868-2021; Ciftci, Abbas Kenan/AAC-5487-2022; da via, cinzia/AAS-3978-2021; Carquin, Edson/GLU-9641-2022; Mitsou, Vasiliki/D-1967-2009; Staroba, Pavel/G-8850-2014; Anjos, Nuno/I-3918-2013; Mashinistov, Ruslan/M-8356-2015; Schernau, Michael/GRY-3808-2022; Vaniachine, Alexandre/H-7796-2013; Lange, Clemens/AAL-6635-2020; Kostyukhin, Vadim/F-3171-2019; Staszewski, Rafał/AAO-6844-2021; Vanadia, Marco/K-5870-2016; Veneziano, Stefano/J-1610-2012; Grabowska-Bołd, Iwona/ABI-7829-2020; Uhlen, Mathias/B-3262-2016; Ji, Haoshuang/F-4525-2014; Jones, Roger WL/H-5578-2011; Nessi, Marzio/L-5194-2017; Monzani, Simone/D-6328-2017; Giordani, Mario P/Q-6211-2018; Tikhomirov, Vladimir/M-6194-2015; Fassouliotis, Dimitrios/AAL-7081-2021; SULIN, VLADIMIR V/N-2793-2015; Valero, Alberto/G-9866-2015; Olszowska, Jolanta/P-2889-2017; Warburton, Andreas/N-8028-2013; Zenin, Oleg/E-6116-2018; Ippolito, Valerio/L-1435-2016; Della Pietra, Massimo/J-5008-2012; Price, Darren D/E-6162-2012; Lagouri, Theodota/AAC-7358-2021; Banerjee, Swagato/AAN-3326-2021; Wemans, Andre/A-6738-2012; Ohm, Christian/AAU-6572-2020; Dolejší, Jiří/P-1509-2017; Moraes, Arthur/F-6478-2010; Sbarra, Carla/M-9669-2018; Gauzzi, Paolo/D-2615-2009; Annovi, Alberto/AAA-8638-2020; Testa, Marianna/L-9768-2019; Nepomuceno, Andre/AAT-2000-2020; Tomasek, Lukas/G-6370-2014; Olszewski, Andrzej J/W-1825-2018; MEONI, Evelin/ABD-9498-2021; KHODINOV, ALEKSANDR/D-6269-2015; Lee, Lawrence/AAU-6790-2021; Jiménez, Yesenia Hernández/ABH-1107-2020; Padilla, Cristobal/C-3218-2017; Carvalho, Joao/M-4060-2013; Gladilin, Leonid/B-5226-2011; KHOO, TENG JIN/E-1285-2011; de Almeida, Fernando Marroquim Leao/D-6947-2019; Sadykov, Renat/AAN-9602-2020; Chudoba, Jiri/G-7737-2014; Carquin López, Edson/GZG-4712-2022; Lacasta, Carlos/C-7254-2008; Chelkov, Georgy A./G-9934-2019; Li, Hao/GPS-9834-2022; Gorelov, Igor V/J-9010-2015; Robson, Aidan/G-1087-2011; Fabbri, Laura/H-3442-2012; Talyshev, Alexey/HGC-6910-2022; Kuday, Sinan/C-8528-2014; Davidek, Tomas/P-2697-2017; Giordano, Raffaele/J-3695-2012; De, Kaushik/N-1953-2013; Bosman, Martine/J-9917-2014; Brooks, William K/C-8636-2013; Villa, Mauro/C-9883-2009; Lokajicek, Milos/G-7800-2014; Leyton, Michael/G-2214-2016; Kepka, Oldrich/G-6375-2014; Jakoubek, Tomas/G-8644-2014; Rosati, Stefano/AAF-6968-2019; Dawson, Ian/K-6090-2013; Svatos, Michal/ABA-2041-2020; Lee, Shih-Chang/AAV-7016-2021; Nordberg, Markus/L-4255-2017; Mehdiyev, Rashid/H-6299-2013; do Vale, Maria Aline Barros/D-2357-2019; Artoni, Giacomo/ABA-2164-2020; Derendarz, Dominik/AAO-3512-2021; gaudio, gabriella/AAN-6039-2021; Zhemchugov, Alexey/N-1717-2017; Ibáñez, Carlos Escobar/B-3761-2017; Pedraza Morales, Maria Isabel/ABC-7289-2021; Doyle, Anthony T/C-5889-2009; Psoroulas, Serena/Q-3929-2019; Solodkov, Alexander A/B-8623-2017; Kalinovskaya, Lidia/AAO-1352-2020; YILDIZ, Hatice DURAN/AAN-3727-2021; Ventura, Andrea/CAH-0226-2022; Hansen, John R/B-9058-2015; Capua, Marcella/AAJ-8419-2020; Parodi, Fabrizio/AHE-5089-2022; Lambourne, Luke/AAG-7298-2020; Camarri, Paolo/AAF-9629-2020; Lang, Ming/HIK-0758-2022; Kupco, Alexander/G-9713-2014; Livan, Michele M/D-7531-2012; Benekos, Nektarios/J-8629-2017; Mamuzic, Judita/U-3509-2017; Shmeleva, Alevtina/M-6199-2015; Nemecek, Stanislav/G-5931-2014; Kostyukhin, Vadim/ABA-9033-2020; Perrino, Roberto/B-4633-2010; Orlando, Nicola/AAL-1723-2021; Watson, Ian James/AAH-1423-2022; Ferrer, Antonio/H-2942-2015; La Rosa, Alessandro/I-1856-2013; Klinkby, Esben/AAN-1630-2020; Cetin, Serkant Ali/AGF-0147-2022; Koperny, Stefan/ABB-4747-2020; Casado, Pilar/H-1484-2015; Romaniouk, Anatoli/Q-6674-2017; Behera, Prafulla Kumar/AAK-8686-2020; Kaczmarska, Anna/B-2753-2019; Zanzi, Daniele/AAY-4102-2020; Kabana, Sonia/ABF-5974-2020; Benekos, Nektarios/I-9928-2017; SULIN, Vladimir V/J-6966-2014; Price, Darren/AAB-5991-2021; Amorim, Antonio/C-8460-2013; Pásztor, Gabriella/D-9716-2016; Burdin, Sergey/AAZ-9062-2021; Trzebinski, Maciej/AAO-6821-2021; Capua, Marcella/A-8549-2015; Joergensen, Morten D/E-6847-2015; Alexa, Calin/F-6345-2010; Marcisovsky, Michal/AAM-2404-2020; Christov, Asen/S-4508-2018; Huseynov, Nazim/AAE-4663-2019; Ros, Eduardo/P-2625-2018; Caprini, Irinel/AAP-3760-2020; Kepka, Oldrich/ABF-5327-2021; Bates, Richard L/D-6596-2013; Oh, Alexander/HHZ-4386-2022; Pages, Andres Pacheco/C-5353-2011; Chizhov, Mihail/CAG-2076-2022; Salt, Jose/F-4928-2016; Svatos, Michal/G-8437-2014; Prokoshin, Fedor/E-2795-2012; Barreiro, Fernando/D-9808-2012; Cavalli-Sforza, Matteo/H-7102-2015; Watson, Ian James/AFL-9360-2022; Chang, Philip/AAN-3350-2021; banerjee, swagato/AAN-3165-2021; García, Elena Oliver/AAZ-1125-2020; Franchini, Matteo/AAC-9259-2021; Gao, Y./GWZ-3665-2022; Sultansoy, Saleh/AAV-6853-2021; Perez, Miguel Villaplana/B-2717-2015; Ventura, Andrea/A-9544-2015; Costa, Maria Jose/H-5962-2015; Grancagnolo, Sergio/J-3957-2015; Sultansoy, Saleh/AAA-8267-2019; Fassi, Farida/F-3571-2016; Bogdanchikov, Alexander/AAB-9414-2022; Kuze, Masahiro/V-4251-2018; Wu, Xin/ABH-1729-2020; Woźniak, Krzysztof/AAQ-6119-2021; Guo, Jun/O-5202-2015; Salamon, Andrea/AGN-6159-2022; Zaitsev, Alexandre M/B-8989-2017; Schultz-Coulon, Hans-Christian/X-5006-2018; Vos, Marcel/G-8123-2015; Korcyl, Krzysztof/W-2111-2018; McKee, Shawn/B-6435-2012; Juste, Aurelio/I-2531-2015; Dam, Mogens/C-2081-2015; Garcia Navarro, Jose Enrique/H-6339-2015; Faltova, Jana/P-6842-2017; xella, stefania/E-6752-2015; Goncalo, Jose/M-3153-2016; MARTINEZ, MARIO/I-3549-2015; Leitner, Rupert/C-2004-2017; Monk, James/A-9021-2017; Britton, David/F-2602-2010; Dolezal, Zdenek/K-6861-2017; cerri, alessandro/Q-6884-2016; Zabinski, Bartlomiej/Q-6483-2017; Konig, Adriaan/B-6439-2013; Soldatov, Evgeny/E-3990-2017; Hansen, Peter Henrik/C-2098-2015; Wolter, Marcin/A-7412-2012; Carli, Ina/C-2189-2017; la rotonda, laura/B-4028-2016; Malecki, Pawel/W-1710-2018; Cascella, Michele/B-6156-2013; Kreiss, Sven/R-4967-2018; Carquin, Edson/G-5221-2015; Rebuzzi, Daniela Marcella/D-9727-2018; Izen, Joseph/A-4392-2018; Zenis, Tibor/T-5270-2018; Tartarelli, Giuseppe Francesco/A-5629-2016; Sykora, Ivan/T-5252-2018; Hamal, Petr/G-5540-2014; Petersen, Troels/P-5538-2015; Tykhonov, Andrii/Q-8688-2018	García, Josu Cantero/0000-0001-8449-1019; Llácer, María Moreno/0000-0001-9045-5305; BLOCKI, Jacek/0000-0002-5947-9509; Berger, N/0000-0002-7963-9725; Iengo, Paolo/0000-0002-5035-1242; Řezníček, Pavel/0000-0003-4017-9829; Perrino, Roberto/0000-0002-5764-7337; Busato, Emmanuel/0000-0003-2174-8512; Gutierrez, Phillip/0000-0003-2326-3877; Llácer, María Moreno/0000-0003-1113-3645; Garcia, Carmen/0000-0003-1625-7452; Boyko, Igor R/0000-0002-3355-4662; CAKIR, Orhan/0000-0002-9016-138X; Coadou, Yann/0000-0001-8195-7004; Bachas, Konstantinos/0000-0002-9047-6517; Di Nardo, Roberto/0000-0003-1111-3783; Alimonti, Gianluca/0000-0002-7128-9046; Malecki, Piotr/0000-0002-7991-5902; Andreazza, Attilio/0000-0001-5161-5759; Herrera, Maria Clemencia Mora/0000-0003-3915-3170; Paganis, Stathes/0000-0002-1950-8993; Canelli, Florencia/0000-0001-6361-2117; Fiorini, Luca/0000-0002-5070-2735; Milosavljevic, Marija Vranjes/0000-0003-4477-9733; Ozcan, Veysi Erkcan/0000-0003-4643-6347; Muino, Patricia Conde/0000-0002-9187-7478; Annovi, Alberto/0000-0002-4649-4398; Kodys, Peter/0000-0002-8644-2349; Dabrowski, Wladyslaw/0000-0001-9061-9568; Wozniak, Krzysztof W/0000-0003-1171-0887; Grinstein, Sebastian/0000-0002-6460-8694; Banaś, Elżbieta A/0000-0001-5325-6040; Stoicea, Gabriel/0000-0002-7511-4614; Vandelli, Wainer/0000-0001-6581-9410; de la Torre Perez, Hector/0000-0002-4516-5269; Cavaliere, Viviana/0000-0002-4297-8539; Cavaliere, Viviana/0000-0002-4297-8539; Kuleshov, Sergey V/0000-0002-3065-326X; Donadelli, Marisilvia/0000-0001-8329-4240; Maneira, Jose/0000-0002-3222-2738; Tassi, Enrico/0000-0002-3335-6500; Camarri, Paolo/0000-0002-5732-5645; Mikestikova, Marcela/0000-0003-1277-2596; Smirnov, Sergei Y/0000-0002-6778-073X; Yang, Haijun/0000-0001-7367-1380; Albert, Justin/0000-0003-0253-2505; O'Shea, Val/0000-0001-7183-1205; Gonzalez, Barbara Alvarez/0000-0001-7767-4810; Solfaroli Camillocci, Elena/0000-0002-5347-7764; Peleganchuk, Sergey V/0000-0003-0907-7592; Buttar, Craig/0000-0003-0188-6491; Villaplana Perez, Miguel/0000-0002-0048-4602; de Renstrom, Pawel Bruckman/0000-0002-0206-1160; Demirköz, Bilge M/0000-0001-7171-5976; Negrini, Matteo/0000-0003-0101-6963; Glasman, Claudia/0000-0003-2025-3817; Wolters, Helmut/0000-0002-9588-1773; Torro Pastor, Emma/0000-0002-5507-7924; Saavedra, Juan Antonio Aguilar/0000-0002-5475-8920; Zivkovic, Lidija/0000-0003-4236-8930; Nechaeva, Polina Y/0000-0002-5910-4117; Torregrosa, Esteban Fullana/0000-0003-3082-621X; Castillo, Luis Roberto Flores/0000-0003-1551-5974; Darbo, Giovanni/0000-0003-2165-0638; Coccaro, Andrea/0000-0003-2368-4559; Snesarev, Andrei/0000-0002-9067-8362; Ferrando, James E/0000-0002-1007-7816; Trzebinski, Maciej/0000-0002-5151-7101; Orlov, Ilya O/0000-0003-4073-0326; Kartvelishvili, Vakhtang G/0000-0002-1957-3787; Benslama, Kamal/0000-0002-2532-2415; Smirnova, Oxana/0000-0003-2517-531X; Passeri, Antonio/0000-0003-4864-3411; Santos, Denis R./0000-0001-7992-9602; Pina, Joao/0000-0001-8959-5044; Petrucci, Fabrizio/0000-0002-5278-2206; de la Hoz, Santiago Gonzalez/0000-0001-5304-5390; Malek, Fairouz/0000-0002-0948-5775; Di Simone, Andrea/0000-0003-0201-3377; Ríos, Cibrán Santamarina/0000-0002-9810-1816; spagnolo, stefania/0000-0001-7482-6348; Lee, Jason SH/0000-0002-2153-1519; Trzupek, Adam/0000-0001-6938-5867; Olshevskiy, Alexander/0000-0002-8902-1793; Castro, Nuno/0000-0001-8491-4376; Górnicki, Edward/0000-0001-6243-9121; Kantserov, Vadim/0000-0001-8255-416X; Irles, Adrian/0000-0001-5668-151X; Canelli, Florencia/0000-0001-6361-2117; Berge, David/0000-0002-2918-1824; Moorhead, Gareth F/0000-0002-9299-9549; Fazio, Salvatore/0000-0002-4321-1946; Succurro, Antonella/0000-0003-0227-2803; Busato, Emmanuel/0000-0003-2174-8512; Ciftci, Rena/0000-0003-4461-1252; Sýkora, Tomáš/0000-0001-9585-7215; Giagu, Stefano/0000-0001-9192-3537; Šolc, Jaroslav/0000-0002-1629-5697; da via, cinzia/0000-0001-6154-7323; Mitsou, Vasiliki/0000-0002-1533-8886; Staroba, Pavel/0000-0001-6009-6321; Mashinistov, Ruslan/0000-0001-7925-4676; Vaniachine, Alexandre/0000-0002-0367-5666; Lange, Clemens/0000-0002-3632-3157; Kostyukhin, Vadim/0000-0002-0490-9209; Staszewski, Rafał/0000-0001-7708-9259; Vanadia, Marco/0000-0003-2684-276X; Veneziano, Stefano/0000-0002-2598-2659; Grabowska-Bołd, Iwona/0000-0001-9159-1210; Uhlen, Mathias/0000-0002-4858-8056; Jones, Roger WL/0000-0002-6427-3513; Monzani, Simone/0000-0002-0479-2207; Giordani, Mario P/0000-0002-0792-6039; Tikhomirov, Vladimir/0000-0002-9634-0581; SULIN, VLADIMIR V/0000-0003-3943-2495; Valero, Alberto/0000-0002-9776-5880; Olszowska, Jolanta/0000-0003-0520-9500; Warburton, Andreas/0000-0002-2298-7315; Ippolito, Valerio/0000-0001-5126-1620; Della Pietra, Massimo/0000-0003-4446-3368; Banerjee, Swagato/0000-0001-8852-2409; Wemans, Andre/0000-0002-9669-9500; Ohm, Christian/0000-0002-8015-7512; Dolejší, Jiří/0000-0001-5821-7067; Moraes, Arthur/0000-0002-5157-5686; Sbarra, Carla/0000-0002-8236-5251; Gauzzi, Paolo/0000-0003-4841-5822; Tomasek, Lukas/0000-0002-5224-1936; Olszewski, Andrzej J/0000-0003-3368-5475; MEONI, Evelin/0000-0002-6934-3752; KHODINOV, ALEKSANDR/0000-0003-3551-5808; Lee, Lawrence/0000-0002-5590-335X; Jiménez, Yesenia Hernández/0000-0001-9844-6200; Padilla, Cristobal/0000-0001-7951-0166; Carvalho, Joao/0000-0002-3015-7821; Gladilin, Leonid/0000-0001-9422-8636; de Almeida, Fernando Marroquim Leao/0000-0003-2265-784X; Sadykov, Renat/0000-0002-9157-6819; Chudoba, Jiri/0000-0002-6425-2579; Lacasta, Carlos/0000-0002-2623-6252; Gorelov, Igor V/0000-0001-5570-0133; Fabbri, Laura/0000-0002-4002-8353; Talyshev, Alexey/0000-0001-8560-3756; Kuday, Sinan/0000-0002-0116-5494; Davidek, Tomas/0000-0002-3770-8307; De, Kaushik/0000-0002-5647-4489; Bosman, Martine/0000-0002-7290-643X; Brooks, William K/0000-0001-6161-3570; Villa, Mauro/0000-0002-9181-8048; Leyton, Michael/0000-0002-0727-8107; Rosati, Stefano/0000-0003-0838-5980; Svatos, Michal/0000-0002-7199-3383; Lee, Shih-Chang/0000-0002-3353-2658; do Vale, Maria Aline Barros/0000-0002-0836-6483; Artoni, Giacomo/0000-0002-3477-4499; Derendarz, Dominik/0000-0001-5660-3095; gaudio, gabriella/0000-0002-6833-0933; Zhemchugov, Alexey/0000-0002-3360-4965; Ibáñez, Carlos Escobar/0000-0003-4442-4537; Pedraza Morales, Maria Isabel/0000-0002-2669-4659; Doyle, Anthony T/0000-0001-6322-6195; Psoroulas, Serena/0000-0001-7576-3238; Solodkov, Alexander A/0000-0002-2737-8674; YILDIZ, Hatice DURAN/0000-0003-3469-6045; Ventura, Andrea/0000-0002-3368-3413; Hansen, John R/0000-0002-8422-5543; Lambourne, Luke/0000-0002-7001-7575; Camarri, Paolo/0000-0002-5732-5645; Livan, Michele M/0000-0002-5877-0062; Mamuzic, Judita/0000-0002-3203-4243; Kostyukhin, Vadim/0000-0002-0490-9209; Perrino, Roberto/0000-0002-5764-7337; Orlando, Nicola/0000-0003-0616-245X; Watson, Ian James/0000-0003-2141-3413; Ferrer, Antonio/0000-0003-0532-711X; La Rosa, Alessandro/0000-0001-6291-2142; Klinkby, Esben/0000-0002-1908-5644; Cetin, Serkant Ali/0000-0001-5050-8441; Casado, Pilar/0000-0002-0394-5646; Behera, Prafulla Kumar/0000-0002-1527-2266; Kaczmarska, Anna/0000-0002-8880-4120; Zanzi, Daniele/0000-0002-1222-7937; Kabana, Sonia/0000-0003-0568-5750; Benekos, Nektarios/0000-0001-7831-8762; SULIN, Vladimir V/0000-0003-3943-2495; Price, Darren/0000-0003-2750-9977; Amorim, Antonio/0000-0003-0638-2321; Pásztor, Gabriella/0000-0003-0707-9762; Burdin, Sergey/0000-0003-4831-4132; Trzebinski, Maciej/0000-0002-5151-7101; Capua, Marcella/0000-0002-2443-6525; Joergensen, Morten D/0000-0002-6790-9361; Marcisovsky, Michal/0000-0003-0860-7897; Christov, Asen/0000-0001-8121-5860; Ros, Eduardo/0000-0003-2812-9554; Caprini, Irinel/0000-0003-3343-3200; Pages, Andres Pacheco/0000-0001-8210-1734; Chizhov, Mihail/0000-0001-5841-3316; Salt, Jose/0000-0003-4181-2788; Svatos, Michal/0000-0002-7199-3383; Prokoshin, Fedor/0000-0001-6389-5399; Barreiro, Fernando/0000-0002-3021-0258; Watson, Ian James/0000-0003-2141-3413; Chang, Philip/0000-0002-2095-6320; banerjee, swagato/0000-0001-8852-2409; García, Elena Oliver/0000-0002-9214-9384; Franchini, Matteo/0000-0002-4554-252X; Perez, Miguel Villaplana/0000-0002-0048-4602; Ventura, Andrea/0000-0002-3368-3413; Grancagnolo, Sergio/0000-0001-8490-8304; Fassi, Farida/0000-0002-6423-7213; Kuze, Masahiro/0000-0001-8858-8440; Wu, Xin/0000-0001-7655-389X; Woźniak, Krzysztof/0000-0003-1171-0887; Guo, Jun/0000-0001-8125-9433; Zaitsev, Alexandre M/0000-0002-4961-8368; Jakobsen, Sune/0000-0002-6564-040X; Nagasaka, Yasushi/0000-0002-3669-9525; Weingarten, Jens/0000-0003-2165-871X; Vetterli, Michel/0000-0002-7223-2965; Burgess, Thomas/0000-0002-6993-5918; abi, babak/0000-0001-7036-9645; Lafaye, Remi/0000-0001-7848-6088; Turra, Ruggero/0000-0001-8740-796X; Mechnich, Jorg/0000-0002-6406-4906; Mermod, Philippe/0000-0001-9656-9901; Francavilla, Paolo/0000-0003-1164-6870; CIFTCI, ABBAS KENAN/0000-0001-9108-0023; Keeler, Richard/0000-0002-0510-4189; Pralavorio, Pascal/0000-0002-2452-6715; Dietrich, Janet/0000-0001-7061-1585; Romaniouk, Anatoli/0000-0001-9241-1189; Nikolopoulos, Konstantinos/0000-0002-3048-489X; Thomson, Mark/0000-0002-2654-9005; Pastore, Francesca/0000-0001-5962-7826; Guenther, Jaroslav/0000-0003-3189-3959; Robinson, James/0000-0002-2856-9413; Tisserant, Sylvain/0000-0002-0294-6727; Konstantinidis, Nikolaos/0000-0002-4140-6360; Trincaz-Duvoid, Sophie/0000-0001-5913-0828; Sawyer, Lee/0000-0001-8295-0605; Sadeh, Iftach/0000-0003-1387-8915; Mengarelli, Alberto/0000-0002-1884-854X; Schultz-Coulon, Hans-Christian/0000-0002-0860-7240; Butterworth, Jonathan/0000-0002-5905-5394; Vos, Marcel/0000-0001-8474-5357; Schmitt, Christian/0000-0003-1471-690X; Przybycien, Mariusz/0000-0002-9235-2649; Makovec, Nikola/0000-0001-5124-904X; Adye, Tim/0000-0003-0627-5059; Spano, Francesco/0000-0002-6551-1878; Korcyl, Krzysztof/0000-0001-8085-4505; Ahlen, Steven/0000-0001-6098-7247; Meirose, Bernhard/0000-0003-0032-7022; Sasaki, Osamu/0000-0002-2910-3906; Iliadis, Dimitrios/0000-0001-6303-2761; Haug, Sigve/0000-0003-0442-3361; Wiglesworth, Craig/0000-0001-6219-8946; Garcia-Sciveres, Maurice/0000-0002-5800-4210; Bordoni, Stefania/0000-0002-5675-0631; Schieck, Jochen/0000-0002-1058-8093; Morettini, Paolo/0000-0001-7139-7912; Lassnig, Mario/0000-0002-9541-0592; Yorita, Kohei/0000-0003-1988-8401; Kolanoski, Hermann/0000-0003-0435-2524; Potter, Christina/0000-0002-9815-5208; McKee, Shawn/0000-0002-4551-4502; Akesson, Torsten/0000-0003-4141-5408; Juste, Aurelio/0000-0002-1558-3291; Dervan, Paul/0000-0003-3929-8046; Dell'Asta, Lidia/0000-0002-9601-4225; Dam, Mogens/0000-0001-6278-9674; Yabsley, Bruce/0000-0002-2680-0474; Gallin-Martel, Marie-Laure/0000-0002-8276-6688; Landon, Murrough/0000-0001-6828-9769; Garcia Navarro, Jose Enrique/0000-0002-0279-0523; chevalier, laurent/0000-0003-3762-7264; tian zhong, xiu zhi/0000-0002-6029-6216; Genest, Marie-Helene/0000-0002-4098-2024; de Vivie, Jean-Baptiste/0000-0001-9163-2211; , Alessandro/0000-0002-8224-6105; Marzin, Antoine/0000-0003-4364-4351; Gregersen, Kristian/0000-0003-0295-1670; Litke, Alan/0000-0003-3973-3642; Faltova, Jana/0000-0003-4278-7182; Bouhova-Thacker, Evelina/0000-0002-5103-1558; De Cecco, Sandro/0000-0003-4907-8610; Nairz, Armin/0000-0003-3561-0880; Ereditato, Antonio/0000-0002-5423-8079; Binet, Sebastien/0000-0003-4913-6104; Cabrera Urban, Susana/0000-0001-7640-7913; Kirk, Julie/0000-0001-8096-7577; Branchini, Paolo/0000-0002-2270-9673; Gomez Fajardo, Luz Stella/0000-0001-9555-0176; Lister, Alison/0000-0002-1552-3651; TAYLOR, GEOFFREY/0000-0002-1831-4871; Begel, Michael/0000-0002-1634-4399; Sadrozinski, Hartmut/0000-0003-0019-5410; Loch, Peter/0000-0002-2005-671X; Capeans, Mar/0000-0001-7727-9175; Lleres, Annick/0000-0003-1769-8524; Liu, Minghui/0000-0003-0056-7296; snyder, scott/0000-0001-8610-8423; Elsing, Markus/0000-0002-1213-0545; Cristinziani, Markus/0000-0003-3893-9171; xella, stefania/0000-0002-0988-1655; Lefebvre, Michel/0000-0002-5560-0586; Schoeffel, Laurent/0000-0002-8081-2353; Heelan, Louise/0000-0002-4879-0131; Chen, Hucheng/0000-0002-9936-0115; franklin, melissa/0000-0002-6595-883X; Iakovidis, George/0000-0002-0330-5921; Kono, Takanori/0000-0003-1553-2950; Ould-Saada, Farid/0000-0002-9404-835X; Lima, Jose Guilherme/0000-0003-4585-0546; , Sascha/0000-0003-2941-2829; Alonso, Alejandro/0000-0003-1259-0573; Morley, Anthony/0000-0003-0373-1346; iacobucci, giuseppe/0000-0001-9965-5442; Salvucci, Antonio/0000-0003-4876-2613; Wengler, Thorsten/0000-0002-4375-5265; Goncalo, Jose/0000-0002-3826-3442; Beringer, Juerg/0000-0002-9975-1781; Khoo, Teng Jian/0000-0002-5954-3101; Zhou, Ning/0000-0002-1775-2511; Simioni, Eduard/0000-0002-8929-6236; Straessner, Arno/0000-0003-2460-6659; Vercesi, Valerio/0000-0001-7670-4563; Marchand, Jean-Francois/0000-0002-4111-0797; Bachacou, Henri/0000-0002-2256-4515; Bindi, Marcello/0000-0001-6172-545X; Grosse-Knetter, Jorn/0000-0003-3085-7067; Terashi, Koji/0000-0001-6520-8070; Wijeratne, Peter/0000-0002-4885-6241; Jon-And, Kerstin/0000-0001-8201-7700; Lowe, Andrew/0000-0002-2358-6070; Luehring, Frederick/0000-0001-8721-6901; Lohwasser, Kristin/0000-0003-1833-9160; Hall, David/0000-0002-2193-0480; Wasicki, Christoph/0000-0001-8041-741X; Wiedenmann, Werner/0000-0003-3605-3633; Duda, Dominik/0000-0002-5916-3467; Lancon, Eric/0000-0002-0225-187X; MARTINEZ, MARIO/0000-0002-3135-945X; Broggi, Francesco/0000-0003-1628-1604; Vickey Boeriu, Oana/0000-0002-6497-6809; Avolio, Giuseppe/0000-0003-2664-3437; Sauvan, Emmanuel/0000-0003-1921-2647; Weber, Michele/0000-0002-2770-9031; Migas, Sylwia/0000-0001-5440-9491; Wrona, Bozydar/0000-0002-1555-0262; Farooque, Trisha/0000-0003-1363-9324; Leroy, Claude/0000-0003-3105-7045; Galhardo, Bruno/0000-0003-0641-301X; Doglioni, Caterina/0000-0002-1509-0390; Morange, Nicolas/0000-0003-0047-7215; Shabalina, Elizaveta/0000-0003-4849-556X; Burke, Stephen/0000-0002-1962-8493; Cooper-Sarkar, Amanda/0000-0002-7107-5902; Wardrope, David/0000-0002-8208-2964; Dittus, Fridolin/0000-0002-1760-8237; Hadavand, Haleh/0000-0001-5447-3346; Tokushuku, Katsuo/0000-0002-8262-1577; Lobodzinska, Ewelina Maria/0000-0001-9012-3431; Alexa, Calin/0000-0003-0922-7669; Nemecek, Stanislav/0000-0001-8978-7150; Lucotte, Arnaud/0000-0002-5992-0640; Stugu, Bjarne/0000-0002-1728-9272; Zevi Della Porta, Giovanni/0000-0003-0495-6061; Leitner, Rupert/0000-0002-2994-2187; Shimojima, Makoto/0000-0002-8738-1664; Panduro Vazquez, Jose Guillermo/0000-0003-2605-8940; Schroeder, Christian/0000-0001-6449-0668; Bednyakov, Vadim/0000-0003-4864-8909; Duckeck, Guenter/0000-0002-7756-7801; Mapelli, Alessandro/0000-0002-4128-1019; Varvell, Kevin/0000-0003-1017-1295; Taylor, Wendy/0000-0002-6596-9125; Masetti, Lucia/0000-0002-0038-5372; Hill, John/0000-0002-8650-2807; Aielli, Giulio/0000-0002-0573-8114; Wielers, Monika/0000-0001-9232-4827; Backhaus, Malte/0000-0002-5888-2304; Della Volpe, Domenico/0000-0001-8530-7447; Lazovich, Tomo/0000-0001-8183-2295; Qian, Jianming/0000-0003-4813-8167; Kourkoumelis, Christine/0000-0003-0083-274X; Lloyd, Stephen/0000-0002-5073-2264; Azuelos, Georges/0000-0003-4241-022X; Monk, James/0000-0001-8471-9247; Di Donato, Camilla/0000-0003-2213-9284; Costanzo, Davide/0000-0003-4920-6264; Farrington, Sinead/0000-0001-5350-9271; Kiryunin, Andrey/0000-0001-7490-6890; Hodgkinson, Mark/0000-0002-1040-1241; Alonso, Francisco/0000-0001-9431-8156; Angerami, Aaron/0000-0001-7834-8750; Britton, David/0000-0001-9998-4342; Onyisi, Peter/0000-0003-4201-7997; Ridel, Melissa/0000-0002-2601-7420; Filthaut, Frank/0000-0003-3338-2247; Oda, Susumu/0000-0001-5836-768X; giacobbe, benedetto/0000-0002-3789-7259; Vranjes, Nenad/0000-0001-5415-5225; Lenzi, Bruno/0000-0002-1024-4004; Kar, Deepak/0000-0002-4238-9822; Kulchitsky, Yuri/0000-0002-3036-5575; Erdmann, Johannes/0000-0002-8073-2740; Dolezal, Zdenek/0000-0002-5662-3675; Wenaus, Torre/0000-0002-8678-893X; Vukotic, Ilija/0000-0003-0472-3516; Khramov, Evgeny/0000-0001-7400-6454; Nisati, Aleandro/0000-0002-5080-2293; Lovschall-Jensen, Ask Emil/0000-0003-1834-4904; Behar Harpaz, Silvia/0000-0003-2287-8220; Bona, Marcella/0000-0002-9660-580X; Sankey, David/0000-0003-0955-4213; Clement, Benoit/0000-0002-0079-6104; Hanagaki, Kazunori/0000-0003-0676-0441; Morii, Masahiro/0000-0001-9324-057X; Adelman, Jahred/0000-0002-1041-3496; Barberio, Elisabetta/0000-0002-3111-0910; jia, Jiangyong/0000-0002-5725-3397; Moreno Lopez, Deywis/0000-0001-7914-1495; Barak, Liron/0000-0002-3436-2726; cerri, alessandro/0000-0002-1904-6661; Watkins, Peter/0000-0002-1290-6833; Chen, Chunhui/0000-0003-1589-9955; McCarthy, Thomas G/0000-0002-1182-3526; Farbin, Amir/0000-0003-0000-2439; Castaneda Hernandez, Alfredo/0000-0003-4766-1546; Caminada, Lea/0000-0001-5677-6033; Mohapatra, Soumya/0000-0003-3006-6337; Stupak III, John/0000-0001-9610-0783; Zabinski, Bartlomiej/0000-0001-5626-0993; Hugging, Fabian/0000-0002-7472-3151; Rozen, Yoram/0000-0001-6969-0634; Nobe, Takuya/0000-0002-5809-325X; Golling, Tobias/0000-0001-8535-6687; Vincter, Manuella/0000-0002-5338-8972; Redlinger, George/0000-0002-6437-9991; Curatolo, Maria/0000-0003-0978-4879; Leney, Katharine/0000-0002-1525-2695; Besson, Nathalie/0000-0001-9248-6252; Phan, Anna/0000-0002-6346-5628; Konig, Adriaan/0000-0001-6702-6473; GOUSSIOU, ANNA/0000-0001-6211-7122; Hoffmann, Dirk/0000-0001-5209-5265; Allport, Philip/0000-0001-7303-2570; Federic, Pavol/0000-0001-5137-473X; Soldatov, Evgeny/0000-0003-0694-3272; McPherson, Robert/0000-0001-9211-7019; Shapiro, Marjorie/0000-0001-8540-9654; Djobava, Tamar/0000-0002-9414-8350; Moyse, Edward/0000-0003-4449-6178; Walder, James/0000-0002-9039-8758; March, Luis/0000-0002-0849-2244; Hansen, Peter Henrik/0000-0002-6764-4789; Yamaguchi, Yohei/0000-0002-3725-4800; Amako, Katsuya/0000-0003-3307-2951; Smirnov, Yury/0000-0002-2891-0781; Lester, Christopher Gorham/0000-0001-5770-4883; Ellinghaus, Frank/0000-0003-3596-5331; Bailey, David C/0000-0002-7970-7839; Wolter, Marcin/0000-0001-9184-2921; Heim, Sarah/0000-0002-2639-6571; Liu, Kun/0000-0001-5807-0501; Duehrssen-Debling, Michael/0000-0002-5833-7058; Cranmer, Kyle/0000-0002-5769-7094; Mijovic, Liza/0000-0003-0162-2891; Gonella, Laura/0000-0002-4919-0808; Coniavitis, Elias/0000-0002-2148-8012; Robson, Aidan/0000-0002-1659-8284; Yamazaki, Yuji/0000-0003-3710-6995; Mezquita, Costa/0000-0002-2064-2954; Lokajicek, Milos/0000-0001-8929-1243; Gwenlan, Claire/0000-0002-3518-0617; Brandt, Oleg/0000-0001-5219-1417; Jinnouchi, Osamu/0000-0001-5073-0974; Belloni, Alberto/0000-0002-1727-656X; Czodrowski, Patrick/0000-0003-0723-1437; Jackson, Paul/0000-0002-0847-402X; Thompson, Paul/0000-0002-6239-7715; Musto, Elisa/0000-0003-3213-7848; Giordano, Raffaele/0000-0002-5496-7247; Carli, Ina/0000-0002-0411-1141; Hubaut, Fabrice/0000-0002-0113-2465; Moenig, Klaus/0000-0002-3169-7117; Cindro, Vladimir/0000-0002-2037-7185; Murray, William/0000-0003-1710-6306; Serkin, Leonid/0000-0003-4749-5250; Ferrere, Didier/0000-0002-5687-9240; Walsh, Brian/0000-0003-1689-2309; Balek, Petr/0000-0002-0942-1966; Strandberg, Jonas/0000-0002-8913-0981; Calkins, Robert/0000-0002-8079-5688; Haller, Johannes/0000-0001-9347-7657; Ellert, Mattias/0000-0001-5265-3175; Kersevan, Borut/0000-0002-4529-452X; la rotonda, laura/0000-0002-6780-5829; Avramidou, Rachel Maria/0000-0002-1645-1290; Veloso, Filipe/0000-0002-5956-4244; Malecki, Pawel/0000-0001-8183-0468; Kowalewski, Robert/0000-0002-7314-0990; Pleier, Marc-Andre/0000-0002-9461-3494; Grivaz, Jean-Francois/0000-0003-4793-7995; cobal, marina/0000-0003-3309-0762; Llorente Merino, Javier/0000-0003-0027-7969; Maio, Amelia/0000-0001-9099-0009; Bell, William/0000-0002-0138-8639; Tsuno, Soshi/0000-0002-2055-4364; Rotaru, Marina/0000-0003-4088-6275; Acharya, Bobby/0000-0002-8588-9157; Manjarres Ramos, Joany/0000-0003-3896-5222; Gray, Heather/0000-0002-5293-4716; Davey, William/0000-0002-8140-8619; Nozaki, Mitsuaki/0000-0001-7834-9614; Smolek, Karel/0000-0002-5996-7000; Tudorache, Valentina/0000-0001-5384-3843; Beck, Hans Peter/0000-0001-7212-1096; Dwuznik, Michal/0000-0003-3088-4305; Kawagoe, Kiyotomo/0000-0001-8882-129X; Delsart, Pierre-Antoine/0000-0002-9556-2924; Ocariz, Jose/0000-0003-2262-0780; Cascella, Michele/0000-0003-2091-2501; HENROT, Sophie/0000-0003-1218-2991; Hauschild, Michael/0000-0001-6283-5116; Winklmeier, Frank/0000-0001-8290-3200; Prokofiev, Kirill/0000-0002-2177-6401; Gee, Norman/0000-0002-8833-3154; Cerqueira, Augusto/0000-0002-4300-703X; Solovyev, Victor/0000-0002-9402-6329; Meyer, Jorg/0000-0003-0861-8481; Nagel, Martin/0000-0002-2588-6691; Borissov, Guennadi/0000-0002-4226-9521; Zhu, Hongbo/0000-0001-8066-7048; Vari, Riccardo/0000-0002-2814-1337; Salamon, Andrea/0000-0002-8438-8983; Viel, Simon/0000-0001-9554-4059; Wu, Sau Lan/0000-0001-5866-1504; Losada, Marta/0000-0001-8374-5806; Tal Hod, Noam/0000-0001-5241-0544; Ragusa, Francesco/0000-0002-4064-0489; Mueller, James/0000-0001-5099-4718; Sliwa, Krzysztof/0000-0002-1201-4771; Zaidan, Remi/0000-0002-3710-4554; Simoniello, Rosa/0000-0003-2042-6394; Chromek-Burckhart, Doris/0000-0003-4243-3288; Sandoval, Carlos/0000-0003-1038-723X; Weiser, Christian/0000-0002-6456-6834; Citron, Zvi/0000-0003-1831-6452; Roos, Lydia/0000-0001-7151-9983; URQUIJO, PHILLIP/0000-0002-0887-7953; Beau, Tristan/0000-0002-2022-2140; Kreiss, Sven/0000-0002-2246-5680; Carquin, Edson/0000-0002-7863-1166; Moore, Roger/0000-0003-4160-4700; Anders, Christoph Falk/0000-0001-6632-6327; TERRON, JUAN/0000-0003-0132-5723; Baines, John/0000-0003-0770-2702; Escalier, Marc/0000-0003-4270-2775; Belanger-Champagne, Camille/0000-0003-2368-2617; Morvaj, Ljiljana/0000-0003-2061-2904; Ruehr, Frederik/0000-0003-4452-620X; Formica, Andrea/0000-0001-8308-2643; Haas, Andrew/0000-0002-4832-0455; Whalen, Kathleen/0000-0002-9383-8763; Kugel, Andreas/0000-0002-8493-6660; Hays, Chris/0000-0003-2371-9723; JEZEQUEL, Stephane/0000-0001-7369-6975; Reeves, Kendall/0000-0003-3504-4882; Majewski, Stephanie/0000-0002-6871-3395; Rebuzzi, Daniela Marcella/0000-0003-4461-3880; Navarro, Gabriela Alejandra/0000-0002-5108-0042; Rinaldi, Lorenzo/0000-0001-9608-9940; Klimek, Pawel/0000-0003-1661-6873; BOUMEDIENE, Djamel/0000-0002-7809-3118; Cataldi, Gabriella/0000-0001-8066-7718; Izen, Joseph/0000-0002-9846-5601; Kretzschmar, Jan/0000-0002-8515-1355; Vazquez Schroeder, Tamara/0000-0002-9780-099X; Vermeulen, Jos/0000-0003-4378-5736; Berghaus, Frank/0000-0003-1887-3910; Gibson, Stephen/0000-0002-1236-9249; PERINI, LAURA/0000-0003-3715-0523; Zenis, Tibor/0000-0001-8265-6916; Corriveau, Francois/0000-0002-4970-7600; Rurikova, Zuzana/0000-0003-3051-9607; Cinca, Diane/0000-0003-0944-8998; White, Martin/0000-0001-5474-4580; Palestini, Sandro/0000-0002-4110-096X; Peters, Krisztian/0000-0002-7654-1677; Dobbs, Matt/0000-0001-7166-6422; Tartarelli, Giuseppe Francesco/0000-0002-4244-502X; Sykora, Ivan/0000-0003-3447-5621; Bhimji, Wahid/0000-0002-6213-8617; Masubuchi, Tatsuya/0000-0001-9984-8009; Vivarelli, Iacopo/0000-0003-0097-123X; Walkowiak, Wolfgang/0000-0002-0385-3784; Lie, Ki/0000-0002-5779-5989; Chelstowska, Magda Anna/0000-0003-1030-2099; Blanchard, Jean Baptiste/0000-0003-0886-9125; Oreglia, Mark/0000-0001-6203-2209; De Sanctis, Umberto/0000-0003-4704-525X; Hamal, Petr/0000-0003-3139-7234; Rosbach, Kilian/0000-0002-4241-2949; Adamczyk, Leszek/0000-0002-5859-2075; Kroninger, Kevin/0000-0001-9873-0228; van Vulpen, Ivo/0000-0001-7074-5655; Wu, Yusheng/0000-0002-1528-4865; Mastrandrea, Paolo/0000-0002-9853-0194; Yang, Hongtao/0000-0003-3554-7113; Benchekroun, Driss/0000-0001-5196-8327; Gwilliam, Carl/0000-0002-9401-5304; Sanchez, Javier/0000-0001-9913-310X; Liu, Chuanlei/0000-0003-2205-8425; Jakoubek, Tomas/0000-0001-7038-0369; Toth, Jozsef/0000-0001-9128-6080; Dallapiccola, Carlo/0000-0002-1391-2477; Quinonez Granados, Fernando Andres/0000-0002-0153-6160; Sumida, Toshi/0000-0002-2685-6187; Vahsen, Sven/0000-0003-1685-9824; Gramstad, Eirik/0000-0001-5792-5352; Vickey, Trevor/0000-0002-1596-2611; Sukharev, Andrey/0000-0002-2210-0913; Kouskoura, Vasiliki/0000-0002-8987-3208; Chiodini, Gabriele/0000-0002-2458-9513; Di Mattia, Alessandro/0000-0002-9964-015X; Goossens, Luc/0000-0002-2536-4498; Calafiura, Paolo/0000-0002-1692-1678; Aad, Georges/0000-0002-6665-4934; Anisenkov, Alexey/0000-0002-7201-5936; Dell'Acqua, Andrea/0000-0003-2453-7745; Caprini, Mihai/0000-0002-6806-6730; Montejo Berlingen, Javier/0000-0001-9213-904X; Laycock, Paul/0000-0002-8572-5339; Feligioni, Lorenzo/0000-0002-1403-0951; Ferreira de Lima, Danilo Enoque/0000-0002-6606-3595; Long, Jonathan David/0000-0002-2115-9382; Troncon, Clara/0000-0002-7997-8524; van Gemmeren, Peter/0000-0002-7227-4006; Zhang, Zhiqing/0000-0002-7853-9079; Ju, Xiangyang/0000-0002-9745-1638; MAKIDA, Yasuhiro/0000-0003-3638-9970; Minano Moya, Mercedes/0000-0002-1291-143X; Martin-Haugh, Stewart/0000-0001-9457-1928; Bella, Gideon/0000-0002-4009-0990; Hillier, Stephen/0000-0002-7599-6469; Dao, Valerio/0000-0003-1645-8393; Basye, Austin/0000-0002-7519-1310; Schmitt, Sebastian/0000-0002-7935-0470; Koffas, Thomas/0000-0001-9612-4988; Salvatore, Fabrizio/0000-0002-3709-1554; Thomson, Evelyn/0000-0001-6031-2768; Starovoitov, Pavel/0000-0003-1990-0992; Yacoob, Sahal/0000-0001-6977-3456; Bianchi, Riccardo Maria/0000-0001-7345-7798; Benjamin, TROCME/0000-0001-9500-2487; Maleev, Victor/0000-0003-1028-8602; Mincer, Allen/0000-0002-6307-1418; Nielsen, Jason/0000-0002-9175-4419; Unal, Guillaume/0000-0001-8130-7423; Policicchio, Antonio/0000-0002-1290-220X; Alhroob, Muhammad/0000-0001-7569-7111; Knue, Andrea/0000-0002-1559-9285; Schaarschmidt, Jana/0000-0002-0433-6439; Abdelalim, Ahmed Ali/0000-0002-2056-7894; Aperio Bella, Ludovica/0000-0003-3942-1702; Lipniacka, Anna/0000-0002-8759-8564; Petersen, Troels/0000-0003-0221-3037; Ellis, Nicolas/0000-0002-1920-4930; Madaras, Ronald/0000-0001-7399-2993; Fox, Harald/0000-0003-3089-6090; Poveda, Joaquin/0000-0001-8144-1964; Tykhonov, Andrii/0000-0003-2908-7915	STFC [ST/I003142/1, ST/K001248/1, ST/I003525/1, ST/J002798/1, ST/M001512/1, ST/I003517/1, ST/J005576/1, ST/I006080/1, ST/M001431/1, ST/I005803/1, ST/K001361/1, ST/K001337/1, ST/K501840/1, PP/E003699/1, ST/F011571/1, ST/L001144/1, ST/J004944/1, ST/H001042/2, ST/J005541/1, ST/K00073X/1, ST/J004936/1, PP/E002757/1, PP/E003699/2, ST/F007337/1, ST/G502320/1, ST/I005811/1, PP/E003087/1, ST/H001069/2, ST/J004928/1, ST/I000186/1, ST/J005460/1, ST/H001042/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I003142/1, PP/E002757/1, ST/H001093/1, ST/I006080/1, ST/G502320/1, ST/I005803/1, ST/K001337/1 ATLAS, ST/I005811/1, PP/E003699/1, ST/M001474/1, ST/K001361/1 MINOS/MINOS+, ST/J002798/1, ST/J004936/1, ST/K001361/1 ATLAS Upgrades, ST/H001093/2, PP/E000347/1, ST/K00073X/1, ST/J005460/1, ST/I000186/1, ST/F011571/1, ATLAS, ST/K001264/1 ATLAS, ST/J004928/1, ST/K501840/1 GRIDPP, ST/J005541/1, ST/K001361/1 ATLAS, ST/M001431/1, ST/I003517/1, ST/L001144/1, ST/H001042/1, ST/H001042/2, GRIDPP, ST/K001361/1 LHCb Upgrades, PP/E003699/2, ST/K001337/1, ST/K501840/1, ST/I003525/1, ST/I005803/1 GRIDPP, ST/K001248/1, ST/H001069/2, ST/J004928/1 ATLAS Upgrade, ST/F007337/1, ST/K001361/1 LHCb, ST/J004944/1, ST/M001512/1, ST/J005576/1, ST/K001361/1, PP/E003087/1] Funding Source: researchfish; Direct For Mathematical & Physical Scien [0955626] Funding Source: National Science Foundation; Division Of Physics [1206092] Funding Source: National Science Foundation; Grants-in-Aid for Scientific Research [23340070] Funding Source: KAKEN; ICREA Funding Source: Custom	STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ICREA(ICREA)		Aad G, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.032003; Aad G, 2010, EUR PHYS J C, V70, P823, DOI 10.1140/epjc/s10052-010-1429-9; Aad G., 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08003; Aaltonen T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.071804; Abbaneo D, 2003, PHYS LETT B, V565, P61, DOI 10.1016/S0370-2693(03)00614-2; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; ALEPH CDF D0 DELPHI L3 OPAL SLD Collaborations LEP Electroweak Working Group Tevatron Electroweak Working Group, 2010, TEVATRON ELECTROWEAK; ALEPH DELPHI L3 OPAL SLD Collaborations LEP Electroweak Working Group SLD Electroweak and Heavy Flavour Group, 2006, PHYS REP, V427, P256; Barr A.J., 2009, JHEP, V0907, P072; CDF Collaboration D0 Collaboration, 2012, JINST; Chatrchyan S, 2012, SCIENCE, V338, P1569, DOI 10.1126/science.1230816; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; Chatrchyan S, 2012, PHYS LETT B, V710, P26, DOI 10.1016/j.physletb.2012.02.064; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; Della Negra M, 2012, SCIENCE, V338, P1560, DOI 10.1126/science.1230827; ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321; Evans L, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08001; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; GURALNIK GS, 1964, PHYS REV LETT, V13, P585, DOI 10.1103/PhysRevLett.13.585; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; HIGGS PW, 1966, PHYS REV, V145, P1156, DOI 10.1103/PhysRev.145.1156; HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9; KIBBLE TWB, 1967, PHYS REV, V155, P1554, DOI 10.1103/PhysRev.155.1554; LANDAU LD, 1948, DOKL AKAD NAUK SSSR+, V60, P207; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; THOOFT G, 1972, NUCL PHYS B, VB-44, P189, DOI 10.1016/0550-3213(72)90279-9; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264; YANG CN, 1950, PHYS REV, V77, P242, DOI 10.1103/PhysRev.77.242	29	77	77	3	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1576	1582		10.1126/science.1232005	http://dx.doi.org/10.1126/science.1232005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258888	Green Submitted, Green Published			2022-12-28	WOS:000312533100043
J	Berg, E; Metlitski, MA; Sachdev, S				Berg, Erez; Metlitski, Max A.; Sachdev, Subir			Sign-Problem-Free Quantum Monte Carlo of the Onset of Antiferromagnetism in Metals	SCIENCE			English	Article							SPIN-FERMION MODEL	The quantum theory of antiferromagnetism in metals is necessary for our understanding of numerous intermetallic compounds of widespread interest. In these systems, a quantum critical point emerges as external parameters (such as chemical doping) are varied. Because of the strong coupling nature of this critical point and the "sign problem" plaguing numerical quantum Monte Carlo (QMC) methods, its theoretical understanding is still incomplete. Here, we show that the universal low-energy theory for the onset of antiferromagnetism in a metal can be realized in lattice models, which are free from the sign problem and hence can be simulated efficiently with QMC. Our simulations show Fermi surface reconstruction and unconventional spin-singlet superconductivity across the critical point.	[Berg, Erez; Sachdev, Subir] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Berg, Erez] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-76100 Rehovot, Israel; [Metlitski, Max A.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Sachdev, Subir] Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands	Harvard University; Weizmann Institute of Science; University of California System; University of California Santa Barbara; Leiden University; Leiden University - Excl LUMC	Berg, E (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	erez.berg@gmail.com	Sachdev, Subir/Y-3037-2019; Sachdev, Subir/A-8781-2013; Berg, Erez/AAS-9365-2020	Sachdev, Subir/0000-0002-2432-7070; Sachdev, Subir/0000-0002-2432-7070; 	NSF [DMR-1103860, DMR-0705472, PHY11-25915]; ISF [7113640101]; Multidisciplinary University Research Initiative grant from the Air Force Office of Scientific Research; FAS Science Division Research Computing Group at Harvard University	NSF(National Science Foundation (NSF)); ISF(Israel Science Foundation); Multidisciplinary University Research Initiative grant from the Air Force Office of Scientific Research; FAS Science Division Research Computing Group at Harvard University	We thank F. Assaad, D. Chowdhury, H. Evertz, S. Kivelson, T. Lang, J.-Y. Lee, M. Punk, and P. Strack for discussions. This research was supported by NSF grants DMR-1103860, DMR-0705472, and PHY11-25915; by ISF grant 7113640101; and by a Multidisciplinary University Research Initiative grant from the Air Force Office of Scientific Research. The computations were run on the Odyssey cluster supported by the FAS Science Division Research Computing Group at Harvard University.	Abanov A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.255702; Abanov A, 2000, PHYS REV LETT, V84, P5608, DOI 10.1103/PhysRevLett.84.5608; Assaad F. F., 2008, COMPUTATIONAL MANY P; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; BLANKENBECLER R, 1981, PHYS REV D, V24, P2278, DOI 10.1103/PhysRevD.24.2278; Capponi S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220505; Doiron-Leyraud N, 2012, PHYSICA C, V481, P161, DOI 10.1016/j.physc.2012.04.040; Gull E., ARXIV 1207 2490, V1207, P2490; Hartnoll SA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125115; Hashimoto K, 2012, SCIENCE, V336, P1554, DOI 10.1126/science.1219821; Helm T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.247002; Herbut IF, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.075432; HERTZ JA, 1976, PHYS REV B, V14, P1165, DOI 10.1103/PhysRevB.14.1165; Metlitski MA, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075128; MONTHOUX P, 1991, PHYS REV LETT, V67, P3448, DOI 10.1103/PhysRevLett.67.3448; Moon EG, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104516; Motome Y, 1997, J PHYS SOC JPN, V66, P1872, DOI 10.1143/JPSJ.66.1872; Park T, 2006, NATURE, V440, P65, DOI 10.1038/nature04571; SCALAPINO DJ, 1986, PHYS REV B, V34, P8190, DOI 10.1103/PhysRevB.34.8190; Sordi G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.216401; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; Weber C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125107; WHITE SR, 1989, PHYS REV B, V40, P506, DOI 10.1103/PhysRevB.40.506; Wu CJ, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.155115	26	123	123	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1606	1609		10.1126/science.1227769	http://dx.doi.org/10.1126/science.1227769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258893	Green Submitted			2022-12-28	WOS:000312533100049
J	Ingebritsen, SE				Ingebritsen, Steven E.			Modeling the Formation of Porphyry-Copper Ores	SCIENCE			English	Editorial Material							CONTINENTAL-CRUST; PERMEABILITY		US Geol Survey, Menlo Pk, CA 94025 USA	United States Department of the Interior; United States Geological Survey	Ingebritsen, SE (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	seingebr@usgs.gov						Evans KF, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003168; Fyfe W.S., 1978, FLUIDS EARTHS CRUST; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Haring MO, 2008, GEOTHERMICS, V37, P469, DOI 10.1016/j.geothermics.2008.06.002; Hitzman M., 2009, GSA TODAY, V19, P26; Ingebritsen SE, 2010, GEOFLUIDS, V10, P193, DOI 10.1111/j.1468-8123.2010.00278.x; Manga M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000382; Manning CE, 1999, REV GEOPHYS, V37, P127, DOI 10.1029/1998RG900002; Rojstaczer SA, 2008, GEOFLUIDS, V8, P128, DOI 10.1111/j.1468-8123.2008.00211.x; Simpson F, 2001, GEOFLUIDS, V1, P123, DOI 10.1046/j.1468-8123.2001.00011.x; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Waldhauser F, 2012, GEOLOGY, V40, P243, DOI 10.1130/G32420.1; Weis P, 2012, SCIENCE, V338, P1613, DOI 10.1126/science.1225009	13	11	12	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1551	1552		10.1126/science.1231706	http://dx.doi.org/10.1126/science.1231706			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258882				2022-12-28	WOS:000312533100038
J	Mellen, M; Ayata, P; Dewell, S; Kriaucionis, S; Heintz, N				Mellen, Marian; Ayata, Pinar; Dewell, Scott; Kriaucionis, Skirmantas; Heintz, Nathaniel			MeCP2 Binds to 5hmC Enriched within Active Genes and Accessible Chromatin in the Nervous System	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; DNA METHYLATION; RETT-SYNDROME; HISTONE H1; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PHOSPHORYLATION; EXPRESSION; WIDE; QUANTIFICATION	The high level of 5-hydroxymethylcytosine (5hmC) present in neuronal genomes suggests that mechanisms interpreting 5hmC in the CNS may differ from those present in embryonic stem cells. Here, we present quantitative, genome-wide analysis of 5hmC, 5-methylcytosine (5mC), and gene expression in differentiated CNS cell types in vivo. We report that 5hmC is enriched in active genes and that, surprisingly, strong depletion of 5mC is observed over these regions. The contribution of these epigenetic marks to gene expression depends critically on cell type. We identify methyl-CpG-binding protein 2 (MeCP2) as the major 5hmC-binding protein in the brain and demonstrate that MeCP2 binds 5hmC- and 5mC-containing DNA with similar high affinities. The Rett-syndrome-causing mutation R133C preferentially inhibits 5hmC binding. These findings support a model in which 5hmC and MeCP2 constitute a cell-specific epigenetic mechanism for regulation of chromatin structure and gene expression.	[Kriaucionis, Skirmantas] Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England; [Mellen, Marian; Ayata, Pinar; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA	Ludwig Institute for Cancer Research; University of Oxford; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Kriaucionis, S (corresponding author), Univ Oxford, ORCRB, Ludwig Inst Canc Res, Lab Epigenet Mech, Oxford OX3 7DQ, England.	skirmantas.kriaucionis@ludwig.ox.ac.uk; heintz@rockefeller.edu	Kriaucionis, Skirmantas/A-2986-2015	Kriaucionis, Skirmantas/0000-0002-2273-5994; Mellen, Marian/0000-0003-1056-4371; Ayata, Pinar/0000-0001-7621-832X	Howard Hughes Medical Institute; Simons Foundation Autism Research Initiative; Conte Center PHS [MH090963]; Ludwig Institute for Cancer Research; Spanish MECD; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Simons Foundation Autism Research Initiative; Conte Center PHS; Ludwig Institute for Cancer Research; Spanish MECD(Spanish Government); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Howard Hughes Medical Institute (N.H.), Simons Foundation Autism Research Initiative (N.H.), Conte Center PHS MH090963 (N.H.), Ludwig Institute for Cancer Research (S.K.), and Spanish MECD (M.M.). We wish to thank Chun-Xiao Song and Chuan He for kindly providing 5hmC pull down reagents, Jim Selfridge and Adrian Bird for providing Mecp2-null mouse brains, and Brian Lang at GE Healthcare. We would further like to thank Beatriz Lopez and Betsy Gauthier for their assistance, and Jean-Pierre Roussarie, Anne Schaefer, Emmanuelle Jordi, and Ron Gejman for their advice. We also thank Connie Zhao, Christina Caserio, and Wenxiang Zhang from the Rockefeller University Genomics Resource Center; Svetlana Mazel, Selamawit Tadesse, Xiao Li, and Stanka Semova from the Rockefeller University Flow Cytometry Resource Center; and Henrik Molina, Joseph Fernandez, Milica Tesic Mark, and Susan Powell from The Rockefeller University Proteomics Resource Center.	Adkins NL, 2011, BIOCHEM CELL BIOL, V89, P1, DOI 10.1139/O10-112; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bebbington A, 2008, NEUROLOGY, V70, P868, DOI 10.1212/01.wnl.0000304752.50773.ec; Ben-Shachar S, 2009, HUM MOL GENET, V18, P2431, DOI 10.1093/hmg/ddp181; Booth MJ, 2012, SCIENCE, V336, P934, DOI 10.1126/science.1220671; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; CAMPOY FJ, 1995, J BIOL CHEM, V270, P26473, DOI 10.1074/jbc.270.44.26473; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh RP, 2010, MOL CELL BIOL, V30, P4656, DOI 10.1128/MCB.00379-10; Gonzales ML, 2012, MOL CELL BIOL, V32, P2894, DOI 10.1128/MCB.06728-11; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Karymov MA, 2001, FASEB J, V15, P2631, DOI 10.1096/fj.01-0345com; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; LANGE W, 1975, CELL TISSUE RES, V157, P115; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Palay S. L., 1974, CEREBELLAR CORTEX CY; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rutlin M, 2011, NEURON, V72, P3, DOI 10.1016/j.neuron.2011.09.017; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tao JF, 2009, INT REV NEUROBIOL, V89, P147, DOI 10.1016/S0074-7742(09)89007-7; Thambirajah AA, 2012, NUCLEIC ACIDS RES, V40, P2884, DOI 10.1093/nar/gkr1066; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027	46	666	692	7	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1417	1430		10.1016/j.cell.2012.11.022	http://dx.doi.org/10.1016/j.cell.2012.11.022			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260135	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000312890300009
J	DeWeerdt, S				DeWeerdt, Sarah			PSYCHODERMATOLOGY An emotional response	NATURE			English	Editorial Material							PSORIASIS; STRESS											Evers AWM, 2010, BRIT J DERMATOL, V163, P986, DOI 10.1111/j.1365-2133.2010.09984.x; Fortune DG, 2002, BRIT J DERMATOL, V146, P458, DOI 10.1046/j.1365-2133.2002.04622.x; Heller M M, 2011, Skin Therapy Lett, V16, P1; Kleyn CE, 2008, J INVEST DERMATOL, V128, P1273, DOI 10.1038/sj.jid.5701144; Richards HL, 2005, BRIT J DERMATOL, V153, P1114, DOI 10.1111/j.1365-2133.2005.06817.x; Verhoeven EWM, 2009, BRIT J DERMATOL, V161, P295, DOI 10.1111/j.1365-2133.2009.09194.x	6	8	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					562	563		10.1038/492S62a	http://dx.doi.org/10.1038/492S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254976	Bronze			2022-12-28	WOS:000312488200008
J	Klein, BEK; Howard, KP; Gangnon, RE; Dreyer, JO; Lee, KE; Klein, R				Klein, Barbara E. K.; Howard, Kerri P.; Gangnon, Ronald E.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald			Long-term Use of Aspirin and Age-Related Macular Degeneration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BEAVER-DAM EYE; LOW-DOSE ASPIRIN; VISUAL-ACUITY; INTRAOCULAR HEMORRHAGE; MACULOPATHY; POPULATION; ANTICOAGULANTS; PROGRESSION; PHYSICIANS; PERIOD	Context Aspirin is widely used for relief of pain and for cardioprotective effects. Its use is of concern to ophthalmologists when ocular surgery is being considered and also in the presence of age-related macular degeneration (AMD). Objective To examine the association of regular aspirin use with incidence of AMD. Design, Setting, and Participants The Beaver Dam Eye Study, a longitudinal population-based study of age-related eye diseases conducted in Wisconsin. Examinations were performed every 5 years over a 20-year period (1988-1990 through 20082010). Study participants (N=4926) were aged 43 to 86 years at the baseline examination. At subsequent examinations, participants were asked if they had regularly used aspirin at least twice a week for more than 3 months. Main Outcome Measure Incidence of early AMD, late AMD, and 2 subtypes of late AMD (neovascular AMD and pure geographic atrophy), assessed in retinal photographs according to the Wisconsin Age-Related Maculopathy Grading System. Results The median duration of follow-up was 14.8 years. There were 512 incident cases of early AMD (of 6243 person-visits at risk) and 117 incident cases of late AMD (of 8621 person-visits at risk) over the course of the study. Regular aspirin use 10 years prior to retinal examination was associated with late AMD (hazard ratio [HR], 1.63 [95% CI, 1.01-2.63]; P=.05), with estimated incidence of 1.76% (95% CI, 1.17%-2.64%) in regular users and 1.03% (95% CI, 0.70%-1.51%) in nonusers. For subtypes of late AMD, regular aspirin use 10 years prior to retinal examination was significantly associated with neovascular AMD (HR, 2.20 [95% CI, 1.20-4.15]; P=.01) but not pure geographic atrophy (HR, 0.66 [95% CI, 0.25-1.95]; P=.45). Aspirin use 5 years (HR, 0.86 [95% CI, 0.71-1.05]; P=.13) or 10 years (HR, 0.86 [95% CI, 0.65-1.13]; P=.28) prior to retinal examination was not associated with incident early AMD. Conclusions Among an adult cohort, aspirin use 5 years prior to observed incidence was not associated with incident early or late AMD. However, regular aspirin use 10 years prior was associated with a small but statistically significant increase in the risk of incident late and neovascular AMD. JAMA. 2012;308(23):2469-2478 www.jama.com	[Klein, Barbara E. K.; Howard, Kerri P.; Dreyer, Jennifer O.; Lee, Kristine E.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat, Madison, WI 53726 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Klein, BEK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, 610 N Walnut St,4th Floor WARF, Madison, WI 53726 USA.	kleinb@epi.ophth.wisc.edu		Klein, Ronald/0000-0002-4428-6237; Gangnon, Ronald/0000-0003-2587-6714	National Institutes of Health (NIH) [EY06594]; National Eye Institute; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [U10EY006594] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health (NIH) grant EY06594 (Drs B. E. K. Klein, R. Klein). The National Eye Institute provided funding for the entire study, including for collection and analyses of data. Additional support was provided by Senior Scientific Investigator Awards from Research to Prevent Blindness (Drs B. E. K. Klein, R. Klein).	Battinelli EM, 2011, BLOOD, V118, P1359, DOI 10.1182/blood-2011-02-334524; Christen WG, 2001, ARCH OPHTHALMOL-CHIC, V119, P1143, DOI 10.1001/archopht.119.8.1143; Christen WG, 2009, OPHTHALMOLOGY, V116, P2386, DOI 10.1016/j.ophtha.2009.05.031; de Jong PTVM, 2012, OPHTHALMOLOGY, V119, P112, DOI 10.1016/j.ophtha.2011.06.025; ELBABA F, 1986, OPHTHALMOLOGY, V93, P1581; Goertz O, 2011, BURNS, V37, P656, DOI 10.1016/j.burns.2011.01.004; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Kiernan DF, 2010, RETINA-J RET VIT DIS, V30, P1573, DOI 10.1097/IAE.0b013e3181e2266d; KLEIN BEK, 1990, OPHTHALMOLOGY, V97, P1428; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Klein R, 2001, OPHTHALMOLOGY, V108, P1757, DOI 10.1016/S0161-6420(01)00769-2; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1310; Klein R, 1996, OPHTHALMOLOGY, V103, P1169, DOI 10.1016/S0161-6420(96)30526-5; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Klein R, 2006, AM J OPHTHALMOL, V142, P539, DOI 10.1016/j.ajo.2006.06.015; RIDKER PM, 1991, AM HEART J, V122, P1588, DOI 10.1016/0002-8703(91)90275-M; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Scheck A, DAILY ASPIRIN USE AS; Singer JD, 2003, APPL LONGITUDINAL DA, P407; Tilanus MAD, 2000, GRAEF ARCH CLIN EXP, V238, P482, DOI 10.1007/PL00007887; US FOOD and Drug Administration (FDA), ASP QUEST ANSW	22	47	50	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2469	2478		10.1001/jama.2012.65406	http://dx.doi.org/10.1001/jama.2012.65406			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288416	Green Accepted, Bronze			2022-12-28	WOS:000312441400023
J	Bissler, JJ; Kingswood, JC; Radzikowska, E; Zonnenberg, BA; Frost, M; Belousova, E; Sauter, M; Nonomura, N; Brakemeier, S; de Vries, PJ; Whittemore, VH; Chen, D; Sahmoud, T; Shah, G; Lincy, J; Lebwohl, D; Budde, K				Bissler, John J.; Kingswood, J. Christopher; Radzikowska, Elzbieta; Zonnenberg, Bernard A.; Frost, Michael; Belousova, Elena; Sauter, Matthias; Nonomura, Norio; Brakemeier, Susanne; de Vries, Petrus J.; Whittemore, Vicky H.; Chen, David; Sahmoud, Tarek; Shah, Gaurav; Lincy, Jeremie; Lebwohl, David; Budde, Klemens			Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial	LANCET			English	Article							T-CELL LYMPHOMA; RENAL ANGIOMYOLIPOMATA; CONSENSUS CONFERENCE; CLINICAL-TRIAL; SIROLIMUS; DISEASE; EFFICACY; THERAPY; PHASE-2; WOMEN	Background Angiomyolipomas are slow-growing tumours associated with constitutive activation of mammalian target of rapamycin (mTOR), and are common in patients with tuberous sclerosis complex and sporadic lymphangioleiomyomatosis. The insidious growth of these tumours predisposes patients to serious complications including retroperitoneal haemorrhage and impaired renal function. Everolimus, a rapamycin derivative, inhibits the mTOR pathway by acting on the mTOR complex 1. We compared the angiomyolipoma response rate on everolimus with placebo in patients with tuberous sclerosis or sporadic lymphanioleiomyomatosis-associated angiomyolipomata. Methods In this double-blind, placebo-controlled, phase 3 trial, patients aged 18 years or older with at least one angiomyolipoma 3 cm or larger in its longest diameter (defined by radiological assessment) and a definite diagnosis of tuberous sclerosis or sporadic lymphangioleiomyomatosis were randomly assigned, in a 2: 1 fashion with the use of an interactive web response system, to receive oral everolimus 10 mg per day or placebo. The primary efficacy endpoint was the proportion of patients with confirmed angiomyolipoma response of at least a 50% reduction in total volume of target angiomyolipomas relative to baseline. This study is registered with ClinicalTrials.gov number NCT00790400. Results 118 patients (median age 31.0 years; IQR 18.0-61.0) from 24 centres in 11 countries were randomly assigned to receive everolimus (n=79) or placebo (n=39). At the data cutoff, double-blind treatment was ongoing for 98 patients; two main reasons for discontination were disease progression (nine placebo patients) followed by adverse events (two everolimus patients; four placebo patients). The angiomyolipoma response rate was 42% (33 of 79 [95% CI 31-53%]) for everolimus and 0% (0 of 39 [0-9%]) for placebo (response rate difference 42% [24-58%]; one-sided Cochran-Mantel-Haenszel test p<0.0001). The most common adverse events in the everolimus and placebo groups were stomatitis (48% [38 of 79], 8% [3 of 39], respectively), nasopharyngitis (24% [19 of 79] and 31% [12 of 39]), and acne-like skin lesions (22% [17 of 79] and 5% [2 of 39]). Interpretation Everolimus reduced angiomyolipoma volume with an acceptable safety profi le, suggesting it could be a potential treatment for angiomyolipomas associated with tuberous sclerosis.	[Bissler, John J.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Kingswood, J. Christopher] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Radzikowska, Elzbieta] Natl TB & Lung Dis Res Inst, Warsaw, Poland; [Zonnenberg, Bernard A.] Univ Med Ctr, Utrecht, Netherlands; [Frost, Michael] Minnesota Epilepsy Grp, St Paul, MN USA; [Belousova, Elena] Moscow Res Inst Pediat & Pediat Surg, Moscow, Russia; [Sauter, Matthias] Klinikum Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Nonomura, Norio] Osaka Univ Hosp, Osaka 553, Japan; [Brakemeier, Susanne; Budde, Klemens] Charite, D-13353 Berlin, Germany; [de Vries, Petrus J.] Univ Cape Town, Div Child & Adolescent Psychiat, ZA-7700 Rondebosch, South Africa; [Whittemore, Vicky H.] NINDS, NIH, Bethesda, MD 20892 USA; [Chen, David; Sahmoud, Tarek; Shah, Gaurav; Lebwohl, David] Novartis Pharmaceut, Florham Pk, NJ USA; [Lincy, Jeremie] Novartis Pharmaceut, Basel, Switzerland	Cincinnati Children's Hospital Medical Center; University of Brighton; Utrecht University; Utrecht University Medical Center; University of Munich; Osaka University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cape Town; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Novartis; Novartis	Bissler, JJ (corresponding author), Cincinnati Childrens Hosp Med Ctr, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	john.bissler@cchmc.org	frost, michael/AAG-4031-2021; Radzikowska, Elzbieta/AAH-2507-2020; Budde, Klemens/AAD-2170-2020	Radzikowska, Elzbieta/0000-0002-2585-8594; Budde, Klemens/0000-0002-7929-5942; Belousova, Elena Dmitrievna/0000-0003-3594-6974; Bissler, John/0000-0001-9685-9183	Novartis Pharmaceuticals; Novartis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER	Novartis Pharmaceuticals(Novartis); Novartis(Novartis); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding Novartis Pharmaceuticals.; DC, TS, GS, JL, and DL are employees of Novartis. DC, GS, and DL own Novartis stock. DL has Novartis stock options. JJB, JCK, ER, BAZ, MF, EB, MS, PJdV, and KB are Novartis consultants (including advisory boards), and have had travel paid, research funded, or speaker honoraria/speakers bureau by or for Novartis. MF is a member of speakers bureaus and advisory boards for Lundbeck and UCB. NN, SB, and VHW declare that they have no conflicts of interest.	Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Braun M, 2012, NEW ENGL J MED, V366, P1062, DOI 10.1056/NEJMc1113145; Costello LC, 2000, MAYO CLIN PROC, V75, P591, DOI 10.4065/75.6.591; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Curatolo P, 2008, LANCET, V372, P657, DOI 10.1016/S0140-6736(08)61279-9; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Dibble CC, 2012, MOL CELL, V4, P1, DOI DOI 10.1016/J.M0LCEL.2012.06.009; Dixon BP, 2011, NEPHRON EXP NEPHROL, V118, pE15, DOI 10.1159/000320891; Duvic M, 2001, ARCH DERMATOL, V137, P581; Franz DN, 2010, NEUROPEDIATRICS, V41, P199, DOI 10.1055/s-0030-1269906; Franz D.N., 2012, LANCET; Franz DN, 2001, AM J RESP CRIT CARE, V164, P661, DOI 10.1164/ajrccm.164.4.2011025; Fritsche L, 2004, AM J TRANSPLANT, V4, P130, DOI 10.1046/j.1600-6135.2003.00279.x; Heald P, 2003, J AM ACAD DERMATOL, V49, P801, DOI 10.1016/S0190-9622(03)01475-0; Henske EP, 1996, AM J HUM GENET, V59, P400; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Huyghe E, 2007, TRANSPL INT, V20, P305, DOI 10.1111/j.1432-2277.2006.00423.x; Hyman MH, 2000, ARCH NEUROL-CHICAGO, V57, P662, DOI 10.1001/archneur.57.5.662; Johnson SR, 2010, RESP MED, V104, pS33, DOI 10.1016/j.rmed.2010.03.015; McCormack FX, 2008, CHEST, V133, P507, DOI 10.1378/chest.07-0898; McCormack FX, 2011, NEW ENGL J MED, V364, P1595, DOI 10.1056/NEJMoa1100391; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; National Cancer Institute, 2006, COMM TERM CRIT ADV E; Roach ES, 1998, J CHILD NEUROL, V13, P624, DOI 10.1177/088307389801301206; Sarraf M, 2009, NAT CLIN PRACT NEPHR, V5, P172, DOI 10.1038/ncpneph1033; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Williams JM, 2006, AM J KIDNEY DIS, V47, P95, DOI 10.1053/j.ajkd.2005.09.028; Yamakado K, 2002, RADIOLOGY, V225, P78, DOI 10.1148/radiol.2251011477; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290	30	542	575	2	31	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 9	2013	381	9869					817	824		10.1016/S0140-6736(12)61767-X	http://dx.doi.org/10.1016/S0140-6736(12)61767-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23312829				2022-12-28	WOS:000316060600031
J	Howman, A; Chapman, TL; Langdon, MM; Ferguson, C; Adu, D; Feehally, J; Gaskin, GJ; Jayne, DRW; O'Donoghue, D; Boulton-Jones, M; Mathieson, PW				Howman, Andrew; Chapman, Tracey L.; Langdon, Maria M.; Ferguson, Caroline; Adu, Dwomoa; Feehally, John; Gaskin, Gillian J.; Jayne, David R. W.; O'Donoghue, Donal; Boulton-Jones, Michael; Mathieson, Peter W.			Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial	LANCET			English	Article							NATURAL-HISTORY; CYCLOSPORINE; CYCLOPHOSPHAMIDE; CHLORAMBUCIL; RITUXIMAB; RISK; METHYLPREDNISOLONE; EFFICACY; THERAPY	Background Membranous nephropathy leads to end-stage renal disease in more than 20% of patients. Although immunosuppressive therapy benefits some patients, trial evidence for the subset of patients with declining renal function is not available. We aimed to assess whether immunosuppression preserves renal function in patients with idiopathic membranous nephropathy with declining renal function. Methods This randomised controlled trial was undertaken in 37 renal units across the UK. We recruited patients (18-75 years) with biopsy-proven idiopathic membranous nephropathy, a plasma creatinine concentration of less than 300 mu mol/L, and at least a 20% decline in excretory renal function measured in the 2 years before study entry, based on at least three measurements over a period of 3 months or longer. Patients were randomly assigned (1: 1: 1) by a random number table to receive supportive treatment only, supportive treatment plus 6 months of alternating cycles of prednisolone and chlorambucil, or supportive treatment plus 12 months of ciclosporin. The primary outcome was a further 20% decline in renal function from baseline, analysed by intention to treat. The trial is registered as an International Standard Randomised Controlled Trial, number 99959692. Findings We randomly assigned 108 patients, 33 of whom received prednisolone and chlorambucil, 37 ciclosporin, and 38 supportive therapy alone. Two patients (one who received ciclosporin and one who received supportive therapy) were ineligible, so were not included in the intention-to-treat analysis, and 45 patients deviated from protocol before study end, mostly as a result of minor dose adjustments. Follow up was until primary endpoint or for minimum of 3 years if primary endpoint was not reached. Risk of further 20% decline in renal function was significantly lower in the prednisolone and chlorambucil group than in the supportive care group (19 [58%] of 33 patients reached endpoint vs 31 [84%] of 37, hazard ratio [HR] 0.44 [95% CI 0.24-0.78]; p=0.0042); risk did not differ between the ciclosporin (29 [81%] of 36) and supportive treatment only groups (HR 1.17 [0.70-1.95]; p=0.54), but did differ significantly across all three groups (p=0.003). Serious adverse events were frequent in all three groups but were higher in the prednisolone and chlorambucil group than in the supportive care only group (56 events vs 24 events; p=0.048). Interpretation For the subset of patients with idiopathic membranous nephropathy and deteriorating excretory renal function, 6 months' therapy with prednisolone and chlorambucil is the treatment approach best supported by our evidence. Ciclosporin should be avoided in this subset.	[Howman, Andrew] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham, W Midlands, England; [Chapman, Tracey L.; Langdon, Maria M.; Mathieson, Peter W.] Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England; [Ferguson, Caroline; Boulton-Jones, Michael] Glasgow Royal Infirm, Renal Unit, Glasgow G4 0SF, Lanark, Scotland; [Adu, Dwomoa] Queen Elizabeth Hosp, Renal Unit, Birmingham, W Midlands, England; [Feehally, John] Leicester Gen Hosp, Renal Unit, Leicester LE5 4PW, Leics, England; [Gaskin, Gillian J.] Hammersmith Hosp, Renal Unit, London, England; [Jayne, David R. W.] Addenbrookes Hosp, Renal Unit, Cambridge, England; [O'Donoghue, Donal] Hope Hosp, Renal Unit, Salford M6 8HD, Lancs, England	University of Birmingham; Southmead Hospital; University of Glasgow; University of Birmingham; University Hospitals of Leicester NHS Trust; Leicester General Hospital; Imperial College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Mathieson, PW (corresponding author), Southmead Hosp, Acad Renal Unit, Bristol BS10 5NB, Avon, England.	p.mathieson@bristol.ac.uk		Jayne, David/0000-0002-1712-0637; Jayne, David/0000-0002-8725-3283	Medical Research Council (MRC) [G9721265]; Novartis; Kidney Research UK; Renal Association; MRC [G9721265] Funding Source: UKRI; Medical Research Council [G9721265] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis(Novartis); Kidney Research UK(Kidney Research UK (KRUK)); Renal Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The trial was largely funded by two grants from the Medical Research Council (MRC; grant reference G9721265). Before MRC funding was obtained, a small unrestricted grant from Novartis supported the purchase of trial record books and some other trial materials. Additional contributions to continuation funding came from Kidney Research UK and the Renal Association. The drug treatments, investigations, and clinic visits were not funded by the trial, they were all provided as part of routine clinical management.	Alexopoulos E, 2006, NEPHROL DIAL TRANSPL, V21, P3127, DOI 10.1093/ndt/gfl360; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Cattran DC, 2011, CLIN J AM SOC NEPHRO, V6, P1591, DOI 10.2215/CJN.11001210; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; Cattran DC, 2001, KIDNEY INT, V59, P1484, DOI 10.1046/j.1523-1755.2001.0590041484.x; Cravedi P, 2011, AM J NEPHROL, V33, P461, DOI 10.1159/000327611; DAVISON AM, 1984, CLIN NEPHROL, V22, P61; DONADIO JV, 1988, KIDNEY INT, V33, P708, DOI 10.1038/ki.1988.56; Fervenza FC, 2010, CLIN J AM SOC NEPHRO, V5, P2188, DOI 10.2215/CJN.05080610; Hofstra JM, 2008, NEPHROL DIAL TRANSPL, V23, P3534, DOI 10.1093/ndt/gfn350; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P1760, DOI 10.1093/ndt/gfq017; International Society of Nephrology, 2012, KIDNEY INT S, V2, P186; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Li J, 2010, AM J MED SCI, V339, P532, DOI 10.1097/MAJ.0b013e3181d9f00b; Mathieson P, 1998, QJM-MON J ASSOC PHYS, V91, P167, DOI 10.1093/qjmed/91.2.167; Mathieson P W, 1991, Adv Nephrol Necker Hosp, V20, P151; MATHIESON PW, 1988, LANCET, V2, P869; Medicines and Healthcare products Regulatory Agency, CLIN TRIALS MED SAF; National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC), NAT KIDN UR DIS INF; PONTICELLI C, 1989, NEW ENGL J MED, V320, P8, DOI 10.1056/NEJM198901053200102; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; SCHIEPPATI A, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004293; Stanescu HC, 2011, NEW ENGL J MED, V364, P616, DOI 10.1056/NEJMoa1009742; Tuccori M, 2010, ONCOLOGIST, V15, P1214, DOI 10.1634/theoncologist.2010-0098; WINEARLS CG, 1994, Q J MED, V87, P199	27	136	149	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					744	751		10.1016/S0140-6736(12)61566-9	http://dx.doi.org/10.1016/S0140-6736(12)61566-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098TC	23312808	Green Published, Bronze			2022-12-28	WOS:000315570900028
J	Ferrari, R				Ferrari, Robert			Rewriting the book on whiplash	LANCET			English	Editorial Material							INJURY; DISORDERS; TRAUMA; SPINE; RULE		[Ferrari, Robert] Univ Alberta, Dept Rheumat Dis, Edmonton, AB T6G 2P4, Canada; [Ferrari, Robert] Univ Alberta, Dept Med, Edmonton, AB T6G 2P4, Canada	University of Alberta; University of Alberta	Ferrari, R (corresponding author), Univ Alberta, Dept Rheumat Dis, Edmonton, AB T6G 2P4, Canada.	rferrari@shaw.ca						Carroll LJ, 2009, J RHEUMATOL, V36, P1063, DOI 10.3899/jrheum.080680; Cassidy JD, 2000, NEW ENGL J MED, V342, P1179, DOI 10.1056/NEJM200004203421606; Ferrari R, 2011, HEADACHE, V51, P163, DOI 10.1111/j.1526-4610.2010.01748.x; Hoffman JR, 2000, NEW ENGL J MED, V343, P94, DOI 10.1056/NEJM200007133430203; Lamb SE, 2012, LANCET; McClune T, 2003, EMERG MED J, V20, P514, DOI 10.1136/emj.20.6.514; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841	7	4	5	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					514	515		10.1016/S0140-6736(12)61416-0	http://dx.doi.org/10.1016/S0140-6736(12)61416-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23260166				2022-12-28	WOS:000314927500007
J	Vertefeuille, JF; Dowell, SF; Domercant, JW; Tappero, JW				Vertefeuille, John F.; Dowell, Scott F.; Domercant, Jean W.; Tappero, Jordan W.			Cautious optimism on public health in post-earthquake Haiti	LANCET			English	Editorial Material									[Vertefeuille, John F.; Domercant, Jean W.] US Ctr Dis Control & Prevent, Haiti Off, Tabarre, Port Au Prince, Haiti; [Vertefeuille, John F.; Dowell, Scott F.; Tappero, Jordan W.] US Ctr Dis Control & Prevent, Div Global Dis Detect & Emergency Response, Ctr Global Hlth, Atlanta, GA 30329 USA; [Domercant, Jean W.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Vertefeuille, JF (corresponding author), US Ctr Dis Control & Prevent, Haiti Off, Tabarre, Port Au Prince, Haiti.	dki4@cdc.gov						Barzilay EJ, 2013, N ENGL J MED; De Rochars MVEB, 2004, AM J TROP MED HYG, V71, P598, DOI 10.4269/ajtmh.2004.71.598; Government of the Republic of Haiti, 2010, ACT PLAN NAT REC DEV; MESI: monitoring evaluation and surveillance interface, MESI MON EV SURV INT; Pan American Health Organization. Technical Advisory Group on Vaccine Preventable Diseases, 2012, 20 M TETCHN ADV GROU; Periago MR, 2012, LANCET, V379, pE12, DOI 10.1016/S0140-6736(12)60031-2; Rainey JJ, 2012, VACCINE, V30, P1746, DOI 10.1016/j.vaccine.2011.12.015; Republique D'Haiti Ministere de la Sante Publique et de la Population, 2012, DECLARATION ENGAGEME; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; United Nations Office of the Haiti Special Envoy, 2012, MON RAIS DISP SUPP O; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, NEGL TROP DIS PCT DA	12	11	11	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 16	2013	381	9866					517	519		10.1016/S0140-6736(13)60051-3	http://dx.doi.org/10.1016/S0140-6736(13)60051-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	089RK	23332167				2022-12-28	WOS:000314927500009
J	Barzilay, EJ; Schaad, N; Magloire, R; Mung, KS; Boncy, J; Dahourou, GA; Mintz, ED; Steenland, MW; Vertefeuille, JF; Tappero, JW				Barzilay, Ezra J.; Schaad, Nicolas; Magloire, Roc; Mung, Kam S.; Boncy, Jacques; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.			Cholera Surveillance during the Haiti Epidemic - The First 2 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; OUTBREAK; DISEASE	BACKGROUND In October 2010, nearly 10 months after a devastating earthquake, Haiti was stricken by epidemic cholera. Within days after detection, the Ministry of Public Health and Population established a National Cholera Surveillance System (NCSS). METHODS The NCSS used a modified World Health Organization case definition for cholera that included acute watery diarrhea, with or without vomiting, in persons of all ages residing in an area in which at least one case of Vibrio cholerae O1 infection had been confirmed by culture. RESULTS Within 29 days after the first report, cases of V. cholerae O1 (serotype Ogawa, biotype El Tor) were confirmed in all 10 administrative departments (similar to states or provinces) in Haiti. Through October 20, 2012, the public health ministry reported 604,634 cases of infection, 329,697 hospitalizations, and 7436 deaths from cholera and isolated V. cholerae O1 from 1675 of 2703 stool specimens tested (62.0%). The cumulative attack rate was 5.1% at the end of the first year and 6.1% at the end of the second year. The cumulative case fatality rate consistently trended downward, reaching 1.2% at the close of year 2, with departmental cumulative rates ranging from 0.6% to 4.6% (median, 1.4%). Within 3 months after the start of the epidemic, the rolling 14-day case fatality rate was 1.0% and remained at or below this level with few, brief exceptions. Overall, the cholera epidemic in Haiti accounted for 57% of all cholera cases and 53% of all cholera deaths reported to the World Health Organization in 2010 and 58% of all cholera cases and 37% of all cholera deaths in 2011. CONCLUSIONS A review of NCSS data shows that during the first 2 years of the cholera epidemic in Haiti, the cumulative attack rate was 6.1%, with cases reported in all 10 departments. Within 3 months after the first case was reported, there was a downward trend in mortality, with a 14-day case fatality rate of 1.0% or less in most areas.	[Barzilay, Ezra J.; Schaad, Nicolas; Dahourou, Georges A.; Mintz, Eric D.; Steenland, Maria W.; Vertefeuille, John F.; Tappero, Jordan W.] Ctr Dis Control & Prevent, Atlanta, GA 30329 USA; [Magloire, Roc] Minist Sante Publ & Populat, Direct Epidemiol Lab & Rech, Port Au Prince, Haiti; [Mung, Kam S.] Pan Amer Hlth Org, Port Au Prince, Haiti; [Boncy, Jacques] Minist Sante Publ & Populat, Lab Natl Sante Publ, Port Au Prince, Haiti; [Dahourou, Georges A.; Vertefeuille, John F.] Ctr Dis Control & Prevent, Haiti Off, Port Au Prince, Haiti	Centers for Disease Control & Prevention - USA; Pan American Health Organization	Barzilay, EJ (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS A-05, Atlanta, GA 30329 USA.	ebarzilay@cdc.gov						Abrams JY, 2012, EPIDEMIOL INFECT, V1, P1; Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Andrews JR, 2011, LANCET, V377, P1248, DOI 10.1016/S0140-6736(11)60273-0; [Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P325; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P933; [Anonymous], 2011, HAITI CHOLERA TRAINI; [Anonymous], 2011, HAIT CHOL OUTBR SIT; [Anonymous], 1993, MMWR-MORBID MORTAL W, V42, P639; Bauernfeind A, 2004, CHOLERA GUIDELINES; Brunkard Joan M., 2012, Morbidity and Mortality Weekly Report, V61, P309; Chao DL, 2011, P NATL ACAD SCI USA, V108, P7081, DOI 10.1073/pnas.1102149108; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Dowell SF, 2011, NEW ENGL J MED, V364, P300, DOI 10.1056/NEJMp1100118; Ernst S, 2011, EMERG INFECT DIS, V17, P2155, DOI 10.3201/eid1711.110815; European Centre for Disease Prevention and Control, 2012, OUTBR CHOL CUB POT R; Farmer P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001145; Gerard JA, 2012, AM SOC TROP MED HYG; German R R, 2001, MMWR Recomm Rep, V50, P1; Global Task force on Cholera Control, 2004, WHOCDSCPEZFK20044; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Jackson BR, 2012, SERO EPIDEMIOLOGIC S; Jenson D, 2011, EMERG INFECT DIS, V17, P2130, DOI 10.3201/eid1711.110958; Koo D, 1996, Bull Pan Am Health Organ, V30, P134; Jimenez ML, 2011, EMERG INFECT DIS, V17, P2172, DOI 10.3201/eid1711.111263; Fernandez MAL, 2009, T ROY SOC TROP MED H, V103, P137, DOI 10.1016/j.trstmh.2008.07.017; NALIN DR, 1978, LANCET, V2, P856; Newton AE, 2011, EMERG INFECT DIS, V17, P2166, DOI 10.3201/eid1711.110808; PALMER DL, 1976, J INFECT DIS, V134, P8, DOI 10.1093/infdis/134.1.8; Pan American Health Organization, 2012, CHOL SIT UPD; Pan American Health Organization Division of Vaccines and Immunization, 2012, 20 M TECHN ADV GROUP; Periago MR, 2012, LANCET, V379, pE12, DOI 10.1016/S0140-6736(12)60031-2; Pun SB, 2011, EMERG INFECT DIS, V17, P2178, DOI [10.3201/eid1711.110981, 10.3201/eid1707.110059]; Rapid establishment of an internally displaced persons disease surveillance system after an earthquake-Haiti, 2010, MMWR MORB MORTAL WKL, V59, P939; Routh JA, 2011, EMERG INFECT DIS, V17, P2139, DOI 10.3201/eid1711.110747; Ryan ET, 2011, EMERG INFECT DIS, V17, P2175, DOI 10.3201/eid1711.110849; Shikanga OT, 2009, AM J TROP MED HYG, V81, P1085, DOI 10.4269/ajtmh.2009.09-0400; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720; SWERDLOW DL, 1994, J INFECT DIS, V170, P468, DOI 10.1093/infdis/170.2.468; Talkington D, 2011, EMERG INFECT DIS, V17, P2122, DOI 10.3201/eid1711.110805; Talkington DF, 2012, 2012 AM SOC MICR GEN; Tappero JW, 2011, EMERG INFECT DIS, V17, P2087, DOI 10.3201/eid1711.110827; Tauxe Robert, 1994, P321; Tauxe RV, 2011, EMERG INFECT DIS, V17, P2094, DOI 10.3201/eid1711.110857; Tuite AR, 2011, ANN INTERN MED, V154, P593, DOI 10.7326/0003-4819-154-9-201105030-00334; UNICEF, 2010, PROGR SAN DRINK WAT; World Health Organization, 1993, GUID CHOL CONTR	48	143	147	0	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					599	609		10.1056/NEJMoa1204927	http://dx.doi.org/10.1056/NEJMoa1204927			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	194VA	23301694	Bronze			2022-12-28	WOS:000322659600005
J	Roberts, AE; Allanson, JE; Tartaglia, M; Gelb, BD				Roberts, Amy E.; Allanson, Judith E.; Tartaglia, Marco; Gelb, Bruce D.			Noonan syndrome	LANCET			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; PROTEIN-TYROSINE-PHOSPHATASE; FACIO-CUTANEOUS SYNDROME; GERMLINE KRAS MUTATIONS; CELL LESION SYNDROME; OF-THE-LITERATURE; SOMATIC PTPN11 MUTATIONS; GROWTH-HORMONE TREATMENT; TERM-FOLLOW-UP; COSTELLO-SYNDROME	Noonan syndrome is a genetic multisystem disorder characterised by distinctive facial features, developmental delay, learning difficulties, short stature, congenital heart disease, renal anomalies, lymphatic malformations, and bleeding difficulties. Mutations that cause Noonan syndrome alter genes encoding proteins with roles in the RAS-MAPK pathway, leading to pathway dysregulation. Management guidelines have been developed. Several clinically relevant genotype-phenotype correlations aid risk assessment and patient management. Increased understanding of the pathophysiology of the disease could help development of pharmacogenetic treatments.	[Roberts, Amy E.] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Roberts, Amy E.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Allanson, Judith E.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, Dept Pediat, New York, NY USA; [Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, Dept Genet & Genom Sci, New York, NY USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Ottawa; Children's Hospital of Eastern Ontario; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Roberts, AE (corresponding author), Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	amy.roberts@cardio.chboston.org	Tartaglia, Marco/K-2955-2018	Tartaglia, Marco/0000-0001-7736-9672	NIH [HL71207]; Telethon-Italy [GGP10020]; European commission sixth framework programme; ERA-net for research programmes on rare diseases (NSEuroNet); Associazone Italiana Sindrome di Costello; Children's Hospital Boston Clinical Research Program Grant; GeneDx; Prevention Genetics; Correlagen; Harvard/Partners; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Telethon-Italy(Fondazione Telethon); European commission sixth framework programme(European CommissionEuropean Commission Joint Research Centre); ERA-net for research programmes on rare diseases (NSEuroNet); Associazone Italiana Sindrome di Costello; Children's Hospital Boston Clinical Research Program Grant; GeneDx; Prevention Genetics; Correlagen; Harvard/Partners; Baylor College of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	BDG and MT have received royalties for genetic testing for Noonan syndrome from the following: GeneDx, Prevention Genetics, Correlagen, Harvard/Partners, and Baylor College of Medicine. AER and JEA declare that they have no conflicts of interest.; BDG was partly funded by a grant from the NIH (HL71207). MT was partly funded by grants from Telethon-Italy (GGP10020), European commission sixth framework programme, ERA-net for research programmes on rare diseases (NSEuroNet), and Associazone Italiana Sindrome di Costello. AER was partly funded by a Children's Hospital Boston Clinical Research Program Grant. We thank The Noonan Syndrome Support Group and the many individuals with Noonan syndrome and their families who participated in the research studies cited in this report.	Adekunle O, 1999, BRIT J RADIOL, V72, P457, DOI 10.1259/bjr.72.857.10505009; Alfieri P, 2011, BEHAV GENET, V41, P423, DOI 10.1007/s10519-011-9446-5; ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; ALLANSON JE, 1985, AM J MED GENET, V21, P507, DOI 10.1002/ajmg.1320210313; Allanson JE, 2007, AM J MED GENET C, V145C, P274, DOI 10.1002/ajmg.c.30138; Allanson JE, 2010, AM J MED GENET A, V152A, P1960, DOI 10.1002/ajmg.a.33518; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; BaderMeunier B, 1997, J PEDIATR-US, V130, P885, DOI 10.1016/S0022-3476(97)70273-7; Bertola DR, 2001, AM J MED GENET, V98, P230, DOI 10.1002/1096-8628(20010122)98:3<230::AID-AJMG1080>3.0.CO;2-K; Binder G, 2005, J CLIN ENDOCR METAB, V90, P5377, DOI 10.1210/jc.2005-0995; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Cesarini L, 2009, AM J MED GENET A, V149A, P140, DOI 10.1002/ajmg.a.32488; Choong K, 1999, J PEDIAT HEMATOL ONC, V21, P523, DOI 10.1097/00043426-199911000-00014; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; COHEN MM, 1991, AM J MED GENET, V40, P159, DOI 10.1002/ajmg.1320400208; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; COTTON JL, 1995, ARCH PEDIAT ADOL MED, V149, P1280, DOI 10.1001/archpedi.1995.02170240098019; CREMERS CWRJ, 1992, INT J PEDIATR OTORHI, V23, P81, DOI 10.1016/0165-5876(92)90082-Z; Davenport ML, 2010, J CLIN ENDOCR METAB, V95, P1487, DOI 10.1210/jc.2009-0926; Denayer E, 2010, GENE CHROMOSOME CANC, V49, P242, DOI 10.1002/gcc.20735; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Dikic I, 2007, EUR J CELL BIOL, V86, P505, DOI 10.1016/j.ejcb.2007.04.005; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Fryssira H, 2008, EUR J PEDIATR, V167, P1025, DOI 10.1007/s00431-007-0636-3; Fukuda M, 1997, J PEDIAT HEMATOL ONC, V19, P177, DOI 10.1097/00043426-199703000-00019; Ganesan V, 1997, PEDIATR NEUROL, V16, P256, DOI 10.1016/S0887-8994(97)89980-8; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gripp KW, 2005, AM J MED GENET C, V137C, P72, DOI 10.1002/ajmg.c.30065; Hanna N, 2009, CLIN GENET, V75, P568, DOI 10.1111/j.1399-0004.2009.01149.x; Hennekam RCM, 2003, AM J MED GENET C, V117C, P42, DOI 10.1002/ajmg.c.10019; Hiippala A, 2001, ULTRASOUND OBST GYN, V18, P18, DOI 10.1046/j.1469-0705.2001.00481.x; Houweling AC, 2010, PRENATAL DIAG, V30, P284, DOI 10.1002/pd.2458; Ijiri R, 2000, PEDIATR RADIOL, V30, P432, DOI 10.1007/s002470050781; Jongmans MCJ, 2011, EUR J HUM GENET, V19, P870, DOI 10.1038/ejhg.2011.37; Jongmans MCJ, 2010, GENE CHROMOSOME CANC, V49, P635, DOI 10.1002/gcc.20773; Jung A, 2003, J PEDIAT HEMATOL ONC, V25, P330, DOI 10.1097/00043426-200304000-00014; KHAN S, 1995, J MED GENET, V32, P743, DOI 10.1136/jmg.32.9.743; Kirk JMW, 2001, ARCH DIS CHILD, V84, P440, DOI 10.1136/adc.84.5.440; Kratz C., 2009, V17, P119; Kratz CP, 2009, AM J MED GENET A, V149A, P1036, DOI 10.1002/ajmg.a.32786; Lee CK, 2001, J BONE JOINT SURG AM, V83A, P1495, DOI 10.2106/00004623-200110000-00006; Lee DA, 2005, DEV MED CHILD NEUROL, V47, P35, DOI 10.1017/S00121622050006X; Lee KA, 2009, CLIN GENET, V75, P190, DOI 10.1111/j.1399-0004.2008.01085.x; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Lepri F, 2011, HUM MUTAT, V32, P760, DOI 10.1002/humu.21492; Lin AE, 2002, AM J MED GENET, V111, P115, DOI 10.1002/ajmg.10558; Lin AE, 2008, GENET MED, V10, P469, DOI [10.1097/GIM.0b013e3181772111, 10.1097GIM.0b013e3181772111]; Lo FS, 2009, EUR J PEDIATR, V168, P919, DOI 10.1007/s00431-008-0858-z; Maheshwari M, 2002, HUM MUTAT, V20, P298, DOI 10.1002/humu.10129; Marcus KA, 2008, J PEDIATR ENDOCR MET, V21, P1079; Marino B, 1999, J PEDIATR-US, V135, P703, DOI 10.1016/S0022-3476(99)70088-0; Martinelli S, 2010, AM J HUM GENET, V87, P250, DOI 10.1016/j.ajhg.2010.06.015; Matozaki T, 2009, CANCER SCI, V100, P1786, DOI 10.1111/j.1349-7006.2009.01257.x; MENDEZ HMM, 1985, AM J MED GENET, V21, P493, DOI 10.1002/ajmg.1320210312; MILLER M, 1978, AM J MED, V65, P379, DOI 10.1016/0002-9343(78)90836-7; Moschovi M, 2007, J PEDIAT HEMATOL ONC, V29, P341, DOI 10.1097/MPH.0b013e31805d8f57; Naficy S, 1997, OTOLARYNG HEAD NECK, V116, P265, DOI 10.1016/S0194-5998(97)70339-5; Narumi Y, 2007, AM J MED GENET A, V143A, P799, DOI 10.1002/ajmg.a.31658; Nava C, 2007, J MED GENET, V44, P763, DOI 10.1136/jmg.2007.050450; Niemeyer CM, 2010, NAT GENET, V42, P794, DOI 10.1038/ng.641; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Nisbet DL, 1999, PRENATAL DIAG, V19, P642, DOI 10.1002/(SICI)1097-0223(199907)19:7<642::AID-PD610>3.0.CO;2-1; Noonan J.A., 2005, HDB NEURODEVELOPMENT, P308; Noonan JA, 2003, AM J MED GENET A, V123A, P68, DOI 10.1002/ajmg.a.20502; NOONAN JA, 1963, J PEDIATR-US, V63, P468; Noordam C, 2001, CLIN ENDOCRINOL, V54, P53, DOI 10.1046/j.1365-2265.2001.01188.x; Nystrom AM, 2008, J MED GENET, V45, P500, DOI 10.1136/jmg.2008.057653; Orrico A, 2000, FEBS LETT, V478, P216, DOI 10.1016/S0014-5793(00)01857-3; Pandit B, 2007, NAT GENET, V39, P1007, DOI 10.1038/ng2073; PARDO JM, 1994, INT PEDIAT, V9, P55; Patton M.A., 1994, NOONAN SYNDROME REV, V33, P1; Peer CNPGM, 2008, EUR J ENDOCRINOL, V159, P203, DOI 10.1530/EJE-08-0413; Perez B, 2010, J MED GENET, V47, P686, DOI 10.1136/jmg.2010.076836; Pierpont EI, 2009, GENES BRAIN BEHAV, V8, P275, DOI 10.1111/j.1601-183X.2008.00469.x; Pierpont EI, 2010, J SPEECH LANG HEAR R, V53, P917, DOI 10.1044/1092-4388(2009/09-0046); Qiu WW, 1998, OTOLARYNG HEAD NECK, V118, P319, DOI 10.1016/S0194-5998(98)70308-0; Raaijmakers R, 2008, J PEDIATR ENDOCR MET, V21, P267; Razzaque MA, 2007, NAT GENET, V39, P1013, DOI 10.1038/ng2078; Reynders CS, 1997, J ULTRAS MED, V16, P101, DOI 10.7863/jum.1997.16.2.101; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Romano AA, 1996, J PEDIATR-US, V128, pS18, DOI 10.1016/S0022-3476(96)70005-7; Romano AA, 2010, PEDIATRICS, V126, P746, DOI 10.1542/peds.2009-3207; Romano AA, 2009, J CLIN ENDOCR METAB, V94, P2338, DOI 10.1210/jc.2008-2094; SANCHEZCASCOS A, 1983, EUR HEART J, V4, P223, DOI 10.1093/oxfordjournals.eurheartj.a061452; Sanford RA, 1999, PEDIATR NEUROSURG, V30, P47, DOI 10.1159/000028761; Sarkozy A, 2009, HUM MUTAT, V30, P695, DOI 10.1002/humu.20955; SCHON F, 1992, POSTGRAD MED J, V68, P37, DOI 10.1136/pgmj.68.795.37; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; SHARLAND M, 1992, ARCH DIS CHILD, V67, P178, DOI 10.1136/adc.67.2.178; SHARLAND M, 1992, LANCET, V339, P19, DOI 10.1016/0140-6736(92)90141-O; Shaw AC, 2007, ARCH DIS CHILD, V92, P128, DOI 10.1136/adc.2006.104547; Sherman CB, 2009, J PEDIAT HEMATOL ONC, V31, P61, DOI 10.1097/MPH.0b013e31818ab2cf; Sznajer Y, 2007, PEDIATRICS, V119, pE1325, DOI 10.1542/peds.2006-0211; Takagi M, 2000, CALCIFIED TISSUE INT, V66, P200, DOI 10.1007/s002230010040; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2010, MOL SYNDROMOL, V1, P2, DOI 10.1159/000276766; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Tidyman WE, 2009, CURR OPIN GENET DEV, V19, P230, DOI 10.1016/j.gde.2009.04.001; Tofil Nancy M, 2005, Pediatr Crit Care Med, V6, P352, DOI 10.1097/01.PCC.0000160656.71424.D1; van der Burgt I, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-4; Verhoeven W, 2008, AM J MED GENET A, V146A, P191, DOI 10.1002/ajmg.a.32115; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; WHITE SW, 1984, INT J DERMATOL, V23, P656, DOI 10.1111/j.1365-4362.1984.tb01226.x; WITT DR, 1988, AM J MED GENET, V31, P305, DOI 10.1002/ajmg.1320310208; WOOD A, 1995, ARCH DIS CHILD, V72, P153, DOI 10.1136/adc.72.2.153; Yoshida R, 2004, J CLIN ENDOCR METAB, V89, P3359, DOI 10.1210/jc.2003-032091; Zandrino F, 2003, EUR RADIOL, V13, P1072, DOI 10.1007/s00330-002-1566-0; Zenker M, 2004, J PEDIATR-US, V144, P368, DOI 10.1016/j.jpeds.2003.11.032; Zenker M, 2007, J MED GENET, V44, P651, DOI 10.1136/jmg.2007.051276; Zenker M, 2007, J MED GENET, V44, P131, DOI 10.1136/jmg.2006.046300	121	446	470	4	68	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 26	2013	381	9863					333	342		10.1016/S0140-6736(12)61023-X	http://dx.doi.org/10.1016/S0140-6736(12)61023-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077IT	23312968	Green Accepted			2022-12-28	WOS:000314021800030
J	Barik, J; Marti, F; Morel, C; Fernandez, SP; Lanteri, C; Godeheu, G; Tassin, JP; Mombereau, C; Faure, P; Tronche, F				Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Mombereau, Cedric; Faure, Philippe; Tronche, Francois			Chronic Stress Triggers Social Aversion via Glucocorticoid Receptor in Dopaminoceptive Neurons	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; NIGRAL DOPAMINE NEURONS; NUCLEUS-ACCUMBENS; FIRING PATTERN; AGGRESSION; COCAINE; ANXIETY; DEFEAT; BRAIN; SUSCEPTIBILITY	Repeated traumatic events induce long-lasting behavioral changes that are key to organism adaptation and that affect cognitive, emotional, and social behaviors. Rodents subjected to repeated instances of aggression develop enduring social aversion and increased anxiety. Such repeated aggressions trigger a stress response, resulting in glucocorticoid release and activation of the ascending dopamine (DA) system. We bred mice with selective inactivation of the gene encoding the glucocorticoid receptor (GR) along the DA pathway, and exposed them to repeated aggressions. GR in dopaminoceptive but not DA-releasing neurons specifically promoted social aversion as well as dopaminergic neurochemical and electrophysiological neuroadaptations. Anxiety and fear memories remained unaffected. Acute inhibition of the activity of DA-releasing neurons fully restored social interaction in socially defeated wild-type mice. Our data suggest a GR-dependent neuronal dichotomy for the regulation of emotional and social behaviors, and clearly implicate GR as a link between stress resiliency and dopaminergic tone.	[Barik, Jacques; Tronche, Francois] CNRS, UMR 7224, Mol Genet Neurophysiol & Behav Grp, F-75005 Paris, France; [Barik, Jacques; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Tronche, Francois] INSERM, U952S, F-75005 Paris, France; [Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol; Mombereau, Cedric; Faure, Philippe; Tronche, Francois] Univ Paris 06, F-75005 Paris, France; [Barik, Jacques; Marti, Fabio; Morel, Carole; Fernandez, Sebastian P.; Mombereau, Cedric; Faure, Philippe; Tronche, Francois] Lab Excellence Labex Biol Psychiat Lab, F-75005 Paris, France; [Marti, Fabio; Morel, Carole; Faure, Philippe] CNRS, UMR7102, Neurophysiol & Behav Grp, F-75005 Paris, France; [Fernandez, Sebastian P.] INSERM, U839, Neurotransmiss & Dev Grp, F-75005 Paris, France; [Lanteri, Christophe; Godeheu, Gerard; Tassin, Jean-Pol] CNRS, UMR7224, Physiopathol Addict & Relapse Grp, F-75005 Paris, France; [Mombereau, Cedric] INSERM, U839, Mol & Cellular Mech Cort Dev Grp, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Barik, J (corresponding author), CNRS, UMR 7224, Mol Genet Neurophysiol & Behav Grp, F-75005 Paris, France.	jacques.barik@snv.jussieu.fr; francois.tronche@upmc.fr	TRONCHE, François/F-3895-2011	Faure, Philippe/0000-0003-3573-4971; BARIK, Jacques/0000-0002-4276-0927; Tassin, Jean-Pol/0000-0001-6658-9581; marti, fabio/0000-0002-3604-457X; Fernandez, Sebastian/0000-0003-0683-5562	CNRS; INSERM; Agence Nationale de la Recherche (TIMMS); UPMC (Emergence program); Region Ile-de-France (NeRF); European Union; Bettencourt Schueller Foundation; Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (TIMMS)(French National Research Agency (ANR)); UPMC (Emergence program); Region Ile-de-France (NeRF)(Region Ile-de-France); European Union(European Commission); Bettencourt Schueller Foundation; Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Wonnacott for critical reading of the manuscript, and staff from the IFR83 animal facility for assistance. This work was funded by CNRS, INSERM, the Agence Nationale de la Recherche (TIMMS grants), the UPMC (Emergence program), the Region Ile-de-France (NeRF), the European Union (FP7 STREPs PheComp and NovelTune), the Bettencourt Schueller Foundation, and the Mission Interministerielle de Lutte contre la Dependance et la Toxicomanie. J.B. has been supported by the Fondation pour la Recherche Medicale. The authors declare no competing financial interests.	Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Anzalone A, 2012, J NEUROSCI, V32, P9023, DOI 10.1523/JNEUROSCI.0918-12.2012; Barik J, 2010, BIOL PSYCHIAT, V68, P231, DOI 10.1016/j.biopsych.2010.03.037; Beiderbeck DI, 2012, PSYCHONEUROENDOCRINO, V37, P1969, DOI 10.1016/j.psyneuen.2012.04.011; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Cao JL, 2010, J NEUROSCI, V30, P16453, DOI 10.1523/JNEUROSCI.3177-10.2010; Dalley JW, 2009, SEMIN CELL DEV BIOL, V20, P403, DOI 10.1016/j.semcdb.2009.01.002; de Kloet ER, 2008, EUR J PHARMACOL, V585, P473, DOI 10.1016/j.ejphar.2008.03.011; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; Groeneweg FL, 2011, J ENDOCRINOL, V209, P153, DOI 10.1530/JOE-10-0472; Haller J, 2006, NEUROSCI BIOBEHAV R, V30, P292, DOI 10.1016/j.neubiorev.2005.01.005; Haller J, 2000, J NEUROENDOCRINOL, V12, P431; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Kelleher I, 2008, BRIT J PSYCHIAT, V193, P378, DOI 10.1192/bjp.bp.108.049536; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Lemberger T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-4; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Marinelli Michela, 2007, P41, DOI 10.1016/B978-012370632-4/50006-1; McEwen BS, 2004, ANN NY ACAD SCI, V1032, P1, DOI 10.1196/annals.1314.001; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Omelchenko N, 2009, SYNAPSE, V63, P895, DOI 10.1002/syn.20668; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Valenti O, 2011, J NEUROSCI, V31, P4280, DOI 10.1523/JNEUROSCI.5310-10.2011; Veenema AH, 2003, HORM BEHAV, V43, P197, DOI 10.1016/S0018-506X(02)00013-2; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Xia YF, 2011, J NEUROSCI, V31, P7811, DOI 10.1523/JNEUROSCI.1504-11.2011; Zweifel LS, 2011, NAT NEUROSCI, V14, P620, DOI 10.1038/nn.2808	32	131	137	0	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					332	335		10.1126/science.1226767	http://dx.doi.org/10.1126/science.1226767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329050				2022-12-28	WOS:000313622000048
J	Rodriguez, LL; Brooks, LD; Greenberg, JH; Green, ED				Rodriguez, Laura L.; Brooks, Lisa D.; Greenberg, Judith H.; Green, Eric D.			The Complexities of Genomic Identifiability	SCIENCE			English	Editorial Material									[Rodriguez, Laura L.; Brooks, Lisa D.; Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA; [Greenberg, Judith H.] NIGMS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)	Green, ED (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; [Anonymous], 2012, NIH WORKSH ROCKV MD; Batelle Technology Partnership Practice, 2011, EC IMP HUM GEN PROJ; Birney E., 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Coriell Institute for Medical Research Centre de'Etude du Polymorphism Humain (CEPH) Resources, CTR ET POL HUM CEPH; Curren L, 2010, EUR J HEALTH LAW, V17, P329, DOI 10.1163/157180910X516943; Gymrek M, 2013, SCIENCE, V339, P321, DOI 10.1126/science.1229566; Heeney C, 2011, PUBLIC HEALTH GENOM, V14, P17, DOI 10.1159/000294150; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Im HK, 2012, AM J HUM GENET, V90, P591, DOI 10.1016/j.ajhg.2012.02.008; Kaye J, 2012, NAT REV GENET, V13, P371, DOI 10.1038/nrg3218; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; P. C. for the Study of Bioethical Issues, 2012, PRIVACY PROGR WHOLE; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Sorenson Molecular Genealogy Foundation, OV SOR DAT; Wagner Jennifer K., 2012, GENETIC RIGHTS STATE; Wellcome Trust, 2003, SHAR DAT LARG SCAL B	19	84	84	0	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					275	276		10.1126/science.1234593	http://dx.doi.org/10.1126/science.1234593			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329035				2022-12-28	WOS:000313622000028
J	Grosche, A; Reichenbach, A				Grosche, Antje; Reichenbach, Andreas			Developmental Refining of Neuroglial Signaling?	SCIENCE			English	Editorial Material							ASTROCYTES; SYNAPSES; TRANSMISSION; PLASTICITY; MODULATION; GLIA		[Grosche, Antje; Reichenbach, Andreas] Univ Leipzig, Paul Flechsig Inst Brain Res, D-04109 Leipzig, Germany	Leipzig University	Grosche, A (corresponding author), Univ Leipzig, Paul Flechsig Inst Brain Res, Jahnallee 59, D-04109 Leipzig, Germany.	reia@medizin.uni-leipzig.de	Reichenbach, Andreas/B-2510-2017; Grosche, Antje/N-1978-2014	Grosche, Antje/0000-0003-0338-7530				Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 1998, J NEUROSCI, V18, P6822; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Kilb W, 2011, EUR J NEUROSCI, V34, P1677, DOI 10.1111/j.1460-9568.2011.07878.x; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Sun W, 2013, SCIENCE, V339, P197, DOI 10.1126/science.1226740; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Verkhratsky A, 2007, J ANAT, V210, P651, DOI 10.1111/j.1469-7580.2007.00734.x; Virchow R., 1856, CELLULARPATHOLOGIE I	15	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					152	153		10.1126/science.1233208	http://dx.doi.org/10.1126/science.1233208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307730				2022-12-28	WOS:000313328200031
J	Agrawal, N				Agrawal, Nisha			Should rich countries stop sending development aid to India? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Oxfam India, New Delhi 110025, India		Agrawal, N (corresponding author), Oxfam India, 2nd Floor,1 Community Ctr, New Delhi 110025, India.	nisha@oxfamindia.org						Bandhu Y, ARTIFICIAL MARKET PR; Department for International Development, 2012, A MITCHELL OUR AID P; Forbes, IND RICH; Peev G, 2011, DAILY MAIL; Ravallion M, 2012, SHOULD WE CARE EQUAL; The World Bank, POV EQ; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8	7	1	1	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2013	346								f73	10.1136/bmj.f73	http://dx.doi.org/10.1136/bmj.f73			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZV	23305912				2022-12-28	WOS:000313555300010
J	Allen, VG; Mitterni, L; Seah, C; Rebbapragada, A; Martin, IE; Lee, C; Siebert, H; Towns, L; Melano, RG; Low, DE				Allen, Vanessa G.; Mitterni, Leo; Seah, Christine; Rebbapragada, Anuradha; Martin, Irene E.; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.; Low, Donald E.			Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PENICILLIN-BINDING PROTEIN-2; DISEASES-TREATMENT-GUIDELINES; REDUCED SUSCEPTIBILITY; DECREASED SUSCEPTIBILITY; CEFTRIAXONE; MUTATIONS; PENA; TIME; RESISTANCE; EMERGENCE	Importance Although cephalosporins are the cornerstone of treatment of Neisseria gonorrhoeae infections, cefixime is the only oral antimicrobial option. Increased minimum inhibitory concentrations (MICs) to cefixime have been identified worldwide and have been associated with reports of clinical failure. Objective To assess the risk of clinical treatment failure of N gonorrhoeae infections associated with the use of cefixime. Design, Setting, and Population A retrospective cohort study of culture-positive N gonorrhoeae infections at a single sexual health clinic in Toronto, Canada, that routinely performs test of cure. The cohort comprised N gonorrhoeae culture-positive individuals identified between May 1, 2010, and April 30, 2011, treated with cefixime as recommended by Public Health Agency of Canada guidelines. Main Outcome Measures Cefixime treatment failure, defined as the repeat isolation of N gonorrhoeae at the test-of-cure visit identical to the pretreatment isolate by molecular typing and explicit denial of reexposure. Results There were 291 N gonorrhoeae culture-positive individuals identified. Of 133 who returned for test of cure, 13 were culture positive; 9 patients were determined to have experienced cefixime treatment failure, involving urethral (n=4), pharyngeal (n=2), and rectal (n=3) sites. The overall rate of clinical treatment failure among those who had a test of cure was 6.77% (95% CI, 3.14%-12.45%; 9/133). The rate of clinical failure associated with a cefixime MIC of 0.12 mu g/mL or greater was 25.0% (95% CI, 10.69%-44.87%; 7/28) compared with 1.90% (95% CI, 0.23%-6.71%; 2/105) of infections with cefixime MICs less than 0.12 mu g/mL, with a relative risk of 13.13 (95% CI, 2.88-59.72; P < .001). Conclusion and Relevance The rate of clinical failure following treatment of N gonorrhoeae infections with cefixime was relatively high at a Toronto clinic and was associated with elevated MICs. JAMA. 2013; 309(2):163-170	[Allen, Vanessa G.; Seah, Christine; Rebbapragada, Anuradha; Lee, Colin; Siebert, Heather; Towns, Lynn; Melano, Roberto G.] Publ Hlth Ontario, Toronto, ON, Canada; [Allen, Vanessa G.; Rebbapragada, Anuradha; Melano, Roberto G.; Low, Donald E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Lee, Colin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mitterni, Leo] Hassle Free Clin, Toronto, ON, Canada; [Martin, Irene E.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Low, Donald E.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; Public Health Agency of Canada; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Allen, VG (corresponding author), Publ Hlth Ontario Labs, 81 Resources Rd, Toronto, ON M9P 3T1, Canada.	vanessa.allen@oahpp.ca	Allen, Vanessa/AAE-2756-2022	Allen, Vanessa/0000-0001-9802-9730				Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], SEX TRANSM DIS FIG H; [Anonymous], VOL TYP LAB TEST MET; Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Bolan GA, 2012, NEW ENGL J MED, V366, P485, DOI 10.1056/NEJMp1112456; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P873; Chisholm SA, 2011, J ANTIMICROB CHEMOTH, V66, P2509, DOI 10.1093/jac/dkr332; Chisholm SA, 2010, J ANTIMICROB CHEMOTH, V65, P2141, DOI 10.1093/jac/dkq289; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Deguchi Takashi, 2003, Journal of Infection and Chemotherapy, V9, P35, DOI 10.1007/s10156-002-0204-8; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Forsyth S, 2011, INT J STD AIDS, V22, P296, DOI 10.1258/ijsa.2009.009191; HANDSFIELD HH, 1992, CLIN INFECT DIS, V15, pS123, DOI 10.1093/clind/15.Supplement_1.S123; Ison CA, 2011, EURO SURVEILL, V16; Kelsey JL., 1996, METHODS OBSERVATIONA; Lee SG, 2010, J ANTIMICROB CHEMOTH, V65, P669, DOI 10.1093/jac/dkp505; Lewis DA, 2010, SEX TRANSM INFECT, V86, P415, DOI 10.1136/sti.2010.042648; Liao MM, 2011, J ANTIMICROB CHEMOTH, V66, P1016, DOI 10.1093/jac/dkr021; Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Martin I, 2012, SEX TRANSM DIS, V39, P316, DOI 10.1097/OLQ.0b013e3182401b69; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; Olesky M, 2006, J BACTERIOL, V188, P2300, DOI 10.1128/JB.188.7.2300-2308.2006; Osaka Kazuyoshi, 2008, Journal of Infection and Chemotherapy, V14, P195, DOI 10.1007/s10156-008-0610-7; PLOURDE PJ, 1992, J INFECT DIS, V166, P919, DOI 10.1093/infdis/166.4.919; Public Health Agency of Canada, IMP NOT PUBL HLTH IN; Public Health Agency of Canada, CAN GUID SEX TRANSM; Sathia L, 2007, INT J STD AIDS, V18, P647, DOI 10.1258/095646207781568556; Takahata S, 2006, ANTIMICROB AGENTS CH, V50, P3638, DOI 10.1128/AAC.00626-06; Tapsall J, ANTIMICROBIAL RESIST; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2011, EURO SURVEILL, V16; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P2543, DOI 10.1093/jac/dkq377; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1; World Health Organization, GLOB ACT PLAN CONTR; Yokoi S, 2007, EMERG INFECT DIS, V13, P1275; Zhao SQ, 2009, ANTIMICROB AGENTS CH, V53, P3744, DOI 10.1128/AAC.00304-09	41	149	152	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					163	170		10.1001/jama.2012.176575	http://dx.doi.org/10.1001/jama.2012.176575			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299608	Bronze			2022-12-28	WOS:000313517000025
J	Jiang, HC; Block, MS; Mishmash, RV; Garrison, JR; Sheng, DN; Motrunich, OI; Fisher, MPA				Jiang, Hong-Chen; Block, Matthew S.; Mishmash, Ryan V.; Garrison, James R.; Sheng, D. N.; Motrunich, Olexei I.; Fisher, Matthew P. A.			Non-Fermi-liquid d-wave metal phase of strongly interacting electrons	NATURE			English	Article							VALENCE-BOND STATE; QUANTUM RENORMALIZATION-GROUPS; SUPERCONDUCTIVITY; PHYSICS; TRANSPORT; DIAGRAM; SYSTEM; MODEL	Developing a theoretical framework for conducting electronic fluids qualitatively distinct from those described by Landau's Fermi-liquid theory is of central importance to many outstanding problems in condensed matter physics. One such problem is that, above the transition temperature and near optimal doping, high-transition-temperature copper-oxide superconductors exhibit 'strange metal' behaviour that is inconsistent with being a traditional Landau Fermi liquid. Indeed, a microscopic theory of a strange-metal quantum phase could shed new light on the interesting low-temperature behaviour in the pseudogap regime and on the d-wave superconductor itself. Here we present a theory for a specific example of a strange metal-the 'd-wave metal'. Using variational wavefunctions, gauge theoretic arguments, and ultimately large-scale density matrix renormalization group calculations, we show that this remarkable quantum phase is the ground state of a reasonable microscopic Hamiltonian-the usual t-J model with electron kinetic energy t and two-spin exchange J supplemented with a frustrated electron 'ring-exchange' term, which we here examine extensively on the square lattice two-leg ladder. These findings constitute an explicit theoretical example of a genuine non-Fermi-liquid metal existing as the ground state of a realistic model.	[Mishmash, Ryan V.; Garrison, James R.; Fisher, Matthew P. A.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Jiang, Hong-Chen] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Block, Matthew S.] Univ Kentucky, Dept Phys & Astron, Lexington, KY 40506 USA; [Sheng, D. N.] Calif State Univ Northridge, Dept Phys & Astron, Northridge, CA 91330 USA; [Motrunich, Olexei I.] CALTECH, Dept Phys, Pasadena, CA 91125 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Kentucky; California State University System; California State University Northridge; California Institute of Technology	Mishmash, RV (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	mishmash@physics.ucsb.edu	Jiang, Hongchen/F-8843-2011	Jiang, Hongchen/0000-0003-2842-6591	NSF under the KITP [PHY05-51164]; MRSEC [DMR-1121053]; NSF [DMR-1101912, DMR-1056536, DMR-0906816, DMR-1205734, DMR-0907145, CNS-0960316]; Caltech Institute of Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation; Center for Scientific Computing from the CNSI, MRL: an NSF MRSEC [DMR-1121053]	NSF under the KITP; MRSEC(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Caltech Institute of Quantum Information and Matter, an NSF Physics Frontiers Center; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Scientific Computing from the CNSI, MRL: an NSF MRSEC	We thank T. Senthil, R. Kaul, L. Balents, S. Sachdev, A. Vishwanath and P. Lee for discussions. This work was supported by the NSF under the KITP grant PHY05-51164 and the MRSEC programme under award number DMR-1121053 (H.-C.J.), the NSF under grants DMR-1101912 (M. S. B., R. V. M., J.R.G. and M. P. A. F.), DMR-1056536 (M. S. B.), DMR-0906816 and DMR-1205734 (D.N.S.), DMR-0907145 (O.I.M.), and by the Caltech Institute of Quantum Information and Matter, an NSF Physics Frontiers Center with the support of the Gordon and Betty Moore Foundation (O.I.M. and M. P. A. F.). We also acknowledge support from the Center for Scientific Computing from the CNSI, MRL: an NSF MRSEC award (DMR-1121053), and an NSF grant (CNS-0960316).	ALTSHULER BL, 1994, PHYS REV B, V50, P14048, DOI 10.1103/PhysRevB.50.14048; ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; ANDERSON PW, 1988, PHYS REV LETT, V60, P132, DOI 10.1103/PhysRevLett.60.132; ANDERSON PW, 1987, PHYS REV LETT, V58, P2790, DOI 10.1103/PhysRevLett.58.2790; Block MS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.157202; Block MS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.046402; Boebinger GS, 2009, SCIENCE, V323, P590, DOI 10.1126/science.1168952; Calabrese P, 2004, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2004/06/P06002; Calabrese P, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.095701; CEPERLEY D, 1977, PHYS REV B, V16, P3081, DOI 10.1103/PhysRevB.16.3081; CEPERLEY DM, 1991, J STAT PHYS, V63, P1237, DOI 10.1007/BF01030009; Cooper RA, 2009, SCIENCE, V323, P603, DOI 10.1126/science.1165015; Corboz P, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.165104; Faulkner T, 2010, SCIENCE, V329, P1043, DOI 10.1126/science.1189134; FEIGELMAN MV, 1993, PHYS REV B, V48, P16641, DOI 10.1103/PhysRevB.48.16641; Fjaerestad JO, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125106; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; Giamarchi T., 2003, QUANTUM PHYS ONE DIM, V121; GROS C, 1989, ANN PHYS-NEW YORK, V189, P53, DOI 10.1016/0003-4916(89)90077-8; HALPERIN BI, 1993, PHYS REV B, V47, P7312, DOI 10.1103/PhysRevB.47.7312; Hastings MB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157201; HELLBERG CS, 1991, PHYS REV LETT, V67, P2080, DOI 10.1103/PhysRevLett.67.2080; Imada M, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.112001; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; LEE PA, 1992, PHYS REV B, V46, P5621, DOI 10.1103/PhysRevB.46.5621; Lin HH, 1998, PHYS REV B, V58, P1794, DOI 10.1103/PhysRevB.58.1794; LUTTINGER JM, 1960, PHYS REV, V119, P1153, DOI 10.1103/PhysRev.119.1153; Mishmash RV, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.245127; Motrunich OI, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.235116; NAGAOSA N, 1990, PHYS REV LETT, V64, P2450, DOI 10.1103/PhysRevLett.64.2450; Nandkishore R, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.045128; Normand B, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134407; POLCHINSKI J, 1994, NUCL PHYS B, V422, P617, DOI 10.1016/0550-3213(94)90449-9; Sachdev S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.151602; Schofield AJ, 1999, CONTEMP PHYS, V40, P95, DOI 10.1080/001075199181602; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; Shankar R, 1995, ACTA PHYS POL B, V26, P1835; Sheng DN, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205112; Sheng DN, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.054520; Troyer M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.170201; VARMA CM, 1989, PHYS REV LETT, V63, P1996, DOI 10.1103/PhysRevLett.63.1996; Wen XG, 1996, PHYS REV LETT, V76, P503, DOI 10.1103/PhysRevLett.76.503; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; Zhang Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.067202	50	49	49	0	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					39	44		10.1038/nature11732	http://dx.doi.org/10.1038/nature11732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254935	Green Submitted, Green Accepted			2022-12-28	WOS:000312933800026
J	Al-Khatib, SM; Hellkamp, A; Bardy, GH; Hammill, S; Hall, WJ; Mark, DB; Anstrom, KJ; Curtis, J; Al-Khalidi, H; Curtis, LH; Heidenreich, P; Peterson, ED; Sanders, G; Clapp-Channing, N; Lee, KL; Moss, AJ				Al-Khatib, Sana M.; Hellkamp, Anne; Bardy, Gust H.; Hammill, Stephen; Hall, W. Jackson; Mark, Daniel B.; Anstrom, Kevin J.; Curtis, Jeptha; Al-Khalidi, Hussein; Curtis, Lesley H.; Heidenreich, Paul; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.; Moss, Arthur J.			Survival of Patients Receiving a Primary Prevention Implantable Cardioverter-Defibrillator in Clinical Practice vs Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICARE BENEFICIARIES; HEART-FAILURE; GENERALIZABILITY; OUTCOMES; REGISTRY; DISEASE	Importance Randomized clinical trials have shown that implantable cardioverter-defibrillator (ICD) therapy saves lives. Whether the survival of patients who received an ICD in primary prevention clinical trials differs from that of trial-eligible patients receiving a primary prevention ICD in clinical practice is unknown. Objective To determine whether trial-eligible patients who received a primary prevention ICD as documented in a large national registry have a survival rate that differs from the survival rate of similar patients who received an ICD in the 2 largest primary prevention clinical trials, MADIT-II (n = 742) and SCD-HeFT (n = 829). Design, Setting, and Patients Retrospective analysis of data for patients enrolled in the National Cardiovascular Data Registry ICD Registry between January 1, 2006, and December 31, 2007, meeting the MADIT-II criteria (2464 propensity score-matched patients) or the SCD-HeFT criteria (3352 propensity score-matched patients). Mortality data for the registry patients were collected through December 31, 2009. Main Outcome Measures Cox proportional hazards models were used to compare mortality from any cause. Results The median follow-up time in MADIT-II, SCD-HeFT, and the ICD Registry was 19.5, 46.1, and 35.2 months, respectively. Compared with patients enrolled in the clinical trials, patients in the ICD Registry were significantly older and had a higher burden of comorbidities. In the matched cohorts, there was no significant difference in survival between MADIT-II-like patients in the registry and MADIT-II patients randomized to receive an ICD (2-year mortality rates: 13.9% and 15.6%, respectively; adjusted ICD Registry vs trial hazard ratio, 1.06; 95% CI, 0.85-1.31; P = .62). Likewise, the survival among SCD-HeFT-like patients in the registry was not significantly different from survival among patients randomized to receive ICD therapy in SCD-HeFT (3-year mortality rates: 17.3% and 17.4%, respectively; adjusted registry vs trial hazard ratio, 1.16; 95% CI, 0.97-1.38; P = .11). Conclusions and Relevance There was no significant difference in survival between clinical trial patients randomized to receive an ICD and a similar group of clinical registry patients who received a primary prevention ICD. Our findings support the continued use of primary prevention ICDs in similar patients seen in clinical practice.	[Al-Khatib, Sana M.; Hellkamp, Anne; Mark, Daniel B.; Anstrom, Kevin J.; Al-Khalidi, Hussein; Curtis, Lesley H.; Peterson, Eric D.; Sanders, Gillian; Clapp-Channing, Nancy; Lee, Kerry L.] Duke Clin Res Inst, Durham, NC 27715 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Ctr Clin & Genet Econ, Durham, NC 27710 USA; [Al-Khatib, Sana M.; Mark, Daniel B.; Peterson, Eric D.] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA; [Curtis, Lesley H.] Duke Univ, Med Ctr, Dept Med, Div Gen Internal Med, Durham, NC 27710 USA; [Bardy, Gust H.] Univ Washington, Med Ctr, Seattle, WA 98195 USA; [Hammill, Stephen] Mayo Clin, Rochester, MN USA; [Hall, W. Jackson; Moss, Arthur J.] Univ Rochester, Rochester, NY USA; [Curtis, Jeptha] Yale Univ, Sch Med, West Haven, CT 06516 USA; [Heidenreich, Paul] Stanford Univ, Palo Alto Vet Hlth Care Syst, Palo Alto, CA 94304 USA	Duke University; Duke University; Duke University; Duke University; University of Washington; University of Washington Seattle; Mayo Clinic; University of Rochester; Yale University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Al-Khatib, SM (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	alkha001@mc.duke.edu	Heidenreich, Paul/AAU-6864-2021; Peterson, Eric David/ABF-5033-2021	Heidenreich, Paul/0000-0001-7730-8490; Mark, Daniel/0000-0001-6340-8087	Cameron Health; Eli Lilly; Medtronic; AstraZeneca; Gilead Sciences; American College of Cardiology Foundation; Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI); Johnson Johnson; GlaxoSmithKline; Agency for Healthcare Research and Quality; NHLBI; Boston Scientific; St Jude; Biotronic; National Heart, Lung, and Blood Institute [1R01-HL093071-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093071] Funding Source: NIH RePORTER	Cameron Health; Eli Lilly(Eli Lilly); Medtronic(Medtronic); AstraZeneca(AstraZeneca); Gilead Sciences(Gilead Sciences); American College of Cardiology Foundation(General Electric); Center for Medicare & Medicaid Services; National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); GlaxoSmithKline(GlaxoSmithKline); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston Scientific(Boston Scientific); St Jude(St. Jude Medical); Biotronic; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bardy reported consulting fees, equity, and intellectual property rights in Cameron Health. Dr Mark reported receiving research grants from Eli Lilly, Medtronic, AstraZeneca, and Gilead Sciences. Dr Anstrom reported receiving research support from AstraZeneca, Eli Lilly, and Medtronic; having served as a consultant for Abbott Vascular, AstraZeneca, Bristol Meyer Squibb, and Ikaria; and having served on data monitoring committees for Pfizer and Vertex. Dr J. Curtis reported owning stock in Medtronic and receiving salary support from the American College of Cardiology Foundation, Center for Medicare & Medicaid Services, and National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI). Dr L. Curtis reported receiving research and salary support from Johnson & Johnson, GlaxoSmithKline, Agency for Healthcare Research and Quality, and NHLBI. Dr Curtis has made available online a detailed listing of financial disclosures (http://www.dcri.duke.edu/research/coi.jsp). Dr Heidenreich reported receiving research support from Medtronic. Dr Lee reported receiving modest consulting fees from Medtronic. Dr Moss reported receiving research grants from Boston Scientific and salary support from Boston Scientific, Medtronic, St Jude, and Biotronic. No other disclosures were reported.; This analysis was funded by a grant (1R01-HL093071-01A1) from the National Heart, Lung, and Blood Institute.	Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Al-Khatib SM, 2012, HEART RHYTHM S, V9, pS381; Badano Luigi P, 2003, Ital Heart J, V4, P84; Bahit MC, 2003, AM HEART J, V145, P109, DOI 10.1067/mhj.2003.43; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; Cardinal H, 2004, CAN J CARDIOL, V20, P417; Hammill SC, 2009, HEART RHYTHM, V6, P1397, DOI 10.1016/j.hrthm.2009.07.015; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Keitner GI, 2003, J CLIN PSYCHIAT, V64, P1091, DOI 10.4088/JCP.v64n0915; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Pedone C, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-24; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Walsh CR, 2000, AM J CARDIOL, V86, P908, DOI 10.1016/S0002-9149(00)01120-6	16	71	72	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					55	62		10.1001/jama.2012.157182	http://dx.doi.org/10.1001/jama.2012.157182			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280225	Green Accepted			2022-12-28	WOS:000319113000027
J	Mulla, SM; Scott, IA; Jackevicius, CA; You, JJ; Guyatt, GH				Mulla, Sohail M.; Scott, Ian A.; Jackevicius, Cynthia A.; You, John J.; Guyatt, Gordon H.			How to Use a Noninferiority Trial Users' Guides to the Medical Literature	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-FIBRILLATION; NON-INFERIORITY; OPEN-LABEL	Clinical investigators are increasingly testing treatments that have the primary benefit of decreased burden or harms relative to an existing standard. The goal of the resulting randomized trials-called noninferiority trials-is to establish that the novel treatment's effectiveness is not substantially less than the existing standard. Conclusions from these trials are, however, based on noninferiority thresholds specified by authors whose judgments may not coincide with those of patients and clinicians. This article highlights issues related to validity, interpretation, and applicability of results specific to noninferiority trials. Suboptimal administration of standard treatment or exclusive reliance on the analyze-as-randomized approach that is standard for conventional superiority trials may produce misleading results in noninferiority trials. Clinicians should judge whether the novel treatment's impact on effectiveness outcomes-the prime reason for wanting to prescribe it-is sufficiently close to that of standard treatment that they are comfortable substituting it for the existing standard. Trading off desirable and undesirable consequences is an individual decision: given the benefits of a novel treatment, some patients may perceive the uncertainty regarding a reduction in treatment effectiveness as acceptable while others may not. JAMA 2012;308(24):2605-2611	[Mulla, Sohail M.; You, John J.; Guyatt, Gordon H.] McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [You, John J.; Guyatt, Gordon H.] McMaster Univ, Fac Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Scott, Ian A.] Princess Alexandra Hosp, Dept Internal Med & Clin Epidemiol, Brisbane, Qld 4102, Australia; [Jackevicius, Cynthia A.; You, John J.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA USA; [Jackevicius, Cynthia A.] Univ Toronto, Fac Med, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	McMaster University; McMaster University; University of Toronto; Western University of Health Sciences; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Guyatt, GH (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, 1200 Main St W,Room 2C12, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Scott, Ian/Z-4577-2019; Scott, Ian A/F-1482-2011	Scott, Ian/0000-0002-7596-0837				Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Fleming TR, 2011, NEW ENGL J MED, V365, P1557, DOI 10.1056/NEJMp1110639; Flerning TR, 2008, STAT MED, V27, P317, DOI 10.1002/sim.2855; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Jackson K, 2008, AM HEART J, V155, P829, DOI 10.1016/j.ahj.2008.01.023; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Kunz R, 2006, TRANSFUSION, V46, P881, DOI 10.1111/j.1537-2995.2006.00854.x; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; MacLean S, 2012, CHEST, V141, pE1S, DOI 10.1378/chest.11-2290; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Nout RA, 2010, LANCET, V375, P816, DOI 10.1016/S0140-6736(09)62163-2; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Piaggio G, 2012, JAMA-J AM MED ASSOC, V308, P2594, DOI 10.1001/jama.2012.87802; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Scott IA, 2009, MED J AUSTRALIA, V190, P326, DOI 10.5694/j.1326-5377.2009.tb02425.x; Temple R, 2010, GUIDANCE IND NONINFE; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Yank V, 2007, BMJ-BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE	21	68	68	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2605	2611		10.1001/2012.jama.11235	http://dx.doi.org/10.1001/2012.jama.11235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268519				2022-12-28	WOS:000312916600026
J	Aflaifel, N; Weeks, A				Aflaifel, Nasreen; Weeks, Andrew			CHRISTMAS 2012: EVOLUTION OF PRACTICE Push, pull, squeeze, clamp: 100 years of changes in the management of the third stage of labour as described by Ten Teachers	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Aflaifel, Nasreen; Weeks, Andrew] Univ Liverpool, Liverpool Womens Hosp, Dept Womens & Childrens Hlth, Sanyu Res Unit, Liverpool L8 7SS, Merseyside, England	University of Liverpool	Aflaifel, N (corresponding author), Omer Al Mukhtar Univ, Dept Obstet & Gynaecol, El Byda, Libya.	aflaifel@liv.ac.uk		Weeks, Andrew/0000-0002-1909-337X				Aflaifel N, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4546; Berkeley C, 1917, MIDWIFERY 10 TEACHER; Bullarbo M, 2005, INT J GYNECOL OBSTET, V91, P228, DOI 10.1016/j.ijgo.2005.08.020; Clayton S, 1966, OBSTET 10 TEACHERS	4	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8270	10.1136/bmj.e8270	http://dx.doi.org/10.1136/bmj.e8270			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255585				2022-12-28	WOS:000312700100015
J	Pride, YB; Cutlip, DE				Pride, Yuri B.; Cutlip, Donald E.			Disappearing stents-DREAMS of a sorcerer's apprentice?	LANCET			English	Editorial Material							ELUTING STENTS; VASCULAR SCAFFOLD; CORONARY-ARTERIES; EVEROLIMUS; THROMBOSIS; 2ND-GENERATION; OUTCOMES		[Pride, Yuri B.; Cutlip, Donald E.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Cutlip, DE (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Dept Med, Boston, MA 02215 USA.	dcutlip@bidmc.harvard.edu		Pride, Yuri/0000-0002-5884-0964				Baber U, 2011, J AM COLL CARDIOL, V58, P1569, DOI 10.1016/j.jacc.2011.06.049; COLOMBO A, 1995, CIRCULATION, V91, P1676, DOI 10.1161/01.CIR.91.6.1676; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Grines CL, 2007, CATHETER CARDIO INTE, V69, P334, DOI 10.1002/ccd.21124; Haude M, 2012, LANCET; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Ormiston JA, 2012, CIRC-CARDIOVASC INTE, V5, P620, DOI 10.1161/CIRCINTERVENTIONS.112.971549; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; SERRUYS PW, 1989, EUR HEART J, V10, P774, DOI 10.1093/oxfordjournals.eurheartj.a059570; Stefanini GG, 2011, LANCET, V378, P1940, DOI 10.1016/S0140-6736(11)61672-3; Stone GW, 2011, J AM COLL CARDIOL, V58, P19, DOI 10.1016/j.jacc.2011.02.022; Tamai H, 2000, CIRCULATION, V102, P399	16	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					787	789		10.1016/S0140-6736(12)62036-4	http://dx.doi.org/10.1016/S0140-6736(12)62036-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	105IL	23332166				2022-12-28	WOS:000316060600009
J	Sooriakumaran, P; Anderson, CJ				Sooriakumaran, Prasanna; Anderson, Christopher J.			Everolimus for renal angiomyolipoma in tuberous sclerosis	LANCET			English	Editorial Material							LYMPHANGIOLEIOMYOMATOSIS; COMPLEX; SIROLIMUS; RAPAMYCIN		[Sooriakumaran, Prasanna; Anderson, Christopher J.] St Georges NHS Trust, Dept Urol, London SW17 0QT, England		Sooriakumaran, P (corresponding author), St Georges NHS Trust, Dept Urol, London SW17 0QT, England.	sooriakumaran@gmail.com						Bissler JJ, 2004, KIDNEY INT, V66, P924, DOI 10.1111/j.1523-1755.2004.00838.x; Bissler JJ, 2012, LANCET; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Budde K, 2012, AM J KIDNEY DIS, V59, P276, DOI 10.1053/j.ajkd.2011.10.013; Dabora SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023379; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Franz D.N., 2012, LANCET; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Sooriakumaran P, 2010, BJU INT, V105, P101, DOI 10.1111/j.1464-410X.2009.08649.x; Wienecke R, 2006, AM J KIDNEY DIS, V48, pE27, DOI 10.1053/j.ajkd.2006.05.018; Wright Timothy, 2008, Cases J, V1, P213, DOI 10.1186/1757-1626-1-213	12	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					783	785		10.1016/S0140-6736(12)61954-0	http://dx.doi.org/10.1016/S0140-6736(12)61954-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23312828				2022-12-28	WOS:000316060600007
J	Waters, LJ; Barber, TJ				Waters, Laura J.; Barber, Tristan J.			Dolutegravir for treatment of HIV: SPRING forwards?	LANCET			English	Editorial Material							MYOCARDIAL-INFARCTION; ABACAVIR USE; THERAPY; EVENTS; RISK		[Waters, Laura J.; Barber, Tristan J.] Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London WC1E 6JB, England		Barber, TJ (corresponding author), Cent & North West London NHS Fdn Trust, Mortimer Market Ctr, London WC1E 6JB, England.	t.barber@nhs.net						[Anonymous], 2012, EUR AIDS CLIN SOC GU; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Choi AI, 2011, AIDS, V25, P1289, DOI 10.1097/QAD.0b013e328347fa16; Ding X, 2012, JAIDS-J ACQ IMM DEF, V61, P441, DOI 10.1097/QAI.0b013e31826f993c; Hurt CB, 2011, ANTIVIR THER, V16, P137, DOI 10.3851/IMP1750; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Oliveira M, 2012, 19 C RETR OPP INF SE, P692; Raffi F, 2013, LANCET; Song I BJ, 2012, 13 INT WORKSH CLIN P; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Walmsley S, 2012, 52 INT C ANT AG CHEM; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897	13	8	9	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					705	706		10.1016/S0140-6736(12)62004-2	http://dx.doi.org/10.1016/S0140-6736(12)62004-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098TC	23306001				2022-12-28	WOS:000315570900006
J	Burgess, JAJ; Fraser, AE; Sani, FF; Vick, D; Hauer, BD; Davis, JP; Freeman, MR				Burgess, J. A. J.; Fraser, A. E.; Sani, F. Fani; Vick, D.; Hauer, B. D.; Davis, J. P.; Freeman, M. R.			Quantitative Magneto-Mechanical Detection and Control of the Barkhausen Effect	SCIENCE			English	Article							MAGNETIC VORTEX	Quantitative characterization of intrinsic and artificial defects in ferromagnetic structures is critical to future magnetic storage based on vortices or domain walls moving through nanostructured devices. Using torsional magnetometry, we observe finite size modifications to the Barkhausen effect in the limiting case of a single vortex core interacting with individual pointlike pinning sites in a magnetic thin film. The Barkhausen effect in this limit becomes a quantitative two-dimensional nanoscale probe of local energetics in the film. Tailoring the pinning potential using single-point focused ion beam implantation demonstrates control of the effect and points the way to integrated magneto-mechanical devices incorporating quantum pinning effects.	[Burgess, J. A. J.; Fraser, A. E.; Sani, F. Fani; Hauer, B. D.; Davis, J. P.; Freeman, M. R.] Univ Alberta, Dept Phys, Centennial Ctr Interdisciplinary Sci 4 181, Edmonton, AB T6G 2E1, Canada; [Burgess, J. A. J.; Sani, F. Fani; Vick, D.; Davis, J. P.; Freeman, M. R.] Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	University of Alberta; National Research Council Canada	Freeman, MR (corresponding author), Univ Alberta, Dept Phys, Centennial Ctr Interdisciplinary Sci 4 181, Edmonton, AB T6G 2E1, Canada.	mark.freeman@ualberta.ca	Davis, John/C-8274-2011; Freeman, Mark R/E-4609-2013; Fani Sani, Fatemeh/I-1131-2013	Davis, John/0000-0002-3798-0976; Freeman, Mark R/0000-0002-6607-6521; Hauer, Bradley/0000-0002-2715-0223	Natural Sciences and Engineering Research Council, Canada; Canadian Institute for Advanced Research; Informatics Circle of Research Excellence; Canada Research Chairs; Integrated Nanosystems Research Facility; Canadian Foundation for Innovation; nanoAlberta; National Institute for Nanotechnology; Alberta Ingenuity Foundation/Alberta Innovates	Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Informatics Circle of Research Excellence; Canada Research Chairs(Canada Research ChairsCGIAR); Integrated Nanosystems Research Facility; Canadian Foundation for Innovation(Canada Foundation for Innovation); nanoAlberta; National Institute for Nanotechnology; Alberta Ingenuity Foundation/Alberta Innovates	This work was supported by the Natural Sciences and Engineering Research Council, Canada, the Canadian Institute for Advanced Research, the Informatics Circle of Research Excellence, Canada Research Chairs, the Integrated Nanosystems Research Facility, the Canadian Foundation for Innovation, nanoAlberta, and the National Institute for Nanotechnology. The samples were fabricated using the electron microscopy facilities of the National Institute for Nanotechnology and Infrastructure of the Centre for Nanoscale Physics and Nanomaterials Research at the University of Alberta. J.B. thanks the Alberta Ingenuity Foundation/Alberta Innovates for support. We are grateful to W. Hiebert, J. Losby, Z. Diao, M. Malac, and V. Sauer for many discussions; to P. Li for TEM work; and to D. Fortin for technical assistance.	Allwood DA, 2005, SCIENCE, V309, P1688, DOI 10.1126/science.1108813; Apolonio FA, 2009, J APPL PHYS, V106, DOI 10.1063/1.3247542; Barkhausen H, 1919, PHYS Z, V20, P401; Burgess JAJ, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144403; Chappert C, 1998, SCIENCE, V280, P1919, DOI 10.1126/science.280.5371.1919; Chen TY, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180406; Compton RL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.144412; Compton RL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.137202; Cowburn RP, 1999, PHYS REV LETT, V83, P1042, DOI 10.1103/PhysRevLett.83.1042; Davis JP, 2011, J APPL PHYS, V109, DOI 10.1063/1.3540643; Eltschka M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.056601; Franken JH, 2012, NAT NANOTECHNOL, V7, P499, DOI [10.1038/nnano.2012.111, 10.1038/NNANO.2012.111]; Guslienko KY, 2002, J APPL PHYS, V91, P8037, DOI 10.1063/1.1450816; Guslienko KY, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.024414; Kim JS, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104427; Metlov KL, 2002, J MAGN MAGN MATER, V242, P1015, DOI 10.1016/S0304-8853(01)01360-9; Mihajlovic G, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3360841; Min HK, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.064411; Min HK, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.217201; Moreland J, 2003, J PHYS D APPL PHYS, V36, pR39, DOI 10.1088/0022-3727/36/5/201; Parkin SSP, 2008, SCIENCE, V320, P190, DOI 10.1126/science.1145799; Raabe J, 2000, J APPL PHYS, V88, P4437, DOI 10.1063/1.1289216; Rahm M, 2004, J APPL PHYS, V95, P6708, DOI 10.1063/1.1667448; Rahm M, 2004, APPL PHYS LETT, V85, P1553, DOI 10.1063/1.1785281; Shinjo T, 2000, SCIENCE, V289, P930, DOI 10.1126/science.289.5481.930; Toscano D, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573518; Uhlig T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.237205; Wachowiak A, 2002, SCIENCE, V298, P577, DOI 10.1126/science.1075302; Zarzuela R, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.180401	29	68	68	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1051	1054		10.1126/science.1231390	http://dx.doi.org/10.1126/science.1231390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328394				2022-12-28	WOS:000315452000034
J	Ernst, A; Avvakumov, G; Tong, JF; Fan, YH; Zhao, YL; Alberts, P; Persaud, A; Walker, JR; Neculai, AM; Neculai, D; Vorobyov, A; Garg, P; Beatty, L; Chan, PK; Juang, YC; Landry, MC; Yeh, C; Zeqiraj, E; Karamboulas, K; Allali-Hassani, A; Vedadi, M; Tyers, M; Moffat, J; Sicheri, F; Pelletier, L; Durocher, D; Raught, B; Rotin, D; Yang, JH; Moran, MF; Dhe-Paganon, S; Sidhu, SS				Ernst, Andreas; Avvakumov, George; Tong, Jiefei; Fan, Yihui; Zhao, Yanling; Alberts, Philipp; Persaud, Avinash; Walker, John R.; Neculai, Ana-Mirela; Neculai, Dante; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Chan, Pak-Kei; Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Karamboulas, Konstantina; Allali-Hassani, Abdellah; Vedadi, Masoud; Tyers, Mike; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Raught, Brian; Rotin, Daniela; Yang, Jianhua; Moran, Michael F.; Dhe-Paganon, Sirano; Sidhu, Sachdev S.			A Strategy for Modulation of Enzymes in the Ubiquitin System	SCIENCE			English	Article							DEUBIQUITINATING ENZYME; STRUCTURAL BASIS; SPECIFICITY; LIGASE; CANCER; TRAFFICKING; RECOGNITION; ENDOCYTOSIS; INHIBITION; PROTEASES	The ubiquitin system regulates virtually all aspects of cellular function. We report a method to target the myriad enzymes that govern ubiquitination of protein substrates. We used massively diverse combinatorial libraries of ubiquitin variants to develop inhibitors of four deubiquitinases (DUBs) and analyzed the DUB-inhibitor complexes with crystallography. We extended the selection strategy to the ubiquitin conjugating (E2) and ubiquitin ligase (E3) enzymes and found that ubiquitin variants can also enhance enzyme activity. Last, we showed that ubiquitin variants can bind selectively to ubiquitin-binding domains. Ubiquitin variants exhibit selective function in cells and thus enable orthogonal modulation of specific enzymatic steps in the ubiquitin system.	[Ernst, Andreas; Neculai, Ana-Mirela; Vorobyov, Andrew; Garg, Pankaj; Beatty, Linda; Karamboulas, Konstantina; Moffat, Jason; Sidhu, Sachdev S.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Avvakumov, George; Walker, John R.; Neculai, Dante; Allali-Hassani, Abdellah; Vedadi, Masoud; Dhe-Paganon, Sirano] MaRS Ctr, Struct Genom Consortium, 101 Coll St,Suite 700, Toronto, ON M5G 1L7, Canada; [Tong, Jiefei; Alberts, Philipp; Persaud, Avinash; Rotin, Daniela; Moran, Michael F.] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Fan, Yihui; Zhao, Yanling; Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Persaud, Avinash; Rotin, Daniela] Univ Toronto, Dept Biochem, Toronto, ON M5S 3E1, Canada; [Chan, Pak-Kei; Tyers, Mike] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Juang, Yu-Chi; Landry, Marie-Claude; Yeh, Christina; Zeqiraj, Elton; Tyers, Mike; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Yeh, Christina; Moffat, Jason; Sicheri, Frank; Pelletier, Laurence; Durocher, Daniel; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Moran, Michael F.; Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Moffat, Jason; Raught, Brian; Sidhu, Sachdev S.] Univ Toronto, McLaughlin Ctr Mol Med, Toronto, ON M5G 1L7, Canada; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Baylor College of Medicine; Texas Children's Cancer Center; University of Toronto; Universite de Montreal; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Sidhu, SS (corresponding author), Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	sachdev.sidhu@utoronto.ca	Neculai, Dante/M-2884-2013; 高, 雨莉/HGU-8187-2022; Moffat, Jason/AAC-1110-2020; Durocher, Daniel/A-7733-2010; Tyers, Michael/ABE-3194-2021; Neculai, Dante/A-9923-2011; Ernst, Andreas/M-3013-2019; Pelletier, Laurence/F-8858-2013; Moran, Michael/GYD-3631-2022; Sicheri, Frank/F-8856-2013	Moffat, Jason/0000-0002-5663-8586; Durocher, Daniel/0000-0003-3863-8635; Neculai, Dante/0000-0001-8887-9168; Zeqiraj, Elton/0000-0003-0239-5926; /0000-0002-5255-895X	Canadian Institutes for Health Research [MOP-111149, MOP-13494, MOP-57795, MOP-102536, 1097737]; NIH-National Institute of Neurological Disorders and Stroke [1R01NS072420-01]; Canada Research Chairs in Structural Principles of Signal Transduction; Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072420] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NIH-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canada Research Chairs in Structural Principles of Signal Transduction(Canada Research Chairs); Canadian Foundation for Innovation, Systems and Synthetic Biology; Molecular Signatures; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank I. Pot and J.J. Adams for helpful comments on the manuscript and Y. Li for cloning protease constructs. This project was supported by operating grants from the Canadian Institutes for Health Research to S. S. S. (MOP-111149), D. R. (MOP-13494), F. S., M. T. (MOP-57795), and M. F. M. (MOP-102536). J.Y. receives funding from a NIH-National Institute of Neurological Disorders and Stroke grant (1R01NS072420-01). F. S., D. R., M. T., and M. F. M. hold Canada Research Chairs (Tier 1) in Structural Principles of Signal Transduction, Canadian Foundation for Innovation, Systems and Synthetic Biology, and Molecular Signatures, respectively. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A. E., G. A., S. D., and S. S. S. designed the study. A. E., A. V., P. G., and L. B. performed phage display selections, protein purification, and in vitro inhibition assays. G. A., A.-M.N., D.N., J.W., Y.-C.J., and S. D. purified proteins used in this study and solved all the crystal structures. J.T. and M. F. M. performed intracellular USP8 inhibition experiments. Y. F., Y.Z., and J.Y. performed intracellular USP21 inhibition experiments. Y.-C.J., M.-C. L., C. Y., E.Z, F. S., L. P., M. T., and D. D. purified proteins used as targets for phage display selections. K. K. and J.M. performed initial intracellular characterizations of Ub variants. A. A.-H. and M. V. performed in vitro enzymatic assays. P.-K.C. and B. R. provided Ub variants expressing stable cell lines and performed mass spectrometry experiments. P. A., A. P., and D. R. performed NEDD4 ubiquitination experiments; A. E. and S. S. S. analyzed data, prepared figures, and wrote the paper. S. S. S., L. B., and A. E. are inventors on a pending patent, "Specific Active Site Inhibitors of Enzymes or Substrate Binding Partners and Methods of Producing the Same" (PCT/US11/39601).	Avvakumov GV, 2006, J BIOL CHEM, V281, P38061, DOI 10.1074/jbc.M606704200; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; Cohen P, 2010, CELL, V143, P686, DOI 10.1016/j.cell.2010.11.016; Colland F, 2010, BIOCHEM SOC T, V38, P137, DOI 10.1042/BST0380137; Cooper EM, 2010, J BIOL CHEM, V285, P10344, DOI 10.1074/jbc.M109.059667; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Daviet L, 2008, BIOCHIMIE, V90, P270, DOI 10.1016/j.biochi.2007.09.013; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fellouse F. A., 2005, PHAGE DISPLAY BIIOTE, V3, P111; Grunda JM, 2006, J NEURO-ONCOL, V80, P261, DOI 10.1007/s11060-006-9191-4; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Juang YC, 2012, MOL CELL, V45, P384, DOI 10.1016/j.molcel.2012.01.011; Kapuria V, 2010, CANCER RES, V70, P9265, DOI 10.1158/0008-5472.CAN-10-1530; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Meijer IMJ, 2011, CELL SIGNAL, V23, P458, DOI 10.1016/j.cellsig.2010.10.023; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Nakada S, 2010, NATURE, V466, P941, DOI 10.1038/nature09297; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; Wenzel DM, 2011, BIOCHEM J, V433, P31, DOI 10.1042/BJ20100985; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wilkinson KD, 2005, METHOD ENZYMOL, V399, P37, DOI 10.1016/S0076-6879(05)99003-4; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125	46	195	207	2	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					590	595		10.1126/science.1230161	http://dx.doi.org/10.1126/science.1230161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287719	Green Accepted			2022-12-28	WOS:000314270000062
J	Wang, Q				Wang, Qiang			China has the capacity to lead in carbon trading	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Western Res Ctr Energy Ecoenvironm Policy, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Western Res Ctr Energy Ecoenvironm Policy, Urumqi, Peoples R China.	wang_q@ms.xjb.ac.cn	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093				Guan DB, 2012, NAT CLIM CHANGE, V2, P672, DOI [10.1038/NCLIMATE1560, 10.1038/nclimate1560]	1	49	50	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					273	273		10.1038/493273a	http://dx.doi.org/10.1038/493273a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TA	23325173	Bronze			2022-12-28	WOS:000313615900004
J	Van Spall, HGC				Van Spall, Harriette G. C.			Review: Case management reduces mortality and HF readmissions in patients with HF	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HEART-FAILURE; OLDER PATIENTS; METAANALYSIS		McMaster Univ, Hamilton, ON, Canada	McMaster University	Van Spall, HGC (corresponding author), McMaster Univ, Hamilton, ON, Canada.			Van Spall, Harriette Gillian Christine/0000-0002-8370-4569				Gonseth J, 2004, EUR HEART J, V25, P1570, DOI 10.1016/j.ehj.2004.04.022; Gwadry-Sridhar FH, 2004, ARCH INTERN MED, V164, P2315, DOI 10.1001/archinte.164.21.2315; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC11	10.7326/0003-4819-158-2-201301150-02011	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318333				2022-12-28	WOS:000314029400010
J	Gupta, J; Kai, J; Middleton, L; Pattison, H; Gray, R; Daniels, J				Gupta, Janesh; Kai, Joe; Middleton, Lee; Pattison, Helen; Gray, Richard; Daniels, Jane		ECLIPSE Trial Collaborative Grp	Levonorgestrel Intrauterine System versus Medical Therapy for Menorrhagia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; THERMAL BALLOON ABLATION; ENDOMETRIAL ABLATION; MENSTRUAL PROBLEMS; COST-EFFECTIVENESS; HYSTERECTOMY; WOMEN; PATIENT; MIRENA; TRIAL	BACKGROUND Menorrhagia is a common problem, yet evidence to inform decisions about therapy is limited. In a pragmatic, multicenter, randomized trial, we compared the levonorgestrel-releasing intrauterine system (levonorgestrel-IUS) with usual medical treatment in women with menorrhagia who presented to their primary care providers. METHODS We randomly assigned 571 women with menorrhagia to treatment with levonorgestrel-IUS or usual medical treatment (tranexamic acid, mefenamic acid, combined estrogen-progestogen, or progesterone alone). The primary outcome was the patient-reported score on the Menorrhagia Multi-Attribute Scale (MMAS) (ranging from 0 to 100, with lower scores indicating greater severity), assessed over a 2-year period. Secondary outcomes included general quality-of-life and sexual-activity scores and surgical intervention. RESULTS MMAS scores improved from baseline to 6 months in both the levonorgestrel-IUS group and the usual-treatment group (mean increase, 32.7 and 21.4 points, respectively; P<0.001 for both comparisons). The improvements were maintained over a 2-year period but were significantly greater in the levonorgestrel-IUS group than in the usual-treatment group (mean between-group difference, 13.4 points; 95% confidence interval, 9.9 to 16.9; P<0.001). Improvements in all MMAS domains (practical difficulties, social life, family life, work and daily routine, psychological well-being, and physical health) were significantly greater in the levonorgestrel-IUS group than in the usual-treatment group, and this was also true for seven of the eight quality-of-life domains. At 2 years, more of the women were still using the levonorgestrel-IUS than were undergoing the usual medical treatment (64% vs. 38%, P<0.001). There were no significant between-group differences in the rates of surgical intervention or sexual-activity scores. There were no significant differences in serious adverse events between groups. CONCLUSIONS In women with menorrhagia who presented to primary care providers, the levonorgestrel-IUS was more effective than usual medical treatment in reducing the effect of heavy menstrual bleeding on quality of life. (Funded by the National Institute of Health Research Health Technology Assessment Programme; ECLIPSE Controlled-Trials.com number, ISRCTN86566246.)	[Daniels, Jane] Univ Birmingham, Clin Trials Unit, ECLIPSE Trial Off, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Middleton, Lee; Daniels, Jane] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Kai, Joe] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Kai, Joe] Univ Nottingham, Natl Inst Hlth Res, Sch Primary Care Res, Nottingham NG7 2RD, England; [Pattison, Helen] Aston Univ, Sch Hlth & Life Sci, Birmingham B4 7ET, W Midlands, England; [Gray, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford, England	University of Birmingham; University of Birmingham; University of Nottingham; University of Nottingham; Aston University; University of Oxford	Daniels, J (corresponding author), Univ Birmingham, Clin Trials Unit, ECLIPSE Trial Off, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England.	j.p.daniels@bham.ac.uk	Pattison, Helen/D-2702-2009	Pattison, Helen/0000-0002-9483-4342; Middleton, Lee/0000-0003-4621-1922; Hills, Robert/0000-0003-0166-0062; Gray, Richard/0000-0003-4440-574X; Kai, Joe/0000-0001-9040-9384; Takwoingi, Yemisi/0000-0002-5828-9746	NIHR Health Technology Assessment Programme; Ethicon Gynecare; MRC [MC_U137686861] Funding Source: UKRI; Medical Research Council [MC_U137686861] Funding Source: researchfish; National Institute for Health Research [02/06/02] Funding Source: researchfish	NIHR Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Ethicon Gynecare; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the NIHR Health Technology Assessment Programme.; Dr. Gupta reports receiving royalties from Hodder Arnold Publishing and lecture fees from Ethicon Gynecare, being an employee of Femcare-Nikomed, and receiving payment for expert testimony for clinical negligence cases in the United Kingdom National Health Service regarding vaginal hysterectomy and uterine rupture and for expert testimony on behalf of the Lincolnshire Police Force in a criminal case regarding the death of an unborn baby in utero. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1998, IN MAN MEN EV BAS GU; Busfield RA, 2006, BJOG-INT J OBSTET GY, V113, P257, DOI 10.1111/j.1471-0528.2006.00863.x; Cohen J., 1988, STAT POWER ANAL BEHA, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; COULTER A, 1991, BRIT J OBSTET GYNAEC, V98, P789, DOI 10.1111/j.1471-0528.1991.tb13484.x; Cromwell DA, 2009, BJOG-INT J OBSTET GY, V116, P1373, DOI 10.1111/j.1471-0528.2009.02284.x; Endrikat J, 2012, ARCH GYNECOL OBSTET, V285, P117, DOI 10.1007/s00404-011-1902-1; Ewies AAA, 2009, GYNECOL ENDOCRINOL, V25, P668, DOI 10.1080/09513590903159656; Frick KD, 2009, WOMEN HEALTH ISS, V19, P70, DOI 10.1016/j.whi.2008.07.002; Gibbons E, 2010, STRUCTURED REV PATIE; Habiba M, 2010, EUR J OBSTET GYN R B, V148, P81, DOI 10.1016/j.ejogrb.2009.09.021; Higham JM, 1999, EUR J OBSTET GYN R B, V82, P73, DOI 10.1016/S0301-2115(98)00224-3; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Hurskainen R, 2001, LANCET, V357, P273, DOI 10.1016/S0140-6736(00)03615-1; Kittelsen N, 1998, GYNAECOL ENDOSC, V7, P61, DOI 10.1046/j.1365-2508.1998.00165.x; Matteson KA, 2009, FERTIL STERIL, V92, P205, DOI 10.1016/j.fertnstert.2008.04.023; Middleton LJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3929; National Collaborating Centre for Women's and Children's Health, 2007, HEAV MENSTR BLEED; Nicholson WK, 2001, AM J OBSTET GYNECOL, V184, P523, DOI 10.1067/mob.2001.111795; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Office of Population Censuses and Surveys, 1995, MORB STAT GEN PRACT; Pattison H, 2011, BJOG-INT J OBSTET GY, V118, P1528, DOI 10.1111/j.1471-0528.2011.03057.x; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Protheroe J, 2007, MED DECIS MAKING, V27, P575, DOI 10.1177/0272989x07306785; Roberts TE, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2202; Rubin DB, 1987, MULTIPLE IMPUTATION; Santer Miriam, 2007, BMC Womens Health, V7, P8, DOI 10.1186/1472-6874-7-8; Shapley M, 2012, BJOG-INT J OBSTET GY, V119, P545, DOI 10.1111/j.1471-0528.2012.03282.x; Shaw RW, 2007, AUST NZ J OBSTET GYN, V47, P335, DOI 10.1111/j.1479-828X.2007.00747.x; Shaw RW, 1998, BRIT J OBSTET GYNAEC, V105, P1155, DOI 10.1111/j.1471-0528.1998.tb09968.x; Stewart A, 2001, BRIT J OBSTET GYNAEC, V108, P74, DOI 10.1016/S0306-5456(00)00020-6; Thirlaway K, 1996, QUAL LIFE RES, V5, P81, DOI 10.1007/BF00435972; Thirlaway K, 1997, QUAL LIFE RES, V6, P606; Warner P, 2001, BRIT MED J, V323, P24, DOI 10.1136/bmj.323.7303.24; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40; Whiteman MK, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.12.013	36	95	98	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					128	137		10.1056/NEJMoa1204724	http://dx.doi.org/10.1056/NEJMoa1204724			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301731	Green Accepted			2022-12-28	WOS:000313238100003
J	Parvanescu, H				Parvanescu, Horia			Large Right Inguinal Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Clin Emergency Hosp Craiova, Dolj, Romania		Parvanescu, H (corresponding author), Clin Emergency Hosp Craiova, Dolj, Romania.	horia_parvanescu@yahoo.com							0	1	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					171	171		10.1056/NEJMicm1208699	http://dx.doi.org/10.1056/NEJMicm1208699			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301734				2022-12-28	WOS:000313238100007
J	Buskirk, AR; Green, R				Buskirk, Allen R.; Green, Rachel			Getting Past Polyproline Pauses	SCIENCE			English	Editorial Material							ELONGATION-FACTOR-P; PEPTIDE-BOND; TRANSLATION ELONGATION; RIBOSOME; PROTEIN; RNA		[Buskirk, Allen R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Brigham Young University; Howard Hughes Medical Institute; Johns Hopkins University	Buskirk, AR (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.	ragreen@jhmi.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM059425] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; GLICK BR, 1975, P NATL ACAD SCI USA, V72, P4257, DOI 10.1073/pnas.72.11.4257; Hanawa-Suetsugu K, 2004, P NATL ACAD SCI USA, V101, P9595, DOI 10.1073/pnas.0308667101; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ito K, 2010, BIOCHEM BIOPH RES CO, V393, P1, DOI 10.1016/j.bbrc.2010.01.073; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142	16	11	11	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					38	39		10.1126/science.1233338	http://dx.doi.org/10.1126/science.1233338			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288527	Green Accepted			2022-12-28	WOS:000312985800040
J	Wakamoto, Y; Dhar, N; Chait, R; Schneider, K; Signorino-Gelo, F; Leibler, S; McKinney, JD				Wakamoto, Yuichi; Dhar, Neeraj; Chait, Remy; Schneider, Katrin; Signorino-Gelo, Francois; Leibler, Stanislas; McKinney, John D.			Dynamic Persistence of Antibiotic-Stressed Mycobacteria	SCIENCE			English	Article							BACTERIAL PERSISTENCE; PHENOTYPIC VARIABILITY; ESCHERICHIA-COLI; OXIDATIVE STRESS; MECHANISM; ENVIRONMENTS; TOLERANCE; GROWTH; NOISE; CELLS	Exposure of an isogenic bacterial population to a cidal antibiotic typically fails to eliminate a small fraction of refractory cells. Historically, fractional killing has been attributed to infrequently dividing or nondividing "persisters." Using microfluidic cultures and time-lapse microscopy, we found that Mycobacterium smegmatis persists by dividing in the presence of the drug isoniazid (INH). Although persistence in these studies was characterized by stable numbers of cells, this apparent stability was actually a dynamic state of balanced division and death. Single cells expressed catalase-peroxidase (KatG), which activates INH, in stochastic pulses that were negatively correlated with cell survival. These behaviors may reflect epigenetic effects, because KatG pulsing and death were correlated between sibling cells. Selection of lineages characterized by infrequent KatG pulsing could allow nonresponsive adaptation during prolonged drug exposure.	[Wakamoto, Yuichi; Dhar, Neeraj; Schneider, Katrin; Signorino-Gelo, Francois; McKinney, John D.] Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Chait, Remy; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	McKinney, JD (corresponding author), Swiss Fed Inst Technol, Sch Life Sci, CH-1015 Lausanne, Switzerland.	john.mckinney@epfl.ch	Dhar, Neeraj/K-8171-2013	Dhar, Neeraj/0000-0002-5887-8137; Chait, Remy/0000-0003-0876-3187	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation; NIH [HL088906]; Swiss National Science Foundation [310030_135639]; Grants-in-Aid for Scientific Research [24657014] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088906] Funding Source: NIH RePORTER	Charles H. Revson Foundation; New York Community Trust; Harvey L. Karp Discovery Fellowship; JST PRESTO Program; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by fellowships from the Charles H. Revson Foundation and the Heiser Program for Research in Leprosy and Tuberculosis of the New York Community Trust (N.D.); a Harvey L. Karp Discovery Fellowship and the JST PRESTO Program (Y.W.); and the Bill and Melinda Gates Foundation, NIH grant HL088906, and Swiss National Science Foundation grant 310030_135639 (J.D.M.).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Baek SH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001065; Balaban NQ, 2011, CURR OPIN GENET DEV, V21, P768, DOI 10.1016/j.gde.2011.10.001; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Bigger JW, 1944, LANCET, V2, P497; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Coates ARM, 2008, TRENDS PHARMACOL SCI, V29, P143, DOI 10.1016/j.tips.2007.12.001; Cogan NG, 2006, J THEOR BIOL, V238, P694, DOI 10.1016/j.jtbi.2005.06.017; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Gardner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000752; Grant SS, 2012, P NATL ACAD SCI USA, V109, P12147, DOI 10.1073/pnas.1203735109; Hobby GL, 1944, P SOC EXP BIOL MED, V56, P181, DOI 10.3181/00379727-56-14643; Hobby GL, 1942, P SOC EXP BIOL MED, V50, P281, DOI 10.3181/00379727-50-13773; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; KUBITSCHEK HE, 1964, MUTAT RES, V1, P113, DOI 10.1016/0027-5107(64)90013-2; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lipsitch M, 1997, ANTIMICROB AGENTS CH, V41, P363, DOI 10.1128/AAC.41.2.363; Locke JCW, 2011, SCIENCE, V334, P366, DOI 10.1126/science.1208144; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wu YX, 2012, ANTIMICROB AGENTS CH, V56, P4922, DOI 10.1128/AAC.00921-12	39	358	366	2	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					91	95		10.1126/science.1229858	http://dx.doi.org/10.1126/science.1229858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288538				2022-12-28	WOS:000312985800059
J	Fuchs, VR				Fuchs, Victor R.			How and Why US Health Care Differs From That in Other OECD Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stanford Univ, Stanford Inst Econ Policy Res, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford Inst Econ Policy Res, 366 Galvez, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Bundorf M. K., 2008, FORUM HLTH EC POLICY, V10, P1; de Crevecoeur H.S.J.., 1782, LETT AM FARMER; Fuchs VR, 2010, DEDICATED VAT SOLUTI; OECD iLibrary, OECD HLTH STAT; The Pew Research Center for The People & The Press, 2005 POL TYP SURV	5	25	25	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					33	34		10.1001/jama.2012.125458	http://dx.doi.org/10.1001/jama.2012.125458			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280219				2022-12-28	WOS:000319113000021
J	Susman, E				Susman, Ed			HEALTH INSURANCE State health exchanges: why Republicans have opted out	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												edwardsusman44@aol.com						National Conference of State Legislatures, 2012, STAT ACT ADDR HLTH I	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8616	10.1136/bmj.e8616	http://dx.doi.org/10.1136/bmj.e8616			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284158				2022-12-28	WOS:000313236300015
J	Tolwani, A				Tolwani, Ashita			Continuous Renal-Replacement Therapy for Acute Kidney Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; CONTINUOUS VENOVENOUS HEMODIAFILTRATION; ULTRASOUND GUIDANCE; CYTOKINE REMOVAL; SEPTIC PATIENTS; FAILURE; COMPLICATIONS; DIALYSIS; HEMODIALYSIS	Acute limb ischemia due to a perioperative type B (distal) thoracic aortic dissection develops in a 90-kg, 20-year-old man with Marfan's syndrome who is admitted to the hospital for elective aortic-valve replacement. On postoperative day 1, he undergoes endovascular repair of the thoracic aorta. On postoperative day 4, his urine output decreases to 420 ml over a 24-hour period. He requires mechanical ventilation with a fraction of inspired oxygen (FiO(2)) of 0.70; his mean arterial pressure is 74 mm Hg with vasopressor support. He has had a positive fluid balance of 9.8 liters since admission. The serum creatinine level has increased from a baseline of 0.6 mg per deciliter (53.0 mu mol per liter) to 4.4 mg per deciliter (389.0 mu mol per liter). The bicarbonate level is 19 mmol per liter despite bicarbonate infusion, and the potassium level is 6.1 mmol per liter. The creatine kinase level has increased to 129,040 U per liter. An intensive care specialist evaluates the patient and recommends initiation of continuous renal-replacement therapy.	Univ Alabama Birmingham, Div Nephrol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Tolwani, A (corresponding author), Univ Alabama Birmingham, Div Nephrol, 1720 2nd Ave S,Zeigler Res Bldg 604, Birmingham, AL 35294 USA.	atolwani@uab.edu						Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; BELLOMO R, 1993, INTENS CARE MED, V19, P329, DOI 10.1007/BF01694706; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bouchard J, 2009, KIDNEY INT, V76, P422, DOI 10.1038/ki.2009.159; Briglia A, 1999, CLIN CHEST MED, V20, P347, DOI 10.1016/S0272-5231(05)70146-5; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; Brochard L, 2010, AM J RESP CRIT CARE, V181, P1128, DOI 10.1164/rccm.200711-1664ST; Cerda J, 2009, SEMIN DIALYSIS, V22, P114, DOI 10.1111/j.1525-139X.2008.00549.x; Clark WR, 2003, ARTIF ORGANS, V27, P815, DOI 10.1046/j.1525-1594.2003.07288.x; Claure-Del Gramdo R, 2011, CLIN J AM SOC NEPHRO, V6, P467, DOI 10.2215/CJN.02500310; Claure-Del Granado R, 2011, CLIN J AM SOC NEPHRO, V6, P1802; Conger J, 1998, SEMIN NEPHROL, V18, P533; Coryell L, 2009, J VASC INTERV RADIOL, V20, P1578, DOI 10.1016/j.jvir.2009.08.014; DAVENPORT A, 1993, CRIT CARE MED, V21, P328, DOI 10.1097/00003246-199303000-00007; De Vriese AS, 1999, J AM SOC NEPHROL, V10, P846; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Emili S, 1999, AM J KIDNEY DIS, V33, P1107, DOI 10.1016/S0272-6386(99)70148-4; Erickson J David, 2002, MMWR Recomm Rep, V51, P1; Farese S, 2009, ARTIF ORGANS, V33, P634, DOI 10.1111/j.1525-1594.2009.00794.x; Finkel KW, 2009, SEMIN DIALYSIS, V22, P155, DOI 10.1111/j.1525-139X.2008.00550.x; Hassan C, 2008, AM SURGEON, V74, P1111; Heering P, 1997, INTENS CARE MED, V23, P288, DOI 10.1007/s001340050330; Hoffmann JN, 1996, INTENS CARE MED, V22, P1360, DOI 10.1007/BF01709552; Karakitsos D, 2006, CRIT CARE, V10, DOI 10.1186/cc5101; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; KAUFMAN J, 1991, AM J KIDNEY DIS, V17, P191, DOI 10.1016/S0272-6386(12)81128-0; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Klouche K, 2007, AM J KIDNEY DIS, V49, P99, DOI 10.1053/j.ajkd.2006.09.014; Lameire N, 2010, NAT CLIN PRACT NEPHR, V6, P446; Lameire N, 2006, NAT CLIN PRACT NEPHR, V2, P364, DOI 10.1038/ncpneph0218; Lins RL, 2009, NEPHROL DIAL TRANSPL, V24, P512, DOI 10.1093/ndt/gfn560; Lyndon WD, 2012, NEPHROL DIAL TRANSPL, V27, P952, DOI 10.1093/ndt/gfr480; Manns B, 2003, CRIT CARE MED, V31, P449, DOI 10.1097/01.CCM.0000045182.90302.B3; MANSFIELD PF, 1994, NEW ENGL J MED, V331, P1735, DOI 10.1056/NEJM199412293312602; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Metcalfe W, 2002, QJM-INT J MED, V95, P579, DOI 10.1093/qjmed/95.9.579; Morgera S, 2004, AM J KIDNEY DIS, V43, P444, DOI 10.1053/j.ajkd.2003.11.006; Morgera S, 2011, CRIT CARE MED, V39, P399, DOI 10.1097/CCM.0b013e318205c500; Oliver MJ, 2001, SEMIN DIALYSIS, V14, P432, DOI 10.1046/j.1525-139x.2001.00107.x; Oudemans-van Straaten HM, 2011, CRIT CARE, V15, DOI 10.1186/cc9358; Paganini EP, 1996, NEPHROL DIAL TRANSPL, V11, P32; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Palevsky PM, 2009, CRIT CARE, V13, DOI 10.1186/cc7901; Rabindranath K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003773.pub3; Randolph AG, 1996, CRIT CARE MED, V24, P2053, DOI 10.1097/00003246-199612000-00020; Rauf Anis Abdul, 2008, J Intensive Care Med, V23, P195, DOI 10.1177/0885066608315743; Ronco C, 1996, INT J ARTIF ORGANS, V19, P95, DOI 10.1177/039139889601900207; Ronco C, 2008, INTENS CARE MED, V34, P2139, DOI 10.1007/s00134-008-1258-6; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Seabra VF, 2008, AM J KIDNEY DIS, V52, P272, DOI 10.1053/j.ajkd.2008.02.371; Selby NM, 2006, NEPHROL DIAL TRANSPL, V21, P1883, DOI 10.1093/ndt/gfl126; Sharfuddin AA, 2011, NAT REV NEPHROL, V7, P189, DOI 10.1038/nrneph.2011.16; Shingarev R, 2011, SEMIN DIALYSIS, V24, P164, DOI 10.1111/j.1525-139X.2011.00828.x; SZNAJDER JI, 1986, ARCH INTERN MED, V146, P259, DOI 10.1001/archinte.146.2.259; Tan HK, 2000, INTENS CARE MED, V26, P1652, DOI 10.1007/s001340000691; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; The VA/NIH Acute Renal Failure Trial Network, 2009, NEW ENGL J MED, V361, P2391; Tolwani AJ, 2006, CLIN J AM SOC NEPHRO, V1, P79, DOI 10.2215/CJN.00040505; Tolwani AJ, 2009, SEMIN DIALYSIS, V22, P141, DOI 10.1111/j.1525-139X.2008.00545.x; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2007, INTENS CARE MED, V33, P1563, DOI 10.1007/s00134-007-0754-4; Uchino S, 2009, CRIT CARE MED, V37, P2576, DOI 10.1097/CCM.0b013e3181a38241; van Deuren M, 2000, INTENS CARE MED, V26, P1176, DOI 10.1007/s001340000583; Venkataraman R, 2002, J CRIT CARE, V17, P246, DOI 10.1053/jcrc.2002.36757; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3; Wu VC, 2008, INTENS CARE MED, V34, P101, DOI 10.1007/s00134-007-0813-x	67	112	123	1	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2505	2514		10.1056/NEJMct1206045	http://dx.doi.org/10.1056/NEJMct1206045			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268665				2022-12-28	WOS:000312714200008
J	Goode, J				Goode, Jamie			VITICULTURE Fruity with a hint of drought	NATURE			English	Editorial Material												jamie@wineanorak.com							0	8	8	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					351	353		10.1038/492351a	http://dx.doi.org/10.1038/492351a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257865	Bronze			2022-12-28	WOS:000312488200063
J	Cork, R				Cork, Richard			CHRISTMAS 2012: YESTERDAY'S WORLD Barbara Hepworth's hospital drawings	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ART					richardcork@hotmail.com						Curran J, 2008, BRIT MED J, V337, pa1121; Hepburn N, 2012, BARBARA HEPWORTH HOS; Lenihan Michael, 2012, PURE CORK; LOMAS D, 1989, BMJ-BRIT MED J, V299, P1584, DOI 10.1136/bmj.299.6715.1584; Park MP, 2004, BMJ-BRIT MED J, V329, P1475, DOI 10.1136/bmj.329.7480.1475	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 19	2012	345								e8529	10.1136/bmj.e8529	http://dx.doi.org/10.1136/bmj.e8529			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23253488				2022-12-28	WOS:000312700100012
J	Wegner, M				Wegner, Michael			Mighty Bugs: Leprosy Bacteria Turn Schwann Cells into Stem Cells	CELL			English	Editorial Material							MYCOBACTERIUM-LEPRAE; MYELINATION	For intracellular parasites that strongly prefer infecting a particular cell type, systemic spread is challenging. Masaki et al. show that the leprosy bacterium cleverly expands its repertoire by driving dedifferentiation of Schwann cells, their preferred host, to cells with stem cell properties that can subsequently redifferentiate into mesodermal lineages.	Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Wegner, M (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany.	m.wegner@biochem.uni-erlangen.de		Wegner, Michael/0000-0002-4586-3294				Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Jacob C, 2011, NAT NEUROSCI, V14, P429, DOI 10.1038/nn.2762; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Masaki T, 2013, CELL, V152, P51, DOI 10.1016/j.cell.2012.12.014; Pinheiro RO, 2011, FUTURE MICROBIOL, V6, P217, DOI 10.2217/FMB.10.173; Rambukkana A, 2010, PROG NEUROBIOL, V91, P102, DOI 10.1016/j.pneurobio.2009.12.002; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; STONER GL, 1979, LANCET, V2, P994; Weider M, 2012, DEV CELL, V23, P193, DOI 10.1016/j.devcel.2012.05.017; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105	10	4	4	1	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					15	16		10.1016/j.cell.2013.01.001	http://dx.doi.org/10.1016/j.cell.2013.01.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332743	Bronze			2022-12-28	WOS:000313719800002
J	Cowley, NJ; Owen, A; Bion, JF				Cowley, Nicholas J.; Owen, Andrew; Bion, Julian F.			Interpreting arterial blood gas results	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEVERE SEPSIS; SEPTIC SHOCK		[Cowley, Nicholas J.; Owen, Andrew] Queen Elizabeth Hosp, Dept Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England; [Bion, Julian F.] Queen Elizabeth Hosp, Univ Dept Anaesthesia & Intens Care Med, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Cowley, NJ (corresponding author), Queen Elizabeth Hosp, Dept Anaesthesia & Crit Care, Birmingham B15 2WB, W Midlands, England.	n.j.cowley@bham.ac.uk	Owen, Andrew/B-6302-2014	Owen, Andrew/0000-0002-3192-747X; Bion, Julian/0000-0003-0344-5403	National Institute for Health Research [ACF-2011-09-004] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Carraro P, 2007, CLIN CHEM, V53, P1338, DOI 10.1373/clinchem.2007.088344; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Gehring H, 2002, ACTA ANAESTH SCAND, V46, P980, DOI 10.1034/j.1399-6576.2002.460809.x; Kraut JA, 2007, CLIN J AM SOC NEPHRO, V2, P162, DOI 10.2215/CJN.03020906; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rhee AJ, 2010, CURR OPIN ANESTHESIO, V23, P741, DOI 10.1097/ACO.0b013e32834015bd; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Salvagno GL, 2012, CLIN BIOCHEM, V45, P372, DOI 10.1016/j.clinbiochem.2011.12.005; Schlebusch H, 2001, CLIN CHIM ACTA, V307, P107, DOI 10.1016/S0009-8981(01)00440-5; Shamir MY, 2012, ANESTH ANALG, V114, P972, DOI 10.1213/ANE.0b013e318233041a	10	15	16	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f16	10.1136/bmj.f16	http://dx.doi.org/10.1136/bmj.f16			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FI	23325867				2022-12-28	WOS:000313868800003
J	Morenga, LT; Mallard, S; Mann, J				Morenga, Lisa Te; Mallard, Simonette; Mann, Jim			Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SWEETENED BEVERAGE CONSUMPTION; SOFT DRINK CONSUMPTION; II DIABETIC SUBJECTS; WAIST CIRCUMFERENCE; SERUM-LIPIDS; FOOD-INTAKE; METABOLIC SYNDROME; BLOOD-LIPIDS; LIFE-STYLE; MASS INDEX	Objective To summarise evidence on the association between intake of dietary sugars and body weight in adults and children. Design Systematic review and meta-analysis of randomised controlled trials and prospective cohort studies. Data sources OVID Medline, Embase, PubMed, Cumulative Index to Nursing and Allied Health Literature, Scopus, and Web of Science (up to December 2011). Review methods Eligible studies reported the intake of total sugars, intake of a component of total sugars, or intake of sugar containing foods or beverages; and at least one measure of body fatness. Minimum duration was two weeks for trials and one year for cohort studies. Trials of weight loss or confounded by additional medical or lifestyle interventions were excluded. Study selection, assessment, validity, data extraction, and analysis were undertaken as specified by the Cochrane Collaboration and the GRADE working group. For trials, we pooled data for weight change using inverse variance models with random effects. We pooled cohort study data where possible to estimate effect sizes, expressed as odds ratios for risk of obesity or beta coefficients for change in adiposity per unit of intake. Results 30 of 7895 trials and 38 of 9445 cohort studies were eligible. In trials of adults with ad libitum diets (that is, with no strict control of food intake), reduced intake of dietary sugars was associated with a decrease in body weight (0.80 kg, 95% confidence interval 0.39 to 1.21; P<0.001); increased sugars intake was associated with a comparable weight increase (0.75 kg, 0.30 to 1.19; P=0.001). Isoenergetic exchange of dietary sugars with other carbohydrates showed no change in body weight (0.04 kg, -0.04 to 0.13). Trials in children, which involved recommendations to reduce intake of sugar sweetened foods and beverages, had low participant compliance to dietary advice; these trials showed no overall change in body weight. However, in relation to intakes of sugar sweetened beverages after one year follow-up in prospective studies, the odds ratio for being overweight or obese increased was 1.55 (1.32 to 1.82) among groups with the highest intake compared with those with the lowest intake. Despite significant heterogeneity in one meta-analysis and potential bias in some trials, sensitivity analyses showed that the trends were consistent and associations remained after these studies were excluded. Conclusions Among free living people involving ad libitum diets, intake of free sugars or sugar sweetened beverages is a determinant of body weight. The change in body fatness that occurs with modifying intakes seems to be mediated via changes in energy intakes, since isoenergetic exchange of sugars with other carbohydrates was not associated with weight change.	[Morenga, Lisa Te; Mallard, Simonette; Mann, Jim] Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand; [Morenga, Lisa Te; Mallard, Simonette; Mann, Jim] Univ Otago, Dept Med, Dunedin 9054, New Zealand; [Morenga, Lisa Te; Mann, Jim] Univ Otago, Riddet Inst, Dunedin 9054, New Zealand; [Mann, Jim] Univ Otago, Edgar Natl Ctr Diabet & Obes Res, Dunedin 9054, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, POB 56, Dunedin 9054, New Zealand.	jim.mann@otago.ac.nz	Te Morenga, Lisa/C-4459-2011; Mallard, Simonette R/AAT-3266-2021	Te Morenga, Lisa/0000-0003-3526-0091; 	University of Otago; Riddet Institute, a New Zealand National Centre of Research Excellence; Riddet Institute; WHO	University of Otago; Riddet Institute, a New Zealand National Centre of Research Excellence; Riddet Institute; WHO(World Health Organization)	The authors were supported by the University of Otago and the Riddet Institute, a New Zealand National Centre of Research Excellence. The research was supported by the University of Otago, Riddet Institute, and WHO. The authors undertook the submitted work for WHO for the purposes of updating WHO guidelines on sugars intake, and WHO provided some funding to the University of Otago towards the cost of carrying out the review.	Aeberli I, 2011, AM J CLIN NUTR, V94, P479, DOI 10.3945/ajcn.111.013540; [Anonymous], 1998, FAO Food Nutr Pap, V66, P1; [Anonymous], 2011, REV MAN REVMAN VERS; BANTLE JP, 1992, DIABETES CARE, V15, P1468, DOI 10.2337/diacare.15.11.1468; BANTLE JP, 1993, DIABETES CARE, V16, P1301, DOI 10.2337/diacare.16.9.1301; Berkey CS, 2004, OBES RES, V12, P778, DOI 10.1038/oby.2004.94; Bes-Rastrollo M, 2010, CLIN NUTR, V29, P323, DOI 10.1016/j.clnu.2009.08.017; Blum JW, 2005, J AM COLL NUTR, V24, P93, DOI 10.1080/07315724.2005.10719449; BRISTOL JB, 1985, BMJ-BRIT MED J, V291, P1467, DOI 10.1136/bmj.291.6507.1467; Brynes AE, 2003, BRIT J NUTR, V89, P207, DOI 10.1079/BJN2002769; Burt B A, 2001, J Dent Educ, V65, P1017; Butte NF, 2007, AM J CLIN NUTR, V85, P1478, DOI 10.1093/ajcn/85.6.1478; Buyken AE, 2008, AM J CLIN NUTR, V88, P755, DOI 10.1093/ajcn/88.3.755; COLDITZ GA, 1990, AM J CLIN NUTR, V51, P1100, DOI 10.1093/ajcn/51.6.1100; Davis JN, 2009, OBESITY, V17, P1542, DOI 10.1038/oby.2009.19; de Ruyter JC, 2012, NEW ENGL J MED, V367, P1397, DOI 10.1056/NEJMoa1203034; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; Dolan LC, 2010, CRIT REV FOOD SCI, V50, P53, DOI 10.1080/10408390903461426; Drapeau V, 2004, AM J CLIN NUTR, V80, P29; Drewnowski A, 2007, AM J CLIN NUTR, V85, P651, DOI 10.1093/ajcn/85.3.651; Dubois L, 2007, J AM DIET ASSOC, V107, P34; Dubois L, 2007, J AM DIET ASSOC, V107, P924, DOI 10.1016/j.jada.2007.03.004; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ebbeling CB, 2012, NEW ENGL J MED, V367, P1407, DOI 10.1056/NEJMoa1203388; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Faith MS, 2006, PEDIATRICS, V118, P2066, DOI 10.1542/peds.2006-1117; Fiorito LM, 2009, AM J CLIN NUTR, V90, P935, DOI 10.3945/ajcn.2009.27623; Forshee RA, 2008, AM J CLIN NUTR, V87, P1662, DOI 10.1093/ajcn/87.6.1662; FRENCH SA, 1994, INT J OBESITY, V18, P145; Gatenby SJ, 1997, AM J CLIN NUTR, V65, P1867, DOI 10.1093/ajcn/65.6.1867; Gibson S, 2008, NUTR RES REV, V21, P134, DOI 10.1017/S0954422408110976; GRIGORESCO C, 1988, DIABETES CARE, V11, P546, DOI 10.2337/diacare.11.7.546; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haerens L, 2010, PUBLIC HEALTH NUTR, V13, P1722, DOI 10.1017/S1368980010002284; Halkjaer J, 2004, BRIT J NUTR, V92, P735, DOI 10.1079/BJN20041246; Halkjaer J, 2006, AM J CLIN NUTR, V84, P789, DOI 10.1093/ajcn/84.4.789; Halkjer J, 2009, J AM DIET ASSOC, V109, P1356, DOI 10.1016/j.jada.2009.05.015; Hendriksen MAH, 2011, AM J CLIN NUTR, V94, P19, DOI 10.3945/ajcn.111.014795; Herbst A, 2011, J NUTR, V141, P1348, DOI 10.3945/jn.110.137000; Higgins JPT, COCHRANE HDB SYSTEMA, P4; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Johnson L, 2007, NUTRITION, V23, P557, DOI 10.1016/j.nut.2007.05.005; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Johnson RJ, 2007, AM J CLIN NUTR, V86, P899; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Kenneth F, 2000, CAMBRIDGE WORLD HIST; KOIVISTO VA, 1993, J INTERN MED, V233, P145, DOI 10.1111/j.1365-2796.1993.tb00667.x; Kvaavik E, 2005, PUBLIC HEALTH NUTR, V8, P149, DOI 10.1079/PHN2004669; Libuda L, 2008, BRIT J NUTR, V99, P1370, DOI 10.1017/S0007114507862362; Lim S, 2009, OBESITY, V17, P1262, DOI 10.1038/oby.2008.656; Livesey G, 2008, AM J CLIN NUTR, V88, P1419, DOI 10.3945/ajcn.2007.25700; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Maersk M, 2012, AM J CLIN NUTR, V95, P283, DOI 10.3945/ajcn.111.022533; Malerbi DA, 1996, DIABETES CARE, V19, P1249, DOI 10.2337/diacare.19.11.1249; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mann J, 2007, EUR J CLIN NUTR, V61, pS132, DOI 10.1038/sj.ejcn.1602943; MANN JI, 1970, LANCET, V1, P870; MANN JI, 1973, LANCET, V2, P153; MANN JI, 1972, S AFR MED J, V46, P827; MANN JI, 1972, BRIT J NUTR, V27, P395, DOI 10.1079/BJN19720105; Marckmann P, 2000, METABOLISM, V49, P731, DOI 10.1053/meta.2000.6237; Mattes RD, 2011, OBES REV, V12, P346, DOI 10.1111/j.1467-789X.2010.00755.x; MILICH R, 1986, CLIN PSYCHOL REV, V6, P493, DOI 10.1016/0272-7358(86)90034-6; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nissinen K, 2009, PUBLIC HEALTH NUTR, V12, P2018, DOI 10.1017/S1368980009005849; Nooyens ACJ, 2005, PUBLIC HEALTH NUTR, V8, P1266, DOI 10.1079/PHN2005756; Odegaard AO, 2010, AM J EPIDEMIOL, V171, P701, DOI 10.1093/aje/kwp452; OSEI K, 1989, DIABETIC MED, V6, P506, DOI 10.1111/j.1464-5491.1989.tb01218.x; Paineau DL, 2008, ARCH PEDIAT ADOL MED, V162, P34, DOI 10.1001/archpediatrics.2007.2; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Parker DR, 1997, INT J OBESITY, V21, P103, DOI 10.1038/sj.ijo.0800373; PETERSON DB, 1986, DIABETOLOGIA, V29, P216, DOI 10.1007/BF00454878; Phillips SM, 2004, OBES RES, V12, P461, DOI 10.1038/oby.2004.52; Poppitt SD, 2002, AM J CLIN NUTR, V75, P11, DOI 10.1093/ajcn/75.1.11; Raben A, 1997, INT J OBESITY, V21, P846, DOI 10.1038/sj.ijo.0800494; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Reid M, 2007, BRIT J NUTR, V97, P193, DOI 10.1017/S0007114507252705; Reid M, 2010, APPETITE, V55, P130, DOI 10.1016/j.appet.2010.05.001; Ruxton CHS, 2010, CRIT REV FOOD SCI, V50, P1, DOI 10.1080/10408390802248569; SANTACROCE G, 1990, ACTA DIABETOL LAT, V27, P365, DOI 10.1007/BF02580942; Saris WHM, 2000, INT J OBESITY, V24, P1310, DOI 10.1038/sj.ijo.0801451; Schulz M, 2002, J NUTR, V132, P1335, DOI 10.1093/jn/132.6.1335; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; Sievenpiper JL, 2012, ANN INTERN MED, V156, P291, DOI 10.7326/0003-4819-156-4-201202210-00007; Silbernagel G, 2011, BRIT J NUTR, V106, P79, DOI 10.1017/S000711451000574X; Skinner JD, 2001, J AM DIET ASSOC, V101, P432, DOI 10.1016/S0002-8223(01)00111-0; Smith JB, 1996, EUR J CLIN NUTR, V50, P498; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stoof SP, 2011, PUBLIC HEALTH NUTR, P1; Striegel-Moore RH, 2006, J PEDIATR-US, V148, P183, DOI 10.1016/j.jpeds.2005.11.025; SWANSON JE, 1992, AM J CLIN NUTR, V55, P851, DOI 10.1093/ajcn/55.4.851; SZANTO S, 1969, POSTGRAD MED J, V45, P602, DOI 10.1136/pgmj.45.527.602; Tate DF, 2012, AM J CLIN NUTR, V95, P555, DOI 10.3945/ajcn.111.026278; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; U.S. Department of Agriculture Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; van Baak MA, 2009, OBES REV, V10, P9, DOI 10.1111/j.1467-789X.2008.00561.x; Vanselow MS, 2009, AM J CLIN NUTR, V90, P1489, DOI 10.3945/ajcn.2009.27573; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183; Weijs PJM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-95; Welsh JA, 2005, PEDIATRICS, V115, pE223, DOI 10.1542/peds.2004-1148; WERNER D, 1984, GUT, V25, P269, DOI 10.1136/gut.25.3.269; WHO, 2012, 1 M WHO NUTR GUID EX; WHO, 2010, WHO HDB GUID DEV; WHO, 2003, WHO TECHN REP SER, V916, P54; Williams Christine L, 2008, Prev Cardiol, V11, P11, DOI 10.1111/j.1520-037X.2007.06677.x; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	111	735	747	3	36	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								e7492	10.1136/bmj.e7492	http://dx.doi.org/10.1136/bmj.e7492			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075ER	23321486	hybrid, Green Submitted			2022-12-28	WOS:000313867100001
J	Chan, AW; Tetzlaff, JM; Gotzsche, PC; Altman, DG; Mann, H; Berlin, JA; Dickersin, K; Hrobjartsson, A; Schulz, KF; Parulekar, WR; Krleza-Jeric, K; Laupacis, A; Moher, D				Chan, An-Wen; Tetzlaff, Jennifer M.; Gotzsche, Peter C.; Altman, Douglas G.; Mann, Howard; Berlin, Jesse A.; Dickersin, Kay; Hrobjartsson, Asbjorn; Schulz, Kenneth F.; Parulekar, Wendy R.; Krleza-Jeric, Karmela; Laupacis, Andreas; Moher, David			SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; DOUBLE DATA-ENTRY; CONFLICTS-OF-INTEREST; RESEARCH ETHICS COMMITTEE; SAMPLE-SIZE CALCULATIONS; OUTCOME REPORTING BIAS; INFORMED-CONSENT; PUBLICATION BIAS; DRUG TRIALS; EMPIRICAL-EVIDENCE	High quality protocols facilitate proper conduct, reporting, and external review of clinical trials. However, the completeness of trial protocols is often inadequate. To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for International Trials). The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol. This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations. For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance. We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement. A website of resources is also available (www.spirit-statement.org). The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols. Complete documentation of key trial elements can facilitate transparency and protocol review of the benefit of all stakeholders.	[Chan, An-Wen] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON, Canada; [Tetzlaff, Jennifer M.; Moher, David] Ottawa Hosp, Ottawa Methods Ctr, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Gotzsche, Peter C.; Hrobjartsson, Asbjorn] Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen, Denmark; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Mann, Howard] Univ Utah, Sch Med, Div Med Eth & Humanities, Salt Lake City, UT USA; [Berlin, Jesse A.] Janssen Res & Dev, Titusville, FL USA; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Schulz, Kenneth F.] Quantitat Sci, FHI 360, Res Triangle Pk, NC USA; [Parulekar, Wendy R.] Queens Univ, NCIC Clin Trials Grp, Canc Res Inst, Kingston, ON, Canada; [Krleza-Jeric, Karmela; Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Laupacis, Andreas] Univ Toronto, Keenan Res Ctrsp, Li Ka Shing Knowledge Inst Med, St Michaels Hosp,Fac Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Ottawa; Ottawa Hospital Research Institute; Rigshospitalet; University of Copenhagen; University of Oxford; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; FHI 360; Queens University - Canada; Canadian Cancer Trials Group; University of Ottawa; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Chan, AW (corresponding author), Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Dept Med, Toronto, ON, Canada.	anwen.chan@utoronto.ca	Moher, David/I-3408-2019; Krleza-Jeric, Karmela/M-5253-2018	Moher, David/0000-0003-2434-4206; Krleza-Jeric, Karmela/0000-0001-9377-0917	Canadian Institutes of Health Research (CIHR) [DET-106068, MET-117434]; Canadian Cancer Society Research Institute; Canadian Agency for Drugs and Technologies in Health	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Agency for Drugs and Technologies in Health	The SPIRIT meetings were funded by the Canadian Institutes of Health Research (CIHR grant DET-106068); National Cancer Institute of Canada (now Canadian Cancer Society Research Institute); and Canadian Agency for Drugs and Technologies in Health. CIHR has also funded ongoing dissemination activities (grant MET-117434). KKJ was formerly employed by CIHR (Knowledge Translation Branch), and WRP is affiliated with the NCIC Clinical Trials Group. The funders had no input into the design and conduct of the project; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Abbott JH, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-11; Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Abraham NS, 2006, SURGERY, V139, P469, DOI 10.1016/j.surg.2005.08.014; Ahmer S, 2005, PSYCHIATR BULL, V29, P302, DOI 10.1192/pb.29.8.302; Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; Altman DG, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-6; Altman DG, 1999, BRIT MED J, V319, P703, DOI 10.1136/bmj.319.7211.703; Altman DG, 1991, PRACTICAL STAT MED R; [Anonymous], 2008, PLOS ONE, V5, pe90; [Anonymous], 1999, EVALUATION STUDY CON; [Anonymous], 2012, TRIALS; [Anonymous], 2011, SHARING MAT METHODS; [Anonymous], 1999, BETA BLOCKER EVALUAT; [Anonymous], 2010, RANDOMIZED DOUBLE BL; [Anonymous], 2010, PHASE 3 ACTIVE WARFA; [Anonymous], 2009, PHARM MED; [Anonymous], 2011, EFFECT TRANEXAMIC AC; [Anonymous], 2006, RES OUTC CONS PREH R; [Anonymous], 2005, CLIN TRIAL PROT VERS; [Anonymous], 2007, PHASE 3 MULTICENTRE; Armitage P, 1982, Stat Med, V1, P345, DOI 10.1002/sim.4780010412; Aronson JK, 2005, DRUG SAFETY, V28, P851, DOI 10.2165/00002018-200528100-00003; Asthma Chnical Research Network, 1999, BET ADR RESP GEN BAR; Azuara-Blanco A, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-133; Bailey CS, 2004, SPINE, V29, P1146, DOI 10.1097/00007632-200405150-00018; Bakker OJ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-73; BALLINTINE EJ, 1975, AM J OPHTHALMOL, V79, P763, DOI 10.1016/0002-9394(75)90734-5; Bartlett C, 2005, HEALTH TECHNOL ASSES, V9, P1; Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; BEDARD M, 1995, J AM GERIATR SOC, V43, P1127, DOI 10.1111/j.1532-5415.1995.tb07013.x; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Belsky L, 2004, BRIT MED J, V328, P1494, DOI 10.1136/bmj.328.7454.1494; Beni S, 2006, ANN INTERN MED, V144, P257; Berger VW, 2006, J CRIT CARE, V21, P229, DOI 10.1016/j.jcrc.2006.01.002; Berger VW, 2012, CONTEMP CLIN TRIALS, V33, P460, DOI 10.1016/j.cct.2012.02.008; Berger VW, 2010, CONTEMP CLIN TRIALS, V31, P406, DOI 10.1016/j.cct.2010.05.001; Bernhard Nocht Institute for Tropical Medicine, PROB SACCH BOUL PREV; BERRY DA, 1985, STAT MED, V4, P521, DOI 10.1002/sim.4780040412; Beskow LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013302; Bhandari M, 2002, ARCH ORTHOP TRAUM SU, V122, P96, DOI 10.1007/s004020100347; Bhandari M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-85; Blanco C, 2008, J CLIN PSYCHIAT, V69, P1276, DOI 10.4088/JCP.v69n0810; Blumle A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1828; BMJ Publishing Group Ltd, 2012, INSTR AUTH; Bond J, 2006, BMC EAR NOSE THROAT, V6, DOI 10.1186/1472-6815-6-13; Boonacker CWB, 2011, AM J EPIDEMIOL, V174, P219, DOI 10.1093/aje/kwr075; Booth R, 2010, NIDACTN0017 STUDY; Bourgeois FT, 2010, ANN INTERN MED, V153, P158, DOI 10.7326/0003-4819-153-3-201008030-00006; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2006, PLOS MED, V3, P1931, DOI 10.1371/journal.pmed.0030425; Breast Cancer International Research Group, BCIRG 006 MULT PHASE; Breau RH, 2006, J UROLOGY, V176, P263, DOI 10.1016/S0022-5347(06)00505-2; Buchbinder S, 2007, PHASE 2 EXTENDED SAF; Caldwell PHY, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000368; Califf RM, 2012, JAMA-J AM MED ASSOC, V307, P1838, DOI 10.1001/jama.2012.3424; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Campbell NL, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-139; Canadian Institutes of Health Rasearch, 2010, RCI EV CRIT HEAD; Cech T. R., 2003, PLANT PHYSIOL, V132, P1; Centre For Reviews and Dissemination, 2006, 31 CRD U YORK; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; CHALMERS TC, 1987, STAT MED, V6, P315, DOI 10.1002/sim.4780060320; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; CHARLSON ME, 1984, BRIT MED J, V289, P1281, DOI 10.1136/bmj.289.6454.1281; Chilcott Warner, COMP ONCE DAY DOSE C; Clarke M, 2004, PLOS MED, V1, P100, DOI 10.1371/journal.pmed.0010035; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Clarke M, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-39; Cockayne NL, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-10; Cohen SB, 2004, RHEUMATOLOGY, V43, P704, DOI 10.1093/rheumatology/keh152; Cohn E, 2007, J NURS SCHOLARSHIP, V39, P273, DOI 10.1111/j.1547-5069.2007.00180.x; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Copay AG, 2007, SPINE J, V7, P541, DOI 10.1016/j.spinee.2007.01.008; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Couper MP, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.2.e16; COWLEY AJ, 1993, INT J CARDIOL, V40, P161, DOI 10.1016/0167-5273(93)90279-P; CRASH 2 Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage, 2005, CRASH2 CLIN RAND ANT; Crossman DC, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-8; Crowe BJ, 2009, CLIN TRIALS, V6, P430, DOI 10.1177/1740774509344101; Curfman GD, 2006, NEW ENGL J MED, V354, P1193, DOI 10.1056/NEJMe068054; Dal-Re R, 1998, MED CLIN-BARCELONA, V110, P521; Dale O, 2007, J CLIN EPIDEMIOL, V60, P8, DOI 10.1016/j.jclinepi.2006.04.005; Dalessandro M, 2005, PROTOCOL SB 275833 0; Dalum HS, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-195; Dawson L, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000111; Day S, 1998, CONTROL CLIN TRIALS, V19, P15, DOI 10.1016/S0197-2456(97)00096-2; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier Evelyne, 2005, BMC Med Ethics, V6, pE9; Delgado-Rodriguez M, 2001, J EPIDEMIOL COMMUN H, V55, P569, DOI 10.1136/jech.55.8.569; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Devereaux PJ, 2001, JAMA-J AM MED ASSOC, V285, P2000, DOI 10.1001/jama.285.15.2000; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P796, DOI 10.1001/archsurg.136.7.796; Djulbegovic Benjamin, 2003, Account Res, V10, P301; Doshi P, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001201; Doshi P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7898; Dragalin V, 2006, DRUG INF J, V40, P425, DOI 10.1177/216847900604000408; Drazen Jeffrey M, 2010, BMJ, V340, pc3239, DOI 10.1136/bmj.c3239; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Dumville JC, 2006, CONTEMP CLIN TRIALS, V27, P1, DOI 10.1016/j.cct.2005.08.003; Dwan K, 2011, COCHRANE DATABASE SY, V1; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Eldridge Sandra M, 2004, Clin Trials, V1, P80, DOI 10.1191/1740774504cn006rr; Elkins JS, 2006, STROKE, V37, P123, DOI 10.1161/01.STR.0000195149.44390.aa; Ellenberg SS, 2001, STAT MED, V20, P2573, DOI 10.1002/sim.730; Ellenberg SS., 2002, DATA MONITORING COMM; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Emerson GB, 2010, ARCH INTERN MED, V170, P1934, DOI 10.1001/archinternmed.2010.406; Enwere G, 2005, TROP MED INT HEALTH, V10, P1171, DOI 10.1111/j.1365-3156.2005.01505.x; Etter JF, 2007, ADDICTION, V102, P815, DOI 10.1111/j.1360-0443.2007.01822.x; European Commission, 2010, OFF J EUROPEAN UNION, P53; European Commission, 2008, OFFICIAL J EUROPEAN, V51, P3; European Medicines Agency, 2010, EUR MED AG POL ACC D; European Vasculitis Study Group (EUVAS), 2005, RITUXVAS CLIN TRIAL; Fabricatore AN, 2009, OBES REV, V10, P333, DOI 10.1111/j.1467-789X.2009.00567.x; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Fergusson D, 2004, BRIT MED J, V328, P432, DOI 10.1136/bmj.37952.631667.EE; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Ferreira-Gonzalez I, 2007, BRIT MED J, V334, P786, DOI 10.1136/bmj.39136.682083.AE; Fielding S, 2012, CONTEMP CLIN TRIALS, V33, P461, DOI 10.1016/j.cct.2011.12.002; Flanagin A, 2002, JAMA-J AM MED ASSOC, V288, P3166, DOI 10.1001/jama.288.24.3166; Fleming TR, 2011, CLIN TRIALS, V8, P432, DOI 10.1177/1740774511410994; Fleming TR, 2011, ANN INTERN MED, V154, P113, DOI 10.7326/0003-4819-154-2-201101180-00010; Fleming TR, 2010, ANN INTERN MED, V153, P400, DOI 10.7326/0003-4819-153-6-201009210-00008; Floriani I, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-46; Flory J, 2004, JAMA-J AM MED ASSOC, V292, P1593, DOI 10.1001/jama.292.13.1593; Fong DYT, 2001, DRUG INF J, V35, P839, DOI 10.1177/009286150103500321; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Ford ME, 2006, GERONTOLOGIST, V46, P545, DOI 10.1093/geront/46.4.545; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; Fromme EK, 2004, J CLIN ONCOL, V22, P3485, DOI 10.1200/JCO.2004.03.025; Gandhi M, 2005, AIDS, V19, P1885, DOI 10.1097/01.aids.0000189866.67182.f7; GASSMAN JJ, 1995, CONTROL CLIN TRIALS, V16, pS104; Gertel A, 2009, CDISC CLIN RES GLOSS; Getz KA, 2011, DRUG INF J, V45, P265, DOI 10.1177/009286151104500307; GIBSON D, 1994, CONTROL CLIN TRIALS, V15, P482, DOI 10.1016/0197-2456(94)90005-1; Gilbody S, 2008, J CLIN EPIDEMIOL, V61, P160, DOI 10.1016/j.jclinepi.2007.04.015; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3852; Golder S, 2008, BRIT J CLIN PHARMACO, V66, P767, DOI 10.1111/j.1365-2125.2008.03272.x; Golomb BA, 2010, ANN INTERN MED, V153, P532, DOI 10.7326/0003-4819-153-8-201010190-00010; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gotzsche PC, 2000, BRIT MED J, V320, P1058, DOI 10.1136/bmj.320.7241.1058; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Gotzsche PC, 2009, PLOS MED, V6, P122, DOI 10.1371/journal.pmed.1000023; Goudie AC, 2010, J CLIN EPIDEMIOL, V63, P983, DOI 10.1016/j.jclinepi.2010.01.022; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Grant AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Grant AM, 2005, LANCET, V365, P711; Greenland S, 1990, Epidemiology, V1, P421, DOI 10.1097/00001648-199011000-00003; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Haahr MT, 2006, CLIN TRIALS, V3, P360, DOI 10.1177/1740774506069153; Han BG, 2009, STAT MED, V28, P3329, DOI 10.1002/sim.3710; Hart B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7202; Harvey Lisa A, 2011, Trials, V12, P14, DOI 10.1186/1745-6215-12-14; Heger U, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-245; Hen X, 2005, DRUG INF J, V39, P373; Heo M, 2009, INT J GERIATR PSYCH, V24, P990, DOI 10.1002/gps.2211; Herbison P, 2011, J CLIN EPIDEMIOL, V64, P1070, DOI 10.1016/j.jclinepi.2010.12.018; Heres S, 2006, AM J PSYCHIAT, V163, P185, DOI 10.1176/appi.ajp.163.2.185; Herland K, 2005, RESP MED, V99, P11, DOI 10.1016/j.rmed.2004.03.026; Hernandez AV, 2006, AM HEART J, V151, P257, DOI 10.1016/j.ahj.2005.04.020; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hirji KF, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-33; HIV Prevention Trials Network, 2003, HPTN 037 PHAS 3 RAND; HIV Prevention Trials Network and the International Maternal Pediatric and Adolescent AIDS Clinical Trials Network, 2007, HPTN 046 PHAS 3 TRIA; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hordijk-Trion M, 2006, EUR HEART J, V27, P671, DOI 10.1093/eurheartj/ehi731; Hotopf M, 1997, J EPIDEMIOL COMMUN H, V51, P354, DOI 10.1136/jech.51.4.354; Hrobjartsson A, 2011, CLIN PHARMACOL THER, V90, P732, DOI 10.1038/clpt.2011.207; Hrobjartsson A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1119; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Hrobjartsson A, 2009, J CLIN EPIDEMIOL, V62, P967, DOI 10.1016/j.jclinepi.2009.04.003; Hrynaszkiewicz Iain, 2010, BMJ, V340, pc181, DOI [10.1186/1745-6215-11-9, 10.1136/bmj.c181]; International Committee of Medical Journal Editors, 2010, UN REQ MAN BIO UNPUB; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Ioannidis JPA, 1997, J ACQ IMMUN DEF SYND, V16, P22, DOI 10.1097/00042560-199709010-00004; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; Jacobs A, 2005, CURR MED RES OPIN, V21, P317, DOI 10.1185/030079905X25578; Jagsi R, 2009, CANCER-AM CANCER SOC, V115, P2783, DOI 10.1002/cncr.24315; JASPERSE DM, 1989, CONTROL CLIN TRIALS, V10, P282, DOI 10.1016/0197-2456(89)90068-8; Jayaraman S, 2005, J POPUL THER CLIN PH, V12, pE251; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; Jones R, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-5; Julious S A, 1999, J Biopharm Stat, V9, P241, DOI 10.1081/BIP-100101174; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kairalla JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-145; Katz J, 2008, NEUROLOGY, V70, P263, DOI 10.1212/01.wnl.0000275528.01263.6c; Kawado M, 2003, CONTROL CLIN TRIALS, V24, P560, DOI 10.1016/S0197-2456(03)00089-8; Keen HI, 2005, J RHEUMATOL, V32, P2083; Kernan WN, 1999, J CLIN EPIDEMIOL, V52, P19, DOI 10.1016/S0895-4356(98)00138-3; Khan KS, 1996, FERTIL STERIL, V65, P939, DOI 10.1016/S0015-0282(16)58265-X; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Klingberg S, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-123; Knatterud GL, 1998, CONTROL CLIN TRIALS, V19, P477, DOI 10.1016/S0197-2456(98)00033-6; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Krysan DJ, 2002, PEDIATR INFECT DIS J, V21, P753, DOI 10.1097/00006454-200208000-00011; Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011; Kunz R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000012.pub2; Lai GY, 2006, CLIN TRIALS, V3, P133, DOI 10.1191/1740774506cn143oa; Laine C, 2007, BRIT MED J, V334, P1177, DOI 10.1136/bmj.39233.510810.80; Laine C, 2007, ANN INTERN MED, V146, P450, DOI 10.7326/0003-4819-146-6-200703200-00154; Lane SJ., 2006, BMC MED INFORM DECIS, V6, P23, DOI DOI 10.1186/1472-6947-6-23]; Lassere M, 2002, LANCET, V360, P1620, DOI 10.1016/S0140-6736(02)11652-7; Lathyris DN, 2007, INT J EPIDEMIOL, V36, P422, DOI 10.1093/ije/dym001; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Lemieux J, 2008, J CLIN ONCOL, V26, P4458, DOI 10.1200/JCO.2007.15.3726; Lester RT, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-87; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lieverse R, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-48; Liss H, 2006, ISR MED ASSOC J, V8, P451; Litchfield J, 2005, CLIN TRIALS, V2, P72, DOI 10.1191/1740774505cn069oa; Liu M, 2006, PHARM STAT, V5, P7, DOI 10.1002/pst.189; Llorca J, 2005, J GLAUCOMA, V14, P190, DOI 10.1097/01.ijg.0000159124.57112.69; Lochner HV, 2001, J BONE JOINT SURG AM, V83A, P1650, DOI 10.2106/00004623-200111000-00005; Losch C, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-16; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Maggard MA, 2003, SURGERY, V134, P275, DOI 10.1067/msy.2003.235; Mann H, 2002, LANCET, V360, P406, DOI 10.1016/S0140-6736(02)09613-7; Marshall M, 2000, BRIT J PSYCHIAT, V176, P249, DOI 10.1192/bjp.176.3.249; Matheson A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001072; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; McCarthy M, 2000, LANCET, V356, P1659, DOI 10.1016/S0140-6736(00)03166-4; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McEntegart DJ, 2003, DRUG INF J, V37, P293, DOI 10.1177/009286150303700305; McGauran N, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-37; McMurran M, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-198; McRae AD, 2011, TRIALS, V12, DOI [10.1186/1745-6215-12-202, 10.1186/1745-6215-12-183]; Medical Research Council Working Party on Prostate Cancer, 1995, MRC PR05 MED RES COU; Meinert CL, 1998, NEW ENGL J MED, V338, P1381, DOI 10.1056/NEJM199805073381911; Mello MM, 2005, NEW ENGL J MED, V352, P2202, DOI 10.1056/NEJMsa044115; Meyerson LJ, 2000, HEMATOL ONCOL CLIN N, V14, P953, DOI 10.1016/S0889-8588(05)70321-X; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Microbicide Trials Network, 2010, MTN 003 PHAS 2B SAF; Miller NL, 1999, J PSYCHIAT RES, V33, P81, DOI 10.1016/S0022-3956(98)00045-4; Mills EJ, 2006, LANCET ONCOL, V7, P141, DOI 10.1016/S1470-2045(06)70576-9; Min Y-I, 2005, INT C PEER REV BIOM; Mitchell SL, 1997, ARCH NEUROL-CHICAGO, V54, P1393, DOI 10.1001/archneur.1997.00550230060018; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Mohr JP, 2008, RANDOMIZED MULTICENT; Montgomery JH, 2004, CONTROL CLIN TRIALS, V25, P598, DOI 10.1016/j.cct.2004.09.002; Montori VM, 2006, DIABETES CARE, V29, P1833, DOI 10.2337/dc06-0077; Montori VM, 2005, BMJ-BRIT MED J, V330, P596; Murray DM, 2008, JNCI-J NATL CANCER I, V100, P483, DOI 10.1093/jnci/djn066; Murray GD, 2001, BRIT MED J, V322, P1461; MYERS MG, 1987, CLIN PHARMACOL THER, V42, P250, DOI 10.1038/clpt.1987.142; Nathan DG, 2002, NEW ENGL J MED, V347, P1368, DOI 10.1056/NEJMsb020394; National Institute for Health Research, 2012, EFF MECH EV PROGR IM; National Institutes of Health, 2003, FIN NIH STAT SHAR RE; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Odgaard-Jensen J, 2011, COCHRANE DATABASE SY, V4; Olson CM, 2002, JAMA-J AM MED ASSOC, V287, P2825, DOI 10.1001/jama.287.21.2825; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pals SL, 2008, AM J PUBLIC HEALTH, V98, P1418, DOI 10.2105/AJPH.2007.127027; Panel on Handling Missing Data in Clinical Trials National Research Council, 2010, PREV TREATM MISS DAT; Paris A, 2005, PRESSE MED, V34, P13, DOI 10.1016/S0755-4982(05)83877-1; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Pierce MA, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-57; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Prescott RJ, 1999, HEALTH TECHNOL ASSES, V3, P1, DOI DOI 10.3310/hta3200; Prevention Study Group, 2008, HEALTHY PRIM PREV TR; Project Accept Study Group, 2011, PROJ ACC HPTN 043 PH; Proschan MA, 2009, BIOMETRICAL J, V51, P348, DOI 10.1002/bimj.200800266; Puhan MA, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-28; RAJU TNK, 1992, AM J DIS CHILD, V146, P407, DOI 10.1001/archpedi.1992.02160160027007; Rendell JM, 2007, COCHRANE DATABASE SY, V2; Renfroe EG, 2002, CONTROL CLIN TRIALS, V23, P521, DOI 10.1016/S0197-2456(02)00225-8; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Rennie D, 1997, JAMA-J AM MED ASSOC, V278, P579, DOI 10.1001/jama.278.7.579; REYNOLDSHAERTLE RA, 1992, CONTROL CLIN TRIALS, V13, P487, DOI 10.1016/0197-2456(92)90205-E; Richardson HS, 2004, HASTINGS CENT REP, V34, P25, DOI 10.2307/3528248; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Roberts L, 1998, STROKE, V29, P986, DOI 10.1161/01.STR.29.5.986; Robiner WN, 2005, CONTEMP CLIN TRIALS, V26, P59, DOI 10.1016/j.cct.2004.11.015; Robinson KA, 2007, J CLIN EPIDEMIOL, V60, P757, DOI 10.1016/j.jclinepi.2006.11.023; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Rochon J, 1999, DRUG INF J, V33, P1219, DOI 10.1177/009286159903300425; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; Rochon Paula A, 2010, Open Med, V4, pe69; Rochon PA, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-9; Ross JS, 2008, JAMA-J AM MED ASSOC, V299, P1800, DOI 10.1001/jama.299.15.1800; Ross JS, 2012, CIRC-CARDIOVASC QUAL, V5, P238, DOI 10.1161/CIRCOUTCOMES.112.965798; Ross JS, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7292; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Ross S, 1999, J CLIN EPIDEMIOL, V52, P1143, DOI 10.1016/S0895-4356(99)00141-9; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Ruiz-Canela M, 1999, NEW ENGL J MED, V340, P1114, DOI 10.1056/NEJM199904083401412; Rutherford BR, 2009, PSYCHOTHER PSYCHOSOM, V78, P172, DOI 10.1159/000209348; Ryan RE, 2008, COCHRANE DB SYST REV, V1; Sackett DL, 2011, CLIN TRIALS, V8, P674, DOI 10.1177/1740774511419685; Sackett DL, 2011, CLIN TRIALS, V8, P440, DOI 10.1177/1740774511410995; Sandercock P, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-37; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Schroy PC, 2009, CLIN TRIALS, V6, P597, DOI 10.1177/1740774509346703; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2010, LANCET, V375, P1144, DOI 10.1016/S0140-6736(10)60413-8; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz KF, 2005, LANCET, V365, P1657, DOI 10.1016/S0140-6736(05)66516-6; SCHULZ KF, 1994, JAMA-J AM MED ASSOC, V272, P125, DOI 10.1001/jama.272.2.125; Schulz KF, 2002, ANN INTERN MED, V136, P254, DOI 10.7326/0003-4819-136-3-200202050-00022; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P614, DOI 10.1016/S0140-6736(02)07750-4; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; Schulz KF, 2006, LANCET HDB ESSENTIAL; Shapiro SH, 2000, J CLIN EPIDEMIOL, V53, P973, DOI 10.1016/S0895-4356(00)00227-4; Shaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-152; Sherman RB, 2011, NEW ENGL J MED, V365, P3, DOI 10.1056/NEJMp1103464; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Simpson F, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-17; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Sinyor M, 2010, J CLIN PSYCHIAT, V71, P270, DOI 10.4088/JCP.08r04516blu; Smith DL, 2012, DRUG INF J, V46, P27, DOI 10.1177/0092861511428300; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Sneed JR, 2008, AM J GERIAT PSYCHIAT, V16, P65, DOI 10.1097/JGP.0b013e3181256b1d; Sofaer N, 2011, PUBLIC HEALTH ETH-UK, V4, P160, DOI 10.1093/phe/phr013; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Sood A, 2007, J CLIN EPIDEMIOL, V60, P1123, DOI 10.1016/j.jclinepi.2007.01.009; Southwest Oncology Group, 2001, CHEM PROST CANC FIN; Stang A, 2005, PLOS MED, V2, P177, DOI 10.1371/journal.pmed.0020072; Steinbrook R, 2005, NEW ENGL J MED, V352, P2160, DOI 10.1056/NEJMp048353; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Streiner DL, 2008, EVID-BASED MENT HEAL, V11, P3, DOI 10.1136/ebmh.11.1.3-a; Sugarman J, 1998, J AM GERIATR SOC, V46, P517, DOI 10.1111/j.1532-5415.1998.tb02477.x; Summerskill W, 2009, LANCET, V373, P992, DOI 10.1016/S0140-6736(09)60590-0; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Sydes Matthew R, 2004, Clin Trials, V1, P48, DOI 10.1191/1740774504cn003oa; Tang JL, 1999, BMJ-BRIT MED J, V319, P160, DOI 10.1136/bmj.319.7203.160; Tendal B, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4829; Tetzlaff JM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-43; Tetzlaff JM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-176; The Danish National Committe on Biomedical Research Ethics, 2011, GUID NOT ETC BIOM RE; The Royal Society Science Policy Centre, 2012, SCI OP ENT; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Tinmouth JM, 2004, GASTROENTEROLOGY, V126, P1700, DOI 10.1053/j.gastro.2004.03.005; Tournoux C, 2006, CANCER-AM CANCER SOC, V106, P258, DOI 10.1002/cncr.21613; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Treasure T, 1998, BRIT MED J, V317, P362; Treweek S, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000013.pub5, 10.1002/14651858.MR000013.pub4]; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; Tworoger SS, 2002, CANCER EPIDEM BIOMAR, V11, P73; Uchino K, 2001, STROKE, V32, P909, DOI 10.1161/01.STR.32.4.909; Uijen AA, 2007, J CLIN EPIDEMIOL, V60, P330, DOI 10.1016/j.jclinepi.2006.05.015; UyBico SJ, 2007, J GEN INTERN MED, V22, P852, DOI 10.1007/s11606-007-0126-3; van der Lee JH, 2008, J CLIN EPIDEMIOL, V61, P324, DOI 10.1016/j.jclinepi.2007.07.008; van Luijn JCF, 2008, ANN PHARMACOTHER, V42, P1605, DOI 10.1345/aph.1L115; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; Vedula SS, 2009, NEW ENGL J MED, V361, P1963, DOI 10.1056/NEJMsa0906126; Verhagen AP, 2008, J CLIN EPIDEMIOL, V61, P813, DOI 10.1016/j.jclinepi.2007.10.006; Vickers AJ, 2003, J CLIN EPIDEMIOL, V56, P717, DOI 10.1016/S0895-4356(03)00141-0; Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323; Vlad SC, 2007, ARTHRITIS RHEUM-US, V56, P2267, DOI 10.1002/art.22728; Wahlbeck K, 2001, PSYCHOPHARMACOLOGY, V155, P230, DOI 10.1007/s002130100711; WALLIN J, 1981, CLIN THER, V3, P450; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Walther B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025348; Weijer C., 1995, CHARACTERIZING POPUL; Wendler DS, 2006, J MED ETHICS, V32, P229, DOI 10.1136/jme.2004.011114; Whittington CJ, 2004, LANCET, V363, P1341, DOI 10.1016/S0140-6736(04)16043-1; *WHO, 2012, ADH LONG TERM THER E; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; WILLIAMS CJ, 1994, EUR J CANCER, V30A, P907, DOI 10.1016/0959-8049(94)90111-2; Williams GW, 2006, CLIN TRIALS, V3, P530, DOI 10.1177/1740774506073104; Williamson P, 2012, J HEALTH SERV RES PO, V17, P1, DOI 10.1258/jhsrp.2011.011131; Wise P, 1996, BRIT MED J, V313, P1245, DOI 10.1136/bmj.313.7067.1245; Wislar JS, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6128; Wolinsky FD, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000218; Wood Angela M, 2004, Clin Trials, V1, P368; World Association of Medical Editors Editorial Policy and Publication Ethics Committees, 2009, CONFL INT PEER REV M; World Health Organization, 2002, HDB GOOD CLIN RES PR; World Health Organization, 2000, OP GUID ETH COMM REV; World Medical Association, 2012, WMA STAT CONFL INT; Wright JM, 2001, JAMA-J AM MED ASSOC, V286, P2398; Wu TX, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-46; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565; Yazici Y, 2008, RHEUMATOLOGY, V47, P1054, DOI 10.1093/rheumatology/ken190; You BO, 2012, J CLIN ONCOL, V30, P210, DOI 10.1200/JCO.2011.37.0890; Yu LM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-59; Zarin DA, 2005, SOC PSYCH PSYCH EPID, V40, P27, DOI 10.1007/s00127-005-0838-9; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	413	2195	2223	5	145	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e7586	10.1136/bmj.e7586	http://dx.doi.org/10.1136/bmj.e7586			42	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303884	hybrid, Green Published			2022-12-28	WOS:000313554900022
J	Patel, SM; Miller, TD				Patel, Sandeep M.; Miller, Todd D.			Diffuse Calcification and a Draining Wound	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UREMIC TUMORAL CALCINOSIS; LONG-TERM HEMODIALYSIS; PATIENT		[Patel, Sandeep M.] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; [Miller, Todd D.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Patel, Sandeep M.] Univ Pittsburgh, Med Ctr, Inst Heart & Vasc, Pittsburgh, PA USA	Mayo Clinic; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Miller, TD (corresponding author), Mayo Clin, Div Cardiovasc Dis, Gonda 5,200 1st St SW, Rochester, MN 55905 USA.	miller.todd@mayo.edu						Akasbi N, 2011, JCR-J CLIN RHEUMATOL, V17, P272, DOI 10.1097/RHU.0b013e3182288acd; Cofan F, 1999, J RHEUMATOL, V26, P379; DCRUZ IA, 1987, J ROY COLL PHYS LOND, V21, P143; Floege J, 2004, KIDNEY INT, V65, P2447, DOI 10.1111/j.1523-1755.2004.00664.x; Garcia S, 2002, FOOT ANKLE INT, V23, P260, DOI 10.1177/107110070202300313; Huang YT, 2006, CLIN IMAG, V30, P66, DOI 10.1016/j.clinimag.2005.06.024; Ibels L S, 1980, Prog Biochem Pharmacol, V17, P242; Remy-Leroux V, 2009, ANN DERMATOL VENER, V136, P350, DOI 10.1016/j.annder.2008.10.035; ROSTAND SG, 1994, CONTRIB NEPHROL, V106, P26	9	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					181	182		10.1001/jama.2012.91090	http://dx.doi.org/10.1001/jama.2012.91090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299610				2022-12-28	WOS:000313517000027
J	Hernandez-Martin, A; Torrelo, A				Hernandez-Martin, Angela; Torrelo, Antonio			Ranula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hernandez-Martin, Angela; Torrelo, Antonio] Hosp Infantil Nino Jesus, Madrid, Spain		Hernandez-Martin, A (corresponding author), Hosp Infantil Nino Jesus, Madrid, Spain.	ahernandez_hnj@yahoo.es							0	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					E38	E38		10.1056/NEJMicm1202636	http://dx.doi.org/10.1056/NEJMicm1202636			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268686				2022-12-28	WOS:000312714200011
J	Maldonado, M				Maldonado, Maria			Warning Shot	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Stamford Hosp, Dept Med, Stamford, CT USA	Stamford Hospital	Maldonado, M (corresponding author), Stamford Hosp, Dept Med, Stamford, CT USA.	memaldonado@msn.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2575	2576		10.1001/jama.2012.128365	http://dx.doi.org/10.1001/jama.2012.128365			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268515				2022-12-28	WOS:000312916600022
J	Powell, T; Hanfling, D; Gostin, LO				Powell, Tia; Hanfling, Dan; Gostin, Lawrence O.			Emergency Preparedness and Public Health The Lessons of Hurricane Sandy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Powell, Tia] Albert Einstein Coll Med, Montefiore Einstein Ctr Bioeth, Bronx, NY 10467 USA; [Hanfling, Dan] Inova Hlth Syst, Falls Church, VA USA; [Hanfling, Dan] Georgetown Univ, Dept Emergency Med, Washington, DC 20001 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Yeshiva University; Albert Einstein College of Medicine; Inova Health System; Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Committee on Guidance for Establishing Crisis Standards of Care for Use in Disaster Situations; Institute of Medicine, 2012, CRIS STAND CAR SYST, DOI DOI 10.17226/13351; Hartocollis A, 2012, NY TIMES; Katz C, 2012, NYC             1027; Kolker Robert, 2021, NEW YORK TIMES MAGAZ; Ofri D, 2012, NEW ENGL J MED, V367, P2265, DOI 10.1056/NEJMp1213843; Shapiro J, BELLEVUE HOSP EVACUA	6	85	86	0	60	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2569	2570		10.1001/jama.2012.108940	http://dx.doi.org/10.1001/jama.2012.108940			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23281545				2022-12-28	WOS:000312916600019
J	Tsai, NP; Wilkerson, JR; Guo, WR; Maksimova, MA; DeMartino, GN; Cowan, CW; Huber, KM				Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; DeMartino, George N.; Cowan, Christopher W.; Huber, Kimberly M.			Multiple Autism-Linked Genes Mediate Synapse Elimination via Proteasomal Degradation of a Synaptic Scaffold PSD-95	CELL			English	Article							FRAGILE-X-SYNDROME; MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; OL-PROTOCADHERIN; TRANSLATION; MEF2; ENDOCYTOSIS; TRAFFICKING; EXPRESSION; DIVERSITY	The activity-dependent transcription factor myocyte enhancer factor 2 (MEF2) induces excitatory synapse elimination in mouse neurons, which requires fragile X mental retardation protein (FMRP), an RNA-binding protein implicated in human cognitive dysfunction and autism. We report here that protocadherin 10 (Pcdh10), an autism-spectrum disorders gene, is necessary for this process. MEF2 and FMRP cooperatively regulate the expression of Pcdh10. Upon MEF2 activation, PSD-95 is ubiquitinated by the ubiquitin E3 ligase murine double minute 2 (Mdm2) and then binds to Pcdh10, which links it to the proteasome for degradation. Blockade of the Pcdh10-proteasome interaction inhibits MEF2-induced PSD-95 degradation and synapse elimination. In FMRP-lacking neurons, elevated protein levels of eukaryotic translation elongation factor 1 alpha (EF1 alpha), an Mdm2-interacting protein and FMRP target mRNA, sequester Mdm2 and prevent MEF2-induced PSD-95 ubiquitination and synapse elimination. Together, our findings reveal roles for multiple autism-linked genes in activity-dependent synapse elimination.	[Tsai, Nien-Pei; Wilkerson, Julia R.; Guo, Weirui; Maksimova, Marina A.; Huber, Kimberly M.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [DeMartino, George N.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cowan, Christopher W.] Univ Texas SW Med Ctr Dallas, Dept Ophthalmol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huber, KM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	kimberly.huber@utsouthwestern.edu	Guo, Weirui/G-2868-2015; Cowan, Christopher W/I-2497-2014; Huber, Kimberly/X-5534-2019; Litvinova, Marina/C-6154-2017	WILKERSON, JULIA/0000-0002-7497-2270; Litvinova, Marina/0000-0002-2622-6548	National Institutes of Health [NS045711, HD052731, F32HD069111, F32HD062120]; Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052731, F32HD069111] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD062120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundations; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grants from the National Institutes of Health NS045711, HD052731 (K.M.H.), F32HD069111 (N.-P.T.), F32HD062120 (J.R.W.) and from the Simons Foundations (K.M.H. and C.W.C.). We would also like to thank L. Ormazabal, N. Cabalo, F. Niere, K. Loerwald, T. Zang, D. Thompson, X. Li, and B. Chen for technical assistance; Dr. M. Rosen for the GST-Pcdh10 constructs; Dr. J. Gibson for helpful discussions; and Drs. Robert and Jennifer Darnell for sharing their FMRP-CLIP target list prior to publication.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Berry-Kravis E, 2002, DEV MED CHILD NEUROL, V44, P724; Bingol B, 2010, CELL, V140, P567, DOI 10.1016/j.cell.2010.01.024; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Dolezelova P, 2012, CELL CYCLE, V11, P953, DOI 10.4161/cc.11.5.19445; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frum R, 2007, J PROTEOME RES, V6, P1410, DOI 10.1021/pr060584p; Giagtzoglou N, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003079; Haas KF, 2007, MOL CELL NEUROSCI, V35, P64, DOI 10.1016/j.mcn.2007.02.002; Hirano S, 1999, J NEUROSCI, V19, P995; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kim SY, 2011, CELL ADHES MIGR, V5, P97, DOI 10.4161/cam.5.2.14374; Kim YC, 2011, J BIOL CHEM, V286, P26652, DOI 10.1074/jbc.M111.246793; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Novara F, 2010, CLIN GENET, V78, P471, DOI 10.1111/j.1399-0004.2010.01413.x; Opazo P, 2012, CURR OPIN NEUROBIOL, V22, P453, DOI 10.1016/j.conb.2011.10.010; Pan F, 2010, P NATL ACAD SCI USA, V107, P17768, DOI 10.1073/pnas.1012496107; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rezvani K, 2007, J NEUROSCI, V27, P10508, DOI 10.1523/JNEUROSCI.3353-07.2007; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Woods GF, 2011, J NEUROSCI, V31, P12129, DOI 10.1523/JNEUROSCI.6662-10.2011; Xu TH, 2009, NATURE, V462, P915, DOI 10.1038/nature08389; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104	41	187	190	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1581	1594		10.1016/j.cell.2012.11.040	http://dx.doi.org/10.1016/j.cell.2012.11.040			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260144	Bronze, Green Accepted			2022-12-28	WOS:000312890300021
J	Boffano, P; Gallesio, C				Boffano, Paolo; Gallesio, Cesare			Lipoma of the Tongue	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Boffano, Paolo; Gallesio, Cesare] Univ Turin, Turin, Italy	University of Turin	Boffano, P (corresponding author), Univ Turin, Turin, Italy.	paolo.boffano@gmail.com	Boffano, Paolo/J-1094-2016	GALLESIO, CESARE/0000-0003-3863-3009; Boffano, Paolo/0000-0002-0782-9933					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 20	2012	367	25					E37	E37		10.1056/NEJMicm1204020	http://dx.doi.org/10.1056/NEJMicm1204020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	056ZP	23252550				2022-12-28	WOS:000312531600011
J	Fidler, S; Porter, K; Ewings, F; Frater, J; Ramjee, G; Cooper, D; Rees, H; Fisher, M; Schechter, M; Kaleebu, P; Tambussi, G; Kinloch, S; Miro, JM; Kelleher, A; McClure, M; Kaye, S; Gabriel, M; Phillips, R; Weber, J				Fidler, Sarah; Porter, Kholoud; Ewings, Fiona; Frater, John; Ramjee, Gita; Cooper, David; Rees, Helen; Fisher, Martin; Schechter, Mauro; Kaleebu, Pontiano; Tambussi, Giuseppe; Kinloch, Sabine; Miro, Jose M.; Kelleher, Anthony; McClure, Myra; Kaye, Steve; Gabriel, Michelle; Phillips, Rodney; Weber, Jonathan		SPARTAC Trial Investigators	Short-Course Antiretroviral Therapy in Primary HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRAL SET-POINT; TYPE-1 INFECTION; PLASMA; SEROCONVERSION; DETERMINANTS; INDIVIDUALS; NEVIRAPINE; MORTALITY; RESPONSES; CD8(+)	Background Short-course antiretroviral therapy (ART) in primary human immunodeficiency virus (HIV) infection may delay disease progression but has not been adequately evaluated. Methods We randomly assigned adults with primary HIV infection to ART for 48 weeks, ART for 12 weeks, or no ART (standard of care), with treatment initiated within 6 months after seroconversion. The primary end point was a CD4+ count of less than 350 cells per cubic millimeter or long-term ART initiation. Results A total of 366 participants (60% men) underwent randomization to 48-week ART (123 participants), 12-week ART (120), or standard care (123), with an average follow-up of 4.2 years. The primary end point was reached in 50% of the 48-week ART group, as compared with 61% in each of the 12-week ART and standard-care groups. The average hazard ratio was 0.63 (95% confidence interval [CI], 0.45 to 0.90; P=0.01) for 48-week ART as compared with standard care and was 0.93 (95% CI, 0.67 to 1.29; P=0.67) for 12-week ART as compared with standard care. The proportion of participants who had a CD4+ count of less than 350 cells per cubic millimeter was 28% in the 48-week ART group, 40% in the 12-week group, and 40% in the standard-care group. Corresponding values for long-term ART initiation were 22%, 21%, and 22%. The median time to the primary end point was 65 weeks (95% CI, 17 to 114) longer with 48-week ART than with standard care. Post hoc analysis identified a trend toward a greater interval between ART initiation and the primary end point the closer that ART was initiated to estimated seroconversion (P=0.09), and 48-week ART conferred a reduction in the HIV RNA level of 0.44 log(10) copies per milliliter (95% CI, 0.25 to 0.64) 36 weeks after the completion of short-course therapy. There were no significant between-group differences in the incidence of the acquired immunodeficiency syndrome, death, or serious adverse events. Conclusions A 48-week course of ART in patients with primary HIV infection delayed disease progression, although not significantly longer than the duration of the treatment. There was no evidence of adverse effects of ART interruption on the clinical outcome. (Funded by the Wellcome Trust; SPARTAC Controlled-Trials.com number, ISRCTN76742797, and EudraCT number, 2004-000446-20.)	[Fidler, Sarah; McClure, Myra; Kaye, Steve; Weber, Jonathan] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W2 1PG, England; [Porter, Kholoud; Ewings, Fiona; Gabriel, Michelle] Med Res Council Clin Trials Unit, London, England; [Frater, John; Phillips, Rodney] Univ Oxford, Oxford, England; [Ramjee, Gita] MRC, HIV Prevent Unit, Durban, South Africa; [Cooper, David] Univ New S Wales, Kirby Inst, Sydney, NSW, Australia; [Rees, Helen] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Fisher, Martin] Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England; [Schechter, Mauro] Univ Fed Rio de Janeiro, Hosp Escola Sao Francisco Assis, Rio De Janeiro, Brazil; [Kaleebu, Pontiano] Uganda Virus Res Inst, Med Res Council, Entebbe, Uganda; [Kinloch, Sabine] Royal Free Hosp, London NW3 2QG, England; [Tambussi, Giuseppe] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy; [Miro, Jose M.] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain; [Kelleher, Anthony] St Vincents Hosp, Sydney, NSW 2010, Australia	Imperial College London; Medical Research Council Clinical Trials Unit; University of Oxford; University of New South Wales Sydney; Kirby Institute; University of Witwatersrand; University of Brighton; Universidade Federal do Rio de Janeiro; Uganda Virus Research Institute; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; St Vincents Hospital Sydney	Weber, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	j.weber@imperial.ac.uk	Schechter, Mauro/AAG-7445-2020; Pumarola, Tomàs/AAB-5532-2019; Thomson, Emma C/M-8690-2017; Suñe, Tomàs Pumarola/F-7583-2017	Pumarola, Tomàs/0000-0002-5171-7461; Thomson, Emma C/0000-0003-1482-0889; Suñe, Tomàs Pumarola/0000-0002-5171-7461; fox, Julie/0000-0002-0583-8019; bonsall, david/0000-0003-2187-0550; Frater, John/0000-0001-7163-7277; Gabriel, Michelle/0000-0002-3766-2046; Arenas-Pinto, Alejandro/0000-0002-3368-5005; Porter, Kholoud/0000-0002-9226-6206; Rees, Helen/0000-0003-1442-6734; Tuset, Montse/0000-0002-9153-6956; Leen, Clifford/0000-0001-8439-7719; Tambussi, Giuseppe/0000-0002-0604-2960; Thomason, Margaret/0000-0003-3590-0140; McClure, Myra/0000-0002-5494-407X; Fidler, Sarah/0000-0003-1676-7583	Wellcome Trust [069598/Z/02/Z]; Bristol-Myers Squibb Pharmaceuticals; Abbott Laboratories; Gilead Sciences; Janssen-Cilag; Merck; ViiV Healthcare; Boehringer Ingelheim; Cubist Pharmaceuticals; Novartis; Pfizer; Theravance; GlaxoSmithKline; Merck Sharp Dohme; Roche; Schering-Plough; Janssen Therapeutics; MRC [MC_U122886352, G108/626, MC_UU_12023/16] Funding Source: UKRI; Medical Research Council [MC_UU_12023/16, G108/626, MC_U122886352] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10313] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Bristol-Myers Squibb Pharmaceuticals(Bristol-Myers Squibb); Abbott Laboratories(Abbott Laboratories); Gilead Sciences(Gilead Sciences); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); ViiV Healthcare; Boehringer Ingelheim(Boehringer Ingelheim); Cubist Pharmaceuticals; Novartis(Novartis); Pfizer(Pfizer); Theravance; GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Janssen Therapeutics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by a grant from the Wellcome Trust (069598/Z/02/Z).; Dr. Fidler reports receiving lecture fees from Bristol-Myers Squibb Pharmaceuticals through her institution. Dr. Fisher reports receiving lecture fees from Abbott Laboratories, Bristol-Myers Squibb Pharmaceuticals, Gilead Sciences, Janssen-Cilag, Merck, and ViiV Healthcare. Dr. Kelleher reports receiving consulting fees, lecture fees, and payment for development of educational material from ViiV Healthcare through his institution; receiving grant support, lecture fees, and payment for development of educational material (all through his institution) and payment for travel and accommodations from Merck; receiving lecture fees from Boehringer Ingelheim through his institution; and being a named inventor in a patent with Becton Dickinson. Dr. Kinloch reports receiving payment for travel and accommodations from Bristol-Myers Squibb Pharmaceuticals. Dr. Miro reports serving on the board and receiving lecture fees (and grant support through his institution) from Cubist Pharmaceuticals, serving on the board and receiving lecture fees (and grant support through his institution) from Novartis, receiving consulting fees and lecture fees from Abbott Laboratories, Bristol-Myers Squibb Pharmaceuticals, Gilead Sciences, Merck, Pfizer, and Theravance, and receiving lecture fees from Boehringer Ingelheim, GlaxoSmithKline, Janssen-Cilag, Merck Sharp & Dohme, Roche, Schering-Plough, and ViiV Healthcare. Dr. Porter reports receiving lecture fees from Janssen Therapeutics (formerly Tibotec Therapeutics). Dr. Tambussi reports serving on the board and receiving consulting fees and payment for development of educational material (and grant support through his institution) from ViiV Healthcare, receiving grant support from Abbott Laboratories through his institution, and receiving payment for travel and accommodations from Gilead Sciences and Bristol-Myers Squibb Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Al-Harthi L, 2007, CLIN IMMUNOL, V125, P299, DOI 10.1016/j.clim.2007.08.011; Ananworanich J, 2005, AIDS, V19, P185, DOI 10.1097/00002030-200501280-00011; Bell SK, 2010, J INFECT DIS, V202, pS278, DOI 10.1086/655655; Centlivre M, 2007, AIDS, V21, P1, DOI 10.1097/QAD.0b013e3280117f7f; Chamberland A, 2011, INT J STD AIDS, V22, P146, DOI 10.1258/ijsa.2010.010292; Cohen MS, 2011, NEW ENGL J MED, V364, P1943, DOI 10.1056/NEJMra1011874; Cressey TR, 2008, CLIN INFECT DIS, V46, P1601, DOI 10.1086/587657; D'Souza MP, 2010, J INFECT DIS, V202, pS267, DOI 10.1086/655650; Detels R, 1998, JAMA-J AM MED ASSOC, V280, P1497, DOI 10.1001/jama.280.17.1497; DHHS Panel on Antiretroviral Guide-lines for Adults and Adolescents, 2009, GUID US ANT AG HIV 1; DHHS Panel on Antiretroviral Guide-lines for Adults and Adolescents, 2007, GUID US ANT AG HIV 1; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; Fidler S, 2008, CURR OPIN INFECT DIS, V21, P4, DOI 10.1097/QCO.0b013e3282f428bf; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fox J, 2008, CLIN EXP IMMUNOL, V152, P532, DOI 10.1111/j.1365-2249.2008.03653.x; Gianella S, 2011, ANTIVIR THER, V16, P535, DOI 10.3851/IMP1776; Grijsen ML, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001196; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hogan CM, 2012, J INFECT DIS, V205, P87, DOI 10.1093/infdis/jir699; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kikaire B, 2007, AIDS, V21, P733, DOI 10.1097/QAD.0b013e3280121801; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Malhotra U, 2000, J INFECT DIS, V181, P121, DOI 10.1086/315202; Murphy G, 2008, EURO SURVEILL, V13; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pires A, 2004, JAIDS-J ACQ IMM DEF, V36, P783, DOI 10.1097/00126334-200407010-00004; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Schmid A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013310; Steingrover R, 2010, AIDS RES HUM RETROV, V26, P379, DOI 10.1089/aid.2009.0041; Streeck H, 2009, J VIROL, V83, P7641, DOI 10.1128/JVI.00182-09	34	161	163	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					207	217		10.1056/NEJMoa1110039	http://dx.doi.org/10.1056/NEJMoa1110039			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323897	Green Accepted, Green Published			2022-12-28	WOS:000313549900005
J	Gaudry, Q; Hong, EJ; Kain, J; de Bivort, BL; Wilson, RI				Gaudry, Quentin; Hong, Elizabeth J.; Kain, Jamey; de Bivort, Benjamin L.; Wilson, Rachel I.			Asymmetric neurotransmitter release enables rapid odour lateralization in Drosophila	NATURE			English	Article							OLFACTORY LOCAL INTERNEURONS; ANTENNAL LOBE; MELANOGASTER; CIRCUIT; NEURONS; OSMOTROPOTAXIS; INFORMATION; MARKER; SYSTEM; GENE	In Drosophila, most individual olfactory receptor neurons (ORNs) project bilaterally to both sides of the brain(1,2). Having bilateral rather than unilateral projections may represent a useful redundancy. However, bilateral ORN projections to the brain should also compromise the ability to lateralize odours. Nevertheless, walking or flying Drosophila reportedly turn towards the antenna that is more strongly stimulated by odour(3-5). Here we show that each ORN spike releases approximately 40% more neurotransmitter from the axon branch ipsilateral to the soma than from the contralateral branch. As a result, when an odour activates the antennae asymmetrically, ipsilateral central neurons begin to spike a few milliseconds before contralateral neurons, and at a 30 to 50% higher rate than contralateral neurons. We show that a walking fly can detect a 5% asymmetry in total ORN input to its left and right antennal lobes, and can turn towards the odour in less time than it requires the fly to complete a stride. These results demonstrate that neurotransmitter release properties can be tuned independently at output synapses formed by a single axon onto two target cells with identical functions and morphologies. Our data also show that small differences in spike timing and spike rate can produce reliable differences in olfactory behaviour.	[Gaudry, Quentin; Hong, Elizabeth J.; Wilson, Rachel I.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Kain, Jamey; de Bivort, Benjamin L.] Harvard Univ, Rowland Inst, Cambridge, MA 02142 USA; [de Bivort, Benjamin L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [de Bivort, Benjamin L.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard University	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu		Wilson, Rachel/0000-0001-8573-9266	National Institutes of Health [R01DC008174]; Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rowland Junior Fellows Program; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to M. Dickinson, V. Jayaraman, L. Luo, D. Tracey and L. Vosshall for gifts of fly stocks. A. Baker helped construct and improve the spherical treadmill apparatus. Members of the Wilson laboratory provided feedback on the manuscript. This work was supported by a research project grant from the National Institutes of Health (R01DC008174). R. I. W. is an HHMI Early Career Scientist. B.L.d.B. and J.K. were supported by the Rowland Junior Fellows Program.	Agarwal G, 2011, J NEUROPHYSIOL, V105, P1711, DOI 10.1152/jn.00591.2010; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Bhandawat V, 2010, J EXP BIOL, V213, P3625, DOI 10.1242/jeb.040402; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Chou YH, 2010, NAT NEUROSCI, V13, P439, DOI 10.1038/nn.2489; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33; Duistermars BJ, 2009, CURR BIOL, V19, P1301, DOI 10.1016/j.cub.2009.06.022; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; FLUGGE CHARLOTTE, 1934, ZEITSCHR WISS BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V20, P463; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HANGART.W, 1967, Z VERGL PHYSIOL, V57, P103, DOI 10.1007/BF00303068; Hwang RY, 2007, CURR BIOL, V17, P2105, DOI 10.1016/j.cub.2007.11.029; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Kazama H, 2011, J NEUROSCI, V31, P7619, DOI 10.1523/JNEUROSCI.5984-10.2011; Kazama H, 2009, NAT NEUROSCI, V12, P1136, DOI 10.1038/nn.2376; KENNEDY JS, 1969, ENTOMOL EXP APPL, V12, P487, DOI 10.1007/BF00297080; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LOCKERY SR, 1990, J NEUROSCI, V10, P1816; MARTIN H, 1965, NATURE, V208, P59, DOI 10.1038/208059a0; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Pelkey KA, 2007, CURR OPIN NEUROBIOL, V17, P366, DOI 10.1016/j.conb.2007.04.008; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; STRAUSS R, 1990, J COMP PHYSIOL A, V167, P403, DOI 10.1007/BF00192575; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	36	87	87	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					424	U175		10.1038/nature11747	http://dx.doi.org/10.1038/nature11747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263180	Green Submitted, Green Accepted			2022-12-28	WOS:000313615900056
J	Schwitalla, S; Fingerle, AA; Cammareri, P; Nebelsiek, T; Goktuna, SI; Ziegler, PK; Canli, O; Heijmans, J; Huels, DJ; Moreaux, G; Rupec, RA; Gerhard, M; Schmid, R; Barker, N; Clevers, H; Lang, R; Neumann, J; Kirchner, T; Taketo, MM; van den Brink, GR; Sansom, OJ; Arkan, MC; Greten, FR				Schwitalla, Sarah; Fingerle, Alexander A.; Cammareri, Patrizia; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Heijmans, Jarom; Huels, David J.; Moreaux, Guenievre; Rupec, Rudolf A.; Gerhard, Markus; Schmid, Roland; Barker, Nick; Clevers, Hans; Lang, Roland; Neumann, Jens; Kirchner, Thomas; Taketo, Makoto M.; van den Brink, Gijs R.; Sansom, Owen J.; Arkan, Melek C.; Greten, Florian R.			Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties	CELL			English	Article							NF-KAPPA-B; BETA-CATENIN; PANCREATIC-CANCER; TUMOR PROGRESSION; MOUSE MODEL; IN-VIVO; INFLAMMATION; EXPRESSION; IKK; APC	Cell-type plasticity within a tumor has recently been suggested to cause a bidirectional conversion between tumor-initiating stem cells and nonstem cells triggered by an inflammatory stroma. NF-kappa B represents a key transcription factor within the inflammatory tumor microenvironment. However, NF-kappa B's function in tumor-initiating cells has not been examined yet. Using a genetic model of intestinal epithelial cell (IEC)-restricted constitutive Wnt-activation, which comprises the most common event in the initiation of colon cancer, we demonstrate that NF-kappa B modulates Wnt signaling and show that IEC-specific ablation of RelA/p65 retards crypt stem cell expansion. In contrast, elevated NF-kappa B signaling enhances Wnt activation and induces dedifferentiation of nonstem cells that acquire tumor-initiating capacity. Thus, our data support the concept of bidirectional conversion and highlight the importance of inflammatory signaling for dedifferentiation and generation of tumor-initiating cells in vivo.	[Schwitalla, Sarah; Nebelsiek, Tim; Goektuna, Serkan I.; Ziegler, Paul K.; Canli, Ozge; Arkan, Melek C.; Greten, Florian R.] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany; [Fingerle, Alexander A.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiol, D-81675 Munich, Germany; [Gerhard, Markus] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Schmid, Roland] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-81675 Munich, Germany; [Cammareri, Patrizia; Huels, David J.; Moreaux, Guenievre; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Heijmans, Jarom; van den Brink, Gijs R.] Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 BK Amsterdam, Netherlands; [Rupec, Rudolf A.] Univ Munich, Dept Dermatol & Allergol, D-80337 Munich, Germany; [Neumann, Jens; Kirchner, Thomas] Univ Munich, Inst Pathol, D-80337 Munich, Germany; [Barker, Nick] Inst Med Biol, Singapore 138648, Singapore; [Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Lang, Roland] Univ Hosp Erlangen, Inst Clin Microbiol Immunol & Hyg, D-91054 Erlangen, Germany; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Beatson Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Munich; University of Munich; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Erlangen Nuremberg; Kyoto University	Greten, FR (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, D-81675 Munich, Germany.	florian.greten@lrz.tum.de	Gerhard, Markus/N-3387-2014; Greten, Florian R/AAF-5196-2020; Barker, Nick/A-5535-2011; Gerhard, Markus/P-8996-2019; Lang, Roland/C-3287-2011; Barker, Nick/AAS-2774-2020; Sch/AAA-9548-2021; Barker, Nick/AAE-9833-2021; Ziegler, Paul/AAO-4379-2021	Gerhard, Markus/0000-0001-9110-3950; Greten, Florian R/0000-0002-3928-6080; Gerhard, Markus/0000-0001-9110-3950; Barker, Nick/0000-0003-3566-4475; Ziegler, Paul/0000-0002-7703-7747; Huels, David/0000-0001-6154-1183; Sansom, Owen J./0000-0001-9540-3010; Heijmans, Jarom/0000-0001-9615-7851; Cammareri, Patrizia/0000-0002-5888-6903; Huels, Roland/0000-0002-1970-744X; Lang, Roland/0000-0003-0502-3677; Goktuna, Serkan/0000-0001-6169-768X	European Research Council [ROSCAN-281967]; Deutsche Forschungsgemeinschaft; Deutsche Krebshilfe; Cancer Research UK [12481] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe); Cancer Research UK(Cancer Research UK)	We thank Kristin Retzlaff, Saskia Ettl, and Kerstin Burmeister for technical assistance; Jorg Mages and Angela Servatius for generation of microarray data; and Matthias Schiemann for FACS sorting as well as Michael Allgauer for help with in situ hybridization. We are grateful to Sylvie Robine for generously providing villin-creER<SUP>T2</SUP> mice. We thank Bert Vogelstein and Kenneth Kinzler for providing beta-catenin<SUP>S33Y</SUP> and TCF4 plasmids as well as TOPFLASH and FOPFLASH reporter constructs. We also thank Masayuki Miura for providing ERAI-transgenic mice and the pCAX-F-XBP1 Delta DBD-venus plasmid. This work was supported by grants from the European Research Council (ROSCAN-281967), Deutsche Forschungsgemeinschaft, and Deutsche Krebshilfe to F.R.G.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; COLE JW, 1963, CANCER, V16, P998, DOI 10.1002/1097-0142(196308)16:8<998::AID-CNCR2820160806>3.0.CO;2-C; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Friedlander SYG, 2009, CANCER CELL, V16, P379, DOI 10.1016/j.ccr.2009.09.027; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Guerra C, 2011, CANCER CELL, V19, P728, DOI 10.1016/j.ccr.2011.05.011; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Janssen KP, 2006, GASTROENTEROLOGY, V131, P1096, DOI 10.1053/j.gastro.2006.08.011; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Preston SL, 2003, CANCER RES, V63, P3819; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rupec RA, 2005, IMMUNITY, V22, P479, DOI 10.1016/j.immuni.2005.02.009; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Wagner M, 2001, GENE DEV, V15, P286, DOI 10.1101/gad.184701; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	48	721	742	3	167	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					25	38		10.1016/j.cell.2012.12.012	http://dx.doi.org/10.1016/j.cell.2012.12.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273993	Bronze			2022-12-28	WOS:000313719800004
J	Spence, D				Spence, Des			A conspiracy of anonymity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								f32	10.1136/bmj.f32	http://dx.doi.org/10.1136/bmj.f32			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295249				2022-12-28	WOS:000313552300008
J	Cobb, KM; Westphal, N; Sayani, HR; Watson, JT; Di Lorenzo, E; Cheng, H; Edwards, RL; Charles, CD				Cobb, Kim M.; Westphal, Niko; Sayani, Hussein R.; Watson, Jordan T.; Di Lorenzo, Emanuele; Cheng, H.; Edwards, R. L.; Charles, Christopher D.			Highly Variable El Nino-Southern Oscillation Throughout the Holocene	SCIENCE			English	Article							TROPICAL PACIFIC CLIMATE; NINO/SOUTHERN-OSCILLATION; VARIABILITY; OCEAN; ENSO; MIDHOLOCENE	The El Nino-Southern Oscillation (ENSO) drives large changes in global climate patterns from year to year, yet its sensitivity to continued anthropogenic greenhouse forcing is uncertain. We analyzed fossil coral reconstructions of ENSO spanning the past 7000 years from the Northern Line Islands, located in the center of action for ENSO. The corals document highly variable ENSO activity, with no evidence for a systematic trend in ENSO variance, which is contrary to some models that exhibit a response to insolation forcing over this same period. Twentieth-century ENSO variance is significantly higher than average fossil coral ENSO variance but is not unprecedented. Our results suggest that forced changes in ENSO, whether natural or anthropogenic, may be difficult to detect against a background of large internal variability.	[Cobb, Kim M.; Sayani, Hussein R.; Di Lorenzo, Emanuele] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Westphal, Niko; Watson, Jordan T.; Charles, Christopher D.] Scripps Inst Oceanog, La Jolla, CA 92037 USA; [Cheng, H.] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710049, Peoples R China; [Cheng, H.; Edwards, R. L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California San Diego; Scripps Institution of Oceanography; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities	Cobb, KM (corresponding author), Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA.	kcobb@eas.gatech.edu	Edwards, R. Lawrence/I-3124-2014; CHENG, HAI/H-3413-2017; Di Lorenzo, Emanuele/E-9107-2012; Watson, Jordan/U-9798-2019	Edwards, R. Lawrence/0000-0002-7027-5881; CHENG, HAI/0000-0002-5305-9458; Di Lorenzo, Emanuele/0000-0002-1935-7363; Watson, Jordan/0000-0002-1686-0377; Cobb, Kim/0000-0002-2125-9164	NSF-Division of Ocean Sciences [0752091]; National Natural Science Foundation of China [41230524]; NSF-Division of Atmospheric Sciences [1103403]; U.S. Department of Energy (DOE) [DOE-SC0005597]; Division Of Ocean Sciences [0752091] Funding Source: National Science Foundation	NSF-Division of Ocean Sciences(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSF-Division of Atmospheric Sciences; U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors acknowledge field support from the Norwegian Cruise Lines, the National Geographic Waitt program, and the Palmyra Atoll Research Consortium. The research was funded by NSF-Division of Ocean Sciences award 0752091 to K.M.C. and C.D.C., National Natural Science Foundation of China award 41230524 to H.C., NSF-Division of Atmospheric Sciences award 1103403 to R.L.E. and H.C., and U.S. Department of Energy (DOE) award DOE-SC0005597 to E.D.L. A. Wittenberg and C. Ammann generously provided the NINO3.4 time series from the long control runs of the NOAA-GFDL-CM2.1 and NCAR-CCSM4 models, respectively. Data availability: All data and metadata are archived at NCDC (ftp://ftp.ncdc.noaa.gov/pub/data/paleo/coral/east_pacific/line-islands2013.txt).	Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Brown J, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001512; Clement AC, 2000, PALEOCEANOGRAPHY, V15, P731, DOI 10.1029/1999PA000466; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; Collins M, 2010, NAT GEOSCI, V3, P391, DOI 10.1038/NGEO868; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Deser C, 2012, J CLIMATE, V25, P2622, DOI 10.1175/JCLI-D-11-00301.1; Evans MN, 1999, J GEOPHYS RES-OCEANS, V104, P13409, DOI 10.1029/1999JC900001; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Koutavas A, 2006, GEOLOGY, V34, P993, DOI 10.1130/G22810A.1; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; McGregor HV, 2011, GEOCHIM COSMOCHIM AC, V75, P3930, DOI 10.1016/j.gca.2011.04.017; McGregor HV, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019972; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Nurhati IS, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040270; Otto-Bliesner BL, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018553; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stevenson S, 2012, J CLIMATE, V25, P2129, DOI 10.1175/JCLI-D-11-00252.1; Thompson DM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048224; Timmermann A, 2007, J CLIMATE, V20, P4147, DOI 10.1175/JCLI4240.1; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wittenberg AT, 2006, J CLIMATE, V19, P698, DOI 10.1175/JCLI3631.1; Woodroffe CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015868; Zaunbrecher LK, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001788; Zheng W, 2008, CLIM DYNAM, V30, P745, DOI 10.1007/s00382-007-0320-3	30	297	303	23	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					67	70		10.1126/science.1228246	http://dx.doi.org/10.1126/science.1228246			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288537				2022-12-28	WOS:000312985800052
J	Roos, C; Spaanderman, MEA; Schuit, E; Bloemenkamp, KWM; Bolte, AC; Cornette, J; Duvekot, JJJ; van Eyck, J; Franssen, MTM; de Groot, CJ; Kok, JH; Kwee, A; Merien, A; Bijvank, BN; Opmeer, BC; Oudijk, MA; van Pampus, MG; Papatsonis, DNM; Porath, MM; Scheepers, HCJ; Scherjon, SA; Sollie, KM; Vijgen, SMC; Willekes, C; Mol, BJ; van der Post, JAM; Lotgering, FK				Roos, Carolien; Spaanderman, Marc E. A.; Schuit, Ewoud; Bloemenkamp, Kitty W. M.; Bolte, Antoinette C.; Cornette, Jerome; Duvekot, Johannes J. J.; van Eyck, Jim; Franssen, Maureen T. M.; de Groot, Christianne J.; Kok, Joke H.; Kwee, Anneke; Merien, Ashley; Bijvank, Bas Nij; Opmeer, Brent C.; Oudijk, Martijn A.; van Pampus, Marielle G.; Papatsonis, Dimitri N. M.; Porath, Martina M.; Scheepers, Hubertina C. J.; Scherjon, Sicco A.; Sollie, Krystyna M.; Vijgen, Sylvia M. C.; Willekes, Christine; Mol, Ben Willem J.; van der Post, Joris A. M.; Lotgering, Fred K.		APOSTEL-II Study Grp	Effect of Maintenance Tocolysis With Nifedipine in Threatened Preterm Labor on Perinatal Outcomes A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL NIFEDIPINE; BIRTH; INFANTS; METAANALYSIS; PREVENTION; PLACEBO	Importance In threatened preterm labor, maintenance tocolysis with nifedipine, after an initial course of tocolysis and corticosteroids for 48 hours, may improve perinatal outcome. Objective To determine whether maintenance tocolysis with nifedipine will reduce adverse perinatal outcomes due to premature birth. Design, Setting, and Participants APOSTEL-II (Assessment of Perinatal Outcome with Sustained Tocolysis in Early Labor) is a double-blind, placebo-controlled trial performed in 11 perinatal units including all tertiary centers in the Netherlands. From June 2008 to February 2010, women with threatened preterm labor between 26 weeks (plus 0 days) and 32 weeks (plus 2 days) gestation, who had not delivered after 48 hours of tocolysis and a completed course of corticosteroids, were enrolled. Surviving infants were followed up until 6 months after birth (ended August 2010). Intervention Randomization assigned 406 women to maintenance tocolysis with nifedipine orally (80 mg/d; n=201) or placebo (n=205) for 12 days. Assigned treatment was masked from investigators, participants, clinicians, and research nurses. Main Outcome Measures Primary outcome was a composite of adverse perinatal outcomes (perinatal death, chronic lung disease, neonatal sepsis, intraventricular hemorrhage > grade 2, periventricular leukomalacia > grade 1, or necrotizing enterocolitis). Analyses were completed on an intention-to-treat basis. Results Mean (SD) gestational age at randomization was 29.2 (1.7) weeks for both groups. Adverse perinatal outcome was not significantly different between groups: 11.9% (24/201; 95% CI, 7.5%-16.4%) for nifedipine vs 13.7% (28/205; 95% CI, 9.0%-18.4%) for placebo (relative risk, 0.87; 95% CI, 0.53-1.45). Conclusions and Relevance In patients with threatened preterm labor, nifedipine-maintained tocolysis did not result in a statistically significant reduction in adverse perinatal outcomes when compared with placebo. Although the lower than anticipated rate of adverse perinatal outcomes in the control group indicates that a benefit of nifedipine cannot completely be excluded, its use for maintenance tocolysis does not appear beneficial at this time.	[Roos, Carolien; Spaanderman, Marc E. A.; Lotgering, Fred K.] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, NL-6500 HB Nijmegen, Netherlands; [Schuit, Ewoud] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [Kwee, Anneke; Oudijk, Martijn A.] Univ Med Ctr Utrecht, Dept Obstet & Gynecol, Utrecht, Netherlands; [Bloemenkamp, Kitty W. M.; Scherjon, Sicco A.] Leiden Univ, Med Ctr, Dept Obstet & Gynecol, Leiden, Netherlands; [Bolte, Antoinette C.; de Groot, Christianne J.] Vrije Univ Amsterdam, Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Cornette, Jerome; Duvekot, Johannes J. J.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [van Eyck, Jim; Bijvank, Bas Nij] Isala Clin, Dept Obstet & Gynecol, Zwolle, Netherlands; [Franssen, Maureen T. M.; van Pampus, Marielle G.; Sollie, Krystyna M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, NL-9713 AV Groningen, Netherlands; [Kok, Joke H.] Univ Amsterdam, Acad Med Ctr, Dept Neonatol, NL-1105 AZ Amsterdam, Netherlands; [Vijgen, Sylvia M. C.; Mol, Ben Willem J.; van der Post, Joris A. M.] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, NL-1105 AZ Amsterdam, Netherlands; [Opmeer, Brent C.] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, NL-1105 AZ Amsterdam, Netherlands; [Merien, Ashley; Porath, Martina M.] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Papatsonis, Dimitri N. M.] Amphia Hosp, Dept Obstet & Gynecol, Breda, Netherlands; [Scheepers, Hubertina C. J.; Willekes, Christine] Maastricht Univ, Med Ctr, Dept Obstet & Gynecol, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Isala Clinics; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maxima Medical Center; Amphia Hospital; Maastricht University	Roos, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynecol, Local Postal Code 791,POB 9101, NL-6500 HB Nijmegen, Netherlands.	c.roos@obgyn.umcn.nl	Willekes, Christine/GWZ-1205-2022; Oudijk, Martijn A/C-1520-2019; Bolte, A.C./L-4212-2015; Lotgering, F.K./H-8069-2014; Schuit, Ewoud/N-1869-2014; van der Post, Joris A M/A-8991-2008; Merz, Eva-Maria/G-6920-2016	Oudijk, Martijn A/0000-0001-8672-4365; Schuit, Ewoud/0000-0002-9548-3214; Liefbroer, Aart/0000-0002-7884-3150; de Groot, Christianne/0000-0003-3277-2542; van Pampus, Maria/0000-0002-3020-8908; van der Post, Joris/0000-0003-3311-2116; Merz, Eva-Maria/0000-0001-5567-7041	CSL Behring; ZonMw, the Netherlands Organization for Health Research and Development Healthcare Efficiency Program [80-82310-98-08210]	CSL Behring; ZonMw, the Netherlands Organization for Health Research and Development Healthcare Efficiency Program	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Scheepers reports receipt of a grant or pending grant and payment for manuscript preparation from CSL Behring. Dr Lotgering reports provision of expert testimony for the Dutch courts; payment for lectures including service on speakers bureaus from Dutch training institutions; royalties for a Dutch textbook on obstetrics; and stocks/stock options that are private and unrelated. The remaining authors report no disclosures.; This trial was funded by ZonMw, the Netherlands Organization for Health Research and Development Healthcare Efficiency Program grant 80-82310-98-08210.	BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bolisetty S, 2006, AUST NZ J OBSTET GYN, V46, P189, DOI 10.1111/j.1479-828X.2006.00564.x; Carr DB, 1999, AM J OBSTET GYNECOL, V181, P822, DOI 10.1016/S0002-9378(99)70308-X; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P1045, DOI 10.1016/S1470-0328(03)03971-5; DEVRIES LS, 1992, BEHAV BRAIN RES, V49, P1, DOI 10.1016/S0166-4328(05)80189-5; Dodd JM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003927.pub2; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Han SS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000940.pub2; Hibbs AM, 2010, J PEDIATR-US, V156, P202, DOI 10.1016/j.jpeds.2009.08.049; Keirse MJNC, 2003, BJOG-INT J OBSTET GY, V110, P94, DOI 10.1016/S1470-0328(03)00051-X; Lyell DJ, 2007, OBSTET GYNECOL, V110, P61, DOI 10.1097/01.AOG.0000269048.06634.35; Lyell DJ, 2008, OBSTET GYNECOL, V112, P1221, DOI 10.1097/AOG.0b013e31818d8386; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Papatsonis D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005938.pub2; Papatsonis DNM, 1997, OBSTET GYNECOL, V90, P230, DOI 10.1016/S0029-7844(97)00182-8; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Petrou S, 2011, ARCH DIS CHILD-FETAL, V96, pF225, DOI 10.1136/adc.2009.161117; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Sayin NC, 2004, J PERINAT MED, V32, P220, DOI 10.1515/JPM.2004.041; SHENNAN AT, 1988, PEDIATRICS, V82, P527	21	61	64	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					41	47		10.1001/jama.2012.153817	http://dx.doi.org/10.1001/jama.2012.153817			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280223	Green Published, Bronze			2022-12-28	WOS:000319113000025
J	Song, ZR; Lee, TH				Song, Zirui; Lee, Thomas H.			The Era of Delivery System Reform Begins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; PHYSICIANS; PATH		[Song, Zirui] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Song, Zirui] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Lee, Thomas H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Lee, Thomas H.] Partners HealthCare, Boston, MA USA	Harvard University; Harvard Medical School; National Bureau of Economic Research; Harvard University; Brigham & Women's Hospital; Partners Healthcare System	Song, ZR (corresponding author), Harvard Univ, Sch Med, 260 Longwood Ave, Boston, MA 02115 USA.	zirui_song@hms.harvard.edu			NATIONAL INSTITUTE ON AGING [T32AG000186, F30AG039175] Funding Source: NIH RePORTER; NIA NIH HHS [F30 AG039175, T32 AG000186] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bohmer RMJ, 2009, NEW ENGL J MED, V361, P551, DOI 10.1056/NEJMp0903406; Fisher ES, 2011, NEW ENGL J MED, V365, P2445, DOI 10.1056/NEJMp1112442; Gabow P, 2012, JAMA-J AM MED ASSOC, V308, P239, DOI 10.1001/jama.2012.7081; Groopman J, 2007, DOCTORS THINK; Landon BE, 2012, JAMA-J AM MED ASSOC, V308, P265, DOI 10.1001/jama.2012.7615; Lee TH, 2012, HEALTH AFFAIR, V31, P2068, DOI 10.1377/hlthaff.2011.0940; Lee TH, 2012, NEW ENGL J MED, V367, P466, DOI 10.1056/NEJMhpr1204386	7	36	36	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					35	36		10.1001/jama.2012.96870	http://dx.doi.org/10.1001/jama.2012.96870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280220	Green Accepted			2022-12-28	WOS:000319113000022
J	Vaucher, YE; Peralta-Carcelen, M; Finer, NN; Carlo, WA; Gantz, MG; Walsh, MC; Laptook, AR; Yoder, BA; Faix, RG; Das, A; Schibler, K; Rich, W; Newman, NS; Vohr, BR; Yolton, K; Heyne, RJ; Wilson-Costello, DE; Evans, PW; Goldstein, RF; Acarregui, MJ; Adams-Chapman, I; Pappas, A; Hintz, SR; Poindexter, B; Dusick, AM; McGowan, EC; Ehrenkranz, RA; Bodnar, A; Bauer, CR; Fuller, J; O'Shea, TM; Myers, GJ; Higgins, RD				Vaucher, Yvonne E.; Peralta-Carcelen, Myriam; Finer, Neil N.; Carlo, Waldemar A.; Gantz, Marie G.; Walsh, Michele C.; Laptook, Abbot R.; Yoder, Bradley A.; Faix, Roger G.; Das, Abhik; Schibler, Kurt; Rich, Wade; Newman, Nancy S.; Vohr, Betty R.; Yolton, Kimberly; Heyne, Roy J.; Wilson-Costello, Deanne E.; Evans, Patricia W.; Goldstein, Ricki F.; Acarregui, Michael J.; Adams-Chapman, Ira; Pappas, Athina; Hintz, Susan R.; Poindexter, Brenda; Dusick, Anna M.; McGowan, Elisabeth C.; Ehrenkranz, Richard A.; Bodnar, Anna; Bauer, Charles R.; Fuller, Janell; O'Shea, T. Michael; Myers, Gary J.; Higgins, Rosemary D.		Eunice Kennedy Shriver NICHD Neona	Neurodevelopmental Outcomes in the Early CPAP and Pulse Oximetry Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; FREQUENCY OSCILLATORY VENTILATION; PRETERM INFANTS; CEREBRAL-PALSY; CONVENTIONAL VENTILATION; NEONATAL MORBIDITIES; OXYGEN-SATURATION; AGE; RETINOPATHY; PREMATURITY	BACKGROUND Previous results from our trial of early treatment with continuous positive airway pressure (CPAP) versus early surfactant treatment in infants showed no significant difference in the outcome of death or bronchopulmonary dysplasia. A lower (vs. higher) target range of oxygen saturation was associated with a lower rate of severe retinopathy but higher mortality. We now report longer-term results from our prespecified hypotheses. METHODS Using a 2-by-2 factorial design, we randomly assigned infants born between 24 weeks 0 days and 27 weeks 6 days of gestation to early CPAP with a limited ventilation strategy or early surfactant administration and to lower or higher target ranges of oxygen saturation (85 to 89% or 91 to 95%). The primary composite outcome for the longer-term analysis was death before assessment at 18 to 22 months or neurodevelopmental impairment at 18 to 22 months of corrected age. RESULTS The primary outcome was determined for 1234 of 1316 enrolled infants (93.8%); 990 of the 1058 surviving infants (93.6%) were evaluated at 18 to 22 months of corrected age. Death or neurodevelopmental impairment occurred in 27.9% of the infants in the CPAP group (173 of 621 infants), versus 29.9% of those in the surfactant group (183 of 613) (relative risk, 0.93; 95% confidence interval [CI], 0.78 to 1.10; P = 0.38), and in 30.2% of the infants in the lower-oxygen-saturation group (185 of 612), versus 27.5% of those in the higher-oxygen-saturation group (171 of 622) (relative risk, 1.12; 95% CI, 0.94 to 1.32; P = 0.21). Mortality was increased with the lower-oxygen-saturation target (22.1%, vs. 18.2% with the higher-oxygen-saturation target; relative risk, 1.25; 95% CI, 1.00 to 1.55; P = 0.046). CONCLUSIONS We found no significant differences in the composite outcome of death or neurodevelopmental impairment among extremely premature infants randomly assigned to early CPAP or early surfactant administration and to a lower or higher target range of oxygen saturation. (Funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute; SUPPORT ClinicalTrials.gov number, NCT00233324.)	[Finer, Neil N.] Univ Calif San Diego, Div Neonatol, Dept Pediat, San Diego, CA 92013 USA; [Hintz, Susan R.] Stanford Univ, Sch Med, Dept Pediat, Div Neonatal & Dev Med, Palo Alto, CA 94304 USA; [Hintz, Susan R.] Lucile Packard Childrens Hosp, Palo Alto, CA USA; [Peralta-Carcelen, Myriam; Carlo, Waldemar A.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [Gantz, Marie G.] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA; [Goldstein, Ricki F.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [O'Shea, T. Michael] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA; [Walsh, Michele C.; Newman, Nancy S.; Wilson-Costello, Deanne E.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Dept Pediat, Cleveland, OH 44106 USA; [Schibler, Kurt; Yolton, Kimberly] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH USA; [Schibler, Kurt; Yolton, Kimberly] Univ Cincinnati, Cincinnati, OH 45221 USA; [Laptook, Abbot R.; Vohr, Betty R.] Brown Univ, Women & Infants Hosp, Dept Pediat, Providence, RI 02908 USA; [Yoder, Bradley A.; Faix, Roger G.; Bodnar, Anna] Univ Utah, Sch Med, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Das, Abhik] RTI Int, Stat & Epidemiol Unit, Rockville, MD USA; [Higgins, Rosemary D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Heyne, Roy J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Evans, Patricia W.] Univ Texas Houston, Med Sch Houston, Houston, TX USA; [Acarregui, Michael J.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Adams-Chapman, Ira] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Adams-Chapman, Ira] Childrens Healthcare Atlanta, Atlanta, GA USA; [Pappas, Athina] Wayne State Univ, Dept Pediat, Detroit, MI 48202 USA; [Poindexter, Brenda; Dusick, Anna M.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN USA; [McGowan, Elisabeth C.] Floating Hosp Children, Tufts Med Ctr, Div Newborn Med, Dept Pediat, Boston, MA USA; [Ehrenkranz, Richard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Bauer, Charles R.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA; [Fuller, Janell] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Myers, Gary J.] Univ Rochester, Med Ctr, Dept Pediat, Rochester, NY 14642 USA	University of California System; University of California San Diego; Stanford University; Lucile Packard Children's Hospital (LPCH); University of Alabama System; University of Alabama Birmingham; Research Triangle Institute; Duke University; Wake Forest University; Wake Forest Baptist Medical Center; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Brown University; Women & Infants Hospital Rhode Island; Utah System of Higher Education; University of Utah; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Iowa; Emory University; Children's Healthcare of Atlanta (CHOA); Wayne State University; Indiana University System; Indiana University Bloomington; Floating Hospital For Children; Tufts Medical Center; Yale University; University of Miami; University of New Mexico; University of New Mexico's Health Sciences Center; University of Rochester	Finer, NN (corresponding author), Univ Calif San Diego, Div Neonatol, Dept Pediat, 200 W Arbor Dr, San Diego, CA 92013 USA.	nfiner@ucsd.edu	Yunkunis, Kimberly/AAO-5605-2021; Das, Abhik/AAF-1883-2020	Das, Abhik/0000-0003-2722-0479; Gantz, Marie/0000-0001-8528-0184; Hintz, Susan/0000-0001-7023-4433; Gelbard, Harris/0000-0001-5095-7976	Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Heart, Lung, and Blood Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD040461, UG1HD053089, U10HD021373, U10HD053089] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Heart, Lung, and Blood Institute.	Amiel-Tison C., 1998, NEUROLOGICAL DEV BIR; [Anonymous], 2006, BAYLEY SCALES INFANT; Arpino C, 2010, CHILD NERV SYST, V26, P1139, DOI 10.1007/s00381-010-1125-y; Askie LM, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-6; Barrington KJ, 2010, COCHRANE DB SYST REV, V12; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Beaino G, 2010, DEV MED CHILD NEUROL, V52, pE119, DOI 10.1111/j.1469-8749.2010.03612.x; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chen J, 2011, CURR OPIN PEDIATR, V23, P173, DOI 10.1097/MOP.0b013e3283423f35; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Donohue PK, 2011, PEDIATRICS, V127, pE414, DOI 10.1542/peds.2010-3428; Farooqi A, 2011, PEDIATRICS, V127, pE1247, DOI 10.1542/peds.2010-0806; Finer NN, 2010, NEW ENGL J MED, V362, P2235; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kobaly K, 2008, PEDIATRICS, V121, P73, DOI 10.1542/peds.2007-1444; Laptook AR, 2005, PEDIATRICS, V115, P673, DOI 10.1542/peds.2004-0667; Marlow N, 2006, ARCH DIS CHILD-FETAL, V91, P320, DOI 10.1136/adc.2005.079632; Mikkola K, 2005, PEDIATRICS, V116, P1391, DOI 10.1542/peds.2005-0171; Neubauer AP, 2008, EUR J PEDIATR, V167, P87, DOI 10.1007/s00431-007-0435-x; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Palmer EA, 2005, ARCH OPHTHALMOL-CHIC, V123, P311; Rich W, 2012, PEDIATRICS, V129, P480, DOI 10.1542/peds.2011-2121; Rich WD, 2010, PEDIATRICS, V126, pE215, DOI 10.1542/peds.2009-3353; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Saugstad Ola Didrik, 2003, J Matern Fetal Neonatal Med, V14, P145, DOI 10.1080/713606611; Saugstad OD, 2011, NEONATOLOGY, V100, P1, DOI 10.1159/000322001; Schulzke SM, 2007, ARCH PEDIAT ADOL MED, V161, P583, DOI 10.1001/archpedi.161.6.583; Sinn JKH, 2002, J PAEDIATR CHILD H, V38, P597, DOI 10.1046/j.1440-1754.2002.00061.x; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Tin W, 2001, ARCH DIS CHILD-FETAL, V84, pF106, DOI 10.1136/fn.84.2.F106; Truffert P, 2007, PEDIATRICS, V119, pE860, DOI 10.1542/peds.2006-2082; Vohr BR, 2000, PEDIATRICS, V105, P1216, DOI 10.1542/peds.105.6.1216; Vohr BR, 2012, J PEDIAT, V161; Walsh MC, 2005, J PEDIATR-US, V146, P798, DOI 10.1016/j.jpeds.2005.01.047; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601	37	133	139	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2495	2504		10.1056/NEJMoa1208506	http://dx.doi.org/10.1056/NEJMoa1208506			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268664	Bronze, Green Accepted			2022-12-28	WOS:000312714200007
J	Smith, R				Smith, Richard			THOUGHTS FOR TODAY Learning from the abolitionists, the first social movement	BRITISH MEDICAL JOURNAL			English	Editorial Material												richardswsmith@yahoo.co.uk						Hague W., 2008, W WILBERFORCE LIFE G; Hochschild Adam, 2005, BURY CHAINS BRIT STR; Tilly Charles, 2004, SOCIAL MOVEMENTS 176	3	4	4	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8301	10.1136/bmj.e8301	http://dx.doi.org/10.1136/bmj.e8301			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23253354				2022-12-28	WOS:000312700100013
J	Webster, S; Shotliff, K; Sharma, U; Bell, D				Webster, Shelby; Shotliff, Kevin; Sharma, Urvashi; Bell, Derek			CHRISTMAS 2012: LIVES OF DOCTORS Doctors on television: analysis of doctors' experiences during filming of a documentary in the workplace	BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDIA		[Webster, Shelby; Shotliff, Kevin] Chelsea & Westminster Hosp NHS Fdn Trust, Dept Postgrad Med Educ, London SW10 9NH, England; [Sharma, Urvashi; Bell, Derek] Chelsea & Westminster Hosp, NIHR Collaborat Leadership Appl Hlth Res & Care, London, England; [Sharma, Urvashi; Bell, Derek] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Webster, S (corresponding author), Chelsea & Westminster Hosp NHS Fdn Trust, Dept Postgrad Med Educ, London SW10 9NH, England.	shelbywebster@doctors.org.uk		Bell, Derek/0000-0002-9944-1097				American Medical Association, 2005, ETH PHYS PART REAL T; British Medical Association, 2011, SOC MED GUID; Bruzzi S, 2006, NEW DOCUMENTARY, P120; Department of Health, 2005, GUID FILM NHS; General Medical Council, 2006, GOOD MED PRACT; General Medical Council, 2011, MAK US VIS AUD REC P; Hewson MG, 1998, J GEN INTERN MED, V13, P111, DOI 10.1046/j.1525-1497.1998.00027.x; Hill Annette., 2005, REALITY TV AUDIENCES; Launer J, 2006, SUPERVISION MENTORIN; Lee-Wright Peter, 2010, DOCUMENTARY HDB; Marco CA, 2002, ACAD EMERG MED, V9, P248; Medical Protection Society, 2012, GUID DOCT HANDL MED; Mirza Y, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1843; Murphy-Hoefer R, 2010, J AM COLL HEALTH, V58, P373, DOI 10.1080/07448480903380276; Nelkin D, 1996, LANCET, V347, P1600, DOI 10.1016/S0140-6736(96)91081-8; Nilsen Stein, 2005, BMC Med Educ, V5, P28, DOI 10.1186/1472-6920-5-28; Primack BA, 2008, PUBLIC HEALTH, V122, P379, DOI 10.1016/j.puhe.2007.07.022; Reynolds EE, 2000, TEACH LEARN MED, P109; Schon D.A, 2017, REFLECTIVE PRACTITIO; Sipple L, 2008, WATCH NOT WATCH IS Q; Summers G, BMJ CAREERS	21	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 19	2012	345								e8220	10.1136/bmj.e8220	http://dx.doi.org/10.1136/bmj.e8220			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JE	23255586				2022-12-28	WOS:000312700100014
J	Wallentin, J; Anttu, N; Asoli, D; Huffman, M; Aberg, I; Magnusson, MH; Siefer, G; Fuss-Kailuweit, P; Dimroth, F; Witzigmann, B; Xu, HQ; Samuelson, L; Deppert, K; Borgstrom, MT				Wallentin, Jesper; Anttu, Nicklas; Asoli, Damir; Huffman, Maria; Aberg, Ingvar; Magnusson, Martin H.; Siefer, Gerald; Fuss-Kailuweit, Peter; Dimroth, Frank; Witzigmann, Bernd; Xu, H. Q.; Samuelson, Lars; Deppert, Knut; Borgstrom, Magnus T.			InP Nanowire Array Solar Cells Achieving 13.8% Efficiency by Exceeding the Ray Optics Limit	SCIENCE			English	Article							ABSORPTION; LIGHT; PHOTOLUMINESCENCE	Photovoltaics based on nanowire arrays could reduce cost and materials consumption compared with planar devices but have exhibited low efficiency of light absorption and carrier collection. We fabricated a variety of millimeter-sized arrays of p-type/intrinsic/n-type (p-i-n) doped InP nanowires and found that the nanowire diameter and the length of the top n-segment were critical for cell performance. Efficiencies up to 13.8% (comparable to the record planar InP cell) were achieved by using resonant light trapping in 180-nanometer-diameter nanowires that only covered 12% of the surface. The share of sunlight converted into photocurrent (71%) was six times the limit in a simple ray optics description. Furthermore, the highest open-circuit voltage of 0.906 volt exceeds that of its planar counterpart, despite about 30 times higher surface-to-volume ratio of the nanowire cell.	[Wallentin, Jesper; Anttu, Nicklas; Xu, H. Q.; Samuelson, Lars; Deppert, Knut; Borgstrom, Magnus T.] Lund Univ, S-22100 Lund, Sweden; [Asoli, Damir; Huffman, Maria; Aberg, Ingvar; Magnusson, Martin H.] Sol Volta AB, S-22370 Lund, Sweden; [Siefer, Gerald; Fuss-Kailuweit, Peter; Dimroth, Frank] Fraunhofer ISE, D-79110 Freiburg, Germany; [Witzigmann, Bernd] Univ Kassel, D-34121 Kassel, Germany; [Xu, H. Q.] Peking Univ, Key Lab Phys & Chem Nanodevices, Beijing 100871, Peoples R China; [Xu, H. Q.] Peking Univ, Dept Elect, Beijing 100871, Peoples R China	Lund University; Universitat Kassel; Peking University; Peking University	Borgstrom, MT (corresponding author), Lund Univ, Box 118, S-22100 Lund, Sweden.	magnus.borgstrom@ftf.lth.se	Deppert, Knut/A-6719-2008; Wallentin, Jesper/A-7265-2010; Borgström, Magnus T/B-2237-2008; Anttu, Nicklas/K-8807-2012; Magnusson, Martin H/B-2518-2013; Xu, Hongqi/D-4248-2017; Magnusson, Martin/AAH-9688-2020; Samuelson, Lars/A-2171-2010	Deppert, Knut/0000-0002-0471-951X; Wallentin, Jesper/0000-0001-5909-0483; Borgström, Magnus T/0000-0001-8061-0746; Magnusson, Martin H/0000-0002-8049-2142; Xu, Hongqi/0000-0001-6434-2569; Magnusson, Martin/0000-0002-8049-2142; Samuelson, Lars/0000-0003-1971-9894; Witzigmann, Bernd/0000-0001-9705-9516; Siefer, Gerald/0000-0001-9387-0010; Huffman, Maria/0000-0003-2893-5679	Swedish Research Council (Vetenskapsradet); Knut and Alice Wallenberg Foundation; Swedish Energy Agency; European Union program AMON-RA [214814]; E.ON AG as part of the E.ON International Research Initiative	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); European Union program AMON-RA; E.ON AG as part of the E.ON International Research Initiative	This work was performed within the Nanometer Structure Consortium at Lund University (nmC@LU) and was supported by the Swedish Research Council (Vetenskapsradet), by the Knut and Alice Wallenberg Foundation, by the Swedish Energy Agency, and by the European Union program AMON-RA (214814). This Report is based on a project that was funded by E.ON AG as part of the E.ON International Research Initiative. We thank M. Graczyk for nanoimprint lithography and S. Lehmann for transmission electron microscopy.	Anttu N, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.165431; Anttu N, 2010, J NANOSCI NANOTECHNO, V10, P7183, DOI 10.1166/jnn.2010.2907; Borgstrom MT, 2011, IEEE J SEL TOP QUANT, V17, P1050, DOI 10.1109/JSTQE.2010.2073681; Borgstrom MT, 2010, NANO RES, V3, P264, DOI 10.1007/s12274-010-1029-x; Colombo C, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3125435; Garnett E, 2010, NANO LETT, V10, P1082, DOI 10.1021/nl100161z; Garnett EC, 2011, ANNU REV MATER RES, V41, P269, DOI 10.1146/annurev-matsci-062910-100434; Glembocki O. J., 1985, HDB OPTICAL CONSTANT, P503; Goto H, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.035004; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P606, DOI 10.1002/pip.2267; Hu L, 2007, NANO LETT, V7, P3249, DOI 10.1021/nl071018b; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Ip AH, 2012, NAT NANOTECHNOL, V7, P577, DOI [10.1038/nnano.2012.127, 10.1038/NNANO.2012.127]; Joyce HJ, 2012, NANO LETT, V12, P5325, DOI 10.1021/nl3026828; Keavney C. J., 1990, PHOT SPEC C 1990 21, V1, P141; Kelzenberg MD, 2010, NAT MATER, V9, P368, DOI 10.1038/nmat2727; Kupec J, 2010, OPT EXPRESS, V18, P27589, DOI 10.1364/OE.18.027589; Martensson T, 2004, NANO LETT, V4, P1987, DOI 10.1021/nl0487267; Martensson T, 2004, NANO LETT, V4, P699, DOI 10.1021/nl035100s; Mishra A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2828034; Munch S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/10/105711; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Polman A, 2012, NAT MATER, V11, P174, DOI 10.1038/nmat3263; van Weert MHM, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168255; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340; Wu PM, 2012, NANO LETT, V12, P1990, DOI 10.1021/nl204552v; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688	27	953	967	11	813	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1057	1060		10.1126/science.1230969	http://dx.doi.org/10.1126/science.1230969			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328392				2022-12-28	WOS:000315452000036
J	Palfrey, JS; Palfrey, S				Palfrey, Judith S.; Palfrey, Sean			Preventing Gun Deaths in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Palfrey, Judith S.] Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA; [Palfrey, Sean] Boston Med Ctr, Dept Pediat, Boston, MA USA	Harvard University; Boston Children's Hospital; Boston Medical Center	Palfrey, JS (corresponding author), Boston Childrens Hosp, Div Gen Pediat, Boston, MA USA.							Barkin SL, 2008, PEDIATRICS, V122, pE15, DOI 10.1542/peds.2007-2611; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Kellermann AL, JAMA; Olson LM, 2010, PED AC SOC ANN M VAN	4	27	27	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					401	403		10.1056/NEJMp1215606	http://dx.doi.org/10.1056/NEJMp1215606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23272974				2022-12-28	WOS:000314215400003
J	Tian, YJ; Xu, B; Yu, DL; Ma, YM; Wang, YB; Jiang, YB; Hu, WT; Tang, CC; Gao, YF; Luo, K; Zhao, ZS; Wang, LM; Wen, B; He, JL; Liu, ZY				Tian, Yongjun; Xu, Bo; Yu, Dongli; Ma, Yanming; Wang, Yanbin; Jiang, Yingbing; Hu, Wentao; Tang, Chengchun; Gao, Yufei; Luo, Kun; Zhao, Zhisheng; Wang, Li-Min; Wen, Bin; He, Julong; Liu, Zhongyuan			Ultrahard nanotwinned cubic boron nitride	NATURE			English	Article							MECHANICAL-PROPERTIES; HIGH-PRESSURE; MAXIMUM STRENGTH; HIGH-TEMPERATURE; HARDNESS; DIAMOND; NUCLEATION; METALS; COPPER; TOOLS	Cubic boron nitride (cBN) is a well known superhard material that has a wide range of industrial applications. Nanostructuring of cBN is an effective way to improve its hardness by virtue of the Hall-Petch effect-the tendency for hardness to increase with decreasing grain size(1,2). Polycrystalline cBN materials are often synthesized by using the martensitic transformation of a graphite-like BN precursor, in which high pressures and temperatures lead to puckering of the BN layers(3). Such approaches have led to synthetic polycrystalline cBN having grain sizes as small as similar to 14 nm (refs 1, 2, 4, 5). Here we report the formation of cBN with a nanostructure dominated by fine twin domains of average thickness similar to 3.8 nm. This nanotwinned cBN was synthesized from specially prepared BN precursor nanoparticles possessing onion-like nested structures with intrinsically puckered BN layers and numerous stacking faults. The resulting nanotwinned cBN bulk samples are optically transparent with a striking combination of physical properties: an extremely high Vickers hardness (exceeding 100 GPa, the optimal hardness of synthetic diamond), a high oxidization temperature (similar to 1,294 degrees C) and a large fracture toughness (>12 MPa m(1/2), well beyond the toughness of commercial cemented tungsten carbide, similar to 10 MPa m(1/2)). We show that hardening of cBN is continuous with decreasing twin thickness down to the smallest sizes investigated, contrasting with the expected reverse Hall-Petch effect below a critical grain size or the twin thickness of similar to 10-15 nm found in metals and alloys.	[Tian, Yongjun; Xu, Bo; Yu, Dongli; Hu, Wentao; Gao, Yufei; Luo, Kun; Zhao, Zhisheng; Wang, Li-Min; Wen, Bin; He, Julong; Liu, Zhongyuan] Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China; [Ma, Yanming] Jilin Univ, State Key Lab Superhard Mat, Changchun 130012, Peoples R China; [Wang, Yanbin] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60439 USA; [Jiang, Yingbing] Univ New Mexico, TEM Lab, Albuquerque, NM 87131 USA; [Tang, Chengchun] Hebei Univ Technol, Sch Mat Sci & Engn, Tianjin 300130, Peoples R China	Yanshan University; Jilin University; University of Chicago; University of New Mexico; Hebei University of Technology	Tian, YJ (corresponding author), Yanshan Univ, State Key Lab Metastable Mat Sci & Technol, Qinhuangdao 066004, Peoples R China.	fhcl@ysu.edu.cn	Ma, Yanming/ABE-8450-2020; Zhao, Zhisheng/AAA-7969-2021; Gao, Yu/HGE-1937-2022; Zhao, Zhisheng/G-8199-2015; Wen, Bin/G-8404-2012; Tian, Yongjun/A-1693-2010; Xu, Bo/C-6925-2008; Luo, Kun/AAV-6532-2021; Ma, Yanming/A-7297-2008	Zhao, Zhisheng/0000-0001-8492-0151; Zhao, Zhisheng/0000-0001-8492-0151; Wen, Bin/0000-0001-9846-5452; Tian, Yongjun/0000-0002-4594-4879; Xu, Bo/0000-0002-9804-1614; Luo, Kun/0000-0002-5826-1612; Ma, Yanming/0000-0003-3711-0011; Wang, Yanbin/0000-0001-5716-3183; Yu, Dongli/0000-0002-0914-6837; Liu, Zhongyuan/0000-0002-5600-8998	Ministry of Science and Technology of China [2011CB808205, 2010CB731605]; National Natural Science Foundation of China [51121061, 51172197, 11025418, 91022029]; US National Science Foundation [EAR-0968456]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); US National Science Foundation(National Science Foundation (NSF))	We thank J. K. Yu for help with the differential scanning calorimetry measurements. Y.J.T. and Z.Y.L. acknowledge financial support from the Ministry of Science and Technology of China (grants 2011CB808205 and 2010CB731605), Y.J.T., D.L.Y., Y.M.M. and J.L.H. are grateful for financial support from the National Natural Science Foundation of China (grants 51121061, 51172197, 11025418 and 91022029), and Y.B.W. acknowledges financial support from the US National Science Foundation (EAR-0968456).	Berger C, 2010, MATERIALWISS WERKST, V41, P5, DOI 10.1002/mawe.200900529; Brazhkin V, 2004, NAT MATER, V3, P576, DOI 10.1038/nmat1196; Britun VF, 2000, HIGH PRESSURE RES, V17, P101, DOI 10.1080/08957950008200933; Dub SN, 2006, HIGH PRESSURE RES, V26, P71, DOI 10.1080/08957950600764239; Dubrovinskaia N, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2711277; Gao FM, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.015502; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Harris TK, 2004, INT J REFRACT MET H, V22, P105, DOI 10.1016/j.ijrmhm.2004.01.004; He LL, 1998, MICROSC RES TECHNIQ, V40, P243, DOI 10.1002/(SICI)1097-0029(19980215)40:4<243::AID-JEMT1>3.3.CO;2-8; Irifune T, 2003, NATURE, V421, P599, DOI 10.1038/421599b; Krauss AR, 2001, DIAM RELAT MATER, V10, P1952, DOI 10.1016/S0925-9635(01)00385-5; Leinenweber KD, 2012, AM MINERAL, V97, P353, DOI 10.2138/am.2012.3844; Li XY, 2010, NATURE, V464, P877, DOI 10.1038/nature08929; Liew WYH, 2004, INT J ADV MANUF TECH, V23, P11, DOI 10.1007/s00170-002-1520-y; Lu L, 2009, SCIENCE, V323, P607, DOI 10.1126/science.1167641; Oku T, 2003, DIAM RELAT MATER, V12, P1138, DOI 10.1016/S0925-9635(02)00329-1; Oleinik GS, 1998, DIAM RELAT MATER, V7, P1684, DOI 10.1016/S0925-9635(98)00248-9; Pande CS, 2009, PROG MATER SCI, V54, P689, DOI 10.1016/j.pmatsci.2009.03.008; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schiotz J, 1998, NATURE, V391, P561, DOI 10.1038/35328; Solozhenko VL, 2001, DIAM RELAT MATER, V10, P2228, DOI 10.1016/S0925-9635(01)00513-1; Solozhenko VL, 2012, ADV MATER, V24, P1540, DOI 10.1002/adma.201104361; Sumiya H, 2007, J MATER RES, V22, P2345, DOI 10.1557/JMR.2007.0295; Sumiya H, 2000, J MATER SCI, V35, P1181, DOI 10.1023/A:1004780218732; Tang CC, 2008, ADV FUNCT MATER, V18, P3653, DOI 10.1002/adfm.200800493; Tian YJ, 2012, INT J REFRACT MET H, V33, P93, DOI 10.1016/j.ijrmhm.2012.02.021; Tse JS, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140102; Wang YB, 2009, PHYS EARTH PLANET IN, V174, P270, DOI 10.1016/j.pepi.2008.06.017; WENTORF RH, 1980, SCIENCE, V208, P873, DOI 10.1126/science.208.4446.873	30	539	570	59	1215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					385	388		10.1038/nature11728	http://dx.doi.org/10.1038/nature11728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325219				2022-12-28	WOS:000313615900047
J	Erren, TC; Erren, M; Shaw, DM				Erren, Thomas C.; Erren, Michael; Shaw, David M.			Peer reviewers can meet journals' criteria for authorship	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Erren, Thomas C.] Univ Hosp Cologne, Cologne, Germany; [Erren, Michael] Univ Munster, Univ Hosp Munster, Ctr Lab Med, Munster, Germany; [Shaw, David M.] Univ Basel, Inst Biomed Eth, Basel, Switzerland	University of Cologne; University of Munster; University of Basel	Shaw, DM (corresponding author), Univ Basel, Inst Biomed Eth, Basel, Switzerland.	davidmartinshaw@gmail.com						[Anonymous], 2009, NAT STRUCT MOL BIOL, V16, P899; Erren TC, 2012, NATURE, V488, P590, DOI 10.1038/488590c; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; *ICMJE, 2009, BIOMEDICAL J UNPUB; Shaw D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7192; Shaw DM, 2011, J MED ETHICS, V37, P706, DOI 10.1136/medethics-2011-100120	6	3	3	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f166	10.1136/bmj.f166	http://dx.doi.org/10.1136/bmj.f166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075FI	23325884				2022-12-28	WOS:000313868800005
J	Hirsch, C				Hirsch, Calvin			Ginkgo biloba extract did not reduce risk for Alzheimer disease in elderly patients with memory complaints	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; Leoutsakos JMS, 2012, INT J GERIATR PSYCH, V27, P364, DOI 10.1002/gps.2723; Middleton LE, 2011, ARCH INTERN MED, V171, P1251, DOI 10.1001/archinternmed.2011.277	3	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC7	10.7326/0003-4819-158-2-201301150-02007	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318341				2022-12-28	WOS:000314029400006
J	Phu, NH; Nguyen, THM; Ho, DTN; Tran, THC; Loc, PP; Thai, LH; Phuong, TM; Thai, CQ; Dinh, NHM; Nguyen, VVC; Tran, VTN; Campbell, J; Baker, S; Whitehorn, J				Nguyen Hoan Phu; Nguyen Thi Hoang Mai; Ho Dang Trung Nghia; Tran Thi Hong Chau; Pham Phu Loc; Le Hong Thai; Tran My Phuong; Cao Quang Thai; Dinh Nguyen Huy Man; Nguyen Van Vinh Chau; Tran Vu Thieu Nga; Campbell, James; Baker, Stephen; Whitehorn, James			Fatal consequences of freshwater pearl diving	LANCET			English	Editorial Material							NAEGLERIA-FOWLERI; BALAMUTHIA-MANDRILLARIS; ACANTHAMOEBA SPP.		[Tran Vu Thieu Nga; Campbell, James; Baker, Stephen; Whitehorn, James] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Campbell, James; Baker, Stephen] Univ Oxford, Ctr Trop Dis, Oxford, England; [Whitehorn, James] Univ London London Sch Hyg & Trop Med, Dept Clin Res, London WC1E 7HT, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Whitehorn, J (corresponding author), Univ Oxford, Clin Res Unit, Hosp Trop Dis, 764 Vo Van Kiet,Ward 1,Dist 5, Ho Chi Minh City, Vietnam.	james.whitehorn@lshtm.ac.uk		Whitehorn, James/0000-0003-0789-5954; Baker, Stephen/0000-0003-1308-5755	Wellcome Trust [100087, 089276] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cervantes-Sandoval I, 2008, PARASITOL INT, V57, P307, DOI 10.1016/j.parint.2008.01.006; Heggie TW, 2010, TRAVEL MED INFECT DI, V8, P201, DOI 10.1016/j.tmaid.2010.06.001; Kemble SK, 2012, CLIN INFECT DIS, V54, P805, DOI 10.1093/cid/cir961; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x	5	12	12	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					176	176		10.1016/S0140-6736(12)61730-9	http://dx.doi.org/10.1016/S0140-6736(12)61730-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23312755	Green Accepted			2022-12-28	WOS:000313420900034
J	Sun, W; McConnell, E; Pare, JF; Xu, QW; Chen, M; Peng, WG; Lovatt, D; Han, XN; Smith, Y; Nedergaard, M				Sun, Wei; McConnell, Evan; Pare, Jean-Francois; Xu, Qiwu; Chen, Michael; Peng, Weiguo; Lovatt, Ditte; Han, Xiaoning; Smith, Yoland; Nedergaard, Maiken			Glutamate-Dependent Neuroglial Calcium Signaling Differs Between Young and Adult Brain	SCIENCE			English	Article							IN-VIVO; ASTROCYTES; CORTEX; COMMUNICATION; TRANSCRIPTOME; MODULATION; REGULATORS; SYNAPSES; NEURONS; GLIA	An extensive literature shows that astrocytes exhibit metabotropic glutamate receptor 5 (mGluR5)-dependent increases in cytosolic calcium ions (Ca2+) in response to glutamatergic transmission and, in turn, modulate neuronal activity by their Ca2+-dependent release of gliotransmitters. These findings, based on studies of young rodents, have led to the concept of the tripartite synapse, in which astrocytes actively participate in neurotransmission. Using genomic analysis, immunoelectron microscopy, and two-photon microscopy of astrocytic Ca2+ signaling in vivo, we found that astrocytic expression of mGluR5 is developmentally regulated and is undetectable after postnatal week 3. In contrast, mGluR3, whose activation inhibits adenylate cyclase but not calcium signaling, was expressed in astrocytes at all developmental stages. Neuroglial signaling in the adult brain may therefore occur in a manner fundamentally distinct from that exhibited during development.	[Sun, Wei; McConnell, Evan; Xu, Qiwu; Chen, Michael; Peng, Weiguo; Lovatt, Ditte; Han, Xiaoning; Nedergaard, Maiken] Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, Rochester, NY 14642 USA; [Pare, Jean-Francois; Smith, Yoland] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Pare, Jean-Francois; Smith, Yoland] Emory Univ, Dept Neurol, Atlanta, GA 30329 USA	University of Rochester; Emory University; Emory University	Nedergaard, M (corresponding author), Univ Rochester, Ctr Translat Neuromed, Div Glial Dis & Therapeut, 601 Elmwood Ave, Rochester, NY 14642 USA.	Nedergaard@URMC.Rochester.edu			National Institute of Neurological Disorders and Stroke, NIH [NS075177, NS078304]; NIH National Center for Research Resources of the Yerkes National Primate Research Center [RR00165]; National Center for Research Resources the Office of Research Infrastructure Programs/OD [P51RR000165, P51OD011132]; American Heart Association [12PRE12030048]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078167, R01NS075177, R01NS078304] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH National Center for Research Resources of the Yerkes National Primate Research Center; National Center for Research Resources the Office of Research Infrastructure Programs/OD; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Neurological Disorders and Stroke, NIH (NS075177 and NS078304), the NIH National Center for Research Resources base grant of the Yerkes National Primate Research Center (RR00165), and the National Center for Research Resources P51RR000165 the Office of Research Infrastructure Programs/OD P51OD011132 to the Yerkes National Primate Research Center, and an American Heart Association Predoctoral Fellowship (12PRE12030048). We thank A. Cornwell, P. Kammermeier, T. Takano, and B. Kress for discussions; J. Rothstein for transgenic mice; and B. Barres and N. Heintz for generously sharing their transcriptome data.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bekar LK, 2008, CEREB CORTEX, V18, P2789, DOI 10.1093/cercor/bhn040; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Lovatt D., 2012, NEUROGLIA, P347; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Panatier A, 2011, CELL, V146, P785, DOI 10.1016/j.cell.2011.07.022; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Peters A, 1991, FINE STRUCTURE NERVO, Vxviii; Petralia RS, 1996, NEUROSCIENCE, V71, P949, DOI 10.1016/0306-4522(95)00533-1; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI 10.1177/1073858410387304; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Thrane AS, 2012, P NATL ACAD SCI USA, V109, P18974, DOI 10.1073/pnas.1209448109; Torres A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002160; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	21	343	350	2	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					197	200		10.1126/science.1226740	http://dx.doi.org/10.1126/science.1226740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307741	Green Accepted			2022-12-28	WOS:000313328200042
J	Pedersen, VK; Egholm, DL				Pedersen, Vivi Kathrine; Egholm, David Lundbek			Glaciations in response to climate variations preconditioned by evolving topography	NATURE			English	Article							ICE MASSES; EROSION; RELIEF; DENUDATION; MORPHOLOGY; MECHANISM; BUZZSAW; LIMITS; ALPS	Landscapes modified by glacial erosion show a distinct distribution of surface area with elevation(1-3) (hypsometry). In particular, the height of these regions is influenced by climatic gradients controlling the altitude where glacial and periglacial processes are the most active, and as a result, surface area is focused just below the snowline altitude(1-9). Yet the effect of this distinct glacial hypsometric signature on glacial extent and therefore on continued glacial erosion has not previously been examined. Here we show how this topographic configuration influences the climatic sensitivity of Alpine glaciers, and how the development of a glacial hypsometric distribution influences the intensity of glaciations on timescales of more than a few glacial cycles. We find that the relationship between variations in climate and the resulting variation in areal extent of glaciation changes drastically with the degree of glacial modification in the landscape. First, in landscapes with novel glaciations, a nearly linear relationship between climate and glacial area exists. Second, in previously glaciated landscapes with extensive area at a similar elevation, highly nonlinear and rapid glacial expansions occur with minimal climate forcing, once the snowline reaches the hypsometric maximum. Our results also show that erosion associated with glaciations before the mid-Pleistocene transition at around 950,000 years ago probably preconditioned the landscape-producing glacial landforms and hypsometric maxima-such that ongoing cooling led to a significant change in glacial extent and erosion, resulting in more extensive glaciations and valley deepening in the late Pleistocene epoch. We thus provide a mechanism that explains previous observations from exposure dating(10) and low-temperature thermochronology(11) in the European Alps, and suggest that there is a strong topographic control on the most recent Quaternary period glaciations.	[Pedersen, Vivi Kathrine] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Egholm, David Lundbek] Aarhus Univ, Dept Geosci, DK-8000 Aarhus, Denmark	University of Bergen; Aarhus University	Pedersen, VK (corresponding author), Univ Bergen, Dept Earth Sci, Allegaten 41, N-5007 Bergen, Norway.	vivi.pedersen@geo.uib.no	Egholm, David/G-8227-2011; Pedersen, Vivi Kathrine/H-7865-2016; Pedersen, Vivi Kathrine/AAX-3985-2020	Pedersen, Vivi Kathrine/0000-0002-5004-8438; Pedersen, Vivi Kathrine/0000-0002-5004-8438; Egholm, David Lundbek/0000-0003-4045-240X	Danish Council for Independent Research; Inge Lehmanns Fund; Danish Council for Independent Research under the Sapere Aude Programme	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Inge Lehmanns Fund; Danish Council for Independent Research under the Sapere Aude Programme	V.K.P. thanks the Danish Council for Independent Research and Inge Lehmanns Fund for funding this research. D. L. E. acknowledges funding from the Danish Council for Independent Research under the Sapere Aude Programme. We thank S. Brocklehurst and P. van der Beek for reviews that improved the manuscript considerably.	Alberti AP, 2004, DEV QUA SCI, V2, P389; Braun J, 1999, ANN GLACIOL-SER, V28, P282, DOI 10.3189/172756499781821797; Brocklehurst SH, 2004, EARTH SURF PROC LAND, V29, P907, DOI 10.1002/esp.1083; Brocklehurst SH, 2002, GEOMORPHOLOGY, V42, P1, DOI 10.1016/S0169-555X(01)00069-1; Brozovic N, 1997, SCIENCE, V276, P571, DOI 10.1126/science.276.5312.571; Delunel R, 2010, EARTH PLANET SC LETT, V293, P72, DOI 10.1016/j.epsl.2010.02.020; Egholm DL, 2012, GEOMORPHOLOGY, V141, P67, DOI 10.1016/j.geomorph.2011.12.020; Egholm DL, 2012, GEOMORPHOLOGY, V141, P47, DOI 10.1016/j.geomorph.2011.12.019; Egholm DL, 2009, NATURE, V460, P884, DOI 10.1038/nature08263; Egholm DL, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001900; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Foster D, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2008JF001135; Haeuselmann P, 2007, GEOLOGY, V35, P143, DOI 10.1130/G23094A; Hales TC, 2009, GEOMORPHOLOGY, V107, P241, DOI 10.1016/j.geomorph.2008.12.012; Herman F, 2011, EARTH PLANET SC LETT, V310, P498, DOI 10.1016/j.epsl.2011.08.022; Kaplan MR, 2009, GEOMORPHOLOGY, V103, P172, DOI 10.1016/j.geomorph.2008.04.020; KERR A, 1993, TERRA NOVA, V5, P332, DOI 10.1111/j.1365-3121.1993.tb00266.x; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; MacGregor KR, 2000, GEOLOGY, V28, P1031, DOI 10.1130/0091-7613(2000)28<1031:NSOGLP>2.0.CO;2; Mitchell SG, 2006, QUATERNARY RES, V65, P96, DOI 10.1016/j.yqres.2005.08.018; Montgomery DR, 2001, GEOLOGY, V29, P579, DOI 10.1130/0091-7613(2001)029<0579:CTATMO>2.0.CO;2; Oerlemans J, 1984, Z GLETSCHERKUNDE GLA, V20, P107; Pedersen VK, 2010, GEOMORPHOLOGY, V122, P129, DOI 10.1016/j.geomorph.2010.06.005; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Steer P, 2012, NAT GEOSCI, V5, P635, DOI [10.1038/NGEO1549, 10.1038/ngeo1549]; Tomkin JH, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002087; Valla PG, 2011, NAT GEOSCI, V4, P688, DOI [10.1038/ngeo1242, 10.1038/NGEO1242]; Weber W. M, 1972, BUR MINES GEOL MEM, V42, P1; Whipple KX, 1999, NATURE, V401, P39, DOI 10.1038/43375; Yanites BJ, 2012, EARTH PLANET SC LETT, V325, P63, DOI 10.1016/j.epsl.2012.01.030	30	84	86	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					206	210		10.1038/nature11786	http://dx.doi.org/10.1038/nature11786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302860				2022-12-28	WOS:000313259600036
J	Rong, Y; Chen, L; Zhu, TT; Song, YD; Yu, M; Shan, ZL; Sands, A; Hu, FB; Liu, LG				Rong, Ying; Chen, Li; Zhu, Tingting; Song, Yadong; Yu, Miao; Shan, Zhilei; Sands, Amanda; Hu, Frank B.; Liu, Liegang			Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; HEALTH-CARE PROFESSIONALS; FACTOR INTERVENTION TRIAL; CARDIOVASCULAR-DISEASE; SERUM-CHOLESTEROL; DIETARY-CHOLESTEROL; VASCULAR-DISEASE; LDL-CHOLESTEROL; STATISTICS-2012 UPDATE; PHYSICIANS HEALTH	Objective To investigate and quantify the potential dose-response association between egg consumption and risk of coronary heart disease and stroke. Design Dose-response meta-analysis of prospective cohort studies. Data sources PubMed and Embase prior to June 2012 and references of relevant original papers and review articles. Eligibility criteria for selecting studies Prospective cohort studies with relative risks and 95% confidence intervals of coronary heart disease or stroke for three or more categories of egg consumption. Results Eight articles with 17 reports (nine for coronary heart disease, eight for stroke) were eligible for inclusion in the meta-analysis (3 081 269 person years and 5847 incident cases for coronary heart disease, and 4 148 095 person years and 7579 incident cases for stroke). No evidence of a curve linear association was seen between egg consumption and risk of coronary heart disease or stroke (P=0.67 and P=0.27 for non-linearity, respectively). The summary relative risk of coronary heart disease for an increase of one egg consumed per day was 0.99 (95% confidence interval 0.85 to 1.15; P=0.88 for linear trend) without heterogeneity among studies (P=0.97, I-2=0%). For stroke, the combined relative risk for an increase of one egg consumed per day was 0.91 (0.81 to 1.02; P=0.10 for linear trend) without heterogeneity among studies (P=0.46, I-2=0%). In a subgroup analysis of diabetic populations, the relative risk of coronary heart disease comparing the highest with the lowest egg consumption was 1.54 (1.14 to 2.09; P=0.01). In addition, people with higher egg consumption had a 25% (0.57 to 0.99; P=0.04) lower risk of developing hemorrhagic stroke. Conclusions Higher consumption of eggs (up to one egg per day) is not associated with increased risk of coronary heart disease or stroke. The increased risk of coronary heart disease among diabetic patients and reduced risk of hemorrhagic stroke associated with higher egg consumption in subgroup analyses warrant further studies.	[Rong, Ying; Chen, Li; Zhu, Tingting; Song, Yadong; Yu, Miao; Shan, Zhilei; Liu, Liegang] Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Key Lab Food Nutr & Safety, Dept Nutr & Food Hyg, Wuhan 430030, Peoples R China; [Rong, Ying; Chen, Li; Zhu, Tingting; Song, Yadong; Yu, Miao; Shan, Zhilei; Liu, Liegang] Tongji Med Coll, Sch Publ Hlth, Key Lab Environm & Hlth, Minist Educ, Wuhan, Peoples R China; [Sands, Amanda; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Sands, Amanda; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Liu, LG (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Hubei Key Lab Food Nutr & Safety, Dept Nutr & Food Hyg, Wuhan 430030, Peoples R China.	lgliu@mails.tjmu.edu.cn	Shan, Zhilei/S-5189-2019	Rong, Ying/0000-0002-8561-7872; Song, Yadong/0000-0003-1424-2011; Shan, Zhilei/0000-0002-6723-3381	National Science and Technology Support Program [2012BAI02B02]; National Natural Science Foundation [NSFC 81072291]; National Basic Research Program of China [2009CB118803]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	National Science and Technology Support Program; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Science and Technology Support Program (2012BAI02B02), National Natural Science Foundation (NSFC 81072291), and National Basic Research Program (2009CB118803) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bernstein AM, 2012, STROKE, V43, P637, DOI 10.1161/STROKEAHA.111.633404; Better Health Channel (Australia), 2009, CHOL; Bingham SA, 2003, LANCET, V362, P212, DOI 10.1016/S0140-6736(03)13913-X; Borggreve SE, 2003, EUR J CLIN INVEST, V33, P1051, DOI 10.1111/j.1365-2362.2003.01263.x; Brandenburg VM, 2012, ATHEROSCLEROSIS, V225, P253, DOI 10.1016/j.atherosclerosis.2012.08.005; Briel M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b92; Burke V, 2007, PREV MED, V44, P135, DOI 10.1016/j.ypmed.2006.09.008; Celermajer DS, 2012, J AM COLL CARDIOL, V60, P1207, DOI 10.1016/j.jacc.2012.03.074; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; DAWBER TR, 1982, AM J CLIN NUTR, V36, P617, DOI 10.1093/ajcn/36.4.617; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Djousse L, 2008, AM J CLIN NUTR, V87, P964, DOI 10.1093/ajcn/87.4.964; Djousse L, 2008, CIRCULATION, V117, P512, DOI 10.1161/CIRCULATIONAHA.107.734210; FIELDING CJ, 1986, J LIPID RES, V27, P1052; Food and Agriculture Organization of the United Nations (FAO), 2009, FOOD BAS DIET GUID C; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Greene CM, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-6; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; He K, 2003, BRIT MED J, V327, P777, DOI 10.1136/bmj.327.7418.777; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2008, INT J EPIDEMIOL, V37, P1158, DOI 10.1093/ije/dyn204; Houston DK, 2011, NUTR METAB CARDIOVAS, V21, P430, DOI 10.1016/j.numecd.2009.11.007; Howard BV, 1999, AM J CARDIOL, V84, p28J; Howell WH, 1997, AM J CLIN NUTR, V65, P1747, DOI 10.1093/ajcn/65.6.1747; Hu FB, 1999, JAMA-J AM MED ASSOC, V281, P1387, DOI 10.1001/jama.281.15.1387; Huxley RR, 2011, CIRCULATION, V124, P2056, DOI 10.1161/CIRCULATIONAHA.111.028373; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kanter MM, 2012, ADV NUTR, V3, P711, DOI 10.3945/an.111.001321; Kipnis V, 2008, J NATL CANCER I, V100, P1658, DOI 10.1093/jnci/djn408; Krauss RM, 2000, STROKE, V31, P2751, DOI 10.1161/01.STR.31.11.2751; Larsen TM, 2010, NEW ENGL J MED, V363, P2102, DOI 10.1056/NEJMoa1007137; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lichtenstein AH, 2006, ARTERIOSCL THROM VAS, V26, P2186, DOI 10.1161/01.ATV.0000238352.25222.5e; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mutungi G, 2008, J NUTR, V138, P272, DOI 10.1093/jn/138.2.272; Mutungi G, 2010, J NUTR BIOCHEM, V21, P261, DOI 10.1016/j.jnutbio.2008.12.011; Nakamura Y, 2004, AM J CLIN NUTR, V80, P58; Nakamura Y, 2006, BRIT J NUTR, V96, P921, DOI 10.1017/BJN20061937; NEATON JD, 1992, ARCH INTERN MED, V152, P1490, DOI 10.1001/archinte.152.7.1490; OConnell D, 2019, NEWCASTLE OTTAWA SCA; OONEDA G, 1978, BLOOD VESSELS, V15, P148; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Qureshi AI, 2007, MED SCI MONITOR, V13, pCR1; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Riemens SC, 1999, J LIPID RES, V40, P1467; Rodgers A, 1998, LANCET, V352, P1801; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenblum JL, 2012, AM J CLIN NUTR, V95, P101, DOI 10.3945/ajcn.111.019489; Sauvaget C, 2003, INT J EPIDEMIOL, V32, P536, DOI 10.1093/ije/dyg151; Scrafford C, 2009, FASEB J, V23; Scrafford CG, 2011, PUBLIC HEALTH NUTR, V14, P261, DOI 10.1017/S1368980010001874; SMITH MA, 1983, PRACTITIONER, V227, P673; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; Song WO, 2000, J AM COLL NUTR, V19, p556S, DOI 10.1080/07315724.2000.10718980; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; Spence JD, 2012, ATHEROSCLEROSIS, V224, P469, DOI 10.1016/j.atherosclerosis.2012.07.032; Spence JD, 2010, CAN J CARDIOL, V26, pE336, DOI 10.1016/S0828-282X(10)70456-6; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TANAKA H, 1982, STROKE, V13, P62, DOI 10.1161/01.STR.13.1.62; TANDON N, 1983, J BIOL CHEM, V258, P1840; VENKATESAN S, 1995, BIOCHEM SOC T, V23, pS278, DOI 10.1042/bst023278s; Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006; YANO K, 1989, STROKE, V20, P1460, DOI 10.1161/01.STR.20.11.1460; Zampelas A, 2012, ATHEROSCLEROSIS, V224, P318, DOI 10.1016/j.atherosclerosis.2012.08.024; Zazpe I, 2011, EUR J CLIN NUTR, V65, P676, DOI 10.1038/ejcn.2011.30	70	258	271	4	141	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								e8539	10.1136/bmj.e8539	http://dx.doi.org/10.1136/bmj.e8539			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YU	23295181	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000313552300001
J	Kressin, NR; Atz, JM				Kressin, Nancy R.; Atz, Joshua M.			Mind the Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kressin, Nancy R.] VA Boston Healthcare Syst, Boston, MA USA; [Kressin, Nancy R.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Atz, Joshua M.] Manchester Vet Clin, Manchester, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University	Kressin, NR (corresponding author), VA Boston Healthcare Syst, Boston, MA USA.	nkressin@bu.edu		Kressin, Nancy/0000-0003-2767-4286	NHLBI NIH HHS [1U01HL105342] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105342] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Detsky AS, 2012, JAMA-J AM MED ASSOC, V308, P1329, DOI 10.1001/2012.jama.11869; Kahrilas PJ, 2008, GASTROENTEROLOGY, V135, P1392, DOI 10.1053/j.gastro.2008.08.044; Kressin NR, 2009, MED CARE, V47, P1121, DOI 10.1097/MLR.0b013e3181b58867; Kressin NR, 2010, 33 ANN M SOC GEN INT; Longman P., 2012, BEST CARE ANYWHERE W; Welch HG, 2004, SHOULD I BE TESTED C	6	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					39	40		10.1001/jama.2012.153826	http://dx.doi.org/10.1001/jama.2012.153826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280222				2022-12-28	WOS:000319113000024
J	Coffin, PO; Sullivan, SD				Coffin, Phillip O.; Sullivan, Sean D.			Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; NEW-YORK-CITY; SAN-FRANCISCO; NONFATAL OVERDOSE; OPIOID OVERDOSE; UNITED-STATES; METHADONE-MAINTENANCE; PROSPECTIVE COHORT; HEALTH-CARE; FOLLOW-UP	Background: Opioid overdose is a leading cause of accidental death in the United States. Objective: To estimate the cost-effectiveness of distributing naloxone, an opioid antagonist, to heroin users for use at witnessed overdoses. Design: Integrated Markov and decision analytic model using deterministic and probabilistic analyses and incorporating recurrent overdoses and a secondary analysis assuming heroin users are a net cost to society. Data Sources: Published literature calibrated to epidemiologic data. Target Population: Hypothetical 21-year-old novice U. S. heroin user and more experienced users with scenario analyses. Time Horizon: Lifetime. Perspective: Societal. Intervention: Naloxone distribution for lay administration. Outcome Measures: Overdose deaths prevented and incremental cost-effectiveness ratio (ICER). Results of Base-Case Analysis: In the probabilistic analysis, 6% of overdose deaths were prevented with naloxone distribution; 1 death was prevented for every 227 naloxone kits distributed (95% CI, 71 to 716). Naloxone distribution increased costs by $53 (CI, $3 to $156) and quality-adjusted life-years by 0.119 (CI, 0.017 to 0.378) for an ICER of $438 (CI, $48 to $1706). Results of Sensitivity Analysis: Naloxone distribution was cost-effective in all deterministic and probabilistic sensitivity and scenario analyses, and it was cost-saving if it resulted in fewer overdoses or emergency medical service activations. In a "worst-case scenario" where overdose was rarely witnessed and naloxone was rarely used, minimally effective, and expensive, the ICER was $14 000. If national drug-related expenditures were applied to heroin users, the ICER was $2429. Limitation: Limited sources of controlled data resulted in wide CIs. Conclusion: Naloxone distribution to heroin users is likely to reduce overdose deaths and is cost-effective, even under markedly conservative assumptions. Primary Funding Source: National Institute of Allergy and Infectious Diseases. Ann Intern Med. 2013;158:1-9.	[Coffin, Phillip O.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Univ Washington, Seattle, WA 98195 USA	San Francisco Department of Public Health; University of Washington; University of Washington Seattle	Coffin, PO (corresponding author), San Francisco Dept Publ Hlth, 25 Van Ness Ave,Suite 500, San Francisco, CA 94102 USA.	pcoffin@gmail.com	Coffin, Phillip O/G-3286-2012	Coffin, Phillip O/0000-0002-3891-6570	National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [5T32AI007140-33]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases.; Grant Support: By grant 5T32AI007140-33 from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.	Albert S, 2011, PAIN MED, V12, pS77, DOI 10.1111/j.1526-4637.2011.01128.x; Bassett IV, 2010, CLIN INFECT DIS, V50, pS77, DOI 10.1086/651477; Bohnert ASB, 2012, DRUG ALCOHOL DEPEN, V120, P168, DOI 10.1016/j.drugalcdep.2011.07.018; Bohnert ASB, 2009, ANN EMERG MED, V54, P618, DOI 10.1016/j.annemergmed.2009.05.004; Briggs A, 2006, DECISION MODELLING H; Bruneau J, 2004, ADDICTION, V99, P727, DOI 10.1111/j.1360-0443.2004.00713.x; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Coffin P, 2012, 19 INT AIDS C WASH D; Coffin PO, 2007, ACAD EMERG MED, V14, P616, DOI [10.1197/j.aem.2007.04.005, 10.1111/j.1553-2712.2007.tb01846.x]; Coffin PO, 2003, ADDICTION, V98, P739, DOI 10.1046/j.1360-0443.2003.00376.x; Coffin PO, 2011, EPIDEMIOLOGIC TRENDS; Darke S, 1996, ADDICTION, V91, P413, DOI 10.1046/j.1360-0443.1996.91341310.x; Darke S, 1996, ADDICTION, V91, P405, DOI 10.1111/j.1360-0443.1996.tb02289.x; Darke S, 2007, J URBAN HEALTH, V84, P283, DOI 10.1007/s11524-006-9156-0; Darke S, 2011, DRUG ALCOHOL DEPEN, V115, P190, DOI 10.1016/j.drugalcdep.2010.10.021; Davidson PJ, 2003, J URBAN HEALTH, V80, P261, DOI 10.1093/jurban/jtg029; Davidson PJ, 2002, ADDICTION, V97, P1511, DOI 10.1046/j.1360-0443.2002.00210.x; Doe-Simkins M, 2009, AM J PUBLIC HEALTH, V99, P788, DOI 10.2105/AJPH.2008.146647; Enteen L, 2010, J URBAN HEALTH, V87, P931, DOI 10.1007/s11524-010-9495-8; Evans JL, 2012, AM J EPIDEMIOL, V175, P302, DOI 10.1093/aje/kwr318; Evans JL, 2009, DRUG ALCOHOL DEPEN, V101, P152, DOI 10.1016/j.drugalcdep.2008.12.007; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Galea S, 2006, ADDICT BEHAV, V31, P907, DOI 10.1016/j.addbeh.2005.07.020; Gossop M, 1996, BRIT MED J, V313, P402; Green TC, 2008, ADDICTION, V103, P979, DOI 10.1111/j.1360-0443.2008.02182.x; Hakansson A, 2008, DRUG ALCOHOL DEPEN, V94, P48, DOI 10.1016/j.drugalcdep.2007.10.014; Hart A, 2011, ANN REPORT FISCAL YE, P148; Hart A, 2004, ANN REPORT JULY 2002, P30; Havens JR, 2011, DRUG ALCOHOL DEPEN, V115, P107, DOI 10.1016/j.drugalcdep.2010.11.003; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hser YI, 2002, OAS ANAL SERIES A; Huo DZ, 2006, ADDICTION, V101, P1606, DOI 10.1111/j.1360-0443.2006.01577.x; Jenkins LM, 2011, J URBAN HEALTH, V88, P118, DOI 10.1007/s11524-010-9525-6; Lankenau SE, 2012, J COMMUNITY HLTH; Larimer ME, 2009, JAMA-J AM MED ASSOC, V301, P1349, DOI 10.1001/jama.2009.414; Leavitt SB, 2010, PRACT PAIN MANAG, V10; Lee CP, 2009, VALUE HEALTH, V12, P80, DOI 10.1111/j.1524-4733.2008.00401.x; Lenton SR, 2000, MED J AUSTRALIA, V173, P260, DOI 10.5694/j.1326-5377.2000.tb125633.x; Mackesy-Amiti ME, 2011, ADDICTION, V106, P601, DOI 10.1111/j.1360-0443.2010.03251.x; Maxwell S, 2006, J ADDICT DIS, V25, P89, DOI 10.1300/J069v25n03_11; McAuley A, 2012, DRUG-EDUC PREV POLIC, V19, P309, DOI 10.3109/09687637.2012.682232; Milloy MJS, 2008, AM J DRUG ALCOHOL AB, V34, P499, DOI 10.1080/00952990802122457; Nosyk B, 2010, J CLIN EPIDEMIOL, V63, P1132, DOI 10.1016/j.jclinepi.2009.12.003; Ochoa KC, 2005, DRUG ALCOHOL DEPEN, V80, P297, DOI 10.1016/j.drugalcdep.2005.04.012; Office of National Drug Control Policy, 2004, OFF NAT DRUG CONT PO; Paone D, 2010, ILLICIT DRUG USE NEW; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Piper TM, 2008, SUBST USE MISUSE, V43, P858, DOI 10.1080/10826080701801261; Pollini RA, 2006, DRUG ALCOHOL DEPEN, V83, P104, DOI 10.1016/j.drugalcdep.2005.10.015; Pyne JM, 2011, ADDICTION, V106, P507, DOI 10.1111/j.1360-0443.2010.03299.x; Rudolph SS, 2011, RESUSCITATION, V82, P1414, DOI 10.1016/j.resuscitation.2011.06.027; Sporer KA, 1996, ACAD EMERG MED, V3, P660, DOI 10.1111/j.1553-2712.1996.tb03487.x; Sporer KA, 1999, ANN INTERN MED, V130, P584, DOI 10.7326/0003-4819-130-7-199904060-00019; Sporer KA, 2007, ANN EMERG MED, V49, P172, DOI 10.1016/j.annemergmed.2006.05.025; Stoove MA, 2009, DRUG ALCOHOL REV, V28, P347, DOI 10.1111/j.1465-3362.2009.00057.x; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; Strang J, 2008, ADDICTION, V103, P1648, DOI 10.1111/j.1360-0443.2008.02314.x; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER A; Teesson M, 2008, ADDICTION, V103, P80, DOI 10.1111/j.1360-0443.2007.02029.x; Tobin KE, 2009, INT J DRUG POLICY, V20, P131, DOI 10.1016/j.drugpo.2008.03.002; Tracy M, 2005, DRUG ALCOHOL DEPEN, V79, P181, DOI 10.1016/j.drugalcdep.2005.01.010; Vanagas G, 2010, MEDICINA-LITHUANIA, V46, P286, DOI 10.3390/medicina46040040; Vilke GM, 2003, ACAD EMERG MED, V10, P893, DOI 10.1197/aemj.10.8.893; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Vlahov D, 2008, SUBST USE MISUSE, V43, P413, DOI 10.1080/10826080701203013; Wagner KD, 2010, INT J DRUG POLICY, V21, P186, DOI 10.1016/j.drugpo.2009.01.003; Walley AY, 2012, ROL NAL OP OV FAT PR; Wampler DA, 2011, PREHOSP EMERG CARE, V15, P320, DOI 10.3109/10903127.2011.569854; Wheeler Eliza, 2012, Morbidity and Mortality Weekly Report, V61, P101; Wu LT, 2011, SUBST ABUSE REHABIL, V2, P77, DOI 10.2147/SAR.S18969; Yokell Michael A, 2011, Med Health R I, V94, P240; Zador D, 1996, MED J AUSTRALIA, V164, P204, DOI 10.5694/j.1326-5377.1996.tb94136.x; Zaric GS, 2000, AM J PUBLIC HEALTH, V90, P1100, DOI 10.2105/AJPH.90.7.1100	73	209	211	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					1	U42		10.7326/0003-4819-158-1-201301010-00003	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277895				2022-12-28	WOS:000313119900002
J	Pitts, SR				Pitts, Stephen R.			Higher-Complexity ED Billing Codes - Sicker Patients, More Intensive Practice, or Improper Payments?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA	Emory University	Pitts, SR (corresponding author), Emory Univ, Sch Med, Dept Emergency Med, Atlanta, GA 30322 USA.							Cubanski J, 2010, HLTH AFF MILLWOOD; Department of Health and Human Services Office of Inspector General, 2012, COD TRENDS MED EV MA; O'Malley Ann S, 2011, Issue Brief Cent Stud Health Syst Change, P1; Pitts SR, 2012, ANN EMERG MED, V60, P679, DOI 10.1016/j.annemergmed.2012.05.014	4	33	33	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2465	2467		10.1056/NEJMp1211315	http://dx.doi.org/10.1056/NEJMp1211315			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268662				2022-12-28	WOS:000312714200003
J	Piaggio, G; Elbourne, DR; Pocock, SJ; Evans, SJW; Altman, DG				Piaggio, Gilda; Elbourne, Diana R.; Pocock, Stuart J.; Evans, Stephen J. W.; Altman, Douglas G.		CONSORT Grp	Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NON-INFERIORITY TRIALS; CLINICAL-TRIALS; DOUBLE-BLIND; ACTIVE-W; ISSUES; EXPLANATION; MULTICENTER; PREVENTION; QUALITY; CANCER	The CONSORT (Consolidated Standards of Reporting Trials) Statement, which includes a checklist and a flow diagram, is a guideline developed to help authors improve the reporting of the findings from randomized controlled trials. It was updated most recently in 2010. Its primary focus is on individually randomized trials with 2 parallel groups that assess the possible superiority of one treatment compared with another. The CONSORT Statement has been extended to other trial designs such as cluster randomization, and recommendations for noninferiority and equivalence trials were made in 2006. In this article, we present an updated extension of the CONSORT checklist for reporting noninferiority and equivalence trials, based on the 2010 version of the CONSORT Statement and the 2008 CONSORT Statement for the reporting of abstracts, and provide illustrative examples and explanations for those items that differ from the main 2010 CONSORT checklist. The intent is to improve reporting of noninferiority and equivalence trials, enabling readers to assess the reliability of their results and conclusions. JAMA. 2012;308(24).2594-2604 www.jama.com	[Piaggio, Gilda] Stat Consultoria, F-01220 Divonne Les Bains, France; [Piaggio, Gilda] Stat Consultoria, Sao Paulo, Brazil; [Piaggio, Gilda; Elbourne, Diana R.; Pocock, Stuart J.; Evans, Stephen J. W.] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Piaggio, G (corresponding author), Stat Consultoria, 1764 Vie Etraz, F-01220 Divonne Les Bains, France.	gilda.piaggio@gmail.com		Evans, Stephen/0000-0002-1474-2596	UK Medical Research Council; Cancer Research UK [C5529]; MRC [MR/J004871/1] Funding Source: UKRI; Medical Research Council [MR/J004871/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The CONSORT Group receives funding from the UK Medical Research Council. Dr Piaggio and Dr Elbourne received a small contribution from the CONSORT group toward the time spent on this and other CONSORT work. Dr Piaggio was supported by the CONSORT group to attend meetings in London. Dr Altman is supported by a Cancer Research UK programme grant (C5529).	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 2006, STAT MED, V25, P1628, DOI 10.1002/sim.2584; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brown D, 2007, STAT MED, V26, P230, DOI 10.1002/sim.2665; Cairns JA, 2008, AM HEART J, V155, P33, DOI 10.1016/j.ahj.2007.09.011; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Chadwick D, 1999, LANCET, V354, P13, DOI 10.1016/S0140-6736(98)10531-7; Chuang-Stein C, 2008, LANCET, V371, P895, DOI 10.1016/S0140-6736(08)60407-9; Committee for Proprietary Medicnal Products, 2004, NOT GUID EV MED PROD; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Costa LJM, 2004, CONTROL CLIN TRIALS, V25, P525, DOI 10.1016/j.cct.2004.08.001; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Dimick JB, 2001, ARCH SURG-CHICAGO, V136, P796, DOI 10.1001/archsurg.136.7.796; Djulbegovic B, 2001, JAMA-J AM MED ASSOC, V285, P1206, DOI 10.1001/jama.285.9.1206; Durkalski VL, 2002, CONTROL CLIN TRIALS, V23, P570, DOI 10.1016/S0197-2456(02)00232-5; DURRLEMAN S, 1990, BIOMETRICS, V46, P329, DOI 10.2307/2531438; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; European Medicines Agency (EMA), 2000, POINTS CONS SWITCH S; Eyawo O, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-69; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Gandjour A, 2008, LANCET, V371, P895, DOI 10.1016/S0140-6736(08)60405-5; Garattini S, 2007, LANCET, V370, P1875, DOI 10.1016/S0140-6736(07)61604-3; Giuliano AE, 2011, JAMA-J AM MED ASSOC, V305, P569, DOI 10.1001/jama.2011.90; Greene WL, 2000, ANN INTERN MED, V132, P715, DOI 10.7326/0003-4819-132-9-200005020-00006; Gulmezoglu AM, 2012, LANCET, V379, P1721, DOI 10.1016/S0140-6736(12)60206-2; Gunnell D, 2005, BMJ-BRIT MED J, V330, P385, DOI 10.1136/bmj.330.7488.385; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; Kaul S, 2005, J AM COLL CARDIOL, V46, P1986, DOI 10.1016/j.jacc.2005.07.062; Kaul S, 2006, ANN INTERN MED, V145, P62, DOI 10.7326/0003-4819-145-1-200607040-00011; Krysan DJ, 2002, PEDIATR INFECT DIS J, V21, P753, DOI 10.1097/00006454-200208000-00011; Lange S, 2005, BIOMETRICAL J, V47, P12, DOI 10.1002/bimj.200410085; Lange S, 2005, BIOMETRICAL J, V47, P99; Lavender T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-59; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; Menten J, 2008, LANCET, V371, P896, DOI 10.1016/S0140-6736(08)60408-0; MOHER D, 1994, JAMA-J AM MED ASSOC, V272, P122, DOI 10.1001/jama.272.2.122; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nunn AJ, 2008, LANCET, V371, P895, DOI 10.1016/S0140-6736(08)60404-3; Parienti Jean-Jacques, 2006, BMC Med Res Methodol, V6, P46, DOI 10.1186/1471-2288-6-46; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Piaggio G, 2001, STAT MED, V20, P3571, DOI 10.1002/sim.1078; POCOCK SJ, 2000, SCI PLACEBO INTERDIS, P236; Rothman KJ, 1996, BMJ-BRIT MED J, V313, P3, DOI 10.1136/bmj.313.7048.3a; Rothmann M, 2003, STAT MED, V22, P239, DOI 10.1002/sim.1400; Sacco RL, 2008, NEW ENGL J MED, V359, P1238, DOI 10.1056/NEJMoa0805002; Schiller P, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-214; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Suda KJ, 2011, PHARMACOTHERAPY, V31, P833, DOI 10.1592/phco.31.9.833; Tanaka S, 2012, CLIN CANCER RES, V18, P1837, DOI 10.1158/1078-0432.CCR-11-1653; Tanenberg RJ, 2011, MAYO CLIN PROC, V86, P615, DOI 10.4065/mcp.2010.0681; Topol EJ, 2001, NEW ENGL J MED, V344, P1888, DOI 10.1056/NEJM200106213442502; US Food and Drug Administration (FDA), 2010, GUID IND NON CLIN TR; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Wangge G, 2010, CLIN PHARMACOL THER, V88, P420, DOI 10.1038/clpt.2010.134; Wangge G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013550; Warriner IK, 2011, LANCET, V377, P1155, DOI 10.1016/S0140-6736(10)62229-5; Wellek S., 2003, TESTING STAT HYPOTHE; Willburger RE, 2007, RHEUMATOLOGY, V46, P1126, DOI 10.1093/rheumatology/kem090; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	68	746	750	3	76	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2594	2604		10.1001/jama.2012.87802	http://dx.doi.org/10.1001/jama.2012.87802			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268518				2022-12-28	WOS:000312916600025
J	Neylon, C				Neylon, Cameron			Open access must enable open use	NATURE			English	Editorial Material												cn@cameronneylon.net		Neylon, Cameron/0000-0002-0068-716X				Battelle Technology Partnership Practice, 2011, EC IMP HUM GEN PROJ; Murray Fiona, 2009, 14819 NBER; Solomon DJ, 2012, J AM SOC INF SCI TEC, V63, P1485, DOI 10.1002/asi.22673; Swan A., 2005, OPEN ACCESS SELF ARC; Swan A., 2012, GOING GOLD REPORT UK; Swan Alma, 2012, POLICY GUIDELINES DE; Williams Heidi L., 2010, 16213 NBER	7	17	17	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					348	349		10.1038/492348a	http://dx.doi.org/10.1038/492348a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23257864				2022-12-28	WOS:000312488200031
J	Ruggenenti, P; Remuzzi, G				Ruggenenti, Piero; Remuzzi, Giuseppe			Idiopathic membranous nephropathy: back to the future?	LANCET			English	Editorial Material							CONTROLLED-TRIAL; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; CHLORAMBUCIL; STEROIDS		[Remuzzi, Giuseppe] Ctr Anna Maria Astori, Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, I-24126 Bergamo, Italy; Azienda Osped Osped Riuniti Bergamo, Nephrol Unit, Bergamo, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo	Remuzzi, G (corresponding author), Ctr Anna Maria Astori, Mario Negri Inst Pharmacol Res, Clin Res Ctr Rare Dis Aldo & Cele Dacco, Sci & Technol Pk Kilometro Rosso, I-24126 Bergamo, Italy.	giuseppe.remuzzi@marionegri.it	Remuzzi, Giuseppe/V-9766-2017	Remuzzi, Giuseppe/0000-0002-6194-3446				Appel GB, 2012, J AM SOC NEPHROL, V23, P1280, DOI 10.1681/ASN.2012060602; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; CATTRAN DC, 1995, KIDNEY INT, V47, P1130, DOI 10.1038/ki.1995.161; DAVISON AM, 1984, CLIN NEPHROL, V22, P61; Faurschou M, 2008, J RHEUMATOL, V35, P100; GARATTINI S, 1988, NEPHRON, V50, P263, DOI 10.1159/000185178; Glassock RJ, 2004, AM J KIDNEY DIS, V44, P562, DOI 10.1053/j.ajkd.2004.06.003; Howman A, 2013, LANCET; International Conference on Harmonisation of technical requirements for pharmaceuticals for human use (ICH), 1996, GUID GOOD CLIN PRACT; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; Perna A, 2004, AM J KIDNEY DIS, V44, P385, DOI 10.1053/j.ajkd.2004.05.020; PONTICELLI C, 1989, NEW ENGL J MED, V320, P8, DOI 10.1056/NEJM198901053200102; Ponticelli C, 1998, J AM SOC NEPHROL, V9, P444; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203	14	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					706	708		10.1016/S0140-6736(12)62033-9	http://dx.doi.org/10.1016/S0140-6736(12)62033-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	098TC	23312809				2022-12-28	WOS:000315570900007
J	Broome, MA; Fedrizzi, A; Rahimi-Keshari, S; Dove, J; Aaronson, S; Ralph, TC; White, AG				Broome, Matthew A.; Fedrizzi, Alessandro; Rahimi-Keshari, Saleh; Dove, Justin; Aaronson, Scott; Ralph, Timothy C.; White, Andrew G.			Photonic Boson Sampling in a Tunable Circuit	SCIENCE			English	Article								Quantum computers are unnecessary for exponentially efficient computation or simulation if the Extended Church-Turing thesis is correct. The thesis would be strongly contradicted by physical devices that efficiently perform tasks believed to be intractable for classical computers. Such a task is boson sampling: sampling the output distributions of n bosons scattered by some passive, linear unitary process. We tested the central premise of boson sampling, experimentally verifying that three-photon scattering amplitudes are given by the permanents of submatrices generated from a unitary describing a six-mode integrated optical circuit. We find the protocol to be robust, working even with the unavoidable effects of photon loss, non-ideal sources, and imperfect detection. Scaling this to large numbers of photons should be a much simpler task than building a universal quantum computer.	[Broome, Matthew A.; Fedrizzi, Alessandro; White, Andrew G.] Univ Queensland, Sch Math & Phys, Ctr Engn Quantum Syst, Brisbane, Qld 4072, Australia; [Broome, Matthew A.; Fedrizzi, Alessandro; Rahimi-Keshari, Saleh; Ralph, Timothy C.; White, Andrew G.] Univ Queensland, Sch Math & Phys, Ctr Quantum Computat & Commun Technol, Brisbane, Qld 4072, Australia; [Dove, Justin; Aaronson, Scott] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	University of Queensland; University of Queensland; Massachusetts Institute of Technology (MIT)	Broome, MA (corresponding author), Univ Queensland, Sch Math & Phys, Ctr Engn Quantum Syst, Brisbane, Qld 4072, Australia.	m.a.broome@googlemail.com	White, Andrew G/A-1088-2009; Broome, Matthew A/D-2560-2010; White, Andrew G./AAI-1062-2020; Ralph, Timothy C/A-1858-2011; Fedrizzi, Alessandro/E-2888-2010	White, Andrew G/0000-0001-9639-5200; Broome, Matthew A/0000-0003-1938-7543; Ralph, Timothy C/0000-0003-0692-8427; Fedrizzi, Alessandro/0000-0002-5089-3148; Rahimi-Keshari, Saleh/0000-0003-2108-7486	Australian Research Council's Federation Fellow program [FF0668810]; Centre for Engineered Quantum Systems [CE110001013]; Centre for Quantum Computation and Communication Technology [CE110001027]; University of Queensland Vice-Chancellor's Senior Research Fellowship program; NSF [0844626]; Science and Technology Centre grant; Defense Advanced Research Projects Agency Young Faculty Award grant; TIBCO Chair; Sloan Fellowship	Australian Research Council's Federation Fellow program(Australian Research Council); Centre for Engineered Quantum Systems; Centre for Quantum Computation and Communication Technology; University of Queensland Vice-Chancellor's Senior Research Fellowship program; NSF(National Science Foundation (NSF)); Science and Technology Centre grant; Defense Advanced Research Projects Agency Young Faculty Award grant(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); TIBCO Chair; Sloan Fellowship(Alfred P. Sloan Foundation)	We thank R. Fickler for help with characterization; M. de Almeida, D. Biggerstaff, and G. Gillett for experimental assistance; and A. Arkhipov, M. Bremner, and T. Rudolph for discussions. This work was supported in part by the Australian Research Council's Federation Fellow program (grant FF0668810), the Centre for Engineered Quantum Systems (grant CE110001013), and the Centre for Quantum Computation and Communication Technology (grant CE110001027); the University of Queensland Vice-Chancellor's Senior Research Fellowship program; NSF grant no. 0844626 and a Science and Technology Centre grant; a Defense Advanced Research Projects Agency Young Faculty Award grant; a TIBCO Chair; and a Sloan Fellowship.	Aaronson S, 2011, ACM S THEORY COMPUT, P333; Boixo S, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.052320; Bremner MJ, 2011, P ROY SOC A-MATH PHY, V467, P459, DOI 10.1098/rspa.2010.0301; Datta A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050502; Davies PCW, 2007, FLUCT NOISE LETT, V7, pC37, DOI 10.1142/S0219477507004021; Dousse A, 2010, NATURE, V466, P217, DOI 10.1038/nature09148; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jerrum M, 2004, J ACM, V51, P671, DOI 10.1145/1008731.1008738; Jordan SP, 2010, QUANTUM INF COMPUT, V10, P470; Kok P, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.033812; Lanyon BP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.200501; Lau HK, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.062329; Lita AE, 2008, OPT EXPRESS, V16, P3032, DOI 10.1364/OE.16.003032; Metcalf BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2349; Owens JO, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075003; Paul H, 1996, PHYS REV LETT, V76, P2464, DOI 10.1103/PhysRevLett.76.2464; Peruzzo A, 2010, SCIENCE, V329, P1500, DOI 10.1126/science.1193515; Rohde PP, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022332; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Shor PW, 2008, QUANTUM INF COMPUT, V8, P681; SHOR PW, 1994, AN S FDN CO, P124; Smith DH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1628	23	438	463	3	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					794	798		10.1126/science.1231440	http://dx.doi.org/10.1126/science.1231440			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258411	Green Submitted			2022-12-28	WOS:000314874400041
J	Prota, AE; Bargsten, K; Zurwerra, D; Field, JJ; Diaz, JF; Altmann, KH; Steinmetz, MO				Prota, Andrea E.; Bargsten, Katja; Zurwerra, Didier; Field, Jessica J.; Fernando Diaz, Jose; Altmann, Karl-Heinz; Steinmetz, Michel O.			Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents	SCIENCE			English	Article							ALPHA-BETA-TUBULIN; EPOTHILONE-A; BINDING MODE; GDP-TUBULIN; COMPLEX; TAXOL; DIMER	Microtubule-stabilizing agents (MSAs) are efficacious chemotherapeutic drugs widely used for the treatment of cancer. Despite the importance of MSAs for medical applications and basic research, their molecular mechanisms of action on tubulin and microtubules remain elusive. We determined high-resolution crystal structures of ab-tubulin in complex with two unrelated MSAs, zampanolide and epothilone A. Both compounds were bound to the taxane pocket of beta-tubulin and used their respective side chains to induce structuring of the M-loop into a short helix. Because the M-loop establishes lateral tubulin contacts in microtubules, these findings explain how taxane-site MSAs promote microtubule assembly and stability. Further, our results offer fundamental structural insights into the control mechanisms of microtubule dynamics.	[Prota, Andrea E.; Bargsten, Katja; Steinmetz, Michel O.] Paul Scherrer Inst, Villigen, Switzerland; [Zurwerra, Didier; Altmann, Karl-Heinz] Swiss Fed Inst Technol, Inst Pharmaceut Sci, Dept Chem & Appl Biosci, Zurich, Switzerland; [Field, Jessica J.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Fernando Diaz, Jose] CSIC, CIB, Madrid, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Victoria University Wellington; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Steinmetz, MO (corresponding author), Paul Scherrer Inst, Villigen, Switzerland.	michel.steinmetz@psi.ch	Prota, Andrea Enrico/R-9526-2019; Steinmetz, Michel O/AAA-3349-2022; Díaz, J. Fernando/M-6853-2019; Díaz, J. Fernando/U-3532-2017	Prota, Andrea Enrico/0000-0003-0875-5339; Steinmetz, Michel O/0000-0001-6157-3687; Díaz, J. Fernando/0000-0003-2743-3319; Díaz, J. Fernando/0000-0003-2743-3319	European Molecular Biology Organization; Genesis Oncology Trust; Ministerio de Economia y Competitividad [BIO2010-16351]; Comunidad Autonoma de Madrid [S2010/BMD-2457]; Roche Research Foundation; Swiss National Science Foundation [310030B_138659]; Swiss SystemsX.ch initiative [BIP-2011/122]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Genesis Oncology Trust; Ministerio de Economia y Competitividad(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Roche Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss SystemsX.ch initiative	We thank R. Kammerer, F. Winkler, and Y. Barral for critical reading of the manuscript; V. de Lucas de Segovia for providing calf brains for tubulin purification; and V. Olieric and M. Wang for excellent technical assistance with the collection of x-ray data at beamline X06SA and X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen, Switzerland). J.J.F. received a short-term fellowship from the European Molecular Biology Organization and a Professional Development Grant from the Genesis Oncology Trust. This work was supported by grants from the Ministerio de Economia y Competitividad (BIO2010-16351) and the Comunidad Autonoma de Madrid (S2010/BMD-2457) (to J.F.D.), a Ph.D. fellowship from the Roche Research Foundation (to D.Z.), and grants from the Swiss National Science Foundation (310030B_138659) and the Swiss SystemsX.ch initiative (BIP-2011/122) (to M.O.S.). Coordinates have been deposited at the Protein Data Bank (PDB) under identification (ID) nos. 4I4T (T<INF>2</INF>R-TTL-Zampa), 4I50 (T<INF>2</INF>R-TTL-EpoA), and 4I55 (T<INF>2</INF>R-TTL).	Altmann KH, 2007, CHEMMEDCHEM, V2, P396, DOI 10.1002/cmdc.200600206; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P2747, DOI 10.1021/bi00062a003; DIAZ JF, 1993, BIOCHEMISTRY-US, V32, P10067, DOI 10.1021/bi00089a023; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; Elie-Caille C, 2007, CURR BIOL, V17, P1765, DOI 10.1016/j.cub.2007.08.063; Field JJ, 2012, CHEM BIOL, V19, P686, DOI 10.1016/j.chembiol.2012.05.008; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Lechleider RJ, 2008, CLIN CANCER RES, V14, P4378, DOI 10.1158/1078-0432.CCR-08-0015; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Nettles JH, 2009, TOP CURR CHEM, V286, P209, DOI 10.1007/128_2008_24; Nettles JH, 2004, SCIENCE, V305, P866, DOI 10.1126/science.1099190; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Pecqueur L, 2012, P NATL ACAD SCI USA, V109, P12011, DOI 10.1073/pnas.1204129109; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Reese M, 2007, ANGEW CHEM INT EDIT, V46, P1864, DOI 10.1002/anie.200604505; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Zurwerra D, 2012, CHEM-EUR J, V18, P16868, DOI 10.1002/chem.201202553	21	345	352	14	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					587	590		10.1126/science.1230582	http://dx.doi.org/10.1126/science.1230582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23287720	Green Submitted, Green Accepted			2022-12-28	WOS:000314270000061
J	Efeyan, A; Zoncu, R; Chang, S; Gumper, I; Snitkin, H; Wolfson, RL; Kirak, O; Sabatini, DD; Sabatini, DM				Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Gumper, Iwona; Snitkin, Harriet; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David D.; Sabatini, David M.			Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival	NATURE			English	Article							INDUCTION; MECHANISM; LYSOSOME; REVEALS; KINASE; SENSES	The mechanistic target of rapamycin complex 1 (mTORC1) pathway regulates organismal growth in response to many environmental cues, including nutrients and growth factors(1). Cell-based studies showed that mTORC1 senses amino acids through the RagA-D family of GTPases(2,3) (also known as RRAGA, B, C and D), but their importance in mammalian physiology is unknown. Here we generate knock-in mice that express a constitutively active form of RagA (RagA(GTP)) from its endogenous promoter. RagA(GTP/GTP) mice develop normally, but fail to survive postnatal day 1. When delivered by Caesarean section, fasted RagA(GTP/GTP) neonates die almost twice as rapidly as wild-type littermates. Within an hour of birth, wild-type neonates strongly inhibit mTORC1, which coincides with profound hypoglycaemia and a decrease in plasma amino-acid concentrations. In contrast, mTORC1 inhibition does not occur in RagA(GTP/GTP) neonates, despite identical reductions in blood nutrient amounts. With prolonged fasting, wild-type neonates recover their plasma glucose concentrations, but RagA(GTP/GTP) mice remain hypoglycaemic until death, despite using glycogen at a faster rate. The glucose homeostasis defect correlates with the inability of fasted RagA(GTP/GTP) neonates to trigger autophagy and produce amino acids for de novo glucose production. Because profound hypoglycaemia does not inhibit mTORC1 inRagA(GTP/GTP) neonates, we considered the possibility that the Rag pathway signals glucose as well as amino-acid sufficiency to mTORC1. Indeed, mTORC1 is resistant to glucose deprivation in RagA(GTP/GTP) fibroblasts, and glucose, like amino acids, controls its recruitment to the lysosomal surface, the site of mTORC1 activation. Thus, the Rag GTPases signal glucose and amino-acid concentrations to mTORC1, and have an unexpectedly key role in neonates in autophagy induction and thus nutrient homeostasis and viability.	[Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Kirak, Oktay; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] Broad Inst Harvard & Massachusetts Inst Technol, Seven Cambridge Ctr, Cambridge, MA 02142 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Efeyan, Alejo; Zoncu, Roberto; Chang, Steven; Wolfson, Rachel L.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gumper, Iwona; Snitkin, Harriet; Sabatini, David D.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); New York University	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Efeyan, Alejo/J-8197-2016; Kirak, Oktay/H-6347-2013	Efeyan, Alejo/0000-0002-3806-6799; Kirak, Oktay/0000-0002-6524-4685; /0000-0002-1446-7256	National Institutes of Health [R01 CA129105, R01 CA103866, R37 AI047389]; American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation; Human Frontiers Science Program; Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation for Aging; Starr Foundation; Koch Institute Frontier Research Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Human Frontiers Science Program(Human Frontier Science Program); Jane Coffin Childs Memorial Fund for Medical Research; LAM Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini laboratory for suggestions, and A. Hutchins for technical assistance. We thank R. Shaw for providing the AMPK-DKO MEFs, D. Ron for the GCN2-KO MEFs and M. Barbacid for the transcriptional STOP cassette. This work was supported by grants from the National Institutes of Health (R01 CA129105, R01 CA103866 and R37 AI047389) and awards from the American Federation for Aging, Starr Foundation, Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D. M. S., fellowships from the Human Frontiers Science Program to A. E., and the Jane Coffin Childs Memorial Fund for Medical Research and the LAM Foundation to R.Z. D. M. S. in an investigator of Howard Hughes Medical Institute.	Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Hirose E, 1998, J CELL SCI, V111, P11; Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MORTIMORE GE, 1977, NATURE, V270, P174, DOI 10.1038/270174a0; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	23	297	306	5	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					679	+		10.1038/nature11745	http://dx.doi.org/10.1038/nature11745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23263183	Green Accepted, Green Submitted			2022-12-28	WOS:000314219600058
J	Walkup, JT; Rubin, DH				Walkup, John T.; Rubin, David H.			Social Withdrawal and Violence - Newtown, Connecticut	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Walkup, John T.] Weill Cornell Med Coll, Div Child & Adolescent Psychiat, Dept Psychiat, New York, NY USA; New York Presbyterian Hosp, New York, NY USA	Cornell University; NewYork-Presbyterian Hospital	Walkup, JT (corresponding author), Weill Cornell Med Coll, Div Child & Adolescent Psychiat, Dept Psychiat, New York, NY USA.							Flannery DJ, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-012-0331-6; Follman M, 2012, MOTHER JONES    1215; Friedman R. A., 2012, NY TIMES; Rubin DH, 2012, CHILD PSYCHIAT  0912	4	10	10	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					399	401		10.1056/NEJMp1215605	http://dx.doi.org/10.1056/NEJMp1215605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23272975	Bronze			2022-12-28	WOS:000314215400002
J	Noda, H; Lapusta, N				Noda, Hiroyuki; Lapusta, Nadia			Stable creeping fault segments can become destructive as a result of dynamic weakening	NATURE			English	Article							TOHOKU-OKI EARTHQUAKE; STATE-DEPENDENT FRICTION; CHELUNGPU FAULT; FLUID PRESSURE; PORE-FLUID; CHI-CHI; SLIP; RUPTURE; TAIWAN; MEGATHRUST	Faults in Earth's crust accommodate slow relative motion between tectonic plates through either similarly slow slip or fast, seismic-wave-producing rupture events perceived as earthquakes(1-3). These types of behaviour are often assumed to be separated in space and to occur on two different types of fault segment: one with stable, rate-strengthening friction and the other with rate-weakening friction that leads to stick-slip(2-5). The 2011 Tohoku-Oki earthquake with moment magnitude M-w = 9.0 challenged such assumptions by accumulating its largest seismic slip in the area that had been assumed to be creeping(6-10). Here we propose a model in which stable, rate-strengthening behaviour at low slip rates(11,12) is combined with coseismic weakening due to rapid shear heating of pore fluids(13-16), allowing unstable slip to occur in segments that can creep between events. The model parameters are based on laboratory measurements on samples from the fault of the M-w 7.6 1999 Chi-Chi earthquake(17). The long-term slip behaviour of the model, which we examine using a unique numerical approach that includes all wave effects(16,18), reproduces and explains a number of both long-term and coseismic observations-some of them seemingly contradictory-about the faults at which the Tohoku-Oki and Chi-Chi earthquakes occurred, including there being more high-frequency radiation from areas of lower slip(8,19-21), the largest seismic slip in the Tohoku-Oki earthquake having occurred in a potentially creeping segment(6,7), the overall pattern of previous events in the area(8) and the complexity of the Tohoku-Oki rupture(9). The implication that earthquake rupture may break through large portions of creeping segments, which are at present considered to be barriers, requires a re-evaluation of seismic hazard in many areas.	[Noda, Hiroyuki] Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokohama, Kanagawa 2360001, Japan; [Lapusta, Nadia] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Lapusta, Nadia] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); California Institute of Technology; California Institute of Technology	Noda, H (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Res Earth Evolut, Yokohama, Kanagawa 2360001, Japan.	hnoda@jamstec.go.jp	Noda, Hiroyuki/B-1573-2014		US National Science Foundation (NSF) [EAR 0548277]; Southern California Earthquake Center (SCEC); Gordon and Betty Moore Foundation; NSF [EAR-0106924]; USGS [02HQAG0008]	US National Science Foundation (NSF)(National Science Foundation (NSF)); Southern California Earthquake Center (SCEC); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); USGS(United States Geological Survey)	This study was supported by the US National Science Foundation (NSF) (grant EAR 0548277), the Southern California Earthquake Center (SCEC) and the Gordon and Betty Moore Foundation. The SCEC is funded by NSF Cooperative Agreement EAR-0106924 and USGS Cooperative Agreement 02HQAG0008. This is SCEC contribution no. 1675 and Caltech Tectonics Observatory contribution no. 213. Numerical simulations for this study were performed on the CITerra Dell cluster at the Division of Geological and Planetary Sciences of the California Institute of Technology.	Andrews DJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2002JB001942; Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; Burgmann R, 2000, SCIENCE, V289, P1178, DOI 10.1126/science.289.5482.1178; Chlieh M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004981; Dieterich J. H., 2007, TREATISE GEOPHYS, V4, P107, DOI [10.1016/B978-044452748-6/00065-1, DOI 10.1016/B978-044452748-6/00065-1, 10.1016/B978-044452748-6.00065-1, DOI 10.1016/B978-044452748-6.00065-1]; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; DIETERICH JH, 1981, GEOPHYS MONOGR SER, V24, P103, DOI DOI 10.1029/GM024P0103; Faulkner DR, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048552; Ide S, 2011, SCIENCE, V332, P1426, DOI 10.1126/science.1207020; Ishikawa T, 2008, NAT GEOSCI, V1, P679, DOI 10.1038/ngeo308; Kaneko Y, 2010, NAT GEOSCI, V3, P363, DOI 10.1038/NGEO843; LACHENBRUCH AH, 1980, J GEOPHYS RES, V85, P6097, DOI 10.1029/JB085iB11p06097; Lapusta N, 2000, J GEOPHYS RES-SOL EA, V105, P23765, DOI 10.1029/2000JB900250; Lapusta N, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005934; LAY T, 1982, EARTHQUAKE PRED RES, V1, P3; Loveless JP, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2008JB006248; Ma KF, 2000, GEOPHYS RES LETT, V27, P3417, DOI 10.1029/2000GL011393; Ma KF, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015380; Meng LS, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048118; Noda H, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007780; Ota Y, 2007, TERR ATMOS OCEAN SCI, V18, P55, DOI 10.3319/TAO.2007.18.1.55(T); Perfettini H, 2010, NATURE, V465, P78, DOI 10.1038/nature09062; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; Rice JR, 2001, J MECH PHYS SOLIDS, V49, P1865, DOI 10.1016/S0022-5096(01)00042-4; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sakaguchi A, 2011, GEOLOGY, V39, P395, DOI 10.1130/G31642.1; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Schubert G., 2007, EARTHQUAKE SEISMOLOG, V4, P131; Segall P, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007449; Shibazaki B, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049308; SIBSON RH, 1973, NATURE-PHYS SCI, V243, P66, DOI 10.1038/physci243066a0; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; Tanikawa W, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005750; Tsuru T, 2000, J GEOPHYS RES-SOL EA, V105, P16403, DOI 10.1029/2000JB900132; Tsutsumi A, 1997, GEOPHYS RES LETT, V24, P699, DOI 10.1029/97GL00503; Wei SJ, 2012, EARTH PLANET SC LETT, V333, P91, DOI 10.1016/j.epsl.2012.04.006	36	322	332	9	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 24	2013	493	7433					518	+		10.1038/nature11703	http://dx.doi.org/10.1038/nature11703			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23302798				2022-12-28	WOS:000313871400035
J	Tan, DZ; Marzluff, WF; Dominski, Z; Tong, L				Tan, Dazhi; Marzluff, William F.; Dominski, Zbigniew; Tong, Liang			Structure of Histone mRNA Stem-Loop, Human Stem-Loop Binding Protein, and 3 ' hExo Ternary Complex	SCIENCE			English	Article							U7 SNRNP; HAIRPIN; 3'-END; SITE; PHOSPHORYLATION; 3'-EXONUCLEASE; INTERACTS; DOMAIN; GENE; END	Metazoan replication-dependent histone messenger RNAs (mRNAs) have a conserved stem-loop (SL) at their 3'-end. The stem-loop binding protein (SLBP) specifically recognizes the SL to regulate histone mRNA metabolism, and the 3'-5' exonuclease 3'hExo trims its 3'-end after processing. We report the crystal structure of a ternary complex of human SLBP RNA binding domain, human 3'hExo, and a 26-nucleotide SL RNA. Only one base of the SL is recognized specifically by SLBP, and the two proteins primarily recognize the shape of the RNA. SLBP and 3'hExo have no direct contact with each other, and induced structural changes in the loop of the SL mediate their cooperative binding. The 3' flanking sequence is positioned in the 3'hExo active site, but the ternary complex limits the extent of trimming.	[Tan, Dazhi; Tong, Liang] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Marzluff, William F.; Dominski, Zbigniew] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	Columbia University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	ltong@columbia.edu		Tan, Dazhi/0000-0002-1862-8125; Tong, Liang/0000-0002-0563-6468	NIH [GM077175, GM029832]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029832, R01GM077175] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Whalen, S. Myers, R. Jackimowicz, and H. Robinson for access to the X29A beamline at the National Synchrotron Light Source. Supported by NIH grants GM077175 (L.T.) and GM029832 (W.F.M. and Z.D.). The structure has been deposited at the Protein Data Bank (accession code 4HXH).	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Battle DJ, 2001, RNA, V7, P123, DOI 10.1017/S1355838201001820; Biertumpfel C, 2007, NATURE, V449, P616, DOI 10.1038/nature06152; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Cheng Y, 2004, J MOL BIOL, V343, P305, DOI 10.1016/j.jmb.2004.08.055; DeJong ES, 2002, RNA, V8, P83, DOI 10.1017/S1355838202013869; Dominski Z, 1999, MOL CELL BIOL, V19, P3561; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Dominski Z, 2001, MOL CELL BIOL, V21, P2008, DOI 10.1128/MCB.21.6.2008-2017.2001; Dominski Z, 2007, GENE, V396, P373, DOI 10.1016/j.gene.2007.04.021; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Hoefig KP, 2013, NAT STRUCT MOL BIOL, V20, P73, DOI 10.1038/nsmb.2450; Jaeger S, 2004, FEBS LETT, V556, P265, DOI 10.1016/S0014-5793(03)01433-9; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Martin F, 2000, NUCLEIC ACIDS RES, V28, P1594, DOI 10.1093/nar/28.7.1594; Martin F, 1997, EMBO J, V16, P769, DOI 10.1093/emboj/16.4.769; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Michel F, 2000, RNA, V6, P1539, DOI 10.1017/S135583820000056X; MOWRY KL, 1987, SCIENCE, V238, P1682, DOI 10.1126/science.2825355; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Thomas MF, 2012, BLOOD, V120, P130, DOI 10.1182/blood-2011-11-394072; Wang ZF, 1996, GENE DEV, V10, P3028, DOI 10.1101/gad.10.23.3028; WILLIAMS AS, 1995, NUCLEIC ACIDS RES, V23, P654, DOI 10.1093/nar/23.4.654; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Yang XC, 2009, MOL CELL BIOL, V29, P4045, DOI 10.1128/MCB.00296-09; Zanier K, 2002, RNA, V8, P29, DOI 10.1017/S1355838202014061; Zhang MY, 2012, BIOCHEMISTRY-US, V51, P3215, DOI 10.1021/bi2018255; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	28	84	85	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					318	321		10.1126/science.1228705	http://dx.doi.org/10.1126/science.1228705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329046	Green Accepted, Green Submitted			2022-12-28	WOS:000313622000044
J	Jia, X; Zhang, J; Sun, WX; He, WZ; Jiang, HY; Chen, DR; Murchie, AIH				Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.			Riboswitch Control of Aminoglycoside Antibiotic Resistance	CELL			English	Article							PEPTIDYL TRANSFERASE CENTER; RIBOSOMAL-RNA METHYLASE; HIV-1 TAR RNA; NASCENT PEPTIDE; MESSENGER-RNA; TRANSLATIONAL REGULATION; BACILLUS-SUBTILIS; GENE-EXPRESSION; BINDING; BACTERIA	The majority of riboswitches are regulatory RNAs that regulate gene expression by binding small-molecule metabolites. Here we report the discovery of an aminoglycoside-binding riboswitch that is widely distributed among antibiotic-resistant bacterial pathogens. This riboswitch is present in the leader RNA of the resistance genes that encode the aminoglycoside acetyl transferase (AAC) and aminoglycoside adenyl transferase (AAD) enzymes that confer resistance to aminoglycoside antibiotics through modification of the drugs. We show that expression of the AAC and AAD resistance genes is regulated by aminoglycoside binding to a secondary structure in their 50 leader RNA. Reporter gene expression, direct measurements of drug RNA binding, chemical probing, and UV crosslinking combined with mutational analysis demonstrate that the leader RNA functions as an aminoglycoside-sensing riboswitch in which drug binding to the leader RNA leads to the induction of aminoglycosides antibiotic resistance.	[Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China; [Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Jia, Xu; Zhang, Jing; Sun, Wenxia; He, Weizhi; Jiang, Hengyi; Chen, Dongrong; Murchie, Alastair I. H.] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Jia, Xu] Chengdu Med Coll, Dept Biomed Sci, Chengdu 610083, Peoples R China	Fudan University; Fudan University; Fudan University; Chengdu Medical College	Murchie, AIH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Key Lab Mol Med,Minist Educ, Shanghai 200032, Peoples R China.	drchen@fudan.edu.cn; aihm@fudan.edu.cn	He, Weizhi/GQQ-5629-2022	He, Weizhi/0000-0002-8061-4947	National Key 973 [2010CB912602]; City of Shanghai Key project [09DJ1400601]; Natural Science Foundation [31170749, 31100543]	National Key 973; City of Shanghai Key project; Natural Science Foundation(National Natural Science Foundation of China (NSFC))	We thank Professor Eric Westhof (University of Strasbourg) for constructive and insightful discussions. We thank Drs Di Qu, Ming Gui Wang and Jin Wei Huang (Fudan University) for the gift of the RMTB plasmid and Acinetobacter baumannii strain. This work was supported by National Key 973 grant (2010CB912602). City of Shanghai Key project grant (09DJ1400601). Natural Science Foundation grant 31170749 to A.M and 31100543 to W.X.S.	Armstrong ES, 2010, CURR OPIN MICROBIOL, V13, P565, DOI 10.1016/j.mib.2010.09.004; Bailey M, 2008, ANTIMICROB AGENTS CH, V52, P866, DOI 10.1128/AAC.01266-07; Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Carter AP, 2000, NATURE, V407, P340, DOI 10.1038/35030019; Cromie MJ, 2006, CELL, V125, P71, DOI 10.1016/j.cell.2006.01.043; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; DAVIES J, 1968, J BIOL CHEM, V243, P3312; Davis B, 2004, J MOL BIOL, V336, P343, DOI 10.1016/j.jmb.2003.12.046; Doi Y, 2004, ANTIMICROB AGENTS CH, V48, P491, DOI 10.1128/AAC.48.2.491-496.2004; DUBNAU D, 1984, CRC CR REV BIOCH MOL, V16, P103, DOI 10.3109/10409238409102300; DUVALL EJ, 1984, J BACTERIOL, V158, P784, DOI 10.1128/JB.158.3.784-790.1984; Ehresmann Chantal, 2004, RNA Biol, V1, P66; Famulok M, 1996, BIOCHEMISTRY-US, V35, P4265, DOI 10.1021/bi952479r; Fourmy D, 1996, SCIENCE, V274, P1367, DOI 10.1126/science.274.5291.1367; Fuchs RT, 2006, NAT STRUCT MOL BIOL, V13, P226, DOI 10.1038/nsmb1059; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Grundy FJ, 2006, CRIT REV BIOCHEM MOL, V41, P329, DOI 10.1080/10409230600914294; GRYCZAN TJ, 1984, MOL GEN GENET, V194, P357, DOI 10.1007/BF00425544; Hall RM, 2007, NAT REV MICROBIOL, V5, P1; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; Hendrix M, 1997, J AM CHEM SOC, V119, P3641, DOI 10.1021/ja964290o; Hermann T, 1999, J MED CHEM, V42, P1250, DOI 10.1021/jm981108g; Jacquier H, 2009, MOL MICROBIOL, V72, P1475, DOI 10.1111/j.1365-2958.2009.06736.x; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lentzen G, 2003, CHEM BIOL, V10, P769, DOI 10.1016/S1074-5521(03)00173-X; Liebert CA, 1999, MICROBIOL MOL BIOL R, V63, P507, DOI 10.1128/MMBR.63.3.507-522.1999; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Marzi S, 2007, CELL, V130, P1019, DOI 10.1016/j.cell.2007.07.008; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Murchie AIH, 2004, J MOL BIOL, V336, P625, DOI 10.1016/j.jmb.2003.12.028; Nahvi A, 2002, CHEM BIOL, V9, P1043, DOI 10.1016/S1074-5521(02)00224-7; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Porse BT, 1999, P NATL ACAD SCI USA, V96, P9003, DOI 10.1073/pnas.96.16.9003; Ramu H, 2011, MOL CELL, V41, P321, DOI 10.1016/j.molcel.2010.12.031; Serganov A, 2003, EMBO J, V22, P1898, DOI 10.1093/emboj/cdg170; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; SWIATLO E, 1987, J ANTIMICROB CHEMOTH, V19, P27, DOI 10.1093/jac/19.1.27; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Yu FY, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-184; ZAPP ML, 1993, CELL, V74, P969, DOI 10.1016/0092-8674(93)90720-B; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181	50	61	72	1	119	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					68	81		10.1016/j.cell.2012.12.019	http://dx.doi.org/10.1016/j.cell.2012.12.019			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332747	Bronze			2022-12-28	WOS:000313719800007
J	Manary, MP; Boulding, W; Staelin, R; Glickman, SW				Manary, Matthew P.; Boulding, William; Staelin, Richard; Glickman, Seth W.			The Patient Experience and Health Outcomes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SATISFACTION; CARE; MORTALITY; QUALITY		[Manary, Matthew P.; Boulding, William; Staelin, Richard] Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA; [Glickman, Seth W.] Univ N Carolina, Dept Emergency Med, Sch Med, Chapel Hill, NC USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Manary, MP (corresponding author), Duke Univ, Fuqua Sch Business, Durham, NC 27706 USA.							Boulding W, 2011, AM J MANAG CARE, V17, P41; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Glickman SW, 2010, CIRC-CARDIOVASC QUAL, V3, P188, DOI 10.1161/CIRCOUTCOMES.109.900597; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; PARASURAMAN A, 1988, J RETAILING, V64, P12	5	496	505	3	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					201	203		10.1056/NEJMp1211775	http://dx.doi.org/10.1056/NEJMp1211775			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YG	23268647				2022-12-28	WOS:000313549900003
J	O'Neill, LAJ; Hardie, DG				O'Neill, Luke A. J.; Hardie, D. Grahame			Metabolism of inflammation limited by AMPK and pseudo-starvation	NATURE			English	Review							ACTIVATED PROTEIN-KINASE; FATTY-ACID OXIDATION; T-CELL MEMORY; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; MACROPHAGE POLARIZATION; COACTIVATOR PGC-1-BETA; MAMMALIAN TARGET; YEAST SNF1; GLUCOSE; PHOSPHORYLATION	Metabolic changes in cells that participate in inflammation, such as activated macrophages and T-helper 17 cells, include a shift towards enhanced glucose uptake, glycolysis and increased activity of the pentose phosphate pathway. Opposing roles in these changes for hypoxia-inducible factor 1 alpha and AMP-activated protein kinase have been proposed. By contrast, anti-inflammatory cells, such as M2 macrophages, regulatory T cells and quiescent memory T cells, have lower glycolytic rates and higher levels of oxidative metabolism. Some anti-inflammatory agents might act by inducing, through activation of AMP-activated protein kinase, a state akin to pseudo-starvation. Altered metabolism may thus participate in the signal-directed programs that promote or inhibit inflammation.	[O'Neill, Luke A. J.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland	Trinity College Dublin; University of Dundee	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	laoneill@tcd.ie	Hardie, David/Z-1979-2019	O'Neill, Luke/0000-0002-4333-2748	Wellcome Trust; Cancer Research UK; Science Foundation Ireland; European Research Council; Cancer Research UK [15101] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	Work in the D.G.H. laboratory is supported by the Wellcome Trust and Cancer Research UK. Work in the L.O.N. laboratory is supported by Science Foundation Ireland and the European Research Council.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Arwadi MS, 1982, BIOCHEM J, V208, P743; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; BENNETT WE, 1966, J EXP MED, V123, P145, DOI 10.1084/jem.123.1.145; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Degoffe G. M., 2011, NATURE IMMUNOL, V12, P295; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; GANCEDO JM, 1992, EUR J BIOCHEM, V206, P297, DOI 10.1111/j.1432-1033.1992.tb16928.x; Garedew A, 2010, CELL DEATH DIFFER, V17, P1540, DOI 10.1038/cdd.2010.27; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Haschemi A, 2012, CELL METAB, V15, P813, DOI 10.1016/j.cmet.2012.04.023; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HEDESKOV CJ, 1966, BLOOD-J HEMATOL, V28, P163, DOI 10.1182/blood.V28.2.163.163; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Labuzek K, 2010, NEUROTOXICOLOGY, V31, P134, DOI 10.1016/j.neuro.2009.10.006; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Matsui T, 2009, J NUCL MED, V50, P920, DOI 10.2967/jnumed.108.060103; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Myerburg MM, 2010, AM J RESP CELL MOL, V42, P676, DOI 10.1165/2009-0147OC; Nath N, 2005, J IMMUNOL, V175, P566, DOI 10.4049/jimmunol.175.1.566; Nath N, 2009, BIOCHEM BIOPH RES CO, V386, P16, DOI 10.1016/j.bbrc.2009.05.106; Nath N, 2009, J IMMUNOL, V182, P8005, DOI 10.4049/jimmunol.0803563; NEWSHOLME P, 1989, BIOCHEM J, V261, P211, DOI 10.1042/bj2610211; NEWSHOLME P, 1986, BIOCHEM J, V239, P121, DOI 10.1042/bj2390121; Nishi T, 2002, J BIOL CHEM, V277, P44548, DOI 10.1074/jbc.M202970200; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; OREN R, 1963, J CELL BIOL, V17, P487, DOI 10.1083/jcb.17.3.487; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peyssonnaux C, 2007, J IMMUNOL, V178, P7516, DOI 10.4049/jimmunol.178.12.7516; Pilon G, 2004, J BIOL CHEM, V279, P20767, DOI 10.1074/jbc.M401390200; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Rolf J., EUR J IMMUN IN PRESS; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Soranna D, 2012, ONCOLOGIST, V17, P813, DOI 10.1634/theoncologist.2011-0462; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Warburg O, 1923, BIOCHEM Z, V142, P317; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; WOODS A, 1994, J BIOL CHEM, V269, P19509; Wu Z., 2010, CELL, V98, P115; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhao X, 2008, AM J PHYSIOL-LUNG C, V295, pL497, DOI 10.1152/ajplung.90210.2008; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	96	781	821	15	317	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					346	355		10.1038/nature11862	http://dx.doi.org/10.1038/nature11862			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325217	Green Submitted			2022-12-28	WOS:000313615900041
J	Ginn, S				Ginn, Stephen			Women prisoners	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Ginn, S (corresponding author), BMJ, London WC1H 9JR, England.	mail@stephenginn.com						Angiolini E, 2012, PRISON REFORM TRUST; [Anonymous], 2008, PRISONER MOTHER BABY; [Anonymous], [No title captured]; [Anonymous], 2010, GUARDIAN; [Anonymous], 1996, HOLL PRIS SHACKL BIR; Berman G., 2012, PRISON POPULATION ST; Cabinet Office Social Exclusion Task Force, 2009, SHORT STUD WOM OFF; Carlen P., 1983, WOMENS IMPRISONMENT; Commission on Women and the Criminal Justice System, 2009, ENG JUST POL PRACT; CORSTON J, 2007, CORSTON REPORT; Criminal Justice Joint Inspection, 2011, THEM INSP REP EQ DIF; Department of Health, 2009, BRADL REP 2009; Eagle M, 2009, FEMALE PRISONES; Fazel S, 2009, BRIT J PSYCHIAT, V194, P183, DOI 10.1192/bjp.bp.107.046490; Harwick N, 2012, WOMEN PRISON CORSTON; Harwick N, 2012, KEYNOTE SPEECH REPOR; Hedderman C., 2012, EMPTY CELLS EMPTY WO; HM Inspectorate of Prisons, 2010, ALC SERV PRIS UNM NE; HM Inspectorate of Prisons, 2010, WOM PRIS SHORT THEM; Home Office, 2011, DEATHS PRIS CUST 201; Home Office, 2012, ARR KEY FACTS; Home Office, 2011, OFF MAN STAT Q TABL; Howard League for Penal Reform, 2012, JUST SEL CO IN PRESS; Ministry of Justice, 2013, MIN JUST PRIS POP B; Ministry of Justice, WOM PRIS; Ministry of Justice, POP CAP BRIEF 8 JUL; Ministry of Justice, PRIS SERV INSTR 64 2; North J, 2006, NORTH J GETTING IT R; Plugge E., 2006, HLTH WOMEN PRISON ST; Price S., 2005, BRIT J MIDWIFERY, V13, P362; Prison Reform Trust, 2012, BROML BRIEF FACTF; Prison Reform Trust, 2011, REF WOM JUST FIN REP; Royal College of Midwives, 2011, CAR CHILDB PRIS; Scott David, 2010, CONTROVERSIAL ISSUES; Scottish Government Commission on Women Offenders, 2012, FIN REP; Singleton N., 1998, PSYCHIAT MORBIDITY P; Social Exclusion Unit, 2002, RED REOFF EXPR; Stewart D, PROBLEMS NEEDS NEWLY; WEDDERBURN D, 2000, JUSTICE WOMEN NEED R; Women in Prison, 2012, CORST REP 5 YEARS FA	40	8	8	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2013	346								e8318	10.1136/bmj.e8318	http://dx.doi.org/10.1136/bmj.e8318			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZX	23315254				2022-12-28	WOS:000313555500005
J	Regenstein, M; Andres, E; Wynia, MK				Regenstein, Marsha; Andres, Ellie; Wynia, Matthew K.			Appropriate Use of Non-English-Language Skills in Clinical Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; SPANISH		[Regenstein, Marsha; Andres, Ellie] George Washington Univ, Sch Publ Hlth & Hlth Serv, Dept Hlth Policy, Washington, DC USA; [Wynia, Matthew K.] Amer Med Assoc, Inst Eth, Chicago, IL 60654 USA; [Wynia, Matthew K.] Amer Med Assoc, Ctr Patient Safety, Chicago, IL 60654 USA	George Washington University; American Medical Association; American Medical Association	Wynia, MK (corresponding author), Amer Med Assoc, Inst Eth, 515 N State St, Chicago, IL 60654 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019	Andres, Ellie/0000-0001-9086-8222				Am. Coll. Physicians, 2007, LANG SERV PAT LTD EN; Andres E, 2011, AC HLTH ANN RES M JU; Diamond LC, 2012, J GEN INTERN MED, V27, P117, DOI 10.1007/s11606-011-1779-5; Diamond LC, 2009, JAMA-J AM MED ASSOC, V301, P426, DOI 10.1001/jama.2009.6; Diamond LC, 2009, J GEN INTERN MED, V24, P256, DOI 10.1007/s11606-008-0875-7; Maul L, 2012, JT COMM J QUAL PATIE, V38, P328, DOI 10.1016/S1553-7250(12)38043-4; Regenstein M, COMM END HLTH CAR DI; US Census Bureau, 2011, 2011 AM COMM SURV SE	8	12	12	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					145	146		10.1001/jama.2012.116984	http://dx.doi.org/10.1001/jama.2012.116984			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299604				2022-12-28	WOS:000313517000021
J	Thomas, BC; Neal, DE				Thomas, Benjamin C.; Neal, David E.			Androgen deprivation treatment in prostate cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCREASED SURVIVAL; COST-EFFECTIVENESS; PHASE-III; THERAPY; SUPPRESSION; MEN; MONOTHERAPY; CASTRATION; DEGARELIX; RISK		[Thomas, Benjamin C.] Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England; [Thomas, Benjamin C.; Neal, David E.] Univ Cambridge, Dept Oncol, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Thomas, BC (corresponding author), Addenbrookes Hosp, Dept Urol, Cambridge CB2 0QQ, England.	bct26@cam.ac.uk	Shah, Syed Imran Ali/D-1324-2012	Shah, Syed Imran Ali/0000-0002-0833-0771; Neal, David/0000-0002-6033-5086	Medical Research Council [G0900871] Funding Source: Medline; MRC [G0900871] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler A, 2012, ABIRATERONE CASTRATI; [Anonymous], 1997, Br J Urol, V79, P235; Bayoumi AM, 2000, JNCI-J NATL CANCER I, V92, P1731, DOI 10.1093/jnci/92.21.1731; Bolla M, 2010, LANCET ONCOL, V11, P1066, DOI 10.1016/S1470-2045(10)70223-0; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Bubley GJ, 2001, UROLOGY, V58, P5, DOI 10.1016/S0090-4295(01)01235-3; Crawford ED, 2011, J UROLOGY, V186, P889, DOI 10.1016/j.juro.2011.04.083; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Derweesh IH, 2007, BJU INT, V100, P1060, DOI 10.1111/j.1464-410X.2007.07184.x; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Heidenreich A, 2012, GUIDELINES PROSTATE; Iversen P, 2000, J UROLOGY, V164, P1579, DOI 10.1016/S0022-5347(05)67032-2; Klotz L, 2008, BJU INT, V102, P1531, DOI 10.1111/j.1464-410X.2008.08183.x; Lawton CA, 2005, J CLIN ONCOL, V23, P800, DOI 10.1200/JCO.2005.08.141; Loblaw DA, 2004, J CLIN ONCOL, V22, P2927, DOI 10.1200/jco.2004.04.579; Lu LT, 2012, BJU INT, V109, P1183, DOI 10.1111/j.1464-410X.2011.10434.x; MOFFAT LEF, 1990, EUR UROL, V18, P26; National Institute for Health and Clinical Excellence, 2008, PROST CANC DIAGN TRE; Potosky AL, 2001, J CLIN ONCOL, V19, P3750, DOI 10.1200/JCO.2001.19.17.3750; Ryan CJ, 2003, UROLOGY, V62, P87, DOI 10.1016/j.urology.2003.10.002; Saigal CS, 2007, CANCER-AM CANCER SOC, V110, P1493, DOI 10.1002/cncr.22933; Samson DJ, 2002, CANCER, V95, P361, DOI 10.1002/cncr.10647; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Seidenfeld J, 2000, ANN INTERN MED, V132, P566, DOI 10.7326/0003-4819-132-7-200004040-00009; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238; Strum SB, 1997, BRIT J UROL, V79, P933, DOI 10.1046/j.1464-410X.1997.00234.x; The Veterans Administration Co-operative Urological Research Group, 1967, SURG GYNECOL OBSTET, V124, P1011; Tyrrell CJ, 1998, EUR UROL, V33, P447, DOI 10.1159/000019634	29	9	9	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e8555	10.1136/bmj.e8555	http://dx.doi.org/10.1136/bmj.e8555			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303885				2022-12-28	WOS:000313554900010
J	Braun, S; Ronzheimer, JP; Schreiber, M; Hodgman, SS; Rom, T; Bloch, I; Schneider, U				Braun, S.; Ronzheimer, J. P.; Schreiber, M.; Hodgman, S. S.; Rom, T.; Bloch, I.; Schneider, U.			Negative Absolute Temperature for Motional Degrees of Freedom	SCIENCE			English	Article							ULTRACOLD ATOMS; PHASE; DYNAMICS; GAS	Absolute temperature is usually bound to be positive. Under special conditions, however, negative temperatures-in which high-energy states are more occupied than low-energy states-are also possible. Such states have been demonstrated in localized systems with finite, discrete spectra. Here, we prepared a negative temperature state for motional degrees of freedom. By tailoring the Bose-Hubbard Hamiltonian, we created an attractively interacting ensemble of ultracold bosons at negative temperature that is stable against collapse for arbitrary atom numbers. The quasimomentum distribution develops sharp peaks at the upper band edge, revealing thermal equilibrium and bosonic coherence over several lattice sites. Negative temperatures imply negative pressures and open up new parameter regimes for cold atoms, enabling fundamentally new many-body states.	[Braun, S.; Ronzheimer, J. P.; Schreiber, M.; Hodgman, S. S.; Rom, T.; Bloch, I.; Schneider, U.] Univ Munich, Fak Phys, D-80799 Munich, Germany; [Braun, S.; Ronzheimer, J. P.; Schreiber, M.; Hodgman, S. S.; Rom, T.; Bloch, I.; Schneider, U.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	University of Munich; Max Planck Society	Schneider, U (corresponding author), Univ Munich, Fak Phys, Schellingstr 4, D-80799 Munich, Germany.	ulrich.schneider@lmu.de	Bloch, Immanuel/G-3174-2010; Hodgman, Sean/B-1334-2015; Hodgman, Sean/AAV-2779-2021; Schneider, Ulrich/N-4820-2015	Bloch, Immanuel/0000-0002-0679-4759; Schneider, Ulrich/0000-0003-4345-9498; Hodgman, Sean/0000-0002-2417-350X	Deutsche Forschungsgemeinschaft [FOR801]; U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program; Nanosystems Initiative Munich	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nanosystems Initiative Munich	We thank A. Rapp, A. Rosch, S. Mandt, and W. Hofstetter for helpful discussions and D. Garbe for technical assistance. We acknowledge financial support by the Deutsche Forschungsgemeinschaft (FOR801, Deutsch-Israelisches Kooperationsprojekt Quantum phases of ultracold atoms in optical lattices), the U.S. Defense Advanced Research Projects Agency Optical Lattice Emulator program, and Nanosystems Initiative Munich.	[Anonymous], 1987, STAT MECH; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Capogrosso-Sansone B, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.015602; Donley EA, 2001, NATURE, V412, P295, DOI 10.1038/35085500; Frieman JA, 2008, ANNU REV ASTRON ASTR, V46, P385, DOI 10.1146/annurev.astro.46.060407.145243; Fukuyama T., 2008, J COSMOL ASTROPART P, V2008, P033; Gerbier F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.155303; Haller E, 2009, SCIENCE, V325, P1224, DOI [10.1126/science.11758510, 10.1126/science.1175850]; Jo GB, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.045305; KASTBERG A, 1995, PHYS REV LETT, V74, P1542, DOI 10.1103/PhysRevLett.74.1542; KLEIN MJ, 1956, PHYS REV, V104, P589, DOI 10.1103/PhysRev.104.589; Mark MJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.215302; Medley P, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.195301; Mosk AP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040403; Oja AS, 1997, REV MOD PHYS, V69, P1, DOI 10.1103/RevModPhys.69.1; PURCELL EM, 1951, PHYS REV, V81, P279, DOI 10.1103/PhysRev.81.279; RAMSEY NF, 1956, PHYS REV, V103, P20, DOI 10.1103/PhysRev.103.20; Rapp A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.043612; Rapp A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220405; Schneider U, 2012, NAT PHYS, V8, P213, DOI [10.1038/nphys2205, 10.1038/NPHYS2205]; Tsuji N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.236401; Xu K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.180405; Zaccanti M, 2009, NAT PHYS, V5, P586, DOI 10.1038/NPHYS1334	27	144	145	0	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					52	55		10.1126/science.1227831	http://dx.doi.org/10.1126/science.1227831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288533	Green Submitted			2022-12-28	WOS:000312985800048
J	Hawkes, N				Hawkes, Nigel			MEDICINE IN DEVELOPING COUNTRIES Deworming debunked	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRESCHOOL-CHILDREN; TRIAL					nigel.hawkes1@btinternet.com						Alderman H, 2006, BRIT MED J, V333, P122, DOI 10.1136/bmj.38877.393530.7C; [Anonymous], COPENHAGEN CONSENSUS; [Anonymous], 2008, TIME; [Anonymous], 2012, COCHRANES INCOMPLETE; Awasthi S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000223; Baird S, 2011, WORMS AT WORK LONG R; Barrett W, 2011, FORBES; Bundy D, TRENDS PARASITOL FOR; Bundy D, 2011, NEW REASONS WHY SCHO; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Disease Control Priorities Project, 2008, DEWORMING CHILDREN B; GiveWell, COMBINATION DEWORMIN; GiveWell, 2011, ERRORS IN DCP2 COST; Ozier O, 2011, EXPLOITING EXTERNALI; Taylor-Robinson DC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000371.pub5; WHO, 2005, THE EVIDENCE IS IN D	16	16	16	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8558	10.1136/bmj.e8558	http://dx.doi.org/10.1136/bmj.e8558			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284157				2022-12-28	WOS:000313236300014
J	Hussey, PS; Wertheimer, S; Mehrotra, A				Hussey, Peter S.; Wertheimer, Samuel; Mehrotra, Ateev			The Association Between Health Care Quality and Cost A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							NURSING-HOME COSTS; OF-CARE; MEDICAID REIMBURSEMENT; REGIONAL-VARIATIONS; HOSPITAL COST; TRADE-OFF; INSTRUMENTAL VARIABLES; PATIENT-SATISFACTION; RESOURCE-ALLOCATION; EMPIRICAL-ANALYSIS	Background: Although there is broad policy consensus that both cost containment and quality improvement are critical, the association between costs and quality is poorly understood. Purpose: To systematically review evidence of the association between health care quality and cost. Data Sources: Electronic literature search of PubMed, EconLit, and EMBASE databases for U. S.-based studies published between 1990 and 2012. Study Selection: Title, abstract, and full-text review to identify relevant studies. Data Extraction: Two reviewers independently abstracted data with differences reconciled by consensus. Studies were categorized by level of analysis, type of quality measure, type of cost measure, and method of addressing confounders. Data Synthesis: Of 61 included studies, 21 (34%) reported a positive or mixed-positive association (higher cost associated with higher quality); 18 (30%) reported a negative or mixed-negative association; and 22 (36%) reported no difference, an imprecise or indeterminate association, or a mixed association. The associations were of low to moderate clinical significance in many studies. Of 9 studies using instrumental variables analysis to address confounding by unobserved patient health status, 7 (78%) reported a positive association, but other characteristics of these studies may have affected their findings. Limitations: Studies used widely heterogeneous methods and measures. The review is limited by the quality of underlying studies. Conclusion: Evidence of the direction of association between health care cost and quality is inconsistent. Most studies have found that the association between cost and quality is small to moderate, regardless of whether the direction is positive or negative. Future studies should focus on what types of spending are most effective in improving quality and what types of spending represent waste. Primary Funding Source: Robert Wood Johnson Foundation. Ann Intern Med. 2013;158:27-34.	RAND Hlth, Arlington, VA USA; RAND Hlth, Pittsburgh, PA USA; Harvard Univ, Sch Business, Boston, MA 02163 USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	RAND Corporation; RAND Corporation; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hussey, PS (corresponding author), RAND, 1200 S Hayes St,W7W, Arlington, VA 22202 USA.	peter_hussey@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	Robert Wood Johnson Foundation [68339]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Grant Support: By grant 68339 from the Robert Wood Johnson Foundation.	*AG HEALTHC RES QU, NAT QUAL MEAS CLEAR; Anderson GF, 2008, JAMA-J AM MED ASSOC, V299, P2444, DOI 10.1001/jama.299.20.2444; Anderson RA, 1998, RES NURS HEALTH, V21, P297, DOI 10.1002/(SICI)1098-240X(199808)21:4<297::AID-NUR3>3.3.CO;2-F; Angrist JD, 2001, J ECON PERSPECT, V15, P69, DOI 10.1257/jep.15.4.69; Auerbach AD, 2010, ARCH INTERN MED, V170, P1202, DOI 10.1001/archinternmed.2010.237; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Baicker K, 2004, HLTH AFF MILLWOOD, P184; Baicker K, 2006, HEALTH AFFAIR, V25, pW355, DOI 10.1377/hlthaff.25.w355; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Birkmeyer JD, 2012, ANN SURG, V255, P1, DOI 10.1097/SLA.0b013e3182402c17; Bradbury R C, 2000, Health Serv Manage Res, V13, P57; Bradbury R C, 1997, Health Serv Manage Res, V10, P231; BRADBURY RC, 1994, INQUIRY-J HEALTH CAR, V31, P56; Byrne MM, 2007, HEALTH ECON, V16, P385, DOI 10.1002/hec.1173; Carey K, 1999, HEALTH ECON, V8, P509, DOI 10.1002/(SICI)1099-1050(199909)8:6<509::AID-HEC460>3.3.CO;2-S; Chen LM, 2010, ARCH INTERN MED, V170, P340, DOI 10.1001/archinternmed.2009.511; Cohen JW, 1996, J HEALTH ECON, V15, P23, DOI 10.1016/0167-6296(95)00030-5; Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103; Cunningham PJ, 2009, J GEN INTERN MED, V24, P415, DOI 10.1007/s11606-008-0879-3; Dartmouth Institute for Health Policy and Clinical Practice, DARTM ATL HLTH CAR; Deily ME, 2006, HEALTH ECON, V15, P419, DOI 10.1002/hec.1078; Doyle J., 2007, 13301 NAT BUR EC RES; Doyle JJ, 2012, 17936 NAT BUR EC RES; Englesbe MJ, 2009, AM J TRANSPLANT, V9, P1108, DOI 10.1111/j.1600-6143.2009.02592.x; Fenton JJ, 2012, ARCH INTERN MED, V172, P405, DOI 10.1001/archinternmed.2011.1662; Fisher E, 2010, HEALTH SERV RES, V45, P1893, DOI 10.1111/j.1475-6773.2010.01186.x; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2004, HLTH AFF MILLWOOD S; FLEMING ST, 1991, INQUIRY-J HEALTH CAR, V28, P29; Fowler FJ, 2008, JAMA-J AM MED ASSOC, V299, P2406, DOI 10.1001/jama.299.20.2406; Fu AZ, 2008, CURR MED RES OPIN, V24, P1385, DOI [10.1185/030079908X291994, 10.1185/030079908X291994 ]; Glance LG, 2010, ANN SURG, V252, P217, DOI 10.1097/SLA.0b013e3181e623f6; Grabowski DC, 2001, J GERONTOL B-PSYCHOL, V56, pS84, DOI 10.1093/geronb/56.2.S84; Grabowski DC, 2001, J HEALTH ECON, V20, P549, DOI 10.1016/S0167-6296(01)00083-2; Hadley J, 2011, HEALTH SERV RES, V46, P1333, DOI 10.1111/j.1475-6773.2011.01276.x; Hicks LL, 2004, NURS ECON, V22, P178; Huerta TR, 2008, HEALTH CARE MANAGE R, V33, P341, DOI 10.1097/01.HCM.0000318770.82642.c6; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Jha AK, 2009, HEALTH AFFAIR, V28, P897, DOI 10.1377/hlthaff.28.3.897; Kaestner R, 2010, MILBANK Q, V88, P560, DOI 10.1111/j.1468-0009.2010.00612.x; Kralewski John E, 2011, Minn Med, V94, P41; Lagu T, 2011, ARCH INTERN MED, V171, P292, DOI 10.1001/archinternmed.2011.12; Landrum MB, 2008, HEALTH AFFAIR, V27, P159, DOI 10.1377/hlthaff.27.1.159; Mangione CM, 2006, ANN INTERN MED, V145, P107, DOI 10.7326/0003-4819-145-2-200607180-00008; McKay NL, 2008, HEALTH ECON, V17, P833, DOI 10.1002/hec.1299; MOREY RC, 1992, MED CARE, V30, P677, DOI 10.1097/00005650-199208000-00002; Mukamel DB, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-10; Mukamel DB, 2001, HEALTH SERV RES, V36, P1019; Mukamel DB, 2000, MED CARE, V38, P78, DOI 10.1097/00005650-200001000-00009; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Painter M., 2012, COUNTING CHANGE MEAS; Picone GA, 2003, REV ECON STAT, V85, P51, DOI 10.1162/003465303762687703; Romley J, 2008, 13730 NAT BUR EC RES; Romley JA, 2011, ANN INTERN MED, V154, P160, DOI 10.7326/0003-4819-154-3-201102010-00005; Rosenthal MB, 2008, AM J MANAG CARE, V14, P670; Roski J, 2008, AM J MED QUAL, V23, P365, DOI 10.1177/1062860608316180; Saleh Shadi, 2012, J Health Care Finance, V38, P50; Schreyogg J, 2010, HEALTH SERV RES, V45, P1585, DOI 10.1111/j.1475-6773.2010.01161.x; Silber JH, 2010, HEALTH SERV RES, V45, P1872, DOI 10.1111/j.1475-6773.2010.01180.x; Sirovich BE, 2006, ANN INTERN MED, V144, P641, DOI 10.7326/0003-4819-144-9-200605020-00007; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Solberg LI, 2002, AM J MANAG CARE, V8, P413; STARFIELD B, 1994, JAMA-J AM MED ASSOC, V272, P1903, DOI 10.1001/jama.272.24.1903; The Dartmouth Institute for Health Policy & Clinical Practice, DARTM ATL HLTH CAR R; Weech-Maldonado R, 2006, AM J MED QUAL, V21, P40, DOI 10.1177/1062860605280643; Weech-Maldonado R, 2003, HEALTH CARE MANAGE R, V28, P201, DOI 10.1097/00004010-200307000-00002; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; Wennberg JE, 2009, HEALTH AFFAIR, V28, P103, DOI 10.1377/hlthaff.28.1.103; Yasaitis L, 2009, J AMBUL CARE MANAG, V32, P226, DOI 10.1097/JAC.0b013e3181ac9cff; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	73	165	166	0	51	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					27	U86		10.7326/0003-4819-158-1-201301010-00006	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00006			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277898	Green Accepted			2022-12-28	WOS:000313119900005
J	Igonet, S; Rey, FA				Igonet, Sebastien; Rey, Felix A.			SnapShot: Viral and Eukaryotic Protein Fusogens	CELL			English	Editorial Material							FUSION		[Igonet, Sebastien; Rey, Felix A.] Inst Pasteur, CNRS, URA 3015, Unite Virol Struct, F-75724 Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Igonet, S (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.			Rey, Felix/0000-0002-9953-7988				Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Igonet S, 2011, P NATL ACAD SCI USA, V108, P19967, DOI 10.1073/pnas.1108910108	4	14	14	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1634	U264		10.1016/j.cell.2012.11.041	http://dx.doi.org/10.1016/j.cell.2012.11.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260148	Bronze			2022-12-28	WOS:000312890300026
J	Rosenzweig, A				Rosenzweig, Anthony			Cardiac Regeneration	SCIENCE			English	Editorial Material							PRESERVED EJECTION FRACTION; RANDOMIZED PHASE-1 TRIAL; CARDIOMYOCYTE PROLIFERATION; HEART-FAILURE; STEM-CELLS; MYOCARDIAL-INFARCTION; FIBROBLASTS; APOPTOSIS; MYOCYTES; THERAPY		[Rosenzweig, Anthony] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA; [Rosenzweig, Anthony] Harvard Stem Cell Inst, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University	Rosenzweig, A (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Cardiovasc, Boston, MA 02215 USA.	arosenzw@bidmc.harvard.edu	Rosenzweig, Anthony/AAD-7893-2019		NHLBI NIH HHS [R01 HL122987] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bostrom P, 2010, CELL, V143, P1072, DOI 10.1016/j.cell.2010.11.036; DeFrances Carol J, 2006, Adv Data, P1; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang GN, 2012, SCIENCE, V338, P1599, DOI 10.1126/science.1229765; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Porrello ER, 2011, CIRC RES, V109, P670, DOI 10.1161/CIRCRESAHA.111.248880; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rosenzweig A, 2006, NEW ENGL J MED, V355, P1274, DOI 10.1056/NEJMe068172; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278	27	24	28	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1549	1550		10.1126/science.1228951	http://dx.doi.org/10.1126/science.1228951			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258880				2022-12-28	WOS:000312533100036
J	Spillane, J; Higham, E; Kullmann, DM				Spillane, J.; Higham, E.; Kullmann, D. M.			Myasthenia gravis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES; DIAGNOSIS		[Spillane, J.; Kullmann, D. M.] UCL Inst Neurol, London WC1N 3BG, England; [Higham, E.] Cent Med Ctr, Morden SM4 5RT, England	University of London; University College London	Spillane, J (corresponding author), UCL Inst Neurol, London WC1N 3BG, England.	jennifer.spillane.09@ucl.ac.uk		Kullmann, Dimitri/0000-0001-6696-3545; Spillane, Jennifer/0000-0002-9339-0938	MRC [G116/147, G0400136, G0601440, G0600368, G0400627, G0801316, G0900613, G9805989] Funding Source: UKRI; Medical Research Council [G0601440, G116/147, G0600368, G9805989, G0400136, G0801316, G0900613, G0400627] Funding Source: Medline; Wellcome Trust [095580] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AAEM Quality Assurance Comm, 2001, MUSCLE NERVE, V24, P1239; Aarli JA, 2008, ANN NY ACAD SCI, V1132, P238, DOI 10.1196/annals.1405.040; Beekman R, 1997, J NEUROL, V244, P112, DOI 10.1007/s004150050059; Carr AS, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-46; Chan KH, 2007, MUSCLE NERVE, V36, P651, DOI 10.1002/mus.20854; Collongues N, 2012, MUSCLE NERVE, V46, P687, DOI 10.1002/mus.23412; Gilhus NE, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/847393; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Jani-Aesadi A, 2007, J NEUROL SCI, V261, P127, DOI 10.1016/j.jns.2007.04.045; Libman R, 2002, J NEUROL, V249, P1512, DOI 10.1007/s00415-002-0858-2; Meriggioli MN, 2005, AM J PHYS MED REHAB, V84, P627, DOI 10.1097/01.phm.0000171169.79816.4c; Montero-Odasso M, 2006, J GEN INTERN MED, V21, pC4, DOI 10.1111/j.1525-1497.2006.00343.x; Palace J, 2001, CURR OPIN NEUROL, V14, P583, DOI 10.1097/00019052-200110000-00006; Phillips LH, 2003, ANN NY ACAD SCI, V998, P407, DOI 10.1196/annals.1254.053; Reddy Aravind R, 2007, Pract Neurol, V7, P109; Robertson NP, 1998, J NEUROL NEUROSUR PS, V65, P492, DOI 10.1136/jnnp.65.4.492; Skeie GO, 2008, EUR J NEUROL, V15, P1029, DOI 10.1111/j.1468-1331.2008.02242.x; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Vincent A, 2003, J NEUROL NEUROSUR PS, V74, P1105, DOI 10.1136/jnnp.74.8.1105	19	34	35	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 21	2012	345								e8497	10.1136/bmj.e8497	http://dx.doi.org/10.1136/bmj.e8497			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059JR	23261848				2022-12-28	WOS:000312701700015
J	Paterson, AH; Wendel, JF; Gundlach, H; Guo, H; Jenkins, J; Jin, DC; Llewellyn, D; Showmaker, KC; Shu, SQ; Udall, J; Yoo, MJ; Byers, R; Chen, W; Doron-Faigenboim, A; Duke, MV; Gong, L; Grimwood, J; Grover, C; Grupp, K; Hu, GJ; Lee, TH; Li, JP; Lin, LF; Liu, T; Marler, BS; Page, JT; Roberts, AW; Romanel, E; Sanders, WS; Szadkowski, E; Tan, X; Tang, HB; Xu, CM; Wang, JP; Wang, ZN; Zhang, D; Zhang, L; Ashrafi, H; Bedon, F; Bowers, JE; Brubaker, CL; Chee, PW; Das, S; Gingle, AR; Haigler, CH; Harker, D; Hoffmann, LV; Hovav, R; Jones, DC; Lemke, C; Mansoor, S; Rahman, MU; Rainville, LN; Rambani, A; Reddy, UK; Rong, JK; Saranga, Y; Scheffler, BE; Scheffler, JA; Stelly, DM; Triplett, BA; Van Deynze, A; Vaslin, MFS; Waghmare, VN; Walford, SA; Wright, RJ; Zaki, EA; Zhang, TZ; Dennis, ES; Mayer, KFX; Peterson, DG; Rokhsar, DS; Wang, XY; Schmutz, J				Paterson, Andrew H.; Wendel, Jonathan F.; Gundlach, Heidrun; Guo, Hui; Jenkins, Jerry; Jin, Dianchuan; Llewellyn, Danny; Showmaker, Kurtis C.; Shu, Shengqiang; Udall, Joshua; Yoo, Mi-jeong; Byers, Robert; Chen, Wei; Doron-Faigenboim, Adi; Duke, Mary V.; Gong, Lei; Grimwood, Jane; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Liu, Tao; Marler, Barry S.; Page, Justin T.; Roberts, Alison W.; Romanel, Elisson; Sanders, William S.; Szadkowski, Emmanuel; Tan, Xu; Tang, Haibao; Xu, Chunming; Wang, Jinpeng; Wang, Zining; Zhang, Dong; Zhang, Lan; Ashrafi, Hamid; Bedon, Frank; Bowers, John E.; Brubaker, Curt L.; Chee, Peng W.; Das, Sayan; Gingle, Alan R.; Haigler, Candace H.; Harker, David; Hoffmann, Lucia V.; Hovav, Ran; Jones, Donald C.; Lemke, Cornelia; Mansoor, Shahid; Rahman, Mehboob Ur; Rainville, Lisa N.; Rambani, Aditi; Reddy, Umesh K.; Rong, Jun-kang; Saranga, Yehoshua; Scheffler, Brian E.; Scheffler, Jodi A.; Stelly, David M.; Triplett, Barbara A.; Van Deynze, Allen; Vaslin, Maite F. S.; Waghmare, Vijay N.; Walford, Sally A.; Wright, Robert J.; Zaki, Essam A.; Zhang, Tianzhen; Dennis, Elizabeth S.; Mayer, Klaus F. X.; Peterson, Daniel G.; Rokhsar, Daniel S.; Wang, Xiyin; Schmutz, Jeremy			Repeated polyploidization of Gossypium genomes and the evolution of spinnable cotton fibres	NATURE			English	Article							DNA; SEQUENCE; RECOMBINATION; ARABIDOPSIS; PLANTS; ORGANIZATION; BARBADENSE; PATHWAYS; ANCIENT; PROTEIN	Polyploidy often confers emergent properties, such as the higher fibre productivity and quality of tetraploid cottons than diploid cottons bred for the same environments(1). Here we show that an abrupt five-to sixfold ploidy increase approximately 60 million years (Myr) ago, and allopolyploidy reuniting divergent Gossypium genomes approximately 1-2 Myr ago(2), conferred about 30-36-fold duplication of ancestral angiosperm (flowering plant) genes in elite cottons (Gossypium hirsutum and Gossypium barbadense), genetic complexity equalled only by Brassica(3) among sequenced angiosperms. Nascent fibre evolution, before allopolyploidy, is elucidated by comparison of spinnable-fibred Gossypium herbaceum A and non-spinnable Gossypium longicalyx F genomes to one another and the outgroup D genome of non-spinnable Gossypium raimondii. The sequence of a G. hirsutum A(t)D(t) (in which 't' indicates tetraploid) cultivar reveals many non-reciprocal DNA exchanges between subgenomes that may have contributed to phenotypic innovation and/or other emergent properties such as ecological adaptation by polyploids. Most DNA-level novelty in G. hirsutum recombines alleles from the D-genome progenitor native to its New World habitat and the Old World A-genome progenitor in which spinnable fibre evolved. Coordinated expression changes in proximal groups of functionally distinct genes, including a nuclear mitochondrial DNA block, may account for clusters of cotton-fibre quantitative trait loci affecting diverse traits. Opportunities abound for dissecting emergent properties of other polyploids, particularly angiosperms, by comparison to diploid progenitors and outgroups.	[Paterson, Andrew H.; Guo, Hui; Lee, Tae-ho; Li, Jingping; Lin, Lifeng; Marler, Barry S.; Tan, Xu; Tang, Haibao; Wang, Zining; Zhang, Dong; Bowers, John E.; Das, Sayan; Gingle, Alan R.; Lemke, Cornelia; Mansoor, Shahid; Rainville, Lisa N.; Rong, Jun-kang; Wang, Xiyin] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Wendel, Jonathan F.; Yoo, Mi-jeong; Gong, Lei; Grover, Corrinne; Grupp, Kara; Hu, Guanjing; Szadkowski, Emmanuel; Xu, Chunming] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Gundlach, Heidrun; Mayer, Klaus F. X.] German Res Ctr Environm Hlth GmbH, MIPS IBIS Inst Bioinformat & Syst Biol, D-85764 Neuherberg, Germany; [Jenkins, Jerry; Shu, Shengqiang; Grimwood, Jane; Rokhsar, Daniel S.; Schmutz, Jeremy] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94595 USA; [Jenkins, Jerry; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Life Sci, Ctr Genom & Computat Biol, Tangshan 063000, Hebei, Peoples R China; [Jin, Dianchuan; Chen, Wei; Liu, Tao; Wang, Jinpeng; Zhang, Lan; Wang, Xiyin] Hebei United Univ, Sch Sci, Tangshan 063000, Hebei, Peoples R China; [Llewellyn, Danny; Bedon, Frank; Brubaker, Curt L.; Walford, Sally A.; Dennis, Elizabeth S.] CSIRO Plant Ind, Canberra, ACT 2601, Australia; [Showmaker, Kurtis C.; Sanders, William S.; Peterson, Daniel G.] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Udall, Joshua; Byers, Robert; Page, Justin T.; Harker, David; Rambani, Aditi] Brigham Young Univ, Plant & Wildlife Sci Dept, Provo, UT 84602 USA; [Doron-Faigenboim, Adi; Hovav, Ran] Agr Res Org, Inst Plant Sci, Dept Field Crops, IL-50250 Bet Dagan, Israel; [Duke, Mary V.; Scheffler, Brian E.; Scheffler, Jodi A.] USDA ARS, Jamie Whitten Delta States Res Ctr, Stoneville, MS 38776 USA; [Roberts, Alison W.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Romanel, Elisson] Univ Fed Rio de Janeiro, Dept Genet, BR-21941901 Rio De Janeiro, Brazil; [Tang, Haibao] J Craig Venter Inst, Rockville, MD 20850 USA; [Xu, Chunming] NE Normal Univ, Inst Cytol & Genet, Unit Plant Epigenet, Key Lab Mol Epigenet MOE, Changchun 5268, Peoples R China; [Ashrafi, Hamid; Van Deynze, Allen] Univ Calif Davis, Plant Reprod Biol Extens Ctr, Davis, CA 95616 USA; [Brubaker, Curt L.] Bayer CropSci, B-9052 Ghent, Belgium; [Chee, Peng W.] Univ Georgia, Coastal Plain Expt Stn, Tifton, GA 31793 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Haigler, Candace H.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Hoffmann, Lucia V.] EMBRAPA, Ctr Nacl Pesquisa Algodao, BR-75375000 Santo Antonio De Goias, Go, Brazil; [Jones, Donald C.] Cotton Inc, Cary, NC 27513 USA; [Mansoor, Shahid; Rahman, Mehboob Ur] Natl Inst Biotechnol & Genet Engn, Faisalabad 38000, Pakistan; [Reddy, Umesh K.] W Virginia State Univ, Dept Biol, Institute, WV 25112 USA; [Saranga, Yehoshua] Hebrew Univ Jerusalem, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Stelly, David M.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Triplett, Barbara A.] USDA ARS, New Orleans, LA 70124 USA; [Vaslin, Maite F. S.] Univ Fed Rio de Janeiro, Dept Microbiol, BR-21941971 Rio De Janeiro, Brazil; [Waghmare, Vijay N.] Cent Inst Cotton Res, Nagpur 440010, Maharashtra, India; [Wright, Robert J.] Texas Tech Univ, Dept Plant Sci, Lubbock, TX 79415 USA; [Zaki, Essam A.] Genet Engn & Biotechnol Res Inst, Nucle Acids Dept, Alexandria 21934, Egypt; [Zhang, Tianzhen] Nanjing Agr Univ, Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China	University System of Georgia; University of Georgia; Iowa State University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; HudsonAlpha Institute for Biotechnology; North China University of Science & Technology; North China University of Science & Technology; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Mississippi State University; Brigham Young University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; United States Department of Agriculture (USDA); University of Rhode Island; Universidade Federal do Rio de Janeiro; J. Craig Venter Institute; Northeast Normal University - China; University of California System; University of California Davis; Bayer AG; Bayer CropScience; University System of Georgia; University of Georgia; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cotton Incorporated; Pakistan Institute of Engineering & Applied Science; West Virginia State University; Hebrew University of Jerusalem; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Universidade Federal do Rio de Janeiro; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research; Texas Tech University System; Texas Tech University; Nanjing Agricultural University	Paterson, AH (corresponding author), Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA.	paterson@plantbio.uga.edu; jschmutz@hudsonalpha.org	Vaslin, Maite F/G-5074-2011; Schmutz, Jeremy/N-3173-2013; Romanel, Elisson AC/F-1933-2013; Grover, Corrinne E/K-3194-2019; Yoo, Michelle/L-3668-2019; Hu, Guanjing/AAA-4497-2020; Stelly, David/ABC-7400-2020; Bowers, John/AAD-7601-2019; Yoo, Mi-Jeong/ABH-9752-2020; Saranga, Yehoshua/GXV-3347-2022; Dennis, Elizabeth S/A-6074-2008; Romanel, Elisson AC/E-5888-2019; Jenkins, Jerry/ABE-6479-2020; Mayer, Klaus FX/M-7941-2015; Chen, Wei/W-8311-2019; Grimwood, Jane/ABD-5737-2021; Bowers, John/B-9245-2009; Hoffmann, Lucia Vieira/C-1161-2013; Zaki, Essam/K-8456-2015; Bedon, Frank/B-5497-2011; Rahman, Mehboob-ur-/I-7983-2015; Chen, Wei/O-6774-2017; Walford, Sally/B-5488-2011; Rambani, Aditi/I-2573-2019; Llewellyn, Danny J/D-5230-2009; Tang, Haibao/A-6715-2011	Vaslin, Maite F/0000-0002-7252-7050; Schmutz, Jeremy/0000-0001-8062-9172; Romanel, Elisson AC/0000-0002-4794-4215; Grover, Corrinne E/0000-0003-3878-5459; Hu, Guanjing/0000-0001-8552-7394; Stelly, David/0000-0002-3468-4119; Yoo, Mi-Jeong/0000-0003-4991-2636; Dennis, Elizabeth S/0000-0002-7850-591X; Romanel, Elisson AC/0000-0002-4794-4215; Jenkins, Jerry/0000-0002-7943-3997; Mayer, Klaus FX/0000-0001-6484-1077; Bowers, John/0000-0001-8984-9796; Hoffmann, Lucia Vieira/0000-0003-2150-1990; Zaki, Essam/0000-0002-3906-623X; Bedon, Frank/0000-0002-9940-5926; Chen, Wei/0000-0002-6857-7696; Rambani, Aditi/0000-0002-3691-6737; Llewellyn, Danny J/0000-0001-9535-8707; Tang, Haibao/0000-0002-3460-8570; Gundlach, Heidrun/0000-0002-6757-0943; Scheffler, Brian/0000-0003-1968-8952; Ashrafi, Hamid/0000-0002-2094-2367; Xu, Chunming/0000-0002-0986-0993; Rokhsar, Daniel/0000-0002-8704-2224; Shu, Shengqiang/0000-0002-4336-8994; Haigler, Candace/0000-0001-7810-4035; Showmaker, Kurt/0000-0002-6317-9402; Mansoor, Shahid/0000-0001-7418-1826; Bowers, John/0000-0001-5693-2796; Peterson, Daniel/0000-0002-0274-5968; Guo, Hui/0000-0001-7830-8564	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; US National Science Foundation [DBI 98-72630, DBI 02-11700, DBI 02-08311, IIP-0917856, IIP-1127755, IOS 1025947]; USDA [ARS-58-6402-7-241, 58-6402-1-644, 58-6402-1-645, ARS 6402-21310-003-00, NRI 00-52100-9685, 02-35301-12045]; Bayer CropScience; Consortium for Plant Biotechnology Research; Cotton, Inc.; Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program; Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PDJ150690/2012-6]; Fundacao de Amparo a Pesquisa Pensa Rio [E-26/110.324/2010]; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences [1025947] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0841821] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Bayer CropScience(Bayer AG); Consortium for Plant Biotechnology Research; Cotton, Inc.(Cotton R&D Corp); Georgia State Support Committee; Texas State Support Committee; Pakistan-US Science and Technology Cooperation Program; US-Egypt Science and Technology Cooperation Program(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); Fulbright Scholar Program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa Pensa Rio; Texas AgriLife; Brigham Young University (BYU); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work, conducted by the US Department of Energy Joint Genome Institute, is supported by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. The authors appreciate financial support from the US National Science Foundation (DBI 98-72630 to A.H.P., J.F.W., A.R.G.; DBI 02-11700 to J.F.W., A.H.P., J.U., A.R.G.; DBI 02-08311, IIP-0917856; IIP-1127755 to A.H.P.; IOS 1025947 to C.H.H.), USDA (ARS-58-6402-7-241, 58-6402-1-644 and 58-6402-1-645 to D.G.P.; ARS 6402-21310-003-00 to B.E.S.; NRI 00-52100-9685 and 02-35301-12045 to A.H.P.), Bayer CropScience and The Consortium for Plant Biotechnology Research (A.H.P.), Cotton, Inc. (P.W.C., D.C.J., A.H.P., D.M.S., A.V.-D., J.F.W.), Georgia State Support Committee (P.W.C., A.H.P.), Texas State Support Committee (R.J.W.), Pakistan-US Science and Technology Cooperation Program (P.W.C., S.M., A.H.P., M.u.R.), US-Egypt Science and Technology Cooperation Program (A.H.P., E.A.Z.), Fulbright Scholar Program (S.M., E.A.Z.), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico PDJ150690/2012-6 (E.R.), Fundacao de Amparo a Pesquisa Pensa Rio E-26/110.324/2010 (M.F.S.V.), Texas AgriLife (D.M.S.), and Brigham Young University (BYU) Mentored Environment Grants (J.U.). RNA-seq reads were mapped by students on Marylou at the Fulton Supercomputer Center at BYU. We thank L.S. Dure III, G.O. Myers, J. McD Stewart, T.A. Wilkins and J. Zhu for co-endorsing the sequencing of G. raimondii by the US Department of Energy.	ADKISSON PL, 1982, SCIENCE, V216, P19, DOI 10.1126/science.216.4541.19; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carvalho MR, 2011, AM J BOT, V98, P1337, DOI 10.3732/ajb.1000539; Cronn R, 2003, EVOLUTION, V57, P2475, DOI 10.1111/j.0014-3820.2003.tb01493.x; Doblin MS, 2010, FUNCT PLANT BIOL, V37, P357, DOI 10.1071/FP09279; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Flagel LE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-302; GEEVER RF, 1989, THEOR APPL GENET, V77, P553, DOI 10.1007/BF00274278; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Haigler CH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00104; Hendrix B, 2005, ANN BOT-LONDON, V95, P789, DOI 10.1093/aob/mci078; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Jiao YN, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r3; KADIR ZBA, 1976, CHROMOSOMA, V56, P85, DOI 10.1007/BF00293732; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Lin LF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-395; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Muravenko OV, 1998, GENOME, V41, P616, DOI 10.1139/gen-41-4-616; REINISCH AJ, 1994, GENETICS, V138, P829; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rong J, 2005, GENOME RES, V15, P1198, DOI 10.1101/gr.3907305; Rong JK, 2004, GENETICS, V166, P389, DOI 10.1534/genetics.166.1.389; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Senchina DS, 2003, MOL BIOL EVOL, V20, P633, DOI 10.1093/molbev/msg065; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; WALBOT V, 1976, J MOL BIOL, V101, P503, DOI 10.1016/0022-2836(76)90242-4; WANG GL, 1995, THEOR APPL GENET, V91, P1153, DOI 10.1007/BF00223934; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang XY, 2011, PLANT CELL, V23, P27, DOI 10.1105/tpc.110.080622; WENDEL JF, 1989, P NATL ACAD SCI USA, V86, P4132, DOI 10.1073/pnas.86.11.4132; WENDEL JF, 1995, MOL PHYLOGENET EVOL, V4, P298, DOI 10.1006/mpev.1995.1027; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zhao XP, 1998, GENOME RES, V8, P479, DOI 10.1101/gr.8.5.479	42	831	906	13	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					423	+		10.1038/nature11798	http://dx.doi.org/10.1038/nature11798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257886	Green Published, hybrid			2022-12-28	WOS:000312488200055
J	Raffi, F; Rachlis, A; Stellbrink, HJ; Hardy, WD; Torti, C; Orkin, C; Bloch, M; Podzamczer, D; Pokrovsky, V; Pulido, F; Almond, S; Margolis, D; Brennan, C; Min, S				Raffi, Francois; Rachlis, Anita; Stellbrink, Hans-Juergen; Hardy, W. David; Torti, Carlo; Orkin, Chloe; Bloch, Mark; Podzamczer, Daniel; Pokrovsky, Vadim; Pulido, Federico; Almond, Steve; Margolis, David; Brennan, Clare; Min, Sherene		SPRING-2 Study Grp	Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study	LANCET			English	Article							COMBINATION THERAPY; INTEGRASE INHIBITOR; EFAVIRENZ; PHARMACOKINETICS; ELVITEGRAVIR; GUIDELINES; EFFICACY; SAFETY	Background Dolutegravir (S/GSK1349572) is a once-daily HIV integrase inhibitor with potent antiviral activity and a favourable safety profile. We compared dolutegravir with HIV integrase inhibitor raltegravir, as initial treatment for adults with HIV-1. Methods SPRING-2 is a 96 week, phase 3, randomised, double-blind, active-controlled, non-inferiority study that began on Oct 19, 2010, at 100 sites in Canada, USA, Australia, and Europe. Treatment-naive adults (aged >= 18 years) with HIV-1 infection and HIV-1 RNA concentrations of 1000 copies per mL or greater were randomly assigned (1: 1) via a computer-generated randomisation sequence to receive either dolutegravir (50 mg once daily) or raltegravir (400 mg twice daily). Study drugs were given with coformulated tenofovir/emtricitabine or abacavir/lamivudine. Randomisation was stratified by screening HIV-1 RNA (<= 100 000 copies per mL or >100 000 copies per mL) and nucleoside reverse transcriptase inhibitor backbone. Investigators were not masked to HIV-1 RNA results before randomisation. The primary endpoint was the proportion of participants with HIV-1 RNA less than 50 copies per mL at 48 weeks, with a 10% non-inferiority margin. Main secondary endpoints were changes from baseline in CD4 cell counts, incidence and severity of adverse events, changes in laboratory parameters, and genotypic or phenotypic evidence of resistance. Our primary analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT01227824. Findings 411 patients were randomly allocated to receive dolutegravir and 411 to receive raltegravir and received at least one dose of study drug. At 48 weeks, 361 (88%) patients in the dolutegravir group achieved an HIV-1 RNA value of less than 50 copies per mL compared with 351 (85%) in the raltegravir group (adjusted difference 2.5%; 95% CI -2.2 to 7.1). Adverse events were similar between treatment groups. The most common events were nausea (59 [14%] patients in the dolutegravir group vs 53 [13%] in the raltegravir group), headache (51 [12%] vs 48 [12%]), nasopharyngitis (46 [11%] vs 48 [12%]), and diarrhoea (47 [11%] in each group). Few patients had drug-related serious adverse events (three [<1%] vs five [1%]), and few had adverse events leading to discontinuation (ten [2%] vs seven [2%] in each group). CD4 cell counts increased from baseline to week 48 in both treatment groups by a median of 230 cells per mu L. Rates of graded laboratory toxic effects were similar. We noted no evidence of treatment-emergent resistance in patients with virological failure on dolutegravir, whereas of the patients with virologic failure who received raltegravir, one (6%) had integrase treatment-emergent resistance and four (21%) had nucleoside reverse transcriptase inhibitors treatment-emergent resistance. Interpretation The non-inferior efficacy and similar safety profile of dolutegravir compared with raltegravir means that if approved, combination treatment with once-daily dolutegravir and fixed-dose nucleoside reverse transcriptase inhibitors would be an effective new option for treatment of HIV-1 in treatment-naive patients.	[Raffi, Francois] Univ Nantes, F-44093 Nantes, France; [Rachlis, Anita] Univ Toronto, Sunnybrook Hlth Sci Ctr, Toronto, ON M5S 1A1, Canada; [Stellbrink, Hans-Juergen] Hamburg Study Ctr, Infekt Med Ctr, Hamburg, Germany; [Hardy, W. David] Univ Calif Los Angeles, David Geffen Sch Med, Cedars Sinai Med Ctr, Los Angeles, CA 90095 USA; [Torti, Carlo] Univ Brescia, Brescia, Italy; [Torti, Carlo] Magna Graecia Univ Catanzaro, Catanzaro, Italy; [Orkin, Chloe] Royal London Hosp, London E1 1BB, England; [Bloch, Mark] Holdsworth House Med Practice, Darlinghurst, NSW, Australia; [Podzamczer, Daniel] Hosp Univ Bellvitge, Barcelona, Spain; [Pokrovsky, Vadim] Russian Fed Guidance Ctr AIDS, Moscow, Russia; [Pulido, Federico] Hosp 12 Octubre, E-28041 Madrid, Spain; [Almond, Steve] GlaxoSmithKline, Mississauga, ON, Canada; [Margolis, David; Brennan, Clare; Min, Sherene] GlaxoSmithKline, Res Triangle Pk, NC USA	Nantes Universite; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Brescia; Magna Graecia University of Catanzaro; Barts Health NHS Trust; Royal London Hospital; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Hospital Universitario 12 de Octubre; GlaxoSmithKline; GlaxoSmithKline	Raffi, F (corresponding author), Univ Nantes, Hotel Dieu, Dept Infect Dis, F-44093 Nantes, France.	francois.raffi@wanadoo.fr	Portilla, Joaquín/O-7609-2018; Arribas, Jose R/A-1595-2015; Shuldyakov, Andrey/U-5598-2017; Pokrovsky, Vadim/AAH-7554-2020; Soriano, Vicente/O-5730-2018; Pulido, Federico/B-8417-2009; Bergmann, Jean-Francois/L-6044-2017	Portilla, Joaquín/0000-0002-3676-9511; Shuldyakov, Andrey/0000-0002-3009-9262; Soriano, Vicente/0000-0002-4624-5199; Pulido, Federico/0000-0002-7414-8812; CAUDA, Roberto/0000-0002-1498-4229; Bergmann, Jean-Francois/0000-0001-6861-9748; Pasquau, Juan/0000-0001-9409-9205; Pokrovsky, Vadim/0000-0002-9514-7288; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758	Abbott Labs; Merck; Boehringer Ingelheim; ViiV Healthcare; Pfizer; GlaxoSmithKline (GSK); Bristol-Myers Squibb; Janssen; Tibotec; Astellas; Gilead Sciences; Vii; Merck Laboratories; Janssen-Cilag; Roche; Schering-Plough; Theratechnologies; Avexa	Abbott Labs(Abbott Laboratories); Merck(Merck & Company); Boehringer Ingelheim(Boehringer Ingelheim); ViiV Healthcare; Pfizer(Pfizer); GlaxoSmithKline (GSK)(GlaxoSmithKline); Bristol-Myers Squibb(Bristol-Myers Squibb); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Tibotec; Astellas(Astellas Pharmaceuticals); Gilead Sciences(Gilead Sciences); Vii; Merck Laboratories(Merck & Company); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Theratechnologies; Avexa	AR has received honoraria for participation as a consultant, member of advisory boards, and provision of continuing education, and has been an investigator in clinical trials for Bristol-Myers Squibb, Merck, Gilead Science, ViiV Healthcare, Pfizer, Abbott Labs, and Janssen. CB, DM, SA, and SM are employees of GlaxoSmithKline and hold stock in the company. CO has received honoraria and travel grants and research funding from Abbott Labs, Merck, Boehringer Ingelheim, ViiV Healthcare, Pfizer, GlaxoSmithKline (GSK), Bristol-Myers Squibb, Janssen, Tibotec, Astellas, and Gilead Sciences. CT has received financial support for participation in a scientific meeting; honoraria for speaking at scientific meetings and workshops from several pharmaceutical companies that produce antiretroviral drugs, including ViiV Healthcare, Bristol-Myers Squibb, Gilead Sciences, and Abbott Labs; and funding for undertaking researches from Gilead Sciences and Bristol-Myers Squibb. However, these potential conflicts did not affect the given contributions to this article. DP has received research grants or honoraria for advisories or conferences from Boehringer Ingelheim, GSK, Vii, Pfizer, Bristol-Myers Squibb, Abbott Labs, Gilead Sciences, Janssen, and Merck. FP has received consulting and lecture fees from Abbott Labs, Bristol-Myers Squibb, Gilead Sciences, GSK, Janssen, and ViiV Healthcare. FR has received research support from Gilead Sciences, Merck Laboratories, and Tibotec and consulting fees from Abbott Labs, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Janssen-Cilag, Merck, Roche, Schering-Plough, ViiV Healthcare, Theratechnologies, and Avexa. HJS is a member of advisory boards for ViiV Healthcare, Abbott Labs, Gilead Sciences, Janssen-Cilag, Boehringer Ingelheim, and Bristol-Myers Squibb, and has received honoraria for scientific presentation by the above-mentioned companies and payment for expert testimony by Bristol-Myers Squibb; travel grants were provided at some point in the last 3 years by each of those companies, mostly for participation in company-sponsored symposia. MB has participated on advisory boards for ViiV Healthcare, Gilead Sciences, Merck, Abbott, Boehringer-Ingelheim, Eli Lilly, and Bristol-Myers Squibb, and has received research funding from ViiV Healthcare, Gilead Sciences, Merck, Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Novartis, Baxter Healthcare, and Janssen, and support for travel to attend scientific meetings from ViiV Healthcare, Merck, Gilead Sciences, Janssen, and Bristol-Myers Squibb. VP declares that he has no conflicts of interest. WDH has been a clinical trial investigator (via contracts between his employer, Cedars-Sinai and sponsors) and has received honoraria for participation as a consultant and advisory board member from Bionor Pharma, Gilead, ViiV/GSK, ViiV/Pfizer, and Vertex; he owns less than US$5000 of Merck stock.	BURGESS E, 1982, RENAL PHYSIOL BIOCH, V5, P27; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Cohen CJ, 2012, JAIDS-J ACQ IMM DEF, V60, P33, DOI 10.1097/QAI.0b013e31824d006e; Cruciani M, 2011, AIDS, V25, P1993, DOI 10.1097/QAD.0b013e328349c6ee; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hill A, 2008, AIDS, V22, P913, DOI 10.1097/QAD.0b013e3282f5556d; Kassahun K, 2007, DRUG METAB DISPOS, V35, P1657, DOI 10.1124/dmd.107.016196; KASTRUP J, 1985, BRIT J UROL, V57, P265, DOI 10.1111/j.1464-410X.1985.tb06340.x; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Koteff J, 2013, BRIT J CLIN PHARMACO, V75, P990, DOI 10.1111/j.1365-2125.2012.04440.x; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lepist EI, 2011, 51 INT C ANT AG CHEM, pA1; Merck, 2011, IS SUMM PROD CHAR; Merck, 2011, IS US PRESCR INF; Min S, 2010, ANTIMICROB AGENTS CH, V54, P254, DOI 10.1128/AAC.00842-09; Powderly WG, 2010, J ANTIMICROB CHEMOTH, V65, P2485, DOI 10.1093/jac/dkq350; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Schrijvers R, 2012, LANCET, V379, P2403, DOI 10.1016/S0140-6736(12)61029-0; Song I, 2012, REV ANTIVIR THER INF, V3, P9; Song I, 2012, ANTIMICROB AGENTS CH, V56, P1627, DOI 10.1128/AAC.05739-11; Song I, 2011, ANTIMICROB AGENTS CH, V55, P3517, DOI 10.1128/AAC.00073-11; Stellbrink H-J, 2012, 19 C RETR OPP INF SE; Tozzi V, 2008, CURR HIV RES, V6, P544, DOI 10.2174/157016208786501535; US Department of Health and Human Services, 2012, GUID US ANT AG HIV 1; US Department of Health and Human Services, 2009, FDA GUID IND DRUG IN; US Food and Dr ug Administration, 2012, FDA APPR NEW COMB PI; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Walmsley S, 2012, 52 INT C ANT AG CHEM; Zolopa AR, 2010, J INFECT DIS, V201, P814, DOI 10.1086/650698	31	389	409	0	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 2	2013	381	9868					735	743		10.1016/S0140-6736(12)61853-4	http://dx.doi.org/10.1016/S0140-6736(12)61853-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	098TC	23306000				2022-12-28	WOS:000315570900027
J	Burmester, GR; Blanco, R; Charles-Schoeman, C; Wollenhaupt, J; Zerbini, C; Benda, B; Gruben, D; Wallenstein, G; Krishnaswami, S; Zwillich, SH; Koncz, T; Soma, K; Bradley, J; Mebus, C				Burmester, Gerd R.; Blanco, Ricardo; Charles-Schoeman, Christina; Wollenhaupt, Juergen; Zerbini, Cristiano; Benda, Birgitta; Gruben, David; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Samuel H.; Koncz, Tamas; Soma, Koshika; Bradley, John; Mebus, Charles		ORAL Step Investigators	Tofacitinib (CP-690,550) in combination with methotrexate in patients with active rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitors: a randomised phase 3 trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; AMERICAN-COLLEGE; DOUBLE-BLIND; PLACEBO; OUTCOMES; RECOMMENDATIONS; MULTICENTER; DEFINITION; ADALIMUMAB; EFFICACY	Background Rheumatoid arthritis is a heterogeneous chronic disease, and no therapeutic agent has been identified which is universally and persistently effective in all patients. We investigated the effectiveness of tofacitinib (CP-690,550), a novel oral Janus kinase inhibitor, as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis. Methods We did a 6-month, double-blind, parallel-group phase 3 study at 82 centres in 13 countries, including North America, Europe, and Latin America. 399 patients aged 18 years or older with moderate-to-severe rheumatoid arthritis and inadequate response to tumour necrosis factor inhibitors (TNFi) were randomly assigned in a 2: 2: 1: 1 ratio with an automated internet or telephone system to receive twice a day treatment with: tofacitinib 5 mg (n=133); tofacitinib 10 mg (n=134); or placebo (n=132), all with methotrexate. At month 3, patients given placebo advanced to either tofacitinib 5 mg twice a day (n=66) or 10 mg twice a day (n=66). Primary endpoints included American College of Rheumatology (ACR) 20 response rate, mean change from baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI), and rates of disease activity score (DAS) 28-4(ESR) less than 2.6 (referred to as DAS28<2.6), all at month 3. The full analysis set for the primary analysis included all randomised patients who received at least one dose of study medication and had at least one post-baseline assessment. This trial is registered with www.ClinicalTrials.gov, number NCT00960440. Findings At month 3, ACR20 response rates were 41.7% (55 of 132 [95% CI vs placebo 6.06-28.41]; p=0.0024) for tofacitinib 5 mg twice a day and 48.1% (64 of 133; [12.45-34.92]; p<0.0001) for tofacitinib 10 mg twice a day versus 24.4% (32 of 131) for placebo. Improvements from baseline in HAQ-DI were -0.43 ([-0.36 to -0.15]; p<0.0001) for 5 mg twice a day and -0.46 ([-0.38 to -0.17]; p<0.0001) for 10 mg twice a day tofacitinib versus -0.18 for placebo; DAS28<2.6 rates were 6.7% (eight of 119; [0-10.10]; p=0.0496) for 5 mg twice a day tofacitinib and 8.8% (11 of 125 [1.66-12.60]; p=0.0105) for 10 mg twice a day tofacitinib versus 1.7% (two of 120) for placebo. Safety was consistent with phase 2 and 3 studies. The most common adverse events in months 0-3 were diarrhoea (13 of 267; 4.9%), nasopharyngitis (11 of 267; 4.1%), headache (11 of 267; 4.1%), and urinary tract infection (eight of 267; 3.0%) across tofacitinib groups, and nausea (nine of 132; 6.8%) in the placebo group. Interpretation In this treatment-refractory population, tofacitinib with methotrexate had rapid and clinically meaningful improvements in signs and symptoms of rheumatoid arthritis and physical function over 6 months with manageable safety. Tofacitinib could provide an effective treatment option in patients with an inadequate response to TNFi.	[Burmester, Gerd R.] Charite, D-10117 Berlin, Germany; [Blanco, Ricardo] Hosp Univ Marques de Valdecilla, Santander, Spain; [Charles-Schoeman, Christina] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Wollenhaupt, Juergen] Univ Hamburg, Teaching Hosp, Schoen Klin Hamburg Eilbek, Hamburg, Germany; [Zerbini, Cristiano] Ctr Paulista Invest Clin, Sao Paulo, Brazil; [Zerbini, Cristiano] Hosp Heliopolis, Dept Rheumatol, Sao Paulo, Brazil; [Benda, Birgitta] Pfizer, Collegeville, PA USA; [Gruben, David; Wallenstein, Gene; Krishnaswami, Sriram; Zwillich, Samuel H.; Soma, Koshika; Bradley, John; Mebus, Charles] Pfizer, Groton, CT USA; [Koncz, Tamas] Pfizer, New York, NY USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hospital Universitario Marques de Valdecilla (HUMV); University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Hamburg; Pfizer; Pfizer; Pfizer	Burmester, GR (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Charitepl 1, D-10117 Berlin, Germany.	gerd.burmester@charite.de	Burmester, Gerd R./AAY-7514-2020; blanco, ricardo/AAA-1248-2020; Zerbini, Cristiano/G-7566-2012	blanco, ricardo/0000-0003-2344-2285; 	Pfizer; Wyeth; Abbott; Bristol-Myers Squibb; Roche; UCB	Pfizer(Pfizer); Wyeth(Wyeth); Abbott(Abbott Laboratories); Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); UCB(UCB Pharma SA)	GRB is a consultant and member of the Speakers Bureau for Pfizer, Abbott, Bristol-Myers Squibb, MDS Pharma Services, Roche, and UCB, and receives research support from Pfizer, Wyeth, Abbott, Bristol-Myers Squibb, Roche, and UCB, and has received travel support from Pfizer. CC-S is a consultant for, and receives research support from, Pfizer. JW is a consultant and a member of the Speakers Bureau for and has received travel support from Pfizer. BB, DG, GW, SK, SHZ, TK, KS, JB, and CM are employees of Pfizer and hold stock or options in Pfizer. CZ receives research support from Centro Paulista de Investigacao Clinica. RB declares that he has no conflicts of interest.	Cella D, 2002, CANCER-AM CANCER SOC, V94, P528, DOI 10.1002/cncr.10245; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Finckh A, 2006, ANN RHEUM DIS, V65, P746, DOI 10.1136/ard.2005.045062; Fleischmann R, 2011, ANN RHEUM DIS     S3, V70, P600; FLEISCHMANN RM, 2009, ARTHRITIS RHEUM S10, V60, pS718; FRIES JF, 1982, J RHEUMATOL, V9, P789; Genovese MC, 2005, NEW ENGL J MED, V353, P1114, DOI 10.1056/NEJMoa050524; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Kremer J, 2011, ANN RHEUM DIS, V70, P170; Kremer JM, 2008, ARTHRITIS RHEUM, V58, P4030; Kremer JM, 2009, ARTHRITIS RHEUM-US, V60, P1895, DOI 10.1002/art.24567; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radboud University Nijmegen Medical Centre, DAS SCOR NL DIS ACT; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Strand V, 2007, AM J MANAG CARE, V13, pS237; Tanaka Y, 2009, ANN RHEUM DIS S13, V68, P594; van der Heijde D, 2011, ARTHRITIS RHEUM-US, V63, pS1017; van Vollenhoven RF, 2011, ARTHRITIS RHEUM-US, V63, pS153	27	476	521	3	54	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					451	460		10.1016/S0140-6736(12)61424-X	http://dx.doi.org/10.1016/S0140-6736(12)61424-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23294500				2022-12-28	WOS:000314810900030
J	Sommers, BD; Epstein, AM				Sommers, Benjamin D.; Epstein, Arnold M.			U.S. Governors and the Medicaid Expansion - No Quick Resolution in Sight	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sommers, Benjamin D.; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Sommers, BD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							[Anonymous], 2012, US TODAY; [Anonymous], 2012, MOTHER JONES    0718; [Anonymous], 2012, EACH STAT STANDS ACA; Centers for Medicare & Medicaid Services, 2012, FREQ ASK QUEST EXCH; Kaiser Commission on Medicaid and the Uninsured, 2012, HIST REV STAT HAV RE	5	31	31	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	2013	368	6					496	499		10.1056/NEJMp1215785	http://dx.doi.org/10.1056/NEJMp1215785			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	083VU	23323866	Green Submitted, Green Published			2022-12-28	WOS:000314494100013
J	Lan, SY; Kuan, PC; Estey, B; English, D; Brown, JM; Hohensee, MA; Muller, H				Lan, Shau-Yu; Kuan, Pei-Chen; Estey, Brian; English, Damon; Brown, Justin M.; Hohensee, Michael A.; Mueller, Holger			A Clock Directly Linking Time to a Particle's Mass	SCIENCE			English	Article							UNCERTAINTY; OPTICS	Historically, time measurements have been based on oscillation frequencies in systems of particles, from the motion of celestial bodies to atomic transitions. Relativity and quantum mechanics show that even a single particle of mass m determines a Compton frequency omega(0) = mc(2)/(h) over bar, where c is the speed of light and h is Planck's constant h divided by 2 pi. A clock referenced to omega(0) would enable high-precision mass measurements and a fundamental definition of the second. We demonstrate such a clock using an optical frequency comb to self-reference a Ramsey-Borde atom interferometer and synchronize an oscillator at a subharmonic of omega(0). This directly demonstrates the connection between time and mass. It allows measurement of microscopic masses with 4 x 10(-9) accuracy in the proposed revision to SI units. Together with the Avogadro project, it yields calibrated kilograms.	[Lan, Shau-Yu; Kuan, Pei-Chen; Estey, Brian; English, Damon; Brown, Justin M.; Hohensee, Michael A.; Mueller, Holger] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Mueller, Holger] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Muller, H (corresponding author), Univ Calif Berkeley, Dept Phys, 366 Le Conte Hall,MS7300, Berkeley, CA 94720 USA.	hm@berkeley.edu	Lan, Shau-Yu/AAB-9094-2022; Mueller, Holger/E-3194-2015; Lan, Shau-Yu/B-5567-2014	Lan, Shau-Yu/0000-0003-2608-9472; Lan, Shau-Yu/0000-0003-2608-9472; Hohensee, Michael/0000-0002-8106-4502	Miller Institute for Basic Research in Science; Alfred P. Sloan Foundation; David and Lucile Packard Foundation; National Institute of Standards and Technology; National Science Foundation; National Aeronautics and Space Administration	Miller Institute for Basic Research in Science; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA))	We thank S. Chu, P. Hamilton, and M. Kasevich for stimulating discussions; D. Budker, P. Kehaiyas, G. Kim, M. Xu, E. Ronayne Sohr, and D. Schlippert for experimental assistance; and A. Brachmann, R. Falcone, and W. E. White for providing a laser. J.M.B. acknowledges support by the Miller Institute for Basic Research in Science. This work was supported by the Alfred P. Sloan Foundation, the David and Lucile Packard Foundation, the National Institute of Standards and Technology, the National Science Foundation, and the National Aeronautics and Space Administration.	Andreas B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030801; [Anonymous], 2011, GEN C WEIGHTS MEAS S; Aoyama T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.111807; Borde CJ, 2008, EUR PHYS J-SPEC TOP, V163, P315, DOI 10.1140/epjst/e2008-00827-3; Bouchendira R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080801; Chou CW, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070802; Cronin AD, 2009, REV MOD PHYS, V81, P1051, DOI 10.1103/RevModPhys.81.1051; de Broglie L., 1924, THESIS U PARIS PARIS; Dimopoulos S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.111102; Freimund DL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.283602; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Hohensee MA, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.230404; Hohensee MA, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.151102; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Lan SY, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.090402; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Mohr P., 2010 CODATA RECOMMEN; Muller H, 2010, NATURE, V463, P926, DOI 10.1038/nature08776; Muller H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.180405; Parker TE, 2010, METROLOGIA, V47, P1, DOI 10.1088/0026-1394/47/1/001; Parry J. V. L., 1955, NATURE, V176, P280, DOI DOI 10.1038/176280A0; Penrose R, 2011, CYCLES TIME EXTRAORD; Robinson IA, 2007, METROLOGIA, V44, P427, DOI 10.1088/0026-1394/44/6/001; Steiner RL, 2007, IEEE T INSTRUM MEAS, V56, P592, DOI 10.1109/TIM.2007.890590; WIGNALL JWG, 1992, PHYS REV LETT, V68, P5, DOI 10.1103/PhysRevLett.68.5; Wolf P, 2011, CLASSICAL QUANT GRAV, V28, DOI 10.1088/0264-9381/28/14/145017	26	83	83	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 1	2013	339	6119					554	557		10.1126/science.1230767	http://dx.doi.org/10.1126/science.1230767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080UR	23306441				2022-12-28	WOS:000314270000052
J	Bieniossek, C; Papai, G; Schaffitzel, C; Garzoni, F; Chaillet, M; Scheer, E; Papadopoulos, P; Tora, L; Schultz, P; Berger, I				Bieniossek, Christoph; Papai, Gabor; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Scheer, Elisabeth; Papadopoulos, Petros; Tora, Laszlo; Schultz, Patrick; Berger, Imre			The architecture of human general transcription factor TFIID core complex	NATURE			English	Article							CRYSTAL-STRUCTURE; TERMINAL DOMAIN; YEAST; IDENTIFICATION; SUBCOMPLEX; SUBUNIT; OCTAMER; TAFS	The initiation of gene transcription by RNA polymerase II is regulated by a plethora of proteins in human cells. The first general transcription factor to bind gene promoters is transcription factor IID (TFIID). TFIID triggers pre-initiation complex formation, functions as a coactivator by interacting with transcriptional activators and reads epigenetic marks(1-3). TFIID is a megadalton-sized multiprotein complex composed of TATA-box-binding protein (TBP) and 13 TBP-associated factors (TAFs)(3). Despite its crucial role, the detailed architecture and assembly mechanism of TFIID remain elusive. Histone fold domains are prevalent in TAFs, and histone-like tetramer and octamer structures have been proposed in TFIID4-6. A functional core-TFIID subcomplex was revealed in Drosophila nuclei, consisting of a subset of TAFs (TAF4, TAF5, TAF6, TAF9 and TAF12)(7). These core subunits are thought to be present in two copies in holo-TFIID, in contrast to TBP and other TAFs that are present in a single copy(8), conveying a transition from symmetry to asymmetry in the TFIID assembly pathway. Here we present the structure of human core-TFIID determined by cryoelectron microscopy at 11.6 angstrom resolution. Our structure reveals a two-fold symmetric, interlaced architecture, with pronounced protrusions, that accommodates all conserved structural features of the TAFs including the histone folds. We further demonstrate that binding of one TAF8-TAF10 complex breaks the original symmetry of core-TFIID. We propose that the resulting asymmetric structure serves as a functional scaffold to nucleate holo-TFIID assembly, by accreting one copy each of the remaining TAFs and TBP.	[Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, European Mol Biol Lab EMBL Grenoble Outstn, F-38042 Grenoble 9, France; [Bieniossek, Christoph; Schaffitzel, Christiane; Garzoni, Frederic; Chaillet, Maxime; Berger, Imre] UJF CNRS EMBL, Unite Mixte Int UMI 3265, Unit Virus Host Cell Interact UVHCI, F-38042 Grenoble 9, France; [Papai, Gabor; Schultz, Patrick] IGBMC, Dept Integrated Struct Biol, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] INSERM, U964, F-67400 Paris, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] CNRS Illkirch, UMR7104, F-67000 Strasbourg, France; [Papai, Gabor; Scheer, Elisabeth; Tora, Laszlo; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Scheer, Elisabeth; Tora, Laszlo] IGBMC, Dept Funct Genom & Canc, F-67404 Illkirch Graffenstaden, France; [Papadopoulos, Petros] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Erasmus University Rotterdam; Erasmus MC	Schultz, P (corresponding author), IGBMC, Dept Integrated Struct Biol, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	patrick.schultz@igbmc.fr; iberger@embl.fr	Tora, Laszlo/E-9999-2018; Papadopoulos, Petros/B-1913-2015	Tora, Laszlo/0000-0001-7398-2250; Papadopoulos, Petros/0000-0002-8342-329X; Papai, Gabor/0000-0002-2779-8679; Berger, Imre/0000-0001-7518-9045; schultz, patrick/0000-0002-7310-6186; Chaillet, Maxime/0000-0001-6812-4147; Berger-Schaffitzel, Christiane Helene/0000-0002-1516-9760	European Research Council (ERC); Agence Nationale de la Recherche (ANR); EC Marie Curie Action; EC; Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National pour la Recherche Scientifique (CNRS); Association pour la Recherche sur le Cancer (ARC); Fondation pour la Recherche Medicale (FRM); ANR; ChromAct; TFIID-Complexes	European Research Council (ERC)(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); EC Marie Curie Action(European Commission); EC(European CommissionEuropean Commission Joint Research Centre); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ChromAct; TFIID-Complexes	We thank all members of the Berger, Schultz and Tora laboratories for advice and discussions. We are grateful to C. Romier for providing the X-ray structure of the TAF6 C-terminal domain before publication. We thank J. Demmers for mass spectrometric analyses and F. Grosveld for discussions. The EMBL, IBS and IGBMC core facilities are acknowledged for services. We are indebted to G. Schoehn for maintaining the electron microscopes in Grenoble. T. J. Richmond is acknowledged for advice and support. C. B. is a fellow of the joint European Commission (EC)/EMBL interdisciplinary research opportunities program (EIPOD). C. S. is recipient of a European Research Council (ERC) Starting Grant and an Agence Nationale de la Recherche (ANR) Jeunes Chercheuses award. I. B. acknowledges support from the EC Marie Curie Action and the EC Framework Programme (FP) 7 projects INSTRUCT, PCUBE, BioSTRUCT-X, 4D-CellFate and ComplexINC. P. S. acknowledges support from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Centre National pour la Recherche Scientifique (CNRS), the Association pour la Recherche sur le Cancer (ARC) and the Fondation pour la Recherche Medicale (FRM). This work was supported by the ANR Projets Blancs puzzle-fit (to P. S.), ChromAct (to P. S. and L. T.) and TFIID-Complexes (to L.T., P.S. and I.B.).	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bell B, 2001, MOL CELL, V8, P591, DOI 10.1016/S1097-2765(01)00325-2; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Cler E, 2009, CELL MOL LIFE SCI, V66, P2123, DOI 10.1007/s00018-009-0009-3; Demeny MA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000316; Dubrovskaya V, 1996, EMBO J, V15, P3702, DOI 10.1002/j.1460-2075.1996.tb00740.x; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Mengus G, 2005, EMBO J, V24, P2753, DOI 10.1038/sj.emboj.7600748; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Romier C, 2007, J MOL BIOL, V368, P1292, DOI 10.1016/j.jmb.2007.02.039; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Scheer E, 2012, J BIOL CHEM, V287, P27580, DOI 10.1074/jbc.M112.379206; Selleck W, 2001, NAT STRUCT BIOL, V8, P695, DOI 10.1038/90408; Soutoglou E, 2005, MOL CELL BIOL, V25, P4092, DOI 10.1128/MCB.25.10.4092-4104.2005; Timmers HTM, 2005, TRENDS BIOCHEM SCI, V30, P7, DOI 10.1016/j.tibs.2004.11.007; Wang XP, 2007, P NATL ACAD SCI USA, V104, P7839, DOI 10.1073/pnas.0608570104; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	30	110	114	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					699	702		10.1038/nature11791	http://dx.doi.org/10.1038/nature11791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23292512				2022-12-28	WOS:000314219600062
J	Ma, C; Su, LJ; Seven, AB; Xu, YB; Rizo, J				Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep			Reconstitution of the Vital Functions of Munc18 and Munc13 in Neurotransmitter Release	SCIENCE			English	Article							DEPENDENT MEMBRANE-FUSION; SYNAPTIC VESICLE FUSION; NEURONAL SNARE COMPLEX; CRYSTAL-STRUCTURE; ALPHA-SNAP; C2B DOMAIN; SYNAPTOTAGMIN; EXOCYTOSIS; DOCKING; CALCIUM	Neurotransmitter release depends critically on Munc18-1, Munc13, the Ca2+ sensor synaptotagmin-1, and the soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein (SNAP) receptors (SNAREs) syntaxin-1, synaptobrevin, and SNAP-25. In vitro reconstitutions have shown that syntaxin-1-SNAP-25 liposomes fuse efficiently with synaptobrevin liposomes in the presence of synaptotagmin-1-Ca2+, but neurotransmitter release also requires Munc18-1 and Munc13 in vivo. We found that Munc18-1 could displace SNAP-25 from syntaxin-1 and that fusion of syntaxin-1-Munc18-1 liposomes with synaptobrevin liposomes required Munc13, in addition to SNAP-25 and synaptotagmin-1-Ca2+. Moreover, when starting with syntaxin-1-SNAP-25 liposomes, NSF-alpha-SNAP disassembled the syntaxin-1-SNAP-25 heterodimers and abrogated fusion, which then required Munc18-1 and Munc13. We propose that fusion does not proceed through syntaxin-1-SNAP-25 heterodimers but starts with the syntaxin-1-Munc18-1 complex; Munc18-1 and Munc13 then orchestrate membrane fusion together with the SNAREs and synaptotagmin-1-Ca2+ in an NSF- and SNAP-resistant manner.	[Ma, Cong] Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China; [Ma, Cong] Huazhong Univ Sci & Technol, Inst Biochem & Biophys, Wuhan 430074, Peoples R China; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Ma, Cong; Su, Lijing; Seven, Alpay B.; Xu, Yibin; Rizo, Josep] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ma, C (corresponding author), Huazhong Univ Sci & Technol, Minist Educ, Key Lab Mol Biophys, Wuhan 430074, Peoples R China.	cong.ma7@gmail.com; jose@arnie.swmed.edu			Welch Foundation [I-1304]; National Science Foundation of China [31200618]; NIH [NS37200, NS40944]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944, R01NS037200] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Y. Sun for expert technical assistance; Y. Liu for initial efforts to reconstitute syntaxin-1-Munc18-1 complexes; and W. Li, W. Wickner, and M. Brown for fruitful discussions. This work was supported by grant I-1304 from the Welch Foundation (to J.R.), grant 31200618 from the National Science Foundation of China (to C. M.), and grants NS37200 and NS40944 from the NIH (to J.R.).	Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Boswell KL, 2012, J CELL BIOL, V197, P301, DOI 10.1083/jcb.201109132; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00109; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Lee HK, 2010, SCIENCE, V328, P760, DOI 10.1126/science.1187722; Li W, 2011, STRUCTURE, V19, P1443, DOI 10.1016/j.str.2011.07.012; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pei JM, 2009, J MOL BIOL, V391, P509, DOI 10.1016/j.jmb.2009.06.054; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shin OH, 2010, NAT STRUCT MOL BIOL, V17, P280, DOI 10.1038/nsmb.1758; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508	35	258	260	7	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 25	2013	339	6118					421	425		10.1126/science.1230473	http://dx.doi.org/10.1126/science.1230473			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	076MN	23258414	Green Accepted			2022-12-28	WOS:000313960700036
J	Simakov, O; Marletaz, F; Cho, SJ; Edsinger-Gonzales, E; Havlak, P; Hellsten, U; Kuo, DH; Larsson, T; Lv, J; Arendt, D; Savage, R; Osoegawa, K; de Jong, P; Grimwood, J; Chapman, JA; Shapiro, H; Aerts, A; Otillar, RP; Terry, AY; Boore, JL; Grigoriev, IV; Lindberg, DR; Seaver, EC; Weisblat, DA; Putnam, NH; Rokhsar, DS				Simakov, Oleg; Marletaz, Ferdinand; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Havlak, Paul; Hellsten, Uffe; Kuo, Dian-Han; Larsson, Tomas; Lv, Jie; Arendt, Detlev; Savage, Robert; Osoegawa, Kazutoyo; de Jong, Pieter; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Lindberg, David R.; Seaver, Elaine C.; Weisblat, David A.; Putnam, Nicholas H.; Rokhsar, Daniel S.			Insights into bilaterian evolution from three spiralian genomes	NATURE			English	Article							SCHMIDTEA-MEDITERRANEA; SCHISTOSOMA-MANSONI; GENES; TREE; REPERTOIRE; RESOLUTION; ORGANISM; LIFE	Current genomic perspectives on animal diversity neglect two prominent phyla, the molluscs and annelids, that together account for nearly one-third of known marine species and are important both ecologically and as experimental systems in classical embryology(1-3). Here we describe the draft genomes of the owl limpet (Lottia gigantea), a marine polychaete (Capitella teleta) and a freshwater leech (Helobdella robusta), and compare them with other animal genomes to investigate the origin and diversification of bilaterians from a genomic perspective. We find that the genome organization, gene structure and functional content of these species are more similar to those of some invertebrate deuterostome genomes (for example, amphioxus and sea urchin) than those of other protostomes that have been sequenced to date (flies, nematodes and flatworms). The conservation of these genomic features enables us to expand the inventory of genes present in the last common bilaterian ancestor, establish the tripartite diversification of bilaterians using multiple genomic characteristics and identify ancient conserved long-and short-range genetic linkages across metazoans. Superimposed on this broadly conserved pan-bilaterian background we find examples of lineage-specific genome evolution, including varying rates of rearrangement, intron gain and loss, expansions and contractions of gene families, and the evolution of clade-specific genes that produce the unique content of each genome.	[Simakov, Oleg; Marletaz, Ferdinand; Larsson, Tomas; Arendt, Detlev] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Simakov, Oleg; Cho, Sung-Jin; Edsinger-Gonzales, Eric; Kuo, Dian-Han; Weisblat, David A.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Havlak, Paul; Lv, Jie; Putnam, Nicholas H.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Hellsten, Uffe; Grimwood, Jane; Chapman, Jarrod A.; Shapiro, Harris; Aerts, Andrea; Otillar, Robert P.; Terry, Astrid Y.; Boore, Jeffrey L.; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Savage, Robert] Williams Coll, Dept Biol, Thompson Biol Lab, Williamstown, MA 01267 USA; [Osoegawa, Kazutoyo; de Jong, Pieter] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA; [Grimwood, Jane] Hudson Alpha Inst Biotechnol, Huntsville, AL 35806 USA; [Lindberg, David R.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Seaver, Elaine C.] Univ Hawaii Manoa, Kewalo Marine Lab, Honolulu, HI 96813 USA; [Putnam, Nicholas H.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Rokhsar, Daniel S.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan	European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; Rice University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Williams College; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Berkeley; University of Hawaii System; University of Hawaii Manoa; Rice University; Okinawa Institute of Science & Technology Graduate University	Putnam, NH (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, POB 1892, Houston, TX 77251 USA.	nputnam@gmail.com; dsrokhsar@gmail.com	LU, JIE/AAP-6595-2020; Lindberg, David R/D-8138-2011; Marlétaz, Ferdinand/H-3018-2019; Simakov, Oleg/G-4572-2015; Putnam, Nicholas/B-9968-2008; Simakov, Oleg/AAV-2494-2020; Terry, Astrid Y/A-2538-2011; Grimwood, Jane/ABD-5737-2021	LU, JIE/0000-0001-5071-8959; Marlétaz, Ferdinand/0000-0001-8124-4266; Simakov, Oleg/0000-0002-3585-4511; Putnam, Nicholas/0000-0002-1315-782X; Simakov, Oleg/0000-0002-3585-4511; Terry, Astrid Y/0000-0002-5234-1224; Rokhsar, Daniel/0000-0002-8704-2224; Edsinger, Eric/0000-0002-1012-1506; Grigoriev, Igor/0000-0002-3136-8903; Kuo, Dian-Han/0000-0002-6461-2562	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Gordon and Betty Moore Foundation; National Science Foundation (NSF) [EF-0850294, I0S-0922792]; National Institutes of Health (NIH) [RO1 GM 074619]; Boehringer Ingelheim Fonds; US National Human Genome Research Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074619] Funding Source: NIH RePORTER; Direct For Biological Sciences [0850294] Funding Source: National Science Foundation	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Work conducted by the US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under contract no. DE-AC02-05CH11231. Early work on the analysis of these genomes was also supported by the Gordon and Betty Moore Foundation through a grant to the Center for Integrative Genomics at the University of California. D. S. R. thanks R. Melmon for a grant in support of this project. N.H.P. is supported by the National Science Foundation (NSF) under grant EF-0850294; D. A. W. is supported by the National Institutes of Health (NIH; RO1 GM 074619) and NSF (I0S-0922792); and O.S. is supported by Boehringer Ingelheim Fonds. E.E-G. was supported by a training grant from the US National Human Genome Research Institute. We thank A. Meyer and J. Gerhart for helpful discussions.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Cho SJ, 2010, MOL BIOL EVOL, V27, P1645, DOI 10.1093/molbev/msq052; Conklin EG, 1897, EMBRYOLOGY CREPIDULA; de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; Frobius AC, 2006, GENE EXPR PATTERNS, V6, P985, DOI 10.1016/j.modgep.2006.04.002; Henry JQ, 2007, INTEGR COMP BIOL, V47, P865, DOI 10.1093/icb/icm035; Maloof AC, 2010, GEOL SOC AM BULL, V122, P1731, DOI 10.1130/B30346.1; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Purschke G, 2005, HYDROBIOLOGIA, V535, P53, DOI 10.1007/s10750-004-4358-5; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; Robb SMC, 2008, NUCLEIC ACIDS RES, V36, pD599, DOI 10.1093/nar/Gkm684; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Roy SW, 2008, MOL BIOL EVOL, V25, P620, DOI 10.1093/molbev/msn035; Roy SW, 2005, P NATL ACAD SCI USA, V102, P4403, DOI 10.1073/pnas.0409891102; Schistosoma japonicum Genome Sequencing and Functional Analysis Consortium, 2009, NATURE, V460, P345; Shimeld SM, 2010, DEV BIOL, V340, P234, DOI 10.1016/j.ydbio.2010.01.015; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Telford MJ, 2011, TRENDS GENET, V27, P186, DOI 10.1016/j.tig.2011.02.003; Wilson EB, 1892, J MORPHOL, V6, P361; Zamanian M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-596	28	409	422	7	174	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 24	2013	493	7433					526	531		10.1038/nature11696	http://dx.doi.org/10.1038/nature11696			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	075GF	23254933	Green Accepted, Green Published, hybrid, Green Submitted			2022-12-28	WOS:000313871400037
J	Park, S; Lee, C; Sabharwal, P; Zhang, M; Meyers, CLF; Sockanathan, S				Park, Sungjin; Lee, Changhee; Sabharwal, Priyanka; Zhang, Mei; Meyers, Caren L. Freel; Sockanathan, Shanthini			GDE2 Promotes Neurogenesis by Glycosylphosphatidylinositol-Anchor Cleavage of RECK	SCIENCE			English	Article							VARIANT SURFACE GLYCOPROTEIN; DIFFERENTIATION; PROTEIN; ENZYME; EXPRESSION; DELTA1; GROWTH	The six-transmembrane protein glycerophosphodiester phosphodiesterase 2 (GDE2) induces spinal motor neuron differentiation by inhibiting Notch signaling in adjacent motor neuron progenitors. GDE2 function requires activity of its extracellular domain that shares homology with glycerophosphodiester phosphodiesterases (GDPDs). GDPDs metabolize glycerophosphodiesters into glycerol-3-phosphate and corresponding alcohols, but whether GDE2 inhibits Notch signaling by this mechanism is unclear. Here, we show that GDE2, unlike classical GDPDs, cleaves glycosylphosphatidylinositol (GPI) anchors. GDE2 GDPD activity inactivates the Notch activator RECK (reversion-inducing cysteine-rich protein with kazal motifs) by releasing it from the membrane through GPI-anchor cleavage. RECK release disinhibits ADAM (a disintegrin and metalloproteinase) protease-dependent shedding of the Notch ligand Delta-like 1 (Dll1), leading to Notch inactivation. This study identifies a previously unrecognized mechanism to initiate neurogenesis that involves GDE2-mediated surface cleavage of GPI-anchored targets to inhibit Dll1-Notch signaling.	[Park, Sungjin; Lee, Changhee; Sabharwal, Priyanka; Zhang, Mei; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Meyers, Caren L. Freel] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, PCTB1004,725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu	Sabharwal, Priyanka/AAA-3303-2019	Sabharwal, Priyanka/0000-0002-2099-1994; Lee, ChangHee/0000-0002-9994-3142; Freel Meyers, Caren/0000-0003-1458-0897	National Institute of Neurological Disorders and Stroke [RO1NS046336]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046336] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Englund, M. Goulding, T. M. Jessell, and B. Novitch for antibodies; J. Filmus for Notum plasmids; the Flow Cytometry and Cell Sorting Core Facility, Johns Hopkins Bloomberg School of Public Health; C. Cave III, A. L. Kolodkin, P. F. Worley, and Y. Yan for comments on the manuscript; and lab members for discussions. This work was funded by National Institute of Neurological Disorders and Stroke RO1NS046336.	BANGS JD, 1985, P NATL ACAD SCI USA, V82, P3207, DOI 10.1073/pnas.82.10.3207; Corda D, 2009, J BIOL CHEM, V284, P24848, DOI 10.1074/jbc.M109.035444; D'Souza B, 2010, CURR TOP DEV BIOL, V92, P73, DOI 10.1016/S0070-2153(10)92003-6; Fico A, 2011, CELL MOL LIFE SCI, V68, P923, DOI 10.1007/s00018-007-7471-6; Gallet A, 2008, DEV CELL, V14, P712, DOI 10.1016/j.devcel.2008.03.001; Hart G. W., 2001, CURR PROTOC PROTEIN; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Muraguchi T, 2007, NAT NEUROSCI, V10, P838, DOI 10.1038/nn1922; Ohshima N, 2008, J BACTERIOL, V190, P1219, DOI 10.1128/JB.01223-07; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee JS, 2002, TRENDS CELL BIOL, V12, P209, DOI 10.1016/S0962-8924(02)02280-8; Sabharwal P, 2011, NEURON, V71, P1058, DOI 10.1016/j.neuron.2011.07.028; Shi L, 2008, PROTEINS, V72, P280, DOI 10.1002/prot.21921; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Tujioka H, 1998, BIOCHEM BIOPH RES CO, V251, P737, DOI 10.1006/bbrc.1998.9542; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yan D, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002493; Yan D, 2009, DEV CELL, V17, P470, DOI 10.1016/j.devcel.2009.09.001; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; ZAMZE SE, 1988, EUR J BIOCHEM, V176, P527, DOI 10.1111/j.1432-1033.1988.tb14310.x; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100; Zhuang BQ, 2009, NEURON, V61, P359, DOI 10.1016/j.neuron.2008.12.022	28	70	73	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					324	328		10.1126/science.1231921	http://dx.doi.org/10.1126/science.1231921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329048	Green Accepted			2022-12-28	WOS:000313622000046
J	Bradshaw, RA				Bradshaw, Ralph A.			Rita Levi-Montalcini (1909-2012) OBITUARY	NATURE			English	Biographical-Item									Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine	Bradshaw, RA (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA.	rablab@uci.edu	Bradshaw, Ralph A/K-1515-2013					LEVIMONTALCINI R, PUBLICATION LIST	1	4	5	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					306	306		10.1038/493306a	http://dx.doi.org/10.1038/493306a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325208	Bronze			2022-12-28	WOS:000313615900028
J	Ebert, DH; Greenberg, ME				Ebert, Daniel H.; Greenberg, Michael E.			Activity-dependent neuronal signalling and autism spectrum disorder	NATURE			English	Review							X MENTAL-RETARDATION; DE-NOVO MUTATIONS; DENDRITIC SPINE MORPHOLOGY; LONG-TERM DEPRESSION; FRAGILE-X; MOUSE MODEL; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; RETT-SYNDROME; FMRP PHOSPHORYLATION	Neuronal activity induces the post-translational modification of synaptic molecules, promotes localized protein synthesis within dendrites and activates gene transcription, thereby regulating synaptic function and allowing neuronal circuits to respond dynamically to experience. Evidence indicates that many of the genes that are mutated in autism spectrum disorder are crucial components of the activity-dependent signalling networks that regulate synapse development and plasticity. Dysregulation of activity-dependent signalling pathways in neurons may, therefore, have a key role in the aetiology of autism spectrum disorder.	[Ebert, Daniel H.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Ebert, Daniel H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	michael_greenberg@hms.harvard.edu			NIH [RO1NS048276, K08MH90306]; Rett Syndrome Research Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH090306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	M.E.G. is supported by NIH grant RO1NS048276 and the Rett Syndrome Research Trust. D.H.E. is supported by NIH grant K08MH90306.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Bateup HS, 2011, J NEUROSCI, V31, P8862, DOI 10.1523/JNEUROSCI.1617-11.2011; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bhakar AL, 2012, ANNU REV NEUROSCI, V35, P417, DOI 10.1146/annurev-neuro-060909-153138; Bhat S, 2012, PROG NEUROBIOL, V99, P1, DOI 10.1016/j.pneurobio.2012.06.001; Bingol B, 2011, NEURON, V69, P22, DOI 10.1016/j.neuron.2010.11.006; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Deng JV, 2010, NAT NEUROSCI, V13, P1128, DOI 10.1038/nn.2614; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Etherton MR, 2011, EMBO J, V30, P2908, DOI 10.1038/emboj.2011.182; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Han JM, 2011, FEBS LETT, V585, P973, DOI 10.1016/j.febslet.2011.02.001; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Harlow EG, 2010, NEURON, V65, P385, DOI 10.1016/j.neuron.2010.01.024; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Hung AY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009842; Iijima T, 2011, CELL, V147, P1601, DOI 10.1016/j.cell.2011.11.028; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kelleher RJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0035003, 10.1371/journal.pone.0050716]; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kim J, 2008, P NATL ACAD SCI USA, V105, P9087, DOI 10.1073/pnas.0803448105; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Li HD, 2011, NAT NEUROSCI, V14, P1001, DOI 10.1038/nn.2866; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Luscher C, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005710; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Missler M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005694; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Muddashetty RS, 2011, MOL CELL, V42, P673, DOI 10.1016/j.molcel.2011.05.006; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Niere F, 2012, J NEUROSCI, V32, P5924, DOI 10.1523/JNEUROSCI.4650-11.2012; Noutel J, 2011, NEURON, V70, P35, DOI 10.1016/j.neuron.2011.03.001; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Pfeiffer BE, 2010, NEURON, V66, P191, DOI 10.1016/j.neuron.2010.03.017; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sato D, 2012, AM J HUM GENET, V90, P879, DOI 10.1016/j.ajhg.2012.03.017; Schmeisser MJ, 2012, NATURE, V486, P256, DOI 10.1038/nature11015; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; State MW, 2011, NAT NEUROSCI, V14, P1499, DOI 10.1038/nn.2924; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thyagarajan A, 2010, CELL, V143, P456, DOI 10.1016/j.cell.2010.09.025; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; Won H, 2012, NATURE, V486, P261, DOI 10.1038/nature11208; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhou J, 2012, CURR OPIN NEUROBIOL, V22, P873, DOI 10.1016/j.conb.2012.05.004; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886	98	406	417	10	215	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					327	337		10.1038/nature11860	http://dx.doi.org/10.1038/nature11860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325215	Green Accepted			2022-12-28	WOS:000313615900039
J	Purves, D; Scharlemann, J; Harfoot, M; Newbold, T; Tittensor, DP; Hutton, J; Emmott, S				Purves, Drew; Scharlemann, Jorn; Harfoot, Mike; Newbold, Tim; Tittensor, Derek P.; Hutton, Jon; Emmott, Stephen			Time to model all life on Earth	NATURE			English	Editorial Material									[Purves, Drew] Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England	Microsoft	Purves, D (corresponding author), Microsoft Res, Computat Ecol & Environm Sci Grp, Cambridge, England.	dpurves@microsoft.com	Newbold, Tim/D-1524-2012; Newbold, Tim/R-8958-2019; Tittensor, Derek P./AAV-1117-2021; Scharlemann, Jorn/A-4737-2008	Newbold, Tim/0000-0001-7361-0051; Newbold, Tim/0000-0001-7361-0051; Tittensor, Derek P./0000-0002-9550-3123; Scharlemann, Jorn/0000-0002-2834-6367				Boyd IL, 2012, SCIENCE, V337, P306, DOI 10.1126/science.1225049; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Christensen V, 2004, ECOL MODEL, V172, P109, DOI 10.1016/j.ecolmodel.2003.09.003; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606	5	96	96	2	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					295	297		10.1038/493295a	http://dx.doi.org/10.1038/493295a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071TA	23325192	Bronze			2022-12-28	WOS:000313615900013
J	Rice, TW				Rice, Todd W.			Hypoglycemia was associated with increased mortality in ICU patients regardless of glucose control strategy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTENSIVE INSULIN THERAPY; CRITICALLY-ILL PATIENTS		Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Rice, TW (corresponding author), Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA.		Rice, Todd/X-7853-2019	Rice, Todd/0000-0002-7136-5408				Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC3	10.7326/0003-4819-158-2-201301150-02003	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318337				2022-12-28	WOS:000314029400002
J	Kim, H; Kwon, S				Kim, Hyoki; Kwon, Sunghoon			Water-Responsive Polymer Composites on the Move	SCIENCE			English	Editorial Material							DRIVEN		[Kim, Hyoki; Kwon, Sunghoon] Seoul Natl Univ, Dept Elect Engn & Comp Sci, Ctr Nanoparticle Res, Inst Basic Sci, Seoul 151744, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, H (corresponding author), Seoul Natl Univ, Dept Elect Engn & Comp Sci, Ctr Nanoparticle Res, Inst Basic Sci, Seoul 151744, South Korea.	skwon@snu.ac.kr						Kraemer D, 2011, NAT MATER, V10, P532, DOI [10.1038/NMAT3013, 10.1038/nmat3013]; Ma MM, 2013, SCIENCE, V339, P186, DOI 10.1126/science.1230262; Okuzaki H, 1997, POLYMER, V38, P5491, DOI 10.1016/S0032-3861(97)00196-1; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; Seah W. K. G., 2009, 1 INT C WIR COMM SOC; van Oosten CL, 2009, NAT MATER, V8, P677, DOI [10.1038/NMAT2487, 10.1038/nmat2487]	6	16	17	3	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					150	151		10.1126/science.1232733	http://dx.doi.org/10.1126/science.1232733			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307728				2022-12-28	WOS:000313328200029
J	Ma, MM; Guo, L; Anderson, DG; Langer, R				Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert			Bio-Inspired Polymer Composite Actuator and Generator Driven by Water Gradients	SCIENCE			English	Article							SHAPE-MEMORY POLYMERS; BIOMEDICAL APPLICATIONS; ARTIFICIAL MUSCLES; POLYPYRROLE; LIGHT; SYSTEMS; RANGE; GEL; PH	Here we describe the development of a water-responsive polymer film. Combining both a rigid matrix (polypyrrole) and a dynamic network (polyol-borate), strong and flexible polymer films were developed that can exchange water with the environment to induce film expansion and contraction, resulting in rapid and continuous locomotion. The film actuator can generate contractile stress up to 27 megapascals, lift objects 380 times heavier than itself, and transport cargo 10 times heavier than itself. We have assembled a generator by associating this actuator with a piezoelectric element. Driven by water gradients, this generator outputs alternating electricity at similar to 0.3 hertz, with a peak voltage of similar to 1.0 volt. The electrical energy is stored in capacitors that could power micro-and nanoelectronic devices.	[Ma, Mingming; Guo, Liang; Anderson, Daniel G.; Langer, Robert] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Langer, R (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	rlanger@mit.edu	Guo, Liang/B-8413-2012; Ma, Mingming/G-1703-2011	Guo, Liang/0000-0003-4738-4366; Ma, Mingming/0000-0002-7967-8927	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award [HHSN268201000045C]; National Cancer Institute [CA151884]; Armed Forces Institute of Regenerative Medicine [W81XWH-08-2-0034]; NATIONAL CANCER INSTITUTE [U54CA151884] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Armed Forces Institute of Regenerative Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.M. and R.L. conceived the idea and designed the experiments. M. M. and L. G. performed the experiments. M. M., L. G., D. G. A., and R. L. contributed materials and/or tools, analyzed the data, and wrote the paper. This research was supported in part by a National Heart, Lung, and Blood Institute Program of Excellence in Nanotechnology (PEN) Award, contract no. HHSN268201000045C; National Cancer Institute grant CA151884; and Armed Forces Institute of Regenerative Medicine Award no. W81XWH-08-2-0034. Experimental procedures, additional data for materials characterization, and the device test are presented in the supplementary materials. We thank D. Bong for thoughtful discussion and N. Zhang for help in the preparation of figures.	Baughman RH, 2005, SCIENCE, V308, P63, DOI 10.1126/science.1099010; Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047; Benns JM, 2000, BIOCONJUGATE CHEM, V11, P637, DOI 10.1021/bc0000177; Caldorera-Moore ME, 2011, ACCOUNTS CHEM RES, V44, P1061, DOI 10.1021/ar2001777; Camacho-Lopez M, 2004, NAT MATER, V3, P307, DOI 10.1038/nmat1118; CHEN GH, 1995, NATURE, V373, P49, DOI 10.1038/373049a0; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Hara S, 2004, POLYM J, V36, P151, DOI 10.1295/polymj.36.151; Jager EWH, 2000, SCIENCE, V290, P1540, DOI 10.1126/science.290.5496.1540; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496; Madden JD, 2002, MATER RES SOC SYMP P, V698, P137; Minko S., 2006, RESPONSIVE POLYM MAT; Okuzaki H, 1998, J POLYM SCI POL PHYS, V36, P2237, DOI 10.1002/(SICI)1099-0488(19980915)36:12<2237::AID-POLB20>3.0.CO;2-#; OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Park T, 2006, J AM CHEM SOC, V128, P13986, DOI 10.1021/ja064116s; Qin Y, 2008, NATURE, V451, P809, DOI [10.1038/nature06601, 10.1038/nature066O1]; REN XM, 1993, J PHYS CHEM-US, V97, P5356, DOI 10.1021/j100122a029; SHIBAYAMA M, 1988, POLYMER, V29, P336, DOI 10.1016/0032-3861(88)90343-6; Sidorenko A, 2007, SCIENCE, V315, P487, DOI 10.1126/science.1135516; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; SZAFRAN M, 1994, J MOL STRUCT, V321, P57, DOI 10.1016/0022-2860(93)08206-J; Ushiki T, 2002, ARCH HISTOL CYTOL, V65, P109, DOI 10.1679/aohc.65.109; van Oosten CL, 2009, NAT MATER, V8, P677, DOI [10.1038/NMAT2487, 10.1038/nmat2487]; Yu YL, 2003, NATURE, V425, P145, DOI 10.1038/425145a	26	607	627	41	1285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					186	189		10.1126/science.1230262	http://dx.doi.org/10.1126/science.1230262			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307738	Green Accepted, Green Submitted			2022-12-28	WOS:000313328200039
J	Lauschke, VM; Tsiairis, CD; Francois, P; Aulehla, A				Lauschke, Volker M.; Tsiairis, Charisios D.; Francois, Paul; Aulehla, Alexander			Scaling of embryonic patterning based on phase-gradient encoding	NATURE			English	Article							SOMITE SEGMENTATION CLOCK; VERTEBRATE SEGMENTATION; MORPHOGEN GRADIENTS; MOUSE EMBRYO; SOMITOGENESIS; DYNAMICS; OSCILLATION; INITIATION; SYSTEMS; NUMBER	A fundamental feature of embryonic patterning is the ability to scale and maintain stable proportions despite changes in overall size, for instance during growth(1-6). A notable example occurs during vertebrate segment formation: after experimental reduction of embryo size, segments form proportionally smaller, and consequently, a normal number of segments is formed(1,7,8). Despite decades of experimental(1,7) and theoretical work(9-11), the underlying mechanism remains unknown. More recently, ultradian oscillations in gene activity have been linked to the temporal control of segmentation(12); however, their implication in scaling remains elusive. Here we show that scaling of gene oscillation dynamics underlies segment scaling. To this end, we develop a new experimental model, an ex vivo primary cell culture assay that recapitulates mouse mesoderm patterning and segment scaling, in a quasi-monolayer of presomitic mesoderm cells (hereafter termed monolayer PSM or mPSM). Combined with real-time imaging of gene activity, this enabled us to quantify the gradual shift in the oscillation phase and thus determine the resulting phase gradient across the mPSM. Crucially, we show that this phase gradient scales by maintaining a fixed amplitude across mPSM of different lengths. We identify the slope of this phase gradient as a single predictive parameter for segment size, which functions in a size-and temperature-independent manner, revealing a hitherto unrecognized mechanism for scaling. Notably, in contrast to molecular gradients, a phase gradient describes the distribution of a dynamical cellular state. Thus, our phase-gradient scaling findings reveal a new level of dynamic information-processing, and provide evidence for the concept of phase-gradient encoding during embryonic patterning and scaling.	[Lauschke, Volker M.; Tsiairis, Charisios D.; Aulehla, Alexander] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Francois, Paul] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada	European Molecular Biology Laboratory (EMBL); McGill University	Aulehla, A (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	aulehla@embl.de	Tsiairis, Charisios/A-9145-2018; Lauschke, Volker/O-3014-2017; Francois, Paul/G-5673-2010	Lauschke, Volker/0000-0002-1140-6204; Francois, Paul/0000-0002-2223-839X; Aulehla, Alexander/0000-0003-3487-9239; Tsiairis, Charisios/0000-0002-9788-9875	Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN 401950-11]; Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Regroupement Quebecois pour les materiaux de pointe (RQMP); McGill University	We thank members of the Aulehla laboratory for discussion and comments on the manuscript. We thank M. Snaebjornsson for providing Supplementary Video 1. We thank F. Peri, D. Gilmour, T. Hiiragi and F. Spitz for comments on the manuscript and P. Riedinger for artwork. This work was supported by EMBL Imaging and Laboratory animal resource core facilities. The Mesp2-GFP line was provided by Y. Saga. P. F. was supported by Natural Science and Engineering Research Council of Canada (NSERC), Discovery Grant program RGPIN 401950-11, Regroupement Quebecois pour les materiaux de pointe (RQMP) and McGill University.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Brown D, 2006, P NATL ACAD SCI USA, V103, P9918, DOI 10.1073/pnas.0603950103; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; COOKE J, 1975, NATURE, V254, P196, DOI 10.1038/254196a0; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOODWIN BC, 1969, J THEOR BIOL, V25, P49, DOI 10.1016/S0022-5193(69)80017-2; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; KEYNES RJ, 1988, DEVELOPMENT, V103, P413; KOPELL N, 1973, SCIENCE, V180, P1171, DOI 10.1126/science.180.4091.1171; Masamizu Y, 2006, P NATL ACAD SCI USA, V103, P1313, DOI 10.1073/pnas.0508658103; MEINHARDT H, 1986, SOMITES DEV EMBRYOS, P179; Meinhardt H., 1982, MODELS BIOL PATTERN; Morelli LG, 2009, HFSP J, V3, P55, DOI 10.2976/1.3027088; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Morimoto M, 2006, DEV BIOL, V300, P687, DOI 10.1016/j.ydbio.2006.08.043; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Restrepo S, 2011, CURR BIOL, V21, pR815, DOI 10.1016/j.cub.2011.08.041; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Roeling D, 2011, CELL, V145, P800, DOI 10.1016/j.cell.2011.05.007; ROSS J, 1988, SCIENCE, V240, P460, DOI 10.1126/science.240.4851.460; Sarrazin AF, 2012, SCIENCE, V336, P338, DOI 10.1126/science.1218256; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schroter C, 2008, DEV DYNAM, V237, P545, DOI 10.1002/dvdy.21458; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	34	118	118	1	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					101	+		10.1038/nature11804	http://dx.doi.org/10.1038/nature11804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23254931				2022-12-28	WOS:000312933800039
J	Pan, LP; Blanck, HM; Sherry, B; Dalenius, K; Grummer-Strawn, LM				Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.			Trends in the Prevalence of Extreme Obesity Among US Preschool-Aged Children Living in Low-Income Families, 1998-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							RISK-FACTORS; CHILDHOOD		[Pan, Liping; Blanck, Heidi M.; Sherry, Bettylou; Dalenius, Karen; Grummer-Strawn, Laurence M.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Pan, LP (corresponding author), Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Atlanta, GA 30329 USA.	lpan@cdc.gov		Pan, Liping/0000-0003-0926-8719	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Polhamus B., PEDIAT NUTR SURVEILL; Sen Y, 2008, EUR J PEDIATR, V167, P1183, DOI 10.1007/s00431-007-0658-x; Sharma A. J., 2009, Morbidity and Mortality Weekly Report, V58, P769; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	6	107	108	1	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2563	2565		10.1001/jama.2012.108099	http://dx.doi.org/10.1001/jama.2012.108099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268509	Green Accepted, Bronze			2022-12-28	WOS:000312916600014
J	Chatterjee, P				Chatterjee, Patralekha			Can India walk the talk when it comes to mental health?	BRITISH MEDICAL JOURNAL			English	Editorial Material												patralekha.chatterjee@gmail.com						Ministry of Health and Family Welfare Government of India, 2005, REP NAT COMM MACR HL, P32; National Crime Records Bureau, 2011, ACC DEATHS SUIC IND; Planning Commission of India, 12 5 YEAR PLAN 2012, VIII	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	DEC 21	2012	345								e8507	10.1136/bmj.e8507	http://dx.doi.org/10.1136/bmj.e8507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JR	23264602				2022-12-28	WOS:000312701700001
J	Wilmut, I				Wilmut, Ian			Keith Campbell (1954-2012)	SCIENCE			English	Biographical-Item									Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland	University of Edinburgh	Wilmut, I (corresponding author), Univ Edinburgh, MRC, Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.	iwilmut@staffmail.ed.ac.uk			Medical Research Council [G0700711B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		CAMPBELL K, PUBLICATION LIST	1	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1553	1553		10.1126/science.1233495	http://dx.doi.org/10.1126/science.1233495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258883				2022-12-28	WOS:000312533100039
J	Zong, CH; Lu, SJ; Chapman, AR; Xie, XS				Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney			Genome-Wide Detection of Single-Nucleotide and Copy-Number Variations of a Single Human Cell	SCIENCE			English	Article							GENETIC-ANALYSIS; MUTATION-RATES; HUMAN CANCERS; TUMOR-CELLS; AMPLIFICATION; DNA; EVOLUTION; POLYMERASE; PRIMER; PCR	Kindred cells can have different genomes because of dynamic changes in DNA. Single-cell sequencing is needed to characterize these genomic differences but has been hindered by whole-genome amplification bias, resulting in low genome coverage. Here, we report on a new amplification method-multiple annealing and looping-based amplification cycles (MALBAC)-that offers high uniformity across the genome. Sequencing MALBAC-amplified DNA achieves 93% genome coverage >= 1x for a single human cell at 25x mean sequencing depth. We detected digitized copy-number variations (CNVs) of a single cancer cell. By sequencing three kindred cells, we were able to identify individual single-nucleotide variations (SNVs), with no false positives detected. We directly measured the genome-wide mutation rate of a cancer cell line and found that purine-pyrimidine exchanges occurred unusually frequently among the newly acquired SNVs.	[Zong, Chenghang; Lu, Sijia; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA	Harvard University; Harvard University	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Zong, Chenghang/F-3243-2013	Zong, Chenghang/0000-0002-8337-8038	U.S. National Institutes of Health National Human Genome Research Institute [HG005097-1, HG005613-01]; Bill & Melinda Gates Foundation [OPP42867]; NIH [NIH/NIGMS T32 GM008313]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005613, R01HG005097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health National Human Genome Research Institute grants (HG005097-1 and HG005613-01) and in part by Bill & Melinda Gates Foundation OPP42867 to X.S.X. A.R.C. was supported by an NIH Molecular Biophysics Training grant (NIH/NIGMS T32 GM008313). We thank P. Choi for his involvement in the early stage of the project and J. Lu and L. Song for their assistance on the experiments. We thank J. Yong for his help on single-cell expansion and isolation and Y. Zhang at Biodynamic and Optical Imaging Center (BIOPIC) at Peking University for assistance on sequencing. The sequencing data are deposited at the National Center for Biotechnology Information with accession no. SRA060929. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Drake JW, 1998, GENETICS, V148, P1667; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Gundry M, 2012, NUCLEIC ACIDS RES, V40, P2032, DOI 10.1093/nar/gkr949; Hanson EK, 2005, ANAL BIOCHEM, V346, P246, DOI 10.1016/j.ab.2005.08.017; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Lao Kaiqin, 2008, Biotechnol J, V3, P378, DOI 10.1002/biot.200700253; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li GW, 2011, NATURE, V475, P308, DOI 10.1038/nature10315; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; MacArthur D, 2012, NATURE, V487, P427, DOI 10.1038/487427a; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rochette PJ, 2005, J MOL BIOL, V352, P44, DOI 10.1016/j.jmb.2005.06.033; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	31	709	877	13	444	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1622	1626		10.1126/science.1229164	http://dx.doi.org/10.1126/science.1229164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258894	Green Accepted, Green Submitted			2022-12-28	WOS:000312533100054
J	Grayson, M				Grayson, Michelle			PSORIASIS	NATURE			English	Editorial Material																			0	11	13	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					549	549		10.1038/492S49a	http://dx.doi.org/10.1038/492S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254969	Bronze			2022-12-28	WOS:000312488200001
J	Collinger, JL; Wodlinger, B; Downey, JE; Wang, W; Tyler-Kabara, EC; Weber, DJ; McMorland, AJC; Velliste, M; Boninger, ML; Schwartz, AB				Collinger, Jennifer L.; Wodlinger, Brian; Downey, John E.; Wang, Wei; Tyler-Kabara, Elizabeth C.; Weber, Douglas J.; McMorland, Angus J. C.; Velliste, Meel; Boninger, Michael L.; Schwartz, Andrew B.			High-performance neuroprosthetic control by an individual with tetraplegia	LANCET			English	Article							MOTOR CORTICAL REPRESENTATION; PROSTHETIC ARM; INTERFACE; DIRECTION; PARADIGM; MUSCLES; GRASP	Background Paralysis or amputation of an arm results in the loss of the ability to orient the hand and grasp, manipulate, and carry objects, functions that are essential for activities of daily living. Brain-machine interfaces could provide a solution to restoring many of these lost functions. We therefore tested whether an individual with tetraplegia could rapidly achieve neurological control of a high-performance prosthetic limb using this type of an interface. Methods We implanted two 96-channel intracortical microelectrodes in the motor cortex of a 52-year-old individual with tetraplegia. Brain-machine-interface training was done for 13 weeks with the goal of controlling an anthropomorphic prosthetic limb with seven degrees of freedom (three-dimensional translation, three-dimensional orientation, one-dimensional grasping). The participant's ability to control the prosthetic limb was assessed with clinical measures of upper limb function. This study is registered with ClinicalTrials.gov, NCT01364480. Findings The participant was able to move the prosthetic limb freely in the three-dimensional workspace on the second day of training. After 13 weeks, robust seven-dimensional movements were performed routinely. Mean success rate on target-based reaching tasks was 91.6% (SD 4.4) versus median chance level 6.2% (95% CI 2.0-15.3). Improvements were seen in completion time (decreased from a mean of 148 s [SD 60] to 112 s [6]) and path efficiency (increased from 0.30 [0.04] to 0.38 [0.02]). The participant was also able to use the prosthetic limb to do skilful and coordinated reach and grasp movements that resulted in clinically significant gains in tests of upper limb function. No adverse events were reported. Interpretation With continued development of neuroprosthetic limbs, individuals with long-term paralysis could recover the natural and intuitive command signals for hand placement, orientation, and reaching, allowing them to perform activities of daily living.	[Collinger, Jennifer L.; Weber, Douglas J.; Boninger, Michael L.] Dept Vet Affairs Med Ctr, Pittsburgh, PA USA; [Collinger, Jennifer L.; Wodlinger, Brian; Wang, Wei; Tyler-Kabara, Elizabeth C.; Weber, Douglas J.; Boninger, Michael L.; Schwartz, Andrew B.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; [Collinger, Jennifer L.; Downey, John E.; Wang, Wei; Tyler-Kabara, Elizabeth C.; Weber, Douglas J.; Boninger, Michael L.; Schwartz, Andrew B.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; [Wang, Wei] Univ Pittsburgh, Clin & Translat Neurosci Inst, Pittsburgh, PA 15213 USA; [Tyler-Kabara, Elizabeth C.] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15213 USA; [Tyler-Kabara, Elizabeth C.; Boninger, Michael L.; Schwartz, Andrew B.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [McMorland, Angus J. C.; Velliste, Meel; Schwartz, Andrew B.] Univ Pittsburgh, Syst Neurosci Inst, Pittsburgh, PA 15213 USA; [McMorland, Angus J. C.; Velliste, Meel; Schwartz, Andrew B.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15213 USA; [Wodlinger, Brian; Downey, John E.; Wang, Wei; Weber, Douglas J.; Schwartz, Andrew B.] Ctr Neural Basis Cognit, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Schwartz, AB (corresponding author), Univ Pittsburgh, Dept Neurobiol, E1440 Biosci Tower W,200 Lothrop St, Pittsburgh, PA 15213 USA.	abs21@pitt.edu	Downey, John/AAF-3837-2020; Tyler-Kabara, Elizabeth/H-4930-2013	Downey, John/0000-0002-2992-2848; Tyler-Kabara, Elizabeth/0000-0003-3286-1094; Collinger, Jennifer/0000-0002-4517-5395; Boninger, Michael/0000-0001-6966-919X; Wodlinger, Brian/0000-0001-6808-4448; McMorland, Angus/0000-0001-8639-8782	Defense Advanced Research Projects Agency; National Institutes of Health; Department of Veterans Affairs; UPMC Rehabilitation Institute; Defense Advanced Research Projects Agency (Arlington, VA, USA) [N66001-10-C-4056]; National Institutes of Health, (Bethesda, MD, USA) [8KL2TR000146-07]; Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans Affairs (Washington, DC, USA) [B6789C, B7143R, RX720]; UPMC Rehabilitation Institute (Pittsburgh, PA, USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146, UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050256, RC1NS070311] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); UPMC Rehabilitation Institute; Defense Advanced Research Projects Agency (Arlington, VA, USA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institutes of Health, (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans Affairs (Washington, DC, USA); UPMC Rehabilitation Institute (Pittsburgh, PA, USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Defense Advanced Research Projects Agency, National Institutes of Health, Department of Veterans Affairs, and UPMC Rehabilitation Institute.; This study is funded by the Defense Advanced Research Projects Agency's (Arlington, VA, USA) Revolutionizing Prosthetics programme (contract number N66001-10-C-4056), National Institutes of Health, (Bethesda, MD, USA, grant 8KL2TR000146-07), Office of Research and Development, Rehabilitation Research and Development Service, Department of Veterans Affairs (Washington, DC, USA, grant numbers B6789C, B7143R, and RX720), and UPMC Rehabilitation Institute (Pittsburgh, PA, USA). This study was done under an investigational device exemption granted by the US Food and Drug Administration. We thank Jan Scheuermann for her extraordinary commitment and effort in relation to this study and insightful discussions with the study team; Karina Palko for her participation as an honorary research team member and support of the study; the clinicians and researchers at the University of Pittsburgh and UPMC including Joseph Ricker for the presurgical neuropsychological screening, Richard Barbara (both Physical Medicine and Rehabilitation) for providing psychological monitoring throughout the study, Ferenc Gyulai (Anesthesiology) for directing general anaesthesia for the implantation surgery, and Elizabeth Skidmore (Occupational Therapy) for advice about functional assessments of the prosthetic limb; Ramana Vinjamuri and Robin Ashmore for technical and software development efforts, Stephen Foldes for assistance with presurgical neuroimaging, Elke Brown (all four Physical Medicine and Rehabilitation) for assistance with brain-machine-interface testing sessions, Samuel Clanton (School of Medicine) who developed a prototype-system for high-dimensional decoding and participant training that was adapted for this experiment, Elizabeth Harchick for assistance with presurgical neuroimaging, recruitment, and regulatory compliance, and Alisha Shane-Cuniff (both Physical Medicine and Rehabilitation) for coordination of the data and safety monitoring board (DSMB); the University of Pittsburgh Clinical and Translational Science Institute and the Office of Investigator-Sponsored Investigational New Drugs and Investigational Device Exemption support for assistance with protocol development and regulatory reporting and compliance; the volunteer members of the DSMB for their continued monitoring of this study; the Johns Hopkins University Applied Physics Laboratory (Laurel, MD, USA) and Blackrock Microsystems (Salt Lake City, UT, USA) for coordination efforts and technical support in relation to this project. The views expressed herein are those of the authors and do not represent the official policy or position of the Department of Veterans Affairs, Department of Defense, or US Government.	Benvenuto A, 2010, IEEE ENG MED BIO, P1800, DOI 10.1109/IEMBS.2010.5626401; Clanton ST, 2011, THESIS CMU; Collinger JL, J REHABIL R IN PRESS; Degenhart AD, 2012, NEUR INT C SALT LAK; DESMURGET M, 1995, J NEUROPHYSIOL, V74, P905, DOI 10.1152/jn.1995.74.2.905; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Ganguly K, 2011, NAT NEUROSCI, V14, P662, DOI 10.1038/nn.2797; Ganguly K, 2010, J MOTOR BEHAV, V42, P355, DOI 10.1080/00222895.2010.526457; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Kendall FP, 1993, MUSCLES TESTING FUNC; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Losier Y, 2011, J REHABIL RES DEV, V48, P669, DOI 10.1682/JRRD.2010.08.0165; LYLE RC, 1981, INT J REHABIL RES, V4, P483, DOI 10.1097/00004356-198112000-00001; MARQUARDT DW, 1970, TECHNOMETRICS, V12, P591, DOI 10.2307/1267205; McFarland DJ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036007; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Santello M, 1998, J NEUROSCI, V18, P10105; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; SOECHTING JF, 1984, NEUROSCIENCE, V13, P595, DOI 10.1016/0306-4522(84)90252-5; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wang W, 2007, J NEUROPHYSIOL, V97, P4258, DOI 10.1152/jn.01180.2006; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	29	995	1010	21	132	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					557	564		10.1016/S0140-6736(12)61816-9	http://dx.doi.org/10.1016/S0140-6736(12)61816-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23253623	Green Accepted			2022-12-28	WOS:000314927500030
J	Wu, JX; Sun, LJ; Chen, X; Du, FH; Shi, HP; Chen, C; Chen, ZJJ				Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Shi, Heping; Chen, Chuo; Chen, Zhijian J.			Cyclic GMP-AMP Is an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA	SCIENCE			English	Article								Cytosolic DNA induces type I interferons and other cytokines that are important for antimicrobial defense but can also result in autoimmunity. This DNA signaling pathway requires the adaptor protein STING and the transcription factor IRF3, but the mechanism of DNA sensing is unclear. We found that mammalian cytosolic extracts synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vitro from adenosine triphosphate and guanosine triphosphate in the presence of DNA but not RNA. DNA transfection or DNA virus infection of mammalian cells also triggered cGAMP production. cGAMP bound to STING, leading to the activation of IRF3 and induction of interferon-beta. Thus, cGAMP in metazoans and functions as an endogenous second messenger that triggers interferon production in response to cytosolic DNA.	[Wu, Jiaxi; Sun, Lijun; Chen, Xiang; Du, Fenghe; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Shi, Heping; Chen, Chuo] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012; Sun, Lijun/ABD-4470-2021; Wu, Jiaxi/K-3322-2016; shi, heping/G-3238-2015	Chen, Zhijian/0000-0002-8475-8251; Wu, Jiaxi/0000-0002-6976-4784; Chen, Chuo/0000-0002-3118-4901	NIH [AI-093967, GM-079554]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079554] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Tanaka for generating HEK293T-STING and L929-shSTING cell lines; J. Bell, B. Levine, and L. Deng for VSV, HSV-1, and VACV, respectively; R. Debose-Boyd for the PFO plasmid; and V. Sperandio for V. cholerae strain C6709. Supported by NIH grants AI-093967 (Z.J.C.) and GM-079554 (C. C.). Z.J.C. is an investigator of Howard Hughes Medical Institute.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Blumenthal SA, 2012, PERSPECT BIOL MED, V55, P236, DOI 10.1353/pbm.2012.0017; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Mossman KL, 2002, J VIROL, V76, P1995, DOI 10.1128/JVI.76.4.1995-1998.2002; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yin Q, 2012, MOL CELL, V46, P735, DOI 10.1016/j.molcel.2012.05.029	17	1260	1353	23	318	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					826	830		10.1126/science.1229963	http://dx.doi.org/10.1126/science.1229963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258412	Green Accepted			2022-12-28	WOS:000314874400051
J	Di Virgilio, M; Callen, E; Yamane, A; Zhang, WZ; Jankovic, M; Gitlin, AD; Feldhahn, N; Resch, W; Oliveira, TY; Chait, BT; Nussenzweig, A; Casellas, R; Robbiani, DF; Nussenzweig, MC				Di Virgilio, Michela; Callen, Elsa; Yamane, Arito; Zhang, Wenzhu; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Resch, Wolfgang; Oliveira, Thiago Y.; Chait, Brian T.; Nussenzweig, Andre; Casellas, Rafael; Robbiani, Davide F.; Nussenzweig, Michel C.			Rif1 Prevents Resection of DNA Breaks and Promotes Immunoglobulin Class Switching	SCIENCE			English	Article							53BP1; PROTEIN; REPAIR; DAMAGE; AID; RECOMBINATION; REGULATOR; TELOMERES; SITES; FOCUS	DNA double-strand breaks (DSBs) represent a threat to the genome because they can lead to the loss of genetic information and chromosome rearrangements. The DNA repair protein p53 binding protein 1 (53BP1) protects the genome by limiting nucleolytic processing of DSBs by a mechanism that requires its phosphorylation, but whether 53BP1 does so directly is not known. Here, we identify Rap1-interacting factor 1 (Rif1) as an ATM (ataxia-telangiectasia mutated) phosphorylation-dependent interactor of 53BP1 and show that absence of Rif1 results in 5'-3' DNA-end resection in mice. Consistent with enhanced DNA resection, Rif1 deficiency impairs DNA repair in the G(1) and S phases of the cell cycle, interferes with class switch recombination in B lymphocytes, and leads to accumulation of chromosome DSBs.	[Di Virgilio, Michela; Jankovic, Mila; Gitlin, Alexander D.; Feldhahn, Niklas; Oliveira, Thiago Y.; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst HHMI, New York, NY 10065 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Callen, Elsa; Nussenzweig, Andre] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NCI, Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, NIH, Bethesda, MD 20892 USA; [Zhang, Wenzhu; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Oliveira, Thiago Y.] Univ Sao Paulo, Fac Med, Dept Genet, BR-14049 Ribeirao Preto, Brazil; [Oliveira, Thiago Y.] Natl Inst Sci & Technol Stem Cells & Cell Therapy, BR-14049 Ribeirao Preto, Brazil	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Universidade de Sao Paulo	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.	nussen@rockefeller.edu	Robbiani, Davide F./AAF-7662-2019; Yamane, Arito/A-2959-2013; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019; Oliveira, Thiago Y/ABF-5186-2020; Di Virgilio, Michela/AAE-9298-2022	Robbiani, Davide F./0000-0001-7379-3484; Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Resch, Wolfgang/0000-0001-7594-5963; Gitlin, Alexander/0000-0002-9229-0919; Di Virgilio, Michela/0000-0001-5189-0793	NIH [GM007739, AI037526, RR022220, RR00862, GM103314]; NIAMS at the NIH; NCI at the NIH; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037526, R37AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS at the NIH; NCI at the NIH; Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Nussenzweig laboratory for discussion, D. Bosque and T. Eisenreich for help in managing mouse colonies, A. Gazumyan for assistance with Igh germline and AID transcript levels analysis, and K. Yao for help with genotyping. We thank T. de Lange (The Rockefeller University, New York) for Rif1<SUP>F/F</SUP> mice; S. Buonomo (European Molecular Biology Laboratory Mouse Biology Unit, Monterotondo, Italy) for the anti-mouse Rif1 serum #1240; G. Gutierrez (NIAMS, NIH, Bethesda, MD) for Illumina sequencing; N. Zampieri (Columbia University, New York) for assistance with immunofluorescence image processing, and M. P. Rout, J. LaCava, S. Obado, and L. Hough (The Rockefeller University) for invaluable help, discussions, and protocols for cryolysis and magnetic bead-mediated immunoisolation. The data presented in the manuscript are tabulated in the main text and in the supplementary materials. Sequence data shown in Fig. 4 have been deposited in the Gene Expression Omnibus database (accession number GSE42298) at www.ncbi.nlm.nih.gov/geo/. M. D. V. was a Fellow of the American Italian Cancer Foundation, and A. D. G. was supported by NIH Medical Scientist Training Program grant GM007739. This work was supported in part by NIH grants AI037526 (M. C. N.), RR022220 (B. T. C.), RR00862 (B. T. C.), and GM103314 (B. T. C.); and by the intramural program of NIAMS at the NIH (R. C.); and the intramural research program of NCI at the NIH and Center for Cancer Research (A. N. and E. C.). M. C. N. is an HHMI Investigator.	Adams MM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-19; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Kumar S, 2012, CELL CYCLE, V11, P1183, DOI 10.4161/cc.11.6.19636; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Manis JP, 2004, NAT IMMUNOL, V5, P481, DOI 10.1038/ni1067; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Reina-San-Martin B, 2007, EUR J IMMUNOL, V37, P235, DOI 10.1002/eji.200636789; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Ward IM, 2004, J CELL BIOL, V165, P459, DOI 10.1083/jcb.200403021; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180	26	294	297	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					711	715		10.1126/science.1230624	http://dx.doi.org/10.1126/science.1230624			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306439	Green Accepted			2022-12-28	WOS:000314585600047
J	Powell, KI; Chase, JM; Knight, TM				Powell, Kristin I.; Chase, Jonathan M.; Knight, Tiffany M.			Invasive Plants Have Scale-Dependent Effects on Diversity by Altering Species-Area Relationships	SCIENCE			English	Article							BIOLOGICAL INVASION; LONICERA-MAACKII; RICHNESS; BIODIVERSITY; EXTINCTION; DEMOGRAPHY; PATTERNS; IMPACTS; HERBS	Although invasive plant species often reduce diversity, they rarely cause plant extinctions. We surveyed paired invaded and uninvaded plant communities from three biomes. We reconcile the discrepancy in diversity loss from invaders by showing that invaded communities have lower local richness but steeper species accumulation with area than that of uninvaded communities, leading to proportionately fewer species loss at broader spatial scales. We show that invaders drive scale-dependent biodiversity loss through strong neutral sampling effects on the number of individuals in a community. We also show that nonneutral species extirpations are due to a proportionately larger effect of invaders on common species, suggesting that rare species are buffered against extinction. Our study provides a synthetic perspective on the threat of invasions to biodiversity loss across spatial scales.	[Powell, Kristin I.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Powell, KI (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kipowell@wustl.edu	B, A/AHB-5155-2022		NSF [DGE 1143954, DEB 1110629]; Tyson Research Center at Washington University in St. Louis	NSF(National Science Foundation (NSF)); Tyson Research Center at Washington University in St. Louis	We are grateful to H. Bailey, J. Hidalgo, J. Powell, and M. Schutzenhofer for field assistance. We thank B. Allan, E. Gandy, T. Hingtgen, R. Loh, T. Mohrman, and J. Shaw for support with permits and logistics at each field site. The members of the Chase and Knight labs and three anonymous reviewers provided invaluable feedback and greatly improved the analysis and presentation of the manuscript. J. M. C. is an independent researcher. Funding was provided by NSF DGE 1143954 (to K. I. P.), DEB 1110629, and the Tyson Research Center at Washington University in St. Louis. Original data for species richness and area available on Dryad (doi: 10.5061/dryad.qq08m).	Adler Peter B., 1998, Pacific Science, V52, P69; BIERZYCHUDEK P, 1982, NEW PHYTOL, V90, P757, DOI 10.1111/j.1469-8137.1982.tb03285.x; Chabrerie O, 2010, BIOL INVASIONS, V12, P1891, DOI 10.1007/s10530-009-9599-9; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Collier MH, 2002, AM MIDL NAT, V147, P60, DOI 10.1674/0003-0031(2002)147[0060:DPRAAB]2.0.CO;2; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Davis MA, 2003, BIOSCIENCE, V53, P481, DOI 10.1641/0006-3568(2003)053[0481:BGDCFI]2.0.CO;2; Davis M, 2011, NATURE, V474, P153, DOI 10.1038/474153a; Dorning M, 2006, PLANT ECOL, V184, P287, DOI 10.1007/s11258-005-9073-4; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Green JL, 2003, ECOLOGY, V84, P3090, DOI 10.1890/02-3096; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Gurevitch J, 2011, ECOL LETT, V14, P407, DOI 10.1111/j.1461-0248.2011.01594.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hutchinson JT, 2011, INVAS PLANT SCI MANA, V4, P349, DOI 10.1614/IPSM-D-10-00076.1; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; MacDougall AS, 2009, J ECOL, V97, P609, DOI 10.1111/j.1365-2745.2009.01514.x; Maskell LC, 2006, J ECOL, V94, P1052, DOI 10.1111/j.1365-2745.2006.01172.x; May R.M., 1975, P81; Meiners SJ, 2002, ECOGRAPHY, V25, P215, DOI 10.1034/j.1600-0587.2002.250209.x; Olszewski TD, 2004, OIKOS, V104, P377, DOI 10.1111/j.0030-1299.2004.12519.x; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; PRESTON FW, 1962, ECOLOGY, V43, P185, DOI 10.2307/1931976; Rooney TP, 2004, CONSERV BIOL, V18, P787, DOI 10.1111/j.1523-1739.2004.00515.x; Sax DF, 2002, AM NAT, V160, P766, DOI 10.1086/343877; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Stohigren TJ, 2008, ECOL LETT, V11, P313, DOI 10.1111/j.1461-0248.2008.01153.x; Stohlgren TJ, 2008, ECOL LETT, V11, P324, DOI 10.1111/j.1461-0248.2008.01161.x; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601	33	199	214	8	371	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					316	318		10.1126/science.1226817	http://dx.doi.org/10.1126/science.1226817			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329045				2022-12-28	WOS:000313622000043
J	Cianfrocco, MA; Kassavetis, GA; Grob, P; Fang, J; Juven-Gershon, T; Kadonaga, JT; Nogales, E				Cianfrocco, Michael A.; Kassavetis, George A.; Grob, Patricia; Fang, Jie; Juven-Gershon, Tamar; Kadonaga, James T.; Nogales, Eva			Human TFIID Binds to Core Promoter DNA in a Reorganized Structural State	CELL			English	Article							RNA-POLYMERASE-II; ELECTRON-MICROSCOPY; TRANSCRIPTION FACTOR; CRYSTAL-STRUCTURE; TERNARY COMPLEX; NEW-GENERATION; TATA-ELEMENT; MINOR-GROOVE; TBP; RESOLUTION	A mechanistic description of metazoan transcription is essential for understanding the molecular processes that govern cellular decisions. To provide structural insights into the DNA recognition step of transcription initiation, we used single-particle electron microscopy (EM) to visualize human TFIID with promoter DNA. This analysis revealed that TFIID coexists in two predominant and distinct structural states that differ by a 100 angstrom translocation of TFIID's lobe A. The transition between these structural states is modulated by TFIIA, as the presence of TFIIA and promoter DNA facilitates the formation of a rearranged state of TFIID that enables promoter recognition and binding. DNA labeling and footprinting, together with cryo-EM studies, were used to map the locations of TATA, Initiator (Inr), motif ten element (MTE), and downstream core promoter element (DPE) promoter motifs within the TFIID-TFIIA-DNA structure. The existence of two structurally and functionally distinct forms of TFIID suggests that the different conformers may serve as specific targets for the action of regulatory factors.	[Cianfrocco, Michael A.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Grob, Patricia; Fang, Jie; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kassavetis, George A.; Kadonaga, James T.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Juven-Gershon, Tamar] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Life Sci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego; Bar Ilan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov	Juven-Gershon, Tamar/AAC-7799-2022	Juven-Gershon, Tamar/0000-0003-2607-5476; Grob, Patricia/0000-0002-8330-8961	National Institutes of Health [GM041249, GM63072]; Human Frontier in Science Program [RGP0039/2008]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063072, R01GM041249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier in Science Program(Human Frontier Science Program); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Nogales laboratory for constant advice and help with EM analysis; R.J. Hall for initial work on this project; A. Leschziner for advice on the implementation of OTR; S. Zheng for providing TAF4 mAb; D. King for providing peptides; and R. Tjian, W.L. Liu, and R. Coleman for critical feedback and helpful discussions. This work was supported by grants from the National Institutes of Health (GM041249 to J.T.K. and GM63072 to E.N.) and the Human Frontier in Science Program (RGP0039/2008 to E.N.). E.N. is a Howard Hughes Medical Institute Investigator.	Andel F, 1999, SCIENCE, V286, P2153, DOI 10.1126/science.286.5447.2153; Bagby S, 2000, FEBS LETT, V468, P149, DOI 10.1016/S0014-5793(00)01213-8; Bhattacharya S, 2007, P NATL ACAD SCI USA, V104, P1189, DOI 10.1073/pnas.0610297104; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Chi TH, 1996, GENE DEV, V10, P2540, DOI 10.1101/gad.10.20.2540; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Emami KH, 1997, GENE DEV, V11, P3007, DOI 10.1101/gad.11.22.3007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; HERTZBERG RP, 1984, BIOCHEMISTRY-US, V23, P3934, DOI 10.1021/bi00312a022; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Juven-Gershon T, 2006, NAT METHODS, V3, P917, DOI 10.1038/NMETH937; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Leschziner AE, 2006, J STRUCT BIOL, V153, P284, DOI 10.1016/j.jsb.2005.10.012; Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu DJ, 1998, CELL, V94, P573, DOI 10.1016/S0092-8674(00)81599-8; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; PAPAVASSILIOU AG, 1995, BIOCHEM J, V305, P345, DOI 10.1042/bj3050345; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; SUN XQ, 1994, GENE DEV, V8, P2336, DOI 10.1101/gad.8.19.2336; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Theisen JWM, 2010, MOL CELL BIOL, V30, P3471, DOI 10.1128/MCB.00053-10; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; UCHIDA K, 1989, NUCLEIC ACIDS RES, V17, P10259, DOI 10.1093/nar/17.24.10259; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0	57	89	90	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					120	131		10.1016/j.cell.2012.12.005	http://dx.doi.org/10.1016/j.cell.2012.12.005			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332750	Green Accepted, Bronze			2022-12-28	WOS:000313719800011
J	Holmes, D				Holmes, David			Caroline Dive: leader in translational oncology research	LANCET			English	Biographical-Item																		DIVE C, PUBLICATION LIST	1	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 12	2013	381	9861					107	107		10.1016/S0140-6736(13)60036-7	http://dx.doi.org/10.1016/S0140-6736(13)60036-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	069FO	23312743	Bronze			2022-12-28	WOS:000313420900012
J	Morris, P				Morris, Peter			Joseph E. Murray (1919-2012) OBITUARY	NATURE			English	Biographical-Item									[Morris, Peter] Univ Oxford, Oxford OX1 2JD, England; [Morris, Peter] Oxford Transplant Ctr, Oxford, England; [Morris, Peter] Royal Coll Surgeons England, Ctr Evidence Transplantat, London, England; [Morris, Peter] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Oxford; Royal College of Surgeons of England; Harvard University; Massachusetts General Hospital	Morris, P (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	pmorris@rcseng.ac.uk						MURRAY JR, PUBLICATION LIST	1	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					164	164		10.1038/493164a	http://dx.doi.org/10.1038/493164a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302851	Bronze			2022-12-28	WOS:000313259600021
J	Iglehart, JK; Baron, RB				Iglehart, John K.; Baron, Robert B.			Ensuring Physicians' Competence - Is Maintenance of Certification the Answer?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							QUALITY; PROFESSIONALISM; CARE		[Baron, Robert B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco								Aligning incentives in Medicare, 2010, REP C; American Board of Medical Specialties, CERT MATT 2011 ANN R; American Medical Association, AMA MEDED; Brennan TA, 2005, NEW ENGL J MED, V353, P1989, DOI 10.1056/NEJMp058223; Chaudhry HJ, 2012, J MED REGULATION, V97, P8; Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Conway PH, 2012, JAMA-J AM MED ASSOC, V308, P979, DOI 10.1001/jama.2012.9844; Drazen JM, 2010, NEW ENGL J MED, V362, P946, DOI 10.1056/NEJMe1000174; Hackbarth G, 2011, NEW ENGL J MED, V364, P693, DOI 10.1056/NEJMp1012691; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Interprofessional Education Collaborative Expert Panel, 2011, COR COMP INT COLL PR; Johnson David A., 2012, MED LICENSING DISCIP, P156; Jost TS, 1997, REGULATION HEALTHCAR; Kritek Patricia A, 2010, N Engl J Med, V362, pe54, DOI 10.1056/NEJMclde1003227; LEAF A, 1984, NEW ENGL J MED, V310, P718, DOI 10.1056/NEJM198403153101111; Levinson W, 2010, NEW ENGL J MED, V362, P949; Levinson W, 2011, AM J MED, V124, P180, DOI 10.1016/j.amjmed.2010.09.019; Levinson W, 2010, NEW ENGL J MED, V362, P948, DOI 10.1056/NEJMclde0911205; Maintenance of Certification Activity Manager, 2012, PORTF PROGR REV; Nasca TJ, 2012, NEW ENGL J MED, V366, P1051, DOI 10.1056/NEJMsr1200117; Pawlson LG, 2002, HEALTH AFFAIR, V21, P200, DOI 10.1377/hlthaff.21.3.200; Puffer JC, 2011, J AM BOARD FAM MED, V24, P483, DOI 10.3122/jabfm.2011.05.110170; Shojania KG, 2012, ANN INTERN MED, V156, P305, DOI 10.7326/0003-4819-156-4-201202210-00008; Steinman MA, 2012, NEW ENGL J MED, V366, P1069, DOI 10.1056/NEJMp1114776; Stevens R., 1998, AM MED PUBLIC INTERE; Weinberger SE, 2011, ANN INTERN MED, V155, P386, DOI 10.7326/0003-4819-155-6-201109200-00007; Xierali IM, 2011, ANN FAM MED, V9, P203, DOI 10.1370/afm.1251	27	75	75	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2543	2549		10.1056/NEJMhpr1211043	http://dx.doi.org/10.1056/NEJMhpr1211043			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268670				2022-12-28	WOS:000312714200016
J	Roorda, S; Lewis, LJ				Roorda, Sjoerd; Lewis, Laurent J.			Comment on "The Local Structure of Amorphous Silicon"	SCIENCE			English	Editorial Material							MEDIUM-RANGE ORDER; DIFFRACTION	Treacy and Borisenko (Reports, 24 February 2012, p. 950) argue from reverse Monte Carlo modeling of electron diffraction and fluctuation electron microscopy data that amorphous silicon is paracrystalline and not described by a continuous random network. However, their models disagree with high-resolution x-ray measurements and other evidence, whereas the agreement with fluctuation electron microscopy is at best qualitative.	[Roorda, Sjoerd; Lewis, Laurent J.] Univ Montreal, Dept Phys, Montreal, PQ H3T 1J4, Canada	Universite de Montreal	Roorda, S (corresponding author), Univ Montreal, Dept Phys, 2900 Blvd Edouard Montpetit, Montreal, PQ H3T 1J4, Canada.	sjoerd.roorda@umontreal.ca; laurent.lewis@umontreal.ca	Lewis, Laurent/E-5546-2013; Roorda, Sjoerd/N-2604-2014	Roorda, Sjoerd/0000-0001-5293-8015				Barkema GT, 2000, PHYS REV B, V62, P4985, DOI 10.1103/PhysRevB.62.4985; Biswas P, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/45/455202; Borisenko KB, 2012, ACTA MATER, V60, P359, DOI 10.1016/j.actamat.2011.09.039; Cheng JY, 2001, J MATER RES, V16, P3030, DOI 10.1557/JMR.2001.0416; Haberl B, 2011, J APPL PHYS, V110, DOI 10.1063/1.3658628; Haberl B, 2010, THESIS AUSTR NATL U; JACOBSON DC, 1986, APPL PHYS LETT, V48, P118, DOI 10.1063/1.96970; KELTON KF, 1983, J CHEM PHYS, V79, P6261, DOI 10.1063/1.445731; KOSTER U, 1978, PHYS STATUS SOLIDI A, V48, P313, DOI 10.1002/pssa.2210480207; Laaziri K, 1999, PHYS REV B, V60, P13520, DOI 10.1103/PhysRevB.60.13520; Roorda S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.255501; Treacy MMJ, 2012, SCIENCE, V335, P950, DOI 10.1126/science.1214780; Treacy MMJ, 2005, REP PROG PHYS, V68, P2899, DOI 10.1088/0034-4885/68/12/R06; WILLIAMSON DL, 1995, APPL PHYS LETT, V67, P226, DOI 10.1063/1.114675	14	16	16	0	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114								10.1126/science.1221738	http://dx.doi.org/10.1126/science.1221738			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258875	Bronze			2022-12-28	WOS:000312533100029
J	Kaiser, D; Moreno, JD				Kaiser, David; Moreno, Jonathan D.			Self-censorship is not enough	NATURE			English	Editorial Material									[Kaiser, David] MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA; [Moreno, Jonathan D.] Univ Penn, Philadelphia, PA 19104 USA	Massachusetts Institute of Technology (MIT); University of Pennsylvania	Kaiser, D (corresponding author), MIT, Program Sci Technol & Soc, Cambridge, MA 02139 USA.	dikaiser@mit.edu; morenojd@upenn.edu	Kaiser, David/C-7149-2014	Kaiser, David/0000-0002-5054-6744				BERG P, 1975, P NATL ACAD SCI USA, V72, P1981, DOI 10.1073/pnas.72.6.1981; Butler D, 2012, NATURE, V486, P449, DOI 10.1038/486449a; Durant J., 2010, BECOMING MIT MOMENTS, P145; Kaiser D, 2005, REPRESENTATIONS, P28; Kaiser J, 2005, SCIENCE, V308, P31; Maher B, 2012, NATURE, V485, P431, DOI 10.1038/485431a; Mirowski Philip, 2011, SCI MART PRIVATIZING; National Research Council, 2007, SCI SEC POST9 11 WOR; WEART SR, 1976, PHYS TODAY, V29, P23, DOI 10.1063/1.3023312; Wein LM, 2005, P NATL ACAD SCI USA, V102, P9984, DOI 10.1073/pnas.0408526102	10	10	11	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					345	347		10.1038/492345a	http://dx.doi.org/10.1038/492345a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23257863	Bronze			2022-12-28	WOS:000312488200030
J	Allen, H; Nobel, JJ; Burton, WN				Allen, Harris; Nobel, Jeremy J.; Burton, Wayne N.			Making Health Care Reform Work Where Physician and Employer Interests Converge	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Allen, Harris] Harris Allen Grp, Brookline, MA USA; [Nobel, Jeremy J.] Harvard Univ, Sch Publ Hlth, NE Business Grp Hlth, Boston, MA 02115 USA; [Nobel, Jeremy J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Burton, Wayne N.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Northwestern University; Feinberg School of Medicine	Allen, H (corresponding author), 150 Walnut St,Rd 2, Brookline, MA 02445 USA.	harris@harrisallengroup.com	Allen, Harris/V-1480-2019					Adler-Milstein J, 2008, HEALTH AFFAIR, V27, pW60, DOI 10.1377/hlthaff.27.1.w60; Allen H, 2011, J HLTH PRODUCTIVITY, V5, P2; Allen H, 2012, MILKEN I REV     OCT; Allen H, 2012, J OCCUP ENVIRON MED, V54, P904, DOI 10.1097/JOM.0b013e318267f1b1; Berwick D, 2012, SUPREME COURT MOVING; Centers for Medicare & Medicaid Services, 2011, FED REG, V76, P67889; Crown Copyright, 2008, WORK HEALTH TOM DC B; Integrated Benefits Institute, 2012, POOR HLTH COSTS US E	8	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2465	2466		10.1001/jama.2012.45428	http://dx.doi.org/10.1001/jama.2012.45428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288038				2022-12-28	WOS:000312441400021
J	Corrales-Medina, VF; Musher, DM; Shachkina, S; Chirinos, JA				Corrales-Medina, Vicente F.; Musher, Daniel M.; Shachkina, Svetlana; Chirinos, Julio A.			Acute pneumonia and the cardiovascular system	LANCET			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; ANGIOTENSIN-CONVERTING ENZYME; THROMBOSIS-INDUCING ACTIVITY; ACUTE KIDNEY INJURY; RISK-FACTORS; NATRIURETIC PEPTIDE; PNEUMOCOCCAL PNEUMONIA; NONINVASIVE EVALUATION; MYOCARDIAL-INFARCTION; HOSPITALIZED-PATIENTS	Although traditionally regarded as a disease confined to the lungs, acute pneumonia has important effects on the cardiovascular system at all severities of infection. Pneumonia tends to affect individuals who are also at high cardiovascular risk. Results of recent studies show that about a quarter of adults admitted to hospital with pneumonia develop a major acute cardiac complication during their hospital stay, which is associated with a 60% increase in short-term mortality. These findings suggest that outcomes of patients with pneumonia can be improved by prevention of the development and progression of associated cardiac complications. Before this hypothesis can be tested, however, an adequate mechanistic understanding of the cardiovascular changes that occur during pneumonia, and their role in the trigger of various cardiac complications, is needed. In this Review, we summarise knowledge about the burden of cardiac complications in adults with acute pneumonia, the cardiovascular response to this infection, the potential effects of commonly used cardiovascular and anti-infective drugs on these associations, and possible directions for future research.	[Corrales-Medina, Vicente F.; Shachkina, Svetlana] Univ Ottawa, Dept Med, Ottawa, ON K1Y 4E9, Canada; [Corrales-Medina, Vicente F.; Shachkina, Svetlana] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Musher, Daniel M.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Musher, Daniel M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Musher, Daniel M.] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Houston, TX USA; [Chirinos, Julio A.] Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; [Chirinos, Julio A.] Philadelphia VA Med Ctr, Philadelphia, PA USA	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Corrales-Medina, VF (corresponding author), Univ Ottawa, Dept Med, 1053 Carling Ave,CPC 470, Ottawa, ON K1Y 4E9, Canada.	vcorrales@toh.on.ca		Corrales-Medina, Vicente/0000-0002-9691-491X	Research Priority Grant from the Department of Medicine of The Ottawa Hospital; Junior Investigator Award of the Ottawa Hospital Research Institute	Research Priority Grant from the Department of Medicine of The Ottawa Hospital; Junior Investigator Award of the Ottawa Hospital Research Institute	We thank Alexandra Davis, librarian at The Ottawa Hospital, for her assistance in the design of our search strategies and the retrieval of selected articles. We also acknowledge Yoko S Schreiber and Bing Wang, from the Division of Infectious Diseases at the University of Ottawa, for their assistance with the translation of articles in French, German, and Chinese; and Waheed Raja and Zubair A Khan, from the Divisions of Internal Medicine at Texas Tech University Health Sciences Center and Cooper University Hospital, respectively, for their helpful assistance during the literature search process. VFC-M is supported by a Research Priority Grant from the Department of Medicine of The Ottawa Hospital, and a Junior Investigator Award of the Ottawa Hospital Research Institute.	Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; Aliberti S, 2008, CHEST, V134, P955, DOI 10.1378/chest.08-0334; ANDERSON RJ, 1986, KIDNEY INT, V29, P1237, DOI 10.1038/ki.1986.134; Andreoletti L, 2009, ARCH CARDIOVASC DIS, V102, P559, DOI 10.1016/j.acvd.2009.04.010; Baylin A, 2007, ANN EPIDEMIOL, V17, P112, DOI 10.1016/j.annepidem.2006.05.004; BENSON H, 1970, J CLIN INVEST, V49, P791, DOI 10.1172/JCI106292; Birck MM, 2011, AM J PHYSIOL-HEART C, V300, pH1595, DOI 10.1152/ajpheart.01253.2010; Carr GE, 2012, CHEST, V141, P1528, DOI 10.1378/chest.11-1547; Chalmers JD, 2008, AM J MED, V121, P1002, DOI 10.1016/j.amjmed.2008.06.030; Chelazzi C, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/652967; Chirinos JA, 2010, HYPERTENSION, V56, P563, DOI 10.1161/HYPERTENSIONAHA.110.157339; Chirinos JA, 2010, HYPERTENSION, V56, P555, DOI 10.1161/HYPERTENSIONAHA.110.157321; Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x; COHEN LS, 1970, AM J CARDIOL, V26, P505, DOI 10.1016/0002-9149(70)90708-3; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2011, J INFECTION, V63, P187, DOI 10.1016/j.jinf.2011.06.009; Corrales-Medina VF, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001048; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; de Garde EMWV, 2007, CLIN CHEM LAB MED, V45, P1326, DOI 10.1515/CCLM.2007.268; Dong M, 2011, INT J CARDIOL, V147, P479, DOI 10.1016/j.ijcard.2011.01.035; Doshi SM, 2013, AM J MED SCI, V345, P173, DOI 10.1097/MAJ.0b013e3182639c26; Douglas I, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1642; Dremsizov T, 2006, CHEST, V129, P968, DOI 10.1378/chest.129.4.968; DREYFUSS D, 1988, AM REV RESPIR DIS, V138, P583, DOI 10.1164/ajrccm/138.3.583; ERMAKOV EV, 1987, TERAPEVT ARKH, V59, P84; ERMAKOV EV, 1984, TERAPEVT ARKH, V56, P103; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Gandhi T, 2008, HEART LUNG, V37, P394, DOI 10.1016/j.hrtlng.2007.07.003; GAVRISYUK VK, 1987, TERAPEVT ARKH, V59, P92; Gel'tser B I, 2005, Klin Med (Mosk), V83, P19; Haddad F, 2007, J HEART LUNG TRANSPL, V26, P745, DOI 10.1016/j.healun.2007.04.010; Haidari M, 2010, ATHEROSCLEROSIS, V208, P90, DOI 10.1016/j.atherosclerosis.2009.07.028; HARFORD C G, 1947, Proc Annu Meet Cent Soc Clin Res U S, V20, P15; HEALY DP, 1990, ANTIMICROB AGENTS CH, V34, P550, DOI 10.1128/AAC.34.4.550; Hunter JD, 2010, BRIT J ANAESTH, V104, P3, DOI 10.1093/bja/aep339; Janda S, 2010, J CRIT CARE, V25; Jasti H, 2008, CLIN INFECT DIS, V46, P550, DOI 10.1086/526526; John J, 2010, J CRIT CARE, V25, P270, DOI 10.1016/j.jcrc.2009.12.001; Khand AU, 2001, EUR HEART J, V22, P153, DOI 10.1053/euhj.2000.2175; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; KOIVULA I, 1994, AM J MED, V96, P313, DOI 10.1016/0002-9343(94)90060-4; Kruger S, 2010, AM J RESP CRIT CARE, V182, P1426, DOI 10.1164/rccm.201003-0415OC; KUMAR R, 1970, J CLIN INVEST, V49, P799, DOI 10.1172/JCI106293; LAFORCE FM, 1973, J LAB CLIN MED, V82, P634; Landry DW, 2001, NEW ENGL J MED, V345, P588, DOI 10.1056/NEJMra002709; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Light R B, 1999, Semin Respir Infect, V14, P218; Lim WS, 2009, THORAX, V64, P1, DOI 10.1136/thx.2009.121434; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Madjid M, 2007, TEX HEART I J, V34, P11; MAEV IV, 1991, TERAPEVT ARKH, V63, P30; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Marrie TJ, 2007, MEDICINE, V86, P103, DOI 10.1097/MD.0b013e3180421c16; Meijvis SCA, 2011, CLIN CHEM LAB MED, V49, P1525, DOI 10.1515/CCLM.2011.626; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; Moammar MQ, 2010, HEART LUNG CIRC, V19, P90, DOI 10.1016/j.hlc.2009.08.009; Modica A, 2007, J THROMB HAEMOST, V5, P507, DOI 10.1111/j.1538-7836.2007.02378.x; Mortensen EM, 2008, EUR RESPIR J, V31, P611, DOI 10.1183/09031936.00162006; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Mortensen Eric M, 2005, BMC Pulm Med, V5, P12, DOI 10.1186/1471-2466-5-12; Mortensen EM, 2008, AM J MED SCI, V336, P462, DOI 10.1097/MAJ.0b013e31817149ed; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Myles PR, 2009, PHARMACOEPIDEM DR S, V18, P697, DOI 10.1002/pds.1769; Naghavi M, 2003, CIRCULATION, V107, P762, DOI 10.1161/01.CIR.0000048190.68071.2B; NAKANISHI M, 1991, ONCOLOGY, V48, P297; Nelson KH, 2009, CARDIOL REV, V17, P24, DOI 10.1097/CRD.0b013e318184b383; OGATA K, 1991, RESPIRATION, V58, P176; PETERSDORF RG, 1957, B JOHNS HOPKINS HOSP, V101, P1; Prat C, 2007, J INFECTION, V55, P400, DOI 10.1016/j.jinf.2007.07.018; Ramirez J, 2008, CLIN INFECT DIS, V47, P182, DOI 10.1086/589246; Renz CL, 1999, CRIT CARE MED, V27, P1732, DOI 10.1097/00003246-199909000-00006; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rothberg MB, 2012, J GEN INTERN MED, V27, P280, DOI 10.1007/s11606-011-1826-2; Ruuskanen O, 2011, LANCET, V377, P1264, DOI 10.1016/S0140-6736(10)61459-6; SAPHIR O, 1948, ANN INTERN MED, V28, P963, DOI 10.7326/0003-4819-28-5-963; Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99; Schuetz P, 2011, INTENS CARE MED, V37, P970, DOI 10.1007/s00134-011-2208-2; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; Schultz MJ, 2006, CRIT CARE MED, V34, P871, DOI 10.1097/01.CCM.0000202136.91651.34; SEEDAT MA, 1993, Q J MED, V86, P669, DOI 10.1093/qjmed/86.10.669; Singanayagam A, 2012, EUR RESPIR J, V39, P187, DOI 10.1183/09031936.00049111; STUDDY PR, 1983, J CLIN PATHOL, V36, P938, DOI 10.1136/jcp.36.8.938; THOMSON KJ, 1946, AM HEART J, V31, P565, DOI 10.1016/0002-8703(46)90003-8; TONG CYW, 1995, LANCET, V346, P710, DOI 10.1016/S0140-6736(95)92327-6; Vallance P, 1997, LANCET, V349, P1391, DOI 10.1016/S0140-6736(96)09424-X; van de Garde EMW, 2008, CHEST, V133, P220, DOI 10.1378/chest.07-1400; Vardeny O, 2009, J CARD FAIL, V15, P368, DOI 10.1016/j.cardfail.2008.11.009; Vassallo M, 1997, INT J CLIN PRACT, V51, P438; Vlachopoulos C, 2005, CIRCULATION, V112, P2193, DOI 10.1161/CIRCULATIONAHA.105.535435; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Winning J, 2009, PLATELETS, V20, P50, DOI 10.1080/09537100802503368; Yende S, 2011, CRIT CARE MED, V39, P1871, DOI 10.1097/CCM.0b013e31821b8290; Yetkin O, 2008, INT J CLIN PRACT, V62, P488, DOI 10.1111/j.1742-1241.2007.01305.x	100	252	266	2	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					496	505		10.1016/S0140-6736(12)61266-5	http://dx.doi.org/10.1016/S0140-6736(12)61266-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23332146				2022-12-28	WOS:000314810900035
J	Koyanagi, A; Zhang, J; Dagvadorj, A; Hirayama, F; Shibuya, K; Souza, JP; Gulmezoglu, AM				Koyanagi, Ai; Zhang, Jun; Dagvadorj, Amarjargal; Hirayama, Fumi; Shibuya, Kenji; Souza, Joao Paulo; Guelmezoglu, Ahmet Metin			Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional survey	LANCET			English	Article							FETAL MACROSOMIA; CESAREAN DELIVERY; PERINATAL HEALTH; GLOBAL SURVEY; PREGNANCY; WOMEN; MANAGEMENT; OBSTETRICS; OUTCOMES; OBESITY	Background Macrosomia is a risk factor for adverse delivery outcomes. We investigated the prevalence, risk factors, and delivery outcomes of babies with macrosomia in 23 developing countries in Africa, Asia, and Latin America. Methods We analysed data from WHO's Global Survey on Maternal and Perinatal Health, which was a facility-based cross-sectional study that obtained data for women giving birth in 373 health facilities in 24 countries in Africa and Latin America in 2004-05, and in Asia in 2007-08. Facilities were selected by stratified multistage cluster sampling and women were recruited at admission for delivery. We extracted data from the medical records with a standardised questionnaire. We used logistic regression with random effects to assess the risk factors for macrosomia and the risks for caesarean section and adverse maternal and perinatal outcomes (assessed by a composite score) in babies with the disorder. Findings Of 290 610 deliveries, we analysed data for 276 436 singleton livebirths or fresh stillbirths. Higher maternal age (20-34 years), height, parity, body-mass index, and presence of diabetes, post-term pregnancy, and male fetal sex were associated with a significantly increased risk of macrosomia. Macrosomia was associated with an increased risk of caesarean section because of obstructed labour and post-term pregnancy in all regions. Additionally, macrosomia was associated with an increased risk of adverse maternal birth outcomes in all regions, and of adverse perinatal outcomes only in Africa. Interpretation Increasing prevalence of diabetes and obesity in women of reproductive age in developing countries could be associated with a parallel increase in macrosomic births. The effect and feasibility of control of diabetes and preconception weight on macrosomia should be investigated in these settings. Furthermore, increased institutional delivery in countries where rates are low could be crucial to reduce macrosomia-associated morbidity and mortality.	[Koyanagi, Ai] Hatsuishi Hosp, Kashiwa, Chiba 2770885, Japan; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Minist Educ, Shanghai 200030, Peoples R China; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai Key Lab Childrens Environm Hlth, Shanghai 200030, Peoples R China; [Zhang, Jun] Sch Publ Hlth, Shanghai, Peoples R China; [Dagvadorj, Amarjargal; Shibuya, Kenji] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Tokyo, Japan; [Hirayama, Fumi] Kyushu Univ, Innovat Ctr Med Redox Nav, Med Network Grp, Fukuoka 812, Japan; [Souza, Joao Paulo; Guelmezoglu, Ahmet Metin] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Tokyo; Kyushu University; World Health Organization	Koyanagi, A (corresponding author), Hatsuishi Hosp, Kashiwa, Chiba 2770885, Japan.	koyanagiai@yahoo.com	Souza, João Paulo/G-1982-2010; Koyanagi, Ai/D-3833-2018	Souza, João Paulo/0000-0002-2288-4244; Koyanagi, Ai/0000-0002-9565-5004; Shibuya, Kenji/0000-0003-2528-7530	United States Agency for International Development and UN Development Programme/UN Population Fund/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; Department of Reproductive Health and Research; Ministry of Health, Labor and Welfare of Japan; Beijing Ministry of Public Health; Indian Council of Medical Research	United States Agency for International Development and UN Development Programme/UN Population Fund/WHO/World Bank Special Programme of Research(United States Agency for International Development (USAID)); Development and Research Training in Human Reproduction; Department of Reproductive Health and Research; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Beijing Ministry of Public Health; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	WHO's Global Survey on Maternal and Perinatal Health was financially supported by the United States Agency for International Development and UN Development Programme/UN Population Fund/WHO/World Bank Special Programme of Research; Development and Research Training in Human Reproduction; Department of Reproductive Health and Research; Ministry of Health, Labor and Welfare of Japan; Beijing Ministry of Public Health; and Indian Council of Medical Research. We thank all the contributors to the study design and implementation, the study coordinators, data collectors, and staff of the Ministries of Health and WHO offices, and the participants of the study. The named authors alone are responsible for the views expressed in this paper.	Berkus MD, 1999, CLIN OBSTET GYNECOL, V42, P766, DOI 10.1097/00003081-199912000-00006; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Boulet S L, 2004, J Obstet Gynaecol, V24, P622; Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; BOYD ME, 1983, OBSTET GYNECOL, V61, P715; Chatfield J, 2001, AM FAM PHYSICIAN, V64, P169; Coetzee EJ, 2009, INT J GYNECOL OBSTET, V104, pS39, DOI 10.1016/j.ijgo.2008.11.027; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dennedy MC, 2010, BEST PRACT RES CL EN, V24, P573, DOI 10.1016/j.beem.2010.06.001; Donnay F, 2004, LANCET, V363, P71, DOI 10.1016/S0140-6736(03)15177-X; Ehrenstein Vera, 2009, Clin Epidemiol, V1, P45; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Haram K, 2002, ACTA OBSTET GYN SCAN, V81, P185, DOI 10.1034/j.1600-0412.2002.810301.x; Henriksen T, 2008, ACTA OBSTET GYN SCAN, V87, P134, DOI 10.1080/00016340801899289; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Jovanovic L, 2009, INT J GYNECOL OBSTET, V104, pS17, DOI 10.1016/j.ijgo.2008.11.023; Konje JC, 2000, AM J CLIN NUTR, V72, p291S, DOI 10.1093/ajcn/72.1.291S; Little R. J. A., 1987, STAT ANAL MISSING DA; Lu YY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-818; Martorell R, 2000, EUR J CLIN NUTR, V54, P247, DOI 10.1038/sj.ejcn.1600931; Mikolajczyk RT, 2011, LANCET, V377, P1855, DOI 10.1016/S0140-6736(11)60364-4; Ovesen PG, 2012, MATERNAL OBESITY PRE; Pettitt David J, 2007, Curr Diab Rep, V7, P295, DOI 10.1007/s11892-007-0047-x; Roglic G, 2009, INT J GYNECOL OBSTET, V104, pS11, DOI 10.1016/j.ijgo.2008.11.022; Rouse DJ, 1996, JAMA-J AM MED ASSOC, V276, P1480, DOI 10.1001/jama.276.18.1480; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Tsvieli O, 2012, ARCH GYNECOL OBSTET, V285, P931, DOI 10.1007/s00404-011-2086-4; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Zamorski MA, 2001, AM FAM PHYSICIAN, V63, P302	29	183	201	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 9	2013	381	9865					476	483		10.1016/S0140-6736(12)61605-5	http://dx.doi.org/10.1016/S0140-6736(12)61605-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23290494				2022-12-28	WOS:000314810900033
J	Niwa, M; Jaaro-Peled, H; Tankou, S; Seshadri, S; Hikida, T; Matsumoto, Y; Cascella, NG; Kano, S; Ozaki, N; Nabeshima, T; Sawa, A				Niwa, Minae; Jaaro-Peled, Hanna; Tankou, Stephanie; Seshadri, Saurav; Hikida, Takatoshi; Matsumoto, Yurie; Cascella, Nicola G.; Kano, Shin-ichi; Ozaki, Norio; Nabeshima, Toshitaka; Sawa, Akira			Adolescent Stress-Induced Epigenetic Control of Dopaminergic Neurons via Glucocorticoids	SCIENCE			English	Article							PSYCHOTIC DEPRESSION; ENVIRONMENT; BRAIN; ADAPTATION; FEATURES; GENE	Environmental stressors during childhood and adolescence influence postnatal brain maturation and human behavioral patterns in adulthood. Accordingly, excess stressors result in adult-onset neuropsychiatric disorders. We describe an underlying mechanism in which glucocorticoids link adolescent stressors to epigenetic controls in neurons. In a mouse model of this phenomenon, a mild isolation stress affects the mesocortical projection of dopaminergic neurons in which DNA hypermethylation of the tyrosine hydroxylase gene is elicited, but only when combined with a relevant genetic risk for neuropsychiatric disorders. These molecular changes are associated with several neurochemical and behavioral deficits that occur in this mouse model, all of which are blocked by a glucocorticoid receptor antagonist. The biology and phenotypes of the mouse models resemble those of psychotic depression, a common and debilitating psychiatric disease.	[Niwa, Minae; Matsumoto, Yurie; Nabeshima, Toshitaka] Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan; [Niwa, Minae; Jaaro-Peled, Hanna; Tankou, Stephanie; Seshadri, Saurav; Hikida, Takatoshi; Cascella, Nicola G.; Kano, Shin-ichi; Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Niwa, Minae; Matsumoto, Yurie; Ozaki, Norio] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Hikida, Takatoshi] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Kyoto 6068501, Japan; [Nabeshima, Toshitaka] Meijo Univ, Comparat Cognit Sci Inst, Acad Frontier Project Private Univ, Nagoya, Aichi 4688503, Japan; [Nabeshima, Toshitaka] Meijo Univ, Dept Reg Pharmaceut Care & Sci, Nagoya, Aichi 4688503, Japan	Meijo University; Johns Hopkins University; Nagoya University; Kyoto University; Meijo University; Meijo University	Nabeshima, T (corresponding author), Meijo Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Nagoya, Aichi 4688503, Japan.	tnabeshi@meijo-u.ac.jp; asawa1@jhmi.edu	Ozaki, Norio/M-8908-2014; Kano, Shinichi/F-4144-2015; Niwa, Minae/G-5469-2011; Niwa, Minae/AAV-2639-2021; Hikida, Takatoshi/J-5561-2017	Ozaki, Norio/0000-0002-7360-4898; Kano, Shinichi/0000-0002-5171-3436; Niwa, Minae/0000-0002-8784-7815; Niwa, Minae/0000-0002-8784-7815; Hikida, Takatoshi/0000-0002-8653-311X	Stanley; RUSK; S-R; NARSAD; Maryland Stem Cell Research Fund; NIH [MH-084018, MH-094268, MH-069853, MH-085226, MH-088753, MH-092443, K99MH-094408]; JSPS-Korea; Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW); JSPS [22248033, 20390073, 22659213, 20007152, 23-639]; Strategic Research Program for Brain Sciences; MEXT/MHLW; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092443, K99MH094408, P20MH084018, RC1MH088753, P50MH094268, R21MH085226, R01MH069853] Funding Source: NIH RePORTER	Stanley; RUSK; S-R; NARSAD(NARSAD); Maryland Stem Cell Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS-Korea; Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT/MHLW; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Talalay, J. Roeper, M. A. Landek-Salgado, and Y. Lema for helpful advice. Supported by Stanley, RUSK, S-R, NARSAD, the Maryland Stem Cell Research Fund, and NIH grants MH-084018, MH-094268, MH-069853, MH-085226, MH-088753, and MH-092443 (A. S.); by JSPS-Korea and the Ministry of Education, Culture, Sports, Science and Technology/Ministry of Health, Labour and Welfare of Japan (MEXT/MHLW) and JSPS grants 22248033, 20390073, and 22659213 (T.N.); by Strategic Research Program for Brain Sciences and MEXT/MHLW (N.O.); and by NARSAD, NIH grant K99MH-094408, and JSPS grants 20007152 and 23-639 (M.N.).	Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Ago Y, 2008, NEUROPHARMACOLOGY, V55, P1355, DOI 10.1016/j.neuropharm.2008.08.026; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Brandon NJ, 2011, NAT REV NEUROSCI, V12, P707, DOI 10.1038/nrn3120; Caspi A, 2005, ANNU REV PSYCHOL, V56, P453, DOI 10.1146/annurev.psych.55.090902.141913; CORYELL W, 1984, J NERV MENT DIS, V172, P521, DOI 10.1097/00005053-198409000-00002; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; deKloet ER, 1996, CELL MOL NEUROBIOL, V16, P345; FLESHNER M, 1995, ENDOCRINOLOGY, V136, P5336, DOI 10.1210/en.136.12.5336; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Hagerty T, 2001, J NEUROCHEM, V78, P1379, DOI 10.1046/j.1471-4159.2001.00521.x; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lee RS, 2011, PSYCHOPHARMACOLOGY, V218, P303, DOI 10.1007/s00213-011-2307-3; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moffitt TE, 2005, ARCH GEN PSYCHIAT, V62, P473, DOI 10.1001/archpsyc.62.5.473; Morgan C, 2010, SCHIZOPHRENIA BULL, V36, P655, DOI 10.1093/schbul/sbq051; Murray RM, 2007, NAT REV NEUROSCI, V8, P885, DOI 10.1038/nrn2253; Niwa M, 2011, INT J NEUROPSYCHOPH, V14, P459, DOI 10.1017/S1461145710001239; Ohayon MM, 2002, AM J PSYCHIAT, V159, P1855, DOI 10.1176/appi.ajp.159.11.1855; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563	23	212	223	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					335	339		10.1126/science.1226931	http://dx.doi.org/10.1126/science.1226931			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329051	Green Accepted			2022-12-28	WOS:000313622000049
J	Klein, HG				Klein, Harvey G.			Should Blood Be an Essential Medicine?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Klein, HG (corresponding author), NIH, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA.							Akech SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-256; American Association of Blood Banks (AABB), 2012, AABB STAND BLOOD BAN; European Directorate for the Quality of Medicines & Health Care, 2010, GUID PREP US QUAL AS; Klein HG, 2007, LANCET, V370, P415, DOI 10.1016/S0140-6736(07)61197-0; World Health organization, 2003, SEL US ESS MED	5	20	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					199	201		10.1056/NEJMp1213134	http://dx.doi.org/10.1056/NEJMp1213134			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323895				2022-12-28	WOS:000313549900002
J	Feinmann, J				Feinmann, Jane			Journey of an oximeter	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jane@janefeinmann.com						Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Merry AF, 2009, ANAESTHESIA, V64, P1045, DOI 10.1111/j.1365-2044.2009.06104.x	2	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								f241	10.1136/bmj.f241	http://dx.doi.org/10.1136/bmj.f241			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075ER	23321411				2022-12-28	WOS:000313867100015
J	Walensky, RP; Sax, PE; Nakamura, YM; Weinstein, MC; Pei, PP; Freedberg, KA; Paltiel, AD; Schackman, BR				Walensky, Rochelle P.; Sax, Paul E.; Nakamura, Yoriko M.; Weinstein, Milton C.; Pei, Pamela P.; Freedberg, Kenneth A.; Paltiel, A. David; Schackman, Bruce R.			Economic Savings Versus Health Losses: The Cost-Effectiveness of Generic Antiretroviral Therapy in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							TREATMENT-NAIVE PATIENTS; COMBINATION THERAPY; HIV-1 INFECTION; DOUBLE-BLIND; EFFICACY; EMTRICITABINE; TENOFOVIR; VIRUS; ADHERENCE; REGIMEN	Background: U. S. HIV treatment guidelines recommend branded once-daily, 1-pill efavirenz-emtricitabine-tenofovir as first-line antiretroviral therapy (ART). With the anticipated approval of generic efavirenz in the United States, a once-daily, 3-pill alternative (generic efavirenz, generic lamivudine, and tenofovir) will decrease cost but may reduce adherence and virologic suppression. Objective: To assess the clinical effect, costs, and cost-effectiveness of a 3-pill, generic-based regimen compared with a branded, co-formulated regimen and to project the potential national savings in the first year of a switch to generic-based ART. Design: Mathematical simulation of HIV disease. Setting: United States. Patients: HIV-infected persons. Intervention: No ART (for comparison); 3-pill, generic-based ART; and branded ART. Measurements: Quality-adjusted life expectancy, costs, and incremental cost-effectiveness ratios (ICERs) in dollars per qualityadjusted life-year (QALY). Results: Compared with no ART, generic-based ART has an ICER of $ 21 100/QALY. Compared with generic-based ART, branded ART increases lifetime costs by $ 42 500 and per-person survival gains by 0.37 QALYs for an ICER of $ 114 800/QALY. Estimated first-year savings, if all eligible U. S. patients start or switch to generic-based ART, are $ 920 million. Most plausible assumptions about generic-based ART efficacy and costs lead to branded ART ICERs greater than $ 100 000/QALY. Limitation: The efficacy and price reduction associated with generic drugs are unknown, and estimates are intended to be conservative. Conclusion: Compared with a slightly less effective generic-based regimen, the cost-effectiveness of first-line branded ART exceeds $ 100 000/QALY. Generic-based ART in the United States could yield substantial budgetary savings to HIV programs.	[Walensky, Rochelle P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Brigham & Womens Hosp, Div Infect Dis,Med Practice Evaluat Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02114 USA; Yale Univ, Sch Med, New Haven, CT USA; Weill Cornell Med Coll, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Yale University; Cornell University	Walensky, RP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,Brigham & Womens Hosp, Div Infect Dis,Med Practice Evaluat Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Walensky, Rochelle P./0000-0002-8795-379X	National Institute of Allergy and Infectious Diseases [R37-AI42006, R01-AI093269]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042006, R01AI093269, R01AI042006, P30AI060354] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By grants R37-AI42006 and R01-AI093269 from the National Institute of Allergy and Infectious Diseases.	Althoff KN, 2010, CLIN INFECT DIS, V50, P1512, DOI 10.1086/652650; [Anonymous], 2010, NAT HIV AIDS STRAT U; Bamezai A, 2005, ANN EMERG MED, V45, P483, DOI 10.1016/j.annemergmed.2004.08.029; Bangsberg DR, 2010, AIDS, V24, P2835, DOI 10.1097/QAD.0b013e328340a209; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Braithwaite RS, 2003, MED DECIS MAKING, V23, P562; Buscher A, 2012, INT J STD AIDS, V23, P351, DOI 10.1258/ijsa.2011.011292; Centers for Disease Control and Prevention, 2011, NEW HOP STOPP HIV TE; Centers for Medicare & Medicaid Services, 2012, CLIN LAB FEE SHED; Cohen C, 2012, 52 INT C ANT CHEM SA; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Department of Economic and Social Affairs Population Division, 2009, WORLD POP PROSP 2008; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V38, P96, DOI 10.1097/00126334-200501010-00017; Gold MR, 1996, COST EFFECTIVENESS H; Gopalappa C, 2012, JAIDS-J ACQ IMM DEF, V61, P99, DOI 10.1097/QAI.0b013e31825bd862; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hoerger TJ, 2002, JAMA-J AM MED ASSOC, V287, P2542; *I MED, 2003, HIDD COSTS VAL LOST; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Johnson MA, 2006, JAIDS-J ACQ IMM DEF, V43, P153, DOI 10.1097/01.qai.0000242449.67155.1a; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Levinson D., 2005, MEDICAID DRUG PRICE; Linas BP, 2012, CLIN INFECT DIS, V55, P279, DOI 10.1093/cid/cis382; Martin EG, 2012, JAIDS-J ACQ IMM DEF, V60, P72, DOI 10.1097/QAI.0b013e31824c0dd4; McKinnell JA, 2010, AIDS PATIENT CARE ST, V24, P79, DOI 10.1089/apc.2009.0220; *NAT TECHN INF SER, 1995, MULT AIDS COH STUD M; National Alliance of State & Territorial AIDS Directors, 2011, HIV VIR HEP COINF; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Oguamanam A. C. O., 2012, THESIS MORGAN STATE; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2012, GUID US ANT AG HIV 1; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Rousseau FS, 2003, J INFECT DIS, V188, P1652, DOI 10.1086/379667; Rydzak CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012647; Sax PE, 2012, LANCET, V379, P2439, DOI 10.1016/S0140-6736(12)60917-9; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Sax PE, 2012, GEN LAM HAS ARR HIV; Schinazi RF, 2003, JAIDS-J ACQ IMM DEF, V34, P243, DOI 10.1097/00126334-200310010-00017; Seage GR, 2001, AM J EPIDEMIOL, V153, P619, DOI 10.1093/aje/153.7.619; Shenouda N., 2009, RED BOOK; Svicher V, 2010, JAIDS-J ACQ IMM DEF, V55, P336, DOI 10.1097/QAI.0b013e3181e6763f; Swiss HIV Cohort Study & Mother and Child HIV Cohort Study, 2012, SWISS HIV COHORT STU; Tang MW, 2012, CLIN INFECT DIS, V54, P862, DOI 10.1093/cid/cir1034; The Economist, 2012, ECONOMIST; The Henry J. Kaiser Family Foundation, 2012, US FED FUND HIV AIDS; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; U.S. Food and Drug Administration, 2012, FACTS GEN DRUGS; U.S. Food and Drug Administration, 2012, APPR TENT APPR ANT A; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; United States Food and Drug Administration, 2012, OR BOOK APPR DRUG PR; University HealthSystem Consortium, 2009, 2006 2008 COST DAT; Valdiserri R, 2011, PROPOSED NATL HIV AI; Walensky RP, 2010, CLIN INFECT DIS, V51, P392, DOI 10.1086/655130; Weinstein M C, 2001, Value Health, V4, P348, DOI 10.1046/j.1524-4733.2001.45061.x	60	111	111	0	18	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					84	+		10.7326/0003-4819-158-2-201301150-00002	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00002			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318310	Green Accepted			2022-12-28	WOS:000314029400014
J	Senyuk, B; Liu, QK; He, SL; Kamien, RD; Kusner, RB; Lubensky, TC; Smalyukh, II				Senyuk, Bohdan; Liu, Qingkun; He, Sailing; Kamien, Randall D.; Kusner, Robert B.; Lubensky, Tom C.; Smalyukh, Ivan I.			Topological colloids	NATURE			English	Article							NEMATIC LIQUID-CRYSTALS; POINT-DEFECTS; FRUSTRATION; SHAPE; DNA	Smoke, fog, jelly, paints, milk and shaving cream are common everyday examples of colloids(1), a type of soft matter consisting of tiny particles dispersed in chemically distinct host media. Being abundant in nature, colloids also find increasingly important applications in science and technology, ranging from direct probing of kinetics in crystals and glasses(2) to fabrication of third-generation quantum-dot solar cells(3). Because naturally occurring colloids have a shape that is typically determined by minimization of interfacial tension (for example, during phase separation) or faceted crystal growth(1), their surfaces tend to have minimum-area spherical or topologically equivalent shapes such as prisms and irregular grains (all continuously deformable-homeomorphic-to spheres). Although toroidal DNA condensates and vesicles with different numbers of handles can exist(4-7) and soft matter defects can be shaped as rings(8) and knots(9), the role of particle topology in colloidal systems remains unexplored. Here we fabricate and study colloidal particles with different numbers of handles and genus g ranging from 1 to 5. When introduced into a nematic liquid crystal-a fluid made of rod-like molecules that spontaneously align along the so-called 'director'(10)-these particles induce three-dimensional director fields and topological defects dictated by colloidal topology. Whereas electric fields, photothermal melting and laser tweezing cause transformations between configurations of particle-induced structures, three-dimensional nonlinear optical imaging reveals that topological charge is conserved and that the total charge of particle-induced defects always obeys predictions of the Gauss-Bonnet and Poincare-Hopf index theorems(11-13). This allows us to establish and experimentally test the procedure for assignment and summation of topological charges in three-dimensional director fields. Our findings lay the groundwork for new applications of colloids and liquid crystals that range from topological memory devices(14), through new types of self-assembly(15-23), to the experimental study of low-dimensional topology(6,7,11-13).	[Senyuk, Bohdan; Liu, Qingkun; Smalyukh, Ivan I.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Senyuk, Bohdan; Smalyukh, Ivan I.] Univ Colorado, Mat Sci & Engn Program, Dept Elect Comp & Energy Engn, Boulder, CO 80309 USA; [Senyuk, Bohdan; Smalyukh, Ivan I.] Univ Colorado, Crystal Mat Res Ctr, Boulder, CO 80309 USA; [Liu, Qingkun; He, Sailing] Zhejiang Univ, Ctr Opt & Elect Res, Hangzhou 310058, Zhejiang, Peoples R China; [Kamien, Randall D.; Lubensky, Tom C.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Kusner, Robert B.] Univ Massachusetts, Dept Math & Stat, Amherst, MA 01003 USA; [Smalyukh, Ivan I.] Natl Renewable Energy Lab, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA; [Smalyukh, Ivan I.] Univ Colorado, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Zhejiang University; University of Pennsylvania; University of Massachusetts System; University of Massachusetts Amherst; University of Colorado System; University of Colorado Boulder	Smalyukh, II (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	ivan.smalyukh@colorado.edu	Senyuk, Bohdan/M-3185-2014; Liu, Qing/GWC-9222-2022; Smalyukh, Ivan/AAC-9232-2020; Smalyukh, Ivan I/C-2955-2011; He, Sailing/C-2438-2009	Senyuk, Bohdan/0000-0002-0004-3161; Smalyukh, Ivan/0000-0003-3444-1966; Smalyukh, Ivan I/0000-0003-3444-1966; He, Sailing/0000-0002-3401-1125; Kamien, Randall/0000-0003-1598-5626	International Institute for Complex Adaptive Matter; National Science Foundation [DMR-0844115, DMR-0820579, DMR-0847782, PHY11-25915, DMR-1120901]; Division Of Materials Research [0847782] Funding Source: National Science Foundation	International Institute for Complex Adaptive Matter; National Science Foundation(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank P. Chen, N. Clark, J.-i. Fukuda and S. Zumer for discussions. This work was supported by the International Institute for Complex Adaptive Matter and the National Science Foundation grants DMR-0844115 (Q. L., S. H. and I. I. S.), DMR-0820579 (B. S. and I. I. S.), DMR-0847782 (B. S., Q. L. and I. I. S.), PHY11-25915 (R. D. K., R. B. K., T. C. L. and I. I. S.) and DMR-1120901 (R. D. K. and T. C. L.). R. B. K., R. D. K., T. C. L. and I. I. S. thank the Kavli Institute for Theoretical Physics for their hospitality while this work was being discussed and prepared for publication.	Alexander GP, 2012, REV MOD PHYS, V84, P497, DOI 10.1103/RevModPhys.84.497; Alsayed AM, 2005, SCIENCE, V309, P1207, DOI 10.1126/science.1112399; Araki T, 2011, NAT MATER, V10, P303, DOI [10.1038/nmat2982, 10.1038/NMAT2982]; BOWICK MJ, 1994, SCIENCE, V263, P943, DOI 10.1126/science.263.5149.943; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Han Y, 2006, SCIENCE, V314, P626, DOI 10.1126/science.1130146; Herges R, 2006, CHEM REV, V106, P4820, DOI 10.1021/cr0505425; Hopf H, 1927, MATH ANN, V96, P225, DOI 10.1007/BF01209164; Hsu L., 1992, EXP MATH, V1, P191; HUD NV, 1995, P NATL ACAD SCI USA, V92, P3581, DOI 10.1073/pnas.92.8.3581; Hunter R.J., 2001, FDN COLLOID SCI, V2nd ed.; Irvine WTM, 2010, NATURE, V468, P947, DOI 10.1038/nature09620; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kamien RD, 2002, REV MOD PHYS, V74, P953, DOI 10.1103/RevModPhys.74.953; Kleman M, 2006, PHILOS MAG, V86, P4117, DOI 10.1080/14786430600593016; Lapointe CP, 2009, SCIENCE, V326, P1083, DOI 10.1126/science.1176587; Lavrentovich O. D., 1986, Soviet Physics - JETP, V64, P1237; Lee T, 2010, OPT LETT, V35, P3447, DOI 10.1364/OL.35.003447; Merkel TJ, 2010, LANGMUIR, V26, P13086, DOI 10.1021/la903890h; Milnor J. W., 1965, TOPOLOGY DIFFERENTIA; Montiel S, 2009, CURVES SURFACES; Mosseri R, 2008, CR CHIM, V11, P192, DOI 10.1016/j.crci.2007.03.019; Pettey D, 1999, PHYS REV E, V59, P1834, DOI 10.1103/PhysRevE.59.1834; Poulin P, 1997, SCIENCE, V275, P1770, DOI 10.1126/science.275.5307.1770; Poulin P, 1997, PHYS REV LETT, V79, P4862, DOI 10.1103/PhysRevLett.79.4862; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Semonin OE, 2011, SCIENCE, V334, P1530, DOI 10.1126/science.1209845; Solomon MJ, 2011, CURR OPIN COLLOID IN, V16, P158, DOI 10.1016/j.cocis.2011.01.006; Tkalec U, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.127801; Tkalec U, 2011, SCIENCE, V333, P62, DOI 10.1126/science.1205705; Trivedi RP, 2012, P NATL ACAD SCI USA, V109, P4744, DOI 10.1073/pnas.1119118109; Wood TA, 2011, SCIENCE, V334, P79, DOI 10.1126/science.1209997	33	243	245	14	772	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					200	205		10.1038/nature11710	http://dx.doi.org/10.1038/nature11710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23263182	Green Submitted			2022-12-28	WOS:000313259600035
J	Kaner, E; Bland, M; Cassidy, P; Coulton, S; Dale, V; Deluca, P; Gilvarry, E; Godfrey, C; Heather, N; Myles, J; Newbury-Birch, D; Oyefeso, A; Parrott, S; Perryman, K; Phillips, T; Shepherd, J; Drummond, C				Kaner, Eileen; Bland, Martin; Cassidy, Paul; Coulton, Simon; Dale, Veronica; Deluca, Paolo; Gilvarry, Eilish; Godfrey, Christine; Heather, Nick; Myles, Judy; Newbury-Birch, Dorothy; Oyefeso, Adenekan; Parrott, Steve; Perryman, Katherine; Phillips, Tom; Shepherd, Jonathan; Drummond, Colin			Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE; COST-EFFECTIVENESS; CONSUMPTION; DRINKING; DRINKERS; EFFICACY; METAANALYSIS; READINESS; TIME	Objective To evaluate the effectiveness of different brief intervention strategies at reducing hazardous or harmful drinking in primary care. The hypothesis was that more intensive intervention would result in a greater reduction in hazardous or harmful drinking. Design Pragmatic cluster randomised controlled trial. Setting Primary care practices in the north east and south east of England and in London. Participants 3562 patients aged 18 or more routinely presenting in primary care, of whom 2991 (84.0%) were eligible to enter the trial: 900 (30.1%) screened positive for hazardous or harmful drinking and 756 (84.0%) received a brief intervention. The sample was predominantly male (62%) and white (92%), and 34% were current smokers. Interventions Practices were randomised to three interventions, each of which built on the previous one: a patient information leaflet control group, five minutes of structured brief advice, and 20 minutes of brief lifestyle counselling. Delivery of the patient leaflet and brief advice occurred directly after screening and brief lifestyle counselling in a subsequent consultation. Main outcome measures The primary outcome was patients' self reported hazardous or harmful drinking status as measured by the alcohol use disorders identification test (AUDIT) at six months. A negative AUDIT result (score <8) indicated non-hazardous or non-harmful drinking. Secondary outcomes were a negative AUDIT result at 12 months, experience of alcohol related problems (alcohol problems questionnaire), health utility (EQ-5D), service utilisation, and patients' motivation to change drinking behaviour (readiness to change) as measured by a modified readiness ruler. Results Patient follow-up rates were 83% at six months (n=644) and 79% at 12 months (n=617). At both time points an intention to treat analysis found no significant differences in AUDIT negative status between the three interventions. Compared with the patient information leaflet group, the odds ratio of having a negative AUDIT result for brief advice was 0.85 (95% confidence interval 0.52 to 1.39) and for brief lifestyle counselling was 0.78 (0.48 to 1.25). A per protocol analysis confirmed these findings. Conclusions All patients received simple feedback on their screening outcome. Beyond this input, however, evidence that brief advice or brief lifestyle counselling provided important additional benefit in reducing hazardous or harmful drinking compared with the patient information leaflet was lacking.	[Kaner, Eileen; Newbury-Birch, Dorothy] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Bland, Martin; Dale, Veronica; Godfrey, Christine; Parrott, Steve] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Cassidy, Paul] Teams Family Practice, Gateshead, England; [Coulton, Simon] Univ Kent, Ctr Hlth Serv Studies, Canterbury, Kent, England; [Deluca, Paolo; Drummond, Colin] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London, England; [Gilvarry, Eilish] Northumberland Tyne & Wear NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Heather, Nick] Northumbria Univ, Fac Hlth & Life Sci, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Myles, Judy; Oyefeso, Adenekan] St Georges Univ London, Div Publ Hlth Sci & Educ, London, England; [Perryman, Katherine] Univ Manchester, Greater Manchester CLAHRC Practitioner Theme, Manchester M13 9PL, Lancs, England; [Phillips, Tom] Humber Mental Hlth & Teaching NHS Trust, Willerby, England; [Shepherd, Jonathan] Cardiff Univ, Violence Res Grp, Cardiff CF10 3AX, S Glam, Wales	Newcastle University - UK; University of York - UK; University of Kent; University of London; King's College London; Northumbria University; St Georges University London; University of Manchester; Cardiff University	Kaner, E (corresponding author), Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	e.f.s.kaner@newcastle.ac.uk	Deluca, Paolo/X-2580-2019; Kaner, Eileen/ABF-2444-2020; Drummond, Colin/O-9141-2019	Drummond, Colin/0000-0001-9379-5452; Coulton, Simon/0000-0002-7704-3274; Shepherd, Jonathan/0000-0001-6466-2298; Phillips, Tom/0000-0001-8020-4510; Godfrey, Christine/0000-0001-6290-5532; Deluca, Paolo/0000-0002-9511-7230; Newbury-Birch, Dorothy/0000-0003-0065-8649; Parrott, Steven James/0000-0002-0165-1150; Kaner, Eileen/0000-0002-7169-9344; Perryman, Katherine/0000-0003-1275-6991	Fuse the Centre for Translational Research in Public Health; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Department of Health; Department of Health in England (Alcohol Policy Unit); MRC [G0701818, G0701681] Funding Source: UKRI; Medical Research Council [MR/K02325X/1, G0701818, G0701681] Funding Source: researchfish; National Institute for Health Research [CDRF 2009-81, RP-PG-0609-10162] Funding Source: researchfish	Fuse the Centre for Translational Research in Public Health; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health; Department of Health in England (Alcohol Policy Unit); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	EK was part funded by Fuse the Centre for Translational Research in Public Health. Fuse is a UKCRC Public Health Research Centre of Excellence, and funding comes from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research. This study was funded by the Department of Health. The views expressed herein do not necessarily reflect those of the Department of Health or the National Health Service in England and Wales.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: all authors had financial support from the Department of Health in England (Alcohol Policy Unit) for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Aalto M, 2000, ALCOHOL CLIN EXP RES, V24, P1680, DOI 10.1097/00000374-200011000-00010; Aalto M, 2001, ALCOHOL ALCOHOLISM, V36, P224, DOI 10.1093/alcalc/36.3.224; Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; [Anonymous], 1992, INT CLASS DIS; Babor TF, 2006, ALCOHOL ALCOHOLISM, V41, P624, DOI 10.1093/alcalc/agl078; Ballesteros J, 2004, ALCOHOL CLIN EXP RES, V28, P608, DOI 10.1097/01.ALC.0000122106.84718.67; Beich A, 2003, BMJ-BRIT MED J, V327, P536, DOI 10.1136/bmj.327.7414.536; Bernstein JA, 2010, DRUG ALCOHOL REV, V29, P498, DOI 10.1111/j.1465-3362.2010.00174.x; Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1111/j.1530-0277.1998.tb03991.x; Burke BL, 2003, J CONSULT CLIN PSYCH, V71, P843, DOI 10.1037/0022-006X.71.5.843; Canagasaby A, 2005, ALCOHOL ALCOHOLISM, V40, P208, DOI 10.1093/alcalc/agh156; Coulton S, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-114; Deluca P, 2012, ADDICT SCI CLIN P S1, V7, pA83, DOI [10.1186/1940-0640-7-s1-a83, DOI 10.1186/1940-0640-7-S1-A83]; Drummond C, 2009, BRIT J PSYCHIAT, V195, P448, DOI 10.1192/bjp.bp.108.056697; DRUMMOND DC, 1990, BRIT J ADDICT, V85, P357; Edwards AGK, 1997, ADDICTION, V92, P1699, DOI 10.1111/j.1360-0443.1997.tb02890.x; Funk M, 2005, J STUD ALCOHOL, V66, P379, DOI 10.15288/jsa.2005.66.379; Godfrey C, 2005, BMJ-BRIT MED J, V331, P544; Heather N, 2008, IMPLEMENTING SCREENI; Heather N, 2008, DRUG ALCOHOL DEPEN, V98, P235, DOI 10.1016/j.drugalcdep.2008.06.005; Hodgson R, 2002, ALCOHOL ALCOHOLISM, V37, P61, DOI 10.1093/alcalc/37.1.61; Jenkins RJ, 2009, DRUG ALCOHOL DEPEN, V100, P107, DOI 10.1016/j.drugalcdep.2008.09.016; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kaner E, 2010, ADDICTION, V105, P960, DOI 10.1111/j.1360-0443.2009.02848.x; Kaner E, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-287; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Lane C., 2002, BEHAV CHANGE COUNSEL; Lundahl BW, 2010, RES SOCIAL WORK PRAC, V20, P137, DOI 10.1177/1049731509347850; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; McCambridge J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023748; Michie S, 2010, HEALTH PSYCHOL, V29, P468, DOI 10.1037/a0020844; MILLER WR, 1991, BRIT J ADDICT, V86, P43; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; National Institute for Health and Clinical Excellence, 2010, ALC US DIS PREV DEV; Newbury-Birch D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-418; NHS Employers, 2008, CLIN DIR ENH SERV DE; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rollnick S., 1999, HLTH BEHAV CHANGE GU, V1st; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Saunders JB, 2000, COMPR PSYCHIAT, V41, P95, DOI 10.1016/S0010-440X(00)80015-2; Vasilaki EI, 2006, ALCOHOL ALCOHOLISM, V41, P328, DOI 10.1093/alcalc/agl016; Ware JE, 1976, DEV VALIDATION SCALE; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Williams EC, 2007, ALCOHOL CLIN EXP RES, V31, P428, DOI 10.1111/j.1530-0277.2006.00324.x; Williams S, 2005, DRUG ALCOHOL DEPEN, V77, P205, DOI 10.1016/j.drugalcdep.2004.07.011	47	188	193	2	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e8501	10.1136/bmj.e8501	http://dx.doi.org/10.1136/bmj.e8501			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303891	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000313554900001
J	Largeron, M; Fleury, MB				Largeron, Martine; Fleury, Maurice-Bernard			Bioinspired Oxidation Catalysts	SCIENCE			English	Editorial Material							AEROBIC OXIDATION; PRIMARY AMINES; IMINES; SYSTEM; ALCOHOLS; QUINONE		[Largeron, Martine; Fleury, Maurice-Bernard] Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Largeron, M (corresponding author), Univ Paris 05, CNRS, Fac Sci Pharmaceut & Biol, UMR 8638, F-75270 Paris 06, France.	martine.largeron@parisdescartes.fr; maurice.fleury@parisdescartes.fr	largeron, martine/AAW-4958-2020	largeron, martine/0000-0002-1725-8118				Gnanaprakasam B, 2010, ANGEW CHEM INT EDIT, V49, P1468, DOI 10.1002/anie.200907018; Hu ZZ, 2012, ORG BIOMOL CHEM, V10, P1618, DOI 10.1039/c2ob06670j; Largeron M, 2008, CHEM-EUR J, V14, P996, DOI 10.1002/chem.200700876; Largeron M, 2012, ANGEW CHEM INT EDIT, V51, P5409, DOI 10.1002/anie.201200587; MURAHASHI SI, 1995, ANGEW CHEM INT EDIT, V34, P2443, DOI 10.1002/anie.199524431; Mure M, 2004, ACCOUNTS CHEM RES, V37, P131, DOI 10.1021/ar9703342; Mure M, 2002, BIOCHEMISTRY-US, V41, P9269, DOI 10.1021/bi020246b; Patil RD, 2011, ADV SYNTH CATAL, V353, P1695, DOI 10.1002/adsc.201100100; Que L, 2008, NATURE, V455, P333, DOI 10.1038/nature07371; Samec JSM, 2005, CHEM-EUR J, V11, P2327, DOI 10.1002/chem.200401082; Tian HW, 2012, ADV SYNTH CATAL, V354, P2671, DOI 10.1002/adsc.201200574; Watson AJA, 2010, SCIENCE, V329, P635, DOI 10.1126/science.1191843; Wendlandt AE, 2012, ORG LETT, V14, P2850, DOI 10.1021/ol301095j; Yamaguchi K, 2003, ANGEW CHEM INT EDIT, V42, P1480, DOI 10.1002/anie.200250779; Yuan H, 2012, J AM CHEM SOC, V134, P13970, DOI 10.1021/ja306934b	15	111	112	8	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					43	44		10.1126/science.1232220	http://dx.doi.org/10.1126/science.1232220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288531				2022-12-28	WOS:000312985800044
J	Weaver, JF				Weaver, Jason F.			Entropies of Adsorbed Molecules Exceed Expectations	SCIENCE			English	Editorial Material									Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Weaver, JF (corresponding author), Univ Florida, Dept Chem Engn, Gainesville, FL 32611 USA.	weaver@che.ufl.edu						Antony A, 2012, PHYS CHEM CHEM PHYS, V14, P12202, DOI 10.1039/c2cp41900a; Campbell CT, 2012, J AM CHEM SOC, V134, P18109, DOI 10.1021/ja3080117; Fichthorn KA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196103; Tait SL, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2400235	4	23	23	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					39	40		10.1126/science.1231552	http://dx.doi.org/10.1126/science.1231552			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288528				2022-12-28	WOS:000312985800041
J	Rogelj, J; McCollum, DL; Reisinger, A; Meinshausen, M; Riahi, K				Rogelj, Joeri; McCollum, David L.; Reisinger, Andy; Meinshausen, Malte; Riahi, Keywan			Probabilistic cost estimates for climate change mitigation	NATURE			English	Article							CARBON-CYCLE MODELS; ATMOSPHERE-OCEAN; SIMPLER MODEL; SCENARIOS; TARGETS	For more than a decade, the target of keeping global warming below 2 degrees C has been a key focus of the international climate debate(1). In response, the scientific community has published a number of scenario studies that estimate the costs of achieving such a target(2-5). Producing these estimates remains a challenge, particularly because of relatively well known, but poorly quantified, uncertainties, and owing to limited integration of scientific knowledge across disciplines(6). The integrated assessment community, on the one hand, has extensively assessed the influence of technological and socio-economic uncertainties on low-carbon scenarios and associated costs(2-4,7). The climate modelling community, on the other hand, has spent years improving its understanding of the geophysical response of the Earth system to emissions of greenhouse gases(8-12). This geophysical response remains a key uncertainty in the cost of mitigation scenarios but has been integrated with assessments of other uncertainties in only a rudimentary manner, that is, for equilibrium conditions(6,13). Here we bridge this gap between the two research communities by generating distributions of the costs associated with limiting transient global temperature increase to below specific values, taking into account uncertainties in four factors: geophysical, technological, social and political. Wefind that political choices that delay mitigation have the largest effect on the cost-risk distribution, followed by geophysical uncertainties, social factors influencing future energy demand and, lastly, technological uncertainties surrounding the availability of greenhouse gas mitigation options. Our information on temperature risk and mitigation costs provides crucial information for policy-making, because it clarifies the relative importance of mitigation costs, energy demand and the timing of global action in reducing the risk of exceeding a global temperature increase of 2 degrees C, or other limits such as 3 degrees C or 1.5 degrees C, across a wide range of scenarios.	[Rogelj, Joeri] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Rogelj, Joeri; McCollum, David L.; Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Reisinger, Andy] New Zealand Agr Greenhouse Gas Res Ctr, Palmerston North 4442, New Zealand; [Meinshausen, Malte] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Meinshausen, Malte] Potsdam Inst Climate Impact Res, PRIMAP Grp, D-14412 Potsdam, Germany; [Riahi, Keywan] Graz Univ Technol, A-8010 Graz, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; International Institute for Applied Systems Analysis (IIASA); University of Melbourne; Potsdam Institut fur Klimafolgenforschung; Graz University of Technology	Rogelj, J (corresponding author), ETH, Inst Atmospher & Climate Sci, Univ Str 16, CH-8092 Zurich, Switzerland.	joeri.rogelj@env.ethz.ch	Rogelj, Joeri/I-7108-2012; Meinshausen, Malte/AAG-7985-2019; Riahi, Keywan/B-6426-2011; Reisinger, Andy R/E-1201-2016; Meinshausen, Malte/AAG-6505-2019; Meinshausen, Malte/A-7037-2011	Rogelj, Joeri/0000-0003-2056-9061; Riahi, Keywan/0000-0001-7193-3498; Reisinger, Andy R/0000-0002-6631-7188; Meinshausen, Malte/0000-0003-4048-3521; Meinshausen, Malte/0000-0003-4048-3521; McCollum, David/0000-0003-1293-0179	Swiss National Science Foundation [200021-135067]; IIASA Peccei Award Grant	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); IIASA Peccei Award Grant	We thank V. Krey, P. Kolp and M. Strubegger for their support in developing the model set-up and extracting the results, R. Knutti and R. Socolow for comments and feedback during the writing process and S. Hatfield-Dodds, whose review comments substantially contributed to improving our manuscript. J.R. was supported by the Swiss National Science Foundation (project 200021-135067) and the IIASA Peccei Award Grant.	Archer D, 2009, ANNU REV EARTH PL SC, V37, P117, DOI 10.1146/annurev.earth.031208.100206; Bosetti V, 2009, CLIMATIC CHANGE, V96, P299, DOI 10.1007/s10584-009-9630-2; Clarke L, 2009, ENERG ECON, V31, pS64, DOI 10.1016/j.eneco.2009.10.013; den Elzen MGJ, 2010, CLIMATIC CHANGE, V99, P313, DOI 10.1007/s10584-010-9798-5; Edenhofer O, 2010, ENERG J, V31, P11; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Knutti R, 2008, J CLIMATE, V21, P2651, DOI 10.1175/2007JCLI2119.1; Krey V, 2009, ENERG ECON, V31, pS94, DOI 10.1016/j.eneco.2009.07.001; Mastrandrea M. D., 2010, GUIDANCE NOTE LEAD A, P3; Meehl G. A., 2007, IPCC CLIMATE CHANGE, P747; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1457, DOI 10.5194/acp-11-1457-2011; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Nakicenovic N., 2000, IPCC SPECIAL REPORT; O'Neill BC, 2010, P NATL ACAD SCI USA, V107, P1011, DOI 10.1073/pnas.0903797106; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; Rao S, 2006, ENERG J, P177; Riahi K., 2012, GLOBAL ENERGY ASSESS, P1203; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Schaeffer M, 2008, P NATL ACAD SCI USA, V105, P20621, DOI 10.1073/pnas.0802416106; Smith SM, 2012, NAT CLIM CHANGE, V2, P535, DOI 10.1038/NCLIMATE1496; Smith SJ, 2006, TELLUS B, V58, P586, DOI 10.1111/j.1600-0889.2006.00217.x; UNEP, 2011, BRIDG EM GAP 15 20; United Nations, 2009, WORLD POP PROSP 2008; Vaughan NE, 2009, CLIMATIC CHANGE, V96, P29, DOI 10.1007/s10584-009-9573-7	28	218	223	3	210	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 3	2013	493	7430					79	83		10.1038/nature11787	http://dx.doi.org/10.1038/nature11787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282364				2022-12-28	WOS:000312933800034
J	Goetz, L; Bethel, K; Topol, EJ				Goetz, Laura; Bethel, Kelly; Topol, Eric J.			Rebooting Cancer Tissue Handling in the Sequencing Era Toward Routine Use of Frozen Tumor Tissue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROMISE		[Goetz, Laura; Topol, Eric J.] Scripps Translat Sci Inst, Scripps Genom Med, La Jolla, CA 92037 USA; [Goetz, Laura] Scripps Clin, Div Gen Surg, La Jolla, CA 92037 USA; [Bethel, Kelly] Scripps Clin, Div Pathol, La Jolla, CA 92037 USA; [Topol, Eric J.] Scripps Clin, Div Cardiovasc Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Topol, EJ (corresponding author), Scripps Translat Sci Inst, 3344 N Torrey Pines Ct, La Jolla, CA 92037 USA.	etopol@scripps.edu		Bethel, Kelly/0000-0002-7005-8641; Topol, Eric/0000-0002-1478-4729				Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Esteva FJ, 2010, NAT REV CLIN ONCOL, V7, P98, DOI 10.1038/nrclinonc.2009.216; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Iyer G, 2012, SCIENCE, V338, P221, DOI 10.1126/science.1226344; Klein C, 2012, JAMA-J AM MED ASSOC, V308, P1867, DOI 10.1001/2012.jama.10823; Kolata G, 2012, NY TIMES, pA1; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040	8	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					37	38		10.1001/jama.2012.70832	http://dx.doi.org/10.1001/jama.2012.70832			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280221				2022-12-28	WOS:000319113000023
J	Anderson, IM; Haddad, PM; Scott, J				Anderson, Ian M.; Haddad, Peter M.; Scott, Jan			Bipolar disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPECTRUM DISORDER; MOOD DISORDERS; LITHIUM; MANIA; DEPRESSION; METAANALYSIS; MAINTENANCE; GUIDELINES; THERAPY; PLACEBO		[Anderson, Ian M.; Haddad, Peter M.] Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England; [Haddad, Peter M.] Greater Manchester W Mental Hlth NHS Fdn Trust, Manchester, Lancs, England; [Scott, Jan] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Scott, Jan] Fdn Fondamental, Paris, France; [Scott, Jan] Univ Paris Est Creteil, Paris, France	University of Manchester; Newcastle University - UK; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Anderson, IM (corresponding author), Univ Manchester, Neurosci & Psychiat Unit, Manchester M13 9PT, Lancs, England.	ian.anderson@manchester.ac.uk	Scott, Jan/F-2966-2010	Scott, Jan/0000-0002-7203-8601; Hanstock, Tanya/0000-0002-8905-2231; Anderson, Ian M/0000-0003-2205-9209; Haddad, Peter/0000-0003-3383-9294	Lundbeck; Servier; AstraZeneca; Alkermes; Bristol-Myers Squibb; Eli Lilly; Janssen-Cilag; Otsuka	Lundbeck(Lundbeck Corporation); Servier(Servier); AstraZeneca(AstraZeneca); Alkermes; Bristol-Myers Squibb(Bristol-Myers Squibb); Eli Lilly(Eli Lilly); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Otsuka(Otsuka Pharmaceutical)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any third party for the submitted work; IMA has received expenses to attend conferences from Servier and a lecture fee from Lundbeck; his supporting institution has received unrestricted grants from Servier and AstraZeneca and consultancy fees from Servier and Alkermes; PMH has received expenses to attend conferences or fees for lecturing and consultancy work (including attending advisory boards) from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen-Cilag, Lundbeck, Otsuka, and Servier; JS has received expenses to attend conferences and she or her supporting institution have received fees for lecturing from AstraZeneca, Janssen-Cilag, Lundbeck, and Servier; her supporting institution has received an unrestricted grant from AstraZeneca.	Anaya C, 2012, J AFFECT DISORDERS, V142, P13, DOI 10.1016/j.jad.2012.04.020; Angst J, 2005, J AFFECT DISORDERS, V88, P217, DOI 10.1016/j.jad.2005.05.011; Benazzi F, 2007, PSYCHOTHER PSYCHOSOM, V76, P70, DOI 10.1159/000097965; Bora E, 2012, PSYCHOL MED; Cipriani A, 2005, AM J PSYCHIAT, V162, P1805, DOI 10.1176/appi.ajp.162.10.1805; Cipriani A, 2011, LANCET, V378, P1306, DOI 10.1016/S0140-6736(11)60873-8; Correa R, 2010, J AFFECT DISORDERS, V127, P10, DOI 10.1016/j.jad.2010.06.036; Dierckx B, 2012, BIPOLAR DISORD, V14, P146, DOI 10.1111/j.1399-5618.2012.00997.x; Duffy A, 2010, J AFFECT DISORDERS, V121, P127, DOI 10.1016/j.jad.2009.05.022; Etain B, 2008, BIPOLAR DISORD, V10, P867, DOI 10.1111/j.1399-5618.2008.00635.x; Geddes JR, 2010, LANCET, V375, P385, DOI 10.1016/S0140-6736(09)61828-6; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; GOODWIN GM, 1994, BRIT J PSYCHIAT, V164, P149, DOI 10.1192/bjp.164.2.149; Goodwin GM, 2004, J CLIN PSYCHIAT, V65, P432; Hirschfeld RMA, 2000, AM J PSYCHIAT, V157, P1873, DOI 10.1176/appi.ajp.157.11.1873; Hollon SD, 2010, DEPRESS ANXIETY, V27, P891, DOI 10.1002/da.20741; Howes OD, 2011, CURR PSYCHIAT REP, V13, P493, DOI 10.1007/s11920-011-0229-8; Johnson SL, 2011, ACTA PSYCHIAT SCAND, V123, P206, DOI 10.1111/j.1600-0447.2010.01602.x; Judd LL, 2003, INT J NEUROPSYCHOPH, V6, P127, DOI 10.1017/S1461145703003341; Latalova K, 2012, PSYCHIAT QUART, V83, P293, DOI 10.1007/s11126-011-9200-4; Malhi GS, 2010, BIPOLAR DISORD, V12, P758, DOI 10.1111/j.1399-5618.2010.00872.x; Martinowich K, 2009, J CLIN INVEST, V119, P726, DOI 10.1172/JCI37703; Merikangas KR, 2011, ARCH GEN PSYCHIAT, V68, P241, DOI 10.1001/archgenpsychiatry.2011.12; Miklowitz DJ, 2009, BIPOLAR DISORD, V11, P110, DOI 10.1111/j.1399-5618.2009.00715.x; Mitchell PB, 2008, BIPOLAR DISORD, V10, P144, DOI 10.1111/j.1399-5618.2007.00559.x; Muller-Oerlinghausen B, 2000, J CLIN PSYCHOPHARM, V20, P195, DOI 10.1097/00004714-200004000-00012; National Institute for Health and Clinical Excellence, 2006, BIP DIS MAN BIP DIS, pCG38; National Patient Safety Agency, 2009, NPSA2009PSA005; Nordentoft M, 2011, ARCH GEN PSYCHIAT, V68, P1058, DOI 10.1001/archgenpsychiatry.2011.113; Novick DM, 2010, BIPOLAR DISORD, V12, P1, DOI 10.1111/j.1399-5618.2009.00786.x; Roshanaei-Moghaddam B, 2009, PSYCHIAT SERV, V60, P147, DOI 10.1176/appi.ps.60.2.147; Sajatovic M, 2007, PSYCHIAT SERV, V58, P855, DOI 10.1176/appi.ps.58.6.855; Sharma V, 2012, J CLIN PSYCHIAT, V73, P1447, DOI 10.4088/JCP.11r07499; Sidor MM, 2011, J CLIN PSYCHIAT, V72, P156, DOI 10.4088/JCP.09r05385gre; Smith LA, 2007, ACTA PSYCHIAT SCAND, V115, P12, DOI 10.1111/j.1600-0447.2006.00912.x; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Tondo L, 2010, ACTA PSYCHIAT SCAND, V121, P404, DOI 10.1111/j.1600-0447.2009.01514.x; Treuer T, 2010, EUR PSYCHIAT, V25, P328, DOI 10.1016/j.eurpsy.2009.11.012; Vieta E, 2011, INT J NEUROPSYCHOPH, V14, P1029, DOI 10.1017/S1461145711000885; Vieta E, 2010, J CLIN PSYCHOPHARM, V30, P579, DOI 10.1097/JCP.0b013e3181f15849; Weisler RH, 2011, J CLIN PSYCHIAT, V72, P1452, DOI 10.4088/JCP.11m06878; Wittchen HU, 2003, INT J NEUROPSYCHOPH, V6, P145, DOI 10.1017/S146114570300333X; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x	43	118	123	3	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 27	2012	345								e8508	10.1136/bmj.e8508	http://dx.doi.org/10.1136/bmj.e8508			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	062PL	23271744				2022-12-28	WOS:000312931700011
J	Hartnett, ME; Penn, JS				Hartnett, M. Elizabeth; Penn, John S.			Mechanisms and Management of Retinopathy of Prematurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; PROLYL HYDROXYLASE INHIBITION; RETINAL NEOVASCULARIZATION; CELL-DIVISION; MOUSE MODEL; RAT MODEL; VITAMIN-E; INTRAVITREOUS NEOVASCULARIZATION; NEUTRALIZING ANTIBODY		[Hartnett, M. Elizabeth] Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT USA; [Hartnett, M. Elizabeth] Univ Utah, Moran Eye Ctr, Dept Pediat, Salt Lake City, UT USA; [Hartnett, M. Elizabeth] Univ Utah, Moran Eye Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Penn, John S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37212 USA; [Penn, John S.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Penn, John S.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Vanderbilt University; Vanderbilt University; Vanderbilt University	Hartnett, ME (corresponding author), 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	me.hartnett@hsc.utah.edu			Genentech; Axikin Pharmaceuticals; Alcon; PanOptica; NATIONAL EYE INSTITUTE [R01EY015130] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); Axikin Pharmaceuticals; Alcon(Novartis); PanOptica; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Dr. Hartnett reports receiving consulting fees and travel support from Genentech, royalties from Lippincott Williams and Wilkins, and consulting fees from Axikin Pharmaceuticals through her institution. Dr. Penn reports receiving payment for board membership from Janssen; consulting fees, as well as grant support through his institution, from Alcon; and consulting fees, as well as grant support through his institution, from PanOptica. No other potential conflict of interest relevant to this article was reported.	AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; ASHTON N, 1954, BRIT J OPHTHALMOL, V38, P397, DOI 10.1136/bjo.38.7.397; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Brown MS, 2009, PEDIATRICS, V124, pE681, DOI 10.1542/peds.2008-2701; Brown MS, 2006, J AAPOS, V10, P143, DOI 10.1016/j.jaapos.2005.09.005; Budd S, 2009, EXP EYE RES, V89, P718, DOI 10.1016/j.exer.2009.06.011; Buonocore G, 2001, BIOL NEONATE, V79, P180; Byfield G, 2009, INVEST OPHTH VIS SCI, V50, P3360, DOI 10.1167/iovs.08-3256; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; CHANLING TL, 1995, INVEST OPHTH VIS SCI, V36, P1201; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Zepeda-Romero LC, 2012, ARCH OPHTHALMOL-CHIC, V130, P720, DOI 10.1001/archophthalmol.2012.215; CUNNINGHAM S, 1995, LANCET, V346, P1464, DOI 10.1016/S0140-6736(95)92475-2; Dani Carlo, 2012, J Matern Fetal Neonatal Med, V25, P523, DOI 10.3109/14767058.2011.629252; El-Remessy AB, 2007, FASEB J, V21, P2528, DOI 10.1096/fj.06-7854com; Elsas FJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P417; Gariano RF, 2003, PROG RETIN EYE RES, V22, P295, DOI 10.1016/S1350-9462(02)00062-9; Geisen P, 2008, MOL VIS, V14, P345; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; Hardy P, 2005, PROSTAG LEUKOTR ESS, V72, P301, DOI 10.1016/j.plefa.2005.02.004; Hartnett ME, 2008, INVEST OPHTH VIS SCI, V49, P3107, DOI 10.1167/iovs.08-1780; Hasegawa T, 2008, INVEST OPHTH VIS SCI, V49, P2178, DOI 10.1167/iovs.07-0632; Hauspurg AK, 2011, NEONATOLOGY, V99, P104, DOI 10.1159/000308454; Hellstrom A, 2003, PEDIATRICS, V112, P1016, DOI 10.1542/peds.112.5.1016; Hellstrom A, 2009, PEDIATRICS, V123, pE638, DOI 10.1542/peds.2008-2697; Holmes JM, 1996, CURR EYE RES, V15, P403, DOI 10.3109/02713689608995831; Holmes JM, 1999, INVEST OPHTH VIS SCI, V40, P804; Holmes JM, 1998, CURR EYE RES, V17, P608, DOI 10.1076/ceyr.17.6.608.5176; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Hu J, 2012, ARCH OPHTHALMOL-CHIC, V130, P1000, DOI 10.1001/archophthalmol.2012.592; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; JIANG B, 1994, J CELL SCI, V107, P2499; Kermorvant-Duchemin E, 2005, NAT MED, V11, P1339, DOI 10.1038/nm1336; Lad EM, 2009, AM J OPHTHALMOL, V148, P451, DOI 10.1016/j.ajo.2009.04.018; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Loqvist C, 2009, ARCH OPHTHALMOL-CHIC, V127, P622, DOI 10.1001/archophthalmol.2009.69; Lutty GA, 2011, INVEST OPHTH VIS SCI, V52, P4039, DOI 10.1167/iovs.10-6798; Lutty GA, 2006, EXP EYE RES, V83, P183, DOI 10.1016/j.exer.2005.09.025; MCCONNELL J, 2005, P 6 INT CONS NEW DEV, P387; Michaelson I.C., 1948, T OPHTHALMOL SOC, V68, P137; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morita M, 2003, EMBO J, V22, P1134, DOI 10.1093/emboj/cdg117; Neu J, 2006, INVEST OPHTH VIS SCI, V47, P3151, DOI 10.1167/iovs.05-1473; NIELSEN JC, 1988, INVEST OPHTH VIS SCI, V29, P22; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; Ohlsson A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004863.pub2; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; PATZ A, 1953, AM J OPHTHALMOL, V36, P1511, DOI 10.1016/0002-9394(53)91779-6; PENN, 1995, PEDIATR RES, V37, P353; PENN JS, 1994, PEDIATR RES, V36, P724, DOI 10.1203/00006450-199412000-00007; Penn JS, 1997, FREE RADICAL BIO MED, V22, P977, DOI 10.1016/S0891-5849(96)00479-0; PENN JS, 1995, INVEST OPHTH VIS SCI, V36, P2063; Phelps DL, 2000, PEDIATRICS, V105, P295; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Raju TNK, 1997, J PEDIATR-US, V131, P844, DOI 10.1016/S0022-3476(97)70031-3; Randhawa R, 2005, MOL GENET METAB, V86, P84, DOI 10.1016/j.ymgme.2005.07.028; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Robinson GS, 1996, P NATL ACAD SCI USA, V93, P4851, DOI 10.1073/pnas.93.10.4851; Rogers S, 2000, ARCH PEDIAT ADOL MED, V154, P544, DOI 10.1001/archpedi.154.6.544; Saito Y, 2008, INVEST OPHTH VIS SCI, V49, P1591, DOI 10.1167/iovs.07-1356; Sato T, 2012, AM J OPHTHALMOL, V153, P327, DOI 10.1016/j.ajo.2011.07.005; Sears JE, 2008, P NATL ACAD SCI USA, V105, P19898, DOI 10.1073/pnas.0805817105; *SECT OPHTH AM AC, 2006, PEDIATRICS, V118, P1324; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Soghier LM, 2006, COCHRANE DB SYST REV, V4; Sone H, 1999, LIFE SCI, V65, P2573, DOI 10.1016/S0024-3205(99)00526-3; Stenson B, 2011, NEW ENGL J MED, V364, P1680, DOI 10.1056/NEJMc1101319; Terry TL., 1942, AM J OPHTHALMOL, V25, P203, DOI DOI 10.1016/S0002-9394(42)92088-9; Ueki Y, 2008, J NEUROCHEM, V105, P784, DOI 10.1111/j.1471-4159.2007.05180.x; Ushio-Fukai M, 2004, MOL CELL BIOCHEM, V264, P85, DOI 10.1023/B:MCBI.0000044378.09409.b5; Vanhaesebrouck S, 2009, PEDIATR RES, V65, P307, DOI 10.1203/PDR.0b013e3181973dc8; Wang HB, 2012, AM J PATHOL, V180, P1243, DOI 10.1016/j.ajpath.2011.11.031; Werdich XQ, 2004, EXP EYE RES, V79, P623, DOI 10.1016/j.exer.2004.07.006; Wu C, 2012, ARCH OPHTHALMOL-CHIC, V130, P992, DOI 10.1001/archophthalmol.2012.243; Yanni SE, 2009, INVEST OPHTH VIS SCI, V50, P5479, DOI 10.1167/iovs.09-3652; York Jackie R, 2004, J Perinatol, V24, P82, DOI 10.1038/sj.jp.7211040; Zaniolo K, 2011, INVEST OPHTH VIS SCI, V52, P5376, DOI 10.1167/iovs.10-7152; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	80	313	330	3	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2515	2526		10.1056/NEJMra1208129	http://dx.doi.org/10.1056/NEJMra1208129			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268666	Green Accepted			2022-12-28	WOS:000312714200009
J	Hamdan, A				Hamdan, Allen			Management of Varicose Veins and Venous Insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GREAT SAPHENOUS-VEIN; RANDOMIZED CLINICAL-TRIAL; ENDOVENOUS RADIOFREQUENCY OBLITERATION; COMPRESSION STOCKINGS; FOAM SCLEROTHERAPY; LASER-ABLATION; LEG VEINS; SOCIOECONOMIC IMPACT; PATIENT COMPLIANCE; SEED EXTRACT	Chronic venous disease, reviewed herein, is manifested by a spectrum of signs and symptoms, including cosmetic spider veins, asymptomatic varicosities, large painful varicose veins, edema, hyperpigmentation and lipodermatosclerosis of skin, and ulceration. However, there is no definitive stepwise progression from spider veins to ulcers and, in fact, severe skin complications of varicose veins, even when extensive, are not guaranteed. Treatment options range from conservative (eg, medications, compression stockings, lifestyle changes) to minimally invasive (eg, sclerotherapy or endoluminal ablation), invasive (surgical techniques), and hybrid (combination of >= 1 therapies). Ms L, a 68-year-old woman with varicose veins, is presented. She has had vein problems over the course of her life. Her varicose veins recurred after initial treatment, and she is now seeking guidance regarding her current treatment options. JAMA 2012;308(24):2612-2621	[Hamdan, Allen] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Hamdan, Allen] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hamdan, A (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 110 Francis St,Ste 5B, Boston, MA 02215 USA.	ahamdan@bidmc.harvard.edu						Almeida JI, 2009, J VASC INTERV RADIOL, V20, P752, DOI 10.1016/j.jvir.2009.03.008; Aremu MA, 2004, J VASC SURG, V39, P88, DOI 10.1016/j.jvs.2003.09.044; Babcock W., 1907, NYMEDJ, V86, P153; Baumler W, 2006, BRIT J DERMATOL, V155, P364, DOI 10.1111/j.1365-2133.2006.07314.x; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Bergan JJ, 2006, NEW ENGL J MED, V355, P488, DOI 10.1056/NEJMra055289; Breu FX, 2004, DERMATOL SURG, V30, P709, DOI 10.1111/j.1524-4725.2004.30209.x; BURNAND KG, 1981, BRIT J SURG, V68, P297, DOI 10.1002/bjs.1800680502; CALLAM MJ, 1994, BRIT J SURG, V81, P167, DOI 10.1002/bjs.1800810204; Campbell WB, 2003, ANN ROY COLL SURG, V85, P52, DOI 10.1308/003588403321001462; Carpentier PH, 2003, J VASC SURG, V37, P827, DOI 10.1067/mva.2003.147; Chiesa R, 2005, EUR J VASC ENDOVASC, V30, P674, DOI 10.1016/j.ejvs.2005.06.016; Christenson JT, 2010, J VASC SURG, V52, P1234, DOI 10.1016/j.jvs.2010.06.104; COGO A, 1994, ARCH INTERN MED, V154, P164, DOI 10.1001/archinte.154.2.164; CORNUTHENARD A, 1994, J DERMATOL SURG ONC, V20, P318, DOI 10.1111/j.1524-4725.1994.tb01631.x; Corrales NE, 2002, BRIT J SURG, V89, P323, DOI 10.1046/j.0007-1323.2001.02033.x; COX SJ, 1974, BRIT MED J, V1, P415, DOI 10.1136/bmj.1.5905.415; Critchley G, 1997, ANN ROY COLL SURG, V79, P105; Darwood RJ, 2008, BRIT J SURG, V95, P294, DOI 10.1002/bjs.6101; Dletzek AM, 2007, VASCULAR, V15, P255, DOI 10.2310/6670.2007.00062; Dwerryhouse S, 1999, J VASC SURG, V29, P589, DOI 10.1016/S0741-5214(99)70302-2; Eckmann DM, 2005, DERMATOL SURG, V31, P636, DOI 10.1097/00042728-200506000-00004; Eklof B, 2004, J VASC SURG, V40, P1248, DOI 10.1016/j.jvs.2004.09.027; Eldor A, 2001, THROMB HAEMOSTASIS, V86, P104; ElKaffas KH, 2011, ANGIOLOGY, V62, P49, DOI 10.1177/0003319710380680; Fernandez CF, 2008, J VASC SURG, V48, P947, DOI 10.1016/j.jvs.2008.05.029; Figueiredo M, 2009, EUR J VASC ENDOVASC, V38, P758, DOI 10.1016/j.ejvs.2009.07.015; Fischer R, 2002, J AM COLL SURGEONS, V195, P80, DOI 10.1016/S1072-7515(02)01188-2; Forlee MV, 2006, J VASC SURG, V43, P162, DOI 10.1016/j.jvs.2005.09.032; Franks PJ, 2001, QUAL LIFE RES, V10, P693, DOI 10.1023/A:1013825924765; FRANKS PJ, 1995, AGE AGEING, V24, P490, DOI 10.1093/ageing/24.6.490; Gale SS, 2010, J VASC SURG, V52, P645, DOI 10.1016/j.jvs.2010.04.030; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Gloviczki P, 2011, J VASC SURG, V53, p2S, DOI 10.1016/j.jvs.2011.01.079; Gohel MS, 2009, CURR VASC PHARMACOL, V7, P303, DOI 10.2174/157016109788340758; Goldman MP, 2002, DERMATOL SURG, V28, P52, DOI 10.1046/j.1524-4725.2002.01190.x; Goode SD, 2010, EUR J VASC ENDOVASC, V40, P246, DOI 10.1016/j.ejvs.2010.02.026; GOREN G, 1995, ANN VASC SURG, V9, P401, DOI 10.1007/BF02139415; Guex JJ, 2005, DERMATOL SURG, V31, P123, DOI 10.1097/00042728-200502000-00001; Hamel-Desnos C, 2009, PHLEBOLOGY, V24, P125, DOI 10.1258/phleb.2008.008040; Hamel-Desnos CM, 2010, EUR J VASC ENDOVASC, V39, P500, DOI 10.1016/j.ejvs.2009.11.027; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Hill SL, 2008, PHLEBOLOGY, V23, P35, DOI 10.1258/phleb.2007.007023; Ibegbuna V, 2003, J VASC SURG, V37, P420, DOI 10.1067/mva.2003.104; Jones L, 1996, EUR J VASC ENDOVASC, V12, P442, DOI 10.1016/S1078-5884(96)80011-6; Jull A B, 2004, J Wound Care, V13, P90; Junger M, 1994, Wien Med Wochenschr, V144, P206; Kanwar A, 2010, ANN ROY COLL SURG, V92, P341, DOI 10.1308/003588410X12518836440649; KATZ ML, 1994, J VASC SURG, V19, P361, DOI 10.1016/S0741-5214(94)70111-3; Keller WL, 1905, N Y MED J, V82, P385; Kern P, 2004, DERMATOL SURG, V30, P367, DOI 10.1111/j.1524-4725.2004.30102.x; Kern P, 2007, J VASC SURG, V45, P1212, DOI 10.1016/j.jvs.2007.02.039; KIEV J, 1990, ARCH PHYS MED REHAB, V71, P376; Kistner RL, 1996, MAYO CLIN PROC, V71, P338, DOI 10.4065/71.4.338; Kistner RL, 2009, HDB VENOUS DISORDERS, V3rd, P37; Kurz X, 1999, INT ANGIOL, V18, P83; Labropoulos N., 2003, PHLEBOLYMPHOLOGY, V40, P130; Langer RD, 2005, ARCH INTERN MED, V165, P1420, DOI 10.1001/archinte.165.12.1420; Laurikka JO, 2002, WORLD J SURG, V26, P648, DOI 10.1007/s00268-001-0283-1; Lawrence PF, 2010, J VASC SURG, V52, P388, DOI 10.1016/j.jvs.2010.02.263; Leach BC, 2003, DERMATOL SURG, V29, P612, DOI 10.1046/j.1524-4725.2003.29148.x; Lee AJ, 2003, J CLIN EPIDEMIOL, V56, P171, DOI 10.1016/S0895-4356(02)00518-8; Luebke T, 2008, J CARDIOVASC SURG, V49, P213; Luebke T, 2008, J CARDIOVASC SURG, V49, P757; Lurie F, 2003, J VASC SURG, V38, P207, DOI 10.1016/S0741-5214(03)00228-3; Mayo CH, 1906, SURG GYNECOL OBSTET, V2, P385; McGuckin M, 2002, AM J SURG, V183, P132, DOI 10.1016/S0002-9610(01)00856-X; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038; Merchant RF, 2005, J VASC SURG, V42, P502, DOI 10.1016/j.jvs.2005.05.007; Michaels J A, 2006, Health Technol Assess, V10, P1; Mordon SR, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-26; Morrison C, 2003, J VASC SURG, V38, P886, DOI 10.1016/S0741-5214(03)00790-0; Motykie GD, 1999, DERMATOL SURG, V25, P116, DOI 10.1046/j.1524-4725.1999.08095.x; MUNN SR, 1981, BRIT J SURG, V68, P426, DOI 10.1002/bjs.1800680621; Murad MH, 2011, J VASC SURG, V53, p49S, DOI 10.1016/j.jvs.2011.02.031; NEGUS D, 1993, BRIT J SURG, V80, P823, DOI 10.1002/bjs.1800800705; O'Hare JL, 2010, BRIT J SURG, V97, P650, DOI 10.1002/bjs.6951; Palfreyman SJ, 2009, PHLEBOLOGY, V24, P13, DOI 10.1258/phleb.2009.09s003; Passman Marc A, 2007, Vasc Endovascular Surg, V41, P41, DOI 10.1177/1538574406296207; Payne SPK, 1996, EUR J VASC ENDOVASC, V11, P195, DOI 10.1016/S1078-5884(96)80051-7; Perrin M, 2010, INT ANGIOL, V29, P303; Pittler MH, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003230.pub3; PORTER JM, 1995, J VASC SURG, V21, P635, DOI 10.1016/S0741-5214(95)70195-8; Proebstle TM, 2006, J VASC SURG, V44, P834, DOI 10.1016/j.jvs.2006.05.052; Raju S, 2007, ANN VASC SURG, V21, P790, DOI 10.1016/j.avsg.2007.07.014; Raju S, 2009, NEW ENGL J MED, V360, P2319, DOI 10.1056/NEJMcp0802444; Ramelet AA, 2001, ANGIOLOGY, V52, pS49, DOI 10.1177/0003319701052001S07; RIGBY KA, 2004, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD004980, 10.1002/14651858]; Ruckley CV, 2008, EUR J VASC ENDOVASC, V36, P719, DOI 10.1016/j.ejvs.2008.08.012; Ruckley CV, 1997, ANGIOLOGY, V48, P67, DOI 10.1177/000331979704800111; Sales CM, 1998, ANN VASC SURG, V12, P153, DOI 10.1007/s100169900133; Schanzer H, 2010, VASC ENDOVASC SURG, V44, P545, DOI 10.1177/1538574410375126; Scheltinga MR, 2007, WORLD J SURG, V31, P2236, DOI 10.1007/s00268-007-9211-3; Shepherd AC, 2010, BRIT J SURG, V97, P810, DOI 10.1002/bjs.7091; Siebert U, 2002, INT ANGIOL, V21, P305; Simini B, 1996, LANCET, V347, P1182; Sobreira ML, 2009, INT ANGIOL, V28, P400; Subramonia S, 2010, BRIT J SURG, V97, P328, DOI 10.1002/bjs.6867; Tessari L., 2000, PHLEBOLOGIE, P53; Thaler E, 2001, SWISS MED WKLY, V131, P659; Theivacumar NS, 2008, EUR J VASC ENDOVASC, V35, P119, DOI 10.1016/j.ejvs.2007.08.010; Tisi PV, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001732.pub2; van den Bos R, 2009, J VASC SURG, V49, P230, DOI 10.1016/j.jvs.2008.06.030; van den Bos RR, 2011, J VASC SURG, V53, P181, DOI 10.1016/j.jvs.2010.06.171; Van den Oever R, 1998, INT ANGIOL, V17, P161; van Rij AM, 2004, J VASC SURG, V40, P296, DOI 10.1016/j.jvs.2004.04.031	106	73	79	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2612	2621		10.1001/jama.2012.111352	http://dx.doi.org/10.1001/jama.2012.111352			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268520				2022-12-28	WOS:000312916600027
J	Lu, SJ; Zong, CH; Fan, W; Yang, MY; Li, JS; Chapman, AR; Zhu, P; Hu, XS; Xu, LY; Yan, LY; Bai, F; Qiao, J; Tang, FC; Li, RQ; Xie, XS				Lu, Sijia; Zong, Chenghang; Fan, Wei; Yang, Mingyu; Li, Jinsen; Chapman, Alec R.; Zhu, Ping; Hu, Xuesong; Xu, Liya; Yan, Liying; Bai, Fan; Qiao, Jie; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney			Probing Meiotic Recombination and Aneuploidy of Single Sperm Cells by Whole-Genome Sequencing	SCIENCE			English	Article							HOT-SPOTS; RATES; MAP; AMPLIFICATION; PATTERNS; MEN	Meiotic recombination creates genetic diversity and ensures segregation of homologous chromosomes. Previous population analyses yielded results averaged among individuals and affected by evolutionary pressures. We sequenced 99 sperm from an Asian male by using the newly developed amplification method-multiple annealing and looping-based amplification cycles-to phase the personal genome and map recombination events at high resolution, which are nonuniformly distributed across the genome in the absence of selection pressure. The paucity of recombination near transcription start sites observed in individual sperm indicates that such a phenomenon is intrinsic to the molecular mechanism of meiosis. Interestingly, a decreased crossover frequency combined with an increase of autosomal aneuploidy is observable on a global per-sperm basis.	[Fan, Wei; Yang, Mingyu; Li, Jinsen; Zhu, Ping; Hu, Xuesong; Xu, Liya; Bai, Fan; Tang, Fuchou; Li, Ruiqiang; Xie, X. Sunney] Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China; [Lu, Sijia; Zong, Chenghang; Chapman, Alec R.; Xie, X. Sunney] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Chapman, Alec R.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Yan, Liying; Qiao, Jie] Peking Univ, Ctr Reprod Med, Hosp 3, Beijing 100191, Peoples R China; [Yan, Liying; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Li, Ruiqiang] Peking Univ, Peking Tsinghua Ctr Life Sci, Sch Life Sci, Beijing 100871, Peoples R China	Peking University; Harvard University; Harvard University; Peking University; Peking University	Li, RQ (corresponding author), Peking Univ, Biodynam Opt Imaging Ctr, Sch Life Sci, Beijing 100871, Peoples R China.	lirq@pku.edu.cn; xie@chemistry.harvard.edu	Galaxy, Yuuki/S-4013-2017; Xu, Liya/AAV-5387-2021; Zong, Chenghang/F-3243-2013	Galaxy, Yuuki/0000-0002-7135-520X; Bai, Fan/0000-0001-6119-8936; Fan, Wei/0000-0001-5036-8733; Zhu, Ping/0000-0002-4521-7524; Zong, Chenghang/0000-0002-8337-8038	U.S. NIH National Human Genome Research Institute [HG005097-1, HG005613-01]; Peking University; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005097, RC2HG005613] Funding Source: NIH RePORTER	U.S. NIH National Human Genome Research Institute; Peking University(Peking University); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by U.S. NIH National Human Genome Research Institute grants (HG005097-1 and HG005613-01) to X. S. X. and by funding from Peking University to the Biodynamic Optical Imaging Center (BIOPIC). The computing was carried out at the National Supercomputer Center in Tianjin, China, and the calculations were performed on TianHe-1. We thank G. S. Young for assistance in sample prep and N. Kleckner and J. Zhang for critical comments on the manuscript. The sequencing data has been deposited with the National Center for Biotechnology Information; the accession number is SRA060945. C.Z., S.L., and X.S.X. are authors on a patent applied for by Harvard University that covers the MALBAC technology.	Auton A, 2012, SCIENCE, V336, P193, DOI 10.1126/science.1216872; Browning SR, 2011, NAT REV GENET, V12, P703, DOI 10.1038/nrg3054; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Downie SE, 1997, MOL HUM REPROD, V3, P815, DOI 10.1093/molehr/3.9.815; Epstein CJ., 2007, CONSEQUENCES CHROMOS; Fan HC, 2011, NAT BIOTECHNOL, V29, P51, DOI 10.1038/nbt.1739; Ferguson KA, 2007, HUM MOL GENET, V16, P2870, DOI 10.1093/hmg/ddm246; Fledel-Alon A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000658; Handel MA, 2010, NAT REV GENET, V11, P124, DOI 10.1038/nrg2723; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Kitzman JO, 2011, NAT BIOTECHNOL, V29, P59, DOI 10.1038/nbt.1740; Kleckner N, 2004, P NATL ACAD SCI USA, V101, P12592, DOI 10.1073/pnas.0402724101; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Ma L, 2010, NAT METHODS, V7, P299, DOI [10.1038/NMETH.1443, 10.1038/nmeth.1443]; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Paigen K, 2010, NAT REV GENET, V11, P221, DOI 10.1038/nrg2712; Peters BA, 2012, NATURE, V487, P190, DOI 10.1038/nature11236; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; SPRIGGS EL, 1995, CYTOGENET CELL GENET, V71, P47, DOI 10.1159/000134060; Suk EK, 2011, GENOME RES, V21, P1672, DOI 10.1101/gr.125047.111; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	36	219	256	2	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1627	1630		10.1126/science.1229112	http://dx.doi.org/10.1126/science.1229112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258895	Green Submitted, Green Accepted			2022-12-28	WOS:000312533100055
J	Teng, MW; Bolovan-Fritts, C; Dar, RD; Womack, A; Simpson, ML; Shenk, T; Weinberger, LS				Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Womack, Andrew; Simpson, Michael L.; Shenk, Thomas; Weinberger, Leor S.			An Endogenous Accelerator for Viral Gene Expression Confers a Fitness Advantage	CELL			English	Article							IMMEDIATE-EARLY PROMOTER; HUMAN CYTOMEGALOVIRUS; ENDOTHELIAL-CELLS; ESCHERICHIA-COLI; INFECTED CELLS; PROTEIN; TRANSCRIPTION; IE2; REPLICATION; BINDING	Many signaling circuits face a fundamental tradeoff between accelerating their response speed while maintaining final levels below a cytotoxic threshold. Here, we describe a transcriptional circuitry that dynamically converts signaling inputs into faster rates without amplifying final equilibrium levels. Using time-lapse microscopy, we find that transcriptional activators accelerate human cytomegalovirus (CMV) gene expression in single cells without amplifying steady-state expression levels, and this acceleration generates a significant replication advantage. We map the accelerator to a highly self-cooperative transcriptional negative-feedback loop (Hill coefficient similar to 7) generated by homomultimerization of the virus's essential transactivator protein IE2 at nuclear PML bodies. Eliminating the IE2-accelerator circuit reduces transcriptional strength through mislocalization of incoming viral genomes away from PML bodies and carries a heavy fitness cost. In general, accelerators may provide a mechanism for signal-transduction circuits to respond quickly to external signals without increasing steady-state levels of potentially cytotoxic molecules.	[Teng, Melissa W.; Bolovan-Fritts, Cynthia; Dar, Roy D.; Weinberger, Leor S.] Gladstone Inst, San Francisco, CA 94158 USA; [Teng, Melissa W.; Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Womack, Andrew; Shenk, Thomas] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Weinberger, Leor S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Diego; Princeton University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weinberger, LS (corresponding author), Gladstone Inst, San Francisco, CA 94158 USA.	leor.weinberger@gladstone.ucsf.edu	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888	NSF; Center for Nanophase Materials Sciences; US Department of Energy; NIH [R01CA85786, K25GM083395]; NIH Center for Systems Biology at Princeton University [P50GM71508]; NATIONAL CANCER INSTITUTE [R01CA085786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508, K25GM083395] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Center for Nanophase Materials Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center for Systems Biology at Princeton University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to J. Ferrell, L. Fortunato, M. Elowitz, E. Mocarski, D. Spector, T. Hwa, A. Hoffmann, R. Tsien, J. Nelson, C. Lilley, M. Weitzman, and R. Everett for providing reagents, equipment, helpful discussion, and critical review of previous versions of this manuscript. We thank S. Thiberge and the Lewis-Sigler Imaging Core for invaluable technical expertise. M.W.T. and A.W. acknowledge support from NSF Graduate Research Fellowships. M.L.S. acknowledges support from the Center for Nanophase Materials Sciences, sponsored by the US Department of Energy. T.S. received support from the NIH (R01CA85786) and the NIH Center for Systems Biology at Princeton University (P50GM71508). This work was supported by NIH award K25GM083395 (L.S.W.). L.S.W. conceived and designed the study. M.W.T., C.B.-F., and L.S.W. designed and performed the experiments. M.W.T., C.B.F., R.D.D., M.L.S., T.S. and L.S.W. analyzed the data. A.W. and T.S. provided reagents. M.W.T., C.B.F., and L.S.W. wrote the paper.	Alon U, 2007, INTRO SYSTEMS BIOL D; [Anonymous], 2006, CYTOMEGALOVIRUSES MO; Barrasa MI, 2005, J VIROL, V79, P1428, DOI 10.1128/JVI.79.3.1428-1437.2005; Black HS, 1999, P IEEE, V87, P379, DOI 10.1109/JPROC.1999.740032; Bolovan-Fritts C, 2001, J INFECT DIS, V184, P1252, DOI 10.1086/324010; Bolovan-Fritts CA, 2004, J VIROL, V78, P13173, DOI 10.1128/JVI.78.23.13173-13181.2004; Bresnahan WA, 2000, P NATL ACAD SCI USA, V97, P14506, DOI 10.1073/pnas.97.26.14506; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Carey M., 2009, TRANSCRIPTIONAL REGU; Cauwels A, 2007, ARCH BIOCHEM BIOPHYS, V462, P132, DOI 10.1016/j.abb.2007.01.021; CHEN J, 1994, J BIOL CHEM, V269, P12482; CHIOU CJ, 1993, J VIROL, V67, P6201, DOI 10.1128/JVI.67.10.6201-6214.1993; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Dwarakanath RS, 2001, VIROLOGY, V284, P297, DOI 10.1006/viro.2001.0924; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Fan SS, 2005, J VIROL METHODS, V125, P23, DOI 10.1016/j.jviromet.2004.11.023; Garcia-Pino A, 2010, CELL, V142, P101, DOI 10.1016/j.cell.2010.05.039; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gebert S, 1997, J VIROL, V71, P7048, DOI 10.1128/JVI.71.9.7048-7060.1997; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hofmann H, 2000, J VIROL, V74, P2510, DOI 10.1128/JVI.74.6.2510-2524.2000; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; Hummel M, 2002, J CLIN VIROL, V25, pS123; Isomura H, 2008, J VIROL, V82, P849, DOI 10.1128/JVI.01593-07; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MACIAS MP, 1993, P NATL ACAD SCI USA, V90, P707, DOI 10.1073/pnas.90.2.707; Mocarski E.S., 2006, FIELDS VIROLOGY, P2708; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nevels M, 2004, J VIROL, V78, P7803, DOI 10.1128/JVI.78.14.7803-7812.2004; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Rosenke K, 2004, J VIROL, V78, P7818, DOI 10.1128/JVI.78.14.7818-7822.2004; Roth J, 2006, NEUROL CLIN, V24, P421, DOI 10.1016/j.ncl.2006.03.004; RUNNELS LW, 1995, BIOPHYS J, V69, P1569, DOI 10.1016/S0006-3495(95)80030-5; Sanders RL, 2008, J VIROL, V82, P7059, DOI 10.1128/JVI.00675-08; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Sourvinos G, 2007, J VIROL, V81, P10123, DOI 10.1128/JVI.01009-07; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Stinski MF, 2008, MED MICROBIOL IMMUN, V197, P223, DOI 10.1007/s00430-007-0069-7; Weinberger LS, 2008, NAT GENET, V40, P466, DOI 10.1038/ng.116; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100	47	42	44	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1569	1580		10.1016/j.cell.2012.11.051	http://dx.doi.org/10.1016/j.cell.2012.11.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260143	Bronze, Green Accepted			2022-12-28	WOS:000312890300020
J	[Anonymous]				[Anonymous]			The Higgs Boson	SCIENCE			English	Editorial Material																			0	2	2	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1558	1558						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258885				2022-12-28	WOS:000312533100058
J	Ferraro, FR; Lanzoni, B; Dalessandro, E; Beccari, G; Pasquato, M; Miocchi, P; Rood, RT; Sigurdsson, S; Sills, A; Vesperini, E; Mapelli, M; Contreras, R; Sanna, N; Mucciarelli, A				Ferraro, F. R.; Lanzoni, B.; Dalessandro, E.; Beccari, G.; Pasquato, M.; Miocchi, P.; Rood, R. T.; Sigurdsson, S.; Sills, A.; Vesperini, E.; Mapelli, M.; Contreras, R.; Sanna, N.; Mucciarelli, A.			Dynamical age differences among coeval star clusters as revealed by blue stragglers	NATURE			English	Article							GALACTIC GLOBULAR-CLUSTERS; STELLAR COLLISIONS; OMEGA-CENTAURI; MAIN-SEQUENCE; 47 TUCANAE; POPULATION; MASS; CORE; SIMULATIONS; PARAMETERS	Globular star clusters that formed at the same cosmic time may have evolved rather differently from the dynamical point of view(because that evolution depends on the internal environment) through a variety of processes that tend progressively to segregate stars more massive than the average towards the cluster centre(1). Therefore clusters with the same chronological age may have reached quite different stages of their dynamical history (that is, they may have different 'dynamical ages'). Blue straggler stars have masses greater(2) than those at the turn-off point on the main sequence and therefore must be the result of either a collision(3,4) or a mass-transfer event(5-7). Because they are among the most massive and luminous objects in old clusters, they can be used as test particles with which to probe dynamical evolution. Here we report that globular clusters can be grouped into a few distinct families on the basis of the radial distribution of blue stragglers. This grouping corresponds well to an effective ranking of the dynamical stage reached by stellar systems, thereby permitting a direct measure of the cluster dynamical age purely from observed properties.	[Ferraro, F. R.; Lanzoni, B.; Dalessandro, E.; Pasquato, M.; Miocchi, P.; Contreras, R.; Sanna, N.; Mucciarelli, A.] Univ Bologna, Dept Phys & Astron, I-40127 Bologna, Italy; [Beccari, G.] European So Observ, D-85748 Garching, Germany; [Rood, R. T.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Sigurdsson, S.] Penn State Univ, Dept Astron & Astrophys, Davey Lab 525, University Pk, PA 16802 USA; [Sills, A.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Vesperini, E.] Indiana Univ, Dept Astron, Bloomington, IN 47405 USA; [Mapelli, M.] Osserv Astron Padova, INAF, I-35122 Padua, Italy	University of Bologna; European Southern Observatory; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; McMaster University; Indiana University System; Indiana University Bloomington; Istituto Nazionale Astrofisica (INAF); University of Padua	Ferraro, FR (corresponding author), Univ Bologna, Dept Phys & Astron, Viale Berti Pichat 6-2, I-40127 Bologna, Italy.	francesco.ferraro3@unibo.it	Mapelli, Michela/ABA-4708-2020; mucciarelli, alessio/ABG-9282-2020; Mapelli, Michela/B-1157-2013; Miocchi, Paolo/U-6428-2017	Mapelli, Michela/0000-0001-8799-2548; Mapelli, Michela/0000-0001-8799-2548; Sills, Alison/0000-0003-3551-5090; Beccari, Giacomo/0000-0002-3865-9906; Dalessandro, Emanuele/0000-0003-4237-4601; Sanna, Nicoletta/0000-0001-9275-9492; Miocchi, Paolo/0000-0002-8400-2139; Sigurdsson, Steinn/0000-0002-8187-1144; Mucciarelli, Alessio/0000-0001-9158-8580	European Research Council [ERC-2010-AdG-267675]; European Community [229517]; ESO Visiting Scientist Programme; Space Telescope Science Institute [GO-11975, GO-10524, GO-8709, GO-6607, GO-5903]; NASA [NAS5-26555]; ESO [62.L-0354, 64.L-0439, 59.A-002(A), 69.D-0582(A), 079.D-0220(A), 079.D-0782(A)]	European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); ESO Visiting Scientist Programme; Space Telescope Science Institute(Space Telescope Science Institute); NASA(National Aeronautics & Space Administration (NASA)); ESO	The authors dedicate this paper to the memory of co-author Bob Rood, a pioneer in the theory of the evolution of low mass stars and a friend who shared our enthusiasm for the BSS topic, who passed away on 2 November 2011. This research is part of the project COSMIC-LAB funded by the European Research Council (under contract ERC-2010-AdG-267675). G. B. acknowledges the European Community's Seventh Framework Programme under grant agreement no. 229517. F. R. F. acknowledges support from the ESO Visiting Scientist Programme. This research is based on data acquired with the NASA/ESA HST, under programmes GO-11975, GO-10524, GO-8709, GO-6607 and GO-5903 at the Space Telescope Science Institute, which is operated by AURA, Inc., under NASA contract NAS5-26555. The research is also based on data collected at the ESO telescopes under programmes 62.L-0354, 64.L-0439, 59.A-002(A), 69.D-0582(A), 079.D-0220(A) and 079.D-0782(A), and made use of the ESO/ST-ECF Science Archive facility, which is a joint collaboration of the European Southern Observatory and the Space Telescope - European Coordinating Facility.	Bekki K, 2003, MON NOT R ASTRON SOC, V346, pL11, DOI 10.1046/j.1365-2966.2003.07275.x; Binney J., 1987, GALACTIC DYNAMICS; Buzzoni A., 1986, SPECTRAL EVOLUTION G, P195; Davies MB, 2004, MON NOT R ASTRON SOC, V349, P129, DOI 10.1111/j.1365-2966.2004.07474.x; DJORGOVSKI S, 1993, ASTR SOC P, V50, P373; Dotter A, 2008, ASTRON J, V136, P1407, DOI 10.1088/0004-6256/136/4/1407; Ferraro FR, 2009, NATURE, V462, P1028, DOI 10.1038/nature08607; FERRARO FR, 1993, ASTRON J, V106, P2324, DOI 10.1086/116804; Ferraro FR, 2003, ASTROPHYS J, V595, P179, DOI 10.1086/377352; Ferraro FR, 1999, ASTRON J, V118, P1738, DOI 10.1086/301029; Ferraro FR, 2006, ASTROPHYS J, V638, P433, DOI 10.1086/498735; Geller AM, 2011, NATURE, V478, P356, DOI 10.1038/nature10512; Heggie DC, 2008, MON NOT R ASTRON SOC, V389, P1858, DOI 10.1111/j.1365-2966.2008.13702.x; HILLS JG, 1976, ASTROPHYS LETT COMM, V17, P87; KING IR, 1966, ASTRON J, V71, P64, DOI 10.1086/109857; Knigge C, 2009, NATURE, V457, P288, DOI 10.1038/nature07635; Lanzoni B, 2007, ASTROPHYS J, V668, pL139, DOI 10.1086/522927; Lanzoni B, 2007, ASTROPHYS J, V663, P267, DOI 10.1086/518592; Mapelli M, 2006, MON NOT R ASTRON SOC, V373, P361, DOI 10.1111/j.1365-2966.2006.11038.x; Mapelli M, 2004, ASTROPHYS J, V605, pL29, DOI 10.1086/386370; Mapelli M, 2009, MON NOT R ASTRON SOC, V396, P1771, DOI 10.1111/j.1365-2966.2009.14861.x; Marin-Franch A, 2009, ASTROPHYS J, V694, P1498, DOI 10.1088/0004-637X/694/2/1498; MCCREA WH, 1964, MON NOT R ASTRON SOC, V128, P147, DOI 10.1093/mnras/128.2.147; Meylan G, 1997, ASTRON ASTROPHYS REV, V8, P1, DOI 10.1007/s001590050008; Monelli M, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/2/157; Shara MM, 1997, ASTROPHYS J, V489, pL59, DOI 10.1086/310952; Sills A, 2002, MON NOT R ASTRON SOC, V332, P49, DOI 10.1046/j.1365-8711.2002.05266.x; Sollima A, 2008, ASTRON ASTROPHYS, V481, P701, DOI 10.1051/0004-6361:20079082; TRAGER SC, 1993, ASTR SOC P, V50, P347	29	142	142	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					393	395		10.1038/nature11686	http://dx.doi.org/10.1038/nature11686			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257880	Green Published, Green Submitted			2022-12-28	WOS:000312488200048
J	Gatenby, R				Gatenby, Robert			PERSPECTIVE Finding cancer's first principles	NATURE			English	Editorial Material									[Gatenby, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA; [Gatenby, Robert] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Integrated Math Oncol, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Gatenby, R (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Radiol, Tampa, FL 33682 USA.	robert.gatenby@moffitt.org							0	29	30	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S55	S55		10.1038/491S55a	http://dx.doi.org/10.1038/491S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320287	Bronze			2022-12-28	WOS:000311339800004
J	McEwen, BS				McEwen, Bruce S.			Hormones and the Social Brain	SCIENCE			English	Editorial Material							DNA METHYLATION; GLUCOCORTICOIDS; STRESS; PLASTICITY; RECEPTORS		Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA	Rockefeller University	McEwen, BS (corresponding author), Rockefeller Univ, Neuroendocrinol Lab, New York, NY 10065 USA.	mcewen@rockefeller.edu	McEwen, Bruce/Z-1630-2019					Ambroggi F, 2009, NAT NEUROSCI, V12, P247, DOI 10.1038/nn.2282; Barik J, 2013, SCIENCE, V339, P332, DOI 10.1126/science.1226767; Crudo A, 2012, ENDOCRINOLOGY, V153, P3269, DOI 10.1210/en.2011-2160; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; GOULD E, 1990, NEUROSCIENCE, V37, P367, DOI 10.1016/0306-4522(90)90407-U; Hill MN, 2010, PROG NEURO-PSYCHOPH, V34, P791, DOI 10.1016/j.pnpbp.2009.11.001; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Leuner B, 2012, HIPPOCAMPUS, V22, P861, DOI 10.1002/hipo.20947; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Niwa M, 2013, SCIENCE, V339, P335, DOI 10.1126/science.1226931; Okuda S, 2004, P NATL ACAD SCI USA, V101, P853, DOI 10.1073/pnas.0307803100; Popoli M, 2012, NAT REV NEUROSCI, V13, P22, DOI 10.1038/nrn3138; Prager EM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.286re5; SCHATZBERG AF, 1988, ANN NY ACAD SCI, V537, P462, DOI 10.1111/j.1749-6632.1988.tb42128.x; Spolidoro M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1323; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Yang XJ, 2012, BIOCHEM BIOPH RES CO, V420, P570, DOI 10.1016/j.bbrc.2012.03.035	18	16	17	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					279	280		10.1126/science.1233713	http://dx.doi.org/10.1126/science.1233713			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	071UW	23329037				2022-12-28	WOS:000313622000030
J	Colbert, JA; Adler, JN				Colbert, James A.; Adler, Jonathan N.			Sugar-Sweetened Beverages - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Farley T, 2012, NEW ENGL J MED, V367, P1464, DOI 10.1056/NEJMclde1210278	1	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3								10.1056/NEJMclde1215057	http://dx.doi.org/10.1056/NEJMclde1215057			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YG	23323923				2022-12-28	WOS:000313549900015
J	Reignier, J; Mercier, E; Le Gouge, A; Boulain, T; Desachy, A; Bellec, F; Clavel, M; Frat, JP; Plantefeve, G; Quenot, JP; Lascarrou, JB				Reignier, Jean; Mercier, Emmanuelle; Le Gouge, Amelie; Boulain, Thierry; Desachy, Arnaud; Bellec, Frederic; Clavel, Marc; Frat, Jean-Pierre; Plantefeve, Gaetan; Quenot, Jean-Pierre; Lascarrou, Jean-Baptiste		Clinical Res Intensive Care Sepsis	Effect of Not Monitoring Residual Gastric Volume on Risk of Ventilator-Associated Pneumonia in Adults Receiving Mechanical Ventilation and Early Enteral Feeding A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; NOSOCOMIAL PNEUMONIA; NUTRITION SUPPORT; ICU PATIENTS; COLONIZATION; INTOLERANCE; GUIDELINES; NONINFERIORITY; ERYTHROMYCIN	Importance Monitoring of residual gastric volume is recommended to prevent ventilator-associated pneumonia (VAP) in patients receiving early enteral nutrition. However, studies have challenged the reliability and effectiveness of this measure. Objective To test the hypothesis that the risk of VAP is not increased when residual gastric volume is not monitored compared with routine residual gastric volume monitoring in patients receiving invasive mechanical ventilation and early enteral nutrition. Design, Setting, and Patients Randomized, noninferiority, open-label, multi-center trial conducted from May 2010 through March 2011 in adults requiring invasive mechanical ventilation for more than 2 days and given enteral nutrition within 36 hours after intubation at 9 French intensive care units (ICUs); 452 patients were randomized and 449 included in the intention-to-treat analysis (3 withdrew initial consent). Intervention Absence of residual gastric volume monitoring. Intolerance to enteral nutrition was based only on regurgitation and vomiting in the intervention group and based on residual gastric volume greater than 250 mL at any of the 6 hourly measurements and regurgitation or vomiting in the control group. Main Outcome Measures Proportion of patients with at least 1 VAP episode within 90 days after randomization, as assessed by an adjudication committee blinded to patient group. The prestated noninferiority margin was 10%. Results In the intention-to-treat population, VAP occurred in 38 of 227 patients (16.7%) in the intervention group and in 35 of 222 patients (15.8%) in the control group (difference, 0.9%; 90% CI, -4.8% to 6.7%). There were no significant between-group differences in other ICU-acquired infections, mechanical ventilation duration, ICU stay length, or mortality rates. The proportion of patients receiving 100% of their calorie goal was higher in the intervention group (odds ratio, 1.77; 90% CI, 1.25-2.51; P =. 008). Similar results were obtained in the per-protocol population. Conclusion and Relevance Among adults requiring mechanical ventilation and receiving early enteral nutrition, the absence of gastric volume monitoring was not inferior to routine residual gastric volume monitoring in terms of development of VAP.	[Reignier, Jean; Lascarrou, Jean-Baptiste] Dist Hosp Ctr, Med Surg Intens Care Unit, La Roche Sur Yon, France; [Reignier, Jean] Univ Med, Nantes, France; [Mercier, Emmanuelle] Univ Hosp, Med Intens Care Unit, Tours, France; [Le Gouge, Amelie] INSERM, CIC 0202, Tours, France; [Le Gouge, Amelie] CHRU Tours, Tours, France; [Boulain, Thierry] Dist Hosp Ctr, Med Intens Care Unit, Orleans, France; [Desachy, Arnaud] Dist Hosp Ctr, Med Surg Intens Care Unit, Angouleme, France; [Bellec, Frederic] Dist Hosp Ctr, Med Surg Intens Care Unit, Montauban, France; [Clavel, Marc] Univ Hosp, Med Surg Intens Care Unit, Limoges, France; [Frat, Jean-Pierre] Univ Hosp, Med Intens Care Unit, Poitiers, France; [Plantefeve, Gaetan] Dist Hosp Ctr, Med Surg Intens Care Unit, Argenteuil, France; [Quenot, Jean-Pierre] Univ Hosp, Med Intens Care Unit, Dijon, France	CHD Vendee; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Tours; Centre Hospitalier Regional d'Orleans; CHU Limoges; CHU Poitiers; CHU Dijon Bourgogne	Reignier, J (corresponding author), Ctr Hosp Dept Vendee, Serv Reanimat, F-85000 La Roche Sur Yon, France.	jean.reignier@chd-vendee.fr	Boulain, Thierry/M-3309-2019; Giraudeau, Bruno/L-9003-2015; Lascarrou, Jean Baptiste/I-4079-2014; François, Bruno/O-8404-2016	Boulain, Thierry/0000-0003-4664-3661; Giraudeau, Bruno/0000-0003-3031-8258; Lascarrou, Jean Baptiste/0000-0003-3706-078X; François, Bruno/0000-0002-2531-1652; Ehrmann, Stephan/0000-0001-6221-4467; QUENOT, Jean-Pierre/0000-0003-2351-682X	Centre Hospitalier Departemental de la Vendee	Centre Hospitalier Departemental de la Vendee	The Centre Hospitalier Departemental de la Vendee was the study sponsor.	Abraha I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2697; Adam S, 1997, INTENS CARE MED, V23, P261, DOI 10.1007/s001340050326; Artinian V, 2006, CHEST, V129, P960, DOI 10.1378/chest.129.4.960; Binnekade JM, 2005, CRIT CARE, V9, pR218, DOI 10.1186/cc3504; Bonten MJM, 2011, AM J RESP CRIT CARE, V184, P991, DOI 10.1164/rccm.201108-1537ED; Bonten MJM, 1996, AM J RESP CRIT CARE, V154, P394, DOI 10.1164/ajrccm.154.2.8756812; Bonten MJM, 1997, CLIN INFECT DIS, V24, P309, DOI 10.1093/clinids/24.3.309; BONTEN MJM, 1995, AM J RESP CRIT CARE, V152, P1825, DOI 10.1164/ajrccm.152.6.8520743; Bouadma L, 2010, CRIT CARE MED, V38, P789, DOI 10.1097/CCM.0b013e3181ce21af; Chang WK, 2007, JPEN-PARENTER ENTER, V31, P63, DOI 10.1177/014860710703100163; Chang WK, 2004, JPEN-PARENTER ENTER, V28, P105, DOI 10.1177/0148607104028002105; Chang WK, 2004, CLIN NUTR, V23, P105, DOI 10.1016/S0261-5614(03)00101-8; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cook, 1997, Crit Care, V1, P3, DOI 10.1186/cc1; Cook D, 1998, NEW ENGL J MED, V338, P791, DOI 10.1056/NEJM199803193381203; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Deane A, 2007, WORLD J GASTROENTERO, V13, P3909, DOI 10.3748/wjg.v13.i29.3909; Desachy A, 2008, INTENS CARE MED, V34, P1054, DOI 10.1007/s00134-007-0983-6; Drakulovic MB, 1999, LANCET, V354, P1851, DOI 10.1016/S0140-6736(98)12251-1; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; GarrousteOrgeas M, 1997, AM J RESP CRIT CARE, V156, P1647, DOI 10.1164/ajrccm.156.5.96-04076; Heyland DK, 1999, CRIT CARE MED, V27, P2399, DOI 10.1097/00003246-199911000-00013; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; JACOBS S, 1990, JPEN-PARENTER ENTER, V14, P353, DOI 10.1177/0148607190014004353; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Labeau SO, 2011, LANCET INFECT DIS, V11, P845, DOI 10.1016/S1473-3099(11)70127-X; Le Henanff A, 2006, JAMA-J AM MED ASSOC, V295, P1147, DOI 10.1001/jama.295.10.1147; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Mallampalli A, 2000, CLIN NUTR, V19, P213, DOI 10.1054/clnu.2000.0137; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; MCCLAVE SA, 1992, JPEN-PARENTER ENTER, V16, P99, DOI 10.1177/014860719201600299; McClave SA, 1999, CRIT CARE MED, V27, P1252, DOI 10.1097/00003246-199907000-00003; McClave SA, 2005, CRIT CARE MED, V33, P324, DOI 10.1097/01.CCM.0000153413.46627.3A; McClave Stephen A., 2002, Journal of Parenteral and Enteral Nutrition, V26, pS43, DOI 10.1177/014860710202600607; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Mentec H, 2001, CRIT CARE MED, V29, P1955, DOI 10.1097/00003246-200110000-00018; Metheny NA, 2005, JPEN-PARENTER ENTER, V29, P192, DOI 10.1177/0148607105029003192; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Montejo JC, 1999, CRIT CARE MED, V27, P1447, DOI 10.1097/00003246-199908000-00006; Nguile-Makao M, 2010, INTENS CARE MED, V36, P781, DOI 10.1007/s00134-010-1824-6; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pinilla JC, 2001, JPEN-PARENTER ENTER, V25, P81, DOI 10.1177/014860710102500281; Poulard F, 2010, JPEN-PARENTER ENTER, V34, P125, DOI 10.1177/0148607109344745; POWELL KS, 1993, JPEN-PARENTER ENTER, V17, P243, DOI 10.1177/0148607193017003243; Reignier J, 2002, CRIT CARE MED, V30, P1237, DOI 10.1097/00003246-200206000-00012; Rello J, 2013, CLIN MICROBIOL INFEC, V19, P363, DOI 10.1111/j.1469-0691.2012.03808.x; Rello J, 2010, INTENS CARE MED, V36, P773, DOI 10.1007/s00134-010-1841-5; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2005, NUTRITION, V21, P786, DOI 10.1016/j.nut.2004.11.014; Ritz MA, 2005, INTENS CARE MED, V31, P949, DOI 10.1007/s00134-005-2663-8; Ritz MA, 2001, CRIT CARE MED, V29, P1744, DOI 10.1097/00003246-200109000-00015; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Safdar Nasia, 2005, Respir Care, V50, P725; Schumi J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-106; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TORRES A, 1992, ANN INTERN MED, V116, P540, DOI 10.7326/0003-4819-116-7-540; van Nieuwenhoven CA, 2006, CRIT CARE MED, V34, P396, DOI 10.1097/01.CCM.0000198529.76602.5E; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Zaloga GP, 2005, CRIT CARE MED, V33, P449, DOI 10.1097/01.CCM.0000148086.12949.2F; Zanella A, 2012, INTENS CARE MED, V38, P677, DOI 10.1007/s00134-012-2495-2	61	299	327	2	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					249	256		10.1001/jama.2012.196377	http://dx.doi.org/10.1001/jama.2012.196377			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321763	Bronze			2022-12-28	WOS:000313546800025
J	Greysen, SR; Johnson, D; Kind, T; Chretien, KC; Gross, CP; Young, A; Chaudhry, HJ				Greysen, S. Ryan; Johnson, David; Kind, Terry; Chretien, Katherine C.; Gross, Cary P.; Young, Aaron; Chaudhry, Humayun J.			Online Professionalism Investigations by State Medical Boards: First, Do No Harm	ANNALS OF INTERNAL MEDICINE			English	Article							SOCIAL NETWORKING; PHYSICIANS; PERCEPTIONS; AGE	Despite recent guidelines promoting online professionalism, consequences for specific violations by physicians have not been explored. In this article, the authors gauged consensus among state medical boards in the United States (response rate, 71%) about the likelihood of investigations for violations of online professionalism by using 10 hypothetical vignettes. High consensus was defined as more than 75% of respondents indicating that investigation was "likely" or " very likely," moderate consensus as 50% to 75% indicating this, and low consensus as fewer than 50% indicating this. Four online vignettes demonstrated high consensus: Citing misleading information about clinical outcomes (81%; 39/48), using patient images without consent (79%; 38/48), misrepresenting credentials (77%; 37/48), and inappropriately contacting patients (77%; 37/48). Three demonstrated moderate consensus for investigation: depicting alcohol intoxication (73%; 35/48), violating patient confidentiality (65%; 31/48), and using discriminatory speech (60%; 29/48). Three demonstrated low consensus: using derogatory speech toward patients (46%; 22/48), showing alcohol use without intoxication (40%; 19/48), and providing clinical narratives without violation of confidentiality (16%; 7/48). Areas of high consensus suggest "online behaviors" that physicians should never engage in, whereas moderate-and low-consensus areas provide useful contextual information about "gray areas." Increased awareness of these specific behaviors may reduce investigations and improve online professionalism for physicians.	[Greysen, S. Ryan] Univ Calif San Francisco, Div Hosp Med, Sch Med, San Francisco, CA 94113 USA; Federat State Med Boards, Euless, TX USA; George Washington Univ, Childrens Natl Med Ctr, Sch Med, Washington, DC USA; Washington DC Vet Affairs Med Ctr, Washington, DC USA; Yale Univ, Sch Med, New Haven, CT USA; Univ Texas SW Med Sch, Dallas, TX USA	University of California System; University of California San Francisco; Children's National Health System; George Washington University; Yale University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Greysen, SR (corresponding author), Univ Calif San Francisco, Div Hosp Med, Sch Med, 533 Parnassus Ave,Box 0131, San Francisco, CA 94113 USA.	Ryan.Greysen@ucsf.edu		Kind, Terry/0000-0002-3017-5683	Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	The authors thank the Robert Wood Johnson Foundation Clinical Scholars program and the Department of Veterans Affairs for support of this research. They also thank the key informants at state medical boards and the FSMB for their valuable insight into the structure and function of state medical and osteopathic boards.	American Medical Association, AMA POL PROF US SOC; American Medical Association, 2001, AMA COD MED ETH; Chretien KC, 2011, ACAD MED, V86, P1545, DOI 10.1097/ACM.0b013e3182356128; Chretien KC, 2011, JAMA-J AM MED ASSOC, V305, P566, DOI 10.1001/jama.2011.68; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; CNN.com, 2010, CNN             0129; Edelstein L., 1943, B HIST MED S, V1; Farnan JM, 2010, AJOB PRIM RES, V1, P3, DOI [DOI 10.1080/21507711003697527, 10.1080/21507711003697527]; Federation of State Medical Boards, ADDR SEX BOUNDR GUID; Federation of State Medical Boards, MOD POL GUID APPR US MOD POL GUID APPR US; Federation of State Medical Boards, 2011, POL PHYS IMP FED STA; Federation of State Medical Boards, 2012, ESS MOD MED OST PRAC; Federation of State Medical Boards of the United States Inc, 2002, MOD GUID APPR US INT; Greysen SR, 2012, JAMA-J AM MED ASSOC, V307, P1141, DOI 10.1001/jama.2012.330; Greysen SR, 2010, J GEN INTERN MED, V25, P1227, DOI 10.1007/s11606-010-1447-1; Guseh JS, 2009, J MED ETHICS, V35, P584, DOI 10.1136/jme.2009.029231; Herrin Barry, 2012, J Med Pract Manage, V27, P275; Jain SH, 2009, NEW ENGL J MED, V361, P649, DOI 10.1056/NEJMp0901277; Khaliq AA, 2005, AM J MED, V118, P773, DOI 10.1016/j.amjmed.2005.01.051; Kind T, 2012, ACAD PEDIATR, V12, P142, DOI 10.1016/j.acap.2011.12.003; Lagu T, 2008, J GEN INTERN MED, V23, P1642, DOI 10.1007/s11606-008-0726-6; Lagu T, 2011, J CLIN ETHIC, V22, P187; Lenhart A., 2009, AD SOC NETW WEBS; Morrison J, 1998, JAMA-J AM MED ASSOC, V279, P1889, DOI 10.1001/jama.279.23.1889; Mostaghimi A, 2011, ANN INTERN MED, V154, P560, DOI 10.7326/0003-4819-154-8-201104190-00008; Page ES, 2010, NBC NEWS        0608; Shore R, 2011, J CLIN ETHIC, V22, P165; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8; Thompson LA, 2011, J MED INTERNET RES, V13, P3, DOI 10.2196/jmir.1590; Young A, 2011, J MED REGUL, V96, P10	32	29	29	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					124	+		10.7326/0003-4819-158-2-201301150-00008	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318312				2022-12-28	WOS:000314029400019
J	Odegaard, JI; Chawla, A				Odegaard, Justin I.; Chawla, Ajay			Pleiotropic Actions of Insulin Resistance and Inflammation in Metabolic Homeostasis	SCIENCE			English	Review							DIET-INDUCED OBESITY; ADIPOSE-TISSUE; PPAR-GAMMA; MACROPHAGE POLARIZATION; ENERGY-BALANCE; KUPFFER CELLS; BROWN BEARS; FATTY-ACID; T-CELLS; STRESS	Metabolism and immunity are inextricably linked both to each other and to organism-wide function, allowing mammals to adapt to changes in their internal and external environments. In the modern context of obesogenic diets and lifestyles, however, these adaptive responses can have deleterious consequences. In this Review, we discuss the pleiotropic actions of inflammation and insulin resistance in metabolic homeostasis and disease. An appreciation of the adaptive context in which these responses arose is useful for understanding their pathogenic actions in disease.	[Odegaard, Justin I.; Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chawla, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	ajay.chawla@ucsf.edu			NIH [HL076746, DK094641]; Larry L. Hillblom Foundation Network Grant; Diabetes Family Fund (University of California, San Francisco); American Heart Association Innovative Award [12PILT11840038]; NIH Director's Pioneer Award [DP1AR064158]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [DP1AR064158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081405, R01DK094641] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006415] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation Network Grant; Diabetes Family Fund (University of California, San Francisco); American Heart Association Innovative Award; NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors' work was supported by grants from NIH (HL076746, DK094641), Larry L. Hillblom Foundation Network Grant, Diabetes Family Fund (University of California, San Francisco), American Heart Association Innovative Award (12PILT11840038), and an NIH Director's Pioneer Award (DP1AR064158) to A. C. Because of space limitations, we regret that we are unable to cite all relevant publications on this topic from our colleagues. The authors declare that they have no competing financial interests.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Arinell K, 2012, CTS-CLIN TRANSL SCI, V5, P269, DOI 10.1111/j.1752-8062.2011.00370.x; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; BOGARDUS C, 1984, J CLIN INVEST, V73, P800, DOI 10.1172/JCI111274; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; CRANFORD JA, 1983, COMP BIOCHEM PHYS A, V74, P595, DOI 10.1016/0300-9629(83)90553-4; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hall JE, 2020, GUYTON HALL TXB MED; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Martin SL, 2008, DIABETES VASC DIS RE, V5, P76, DOI 10.3132/dvdr.2008.013; Mominoki K, 2005, COMP BIOCHEM PHYS A, V142, P472, DOI 10.1016/j.cbpa.2005.09.017; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Brien PE, 2006, ANN INTERN MED, V144, P625, DOI 10.7326/0003-4819-144-9-200605020-00005; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Power ML, 2012, PHYSIOL BEHAV, V106, P22, DOI 10.1016/j.physbeh.2011.09.011; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Ravichandran KS, 2011, IMMUNITY, V35, P445, DOI 10.1016/j.immuni.2011.09.004; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenbaum M, 2010, BRAIN RES, V1350, P95, DOI 10.1016/j.brainres.2010.05.062; Saltiel AR, 2012, CELL METAB, V15, P798, DOI 10.1016/j.cmet.2012.03.001; Samocha-Bonet D, 2012, TRENDS ENDOCRIN MET, V23, P116, DOI 10.1016/j.tem.2011.12.005; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tremblay ME, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000527; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	65	466	502	8	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					172	177		10.1126/science.1230721	http://dx.doi.org/10.1126/science.1230721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307735	Green Accepted			2022-12-28	WOS:000313328200036
J	Lee, SJ; Boscardin, WJ; Stijacic-Cenzer, I; Conell-Price, J; O'Brien, S; Walter, LC				Lee, Sei J.; Boscardin, W. John; Stijacic-Cenzer, Irena; Conell-Price, Jessamyn; O'Brien, Sarah; Walter, Louise C.			Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; AGE 40; MORTALITY; MAMMOGRAPHY; TRIAL; SIGMOIDOSCOPY; WOMEN	Objectives To determine a pooled, quantitative estimate of the length of time needed after breast or colorectal cancer screening before a survival benefit is observed. Design Meta-analysis of survival data from population based, randomized controlled trials comparing populations screened and not screened for breast or colorectal cancer. Trials were identified as high quality by reviews from the Cochrane Collaboration and United States Preventive Services Task Force. Setting Trials undertaken in the United States, Denmark, United Kingdom, and Sweden. Population Screened patients older than 40 years. Primary outcome measures Time to death from breast or colorectal cancer in screened and control populations. Interventions Fecal occult blood testing for colorectal cancer screening, mammography for breast cancer screening. Results Our study included five and four eligible trials of breast and colorectal cancer screening, respectively. For breast cancer screening, 3.0 years (95% confidence interval 1.1 to 6.3) passed before one death from breast cancer was prevented for every 5000 women screened. On average across included studies, it took 10.7 years (4.4 to 21.6) before one death from breast cancer was prevented for 1000 women screened. For colorectal cancer screening, 4.8 years (2.0 to 9.7) passed before one death from colorectal cancer was prevented for 5000 patients screened. On average across included studies, it took 10.3 years (6.0 to 16.4) before one death from colorectal cancer was prevented for 1000 patients screened. Conclusions Our results suggest that screening for breast and colorectal cancer is most appropriate for patients with a life expectancy greater than 10 years. Incorporating time lag estimates into screening guidelines would encourage a more explicit consideration of the risks and benefits of screening for breast and colorectal cancer.	[Lee, Sei J.; Stijacic-Cenzer, Irena; Walter, Louise C.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA; [Boscardin, W. John] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94121 USA; [Conell-Price, Jessamyn] Univ Calif San Francisco & Berkeley, Joint Med Program, San Francisco, CA USA; [O'Brien, Sarah] Univ Calif San Francisco, AIDS Educ & Training Evaluat Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lee, SJ (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Div Geriatr, San Francisco, CA 94121 USA.	sei.lee@ucsf.edu			Veterans Affairs Medical Center, San Francisco, CA; San Francisco Veterans Affairs Medical Center; Division of Geriatrics, University of California, San Francisco; Hartford Geriatrics Health Outcomes Research Scholars Award; Hellman Family Award for Early Career Faculty at University of California (San Francisco); American Federation of Aging Research and National Institute on Aging [K23AG040779]; National Center for Research Resources, National Institutes of Health [KL2RR024130]; National Institute on Aging [K24AG041180]; National Cancer Institute [R01CA134425]; NATIONAL CANCER INSTITUTE [R01CA134425] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG040779, K24AG041180] Funding Source: NIH RePORTER	Veterans Affairs Medical Center, San Francisco, CA; San Francisco Veterans Affairs Medical Center; Division of Geriatrics, University of California, San Francisco; Hartford Geriatrics Health Outcomes Research Scholars Award; Hellman Family Award for Early Career Faculty at University of California (San Francisco); American Federation of Aging Research and National Institute on Aging; National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Veterans Affairs Medical Center, San Francisco, CA. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: support from the San Francisco Veterans Affairs Medical Center and Division of Geriatrics, University of California, San Francisco for the submitted work; SJL was supported by Hartford Geriatrics Health Outcomes Research Scholars Award, the Hellman Family Award for Early Career Faculty at University of California (San Francisco), K23AG040779 from the American Federation of Aging Research and National Institute on Aging, and KL2RR024130 from the National Center for Research Resources, a component of the National Institutes of Health; LCW was supported by R01CA134425 from the National Cancer Institute and K24AG041180 from the National Institute on Aging administered by the Northern California Institute for Research and Education; no financial relationships with any organizations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.	Alexander FE, 1999, LANCET, V353, P1903, DOI 10.1016/S0140-6736(98)07413-3; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Andersson I, 1997, J Natl Cancer Inst Monogr, P63; [Anonymous], 2000, J AM GERIATR SOC, V48, P333; Arends LR, 2008, STAT MED, V27, P4381, DOI 10.1002/sim.3311; ARON JL, 1986, INT J EPIDEMIOL, V15, P36, DOI 10.1093/ije/15.1.36; Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bell FC, 2005, LIFE TABLES US SOCIA; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Centers for Disease Control and Prevention, 2009, VIT STAT REP DEATHS; Earle CC, 2000, MED DECIS MAKING, V20, P104, DOI 10.1177/0272989X0002000113; Eurostat, EUR COMM POP STAT; Fiocco M, 2009, STAT MED, V28, P3782, DOI 10.1002/sim.3752; Frisell J, 1997, BREAST CANCER RES TR, V45, P263, DOI 10.1023/A:1005872617944; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; LANG CA, 1994, JAMA-J AM MED ASSOC, V271, P1011, DOI 10.1001/jama.271.13.1011; Lee SJ, 2006, JAMA-J AM MED ASSOC, V295, P801, DOI 10.1001/jama.295.7.801; Lindholm E, 2008, BRIT J SURG, V95, P1029, DOI 10.1002/bjs.6136; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Messori A, 2000, CLIN DRUG INVEST, V20, P309, DOI 10.2165/00044011-200020050-00002; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Nelson HD, 2009, PUBLICATION AGENCY H, P1; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Quanstrum KH, 2010, NEW ENGL J MED, V363, P1076, DOI 10.1056/NEJMsb1002538; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Siontis GCM, 2011, ARCH INTERN MED, V171, P1721, DOI 10.1001/archinternmed.2011.334; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Walter LC, 2001, J GEN INTERN MED, V16, P779, DOI 10.1046/j.1525-1497.2001.10113.x; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Whitlock EP, 2008, AHRQ PUBLICATION, V65, P1; Yourman LC, 2012, JAMA-J AM MED ASSOC, V307, P182, DOI 10.1001/jama.2011.1966	43	137	140	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8441	10.1136/bmj.e8441	http://dx.doi.org/10.1136/bmj.e8441			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299842	Green Published, hybrid			2022-12-28	WOS:000313553800014
J	Quoidbach, J; Gilbert, DT; Wilson, TD				Quoidbach, Jordi; Gilbert, Daniel T.; Wilson, Timothy D.			The End of History Illusion	SCIENCE			English	Article							MECHANICAL TURK; AVAILABILITY; CONSTRUCTION; FUTURE	We measured the personalities, values, and preferences of more than 19,000 people who ranged in age from 18 to 68 and asked them to report how much they had changed in the past decade and/or to predict how much they would change in the next decade. Young people, middle-aged people, and older people all believed they had changed a lot in the past but would change relatively little in the future. People, it seems, regard the present as a watershed moment at which they have finally become the person they will be for the rest of their lives. This "end of history illusion" had practical consequences, leading people to overpay for future opportunities to indulge their current preferences.	[Quoidbach, Jordi; Gilbert, Daniel T.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Quoidbach, Jordi] Natl Fund Sci Res, Brussels, Belgium; [Wilson, Timothy D.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA	Harvard University; Fonds de la Recherche Scientifique - FNRS; University of Virginia	Gilbert, DT (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	gilbert@wjh.harvard.edu			NSF [BCS-0722132]; NATIONAL INSTITUTE ON AGING [P01AG020166] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We acknowledge the support of Research Grant BCS-0722132 from NSF to D.T.G. and T.D.W. Raw data from all studies are on deposit at the Inter-university Consortium for Political and Social Research (deposit no. 32668) and can be accessed at www.icpsr.umich.edu.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Lachman ME, 1997, MIDLIFE DEV INVENTOR; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Prenda KM, 2001, PSYCHOL AGING, V16, P206, DOI 10.1037//0882-7974.16.2.206; Roberts BW, 2006, PSYCHOL BULL, V132, P1, DOI 10.1037/0033-2909.132.1.1; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; ROSS M, 1989, PSYCHOL REV, V96, P341, DOI 10.1037/0033-295X.96.2.341; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; SCHWARZ N, 1991, J PERS SOC PSYCHOL, V61, P195, DOI 10.1037/0022-3514.61.2.195; Sedikides C, OXFORD HDB HUMAN MOT, P303; Swann W.B., 2011, HDB THEORIES SOCIAL, V2, P23, DOI DOI 10.4135/9781446249222.N27; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9	16	132	132	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					96	98		10.1126/science.1229294	http://dx.doi.org/10.1126/science.1229294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288539				2022-12-28	WOS:000312985800060
J	Ferry, G				Ferry, Georgina			Science today, history tomorrow	NATURE			English	Editorial Material												mgf@georginaferry.com						Brenner S, 2007, NATURE, V446, P725, DOI 10.1038/446725a; Gann A, 2010, NATURE, V467, P519, DOI 10.1038/467519a	2	3	3	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					19	21		10.1038/493019a	http://dx.doi.org/10.1038/493019a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062QC	23282348	Bronze			2022-12-28	WOS:000312933800011
J	Ghomrawi, HMK; Schackman, BR; Mushlin, AI				Ghomrawi, Hassan M. K.; Schackman, Bruce R.; Mushlin, Alvin I.			Appropriateness Criteria and Elective Procedures - Total Joint Arthroplasty	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							KNEE; HIP		[Ghomrawi, Hassan M. K.; Schackman, Bruce R.; Mushlin, Alvin I.] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA; [Ghomrawi, Hassan M. K.] Hosp Special Surg, New York, NY 10021 USA	Cornell University	Ghomrawi, HMK (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Ghomrawi, Hassan/0000-0003-1291-5278				Halm EA, 2007, NEUROLOGY, V68, P187, DOI 10.1212/01.wnl.0000251197.98197.e9; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Lawson EH, 2011, ARCH SURG-CHICAGO, V146, P1433, DOI 10.1001/archsurg.2011.581; Quintana JM, 2008, ARCH INTERN MED, V168, P1576, DOI 10.1001/archinte.168.14.1576; vanWalraven C, 1996, CAN MED ASSOC J, V155, P697	5	57	57	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2467	2469		10.1056/NEJMp1209998	http://dx.doi.org/10.1056/NEJMp1209998			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268663				2022-12-28	WOS:000312714200004
J	Ludwig, DS; Blumenthal, SJ; Willett, WC				Ludwig, David S.; Blumenthal, Susan J.; Willett, Walter C.			Opportunities to Reduce Childhood Hunger and Obesity Restructuring the Supplemental Nutrition Assistance Program (the Food Stamp Program)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ludwig, David S.] Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, Boston, MA 02115 USA; [Blumenthal, Susan J.] New Amer Fdn, Washington, DC USA; [Blumenthal, Susan J.] Georgetown Sch Med, Washington, DC USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Ludwig, DS (corresponding author), Boston Childrens Hosp, New Balance Fdn Obes Prevent Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Blumenthal SJ., 2012, ACCESS, V28; Coleman-Jensen A, 2012, HOUSEHOLD FOOD SECUR; Kursmark M, 2009, CURR OPIN CLIN NUTR, V12, P310, DOI 10.1097/MCO.0b013e3283298e37; Nord M, 2009, USDA PUBLICATION, V28; POLHEMUS B, 2011, PEDIAT NUTR SURVEILL; Shenkin JD, 2010, AM J PUBLIC HEALTH, V100, P1562, DOI 10.2105/AJPH.2010.198549; Strayer M, 2012, CHARACTERISTICS SUPP; Zhang LN, 2012, PHYSIOL BEHAV, V105, P376, DOI 10.1016/j.physbeh.2011.08.035	8	31	31	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2567	2568		10.1001/jama.2012.45420	http://dx.doi.org/10.1001/jama.2012.45420			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268513				2022-12-28	WOS:000312916600018
J	Pos, W; Sethi, DK; Call, MJ; Schulze, MSED; Anders, AK; Pyrdol, J; Wucherpfennig, KW				Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.			Crystal Structure of the HLA-DM-HLA-DR1 Complex Defines Mechanisms for Rapid Peptide Selection	CELL			English	Article							CLASS-II MHC; HLA-DR MOLECULES; INVARIANT-CHAIN; ANTIGEN PRESENTATION; HISTOCOMPATIBILITY ANTIGEN; SURFACE EXPRESSION; DM SUSCEPTIBILITY; BINDING; DISSOCIATION; MICE	HLA-DR molecules bind microbial peptides in an endosomal compartment and present them on the cell surface for CD4 T cell surveillance. HLA-DM plays a critical role in the endosomal peptide selection process. The structure of the HLA-DM-HLA-DR complex shows major rearrangements of the HLA-DR peptide-binding groove. Flipping of a tryptophan away from the HLA-DR1 P1 pocket enables major conformational changes that position hydrophobic HLA-DR residues into the P1 pocket. These conformational changes accelerate peptide dissociation and stabilize the empty HLA-DR peptide-binding groove. Initially, incoming peptides have access to only part of the HLA-DR groove and need to compete with HLA-DR residues for access to the P2 site and the hydrophobic P1 pocket. This energetic barrier creates a rapid and stringent selection process for the highest-affinity binders. Insertion of peptide residues into the P2 and P1 sites reverses the conformational changes, terminating selection through DM dissociation.	[Pos, Wouter; Sethi, Dhruv K.; Call, Melissa J.; Schulze, Monika-Sarah E. D.; Anders, Anne-Kathrin; Pyrdol, Jason; Wucherpfennig, Kai W.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Anders, Anne-Kathrin; Wucherpfennig, Kai W.] Harvard Univ, Sch Med, Program Immunol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	kai_wucherpfennig@dfci.harvard.edu	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841	National Institutes of Health [RO1 NS044914, PO1 AI045757]; National Multiple Sclerosis Society; American Diabetes Association; Ruth L. Kirschstein National Research Service Award; National Center for Research Resources [5P41RR015301-10]; National Institute of General Medical Sciences from the National Institutes of Health [8P41 GM103403-10]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P01CA100265] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057493, P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); American Diabetes Association(American Diabetes Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Drs. Eric Sundberg, Shannon Turley, Hao Wu, and Bana Jabri for reading the manuscript. This work was supported by grants from the National Institutes of Health (RO1 NS044914 and PO1 AI045757 to K.W.W.), postdoctoral fellowships from The National Multiple Sclerosis Society (D.K.S.) and the American Diabetes Association (W.P.), as well as a Ruth L. Kirschstein National Research Service Award (to M.J.C.). We thank the staff at the UCLA-DOE crystallization core and the CSIRO Collaborative Crystallization Centre, Melbourne, Australia, for setting up screens. Diffraction data were collected at the Advanced Photon Source using beamlines allocated to the Northeastern Collaborative Access Team. These beamlines are supported by grants from the National Center for Research Resources (5P41RR015301-10) and the National Institute of General Medical Sciences (8P41 GM103403-10) from the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357.	Anders AK, 2011, NAT IMMUNOL, V12, P54, DOI 10.1038/ni.1967; Belmares MP, 2002, J IMMUNOL, V169, P5109, DOI 10.4049/jimmunol.169.9.5109; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Busch R, 1998, J BIOL CHEM, V273, P27557, DOI 10.1074/jbc.273.42.27557; Busch R, 2002, J IMMUNOL METHODS, V263, P111, DOI 10.1016/S0022-1759(02)00034-0; Castellino F, 1998, J IMMUNOL, V161, P4048; Chen MN, 2007, EMBO J, V26, P1681, DOI 10.1038/sj.emboj.7601624; Chou CL, 2000, J EXP MED, V192, P1697, DOI 10.1084/jem.192.12.1697; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Denzin LK, 1996, J EXP MED, V184, P2153, DOI 10.1084/jem.184.6.2153; Doebele RC, 2000, IMMUNITY, V13, P517, DOI 10.1016/S1074-7613(00)00051-0; Dong G, 2009, IMMUNITY, V30, P21, DOI 10.1016/j.immuni.2008.10.018; Fremont DH, 1998, IMMUNITY, V9, P385, DOI 10.1016/S1074-7613(00)80621-4; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Katz JF, 1996, J EXP MED, V184, P1747, DOI 10.1084/jem.184.5.1747; Koonce CH, 2003, J IMMUNOL, V170, P3751, DOI 10.4049/jimmunol.170.7.3751; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; Kropshofer H, 1997, IMMUNITY, V6, P293, DOI 10.1016/S1074-7613(00)80332-5; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Lovitch SB, 2003, J IMMUNOL, V171, P2183, DOI 10.4049/jimmunol.171.5.2183; Mage MG, 2012, J IMMUNOL, V189, P1391, DOI 10.4049/jimmunol.1200831; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; Mosyak L, 1998, IMMUNITY, V9, P377, DOI 10.1016/S1074-7613(00)80620-2; Nelson CA, 1997, P NATL ACAD SCI USA, V94, P628, DOI 10.1073/pnas.94.2.628; Nicholson MJ, 2006, J IMMUNOL, V176, P4208, DOI 10.4049/jimmunol.176.7.4208; Painter CA, 2011, P NATL ACAD SCI USA, V108, P19329, DOI 10.1073/pnas.1108074108; Painter CA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002403; Pashine A, 2003, IMMUNITY, V19, P183, DOI 10.1016/S1074-7613(03)00200-0; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; Rabinowitz JD, 1998, IMMUNITY, V9, P699, DOI 10.1016/S1074-7613(00)80667-6; REAY PA, 1992, EMBO J, V11, P2829, DOI 10.1002/j.1460-2075.1992.tb05350.x; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; Rupp B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018662; Sadegh-Nasseri S, 2008, TRENDS IMMUNOL, V29, P141, DOI 10.1016/j.it.2008.01.001; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Weber DA, 2001, J IMMUNOL, V167, P5167, DOI 10.4049/jimmunol.167.9.5167; Weber DA, 1996, SCIENCE, V274, P618, DOI 10.1126/science.274.5287.618	57	119	122	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1557	1568		10.1016/j.cell.2012.11.025	http://dx.doi.org/10.1016/j.cell.2012.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260142	Bronze, Green Accepted			2022-12-28	WOS:000312890300019
J	Ainsworth, C				Ainsworth, Claire			IMMUNOLOGY A many layered thing	NATURE			English	Editorial Material							PSORIASIS											Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; GOTTLIEB SL, 1995, NAT MED, V1, P442, DOI 10.1038/nm0595-442; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Oh CJ, 2000, J AM ACAD DERMATOL, V42, P829, DOI 10.1067/mjd.2000.105948; Tian SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044274; Valeyev NV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001024	6	6	7	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					552	554		10.1038/492S52a	http://dx.doi.org/10.1038/492S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254971	Bronze			2022-12-28	WOS:000312488200003
J	Siebert, J; Badro, J; Antonangeli, D; Ryerson, FJ				Siebert, Julien; Badro, James; Antonangeli, Daniele; Ryerson, Frederick J.			Terrestrial Accretion Under Oxidizing Conditions	SCIENCE			English	Article							SILICATE PARTITION-COEFFICIENTS; DEEP MAGMA-OCEAN; CORE FORMATION; HIGH-PRESSURE; EARTHS CORE; CHEMICAL-COMPOSITION; OXIDATION-STATE; OXYGEN FUGACITY; CONSTRAINTS; MOON	The abundance of siderophile elements in the mantle preserves the signature of core formation. On the basis of partitioning experiments at high pressure (35 to 74 gigapascals) and high temperature (3100 to 4400 kelvin), we demonstrate that depletions of slightly siderophile elements (vanadium and chromium), as well as moderately siderophile elements (nickel and cobalt), can be produced by core formation under more oxidizing conditions than previously proposed. Enhanced solubility of oxygen in the metal perturbs the metal-silicate partitioning of vanadium and chromium, precluding extrapolation of previous results. We propose that Earth accreted from materials as oxidized as ordinary or carbonaceous chondrites. Transfer of oxygen from the mantle to the core provides a mechanism to reduce the initial magma ocean redox state to that of the present-day mantle, reconciling the observed mantle vanadium and chromium concentrations with geophysical constraints on light elements in the core.	[Siebert, Julien; Antonangeli, Daniele] Univ Paris 06, Inst Phys Globe Paris, Inst Mineral & Phys Milieux Condenses, UMR CNRS 7590, F-75005 Paris, France; [Badro, James; Ryerson, Frederick J.] Univ Paris Diderot, Inst Phys Globe Paris, F-75005 Paris, France; [Ryerson, Frederick J.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Siebert, J (corresponding author), Univ Paris 06, Inst Phys Globe Paris, Inst Mineral & Phys Milieux Condenses, UMR CNRS 7590, F-75005 Paris, France.	julien.siebert@impmc.upmc.fr	Siebert, Julien/A-8336-2014; Badro, James/A-6003-2011; Ryerson, Frederick J/A-2105-2012	Siebert, Julien/0000-0001-9972-6239; Badro, James/0000-0001-9337-4789; 	European Research Council (ERC) under the European Community/ERC [207467]; Lawrence Livermore National Laboratory, U.S. Department of Energy [DE-AC52 07NA27344]; Office of Basic Energy Sciences, Geosciences Research Program; Region Ile de France [I-07-593/R]; INSU-CNRS; Institut de Physique (INP) CNRS; University Pierre et Marie Curie-Paris; French National Research Agency (ANR) [ANR-07-BLAN-0124-01]	European Research Council (ERC) under the European Community/ERC; Lawrence Livermore National Laboratory, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Basic Energy Sciences, Geosciences Research Program; Region Ile de France(Region Ile-de-France); INSU-CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut de Physique (INP) CNRS(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie-Paris; French National Research Agency (ANR)(French National Research Agency (ANR))	The research leading to these results has received funding from the European Research Council (ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement 207467. This work was performed under the auspices of the Lawrence Livermore National Laboratory, U.S. Department of Energy, under contract DE-AC52 07NA27344 and was supported by the Office of Basic Energy Sciences, Geosciences Research Program (F.J.R.). The Focused Ion Beam (FIB) facility of the IMPMC is supported by Region Ile de France grant SESAME 2006 NoI-07-593/R, INSU-CNRS, Institut de Physique (INP) CNRS, University Pierre et Marie Curie-Paris 6, and French National Research Agency (ANR) grant ANR-07-BLAN-0124-01 (J.B.). We thank I. Esteve for assistance during sample preparation with the FIB, and G. Garbarino for assistance on the high-pressure beamline (ID27) of the European Synchrotron Radiation Facility.	ALLEGRE CJ, 1995, EARTH PLANET SC LETT, V134, P515, DOI 10.1016/0012-821X(95)00123-T; Andrault D, 2011, EARTH PLANET SC LETT, V304, P251, DOI 10.1016/j.epsl.2011.02.006; Antonangeli D, 2010, EARTH PLANET SC LETT, V295, P292, DOI 10.1016/j.epsl.2010.04.018; Badro J, 2007, EARTH PLANET SC LETT, V254, P233, DOI 10.1016/j.epsl.2006.11.025; Bouhifd MA, 2011, EARTH PLANET SC LETT, V307, P341, DOI 10.1016/j.epsl.2011.05.006; Chabot NL, 2003, GEOCHIM COSMOCHIM AC, V67, P2077, DOI [10.1016/S0016-7037(02)01272-3, 10.1016/S0016-7037(02)012723]; Corgne A, 2008, GEOCHIM COSMOCHIM AC, V72, P574, DOI 10.1016/j.gca.2007.10.006; Corgne A, 2009, EARTH PLANET SC LETT, V288, P108, DOI 10.1016/j.epsl.2009.09.012; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Gessmann CK, 2000, EARTH PLANET SC LETT, V184, P95, DOI 10.1016/S0012-821X(00)00323-X; Gessmann CK, 1998, GEOCHIM COSMOCHIM AC, V62, P867, DOI 10.1016/S0016-7037(98)00023-4; Javoy M, 2010, EARTH PLANET SC LETT, V293, P259, DOI 10.1016/j.epsl.2010.02.033; Li J, 1996, NATURE, V381, P686, DOI 10.1038/381686a0; Ma ZT, 2001, METALL MATER TRANS B, V32, P87, DOI 10.1007/s11663-001-0011-0; Mann U, 2009, GEOCHIM COSMOCHIM AC, V73, P7360, DOI 10.1016/j.gca.2009.08.006; Ricolleau A, 2011, EARTH PLANET SC LETT, V310, P409, DOI 10.1016/j.epsl.2011.08.004; Righter K, 1997, PHYS EARTH PLANET IN, V100, P115, DOI 10.1016/S0031-9201(96)03235-9; RINGWOOD AE, 1990, NATURE, V347, P174, DOI 10.1038/347174a0; RINGWOOD AE, 1966, GEOCHIM COSMOCHIM AC, V30, P41, DOI 10.1016/0016-7037(66)90090-1; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Siebert J, 2012, EARTH PLANET SC LETT, V321, P189, DOI 10.1016/j.epsl.2012.01.013; Siebert J, 2011, GEOCHIM COSMOCHIM AC, V75, P1451, DOI 10.1016/j.gca.2010.12.013; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wade J, 2001, NATURE, V409, P75, DOI 10.1038/35051064; WANKE H, 1981, PHILOS T R SOC A, V303, P287, DOI 10.1098/rsta.1981.0203; Wood BJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1415, DOI 10.1016/j.gca.2007.11.036; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763	32	158	164	0	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 8	2013	339	6124					1194	1197		10.1126/science.1227923	http://dx.doi.org/10.1126/science.1227923			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	100OG	23306436				2022-12-28	WOS:000315709900044
J	Arnold, CD; Gerlach, D; Stelzer, C; Boryn, LM; Rath, M; Stark, A				Arnold, Cosmas D.; Gerlach, Daniel; Stelzer, Christoph; Boryn, Lukasz M.; Rath, Martina; Stark, Alexander			Genome-Wide Quantitative Enhancer Activity Maps Identified by STARR-seq	SCIENCE			English	Article							OPEN CHROMATIN; GENE; DISSECTION; EXPRESSION	Genomic enhancers are important regulators of gene expression, but their identification is a challenge, and methods depend on indirect measures of activity. We developed a method termed STARR-seq to directly and quantitatively assess enhancer activity for millions of candidates from arbitrary sources of DNA, which enables screens across entire genomes. When applied to the Drosophila genome, STARR-seq identifies thousands of cell type-specific enhancers across a broad continuum of strengths, links differential gene expression to differences in enhancer activity, and creates a genome-wide quantitative enhancer map. This map reveals the highly complex regulation of transcription, with several independent enhancers for both developmental regulators and ubiquitously expressed genes. STARR-seq can be used to identify and quantify enhancer activity in other eukaryotes, including humans.	[Arnold, Cosmas D.; Gerlach, Daniel; Stelzer, Christoph; Boryn, Lukasz M.; Rath, Martina; Stark, Alexander] Res Inst Mol Pathol IMP, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, A (corresponding author), Res Inst Mol Pathol IMP, A-1030 Vienna, Austria.	stark@starklab.org	Stark, Alexander/D-1473-2012	Stark, Alexander/0000-0003-2611-0841; Gerlach, Daniel/0000-0001-9338-3765	European Research Council (ERC) Starting Grant [242922]; Boehringer Ingelheim GmbH	European Research Council (ERC) Starting Grant(European Research Council (ERC)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank H. K. Akyuz, M. Pagani, K. Schernhuber, D. Spies, H. Tagoh, M. Busslinger, S. Westermann, J. M. Peters, J. Zuber (IMP), J. Brennecke and group, U. Elling [Institute of Molecular Biotechnology (IMBA)], and the IMP/IMBA BioOptics and Graphics Services for help. Deep sequencing was performed at the CSF Next-Generation Sequencing Unit (http://csf.ac.at); Vienna Tile (VT) lines were obtained from the Dickson laboratory via the Vienna Drosophila RNAi Center (http://stockcenter.vdrc.at). C. D. A., L. M. B., and M. R. are supported by a European Research Council (ERC) Starting Grant (no. 242922) awarded to A. S. Basic research at the IMP is supported by Boehringer Ingelheim GmbH. C. D. A. and A. S. are authors on a patent application for STARR-seq (EP 12 004 520.8) filed by Boehringer Ingelheim International GmbH. All constructs are available from the authors subject to a Material Transfer Agreement. All deep sequencing data are available at www.starklab.org and GEO (series accession number GSE40739).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Frankel N, 2010, NATURE, V466, P490, DOI 10.1038/nature09158; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Perry MW, 2011, P NATL ACAD SCI USA, V108, P13570, DOI 10.1073/pnas.1109873108; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Yanez-Cuna JO, 2013, TRENDS GENET, V29, P11, DOI 10.1016/j.tig.2012.09.007	21	543	557	6	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1074	1077		10.1126/science.1232542	http://dx.doi.org/10.1126/science.1232542			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328393				2022-12-28	WOS:000315452000041
J	Cameron, L; Erkal, N; Gangadharan, L; Meng, X				Cameron, L.; Erkal, N.; Gangadharan, L.; Meng, X.			Little Emperors: Behavioral Impacts of China's One-Child Policy	SCIENCE			English	Article							PERSONALITY; COMPETITION; TRUST; FIELD; ECONOMICS; OUTCOMES	We document that China's One-Child Policy (OCP), one of the most radical approaches to limiting population growth, has produced significantly less trusting, less trustworthy, more risk-averse, less competitive, more pessimistic, and less conscientious individuals. Our data were collected from economics experiments conducted with 421 individuals born just before and just after the OCP's introduction in 1979. Surveys to elicit personality traits were also used. We used the exogenous imposition of the OCP to identify the causal impact of being an only child, net of family background effects. The OCP thus has significant ramifications for Chinese society.	[Cameron, L.] Monash Univ, Dept Econometr, Clayton, Vic 3800, Australia; [Erkal, N.] Univ Melbourne, Dept Econ, Melbourne, Vic 3010, Australia; [Gangadharan, L.] Monash Univ, Dept Econom, Clayton, Vic 3800, Australia; [Meng, X.] Australian Natl Univ, Res Sch Econ, Coll Business & Econ, Canberra, ACT 0200, Australia	Monash University; University of Melbourne; Monash University; Australian National University	Cameron, L (corresponding author), Monash Univ, Dept Econometr, Clayton, Vic 3800, Australia.	lisa.cameron@monash.edu	Gangadharan, Lata/X-9890-2019	Gangadharan, Lata/0000-0003-3827-3090; Cameron, Lisa/0000-0002-7539-2198	Australian Research Council	Australian Research Council(Australian Research Council)	We gratefully acknowledge funding from the Australian Research Council. We thank Simon Gaechter, Elaine Liu, and participants of various conferences and seminars for their useful comments on previous drafts. The data used in this paper will be made available from the ICPSR data depositary, number 33353. The Rumici data are available at rse.anu.edu.au/rumici. All authors contributed equally to this paper.	Andersen S, 2010, J ECON BEHAV ORGAN, V73, P209, DOI 10.1016/j.jebo.2009.09.006; [Anonymous], 2007, ASIANEWS IT     0316; Benz M, 2008, EXP ECON, V11, P268, DOI 10.1007/s10683-007-9192-y; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; BLAKE J, 1981, POPUL DEV REV, V7, P43, DOI 10.2307/1972763; BLAKE J, 1981, DEMOGRAPHY, V18, P421, DOI 10.2307/2060941; Borghans L, 2008, J HUM RESOUR, V43, P972; Bowlby J., 1969, ATTACHMENT LOSS, V1; Castillo M, 2010, ECON INQ, V48, P266, DOI 10.1111/j.1465-7295.2009.00189.x; Chang Leslie T., 2008, FACTORY GIRLS VILLAG; Charness G, 2009, AM ECON REV, V99, P956, DOI 10.1257/aer.99.3.956; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; FALBO T, 1993, CHILD DEV, V64, P18, DOI 10.2307/1131435; Fehr E, 2011, J PUBLIC ECON, V95, P1144, DOI 10.1016/j.jpubeco.2011.05.013; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gass K, 2007, J CHILD PSYCHOL PSYC, V48, P167, DOI 10.1111/j.1469-7610.2006.01699.x; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Harrison GW, 2010, ECON J, V120, P80, DOI 10.1111/j.1468-0297.2009.02303.x; Heckman JJ, 2006, J LABOR ECON, V24, P411, DOI 10.1086/504455; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Jing Q, 1994, PSYCHOL SCI, V17, P70; Karlan DS, 2005, AM ECON REV, V95, P1688, DOI 10.1257/000282805775014407; LAVELY W, 1990, DEMOGRAPHY, V27, P357, DOI 10.2307/2061373; LEE LC, 1992, CHILD CARE CONTEXT C, P355; LEVY-GARBOUA L., 2006, HDB EC GIVING ALTRUI, V1, P545; Lewis M., 1982, FAMILIES LEARNING EN, P115; Liu E., 2012, RISK REFERENCES PEST; Liu E., 2008, 526 PRINC U IND RELA; Lundberg S., 2011, PERSPEKT WIRTSCH, V12, P66; Niederle M, 2007, Q J ECON, V122, P1067, DOI 10.1162/qjec.122.3.1067; Ostrom E., 2003, TRUST RECIPROCITY IN; Piaget J, 1997, MORAL JUDGMENT CHILD; Roberts L., 2001, J INDIV PSYCHOL, V57, P125; Schechter L, 2007, J ECON BEHAV ORGAN, V62, P272, DOI 10.1016/j.jebo.2005.03.006; Sutter M, 2007, GAME ECON BEHAV, V59, P364, DOI 10.1016/j.geb.2006.07.006; Wang Q, 1998, COGNITION, V69, P73, DOI 10.1016/S0010-0277(98)00061-4; Zhang YC, 2001, SOC BEHAV PERSONAL, V29, P725, DOI 10.2224/sbp.2001.29.7.725	37	206	210	10	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 22	2013	339	6122					953	957		10.1126/science.1230221	http://dx.doi.org/10.1126/science.1230221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	092UX	23306438				2022-12-28	WOS:000315149600048
J	Motz, C; Schuhmann, KM; Kirchhofer, A; Moldt, M; Witte, G; Conzelmann, KK; Hopfner, KP				Motz, Carina; Schuhmann, Kerstin Monika; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Conzelmann, Karl-Klaus; Hopfner, Karl-Peter			Paramyxovirus V Proteins Disrupt the Fold of the RNA Sensor MDA5 to Inhibit Antiviral Signaling	SCIENCE			English	Article							RIG-I; PATTERN-RECOGNITION; STRUCTURAL BASIS; HELICASE LGP2; ACTIVATION; INSIGHTS; FILAMENTS; EVASION; DOMAIN; DDB1	The retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) melanoma differentiation-associated protein 5 (MDA5) senses cytoplasmic viral RNA and activates antiviral innate immunity. To reveal how paramyxoviruses counteract this response, we determined the crystal structure of the MDA5 adenosine 5'-triphosphate (ATP)-hydrolysis domain in complex with the viral inhibitor V protein. The V protein unfolded the ATP-hydrolysis domain of MDA5 via a beta-hairpin motif and recognized a structural motif of MDA5 that is normally buried in the conserved helicase fold. This leads to disruption of the MDA5 ATP-hydrolysis site and prevention of RNA-bound MDA5 filament formation. The structure explains why V proteins inactivate MDA5, but not RIG-I, and mutating only two amino acids in RIG-I induces robust V protein binding. Our results suggest an inhibition mechanism of RLR signalosome formation by unfolding of receptor and inhibitor.	[Motz, Carina; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Hopfner, Karl-Peter] Univ Munich, Dept Biochem, Munich, Germany; [Motz, Carina; Schuhmann, Kerstin Monika; Kirchhofer, Axel; Moldt, Manuela; Witte, Gregor; Conzelmann, Karl-Klaus; Hopfner, Karl-Peter] Univ Munich, Gene Ctr, Munich, Germany; [Schuhmann, Kerstin Monika; Conzelmann, Karl-Klaus] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany; [Hopfner, Karl-Peter] Ctr Integrated Prot Sci, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich	Hopfner, KP (corresponding author), Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@genzentrum.lmu.de	Hopfner, Karl-Peter/B-6864-2014; Witte, Gregor/B-4635-2011; Conzelmann, Karl-Klaus/L-7239-2013	Hopfner, Karl-Peter/0000-0002-4528-8357; Witte, Gregor/0000-0003-0313-0962; Conzelmann, Karl-Klaus/0000-0002-8614-3656	German Research Council [Deutsche Forschungsgemeinschaft (DFG)] [GRK1721]; NIH [U19AI083025]; Bavarian government (BioSysNet); Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science); DFG [GRK1202]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025] Funding Source: NIH RePORTER	German Research Council [Deutsche Forschungsgemeinschaft (DFG)](German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bavarian government (BioSysNet); Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Cui and F. Civril for help in the initial stages of the project and K. Lammens, M. Bennett, and N. Fenn for technical advice. We thank O. Berninghausen, C. Ungewickel, and G. Pfeifer for help with EM. We thank the Max Planck Crystallization Facility (Max Planck Institute Martinsried) for screening of crystallization conditions. We thank T. Frohlich for mass spectrometry analysis, I. Mathes for N-terminal sequencing data, and C. Basquin for support in static light-scattering analysis. We thank the Swiss Light Source (Villingen, Switzerland), the European Synchrotron Radiation Facility (Grenoble, France), and the European Molecular Biology Laboratory (DESY, Hamburg, Germany) for beamtime and on-site support. The data reported in this paper are tabulated in the main paper and in the supplementary materials. Atomic coordinates and structure factors of the reported crystal structure have been deposited in the Protein Data Bank under accession code 4I1S. Details and supplementary materials are available on Science Online. The authors declare no conflict of interest. Correspondence and requests for materials should be addressed to K.-P. H. (hopfner@genzentrum.lmu.de). This work is funded by grants from the German Research Council [Deutsche Forschungsgemeinschaft (DFG) GRK1721] to K.-P. H. and G. W., NIH (U19AI083025), the Bavarian government (BioSysNet), and the Excellence Initiative of the German Ministry of Education and Science (Center for Integrated Proteins Science) to K.-P.H. A.K. and K.M.S. were funded by DFG GRK1202.	Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Andrejeva J, 2002, J VIROL, V76, P11379, DOI 10.1128/JVI.76.22.11379-11386.2002; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Berke IC, 2012, EMBO J, V31, P1714, DOI 10.1038/emboj.2012.19; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; Civril F, 2011, EMBO REP, V12, P1127, DOI 10.1038/embor.2011.190; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Karlin D, 2002, VIROLOGY, V296, P251, DOI 10.1006/viro.2001.1296; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Parisien JP, 2009, J VIROL, V83, P7252, DOI 10.1128/JVI.00153-09; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Ramachandran A, 2010, J VIROL, V84, P11152, DOI 10.1128/JVI.01375-10; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schaap-Nutt A, 2011, J VIROL, V85, P4007, DOI 10.1128/JVI.02542-10; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	33	87	89	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 8	2013	339	6120					690	693		10.1126/science.1230949	http://dx.doi.org/10.1126/science.1230949			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23328395				2022-12-28	WOS:000314585600041
J	Gouw, SC; van der Bom, JG; Ljung, R; Escuriola, C; Cid, AR; Claeyssens-Donadel, S; van Geet, C; Kenet, G; Makipernaa, A; Molinari, AC; Muntean, W; Kobelt, R; Rivard, G; Santagostino, E; Thomas, A; van den Berg, HM				Gouw, Samantha C.; van der Bom, Johanna G.; Ljung, Rolf; Escuriola, Carmen; Cid, Ana R.; Claeyssens-Donadel, Segolene; van Geet, Christel; Kenet, Gili; Makipernaa, Anne; Molinari, Angelo Claudio; Muntean, Wolfgang; Kobelt, Rainer; Rivard, George; Santagostino, Elena; Thomas, Angela; van den Berg, H. Marijke		PedNet RODIN Study Grp	Factor VIII Products and Inhibitor Development in Severe Hemophilia A	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVIOUSLY UNTREATED PATIENTS; RECOMBINANT FACTOR-VIII; RISK-FACTORS; MUTATION TYPE; CANAL COHORT; CLASS-II; POLYMORPHISMS; CHILDREN; GENES	Background For previously untreated children with severe hemophilia A, it is unclear whether the type of factor VIII product administered and switching among products are associated with the development of clinically relevant inhibitory antibodies (inhibitor development). Methods We evaluated 574 consecutive patients with severe hemophilia A (factor VIII activity, <0.01 IU per milliliter) who were born between 2000 and 2010 and collected data on all clotting-factor administration for up to 75 exposure days. The primary outcome was inhibitor development, which was defined as at least two positive inhibitor tests with decreased in vivo recovery of factor VIII levels. Results Inhibitory antibodies developed in 177 of the 574 children (cumulative incidence, 32.4%); 116 patients had a high-titer inhibitory antibody, defined as a peak titer of at least 5 Bethesda units per milliliter (cumulative incidence, 22.4%). Plasma-derived products conferred a risk of inhibitor development that was similar to the risk with recombinant products (adjusted hazard ratio as compared with recombinant products, 0.96; 95% confidence interval [CI], 0.62 to 1.49). As compared with third-generation full-length recombinant products (derived from the full-length complementary DNA sequence of human factor VIII), second-generation full-length products were associated with an increased risk of inhibitor development (adjusted hazard ratio, 1.60; 95% CI, 1.08 to 2.37). The content of von Willebrand factor in the products and switching among products were not associated with the risk of inhibitor development. Conclusions Recombinant and plasma-derived factor VIII products conferred similar risks of inhibitor development, and the content of von Willebrand factor in the products and switching among products were not associated with the risk of inhibitor development. Second-generation full-length recombinant products were associated with an increased risk, as compared with third-generation products. (Funded by Bayer Healthcare and Baxter BioScience.)	[Gouw, Samantha C.] Wilhelmina Childrens Hosp, Dept Pediat, Utrecht, Netherlands; [Gouw, Samantha C.; van den Berg, H. Marijke] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [van der Bom, Johanna G.] Leiden Univ, Med Ctr, Leiden, Netherlands; [van der Bom, Johanna G.] Sanquin Fdn, Ctr Clin Transfus Res, Leiden, Netherlands; [Ljung, Rolf] Lund Univ, Dept Pediat, Malmo, Sweden; [Ljung, Rolf] Skanes Univ Sjukhus, Malmo Ctr Thrombosis & Hemostasis, Malmo, Sweden; [Escuriola, Carmen] JW Goethe Univ Hosp, Dept Pediat, Frankfurt, Germany; [Cid, Ana R.] Hosp Univ & Politecn La Fe, Unidad Hemostasia & Trombosis, Valencia, Spain; [Claeyssens-Donadel, Segolene] Ctr Hosp Univ, Ctr Reg Hemophilie, Toulouse, France; [van Geet, Christel] Univ Hosp Leuven, Dept Pediat, Louvain, Belgium; [van Geet, Christel] Katholieke Univ Leuven, Dept Cardiovasc Sci, Louvain, Belgium; [Kenet, Gili] Chaim Sheba Med Ctr, Minist Hlth, Natl Hemophilia Ctr, IL-52621 Tel Hashomer, Israel; [Makipernaa, Anne] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; [Molinari, Angelo Claudio] Osped Pediat Giannina Gaslini, Unita Trombosi Emostasi, Dipartimento Ematol Oncol, Genoa, Italy; [Santagostino, Elena] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Muntean, Wolfgang] Univ Klin Kinder & Jugendheilkunde, Graz, Austria; [Kobelt, Rainer] Univ Bern, Wabern & Childrens Hosp, Hamophiliezentrum, Bern, Switzerland; [Rivard, George] Hop St Justine, Div Hematol Oncol, Montreal, PQ H3T 1C5, Canada; [Thomas, Angela] Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland	Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hospital Universitari i Politecnic La Fe; CHU de Toulouse; KU Leuven; University Hospital Leuven; KU Leuven; Chaim Sheba Medical Center; University of Helsinki; University of Genoa; IRCCS Istituto Giannina Gaslini; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Bern; Universite de Montreal	van den Berg, HM (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Rm Stratenum 5-125,POB 85500, NL-3508 GA Utrecht, Netherlands.	h.m.vandeberg@umcutrecht.nl	Molinari, Angelo Claudio/AAA-7334-2020; Nolan, Beatrice/AAV-4356-2021; Kenet, Gili/AAF-8416-2020; van der Bom, Johanna G./G-1965-2018; Mancuso, Maria Elisa/AAT-4785-2020	Molinari, Angelo Claudio/0000-0002-8078-8402; Nolan, Beatrice/0000-0003-0145-4736; van der Bom, Johanna G./0000-0001-9095-2475; Gouw, Samantha/0000-0002-1957-4122; Fischer, Kathelijn/0000-0001-7126-6613; Mancuso, Maria Elisa/0000-0002-7113-4028; Oldenburg, Johannes/0000-0002-1585-4100; CHAMBOST, HERVE/0000-0002-5319-1969	Bayer Healthcare; Baxter BioScience	Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Baxter BioScience	Supported by unrestricted research grants from Bayer Healthcare and Baxter BioScience.	Aledort LM, 1998, HAEMOPHILIA, V4, P68; Astermark J, 2007, J THROMB HAEMOST, V5, P263, DOI 10.1111/j.1538-7836.2007.02290.x; Astermark J, 2006, BLOOD, V107, P3167, DOI 10.1182/blood-2005-09-3918; Astermark J, 2001, HAEMOPHILIA, V7, P267, DOI 10.1046/j.1365-2516.2001.00510.x; Astermark J, 2006, BLOOD, V108, P3739, DOI 10.1182/blood-2006-05-024711; Bafunno V, 2010, HAEMOPHILIA, V16, P469, DOI 10.1111/j.1365-2516.2009.02150.x; Berntorp E, 1995, B WORLD HEALTH ORGAN, V73, P691; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; Ettingshausen CE, 2006, HAEMOPHILIA, V12, P102, DOI 10.1111/j.1365-2516.2006.01373.x; Franchini M, 2012, CRIT REV ONCOL HEMAT, V81, P82, DOI 10.1016/j.critrevonc.2011.01.002; Giangrande PLF, 2002, HAEMOPHILIA, V8, P19, DOI 10.1046/j.1351-8216.2001.00133.x; Goudemand J, 2006, BLOOD, V107, P46, DOI 10.1182/blood-2005-04-1371; Gouw SC, 2007, J THROMB HAEMOST, V5, P1383, DOI 10.1111/j.1538-7836.2007.02595.x; Gouw SC, 2007, BLOOD, V109, P4693, DOI 10.1182/blood-2006-11-056317; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Gouw SC, 2012, BLOOD, V119, P2922, DOI 10.1182/blood-2011-09-379453; Hay CRM, 2011, BLOOD, V117, P6367, DOI 10.1182/blood-2010-09-308668; Hay CRM, 1997, THROMB HAEMOSTASIS, V77, P234; Iorio A, 2010, J THROMB HAEMOST, V8, P1256, DOI 10.1111/j.1538-7836.2010.03823.x; Kreuz W, 2005, THROMB HAEMOSTASIS, V93, P457, DOI 10.1160/TH03-10-0643; Kurnik K, 2010, HAEMOPHILIA, V16, P256, DOI 10.1111/j.1365-2516.2009.02122.x; LEE ML, 1993, THROMB HAEMOSTASIS, V69, P87; Lozier JN, 2011, HAEMOPHILIA, V17, P641, DOI 10.1111/j.1365-2516.2010.02473.x; Maclean PS, 2011, HAEMOPHILIA, V17, P282, DOI 10.1111/j.1365-2516.2010.02422.x; Mancuso ME, 2012, J THROMB HAEMOST, V10, P781, DOI 10.1111/j.1538-7836.2012.04691.x; Mannucci PM, 2007, HAEMOPHILIA, V13, P65, DOI 10.1111/j.1365-2516.2007.01580.x; Oldenburg J, 1997, THROMB HAEMOSTASIS, V77, P238; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Santagostino E, 2005, BRIT J HAEMATOL, V130, P422, DOI 10.1111/j.1365-2141.2005.05605.x; Scharrer I, 2004, HAEMOPHILIA, V10, P197, DOI 10.1111/j.1365-2516.2004.00887.x; Schwaab R, 1995, THROMB HAEMOSTASIS, V74, P1402; Vlot AJ, 1998, THROMB HAEMOSTASIS, V79, P456; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	34	328	353	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					231	239		10.1056/NEJMoa1208024	http://dx.doi.org/10.1056/NEJMoa1208024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323899				2022-12-28	WOS:000313549900007
J	Herzberg, C; Asimow, PD; Ionov, DA; Vidito, C; Jackson, MG; Geist, D				Herzberg, Claude; Asimow, Paul D.; Ionov, Dmitri A.; Vidito, Chris; Jackson, Matthew G.; Geist, Dennis			Nickel and helium evidence for melt above the core-mantle boundary	NATURE			English	Article							PARTITION-COEFFICIENTS; BARBERTON KOMATIITES; OXIDATION-STATE; MAGMA OCEAN; PERIDOTITE; OLIVINE; SYSTEMATICS; GARNET; HETEROGENEITY; EVOLUTION	High He-3/He-4 ratios in some basalts have generally been interpreted as originating in an incompletely degassed lower-mantle source(1-9). This helium source may have been isolated at the core-mantle boundary region since Earth's accretion(4-6). Alternatively, it may have taken part in whole-mantle convection and crust production over the age of the Earth(7-9); if so, it is now either a primitive refugium at the core-mantle boundary(8) or is distributed throughout the lower mantle(7,9). Here we constrain the problem using lavas from Baffin Island, West Greenland, the Ontong Java Plateau, Isla Gorgona and Fernandina (Galapagos). Olivine phenocryst compositions show that these lavas originated from a peridotite source that was about 20 per cent higher in nickel content than in the modern mid-ocean-ridge basalt source. Where data are available, these lavas also have high He-3/He-4. We propose that a less-degassed nickel-rich source formed by core-mantle interaction during the crystallization of a melt-rich layer or basal magma ocean(5,6), and that this source continues to be sampled by mantle plumes. The spatial distribution of this source may be constrained by nickel partitioning experiments at the pressures of the core-mantle boundary.	[Herzberg, Claude; Vidito, Chris] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA; [Asimow, Paul D.] CALTECH, Pasadena, CA 91125 USA; [Ionov, Dmitri A.] Univ St Etienne, Dept Geol, F-42023 St Etienne 2, France; [Ionov, Dmitri A.] CNRS, UMR 6524, Lab Magmas & Volcans, F-42023 St Etienne, France; [Jackson, Matthew G.] Boston Univ, Dept Earth & Environm, Boston, MA 02215 USA; [Geist, Dennis] Univ Idaho, Dept Geol Sci, Moscow, ID 83844 USA	Rutgers State University New Brunswick; California Institute of Technology; Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); Universite Clermont Auvergne (UCA); Universite Jean Monnet; Boston University; Idaho; University of Idaho	Herzberg, C (corresponding author), Rutgers State Univ, Dept Earth & Planetary Sci, 610 Taylor Rd, Piscataway, NJ 08854 USA.	herzberg@rci.rutgers.edu	Asimow, Paul D/E-7451-2010; Ionov, Dmitri A./E-5111-2010	Asimow, Paul D/0000-0001-6025-8925; Ionov, Dmitri A./0000-0002-5055-7339	French INSU-CNRS; NSF [EAR-1119522, EAR1145271]; Directorate For Geosciences [1119522] Funding Source: National Science Foundation	French INSU-CNRS(Centre National de la Recherche Scientifique (CNRS)); NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	C.H. thanks L. Larsen, M. Portnyagin, A. Sobolev and D. Walker for discussions. We are very grateful to R. Walker for a critical review. D.A.I. acknowledges PNP grants from the French INSU-CNRS in 2010-2012 and P.D.A. acknowledges NSF grant EAR-1119522. P.D.A. thanks A. Matzen for extended discussions. D.G.'s work is funded by NSF grant EAR1145271.	Arndt N, 2008, KOMATIITE, P363, DOI 10.1017/CBO9780511535550.014; Balta JB, 2011, J PETROL, V52, P2079, DOI 10.1093/petrology/egr040; BEATTIE P, 1991, CONTRIB MINERAL PETR, V109, P212, DOI 10.1007/BF00306480; Berry AJ, 2008, NATURE, V455, P960, DOI 10.1038/nature07377; Bezos A, 2005, GEOCHIM COSMOCHIM AC, V69, P2613, DOI 10.1016/j.gca.2004.10.023; Blichert-Toft J, 2004, CHEM GEOL, V207, P261, DOI 10.1016/j.chemgeo.2004.03.005; Brandon AD, 2003, EARTH PLANET SC LETT, V206, P411, DOI 10.1016/S0012-821X(02)01101-9; Class C, 2005, NATURE, V436, P1107, DOI 10.1038/nature03930; Coltice N, 2011, EARTH PLANET SC LETT, V308, P193, DOI 10.1016/j.epsl.2011.05.045; Corgne A, 2012, LITHOS, V148, P128, DOI 10.1016/j.lithos.2012.06.013; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Gonnermann HM, 2009, NATURE, V459, P560, DOI 10.1038/nature08018; Grove T.L., 1999, MANTLE PETROL, P155; Grove TL, 2004, EARTH PLANET SC LETT, V219, P173, DOI 10.1016/S0012-821X(04)00002-0; Herzberg C, 2004, J PETROL, V45, P2507, DOI 10.1093/petrology/egh039; Herzberg C, 2011, J PETROL, V52, P113, DOI 10.1093/petrology/egq075; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; Herzberg C, 2009, NATURE, V458, P619, DOI 10.1038/nature07857; Ionov DA, 2007, CONTRIB MINERAL PETR, V154, P455, DOI 10.1007/s00410-007-0203-y; Jackson MG, 2011, NATURE, V476, P316, DOI 10.1038/nature10326; Jackson MG, 2010, NATURE, V466, P853, DOI 10.1038/nature09287; JONES JH, 1984, CONTRIB MINERAL PETR, V88, P126, DOI 10.1007/BF00371417; Kurz MD, 2009, EARTH PLANET SC LETT, V286, P23, DOI 10.1016/j.epsl.2009.06.008; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Labrosse S, 2007, NATURE, V450, P866, DOI 10.1038/nature06356; Larsen LM, 2000, J PETROL, V41, P1071, DOI 10.1093/petrology/41.7.1071; Matzen A. K., 2012, GOLDSCHM C; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Parman SW, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002566; Parman SW, 1997, EARTH PLANET SC LETT, V150, P303, DOI 10.1016/S0012-821X(97)00104-0; Puchtel IS, 2009, GEOCHIM COSMOCHIM AC, V73, P6367, DOI 10.1016/j.gca.2009.07.022; Putirka K, 2011, J PETROL, V52, P279, DOI 10.1093/petrology/egq080; Revillon S, 2002, EARTH PLANET SC LETT, V205, P91, DOI 10.1016/S0012-821X(02)01003-8; Robin-Popieul CCM, 2012, J PETROL, V53, P2191, DOI 10.1093/petrology/egs042; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Salters VJM, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000597; Siebert J, 2012, EARTH PLANET SC LETT, V321, P189, DOI 10.1016/j.epsl.2012.01.013; Sobolev AV, 2007, SCIENCE, V316, P412, DOI 10.1126/science.1138113; Starkey NA, 2009, EARTH PLANET SC LETT, V277, P91, DOI 10.1016/j.epsl.2008.10.007; Tenner TJ, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003942; Tolstikhin I, 2005, PHYS EARTH PLANET IN, V148, P109, DOI 10.1016/j.pepi.2004.05.011; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Walker D, 2005, CAN MINERAL, V43, P1553, DOI 10.2113/gscanmin.43.5.1553; Walter MJ, 1998, J PETROL, V39, P29, DOI 10.1093/petrology/39.1.29; Williams Q, 1996, SCIENCE, V273, P1528, DOI 10.1126/science.273.5281.1528	45	71	74	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					393	U134		10.1038/nature11771	http://dx.doi.org/10.1038/nature11771			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23302797				2022-12-28	WOS:000313615900049
J	Johnson, SC; Rabinovitch, PS; Kaeberlein, M				Johnson, Simon C.; Rabinovitch, Peter S.; Kaeberlein, Matt			mTOR is a key modulator of ageing and age-related disease	NATURE			English	Review							CHRONOLOGICAL LIFE-SPAN; MAMMALIAN TARGET; DIETARY RESTRICTION; MACULAR DEGENERATION; CARDIAC-HYPERTROPHY; COGNITIVE DEFICITS; STRESS RESISTANCE; MOUSE MODEL; RAPAMYCIN; INHIBITION	Many experts in the biology of ageing believe that pharmacological interventions to slow ageing are a matter of 'when' rather than 'if'. A leading target for such interventions is the nutrient response pathway defined by the mechanistic target of rapamycin (mTOR). Inhibition of this pathway extends lifespan in model organisms and confers protection against a growing list of age-related pathologies. Characterized inhibitors of this pathway are already clinically approved, and others are under development. Although adverse side effects currently preclude use in otherwise healthy individuals, drugs that target the mTOR pathway could one day become widely used to slow ageing and reduce age-related pathologies in humans.	[Johnson, Simon C.; Rabinovitch, Peter S.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kaeberlein, Matt] Guangdong Med Coll, Inst Aging Res, Dongguan 523808, Peoples R China	University of Washington; University of Washington Seattle; Guangdong Medical University	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu		Johnson, Simon/0000-0002-1942-3674; Kaeberlein, Matt/0000-0002-1311-3421	NIH [R01AG039390, R01AG031108, T32AG000057]; NATIONAL INSTITUTE ON AGING [R01AG038550, R01AG031108, P30AG013280, T32AG000057, R01AG039390] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1150213] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Studies related to this topic in the Kaeberlein laboratory have been supported by NIH grant R01AG039390 and R01AG031108 to M.K. S.C.J. is supported by NIH grant T32AG000057.	Abdulrahman BA, 2011, AUTOPHAGY, V7, P1359, DOI 10.4161/auto.7.11.17660; Alvers AL, 2009, AUTOPHAGY, V5, P847, DOI 10.4161/auto.8824; Amiel E, 2012, J IMMUNOL, V189, P2151, DOI 10.4049/jimmunol.1103741; Anisimov VN, 2011, CELL CYCLE, V10, P4230, DOI 10.4161/cc.10.24.18486; Anisimov VN, 2010, AGING-US, V2, P760, DOI 10.18632/aging.100230; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chen WQ, 2009, BRIT J PHARMACOL, V156, P941, DOI 10.1111/j.1476-5381.2008.00102.x; Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Ding YH, 2011, CIRC RES, V109, P658, DOI 10.1161/CIRCRESAHA.111.248260; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Garber K, 2009, J NATL CANCER I, V101, P288, DOI 10.1093/jnci/djp034; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Halloran J, 2012, NEUROSCIENCE, V223, P102, DOI 10.1016/j.neuroscience.2012.06.054; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; Hansen M, 2007, WESTERN HUM REV, V61, P6; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jagannath C, 2012, METHODS MOL BIOL, V821, P295, DOI 10.1007/978-1-61779-430-8_18; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, AGING CELL, V6, P731, DOI 10.1111/j.1474-9726.2007.00341.x; Kaeberlein M, 2011, AGING CELL, V10, P185, DOI 10.1111/j.1474-9726.2010.00665.x; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kolosova NG, 2012, AM J PATHOL, V181, P472, DOI 10.1016/j.ajpath.2012.04.018; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Leiser SF, 2010, BIOL CHEM, V391, P1131, DOI 10.1515/BC.2010.123; Lieberthal W, 2012, AM J PHYSIOL-RENAL, V303, pF180, DOI 10.1152/ajprenal.00015.2012; Liu Y, 2006, KIDNEY INT, V69, P1925, DOI 10.1038/sj.ki.5001543; Mair W, 2011, NATURE, V470, P404, DOI 10.1038/nature09706; Majumder S, 2012, AGING CELL, V11, P326, DOI 10.1111/j.1474-9726.2011.00791.x; Majumder S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025416; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morgan T. E., 2007, V35, P83; Nuhrenberg TG, 2004, FASEB J, V18, P246, DOI 10.1096/fj.04-2431fje; Nussenblatt RB, 2010, RETINA-J RET VIT DIS, V30, P1579, DOI 10.1097/IAE.0b013e3181e7978e; Onken B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008758; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pierdominici M, 2011, CURR PHARM DESIGN, V17, P3888, DOI 10.2174/138161211798357809; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Ramos FJ, 2012, NATURE, V486, P477, DOI 10.1038/486477a; Robida-Stubbs S, 2012, CELL METAB, V15, P713, DOI 10.1016/j.cmet.2012.04.007; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Ryther RCC, 2012, CURR NEUROL NEUROSCI, V12, P410, DOI 10.1007/s11910-012-0276-5; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Smith ED, 2008, GENOME RES, V18, P564, DOI 10.1101/gr.074724.107; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Steinbaugh MJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE488, DOI 10.1152/ajpendo.00110.2012; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Takano T, 2001, MOL CELL BIOL, V21, P5050, DOI 10.1128/MCB.21.15.5050-5062.2001; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013; Wilkinson JE, 2012, AGING CELL, V11, P675, DOI 10.1111/j.1474-9726.2012.00832.x; Yamaki K, 2012, ALLERGY, V67, P1259, DOI 10.1111/all.12000; Yang SB, 2012, NEURON, V75, P425, DOI 10.1016/j.neuron.2012.03.043; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yin LL, 2012, INT J NEUROSCI, V122, P748, DOI 10.3109/00207454.2012.721827; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006348; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	100	1036	1073	13	472	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					338	345		10.1038/nature11861	http://dx.doi.org/10.1038/nature11861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325216	Green Accepted			2022-12-28	WOS:000313615900040
J	Mahon, J				Mahon, Jeffrey			A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Ontario, London, ON, Canada	Western University (University of Western Ontario)	Mahon, J (corresponding author), Univ Western Ontario, London, ON, Canada.							[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Mahon J, 2000, CAN MED ASSOC J, V162, P1002	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC4	10.7326/0003-4819-158-2-201301150-02004	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318338				2022-12-28	WOS:000314029400003
J	Aguzzi, A; Barres, B; Bennett, ML				Aguzzi, Adriano; Barres, Ben A.; Bennett, Mariko L.			Microglia: Scapegoat, Saboteur, or Something Else?	SCIENCE			English	Review							CENTRAL-NERVOUS-SYSTEM; BETA-AMYLOID PLAQUES; ALZHEIMERS-DISEASE; AXON REGENERATION; APOPTOTIC BODIES; MYELOID CELLS; MOUSE MODEL; BRAIN; COMPLEMENT; ACTIVATION	Microglia are resident immune cells in the brain and spinal cord. These cells provide immune surveillance and are mobilized in response to disparate diseases and injuries. Although microglial activation is often considered neurotoxic, microglia are essential defenders against many neurodegenerative diseases. It also seems increasingly likely that microglial dysfunction can underlie certain neurological diseases without an obvious immune component.	[Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8012 Zurich, Switzerland; [Barres, Ben A.; Bennett, Mariko L.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	University of Zurich; University Zurich Hospital; Stanford University	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8012 Zurich, Switzerland.	adriano.aguzzi@usz.ch; mlhowe@stanford.edu		Bennett, Mariko/0000-0002-1642-2887; Aguzzi, Adriano/0000-0002-0344-6708	Advanced Grant of the European Research Council; European Union (PRIORITY, LUPAS); Swiss National Foundation; Foundation Alliance BioSecure; Clinical Research Focus Program of the University of Zurich; Novartis Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS078813] Funding Source: NIH RePORTER	Advanced Grant of the European Research Council; European Union (PRIORITY, LUPAS); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Foundation Alliance BioSecure; Clinical Research Focus Program of the University of Zurich; Novartis Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	A.A. is the recipient of an Advanced Grant of the European Research Council and is supported by grants from the European Union (PRIORITY, LUPAS), the Swiss National Foundation, the Foundation Alliance BioSecure, the Clinical Research Focus Program of the University of Zurich, and the Novartis Research Foundation. B. A. B. is a cofounder of Annexon, Inc., a company that is making drugs for neurological diseases.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Britschgi M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-220; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Callaway E, 2012, NATURE, V489, P13, DOI 10.1038/489013a; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Celsus A. C., 1478, MEDICINA; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen SK, 2010, CELL, V141, P775, DOI 10.1016/j.cell.2010.03.055; Chen ZH, 2012, J NEUROSCI, V32, P11706, DOI 10.1523/JNEUROSCI.0730-12.2012; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; de Lima S, 2012, P NATL ACAD SCI USA, V109, P9149, DOI 10.1073/pnas.1119449109; Del Rio-Hortega P, 1927, B JOHNS HOPKINS HOSP, V41, P278; DeMattos RB, 2012, NEURON, V76, P908, DOI 10.1016/j.neuron.2012.10.029; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Fassas A, 2011, NEUROLOGY, V76, P1066, DOI 10.1212/WNL.0b013e318211c537; Gensel JC, 2009, J NEUROSCI, V29, P3956, DOI 10.1523/JNEUROSCI.3992-08.2009; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Grathwohl SA, 2009, NAT NEUROSCI, V12, P1361, DOI 10.1038/nn.2432; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hughes MM, 2010, GLIA, V58, P2017, DOI 10.1002/glia.21070; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lowenthal J, 2012, NEW ENGL J MED, V367, P488, DOI 10.1056/NEJMp1203104; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Mandrekar-Colucci S, 2011, EXPERT OPIN THER TAR, V15, P1085, DOI 10.1517/14728222.2011.594043; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Saijo K, 2011, CELL, V145, P584, DOI 10.1016/j.cell.2011.03.050; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schweitzer PJ, 2010, DRUG DISCOV TODAY, V15, P933, DOI 10.1016/j.drudis.2010.08.012; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012	58	580	601	2	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					156	161		10.1126/science.1227901	http://dx.doi.org/10.1126/science.1227901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307732	Green Accepted			2022-12-28	WOS:000313328200033
J	Dasgupta, R; Mallik, A; Tsuno, K; Withers, AC; Hirth, G; Hirschmann, MM				Dasgupta, Rajdeep; Mallik, Ananya; Tsuno, Kyusei; Withers, Anthony C.; Hirth, Greg; Hirschmann, Marc M.			Carbon-dioxide-rich silicate melt in the Earth's upper mantle	NATURE			English	Article							EAST PACIFIC RISE; MIDOCEAN RIDGES; ELECTRICAL-CONDUCTIVITY; PERIDOTITE; SOLIDUS; BENEATH; H2O; CO2; ASTHENOSPHERE; HETEROGENEITY	The onset of melting in the Earth's upper mantle influences the thermal evolution of the planet, fluxes of key volatiles to the exo-sphere, and geochemical and geophysical properties of the mantle. Although carbonatitic melt could be stable 250 km or less beneath mid-oceanic ridges(1,2), owing to the small fraction (similar to 0.03 wt%) its effects on the mantle properties are unclear. Geophysical measurements, however, suggest that melts of greater volume may be present at similar to 200km (refs 3-5) but large melt fractions are thought to be restricted to shallower depths. Here we present experiments on carbonated peridotites over 2-5 GPa that constrain the location and the slope of the onset of silicate melting in the mantle. We find that the pressure-temperature slope of carbonated silicate melting is steeper than the solidus of volatile-free peridotite and that silicate melting of dry peridotite + CO2 beneath ridges commences at similar to 180 km. Accounting for the effect of 50-200 p.p.m. H2O on freezing point depression, the onset of silicate melting for a sub-ridge mantle with similar to 100 p.p.m. CO2 becomes as deep as similar to 220-300 km. We suggest that, on a global scale, carbonated silicate melt generation at a redox front similar to 250-200 km deep(6), with destabilization of metal and majorite in the upwelling mantle, explains the oceanic low-velocity zone and the electrical conductivity structure of the mantle. In locally oxidized domains, deeper carbonated silicate melt may contribute to the seismic X-discontinuity. Furthermore, our results, along with the electrical conductivity of molten carbonated peridotite(7) and that of the oceanic upper mantle(5), suggest that mantle at depth is CO2-rich but H2O-poor. Finally, carbonated silicate melts restrict the stability of carbonatite in the Earth's deep upper mantle, and the inventory of carbon, H2O and other highly incompatible elements at ridges becomes controlled by the flux of the former.	[Dasgupta, Rajdeep; Mallik, Ananya; Tsuno, Kyusei] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Withers, Anthony C.; Hirschmann, Marc M.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Hirth, Greg] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Rice University; University of Minnesota System; University of Minnesota Twin Cities; Brown University	Dasgupta, R (corresponding author), Rice Univ, Dept Earth Sci, 6100 Main St,MS 126, Houston, TX 77005 USA.	Rajdeep.Dasgupta@rice.edu	Mallik, Ananya/D-9908-2019; Hirschmann, marc m/B-9455-2016; Dasgupta, Rajdeep/C-7252-2009; Mallik, Ananya/I-5252-2013; Withers, Anthony C/J-4302-2012	Mallik, Ananya/0000-0001-7458-094X; Hirschmann, marc m/0000-0003-1213-6645; Dasgupta, Rajdeep/0000-0001-5392-415X; Mallik, Ananya/0000-0001-7458-094X; Withers, Anthony C/0000-0003-4835-4281	National Science Foundation; Packard fellowship; Directorate For Geosciences [0911442] Funding Source: National Science Foundation; Division Of Earth Sciences [1019744] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Packard fellowship(The David & Lucile Packard Foundation); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank C. Ballhaus for reviewing the manuscript. This study received support from the National Science Foundation and a Packard fellowship to R.D.	Aubaud C, 2005, EARTH PLANET SC LETT, V235, P511, DOI 10.1016/j.epsl.2005.04.047; Baba K, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2004JB003598; Baba K, 2010, PHYS EARTH PLANET IN, V183, P44, DOI 10.1016/j.pepi.2010.09.010; Bagley B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005692; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Cartigny P, 2008, EARTH PLANET SC LETT, V265, P672, DOI 10.1016/j.epsl.2007.11.011; Dalton CA, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005429; Dasgupta R, 2006, NATURE, V440, P659, DOI 10.1038/nature04612; Dasgupta R, 2004, EARTH PLANET SC LETT, V227, P73, DOI 10.1016/j.epsl.2004.08.004; Dasgupta R, 2007, GEOLOGY, V35, P135, DOI 10.1130/G22856A.1; Dasgupta R, 2007, AM MINERAL, V92, P370, DOI 10.2138/am.2007.2201; Dasgupta R, 2010, EARTH PLANET SC LETT, V298, P1, DOI 10.1016/j.epsl.2010.06.039; Foley SF, 2009, LITHOS, V112, P274, DOI 10.1016/j.lithos.2009.03.020; Gaillard F, 2008, SCIENCE, V322, P1363, DOI 10.1126/science.1164446; Gudfinnsson GH, 2005, J PETROL, V46, P1645, DOI 10.1093/petrology/egi029; Hammond WC, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001789; Hirschmann MM, 2010, PHYS EARTH PLANET IN, V179, P60, DOI 10.1016/j.pepi.2009.12.003; Hirschmann MM, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000070; Karato S.-i, 2003, AM GEOPHYS UNION GEO, P135, DOI DOI 10.1029/138GM08; Langmuir C.H., 1992, AM GEOPHYS UNION GEO, V71, P183, DOI DOI 10.1029/GM071P0183; LIZARRALDE D, 1995, J GEOPHYS RES-SOL EA, V100, P17837, DOI 10.1029/95JB01244; Marty B, 1998, CHEM GEOL, V145, P233, DOI 10.1016/S0009-2541(97)00145-9; MICHAEL PJ, 1988, GEOCHIM COSMOCHIM AC, V52, P555, DOI 10.1016/0016-7037(88)90110-X; O'Leary JA, 2010, EARTH PLANET SC LETT, V297, P111, DOI 10.1016/j.epsl.2010.06.011; Rohrbach A, 2007, NATURE, V449, P456, DOI 10.1038/nature06183; Rohrbach A, 2011, NATURE, V472, P209, DOI 10.1038/nature09899; Saal AE, 2002, NATURE, V419, P451, DOI 10.1038/nature01073; Sobolev AV, 1996, EARTH PLANET SC LETT, V137, P45, DOI 10.1016/0012-821X(95)00203-O; Stagno V, 2010, EARTH PLANET SC LETT, V300, P72, DOI 10.1016/j.epsl.2010.09.038; Stixrude L, 2007, EARTH PLANET SC LETT, V263, P45, DOI 10.1016/j.epsl.2007.08.027; Tsuno K, 2011, CONTRIB MINERAL PETR, V161, P743, DOI 10.1007/s00410-010-0560-9; YASUDA A, 1994, J GEOPHYS RES-SOL EA, V99, P9401, DOI 10.1029/93JB03205; Yoshino T, 2012, PHYS EARTH PLANET IN, V194, P1, DOI 10.1016/j.pepi.2012.01.005; Yoshino T, 2009, EARTH PLANET SC LETT, V283, P167, DOI 10.1016/j.epsl.2009.04.007	34	239	257	4	252	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					211	U222		10.1038/nature11731	http://dx.doi.org/10.1038/nature11731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302861				2022-12-28	WOS:000313259600037
J	Ceelie, I; de Wildt, SN; van Dijk, M; van den Berg, MMJ; van den Bosch, GE; Duivenvoorden, HJ; de Leeuw, TG; Mathot, R; Knibbe, CAJ; Tibboel, D				Ceelie, Ilse; de Wildt, Saskia N.; van Dijk, Monique; van den Berg, Margreeth M. J.; van den Bosch, Gerbrich E.; Duivenvoorden, Hugo J.; de Leeuw, Tom G.; Mathot, Ron; Knibbe, Catherijne A. J.; Tibboel, Dick			Effect of Intravenous Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMFORT-BEHAVIOR SCALE; RECTAL ACETAMINOPHEN; ANALGESIC EFFICACY; CHILDREN; PAIN; ANESTHESIA; PHARMACOKINETICS; METABOLITES; TOLERANCE; MORTALITY	Importance Continuous morphine infusion as standard postoperative analgesic therapy in young infants is associated with unwanted adverse effects such as respiratory depression. Objective To determine whether intravenous paracetamol (acetaminophen) would significantly (>30%) reduce morphine requirements in neonates and infants after major surgery. Design, Setting, and Patients Single-center, randomized, double-blind study conducted in a level 3 pediatric intensive care unit in Rotterdam, the Netherlands. Patients were 71 neonates or infants younger than 1 year undergoing major thoracic (noncardiac) or abdominal surgery between March 2008 and July 2010, with follow-up of 48 hours. Interventions All patients received a loading dose of morphine 30 minutes before the end of surgery, followed by continuous morphine or intermittent intravenous paracetamol up to 48 hours postsurgery. Infants in both study groups received morphine (boluses and/or continuous infusion) as rescue medication on the guidance of the validated pain assessment instruments. Main Outcome Measures Primary outcome was cumulative morphine dose (study and rescue dose). Secondary outcomes were pain scores and morphine-related adverse effects. Results The cumulative median morphine dose in the first 48 hours postoperatively was 121 (interquartile range, 99-264) mu g/kg in the paracetamol group (n = 33) and 357 (interquartile range, 220-605) mu g/kg in the morphine group(n = 38), P < .001, with a between group difference that was 66% (95% CI, 34%-109%) lower in the paracetamol group. Pain scores and adverse effects were not significantly different between groups. Conclusion and Relevance Among infants undergoing major surgery, postoperative use of intermittent intravenous paracetamol compared with continuous morphine resulted in a lower cumulative morphine dose over 48 hours.	[Ceelie, Ilse; de Wildt, Saskia N.; van Dijk, Monique; van den Berg, Margreeth M. J.; van den Bosch, Gerbrich E.; Knibbe, Catherijne A. J.; Tibboel, Dick] Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, NL-3015 GJ Rotterdam, Netherlands; [de Leeuw, Tom G.] Erasmus MC Sophia Childrens Hosp, Dept Anesthesiol, NL-3015 GJ Rotterdam, Netherlands; [Duivenvoorden, Hugo J.] Erasmus MC, Dept Med Psychol, Rotterdam, Netherlands; [Duivenvoorden, Hugo J.] Erasmus MC, Dept Psychotherapy, Rotterdam, Netherlands; [Mathot, Ron] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, Clin Pharmacol Unit, NL-1105 AZ Amsterdam, Netherlands; [Knibbe, Catherijne A. J.] Leiden Univ, Leiden Amsterdam Ctr Drug Res, Div Pharmacol, Leiden, Netherlands; [Knibbe, Catherijne A. J.] St Antonius Hosp, Dept Clin Pharm, Nieuwegein, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; St. Antonius Hospital Utrecht	de Wildt, SN (corresponding author), Erasmus MC Sophia Childrens Hosp, Dept Pediat Surg, Room Sp3458,Dr Molewaterpl 60, NL-3015 GJ Rotterdam, Netherlands.	s.dewildt@erasmusmc.nl	van den Bosch, Gerbrich/AAP-4158-2020; van Dijk, Monique/B-6327-2009; de Wildt, Saskia/A-9589-2008; de Wildt, Saskia/AFX-4656-2022	de Wildt, Saskia/0000-0002-0502-0647; de Wildt, Saskia/0000-0002-0502-0647; van Dijk, Monique/0000-0002-9856-0318; mathot, ron/0000-0001-8401-0879	ZonMw [40-41500-98.9020]	ZonMw(Netherlands Organization for Health Research and Development)	This study was supported by ZonMw Priority Medicines for Children grant 40-41500-98.9020.	Allegaert K, 2008, PEDIATR ANESTH, V18, P388, DOI 10.1111/j.1460-9592.2008.02535.x; Amar PJ, 2007, EXPERT OPIN DRUG SAF, V6, P341, DOI 10.1517/14740338.6.4.341; ANAND KJS, 1987, LANCET, V1, P62; ANAND KJS, 1987, NEW ENGL J MED, V317, P1321, DOI 10.1056/NEJM198711193172105; Anand KJS, 2001, ARCH PEDIAT ADOL MED, V155, P173, DOI 10.1001/archpedi.155.2.173; ANAND KJS, 1988, J PEDIATR SURG, V23, P297, DOI 10.1016/S0022-3468(88)80193-3; Anderson BJ, 2002, ANESTHESIOLOGY, V96, P1336, DOI 10.1097/00000542-200206000-00012; Bai JB, 2012, PAIN MANAG NURS, V13, P18, DOI 10.1016/j.pmn.2010.07.002; Bellomo R, 2009, CRIT CARE MED, V37, P3114, DOI 10.1097/CCM.0b013e3181bc7bd5; Berde CB, 2005, CLIN THER, V27, P900, DOI 10.1016/j.clinthera.2005.06.020; Berde CB, 2002, NEW ENGL J MED, V347, P1094, DOI 10.1056/NEJMra012626; BERRY FA, 1987, ANESTHESIOLOGY, V67, P291; BOOKER PD, 1987, ANAESTHESIA, V42, P343, DOI 10.1111/j.1365-2044.1987.tb03971.x; Bouwmeester NJ, 2003, BRIT J ANAESTH, V90, P642, DOI 10.1093/bja/aeg121; Bremerich DH, 2001, ANESTH ANALG, V92, P907; Hong JY, 2010, ANESTHESIOLOGY, V113, P672, DOI 10.1097/ALN.0b013e3181e2c34b; James LP, 2008, CLIN PHARMACOL THER, V84, P684, DOI 10.1038/clpt.2008.190; Knibbe CAJ, 2009, CLIN PHARMACOKINET, V48, P371, DOI 10.2165/00003088-200948060-00003; Korpela R, 2007, ACTA ANAESTH SCAND, V51, P726, DOI 10.1111/j.1399-6576.2007.01319.x; Korpela R, 1999, ANESTHESIOLOGY, V91, P442, DOI 10.1097/00000542-199908000-00019; Krekels EHJ, 2011, CLIN PHARMACOKINET, V50, P51, DOI 10.2165/11536750-000000000-00000; Lavonas EJ, 2010, PEDIATRICS, V126, pE1430, DOI 10.1542/peds.2009-3352; Maund E, 2011, BRIT J ANAESTH, V106, P292, DOI 10.1093/bja/aeq406; Morton NS, 1999, BRIT J ANAESTH, V82, P715, DOI 10.1093/bja/82.5.715; Murat I, 2005, PEDIATR ANESTH, V15, P663, DOI 10.1111/j.1460-9592.2004.01518.x; Palmer GM, 2008, BRIT J ANAESTH, V101, P523, DOI 10.1093/bja/aen208; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0; Taddio A, 2002, JAMA-J AM MED ASSOC, V288, P857, DOI 10.1001/jama.288.7.857; Valkenburg AJ, 2011, PAIN, V152, P2059, DOI 10.1016/j.pain.2011.05.001; van der Marel CD, 2007, BRIT J ANAESTH, V98, P372, DOI 10.1093/bja/ael371; van Dijk M, 2005, AM J NURS, V105, P33, DOI 10.1097/00000446-200501000-00019; van Dijk M, 2000, PAIN, V84, P367, DOI 10.1016/S0304-3959(99)00239-0; von Baeyer CL, 2009, PAIN, V143, P223, DOI 10.1016/j.pain.2009.03.002; Weisman SJ, 1998, ARCH PEDIAT ADOL MED, V152, P147	36	124	128	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					149	154		10.1001/jama.2012.148050	http://dx.doi.org/10.1001/jama.2012.148050			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299606	Bronze			2022-12-28	WOS:000313517000023
J	Carretti, E; Crocker, RM; Staveley-Smith, L; Haverkorn, M; Purcell, C; Gaensler, BM; Bernardi, G; Kesteven, MJ; Poppi, S				Carretti, Ettore; Crocker, Roland M.; Staveley-Smith, Lister; Haverkorn, Marijke; Purcell, Cormac; Gaensler, B. M.; Bernardi, Gianni; Kesteven, Michael J.; Poppi, Sergio			Giant magnetized outflows from the centre of the Milky Way	NATURE			English	Article							X-RAY-EMISSION; GALACTIC-CENTER; FERMI BUBBLES; COSMIC-RAYS; GAMMA-RAYS; FIELD; WIND; NUCLEUS; GALAXY; BULGE	The nucleus of the Milky Way is known to harbour regions of intense star formation activity as well as a supermassive black hole(1). Recent observations have revealed regions of gamma-ray emission reaching far above and below the Galactic Centre (relative to the Galactic plane), the so-called 'Fermi bubbles'(2). It is uncertain whether these were generated by nuclear star formation or by quasar-like outbursts of the central black hole(3-6) and no information on the structures' magnetic field has been reported. Here we report observations of two giant, linearly polarized radio lobes, containing three ridgelike substructures, emanating from the Galactic Centre. The lobes each extend about 60 degrees in the Galactic bulge, closely corresponding to the Fermi bubbles, and are permeated by strong magnetic fields of up to 15 microgauss. We conclude that the radio lobes originate in a biconical, star-formation-driven (rather than black-hole-driven) outflow from the Galaxy's central 200 parsecs that transports a huge amount of magnetic energy, about 10(55) ergs, into the Galactic halo. The ridges wind around this outflow and, we suggest, constitute a 'phonographic' record of nuclear star formation activity over at least ten million years.	[Carretti, Ettore] CSIRO Astron & Space Sci, Parkes, NSW 2870, Australia; [Crocker, Roland M.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Crocker, Roland M.] Australian Natl Univ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia; [Staveley-Smith, Lister] Univ Western Australia, Int Ctr Radio Astron Res, Crawley, WA 6009, Australia; [Staveley-Smith, Lister] Univ Western Australia, ARC Ctr Excellence All sky Astrophys CAASTRO, Crawley, WA 6009, Australia; [Haverkorn, Marijke] Radboud Univ Nijmegen, Dept Astrophys IMAPP, NL-6500 GL Nijmegen, Netherlands; [Haverkorn, Marijke] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Purcell, Cormac; Gaensler, B. M.] Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW 2006, Australia; [Bernardi, Gianni] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Kesteven, Michael J.] CSIRO Astron & Space Sci, Epping, NSW 1710, Australia; [Poppi, Sergio] INAF Osservatorio Astron Cagliari, I-09012 Capoterra, CA, Italy	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; Australian National University; University of Western Australia; University of Western Australia; Radboud University Nijmegen; Leiden University; Leiden University - Excl LUMC; University of Sydney; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Istituto Nazionale Astrofisica (INAF)	Carretti, E (corresponding author), CSIRO Astron & Space Sci, POB 276, Parkes, NSW 2870, Australia.	Ettore.Carretti@csiro.au	Carretti, Ettore/AAX-6792-2021; Gaensler, Bryan M/F-8655-2010; Staveley-Smith, Lister G/A-1683-2011	Carretti, Ettore/0000-0002-3973-8403; Staveley-Smith, Lister G/0000-0002-8057-0294; Crocker, Roland/0000-0002-2036-2426; Gaensler, Bryan/0000-0002-3382-9558; Purcell, Cormac/0000-0002-7491-7386; Poppi, Sergio/0000-0002-4698-2607; Bernardi, Gianni/0000-0002-0916-7443	Max-Planck-Institut fur Kernphysik; Australian Research Council [FT110100108]; Australian Laureate Fellowship from the Australian Research Council [FL100100114]; Netherlands Organisation for Scientific Research (NWO) [639.042.915]	Max-Planck-Institut fur Kernphysik; Australian Research Council(Australian Research Council); Australian Laureate Fellowship from the Australian Research Council(Australian Research Council); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work has been carried out in the framework of the S-band Polarization All Sky Survey collaboration (S-PASS). We thank the Parkes Telescope staff for support, both while setting up the non-standard observing mode and during the observing runs. R. M. C. thanks F. Aharonian, R. Beck, G. Bicknell, D. Jones, C. Law, M. Morris, C. Pfrommer, W. Reich, A. Stolte, T. Porter and H. Volk for discussions, and the Max-Planck-Institut fur Kernphysik for supporting his research. R. M. C. also acknowledges the support of a Future Fellowship from the Australian Research Council through grant FT110100108. B. M. G. and C. P. acknowledge the support of an Australian Laureate Fellowship from the Australian Research Council through grant FL100100114. M. H. acknowledges the support of research programme 639.042.915, which is partly financed by the Netherlands Organisation for Scientific Research (NWO). The Parkes Radio Telescope is part of the Australia Telescope National Facility, which is funded by the Commonwealth of Australia for operation as a National Facility managed by CSIRO. We acknowledge the use of WMAP data and the HEALPix software package.	Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Almy RC, 2000, ASTROPHYS J, V545, P290, DOI 10.1086/317768; Beck R, 2005, ASTRON NACHR, V326, P414, DOI 10.1002/asna.200510366; Bland-Hawthorn J, 2003, ASTROPHYS J, V582, P246, DOI 10.1086/344573; Brandenburg A, 2005, PHYS REP, V417, P1, DOI 10.1016/j.physrep.2005.06.005; Carretti E., 2011, ASP C SER, VCS-438, P276; Crocker RM, 2012, MON NOT R ASTRON SOC, V423, P3512, DOI 10.1111/j.1365-2966.2012.21149.x; Crocker RM, 2011, MON NOT R ASTRON SOC, V413, P763, DOI 10.1111/j.1365-2966.2010.18170.x; Crocker RM, 2011, MON NOT R ASTRON SOC, V411, pL11, DOI 10.1111/j.1745-3933.2010.00983.x; Crocker RM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.101102; Crocker RM, 2010, NATURE, V463, P65, DOI 10.1038/nature08635; Ferriere K, 2009, ASTRON ASTROPHYS, V505, P1183, DOI 10.1051/0004-6361/200912617; Gaustad JE, 2001, PUBL ASTRON SOC PAC, V113, P1326, DOI 10.1086/323969; Heesen V, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201117618; Hinshaw G, 2009, ASTROPHYS J SUPPL S, V180, P225, DOI 10.1088/0067-0049/180/2/225; Hussmann B, 2012, ASTRON ASTROPHYS, V540, DOI 10.1051/0004-6361/201117637; Jones DI, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L12; KULSRUD R, 1969, ASTROPHYS J, V156, P445, DOI 10.1086/149981; Launhardt R, 2002, ASTRON ASTROPHYS, V384, P112, DOI 10.1051/0004-6361:20020017; Law CJ, 2010, ASTROPHYS J, V708, P474, DOI 10.1088/0004-637X/708/1/474; Molinari S, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L33; Morris M, 1996, ANNU REV ASTRON ASTR, V34, P645, DOI 10.1146/annurev.astro.34.1.645; Muno MP, 2004, ASTROPHYS J, V613, P326, DOI 10.1086/422865; POHL M, 1992, ASTRON ASTROPHYS, V262, P441; SOFUE Y, 1989, ASTROPHYS J, V341, pL47, DOI 10.1086/185454; Su M, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/1/61; Su M, 2010, ASTROPHYS J, V724, P1044, DOI 10.1088/0004-637X/724/2/1044; Yun MS, 2001, ASTROPHYS J, V554, P803, DOI 10.1086/323145; Zubovas K, 2011, MON NOT R ASTRON SOC, V415, pL21, DOI 10.1111/j.1745-3933.2011.01070.x	29	150	150	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					66	69		10.1038/nature11734	http://dx.doi.org/10.1038/nature11734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	062QC	23282363	Green Submitted			2022-12-28	WOS:000312933800031
J	Gu, WF; Lee, HC; Chaves, D; Youngman, EM; Pazour, GJ; Conte, D; Mello, CC				Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.			CapSeq and CIP-TAP Identify Pol II Start Sites and Reveal Capped Small RNAs as C. elegans piRNA Precursors	CELL			English	Article							POLYMERASE-II; DIVERGENT TRANSCRIPTION; EPIGENETIC MEMORY; PRIMAL RNAS; PIWI; GERMLINE; PROMOTER; COMPLEX; IDENTIFICATION; BIOGENESIS	Piwi-interacting (pi) RNAs are germline-expressed small RNAs linked to epigenetic programming. C. elegans piRNAs are thought to be transcribed as independent gene-like loci. To test this idea and to identify potential transcription start (TS) sites for piRNA precursors, we developed CapSeq, an efficient enzymatic method for 5' anchored RNA profiling. Using CapSeq, we identify candidate TS sites, defined by 70-90 nt sequence tags, for >50% of annotated Pol II loci. Surprisingly, however, these CapSeq tags failed to identify the overwhelming majority of piRNA loci. Instead, we show that the likely piRNA precursors are similar to 26 nt capped small (cs) RNAs that initiate precisely 2 nt upstream of mature piRNAs and that piRNA processing or stability requires a U at the csRNA +3 position. Finally, we identify a heretofore unrecognized class of piRNAs processed from csRNAs that are expressed at promoters genome wide, nearly doubling the number of piRNAs available for genome surveillance.	[Gu, Weifeng; Lee, Heng-Chi; Chaves, Daniel; Youngman, Elaine M.; Pazour, Gregory J.; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu	Youngman, Elaine/E-7072-2013; Youngman, Elaine/O-7449-2019	Lee, Heng-Chi/0000-0001-8154-906X; Pazour, Gregory/0000-0002-6285-8796	Ruth L. Kirschstein National Research Service Award [GM099372]; NIH [GM058800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058800, F32GM099372, R01GM058800, R01GM060992] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Mello lab for useful discussions, Tom Blumenthal for providing spliced leader sequences, Stephen Jones for providing mouse sample, Zhiping Weng for providing information about the mouse database, and Ellen Kittler for deep sequencing. H.-C.L. is supported by a Ruth L. Kirschstein National Research Service Award (GM099372). C.C.M. is a Howard Hughes Medical Institute Investigator and is supported by NIH grant GM058800.	Allen MA, 2011, GENOME RES, V21, P255, DOI 10.1101/gr.113811.110; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrecka J, 2008, P NATL ACAD SCI USA, V105, P135, DOI 10.1073/pnas.0703815105; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Beyret E, 2012, CELL RES, V22, P1429, DOI 10.1038/cr.2012.120; Blumenthal T., 1997, RNA PROCESSING GENE; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; BRENNER S, 1974, GENETICS, V77, P71; Cecere G, 2012, MOL CELL, V47, P734, DOI 10.1016/j.molcel.2012.06.021; Chen CY, 2009, P NATL ACAD SCI USA, V106, P127, DOI 10.1073/pnas.0811689106; Conte D, 2010, CELL, V140, P452, DOI 10.1016/j.cell.2010.02.005; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das PP, 2008, MOL CELL, V31, P79, DOI 10.1016/j.molcel.2008.06.003; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Gu WF, 2011, METHODS MOL BIOL, V725, P251, DOI 10.1007/978-1-61779-046-1_17; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Haussecker D, 2008, NAT STRUCT MOL BIOL, V15, P714, DOI 10.1038/nsmb.1440; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kawaoka S, 2011, MOL CELL, V43, P1015, DOI 10.1016/j.molcel.2011.07.029; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lamm AT, 2011, GENOME RES, V21, P265, DOI 10.1101/gr.108845.110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Morton JJ, 2011, RNA, V17, P327, DOI 10.1261/rna.2447111; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shirayama M, 2012, CELL, V150, P65, DOI 10.1016/j.cell.2012.06.015; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Vasale JJ, 2010, P NATL ACAD SCI USA, V107, P3582, DOI 10.1073/pnas.0911908107; Yamamoto YY, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-67	57	133	137	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1488	1500		10.1016/j.cell.2012.11.023	http://dx.doi.org/10.1016/j.cell.2012.11.023			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260138	Bronze, Green Accepted			2022-12-28	WOS:000312890300014
J	Li, JH; Cone, JE; Kahn, AR; Brackbill, RM; Farfel, MR; Greene, CM; Hadler, JL; Stayner, LT; Stellman, SD				Li, Jiehui; Cone, James E.; Kahn, Amy R.; Brackbill, Robert M.; Farfel, Mark R.; Greene, Carolyn M.; Hadler, James L.; Stayner, Leslie T.; Stellman, Steven D.			Association Between World Trade Center Exposure and Excess Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CENTER HEALTH REGISTRY; YORK-CITY FIREFIGHTERS; MULTIPLE-MYELOMA; CENTER DISASTER; PROSTATE-CANCER; COLLAPSE; COHORT; WORKERS; MORTALITY; SYMPTOMS	Context The terrorist attacks of September 11, 2001, resulted in the release of known and suspected carcinogens into the environment. There is public concern that exposures may have resulted in increased cancers. Objective To evaluate cancer incidence among persons enrolled in the World Trade Center Health Registry. Design, Setting, and Participants Observational study of 55 778 New York State residents enrolled in the World Trade Center Health Registry in 2003-2004, including rescue/recovery workers (n=21 850) and those not involved in rescue/recovery (n=33 928), who were followed up from enrollment through December 31, 2008. Within-cohort comparisons using Cox proportional hazards models assessed the relationship between intensity of World Trade Center exposure and selected cancers. Main Outcome Measures Cases were identified through linkage with 11 state cancer registries. Standardized incidence ratios (SIRs) adjusted for age, race/ethnicity, and sex were computed with 2003-2008 New York State rates as the reference, focusing on cancers diagnosed in 2007-2008 as being most likely to be related to exposure during September 11 and its aftermath. The total and site-specific incidence rate differences (RDs) per 100 000 person-years between the study population and the New York State population in 2007-2008 also were calculated. Results There were 1187 incident cancers diagnosed, with an accumulated 253 269 person-years (439 cancers among rescue/recovery workers and 748 among those not involved in rescue/recovery). The SIR for all cancer sites combined in 2007-2008 was not significantly elevated (SIR, 1.14 [95% CI, 0.99 to 1.30]; RD, 67 [95% CI, -6 to 126] per 100 000 person-years among rescue/recovery workers vs SIR, 0.92 [95% CI, 0.83 to 1.03]; RD, -45 [95% CI, -106 to 15] per 100 000 person-years among those not involved in rescue/recovery). Among rescue/recovery workers, the SIRs had significantly increased by 2007-2008 for 3 cancer sites and were 1.43 (95% CI, 1.11 to 1.82) for prostate cancer (n=67; RD, 61 [95% CI, 20 to 91] per 100 000 person-years), 2.02 (95% CI, 1.07 to 3.45) for thyroid cancer (n=13; RD, 16 [95% CI, 2 to 23] per 100 000 person-years), and 2.85 (95% CI, 1.15 to 5.88) for multiple myeloma (n=7; RD, 11 [95% CI, 2 to 14] per 100 000 person-years). No increased incidence was observed in 2007-2008 among those not involved in rescue/recovery. Using within-cohort comparisons, the intensity of World Trade Center exposure was not significantly associated with cancer of the lung, prostate, thyroid, non-Hodgkin lymphoma, or hematological cancer in either group. Conclusions Among persons enrolled in the World Trade Center Health Registry, there was an excess risk for prostate cancer, thyroid cancer, and myeloma in 20072008 compared with that for New York State residents; however, these findings were based on a small number of events and multiple comparisons. No significant associations were observed with intensity of World Trade Center exposures. Longer follow-up for typically long-latency cancers and attention to specific cancer sites are needed. JAMA. 2012;308(23):2479-2488 www.jama.com	[Li, Jiehui] New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, Long Isl City, NY 11101 USA; [Kahn, Amy R.] New York State Dept Hlth, Bur Canc Epidemiol, Albany, NY USA; [Stayner, Leslie T.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA; [Stellman, Steven D.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	New York City Department of Health & Mental Hygiene; State University of New York (SUNY) System; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Columbia University	Li, JH (corresponding author), New York City Dept Hlth & Mental Hyg, World Trade Ctr Hlth Registry, 42-09 28th St,7th Floor, Long Isl City, NY 11101 USA.	jli3@health.nyc.gov			National Institute for Occupational Safety and Health [1U50/OH009739]; Agency for Toxic Substances and Disease Registry [U50/ATU272750]; National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U50OH009739] Funding Source: NIH RePORTER	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Agency for Toxic Substances and Disease Registry(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Center for Environmental Health of the Centers for Disease Control and Prevention; New York City Department of Health and Mental Hygiene; New York State Department of Health; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This study was supported by cooperative agreement 1U50/OH009739 from the National Institute for Occupational Safety and Health and cooperative agreement U50/ATU272750 from the Agency for Toxic Substances and Disease Registry, which included support from the National Center for Environmental Health of the Centers for Disease Control and Prevention, and the New York City Department of Health and Mental Hygiene. Ms Kahn was supported by the New York State Department of Health.	Ahmed S, 2010, AM J ROENTGENOL, V195, P1066, DOI 10.2214/AJR.10.4506; Aldrich TK, 2010, NEW ENGL J MED, V362, P1263, DOI 10.1056/NEJMoa0910087; ARMENIAN HK, 1974, AM J EPIDEMIOL, V99, P92, DOI 10.1093/oxfordjournals.aje.a121599; BOFFETTA P, 1989, INT J CANCER, V43, P554, DOI 10.1002/ijc.2910430404; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Breslow N. E., 1987, STATISTICAL METHODS, V2, P69; Cahill TA, 2004, AEROSOL SCI TECH, V38, P165, DOI 10.1080/02786820490250836; DEMERS PA, 1993, AM J IND MED, V23, P629, DOI 10.1002/ajim.4700230410; Edelman P, 2003, ENVIRON HEALTH PERSP, V111, P1906, DOI 10.1289/ehp.6315; Farfel M, 2008, J URBAN HEALTH, V85, P880, DOI 10.1007/s11524-008-9317-4; Horii Y, 2010, ENVIRON SCI TECHNOL, V44, P5188, DOI 10.1021/es100282d; HOWE GR, 1990, AM J EPIDEMIOL, V132, P1039, DOI 10.1093/oxfordjournals.aje.a115745; Jordan HT, 2011, LANCET, V378, P879, DOI 10.1016/S0140-6736(11)60966-5; Kipen HM, 2005, TXB CLIN OCCUPATIONA; Lioy PJ, 2002, ENVIRON HEALTH PERSP, V110, P703, DOI 10.1289/ehp.02110703; McGee JK, 2003, ENVIRON HEALTH PERSP, V111, P972, DOI 10.1289/ehp.5930; Moline JM, 2009, J OCCUP ENVIRON MED, V51, P896, DOI 10.1097/JOM.0b013e3181ad49c8; Murphy J, 2007, STAT MED, V26, P1688, DOI 10.1002/sim.2806; National Cancer Institute, SEER SIT REC ICD O 3; New York State Department of Health, 1976, PERC CANC DIAGN EARL; Perlman SE, 2011, LANCET, V378, P925, DOI 10.1016/S0140-6736(11)60967-7; Pleil JD, 2004, P NATL ACAD SCI USA, V101, P11685, DOI 10.1073/pnas.0404499101; POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548; Prezant DJ, 2002, NEW ENGL J MED, V347, P806, DOI 10.1056/NEJMoa021300; Rinsky RA, 2002, AM J IND MED, V42, P474, DOI 10.1002/ajim.10138; Russi MB, 2005, TXB CLIN OCCUPATIONA; Savitz DA, 2008, MT SINAI J MED, V75, P77, DOI 10.1002/msj.20023; SHORE RE, 1985, J NATL CANCER I, V74, P1177; Stellman SD, 2006, ENV OCCUPATIONAL MED, P1236; Weakley J, 2011, PREV MED, V53, P364, DOI 10.1016/j.ypmed.2011.09.001; Williams ED, 2004, BRIT J CANCER, V90, P2219, DOI 10.1038/sj.bjc.6601860; Wisnivesky JP, 2011, LANCET, V378, P888, DOI 10.1016/S0140-6736(11)61180-X; Zeig-Owens R, 2011, LANCET, V378, P898, DOI 10.1016/S0140-6736(11)60989-6	34	81	81	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2479	2488		10.1001/jama.2012.110980	http://dx.doi.org/10.1001/jama.2012.110980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288447	Green Published			2022-12-28	WOS:000312441400024
J	Savage, N				Savage, Neil			MODELLING Computing cancer	NATURE			English	Editorial Material																		Fisher J, 2007, NAT BIOTECHNOL, V25, P1239, DOI 10.1038/nbt1356; Mahoney AW, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P215; Stamper IJ, 2007, B MATH BIOL, V69, P2737, DOI 10.1007/s11538-007-9253-6; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8	4	12	13	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	2012	491	7425					S62	S63		10.1038/491S62a	http://dx.doi.org/10.1038/491S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320290				2022-12-28	WOS:000311339800008
J	Waldman, RJ; Mintz, ED; Papowitz, HE				Waldman, Ronald J.; Mintz, Eric D.; Papowitz, Heather E.			The Cure for Cholera - Improving Access to Safe Water and Sanitation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Waldman, Ronald J.] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Mintz, Eric D.] Ctr Dis Control & Prevent, Div Foodborne Waterborne & Environm Dis, Atlanta, GA USA; [Papowitz, Heather E.] UNICEF, Hlth Sect, New York, NY USA	George Washington University; Centers for Disease Control & Prevention - USA; UNICEF	Waldman, RJ (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.		Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257				Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Hutton G, 2008, B WORLD HEALTH ORGAN, V86, P13, DOI 10.2471/BLT.07.046045; Mintz E, 2001, AM J PUBLIC HEALTH, V91, P1565, DOI 10.2105/AJPH.91.10.1565; UNICEF/WHO Joint Monitoring, 2012, PROGR DRINK WAT SAN; World Health Organization, 2012, WKLY EPIDEMIOL REC, V87, P289	5	24	23	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	2013	368	7					592	594		10.1056/NEJMp1214179	http://dx.doi.org/10.1056/NEJMp1214179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	194VA	23301693				2022-12-28	WOS:000322659600003
J	Cesari, F; Chou, IH; Eggleston, AK; Heemels, MT; Marte, B; Weiss, U				Cesari, Francesca; Chou, I-han; Eggleston, Angela K.; Heemels, Marie-Therese; Marte, Barbara; Weiss, Ursula			Frontiers in Biology	NATURE			English	Editorial Material														Eggleston, Angela/0000-0001-8682-397X					0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					317	317		10.1038/493317a	http://dx.doi.org/10.1038/493317a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325213	Bronze			2022-12-28	WOS:000313615900037
J	Gustafson, DH				Gustafson, David H.			A Systems Engineer Meets the System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Wisconsin, Ctr Hlth Enhancement Syst Studies, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Gustafson, DH (corresponding author), Univ Wisconsin, Ctr Hlth Enhancement Syst Studies, Madison, WI 53706 USA.	dhgustaf@wisc.edu						Gustafson D. H., 2011, NIATX MODEL PROCESS	1	0	0	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					247	248		10.1001/jama.2012.176580	http://dx.doi.org/10.1001/jama.2012.176580			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321762				2022-12-28	WOS:000313546800024
J	Mueller, K				Mueller, Kristen			Inflammation's Yin-Yang INTRODUCTION	SCIENCE			English	Editorial Material																			0	21	25	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					155	155		10.1126/science.339.6116.155	http://dx.doi.org/10.1126/science.339.6116.155			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307731				2022-12-28	WOS:000313328200032
J	Arora, S				Arora, Sonal			Surgeons in training may benefit from mental visualisation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SKILLS		Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England	Imperial College London	Arora, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Dept Surg & Canc, London W2 1NY, England.	sonal.arora06@imperial.ac.uk						Arora S, 2011, J AM COLL SURGEONS, V212, P225, DOI 10.1016/j.jamcollsurg.2010.09.025; Arora S, 2011, ANN SURG, V253, P265, DOI 10.1097/SLA.0b013e318207a789; Arora S, 2010, SURG ENDOSC, V24, P179, DOI 10.1007/s00464-009-0624-y; Bolles G., 2009, J DANCE ED, V9, P6, DOI [10.1080/15290824.2009.10387379, DOI 10.1080/15290824.2009.10387379]; Danzer Enrico, 2011, J Surg Educ, V68, P519, DOI 10.1016/j.jsurg.2011.06.004; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Geoffrion R, 2012, BJOG-INT J OBSTET GY, V119, P1040, DOI 10.1111/j.1471-0528.2012.03398.x; Komesu Y, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.008; Sanders CW, 2008, MED EDUC, V42, P607, DOI 10.1111/j.1365-2923.2007.02964.x; WEINBERG R., 2008, J IMAGERY RES SPORT, V3, P1, DOI DOI 10.2202/1932-0191.1025	10	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 7	2013	346								e8611	10.1136/bmj.e8611	http://dx.doi.org/10.1136/bmj.e8611			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070YU	23295370				2022-12-28	WOS:000313552300007
J	Kaplan, HG; Malmgren, JA				Kaplan, Henry G.; Malmgren, Judith A.			The Breast Cancer Overdiagnosis Conundrum: An Oncologist's Viewpoint	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPACT		Swedish Canc Inst, Seattle, WA USA; HealthStat Consulting, Seattle, WA USA; Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA	Swedish Cancer Institute; Swedish Medical Center; University of Washington; University of Washington Seattle	Kaplan, HG (corresponding author), 1221 E Madison St, Seattle, WA 98104 USA.	hank.kaplan@swedish.org	kaplan, henry/ABI-4845-2020		Kaplan Cancer Research Fund	Kaplan Cancer Research Fund	By the Kaplan Cancer Research Fund.	Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Erbas B, 2006, BREAST CANCER RES TR, V97, P135, DOI 10.1007/s10549-005-9101-z; Esserman LJ, 2011, BREAST CANCER RES TR, V130, P725, DOI 10.1007/s10549-011-1748-z; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Kalager M, 2012, ANN INTERN MED, V156, P491, DOI 10.7326/0003-4819-156-7-201204030-00005; Kaplan HG, 2006, CLIN BREAST CANCER, V7, P133, DOI 10.3816/CBC.2006.n.022; Malmgren JA, 2012, RADIOLOGY, V262, P797, DOI 10.1148/radiol.11111734; Malmgren JA, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-131; Smith RA, 2007, CANCER-AM CANCER SOC, V109, P2205, DOI 10.1002/cncr.22671; Smith RA, 2012, ONCOLOGY-NY, V26, P471	10	5	5	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					60	+		10.7326/0003-4819-158-1-201301010-00011	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277900				2022-12-28	WOS:000313119900009
J	Khatri, PJ; Webb, JG; Rodes-Cabau, J; Fremes, SE; Ruel, M; Lau, K; Guo, H; Wijeysundera, HC; Ko, DT				Khatri, Prateek J.; Webb, John G.; Rodes-Cabau, Josep; Fremes, Stephen E.; Ruel, Marc; Lau, Kelly; Guo, Helen; Wijeysundera, Harindra C.; Ko, Dennis T.			Adverse Effects Associated With Transcatheter Aortic Valve Implantation A Meta-analysis of Contemporary Studies	ANNALS OF INTERNAL MEDICINE			English	Review							HIGH-RISK PATIENTS; ACADEMIC RESEARCH CONSORTIUM; EDWARDS SAPIEN VALVE; ACUTE KIDNEY INJURY; PERCUTANEOUS CORONARY INTERVENTION; EXPANDING COREVALVE PROSTHESIS; OUTCOME SOURCE REGISTRY; END-POINT DEFINITIONS; RANDOM-EFFECTS MODEL; QUALITY-OF-LIFE	Background: Transcatheter aortic valve implantation (TAVI) has emerged as an important treatment for patients with severe symptomatic aortic stenosis who are at high operative risk, but accurate estimates of serious adverse effects in contemporary practice are not available. Purpose: To quantify the adverse effects associated with TAVI, and to evaluate whether the type of transcatheter valve and the route of valve implantation are associated with differences in adverse outcomes. Data Source: PubMed to 5 May 2012. Study Selection: All studies that included at least 100 patients who had TAVI and reported at least 1 outcome of interest. Data Extraction: Two reviewers abstracted the data independently. A random-effects model was used to combine data on adverse outcomes and conduct stratified analyses. Data Synthesis: A total of 49 studies enrolling 16 063 patients met the inclusion criteria. Overall 30-day and 1-year survival after TAVI were 91.9% (95% CI, 91.1% to 92.8%) and 79.2% (CI, 76.9% to 81.4%), respectively. Heart block requiring permanent pacemaker implantation was the most common adverse outcome (13.1%) and was 5 times more common with the CoreValve (Medtronic, Minneapolis, Minnesota) than the Sapien valve (Edwards Lifesciences, Irving, California) implanted using the transarterial route (25.2% vs. 5.0%, respectively). The overall rate of vascular complications was 10.4% and was highest with transarterial implantation of the Sapien valve (22.3%). Acute renal failure requiring renal replacement therapy was the third most common complication, occurring in 4.9% of patients. Limitation: Rates of major vascular complications may be overestimated owing to rapidly evolving TAVI technology. Conclusion: The most common adverse effects associated with TAVI are heart block, vascular complications, and renal failure. The type of transcatheter valve and the route of implantation are associated with observed variations in the risks for some adverse effects. Primary Funding Source: Heart and Stroke Foundation of Canada. Ann Intern Med. 2013;158:35-46.	[Ko, Dennis T.] Univ Toronto, Inst Clin Evaluat Sci, G1-06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Fremes, Stephen E.; Wijeysundera, Harindra C.] Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Toronto, ON M4N 3M5, Canada; [Webb, John G.] Univ British Columbia, St Pauls Hosp, Vancouver, BC V5Z 1M9, Canada; [Rodes-Cabau, Josep] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Ruel, Marc] Univ Ottawa, Div Cardiac Surg, Ottawa, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; Laval University; Quebec Heart & Lung Institute; University of Ottawa	Ko, DT (corresponding author), Univ Toronto, Inst Clin Evaluat Sci, G1-06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dennis.ko@ices.on.ca	Fremes, Stephen E/P-7928-2015; Wijeysundera, Harindra/AAA-6058-2020	Fremes, Stephen E/0000-0003-1723-3049; Ko, Dennis/0000-0001-6840-8051; Wijeysundera, Harindra/0000-0001-8464-1080; RUEL, MARC/0000-0002-0487-1319	Canadian Institutes of Health Research New Investigator Award; Heart and Stroke Foundation of Canada	Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Grant Support: Dr. Ko is supported by a Canadian Institutes of Health Research New Investigator Award. Study analyses were funded in part by operating grants from the Heart and Stroke Foundation of Canada.	Abdel-Wahab M, 2012, AM J CARDIOL, V109, P581, DOI 10.1016/j.amjcard.2011.09.053; Abdel-Wahab M, 2011, HEART, V97, P899, DOI 10.1136/hrt.2010.217158; Aktug O, 2012, INT J CARDIOL, V160, P26, DOI 10.1016/j.ijcard.2011.03.004; Amabile N, 2012, INT J CARDIOL; Amat-Santos IJ, 2012, J AM COLL CARDIOL, V59, P178, DOI 10.1016/j.jacc.2011.09.061; [Anonymous], 2011, R LANG ENV STAT COMP; Astarci P, 2011, EUR J CARDIO-THORAC, V40, P475, DOI 10.1016/j.ejcts.2010.11.070; Avanzas P, 2010, REV ESP CARDIOL, V63, P141, DOI 10.1016/S0300-8932(10)70031-2; Bach DS, 2009, CIRC-CARDIOVASC QUAL, V2, P533, DOI 10.1161/CIRCOUTCOMES.109.848259; Bagur R, 2011, JACC-CARDIOVASC IMAG, V4, P115, DOI 10.1016/j.jcmg.2010.10.009; Bagur R, 2010, EUR HEART J, V31, P865, DOI 10.1093/eurheartj/ehp552; Bapat V, 2012, CATHETER CARDIO INTE, V79, P733, DOI 10.1002/ccd.23276; Ben-Dor I, 2011, CARDIOVASC REVASCULA, V12, P345, DOI 10.1016/j.carrev.2011.04.005; Bergmann L, 2011, ANAESTHESIA, V66, P977, DOI 10.1111/j.1365-2044.2011.06788.x; Bleiziffer S, 2009, J THORAC CARDIOV SUR, V138, P1073, DOI 10.1016/j.jtcvs.2009.07.031; Bosmans JM, 2011, INTERACT CARDIOV TH, V12, P762, DOI 10.1510/icvts.2010.253773; Brass EP, 2010, CLIN PHARMACOL THER, V87, P351, DOI 10.1038/clpt.2009.218; Buchanan GL, 2011, EUROINTERVENTION, V7, P556, DOI 10.4244/EIJV7I5A91; Buellesfeld L, 2011, J AM COLL CARDIOL, V57, P1650, DOI 10.1016/j.jacc.2010.11.044; Chorianopoulos E, 2012, CLIN RES CARDIOL, V101, P349, DOI 10.1007/s00392-011-0398-9; Clavel MA, 2011, JACC-CARDIOVASC IMAG, V4, P1053, DOI 10.1016/j.jcmg.2011.06.021; D'Ancona G, 2011, INTERACT CARDIOV TH, V13, P373, DOI 10.1510/icvts.2011.274456; D'Onofrio A, 2012, EUR J CARDIO-THORAC, V42, P480, DOI 10.1093/ejcts/ezs027; D'Onofrio A, 2012, EUR J CARDIO-THORAC, V41, P1271, DOI 10.1093/ejcts/ezr236; D'Onofrio A, 2011, J THORAC CARDIOV SUR, V142, P768, DOI 10.1016/j.jtcvs.2011.06.026; Dehedin B, 2011, J CARDIOTHOR VASC AN, V25, P1036, DOI 10.1053/j.jvca.2011.05.008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Dewey TM, 2010, ANN THORAC SURG, V89, P758, DOI 10.1016/j.athoracsur.2009.12.033; Drews T, 2012, J THORAC CARDIOVASC; Ducrocq G, 2012, EUR J CARDIO-THORAC, V41, P499, DOI 10.1093/ejcts/ezr041; Dworakowski R, 2010, AM HEART J, V160, P237, DOI 10.1016/j.ahj.2010.05.014; Elhmidi Y, 2011, AM HEART J, V161, P735, DOI 10.1016/j.ahj.2011.01.009; Eltchaninoff H, 2012, ARCH CARDIOVASC DIS, V105, P132, DOI 10.1016/j.acvd.2012.02.002; Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Ewe SH, 2011, J AM COLL CARDIOL, V58, P1910, DOI 10.1016/j.jacc.2011.08.027; Ewe SH, 2011, ANN THORAC SURG, V92, P1244, DOI 10.1016/j.athoracsur.2011.01.059; Fusari M, 2012, J CARDIOVASC MED, V13, P229, DOI 10.2459/JCM.0b013e3283515c0f; Gasparetto V., 2012, CATHETER CARDIOVASC; Geisbusch S, 2010, CIRC-CARDIOVASC INTE, V3, P531, DOI 10.1161/CIRCINTERVENTIONS.110.944983; Giannini C, 2012, J AM SOC ECHOCARDIOG, V25, P444, DOI 10.1016/j.echo.2011.12.008; Gilard M, 2012, NEW ENGL J MED, V366, P1705, DOI 10.1056/NEJMoa1114705; Godino C, 2010, JACC-CARDIOVASC INTE, V3, P1110, DOI 10.1016/j.jcin.2010.09.012; Gotzmann M, 2012, CATHETER CARDIO INTE, V79, P693, DOI 10.1002/ccd.23240; Gotzmann M, 2011, AM HEART J, V162, P238, DOI 10.1016/j.ahj.2011.05.011; Grube E, 2008, CIRC-CARDIOVASC INTE, V1, P167, DOI 10.1161/CIRCINTERVENTIONS.108.819839; Gurvitch R, 2011, CATHETER CARDIO INTE, V78, P977, DOI 10.1002/ccd.22961; Gurvitch R, 2011, EUROINTERVENTION, V7, P41, DOI 10.4244/EIJV7I1A10; Halliday BP, 2012, AM J CARDIOL, V109, P724, DOI 10.1016/j.amjcard.2011.10.034; Hamza TH, 2008, J CLIN EPIDEMIOL, V61, P41, DOI 10.1016/j.jclinepi.2007.03.016; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P207, DOI 10.1016/j.jcin.2011.09.020; Hayashida K, 2012, J AM COLL CARDIOL, V59, P566, DOI 10.1016/j.jacc.2011.10.877; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; John D, 2010, JACC-CARDIOVASC INTE, V3, P233, DOI 10.1016/j.jcin.2009.11.015; Kempfert J, 2011, CIRCULATION, V124, pS124, DOI 10.1161/CIRCULATIONAHA.110.013425; Khawaja MZ, 2011, CIRCULATION, V123, P951, DOI 10.1161/CIRCULATIONAHA.109.927152; Krane M, 2012, AM J CARDIOL, V109, P1774, DOI 10.1016/j.amjcard.2012.02.021; Lange R, 2012, J AM COLL CARDIOL, V59, P280, DOI 10.1016/j.jacc.2011.10.868; Lange R, 2011, EUR J CARDIO-THORAC, V40, P1105, DOI 10.1016/j.ejcts.2011.03.022; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; Munoz-Garcia AJ, 2012, INT J CARDIOL, V157, P124, DOI 10.1016/j.ijcard.2012.03.046; Munoz-Garcia AJ, 2012, AM HEART J, V163, P288, DOI 10.1016/j.ahj.2011.11.013; Mussardo M, 2011, JACC-CARDIOVASC INTE, V4, P743, DOI 10.1016/j.jcin.2011.05.004; Nielsen HHM, 2011, SCAND CARDIOVASC J, V45, P261, DOI 10.3109/14017431.2011.575174; Nuis RJ, 2012, NETH HEART J, V20, P16, DOI 10.1007/s12471-011-0224-z; Nuis RJ, 2011, CATHETER CARDIO INTE, V78, P457, DOI 10.1002/ccd.23018; Nuis RJM, 2011, CATHETER CARDIO INTE, V77, P881, DOI 10.1002/ccd.22874; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Pasic M, 2010, ANN THORAC SURG, V90, P1463, DOI 10.1016/j.athoracsur.2010.05.072; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Piazza N, 2008, JACC-CARDIOVASC INTE, V1, P310, DOI 10.1016/j.jcin.2008.04.007; Puls M, 2012, CLIN RES CARDIOL, V101, P553, DOI 10.1007/s00392-012-0426-4; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P1989, DOI 10.1016/j.jacc.2010.11.060; Rodes-Cabau J, 2011, J AM COLL CARDIOL, V57, P18, DOI 10.1016/j.jacc.2010.07.036; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Roques F, 2003, EUR HEART J, V24, P881, DOI 10.1016/S0195-668X(02)00799-6; Sinning JM, 2012, J AM COLL CARDIOL, V59, P1134, DOI 10.1016/j.jacc.2011.11.048; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Spethmann S, 2012, EUR HEART J-CARD IMG, V13, P690, DOI 10.1093/ehjci/jes021; Stahli BE, 2011, J INVASIVE CARDIOL, V23, P307; Stohr R, 2011, CORONARY ARTERY DIS, V22, P595, DOI 10.1097/MCA.0b013e32834d335e; Tamburino C, 2012, AM J CARDIOL, V109, P1487, DOI 10.1016/j.amjcard.2012.01.364; Tamburino C, 2012, CATHETER CARDIO INTE, V79, P132, DOI 10.1002/ccd.23100; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Taramasso M, 2011, EUR J CARDIO-THORAC, V40, P49, DOI 10.1016/j.ejcts.2010.11.039; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Unbehaun A, 2012, J AM COLL CARDIOL, V59, P211, DOI 10.1016/j.jacc.2011.10.857; Unbehaun A, 2011, ANN THORAC SURG, V92, P1315, DOI 10.1016/j.athoracsur.2011.05.077; Ussia GP, 2012, EUR HEART J, V33, P969, DOI 10.1093/eurheartj/ehr491; Ussia GP, 2012, EUROINTERVENTION, V7, P1285, DOI 10.4244/EIJV7I11A203; Ussia GP, 2011, EUROINTERVENTION, V7, P573, DOI 10.4244/EIJV7I5A93; Ussia GP, 2010, CATHETER CARDIO INTE, V76, P757, DOI 10.1002/ccd.22602; van der Boon RM, 2012, CATHETER CARDIO INTE, V79, P702, DOI 10.1002/ccd.23423; Van Linden A, 2011, EUR J CARDIO-THORAC, V39, P835, DOI 10.1016/j.ejcts.2010.11.034; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Walther T, 2007, CIRCULATION, V116, pI240, DOI 10.1161/CIRCULATIONAHA.106.677237; Walther T, 2012, EUR J CARDIO-THORAC, V42, P278, DOI 10.1093/ejcts/ezr325; Walther T, 2012, J THORAC CARDIOV SUR, V143, P326, DOI 10.1016/j.jtcvs.2010.10.063; Walther T, 2011, EUR J CARDIO-THORAC, V39, P532, DOI 10.1016/j.ejcts.2010.06.002; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Wenaweser P, 2011, J AM COLL CARDIOL, V58, P2151, DOI 10.1016/j.jacc.2011.05.063; Wenaweser P, 2011, EUROINTERVENTION, V7, P541, DOI 10.4244/EIJV7I5A89; Wenaweser P, 2011, AM HEART J, V161, P1114, DOI 10.1016/j.ahj.2011.01.025; Wendler O, 2012, EUR J CARDIO-THORAC; Wessely M, 2012, NEPHROL DIAL TRANSPL, V27, P3502, DOI 10.1093/ndt/gfs102; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	112	191	196	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					35	+		10.7326/0003-4819-158-1-201301010-00007	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00007			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277899				2022-12-28	WOS:000313119900006
J	Partridge, L				Partridge, Linda			Diet and Healthy Aging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CALORIC RESTRICTION; RHESUS-MONKEYS		[Partridge, Linda] Max Planck Inst Biol Aging, Cologne, Germany; [Partridge, Linda] UCL, Inst Healthy Aging, Dept Genet Evolut & Environm, London, England	Max Planck Society; University of London; University College London	Partridge, L (corresponding author), Max Planck Inst Biol Aging, Cologne, Germany.		Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015	Partridge, Linda/0000-0001-9615-0094				Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Mattison JA, 2012, NATURE, V489, P318, DOI 10.1038/nature11432; Weindruch R, 1988, RETARDATION AGING DI, P397	5	11	11	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2550	2551		10.1056/NEJMcibr1210447	http://dx.doi.org/10.1056/NEJMcibr1210447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059OG	23268671				2022-12-28	WOS:000312714200017
J	Webber, BJ; Seguin, PG; Burnett, DG; Clark, LL; Otto, JL				Webber, Bryant J.; Seguin, Peter G.; Burnett, Daniel G.; Clark, Leslie L.; Otto, Jean L.			Prevalence of and Risk Factors for Autopsy-Determined Atherosclerosis Among US Service Members, 2001-2011	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY ATHEROSCLEROSIS; NATURAL-HISTORY; PUBLIC-HEALTH; DISEASE; MORTALITY; ASSOCIATIONS; SOLDIERS; TRENDS	Context Autopsies of US service members killed in the Korean and Vietnam wars demonstrated that atherosclerotic changes in the coronary arteries can appear early in the second and third decades of life, long before ischemic heart disease becomes clinically apparent. Objective To estimate the current prevalence of coronary and aortic atherosclerosis in the US armed forces. Design, Setting, and Participants Cross-sectional study of all US service members who died of combat or unintentional injuries in support of Operations Enduring Freedom and Iraqi Freedom/New Dawn between October 2001 and August 2011 and whose cardiovascular autopsy reports were available at the time of data collection in January 2012. Prevalence of atherosclerosis was analyzed by various demographic characteristics and medical history. Classifications of coronary atherosclerosis severity were determined prior to data analysis and designed to provide consistency with previous military studies: minimal (fatty streaking only), moderate (10%-49% luminal narrowing of >= 1 vessel), and severe (>= 50% narrowing >= 1 of vessel). Main Outcome Measures Prevalence of coronary and aortic atherosclerosis in the US armed forces and by age, sex, self-reported race/ethnicity, education, occupation, service branch and component, military rank, body mass index at military entrance, and International Classification of Diseases, Ninth Revision, Clinical Modification, diagnoses of cardiovascular risk factors. Results Of the 3832 service members included in the analysis, the mean age was 25.9 years (range, 18-59 years) and 98.3% were male. The prevalence of any coronary atherosclerosis was 8.5% (95% Cl, 7.6%-9.4%); severe coronary atherosclerosis was present in 2.3% (95% Cl, 1.8%-2.7%), moderate in 4.7% (95% CI,4.0%-5.3%), and minimal in 1.5% (95% Cl, 1.1%-1.9%). Service members with atherosclerosis were significantly older (mean [SD] age, 30.5 [8.1] years) than those without (mean [SD] age, 25.3 [5.6] years; P<.001). Comparing atherosclerosis prevalence among with those with no cardiovascular risk factor diagnoses (11.1% [95% Cl, 10.1%-12.1%]), there was a greater prevalence among those with a diagnosis of dyslipidemia (50.0% [95% Cl, 30.3%-69.7%]; age-adjusted prevalence ratio [PR], 2.09 [95% Cl, 1.43-3.06]), hypertension (43.6% [95% Cl, 27.3%-59.9%]; age-adjusted PR, 1.88 [95% Cl, 1.34-2.65]), or obesity (22.3% [95% Cl, 15.9%-28.7%]; age-adjusted PR, 1.47 [95% Cl, 1.10-1.96]), but smoking (14.1% [95% Cl, 8.0%-20.2%]) was not significantly associated with a higher prevalence of atherosclerosis (age-adjusted PR, 1.12 [95% Cl, 0.73-1.74]). Conclusion Among deployed US service members who died of combat or unintentional injuries and received autopsies, the prevalence of atherosclerosis varied by age and cardiovascular risk factors. JAMA. 2012;308(24):2577-2583 www.jama.com	[Webber, Bryant J.] Uniformed Serv Univ Hlth Sci, PMB, Bethesda, MD 20814 USA; [Seguin, Peter G.] Armed Forces Med Examiner Syst, Dover AFB, DE USA; [Clark, Leslie L.; Otto, Jean L.] Armed Forces Hlth Surveillance Ctr, Silver Spring, MD USA; [Otto, Jean L.] Adv Mil Med Inc, Henry M Jackson Fdn, Bethesda, MD USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Air Force; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Webber, BJ (corresponding author), Uniformed Serv Univ Hlth Sci, PMB, 4301 Jones Bridge Rd,Room A1040A, Bethesda, MD 20814 USA.	bryant.webber@usuhs.edu	Webber, Bryant/ABI-7744-2020	Webber, Bryant/0000-0002-2099-2671; Burnett, Daniel/0000-0003-1277-0486	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	Uniformed Services University of the Health Sciences (USUHS); Armed Forces Medical Examiner System (AFMES); Armed Forces Health Surveillance Center (AFHSC)	This study was supported by the Uniformed Services University of the Health Sciences (USUHS), Armed Forces Medical Examiner System (AFMES), and Armed Forces Health Surveillance Center (AFHSC).	[Anonymous], 1968, AG ADJ DEATH RAT 69, P1968; [Anonymous], 2004, DOD PHYS FITN BOD PR; Armed services exchange policy, 2005, ARM SERV EXCH POL IN; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BOOZE CF, 1987, AVIAT SPACE ENVIR MD, V58, P297; BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Commander Submarine Force Atlantic Commander Submarine Force US Pacific Fleet, 2010, SUBM FORC TOB CESS P; ENOS WF, 1955, JAMA-J AM MED ASSOC, V158, P912, DOI 10.1001/jama.1955.02960110018005; ENOS WF, 1953, JAMA-J AM MED ASSOC, V152, P1090, DOI 10.1001/jama.1953.03690120006002; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Ford ES, 2011, ANNU REV PUBL HEALTH, V32, P5, DOI 10.1146/annurev-publhealth-031210-101211; Gardner JW, 2000, MIL MED, V165, P57, DOI 10.1093/milmed/165.suppl_2.57; Hatzfeld JJ, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110136; HOLME I, 1985, AM J CARDIOL, V55, P40, DOI 10.1016/0002-9149(85)90296-6; Hourani LL, 2008, 2008 DEP DEF SURV HL; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Joseph AM, 2005, MIL MED, V170, P874, DOI 10.7205/MILMED.170.10.874; JUDSON JJ, 1971, J AMER MED ASSOC, V216, P1185; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Long-term trends in diagnosed diabetes, 2012, LONG TERM TRENDS DIA; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; National Heart Lung and Blood Institute, EXP PAN INT GUID CAR; Ogden Cynthia L, 2004, Adv Data, P1; PETTYJOHN FS, 1975, AVIAT SPACE ENVIR MD, V46, P1299; QuickStats, 2009, MMWR-MORBID MORTAL W, V58, P1045; REED DM, 1987, AM J EPIDEMIOL, V126, P214, DOI 10.1093/aje/126.2.214; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Smoke-free DoD facilities, 2001, SMOK FREE DOD FAC IN; STRONG JP, 1986, JAMA-J AM MED ASSOC, V256, P2863, DOI 10.1001/jama.256.20.2863; STRONG JP, 1962, AM J PATHOL, V40, P37; Taneja N, 2002, AVIAT SPACE ENVIR MD, V73, P1025; TEJADA C, 1968, LAB INVEST, V18, P509; Tobacco use in the Air Force, 2012, TOB US AIR FORC INST; UEMURA K, 1964, B WORLD HEALTH ORGAN, V31, P297; Wilkins JT, 2012, JAMA-J AM MED ASSOC, V308, P1795, DOI 10.1001/jama.2012.14312; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339; Yoon Sung Sug Sarah, 2010, NCHS Data Brief, P1; Zhdanov VS, 1999, INT J CARDIOL, V68, P95, DOI 10.1016/S0167-5273(98)00339-8	43	85	92	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2577	2583		10.1001/jama.2012.70830	http://dx.doi.org/10.1001/jama.2012.70830			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268516	Bronze			2022-12-28	WOS:000312916600023
J	Reggiori, F; Ungermann, C				Reggiori, Fulvio; Ungermann, Christian			A Dimer to Bridge Early Autophagosomal Membranes	CELL			English	Editorial Material							ATG PROTEINS; ORGANIZATION; KINASE	The Atg1/ULK complex plays a key role in the early stages of autophagosome assembly. In this issue, Ragusa et al. reveal the molecular basis for some interactions within this complex, finding that the crescent-shaped Atg17 dimer is critical for autophagy, whereas Atg1 may have the ability to cluster membranes.	[Reggiori, Fulvio] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands; [Ungermann, Christian] Univ Osnabruck, Dept Biol Chem, D-49074 Osnabruck, Germany	Utrecht University; Utrecht University Medical Center; University Osnabruck	Reggiori, F (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	f.reggiori@umcutrecht.nl; cu@uos.de	Reggiori, Fulvio/U-8327-2019	Reggiori, Fulvio/0000-0003-2652-2686				Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kabeya Y, 2009, BIOCHEM BIOPH RES CO, V389, P612, DOI 10.1016/j.bbrc.2009.09.034; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Mari M, 2010, AUTOPHAGY, V6, P1221, DOI 10.4161/auto.6.8.13792; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Ragusa MJ, 2012, CELL, V151, P1501, DOI 10.1016/j.cell.2012.11.028; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Yamamoto H, 2012, J CELL BIOL, V198, P219, DOI 10.1083/jcb.201202061	10	3	3	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1403	1405		10.1016/j.cell.2012.12.008	http://dx.doi.org/10.1016/j.cell.2012.12.008			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260133	Bronze			2022-12-28	WOS:000312890300007
J	Crow, JM				Crow, James Mitchell			THERAPEUTICS Silencing psoriasis	NATURE			English	Editorial Material							MONOCLONAL-ANTIBODY; EFFICACY; SAFETY											Krueger G, 2001, ARCH DERMATOL, V137, P280; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp K, 2012, LANCET, V380, P738, DOI 10.1016/S0140-6736(12)60642-4; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Rich P, 2013, BRIT J DERMATOL, V168, P402, DOI 10.1111/bjd.12112	7	26	28	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					558	559		10.1038/492S58a	http://dx.doi.org/10.1038/492S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254974	Bronze			2022-12-28	WOS:000312488200006
J	Han, TH; Helton, JS; Chu, SY; Nocera, DG; Rodriguez-Rivera, JA; Broholm, C; Lee, YS				Han, Tian-Heng; Helton, Joel S.; Chu, Shaoyan; Nocera, Daniel G.; Rodriguez-Rivera, Jose A.; Broholm, Collin; Lee, Young S.			Fractionalized excitations in the spin-liquid state of a kagome-lattice antiferromagnet	NATURE			English	Article							VALENCE-BOND STATE	The experimental realization of quantum spin liquids is a long-sought goal in physics, as they represent new states of matter. Quantum spin liquids cannot be described by the broken symmetries associated with conventional ground states. In fact, the interacting magnetic moments in these systems do not order, but are highly entangled with one another over long ranges(1). Spin liquids have a prominent role in theories describing high-transition-temperature superconductors(2,3), and the topological properties of these states may have applications in quantum information(4). A key feature of spin liquids is that they support exotic spin excitations carrying fractional quantum numbers. However, detailed measurements of these 'fractionalized excitations' have been lacking. Here we report neutron scattering measurements on single-crystal samples of the spin-1/2 kagome-lattice antiferromagnet ZnCu3(OD)(6)Cl-2 (also called herbertsmithite), which provide striking evidence for this characteristic feature of spin liquids. At low temperatures, we find that the spin excitations form a continuum, in contrast to the conventional spin waves expected in ordered antiferromagnets. The observation of such a continuum is noteworthy because, so far, this signature of fractional spin excitations has been observed only in one-dimensional systems. The results also serve as a hallmark of the quantum spin-liquid state in herbertsmithite.	[Han, Tian-Heng; Lee, Young S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Helton, Joel S.; Rodriguez-Rivera, Jose A.; Broholm, Collin] NIST, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Chu, Shaoyan] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA; [Nocera, Daniel G.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Rodriguez-Rivera, Jose A.] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Broholm, Collin] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Broholm, Collin] Johns Hopkins Univ, Inst Quantum Matter, Baltimore, MD 21218 USA	Massachusetts Institute of Technology (MIT); National Institute of Standards & Technology (NIST) - USA; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland College Park; Johns Hopkins University; Johns Hopkins University	Lee, YS (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	tianheng@alum.mit.edu; younglee@mit.edu	Rodriguez-Rivera, Jose/A-4872-2013; Broholm, Collin Leslie/E-8228-2011	Rodriguez-Rivera, Jose/0000-0002-8633-8314; Broholm, Collin Leslie/0000-0002-1569-9892	US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences [DE-FG02-07ER46134]; US National Science Foundation [DMR-0944772]; DOE, Office of Basic Energy Sciences, Division of Material Sciences and Engineering [DE-FG02-08ER46544]	US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US National Science Foundation(National Science Foundation (NSF)); DOE, Office of Basic Energy Sciences, Division of Material Sciences and Engineering	We acknowledge T. Senthil, P. A. Lee, Z. Hao and O. Tchernyshyov for discussions, and J. Wen for assistance with data reduction. The work at MIT was supported by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences under grant no. DE-FG02-07ER46134. This work used facilities supported in part by the US National Science Foundation under agreement no. DMR-0944772. The work at IQM was supported by the DOE, Office of Basic Energy Sciences, Division of Material Sciences and Engineering under award DE-FG02-08ER46544.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Birgeneau RJ, 1999, PHYS REV B, V59, P13788, DOI 10.1103/PhysRevB.59.13788; de Vries MA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.237201; ELSER V, 1989, PHYS REV LETT, V62, P2405, DOI 10.1103/PhysRevLett.62.2405; Freedman DE, 2010, J AM CHEM SOC, V132, P16185, DOI 10.1021/ja1070398; Grohol D, 2005, NAT MATER, V4, P323, DOI 10.1038/nmat1353; Han TH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.100402; Han TH, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157202; Hao ZH, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214445; Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; Helton JS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.147201; Imai T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.020411; Ioffe LB, 2002, NATURE, V415, P503, DOI 10.1038/415503a; KIVELSON SA, 1987, PHYS REV B, V35, P8865, DOI 10.1103/PhysRevB.35.8865; Lecheminant P, 1997, PHYS REV B, V56, P2521, DOI 10.1103/PhysRevB.56.2521; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Lovesey S W, 1984, THEORY NEUTRON SCATT; Matan K, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.247201; Mendels P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077204; Ofer O, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/16/164207; Ran Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.117205; Ryu S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.184406; SACHDEV S, 1992, PHYS REV B, V45, P12377, DOI 10.1103/PhysRevB.45.12377; Shores MP, 2005, J AM CHEM SOC, V127, P13462, DOI 10.1021/ja053891p; Singh RRP, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144415; TENNANT DA, 1995, PHYS REV B, V52, P13368, DOI 10.1103/PhysRevB.52.13368; Wulferding D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144412; Yan SM, 2011, SCIENCE, V332, P1173, DOI 10.1126/science.1201080; Zorko A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026405	30	730	738	21	455	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 20	2012	492	7429					406	410		10.1038/nature11659	http://dx.doi.org/10.1038/nature11659			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257883	Green Submitted			2022-12-28	WOS:000312488200051
J	Kuehn, BM				Kuehn, Bridget M.			Center Takes Broader Look at Preterm Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2448	2448		10.1001/jama.2012.90690	http://dx.doi.org/10.1001/jama.2012.90690			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23287891				2022-12-28	WOS:000312441400003
J	Dusheck, J				Dusheck, Jennie			ONCOLOGY Getting physical	NATURE			English	Editorial Material							CANCER											Adriani G, 2012, BIOMATERIALS, V33, P5504, DOI 10.1016/j.biomaterials.2012.04.027; Janmey P, 2012, ASSESSMENT PHYS SCI; Lambert G, 2011, NAT REV CANCER, V11, P375, DOI 10.1038/nrc3039; Michor F, 2011, NAT REV CANCER, V11, P657, DOI 10.1038/nrc3092; Zhang QC, 2012, ANNU REV CONDEN MA P, V3, P363, DOI 10.1146/annurev-conmatphys-020911-125109	5	6	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S50	S51		10.1038/491S50a	http://dx.doi.org/10.1038/491S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320286	Bronze			2022-12-28	WOS:000311339800002
J	Spring, JB; Metcalf, BJ; Humphreys, PC; Kolthammer, WS; Jin, XM; Barbieri, M; Datta, A; Thomas-Peter, N; Langford, NK; Kundys, D; Gates, JC; Smith, BJ; Smith, PGR; Walmsley, IA				Spring, Justin B.; Metcalf, Benjamin J.; Humphreys, Peter C.; Kolthammer, W. Steven; Jin, Xian-Min; Barbieri, Marco; Datta, Animesh; Thomas-Peter, Nicholas; Langford, Nathan K.; Kundys, Dmytro; Gates, James C.; Smith, Brian J.; Smith, Peter G. R.; Walmsley, Ian A.			Boson Sampling on a Photonic Chip	SCIENCE			English	Article							QUANTUM COMPUTATION	Although universal quantum computers ideally solve problems such as factoring integers exponentially more efficiently than classical machines, the formidable challenges in building such devices motivate the demonstration of simpler, problem-specific algorithms that still promise a quantum speedup. We constructed a quantum boson-sampling machine (QBSM) to sample the output distribution resulting from the nonclassical interference of photons in an integrated photonic circuit, a problem thought to be exponentially hard to solve classically. Unlike universal quantum computation, boson sampling merely requires indistinguishable photons, linear state evolution, and detectors. We benchmarked our QBSM with three and four photons and analyzed sources of sampling inaccuracy. Scaling up to larger devices could offer the first definitive quantum-enhanced computation.	[Spring, Justin B.; Metcalf, Benjamin J.; Humphreys, Peter C.; Kolthammer, W. Steven; Jin, Xian-Min; Barbieri, Marco; Datta, Animesh; Thomas-Peter, Nicholas; Langford, Nathan K.; Smith, Brian J.; Walmsley, Ian A.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Jin, Xian-Min] Shanghai Jiao Tong Univ, Dept Phys, Shanghai 200240, Peoples R China; [Langford, Nathan K.] Univ London, Dept Phys, London TW20 0EX, England; [Kundys, Dmytro; Gates, James C.; Smith, Peter G. R.] Univ Southampton, Optoelect Res Ctr, Southampton SO17 1BJ, Hants, England	University of Oxford; Shanghai Jiao Tong University; University of London; University of Southampton	Spring, JB (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	j.spring1@physics.ox.ac.uk; i.walmsley1@physics.ox.ac.uk	Gates, James/M-3924-2019; Smith, Peter GR/D-5951-2016; Jin, Xian-Min/E-7283-2011; Datta, Animesh/E-8139-2011; Langford, Nathan K/A-5699-2012; Barbieri, Marco/G-5793-2011; Kundys, Dmytro/E-7439-2015	Gates, James/0000-0001-8671-5987; Smith, Peter GR/0000-0003-0319-718X; Jin, Xian-Min/0000-0002-2809-7882; Datta, Animesh/0000-0003-4021-4655; Langford, Nathan K/0000-0003-4338-3059; Barbieri, Marco/0000-0003-2057-9104; Kundys, Dmytro/0000-0001-8670-8146; Walmsley, Ian/0000-0002-4714-0575	Engineering and Physical Sciences Research Council [EP/C013840/1, EP/H03031X/1, EP/J000051/1]; European Commission [248095]; Royal Society; Air Force Office of Scientific Research (European Office of Aerospace Research and Development); European Union [PIIF-GA-2011-300820, PIEF-GA-2010-275103]; U.S. Air Force Institute of Technology; Engineering and Physical Sciences Research Council [EP/C013956/1, EP/E036066/1] Funding Source: researchfish; EPSRC [EP/C013956/1, EP/J000051/1, EP/H03031X/1, EP/E036066/1, EP/C013840/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Royal Society(Royal Society of London); Air Force Office of Scientific Research (European Office of Aerospace Research and Development)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); European Union(European Commission); U.S. Air Force Institute of Technology; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank J. Nunn for valuable insights. This work was supported by the Engineering and Physical Sciences Research Council (EP/C013840/1, EP/H03031X/1, and EP/J000051/1), the European Commission project Q-ESSENCE (248095), the Royal Society, and the Air Force Office of Scientific Research (European Office of Aerospace Research and Development). X. M. J. and N.K.L. are supported by European Union Marie-Curie fellowships (PIIF-GA-2011-300820 and PIEF-GA-2010-275103). J. B. S. acknowledges support from the U.S. Air Force Institute of Technology. The views expressed in this article are those of the authors and do not reflect the official policy or position of the U.S. Air Force, Department of Defense, or the U.S. Government.	Aaronson S., 2011, P 43 ANN ACM S THEOR, P333; CAIANIELLO ER, 1953, NUOVO CIMENTO, V10, P1634, DOI 10.1007/BF02781659; Childs AM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.180501; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Eisaman MD, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3610677; Gerrits T, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.060301; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; HONG CK, 1987, PHYS REV LETT, V59, P2044, DOI 10.1103/PhysRevLett.59.2044; Jordan SP, 2010, QUANTUM INF COMPUT, V10, P470; Knill E, 1998, PHYS REV LETT, V81, P5672, DOI 10.1103/PhysRevLett.81.5672; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Kundys DO, 2009, IEEE PHOTONIC TECH L, V21, P947, DOI 10.1109/LPT.2009.2021071; Lanyon BP, 2011, SCIENCE, V334, P57, DOI 10.1126/science.1208001; Lu CY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250504; Lucero E, 2012, NAT PHYS, V8, P719, DOI [10.1038/nphys2385, 10.1038/NPHYS2385]; Metcalf BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2349; Migdall AL, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.053805; Nielsen MA, 2003, PHYS LETT A, V308, P96, DOI 10.1016/S0375-9601(02)01803-0; Rohde PP, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.052321; Rohde PP, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.022332; Shadbolt PJ, 2012, NAT PHOTONICS, V6, P45, DOI [10.1038/nphoton.2011.283, 10.1038/NPHOTON.2011.283]; Shepherd D, 2009, P ROY SOC A-MATH PHY, V465, P1413, DOI 10.1098/rspa.2008.0443; Smith B. J., 2009, OPT EXPRESS, V17, P264; Troyansky L., 1996, PROC PHYSCOMP96, P314; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347	27	556	583	3	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 15	2013	339	6121					798	801		10.1126/science.1231692	http://dx.doi.org/10.1126/science.1231692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258407	Green Submitted, Green Accepted			2022-12-28	WOS:000314874400042
J	Muzerolle, J; Furlan, E; Flaherty, K; Balog, Z; Gutermuth, R				Muzerolle, James; Furlan, Elise; Flaherty, Kevin; Balog, Zoltan; Gutermuth, Robert			Pulsed accretion in a variable protostar	NATURE			English	Article							YOUNG STELLAR OBJECTS; BINARY DQ TAU; CIRCUMBINARY DISK; CLASS-I; STARS; VARIABILITY; EVOLUTION; DYNAMICS; A0538-66; AURIGA	Periodic increases in luminosity arising from variable accretion rates have been predicted for some pre-main-sequence close binary stars as they grow from circumbinary disks(1-3). The phenomenon is known as pulsed accretion and can affect the orbital evolution and mass distribution of young binaries(2,4), as well as the potential for planet formation(5,6). Accretion variability is a common feature of young stars, with a large range of amplitudes and timescales as measured from multi-epoch observations at optical(7,8) and infrared(9-13) wavelengths. Periodic variations consistent with pulsed accretion have been seen in only a few young binaries via optical accretion tracers(14-16), albeit intermittently with accretion luminosity variations ranging from zero to 50 per cent from orbit to orbit. Here we report that the infrared luminosity of a young protostar (of age about 10(5) years) increases by a factor of ten in roughly one week every 25.34 days. We attribute this to pulsed accretion associated with an unseen binary companion. The strength and regularity of this accretion signal is surprising; it may be related to the very young age of the system, which is a factor of ten younger than the other pulsed accretors previously studied.	[Muzerolle, James] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Furlan, Elise] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Flaherty, Kevin] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Balog, Zoltan] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Gutermuth, Robert] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA	Space Telescope Science Institute; National Optical Astronomy Observatory; University of Arizona; Max Planck Society; University of Massachusetts System; University of Massachusetts Amherst	Muzerolle, J (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	muzerol@stsci.edu		Furlan, Elise/0000-0001-9800-6248	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported in part by NASA through Spitzer and HST GO contracts. We thank S. Lubow, M. Livio and N. Calvet for discussions. E. F. was visiting the Infrared Processing and Analysis Center, Caltech, during the course of this work.	ARTYMOWICZ P, 1994, ASTROPHYS J, V421, P651, DOI 10.1086/173679; Barsony M, 2005, ASTROPHYS J, V630, P381, DOI 10.1086/431351; Basri G, 1997, ASTRON J, V114, P781, DOI 10.1086/118510; Bouvier J, 2007, ASTRON ASTROPHYS, V463, P1017, DOI 10.1051/0004-6361:20066021; Covey KR, 2005, ASTRON J, V129, P2765, DOI 10.1086/429736; DENSHAM RH, 1983, MON NOT R ASTRON SOC, V205, P1117, DOI 10.1093/mnras/205.4.1117; Flaherty KM, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/1/71; Gunther R, 2002, ASTRON ASTROPHYS, V387, P550, DOI 10.1051/0004-6361:20020407; Hartmann L, 1997, ASTROPHYS J, V475, P770, DOI 10.1086/303547; Herbst W, 2010, ASTRON J, V140, P2025, DOI 10.1088/0004-6256/140/6/2025; Jensen ELN, 2007, ASTRON J, V134, P241, DOI 10.1086/518408; KENYON SJ, 1993, ASTROPHYS J, V414, P676, DOI 10.1086/173114; Kospal A, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201016160; Liu MC, 1996, ASTROPHYS J, V461, P334, DOI 10.1086/177060; Mathieu RD, 1997, ASTRON J, V113, P1841, DOI 10.1086/118395; Morales-Calderon M, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/1/50; Nguyen DC, 2009, ASTROPHYS J LETT, V694, pL153, DOI 10.1088/0004-637X/694/2/L153; Nordhagen S, 2006, ASTRON J, V132, P1555, DOI 10.1086/506985; Plavchan P, 2008, ASTROPHYS J LETT, V684, pL37, DOI 10.1086/592107; Quintana EV, 2006, ICARUS, V185, P1, DOI 10.1016/j.icarus.2006.06.016; Shi JM, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/2/118; SKINNER GK, 1980, NATURE, V288, P141, DOI 10.1038/288141a0; Stark DP, 2006, ASTROPHYS J, V649, P900, DOI 10.1086/506926; White RJ, 2004, ASTROPHYS J, V616, P998, DOI 10.1086/425115; Wood K, 1998, ASTROPHYS J, V506, pL43, DOI 10.1086/311643	27	39	39	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					378	380		10.1038/nature11746	http://dx.doi.org/10.1038/nature11746			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283175	Green Submitted			2022-12-28	WOS:000313615900045
J	Maki, DG				Maki, Dennis G.			Clinically indicated and routine replacement of peripheral IV catheters did not differ for phlebitis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RECOMMENDATIONS; INFECTIONS		Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Maki, DG (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA.		Rickard, Claire M./C-3440-2008	Rickard, Claire M./0000-0002-6341-7415				O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; Pujol M, 2007, J HOSP INFECT, V67, P22, DOI 10.1016/j.jhin.2007.06.017; Safdar N, 2011, J HOSP INFECT, V79, P172, DOI 10.1016/j.jhin.2011.06.005; Trinh TT, 2011, INFECT CONT HOSP EP, V32, P579, DOI 10.1086/660099	4	2	3	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC8	10.7326/0003-4819-158-2-201301150-02008	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318342				2022-12-28	WOS:000314029400007
J	Knaden, M; Hansson, BS				Knaden, Markus; Hansson, Bill S.			Specialized But Flexible	SCIENCE			English	Editorial Material									[Knaden, Markus; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany	Max Planck Society	Knaden, M (corresponding author), Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany.	mknaden@ice.mpg.de; hansson@ice.mpg.de	Knaden, Markus/E-2151-2015; Hansson, Bill/G-2774-2013	Knaden, Markus/0000-0002-6710-1071; Hansson, Bill/0000-0002-4811-1223				Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483	3	1	1	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					151	152		10.1126/science.1232930	http://dx.doi.org/10.1126/science.1232930			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307729				2022-12-28	WOS:000313328200030
J	Boettiger, C; Hastings, A				Boettiger, Carl; Hastings, Alan			From patterns to predictions	NATURE			English	Editorial Material							EARLY-WARNING SIGNALS; CRITICAL TRANSITIONS; ECOSYSTEMS; COLLAPSE		[Boettiger, Carl] Univ Calif Santa Cruz, Ctr Stock Assessment Res, Dept Appl Math & Stat, Santa Cruz, CA 95064 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Santa Cruz; University of California System; University of California Davis	Boettiger, C (corresponding author), Univ Calif Santa Cruz, Ctr Stock Assessment Res, Dept Appl Math & Stat, Mail Stop SOE 2, Santa Cruz, CA 95064 USA.	cboettig@ucdavis.edu; amhastings@ucdavis.edu	Boettiger, Carl/F-9784-2010; Hastings, Alan/O-6864-2019	Boettiger, Carl/0000-0002-1642-628X; Hastings, Alan/0000-0002-0717-8026				[Anonymous], 2013, GLOB RISKS IN PRESS; Boettiger C, 2012, J R SOC INTERFACE, V9, P2527, DOI 10.1098/rsif.2012.0125; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2011, AM NAT, V177, pE153, DOI 10.1086/659945; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Lade SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002360; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schreiber S, 2008, ECOL LETT, V11, P576, DOI 10.1111/j.1461-0248.2008.01171.x; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	10	78	79	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 10	2013	493	7431					157	158		10.1038/493157a	http://dx.doi.org/10.1038/493157a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302842	Bronze			2022-12-28	WOS:000313259600013
J	Oisi, Y; Ota, KG; Kuraku, S; Fujimoto, S; Kuratani, S				Oisi, Yasuhiro; Ota, Kinya G.; Kuraku, Shigehiro; Fujimoto, Satoko; Kuratani, Shigeru			Craniofacial development of hagfishes and the evolution of vertebrates	NATURE			English	Article							LETHENTERON-JAPONICUM; BDELLOSTOMA STOUTI; LAMPETRA-JAPONICA; TRIGEMINAL NERVE; NEURAL CREST; GENES; EXPRESSION; LAMPREYS; ADENOHYPOPHYSIS; ORGANIZATION	Cyclostomes, the living jawless vertebrates including hagfishes and lampreys, represent the most basal lineage of vertebrates. Although the monophyly of cyclostomes has been supported by recent molecular analyses, the phenotypic traits of hagfishes, especially the lack of some vertebrate-defining features and the reported endodermal origin of the adenohypophysis, have been interpreted as hagfishes exhibiting a more ancestral state than those of all other vertebrates. Furthermore, the adult anatomy of hagfishes cannot be compared easily with that of lampreys. Here we describe the craniofacial development of a series of staged hagfish embryos, which shows that their adenohypophysis arises ectodermally, consistent with the molecular phylogenetic data. This finding also allowed us to identify a pan-cyclostome pattern, one not shared by jawed vertebrates. Comparative analyses indicated that many of the hagfish-specific traits can be explained by changes secondarily introduced into the hagfish lineage. We also propose a possibility that the pan-cyclostome pattern may reflect the ancestral programme for the craniofacial development of all living vertebrates.	[Oisi, Yasuhiro] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 6578501, Japan; [Oisi, Yasuhiro; Fujimoto, Satoko; Kuratani, Shigeru] RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan; [Ota, Kinya G.] Acad Sinica, Inst Cellular & Organism Biol, Marine Res Stn, Yilan 26242, Taiwan; [Kuraku, Shigehiro] RIKEN Ctr Dev Biol, Genome Resource & Anal Unit, Kobe, Hyogo 6500047, Japan	Kobe University; RIKEN; RIKEN	Kuratani, S (corresponding author), RIKEN Ctr Dev Biol, Lab Evolutionary Morphol, Kobe, Hyogo 6500047, Japan.	saizo@cdb.riken.jp	Kuraku, Shigehiro/B-2801-2009; Kuratani, Shigeru/J-4146-2014	Kuraku, Shigehiro/0000-0003-1464-8388; Kuratani, Shigeru/0000-0001-9717-7221	Grants-in-Aid for Scientific Research [22128003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adachi N, 2012, EVOL DEV, V14, P234, DOI 10.1111/j.1525-142X.2012.00542.x; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; BARDACK D, 1991, SCIENCE, V254, P701, DOI 10.1126/science.254.5032.701; Candiani S, 2008, BRAIN RES BULL, V75, P324, DOI 10.1016/j.brainresbull.2007.10.023; Charles MA, 2005, MOL ENDOCRINOL, V19, P1893, DOI 10.1210/me.2005-0052; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Dean B., 1899, EMBRYOLOGY BDELLOSTO, P220; FOREY P, 1993, NATURE, V361, P129, DOI 10.1038/361129a0; Gai ZK, 2011, NATURE, V476, P324, DOI 10.1038/nature10276; Gess RW, 2006, NATURE, V443, P981, DOI 10.1038/nature05150; GORBMAN A, 1983, AM ZOOL, V23, P639; GORBMAN A, 1985, EVOLUTIONARY BIOL PR, P165; Heimberg AM, 2010, P NATL ACAD SCI USA, V107, P19379, DOI 10.1073/pnas.1010350107; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; Janvier P., 1996, EARLY VERTEBRATES; Janvier P, 2008, ZOOL SCI, V25, P1045, DOI 10.2108/zsj.25.1045; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KOYAMA H, 1987, J COMP NEUROL, V264, P437, DOI 10.1002/cne.902640402; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; Kuratani S, 2008, J EXP ZOOL PART B, V310B, P294, DOI 10.1002/jez.b.21190; Kuratani S, 2012, EVOL DEV, V14, P76, DOI 10.1111/j.1525-142X.2011.00523.x; Mallat J, 1998, MOL BIOL EVOL, V15, P1706, DOI 10.1093/oxfordjournals.molbev.a025897; Marinelli W., 1956, VERGLEICHENDE ANATOM; Maruoka Y, 1998, MECH DEVELOP, V74, P175, DOI 10.1016/S0925-4773(98)00061-6; NISHIZAWA H, 1988, J COMP NEUROL, V267, P281, DOI 10.1002/cne.902670210; Ogasawara M, 2000, DEV BIOL, V223, P399, DOI 10.1006/dbio.2000.9756; Ota KG, 2007, NATURE, V446, P672, DOI 10.1038/nature05633; Ota KG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1355; Schlosser G, 2005, J EXP ZOOL PART B, V304B, P347, DOI 10.1002/jez.b.21055; SONG J, 1993, ACTA ANAT, V148, P139; Soukup V., 2012, J ANAT; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Steinberg M., 1957, YB CARNEGIE I WASH, V56, P347; Stensio E.A., 1927, SKRIFTER SVALBARD NO, DOI DOI 10.3402/POLAR.V14I1.6649; Stockard CR, 1906, AM J ANAT, V5, P481, DOI 10.1002/aja.1000050405; Stockard CR, 1906, AM J ANAT, V6, P511, DOI 10.1002/aja.1000060114; STRAHAN RONALD, 1958, ACTA ZOOL [STOCKHOLM], V39, P227; Sugahara F, 2011, DEVELOPMENT, V138, P1217, DOI 10.1242/dev.059360; TAHARA Y, 1988, ZOOL SCI, V5, P109; Takezaki N, 2003, MOL BIOL EVOL, V20, P287, DOI 10.1093/molbev/msg040; Takio Y, 2007, DEV BIOL, V308, P606, DOI 10.1016/j.ydbio.2007.05.009; Tiecke E, 2007, DEV GENES EVOL, V217, P691, DOI 10.1007/s00427-007-0181-0; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; von Kupffer C., 1900, STUDIEN VERGLEICHEND; WICHT H, 1995, PHILOS T ROY SOC B, V349, P119, DOI 10.1098/rstb.1995.0098; Wicht H, 1998, BIOLOGY OF HAGFISHES, P431; YALDEN DW, 1985, ZOOL J LINN SOC-LOND, V84, P291, DOI 10.1111/j.1096-3642.1985.tb01802.x	50	96	99	0	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					175	180		10.1038/nature11794	http://dx.doi.org/10.1038/nature11794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23254938				2022-12-28	WOS:000313259600030
J	Shulman, C; Annetta, V				Shulman, Carolina; Annetta, Veronica			Clonus after a Stroke	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shulman, Carolina; Annetta, Veronica] Hosp Enrique Tornu Clin Med, Buenos Aires, DF, Argentina		Shulman, C (corresponding author), Hosp Enrique Tornu Clin Med, Buenos Aires, DF, Argentina.	carolinashu@yahoo.com							0	0	0	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					E2	E2		10.1056/NEJMicm1203111	http://dx.doi.org/10.1056/NEJMicm1203111			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301755				2022-12-28	WOS:000313238100008
J	Wordsworth, R; Pierrehumbert, R				Wordsworth, Robin; Pierrehumbert, Raymond			Hydrogen-Nitrogen Greenhouse Warming in Earth's Early Atmosphere	SCIENCE			English	Article							CLIMATE; EVOLUTION; PLANETS; ARCHAEA; GA	Understanding how Earth has sustained surface liquid water throughout its history remains a key challenge, given that the Sun's luminosity was much lower in the past. Here we show that with an atmospheric composition consistent with the most recent constraints, the early Earth would have been significantly warmed by H-2-N-2 collision-induced absorption. With two to three times the present-day atmospheric mass of N-2 and a H-2 mixing ratio of 0.1, H-2-N-2 warming would be sufficient to raise global mean surface temperatures above 0 degrees C under 75% of present-day solar flux, with CO2 levels only 2 to 25 times the present-day values. Depending on their time of emergence and diversification, early methanogens may have caused global cooling via the conversion of H-2 and CO2 to CH4, with potentially observable consequences in the geological record.	[Wordsworth, Robin; Pierrehumbert, Raymond] Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA	University of Chicago	Wordsworth, R (corresponding author), Univ Chicago, Dept Geol Sci, Chicago, IL 60637 USA.	rwordsworth@uchicago.edu		Pierrehumbert, Raymond/0000-0002-5887-1197				Abbot DS, 2012, ASTROPHYS J, V756, DOI 10.1088/0004-637X/756/2/178; Blank CE, 2009, GEOBIOLOGY, V7, P495, DOI 10.1111/j.1472-4669.2009.00219.x; BORYSOW A, 1986, ASTROPHYS J, V303, P495, DOI 10.1086/164096; Catling DC, 2006, SCIENCE, V311, DOI 10.1126/science.1117827; Dhuime B, 2012, SCIENCE, V335, P1334, DOI 10.1126/science.1216066; Driese SG, 2011, PRECAMBRIAN RES, V189, P1, DOI 10.1016/j.precamres.2011.04.003; Feulner G, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000375; Goldblatt C, 2009, NAT GEOSCI, V2, P891, DOI 10.1038/NGEO692; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; House CH, 2003, GEOBIOLOGY, V1, P15, DOI 10.1046/j.1472-4669.2003.00004.x; Kasting J. F, 2012, GLOBAL OXYGEN CYCLE, P93; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; Pavlov AA, 2001, J GEOPHYS RES-PLANET, V106, P23267, DOI 10.1029/2000JE001448; Peck WH, 2001, GEOCHIM COSMOCHIM AC, V65, P4215, DOI 10.1016/S0016-7037(01)00711-6; Pierrehumbert R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L13; Pope EC, 2012, P NATL ACAD SCI USA, V109, P4371, DOI 10.1073/pnas.1115705109; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Stevenson DJ, 1999, NATURE, V400, P32, DOI 10.1038/21811; Tian F, 2006, SCIENCE, V311, DOI 10.1126/science.1118412; Tian F, 2005, SCIENCE, V308, P1014, DOI 10.1126/science.1106983; Tian F, 2011, EARTH PLANET SC LETT, V308, P417, DOI 10.1016/j.epsl.2011.06.011; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; WATSON AJ, 1981, ICARUS, V48, P150, DOI 10.1016/0019-1035(81)90101-9; Wordsworth R, 2012, ICARUS, V219, P267, DOI 10.1016/j.icarus.2012.02.035; Wordsworth RD, 2010, ASTRON ASTROPHYS, V522, DOI 10.1051/0004-6361/201015053; Young GM, 1998, J GEOL, V106, P523, DOI 10.1086/516039	31	132	135	2	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					64	67		10.1126/science.1225759	http://dx.doi.org/10.1126/science.1225759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288536	Green Submitted			2022-12-28	WOS:000312985800051
J	Leng, SY; Nallamothu, BK; Saint, S; Appleman, LJ; Bump, GM				Leng, Siyang; Nallamothu, Brahmajee K.; Saint, Sanjay; Appleman, Leonard J.; Bump, Gregory M.			Simple and Complex	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; POLYCYTHEMIA-VERA; MYELOFIBROSIS; THROMBOSIS; DIAGNOSIS; NEOPLASMS; RUXOLITINIB; MANAGEMENT; DISEASE		[Leng, Siyang; Appleman, Leonard J.; Bump, Gregory M.] Univ Pittsburgh, Med Ctr, Dept Med, Pittsburgh, PA USA; [Appleman, Leonard J.] Univ Pittsburgh, Med Ctr, Div Hematol Oncol, Pittsburgh, PA USA; [Nallamothu, Brahmajee K.; Saint, Sanjay] VA Ann Arbor Healthcare Syst, Dept Internal Med, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] VA Ann Arbor Healthcare Syst, Div Cardiol, Ann Arbor, MI USA; Univ Michigan Hlth Syst, Ann Arbor, MI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Leng, SY (corresponding author), VA Pittsburgh Healthcare Syst, Univ Dr 130-U, Pittsburgh, PA 15240 USA.	siyang.leng@gmail.com	Saint, Sanjay/AAF-5126-2019	Appleman, Leonard/0000-0003-4951-7388				Barbui T, 2011, CURR OPIN ONCOL, V23, P654, DOI 10.1097/CCO.0b013e32834bb867; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barbui T, 2010, BLOOD, V115, P778, DOI 10.1182/blood-2009-08-238956; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Harrison C, 2012, NEW ENGL J MED, V366, P787, DOI 10.1056/NEJMoa1110556; Harrison CN, 2010, BRIT J HAEMATOL, V149, P352, DOI 10.1111/j.1365-2141.2010.08122.x; Kardasz I, 2007, J INTERN MED, V261, P330, DOI 10.1111/j.1365-2796.2007.01788.x; Landolfi R, 2008, LEUKEMIA, V22, P2020, DOI 10.1038/leu.2008.253; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Papadakis E, 2010, BLOOD REV, V24, P227, DOI 10.1016/j.blre.2010.08.002; Schafer AI, 2004, NEW ENGL J MED, V350, P1211, DOI 10.1056/NEJMra035363; Tefferi A, 2008, LEUKEMIA, V22, P14, DOI 10.1038/sj.leu.2404955; Tefferi A, 2011, BLOOD REV, V25, P229, DOI 10.1016/j.blre.2011.06.002; Tefferi A, 2012, AM J HEMATOL, V87, P285, DOI 10.1002/ajh.23135; Verstovsek S, 2012, NEW ENGL J MED, V366, P799, DOI 10.1056/NEJMoa1110557	16	4	4	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					65	71		10.1056/NEJMcps1202256	http://dx.doi.org/10.1056/NEJMcps1202256			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281978				2022-12-28	WOS:000312930600008
J	Ecker, JL; Solt, K; Fitzsimons, MG; MacGillivray, TE				Ecker, Jeffrey L.; Solt, Ken; Fitzsimons, Michael G.; MacGillivray, Thomas E.			Case 40-2012: A 43-Year-Old Woman with Cardiorespiratory Arrest after a Cesarean Section	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AMNIOTIC-FLUID EMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DIAGNOSIS; MORTALITY		[Ecker, Jeffrey L.] Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Solt, Ken] Massachusetts Gen Hosp, Div Obstetr Anesthesia, Boston, MA 02114 USA; [Fitzsimons, Michael G.] Massachusetts Gen Hosp, Div Cardiac Anesthesia, Boston, MA 02114 USA; [MacGillivray, Thomas E.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [MacGillivray, Thomas E.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Ecker, Jeffrey L.] Harvard Univ, Sch Med, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; [Solt, Ken; Fitzsimons, Michael G.] Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; [MacGillivray, Thomas E.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ecker, JL (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.		Solt, Ken/AAX-8188-2020	Solt, Ken/0000-0001-5328-2062				Abenhaim HA, 2008, AM J OBSTET GYNECOL, V199; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Brodie D, 2011, NEW ENGL J MED, V365, P1905, DOI 10.1056/NEJMct1103720; CLARK SL, 1995, AM J OBSTET GYNECOL, V172, P1158, DOI 10.1016/0002-9378(95)91474-9; CLARK SL, 1988, AM J OBSTET GYNECOL, V158, P1124, DOI 10.1016/0002-9378(88)90236-0; Gilbert WM, 1999, OBSTET GYNECOL, V93, P973, DOI 10.1016/S0029-7844(99)00004-6; Gist RS, 2009, ANESTH ANALG, V108, P1599, DOI 10.1213/ane.0b013e31819e43a4; James CF, 2004, INT J OBSTET ANESTH, V13, P279, DOI 10.1016/j.ijoa.2004.03.008; Knight M, 2010, OBSTET GYNECOL, V115, P910, DOI 10.1097/AOG.0b013e3181d9f629; Lee PHU, 2010, ANN THORAC SURG, V90, P1694, DOI 10.1016/j.athoracsur.2010.05.017; LEE W, 1986, AM J OBSTET GYNECOL, V155, P999, DOI 10.1016/0002-9378(86)90334-0; MILLER R, 2005, MILLERS ANESTHESIA, V2, P1; Porat S, 2004, BJOG-INT J OBSTET GY, V111, P506, DOI 10.1111/j.1471-0528.2004.00102.x; ROCHE WD, 1974, OBSTET GYNECOL, V43, P729; Rodgers L, 2000, AANA J, V68, P444; Saad A, 2006, EUR J ECHOCARDIOGR, V7, P332, DOI 10.1016/j.euje.2005.06.012; SELDINGER SI, 1953, ACTA RADIOL, V39, P368, DOI 10.3109/00016925309136722; Shechtman M, 1999, ANESTH ANALG, V89, P1456, DOI 10.1097/00000539-199912000-00025; Stanten RD, 2003, OBSTET GYNECOL, V102, P496, DOI 10.1016/S0029-7844(03)00161-3; VANMAELE L, 1990, INTENS CARE MED, V16, P269, DOI 10.1007/BF01705165; Vellayappan U, 2009, ANESTH ANALG, V108, P1110, DOI 10.1213/ane.0b013e318195b4e3	21	31	37	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2528	2536		10.1056/NEJMcpc1201413	http://dx.doi.org/10.1056/NEJMcpc1201413			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268668				2022-12-28	WOS:000312714200012
J	Lane, N; Martin, WF				Lane, Nick; Martin, William F.			The Origin of Membrane Bioenergetics	CELL			English	Review							OXIDATION-REDUCTION POTENTIALS; EARLY EVOLUTION; COMPLEX; FERREDOXIN; LIFE; EMERGENCE; REDOX; CELLS; FIXATION; BACTERIA	Harnessing energy as ion gradients across membranes is as universal as the genetic code. We leverage new insights into anaerobe metabolism to propose geochemical origins that account for the ubiquity of chemiosmotic coupling, and Na+/H+ transporters in particular. Natural proton gradients acting across thin FeS walls within alkaline hydrothermal vents could drive carbon assimilation, leading to the emergence of protocells within vent pores. Protocell membranes that were initially leaky would eventually become less permeable, forcing cells dependent on natural H+ gradients to pump Na+ ions. Our hypothesis accounts for the Na+/H+ promiscuity of bioenergetic proteins, as well as the deep divergence between bacteria and archaea.	[Lane, Nick] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Martin, William F.] Univ Dusseldorf, Inst Mol Evolut, D-40225 Dusseldorf, Germany	University of London; University College London; Heinrich Heine University Dusseldorf	Lane, N (corresponding author), UCL, Res Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk	Martin, William F./O-5446-2015	Martin, William F./0000-0003-1478-6449; Lane, Nick/0000-0002-5433-3973	UCL Provost's Venture Research Fellowship; Leverhulme Trust; European Research Council	UCL Provost's Venture Research Fellowship; Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission)	We thank Filipa Sousa, Mike Russell, Wolfgang Nitschke, John Allen, Peter Rich, Ana Hidalgo, Don Braben, Frank Harold, Manuela Pereira, John Baross, Volker Muller, Georg Fuchs, and Rolf Thauer for discussions and for criticisms of earlier versions of this paper. N.L. is grateful to the UCL Provost's Venture Research Fellowship and the Leverhulme Trust for funding. W.F.M. thanks the European Research Council for funding.	Amend JP, 2009, ACS SYM SER, V1025, P63; Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; Baaske P, 2007, P NATL ACAD SCI USA, V104, P9346, DOI 10.1073/pnas.0609592104; BARBER MJ, 1982, BIOCHEMISTRY-US, V21, P1638, DOI 10.1021/bi00536a026; BAROSS JA, 1985, ORIGINS LIFE EVOL B, V15, P327, DOI 10.1007/BF01808177; Batista AP, 2012, IUBMB LIFE, V64, P492, DOI 10.1002/iub.1050; Baymann F, 2003, PHILOS T ROY SOC B, V358, P267, DOI 10.1098/rstb.2002.1184; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Branciamore S, 2009, J MOL EVOL, V69, P458, DOI 10.1007/s00239-009-9278-6; Buckel W., 2012, BIOCH BIOPHYS ACTA; Chaves MRM, 2011, SEDIMENT TRANSPORT, P313; Chen KS, 2002, NAT STRUCT BIOL, V9, P188, DOI 10.1038/nsb751; Corrado ME, 1996, EUR J BIOCHEM, V239, P662, DOI 10.1111/j.1432-1033.1996.0662u.x; ECK RV, 1966, SCIENCE, V152, P363, DOI 10.1126/science.152.3720.363; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; FUCHS G, 1986, FEMS MICROBIOL LETT, V39, P181, DOI 10.1111/j.1574-6968.1986.tb01859.x; Fuchs G, 2011, ANNU REV MICROBIOL, V65, P631, DOI 10.1146/annurev-micro-090110-102801; HARMS U, 1995, EUR J BIOCHEM, V228, P640, DOI 10.1111/j.1432-1033.1995.0640m.x; Harold F. M., 1986, VITAL FORCE STUDY BI; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kaster AK, 2011, P NATL ACAD SCI USA, V108, P2981, DOI 10.1073/pnas.1016761108; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Koonin EV, 2005, TRENDS GENET, V21, P647, DOI 10.1016/j.tig.2005.09.006; Lane N, 2010, BIOESSAYS, V32, P271, DOI 10.1002/bies.200900131; Lang SQ, 2010, GEOCHIM COSMOCHIM AC, V74, P941, DOI 10.1016/j.gca.2009.10.045; Li F, 2008, J BACTERIOL, V190, P843, DOI 10.1128/JB.01417-07; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; MADEN BEH, 1995, TRENDS BIOCHEM SCI, V20, P337, DOI 10.1016/S0968-0004(00)89069-6; Marreiros B.C., 2012, BIOCH BIOPHYS ACTA; Martin W, 2003, PHILOS T R SOC B, V358, P59, DOI 10.1098/rstb.2002.1183; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Martin WF, 2012, FEBS LETT, V586, P485, DOI 10.1016/j.febslet.2011.09.031; Mast CB, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.188102; MILLER SL, 1988, NATURE, V334, P609, DOI 10.1038/334609a0; MITCHELL P, 1975, FEBS LETT, V56, P1, DOI 10.1016/0014-5793(75)80098-6; Morowitz H., 1968, ENERGY FLOW BIOL; Mulkidjanian AY, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-13; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Mulkidjanian AY, 2012, P NATL ACAD SCI USA, V109, pE821, DOI 10.1073/pnas.1117774109; Nitschke W, 2009, J MOL EVOL, V69, P481, DOI 10.1007/s00239-009-9289-3; Phillips R, 2009, P NATL ACAD SCI USA, V106, P21465, DOI 10.1073/pnas.0907732106; Poehlein A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033439; Pohorille A, 2009, RES MICROBIOL, V160, P449, DOI 10.1016/j.resmic.2009.06.004; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; Russell MJ, 2004, TRENDS BIOCHEM SCI, V29, P358, DOI 10.1016/j.tibs.2004.05.007; RUSSELL MJ, 1993, TERRA NOVA, V5, P343, DOI 10.1111/j.1365-3121.1993.tb00267.x; Saladino R, 2012, PHYS LIFE REV, V9, P84, DOI 10.1016/j.plrev.2011.12.002; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Shock E, 2010, GEOFLUIDS, V10, P161, DOI 10.1111/j.1468-8123.2010.00277.x; Shock Everett L., 1998, P59; Sleep NH, 2004, P NATL ACAD SCI USA, V101, P12818, DOI 10.1073/pnas.0405289101; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Storbeck S, 2010, ARCHAEA, V2010, DOI 10.1155/2010/175050; Surin S, 2007, FEMS MICROBIOL LETT, V269, P301, DOI 10.1111/j.1574-6968.2007.00655.x; Thauer RK, 2008, NAT REV MICROBIOL, V6, P579, DOI 10.1038/nrmicro1931; vandeVossenberg JLCM, 1995, MOL MICROBIOL, V18, P925, DOI 10.1111/j.1365-2958.1995.18050925.x; WACHTERSHAUSER G, 1988, SYST APPL MICROBIOL, V10, P207; White RH, 2004, BIOCHEMISTRY-US, V43, P7618, DOI 10.1021/bi0495127; Wolthers M, 2005, GEOCHIM COSMOCHIM AC, V69, P3469, DOI 10.1016/j.gca.2005.01.027; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z	67	223	230	9	225	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1406	1416		10.1016/j.cell.2012.11.050	http://dx.doi.org/10.1016/j.cell.2012.11.050			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260134	Bronze			2022-12-28	WOS:000312890300008
J	Vance, E				Vance, Erik			MEGADATA The odd couple	NATURE			English	Editorial Material																			0	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S52	S54		10.1038/491S52a	http://dx.doi.org/10.1038/491S52a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320285	Bronze			2022-12-28	WOS:000311339800003
J	Smolen, JS; Nash, P; Durez, P; Hall, S; Ilivanova, E; Irazoque-Palazuelos, F; Miranda, P; Park, MC; Pavelka, K; Pedersen, R; Szumski, A; Hammond, C; Koenig, AS; Vlahos, B				Smolen, Josef S.; Nash, Peter; Durez, Patrick; Hall, Stephen; Ilivanova, Elena; Irazoque-Palazuelos, Fedra; Miranda, Pedro; Park, Min-Chan; Pavelka, Karel; Pedersen, Ronald; Szumski, Annette; Hammond, Constance; Koenig, Andrew S.; Vlahos, Bonnie			Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial	LANCET			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; DISEASE-ACTIVITY; EULAR RECOMMENDATIONS; DOUBLE-BLIND; FUNCTIONAL-CAPACITY; REMISSION; THERAPY; MANAGEMENT; DAMAGE; COMBINATION	Background Clinical remission and low disease activity are essential treatment targets in patients with rheumatoid arthritis. Although moderately active rheumatoid arthritis is common, treatment effects in moderate disease have not been well studied. Additionally, optimum use of biologics needs further investigation, including the use of induction, maintenance, and withdrawal treatment strategies. The aim of the PRESERVE trial was to assess whether low disease activity would be sustained with reduced doses or withdrawal of etanercept in patients with moderately active disease. Methods In a randomised controlled trial, patients aged between 18 and 70 years with moderately active rheumatoid arthritis (disease activity score in 28 joints [DAS28] >3.2 and <= 5.1) despite treatment with methotrexate were enrolled at 80 centres in Europe, Latin America, Asia, and Australia between March 6, 2008, and Sept 9, 2009. To be eligible, patients had to have been receiving 15-25 mg of methotrexate every week for at least 8 weeks. In an open-label period of 36 weeks, all patients were given 50 mg etanercept plus methotrexate every week. To be eligible for a subsequent double-blind period of 52 weeks, participants had to have achieved sustained low disease activity. These patients were randomly assigned (1: 1: 1) by an interactive voice-response system to one of three treatment groups: 50 mg etanercept plus methotrexate, 25 mg etanercept plus methotrexate, or placebo plus methotrexate. Patients were stratified in blocks of three by DAS28 response (low disease activity or remission) at week 36. Patients, investigators, data analysts, and study staff were all masked to treatment allocation. The primary endpoint was the proportion of patients with low disease activity at week 88 in the groups given 50 mg etanercept or placebo in the double-blind period. A conditional primary endpoint was the proportion of patients receiving 25 mg etanercept who achieved low disease activity. Modified intention-to-treat populations were used for analyses. This trial is registered with ClinicalTrials.gov, number NCT00565409. Findings 604 (72.4%) of 834 enrolled patients were eligible for the double-blind period, of whom 202 were assigned to 50 mg etanercept plus methotrexate, 202 to 25 mg etanercept plus methotrexate, and 200 to placebo plus methotrexate. At week 88, 166 (82.6%) of 201 patients who had received at least one dose of 50 mg etanercept and one or more DAS28 evaluations had low disease activity, compared with 84 (42.6%) of 197 who had received placebo (mean difference 40.8%, 95% CI 32.5-49.1%; p<0.0001). Additionally, 159 (79.1%) of 201 patients given 25 mg etanercept had low disease activity at week 88 (mean difference from placebo 35.9%, 27.0-44.8%; p<0.0001). Interpretation Conventional or reduced doses of etanercept with methotrexate in patients with moderately active rheumatoid arthritis more effectively maintain low disease activity than does methotrexate alone after withdrawal of etanercept.	[Smolen, Josef S.] Med Univ Vienna, Div Rheumatol, A-1090 Vienna, Austria; [Smolen, Josef S.] Hietzing Hosp, A-1090 Vienna, Austria; [Nash, Peter] Univ Queensland, Dept Med, Rheumatol Res Unit, Brisbane, Qld 4000, Australia; [Durez, Patrick] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium; [Hall, Stephen] Cabrini Hlth, Emeritus Res, Malvern East, Vic, Australia; [Hall, Stephen] Monash Univ, Malvern East, Vic, Australia; [Ilivanova, Elena] Leningradskaya Reg Clin Hosp, St Petersburg, Russia; [Irazoque-Palazuelos, Fedra] Hosp Angeles Mocel, Mexico City, DF, Mexico; [Miranda, Pedro] Univ Chile, Dept Rheumatol, Santiago, Chile; [Miranda, Pedro] Hosp San Juan Dios, Santiago, Chile; [Park, Min-Chan] Gangnam Severance Hosp, Seoul, South Korea; [Pavelka, Karel] Charles Univ Prague, Inst Rheumatol, Prague, Czech Republic; [Pavelka, Karel] Charles Univ Prague, Clin Rheumatol, Prague, Czech Republic; [Pedersen, Ronald; Szumski, Annette; Hammond, Constance; Koenig, Andrew S.; Vlahos, Bonnie] Pfizer, Collegeville, PA USA	Medical University of Vienna; Hietzing Hospital; University of Queensland; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Cabrini Health; Monash University; Universidad de Chile; Universidad de Chile; Yonsei University; Yonsei University Health System; Charles University Prague; Institute of Rheumatology; Charles University Prague; Pfizer	Smolen, JS (corresponding author), Med Univ Vienna, Dept Med 3, Div Rheumatol, A-1090 Vienna, Austria.	josef.smolen@wienkav.at	Pavelka, Karel/E-6578-2017; Nash, Peter/D-7392-2013	Pavelka, Karel/0000-0003-1952-8422; Nash, Peter/0000-0002-2571-788X; durez, patrick/0000-0002-7156-2356; Park, Min-Chan/0000-0003-1189-7637	Abbott; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; MSD; Novo Nordisk; Pfizer; Roche; Sandoz; Sanofi; UCB; Janssen; Celltrion; Centocor; Human Genome Sciences; Merck; Neovacs; Wyeth	Abbott(Abbott Laboratories); Amgen(Amgen); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Celgene(Bristol-Myers SquibbCelgene Corporation); GlaxoSmithKline(GlaxoSmithKline); MSD; Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Roche(Roche Holding); Sandoz(Novartis); Sanofi; UCB(UCB Pharma SA); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Celltrion; Centocor; Human Genome Sciences(GlaxoSmithKline); Merck(Merck & Company); Neovacs; Wyeth(Wyeth)	JSS has received honoraria for consultations or speaking engagements, or grant support, or both, from Abbott, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, GlaxoSmithKline, MSD, Novo Nordisk, Pfizer, Roche, Sandoz, Sanofi, and UCB. PN has received grant support and honoraria for consultations from Pfizer. FI-P has received grant support and honoraria for consultations or speaking engagements from Bristol-Myers Squibb, Janssen, Pfizer, and Roche. PM has received grant support from Abbott, Bristol-Myers Squibb, Celltrion, Centocor, GlaxoSmithKline, Human Genome Sciences, Merck, Neovacs, and Pfizer. KP has received honoraria for lectures from Abbott, Fidia, MSD, Pfizer, Roche, and UCB. RP, CH, ASK, and BV are employees of Pfizer and own Pfizer stock. AS is an employee of Inventive Health, who are paid contractors for Pfizer, providing statistical support for the PRESERVE study and the development of this report. The other authors declare that they have no conflicts of interest.; The PRESERVE trial was sponsored by Wyeth, which was acquired by Pfizer in October, 2009, and which was responsible for data collection and analysis. Editorial and medical writing support was provided by Kim Brown and Donna McGuire of UBC Scientific Solutions and was funded by Pfizer. We thank the PRESERVE investigators, their staff, and their patients for their participation in this clinical trial.	Aletaha D, 2006, ARTHRITIS RHEUM-US, V54, P2784, DOI 10.1002/art.22052; Brocq O, 2009, JOINT BONE SPINE, V76, P350, DOI 10.1016/j.jbspin.2008.11.009; de Croon EM, 2004, ANN RHEUM DIS, V63, P1362, DOI 10.1136/ard.2003.020115; Drossaers-Bakker KW, 1999, ARTHRITIS RHEUM, V42, P1854, DOI 10.1002/1529-0131(199909)42:9<1854::AID-ANR9>3.0.CO;2-F; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2009, ARTHRITIS RHEUM-US, V60, P2272, DOI 10.1002/art.24638; Fleischmann R, 2009, ANN RHEUM DIS, V68, P805, DOI 10.1136/ard.2008.099291; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Keystone E, 2010, ANN RHEUM DIS, V69, P1129, DOI 10.1136/ard.2009.116319; Kiely P, 2011, RHEUMATOLOGY, V50, P926, DOI 10.1093/rheumatology/keq406; Klarenbeek NB, 2011, ANN RHEUM DIS, V70, P1815, DOI 10.1136/ard.2010.149260; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Knevel R, 2010, ANN RHEUM DIS, V69, P987, DOI 10.1136/ard.2009.126748; Kremer JM, 2006, ANN INTERN MED, V144, P865, DOI 10.7326/0003-4819-144-12-200606200-00003; Mierau M, 2007, RHEUMATOLOGY, V46, P975, DOI 10.1093/rheumatology/kem007; Montag K, 2011, INTERN MED J, V41, P450, DOI 10.1111/j.1445-5994.2010.02240.x; Nam JL, 2010, ANN RHEUM DIS, V69, P976, DOI 10.1136/ard.2009.126573; National Institute for Health and Clinical Excellence, 2007, AD ET INFL TREATM RH; O'Dell JR, 2011, ARTHRITIS RHEUM-US, V63, P2151, DOI 10.1002/art.30402; O'Mahony R, 2010, ANN RHEUM DIS, V69, P1823, DOI 10.1136/ard.2008.105577; Saleem B, 2010, ANN RHEUM DIS, V69, P1636, DOI 10.1136/ard.2009.117341; Schoels M, 2010, ANN RHEUM DIS, V69, P638, DOI 10.1136/ard.2009.123976; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2009, ANN RHEUM DIS, V68, P823, DOI 10.1136/ard.2008.090019; Smolen J, 2011, ARTHRITIS RHEUM-US, V63, pS864; Smolen JS, 2011, ANN RHEUM DIS, V70, DOI 10.1136/ard.2009.123919corr1; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Sokka T, 2003, J RHEUMATOL, V30, P1138; Sokka T, 2009, ANN RHEUM DIS, V68, P1666, DOI 10.1136/ard.2009.109983; Tanaka Y, 2010, ANN RHEUM DIS, V69, P1286, DOI 10.1136/ard.2009.121491; van der Heijde D, 2008, ANN RHEUM DIS, V67, P1267, DOI 10.1136/ard.2007.081331; Welsing PMJ, 2001, ARTHRITIS RHEUM, V44, P2009, DOI 10.1002/1529-0131(200109)44:9<2009::AID-ART349>3.0.CO;2-L	34	275	299	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					918	929		10.1016/S0140-6736(12)61811-X	http://dx.doi.org/10.1016/S0140-6736(12)61811-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105LB	23332236				2022-12-28	WOS:000316069700027
J	Courtine, G; Micera, S; DiGiovanna, J; Millan, JDR				Courtine, Gregoire; Micera, Silvestro; DiGiovanna, Jack; Millan, Jose del R.			Brain-machine interface: closer to therapeutic reality?	LANCET			English	Editorial Material									[Courtine, Gregoire] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, CH-1015 Lausanne, Switzerland; [Courtine, Gregoire] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Micera, Silvestro; DiGiovanna, Jack] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Translat Neural Engn Lab, CH-1015 Lausanne, Switzerland; [Micera, Silvestro; DiGiovanna, Jack; Millan, Jose del R.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Micera, Silvestro] Scuola Super Sant Anna, BioRobot Inst, Neural Engn Area, Pisa, Italy; [Millan, Jose del R.] Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Defitech Chair Noninvas Brain Machine Interface, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Scuola Superiore Sant'Anna; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Courtine, G (corresponding author), Ecole Polytech Fed Lausanne, Ctr Neuroprosthet, Int Parapleg Fdn Chair Spinal Cord Repair, CH-1015 Lausanne, Switzerland.	gregoire.courtine@epfl.ch	del R. Millan, Jose/F-1696-2011; courtine, gregoire/AAJ-1694-2020; Micera, Silvestro/AAD-6630-2021	del R. Millan, Jose/0000-0001-5819-1522; courtine, gregoire/0000-0002-5744-4142; DiGiovanna, Jack/0000-0002-7757-4120				Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Collinger J. L., 2012, LANCET; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Millan JD, 2004, IEEE T BIO-MED ENG, V51, P1026, DOI 10.1109/TBME.2004.827086; Millan JD, 2010, IEEE ENG MED BIOL, V29, P16, DOI 10.1109/MEMB.2009.935475; Rossini PM, 2010, CLIN NEUROPHYSIOL, V121, P777, DOI 10.1016/j.clinph.2010.01.001; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416	14	23	23	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 16	2013	381	9866					515	517		10.1016/S0140-6736(12)62164-3	http://dx.doi.org/10.1016/S0140-6736(12)62164-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	089RK	23253622				2022-12-28	WOS:000314927500008
J	Wintemute, GJ				Wintemute, Garen J.			Tragedy's Legacy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CRIMINAL ACTIVITY; RISK; HANDGUNS; VIOLENT		Univ Calif Davis, Dept Emergency Med, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Wintemute, GJ (corresponding author), Univ Calif Davis, Dept Emergency Med, Sch Med, Sacramento, CA 95817 USA.							Ludwig J, 2000, JAMA-J AM MED ASSOC, V284, P585, DOI 10.1001/jama.284.5.585; Waldman P, MYTH NRA DOMINANCE 1; Wintemute GJ, 2011, INJURY PREV, V17, P422, DOI 10.1136/ip.2010.031443; Wintemute GJ, 1998, JAMA-J AM MED ASSOC, V280, P2083, DOI 10.1001/jama.280.24.2083; Wintemute GJ, 2001, JAMA-J AM MED ASSOC, V285, P1019, DOI 10.1001/jama.285.8.1019	5	12	12	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					397	399		10.1056/NEJMp1215491	http://dx.doi.org/10.1056/NEJMp1215491			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23268646				2022-12-28	WOS:000314215400001
J	Haberg, SE; Trogstad, L; Gunnes, N; Wilcox, AJ; Gjessing, HK; Samuelsen, SO; Skrondal, A; Cappelen, I; Engeland, A; Aavitsland, P; Madsen, S; Buajordet, I; Furu, K; Nafstad, P; Vollset, SE; Feiring, B; Nokleby, H; Magnus, P; Stoltenberg, C				Haberg, Siri E.; Trogstad, Lill; Gunnes, Nina; Wilcox, Allen J.; Gjessing, Hakon K.; Samuelsen, Sven Ove; Skrondal, Anders; Cappelen, Inger; Engeland, Anders; Aavitsland, Preben; Madsen, Steinar; Buajordet, Ingebjorg; Furu, Kari; Nafstad, Per; Vollset, Stein Emil; Feiring, Berit; Nokleby, Hanne; Magnus, Per; Stoltenberg, Camilla			Risk of Fetal Death after Pandemic Influenza Virus Infection or Vaccination	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MEDICAL BIRTH REGISTRY; PREGNANT-WOMEN; HOSPITALIZATIONS; VALIDATION; OUTCOMES; ILLNESS; NORWAY	Background During the 2009 influenza A (H1N1) pandemic, pregnant women were at risk for severe influenza illness. This concern was complicated by questions about vaccine safety in pregnant women that were raised by anecdotal reports of fetal deaths after vaccination. Methods We explored the safety of influenza vaccination of pregnant women by linking Norwegian national registries and medical consultation data to determine influenza diagnosis, vaccination status, birth outcomes, and background information for pregnant women before, during, and after the pandemic. We used Cox regression models to estimate hazard ratios for fetal death, with the gestational day as the time metric and vaccination and pandemic exposure as time-dependent exposure variables. Results There were 117,347 eligible pregnancies in Norway from 2009 through 2010. Fetal mortality was 4.9 deaths per 1000 births. During the pandemic, 54% of pregnant women in their second or third trimester were vaccinated. Vaccination during pregnancy substantially reduced the risk of an influenza diagnosis (adjusted hazard ratio, 0.30; 95% confidence interval [CI], 0.25 to 0.34). Among pregnant women with a clinical diagnosis of influenza, the risk of fetal death was increased (adjusted hazard ratio, 1.91; 95% CI, 1.07 to 3.41). The risk of fetal death was reduced with vaccination during pregnancy, although this reduction was not significant (adjusted hazard ratio, 0.88; 95% CI, 0.66 to 1.17). Conclusions Pandemic influenza virus infection in pregnancy was associated with an increased risk of fetal death. Vaccination during pregnancy reduced the risk of an influenza diagnosis. Vaccination itself was not associated with increased fetal mortality and may have reduced the risk of influenza-related fetal death during the pandemic. (Funded by the Norwegian Institute of Public Health.)	[Haberg, Siri E.; Trogstad, Lill; Gunnes, Nina; Gjessing, Hakon K.; Samuelsen, Sven Ove; Skrondal, Anders; Cappelen, Inger; Engeland, Anders; Aavitsland, Preben; Furu, Kari; Nafstad, Per; Vollset, Stein Emil; Feiring, Berit; Nokleby, Hanne; Magnus, Per; Stoltenberg, Camilla] Norwegian Inst Publ Hlth, N-0403 Oslo, Norway; [Samuelsen, Sven Ove; Nafstad, Per; Magnus, Per] Univ Oslo, Oslo, Norway; [Madsen, Steinar; Buajordet, Ingebjorg] Norwegian Med Agcy, Oslo, Norway; [Gjessing, Hakon K.; Engeland, Anders; Vollset, Stein Emil] Univ Bergen, Bergen, Norway; [Furu, Kari] Univ Tromso, Tromso, Norway; [Wilcox, Allen J.] NIEHS, Durham, NC USA; [Skrondal, Anders] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	Norwegian Institute of Public Health (NIPH); University of Oslo; University of Bergen; UiT The Arctic University of Tromso; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; London School of Hygiene & Tropical Medicine	Haberg, SE (corresponding author), Norwegian Inst Publ Hlth, POB 4404, N-0403 Oslo, Norway.	siri.haberg@fhi.no	Engeland, Anders/AAG-7437-2021; Gjessing, Hakon K/A-5871-2012; Wilcox, Allen J/C-7723-2019; Skrondal, Anders/C-7342-2008; Stoltenberg, Camilla/G-5090-2017	Wilcox, Allen J/0000-0002-3376-1311; Skrondal, Anders/0000-0002-8171-2282	Norwegian Institute of Public Health; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	Norwegian Institute of Public Health; Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Supported by the Norwegian Institute of Public Health. Dr. Wilcox was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences, National Institutes of Health.	Aalen OO, 2008, STAT BIOL HEALTH, P1; Bloom-Feshbach K, 2011, J INFECT DIS, V204, P1157, DOI 10.1093/infdis/jir510; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; Engeland A, 2009, ACTA OBSTET GYN SCAN, V88, P1083, DOI 10.1080/00016340903128454; European Medicines Agency, 2010, 22 PAND PHARM UPD; Fell Deshayne B, 2012, Am J Public Health, V102, pe33, DOI 10.2105/AJPH.2011.300606; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; KOSMAK GW, 1919, AM J OBSTET, V79, P238; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nishiura H, 2009, EUR J OBSTET GYN R B, V147, P115, DOI 10.1016/j.ejogrb.2009.07.009; Norwegian Institute of Public Health, 2010, STAT REP NEW INFL A; Norwegian Institute of Public Health, SURV SYST COMM DIS; Norwegian Medicines Agency, 2010, REP ADV EV 2010; Pasternak B, 2012, JAMA-J AM MED ASSOC, V308, P165, DOI 10.1001/jama.2012.6131; Pasternak B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2794; Pierce M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3214; Rasmussen S, 2003, ACTA OBSTET GYN SCAN, V82, P109, DOI 10.1034/j.1600-0412.2003.00009.x; Reid A, 2001, POP STUD-J DEMOG, V55, P213, DOI 10.1080/00324720127696; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; *STRAT ADV GROUP E, 2009, WKLY EPIDEMIOL REC, V84, P301; Trogstad L, 2012, EURO SURVEILL, V17; WHO, 2009, INFL SEAS; Xu RH, 2012, PHARMACOEPIDEM DR S, V21, P844, DOI 10.1002/pds.3301; Yates L, 2010, HEALTH TECHNOL ASSES, V14, P121	28	214	219	0	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	2013	368	4					333	340		10.1056/NEJMoa1207210	http://dx.doi.org/10.1056/NEJMoa1207210			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075KX	23323868	Green Accepted			2022-12-28	WOS:000313885900006
J	Kaib, NA; Raymond, SN; Duncan, M				Kaib, Nathan A.; Raymond, Sean N.; Duncan, Martin			Planetary system disruption by Galactic perturbations to wide binary stars	NATURE			English	Article							EXTRASOLAR PLANETS; ECCENTRICITY; COMPANIONS; SEARCH; SCATTERING; EVOLUTION; ORIGIN; ORBITS	Nearly half the exoplanets found within binary star systems reside(1) in very wide binaries with average stellar separations greater than 1,000 astronomical units (one astronomical unit (AU) being the Earth-Sun distance), yet the influence of such distant binary companions on planetary evolution remains largely unstudied. Unlike their tighter counterparts, the stellar orbits of wide binaries continually change under the influence of the Milky Way's tidal field and impulses from other passing stars. Here we report numerical simulations demonstrating that the variable nature of wide binary star orbits dramatically reshapes the planetary systems they host, typically billions of years after formation. Contrary to previous understanding(2), wide binary companions may often strongly perturb planetary systems, triggering planetary ejections and increasing the orbital eccentricities of surviving planets. Although hitherto not recognized, orbits of giant exoplanets within wide binaries are statistically more eccentric than those around isolated stars. Both eccentricity distributions are well reproduced when we assume that isolated stars and wide binaries host similar planetary systems whose outermost giant planets are scattered beyond about 10 AU from their parent stars by early internal instabilities. Consequently, our results suggest that although wide binaries eventually remove the most distant planets from many planetary systems, most isolated giant exoplanet systems harbour additional distant, still undetected planets.	[Kaib, Nathan A.; Duncan, Martin] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Kaib, Nathan A.] Univ Toronto, Canadian Inst Theoret Astrophys, Toronto, ON M5S 3H8, Canada; [Raymond, Sean N.] Univ Bordeaux, Observ Aquitain Sci Univers, F-33271 Floirac, France; [Raymond, Sean N.] CNRS, UMR 5804, Lab Astrophys Bordeaux, F-33271 Floirac, France	Queens University - Canada; University of Toronto; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Kaib, NA (corresponding author), Northwestern Univ, Ctr Interdisciplinary Explorat & Res Astrophys, 2131 Tech Dr, Evanston, IL 60208 USA.	nkaib@astro.queensu.ca		Raymond, Sean/0000-0001-8974-0758	CITA National Fellowship; Canada's NSERC	CITA National Fellowship; Canada's NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank J. Chambers and R. Roskar for discussions. This work was funded by a CITA National Fellowship and Canada's NSERC. S.N.R. thanks the PNP programme of CNRS and the NASA Astrobiology Institute's Virtual Planetary Laboratory team. Our computing was performed on the SciNet General Purpose Cluster at the University of Toronto.	Adams FC, 2001, ICARUS, V150, P151, DOI 10.1006/icar.2000.6567; Batygin K, 2011, ASTRON ASTROPHYS, V533, DOI 10.1051/0004-6361/201117193; Chambers JE, 2002, ASTRON J, V123, P2884, DOI 10.1086/340074; Desidera S, 2007, ASTRON ASTROPHYS, V462, P345, DOI 10.1051/0004-6361:20066319; Eggenberger A, 2007, ASTRON ASTROPHYS, V474, P273, DOI 10.1051/0004-6361:20077447; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Ford EB, 2008, ASTROPHYS J, V686, P621, DOI 10.1086/590926; Heggie DC, 1996, MON NOT R ASTRON SOC, V282, P1064, DOI 10.1093/mnras/282.3.1064; HEISLER J, 1986, ICARUS, V65, P13, DOI 10.1016/0019-1035(86)90060-6; Holman M, 1997, NATURE, V386, P254, DOI 10.1038/386254a0; Innanen KA, 1997, ASTRON J, V113, P1915, DOI 10.1086/118405; Jiang YF, 2010, MON NOT R ASTRON SOC, V401, P977, DOI 10.1111/j.1365-2966.2009.15744.x; Kaib NA, 2011, ASTROPHYS J LETT, V742, DOI 10.1088/2041-8205/742/2/L24; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; LISSAUER JJ, 1993, ANNU REV ASTRON ASTR, V31, P129, DOI 10.1146/annurev.aa.31.090193.001021; Malmberg D, 2009, MON NOT R ASTRON SOC, V394, pL26, DOI 10.1111/j.1745-3933.2008.00603.x; Mugrauer M, 2006, ASTRON NACHR, V327, P321, DOI 10.1002/asna.200510528; Naef D, 2001, ASTRON ASTROPHYS, V375, pL27, DOI 10.1051/0004-6361:20010853; Oort J. H., 1950, B ASTRON I NETH, V11, P91; Raghavan D, 2006, ASTROPHYS J, V646, P523, DOI 10.1086/504823; Roell T, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118051; Sumi T, 2011, NATURE, V473, P349, DOI 10.1038/nature10092; Wright JT, 2009, ASTROPHYS J, V693, P1084, DOI 10.1088/0004-637X/693/2/1084; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598; Zakamska NL, 2004, ASTRON J, V128, P869, DOI 10.1086/422023	30	115	117	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 17	2013	493	7432					381	384		10.1038/nature11780	http://dx.doi.org/10.1038/nature11780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23292514	Green Submitted, Green Accepted			2022-12-28	WOS:000313615900046
J	Le, T; Wright, EJ; Smith, DM; He, WJ; Catano, G; Okulicz, JF; Young, JA; Clark, RA; Richman, DD; Little, SJ; Ahuja, SK				Le, Tuan; Wright, Edwina J.; Smith, Davey M.; He, Weijing; Catano, Gabriel; Okulicz, Jason F.; Young, Jason A.; Clark, Robert A.; Richman, Douglas D.; Little, Susan J.; Ahuja, Sunil K.			Enhanced CD4+T-Cell Recovery with Earlier HIV-1 Antiretroviral Therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LYMPHOID-TISSUE STRUCTURE; SOCIETY-USA PANEL; T-CELLS; PRIMARY INFECTION; AIDS; SEROCONVERSION; CD4; RECOMMENDATIONS; RECONSTITUTION	Background The relationship between the timing of the initiation of antiretroviral therapy (ART) after infection with human immunodeficiency virus type 1 (HIV-1) and the recovery of CD4+ T-cell counts is unknown. Methods In a prospective, observational cohort of persons with acute or early HIV-1 infection, we determined the trajectory of CD4+ counts over a 48-month period in partially overlapping study sets: study set 1 included 384 participants during the time window in which they were not receiving ART and study set 2 included 213 participants who received ART soon after study entry or sometime thereafter and had a suppressed plasma HIV viral load. We investigated the likelihood and rate of CD4+ T-cell recovery to 900 or more cells per cubic millimeter within 48 months while the participants were receiving viral-load-suppressive ART. Results Among the participants who were not receiving ART, CD4+ counts increased spontaneously, soon after HIV-1 infection, from the level at study entry (median, 495 cells per cubic millimeter; interquartile range, 383 to 622), reached a peak value (median, 763 cells per cubic millimeter; interquartile range, 573 to 987) within approximately 4 months after the estimated date of infection, and declined progressively thereafter. Recovery of CD4+ counts to 900 or more cells per cubic millimeter was seen in approximately 64% of the participants who initiated ART earlier (<= 4 months after the estimated date of HIV infection) as compared with approximately 34% of participants who initiated ART later (>4 months) (P<0.001). After adjustment for whether ART was initiated when the CD4+ count was 500 or more cells per cubic millimeter or less than 500 cells per cubic millimeter, the likelihood that the count would increase to 900 or more cells per cubic millimeter was lower by 65% (odds ratio, 0.35), and the rate of recovery was slower by 56% (rate ratio, 0.44), if ART was initiated later rather than earlier. There was no association between the plasma HIV RNA level at the time of initiation of ART and CD4+ T-cell recovery. Conclusions A transient, spontaneous restoration of CD4+ T-cell counts occurs in the 4-month time window after HIV-1 infection. Initiation of ART during this period is associated with an enhanced likelihood of recovery of CD4+ counts. (Funded by the National Institute of Allergy and Infectious Diseases and others.)	[Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Vet Affairs Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA; [Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] S Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX USA; [Le, Tuan; He, Weijing; Catano, Gabriel; Clark, Robert A.; Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Ahuja, Sunil K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Okulicz, Jason F.] San Antonio Mil Med Ctr, Infect Dis Serv, Ft Sam Houston, TX USA; [Wright, Edwina J.] Monash Univ, Alfred Hosp, Dept Infect Dis, Burnet Inst, Melbourne, Vic 3181, Australia; [Wright, Edwina J.] Monash Univ, Dept Infect Dis, Melbourne, Vic 3004, Australia; [Smith, Davey M.; Richman, Douglas D.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Smith, Davey M.; Young, Jason A.; Richman, Douglas D.; Little, Susan J.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Richman, Douglas D.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; San Antonio Military Medical Center; Burnet Institute; Florey Institute of Neuroscience & Mental Health; Monash University; Monash University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; University of California System; University of California San Diego	Ahuja, SK (corresponding author), S Texas Vet Hlth Care Syst, Vet Affairs Res Ctr AIDS & HIV Infect 1, San Antonio, TX 78229 USA.	slittle@ucsd.edu; ahujas@uthscsa.edu	Little, Susan/AAA-6116-2019; Catano, Gabriel/AAQ-5387-2020; Clark, Robert/Q-6764-2019; Wright, Edwina J/I-2950-2014	Clark, Robert/0000-0002-4892-3619; Wright, Edwina J/0000-0001-8626-782X; Lipton, Stuart/0000-0002-3490-1259; Smith, Davey/0000-0003-3603-1733	Veterans Affairs (VA) Center for AIDS and HIV Infection; VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH) [UL1TR000149, R37 AI046326]; NIH [AI43638, AI69432, MH62512, AI74621, MH083552, AI077304, AI007384, AI080193, AI096113]; International AIDS Vaccine Initiative [DMS0714991]; California HIV/AIDS Research Program [RN07-SD-702]; VA Career Development Award-2; National Health and Medical Research Council of Australia; Doris Duke Distinguished Clinical Scientist Award, a VA MERIT; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069432, U01AI043638, T32AI007384, U19AI096113, R24AI106039, P01AI080193, UM1AI069432, R21AI077304, R37AI046326, P01AI074621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083552, P30MH062512] Funding Source: NIH RePORTER	Veterans Affairs (VA) Center for AIDS and HIV Infection(US Department of Veterans Affairs); VA Center for Personalized Medicine of the South Texas Veterans Health Care System; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; California HIV/AIDS Research Program; VA Career Development Award-2; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Doris Duke Distinguished Clinical Scientist Award, a VA MERIT; Elizabeth Glaser Pediatric AIDS Foundation; Burroughs Welcome Clinical Scientist Award in Translational Research; Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by the Veterans Affairs (VA) Center for AIDS and HIV Infection and VA Center for Personalized Medicine of the South Texas Veterans Health Care System and a MERIT grant (R37 AI046326) and a Clinical and Translational Science Award (UL1TR000149) from the National Institutes of Health (NIH) (all for the work at San Antonio) and by grants from the NIH (AI43638, AI69432, MH62512, AI74621, MH083552, AI077304, AI007384, AI080193, and AI096113), the International AIDS Vaccine Initiative (DMS0714991), and the California HIV/AIDS Research Program (RN07-SD-702) (all for the work at San Diego). Dr. Le was supported by a VA Career Development Award-2, Dr. Wright by an Early Career Fellowship from the National Health and Medical Research Council of Australia, and Dr. Ahuja by the Doris Duke Distinguished Clinical Scientist Award, a VA MERIT award, the Elizabeth Glaser Pediatric AIDS Foundation, the Burroughs Welcome Clinical Scientist Award in Translational Research, and the Senior Scholar Award from the Max and Minnie Tomerlin Voelcker Fund.	Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V489, DOI 10.1038/nature11455; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Belloso WH, 2010, HIV MED, V11, P554, DOI 10.1111/j.1468-1293.2010.00824.x; BOFILL M, 1992, CLIN EXP IMMUNOL, V88, P243, DOI 10.1111/j.1365-2249.1992.tb03068.x; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; COOPER DA, 1988, J INFECT DIS, V157, P889, DOI 10.1093/infdis/157.5.889; Drechsler H, 2012, 19 INT AIDS C WASH D; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fernandez S, 2011, J INFECT DIS, V204, P1927, DOI 10.1093/infdis/jir659; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; GAINES H, 1990, AIDS, V4, P995, DOI 10.1097/00002030-199010000-00008; Hecht FM, 2006, J INFECT DIS, V194, P725, DOI 10.1086/506616; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Lodi S, 2011, CLIN INFECT DIS, V53, P817, DOI 10.1093/cid/cir494; Lori F, 1999, J INFECT DIS, V180, P1827, DOI 10.1086/315113; Maman D, 2012, AIDS, V26, P1393, DOI 10.1097/QAD.0b013e328352d054; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Oxenius A, 2000, P NATL ACAD SCI USA, V97, P3382, DOI 10.1073/pnas.97.7.3382; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2011, GUID US ANT AG HIV 1; Rajasuriar R, 2010, J INFECT DIS, V202, P1254, DOI 10.1086/656369; Schacker T, 1997, ANN INTERN MED, V126, P174, DOI 10.7326/0003-4819-126-2-199701150-00024; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Shete A, 2010, INDIAN J MED RES, V132, P667; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Zeng M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002437; Zeng M, 2012, BLOOD, V120, P1856, DOI 10.1182/blood-2012-03-418624; Zeng M, 2012, TRENDS IMMUNOL, V33, P306, DOI 10.1016/j.it.2012.04.002	33	252	264	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					218	230		10.1056/NEJMoa1110187	http://dx.doi.org/10.1056/NEJMoa1110187			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323898	Green Accepted			2022-12-28	WOS:000313549900006
J	Maurice, CF; Haiser, HJ; Turnbaugh, PJ				Maurice, Corinne Ferrier; Haiser, Henry Joseph; Turnbaugh, Peter James			Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome	CELL			English	Article							FLOW-CYTOMETRY; BACTERIA; METABOLISM; ABSORPTION; DIVERSITY; COMMUNITY; DIGOXIN	The human gut contains trillions of microorganisms that influence our health by metabolizing xenobiotics, including host-targeted drugs and antibiotics. Recent efforts have characterized the diversity of this host-associated community, but it remains unclear which microorganisms are active and what perturbations influence this activity. Here, we combine flow cytometry, 16S rRNA gene sequencing, and metatranscriptomics to demonstrate that the gut contains a distinctive set of active microorganisms, primarily Firmicutes. Short-term exposure to a panel of xenobiotics significantly affected the physiology, structure, and gene expression of this active gut microbiome. Xenobiotic-responsive genes were found across multiple bacterial phyla, encoding antibiotic resistance, drug metabolism, and stress response pathways. These results demonstrate the power of moving beyond surveys of microbial diversity to better understand metabolic activity, highlight the unintended consequences of xenobiotics, and suggest that attempts at personalized medicine should consider interindividual variations in the active human gut microbiome.	[Maurice, Corinne Ferrier; Haiser, Henry Joseph; Turnbaugh, Peter James] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University	Turnbaugh, PJ (corresponding author), Harvard Univ, FAS Ctr Syst Biol, 52 Oxford St, Cambridge, MA 02138 USA.	pturnbaugh@fas.harvard.edu	Haiser, Henry/AAN-5187-2020	Turnbaugh, Peter/0000-0002-0888-2875; Maurice, Corinne/0000-0001-7187-3472	NIH [P50 GM068763]; Canadian Institutes of Health Research [MFE-112991]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Rob Knight and Donna Berg-Lyons for contributing barcoded 16S rRNA primers; Claire Reardon, Jiangwen Zhang, and Christian Daly for sequencing support; Brian Tilton and Thierry Bouvier for flow cytometry assistance; and Curtis Huttenhower, Nicola Segata, and Jovian Yu for bioinformatics support. We are indebted to our colleagues Andrew Murray, Erin O'Shea, Bodo Stern, Lawrence David, Julie Button, Rachel Dutton, and Benjamin Wolfe for their helpful suggestions. This work was supported by the NIH (P50 GM068763) and the Canadian Institutes of Health Research (MFE-112991).	Baselt R.C., 2008, DISPOSITION TOXIC DR; Ben-Amor K, 2005, APPL ENVIRON MICROB, V71, P4679, DOI 10.1128/AEM.71.8.4679-4689.2005; Blaut M, 2011, CURR TOP MICROBIOL I; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Bouvier T, 2011, MICROB ECOL, V62, P669, DOI 10.1007/s00248-011-9862-3; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Davey Hazel M., 2003, Current Issues in Molecular Biology, V5, P9; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Guillebault D, 2010, APPL ENVIRON MICROB, V76, P7352, DOI 10.1128/AEM.00621-10; Haiser HJ, 2012, SCIENCE, V336, P1253, DOI 10.1126/science.1224396; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jellett JF, 1996, MAR ECOL PROG SER, V136, P213, DOI 10.3354/meps136213; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447; Joux F, 2000, MICROBES INFECT, V2, P1523, DOI 10.1016/S1286-4579(00)01307-1; Kirchman D.L., 2008, MICROBIAL ECOLOGY OC, V2, P243, DOI DOI 10.1002/9780470281840.CH8; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Le Blay G, 2007, LETT APPL MICROBIOL, V45, P252, DOI 10.1111/j.1472-765X.2007.02178.x; Lee HH, 2012, NAT CHEM BIOL, V8, P6, DOI 10.1038/nchembio.740; Levin BR, 2006, NAT REV MICROBIOL, V4, P556, DOI 10.1038/nrmicro1445; LINDENBAUM J, 1981, NEW ENGL J MED, V305, P789, DOI 10.1056/NEJM198110013051403; MAGNUSSON JO, 1982, BRIT J CLIN PHARMACO, V14, P284, DOI 10.1111/j.1365-2125.1982.tb01976.x; Martinez JL, 2011, FEMS MICROBIOL REV, V35, P768, DOI 10.1111/j.1574-6976.2011.00282.x; McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701; Mortimer FC, 2000, ANTIMICROB AGENTS CH, V44, P676, DOI 10.1128/AAC.44.3.676-681.2000; Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAAFLAUB J, 1975, EUR J CLIN PHARMACOL, V8, P261, DOI 10.1007/BF00567125; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shapiro HH, 2000, J MICROBIOL METH, V42, P3, DOI 10.1016/S0167-7012(00)00167-6; SMITH GE, 1974, XENOBIOTICA, V4, P477, DOI 10.3109/00498257409052100; SOMOGYI AA, 1995, PHARMACEUT RES, V12, P149, DOI 10.1023/A:1016215510223; Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Wickens HJ, 2000, ANTIMICROB AGENTS CH, V44, P682, DOI 10.1128/AAC.44.3.682-687.2000; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zubkov MV, 2004, J MAR BIOL ASSOC UK, V84, P519, DOI 10.1017/S002531540400952Xh	48	526	550	9	280	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					39	50		10.1016/j.cell.2012.10.052	http://dx.doi.org/10.1016/j.cell.2012.10.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332745	Green Accepted, Bronze			2022-12-28	WOS:000313719800005
J	Watts, G				Watts, Geoff			PUBLIC HEALTH Sugar and the heart: old ideas revisited	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CONSUMPTION; RISK					geoff@scileg.freeserve.co.uk						Caprio S, 2012, NEW ENGL J MED, V367, P1462, DOI 10.1056/NEJMe1209884; de Koning L, 2012, CIRCULATION, V125, P1735, DOI 10.1161/CIRCULATIONAHA.111.067017; Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627; Keys A. B., 1980, SEVEN COUNTRIES A MU; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; Welsh JA, 2010, JAMA-J AM MED ASSOC, V303, P1490, DOI 10.1001/jama.2010.449; Yudkin J, 1957, LANCET, V270, P155; Yudkin J, 2012, PURE WHITE AND DEADL	8	7	7	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								e7800	10.1136/bmj.e7800	http://dx.doi.org/10.1136/bmj.e7800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075ER	23321487				2022-12-28	WOS:000313867100002
J	Ferrante, AW				Ferrante, Anthony W., Jr.			Improving Metabolism by Throwing Out All the JNK	SCIENCE			English	Editorial Material							INSULIN-RESISTANCE; TERMINAL KINASE; ADIPOSE-TISSUE; OBESITY; INFLAMMATION; STEATOSIS; CELLS		Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, New York, NY 10032 USA	Columbia University	Ferrante, AW (corresponding author), Columbia Univ, Dept Med, Naomi Berrie Diabet Ctr, 1150 St Nicholas Ave, New York, NY 10032 USA.	awf7@columbia.edu	Ferrante, Anthony/AAC-7763-2019	Ferrante, Anthony/0000-0001-9272-2593				Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Unger EK, 2010, ENDOCRINOLOGY, V151, P671, DOI 10.1210/en.2009-0711; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	12	1	1	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					147	148		10.1126/science.1233223	http://dx.doi.org/10.1126/science.1233223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307726				2022-12-28	WOS:000313328200027
J	Stephansson, O; Kieler, H; Haglund, B; Artama, M; Engeland, A; Furu, K; Gissler, M; Norgaard, M; Nielsen, RB; Zoega, H; Valdimarsdottir, U				Stephansson, Olof; Kieler, Helle; Haglund, Bengt; Artama, Miia; Engeland, Anders; Furu, Kari; Gissler, Mika; Norgaard, Mette; Nielsen, Rikke Beck; Zoega, Helga; Valdimarsdottir, Unnur			Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERSISTENT PULMONARY-HYPERTENSION; POPULATION-BASED COHORT; ANTIDEPRESSANT TREATMENT; SPONTANEOUS-ABORTIONS; MAJOR DEPRESSION; NORDIC COUNTRIES; OUTCOMES; PREVALENCE; REGISTERS; NEWBORN	Importance Maternal psychiatric disease is associated with adverse pregnancy outcomes. Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown. Objective To study risk of stillbirth and infant mortality associated with use of SSRIs during pregnancy. Design, Setting, and Participants Population-based cohort study from all Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) at different periods from 1996 through 2007. The study included women with singleton births. We obtained information on maternal use of SSRIs from prescription registries. Maternal characteristics, pregnancy, and neonatal outcomes were obtained from patient and medical birth registries. Main Outcome Measures We used logistic regression to estimate relative risks of stillbirth, neonatal death, and postneonatal death associated with SSRI use during pregnancy taking into account maternal characteristics and previous psychiatric hospitalization. Results Among 1 633 877 singleton births in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths. A total of 29 228 (1.79%) of mothers had filled a prescription for an SSRI during pregnancy. Women exposed to an SSRI presented with higher rates of stillbirth (4.62 vs 3.69 per 1000, P=.01) and postneonatal death (1.38 vs 0.96 per 1000, P=.03) than those who did not. The rate of neonatal death was similar between groups (2.54 vs 2.21 per 1000, P=.24). Yet in multivariable models, SSRI use was not associated with stillbirth (adjusted odds ratio [OR], 1.17; 95% CI, 0.96-1.41; P=.12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P=.11), or postneonatal death (adjusted OR, 1.34; 95% CI, 0.97-1.86; P=.08). Estimates were further attenuated when stratified by previous hospitalization for psychiatric disease. The adjusted OR for stillbirth in women with a previous hospitalization for psychiatric disease was 0.92 (95% CI, 0.66-1.28; P=.62) and was 1.07 (95% CI, 0.84-1.36; P=.59) for those who had not been previously hospitalized. The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P=.62) for women who were hospitalized and 1.14 (95% CI, 0.84-1.56; P=.39) for women who were not. For postneonatal death, the ORs were 1.02 (95% CI, 0.61-1.69; P=.95) for women who were hospitalized and 1.10 (95% CI, 0.71-1.72; P=.66) for women who were not. Conclusions and Relevance Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.	[Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Stephansson, Olof; Kieler, Helle; Haglund, Bengt] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Stephansson, Olof] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Gissler, Mika] Nord Sch Publ Hlth, Gothenburg, Sweden; [Artama, Miia; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Engeland, Anders; Furu, Kari] Norwegian Inst Publ Hlth, Dept Pharmacoepidemiol, Div Epidemiol, Oslo, Norway; [Engeland, Anders] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Bergen, Norway; [Furu, Kari] Univ Tromso, Dept Pharm, Tromso, Norway; [Norgaard, Mette; Nielsen, Rikke Beck] Aarhus Univ Hosp, Inst Clin Med, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Zoega, Helga; Valdimarsdottir, Unnur] Univ Iceland, Sch Hlth Sci, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Zoega, Helga] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Finland National Institute for Health & Welfare; Norwegian Institute of Public Health (NIPH); University of Bergen; UiT The Arctic University of Tromso; Aarhus University; University of Iceland; Harvard University; Harvard T.H. Chan School of Public Health; Icahn School of Medicine at Mount Sinai	Stephansson, O (corresponding author), Karolinska Univ Hosp Solna, Clin Epidemiol Unit, T2, SE-17176 Stockholm, Sweden.	olof.stephansson@ki.se	Zoega, Helga/M-1968-2015; Engeland, Anders/AAG-7437-2021	Kieler, Helle/0000-0001-9338-7133; Norgaard, Mette/0000-0001-6110-5891; Zoega, Helga/0000-0003-0761-9028; Gissler, Mika/0000-0001-8254-7525; Stephansson, Olof/0000-0003-1528-4563; Valdimarsdottir, Unnur/0000-0001-5382-946X	Swedish Pharmacy Company; Swedish Society of Medicine; MRC [MR/K006525/1] Funding Source: UKRI; Medical Research Council [MR/K006525/1] Funding Source: researchfish	Swedish Pharmacy Company; Swedish Society of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Swedish Pharmacy Company and by the authors' affiliations. Olof Stephansson was supported by a postdoctorate scholarship from the Swedish Society of Medicine.	Agency DM, 2011, RISK DEATH SER SID E; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; Bakker MK, 2008, BRIT J CLIN PHARMACO, V65, P600, DOI 10.1111/j.1365-2125.2007.03048.x; Chalmers JWT, 1998, BRIT MED J, V317, P539; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Colvin Lyn, 2012, CNS Drugs, V26, pe1, DOI 10.2165/11634190-000000000-00000; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gentile S, 2008, CNS SPECTRUMS, V13, P960, DOI 10.1017/S1092852900014012; Gissler M, 1997, EUR J EPIDEMIOL, V13, P169, DOI 10.1023/A:1007379029182; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Hogberg U, 1997, ACTA OBSTET GYN SCAN, V76, P907, DOI 10.3109/00016349709034900; Kieler H, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8012; Klieger-Grossmann C, 2012, J CLIN PHARMACOL, V52, P766, DOI 10.1177/0091270011405524; Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; Nilsson E, 2008, BRIT J PSYCHIAT, V193, P311, DOI 10.1192/bjp.bp.107.045146; Rosen M, 2002, SCAND J PUBLIC HEALT, V30, P81, DOI 10.1080/140349401753683444; Sanz EJ, 2005, LANCET, V365, P482, DOI 10.1016/S0140-6736(05)17865-9; Stephansson Olof, 2011, Clin Epidemiol, V3, P43, DOI 10.2147/CLEP.S16305; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	27	60	66	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					48	54		10.1001/jama.2012.153812	http://dx.doi.org/10.1001/jama.2012.153812			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280224	Bronze			2022-12-28	WOS:000319113000026
J	Felton, SJ; Madan, V				Felton, Sarah J.; Madan, Vishal			Facial and Upper Body Papules in a Patient With a Family History of Recurrent Pneumothorax	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOGG-DUBE-SYNDROME; RISK		[Felton, Sarah J.; Madan, Vishal] Salford Royal NHS Fdn Trust, Dermatol Ctr, Manchester M6 8HD, Lancs, England	Salford Royal NHS Foundation Trust	Felton, SJ (corresponding author), Salford Royal NHS Fdn Trust, Dermatol Ctr, Stott Lane, Manchester M6 8HD, Lancs, England.	sarah.felton@srft.nhs.uk	Felton, Sarah/AAI-5603-2020	Felton, Sarah/0000-0003-3304-0490				BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Houweling AC, 2011, BRIT J CANCER, V105, P1912, DOI 10.1038/bjc.2011.463; Menko FH, 2009, LANCET ONCOL, V10, P1199, DOI 10.1016/S1470-2045(09)70188-3; Toro JR, 2008, J MED GENET, V45, P321, DOI 10.1136/jmg.2007.054304; Toro JR, 2007, AM J RESP CRIT CARE, V175, P1044, DOI 10.1164/rccm.200610-1483OC; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	6	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2622	2623		10.1001/jama.2012.91099	http://dx.doi.org/10.1001/jama.2012.91099			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268521				2022-12-28	WOS:000312916600028
J	Michaelson, JJ; Shi, YJ; Gujral, M; Zheng, HC; Malhotra, D; Jin, X; Jian, MH; Liu, GM; Greer, D; Bhandari, A; Wu, WT; Corominas, R; Peoples, A; Koren, A; Gore, A; Kang, SL; Lin, GN; Estabillo, J; Gadomski, T; Singh, B; Zhang, K; Akshoomoff, N; Corsello, C; McCarroll, S; Iakoucheva, LM; Li, YR; Wang, J; Sebat, J				Michaelson, Jacob J.; Shi, Yujian; Gujral, Madhusudan; Zheng, Hancheng; Malhotra, Dheeraj; Jin, Xin; Jian, Minghan; Liu, Guangming; Greer, Douglas; Bhandari, Abhishek; Wu, Wenting; Corominas, Roser; Peoples, Aine; Koren, Amnon; Gore, Athurva; Kang, Shuli; Lin, Guan Ning; Estabillo, Jasper; Gadomski, Therese; Singh, Balvindar; Zhang, Kun; Akshoomoff, Natacha; Corsello, Christina; McCarroll, Steven; Iakoucheva, Lilia M.; Li, Yingrui; Wang, Jun; Sebat, Jonathan			Whole-Genome Sequencing in Autism Identifies Hot Spots for De Novo Germline Mutation	CELL			English	Article							DNA; GENE; SPECTRUM; EVOLUTION; RATES; CNVS; REARRANGEMENTS; SUBSTITUTION; ASSOCIATION; FREQUENCIES	De novo mutation plays an important role in autism spectrum disorders (ASDs). Notably, pathogenic copy number variants (CNVs) are characterized by high mutation rates. We hypothesize that hypermutability is a property of ASD genes and may also include nucleotide-substitution hot spots. We investigated global patterns of germline mutation by whole-genome sequencing of monozygotic twins concordant for ASD and their parents. Mutation rates varied widely throughout the genome (by 100-fold) and could be explained by intrinsic characteristics of DNA sequence and chromatin structure. Dense clusters of mutations within individual genomes were attributable to compound mutation or gene conversion. Hypermutability was a characteristic of genes involved in ASD and other diseases. In addition, genes impacted by mutations in this study were associated with ASD in independent exome-sequencing data sets. Our findings suggest that regional hypermutation is a significant factor shaping patterns of genetic variation and disease risk in humans.	[Shi, Yujian; Zheng, Hancheng; Jin, Xin; Jian, Minghan; Li, Yingrui; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Michaelson, Jacob J.; Gujral, Madhusudan; Malhotra, Dheeraj; Greer, Douglas; Bhandari, Abhishek; Wu, Wenting; Peoples, Aine; Singh, Balvindar; Sebat, Jonathan] Univ Calif San Diego, Beyster Ctr Genom Psychiat Dis, La Jolla, CA 92093 USA; [Michaelson, Jacob J.; Gujral, Madhusudan; Malhotra, Dheeraj; Greer, Douglas; Bhandari, Abhishek; Wu, Wenting; Corominas, Roser; Peoples, Aine; Kang, Shuli; Lin, Guan Ning; Estabillo, Jasper; Gadomski, Therese; Singh, Balvindar; Akshoomoff, Natacha; Iakoucheva, Lilia M.; Sebat, Jonathan] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Sebat, Jonathan] Univ Calif San Diego, Dept Cellular Mol Med, La Jolla, CA 92093 USA; [Gore, Athurva; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Jin, Xin] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou 510006, Guangdong, Peoples R China; [Liu, Guangming] Natl Univ Def Technol, Sch Comp Sci, Changsha 410073, Hunan, Peoples R China; [Liu, Guangming] Natl Supercomp Ctr, Tianjin 300450, Peoples R China; [Peoples, Aine] Trinity Coll Dublin, Dublin 2, Ireland; [Koren, Amnon; McCarroll, Steven] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Corsello, Christina] Rady Childrens Hosp, San Diego, CA 92123 USA; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-1165 Copenhagen, Denmark	Beijing Genomics Institute (BGI); University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; South China University of Technology; National University of Defense Technology - China; Trinity College Dublin; Harvard University; Harvard Medical School; Rady Childrens Hospital San Diego; University of Copenhagen; Novo Nordisk Foundation; University of Copenhagen	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangj@genomics.org.cn; jsebat@ucsd.edu	wu, wenting/Q-4979-2016; Li, Yingrui/K-1064-2015; Zhang, Kun/ABE-6349-2020; Corominas, Roser/H-4163-2016; Jin, Xin/ABF-1329-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	wu, wenting/0000-0003-0982-771X; Zhang, Kun/0000-0002-7596-5224; Corominas, Roser/0000-0001-8888-5402; Jin, Xin/0000-0001-7554-4975; Michaelson, Jacob/0000-0001-9713-0992; Wang, Jun/0000-0002-8540-8931; Gadomski, Therese/0000-0003-3286-9942; Iakoucheva, Lilia/0000-0002-4542-5219; Sebat, Jonathan/0000-0002-9087-526X; Singh, Balvindar/0000-0002-8288-553X; Estabillo, Jasper/0000-0003-2905-7273; Wang, Jun/0000-0002-2113-5874	National Institutes of Health [MH076431, HG005725, RO1 HD065288, RO1 MH091350]; Simons Foundation Autism Research Initiative [SFARI 178088]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065288] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG005725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091350, R01MH076431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This manuscript is dedicated in honor of James F. Crow, a pioneer in human genetics. This study was supported by grants to J.S. from the National Institutes of Health (MH076431 and HG005725) and the Simons Foundation Autism Research Initiative (SFARI 178088). L.M.I. was supported by NIH RO1 HD065288 and NIH RO1 MH091350. We wish to thank Joe Gleeson for helpful comments on the manuscript. Special thanks to the San Diego Supercomputer Center for providing computing resources. Samples used in this study were provided by the NIMH genetics initiative (http://www.nimhgenetics.org). Acknowledgments for autism biomaterials are provided in Supplemental Information.	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Campbell CD, 2012, NAT GENET, V44, P1277, DOI 10.1038/ng.2418; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Chen WH, 2012, NUCLEIC ACIDS RES, V40, pD901, DOI 10.1093/nar/gkr986; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; DELBRUCK M, 1946, COLD SPRING HARB SYM, V11, P33; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ellegren H, 2003, CURR OPIN GENET DEV, V13, P562, DOI 10.1016/j.gde.2003.10.008; Francino HP, 1999, NATURE, V400, P30, DOI 10.1038/21804; Gupta S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000134; Haldane JBS, 2004, J GENET, V83, P235, DOI 10.1007/BF02717892; Hamdan F.F., 2012, CLIN GENET; Hardison RC, 2003, GENOME RES, V13, P13, DOI 10.1101/gr.844103; Hellmann I, 2005, GENOME RES, V15, P1222, DOI 10.1101/gr.3461105; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang XL, 2010, AM J MED GENET A, V152A, P2112, DOI 10.1002/ajmg.a.33497; Hurles M, 2002, SCIENCE, V298; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Laumonnier F, 2006, AM J PSYCHIAT, V163, P1622, DOI 10.1176/appi.ajp.163.9.1622; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Michaelson JJ, 2012, NAT METHODS, V9, P819, DOI [10.1038/NMETH.2085, 10.1038/nmeth.2085]; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nachman MW, 2000, GENETICS, V156, P297; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Need AC, 2012, J MED GENET, V49, P353, DOI 10.1136/jmedgenet-2012-100819; Nord AS, 2011, EUR J HUM GENET, V19, P727, DOI 10.1038/ejhg.2011.24; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Rattray AJ, 2002, GENETICS, V162, P1063; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Schrider DR, 2011, CURR BIOL, V21, P1051, DOI 10.1016/j.cub.2011.05.013; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sun JX, 2012, NAT GENET, V44, P1161, DOI 10.1038/ng.2398; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Uher R, 2009, MOL PSYCHIATR, V14, P1072, DOI 10.1038/mp.2009.85; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Webster MT, 2003, MOL BIOL EVOL, V20, P278, DOI 10.1093/molbev/msg037; Zweier C, 2007, AM J HUM GENET, V80, P994, DOI 10.1086/515583	56	358	367	1	137	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1431	1442		10.1016/j.cell.2012.11.019	http://dx.doi.org/10.1016/j.cell.2012.11.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260136	Green Accepted, Bronze			2022-12-28	WOS:000312890300010
J	Hansen, LN; Zimmerman, ME; Kohlstedt, DL				Hansen, L. N.; Zimmerman, M. E.; Kohlstedt, D. L.			Laboratory measurements of the viscous anisotropy of olivine aggregates	NATURE			English	Article							LATTICE-PREFERRED ORIENTATION; OCEANIC UPPER-MANTLE; MECHANICAL ANISOTROPY; SEISMIC ANISOTROPY; SIMPLE SHEAR; DEFORMATION; VISCOSITY; STRAIN; FLOW	A marked anisotropy in viscosity develops in Earth's mantle as deformation strongly aligns the crystallographic axes of the individual grains that comprise the rocks. On the basis of geodynamic simulations, processes significantly affected by viscous anisotropy include post-glacial rebound(1,2), foundering of lithosphere(3) and melt production above subduction zones(4). However, an estimate of the magnitude of viscous anisotropy based on the results of deformation experiments on single crystals(5) differs by three orders of magnitude from that obtained by grain-scale numerical models of deforming aggregates with strong crystallographic alignment(6-8). Complicating matters, recent experiments indicate that deformation of the uppermost mantle is dominated by dislocation-accommodated grain-boundary sliding(9), a mechanism not activated in experiments on single crystals and not included in numerical models. Here, using direct measurements of the viscous anisotropy of highly deformed polycrystalline olivine, we demonstrate a significant directional dependence of viscosity. Specifically, shear viscosities measured in high-strain torsion experiments are 15 times smaller than normal viscosities measured in subsequent tension tests performed parallel to the torsion axis. This anisotropy is approximately an order of magnitude larger than that predicted by grain-scale simulations. These results indicate that dislocation-accommodated grain-boundary sliding produces an appreciable anisotropy in rock viscosity. We propose that crystallographic alignment imparts viscous anisotropy because the rate of deformation is limited by the movement of dislocations through the interiors of the crystallographically aligned grains. The maximum degree of anisotropy is reached at geologically low shear strain (of about ten) such that deforming regions of the upper mantle will exhibit significant viscous anisotropy.	[Hansen, L. N.; Zimmerman, M. E.; Kohlstedt, D. L.] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hansen, LN (corresponding author), Stanford Univ, Dept Geol & Environm Sci, 450 Serra Mall,Bldg 320, Stanford, CA 94305 USA.	lars.norman.hansen@gmail.com		Hansen, Lars/0000-0001-6212-1842	NSF [EAR1214876]; NSF through the NNIN programme; Directorate For Geosciences [1214876] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NSF through the NNIN programme; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF grant EAR1214876. Parts of this work were carried out in the Institute of Technology Characterization Facility, University of Minnesota, which receives partial support from NSF through the NNIN programme. We thank T. Becker, B. Holtzman and A. Tommasi for discussions.	Barnett MR, 2009, SCRIPTA MATER, V61, P277, DOI 10.1016/j.scriptamat.2009.04.001; Becker TW, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048584; Behn MD, 2009, EARTH PLANET SC LETT, V282, P178, DOI 10.1016/j.epsl.2009.03.014; BRICKNELL RH, 1979, ACTA METALL MATER, V27, P1313, DOI 10.1016/0001-6160(79)90200-1; Bystricky M, 2000, SCIENCE, V290, P1564, DOI 10.1126/science.290.5496.1564; Castelnau O, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038027; Castelnau O, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005444; CHRISTENSEN UR, 1987, GEOPHYS J INT, V91, P711, DOI 10.1111/j.1365-246X.1987.tb01666.x; Cordier P, 2012, NATURE, V481, P177, DOI 10.1038/nature10687; DURHAM WB, 1977, J GEOPHYS RES, V82, P5737, DOI 10.1029/JB082i036p05737; Han DZ, 1997, PHYS EARTH PLANET IN, V102, P33, DOI 10.1016/S0031-9201(96)03268-2; Hansen LN, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009305; Hansen LN, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008220; HONDA S, 1986, GEOPHYS RES LETT, V13, P1454, DOI 10.1029/GL013i013p01454; Karato S, 2008, ANNU REV EARTH PL SC, V36, P59, DOI 10.1146/annurev.earth.36.031207.124120; Knoll M, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002423; Launeau P, 1998, J GEOPHYS RES-SOL EA, V103, P5067, DOI 10.1029/97JB02670; Lev E, 2008, GEOPHYS J INT, V173, P806, DOI 10.1111/j.1365-246X.2008.03731.x; Lev E, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003382; Paterson M.S., 1990, GEOPHYS MONOGRAPH, V56, P187; Paterson MS, 2000, J STRUCT GEOL, V22, P1341, DOI 10.1016/S0191-8141(00)00042-0; Platt JP, 2011, J STRUCT GEOL, V33, P537, DOI 10.1016/j.jsg.2011.01.018; Podolefsky NS, 2004, GEOPHYS J INT, V158, P287, DOI 10.1111/j.1365-246X.2004.02250.x; Raterron P, 2012, PHYS EARTH PLANET IN, V200, P105, DOI 10.1016/j.pepi.2012.04.006; Skemer P, 2005, TECTONOPHYSICS, V411, P157, DOI 10.1016/j.tecto.2005.08.023; Tommasi A, 2000, J GEOPHYS RES-SOL EA, V105, P7893, DOI 10.1029/1999JB900411; Tommasi A, 2009, NAT GEOSCI, V2, P422, DOI 10.1038/NGEO528; Vauchez A, 1998, TECTONOPHYSICS, V296, P61, DOI 10.1016/S0040-1951(98)00137-1; Zhang SQ, 2000, TECTONOPHYSICS, V316, P133, DOI 10.1016/S0040-1951(99)00229-2; ZHANG SQ, 1995, NATURE, V375, P774, DOI 10.1038/375774a0	30	64	65	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					415	+		10.1038/nature11671	http://dx.doi.org/10.1038/nature11671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257885				2022-12-28	WOS:000312488200053
J	van Beijnum, F; Retif, C; Smiet, CB; Liu, HT; Lalanne, P; van Exter, MP				van Beijnum, Frerik; Retif, Chris; Smiet, Chris B.; Liu, Haitao; Lalanne, Philippe; van Exter, Martin P.			Quasi-cylindrical wave contribution in experiments on extraordinary optical transmission	NATURE			English	Article							SUBWAVELENGTH HOLE ARRAYS; PLASMONS	A metal film perforated by a regular array of subwavelength holes shows unexpectedly large transmission at particular wavelengths, a phenomenon known as the extraordinary optical transmission (EOT) of metal hole arrays(1). EOT was first attributed to surface plasmon polaritons, stimulating a renewed interest in plasmonics(2-4) and metallic surfaces with subwavelength features(5-7). Experiments soon revealed that the field diffracted at a hole or slit is not a surface plasmon polariton mode alone8. Further theoretical analysis(9) predicted that the extra contribution, from quasi-cylindrical waves(10-13), also affects EOT. Here we report the experimental demonstration of the relative importance of surface plasmon polaritons and quasi-cylindrical waves in EOT by considering hole arrays of different hole densities. From the measured transmission spectra, we determine microscopic scattering parameters which allow us to show that quasi-cylindrical waves affect EOT only for high densities, when the hole spacing is roughly one wavelength. Apart from providing a deeper understanding of EOT, the determination of microscopic scattering parameters from the measurement of macroscopic optical properties paves the way to novel design strategies.	[van Beijnum, Frerik; Smiet, Chris B.; van Exter, Martin P.] Leiden Univ, Huygens Lab, NL-2300 RA Leiden, Netherlands; [Retif, Chris] FOM Inst Atom & Mol Phys, NL-1098 XG Amsterdam, Netherlands; [Liu, Haitao] Nankai Univ, Inst Modern Opt, Minist Educ, Key Lab Opt Informat Sci & Technol, Tianjin 300071, Peoples R China; [Lalanne, Philippe] Univ Bordeaux 1, CNRS, Inst Opt, Lab Photon Numer & Nanosci LP2N, F-33405 Talence, France	Leiden University; Leiden University - Excl LUMC; AMOLF; Nankai University; UDICE-French Research Universities; Universite de Bordeaux; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS)	van Beijnum, F (corresponding author), Leiden Univ, Huygens Lab, POB 9504, NL-2300 RA Leiden, Netherlands.	beijnum@physics.leidenuniv.nl	van+Exter, Martin/AAA-4183-2021; lalanne, philippe/AAE-4888-2020		CNRS; 973 Program [2013CB328701]	CNRS(Centre National de la Recherche Scientifique (CNRS)); 973 Program(National Basic Research Program of China)	We acknowledge E. R. Eliel for discussions. H. L. acknowledges a Poste Rouge fellowship from CNRS and the 973 Program (2013CB328701). This work is part of the research program of the Foundation for Fundamental Research on Matter (FOM), which is part of the Netherlands Organisation for Scientific Research (NWO).	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Barnes WL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.107401; Bethe HA, 1944, PHYS REV, V66, P163, DOI 10.1103/PhysRev.66.163; Born M., 1986, PRINCIPLES OPTICS, P705; Dai W, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155407; de Abajo FJG, 2007, REV MOD PHYS, V79, P1267, DOI 10.1103/RevModPhys.79.1267; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Gan CH, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085422; Garcia-Vidal FJ, 2010, REV MOD PHYS, V82, P729, DOI 10.1103/RevModPhys.82.729; Gay G, 2006, NAT PHYS, V2, P262, DOI 10.1038/nphys264; Lalanne P, 2006, NAT PHYS, V2, P551, DOI 10.1038/nphys364; Lalanne P, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125404; Lalanne P, 2009, SURF SCI REP, V64, P453, DOI 10.1016/j.surfrep.2009.07.003; Liu HT, 2008, NATURE, V452, P728, DOI 10.1038/nature06762; Maystre D, 2011, J OPT SOC AM A, V28, P342, DOI 10.1364/JOSAA.28.000342; Nikitin AY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.073902; Nikitin AY, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/12/123020; Oulton RF, 2009, NATURE, V461, P629, DOI 10.1038/nature08364; Palik E D, 1985, HDB OPTICAL CONSTANT, VFirst, P286; Stolwijk D, 2008, OPT LETT, V33, P363, DOI 10.1364/OL.33.000363; van Beijnum F, 2011, OPT LETT, V36, P3666, DOI 10.1364/OL.36.003666; van der Molen KL, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.045421; Yanik AA, 2010, NANO LETT, V10, P4962, DOI 10.1021/nl103025u; Yin LL, 2005, NANO LETT, V5, P1399, DOI 10.1021/nl050723m	25	85	85	6	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					411	414		10.1038/nature11669	http://dx.doi.org/10.1038/nature11669			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257884				2022-12-28	WOS:000312488200052
J	Heneka, MT; Kummer, MP; Stutz, A; Delekate, A; Schwartz, S; Vieira-Saecker, A; Griep, A; Axt, D; Remus, A; Tzeng, TC; Gelpi, E; Halle, A; Korte, M; Latz, E; Golenbock, DT				Heneka, Michael T.; Kummer, Markus P.; Stutz, Andrea; Delekate, Andrea; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy; Remus, Anita; Tzeng, Te-Chen; Gelpi, Ellen; Halle, Annett; Korte, Martin; Latz, Eicke; Golenbock, Douglas T.			NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice	NATURE			English	Article							LONG-TERM POTENTIATION; AMYLOID CLEARANCE; BETA; MICROGLIA; CNS; INTERLEUKIN-1-BETA; EXPRESSION; IL-1-BETA; ENZYME; MEMORY	Alzheimer's disease is the world's most common dementing illness. Deposition of amyloid-beta peptide drives cerebral neuroinflammation by activating microglia(1,2). Indeed, amyloid-beta activation of the NLRP3 inflammasome in microglia is fundamental for interleukin-1 beta maturation and subsequent inflammatory events(3). However, it remains unknown whether NLRP3 activation contributes to Alzheimer's disease in vivo. Here we demonstrate strongly enhanced active caspase-1 expression in human mild cognitive impairment and brains with Alzheimer's disease, suggesting a role for the inflammasome in this neurodegenerative disease. Nlrp3(-/-) or Casp1(-/-) mice carrying mutations associated with familial Alzheimer's disease were largely protected from loss of spatial memory and other sequelae associated with Alzheimer's disease, and demonstrated reduced brain caspase-1 and interleukin-1 beta activation as well as enhanced amyloid-beta clearance. Furthermore, NLRP3 inflammasome deficiency skewed microglial cells to an M2 phenotype and resulted in the decreased deposition of amyloid-beta in the APP/PS1 model of Alzheimer's disease. These results show an important role for the NLRP3/caspase-1 axis in the pathogenesis of Alzheimer's disease, and suggest that NLRP3 inflammasome inhibition represents a new therapeutic intervention for the disease.	[Heneka, Michael T.; Kummer, Markus P.; Schwartz, Stephanie; Vieira-Saecker, Ana; Griep, Angelika; Axt, Daisy] Univ Bonn, Dept Neurol, Clin Neurosci Unit, D-53127 Bonn, Germany; [Heneka, Michael T.; Latz, Eicke] DZNE, D-53175 Bonn, Germany; [Stutz, Andrea; Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Delekate, Andrea; Remus, Anita; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Div Cellular Neurobiol, D-38106 Braunschweig, Germany; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA; [Tzeng, Te-Chen; Latz, Eicke; Golenbock, Douglas T.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Gelpi, Ellen] Univ Barcelona, Hosp Clin, IDIBAPS, Neurol Tissue Bank, E-08036 Barcelona, Spain; [Halle, Annett] Ctr Adv European Studies & Res CAESAR, D-53175 Bonn, Germany; [Korte, Martin] AG NIND, HZI, Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Braunschweig University of Technology; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; Helmholtz-Center for Infection Research	Latz, E (corresponding author), DZNE, D-53175 Bonn, Germany.	michael.Heneka@ukb.uni-bonn.de; eicke.latz@uni-bonn.de; douglas.golenbock@umassmed.edu	Latz, Eicke/H-3951-2014; Heneka, Michael/AAE-8011-2019; Heneka, Michael/E-8072-2015	Latz, Eicke/0000-0003-1488-5666; Kummer, Markus P./0000-0002-0993-2918; Heneka, Michael/0000-0003-4996-1630	Dana Foundation; National Institutes of Health; Deutsche Forschungsgemeinschaft; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713, U19AI084048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054060] Funding Source: NIH RePORTER	Dana Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Dana Foundation (E. L.), the National Institutes of Health (E. L., D. T. G.) and the Deutsche Forschungsgemeinschaft (E. L., M. T. H.). We thank G. Nunez and V. M. Dixit for providing anti-caspase-1 Abs. We thank B. De Strooper and L. Serneels for the BACE1 knockout mice and discussion. We also thank H. Jacobsen for the BACE1 transgenic mice.	Bamberger ME, 2003, J NEUROSCI, V23, P2665; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Heneka MT, 2010, P NATL ACAD SCI USA, V107, P6058, DOI 10.1073/pnas.0909586107; Ho VM, 2011, SCIENCE, V334, P623, DOI 10.1126/science.1209236; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kummer MP, 2011, NEURON, V71, P833, DOI 10.1016/j.neuron.2011.07.001; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Murray CA, 1998, J NEUROSCI, V18, P2974; Nalbantoglu J, 1997, NATURE, V387, P500, DOI 10.1038/387500a0; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Raes Geert, 2002, Dev Immunol, V9, P151, DOI 10.1080/1044667031000137629; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaftel SS, 2007, J CLIN INVEST, V117, P1595, DOI 10.1172/JCI31450; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Wang QW, 2004, J NEUROSCI, V24, P6049, DOI 10.1523/JNEUROSCI.0233-04.2004	30	1544	1637	35	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					674	+		10.1038/nature11729	http://dx.doi.org/10.1038/nature11729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254930	Green Accepted, Green Submitted			2022-12-28	WOS:000314219600057
J	Coelho, PS; Brustad, EM; Kannan, A; Arnold, FH				Coelho, Pedro S.; Brustad, Eric M.; Kannan, Arvind; Arnold, Frances H.			Olefin Cyclopropanation via Carbene Transfer Catalyzed by Engineered Cytochrome P450 Enzymes	SCIENCE			English	Article							STEREOSELECTIVE CYCLOPROPANATION; IRON; PROMISCUITY	Transition metal-catalyzed transfers of carbenes, nitrenes, and oxenes are powerful methods for functionalizing C = C and C-H bonds. Nature has evolved a diverse toolbox for oxene transfers, as exemplified by the myriad monooxygenation reactions catalyzed by cytochrome P450 enzymes. The isoelectronic carbene transfer to olefins, a widely used C-C bond-forming reaction in organic synthesis, has no biological counterpart. Here we report engineered variants of cytochrome P450(BM3) that catalyze highly diastereo- and enantioselective cyclopropanation of styrenes from diazoester reagents via putative carbene transfer. This work highlights the capacity to adapt existing enzymes for the catalysis of synthetically important reactions not previously observed in nature.	[Coelho, Pedro S.; Kannan, Arvind; Arnold, Frances H.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Brustad, Eric M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Brustad, Eric M.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Arnold, FH (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	frances@cheme.caltech.edu		Arnold, Frances H./0000-0002-4027-364X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy [DE-FG02-06ER15762]; Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences [F32GM087102]; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM087102] Funding Source: NIH RePORTER	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE)); Ruth M. Kirschstein National Institutes of Health (NIH) from the National Institute of General Medical Sciences; University of North Carolina Chapel Hill; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the U.S. Department of Energy through grant DE-FG02-06ER15762. E.M.B. was supported by a Ruth M. Kirschstein National Institutes of Health (NIH) postdoctoral fellowship, award number F32GM087102, from the National Institute of General Medical Sciences and a generous startup fund from the University of North Carolina Chapel Hill. P.S.C., E.M.B., and F.H.A. have filed through the California Institute of Technology a provisional patent application that is based on the results presented here. The authors thank Z. J. Wang for helpful discussions during the preparation of the manuscript.	Bornscheuer UT, 2004, ANGEW CHEM INT EDIT, V43, P6032, DOI 10.1002/anie.200460416; Breslow R, 2009, J BIOL CHEM, V284, P1337, DOI 10.1074/jbc.X800011200; Caballero A, 2009, EUR J INORG CHEM, P1137, DOI 10.1002/ejic.200800944; Davies HML, 2008, NATURE, V451, P417, DOI 10.1038/nature06485; Groves JT, 2003, P NATL ACAD SCI USA, V100, P3569, DOI 10.1073/pnas.0830019100; Hyster TK, 2012, SCIENCE, V338, P500, DOI 10.1126/science.1226132; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Lebel H, 2003, CHEM REV, V103, P977, DOI 10.1021/cr010007e; Lewis JC, 2009, CHIMIA, V63, P309, DOI 10.2533/chimia.2009.309; Morandi B, 2012, SCIENCE, V335, P1471, DOI 10.1126/science.1218781; Nicolas I, 2008, COORDIN CHEM REV, V252, P727, DOI 10.1016/j.ccr.2007.09.003; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Wessjohann LA, 2003, CHEM REV, V103, P1625, DOI 10.1021/cr0100188; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; WOLF JR, 1995, J AM CHEM SOC, V117, P9194, DOI 10.1021/ja00141a011	16	495	508	24	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					307	310		10.1126/science.1231434	http://dx.doi.org/10.1126/science.1231434			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23258409				2022-12-28	WOS:000313622000040
J	Cayouette, M; Mattar, P; Harris, WA				Cayouette, Michel; Mattar, Pierre; Harris, William A.			Progenitor Competence: Genes Switching Places	CELL			English	Editorial Material							IDENTITY	Drosophila neural progenitor cells are competent to give rise to certain neuronal cell types only during a limited period of time. Kohwi et al. link the termination of early competence to changes in subnuclear organization of chromatin.	[Cayouette, Michel; Mattar, Pierre] Inst Rech Clin Montreal, Cellular Neurobiol Res Unit, Montreal, PQ H2W 1R7, Canada; [Cayouette, Michel] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Cayouette, Michel] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0G4, Canada; [Cayouette, Michel] McGill Univ, Div Expt Med, Montreal, PQ H3A 0G4, Canada; [Harris, William A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1TN, England	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; McGill University; McGill University; University of Cambridge	Cayouette, M (corresponding author), Inst Rech Clin Montreal, Cellular Neurobiol Res Unit, Montreal, PQ H2W 1R7, Canada.	michel.cayouette@ircm.qc.ca; wah20@cam.ac.uk		Mattar, Pierre/0000-0002-5708-6218; Cayouette, Michel/0000-0003-4655-9048	Wellcome Trust [100329] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Kohwi M, 2013, CELL, V152, P97, DOI 10.1016/j.cell.2012.11.049; Kohwi M, 2011, DEVELOPMENT, V138, P1727, DOI 10.1242/dev.061499; Miyamoto K, 2011, GENE DEV, V25, P946, DOI 10.1101/gad.615211; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Touma JJ, 2012, DEVELOPMENT, V139, P657, DOI 10.1242/dev.071589	9	1	1	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					13	14		10.1016/j.cell.2012.12.038	http://dx.doi.org/10.1016/j.cell.2012.12.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332742	Bronze			2022-12-28	WOS:000313719800001
J	Hassen, GW; Bhardwaj, N				Hassen, Getaw Worku; Bhardwaj, Namita			Bilateral Internuclear Ophthalmoplegia in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hassen, Getaw Worku] New York Med Coll, Metropolitan Hosp Ctr, New York, NY 10029 USA; [Bhardwaj, Namita] Mt Sinai Sch Med, Lutheran Med Ctr, Brooklyn, NY USA	Metropolitan Hospital Center; New York Medical College; Icahn School of Medicine at Mount Sinai	Hassen, GW (corresponding author), New York Med Coll, Metropolitan Hosp Ctr, New York, NY 10029 USA.			Bhardwaj, Namita/0000-0002-0841-4975					0	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3								10.1056/NEJMicm1200499	http://dx.doi.org/10.1056/NEJMicm1200499			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323922				2022-12-28	WOS:000313549900012
J	Nardini, M; Gnesutta, N; Donati, G; Gatta, R; Forni, C; Fossati, A; Vonrhein, C; Moras, D; Romier, C; Bolognesi, M; Mantovani, R				Nardini, Marco; Gnesutta, Nerina; Donati, Giacomo; Gatta, Raffaella; Forni, Claudia; Fossati, Andrea; Vonrhein, Clemens; Moras, Dino; Romier, Christophe; Bolognesi, Martino; Mantovani, Roberto			Sequence-Specific Transcription Factor NF-Y Displays Histone-like DNA Binding and H2B-like Ubiquitination	CELL			English	Article							CRYSTAL-STRUCTURE; CCAAT-BOX; H2B UBIQUITYLATION; FOLD PROTEINS; MINOR-GROOVE; COMPLEX; ARABIDOPSIS; CHROMATIN; PROMOTER; CONSTANS	The sequence-specific transcription factor NF-Y binds the CCAAT box, one of the sequence elements most frequently found in eukaryotic promoters. NF-Y is composed of the NF-YA and NF-YB/NF-YC subunits, the latter two hosting histone-fold domains (HFDs). The crystal structure of NF-Y bound to a 25 bp CCAAT oligonucleotide shows that the HFD dimer binds to the DNA sugar-phosphate backbone, mimicking the nucleosome H2A/H2B-DNA assembly. NF-YA both binds to NF-YB/NF-YC and inserts an a helix deeply into the DNA minor groove, providing sequence-specific contacts to the CCAAT box. Structural considerations and mutational data indicate that NF-YB ubiquitination at Lys138 precedes and is equivalent to H2B Lys120 monoubiquitination, important in transcriptional activation. Thus, NF-Y is a sequence-specific transcription factor with nucleosome-like properties of nonspecific DNA binding and helps establish permissive chromatin modifications at CCAAT promoters. Our findings suggest that other HFD-containing proteins may function in similar ways.	[Nardini, Marco; Gnesutta, Nerina; Donati, Giacomo; Gatta, Raffaella; Forni, Claudia; Fossati, Andrea; Bolognesi, Martino; Mantovani, Roberto] Univ Milan, Dipartimento BioSci, I-20133 Milan, Italy; [Bolognesi, Martino] Univ Milan, Ist Biofis, CNR, I-20133 Milan, Italy; [Bolognesi, Martino] Univ Milan, CIMAINA, I-20133 Milan, Italy; [Vonrhein, Clemens] Global Phasing Ltd, Cambridge CB3 0AX, England; [Moras, Dino; Romier, Christophe] IGBMC, Dept Biol & Genom Struct, F-67404 Illkirch Graffenstaden, France	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; University of Milan; Global Phasing Limited; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bolognesi, M (corresponding author), Univ Milan, Dipartimento BioSci, Via Celoria 26, I-20133 Milan, Italy.	martino.bolognesi@unimi.it; mantor@unimi.it	Gnesutta, Nerina/I-5432-2015; Nardini, Marco/B-7842-2017; Fossati, Andrea/AAN-3814-2020; Bolognesi, Martino/B-7924-2017	Gnesutta, Nerina/0000-0002-2465-8881; Nardini, Marco/0000-0002-3718-2165; Fossati, Andrea/0000-0001-9368-4058; Bolognesi, Martino/0000-0002-9253-5170; DONATI, Giacomo/0000-0002-0370-8288; Romier, Christophe/0000-0002-3680-935X	Regione Lombardia Nepente; CNRS; INSERM; Universite de Strasbourg (UDS); European Commission [LSHG-CT-2006-031220]	Regione Lombardia Nepente(Regione Lombardia); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Strasbourg (UDS); European Commission(European CommissionEuropean Commission Joint Research Centre)	M.N., N.G., G.D., R.G., C.F., and A.F. performed the experiments; M.N. and C.V. analyzed the X-ray data; and M.N., N.G., D.M., C.R., M.B., and R. M. planned the experiments, analyzed the data, and wrote the manuscript. We thank David Horner for comments on the manuscript. This work was supported by Regione Lombardia Nepente grant (to R.M.), and by institutional funds from the CNRS, INSERM, the Universite de Strasbourg (UDS), and the European Commission SPINE2-Complexes project (contract No. LSHG-CT-2006-031220).	Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bi WM, 1997, J BIOL CHEM, V272, P26562, DOI 10.1074/jbc.272.42.26562; Bricogne G., 2010, BUSTER VERSION 2 9; Cai XN, 2007, PLANT PHYSIOL, V145, P98, DOI 10.1104/pp.107.102079; Chen NZ, 2007, J BIOCHEM MOL BIOL, V40, P1083; Corona DFV, 2000, EMBO J, V19, P3049, DOI 10.1093/emboj/19.12.3049; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dolfini D, 2012, CRIT REV BIOCHEM MOL, V47, P29, DOI 10.3109/10409238.2011.628970; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gangloff YG, 2001, TRENDS BIOCHEM SCI, V26, P250, DOI 10.1016/S0968-0004(00)01741-2; Gatta R, 2010, CELL CYCLE, V9, P2149, DOI 10.4161/cc.9.11.11839; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Hartlepp KF, 2005, MOL CELL BIOL, V25, P9886, DOI 10.1128/MCB.25.22.9886-9896.2005; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Juo ZS, 1996, J MOL BIOL, V261, P239, DOI 10.1006/jmbi.1996.0456; Kamada K, 2001, CELL, V106, P71, DOI 10.1016/S0092-8674(01)00417-2; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kukimoto I, 2004, MOL CELL, V13, P265, DOI 10.1016/S1097-2765(03)00523-9; Kumimoto RW, 2010, PLANT J, V63, P379, DOI 10.1111/j.1365-313X.2010.04247.x; Laribee RN, 2007, GENE DEV, V21, P737, DOI 10.1101/gad.1541507; Li Q, 1998, EMBO J, V17, P6300, DOI 10.1093/emboj/17.21.6300; Li Y, 2000, J BIOL CHEM, V275, P23247, DOI 10.1074/jbc.M002548200; Liberati C, 1999, J MOL BIOL, V285, P1441, DOI 10.1006/jmbi.1998.2384; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; RONCHI A, 1995, NUCLEIC ACIDS RES, V23, P4565, DOI 10.1093/nar/23.22.4565; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Werten S, 2002, J BIOL CHEM, V277, P45502, DOI 10.1074/jbc.M206587200; Wright KJ, 2006, P NATL ACAD SCI USA, V103, P12347, DOI 10.1073/pnas.0605499103; Zemzoumi K, 1999, J MOL BIOL, V286, P327, DOI 10.1006/jmbi.1998.2496	48	179	193	2	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					132	143		10.1016/j.cell.2012.11.047	http://dx.doi.org/10.1016/j.cell.2012.11.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332751	Green Submitted, Bronze			2022-12-28	WOS:000313719800012
J	Tierney, JE; Smerdon, JE; Anchukaitis, KJ; Seager, R				Tierney, Jessica E.; Smerdon, Jason E.; Anchukaitis, Kevin J.; Seager, Richard			Multidecadal variability in East African hydroclimate controlled by the Indian Ocean	NATURE			English	Article							RAINFALL VARIABILITY; LAKE MASOKO; ICE-AGE; DROUGHT; SOLAR	The recent decades-long decline in East African rainfall(1) suggests that multidecadal variability is an important component of the climate of this vulnerable region. Prior work based on analysing the instrumental record implicates both Indian(2) and Pacific(1) ocean sea surface temperatures (SSTs) as possible drivers of East African multidecadal climate variability, but the short length of the instrumental record precludes a full elucidation of the underlying physical mechanisms. Here we show that on timescales beyond the decadal, the Indian Ocean drives East African rainfall variability by altering the local Walker circulation, whereas the influence of the Pacific Ocean is minimal. Our results, based on proxy indicators of relative moisture balance for the past millennium paired with long control simulations from coupled climate models, reveal that moist conditions in coastal East Africa are associated with cool SSTs (and related descending circulation) in the eastern Indian Ocean and ascending circulation over East Africa. The most prominent event identified in the proxy record-a coastal pluvial from 1680 to 1765-occurred when Indo-Pacific warm pool SSTs reached their minimum values of the past millennium. Taken together, the proxy and model evidence suggests that Indian Ocean SSTs are the primary influence on East African rainfall over multidecadal and perhaps longer timescales.	[Tierney, Jessica E.; Anchukaitis, Kevin J.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Tierney, Jessica E.; Smerdon, Jason E.; Anchukaitis, Kevin J.; Seager, Richard] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Woods Hole Oceanographic Institution; Columbia University	Tierney, JE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.	tierney@whoi.edu	Smerdon, Jason E/F-9952-2011	Seager, Richard/0000-0003-4772-9707; Tierney, Jessica/0000-0002-9080-9289	US NOAA; NSF [OCE-1203892]; NOAA [NA10OAR431037]; Office of Science, US Department of Energy; US NSF; Directorate For Geosciences [1203892] Funding Source: National Science Foundation; Division Of Ocean Sciences [1636445] Funding Source: National Science Foundation	US NOAA; NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); Office of Science, US Department of Energy(United States Department of Energy (DOE)); US NSF(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	J.E.T. acknowledges the US NOAA Climate and Global Change Postdoctoral Fellowship and NSF OCE-1203892 for support. J.E.S. and R.S. were supported by the NOAA award Global Decadal Hydroclimate Variability and Change (NA10OAR431037). We thank the National Center for Atmospheric Research, who made the CCSM4 control simulation available through the US Earth System Grid (ESG) Center. Support for the ESG is provided by the Office of Science, US Department of Energy, with co-sponsorship from the US NSF. Thanks also to NOAA GFDL for providing the multimillennial control simulation output from the GFDL CM2.1 model, to N. Naik for her on-site support at LDEO and to J. Jungclaus of the Max Planck Institute for providing output from the MPI COSMOS control simulation. This is LDEO contribution number 7641.	Anchukaitis K. J., 2012, CLIM DYN; Black E, 2003, MON WEATHER REV, V131, P74, DOI 10.1175/1520-0493(2003)131<0074:AOSOTR>2.0.CO;2; Brown ET, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2005GC000959; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Delworth TL, 2006, J CLIMATE, V19, P643, DOI 10.1175/JCLI3629.1; Dommenget D, 2002, J CLIMATE, V15, P216, DOI 10.1175/1520-0442(2002)015<0216:ACNOTI>2.0.CO;2; Famine Early Warning System Network, 2011, E AFR PAST YEAR ON D; Funk C, 2008, P NATL ACAD SCI USA, V105, P11081, DOI 10.1073/pnas.0708196105; Garcin Y, 2007, J PALEOLIMNOL, V37, P475, DOI 10.1007/s10933-006-9033-6; Garcin Y, 2006, PALAEOGEOGR PALAEOCL, V239, P334, DOI 10.1016/j.palaeo.2006.02.002; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Johnson TC, 2008, LIMNOL OCEANOGR, V53, P1622, DOI 10.4319/lo.2008.53.4.1622; Lyon B, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050337; NICHOLSON SE, 1986, ARCH METEOR GEOPHY A, V34, P311, DOI 10.1007/BF02257765; Oppo DW, 2009, NATURE, V460, P1113, DOI 10.1038/nature08233; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; Rudolf B., 2011, GPCC STATUS REPORT; Russell JM, 2007, GEOLOGY, V35, P21, DOI 10.1130/G23125A.1; Stager JC, 2005, J PALEOLIMNOL, V33, P243, DOI 10.1007/s10933-004-4227-2; Tierney JE, 2011, QUATERNARY SCI REV, V30, P798, DOI 10.1016/j.quascirev.2011.01.017; Tierney JE, 2010, NAT GEOSCI, V3, P422, DOI [10.1038/ngeo865, 10.1038/NGEO865]; Ummenhofer CC, 2009, J CLIMATE, V22, P993, DOI 10.1175/2008JCLI2493.1; Verschuren D, 2000, NATURE, V403, P410, DOI 10.1038/35000179; Verschuren D., 2004, CLIMATE VARIABILITY, P219; Verschuren D, 2009, NATURE, V462, P637, DOI 10.1038/nature08520; Williams AP, 2011, CLIM DYNAM, V37, P2417, DOI 10.1007/s00382-010-0984-y; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Wolff C, 2011, SCIENCE, V333, P743, DOI 10.1126/science.1203724	29	224	224	3	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					389	392		10.1038/nature11785	http://dx.doi.org/10.1038/nature11785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325220	Green Published			2022-12-28	WOS:000313615900048
J	Vinogradova, Y; Coupland, C; Hippisley-Cox, J				Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia			Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL BISPHOSPHONATES; ESOPHAGEAL CANCER; WOMEN; COHORT; DRUGS; MEN; VALIDATION; DIAGNOSIS; VALIDITY; ENGLAND	Objective To investigate the association between use of bisphosphonates estimated from prescription information and risk of gastrointestinal cancers. Design Series of nested case-control studies. Setting General practices in the United Kingdom contributing to the QResearch primary care database (660) and the Clinical Practice Research Datalink (CPRD) (643). Participants Patients aged >= 50 with a diagnosis of a primary gastrointestinal cancer in 1997-2011, each matched with up to five controls by age, sex, practice, and calendar year. Main outcome measures Odds ratios for incident gastrointestinal cancers (colorectal, oesophageal, gastric) and use of bisphosphonates, adjusted for smoking status, ethnicity, comorbidities, and use of other drugs. Results 20 106 and 19 035 cases of colorectal cancer cases, 5364 and 5135 cases of oesophageal cancer cases, and 3155 and 3157 cases of gastric cancer were identified from QResearch and CPRD, respectively. Overall bisphosphonate use (at least one prescription) was not associated with risk of colorectal, oesophageal, or gastric cancers in either database. Adjusted odds ratios (95% confidence interval) for QResearch and CPRD were 0.97 (0.79 to 1.18) and 1.18 (0.97 to 1.43) for oesophageal cancer; 1.12 (0.87 to 1.44) and 0.79 (0.62 to 1.01) for gastric cancer; and 1.03 (0.94 to 1.14) and 1.10 (1.00 to 1.22) for colorectal cancer. Additional analyses showed no difference between types of bisphosphonate for risk of oesophageal and colorectal cancers. For gastric cancer, alendronate use was associated with an increased risk (1.47, 1.11 to 1.95; P=0.008), but only in data from the QResearch database and without any association with duration and with no definitive confirmation from sensitivity analysis. Conclusions In this series of population based case-control studies in two large primary care databases, exposure to bisphosphonates was not associated with an increased risk of common gastrointestinal cancers.	[Vinogradova, Yana; Coupland, Carol; Hippisley-Cox, Julia] Div Primary Care, Nottingham NG2 7RD, England		Vinogradova, Y (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	yana.vinogradova@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Vinogradova, Yana/0000-0002-3030-5257; Coupland, Carol/0000-0002-2327-3306	division of primary care of University of Nottingham	division of primary care of University of Nottingham	This work was funded by the division of primary care of University of Nottingham.	Abrahamsen B, 2012, J BONE MINER RES, V27, P679, DOI 10.1002/jbmr.1481; Cardwell CR, 2012, INT J CANCER, V131, pE717, DOI 10.1002/ijc.27389; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chang ET, 2006, JNCI-J NATL CANCER I, V98, P61, DOI 10.1093/jnci/djj005; Corley DA, 2010, GASTROENTEROLOGY, V139, P93, DOI 10.1053/j.gastro.2010.03.055; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Croucher P, 2003, BREAST, V12, pS30, DOI 10.1016/S0960-9776(03)80161-3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Rodriguez LAG, 2006, GUT, V55, P1538, DOI 10.1136/gut.2005.086579; Gonzalez-Perez A, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-28; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Hecht SS, 2008, DEVITA HELLMAN ROSEN, P147; Henderson KD, 2008, DEVITA HELLMAN ROSEN, V1, P239; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hippisley-Cox J, 2004, HLTH INFORMATICS J, V10, P91, DOI 10.1177/1460458204042230; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Khalili H, 2012, J CLIN ONCOL, V30, P3229, DOI 10.1200/JCO.2011.39.2670; Mai PL, 2011, JNCI-J NATL CANCER I, V103, P788, DOI 10.1093/jnci/djr114; Mauck KF, 2006, MAYO CLIN PROC, V81, P662, DOI 10.4065/81.5.662; McGlynn KA, 2008, INT J CANCER, V122, P1879, DOI 10.1002/ijc.23290; Mocellin S, 2011, BBA-REV CANCER, V1816, P172, DOI 10.1016/j.bbcan.2011.07.001; National Institute for Health and Clinical Excellence, 2008, AL ET RIS STRONT RAN; Parker C, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4245; Pascoe SW, 2008, FAM PRACT, V25, P215, DOI 10.1093/fampra/cmn023; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2693, DOI 10.1007/s00198-012-1902-4; Recker RR, 2005, MAYO CLIN PROC, V80, P856, DOI 10.4065/80.7.856; Rennert G, 2011, J CLIN ONCOL, V29, P1146, DOI 10.1200/JCO.2010.33.7485; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rustgi AK, 2008, DEVITA HELLMAN ROSEN, P989; Schutze M, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1584; Siris ES, 2009, NEW ENGL J MED, V360, P1791; Stattin P, 2007, DIABETES CARE, V30, P561, DOI 10.2337/dc06-0922; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Thomson ABR, 2002, J RHEUMATOL, V29, P1965; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vestergaard P, 2010, CALCIFIED TISSUE INT, V86, P110, DOI 10.1007/s00223-009-9323-x; Vinogradova Y, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000548; Walker AJ, 2011, BRIT J CANCER, V104, P193, DOI 10.1038/sj.bjc.6605996; Watts NB, 2010, J CLIN ENDOCR METAB, V95, P1555, DOI 10.1210/jc.2009-1947; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Zografos GN, 2009, DIS ESOPHAGUS, V22, P633, DOI 10.1111/j.1442-2050.2009.00972.x	48	33	33	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f114	10.1136/bmj.f114	http://dx.doi.org/10.1136/bmj.f114			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FI	23325866	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000313868800002
J	Linkins, LA; Bates, SM; Lang, E; Kahn, SR; Douketis, JD; Julian, J; Parpia, S; Gross, P; Weitz, JI; Spencer, FA; Lee, AYY; O'Donnell, MJ; Crowther, MA; Chan, HH; Lim, W; Schulman, S; Ginsberg, JS; Kearon, C				Linkins, Lori-Ann; Bates, Shannon M.; Lang, Eddy; Kahn, Susan R.; Douketis, James D.; Julian, Jim; Parpia, Sameer; Gross, Peter; Weitz, Jeffrey I.; Spencer, Frederick A.; Lee, Agnes Y. Y.; O'Donnell, Martin J.; Crowther, Mark A.; Chan, Howard H.; Lim, Wendy; Schulman, Sam; Ginsberg, Jeffrey S.; Kearon, Clive			Selective D-Dimer Testing for Diagnosis of a First Suspected Episode of Deep Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY-EMBOLISM; VEIN THROMBOSIS; PROBABILITY; OUTPATIENTS	Background: D-Dimer testing is sensitive but not specific for diagnosing deep venous thrombosis (DVT). Changing the use of testing and the threshold level for a positive test result on the basis of risk for DVT might improve the tradeoff between sensitivity and specificity and reduce the need for testing. Objective: To determine whether using a selective D-dimer testing strategy based on clinical pretest probability (C-PTP) for DVT is safe and reduces diagnostic testing compared with using a single D-dimer threshold for all patients. Design: Randomized, multicenter, controlled trial. Patients were allocated using a central automated system. Ultrasonographers and study adjudicators but not other study personnel were blinded to trial allocation. (ClinicalTrials. gov: NCT00157677) Setting: 5 Canadian hospitals. Patients: Consecutive symptomatic patients with a first episode of suspected DVT. Intervention: Selective testing (n = 860), defined as D-dimer testing for outpatients with low or moderate C-PTP (DVT excluded at D-dimer levels < 1.0 mu g/mL [ low C-PTP] or <0.5 mu g/mL [ moderate C-PTP]) and venous ultrasonography without D-dimer testing for outpatients with high C-PTP and inpatients, or uniform testing (n = 863), defined as D-dimer testing for all participants (DVT excluded at D-dimer levels <0.5 mu g/mL). Measurements: The proportion of patients not diagnosed with DVT during initial testing who had symptomatic venous thromboembolism during 3-month follow-up and the proportion of patients undergoing D-dimer testing and ultrasonography. Results: The incidence of symptomatic venous thromboembolism at 3 months was 0.5% in both study groups (difference, 0.0 percentage point [95% CI, -0.8 to 0.8 percentage points]). Selective testing reduced the proportion of patients who required D-dimer testing by 21.8 percentage points (CI, 19.1 to 24.8 percentage points). It reduced the proportion who required ultrasonography by 7.6 percentage points (CI, 2.9 to 12.2 percentage points) overall and by 21.0 percentage points (CI, 14.2 to 27.6 percentage points) in outpatients with low C-PTP. Limitation: Results may not be generalizable to all D-dimer assays or patients with previous DVT, study personnel were not blinded, and the trial was stopped prematurely. Conclusion: A selective D-dimer testing strategy seems as safe as and more efficient than having everyone undergo D-dimer testing when diagnosing a first episode of suspected DVT. Primary Funding Source: Heart and Stroke Foundation of Ontario.	McMaster Univ, Hamilton, ON L8S 4K1, Canada; Univ Calgary, Calgary, AB, Canada; McGill Univ, Montreal, PQ, Canada; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Natl Univ Ireland, HRB Clin Res Facil, Galway, Ireland	McMaster University; University of Calgary; McGill University; University of British Columbia; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway	Linkins, LA (corresponding author), McMaster Univ, Juravinski Hosp, Dept Med, Room A3-74,1280 Main St W, Hamilton, ON L8S 4K1, Canada.	linkinla@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Schulman, Sam/I-7559-2019; O'Donnell, Martin/ABE-7459-2020; Lang, Eddy/AAS-2080-2020; Douketis, James/AAO-5659-2021; ginsberg, jeffrey s/ABC-1065-2020; Lang, Eddy/I-4759-2014	Weitz, Jeffrey/0000-0002-1092-7550; Schulman, Sam/0000-0002-8512-9043; O'Donnell, Martin/0000-0002-7347-7761; Lang, Eddy/0000-0003-0850-4337	Heart and Stroke Foundation of Ontario [T6392]; Heart and Stroke Foundation of Canada; Fonds de la Recherche en Sante du Quebec; Canada Research Chair (Tier 1)	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Research Chair (Tier 1)(Canada Research Chairs)	By the Heart and Stroke Foundation of Ontario (T6392). Dr. Linkins is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. Dr. Kahn is a recipient of a National Research Scientist Award from the Fonds de la Recherche en Sante du Quebec. Dr. Douketis is a recipient of the GlaxoSmithKline Distinguished Scholar Award in Thrombosis from the Chest Foundation. Dr. Weitz is the recipient of the Canada Research Chair (Tier 1) in Thrombosis and the Heart and Stroke Foundation of Ontario and J. Fraser Mustard Chair in Cardiovascular Research. Dr. Spencer is a recipient of an Investigator Award from the Heart and Stroke Foundation of Canada. Dr. Crowther holds the Leo Pharma Chair in Thromboembolism Research at McMaster University and is a Career Investigator of the Heart and Stroke Foundation of Ontario. Dr. Lim is the recipient of the E. J. Moran Campbell Internal Career Award from McMaster University. Dr. Ginsberg is a recipient of a Career Investigator Award of the Heart and Stroke Foundation of Ontario and the David Braley and Nancy Gordon Chair for investigation of thromboembolic diseases. Dr. Kearon is a recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Arnason T, 2007, THROMB HAEMOSTASIS, V97, P195, DOI 10.1160/TH06-10-0596; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Crowther MA, 2005, INTENS CARE MED, V31, P48, DOI 10.1007/s00134-004-2467-2; Ginsberg JS, 1997, ARCH INTERN MED, V157, P1077, DOI 10.1001/archinte.157.10.1077; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Kline JA, 2012, J THROMB HAEMOST, V10, P572, DOI 10.1111/j.1538-7836.2012.04647.x; Linkins LA, 2004, J THROMB HAEMOST, V2, P1256, DOI 10.1111/j.1538-7836.2004.00824.x; Righini M, 2008, J THROMB HAEMOST, V6, P1059, DOI 10.1111/j.1538-7836.2008.02981.x; Righini M, 2004, ARCH INTERN MED, V164, P2483, DOI 10.1001/archinte.164.22.2483; Schouten HJ, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2985; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 1998, J INTERN MED, V243, P15; Yamaki T, 2009, J VASC SURG, V50, P1099, DOI 10.1016/j.jvs.2009.06.059	15	56	62	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					93	+		10.7326/0003-4819-158-2-201301150-00003	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00003			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318311				2022-12-28	WOS:000314029400015
J	Sassone-Corsi, P				Sassone-Corsi, Paolo			When Metabolism and Epigenetics Converge	SCIENCE			English	Editorial Material							OXIDATIVE STRESS; DEACETYLASE; RESTRICTION		Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Dept Biol Chem, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu						Evason K, 2008, AGING CELL, V7, P305, DOI 10.1111/j.1474-9726.2008.00375.x; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Lu C., 2012, MOL CELL, V16, P7; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Rajapakse I, 2011, J CELL BIOL, V192, P711, DOI 10.1083/jcb.201010129; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Zhao YM, 2005, J EXP BIOL, V208, P697, DOI 10.1242/jeb.01439	16	59	61	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					148	150		10.1126/science.1233423	http://dx.doi.org/10.1126/science.1233423			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307727				2022-12-28	WOS:000313328200028
J	Boden, WE; Franklin, BA; Wenger, NK				Boden, William E.; Franklin, Barry A.; Wenger, Nanette K.			Physical Activity and Structured Exercise for Patients With Stable Ischemic Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL THERAPY; CORONARY; PREVENTION; INTENSITY		[Boden, William E.] Samuel Stratton VA Med Ctr, Dept Med, Albany, NY 12208 USA; [Boden, William E.] Albany Med Coll, Albany, NY 12208 USA; [Franklin, Barry A.] William Beaumont Hosp, Dept Prevent Cardiol Rehabil, Royal Oak, MI 48072 USA; [Franklin, Barry A.] Oakland Univ, William Beaumont Sch Med, Rochester, MI 48063 USA; [Wenger, Nanette K.] Grady Mem Hosp, Dept Med, Div Cardiol, Atlanta, GA USA; [Wenger, Nanette K.] Emory Univ, Sch Med, Atlanta, GA USA	Albany Medical College; Beaumont Health; Oakland University; Emory University	Boden, WE (corresponding author), Samuel Stratton VA Med Ctr, Dept Med, 113 Holland Ave, Albany, NY 12208 USA.	william.boden@va.gov						Balady GJ, 2011, CIRCULATION, V124, P2951, DOI 10.1161/CIR.0b013e31823b21e2; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Boden WE, 2009, NEW ENGL J MED, V360, P2570, DOI 10.1056/NEJMe0904090; Borden WB, 2011, JAMA-J AM MED ASSOC, V305, P1882, DOI 10.1001/jama.2011.601; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Leon AS, 2005, CIRCULATION, V111, P369, DOI 10.1161/01.CIR.0000151788.08740.5C; Myers J, 2008, CLIN INVEST MED, V31, pE400; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Wen CP, 2012, LANCET, V380, P192, DOI 10.1016/S0140-6736(12)60954-4	10	33	35	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					143	144		10.1001/jama.2012.128367	http://dx.doi.org/10.1001/jama.2012.128367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299603				2022-12-28	WOS:000313517000020
J	Ducros, A; Bousser, MG				Ducros, Anne; Bousser, Marie-Germaine			Thunderclap headache	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CEREBRAL VASOCONSTRICTION SYNDROME; LUMBAR PUNCTURE; SUBARACHNOID HEMORRHAGE; NORMAL CT; FEATURES; SYMPTOM; SERIES		[Ducros, Anne] Lariboisiere Hosp, Assistance Publ Hop Paris, Head & Neck Clin, Emergency Headache Ctr, F-75010 Paris, France; [Bousser, Marie-Germaine] Lariboisiere Hosp, Neurol Dept, Head & Neck Clin, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Ducros, A (corresponding author), Lariboisiere Hosp, Assistance Publ Hop Paris, Head & Neck Clin, Emergency Headache Ctr, F-75010 Paris, France.	anne.ducros@lrb.aphp.fr	DUCROS, Anne/D-1899-2010	DUCROS, Anne/0000-0001-5560-5013				Al-Shahi R, 2006, BMJ-BRIT MED J, V333, P235, DOI 10.1136/bmj.333.7561.235; Arnold M, 2006, J NEUROL NEUROSUR PS, V77, P1021, DOI 10.1136/jnnp.2006.094359; Azevedo LL, 2011, EUR NEUROL, V66, P133, DOI 10.1159/000330675; Bartynski WS, 2008, AM J NEURORADIOL, V29, P447, DOI 10.3174/ajnr.A0839; Broner S, 2007, HEADACHE, V47, P724, DOI 10.1111/j.1526-4610.2007.00795.x; Cumurciuc R, 2005, J NEUROL NEUROSUR PS, V76, P1084, DOI 10.1136/jnnp.2004.056275; Davenport R, 2002, J NEUROL NEUROSUR PS, V72, P33; DAY JW, 1986, LANCET, V2, P1247; deBruijn SFTM, 1996, LANCET, V348, P1623, DOI 10.1016/S0140-6736(96)07294-7; Dodick DW, 2002, J NEUROL NEUROSUR PS, V72, P6, DOI 10.1136/jnnp.72.1.6; Dodick DW, 1998, NEUROLOGY, V50, P1510, DOI 10.1212/WNL.50.5.1510; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Ducros A, 2012, LANCET NEUROL, V11, P906, DOI 10.1016/S1474-4422(12)70135-7; Ducros A, 2010, STROKE, V41, P2505, DOI 10.1161/STROKEAHA.109.572313; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Fugate JE, 2012, STROKE, V43, P670, DOI 10.1161/STROKEAHA.111.639575; Landtblom AM, 2002, CEPHALALGIA, V22, P354, DOI 10.1046/j.1468-2982.2002.00368.x; LINN FHH, 1994, LANCET, V344, P590, DOI 10.1016/S0140-6736(94)91970-4; Linn FHH, 1998, J NEUROL NEUROSUR PS, V65, P791, DOI 10.1136/jnnp.65.5.791; McGeeney BE, 2006, HEADACHE, V46, P517, DOI 10.1111/j.1526-4610.2006.00386_2.x; Mistry Niraj, 2009, Pract Neurol, V9, P294, DOI 10.1136/jnnp.2009.188037; Moussouttas M, 2008, STROKE, V39, P1394, DOI 10.1161/STROKEAHA.107.503169; O'Neill J, 2005, SCOT MED J, V50, P151, DOI 10.1177/003693300505000405; Ohkuma H, 2001, STROKE, V32, P1176, DOI 10.1161/01.STR.32.5.1176; Savitz SI, 2008, STROKE, V39, P1392, DOI 10.1161/STROKEAHA.107.503151; Schievink WI, 2001, J NEUROSURG, V95, P522, DOI 10.3171/jns.2001.95.3.0522; Schievink WI, 2001, NEUROSURGERY, V48, P513, DOI 10.1097/00006123-200103000-00009; Schwedt TJ, 2006, LANCET NEUROL, V5, P621, DOI 10.1016/S1474-4422(06)70497-5; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Singhal AB, 2011, ARCH NEUROL-CHICAGO, V68, P1005, DOI 10.1001/archneurol.2011.68; Timoteo A, 2012, J HEADACHE PAIN, V13, P487, DOI 10.1007/s10194-012-0456-3; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Yeh YC, 2010, CEPHALALGIA, V30, P1329, DOI 10.1177/0333102410364675	33	49	50	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								e8557	10.1136/bmj.e8557	http://dx.doi.org/10.1136/bmj.e8557			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZR	23303883				2022-12-28	WOS:000313554900009
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: sexual health medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION					destwo@yahoo.co.uk						Centers for Disease Control and Prevention, 2012, HIV TRANSM RISK; Centers for Disease Control and Prevention, 2010, CDC AN NAT HERP PREV; Centers for Disease Control and Prevention, 2012, GEN HPV INF FACT SHE; ClinicalTrials.gov, 2012, HOM SELF TEST HIV IN; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Health Protection Agency, 2011, HIV UK 2011 REP; Scoular A, 2002, BRIT MED J, V324, P1366, DOI 10.1136/bmj.324.7350.1366; Spence Des, 2010, BMJ, V340, pc2547, DOI 10.1136/bmj.c2547; van Valkengoed IGM, 2004, INT J EPIDEMIOL, V33, P416, DOI 10.1093/ije/dyh029; Wallace LA, 2008, SEX TRANSM INFECT, V84, P171, DOI 10.1136/sti.2007.026047; Ward H, 2005, BRIT MED J, V330, P1173, DOI 10.1136/bmj.330.7501.1173	11	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8643	10.1136/bmj.e8643	http://dx.doi.org/10.1136/bmj.e8643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284162				2022-12-28	WOS:000313236300001
J	Arnheim-Dahlstrom, L; Hallgren, J; Weibull, CE; Sparen, P				Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par			Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; YOUNG-CHILDREN; UNITED-STATES; A H1N1; IMMUNIZATION; CONVULSIONS; MORTALITY; MEASLES; MUMPS	Objective To assess the risk of epileptic seizures in people with and without epilepsy after vaccination with a monovalent AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix; Glaxo SmithKline, Sweden). Design Register based self controlled case series. Setting Three Swedish counties (source population 750 000). Participants 373 398 people (age 0-106, median 41.2) who were vaccinated. Vaccinated people with epileptic seizures, diagnosed as inpatients or outpatients, at any time from 90 days before until 90 days after any dose of vaccine. Main outcome measures Endpoints were admission to hospital or outpatient hospital care with epileptic seizures as the main diagnosis. The effect estimate of relative incidence was calculated as the incidence of epileptic seizures in period after exposure relative to the incidence of epileptic seizures in two control periods, one before and one after vaccination. Results 859 people experienced epileptic seizures during the study period. There was no increased risk of seizures in people with previously diagnosed epilepsy (relative incidence 1.01, 95% confidence interval 0.74 to 1.39) and a non-significant decrease in risk for people without epilepsy (0.67, 0.27 to 1.65) during the day 1-7 risk period (where day 1 is the day of vaccination). In a second risk period (day 8-30), there was a non-significant increased risk of seizures in people without epilepsy (1.11, 0.73 to 1.70) but no increase in risk for those with epilepsy (1.00, 0.83 to 1.21). Conclusions This study found no evidence of an increase in risk of presentation to hospital with epileptic seizures after vaccination with a monovalent AS03 adjuvanted pandemic H1N1 influenza vaccine.	[Arnheim-Dahlstrom, Lisen; Hallgren, Jonas; Weibull, Caroline E.; Sparen, Par] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden	Karolinska Institutet	Arnheim-Dahlstrom, L (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Nobels Vag 12A, S-17177 Stockholm, Sweden.	lisen.arnheim.dahlstrom@ki.se	Weibull, Caroline/AAJ-5755-2020	Sparen, Par/0000-0002-5184-8971	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline	GlaxoSmithKline Biologicals in Belgium; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by a grant from GlaxoSmithKline Biologicals in Belgium. The authors had full access to all the data in the study and had the full responsibility to submit the report for publication. The opinions presented in the report do not necessarily reflect those of the funders.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that all the authors received unconditional grants from GlaxoSmithKline for the submitted study.	[Anonymous], 1993, EPILEPSIA, V34, P592; Brown NJ, 2007, CURR OPIN NEUROL, V20, P181, DOI 10.1097/WCO.0b013e3280555160; Christensen J, 2007, EPILEPSY RES, V75, P162, DOI 10.1016/j.eplepsyres.2007.05.009; Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908; Epilepsy Foundation America, 2010, SEC EP FDN AM 2010; European Medicines Agency, 13 PAND PHARM UPD; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; GALE JL, 1994, JAMA-J AM MED ASSOC, V271, P37, DOI 10.1001/jama.271.1.37; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; KULENKAMPFF M, 1974, ARCH DIS CHILD, V49, P46, DOI 10.1136/adc.49.1.46; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Leroy Z, 2012, VACCINE, V30, P2020, DOI 10.1016/j.vaccine.2011.12.042; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Mayet A, 2011, VACCINE, V29, P2576, DOI 10.1016/j.vaccine.2011.01.056; Mitrakrishnan S, 2011, VACCINE, V29, P6369, DOI 10.1016/j.vaccine.2011.04.126; Munch JS, 2010, INT MARIT HEALTH, V61, P246; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Polkinghorne BG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-291; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Shorvon S, 2008, EPILEPSIA, V49, P219, DOI 10.1111/j.1528-1167.2007.01478.x; Stowe J, 2011, VACCINE, V29, P9467, DOI 10.1016/j.vaccine.2011.10.029; Tomson T, 2000, J NEUROL, V247, P15, DOI 10.1007/s004150050004; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; van Puijenbroek EP, 2010, DRUG SAFETY, V33, P1097, DOI 10.2165/11539270-000000000-00000; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	27	16	16	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 28	2012	345								e7594	10.1136/bmj.e7594	http://dx.doi.org/10.1136/bmj.e7594			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PQ	23274350	hybrid, Green Published			2022-12-28	WOS:000312932200001
J	Merkin, J; Russell, C; Chen, P; Burge, CB				Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.			Evolutionary Dynamics of Gene and Isoform Regulation in Mammalian Tissues	SCIENCE			English	Article							TIGHT JUNCTIONS; TRANSCRIPTOME; CONSERVATION; EXPRESSION; ERK	Most mammalian genes produce multiple distinct messenger RNAs through alternative splicing, but the extent of splicing conservation is not clear. To assess tissue-specific transcriptome variation across mammals, we sequenced complementary DNA from nine tissues from four mammals and one bird in biological triplicate, at unprecedented depth. We find that while tissue-specific gene expression programs are largely conserved, alternative splicing is well conserved in only a subset of tissues and is frequently lineage-specific. Thousands of previously unknown, lineage-specific, and conserved alternative exons were identified; widely conserved alternative exons had signatures of binding by MBNL, PTB, RBFOX, STAR, and TIA family splicing factors, implicating them as ancestral mammalian splicing regulators. Our data also indicate that alternative splicing often alters protein phosphorylatability, delimiting the scope of kinase signaling.	[Merkin, Jason; Russell, Caitlin; Chen, Ping; Burge, Christopher B.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Burge, Christopher B.] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Chen, Ping] Univ Helsinki, Syst Biol Lab, Res Programs Unit, FIN-00014 Helsinki, Finland; [Chen, Ping] Univ Helsinki, Inst Biomed Biochem & Dev Biol, FIN-00014 Helsinki, Finland	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Helsinki; University of Helsinki	Burge, CB (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	cburge@mit.edu	Burge, Christopher B./AAH-2177-2020; Chen, Ping/AAL-8264-2020	Chen, Ping/0000-0002-8068-1891	Broad Institute SPARC grant; NIH training grant; Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation; FICS; NIH [OD011092]; NSF [0821391]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002439] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	Broad Institute SPARC grant; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland (Center of Excellence in Cancer Genetics Research); Sigrid Juselius Foundation(Sigrid Juselius Foundation); FICS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	J.M. and C. B. B. designed the study and wrote the manuscript. J.M. collected tissue samples, extracted RNA, conducted computational analyses, and prepared figures. C. R. prepared RNA-Seq libraries and developed protocols. P. C. contributed computational analyses. We thank A. Robertson for analysis of coding potential of alternative isoforms; E. Wang for help with the Mbnl1 CLIP analysis; D. Treacy for assistance with library preparation; S. McGeary, D. Page, A. Pai, C. Lin, and members of the Burge lab for comments on the manuscript; and the MIT BioMicro Center for assistance with sequencing. This work was supported by a Broad Institute SPARC grant (C. B. B.), by an NIH training grant (J.M.), by a fellowship from the Academy of Finland (Center of Excellence in Cancer Genetics Research), Sigrid Juselius Foundation and FICS (P. C.), by NIH grant OD011092 to the Oregon National Primate Research Center, by grant 0821391 from the NSF, and by grants from the NIH (to C. B. B.). Sequence data associated with this manuscript have been submitted to NCBI Gene Expession Omnibus (accession no. GSE41637).	Aggarwal S, 2011, BIOCHEM J, V433, P51, DOI 10.1042/BJ20100249; Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Ladd AN, 2002, GENOME BIOL, V3; Lareau LF, 2007, ADV EXP MED BIOL, V623, P190, DOI 10.1007/978-0-387-77374-2_12; Lev-Maor G, 2007, PLOS GENET, V3, P2221, DOI 10.1371/journal.pgen.0030203; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mruk DD, 2010, PHILOS T R SOC B, V365, P1621, DOI 10.1098/rstb.2010.0010; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Samak G, 2011, AM J PHYSIOL-GASTR L, V301, pG50, DOI 10.1152/ajpgi.00494.2010; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Tang XL, 2010, NUCLEIC ACIDS RES, V38, P6610, DOI 10.1093/nar/gkq547; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ET, 2012, CELL, V150, P710, DOI 10.1016/j.cell.2012.06.041; Xiao XS, 2009, NAT STRUCT MOL BIOL, V16, P1094, DOI 10.1038/nsmb.1661; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102	30	561	581	7	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1593	1599		10.1126/science.1228186	http://dx.doi.org/10.1126/science.1228186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258891	Green Submitted, Green Accepted			2022-12-28	WOS:000312533100046
J	Price, RM				Price, Rebecca M.			How We Got Here: An Inquiry-Based Activity About Human Evolution	SCIENCE			English	Editorial Material									Univ Washington, Bothell, WA 98011 USA	University of Washington; University of Washington Bothell	Price, RM (corresponding author), Univ Washington, Box 358530,18115 Campus Way NE, Bothell, WA 98011 USA.	becca.price@uwb.edu						Bransford JD., 2000, PEOPLE LEARN; Bybee R. W., 1997, ACHIEVING SCI LITERA; DeHaan RL, 2011, SCIENCE, V334, P1499, DOI 10.1126/science.1207918; Handelsman J, 2007, SCI TEACHING; Karukstis Kerry K, 2007, DEV SUSTAINING RES S; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Meikle W. E., 2010, EVOLUTION ED OUTREAC, V3, P573; Price RM, 2012, AM BIOL TEACH, V74, P106, DOI 10.1525/abt.2012.74.2.8	8	3	3	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1554	1555		10.1126/science.1215221	http://dx.doi.org/10.1126/science.1215221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258884				2022-12-28	WOS:000312533100040
J	Stagnaro-Green, A; Sullivan, S; Pearce, EN				Stagnaro-Green, Alex; Sullivan, Scott; Pearce, Elizabeth N.			Iodine Supplementation During Pregnancy and Lactation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POSTPARTUM; MANAGEMENT		[Stagnaro-Green, Alex] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Sullivan, Scott] Med Univ S Carolina, Dept Obstet Gynecol, Charleston, SC 29425 USA; [Pearce, Elizabeth N.] Boston Univ, Sch Med, Endocrinol Sect, Boston, MA 02118 USA	George Washington University; Medical University of South Carolina; Boston University	Stagnaro-Green, A (corresponding author), George Washington Univ, Sch Med & Hlth Sci, 2300 1 St,Ross Hall,Ste 712, Washington, DC 20037 USA.	alexsg@gwu.edu		Stagnaro-Green, Alex/0000-0003-2434-3852; Pearce, Elizabeth/0000-0003-3799-0354				[Anonymous], 2007, ASS IOD DEF DIS MON; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Food and Nutrition Board, 2006, DIET REF INT, P320; Glinoer D, 2007, PUBLIC HEALTH NUTR, V10, P1542, DOI 10.1017/S1368980007360886; Gregory CO, 2009, THYROID, V19, P1019, DOI 10.1089/thy.2009.0166; Leung AM, 2009, NEW ENGL J MED, V360, P939, DOI 10.1056/NEJMc0807851; Obican SG, 2012, BIRTH DEFECTS RES A, V94, P677, DOI 10.1002/bdra.23051; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Zimmermann MB, 2012, CURR OPIN ENDOCRINOL, V19, P382, DOI 10.1097/MED.0b013e328357271a	10	26	31	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2463	2464		10.1001/jama.2012.45423	http://dx.doi.org/10.1001/jama.2012.45423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288022				2022-12-28	WOS:000312441400020
J	Haude, M; Erbel, R; Erne, P; Verheye, S; Degen, H; Bose, D; Vermeersch, P; Wijnbergen, I; Weissman, N; Prati, F; Waksman, R; Koolen, J				Haude, Michael; Erbel, Raimund; Erne, Paul; Verheye, Stefan; Degen, Hubertus; Boese, Dirk; Vermeersch, Paul; Wijnbergen, Inge; Weissman, Neil; Prati, Francesco; Waksman, Ron; Koolen, Jacques			Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial	LANCET			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INCOMPLETE STENT APPOSITION; ROUTINE CLINICAL-PRACTICE; INTRAVASCULAR ULTRASOUND; VASCULAR SCAFFOLD; 2-YEAR OUTCOMES; 6-MONTH; SYSTEM; 2ND-GENERATION; GENERATION	Background Bioabsorbable vascular scaffolds were developed to overcome limitations of permanent bare-metal or drug-eluting coronary stents-ie, stent thrombosis (despite prolonged dual antiplatelet therapy), the life-long presence of a caged vessel segment that does not allow vasomotion or remodelling, and chronic vessel wall inflammation. We assessed the safety and performance of a new magnesium-based paclitaxel-eluting absorbable metal scaff old in symptomatic patients with de-novo coronary lesions. Methods We did a prospective, multicentre, first-in-man trial (BIOSOLVE-1) of the drug-eluting absorbable metal scaff old (DREAMS). 46 patients with 47 lesions were enrolled at five European centres. The primary endpoint was target lesion failure, a composite of cardiac death, target vessel myocardial infarction, and clinically driven target lesion revascularisation, at 6 and 12 months. Clinical follow-up was scheduled at 1, 6, 12, 24, and 36 months. Patients were consecutively assigned to angiographic and intravascular ultrasonographic follow-up at 6 months or 12 months. Optical coherence tomography was done in some patients. All patients were recommended to take dual antiplatelet therapy for at least 12 months. This trial is registered with ClinicalTrials.gov, number NCT01168830. Findings Overall device and procedural success was 100%. Two of 46 (4%) patients had target lesion failure at 6 months (both clinically driven target lesion revascularisations), which rose to three of 43 (7%) at 12 months (one periprocedural target vessel myocardial infarction occurred during angiography at the 12 month follow-up visit). We noted no cardiac death or scaff old thrombosis. Interpretation Our results show feasibility, a good safety profile, and promising clinical and angiographic performance results up to 12 months for DREAMS. Our promising clinical results show that absorbable metal scaffolds might be an alternative to polymeric absorbable scaffolds.	[Haude, Michael; Degen, Hubertus] Lukaskrankenhaus GmbH, Stadt Kliniken Neuss, Med Clin 1, D-41464 Neuss, Germany; [Erbel, Raimund; Boese, Dirk] West German Heart Ctr Essen, Dept Cardiol, Essen, Germany; [Erne, Paul] Luzerner Kantonsspital, Dept Cardiol, Luzern, Switzerland; [Verheye, Stefan; Vermeersch, Paul] ZNA Middelheim, Dept Cardiol, Antwerp, Belgium; [Wijnbergen, Inge; Koolen, Jacques] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Weissman, Neil; Waksman, Ron] MedStar Hlth Res Inst, Washington, DC USA; [Prati, Francesco] Ettore Sansavini Hlth Sci Fdn, CLI Fdn, Rome, Italy	Lucerne Cantonal Hospital; ZNA Middelheim Hospital; Catharina Hospital; MedStar Health Research Institute	Haude, M (corresponding author), Lukaskrankenhaus GmbH, Stadt Kliniken Neuss, Med Clin 1, Preussenstr 84, D-41464 Neuss, Germany.	mhaude@lukasneuss.de			Biotronik	Biotronik	Funding Biotronik.	Chevalier B, 2009, CIRC-CARDIOVASC INTE, V2, P188, DOI 10.1161/CIRCINTERVENTIONS.108.823443; Cook S, 2012, EUR HEART J, V33, P1334, DOI 10.1093/eurheartj/ehr484; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Daemen Joost, 2009, Eur Heart J, V30, P152, DOI 10.1093/eurheartj/ehn510; Eggebrecht H, 2005, CIRCULATION, V112, pE303, DOI 10.1161/CIRCULATIONAHA.104.521641; Erbel R, 2007, LANCET, V369, P1869, DOI 10.1016/S0140-6736(07)60853-8; Farooq V, 2012, CATHETER CARDIO INTE, V79, P880, DOI 10.1002/ccd.23177; Gomez-Lara J, 2011, JACC-CARDIOVASC INTE, V4, P992, DOI 10.1016/j.jcin.2011.03.020; Grube E, 2003, CIRCULATION, V107, P38, DOI 10.1161/01.CIR.0000047700.58683.A1; Grube Eberhard, 2005, EuroIntervention, V1, P53; Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651; Imola F, 2010, EUROINTERVENTION, V6, P575, DOI 10.4244/EIJV6I5A97; Juwana YB, 2010, J INVASIVE CARDIOL, V22, P312; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Lasala JM, 2009, CIRC-CARDIOVASC INTE, V2, P285, DOI 10.1161/CIRCINTERVENTIONS.109.852178.109.852178; Lind A Y, 2005, Heart, V91, P1604, DOI 10.1136/hrt.2005.064113; Meredith IT, 2009, JACC-CARDIOVASC INTE, V2, P977, DOI 10.1016/j.jcin.2009.07.007; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Nair A, 2002, CIRCULATION, V106, P2200, DOI 10.1161/01.CIR.0000035654.18341.5E; Nair A, 2001, ULTRASOUND MED BIOL, V27, P1319, DOI 10.1016/S0301-5629(01)00436-7; Nair Anuja, 2007, EuroIntervention, V3, P113; Ormiston JA, 2010, CIRC-CARDIOVASC INTE, V3, P384; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Peeters P, 2005, J ENDOVASC THER, V12, P1, DOI 10.1583/04-1349R.1; Sanchez-Recalde A, 2008, J INVASIVE CARDIOL, V20, P417; Serruys Patrick W, 2005, EuroIntervention, V1, P58; Serruys PW, 2011, J AM COLL CARDIOL, V58, P1578, DOI 10.1016/j.jacc.2011.05.050; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Tamai H, 2000, CIRCULATION, V102, P399; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; Waksman R, 2007, CATHETER CARDIO INTE, V70, P407, DOI 10.1002/ccd.21176; Waksman R, 2006, CATHETER CARDIO INTE, V68, P607, DOI 10.1002/ccd.20727; Waksman R, 2009, JACC-CARDIOVASC INTE, V2, P312, DOI 10.1016/j.jcin.2008.09.015; Wittchow E, EUROINTERVE IN PRESS	38	271	290	6	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					836	844		10.1016/S0140-6736(12)61765-6	http://dx.doi.org/10.1016/S0140-6736(12)61765-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23332165				2022-12-28	WOS:000316060600033
J	Snape, MD; Pollard, AJ				Snape, Matthew D.; Pollard, Andrew J.			The beginning of the end for serogroup B meningococcus?	LANCET			English	Editorial Material							CONTROLLED-TRIAL; VACCINE; IMMUNOGENICITY		[Snape, Matthew D.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England; NIHR Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford	Snape, MD (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford OX3 7LE, England.	matthew.snape@paediatrics.ox.ac.uk		Snape, Matthew/0000-0003-0531-5426				Borrow R, 2005, VACCINE, V23, P2222, DOI 10.1016/j.vaccine.2005.01.051; Christensen H, 2010, LANCET INFECT DIS, V10, P853, DOI 10.1016/S1473-3099(10)70251-6; Donnelly J, 2011, 11 EUR MEN DIS SOC E; European Medicines Agency, 2012, SUMM OP BEXS; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Galloway Y, 2009, INT J EPIDEMIOL, V38, P413, DOI 10.1093/ije/dyn228; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P573, DOI 10.1001/jama.2012.85; Health Protection Agency, 2012, INV MEN B INF LAB RE; Prymula R, 2011, 29 ANN M EUR SOC PAE; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Vesikari T, 2012, LANCET	12	4	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 9	2013	381	9869					785	787		10.1016/S0140-6736(12)62194-1	http://dx.doi.org/10.1016/S0140-6736(12)62194-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23324564				2022-12-28	WOS:000316060600008
J	Behabtu, N; Young, CC; Tsentalovich, DE; Kleinerman, O; Wang, X; Ma, AWK; Bengio, EA; ter Waarbeek, RF; de Jong, JJ; Hoogerwerf, RE; Fairchild, SB; Ferguson, JB; Maruyama, B; Kono, J; Talmon, Y; Cohen, Y; Otto, MJ; Pasquali, M				Behabtu, Natnael; Young, Colin C.; Tsentalovich, Dmitri E.; Kleinerman, Olga; Wang, Xuan; Ma, Anson W. K.; Bengio, E. Amram; ter Waarbeek, Ron F.; de Jong, Jorrit J.; Hoogerwerf, Ron E.; Fairchild, Steven B.; Ferguson, John B.; Maruyama, Benji; Kono, Junichiro; Talmon, Yeshayahu; Cohen, Yachin; Otto, Marcin J.; Pasquali, Matteo			Strong, Light, Multifunctional Fibers of Carbon Nanotubes with Ultrahigh Conductivity	SCIENCE			English	Article							THERMAL TRANSPORT; ELECTRICAL-CONDUCTIVITY; CRYSTALLINE ROPES; FIELD-EMISSION; YARNS; PERFORMANCE; FILMS; NEAT	Broader applications of carbon nanotubes to real-world problems have largely gone unfulfilled because of difficult material synthesis and laborious processing. We report high-performance multifunctional carbon nanotube (CNT) fibers that combine the specific strength, stiffness, and thermal conductivity of carbon fibers with the specific electrical conductivity of metals. These fibers consist of bulk-grown CNTs and are produced by high-throughput wet spinning, the same process used to produce high-performance industrial fibers. These scalable CNT fibers are positioned for high-value applications, such as aerospace electronics and field emission, and can evolve into engineered materials with broad long-term impact, from consumer electronics to long-range power transmission.	[Behabtu, Natnael; Young, Colin C.; Tsentalovich, Dmitri E.; Wang, Xuan; Ma, Anson W. K.; Bengio, E. Amram; Kono, Junichiro; Pasquali, Matteo] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem & Biomol Engn,Dept Phys & Astron, Dept Chem,Dept Elect & Comp Engn,Appl Phys Progra, Houston, TX 77005 USA; [Kleinerman, Olga; Bengio, E. Amram; Talmon, Yeshayahu; Cohen, Yachin] Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel; [Kleinerman, Olga; Bengio, E. Amram; Talmon, Yeshayahu; Cohen, Yachin] Russell Berrie Nanotechnol Inst RBNI, IL-32000 Haifa, Israel; [ter Waarbeek, Ron F.; de Jong, Jorrit J.; Hoogerwerf, Ron E.; Otto, Marcin J.] Teijin Aramid, Arnhem, Netherlands; [Fairchild, Steven B.; Ferguson, John B.; Maruyama, Benji] USAF, Mat & Mfg Directorate, Res Lab, Wright Patterson AFB, OH 45433 USA	Rice University; Technion Israel Institute of Technology; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Pasquali, M (corresponding author), Rice Univ, Smalley Inst Nanoscale Sci & Technol, Dept Chem & Biomol Engn,Dept Phys & Astron, Dept Chem,Dept Elect & Comp Engn,Appl Phys Progra, Houston, TX 77005 USA.	mp@rice.edu	Ma, Anson/A-6005-2011; Talmon, Yeshayahu/N-1076-2019; Maruyama, Benji/AAI-3434-2020; Pasquali, Matteo/A-2489-2008	Ma, Anson/0000-0002-2865-5776; Talmon, Yeshayahu/0000-0002-9854-3972; Maruyama, Benji/0000-0002-3832-628X; Pasquali, Matteo/0000-0001-5951-395X; Kono, Junichiro/0000-0002-4195-0577	Teijin Aramid BV; Teijin Techno Products Ltd.; Air Force Office of Scientific Research [FA9550-09-1-0590]; Russell Berrie Nanotechnology Institute; Air Force Research Laboratory [FA8650-07-2-5061]; U.S. Department of Defense National Defense Science and Engineering Graduate fellowship; Welch Foundation [C-1668]	Teijin Aramid BV; Teijin Techno Products Ltd.; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Russell Berrie Nanotechnology Institute; Air Force Research Laboratory; U.S. Department of Defense National Defense Science and Engineering Graduate fellowship; Welch Foundation(The Welch Foundation)	We thank F. Mirri for the CNT film; T. Back, D. Ramsamoedj, E. Klop, E. Steyn, T. Cohen-Hymas, P. M. Ajayan, B. Carey, F. Matteini, A. Mizes, V. Parolkar, A. Choi, and S. Odumabo for help with fiber characterization; and K. McElrath, E. Vega, X. Hu, W. Adams, R. Hauge, and E. Thomas for useful discussions. This work was supported by Teijin Aramid BV, Teijin Techno Products Ltd., Air Force Office of Scientific Research FA9550-09-1-0590, Russell Berrie Nanotechnology Institute, Air Force Research Laboratory FA8650-07-2-5061, the U.S. Department of Defense National Defense Science and Engineering Graduate fellowship, and the Welch Foundation (C-1668 and Evans Attwell fellowship). European provisional patent application EP12177741 was filed 25 July 2012.	Aliev AE, 2007, CARBON, V45, P2880, DOI 10.1016/j.carbon.2007.10.010; Alvarenga J, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3506703; [Anonymous], 1989, AROMATIC HIGH STRENG; Baughman RH, 2000, SCIENCE, V290, P1310, DOI 10.1126/science.290.5495.1310; Behabtu N, 2008, NANO TODAY, V3, P24, DOI 10.1016/S1748-0132(08)70062-8; Boncel S, 2011, ACS NANO, V5, P9339, DOI 10.1021/nn202685x; Ci L, 2007, ADV MATER, V19, P1719, DOI 10.1002/adma.200602520; COHEN Y, 1985, POLYM ENG SCI, V25, P1093, DOI 10.1002/pen.760251708; Davies RJ, 2009, J APPL CRYSTALLOGR, V42, P1122, DOI 10.1107/S0021889809036280; Ericson LM, 2004, SCIENCE, V305, P1447, DOI 10.1126/science.1101398; Fischer JE, 1997, PHYS REV B, V55, pR4921, DOI 10.1103/PhysRevB.55.R4921; Grigorian L, 1998, PHYS REV LETT, V80, P5560, DOI 10.1103/PhysRevLett.80.5560; HEREMANS J, 1985, PHYS REV B, V32, P6742, DOI 10.1103/PhysRevB.32.6742; Hone J, 2000, APPL PHYS LETT, V77, P666, DOI 10.1063/1.127079; Jakubinek MB, 2012, CARBON, V50, P244, DOI 10.1016/j.carbon.2011.08.041; Jang HS, 2010, CARBON, V48, P4019, DOI 10.1016/j.carbon.2010.07.006; Jarosz P, 2011, NANOSCALE, V3, P4542, DOI 10.1039/c1nr10814j; Kaiser AB, 2001, REP PROG PHYS, V64, P1, DOI 10.1088/0034-4885/64/1/201; Kim P, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.215502; Koziol K, 2007, SCIENCE, V318, P1892, DOI 10.1126/science.1147635; Lashmore D.S., 2011, United States patent, Patent No. [7993620, 7,993,620]; Liu K, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/4/045708; Lu L, 2001, REV SCI INSTRUM, V72, P2996, DOI 10.1063/1.1378340; Maarouf AA, 2000, PHYS REV B, V61, P11156, DOI 10.1103/PhysRevB.61.11156; Mirri F, 2012, ACS NANO, V6, P9737, DOI 10.1021/nn303201g; Nieuwoudt A, 2008, IEEE T ELECTRON DEV, V55, P2097, DOI 10.1109/TED.2008.926733; Parra-Vasquez ANG, 2010, ACS NANO, V4, P3969, DOI 10.1021/nn100864v; Ramesh S, 2004, J PHYS CHEM B, V108, P8794, DOI 10.1021/jp036971t; Thess A, 1996, SCIENCE, V273, P483, DOI 10.1126/science.273.5274.483; Vigolo B, 2000, SCIENCE, V290, P1331, DOI 10.1126/science.290.5495.1331; Vilatela JJ, 2012, CARBON, V50, P1227, DOI 10.1016/j.carbon.2011.10.040; Yakobson BI, 2000, CARBON, V38, P1675, DOI 10.1016/S0008-6223(00)00093-2; Yamamoto T, 2008, TOP APPL PHYS, V111, P165, DOI 10.1007/978-3-540-72865-8_5; Yang YC, 2012, VACUUM, V86, P885, DOI 10.1016/j.vacuum.2011.04.027; Zakhidov AA, 2007, APPL PHYS A-MATER, V88, P593, DOI 10.1007/s00339-007-4009-6; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhao Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00083; Zhong XH, 2010, ADV MATER, V22, P692, DOI 10.1002/adma.200902943	39	907	950	94	1520	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					182	186		10.1126/science.1228061	http://dx.doi.org/10.1126/science.1228061			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307737	Green Submitted			2022-12-28	WOS:000313328200038
J	McCartney, M				McCartney, Margaret			Tweets from the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, US SOC MED PRACT ETH; General Medical Council, DOCT US SOC MED DRAF; NHS Leeds, 2012, HLTH TRUST TAK PART; Nursing and Midwifery Council, 2012, SOC NETW SIT; Royal College of General Practitioners, 2012, SOC MED HIGHW COD DR; Royal College of Psychiatrists, 2008, RETH RISK OTH MENT H; Yorkhill Hospital Emergency Department, MAN ING FOR BOD ED	7	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								f54	10.1136/bmj.f54	http://dx.doi.org/10.1136/bmj.f54			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZR	23303889				2022-12-28	WOS:000313554900008
J	Moynihan, R				Moynihan, Ray			What is disease? And why it's a healthy question	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BREAST-CANCER		Bond Univ, Southport, Qld 4229, Australia	Bond University	Moynihan, R (corresponding author), Bond Univ, Southport, Qld 4229, Australia.	RayMoynihan@bond.edu.au	Moynihan, Ray/ABC-3010-2020					Bewley S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6894; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Moynihan R, 2006, BRIT MED J, V332, P745, DOI 10.1136/bmj.332.7544.745-a; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; ROSENBERG CE, 1989, MILBANK Q, V67, P1, DOI 10.2307/3350182; Rosenberg CE, 2002, MILBANK Q, V80, P237, DOI 10.1111/1468-0009.t01-1-00003; Rosenberg C, 2009, LANCET, V373, P802, DOI 10.1016/S0140-6736(09)60467-0; Tikkinen KAO, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001632; Wise J, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7910	10	3	3	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 9	2013	346								f107	10.1136/bmj.f107	http://dx.doi.org/10.1136/bmj.f107			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZR	23303894				2022-12-28	WOS:000313554900007
J	Hopkins, DR				Hopkins, Donald R.			Disease Eradication	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LYMPHATIC FILARIASIS ELIMINATION; JANUARY 2010-SEPTEMBER 2011; POLIOMYELITIS ERADICATION; PROGRESS; DRACUNCULIASIS; AFRICA; ONCHOCERCIASIS; TRANSMISSION; NIGERIA		Carter Ctr, Atlanta, GA 30307 USA		Hopkins, DR (corresponding author), Carter Ctr, 453 Freedom Pky, Atlanta, GA 30307 USA.	sdsulli@emory.edu						Abdelwahab Jalaa, 2011, Morbidity and Mortality Weekly Report, V60, P1482; Alexander Jim, 2011, Morbidity and Mortality Weekly Report, V60, P1523; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P195; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P341; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P417; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P309; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P199; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P321; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P25; [Anonymous], 2010, SCIENCE, V328, P850, DOI 10.1126/science.328.5980.850; [Anonymous], FIN RES REQ 2012 201; [Anonymous], 2011, MMWR-MORBID MORTAL W, V60, P1053; Cochi SL, 2011, DIS ERADICATION 21 C, V7; Djidina Mathias R., 2011, Morbidity and Mortality Weekly Report, V60, P744; Dorkenoo Ameyo, 2011, Morbidity and Mortality Weekly Report, V60, P989; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Heymann DL, 2011, TROPICAL INFECT DIS, P40; Hopkins D.R, 1998, ERADICATION INFECT D; Hopkins Donald R., 2011, Morbidity and Mortality Weekly Report, V60, P1450; HOPKINS DR, 1981, SCIENCE, V212, P495, DOI 10.1126/science.6451929; Hopkins DR, 2005, AM J TROP MED HYG, V72, P1; HOPKINS DR, 1991, B WORLD HEALTH ORGAN, V69, P533; Hopkins DR, 2009, GLOBAL HLTH MAGAZINE, V3, P14; Mackenzie CD, 2012, TRENDS PARASITOL, V28, P16, DOI 10.1016/j.pt.2011.10.003; Molyneux DH, 2006, LANCET, V367, P966, DOI 10.1016/S0140-6736(06)68404-3; Nutman TB, 2011, TROPICAL INFECT DIS, P729; Ogbuanu I. U., 2011, Morbidity and Mortality Weekly Report, V60, P441; Ogden HG, 1987, HHS PUBLICATION; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; Pigman HA, 2005, CONQUERING POLIO; Richards FO, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001346; RUIZTIBEN E, 2008, INT ENCY PUBLIC HLTH, P294; Stepan Nancy Leys, 2011, ERADICATION RIDDING; WATTS SJ, 1987, AM J TROP MED HYG, V37, P119, DOI 10.4269/ajtmh.1987.37.119; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; World Health Assembly, 1997, WHA50 29 EL LYMPH FI	39	62	63	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					54	63		10.1056/NEJMra1200391	http://dx.doi.org/10.1056/NEJMra1200391			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281976				2022-12-28	WOS:000312930600005
J	Farrell, L				Farrell, Liam			THE BEST MEDICINE Conversation with a pill	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 2	2013	346								e8664	10.1136/bmj.e8664	http://dx.doi.org/10.1136/bmj.e8664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066QW	23284160				2022-12-28	WOS:000313236300002
J	Giazotto, F; Martinez-Perez, MJ				Giazotto, Francesco; Martinez-Perez, Maria Jose			The Josephson heat interferometer	NATURE			English	Article							JUNCTIONS; TRANSPORT; CONDUCTANCE; METALS	The Josephson effect(1) is perhaps the prototypical manifestation of macroscopic phase coherence, and forms the basis of a widely used electronic interferometer-the superconducting quantum interference device(2) (SQUID). In 1965, Maki and Griffin predicted(3) that the thermal current through a temperature-biased Josephson tunnel junction coupling two superconductors should be a stationary periodic function of the quantum phase difference between the superconductors: a temperature-biased SQUID should therefore allow heat currents to interfere(4,5), resulting in a thermal version of the electric Josephson interferometer. This phase-dependent mechanism of thermal transport has been the subject of much discussion(4,6-8) but, surprisingly, has yet to be realized experimentally. Here we investigate heat exchange between two normal metal electrodes kept at different temperatures and tunnel-coupled to each other through a thermal 'modulator' (ref. 5) in the form of a direct-current SQUID. We find that heat transport in the system is phase dependent, in agreement with the original prediction. Our Josephson heat interferometer yields magnetic-flux-dependent temperature oscillations of up to 21 millikelvin in amplitude, and provides a flux-to-temperature transfer coefficient exceeding 60 millikelvin per flux quantum at 235 millikelvin. In addition to confirming the existence of a phase-dependent thermal current unique to Josephson junctions, our results point the way towards the phase-coherent manipulation of heat in solid-state nanocircuits.	[Giazotto, Francesco; Martinez-Perez, Maria Jose] CNR, Ist Nanosci, NEST, I-56127 Pisa, Italy; [Giazotto, Francesco; Martinez-Perez, Maria Jose] Scuola Normale Super Pisa, I-56127 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa	Giazotto, F (corresponding author), CNR, Ist Nanosci, NEST, Piazza San Silvestro 12, I-56127 Pisa, Italy.	giazotto@sns.it	Perez, Maria Jose Martinez/AAB-6349-2019; Martinez-Perez, Maria Jose/B-3446-2014	Perez, Maria Jose Martinez/0000-0002-8125-877X; Martinez-Perez, Maria Jose/0000-0002-8125-877X	EC FP7 programme [228464]	EC FP7 programme	We thank F. Taddei for discussions and for a careful reading of the manuscript. We also thank C. Altimiras, C. W. J. Beenakker, M. Di Ventra, T. T. Heikkila, M. A. Laakso, F. Portier and P. Spathis for comments, and the EC FP7 programme number 228464 "Microkelvin" for partial financial support.	Clarke J., 2004, SQUID HDB; Dubi Y, 2011, REV MOD PHYS, V83, P131, DOI 10.1103/RevModPhys.83.131; Giazotto F, 2006, REV MOD PHYS, V78, P217, DOI 10.1103/RevModPhys.78.217; Giazotto F, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4750068; Guttman GD, 1998, PHYS REV B, V57, P2717, DOI 10.1103/PhysRevB.57.2717; Guttman GD, 1997, PHYS REV B, V55, P3849, DOI 10.1103/PhysRevB.55.3849; JOSEPHSON BD, 1962, PHYS LETT, V1, P251, DOI 10.1016/0031-9163(62)91369-0; MAKI K, 1965, PHYS REV LETT, V15, P921, DOI 10.1103/PhysRevLett.15.921; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; NAHUM M, 1993, APPL PHYS LETT, V63, P3075, DOI 10.1063/1.110237; Ojanen T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155902; PANAITOV GI, 1984, PHYS LETT A, V100, P301, DOI 10.1016/0375-9601(84)90542-5; Pascal LMA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125113; Peltonen JT, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.097004; Quaranta O, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544058; ROUKES ML, 1985, PHYS REV LETT, V55, P422, DOI 10.1103/PhysRevLett.55.422; Ruokola T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144306; Ryazanov T. T., 1982, SOLID STATE COMMUN, V42, P733; Schmidt DR, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.045901; Timofeev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.017003; Timofeev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200801; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; WELLSTOOD FC, 1994, PHYS REV B, V49, P5942, DOI 10.1103/PhysRevB.49.5942; Zhao E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.077003; Zhao E, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134503	25	166	168	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					401	405		10.1038/nature11702	http://dx.doi.org/10.1038/nature11702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056KQ	23257882	Green Submitted			2022-12-28	WOS:000312488200050
J	Chaurasia, AS; Nawale, JM; Patil, SN; Yemul, MA; Mukhedkar, SM; Singh, D; Patil, PK; Chavan, RV				Chaurasia, Ajay S.; Nawale, Jaywant M.; Patil, Sandeep N.; Yemul, Madhusudan A.; Mukhedkar, Sachin M.; Singh, Dhirender; Patil, Pranjal K.; Chavan, Rajendra V.			Jaccoud's arthropathy	LANCET			English	Editorial Material									[Chaurasia, Ajay S.; Nawale, Jaywant M.; Patil, Sandeep N.; Yemul, Madhusudan A.; Mukhedkar, Sachin M.; Singh, Dhirender; Patil, Pranjal K.; Chavan, Rajendra V.] Topiwalla Natl Med Coll, Bombay, Maharashtra, India; [Chaurasia, Ajay S.; Nawale, Jaywant M.; Patil, Sandeep N.; Yemul, Madhusudan A.; Mukhedkar, Sachin M.; Singh, Dhirender; Patil, Pranjal K.; Chavan, Rajendra V.] BYL Nair Charitable Hosp, Bombay, Maharashtra, India	Topiwala National Medical College & B Y L Nair Charitable Hospital; Topiwala National Medical College & B Y L Nair Charitable Hospital	Mukhedkar, SM (corresponding author), Topiwalla Natl Med Coll, Dept Cardiol, 18 ICCU,OPD Bldg, Bombay 400008, Maharashtra, India.	drsachinmukhedkar@yahoo.com	Yemul, Madhusudan/J-6228-2013	Yemul, Madhusudan/0000-0001-7006-4243					0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 15	2013	381	9883					2108	2108		10.1016/S0140-6736(12)61681-X	http://dx.doi.org/10.1016/S0140-6736(12)61681-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	171KA	23290493				2022-12-28	WOS:000320924800033
J	Woolf, SH; Aron, LY				Woolf, Steven H.; Aron, Laudan Y.			The US Health Disadvantage Relative to Other High-Income Countries Findings From a National Research Council/Institute of Medicine Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; ENGLAND		[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Ctr Human Needs, Richmond, VA 23298 USA; [Aron, Laudan Y.] Urban Inst, Ctr Labor Human Serv & Populat, Washington, DC 20037 USA	Virginia Commonwealth University; Virginia Commonwealth University; Urban Institute	Woolf, SH (corresponding author), Virginia Commonwealth Univ, Dept Family Med, West Hosp, 1200 E Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Fuchs VR, 2013, JAMA-J AM MED ASSOC, V309, P33, DOI 10.1001/jama.2012.125458; Isaacs J.B., 2008, GETTING AHEAD LOSING; Martinson ML, 2012, AM J PUBLIC HEALTH, V102, P2049, DOI 10.2105/AJPH.2012.300929; National Research Council; Committee on Population, 2011, EXPLAINING DIVERGENT; Organisation for Economic Co-operation and Development, 2011, HLTH GLANC 2011 OECD; Organization for Economic Cooperation and Development, OECD FAM DAT CO2 2 C; Pew Research Center, 2009, FEW SEE US HLTH CAR; Woolf SH, 2013, US HLTH INT PERSPECT	9	67	68	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 27	2013	309	8					771	772		10.1001/jama.2013.91	http://dx.doi.org/10.1001/jama.2013.91			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	095KD	23307023				2022-12-28	WOS:000315332200018
J	Gymrek, M; McGuire, AL; Golan, D; Halperin, E; Erlich, Y				Gymrek, Melissa; McGuire, Amy L.; Golan, David; Halperin, Eran; Erlich, Yaniv			Identifying Personal Genomes by Surname Inference	SCIENCE			English	Article							Y-STR LOCI; CHROMOSOME; PRIVACY; FOUNDERS; PROJECT; SCIENCE	Sharing sequencing data sets without identifiers has become a common practice in genomics. Here, we report that surnames can be recovered from personal genomes by profiling short tandem repeats on the Y chromosome (Y-STRs) and querying recreational genetic genealogy databases. We show that a combination of a surname with other types of metadata, such as age and state, can be used to triangulate the identity of the target. A key feature of this technique is that it entirely relies on free, publicly accessible Internet resources. We quantitatively analyze the probability of identification for U.S. males. We further demonstrate the feasibility of this technique by tracing back with high probability the identities of multiple participants in public sequencing projects.	[Gymrek, Melissa; Erlich, Yaniv] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Gymrek, Melissa] MIT, Harvard Massachusetts Inst Technol MIT Div Hlth S, Cambridge, MA 02139 USA; [Gymrek, Melissa] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Gymrek, Melissa] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Gymrek, Melissa] Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Golan, David] Tel Aviv Univ, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Halperin, Eran] Int Comp Sci Inst, Berkeley, CA 94704 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Baylor College of Medicine; Tel Aviv University; Tel Aviv University; Tel Aviv University	Erlich, Y (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	yaniv@wi.mit.edu		Gymrek, Melissa/0000-0002-6086-3903	National Defense Science and Engineering Graduate Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University	National Defense Science and Engineering Graduate Fellowship; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University	We thank FamilyTreeDNA and SMGF for technical assistance. We also thank D. Esposito, A. Goren, G. Fink, D. Page, W. Kramer, and R. Ronen for useful discussions. Y.E. is an Andria and Paul Heafy Family Fellow. This publication was supported by a gift from Jim and Cathy Stone (Y. E.), the National Defense Science and Engineering Graduate Fellowship (M. G.), and the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University (D. G. and E. H.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bieber FR, 2006, SCIENCE, V312, P1315, DOI 10.1126/science.1122655; Craig DW, 2011, NAT REV GENET, V12, P730, DOI 10.1038/nrg3067; Gitschier J, 2009, AM J HUM GENET, V84, P251, DOI 10.1016/j.ajhg.2009.01.018; Gymrek M, 2012, GENOME RES, V22, P1154, DOI 10.1101/gr.135780.111; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Im HK, 2012, AM J HUM GENET, V90, P591, DOI 10.1016/j.ajhg.2012.02.008; Jacobs KB, 2009, NAT GENET, V41, P1253, DOI 10.1038/ng.455; King TE, 2006, CURR BIOL, V16, P384, DOI 10.1016/j.cub.2005.12.048; King TE, 2009, TRENDS GENET, V25, P351, DOI 10.1016/j.tig.2009.06.003; King TE, 2009, MOL BIOL EVOL, V26, P1093, DOI 10.1093/molbev/msp022; Leat N, 2007, FORENSIC SCI INT, V168, P154, DOI 10.1016/j.forsciint.2006.07.009; Lehmann-Flaupt R, 2010, SLATE; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lim SK, 2007, INT J LEGAL MED, V121, P124, DOI 10.1007/s00414-006-0124-8; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; Lunshof JE, 2008, NAT REV GENET, V9, P406, DOI 10.1038/nrg2360; McEvoy B, 2006, HUM GENET, V119, P212, DOI 10.1007/s00439-005-0131-8; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; Motluk A, 2005, NEW SCI, V188, P6; Naik G., 2009, WALL STREET J; P. C. for the Study of Bioethical Issues, 2012, PRIVACY PROGR WHOLE; Prescott SM, 2008, ANNU REV GENOM HUM G, V9, P347, DOI 10.1146/annurev.genom.9.081307.164441; Rodriguez LL, 2013, SCIENCE, V339, P275, DOI 10.1126/science.1234593; Schadt EE, 2012, NAT GENET, V44, P603, DOI 10.1038/ng.2248; Stein R., 2005, WASHINGTON POST; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850	27	662	673	1	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	2013	339	6117					321	324		10.1126/science.1229566	http://dx.doi.org/10.1126/science.1229566			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329047				2022-12-28	WOS:000313622000045
J	Hunt, J; Driscoll, T; Mrozack, A; Lipworth, G; Reynolds, M; Brady, D; Smith, DR				Hunt, John; Driscoll, Tom; Mrozack, Alex; Lipworth, Guy; Reynolds, Matthew; Brady, David; Smith, David R.			Metamaterial Apertures for Computational Imaging	SCIENCE			English	Article							COMPRESSIVE HOLOGRAPHY; LENS	By leveraging metamaterials and compressive imaging, a low-profile aperture capable of microwave imaging without lenses, moving parts, or phase shifters is demonstrated. This designer aperture allows image compression to be performed on the physical hardware layer rather than in the postprocessing stage, thus averting the detector, storage, and transmission costs associated with full diffraction-limited sampling of a scene. A guided-wave metamaterial aperture is used to perform compressive image reconstruction at 10 frames per second of two-dimensional (range and angle) sparse still and video scenes at K-band (18 to 26 gigahertz) frequencies, using frequency diversity to avoid mechanical scanning. Image acquisition is accomplished with a 40:1 compression ratio.	[Hunt, John; Driscoll, Tom; Lipworth, Guy; Smith, David R.] Duke Univ, Ctr Metamat & Integrated Plasmon, Durham, NC 27708 USA; [Driscoll, Tom] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Mrozack, Alex] Duke Univ, Fitzpatrick Inst Photon & Elect & Comp Engn, Durham, NC 27708 USA; [Hunt, John; Driscoll, Tom; Lipworth, Guy; Reynolds, Matthew; Brady, David; Smith, David R.] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Duke University; University of California System; University of California San Diego; Duke University; Duke University	Hunt, J (corresponding author), Duke Univ, Ctr Metamat & Integrated Plasmon, Box 90291, Durham, NC 27708 USA.	john.hunt@duke.edu	Smith, David R/E-4710-2012; Driscoll, Tom/GSN-8530-2022	Brady, David Jones/0000-0001-5655-2478	Air Force Office of Scientific Research [FA9550-09-1-0539]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by a grant from the Air Force Office of Scientific Research (no. FA9550-09-1-0539). Data and code are available at http://people.duke.edu/~jdh51/Data_Metamaterial_Apertures_for_Computational_Imaging.zip.	Abbe E., 1883, J R MICROSC SOC, V3, P790, DOI DOI 10.1111/J.1365-2818.1883.TB05956.; Baena JD, 2005, IEEE T MICROW THEORY, V53, P1451, DOI 10.1109/TMTT.2005.845211; Bioucas-Dias JM, 2007, IEEE T IMAGE PROCESS, V16, P2992, DOI 10.1109/TIP.2007.909319; Brady D. J., 2008, OPTICAL IMAGING SPEC; Brady DJ, 2009, OPT EXPRESS, V17, P13040, DOI 10.1364/OE.17.013040; Candes E, 2006, INT C MATH, P1433, DOI DOI 10.4171/022-3/69; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Chan WL, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3147221; Chan WL, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2989126; Chen HT, 2006, NATURE, V444, P597, DOI 10.1038/nature05343; Cull CF, 2010, APPL OPTICS, V49, pE67, DOI 10.1364/AO.49.000E67; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Driscoll T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2174088; Driscoll T, 2009, SCIENCE, V325, P1518, DOI 10.1126/science.1176580; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Kundtz N, 2010, NAT MATER, V9, P129, DOI [10.1038/NMAT2610, 10.1038/nmat2610]; Liu RP, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081399; Lohmann A. W., 1967, RJ438 IBM SAN JOS RE, P1; Mahalanobis A, 2009, APPL OPTICS, V48, P5212, DOI 10.1364/AO.48.005212; Narimanov E, 2008, NAT MATER, V7, P273, DOI 10.1038/nmat2146; Padilla WJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.107401; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Potter LC, 2010, P IEEE, V98, P1006, DOI 10.1109/JPROC.2009.2037526; Shrekenhamer D, 2011, OPT EXPRESS, V19, P9968, DOI 10.1364/OE.19.009968; Takhar D, 2006, PROC SPIE, V6065, DOI 10.1117/12.659602; Urzhumov Y, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205114; Willett RM, 2011, OPT ENG, V50, DOI 10.1117/1.3596602; Xu ZM, 2010, J OPT SOC AM A, V27, P1638, DOI 10.1364/JOSAA.27.001638	28	387	401	20	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					310	313		10.1126/science.1230054	http://dx.doi.org/10.1126/science.1230054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329043				2022-12-28	WOS:000313622000041
J	Lucey, PG				Lucey, Paul G.			A Wet and Volatile Mercury	SCIENCE			English	Editorial Material									Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System	Lucey, PG (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, 2525 Correa Rd, Honolulu, HI 96822 USA.	lucey@higp.hawaii.edu						Lawrence DJ, 2013, SCIENCE, V339, P292, DOI 10.1126/science.1229953; Neumann GA, 2013, SCIENCE, V339, P296, DOI 10.1126/science.1229764; Paige DA, 2013, SCIENCE, V339, P300, DOI 10.1126/science.1231106; Paige DA, 2010, SCIENCE, V330, P479, DOI 10.1126/science.1187726; SLADE MA, 1992, SCIENCE, V258, P635, DOI 10.1126/science.258.5082.635; SPRAGUE AL, 1995, ICARUS, V118, P211, DOI 10.1006/icar.1995.1186	6	2	2	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					282	283		10.1126/science.1232556	http://dx.doi.org/10.1126/science.1232556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329038				2022-12-28	WOS:000313622000032
J	Weber, JN; Peterson, BK; Hoekstra, HE				Weber, Jesse N.; Peterson, Brant K.; Hoekstra, Hopi E.			Discrete genetic modules are responsible for complex burrow evolution in Peromyscus mice	NATURE			English	Article							GENOME-WIDE ASSOCIATION; ARCHITECTURE; RELATEDNESS	Relative to morphological traits, we know little about how genetics influence the evolution of complex behavioural differences in nature(1). It is unclear how the environment influences natural variation in heritable behaviour(2), and whether complex behavioural differences evolve through few genetic changes, each affecting many aspects of behaviour, or through the accumulation of several genetic changes that, when combined, give rise to behavioural complexity(3). Here we show that in nature, oldfield mice (Pero-myscus polionotus) build complex burrows with long entrance and escape tunnels, and that burrow length is consistent across populations, although burrow depth varies with soil composition. This burrow architecture is in contrast with the small, simple burrows of its sister species, deer mice (P. maniculatus). When investigated under laboratory conditions, both species recapitulate their natural burrowing behaviour. Genetic crosses between the two species reveal that the derived burrows of oldfield mice are dominant and evolved through the addition of multiple genetic changes. In burrows built by first-generation backcross mice, entrancetunnel length and the presence of an escape tunnel can be uncoupled, suggesting that these traits are modular. Quantitative trait locus analysis also indicates that tunnel length segregates as a complex trait, affected by at least three independent genetic regions, whereas the presence of an escape tunnel is associated with only a single locus. Together, these results suggest that complex behaviours-in this case, a classic 'extended phenotype'(4)-can evolve through multiple genetic changes each affecting distinct behaviour modules.	[Weber, Jesse N.; Peterson, Brant K.; Hoekstra, Hopi E.] Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Peterson, Brant K.; Hoekstra, Hopi E.] Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA		Hoekstra, HE (corresponding author), Museum Comparat Zool, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Weber, Jesse N/I-8685-2019; Hoekstra, Hopi E/I-6690-2012	Weber, Jesse N/0000-0003-4839-6684; Hoekstra, Hopi E/0000-0003-1431-1769; Peterson, Brant/0000-0002-0433-3035	Chapman Funds for Vertebrate Locomotion; National Science Foundation [IOS-0910164]; Arnold and Mabel Beckman Young Investigator Award	Chapman Funds for Vertebrate Locomotion; National Science Foundation(National Science Foundation (NSF)); Arnold and Mabel Beckman Young Investigator Award	We thank D. Brimmer, A. Chiu, A. Goldberg, J. Hopwood, W. Tong, S. Wolff and the Hoekstra laboratory for assistance with behavioural assays and animal husbandry; D. Haig, B. Olveczky, N. E. Pierce and J. Sanes for helpful discussions; and Harvard's Office of Animal Resources, particularly J. Rocca and M. O'Donnell. We also thank R. Barrett, A. Bendesky, H. Fisher, E. Kay, H. Metz and W. Tong for comments on the manuscript. This research was funded by Chapman Funds for Vertebrate Locomotion to J. N. W., National Science Foundation grant (IOS-0910164) to J. N. W. and H. E. H., and an Arnold and Mabel Beckman Young Investigator Award to H.E.H.	Baker RH., 1968, BIOL PEROMYSCUS RODE; Beavis W. D, 1998, MOL DISSECTION COMPL, P431; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; Boake CRB, 2002, AM NAT, V160, pS143, DOI 10.1086/342902; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cheng R, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-66; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; Dawkins R., 1982, pi; DAWSON WD, 1988, BEHAV GENET, V18, P371, DOI 10.1007/BF01260937; Doerge RW, 1996, HEREDITY, V76, P459, DOI 10.1038/hdy.1996.68; FELTHAUSER M, 1983, J WILDLIFE MANAGE, V47, P555, DOI 10.2307/3808536; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Hansell M., 2005, OXF ANIMAL BIOL SER; Hayne D. W., 1936, Journal of Mammalogy, V17, P420; Houtcooper W. C., 1971, P INDIANA ACAD SCI, V81, P348; Huxley J. S., 1914, P ZOOL SOC LOND, V35, P253; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LORENZ KZ, 1958, SCI AM, V199, P67, DOI 10.1038/scientificamerican1258-67; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rand A. L., 1942, BULL AMER MUS NAT HIST, V80, P1; SCHWARTZ CW, 1981, WILD MAMMALS MISSOUR; Sen S., 2006, R QTLDESIGN INBRED L; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; SUMNER F. B., 1929, JOUR MAMMALOGY, V10, P213, DOI 10.2307/1373928; Tan K.H., 2005, SOIL SAMPLING PREPAR, Vsecond, DOI [10.1201/9781482274769, DOI 10.1201/9781482274769]; Weber JN, 2009, ANIM BEHAV, V77, P603, DOI 10.1016/j.anbehav.2008.10.031; West-Eberhard Mary Jane, 2003, pi; WOLFE JL, 1977, BIOL BEHAV, V2, P343; Wright S, 1935, GENETICS, V20, P0084; Xu XH, 2012, CELL, V148, P596, DOI 10.1016/j.cell.2011.12.018	34	151	155	13	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					402	U145		10.1038/nature11816	http://dx.doi.org/10.1038/nature11816			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325221				2022-12-28	WOS:000313615900051
J	Chan, AW; Tetzlaff, JM; Altman, DG; Dickersin, K; Moher, D				Chan, An-Wen; Tetzlaff, Jennifer M.; Altman, Douglas G.; Dickersin, Kay; Moher, David			SPIRIT 2013: new guidance for content of clinical trial protocols	LANCET			English	Editorial Material									[Chan, An-Wen] Univ Toronto, Womens Coll Hosp, Dept Med, Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Tetzlaff, Jennifer M.; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa Methods Ctr, Ottawa, ON, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Dickersin, Kay] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD USA; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Ottawa; Ottawa Hospital Research Institute; University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Ottawa	Chan, AW (corresponding author), Univ Toronto, Womens Coll Hosp, Dept Med, Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada.	anwen.chan@utoronto.ca	Moher, David/I-3408-2019	Moher, David/0000-0003-2434-4206				Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Decullier Evelyne, 2005, BMC Med Ethics, V6, pE9; Dwan K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000031.pub2; Getz KA, 2011, DRUG INF J, V45, P265, DOI 10.1177/009286151104500307; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; National Research Council, 2010, PREVENTION TREATMENT; Russ Hagen, 2009, Ger Med Sci, V7, pDoc07, DOI 10.3205/000066; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Tetzlaff JM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-43; Tetzlaff JM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-176; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60	15	160	162	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 12	2013	381	9861					91	92		10.1016/S0140-6736(12)62160-6	http://dx.doi.org/10.1016/S0140-6736(12)62160-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	069FO	23305999				2022-12-28	WOS:000313420900004
J	Shapiro, RB; Ossorio, PN				Shapiro, R. Benjamin; Ossorio, Pilar N.			Regulation of Online Social Network Studies	SCIENCE			English	Editorial Material							PRIVACY; ETHICS		[Shapiro, R. Benjamin] Tufts Univ, Medford, MA 02155 USA; [Ossorio, Pilar N.] Morgridge Inst Res, Madison, WI 53706 USA; [Ossorio, Pilar N.] Univ Wisconsin, Sch Law, Madison, WI 53706 USA; [Ossorio, Pilar N.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53706 USA	Tufts University; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ossorio, PN (corresponding author), Morgridge Inst Res, Madison, WI 53706 USA.	pnossorio@wisc.edu		Ossorio, Pilar/0000-0002-3495-7375				[Anonymous], 2012, FED REGISTER, V77, P46643; [Anonymous], 2012, INF WE REC IT IS US; Barab S., 2009, IJLM INT J LEARN MED, V1; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Botkin JR, 2001, JAMA-J AM MED ASSOC, V285, P207, DOI 10.1001/jama.285.2.207; Boyd D., 2011, FIRSTMONDAY, V16; Brothers KB, 2010, AM J BIOETHICS, V10, P15, DOI 10.1080/15265161.2010.492891; Bull SS, 2011, J PEDIATR PSYCHOL, V36, P1082, DOI 10.1093/jpepsy/jsq126; Department of Health and Human Services, 2011, FED REG, V76, P44512; Jianquiang D. S., 2011, CHI, V2011, P581; Moreno MA, 2008, PEDIATRICS, V121, P157, DOI 10.1542/peds.2007-3015; National Research Council, 2011, LEARNING SCI COMPUTE; Newell, 2011, RICHMOND J LAW TECHN, V17, P12; Shapiro R. B., 2011, ANATOMY PRO AM; Steinkuehler C, 2008, J SCI EDUC TECHNOL, V17, P530, DOI 10.1007/s10956-008-9120-8	15	13	13	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					144	145		10.1126/science.1219025	http://dx.doi.org/10.1126/science.1219025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	067XI	23307724				2022-12-28	WOS:000313328200025
J	Swirski, FK; Nahrendorf, M				Swirski, Filip K.; Nahrendorf, Matthias			Leukocyte Behavior in Atherosclerosis, Myocardial Infarction, and Heart Failure	SCIENCE			English	Review							STEM-CELL PROLIFERATION; DENDRITIC CELLS; HEMATOPOIETIC STEM; MONOCYTE SUBSETS; INFLAMMATORY RESPONSES; PROGENITOR CELLS; APOLIPOPROTEIN-E; PROTECTIVE ROLE; DEFICIENT MICE; T-LYMPHOCYTES	Cardiovascular diseases claim more lives worldwide than any other. Etiologically, the dominant trajectory involves atherosclerosis, a chronic inflammatory process of lipid-rich lesion growth in the vascular wall that can cause life-threatening myocardial infarction (MI). Those who survive MI can develop congestive heart failure, a chronic condition of inadequate pump activity that is frequently fatal. Leukocytes (white blood cells) are important participants at the various stages of cardiovascular disease progression and complication. This Review will discuss leukocyte function in atherosclerosis, MI, and heart failure.	[Swirski, Filip K.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Swirski, FK (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	fswirski@mgh.harvard.edu; mnahrendorf@mgh.harvard.edu	Swirski, Filip/AAF-1340-2019	Swirski, Filip/0000-0002-3163-9152	National Heart, Lung, and Blood Institute [R01HL095612, R01HL095629, R01HL096576]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096576, R01HL095629, R01HL095612] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge R. Weissleder and P. Libby for fruitful discussion and critical reading of the manuscript. This work was supported in part by National Heart, Lung, and Blood Institute grants R01HL095612, R01HL095629, and R01HL096576.	Andersson J, 2010, CLIN IMMUNOL, V134, P33, DOI 10.1016/j.clim.2009.07.002; Anzai A, 2012, CIRCULATION, V125, P1234, DOI 10.1161/CIRCULATIONAHA.111.052126; Assmus B, 2012, EUR HEART J, V33, P1911, DOI 10.1093/eurheartj/ehr388; Bloom DE, 2011, GLOBAL EC BURDEN NON; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; Choi JH, 2009, J EXP MED, V206, P497, DOI 10.1084/jem.20082129; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Engstrom G, 2009, CIRC-HEART FAIL, V2, P217, DOI 10.1161/CIRCHEARTFAILURE.108.827071; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; GERRITY RG, 1981, AM J PATHOL, V103, P191; GERRITY RG, 1981, AM J PATHOL, V103, P181; Grabner R, 2009, J EXP MED, V206, P233, DOI 10.1084/jem.20080752; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hilgendorf I, 2012, CURR ATHEROSCLER REP, V14, P450, DOI 10.1007/s11883-012-0274-8; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Koltsova EK, 2012, J CLIN INVEST, V122, P3114, DOI 10.1172/JCI61758; Kyaw T, 2012, TRENDS CARDIOVAS MED, V22, P48, DOI 10.1016/j.tcm.2012.06.011; Kyaw T, 2011, CURR OPIN LIPIDOL, V22, P373, DOI 10.1097/MOL.0b013e32834adaf3; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Leuschner F, 2011, NAT BIOTECHNOL, V29, P1005, DOI 10.1038/nbt.1989; Liao XH, 2012, CELL METAB, V15, P545, DOI 10.1016/j.cmet.2012.01.022; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Menu P, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.18; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Rajamaki K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011765; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stary HC, 1999, ATLAS ATHEROSCLEROSI; STEMME S, 1995, P NATL ACAD SCI USA, V92, P3893, DOI 10.1073/pnas.92.9.3893; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Westerterp M, 2012, CELL STEM CELL, V11, P195, DOI 10.1016/j.stem.2012.04.024; Wright AP, 2010, ATHEROSCLEROSIS, V212, P414, DOI 10.1016/j.atherosclerosis.2010.06.022; YLAHERTTUALA S, 1994, ARTERIOSCLER THROMB, V14, P32, DOI 10.1161/01.ATV.14.1.32; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhu SN, 2009, J EXP MED, V206, P2141, DOI 10.1084/jem.20090866	60	688	718	7	210	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					161	166		10.1126/science.1230719	http://dx.doi.org/10.1126/science.1230719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307733	Green Accepted			2022-12-28	WOS:000313328200034
J	Torjesen, I				Torjesen, Ingrid			Sentinel node biopsy for melanoma: unnecessary treatment?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYMPHADENECTOMY; METASTASES; RECURRENCE; DISSECTION					ingrid_torjesen@hotmail.com						Agnese DM, 2003, SURGERY, V134, P542, DOI 10.1016/S0039-6060(03)00275-7; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P1566, DOI 10.1245/s10434-008-9885-2; Campanholi LL, 2011, J LYMPHOEDEMA, V6, P30; Cancer Research UK, CANC INC STAT; Cormier JN, 2005, J CLIN ONCOL, V23, P6054, DOI 10.1200/JCO.2005.21.360; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Morton D, 2010, ANN SURG ONCOL, V17, pS22; Morton DL, 2004, BRIT J DERMATOL, V151, P308, DOI 10.1111/j.1365-2133.2004.06133.x; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Morton DL, 2012, CLIN EXP METASTASIS; Morton DL, 1990, 42 ANN M SOC SURG ON; Morton DL, 2006, NEW ENGL J MED, V355, P1307, DOI 10.1056/NEJMoa060992; National Cancer Institute, MEL; National Institute for Health and Clinical Excellence, 2006, IMPR OUTC PEOPL SKIN; *OFF NAT STAT, 2003, CANC REG STAT ENGL 2; Reeves ME, 2003, ANN SURG ONCOL, V10, P27, DOI 10.1245/ASO.2003.03.020; Rosenberg SA, 2008, NAT CLIN PRACT ONCOL, V5, P1, DOI 10.1038/ncponc1022; Shamsian N, 2004, BMJ-BRIT MED J, V329, P1272; Skin Cancer Foundation, SKIN CANC FACTS; Thomas JM, 2008, NAT CLIN PRACT ONCOL, V5, P18, DOI 10.1038/ncponc1014; Thomas J Meirion, 2010, Skinmed, V8, P222; Wong SL, SENTINEL LYMPH NODE	22	25	25	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2013	346								e8645	10.1136/bmj.e8645	http://dx.doi.org/10.1136/bmj.e8645			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070ZH	23299845	Green Submitted			2022-12-28	WOS:000313553800010
J	Brossard, D; Scheufele, DA				Brossard, Dominique; Scheufele, Dietram A.			Science, New Media, and the Public	SCIENCE			English	Editorial Material									[Brossard, Dominique; Scheufele, Dietram A.] Univ Wisconsin, Dept Life Sci Commun, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Brossard, D (corresponding author), Univ Wisconsin, Dept Life Sci Commun, 1545 Observ Dr, Madison, WI 53706 USA.	dbrossard@wisc.edu	Scheufele, Dietram A./A-8737-2008	Scheufele, Dietram A./0000-0002-9914-5407				Aral S, 2012, SCIENCE, V337, P337, DOI 10.1126/science.1215842; Cacciatore MA, 2014, PUBLIC UNDERST SCI, V23, P376, DOI 10.1177/0963662512447606; Dudo A, 2011, COMMUN RES, V38, P754, DOI 10.1177/0093650210384988; Facebook Inc, 2012, KEY FACTS; Ladwig P., 2011, ANN C ASS ED JOURN M; Ladwig P, 2010, MATER TODAY, V13, P52, DOI 10.1016/S1369-7021(10)70084-5; National Science Board, 2012, SCI ENG IND 2012; Pariser Eli, 2012, FILTER BUBBLE WHAT I; Purcell K., 2012, SEARCH ENGINE USE 20; Russell Cristine, 2010, SCI MEDIA, P13; Segev E, 2012, PUBLIC UNDERST SCI, V21, P813, DOI 10.1177/0963662510387560; Twitter Inc, 2012, TWITT TURNS 6	12	212	221	4	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					40	41		10.1126/science.1232329	http://dx.doi.org/10.1126/science.1232329			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	063HC	23288529				2022-12-28	WOS:000312985800042
J	Poordad, F; Lawitz, E; Kowdley, KV; Cohen, DE; Podsadecki, T; Siggelkow, S; Heckaman, M; Larsen, L; Menon, R; Koev, G; Tripathi, R; Pilot-Matias, T; Bernstein, B				Poordad, Fred; Lawitz, Eric; Kowdley, Kris V.; Cohen, Daniel E.; Podsadecki, Thomas; Siggelkow, Sara; Heckaman, Michele; Larsen, Lois; Menon, Rajeev; Koev, Gennadiy; Tripathi, Rakesh; Pilot-Matias, Tami; Bernstein, Barry			Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT-NAIVE PATIENTS; PSI-7977 PLUS RBV; PEGYLATED INTERFERON; PROTEASE INHIBITOR; RIBAVIRIN	BACKGROUND There is a need for interferon-free treatment regimens for hepatitis C virus (HCV) infection. The goal of this study was to evaluate ABT-450, a potent HCV NS3 protease inhibitor, combined with low-dose ritonavir (ABT-450/r), in addition to ABT-333, a nonnucleoside NS5B polymerase inhibitor, and ribavirin, for the treatment of HCV infection. METHODS We conducted a 12-week, phase 2a, open-label study involving patients who had HCV genotype 1 infection without cirrhosis. All patients received ABT-333 (400 mg twice daily) and ribavirin (1000 to 1200 mg per day) and one of two daily doses of ABT-450/r. Groups 1 and 2 included previously untreated patients; group 1 received 250 mg of ABT-450 and 100 mg of ritonavir, and group 2 received 150 mg and 100 mg, respectively. Group 3, which included patients who had had a null or partial response to previous therapy with peginterferon and ribavirin, received daily doses of 150 mg of ABT-450 and 100 mg of ritonavir. The primary end point was an undetectable level of HCV RNA from week 4 through week 12 (extended rapid virologic response). RESULTS A total of 17 of the 19 patients in group 1 (89%) and 11 of the 14 in group 2 (79%) had an extended rapid virologic response; a sustained virologic response 12 weeks after the end of treatment was achieved in 95% and 93% of the patients, respectively. In group 3, 10 of 17 patients (59%) had an extended rapid virologic response, and 8 (47%) had a sustained virologic response 12 weeks after therapy; 6 patients had virologic breakthrough, and 3 had a relapse. Adverse events included abnormalities in liver-function tests, fatigue, nausea, headache, dizziness, insomnia, pruritus, rash, and vomiting. CONCLUSIONS This preliminary study suggests that 12 weeks of therapy with a combination of a protease inhibitor, a nonnucleoside polymerase inhibitor, and ribavirin may be effective for treatment of HCV genotype 1 infection. (Funded by Abbott; ClinicalTrials.gov number, NCT01306617.)	[Poordad, Fred] Univ Texas Hlth Sci Ctr San Antonio, Div Gastroenterol & Nutr MC7878, San Antonio, TX 78229 USA; [Kowdley, Kris V.] Virginia Mason Med Ctr, Inst Digest Dis, Seattle, WA 98101 USA; [Cohen, Daniel E.; Podsadecki, Thomas; Siggelkow, Sara; Heckaman, Michele; Larsen, Lois; Menon, Rajeev; Koev, Gennadiy; Tripathi, Rakesh; Pilot-Matias, Tami; Bernstein, Barry] Abbott, Abbott Pk, IL USA	University of Texas System; University of Texas Health San Antonio; Virginia Mason Medical Center; Abbott Laboratories; Abbott Vascular	Poordad, F (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Gastroenterol & Nutr MC7878, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	poordad@uthscsa.edu	Kowdley, Kris/AAF-5202-2019		Abbott	Abbott(Abbott Laboratories)	Funded by Abbott; ClinicalTrials.gov number, NCT01306617.	[Anonymous], GLOB ANTIVIR J; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Gane EJ, 2012, J HEPATOL, V56, pS438, DOI 10.1016/S0168-8278(12)61125-8; Gane EJ, 2011, HEPATOLOGY, V54, p377A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; LAWITZ E, 2012, J HEPATOL S2, V56, pS470; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns MP, 2011, J HEPATOL, V54, P1114, DOI 10.1016/j.jhep.2010.08.040; McGowan CE, 2012, LIVER INT, V32, P151, DOI 10.1111/j.1478-3231.2011.02706.x; Pilot-Matias T, 2011, J HEPATOL, V54, pS485, DOI 10.1016/S0168-8278(11)61231-2; Poordad F, 2012, J HEPATOL, V56, pS478, DOI 10.1016/S0168-8278(12)61218-5; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Sulkowski M, 2012, J HEPATOL, V56, pS560; Sulkowski M, 2012, J HEPATOL, V56, pS560; Suzuki F, 2012, J HEPATOL, V56, pS7, DOI 10.1016/S0168-8278(12)60028-2; Zeuzem S, 2012, J HEPATOL, V56, pS1; Zeuzem S, 2012, HEPATOLOGY, V55, P749, DOI 10.1002/hep.24744	17	237	242	0	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	2013	368	1					45	53		10.1056/NEJMoa1208809	http://dx.doi.org/10.1056/NEJMoa1208809			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062PA	23281975				2022-12-28	WOS:000312930600004
J	McKittrick, N; Frank, I; Jacobson, JM; White, CJ; Kim, D; Kappes, R; DiGiorgio, C; Kenney, T; Boyer, J; Tebas, P				McKittrick, Noah; Frank, Ian; Jacobson, Jeffrey M.; White, C. Jo; Kim, Deborah; Kappes, Rosemarie; DiGiorgio, Carol; Kenney, Thomas; Boyer, Jean; Tebas, Pablo		Ctr AIDS Res	Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-Infected Persons A Single-Center, Parallel, Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNIZATION PRACTICES ACIP; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; HIV-1-INFECTED PATIENTS; ADVISORY-COMMITTEE; DOUBLE-BLIND; ADULTS; RECOMMENDATIONS; INDIVIDUALS	Background: HIV-infected persons have less robust antibody responses to influenza vaccines. Objective: To compare the immunogenicity of high-dose influenza vaccine with that of standard dosing in HIV-positive participants. Design: Randomized, double-blind, controlled trial. (ClinicalTrials.gov: NCT01262846) Setting: The MacGregor Clinic of the Hospital of the University of Pennsylvania, Philadelphia, from 27 October 2010 to 27 March 2011. Participants: HIV-infected persons older than 18 years. Intervention: Participants were randomly assigned to receive either a standard dose (15 mcg of antigen per strain) or a high dose (60 mcg/strain) of the influenza trivalent vaccine. Measurements: The primary end point was the rate of seroprotection, defined as antibody titers of 1: 40 or greater on the hemagglutination inhibition assay 21 to 28 days after vaccination. The primary safety end point was frequency and intensity of adverse events. Secondary end points were seroconversion rate (defined as a greater than 4-fold increase in antibody titers) and the geometric mean antibody titer. Results: 195 participants enrolled, and 190 completed the study (93 in the standard-dose group and 97 in the high-dose group). The seroprotection rates after vaccination were higher in the high-dose group for the H1N1 (96% vs. 87%; treatment difference, 9 percentage points [95% CI, 1 to 17 percentage points]; P = 0.029), H3N2 (96% vs. 92%; treatment difference, 3 percentage points [CI, -3 to 10 percentage points]; P = 0.32), and influenza B (91% vs. 80%; treatment difference, 11 percentage points [CI, 1 to 21 percentage points]; P = 0.030) strains. Both vaccines were well-tolerated, with myalgia (19%), malaise (14%), and local pain (10%) the most frequent adverse events. Limitations: The effectiveness of the vaccine in preventing clinical influenza was not evaluated. The number of participants with CD4 counts less than 0.200 x 10(9) cells/L was limited. Conclusion: HIV-infected persons reach higher levels of influenza seroprotection if vaccinated with the high-dose trivalent vaccine than with the standard-dose. Primary Funding Source: National Institute of Allergy and Infectious Diseases and Center for AIDS Research of the University of Pennsylvania. Ann Intern Med. 2013;158:19-26.	[Tebas, Pablo] Univ Penn, AIDS Clin Res Unit, Philadelphia, PA 19104 USA; Drexel Univ, Philadelphia, PA 19104 USA	University of Pennsylvania; Drexel University	Tebas, P (corresponding author), Univ Penn, AIDS Clin Res Unit, 502 Johnson Pavill,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	pablo.tebas@uphs.upenn.edu		Tebas, Pablo/0000-0001-5345-7942; McKittrick, Noah/0000-0001-6277-2733	National Institute of Allergy and Infectious Diseases [U01-AI069467]; Center for AIDS Research of the University of Pennsylvania; Center for AIDS Research [P30-AI045008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069467, P30AI045008] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research of the University of Pennsylvania; Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institute of Allergy and Infectious Diseases and Center for AIDS Research of the University of Pennsylvania.; Grant Support: In part by grant U01-AI069467 from the National Institute of Allergy and Infectious Diseases and grant P30-AI045008 from the Center for AIDS Research to the University of Pennsylvania.	Aberg JA, 2004, CLIN INFECT DIS, V39, P609, DOI 10.1086/423390; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Archer B, 2009, EURO SURVEILL, V14; Bickel M, 2011, CLIN INFECT DIS, V52, P122, DOI 10.1093/cid/ciq003; Brydak LB, 1999, CLIN DRUG INVEST, V17, P441, DOI 10.2165/00044011-199917060-00004; COHEN JP, 1989, JAMA-J AM MED ASSOC, V261, P245, DOI 10.1001/jama.1989.03420020097023; Cooper C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017758; COUCH RB, 1983, ANNU REV MICROBIOL, V37, P529, DOI 10.1146/annurev.mi.37.100183.002525; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Durando P, 2008, CLIN VACCINE IMMUNOL, V15, P253, DOI 10.1128/CVI.00316-07; El Sahly HM, 2012, J INFECT DIS, V205, P703, DOI 10.1093/infdis/jir837; ENNIS FA, 1977, J INFECT DIS, V136, pS397, DOI 10.1093/infdis/136.Supplement_3.S397; Evison J, 2009, CLIN INFECT DIS, V48, P1402, DOI 10.1086/598193; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Fine AD, 2001, CLIN INFECT DIS, V32, P1784, DOI 10.1086/320747; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Fuller JD, 1999, CLIN INFECT DIS, V28, P541, DOI 10.1086/515170; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Gilsdorf A, 2009, EUROSURVEILLANCE, V14, P19318; Jefferson T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub4; Kroon FP, 1998, AIDS, V12, pF217, DOI 10.1097/00002030-199817000-00002; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Lin JC, 2001, ARCH INTERN MED, V161, P441, DOI 10.1001/archinte.161.3.441; MIOTTI PG, 1989, JAMA-J AM MED ASSOC, V262, P779, DOI 10.1001/jama.262.6.779; Monto AS, 2010, VACCINE, V28, pD33, DOI 10.1016/j.vaccine.2010.08.027; MOSTOW SR, 1973, POSTGRAD MED J, V49, P152, DOI 10.1136/pgmj.49.569.152; NELSON KE, 1988, ANN INTERN MED, V109, P383, DOI 10.7326/0003-4819-109-5-383; Neuzil KM, 2003, JAIDS-J ACQ IMM DEF, V34, P304, DOI 10.1097/00126334-200311010-00008; OLIVEIRA WK, 2009, EURO SURVEILL, V14; Overton ET, 2012, J INFECT DIS, V205, P697, DOI 10.1093/infdis/jir838; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; PALACHE AM, 1993, VACCINE, V11, P3, DOI 10.1016/0264-410X(93)90333-S; Radwan HM, 2000, CLIN INFECT DIS, V31, P604, DOI 10.1086/313985; RAGNI MV, 1987, J LAB CLIN MED, V109, P545; Reyes-Teran G, 2010, 17 C RETR OPP INF 16; SAFRIN S, 1990, CHEST, V98, P33, DOI 10.1378/chest.98.1.33; Soonawala D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016496; Tebas P, 2010, AIDS, V24, P2187, DOI 10.1097/QAD.0b013e32833c6d5c; Tremblay CL, 2011, VACCINE, V29, P1359, DOI 10.1016/j.vaccine.2010.12.023; Yamanaka H, 2005, JAIDS-J ACQ IMM DEF, V39, P167; Zanetti AR, 2002, VACCINE, V20, pB29, DOI 10.1016/S0264-410X(02)00511-X	42	45	46	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					19	U62		10.7326/0003-4819-158-1-201301010-00005	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	065AV	23277897				2022-12-28	WOS:000313119900004
J	Sinha, SK; Detsky, AS				Sinha, Samir K.; Detsky, Allan S.			Measure, Promote, and Reward Mobility to Prevent Falls in Older Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITALIZATION		[Detsky, Allan S.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Sinha, Samir K.; Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Sinha, Samir K.; Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Detsky, AS (corresponding author), 600 Univ Ave,Room 429, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						ASHER RAJ, 1947, BRIT MED J, V2, P967, DOI 10.1136/bmj.2.4536.967; Brown R, 2009, POLYM TEST, V28, P1, DOI 10.1016/j.polymertesting.2008.12.001; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Inouye SK, 2009, NEW ENGL J MED, V360, P2390, DOI 10.1056/NEJMp0900963; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Rizzuto D, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5568; Valkenet K, 2011, CLIN REHABIL, V25, P99, DOI 10.1177/0269215510380830	8	12	12	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2573	2574		10.1001/jama.2012.68313	http://dx.doi.org/10.1001/jama.2012.68313			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268514				2022-12-28	WOS:000312916600021
J	Chatrchyan, S; Khachatryan, V; Sirunyan, AM; Tumasyan, A; Adam, W; Aguilo, E; Bergauer, T; Dragicevic, M; Ero, J; Fabjan, C; Friedl, M; Fruhwirth, R; Ghete, VM; Hoch, M; Hormann, N; Hrubec, J; Jeitler, M; Kiesenhofer, W; Knunz, V; Krammer, M; Kratschmer, I; Liko, D; Majerotto, W; Mikulec, I; Pernicka, M; Rahbaran, B; Rohringer, C; Rohringer, H; Schofbeck, R; Strauss, J; Szoncso, F; Taurok, A; Waltenberger, W; Walzel, G; Widl, E; Wulz, CE; Chekhovsky, V; Emeliantchik, I; Litomin, A; Makarenko, V; Mossolov, V; Shumeiko, N; Solin, A; Stefanovitch, R; Gonzalez, JS; Fedorov, A; Korzhik, M; Missevitch, O; Zuyeuski, R; Bansal, M; Bansal, S; Beaumont, W; Cornelis, T; De Wolf, EA; Druzhkin, D; Janssen, X; Luyckx, S; Mucibello, L; Ochesanu, S; Roland, B; Rougny, R; Selvaggi, M; Staykova, Z; Van Haevermaet, H; Van Mechelen, P; Van Remortel, N; Van Spilbeeck, A; Blekman, F; Blyweert, S; D'Hondt, J; Devroede, O; Suarez, RG; Goorens, R; Kalogeropoulos, A; Maes, M; Olbrechts, A; Tavernier, S; Van Doninck, W; Van Lancker, L; Van Mulders, P; Van Onsem, GP; Villella, I; Clerbaux, B; De Lentdecker, G; Dero, V; Dewulf, JP; Gay, APR; Hreus, T; Leonard, A; Marage, PE; Mohammadi, A; Reis, T; Rugovac, S; Thomas, L; Vander Velde, C; Vanlaer, P; Wang, J; Wickens, J; Adler, V; Beernaert, K; Cimmino, A; Costantini, S; Garcia, G; Grunewald, M; Klein, B; Lellouch, J; Marinov, A; Mccartin, J; Rios, AAO; Ryckbosch, D; Strobbe, N; Thyssen, F; Tytgat, M; Walsh, S; Yazgan, E; Zaganidis, N; Basegmez, S; Bruno, G; Castello, R; Ceard, L; De Jeneret, JD; Delaere, C; Demin, P; du Pree, T; Favart, D; Forthomme, L; Giammanco, A; Gregoire, G; Hollar, J; Lemaitre, V; Liao, J; Militaru, O; Nuttens, C; Pagano, D; Pin, A; Piotrzkowski, K; Schul, N; Garcia, JMV; Beliy, N; Caebergs, T; Daubie, E; Hammad, GH; Alves, GA; Brito, L; Martins, MC; Martins, T; Pol, ME; Souza, MHG; Alda, WL; Carvalho, W; Custodio, A; Da Costa, EM; Damiao, DD; Martins, CD; De Souza, SF; Malbouisson, H; Malek, M; Figueiredo, DM; Mundim, L; Nogima, H; Oguri, V; Da Silva, WLP; Santoro, A; Sznajder, A; Pereira, AV; Anjos, TS; Bernardes, CA; Dias, FA; Tomei, TRFP; Gregores, EM; Iope, RL; Lagana, C; Lietti, SM; Marinho, F; Mercadante, PG; Novaes, SF; Padula, SS; Dimitrov, L; Genchev, V; Iaydjiev, P; Piperov, S; Rodozov, M; Stoykova, S; Sultanov, G; Tcholakov, V; Trayanov, R; Vankov, I; Vutova, M; Roumenin, C; Uzunova, D; Zahariev, R; Dimitrov, A; Hadjiiska, R; Kozhuharov, V; Litov, L; Pavlov, B; Petkov, P; Bian, JG; Chen, GM; Chen, HS; He, KL; Jiang, CH; Li, WG; Liang, D; Liang, S; Meng, X; Sun, G; Sun, HS; Tao, J; Wang, J; Wang, X; Wang, Z; Xiao, H; Xu, M; Yang, M; Zang, J; Zhang, X; Zhang, Z; Zhang, Z; Zhao, WR; Zhu, Z; Asawatangtrakuldee, C; Ban, Y; Cai, J; Guo, S; Guo, Y; Li, W; Liu, HT; Liu, S; Mao, Y; Qian, SJ; Teng, H; Wang, D; Ye, YL; Zhang, L; Zhu, B; Zou, W; Avila, C; Gomez, JP; Moreno, BG; Oliveros, AFO; Sanabria, JC; Godinovic, N; Lelas, D; Plestina, R; Polic, D; Puljak, I; Antunovic, Z; Kovac, M; Brigljevic, V; Duric, S; Kadija, K; Luetic, J; Mekterovic, D; Morovic, S; Attikis, A; Galanti, M; Mavromanolakis, G; Mousa, J; Nicolaou, C; Ptochos, F; Razis, PA; Finger, M; Finger, M; Aly, A; Assran, Y; Awad, A; Elgammal, S; Kamel, AE; Khalil, S; Mahmoud, MA; Mahrous, A; Radi, A; Hektor, A; Kadastik, M; Kannike, K; Muntel, M; Raidal, M; Rebane, L; Strumia, A; Tiko, A; Eerola, P; Fedi, G; Voutilainen, M; Anttila, E; Harkonen, J; Heikkinen, A; Karimaki, V; Katajisto, HM; Kinnunen, R; Kortelainen, MJ; Kotamaki, M; Lampen, T; Lassila-Perini, K; Lehti, S; Linden, T; Luukka, P; Maenpaa, T; Peltola, T; Tuominen, E; Tuominiemi, J; Tuovinen, E; Ungaro, D; Vanhala, TP; Wendland, L; Banzuzi, K; Karjalainen, A; Korpela, A; Tuuva, T; Anfreville, M; Besancon, M; Choudhury, S; Dejardin, M; Denegri, D; Fabbro, B; Faure, JL; Ferri, F; Ganjour, S; Gentit, FX; Givernaud, A; Gras, P; de Monchenault, GH; Jarry, P; Kircher, F; Lemaire, MC; Locci, E; Malcles, J; Mandjavidze, I; Nayak, A; Pansart, JP; Rander, J; Reymond, JM; Rosowsky, A; Titov, M; Verrecchia, P; Badier, J; Baffioni, S; Beaudette, F; Becheva, E; Benhabib, L; Bianchini, L; Bluj, M; Broutin, C; Busson, P; Cerutti, M; Chamont, D; Charlot, C; Daci, N; Dahms, T; Dalchenko, M; Dobrzynski, L; Geerebaert, Y; de Cassagnac, MG; Haguenauer, M; Hennion, P; Milleret, G; Mine, P; Mironov, C; Naranjo, IN; Nguyen, M; Ochando, C; Paganini, P; Romanteau, T; Sabes, D; Salerno, R; Sartirana, A; Sirois, Y; Thiebaux, C; Veelken, C; Zabi, A; Agram, JL; Andrea, J; Besson, A; Bloch, D; Bodin, D; Brom, JM; Cardaci, M; Chabert, EC; Collard, C; Conte, E; Drouhin, F; Fontaine, JC; Gele, D; Goerlach, U; Goetzmann, C; Gross, L; Huss, D; Juillot, P; Kieffer, E; Le Bihan, AC; Pansanel, J; Patois, Y; Van Hove, P; Boutigny, D; Mercier, D; Baulieu, G; Beauceron, S; Beaupere, N; Bedjidian, M; Bondu, O; Boudoul, G; Brochet, S; Chasserat, J; Chierici, R; Combaret, C; Contardo, D; Depasse, P; El Mamouni, H; Fay, J; Gascon, S; Giraud, N; Gouzevitch, M; Haroutunian, R; Ille, B; Kurca, T; Lethuillier, M; Lumb, N; Mathez, H; Mirabito, L; Perries, S; Sgandurra, L; Sordini, V; Tschudi, Y; Vander Donckt, M; Verdier, P; Viret, S; Roinishvili, V; Rurua, L; Amaglobeli, N; Bagaturia, I; Chiladze, B; Kvatadze, R; Lomidze, D; Shanidze, R; Tsamalaidze, Z; Adolphi, R; Autermann, C; Beranek, S; Brauer, R; Braunschweig, W; Calpas, B; Edelhoff, M; Feld, L; Heracleous, N; Hindrichs, O; Jussen, R; Karpinski, W; Klein, K; Lubelsmeyer, K; Merz, J; Ostapchuk, A; Pandoulas, D; Perieanu, A; Raupach, F; Sammet, J; Schael, S; Schmitz, D; von Dratzig, AS; Siedling, R; Sprenger, D; Weber, H; Wittmer, B; Wlochal, M; Zhukov, V; Ata, M; Biallass, P; Caudron, J; Dietz-Laursonn, E; Duchardt, D; Erdmann, M; Fischer, R; Guth, A; Hebbeker, T; Heidemann, C; Hilgers, G; Hoepfner, K; Hof, C; Klimkovich, T; Klingebiel, D; Kreuzer, P; Magass, C; Merschmeyer, M; Meyer, A; Olschewski, M; Papacz, P; Philipps, B; Pieta, H; Reithler, H; Schmitz, SA; Sonnenschein, L; Sowa, M; Steggemann, J; Teyssier, D; Weber, M; Bontenackels, M; Cherepanov, V; Erdogan, Y; Flugge, G; Geenen, H; Geisler, M; Ahmad, WH; Hoehle, F; Kargoll, B; Kress, T; Kuessel, Y; Lingemann, J; Nowack, A; Perchalla, L; Pooth, O; Sauerland, P; Stahl, A; Zoeller, MH; Martin, MA; Behr, J; Behrenhoff, W; Behrens, U; Bergholz, M; Bethani, A; Borras, K; Burgmeier, A; Cakir, A; Calligaris, L; Campbell, A; Castro, E; Costanza, F; Dammann, D; Pardos, CD; Eckerlin, G; Eckstein, D; Flossdorf, A; Flucke, G; Geiser, A; Glushkov, I; Goettlicher, P; Grebenyuk, A; Gunnellini, P; Habib, S; Hauk, J; Hellwig, G; Jung, H; Kasemann, M; Katsas, P; Kleinwort, C; Kluge, H; Knutsson, A; Kramer, M; Krucker, D; Kuznetsova, E; Lange, W; Leonard, J; Lewendel, B; Lohmann, W; Lutz, B; Mankel, R; Marfin, I; Marienfeld, M; Melzer-Pellmann, IA; Meyer, AB; Mnich, J; Muhl, C; Mussgiller, A; Naumann-Emme, S; Novgorodova, O; Olzem, J; Parenti, A; Perrey, H; Petrukhin, A; Pitzl, D; Raspereza, A; Cipriano, PMR; Riedl, C; Ron, E; Rosemann, C; Rosin, M; Salfeld-Nebgen, J; Schmidt, R; Schoerner-Sadenius, T; Sen, N; Spiridonov, A; Stein, M; Tomaszewska, J; Volyanskyy, D; Walsh, R; Wissing, C; Youngman, C; Blobel, V; Draeger, J; Enderle, H; Erfle, J; Gebbert, U; Gorner, M; Hermanns, T; Hoing, RS; Kaschube, K; Kaussen, G; Kirschenmann, H; Klanner, R; Lange, J; Mura, B; Nowak, F; Peiffer, T; Pietsch, N; Rathjens, D; Sander, C; Schettler, H; Schleper, P; Schlieckau, E; Schmidt, A; Schroder, M; Schum, T; Seidel, M; Sibille, J; Sola, V; Stadie, H; Steinbruck, G; Thomsen, J; Vanelderen, L; Barth, C; Bauer, J; Berger, J; Blum, P; Boser, C; Buege, V; Chen, ZY; Chowdhury, S; Chwalek, T; Daeuwel, D; De Boer, W; Descroix, A; Dierlamm, A; Dirkes, G; Fahrer, M; Feindt, M; Felzmann, U; Frey, M; Furgeri, A; Gebauer, I; Gessler, A; Gruschke, J; Guthoff, M; Hackstein, C; Hartmann, F; Hauler, F; Hauth, T; Heier, S; Heindl, SM; Heinrich, M; Heiss, A; Held, H; Hoffmann, KH; Honc, S; Husemann, U; Imhof, M; Jung, C; Junghans, S; Katkov, I; Kerzel, U; Knoblauch, D; Komaragiri, JR; Kraber, M; Kuhr, T; Liamsuwan, T; Pardo, PL; Martschei, D; Menchikov, A; Mol, X; Mormann, D; Mueller, S; Muller, T; Neuberger, D; Neuland, MB; Niegel, M; Nurnberg, A; Oberst, O; Oehler, A; Gomez, TO; Ott, J; Piasecki, C; Poschlad, A; Quast, G; Rabbertz, K; Ratnikov, F; Ratnikova, N; Renz, M; Rocker, S; Roederer, F; Sabellek, A; Saout, C; Scheurer, A; Schieferdecker, D; Schieferdecker, P; Schilling, FP; Schmanau, M; Schott, G; Schwerdtfeger, W; Simonis, HJ; Skiba, A; Stober, FM; Theel, A; Thummel, WH; Troendle, D; Trunov, A; Ulrich, R; Wagner-Kuhr, J; Wayand, S; Weber, M; Weiler, T; Zeise, M; Ziebarth, EB; Zvada, M; Anagnostou, G; Daskalakis, G; Geralis, T; Kesisoglou, S; Kyriakis, A; Loukas, D; Manolakos, I; Markou, A; Markou, C; Mavrommatis, C; Ntomari, E; Gouskos, L; Panagiotou, A; Saoulidou, N; Evangelou, I; Foudas, C; Kokkas, P; Manthos, N; Papadopoulos, I; Patras, V; Triantis, FA; Bencze, G; Hajdu, C; Hidas, P; Horvath, D; Sikler, F; Veszpremi, V; Vesztergombi, G; Zalan, P; Beni, N; Czellar, S; Fenyvesi, A; Molnar, J; Palinkas, J; Szillasi, Z; Karancsi, J; Raics, P; Trocsanyi, ZL; Ujvari, B; Zilizi, G; Beri, SB; Bhandari, V; Bhatnagar, V; Dhingra, N; Gupta, R; Kaur, M; Kohli, JM; Mehta, MZ; Nishu, N; Saini, LK; Sharma, A; Singh, JB; Kumar, A; Kumar, A; Ahuja, S; Bhardwaj, A; Chatterji, S; Choudhary, BC; Gupta, P; Malhotra, S; Naimuddin, M; Ranjan, K; Sharma, V; Shivpuri, RK; Banerjee, S; Bhattacharya, S; Dutta, S; Gomber, B; Jain, S; Jain, S; Khurana, R; Sarkar, S; Sharan, M; Abdulsalam, A; Choudhury, RK; Dutta, D; Ghodgaonkar, M; Kailas, S; Kataria, SK; Kumar, V; Mehta, P; Mohanty, AK; Pant, LM; Shukla, P; Topkar, A; Aziz, T; Chendvankar, S; Deshpande, PV; Ganguli, SN; Ganguly, S; Guchait, M; Gurtu, A; Maity, M; Mazumdar, K; Mohanty, GB; Parida, B; Patil, MR; Raghavan, R; Sudhakar, K; Wickramage, N; Acharya, BS; Banerjee, S; Bheesette, S; Dugad, S; Kalmani, SD; Krishnaswamy, MR; Lakkireddi, VR; Mondal, NK; Narasimham, VS; Panyam, N; Verma, P; Ardalan, F; Arfaei, H; Bakhshiansohi, H; Etesami, SM; Fahim, A; Hashemi, M; Jafari, A; Khakzad, M; Najafabadi, MM; Mehdiabadi, SP; Safarzadeh, B; Zeinali, M; Abbrescia, M; Barbone, L; Calabria, C; Chhibra, SS; Colaleo, A; Creanza, D; De Filippis, N; De Palma, M; De Robertis, G; Donvito, G; Fiore, L; Iaselli, G; Loddo, F; Maggi, G; Maggi, M; Manna, N; Marangelli, B; My, S; Natali, S; Nuzzo, S; Pacifico, N; Pompili, A; Pugliese, G; Ranieri, A; Romano, F; Selvaggi, G; Silvestris, L; Singh, G; Spinoso, V; Venditti, R; Verwilligen, P; Zito, G; Abbiendi, G; Benvenuti, AC; Bonacorsi, D; Braibant-Giacomelli, S; Brigliadori, L; Capiluppi, P; Castro, A; Cavallo, FR; Cuffiani, M; Dallavalle, GM; Fabbri, F; Fanfani, A; Fasanella, D; Giacomelli, P; Grandi, C; Guiducci, L; Marcellini, S; Masetti, G; Meneghelli, M; Montanari, A; Navarria, FL; Odorici, F; Perrotta, A; Primavera, F; Rossi, AM; Rovelli, T; Siroli, GP; Travaglini, R; Albergo, S; Cappello, G; Chiorboli, M; Costa, S; Noto, F; Potenza, R; Saizu, MA; Tricomi, A; Tuve, C; Barbagli, G; Ciulli, V; Civinini, C; D'Alessandro, R; Focardi, E; Frosali, S; Gallo, E; Genta, C; Gonzi, S; Meschini, M; Paoletti, S; Parrini, G; Ranieri, R; Sguazzoni, G; Tropiano, A; Benussi, L; Bianco, S; Colafranceschi, S; Fabbri, F; Piccolo, D; Fabbricatore, P; Farinon, S; Greco, M; Musenich, R; Tosi, S; Benaglia, A; Carbone, L; D'Angelo, P; De Guio, F; Di Matteo, L; Dini, P; Farina, FM; Fiorendi, S; Gennai, S; Ghezzi, A; Malvezzi, S; Manzoni, RA; Martelli, A; Massironi, A; Menasce, D; Moroni, L; Negri, P; Paganoni, M; Pedrini, D; Pullia, A; Ragazzi, S; Redaelli, N; Sala, S; de Fatis, TT; Buontempo, S; Montoya, CAC; Cavallo, N; De Cosa, A; Dogangun, O; Fabozzi, F; Iorio, AOM; Lista, L; Meola, S; Merola, M; Paolucci, P; Azzi, P; Bacchetta, N; Bellato, M; Benettoni, M; Biasotto, M; Bisello, D; Branca, A; Carlin, R; Checchia, P; Dorigo, T; Dosselli, U; Fanzago, F; Gasparini, F; Gasparini, U; Giubilato, P; Gonella, F; Gozzelino, A; Gulmini, M; Kanishchev, K; Lacaprara, S; Lazzizzera, I; Loreti, M; Margoni, M; Maron, G; Mazzucato, M; Meneguzzo, AT; Montecassiano, F; Passaseo, M; Pazzini, J; Pegoraro, M; Pozzobon, N; Ronchese, P; Simonetto, F; Torassa, E; Tosi, M; Vanini, S; Ventura, S; Zotto, P; Zumerle, G; Berzano, U; Gabusi, M; Ratti, SP; Riccardi, C; Torre, P; Vitulo, P; Biasini, M; Bilei, GM; Fano, L; Lariccia, P; Lucaroni, A; Mantovani, G; Menichelli, M; Nappi, A; Passeri, D; Placidi, P; Romeo, F; Saha, A; Santocchia, A; Servoli, L; Spiezia, A; Taroni, S; Valdata, M; Angelini, F; Arezzini, S; Azzurri, P; Bagliesi, G; Basti, A; Bellazzini, R; Bernardini, J; Boccali, T; Bosi, F; Brez, A; Broccolo, G; Calzolari, F; Carboni, A; Castaldi, R; Cerri, C; Ciampa, A; D'Agnolo, RT; Dell'Orso, R; Fiori, F; Foa, L; Giassi, A; Giusti, S; Kraan, A; Latronico, L; Ligabue, F; Linari, S; Lomtadze, T; Martini, L; Massa, M; Massai, MM; Mazzoni, E; Messineo, A; Moggi, A; Palla, F; Raffaelli, F; Rizzi, A; Sanguinetti, G; Segneri, G; Serban, AT; Spagnolo, P; Spandre, G; Squillacioti, P; Tenchini, R; Tonelli, G; Venturi, A; Verdini, PG; Baccaro, S; Barone, L; Bartoloni, A; Cavallari, F; Dafinei, I; Del Re, D; Diemoz, M; Fanelli, C; Grassi, M; Longo, E; Meridiani, P; Micheli, F; Nourbakhsh, S; Organtini, G; Paramatti, R; Rahatlou, S; Sigamani, M; Soffi, L; Talamo, IG; Amapane, N; Arcidiacono, R; Argiro, S; Arneodo, M; Biino, C; Cartiglia, N; Costa, M; Demaria, N; Mariotti, C; Maselli, S; Migliore, E; Monaco, V; Musich, M; Obertino, MM; Pastrone, N; Pelliccioni, M; Peroni, C; Potenza, A; Romero, A; Ruspa, M; Sacchi, R; Solano, A; Staiano, A; Ambroglini, F; Belforte, S; Candelise, V; Casarsa, M; Cossutti, F; Della Ricca, G; Gobbo, B; Kavka, C; Marone, M; Montanino, D; Penzo, A; Schizzi, A; Kim, TY; Nam, SK; Chang, S; Chung, J; Ham, SW; Han, D; Kang, J; Kim, DH; Kim, GN; Kim, JE; Kim, KS; Kong, DJ; Lee, MW; Oh, YD; Park, H; Ro, SR; Son, D; Son, DC; Suh, JS; Kim, JY; Kim, ZJ; Song, S; Choi, S; Gyun, D; Hong, B; Jo, M; Jo, Y; Kang, M; Kim, H; Kim, TJ; Lee, KS; Moon, DH; Park, SK; Roh, Y; Sim, KS; Choi, M; Hahn, G; Kang, S; Kim, H; Kim, JH; Park, C; Park, IC; Park, S; Ryu, G; Choi, Y; Choi, YK; Goh, J; Kim, MS; Kwon, E; Lee, B; Lee, J; Lee, S; Seo, H; Yu, I; Janulis, M; Juodagalvis, A; Naujikas, R; Castilla-Valdez, H; De La Cruz-Burelo, E; Heredia-de La Cruz, I; Lopez-Fernandez, R; Martinez-Ortega, J; Sanchez-Hernandez, A; Villasenor-Cendejas, LM; Moreno, SC; Valencia, FV; Ibarguen, HAS; Linares, EC; Pineda, AM; Reyes-Santos, MA; Allfrey, P; Krofcheck, D; Bell, AJ; Rodrigues, NB; Butler, APH; Butler, PH; Doesburg, R; Pfeiffer, D; Reucroft, S; Silverwood, H; Williams, JC; Ahmad, M; Ansari, MH; Asghar, MI; Butt, J; Hoorani, HR; Khalid, S; Khan, WA; Khurshid, T; Qazi, S; Shah, MA; Shoaib, M; Bialkowska, H; Boimska, B; Frueboes, T; Gokieli, R; Goscilo, L; Gorski, M; Kazana, M; Kudla, IM; Nawrocki, K; Romanowska-Rybinska, K; Szleper, M; Wrochna, G; Zalewski, P; Brona, G; Bunkowski, K; Cwiok, M; Czyrkowski, H; Dabrowski, R; Dominik, W; Doroba, K; Kalinowski, A; Konecki, M; Krolikowski, J; Oklinski, W; Pozniak, K; Zabolotny, W; Zych, P; Kasprowicz, G; Romaniuk, R; Alemany-Fernandez, R; Almeida, N; Bargassa, P; David, A; Faccioli, P; Parracho, PGF; Gallinaro, M; Ribeiro, PQ; Seixas, J; Silva, J; Varela, J; Vischia, P; Afanasiev, S; Belotelov, I; Bunin, P; Ershov, Y; Gavrilenko, M; Golunov, A; Golutvin, I; Gorbounov, N; Gorbunov, I; Gramenitski, I; Kalagin, V; Kamenev, A; Karjavin, V; Konoplyanikov, V; Korenkov, V; Kozlov, G; Kurenkov, A; Lanev, A; Makankin, A; Malakhov, A; Melnitchenko, I; Mitsyn, VV; Moisenz, P; Oleynik, D; Orlov, A; Palichik, V; Perelygin, V; Petrosyan, A; Savina, M; Semenov, R; Shmatov, S; Shulha, S; Skachkova, A; Skatchkov, N; Smetannikov, V; Smirnov, V; Smolin, D; Tikhonenko, E; Vasil'ev, S; Volodko, A; Zarubin, A; Zhiltsov, V; Evstyukhin, S; Golovtsov, V; Ivanov, Y; Kim, V; Levchenko, P; Murzin, V; Oreshkin, V; Smirnov, I; Sulimov, V; Uvarov, L; Vavilov, S; Vorobyev, A; Vorobyev, A; Andreev, Y; Anisimov, A; Dermenev, A; Gninenko, S; Golubev, N; Gorbunov, D; Karneyeu, A; Kirsanov, M; Krasnikov, N; Matveev, V; Pashenkov, A; Pivovarov, G; Postoev, VE; Rubakov, V; Shirinyants, V; Solovey, A; Tlisov, D; Toropin, A; Troitsky, S; Epshteyn, V; Erofeeva, M; Gavrilov, V; Kaftanov, V; Kiselevich, I; Kolosov, V; Konoplyannikov, A; Kossov, M; Kozlov, Y; Krokhotin, A; Litvintsev, D; Lychkovskaya, N; Oulianov, A; Popov, V; Safronov, G; Semenov, S; Shreyber, I; Stepanov, N; Stolin, V; Vlasov, E; Zaytsev, V; Zhokin, A; Belyaev, A; Boos, E; Bunichev, V; Demiyanov, A; Dubinin, M; Dudko, L; Ershov, A; Gribushin, A; Ilyin, V; Kaminskiy, A; Klyukhin, V; Kodolova, O; Korotkikh, V; Kryukov, A; Lokhtin, I; Markina, A; Obraztsov, S; Perfilov, M; Petrushanko, S; Popov, A; Proskuryakov, A; Sarycheva, L; Savrin, V; Snigirev, A; Vardanyan, I; Andreev, V; Azarkin, M; Dremin, I; Kirakosyan, M; Leonidov, A; Mesyats, G; Rusakov, SV; Vinogradov, A; Azhgirey, I; Bayshev, I; Bitioukov, S; Grishin, V; Kachanov, V; Kalinin, A; Konstantinov, D; Korablev, A; Krychkine, V; Levine, A; Petrov, V; Ryabov, A; Ryutin, R; Sobol, A; Talov, V; Tourtchanovitch, L; Troshin, S; Tyurin, N; Uzunian, A; Volkov, A; Adzic, P; Djordjevic, M; Ekmedzic, M; Krpic, D; Milosevic, J; Smiljkovic, N; Zupan, M; Aguilar-Benitez, M; Maestre, JA; Arce, P; Battilana, C; Calvo, E; Cerrada, M; Llatas, MC; Colino, N; De La Cruz, B; Peris, AD; Vazquez, DD; Bedoya, CF; Ramos, JPF; Ferrando, A; Flix, J; Fouz, MC; Garcia-Abia, P; Lopez, OG; Lopez, SG; Hernandez, JM; Josa, MI; Merino, G; Pelayo, JP; Olmeda, AQ; Redondo, I; Romero, L; Santaolalla, J; Soares, MS; Willmott, C; Albajar, C; Codispoti, G; de Troconiz, JF; Brun, H; Cuevas, J; Menendez, JF; Folgueras, S; Caballero, IG; Iglesias, LL; Gomez, JP; Cifuentes, JAB; Cabrillo, IJ; Calderon, A; Chuang, SH; Campderros, JD; Felcini, M; Fernandez, M; Gomez, G; Sanchez, JG; Graziano, A; Jorda, C; Virto, AL; Marco, J; Marco, R; Rivero, CM; Matorras, F; Sanchez, FJM; Rodrigo, T; Rodriguez-Marrero, AY; Ruiz-Jimeno, A; Scodellaro, L; Sanudo, MS; Vila, I; Cortabitarte, RV; Abbaneo, D; Aspell, P; Auffray, E; Auzinger, G; Bachtis, M; Baechler, J; Baillon, P; Ball, AH; Barney, D; Benitez, JF; Bernet, C; Bialas, W; Bianchi, G; Bloch, P; Bocci, A; Bonato, A; Botta, C; Breuker, H; Campi, D; Camporesi, T; Cano, E; Cerminara, G; Charkiewicz, A; Christiansen, T; Perez, JAC; Cure, B; D'Enterria, D; Dabrowski, A; Daguin, J; De Roeck, A; Di Guida, S; Dobson, M; Dupont-Sagorin, N; Elliott-Peisert, A; Eppard, M; Frisch, B; Funk, W; Gaddi, A; Gastal, M; Georgiou, G; Gerwig, H; Giffels, M; Gigi, D; Gill, K; Giordano, D; Girone, M; Giunta, M; Glege, F; Garrido, RGR; Goudard, R; Govoni, P; Gowdy, S; Guida, R; Gutleber, J; Hammarstrom, R; Hammer, J; Hansen, M; Harris, P; Hartl, C; Harvey, J; Hegner, B; Hinzmann, A; Honma, A; Innocente, V; Janot, P; Kaadze, K; Karavakis, E; Kloukinas, K; Kousouris, K; Lecoq, P; Lee, YJ; Lenzi, P; Loos, R; Lourenco, C; Macpherson, A; Magini, N; Maki, T; Malberti, M; Malgeri, L; Mannelli, M; Marchioro, A; Noite, JMP; Masetti, L; Meijers, F; Mersi, S; Meschi, E; Moneta, L; Mozer, MU; Mulders, M; Musella, P; Onnela, A; Orsini, L; Osborne, JA; Cortezon, EP; Perez, E; Perrozzi, L; Petagna, P; Petrilli, A; Petrucci, A; Pfeiffer, A; Pierini, M; Pimia, M; Piparo, D; Polese, G; Postema, H; Quertenmont, L; Racz, A; Reece, W; Ricci, D; Antunes, JR; Rolandi, G; Rovelli, C; Rovere, M; Ryjov, V; Sakulin, H; Samyn, D; Santanastasio, F; Schafer, C; Schwick, C; Sciaba, A; Segoni, I; Sekmen, S; Sharma, A; Siegrist, P; Silva, P; Simon, M; Sphicas, P; Spiga, D; Taylor, BG; Teller, O; Tropea, P; Tropea, J; Tsesmelis, E; Tsirou, A; Vasey, F; Veillet, L; Veres, GI; Vichoudis, P; Vlimant, JR; Wertelaers, P; Wohri, HK; Worm, SD; Zeuner, WD; Bertl, W; Deiters, K; Erdmann, W; Feichtinger, D; Gabathuler, K; Horisberger, R; Ingram, Q; Kaestli, HC; Konig, S; Kotlinski, D; Langenegger, U; Meier, B; Meier, F; Renker, D; Rohe, T; Sakhelashvili, T; Bani, L; Behner, F; Betev, B; Blau, B; Bortignon, P; Buchmann, MA; Casal, B; Chanon, N; Chen, Z; Di Calafiori, DRD; Dambach, S; Davatz, G; Deisher, A; Deisher, G; Dittmar, M; Djambazov, L; Donega, M; Dunser, M; Eggel, C; Eugster, J; Faber, G; Freudenreich, K; Grab, C; Hintz, W; Hits, D; Hofer, H; Holme, O; Horvath, I; Lecomte, P; Lustermann, W; Marchica, C; Marini, AC; del Arbol, PMR; Mohr, N; Moortgat, F; Nageli, C; Nef, P; Nessi-Tedaldi, F; Pandolfi, F; Pape, L; Pauss, F; Peruzzi, M; Punz, T; Ronga, FJ; Roser, U; Rossini, M; Sala, L; Sanchez, AK; Sawley, MC; Schinzel, D; Starodumov, A; Stieger, B; Suter, H; Takahashi, M; Tauscher, L; Thea, A; Theofilatos, K; Treille, D; Trub, P; Udriot, S; Urscheler, C; Urscheler, G; von Gunten, HP; Wallny, R; Weber, HA; Wehrli, L; Weng, J; Zelepoukine, S; Amsler, C; Chiochia, V; De Visscher, S; Favaro, C; Rikova, MI; Kilminster, B; Mejias, BM; Otiougova, P; Robmann, P; Snoek, H; Tupputi, S; Verzetti, M; Chang, YH; Chen, KH; Chen, WT; Ferro, C; Go, A; Kuo, CM; Li, SW; Lin, W; Liu, MH; Liu, ZK; Lu, YJ; Singh, AP; Volpe, R; Wu, JH; Yu, SS; Bartalini, P; Chang, P; Chang, YH; Chang, YW; Chao, Y; Chen, KF; Dietz, C; Gao, Z; Grundler, U; Hou, WS; Hsiung, Y; Kao, KY; Lei, YJ; Liau, JJ; Lin, SW; Lu, RS; Majumder, D; Petrakou, E; Shi, X; Shiu, JG; Tzeng, YM; Ueno, K; Velikzhanin, Y; Wan, X; Wang, CC; Wang, M; Wei, JT; Yeh, P; Asavapibhop, B; Srimanobhas, N; Adiguzel, A; Bakirci, MN; Cerci, S; Dozen, C; Dumanoglu, I; Eskut, E; Girgis, S; Gokbulut, G; Gurpinar, E; Hos, I; Kangal, EE; Karaman, T; Karapinar, G; Topaksu, AK; Onengut, G; Ozdemir, K; Ozturk, S; Polatoz, A; Sogut, K; Cerci, DS; Tali, B; Topakli, H; Vergili, LN; Vergili, M; Akin, IV; Aliev, T; Bilin, B; Deniz, M; Gamsizkan, H; Guler, AM; Ocalan, K; Ozpineci, A; Serin, M; Sever, R; Surat, UE; Zeyrek, M; Deliomeroglu, M; Gulmez, E; Isildak, B; Kaya, M; Kaya, O; Ozkorucuklu, S; Sonmez, N; Cankocak, K; Grynyov, B; Levchuk, L; Lukyanenko, S; Soroka, D; Sorokin, P; Ahmad, MKH; Branson, A; McClatchey, R; Odeh, M; Shamdasani, J; Soomro, K; Barrass, T; Bostock, F; Brooke, JJ; Clement, E; Cussans, D; Flacher, H; Frazier, R; Goldstein, J; Grimes, M; Heath, GP; Heath, HF; Kreczko, L; Lacesso, W; Metson, S; Newbold, DM; Nirunpong, K; Poll, A; Senkin, S; Smith, VJ; Williams, T; Basso, L; Bateman, E; Bell, KW; Belyaev, A; Brew, C; Brown, RM; Camanzi, B; Cockerill, DJA; Connolly, JF; Coughlan, JA; Denton, LG; Flower, PS; French, MJ; Greenhalgh, RJS; Halsall, RNJ; Harder, K; Harper, S; Hill, JA; Jackson, J; Kennedy, BW; Lintern, AL; Lodge, AB; Olaiya, E; Pearson, MR; Petyt, D; Radburn-Smith, BC; Shepherd-Themistocleous, CH; Smith, BJ; Sproston, M; Stephenson, R; Tomalin, IR; Torbet, MJ; Williams, JH; Womersley, WJ; Bainbridge, R; Ball, G; Ballin, J; Bauer, D; Beuselinck, R; Buchmuller, O; Colling, D; Cripps, N; Cutajar, M; Dauncey, P; Davies, G; Della Negra, M; Ferguson, W; Fulcher, J; Futyan, D; Gilbert, A; Bryer, AG; Hall, G; Hatherell, Z; Hays, J; Iles, G; Jarvis, M; Jones, J; Karapostoli, G; Kenzie, M; Leaver, J; Lyons, L; Magnan, AM; Marrouche, J; Mathias, B; Miller, DG; Nandi, R; Nash, J; Nikitenko, A; Noy, M; Papageorgiou, A; Pela, J; Pesaresi, M; Petridis, K; Pioppi, M; Rand, D; Raymond, DM; Rogerson, S; Rose, A; Ryan, MJ; Seez, C; Sharp, P; Sparrow, A; Stoye, M; Tapper, A; Timlin, C; Tourneur, S; Acosta, MV; Virdee, T; Wakefield, S; Wardle, N; Whyntie, T; Wingham, M; Zorba, O; Chadwick, M; Cole, JE; Hobson, PR; Khan, A; Kyberd, P; Leggat, D; Leslie, D; Martin, W; Reid, ID; Symonds, P; Teodorescu, L; Turner, M; Dittmann, J; Hatakeyama, K; Liu, H; Scarborough, T; Charaf, O; Henderson, C; Rumerio, P; Avetisyan, A; Bose, T; Jarrin, EC; Fantasia, C; Hazen, E; Heister, A; St John, J; Lawson, P; Lazic, D; Rohlf, J; Sperka, D; Sulak, L; Rodriguez, FV; Wu, S; Alimena, J; Bhattacharya, S; Cutts, D; Demiragli, Z; Ferapontov, A; Garabedian, A; Heintz, U; Hooper, R; Jabeen, S; Kukartsev, G; Laird, E; Landsberg, G; Luk, M; Narain, M; Nguyen, D; Segala, M; Sinthuprasith, T; Speer, T; Tsang, KV; Unalan, Z; Breedon, R; Breto, G; Sanchez, MCD; Case, M; Chauhan, S; Chertok, M; Conway, J; Conway, R; Cox, PT; Dolen, J; Erbacher, R; Gardner, M; Grim, G; Gunion, J; Holbrook, B; Ko, W; Kopecky, A; Lander, R; Lin, FC; Miceli, T; Murray, P; Nikolic, M; Pellett, D; Ricci-Tam, F; Rowe, J; Rutherford, B; Searle, M; Smith, J; Squires, M; Tripathi, M; Sierra, RV; Yohay, R; Andreev, V; Arisaka, K; Cline, D; Cousins, R; Duris, J; Erhan, S; Everaerts, P; Farrell, C; Hauser, J; Ignatenko, M; Jarvis, C; Kubic, J; Otwinowski, S; Plager, C; Rakness, G; Schlein, P; Traczyk, P; Valuev, V; Weber, M; Yang, X; Zheng, Y; Babb, J; Clare, R; Dinardo, ME; Ellison, J; Gary, JW; Giordano, F; Hanson, G; Jeng, GY; Layter, JG; Liu, H; Long, OR; Luthra, A; Nguyen, H; Paramesvaran, S; Shen, BC; Sturdy, J; Sumowidagdo, S; Wilken, R; Wimpenny, S; Andrews, W; Branson, JG; Cerati, GB; Cinquilli, M; Cittolin, S; Evans, D; Holzner, A; Kelley, R; Lebourgeois, M; Letts, J; Macneill, I; Mangano, B; Martin, T; Mrak-Tadel, A; Padhi, S; Palmer, C; Petrucciani, G; Pieri, M; Sani, M; Sfiligoi, I; Sharma, V; Simon, S; Sudano, E; Tadel, M; Tu, Y; Vartak, A; Wasserbaech, S; Wurthwein, F; Yagil, A; Yoo, J; Barge, D; Bellan, R; Campagnari, C; D'Alfonso, M; Danielson, T; Flowers, K; Geffert, P; Golf, F; Incandela, J; Justus, C; Kalavase, P; Kovalskyi, D; Krutelyov, V; Kyre, S; Lowette, S; Magazzu, G; Villalba, RM; Mccoll, N; Pavlunin, V; Ribnik, J; Richman, J; Rossin, R; Stuart, D; To, W; West, C; White, D; Adamczyk, D; Apresyan, A; Barczyk, A; Bornheim, A; Bunn, J; Chen, Y; Denis, G; Di Marco, E; Duarte, J; Galvez, P; Gataullin, M; Kcira, D; Lebeau, M; Lebeau, I; Litvine, V; Ma, Y; Maxa, Z; Mott, A; Mughal, A; Nae, D; Newman, HB; Ravot, S; Rogan, C; Rozsa, SG; Shevchenko, S; Shin, K; Spiropulu, M; Steenberg, C; Thomas, M; Timciuc, V; van Lingen, F; Veverka, J; Voicu, BR; Wilkinson, R; Xie, S; Yang, Y; Zhang, L; Zhu, K; Zhu, RY; Azzolini, V; Calamba, A; Carroll, R; Ferguson, T; Iiyama, Y; Jang, DW; Jun, SY; Liu, YF; Paulini, M; Russ, J; Terentyev, N; Vogel, H; Vorobiev, I; Cumalat, JP; Drell, BR; Ford, WT; Gaz, A; Heyburn, B; Johnson, D; Lopez, EL; Nauenberg, U; Smith, JG; Stenson, K; Ulmer, KA; Wagner, SR; Zang, SL; Agostino, L; Alexander, J; Chatterjee, A; Eggert, N; Gibbons, LK; Heltsley, B; Khukhunaishvili, A; Kreis, B; Kuznetsov, V; Mirman, N; Kaufman, GN; Patterson, JR; Riley, D; Ryd, A; Salvati, E; Stroiney, S; Sun, W; Teo, WD; Thom, J; Thompson, J; Tucker, J; Vaughan, J; Weng, Y; Winstrom, L; Wittich, P; Winn, D; Abdullin, S; Albert, M; Albrow, M; Anderson, J; Apollinari, G; Atac, M; Badgett, W; Bailleux, D; Bakken, JA; Baldin, B; Banicz, K; Bauerdick, LAT; Beretvas, A; Berryhill, J; Bhat, PC; Binkley, M; Borcherding, F; Burkett, K; Butler, JN; Chetluru, V; Cheung, HWK; Chlebana, F; Cihangir, S; Dagenhart, W; Derylo, G; Dumitrescu, C; Dykstra, D; Eartly, DP; Elias, JE; Elvira, VD; Eulisse, G; Evans, D; Fagan, D; Fisk, I; Foulkes, S; Freeman, J; Gaines, I; Gao, Y; Gartung, P; Giacchetti, L; Gottschalk, E; Green, D; Guo, Y; Gutsche, O; Hahn, A; Hanlon, J; Harris, RM; Hirschauer, J; Holzman, B; Hooberman, B; Howell, J; Huang, CH; Hufnagel, D; Jindariani, S; Johnson, M; Jones, CD; Joshi, U; Juska, E; Klima, B; Kunori, S; Kwan, S; Larson, K; Leonidopoulos, C; Linacre, J; Lincoln, D; Lipton, R; Perez, JAL; Los, S; Lykken, J; Maeshima, K; Marraffino, JM; Maruyama, S; Mason, D; McBride, P; McCauley, T; Mishra, K; Moccia, S; Mommsen, RK; Mrenna, S; Murray, SJ; Musienko, Y; Muzaffar, S; Newman-Holmes, C; O'Dell, V; Osborne, I; Pivarski, J; Popescu, S; Pordes, R; Prokofyev, O; Rapsevicius, V; Ronzhin, A; Rossman, P; Ryu, S; Sexton-Kennedy, E; Sharma, S; Shaw, TM; Smith, RP; Soha, A; Spalding, WJ; Spiegel, L; Tanenbaum, W; Taylor, L; Thompson, R; Tiradani, A; Tkaczyk, S; Tran, NV; Tuura, L; Uplegger, L; Vaandering, EW; Vidal, R; Whitmore, J; Wu, W; Yang, F; Yarba, J; Yun, JC; Zimmerman, T; Acosta, D; Avery, P; Barashko, V; Bourilkov, D; Chen, M; Cheng, T; Das, S; De Gruttola, M; Di Givanni, GP; Dobur, D; Dolinsky, S; Drozdetskiy, A; Field, RD; Fisher, M; Fu, Y; Furic, IK; Gartner, J; Gorn, L; Holmes, D; Hugon, J; Kim, B; Konigsberg, J; Korytov, A; Kropivnitskaya, A; Kypreos, T; Low, JF; Madorsky, A; Matchev, K; Milenovic, P; Mitselmakher, G; Muniz, L; Park, M; Remington, R; Rinkevicius, A; Scurlock, B; Skhirtladze, N; Snowball, M; Stasko, J; Yelton, J; Zakaria, M; Gaultney, V; Hewamanage, S; Lebolo, LM; Linn, S; Markowitz, P; Martinez, G; Rodriguez, JL; Adams, T; Askew, A; Bertoldi, M; Bochenek, J; Chen, J; Dharmaratna, WGD; Diamond, B; Gleyzer, SV; Haas, J; Hagopian, S; Hagopian, V; Jenkins, M; Johnson, KF; Prosper, H; Tentindo, S; Veeraraghavan, V; Weinberg, M; Baarmand, MM; Dorney, B; Hohlmann, M; Kalakhety, H; Ralich, R; Vodopiyanov, I; Yumiceva, F; Adams, MR; Anghel, IM; Apanasevich, L; Bai, Y; Bazterra, VE; Betts, RR; Bucinskaite, I; Callner, J; Cavanaugh, R; Chung, MH; Evdokimov, O; Garcia-Solis, EJ; Gauthier, L; Gerber, CE; Hofman, DJ; Hollis, R; Iordanova, A; Khalatyan, S; Kunde, GJ; Lacroix, F; O'Brien, C; Silkworth, C; Silvestre, C; Smoron, A; Strom, D; Turner, P; Varelas, N; Akgun, U; Albayrak, EA; Ayan, AS; Bilki, B; Clarida, W; Debbins, P; Duru, F; Ingram, FD; McCliment, E; Merlo, JP; Mermerkaya, H; Mestvirishvili, A; Miller, MJ; Moeller, A; Nachtman, J; Newsom, CR; Norbeck, E; Olson, J; Onel, Y; Ozok, F; Schmidt, I; Sen, S; Tan, P; Tiras, E; Wetzel, J; Yetkin, T; Yi, K; Barnett, BA; Blumenfeld, B; Bolognesi, S; Fehling, D; Giurgiu, G; Gritsan, AV; Guo, ZJ; Hu, G; Maksimovic, P; Swartz, M; Whitbeck, A; Baringer, P; Bean, A; Benelli, G; Coppage, D; Grachov, O; Iii, RPK; Murray, M; Noonan, D; Radicci, V; Sanders, S; Stringer, R; Tinti, G; Wood, JS; Barfuss, AF; Bolton, T; Chakaberia, I; Ivanov, A; Khalil, S; Makouski, M; Maravin, Y; Shrestha, S; Svintradze, I; Gronberg, J; Lange, D; Rebassoo, F; Wright, D; Baden, A; Bard, R; Boutemeur, M; Calvert, B; Eno, SC; Gomez, JA; Grassi, T; Hadley, NJ; Kellogg, RG; Kirn, M; Kolberg, T; Lu, Y; Marionneau, M; Mignerey, AC; Pedro, K; Peterman, A; Rossato, K; Skuja, A; Temple, J; Tonjes, MB; Tonwar, SC; Toole, T; Twedt, E; Apyan, A; Bauer, G; Bendavid, J; Busza, W; Butz, E; Cali, IA; Chan, M; Dutta, V; Ceballos, GG; Goncharov, M; Kim, Y; Klute, M; Krajczar, K; Levin, A; Luckey, PD; Ma, T; Nahn, S; Paus, C; Ralph, D; Roland, C; Roland, G; Rudolph, M; Stephans, GSF; Stockli, F; Sumorok, K; Sung, K; Velicanu, D; Wenger, EA; Wolf, R; Wyslouch, B; Yang, M; Yilmaz, Y; Yoon, AS; Zanetti, M; Zhukova, V; Cooper, SI; Cushman, P; Dahmes, B; De Benedetti, A; Egeland, R; Franzoni, G; Gude, A; Haupt, J; Inyakin, A; Kao, SC; Klapoetke, K; Kubota, Y; Mans, J; Pastika, N; Rusack, R; Singovsky, A; Tambe, N; Turkewitz, J; Cremaldi, LM; Kroeger, R; Perera, L; Rahmat, R; Reidy, J; Sanders, DA; Summers, D; Attebury, G; Avdeeva, E; Bloom, K; Bockelman, B; Bose, S; Claes, DR; Dominguez, A; Eads, M; Keller, J; Kravchenko, I; Lazo-Flores, J; Lundstedt, C; Malik, S; Snihur, R; Snow, GR; Swanson, D; Baur, U; Godshalk, A; Iashvili, I; Jain, S; Kharchilava, A; Kumar, A; Rappoccio, S; Shipkowski, SP; Smith, K; Alverson, G; Barberis, E; Baumgartel, D; Chasco, M; Haley, J; Moromisato, J; Nash, D; Orimoto, T; Swain, J; Trocino, D; Von Goeler, E; Wood, D; Zhang, J; Anastassov, A; Gobbi, B; Hahn, KA; Kubik, A; Lusito, L; Odell, N; Ofierzynski, RA; Pollack, B; Pozdnyakov, A; Schmitt, M; Stoynev, S; Velasco, M; Won, S; Antonelli, L; Baumbaugh, B; Berry, D; Brinkerhoff, A; Chan, KM; Heering, AH; Hildreth, M; Jessop, C; Karmgard, DJ; Kellams, N; Kolb, J; Lannon, K; Luo, W; Lynch, S; Marinelli, N; Morse, DM; Pearson, T; Planer, M; Ruchti, R; Slaunwhite, J; Valls, N; Wayne, M; Wolf, M; Woodard, A; Bylsma, B; Durkin, LS; Hill, C; Hughes, R; Kotov, K; Ling, TY; Puigh, D; Rodenburg, M; Rush, CJ; Sehgal, V; Vuosalo, C; Williams, G; Winer, BL; Adam, N; Berry, E; Elmer, P; Gerbaudo, D; Halyo, V; Hebda, P; Hegeman, J; Hunt, A; Jindal, P; Koay, SA; Pegna, DL; Lujan, P; Marlow, D; Medvedeva, T; Mooney, M; Olsen, J; Piroue, P; Quan, X; Raval, A; Saka, H; Stickland, D; Tully, C; Werner, JS; Wildish, T; Xie, Z; Zenz, SC; Zuranski, A; Acosta, JG; Del Alamo, MB; Brownson, E; Huang, XT; Lopez, A; Mendez, H; Oliveros, S; Vargas, JER; Zatserklyaniy, A; Alagoz, E; Arndt, K; Barnes, VE; Benedetti, D; Bolla, G; Bortoletto, D; Bujak, A; De Mattia, M; Everett, A; Gutay, L; Hu, Z; Jones, M; Koybasi, O; Kress, M; Laasanen, AT; Lee, J; Leonardo, N; Liu, C; Maroussov, V; Merkel, P; Miller, DH; Miyamoto, J; Neumeister, N; Rott, C; Roy, A; Shipsey, I; Silvers, D; Svyatkovskiy, A; Marono, MV; Yoo, HD; Zablocki, J; Zheng, Y; Guragain, S; Parashar, N; Adair, A; Akgun, B; Boulahouache, C; Cuplov, V; Ecklund, KM; Geurts, FJM; Lee, SJ; Li, W; Liu, JH; Matveev, M; Padley, BP; Redjimi, R; Roberts, J; Tumanov, A; Yepes, P; Zabel, J; Betchart, B; Bodek, A; Budd, H; Chung, YS; Covarelli, R; de Barbaro, P; Demina, R; Eshaq, Y; Ferbel, T; Garcia-Bellido, A; Ginther, G; Goldenzweig, P; Gotra, Y; Han, J; Harel, A; Korjenevski, S; Miner, DC; Orbaker, D; Sakumoto, W; Slattery, P; Vishnevskiy, D; Zielinski, M; Bhatti, A; Ciesielski, R; Demortier, L; Goulianos, K; Lungu, G; Malik, S; Mesropian, C; Arora, S; Barker, A; Chou, JP; Contreras-Campana, C; Contreras-Campana, E; Duggan, D; Ferencek, D; Gershtein, Y; Gray, R; Halkiadakis, E; Hidas, D; Lath, A; Panwalkar, S; Park, M; Patel, R; Rekovic, V; Robles, J; Rose, K; Salur, S; Schnetzer, S; Seitz, C; Somalwar, S; Stone, R; Thomas, S; Cerizza, G; Hollingsworth, M; Ragghianti, G; Spanier, S; Yang, ZC; York, A; Bouhali, O; Eusebi, R; Flanagan, W; Gilmore, J; Kamon, T; Khotilovich, V; Montalvo, R; Nguyen, CN; Osipenkov, I; Pakhotin, Y; Perloff, A; Roe, J; Safonov, A; Sakuma, T; Sengupta, S; Suarez, I; Tatarinov, A; Toback, D; Akchurin, N; Damgov, J; Dragoiu, C; Dudero, PR; Jeong, C; Kovitanggoon, K; Lee, SW; Libeiro, T; Sill, A; Volobouev, I; Wigmans, R; Appelt, E; Delannoy, AG; Engh, D; Florez, C; Gabella, W; Greene, S; Gurrola, A; Johns, W; Kurt, P; Maguire, C; Melo, A; Sharma, M; Sheldon, P; Snook, B; Tuo, S; Velkovska, J; Andelin, D; Arenton, MW; Balazs, M; Boutle, S; Conetti, S; Cox, B; Francis, B; Goodell, J; Hirosky, R; Ledovskoy, A; Lin, C; Neu, C; Phillips, D; Wood, J; Gollapinni, S; Harr, R; Karchin, PE; Don, CKK; Lamichhane, P; Mattson, M; Milstene, C; Sakharov, A; Anderson, M; Belknap, D; Bellinger, JN; Borrello, L; Bradley, D; Carlsmith, D; Cepeda, M; Crotty, I; Dasu, S; Feyzi, F; Friis, E; Gorski, T; Gray, L; Grogg, KS; Grothe, M; Hall-Wilton, R; Herndon, M; Herve, A; Klabbers, P; Klukas, J; Lackey, J; Lanaro, A; Lazaridis, C; Loveless, R; Lusin, S; de Abril, MM; Maier, W; Mohapatra, A; Ojalvo, I; Palmonari, F; Pierro, GA; Reeder, D; Ross, I; Savin, A; Smith, WH; Swanson, J; Wenman, D				Chatrchyan, S.; Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.; Adam, W.; Aguilo, E.; Bergauer, T.; Dragicevic, M.; Eroe, J.; Fabjan, C.; Friedl, M.; Fruehwirth, R.; Ghete, V. M.; Hoch, M.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Kiesenhofer, W.; Knuenz, V.; Krammer, M.; Kraetschmer, I.; Liko, D.; Majerotto, W.; Mikulec, I.; Pernicka, M.; Rahbaran, B.; Rohringer, C.; Rohringer, H.; Schoefbeck, R.; Strauss, J.; Szoncso, F.; Taurok, A.; Waltenberger, W.; Walzel, G.; Widl, E.; Wulz, C. -E.; Chekhovsky, V.; Emeliantchik, I.; Litomin, A.; Makarenko, V.; Mossolov, V.; Shumeiko, N.; Solin, A.; Stefanovitch, R.; Gonzalez, J. Suarez; Fedorov, A.; Korzhik, M.; Missevitch, O.; Zuyeuski, R.; Bansal, M.; Bansal, S.; Beaumont, W.; Cornelis, T.; De Wolf, E. A.; Druzhkin, D.; Janssen, X.; Luyckx, S.; Mucibello, L.; Ochesanu, S.; Roland, B.; Rougny, R.; Selvaggi, M.; Staykova, Z.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.; Blekman, F.; Blyweert, S.; D'Hondt, J.; Devroede, O.; Suarez, R. Gonzalez; Goorens, R.; Kalogeropoulos, A.; Maes, M.; Olbrechts, A.; Tavernier, S.; Van Doninck, W.; Van Lancker, L.; Van Mulders, P.; Van Onsem, G. P.; Villella, I.; Clerbaux, B.; De Lentdecker, G.; Dero, V.; Dewulf, J. P.; Gay, A. P. R.; Hreus, T.; Leonard, A.; Marage, P. E.; Mohammadi, A.; Reis, T.; Rugovac, S.; Thomas, L.; Vander Velde, C.; Vanlaer, P.; Wang, J.; Wickens, J.; Adler, V.; Beernaert, K.; Cimmino, A.; Costantini, S.; Garcia, G.; Grunewald, M.; Klein, B.; Lellouch, J.; Marinov, A.; Mccartin, J.; Rios, A. A. Ocampo; Ryckbosch, D.; Strobbe, N.; Thyssen, F.; Tytgat, M.; Walsh, S.; Yazgan, E.; Zaganidis, N.; Basegmez, S.; Bruno, G.; Castello, R.; Ceard, L.; De Jeneret, J. De Favereau; Delaere, C.; Demin, P.; du Pree, T.; Favart, D.; Forthomme, L.; Giammanco, A.; Gregoire, G.; Hollar, J.; Lemaitre, V.; Liao, J.; Militaru, O.; Nuttens, C.; Pagano, D.; Pin, A.; Piotrzkowski, K.; Schul, N.; Garcia, J. M. Vizan; Beliy, N.; Caebergs, T.; Daubie, E.; Hammad, G. H.; Alves, G. A.; Brito, L.; Martins Junior, M. Correa; Martins, T.; Pol, M. E.; Souza, M. H. G.; Alda Junior, W. L.; Carvalho, W.; Custodio, A.; Da Costa, E. M.; Damiao, D. De Jesus; Martins, C. De Oliveira; De Souza, S. Fonseca; Malbouisson, H.; Malek, M.; Figueiredo, D. Matos; Mundim, L.; Nogima, H.; Oguri, V.; Da Silva, W. L. Prado; Santoro, A.; Sznajder, A.; Pereira, A. Vilela; Anjos, T. S.; Bernardes, C. A.; Dias, F. A.; Perez Tomei, T. R. Fernandez; Gregores, E. M.; Iope, R. L.; Lagana, C.; Lietti, S. M.; Marinho, F.; Mercadante, P. G.; Novaes, S. F.; Padula, Sandra S.; Dimitrov, L.; Genchev, V.; Iaydjiev, P.; Piperov, S.; Rodozov, M.; Stoykova, S.; Sultanov, G.; Tcholakov, V.; Trayanov, R.; Vankov, I.; Vutova, M.; Roumenin, C.; Uzunova, D.; Zahariev, R.; Dimitrov, A.; Hadjiiska, R.; Kozhuharov, V.; Litov, L.; Pavlov, B.; Petkov, P.; Bian, J. G.; Chen, G. M.; Chen, H. S.; He, K. L.; Jiang, C. H.; Li, W. G.; Liang, D.; Liang, S.; Meng, X.; Sun, G.; Sun, H. S.; Tao, J.; Wang, J.; Wang, X.; Wang, Z.; Xiao, H.; Xu, M.; Yang, M.; Zang, J.; Zhang, X.; Zhang, Z.; Zhang, Z.; Zhao, W. R.; Zhu, Z.; Asawatangtrakuldee, C.; Ban, Y.; Cai, J.; Guo, S.; Guo, Y.; Li, W.; Liu, H. T.; Liu, S.; Mao, Y.; Qian, S. J.; Teng, H.; Wang, D.; Ye, Y. L.; Zhang, L.; Zhu, B.; Zou, W.; Avila, C.; Gomez, J. P.; Moreno, B. Gomez; Oliveros, A. F. Osorio; Sanabria, J. C.; Godinovic, N.; Lelas, D.; Plestina, R.; Polic, D.; Puljak, I.; Antunovic, Z.; Kovac, M.; Brigljevic, V.; Duric, S.; Kadija, K.; Luetic, J.; Mekterovic, D.; Morovic, S.; Attikis, A.; Galanti, M.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.; Finger, M.; Finger, M., Jr.; Aly, A.; Assran, Y.; Awad, A.; Elgammal, S.; Kamel, A. Ellithi; Khalil, S.; Mahmoud, M. A.; Mahrous, A.; Radi, A.; Hektor, A.; Kadastik, M.; Kannike, K.; Muentel, M.; Raidal, M.; Rebane, L.; Strumia, A.; Tiko, A.; Eerola, P.; Fedi, G.; Voutilainen, M.; Anttila, E.; Harkonen, J.; Heikkinen, A.; Karimaki, V.; Katajisto, H. M.; Kinnunen, R.; Kortelainen, M. J.; Kotamaki, M.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Maenpaa, T.; Peltola, T.; Tuominen, E.; Tuominiemi, J.; Tuovinen, E.; Ungaro, D.; Vanhala, T. P.; Wendland, L.; Banzuzi, K.; Karjalainen, A.; Korpela, A.; Tuuva, T.; Anfreville, M.; Besancon, M.; Choudhury, S.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Ferri, F.; Ganjour, S.; Gentit, F. X.; Givernaud, A.; Gras, P.; de Monchenault, G. Hamel; Jarry, P.; Kircher, F.; Lemaire, M. C.; Locci, E.; Malcles, J.; Mandjavidze, I.; Nayak, A.; Pansart, J. P.; Rander, J.; Reymond, J. M.; Rosowsky, A.; Titov, M.; Verrecchia, P.; Badier, J.; Baffioni, S.; Beaudette, F.; Becheva, E.; Benhabib, L.; Bianchini, L.; Bluj, M.; Broutin, C.; Busson, P.; Cerutti, M.; Chamont, D.; Charlot, C.; Daci, N.; Dahms, T.; Dalchenko, M.; Dobrzynski, L.; Geerebaert, Y.; de Cassagnac, M. Granier; Haguenauer, M.; Hennion, P.; Milleret, G.; Mine, P.; Mironov, C.; Naranjo, I. N.; Nguyen, M.; Ochando, C.; Paganini, P.; Romanteau, T.; Sabes, D.; Salerno, R.; Sartirana, A.; Sirois, Y.; Thiebaux, C.; Veelken, C.; Zabi, A.; Agram, J. -L.; Andrea, J.; Besson, A.; Bloch, D.; Bodin, D.; Brom, J. -M.; Cardaci, M.; Chabert, E. C.; Collard, C.; Conte, E.; Drouhin, F.; Fontaine, J. -C.; Gele, D.; Goerlach, U.; Goetzmann, C.; Gross, L.; Huss, D.; Juillot, P.; Kieffer, E.; Le Bihan, A. -C.; Pansanel, J.; Patois, Y.; Van Hove, P.; Boutigny, D.; Mercier, D.; Baulieu, G.; Beauceron, S.; Beaupere, N.; Bedjidian, M.; Bondu, O.; Boudoul, G.; Brochet, S.; Chasserat, J.; Chierici, R.; Combaret, C.; Contardo, D.; Depasse, P.; El Mamouni, H.; Fay, J.; Gascon, S.; Giraud, N.; Gouzevitch, M.; Haroutunian, R.; Ille, B.; Kurca, T.; Lethuillier, M.; Lumb, N.; Mathez, H.; Mirabito, L.; Perries, S.; Sgandurra, L.; Sordini, V.; Tschudi, Y.; Vander Donckt, M.; Verdier, P.; Viret, S.; Roinishvili, V.; Rurua, L.; Amaglobeli, N.; Bagaturia, I.; Chiladze, B.; Kvatadze, R.; Lomidze, D.; Shanidze, R.; Tsamalaidze, Z.; Adolphi, R.; Autermann, C.; Beranek, S.; Brauer, R.; Braunschweig, W.; Calpas, B.; Edelhoff, M.; Feld, L.; Heracleous, N.; Hindrichs, O.; Jussen, R.; Karpinski, W.; Klein, K.; Luebelsmeyer, K.; Merz, J.; Ostapchuk, A.; Pandoulas, D.; Perieanu, A.; Raupach, F.; Sammet, J.; Schael, S.; Schmitz, D.; von Dratzig, A. Schultz; Siedling, R.; Sprenger, D.; Weber, H.; Wittmer, B.; Wlochal, M.; Zhukov, V.; Ata, M.; Biallass, P.; Caudron, J.; Dietz-Laursonn, E.; Duchardt, D.; Erdmann, M.; Fischer, R.; Gueth, A.; Hebbeker, T.; Heidemann, C.; Hilgers, G.; Hoepfner, K.; Hof, C.; Klimkovich, T.; Klingebiel, D.; Kreuzer, P.; Magass, C.; Merschmeyer, M.; Meyer, A.; Olschewski, M.; Papacz, P.; Philipps, B.; Pieta, H.; Reithler, H.; Schmitz, S. A.; Sonnenschein, L.; Sowa, M.; Steggemann, J.; Teyssier, D.; Weber, M.; Bontenackels, M.; Cherepanov, V.; Erdogan, Y.; Fluegge, G.; Geenen, H.; Geisler, M.; Ahmad, W. Haj; Hoehle, F.; Kargoll, B.; Kress, T.; Kuessel, Y.; Lingemann, J.; Nowack, A.; Perchalla, L.; Pooth, O.; Sauerland, P.; Stahl, A.; Zoeller, M. H.; Martin, M. Aldaya; Behr, J.; Behrenhoff, W.; Behrens, U.; Bergholz, M.; Bethani, A.; Borras, K.; Burgmeier, A.; Cakir, A.; Calligaris, L.; Campbell, A.; Castro, E.; Costanza, F.; Dammann, D.; Pardos, C. Diez; Eckerlin, G.; Eckstein, D.; Flossdorf, A.; Flucke, G.; Geiser, A.; Glushkov, I.; Goettlicher, P.; Grebenyuk, A.; Gunnellini, P.; Habib, S.; Hauk, J.; Hellwig, G.; Jung, H.; Kasemann, M.; Katsas, P.; Kleinwort, C.; Kluge, H.; Knutsson, A.; Kraemer, M.; Kruecker, D.; Kuznetsova, E.; Lange, W.; Leonard, J.; Lewendel, B.; Lohmann, W.; Lutz, B.; Mankel, R.; Marfin, I.; Marienfeld, M.; Melzer-Pellmann, I. -A.; Meyer, A. B.; Mnich, J.; Muhl, C.; Mussgiller, A.; Naumann-Emme, S.; Novgorodova, O.; Olzem, J.; Parenti, A.; Perrey, H.; Petrukhin, A.; Pitzl, D.; Raspereza, A.; Cipriano, P. M. Ribeiro; Riedl, C.; Ron, E.; Rosemann, C.; Rosin, M.; Salfeld-Nebgen, J.; Schmidt, R.; Schoerner-Sadenius, T.; Sen, N.; Spiridonov, A.; Stein, M.; Tomaszewska, J.; Volyanskyy, D.; Walsh, R.; Wissing, C.; Youngman, C.; Blobel, V.; Draeger, J.; Enderle, H.; Erfle, J.; Gebbert, U.; Goerner, M.; Hermanns, T.; Hoeing, R. S.; Kaschube, K.; Kaussen, G.; Kirschenmann, H.; Klanner, R.; Lange, J.; Mura, B.; Nowak, F.; Peiffer, T.; Pietsch, N.; Rathjens, D.; Sander, C.; Schettler, H.; Schleper, P.; Schlieckau, E.; Schmidt, A.; Schroeder, M.; Schum, T.; Seidel, M.; Sibille, J.; Sola, V.; Stadie, H.; Steinbrueck, G.; Thomsen, J.; Vanelderen, L.; Barth, C.; Bauer, J.; Berger, J.; Bluem, P.; Boeser, C.; Buege, V.; Chen, Z. Y.; Chowdhury, S.; Chwalek, T.; Daeuwel, D.; De Boer, W.; Descroix, A.; Dierlamm, A.; Dirkes, G.; Fahrer, M.; Feindt, M.; Felzmann, U.; Frey, M.; Furgeri, A.; Gebauer, I.; Gessler, A.; Gruschke, J.; Guthoff, M.; Hackstein, C.; Hartmann, F.; Hauler, F.; Hauth, T.; Heier, S.; Heindl, S. M.; Heinrich, M.; Heiss, A.; Held, H.; Hoffmann, K. H.; Honc, S.; Husemann, U.; Imhof, M.; Jung, C.; Junghans, S.; Katkov, I.; Kerzel, U.; Knoblauch, D.; Komaragiri, J. R.; Kraeber, M.; Kuhr, T.; Liamsuwan, T.; Pardo, P. Lobelle; Martschei, D.; Menchikov, A.; Mol, X.; Moermann, D.; Mueller, S.; Mueller, Th.; Neuberger, D.; Neuland, M. B.; Niegel, M.; Nuernberg, A.; Oberst, O.; Oehler, A.; Gomez, T. Ortega; Ott, J.; Piasecki, C.; Poschlad, A.; Quast, G.; Rabbertz, K.; Ratnikov, F.; Ratnikova, N.; Renz, M.; Roecker, S.; Roederer, F.; Sabellek, A.; Saout, C.; Scheurer, A.; Schieferdecker, D.; Schieferdecker, P.; Schilling, F. -P.; Schmanau, M.; Schott, G.; Schwerdtfeger, W.; Simonis, H. J.; Skiba, A.; Stober, F. M.; Theel, A.; Thuemmel, W. H.; Troendle, D.; Trunov, A.; Ulrich, R.; Wagner-Kuhr, J.; Wayand, S.; Weber, M.; Weiler, T.; Zeise, M.; Ziebarth, E. B.; Zvada, M.; Anagnostou, G.; Daskalakis, G.; Geralis, T.; Kesisoglou, S.; Kyriakis, A.; Loukas, D.; Manolakos, I.; Markou, A.; Markou, C.; Mavrommatis, C.; Ntomari, E.; Gouskos, L.; Panagiotou, A.; Saoulidou, N.; Evangelou, I.; Foudas, C.; Kokkas, P.; Manthos, N.; Papadopoulos, I.; Patras, V.; Triantis, F. A.; Bencze, G.; Hajdu, C.; Hidas, P.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zalan, P.; Beni, N.; Czellar, S.; Fenyvesi, A.; Molnar, J.; Palinkas, J.; Szillasi, Z.; Karancsi, J.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.; Zilizi, G.; Beri, S. B.; Bhandari, V.; Bhatnagar, V.; Dhingra, N.; Gupta, R.; Kaur, M.; Kohli, J. M.; Mehta, M. Z.; Nishu, N.; Saini, L. K.; Sharma, A.; Singh, J. B.; Kumar, Ashok; Kumar, Arun; Ahuja, S.; Bhardwaj, A.; Chatterji, S.; Choudhary, B. C.; Gupta, P.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, V.; Shivpuri, R. K.; Banerjee, S.; Bhattacharya, S.; Dutta, S.; Gomber, B.; Jain, Sa.; Jain, Sh.; Khurana, R.; Sarkar, S.; Sharan, M.; Abdulsalam, A.; Choudhury, R. K.; Dutta, D.; Ghodgaonkar, M.; Kailas, S.; Kataria, S. K.; Kumar, V.; Mehta, P.; Mohanty, A. K.; Pant, L. M.; Shukla, P.; Topkar, A.; Aziz, T.; Chendvankar, S.; Deshpande, P. V.; Ganguli, S. N.; Ganguly, S.; Guchait, M.; Gurtu, A.; Maity, M.; Mazumdar, K.; Mohanty, G. B.; Parida, B.; Patil, M. R.; Raghavan, R.; Sudhakar, K.; Wickramage, N.; Acharya, B. S.; Banerjee, S.; Bheesette, S.; Dugad, S.; Kalmani, S. D.; Krishnaswamy, M. R.; Lakkireddi, V. R.; Mondal, N. K.; Narasimham, V. S.; Panyam, N.; Verma, P.; Ardalan, F.; Arfaei, H.; Bakhshiansohi, H.; Etesami, S. M.; Fahim, A.; Hashemi, M.; Jafari, A.; Khakzad, M.; Najafabadi, M. Mohammadi; Mehdiabadi, S. Paktinat; Safarzadeh, B.; Zeinali, M.; Abbrescia, M.; Barbone, L.; Calabria, C.; Chhibra, S. S.; Colaleo, A.; Creanza, D.; De Filippis, N.; De Palma, M.; De Robertis, G.; Donvito, G.; Fiore, L.; Iaselli, G.; Loddo, F.; Maggi, G.; Maggi, M.; Manna, N.; Marangelli, B.; My, S.; Natali, S.; Nuzzo, S.; Pacifico, N.; Pompili, A.; Pugliese, G.; Ranieri, A.; Romano, F.; Selvaggi, G.; Silvestris, L.; Singh, G.; Spinoso, V.; Venditti, R.; Verwilligen, P.; Zito, G.; Abbiendi, G.; Benvenuti, A. C.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Meneghelli, M.; Montanari, A.; Navarria, F. L.; Odorici, F.; Perrotta, A.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Travaglini, R.; Albergo, S.; Cappello, G.; Chiorboli, M.; Costa, S.; Noto, F.; Potenza, R.; Saizu, M. A.; Tricomi, A.; Tuve, C.; Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Frosali, S.; Gallo, E.; Genta, C.; Gonzi, S.; Meschini, M.; Paoletti, S.; Parrini, G.; Ranieri, R.; Sguazzoni, G.; Tropiano, A.; Benussi, L.; Bianco, S.; Colafranceschi, S.; Fabbri, F.; Piccolo, D.; Fabbricatore, P.; Farinon, S.; Greco, M.; Musenich, R.; Tosi, S.; Benaglia, A.; Carbone, L.; D'Angelo, P.; De Guio, F.; Di Matteo, L.; Dini, P.; Farina, F. M.; Fiorendi, S.; Gennai, S.; Ghezzi, A.; Malvezzi, S.; Manzoni, R. A.; Martelli, A.; Massironi, A.; Menasce, D.; Moroni, L.; Negri, P.; Paganoni, M.; Pedrini, D.; Pullia, A.; Ragazzi, S.; Redaelli, N.; Sala, S.; de Fatis, T. Tabarelli; Buontempo, S.; Montoya, C. A. Carrillo; Cavallo, N.; De Cosa, A.; Dogangun, O.; Fabozzi, F.; Iorio, A. O. M.; Lista, L.; Meola, S.; Merola, M.; Paolucci, P.; Azzi, P.; Bacchetta, N.; Bellato, M.; Benettoni, M.; Biasotto, M.; Bisello, D.; Branca, A.; Carlin, R.; Checchia, P.; Dorigo, T.; Dosselli, U.; Fanzago, F.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Gonella, F.; Gozzelino, A.; Gulmini, M.; Kanishchev, K.; Lacaprara, S.; Lazzizzera, I.; Loreti, M.; Margoni, M.; Maron, G.; Mazzucato, M.; Meneguzzo, A. T.; Montecassiano, F.; Passaseo, M.; Pazzini, J.; Pegoraro, M.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Tosi, M.; Vanini, S.; Ventura, S.; Zotto, P.; Zumerle, G.; Berzano, U.; Gabusi, M.; Ratti, S. P.; Riccardi, C.; Torre, P.; Vitulo, P.; Biasini, M.; Bilei, G. M.; Fano, L.; Lariccia, P.; Lucaroni, A.; Mantovani, G.; Menichelli, M.; Nappi, A.; Passeri, D.; Placidi, P.; Romeo, F.; Saha, A.; Santocchia, A.; Servoli, L.; Spiezia, A.; Taroni, S.; Valdata, M.; Angelini, F.; Arezzini, S.; Azzurri, P.; Bagliesi, G.; Basti, A.; Bellazzini, R.; Bernardini, J.; Boccali, T.; Bosi, F.; Brez, A.; Broccolo, G.; Calzolari, F.; Carboni, A.; Castaldi, R.; Cerri, C.; Ciampa, A.; D'Agnolo, R. T.; Dell'Orso, R.; Fiori, F.; Foa, L.; Giassi, A.; Giusti, S.; Kraan, A.; Latronico, L.; Ligabue, F.; Linari, S.; Lomtadze, T.; Martini, L.; Massa, M.; Massai, M. M.; Mazzoni, E.; Messineo, A.; Moggi, A.; Palla, F.; Raffaelli, F.; Rizzi, A.; Sanguinetti, G.; Segneri, G.; Serban, A. T.; Spagnolo, P.; Spandre, G.; Squillacioti, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.; Baccaro, S.; Barone, L.; Bartoloni, A.; Cavallari, F.; Dafinei, I.; Del Re, D.; Diemoz, M.; Fanelli, C.; Grassi, M.; Longo, E.; Meridiani, P.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Paramatti, R.; Rahatlou, S.; Sigamani, M.; Soffi, L.; Talamo, I. G.; Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Biino, C.; Cartiglia, N.; Costa, M.; Demaria, N.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Musich, M.; Obertino, M. M.; Pastrone, N.; Pelliccioni, M.; Peroni, C.; Potenza, A.; Romero, A.; Ruspa, M.; Sacchi, R.; Solano, A.; Staiano, A.; Ambroglini, F.; Belforte, S.; Candelise, V.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Gobbo, B.; Kavka, C.; Marone, M.; Montanino, D.; Penzo, A.; Schizzi, A.; Kim, T. Y.; Nam, S. K.; Chang, S.; Chung, J.; Ham, S. W.; Han, D.; Kang, J.; Kim, D. H.; Kim, G. N.; Kim, J. E.; Kim, K. S.; Kong, D. J.; Lee, M. W.; Oh, Y. D.; Park, H.; Ro, S. R.; Son, D.; Son, D. C.; Suh, J. S.; Kim, J. Y.; Kim, Zero J.; Song, S.; Choi, S.; Gyun, D.; Hong, B.; Jo, M.; Jo, Y.; Kang, M.; Kim, H.; Kim, T. J.; Lee, K. S.; Moon, D. H.; Park, S. K.; Roh, Y.; Sim, K. S.; Choi, M.; Hahn, G.; Kang, S.; Kim, H.; Kim, J. H.; Park, C.; Park, I. C.; Park, S.; Ryu, G.; Choi, Y.; Choi, Y. K.; Goh, J.; Kim, M. S.; Kwon, E.; Lee, B.; Lee, J.; Lee, S.; Seo, H.; Yu, I.; Janulis, M.; Juodagalvis, A.; Naujikas, R.; Castilla-Valdez, H.; De La Cruz-Burelo, E.; Heredia-de La Cruz, I.; Lopez-Fernandez, R.; Martinez-Ortega, J.; Sanchez-Hernandez, A.; Villasenor-Cendejas, L. M.; Carrillo Moreno, S.; Vazquez Valencia, F.; Salazar Ibarguen, H. A.; Casimiro Linares, E.; Morelos Pineda, A.; Reyes-Santos, M. A.; Allfrey, P.; Krofcheck, D.; Bell, A. J.; Rodrigues, N. Bernardino; Butler, A. P. H.; Butler, P. H.; Doesburg, R.; Pfeiffer, D.; Reucroft, S.; Silverwood, H.; Williams, J. C.; Ahmad, M.; Ansari, M. H.; Asghar, M. I.; Butt, J.; Hoorani, H. R.; Khalid, S.; Khan, W. A.; Khurshid, T.; Qazi, S.; Shah, M. A.; Shoaib, M.; Bialkowska, H.; Boimska, B.; Frueboes, T.; Gokieli, R.; Goscilo, L.; Gorski, M.; Kazana, M.; Kudla, I. M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Wrochna, G.; Zalewski, P.; Brona, G.; Bunkowski, K.; Cwiok, M.; Czyrkowski, H.; Dabrowski, R.; Dominik, W.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Oklinski, W.; Pozniak, K.; Zabolotny, W.; Zych, P.; Kasprowicz, G.; Romaniuk, R.; Alemany-Fernandez, R.; Almeida, N.; Bargassa, P.; David, A.; Faccioli, P.; Ferreira Parracho, P. G.; Gallinaro, M.; Ribeiro, P. Q.; Seixas, J.; Silva, J.; Varela, J.; Vischia, P.; Afanasiev, S.; Belotelov, I.; Bunin, P.; Ershov, Y.; Gavrilenko, M.; Golunov, A.; Golutvin, I.; Gorbounov, N.; Gorbunov, I.; Gramenitski, I.; Kalagin, V.; Kamenev, A.; Karjavin, V.; Konoplyanikov, V.; Korenkov, V.; Kozlov, G.; Kurenkov, A.; Lanev, A.; Makankin, A.; Malakhov, A.; Melnitchenko, I.; Mitsyn, V. V.; Moisenz, P.; Oleynik, D.; Orlov, A.; Palichik, V.; Perelygin, V.; Petrosyan, A.; Savina, M.; Semenov, R.; Shmatov, S.; Shulha, S.; Skachkova, A.; Skatchkov, N.; Smetannikov, V.; Smirnov, V.; Smolin, D.; Tikhonenko, E.; Vasil'ev, S.; Volodko, A.; Zarubin, A.; Zhiltsov, V.; Evstyukhin, S.; Golovtsov, V.; Ivanov, Y.; Kim, V.; Levchenko, P.; Murzin, V.; Oreshkin, V.; Smirnov, I.; Sulimov, V.; Uvarov, L.; Vavilov, S.; Vorobyev, A.; Vorobyev, An.; Andreev, Yu.; Anisimov, A.; Dermenev, A.; Gninenko, S.; Golubev, N.; Gorbunov, D.; Karneyeu, A.; Kirsanov, M.; Krasnikov, N.; Matveev, V.; Pashenkov, A.; Pivovarov, G.; Postoev, V. E.; Rubakov, V.; Shirinyants, V.; Solovey, A.; Tlisov, D.; Toropin, A.; Troitsky, S.; Epshteyn, V.; Erofeeva, M.; Gavrilov, V.; Kaftanov, V.; Kiselevich, I.; Kolosov, V.; Konoplyannikov, A.; Kossov, M.; Kozlov, Y.; Krokhotin, A.; Litvintsev, D.; Lychkovskaya, N.; Oulianov, A.; Popov, V.; Safronov, G.; Semenov, S.; Shreyber, I.; Stepanov, N.; Stolin, V.; Vlasov, E.; Zaytsev, V.; Zhokin, A.; Belyaev, A.; Boos, E.; Bunichev, V.; Demiyanov, A.; Dubinin, M.; Dudko, L.; Ershov, A.; Gribushin, A.; Ilyin, V.; Kaminskiy, A.; Klyukhin, V.; Kodolova, O.; Korotkikh, V.; Kryukov, A.; Lokhtin, I.; Markina, A.; Obraztsov, S.; Perfilov, M.; Petrushanko, S.; Popov, A.; Proskuryakov, A.; Sarycheva, L.; Savrin, V.; Snigirev, A.; Vardanyan, I.; Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Mesyats, G.; Rusakov, S. V.; Vinogradov, A.; Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Grishin, V.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Korablev, A.; Krychkine, V.; Levine, A.; Petrov, V.; Ryabov, A.; Ryutin, R.; Sobol, A.; Talov, V.; Tourtchanovitch, L.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.; Adzic, P.; Djordjevic, M.; Ekmedzic, M.; Krpic, D.; Milosevic, J.; Smiljkovic, N.; Zupan, M.; Aguilar-Benitez, M.; Alcaraz Maestre, J.; Arce, P.; Battilana, C.; Calvo, E.; Cerrada, M.; Chamizo Llatas, M.; Colino, N.; De La Cruz, B.; Delgado Peris, A.; Dominguez Vazquez, D.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Ferrando, A.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Lopez, O. Gonzalez; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Merino, G.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Santaolalla, J.; Soares, M. S.; Willmott, C.; Albajar, C.; Codispoti, G.; de Troconiz, J. F.; Brun, H.; Cuevas, J.; Fernandez Menendez, J.; Folgueras, S.; Gonzalez Caballero, I.; Lloret Iglesias, L.; Piedra Gomez, J.; Brochero Cifuentes, J. A.; Cabrillo, I. J.; Calderon, A.; Chuang, S. H.; Duarte Campderros, J.; Felcini, M.; Fernandez, M.; Gomez, G.; Gonzalez Sanchez, J.; Graziano, A.; Jorda, C.; Lopez Virto, A.; Marco, J.; Marco, R.; Martinez Rivero, C.; Matorras, F.; Munoz Sanchez, F. J.; Rodrigo, T.; Rodriguez-Marrero, A. Y.; Ruiz-Jimeno, A.; Scodellaro, L.; Sobron Sanudo, M.; Vila, I.; Vilar Cortabitarte, R.; Abbaneo, D.; Aspell, P.; Auffray, E.; Auzinger, G.; Bachtis, M.; Baechler, J.; Baillon, P.; Ball, A. H.; Barney, D.; Benitez, J. F.; Bernet, C.; Bialas, W.; Bianchi, G.; Bloch, P.; Bocci, A.; Bonato, A.; Botta, C.; Breuker, H.; Campi, D.; Camporesi, T.; Cano, E.; Cerminara, G.; Charkiewicz, A.; Christiansen, T.; Perez, J. A. Coarasa; Cure, B.; D'Enterria, D.; Dabrowski, A.; Daguin, J.; De Roeck, A.; Di Guida, S.; Dobson, M.; Dupont-Sagorin, N.; Elliott-Peisert, A.; Eppard, M.; Frisch, B.; Funk, W.; Gaddi, A.; Gastal, M.; Georgiou, G.; Gerwig, H.; Giffels, M.; Gigi, D.; Gill, K.; Giordano, D.; Girone, M.; Giunta, M.; Glege, F.; Garrido, R. Gomez-Reino; Goudard, R.; Govoni, P.; Gowdy, S.; Guida, R.; Gutleber, J.; Hammarstrom, R.; Hammer, J.; Hansen, M.; Harris, P.; Hartl, C.; Harvey, J.; Hegner, B.; Hinzmann, A.; Honma, A.; Innocente, V.; Janot, P.; Kaadze, K.; Karavakis, E.; Kloukinas, K.; Kousouris, K.; Lecoq, P.; Lee, Y. -J.; Lenzi, P.; Loos, R.; Lourenco, C.; Macpherson, A.; Magini, N.; Maeki, T.; Malberti, M.; Malgeri, L.; Mannelli, M.; Marchioro, A.; Noite, J. Marques Pinho; Masetti, L.; Meijers, F.; Mersi, S.; Meschi, E.; Moneta, L.; Mozer, M. U.; Mulders, M.; Musella, P.; Onnela, A.; Orsini, L.; Osborne, J. A.; Cortezon, E. Palencia; Perez, E.; Perrozzi, L.; Petagna, P.; Petrilli, A.; Petrucci, A.; Pfeiffer, A.; Pierini, M.; Pimiae, M.; Piparo, D.; Polese, G.; Postema, H.; Quertenmont, L.; Racz, A.; Reece, W.; Ricci, D.; Antunes, J. Rodrigues; Rolandi, G.; Rovelli, C.; Rovere, M.; Ryjov, V.; Sakulin, H.; Samyn, D.; Santanastasio, F.; Schaefer, C.; Schwick, C.; Sciaba, A.; Segoni, I.; Sekmen, S.; Sharma, A.; Siegrist, P.; Silva, P.; Simon, M.; Sphicas, P.; Spiga, D.; Taylor, B. G.; Teller, O.; Tropea, P.; Tropea, J.; Tsesmelis, E.; Tsirou, A.; Vasey, F.; Veillet, L.; Veres, G. I.; Vichoudis, P.; Vlimant, J. R.; Wertelaers, P.; Woehri, H. K.; Worm, S. D.; Zeuner, W. D.; Bertl, W.; Deiters, K.; Erdmann, W.; Feichtinger, D.; Gabathuler, K.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Koenig, S.; Kotlinski, D.; Langenegger, U.; Meier, B.; Meier, F.; Renker, D.; Rohe, T.; Sakhelashvili, T.; Baeni, L.; Behner, F.; Betev, B.; Blau, B.; Bortignon, P.; Buchmann, M. A.; Casal, B.; Chanon, N.; Chen, Z.; Di Calafiori, D. R. Da Silva; Dambach, S.; Davatz, G.; Deisher, A.; Deisher, G.; Dittmar, M.; Djambazov, L.; Donega, M.; Duenser, M.; Eggel, C.; Eugster, J.; Faber, G.; Freudenreich, K.; Grab, C.; Hintz, W.; Hits, D.; Hofer, H.; Holme, O.; Horvath, I.; Lecomte, P.; Lustermann, W.; Marchica, C.; Marini, A. C.; del Arbol, P. Martinez Ruiz; Mohr, N.; Moortgat, F.; Naegeli, C.; Nef, P.; Nessi-Tedaldi, F.; Pandolfi, F.; Pape, L.; Pauss, F.; Peruzzi, M.; Punz, T.; Ronga, F. J.; Roeser, U.; Rossini, M.; Sala, L.; Sanchez, A. K.; Sawley, M. -C.; Schinzel, D.; Starodumov, A.; Stieger, B.; Suter, H.; Takahashi, M.; Tauscher, L.; Thea, A.; Theofilatos, K.; Treille, D.; Trueb, P.; Udriot, S.; Urscheler, C.; Urscheler, G.; von Gunten, H. P.; Wallny, R.; Weber, H. A.; Wehrli, L.; Weng, J.; Zelepoukine, S.; Amsler, C.; Chiochia, V.; De Visscher, S.; Favaro, C.; Rikova, M. Ivova; Kilminster, B.; Mejias, B. Millan; Otiougova, P.; Robmann, P.; Snoek, H.; Tupputi, S.; Verzetti, M.; Chang, Y. H.; Chen, K. H.; Chen, W. T.; Ferro, C.; Go, A.; Kuo, C. M.; Li, S. W.; Lin, W.; Liu, M. H.; Liu, Z. K.; Lu, Y. J.; Singh, A. P.; Volpe, R.; Wu, J. H.; Yu, S. S.; Bartalini, P.; Chang, P.; Chang, Y. H.; Chang, Y. W.; Chao, Y.; Chen, K. F.; Dietz, C.; Gao, Z.; Grundler, U.; Hou, W. -S.; Hsiung, Y.; Kao, K. Y.; Lei, Y. J.; Liau, J. J.; Lin, S. W.; Lu, R. -S.; Majumder, D.; Petrakou, E.; Shi, X.; Shiu, J. G.; Tzeng, Y. M.; Ueno, K.; Velikzhanin, Y.; Wan, X.; Wang, C. C.; Wang, M.; Wei, J. T.; Yeh, P.; Asavapibhop, B.; Srimanobhas, N.; Adiguzel, A.; Bakirci, M. N.; Cerci, S.; Dozen, C.; Dumanoglu, I.; Eskut, E.; Girgis, S.; Gokbulut, G.; Gurpinar, E.; Hos, I.; Kangal, E. E.; Karaman, T.; Karapinar, G.; Topaksu, A. Kayis; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Sogut, K.; Cerci, D. Sunar; Tali, B.; Topakli, H.; Vergili, L. N.; Vergili, M.; Akin, I. V.; Aliev, T.; Bilin, B.; Deniz, M.; Gamsizkan, H.; Guler, A. M.; Ocalan, K.; Ozpineci, A.; Serin, M.; Sever, R.; Surat, U. E.; Zeyrek, M.; Deliomeroglu, M.; Gulmez, E.; Isildak, B.; Kaya, M.; Kaya, O.; Ozkorucuklu, S.; Sonmez, N.; Cankocak, K.; Grynyov, B.; Levchuk, L.; Lukyanenko, S.; Soroka, D.; Sorokin, P.; Ahmad, M. K. H.; Branson, A.; McClatchey, R.; Odeh, M.; Shamdasani, J.; Soomro, K.; Barrass, T.; Bostock, F.; Brooke, J. J.; Clement, E.; Cussans, D.; Flacher, H.; Frazier, R.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Kreczko, L.; Lacesso, W.; Metson, S.; Newbold, D. M.; Nirunpong, K.; Poll, A.; Senkin, S.; Smith, V. J.; Williams, T.; Basso, L.; Bateman, E.; Bell, K. W.; Belyaev, A.; Brew, C.; Brown, R. M.; Camanzi, B.; Cockerill, D. J. A.; Connolly, J. F.; Coughlan, J. A.; Denton, L. G.; Flower, P. S.; French, M. J.; Greenhalgh, R. J. S.; Halsall, R. N. J.; Harder, K.; Harper, S.; Hill, J. A.; Jackson, J.; Kennedy, B. W.; Lintern, A. L.; Lodge, A. B.; Olaiya, E.; Pearson, M. R.; Petyt, D.; Radburn-Smith, B. C.; Shepherd-Themistocleous, C. H.; Smith, B. J.; Sproston, M.; Stephenson, R.; Tomalin, I. R.; Torbet, M. J.; Williams, J. H.; Womersley, W. J.; Bainbridge, R.; Ball, G.; Ballin, J.; Bauer, D.; Beuselinck, R.; Buchmuller, O.; Colling, D.; Cripps, N.; Cutajar, M.; Dauncey, P.; Davies, G.; Della Negra, M.; Ferguson, W.; Fulcher, J.; Futyan, D.; Gilbert, A.; Bryer, A. Guneratne; Hall, G.; Hatherell, Z.; Hays, J.; Iles, G.; Jarvis, M.; Jones, J.; Karapostoli, G.; Kenzie, M.; Leaver, J.; Lyons, L.; Magnan, A. -M.; Marrouche, J.; Mathias, B.; Miller, D. G.; Nandi, R.; Nash, J.; Nikitenko, A.; Noy, M.; Papageorgiou, A.; Pela, J.; Pesaresi, M.; Petridis, K.; Pioppi, M.; Rand, D.; Raymond, D. M.; Rogerson, S.; Rose, A.; Ryan, M. J.; Seez, C.; Sharp, P.; Sparrow, A.; Stoye, M.; Tapper, A.; Timlin, C.; Tourneur, S.; Acosta, M. Vazquez; Virdee, T.; Wakefield, S.; Wardle, N.; Whyntie, T.; Wingham, M.; Zorba, O.; Chadwick, M.; Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Leggat, D.; Leslie, D.; Martin, W.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.; Dittmann, J.; Hatakeyama, K.; Liu, H.; Scarborough, T.; Charaf, O.; Henderson, C.; Rumerio, P.; Avetisyan, A.; Bose, T.; Jarrin, E. Carrera; Fantasia, C.; Hazen, E.; Heister, A.; St. John, J.; Lawson, P.; Lazic, D.; Rohlf, J.; Sperka, D.; Sulak, L.; Rodriguez, F. Varela; Wu, S.; Alimena, J.; Bhattacharya, S.; Cutts, D.; Demiragli, Z.; Ferapontov, A.; Garabedian, A.; Heintz, U.; Hooper, R.; Jabeen, S.; Kukartsev, G.; Laird, E.; Landsberg, G.; Luk, M.; Narain, M.; Nguyen, D.; Segala, M.; Sinthuprasith, T.; Speer, T.; Tsang, K. V.; Unalan, Z.; Breedon, R.; Breto, G.; Sanchez, M. Calderon De La Barca; Case, M.; Chauhan, S.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Dolen, J.; Erbacher, R.; Gardner, M.; Grim, G.; Gunion, J.; Holbrook, B.; Ko, W.; Kopecky, A.; Lander, R.; Lin, F. C.; Miceli, T.; Murray, P.; Nikolic, M.; Pellett, D.; Ricci-Tam, F.; Rowe, J.; Rutherford, B.; Searle, M.; Smith, J.; Squires, M.; Tripathi, M.; Sierra, R. Vasquez; Yohay, R.; Andreev, V.; Arisaka, K.; Cline, D.; Cousins, R.; Duris, J.; Erhan, S.; Everaerts, P.; Farrell, C.; Hauser, J.; Ignatenko, M.; Jarvis, C.; Kubic, J.; Otwinowski, S.; Plager, C.; Rakness, G.; Schlein, P.; Traczyk, P.; Valuev, V.; Weber, M.; Yang, X.; Zheng, Y.; Babb, J.; Clare, R.; Dinardo, M. E.; Ellison, J.; Gary, J. W.; Giordano, F.; Hanson, G.; Jeng, G. Y.; Layter, J. G.; Liu, H.; Long, O. R.; Luthra, A.; Nguyen, H.; Paramesvaran, S.; Shen, B. C.; Sturdy, J.; Sumowidagdo, S.; Wilken, R.; Wimpenny, S.; Andrews, W.; Branson, J. G.; Cerati, G. B.; Cinquilli, M.; Cittolin, S.; Evans, D.; Holzner, A.; Kelley, R.; Lebourgeois, M.; Letts, J.; Macneill, I.; Mangano, B.; Martin, T.; Mrak-Tadel, A.; Padhi, S.; Palmer, C.; Petrucciani, G.; Pieri, M.; Sani, M.; Sfiligoi, I.; Sharma, V.; Simon, S.; Sudano, E.; Tadel, M.; Tu, Y.; Vartak, A.; Wasserbaech, S.; Wuerthwein, F.; Yagil, A.; Yoo, J.; Barge, D.; Bellan, R.; Campagnari, C.; D'Alfonso, M.; Danielson, T.; Flowers, K.; Geffert, P.; Golf, F.; Incandela, J.; Justus, C.; Kalavase, P.; Kovalskyi, D.; Krutelyov, V.; Kyre, S.; Lowette, S.; Magazzu, G.; Villalba, R. Magana; Mccoll, N.; Pavlunin, V.; Ribnik, J.; Richman, J.; Rossin, R.; Stuart, D.; To, W.; West, C.; White, D.; Adamczyk, D.; Apresyan, A.; Barczyk, A.; Bornheim, A.; Bunn, J.; Chen, Y.; Denis, G.; Di Marco, E.; Duarte, J.; Galvez, P.; Gataullin, M.; Kcira, D.; Lebeau, M.; Lebeau, I.; Litvine, V.; Ma, Y.; Maxa, Z.; Mott, A.; Mughal, A.; Nae, D.; Newman, H. B.; Ravot, S.; Rogan, C.; Rozsa, S. G.; Shevchenko, S.; Shin, K.; Spiropulu, M.; Steenberg, C.; Thomas, M.; Timciuc, V.; van Lingen, F.; Veverka, J.; Voicu, B. R.; Wilkinson, R.; Xie, S.; Yang, Y.; Zhang, L.; Zhu, K.; Zhu, R. Y.; Azzolini, V.; Calamba, A.; Carroll, R.; Ferguson, T.; Iiyama, Y.; Jang, D. W.; Jun, S. Y.; Liu, Y. F.; Paulini, M.; Russ, J.; Terentyev, N.; Vogel, H.; Vorobiev, I.; Cumalat, J. P.; Drell, B. R.; Ford, W. T.; Gaz, A.; Heyburn, B.; Johnson, D.; Lopez, E. L.; Nauenberg, U.; Smith, J. G.; Stenson, K.; Ulmer, K. A.; Wagner, S. R.; Zang, S. L.; Agostino, L.; Alexander, J.; Chatterjee, A.; Eggert, N.; Gibbons, L. K.; Heltsley, B.; Khukhunaishvili, A.; Kreis, B.; Kuznetsov, V.; Mirman, N.; Kaufman, G. Nicolas; Patterson, J. R.; Riley, D.; Ryd, A.; Salvati, E.; Stroiney, S.; Sun, W.; Teo, W. D.; Thom, J.; Thompson, J.; Tucker, J.; Vaughan, J.; Weng, Y.; Winstrom, L.; Wittich, P.; Winn, D.; Abdullin, S.; Albert, M.; Albrow, M.; Anderson, J.; Apollinari, G.; Atac, M.; Badgett, W.; Bailleux, D.; Bakken, J. A.; Baldin, B.; Banicz, K.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Binkley, M.; Borcherding, F.; Burkett, K.; Butler, J. N.; Chetluru, V.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Dagenhart, W.; Derylo, G.; Dumitrescu, C.; Dykstra, D.; Eartly, D. P.; Elias, J. E.; Elvira, V. D.; Eulisse, G.; Evans, D.; Fagan, D.; Fisk, I.; Foulkes, S.; Freeman, J.; Gaines, I.; Gao, Y.; Gartung, P.; Giacchetti, L.; Gottschalk, E.; Green, D.; Guo, Y.; Gutsche, O.; Hahn, A.; Hanlon, J.; Harris, R. M.; Hirschauer, J.; Holzman, B.; Hooberman, B.; Howell, J.; Huang, C. H.; Hufnagel, D.; Jindariani, S.; Johnson, M.; Jones, C. D.; Joshi, U.; Juska, E.; Klima, B.; Kunori, S.; Kwan, S.; Larson, K.; Leonidopoulos, C.; Linacre, J.; Lincoln, D.; Lipton, R.; Perez, J. A. Lopez; Los, S.; Lykken, J.; Maeshima, K.; Marraffino, J. M.; Maruyama, S.; Mason, D.; McBride, P.; McCauley, T.; Mishra, K.; Moccia, S.; Mommsen, R. K.; Mrenna, S.; Murray, S. J.; Musienko, Y.; Muzaffar, S.; Newman-Holmes, C.; O'Dell, V.; Osborne, I.; Pivarski, J.; Popescu, S.; Pordes, R.; Prokofyev, O.; Rapsevicius, V.; Ronzhin, A.; Rossman, P.; Ryu, S.; Sexton-Kennedy, E.; Sharma, S.; Shaw, T. M.; Smith, R. P.; Soha, A.; Spalding, W. J.; Spiegel, L.; Tanenbaum, W.; Taylor, L.; Thompson, R.; Tiradani, A.; Tkaczyk, S.; Tran, N. V.; Tuura, L.; Uplegger, L.; Vaandering, E. W.; Vidal, R.; Whitmore, J.; Wu, W.; Yang, F.; Yarba, J.; Yun, J. C.; Zimmerman, T.; Acosta, D.; Avery, P.; Barashko, V.; Bourilkov, D.; Chen, M.; Cheng, T.; Das, S.; De Gruttola, M.; Di Givanni, G. P.; Dobur, D.; Dolinsky, S.; Drozdetskiy, A.; Field, R. D.; Fisher, M.; Fu, Y.; Furic, I. K.; Gartner, J.; Gorn, L.; Holmes, D.; Hugon, J.; Kim, B.; Konigsberg, J.; Korytov, A.; Kropivnitskaya, A.; Kypreos, T.; Low, J. F.; Madorsky, A.; Matchev, K.; Milenovic, P.; Mitselmakher, G.; Muniz, L.; Park, M.; Remington, R.; Rinkevicius, A.; Scurlock, B.; Skhirtladze, N.; Snowball, M.; Stasko, J.; Yelton, J.; Zakaria, M.; Gaultney, V.; Hewamanage, S.; Lebolo, L. M.; Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.; Adams, T.; Askew, A.; Bertoldi, M.; Bochenek, J.; Chen, J.; Dharmaratna, W. G. D.; Diamond, B.; Gleyzer, S. V.; Haas, J.; Hagopian, S.; Hagopian, V.; Jenkins, M.; Johnson, K. F.; Prosper, H.; Tentindo, S.; Veeraraghavan, V.; Weinberg, M.; Baarmand, M. M.; Dorney, B.; Hohlmann, M.; Kalakhety, H.; Ralich, R.; Vodopiyanov, I.; Yumiceva, F.; Adams, M. R.; Anghel, I. M.; Apanasevich, L.; Bai, Y.; Bazterra, V. E.; Betts, R. R.; Bucinskaite, I.; Callner, J.; Cavanaugh, R.; Chung, M. H.; Evdokimov, O.; Garcia-Solis, E. J.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Hollis, R.; Iordanova, A.; Khalatyan, S.; Kunde, G. J.; Lacroix, F.; O'Brien, C.; Silkworth, C.; Silvestre, C.; Smoron, A.; Strom, D.; Turner, P.; Varelas, N.; Akgun, U.; Albayrak, E. A.; Ayan, A. S.; Bilki, B.; Clarida, W.; Debbins, P.; Duru, F.; Ingram, F. D.; McCliment, E.; Merlo, J. P.; Mermerkaya, H.; Mestvirishvili, A.; Miller, M. J.; Moeller, A.; Nachtman, J.; Newsom, C. R.; Norbeck, E.; Olson, J.; Onel, Y.; Ozok, F.; Schmidt, I.; Sen, S.; Tan, P.; Tiras, E.; Wetzel, J.; Yetkin, T.; Yi, K.; Barnett, B. A.; Blumenfeld, B.; Bolognesi, S.; Fehling, D.; Giurgiu, G.; Gritsan, A. V.; Guo, Z. J.; Hu, G.; Maksimovic, P.; Swartz, M.; Whitbeck, A.; Baringer, P.; Bean, A.; Benelli, G.; Coppage, D.; Grachov, O.; Iii, R. P. Kenny; Murray, M.; Noonan, D.; Radicci, V.; Sanders, S.; Stringer, R.; Tinti, G.; Wood, J. S.; Barfuss, A. F.; Bolton, T.; Chakaberia, I.; Ivanov, A.; Khalil, S.; Makouski, M.; Maravin, Y.; Shrestha, S.; Svintradze, I.; Gronberg, J.; Lange, D.; Rebassoo, F.; Wright, D.; Baden, A.; Bard, R.; Boutemeur, M.; Calvert, B.; Eno, S. C.; Gomez, J. A.; Grassi, T.; Hadley, N. J.; Kellogg, R. G.; Kirn, M.; Kolberg, T.; Lu, Y.; Marionneau, M.; Mignerey, A. C.; Pedro, K.; Peterman, A.; Rossato, K.; Skuja, A.; Temple, J.; Tonjes, M. B.; Tonwar, S. C.; Toole, T.; Twedt, E.; Apyan, A.; Bauer, G.; Bendavid, J.; Busza, W.; Butz, E.; Cali, I. A.; Chan, M.; Dutta, V.; Ceballos, G. Gomez; Goncharov, M.; Kim, Y.; Klute, M.; Krajczar, K.; Levin, A.; Luckey, P. D.; Ma, T.; Nahn, S.; Paus, C.; Ralph, D.; Roland, C.; Roland, G.; Rudolph, M.; Stephans, G. S. F.; Stoeckli, F.; Sumorok, K.; Sung, K.; Velicanu, D.; Wenger, E. A.; Wolf, R.; Wyslouch, B.; Yang, M.; Yilmaz, Y.; Yoon, A. S.; Zanetti, M.; Zhukova, V.; Cooper, S. I.; Cushman, P.; Dahmes, B.; De Benedetti, A.; Egeland, R.; Franzoni, G.; Gude, A.; Haupt, J.; Inyakin, A.; Kao, S. C.; Klapoetke, K.; Kubota, Y.; Mans, J.; Pastika, N.; Rusack, R.; Singovsky, A.; Tambe, N.; Turkewitz, J.; Cremaldi, L. M.; Kroeger, R.; Perera, L.; Rahmat, R.; Reidy, J.; Sanders, D. A.; Summers, D.; Attebury, G.; Avdeeva, E.; Bloom, K.; Bockelman, B.; Bose, S.; Claes, D. R.; Dominguez, A.; Eads, M.; Keller, J.; Kravchenko, I.; Lazo-Flores, J.; Lundstedt, C.; Malik, S.; Snihur, R.; Snow, G. R.; Swanson, D.; Baur, U.; Godshalk, A.; Iashvili, I.; Jain, S.; Kharchilava, A.; Kumar, A.; Rappoccio, S.; Shipkowski, S. P.; Smith, K.; Alverson, G.; Barberis, E.; Baumgartel, D.; Chasco, M.; Haley, J.; Moromisato, J.; Nash, D.; Orimoto, T.; Swain, J.; Trocino, D.; Von Goeler, E.; Wood, D.; Zhang, J.; Anastassov, A.; Gobbi, B.; Hahn, K. A.; Kubik, A.; Lusito, L.; Odell, N.; Ofierzynski, R. A.; Pollack, B.; Pozdnyakov, A.; Schmitt, M.; Stoynev, S.; Velasco, M.; Won, S.; Antonelli, L.; Baumbaugh, B.; Berry, D.; Brinkerhoff, A.; Chan, K. M.; Heering, A. H.; Hildreth, M.; Jessop, C.; Karmgard, D. J.; Kellams, N.; Kolb, J.; Lannon, K.; Luo, W.; Lynch, S.; Marinelli, N.; Morse, D. M.; Pearson, T.; Planer, M.; Ruchti, R.; Slaunwhite, J.; Valls, N.; Wayne, M.; Wolf, M.; Woodard, A.; Bylsma, B.; Durkin, L. S.; Hill, C.; Hughes, R.; Kotov, K.; Ling, T. Y.; Puigh, D.; Rodenburg, M.; Rush, C. J.; Sehgal, V.; Vuosalo, C.; Williams, G.; Winer, B. L.; Adam, N.; Berry, E.; Elmer, P.; Gerbaudo, D.; Halyo, V.; Hebda, P.; Hegeman, J.; Hunt, A.; Jindal, P.; Koay, S. A.; Pegna, D. Lopes; Lujan, P.; Marlow, D.; Medvedeva, T.; Mooney, M.; Olsen, J.; Piroue, P.; Quan, X.; Raval, A.; Saka, H.; Stickland, D.; Tully, C.; Werner, J. S.; Wildish, T.; Xie, Z.; Zenz, S. C.; Zuranski, A.; Acosta, J. G.; Del Alamo, M. Bonnett; Brownson, E.; Huang, X. T.; Lopez, A.; Mendez, H.; Oliveros, S.; Vargas, J. E. Ramirez; Zatserklyaniy, A.; Alagoz, E.; Arndt, K.; Barnes, V. E.; Benedetti, D.; Bolla, G.; Bortoletto, D.; Bujak, A.; De Mattia, M.; Everett, A.; Gutay, L.; Hu, Z.; Jones, M.; Koybasi, O.; Kress, M.; Laasanen, A. T.; Lee, J.; Leonardo, N.; Liu, C.; Maroussov, V.; Merkel, P.; Miller, D. H.; Miyamoto, J.; Neumeister, N.; Rott, C.; Roy, A.; Shipsey, I.; Silvers, D.; Svyatkovskiy, A.; Marono, M. Vidal; Yoo, H. D.; Zablocki, J.; Zheng, Y.; Guragain, S.; Parashar, N.; Adair, A.; Akgun, B.; Boulahouache, C.; Cuplov, V.; Ecklund, K. M.; Geurts, F. J. M.; Lee, S. J.; Li, W.; Liu, J. H.; Matveev, M.; Padley, B. P.; Redjimi, R.; Roberts, J.; Tumanov, A.; Yepes, P.; Zabel, J.; Betchart, B.; Bodek, A.; Budd, H.; Chung, Y. S.; Covarelli, R.; de Barbaro, P.; Demina, R.; Eshaq, Y.; Ferbel, T.; Garcia-Bellido, A.; Ginther, G.; Goldenzweig, P.; Gotra, Y.; Han, J.; Harel, A.; Korjenevski, S.; Miner, D. C.; Orbaker, D.; Sakumoto, W.; Slattery, P.; Vishnevskiy, D.; Zielinski, M.; Bhatti, A.; Ciesielski, R.; Demortier, L.; Goulianos, K.; Lungu, G.; Malik, S.; Mesropian, C.; Arora, S.; Barker, A.; Chou, J. P.; Contreras-Campana, C.; Contreras-Campana, E.; Duggan, D.; Ferencek, D.; Gershtein, Y.; Gray, R.; Halkiadakis, E.; Hidas, D.; Lath, A.; Panwalkar, S.; Park, M.; Patel, R.; Rekovic, V.; Robles, J.; Rose, K.; Salur, S.; Schnetzer, S.; Seitz, C.; Somalwar, S.; Stone, R.; Thomas, S.; Cerizza, G.; Hollingsworth, M.; Ragghianti, G.; Spanier, S.; Yang, Z. C.; York, A.; Bouhali, O.; Eusebi, R.; Flanagan, W.; Gilmore, J.; Kamon, T.; Khotilovich, V.; Montalvo, R.; Nguyen, C. N.; Osipenkov, I.; Pakhotin, Y.; Perloff, A.; Roe, J.; Safonov, A.; Sakuma, T.; Sengupta, S.; Suarez, I.; Tatarinov, A.; Toback, D.; Akchurin, N.; Damgov, J.; Dragoiu, C.; Dudero, P. R.; Jeong, C.; Kovitanggoon, K.; Lee, S. W.; Libeiro, T.; Sill, A.; Volobouev, I.; Wigmans, R.; Appelt, E.; Delannoy, A. G.; Engh, D.; Florez, C.; Gabella, W.; Greene, S.; Gurrola, A.; Johns, W.; Kurt, P.; Maguire, C.; Melo, A.; Sharma, M.; Sheldon, P.; Snook, B.; Tuo, S.; Velkovska, J.; Andelin, D.; Arenton, M. W.; Balazs, M.; Boutle, S.; Conetti, S.; Cox, B.; Francis, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Lin, C.; Neu, C.; Phillips, D., II; Wood, J.; Gollapinni, S.; Harr, R.; Karchin, P. E.; Don, C. Kottachchi Kankanamge; Lamichhane, P.; Mattson, M.; Milstene, C.; Sakharov, A.; Anderson, M.; Belknap, D.; Bellinger, J. N.; Borrello, L.; Bradley, D.; Carlsmith, D.; Cepeda, M.; Crotty, I.; Dasu, S.; Feyzi, F.; Friis, E.; Gorski, T.; Gray, L.; Grogg, K. S.; Grothe, M.; Hall-Wilton, R.; Herndon, M.; Herve, A.; Klabbers, P.; Klukas, J.; Lackey, J.; Lanaro, A.; Lazaridis, C.; Loveless, R.; Lusin, S.; de Abril, M. Magrans; Maier, W.; Mohapatra, A.; Ojalvo, I.; Palmonari, F.; Pierro, G. A.; Reeder, D.; Ross, I.; Savin, A.; Smith, W. H.; Swanson, J.; Wenman, D.		CMS Collaboration	A New Boson with a Mass of 125 GeV Observed with the CMS Experiment at the Large Hadron Collider	SCIENCE			English	Article							BROKEN SYMMETRIES; HIGGS BOSONS; GAUGE	The Higgs boson was postulated nearly five decades ago within the framework of the standard model of particle physics and has been the subject of numerous searches at accelerators around the world. Its discovery would verify the existence of a complex scalar field thought to give mass to three of the carriers of the electroweak force-the W+, W-, and Z(0) bosons-as well as to the fundamental quarks and leptons. The CMS Collaboration has observed, with a statistical significance of five standard deviations, a new particle produced in proton-proton collisions at the Large Hadron Collider at CERN. The evidence is strongest in the diphoton and four-lepton (electrons and/or muons) final states, which provide the best mass resolution in the CMS detector. The probability of the observed signal being due to a random fluctuation of the background is about 1 in 3 x 10(6). The new particle is a boson with spin not equal to 1 and has a mass of about 1.25 giga-electron volts. Although its measured properties are, within the uncertainties of the present data, consistent with those expected of the Higgs boson, more data are needed to elucidate the precise nature of the new particle.	[Chatrchyan, S.; Khachatryan, V.; Sirunyan, A. M.; Tumasyan, A.] Yerevan Phys Inst, Yerevan, Armenia; [Adam, W.; Aguilo, E.; Bergauer, T.; Dragicevic, M.; Eroe, J.; Fabjan, C.; Friedl, M.; Fruehwirth, R.; Ghete, V. M.; Hoch, M.; Hoermann, N.; Hrubec, J.; Jeitler, M.; Kiesenhofer, W.; Knuenz, V.; Krammer, M.; Kraetschmer, I.; Liko, D.; Majerotto, W.; Mikulec, I.; Pernicka, M.; Rahbaran, B.; Rohringer, C.; Rohringer, H.; Schoefbeck, R.; Strauss, J.; Szoncso, F.; Taurok, A.; Waltenberger, W.; Walzel, G.; Widl, E.; Wulz, C. -E.] Inst Hochenergiephys OeAW, Vienna, Austria; [Chekhovsky, V.; Emeliantchik, I.; Litomin, A.; Makarenko, V.; Mossolov, V.; Shumeiko, N.; Solin, A.; Stefanovitch, R.; Gonzalez, J. Suarez] Natl Ctr Particle & High Energy Phys, Minsk, BELARUS; [Fedorov, A.; Korzhik, M.; Missevitch, O.; Zuyeuski, R.] Res Inst Nucl Problems, Minsk, BELARUS; [Bansal, M.; Bansal, S.; Beaumont, W.; Cornelis, T.; De Wolf, E. A.; Druzhkin, D.; Janssen, X.; Luyckx, S.; Mucibello, L.; Ochesanu, S.; Roland, B.; Rougny, R.; Selvaggi, M.; Staykova, Z.; Van Haevermaet, H.; Van Mechelen, P.; Van Remortel, N.; Van Spilbeeck, A.] Univ Antwerp, Antwerp, Belgium; [Blekman, F.; Blyweert, S.; D'Hondt, J.; Devroede, O.; Suarez, R. Gonzalez; Goorens, R.; Kalogeropoulos, A.; Maes, M.; Olbrechts, A.; Tavernier, S.; Van Doninck, W.; Van Lancker, L.; Van Mulders, P.; Van Onsem, G. P.; Villella, I.; Clerbaux, B.; De Lentdecker, G.; Dero, V.; Dewulf, J. P.; Gay, A. P. R.; Hreus, T.; Leonard, A.; Marage, P. E.; Mohammadi, A.; Reis, T.; Rugovac, S.; Thomas, L.; Vander Velde, C.; Vanlaer, P.; Wang, J.; Wickens, J.] Vrije Univ Brussels, Brussels, Belgium; [Adler, V.; Beernaert, K.; Cimmino, A.; Costantini, S.; Garcia, G.; Grunewald, M.; Klein, B.; Lellouch, J.; Marinov, A.; Mccartin, J.; Rios, A. A. Ocampo; Ryckbosch, D.; Strobbe, N.; Thyssen, F.; Tytgat, M.; Walsh, S.; Yazgan, E.; Zaganidis, N.] Univ Ghent, Ghent, Belgium; [Basegmez, S.; Bruno, G.; Castello, R.; Ceard, L.; De Jeneret, J. De Favereau; Delaere, C.; Demin, P.; du Pree, T.; Favart, D.; Forthomme, L.; Giammanco, A.; Gregoire, G.; Hollar, J.; Lemaitre, V.; Liao, J.; Militaru, O.; Nuttens, C.; Pagano, D.; Pin, A.; Piotrzkowski, K.; Schul, N.; Garcia, J. M. Vizan] Catholic Univ Louvain, Louvain, Belgium; [Beliy, N.; Caebergs, T.; Daubie, E.; Hammad, G. H.] Univ Mons, Mons, Belgium; [Alves, G. A.; Brito, L.; Martins Junior, M. Correa; Martins, T.; Pol, M. E.; Souza, M. H. G.] Ctr Brasileiro Pesquisas Fis, Rio De Janeiro, Brazil; [Alda Junior, W. L.; Carvalho, W.; Custodio, A.; Da Costa, E. M.; Damiao, D. De Jesus; Martins, C. De Oliveira; De Souza, S. Fonseca; Malbouisson, H.; Malek, M.; Figueiredo, D. Matos; Mundim, L.; Nogima, H.; Oguri, V.; Da Silva, W. L. Prado; Santoro, A.; Sznajder, A.; Pereira, A. Vilela] Univ Estado Rio De Janeiro, Rio De Janeiro, Brazil; [Anjos, T. S.; Bernardes, C. A.; Dias, F. A.; Perez Tomei, T. R. Fernandez; Gregores, E. M.; Iope, R. L.; Lagana, C.; Lietti, S. M.; Marinho, F.; Mercadante, P. G.; Novaes, S. F.; Padula, Sandra S.] Univ Estadual Paulista, Inst Fis Teor, Sao Paulo, Brazil; [Dimitrov, L.; Genchev, V.; Iaydjiev, P.; Piperov, S.; Rodozov, M.; Stoykova, S.; Sultanov, G.; Tcholakov, V.; Trayanov, R.; Vankov, I.; Vutova, M.; Uzunova, D.; Zahariev, R.] Inst Nucl Energy Res, Sofia, Bulgaria; [Roumenin, C.] Inst Syst Engn & Robot, Sofia, Bulgaria; [Dimitrov, A.; Hadjiiska, R.; Kozhuharov, V.; Litov, L.; Pavlov, B.; Petkov, P.] Univ Sofia, Sofia, Bulgaria; [Bian, J. G.; Chen, G. M.; Chen, H. S.; He, K. L.; Jiang, C. H.; Li, W. G.; Liang, D.; Liang, S.; Meng, X.; Sun, G.; Sun, H. S.; Tao, J.; Wang, J.; Wang, X.; Wang, Z.; Xiao, H.; Xu, M.; Yang, M.; Zang, J.; Zhang, X.; Zhang, Z.; Zhang, Z.; Zhao, W. R.; Zhu, Z.] Inst High Energy Phys, Beijing, Peoples R China; [Asawatangtrakuldee, C.; Ban, Y.; Cai, J.; Guo, S.; Guo, Y.; Li, W.; Liu, H. T.; Liu, S.; Mao, Y.; Qian, S. J.; Teng, H.; Wang, D.; Ye, Y. L.; Zhang, L.; Zhu, B.; Zou, W.] Peking Univ, State Key Lab Nucl Phys & Tech, Beijing, Peoples R China; [Avila, C.; Gomez, J. P.; Moreno, B. Gomez; Oliveros, A. F. Osorio; Sanabria, J. C.] Univ Los Andes, Bogota, Colombia; [Godinovic, N.; Lelas, D.; Plestina, R.; Polic, D.; Puljak, I.] Tech Univ Split, Split, Croatia; [Brigljevic, V.; Duric, S.; Kadija, K.; Luetic, J.; Mekterovic, D.; Morovic, S.] Rudjer Boskovic Inst, Zagreb, Croatia; [Attikis, A.; Galanti, M.; Mavromanolakis, G.; Mousa, J.; Nicolaou, C.; Ptochos, F.; Razis, P. A.] Univ Cyprus, Nicosia, Cyprus; [Finger, M.; Finger, M., Jr.] Charles Univ Prague, Prague, Czech Republic; [Aly, A.; Assran, Y.; Awad, A.; Elgammal, S.; Kamel, A. Ellithi; Khalil, S.; Mahmoud, M. A.; Mahrous, A.; Radi, A.] Acad Sci Res & Technol Arab Republ Egypt, Egyptian Network High Energy Phys, Cairo, Egypt; [Giammanco, A.; Hektor, A.; Kadastik, M.; Kannike, K.; Muentel, M.; Raidal, M.; Rebane, L.; Strumia, A.; Tiko, A.] NICPB, Tallinn, Estonia; [Eerola, P.; Fedi, G.; Voutilainen, M.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Anttila, E.; Harkonen, J.; Heikkinen, A.; Karimaki, V.; Katajisto, H. M.; Kinnunen, R.; Kortelainen, M. J.; Kotamaki, M.; Lampen, T.; Lassila-Perini, K.; Lehti, S.; Linden, T.; Luukka, P.; Maenpaa, T.; Peltola, T.; Tuominen, E.; Tuominiemi, J.; Tuovinen, E.; Ungaro, D.; Vanhala, T. P.; Wendland, L.] Helsinki Inst Phys, Helsinki, Finland; [Banzuzi, K.; Karjalainen, A.; Korpela, A.; Tuuva, T.] Lappeenranta Univ Technol, Lappeenranta, Finland; [Anfreville, M.; Besancon, M.; Choudhury, S.; Dejardin, M.; Denegri, D.; Fabbro, B.; Faure, J. L.; Ferri, F.; Ganjour, S.; Gentit, F. X.; Givernaud, A.; Gras, P.; de Monchenault, G. Hamel; Jarry, P.; Kircher, F.; Lemaire, M. C.; Locci, E.; Malcles, J.; Mandjavidze, I.; Nayak, A.; Pansart, J. P.; Rander, J.; Reymond, J. M.; Rosowsky, A.; Titov, M.; Verrecchia, P.] CEA Saclay, DSM IRFU, Gif Sur Yvette, France; [Plestina, R.; Badier, J.; Baffioni, S.; Beaudette, F.; Becheva, E.; Benhabib, L.; Bianchini, L.; Bluj, M.; Broutin, C.; Busson, P.; Cerutti, M.; Chamont, D.; Charlot, C.; Daci, N.; Dahms, T.; Dalchenko, M.; Dobrzynski, L.; Geerebaert, Y.; de Cassagnac, M. Granier; Haguenauer, M.; Hennion, P.; Milleret, G.; Mine, P.; Mironov, C.; Naranjo, I. N.; Nguyen, M.; Ochando, C.; Paganini, P.; Romanteau, T.; Sabes, D.; Salerno, R.; Sartirana, A.; Sirois, Y.; Thiebaux, C.; Veelken, C.; Zabi, A.; Bernet, C.] IN2P3 CNRS, Ecole Polytech, Lab Leprince Ringuet, Palaiseau, France; [Agram, J. -L.; Andrea, J.; Besson, A.; Bloch, D.; Bodin, D.; Brom, J. -M.; Cardaci, M.; Chabert, E. C.; Collard, C.; Conte, E.; Drouhin, F.; Fontaine, J. -C.; Gele, D.; Goerlach, U.; Goetzmann, C.; Gross, L.; Huss, D.; Juillot, P.; Kieffer, E.; Le Bihan, A. -C.; Pansanel, J.; Patois, Y.; Van Hove, P.] Univ Strasbourg, Univ Haute Alsace Mulhouse, CNRS IN2P3, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Boutigny, D.; Mercier, D.] CNRS IN2P3, Inst Natl Phys Nucl & Phys Particules, Ctr Calcul, Villeurbanne, France; [Baulieu, G.; Beauceron, S.; Beaupere, N.; Bedjidian, M.; Bondu, O.; Boudoul, G.; Brochet, S.; Chasserat, J.; Chierici, R.; Combaret, C.; Contardo, D.; Depasse, P.; El Mamouni, H.; Fay, J.; Gascon, S.; Giraud, N.; Gouzevitch, M.; Haroutunian, R.; Ille, B.; Kurca, T.; Lethuillier, M.; Lumb, N.; Mathez, H.; Mirabito, L.; Perries, S.; Sgandurra, L.; Sordini, V.; Tschudi, Y.; Vander Donckt, M.; Verdier, P.; Viret, S.] Univ Lyon, Univ Lyon 1, CNRS IN2P3, Inst Phys Nucl Lyon, Villeurbanne, France; [Roinishvili, V.; Rurua, L.] Acad Sci, E Andronikashvili Inst Phys, Tbilisi, Georgia; [Amaglobeli, N.; Bagaturia, I.; Chiladze, B.; Kvatadze, R.; Lomidze, D.; Shanidze, R.; Tsamalaidze, Z.; Sakhelashvili, T.] Tbilisi State Univ, Inst High Energy Phys & Informatizat, Tbilisi, Georgia; [Adolphi, R.; Autermann, C.; Beranek, S.; Brauer, R.; Braunschweig, W.; Calpas, B.; Edelhoff, M.; Feld, L.; Heracleous, N.; Hindrichs, O.; Jussen, R.; Karpinski, W.; Klein, K.; Luebelsmeyer, K.; Merz, J.; Ostapchuk, A.; Pandoulas, D.; Perieanu, A.; Raupach, F.; Sammet, J.; Schael, S.; Schmitz, D.; von Dratzig, A. Schultz; Siedling, R.; Sprenger, D.; Weber, H.; Wittmer, B.; Wlochal, M.; Zhukov, V.] Rhein Westfal TH Aachen, Inst Phys 1, Aachen, Germany; [Ata, M.; Biallass, P.; Caudron, J.; Dietz-Laursonn, E.; Duchardt, D.; Erdmann, M.; Fischer, R.; Gueth, A.; Hebbeker, T.; Heidemann, C.; Hilgers, G.; Hoepfner, K.; Hof, C.; Klimkovich, T.; Klingebiel, D.; Kreuzer, P.; Magass, C.; Merschmeyer, M.; Meyer, A.; Olschewski, M.; Papacz, P.; Philipps, B.; Pieta, H.; Reithler, H.; Schmitz, S. A.; Sonnenschein, L.; Sowa, M.; Steggemann, J.; Teyssier, D.; Weber, M.] Rhein Westfal TH Aachen, Inst Phys 3, Aachen, Germany; [Bontenackels, M.; Cherepanov, V.; Erdogan, Y.; Fluegge, G.; Geenen, H.; Geisler, M.; Ahmad, W. Haj; Hoehle, F.; Kargoll, B.; Kress, T.; Kuessel, Y.; Lingemann, J.; Nowack, A.; Perchalla, L.; Pooth, O.; Sauerland, P.; Stahl, A.; Zoeller, M. H.] Rhein Westfal TH Aachen, Inst Phys B 3, Aachen, Germany; [Martin, M. Aldaya; Behr, J.; Behrenhoff, W.; Behrens, U.; Bergholz, M.; Bethani, A.; Borras, K.; Burgmeier, A.; Cakir, A.; Calligaris, L.; Campbell, A.; Castro, E.; Costanza, F.; Dammann, D.; Pardos, C. Diez; Eckerlin, G.; Eckstein, D.; Flossdorf, A.; Flucke, G.; Geiser, A.; Glushkov, I.; Goettlicher, P.; Grebenyuk, A.; Gunnellini, P.; Habib, S.; Hauk, J.; Hellwig, G.; Jung, H.; Kasemann, M.; Katsas, P.; Kleinwort, C.; Kluge, H.; Knutsson, A.; Kraemer, M.; Kruecker, D.; Kuznetsova, E.; Lange, W.; Leonard, J.; Lewendel, B.; Lohmann, W.; Lutz, B.; Mankel, R.; Marfin, I.; Marienfeld, M.; Melzer-Pellmann, I. -A.; Meyer, A. B.; Mnich, J.; Muhl, C.; Mussgiller, A.; Naumann-Emme, S.; Novgorodova, O.; Olzem, J.; Parenti, A.; Perrey, H.; Petrukhin, A.; Pitzl, D.; Raspereza, A.; Cipriano, P. M. Ribeiro; Riedl, C.; Ron, E.; Rosemann, C.; Rosin, M.; Salfeld-Nebgen, J.; Schmidt, R.; Schoerner-Sadenius, T.; Sen, N.; Spiridonov, A.; Stein, M.; Tomaszewska, J.; Volyanskyy, D.; Walsh, R.; Wissing, C.; Youngman, C.] DESY, Hamburg, Germany; [Blobel, V.; Draeger, J.; Enderle, H.; Erfle, J.; Gebbert, U.; Goerner, M.; Hermanns, T.; Hoeing, R. S.; Kaschube, K.; Kaussen, G.; Kirschenmann, H.; Klanner, R.; Lange, J.; Mura, B.; Nowak, F.; Peiffer, T.; Pietsch, N.; Rathjens, D.; Sander, C.; Schettler, H.; Schleper, P.; Schlieckau, E.; Schmidt, A.; Schroeder, M.; Schum, T.; Seidel, M.; Sibille, J.; Sola, V.; Stadie, H.; Steinbrueck, G.; Thomsen, J.; Vanelderen, L.] Univ Hamburg, Hamburg, Germany; [Barth, C.; Bauer, J.; Berger, J.; Bluem, P.; Boeser, C.; Buege, V.; Chen, Z. Y.; Chowdhury, S.; Chwalek, T.; Daeuwel, D.; De Boer, W.; Descroix, A.; Dierlamm, A.; Dirkes, G.; Fahrer, M.; Feindt, M.; Felzmann, U.; Frey, M.; Furgeri, A.; Gebauer, I.; Gessler, A.; Gruschke, J.; Guthoff, M.; Hackstein, C.; Hartmann, F.; Hauler, F.; Hauth, T.; Heier, S.; Heindl, S. M.; Heinrich, M.; Heiss, A.; Held, H.; Hoffmann, K. H.; Honc, S.; Husemann, U.; Imhof, M.; Jung, C.; Junghans, S.; Katkov, I.; Kerzel, U.; Knoblauch, D.; Komaragiri, J. R.; Kraeber, M.; Kuhr, T.; Liamsuwan, T.; Pardo, P. Lobelle; Martschei, D.; Menchikov, A.; Mol, X.; Moermann, D.; Mueller, S.; Mueller, Th.; Neuberger, D.; Neuland, M. B.; Niegel, M.; Nuernberg, A.; Oberst, O.; Oehler, A.; Gomez, T. Ortega; Ott, J.; Piasecki, C.; Poschlad, A.; Quast, G.; Rabbertz, K.; Ratnikov, F.; Ratnikova, N.; Renz, M.; Roecker, S.; Roederer, F.; Sabellek, A.; Saout, C.; Scheurer, A.; Schieferdecker, D.; Schieferdecker, P.; Schilling, F. -P.; Schmanau, M.; Schott, G.; Schwerdtfeger, W.; Simonis, H. J.; Skiba, A.; Stober, F. M.; Theel, A.; Thuemmel, W. H.; Troendle, D.; Trunov, A.; Ulrich, R.; Wagner-Kuhr, J.; Wayand, S.; Weber, M.; Weiler, T.; Zeise, M.; Ziebarth, E. B.; Zvada, M.] Inst Expt Kernphys, Karlsruhe, Germany; [Anagnostou, G.; Daskalakis, G.; Geralis, T.; Kesisoglou, S.; Kyriakis, A.; Loukas, D.; Manolakos, I.; Markou, A.; Markou, C.; Mavrommatis, C.; Ntomari, E.] Inst Nucl Phys Demokritos, Aghia Paraskevi, Greece; [Gouskos, L.; Panagiotou, A.; Saoulidou, N.; Hidas, P.; Sphicas, P.] Univ Athens, Athens, Greece; [Evangelou, I.; Foudas, C.; Kokkas, P.; Manthos, N.; Papadopoulos, I.; Patras, V.; Triantis, F. A.] Univ Ioannina, Ioannina, Greece; [Bencze, G.; Hajdu, C.; Hidas, P.; Horvath, D.; Sikler, F.; Veszpremi, V.; Vesztergombi, G.; Zalan, P.; Krajczar, K.] KFKI Res Inst Particle & Nucl Phys, Budapest, Hungary; [Horvath, D.; Beni, N.; Czellar, S.; Fenyvesi, A.; Molnar, J.; Palinkas, J.; Szillasi, Z.] Inst Nucl Res ATOMKI, Debrecen, Hungary; [Karancsi, J.; Raics, P.; Trocsanyi, Z. L.; Ujvari, B.; Zilizi, G.] Univ Debrecen, Debrecen, Hungary; [Beri, S. B.; Bhandari, V.; Bhatnagar, V.; Dhingra, N.; Gupta, R.; Kaur, M.; Kohli, J. M.; Mehta, M. Z.; Nishu, N.; Saini, L. K.; Sharma, A.; Singh, J. B.] Panjab Univ, Chandigarh, India; [Kumar, Ashok; Kumar, Arun; Ahuja, S.; Bhardwaj, A.; Chatterji, S.; Choudhary, B. C.; Gupta, P.; Malhotra, S.; Naimuddin, M.; Ranjan, K.; Sharma, V.; Shivpuri, R. K.] Univ Delhi, Delhi, India; [Banerjee, S.; Bhattacharya, S.; Dutta, S.; Gomber, B.; Jain, Sa.; Jain, Sh.; Khurana, R.; Sarkar, S.; Sharan, M.] Saha Inst Nucl Phys, Kolkata, India; [Abdulsalam, A.; Choudhury, R. K.; Dutta, D.; Ghodgaonkar, M.; Kailas, S.; Kataria, S. K.; Kumar, V.; Mehta, P.; Mohanty, A. K.; Pant, L. M.; Shukla, P.; Topkar, A.] Bhabha Atom Res Ctr, Mumbai, India; [Aziz, T.; Chendvankar, S.; Deshpande, P. V.; Ganguli, S. N.; Ganguly, S.; Guchait, M.; Gurtu, A.; Maity, M.; Mazumdar, K.; Mohanty, G. B.; Parida, B.; Patil, M. R.; Raghavan, R.; Sudhakar, K.; Wickramage, N.] Tata Inst Fundamental Res EHEP, Mumbai, India; [Guchait, M.; Acharya, B. S.; Banerjee, S.; Bheesette, S.; Dugad, S.; Kalmani, S. D.; Krishnaswamy, M. R.; Lakkireddi, V. R.; Mondal, N. K.; Narasimham, V. S.; Panyam, N.; Verma, P.] Tata Inst Fundamental Res HECR, Mumbai, India; [Ardalan, F.; Arfaei, H.; Bakhshiansohi, H.; Etesami, S. M.; Fahim, A.; Hashemi, M.; Jafari, A.; Khakzad, M.; Najafabadi, M. Mohammadi; Mehdiabadi, S. Paktinat; Safarzadeh, B.; Zeinali, M.] Inst Res Fundamental Sci IPM, Tehran, Iran; [Abbrescia, M.; Barbone, L.; Calabria, C.; Chhibra, S. S.; Colaleo, A.; Creanza, D.; De Filippis, N.; De Palma, M.; De Robertis, G.; Donvito, G.; Fiore, L.; Iaselli, G.; Loddo, F.; Maggi, G.; Maggi, M.; Manna, N.; Marangelli, B.; My, S.; Natali, S.; Nuzzo, S.; Pacifico, N.; Pompili, A.; Pugliese, G.; Ranieri, A.; Romano, F.; Selvaggi, G.; Silvestris, L.; Singh, G.; Spinoso, V.; Venditti, R.; Verwilligen, P.; Zito, G.] INFN Sez Bari, Bari, Italy; [Abbrescia, M.; Barbone, L.; Calabria, C.; Chhibra, S. S.; De Palma, M.; Manna, N.; Marangelli, B.; Natali, S.; Nuzzo, S.; Pompili, A.; Selvaggi, G.; Singh, G.; Venditti, R.] Univ Bari, Bari, Italy; [Creanza, D.; De Filippis, N.; Maggi, G.; My, S.; Pugliese, G.; Romano, F.] Politecn Bari, Bari, Italy; [Abbiendi, G.; Benvenuti, A. C.; Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Capiluppi, P.; Castro, A.; Cavallo, F. R.; Cuffiani, M.; Dallavalle, G. M.; Fabbri, F.; Fanfani, A.; Fasanella, D.; Giacomelli, P.; Grandi, C.; Guiducci, L.; Marcellini, S.; Masetti, G.; Meneghelli, M.; Montanari, A.; Navarria, F. L.; Odorici, F.; Perrotta, A.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Travaglini, R.] INFN Sez Bologna, Bologna, Italy; [Bonacorsi, D.; Braibant-Giacomelli, S.; Brigliadori, L.; Capiluppi, P.; Castro, A.; Cuffiani, M.; Fanfani, A.; Fasanella, D.; Guiducci, L.; Meneghelli, M.; Navarria, F. L.; Primavera, F.; Rossi, A. M.; Rovelli, T.; Siroli, G. P.; Travaglini, R.] Univ Bologna, Bologna, Italy; [Albergo, S.; Cappello, G.; Chiorboli, M.; Costa, S.; Noto, F.; Potenza, R.; Saizu, M. A.; Tricomi, A.; Tuve, C.] INFN Sez Catania, Catania, Italy; [Albergo, S.; Cappello, G.; Chiorboli, M.; Costa, S.; Potenza, R.; Tricomi, A.; Tuve, C.] Univ Catania, Catania, Italy; [Barbagli, G.; Ciulli, V.; Civinini, C.; D'Alessandro, R.; Focardi, E.; Frosali, S.; Gallo, E.; Genta, C.; Gonzi, S.; Meschini, M.; Paoletti, S.; Parrini, G.; Ranieri, R.; Sguazzoni, G.; Tropiano, A.] INFN Sez Firenze, Florence, Italy; [Ciulli, V.; D'Alessandro, R.; Focardi, E.; Frosali, S.; Gonzi, S.; Tropiano, A.] Univ Florence, Florence, Italy; [Benussi, L.; Bianco, S.; Colafranceschi, S.; Fabbri, F.; Piccolo, D.] INFN Lab Nazl Frascati, Frascati, Italy; [Fabbricatore, P.; Farinon, S.; Greco, M.; Musenich, R.; Tosi, S.] INFN Sez Genova, Genoa, Italy; [Tosi, S.] Univ Genoa, Genoa, Italy; [Benaglia, A.; Carbone, L.; D'Angelo, P.; De Guio, F.; Di Matteo, L.; Dini, P.; Farina, F. M.; Fiorendi, S.; Gennai, S.; Ghezzi, A.; Malvezzi, S.; Manzoni, R. A.; Martelli, A.; Massironi, A.; Menasce, D.; Moroni, L.; Negri, P.; Paganoni, M.; Pedrini, D.; Pullia, A.; Ragazzi, S.; Redaelli, N.; Sala, S.; de Fatis, T. Tabarelli] INFN Sez Milano Bicocca, Milan, Italy; [De Guio, F.; Di Matteo, L.; Fiorendi, S.; Ghezzi, A.; Manzoni, R. A.; Martelli, A.; Massironi, A.; Negri, P.; Paganoni, M.; Pullia, A.; Ragazzi, S.; de Fatis, T. Tabarelli] Univ Milano Bicocca, Milan, Italy; [Buontempo, S.; Montoya, C. A. Carrillo; Cavallo, N.; De Cosa, A.; Dogangun, O.; Fabozzi, F.; Iorio, A. O. M.; Lista, L.; Meola, S.; Merola, M.; Paolucci, P.] INFN Sez Napoli, Naples, Italy; [De Cosa, A.; Dogangun, O.; Iorio, A. O. M.] Univ Naples Federico II, Naples, Italy; [Azzi, P.; Bacchetta, N.; Bellato, M.; Benettoni, M.; Biasotto, M.; Bisello, D.; Branca, A.; Carlin, R.; Checchia, P.; Dorigo, T.; Dosselli, U.; Fanzago, F.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Gonella, F.; Gozzelino, A.; Gulmini, M.; Kanishchev, K.; Lacaprara, S.; Lazzizzera, I.; Loreti, M.; Margoni, M.; Maron, G.; Mazzucato, M.; Meneguzzo, A. T.; Montecassiano, F.; Passaseo, M.; Pazzini, J.; Pegoraro, M.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Torassa, E.; Tosi, M.; Vanini, S.; Ventura, S.; Zotto, P.; Zumerle, G.; Kaminskiy, A.] INFN Sez Padova, Padua, Italy; [Bisello, D.; Branca, A.; Carlin, R.; Gasparini, F.; Gasparini, U.; Giubilato, P.; Margoni, M.; Meneguzzo, A. T.; Pazzini, J.; Pozzobon, N.; Ronchese, P.; Simonetto, F.; Tosi, M.; Vanini, S.; Zotto, P.; Zumerle, G.; Kaminskiy, A.] Univ Padua, Padua, Italy; [Kanishchev, K.; Lazzizzera, I.; Kaminskiy, A.] Univ Trento, Trento, Italy; [Berzano, U.; Gabusi, M.; Ratti, S. P.; Riccardi, C.; Torre, P.; Vitulo, P.] INFN Sez Pavia, Pavia, Italy; [Gabusi, M.; Ratti, S. P.; Riccardi, C.; Torre, P.; Vitulo, P.] Univ Pavia, Pavia, Italy; [Biasini, M.; Bilei, G. M.; Fano, L.; Lariccia, P.; Lucaroni, A.; Mantovani, G.; Menichelli, M.; Nappi, A.; Passeri, D.; Placidi, P.; Romeo, F.; Saha, A.; Santocchia, A.; Servoli, L.; Spiezia, A.; Taroni, S.; Valdata, M.; Pioppi, M.] INFN Sez Perugia, Perugia, Italy; [Biasini, M.; Fano, L.; Lariccia, P.; Lucaroni, A.; Mantovani, G.; Nappi, A.; Passeri, D.; Placidi, P.; Romeo, F.; Santocchia, A.; Spiezia, A.; Taroni, S.; Valdata, M.; Pioppi, M.] Univ Perugia, Perugia, Italy; [Angelini, F.; Arezzini, S.; Azzurri, P.; Bagliesi, G.; Basti, A.; Bellazzini, R.; Bernardini, J.; Boccali, T.; Bosi, F.; Brez, A.; Broccolo, G.; Calzolari, F.; Carboni, A.; Castaldi, R.; Cerri, C.; Ciampa, A.; D'Agnolo, R. T.; Dell'Orso, R.; Fiori, F.; Foa, L.; Giassi, A.; Giusti, S.; Kraan, A.; Latronico, L.; Ligabue, F.; Linari, S.; Lomtadze, T.; Martini, L.; Massa, M.; Massai, M. M.; Mazzoni, E.; Messineo, A.; Moggi, A.; Palla, F.; Raffaelli, F.; Rizzi, A.; Sanguinetti, G.; Segneri, G.; Serban, A. T.; Spagnolo, P.; Spandre, G.; Squillacioti, P.; Tenchini, R.; Tonelli, G.; Venturi, A.; Verdini, P. G.; Rolandi, G.] INFN Sez Pisa, Pisa, Italy; [Fiori, F.; Messineo, A.; Rizzi, A.; Tonelli, G.] Univ Pisa, Pisa, Italy; [Azzurri, P.; D'Agnolo, R. T.; Foa, L.; Ligabue, F.] Scuola Normale Super Pisa, Pisa, Italy; [Baccaro, S.; Barone, L.; Bartoloni, A.; Cavallari, F.; Dafinei, I.; Del Re, D.; Diemoz, M.; Fanelli, C.; Grassi, M.; Longo, E.; Meridiani, P.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Paramatti, R.; Rahatlou, S.; Sigamani, M.; Soffi, L.; Talamo, I. G.; Rovelli, C.] INFN Sez Roma, Rome, Italy; [Barone, L.; Del Re, D.; Fanelli, C.; Grassi, M.; Longo, E.; Micheli, F.; Nourbakhsh, S.; Organtini, G.; Rahatlou, S.; Soffi, L.] Univ Rome, Rome, Italy; [Amapane, N.; Arcidiacono, R.; Argiro, S.; Arneodo, M.; Biino, C.; Cartiglia, N.; Costa, M.; Demaria, N.; Mariotti, C.; Maselli, S.; Migliore, E.; Monaco, V.; Musich, M.; Obertino, M. M.; Pastrone, N.; Pelliccioni, M.; Peroni, C.; Potenza, A.; Romero, A.; Ruspa, M.; Sacchi, R.; Solano, A.; Staiano, A.] INFN Sez Torino, Turin, Italy; [Amapane, N.; Argiro, S.; Costa, M.; Migliore, E.; Monaco, V.; Peroni, C.; Potenza, A.; Romero, A.; Sacchi, R.; Solano, A.] Univ Turin, Turin, Italy; [Arcidiacono, R.; Arneodo, M.; Obertino, M. M.; Ruspa, M.] Univ Piemonte Orientale, Novara, Italy; [Ambroglini, F.; Belforte, S.; Candelise, V.; Casarsa, M.; Cossutti, F.; Della Ricca, G.; Gobbo, B.; Kavka, C.; Marone, M.; Montanino, D.; Penzo, A.; Schizzi, A.] INFN Sez Trieste, Trieste, Italy; [Ambroglini, F.; Candelise, V.; Della Ricca, G.; Marone, M.; Montanino, D.; Schizzi, A.] Univ Trieste, Trieste, Italy; [Kim, T. Y.; Nam, S. K.] Kangwon Natl Univ, Chunchon, South Korea; [Chang, S.; Chung, J.; Ham, S. W.; Han, D.; Kang, J.; Kim, D. H.; Kim, G. N.; Kim, J. E.; Kim, K. S.; Kong, D. J.; Lee, M. W.; Oh, Y. D.; Park, H.; Ro, S. R.; Son, D.; Son, D. C.; Suh, J. S.; Kamon, T.] Kyungpook Natl Univ, Daegu, South Korea; [Kim, J. Y.; Kim, Zero J.; Song, S.] Chonnam Natl Univ, Inst Universe & Elementary Particles, Kwangju, South Korea; [Choi, S.; Gyun, D.; Hong, B.; Jo, M.; Jo, Y.; Kang, M.; Kim, H.; Kim, T. J.; Lee, K. S.; Moon, D. H.; Park, S. K.; Roh, Y.; Sim, K. S.] Korea Univ, Seoul, South Korea; [Choi, M.; Hahn, G.; Kang, S.; Kim, H.; Kim, J. H.; Park, C.; Park, I. C.; Park, S.; Ryu, G.] Univ Seoul, Seoul, South Korea; [Choi, Y.; Choi, Y. K.; Goh, J.; Kim, M. S.; Kwon, E.; Lee, B.; Lee, J.; Lee, S.; Seo, H.; Yu, I.] Sungkyunkwan Univ, Suwon, South Korea; [Janulis, M.; Juodagalvis, A.; Naujikas, R.] Vilnius Univ, Vilnius, Lithuania; [Castilla-Valdez, H.; De La Cruz-Burelo, E.; Heredia-de La Cruz, I.; Lopez-Fernandez, R.; Martinez-Ortega, J.; Sanchez-Hernandez, A.; Villasenor-Cendejas, L. M.] IPN, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico; [Carrillo Moreno, S.; Vazquez Valencia, F.] Univ Iberoamer, Mexico City, DF, Mexico; [Salazar Ibarguen, H. A.] Benemerita Univ Autonoma Puebla, Puebla, Mexico; [Casimiro Linares, E.; Morelos Pineda, A.; Reyes-Santos, M. A.] Univ Autonoma San Luis Potosi, San Luis Potosi, Mexico; [Allfrey, P.; Krofcheck, D.] Univ Auckland, Auckland, New Zealand; [Bell, A. J.; Rodrigues, N. Bernardino; Butler, A. P. H.; Butler, P. H.; Doesburg, R.; Pfeiffer, D.; Reucroft, S.; Silverwood, H.; Williams, J. C.] Univ Canterbury, Christchurch, New Zealand; [Ahmad, M.; Ansari, M. H.; Asghar, M. I.; Butt, J.; Hoorani, H. R.; Khalid, S.; Khan, W. A.; Khurshid, T.; Qazi, S.; Shah, M. A.; Shoaib, M.] Quaid I Azam Univ, Natl Ctr Phys, Islamabad, Pakistan; [Bluj, M.; Bialkowska, H.; Boimska, B.; Frueboes, T.; Gokieli, R.; Goscilo, L.; Gorski, M.; Kazana, M.; Kudla, I. M.; Nawrocki, K.; Romanowska-Rybinska, K.; Szleper, M.; Wrochna, G.; Zalewski, P.] Natl Ctr Nucl Res, Otwock, Poland; [Brona, G.; Bunkowski, K.; Cwiok, M.; Czyrkowski, H.; Dabrowski, R.; Dominik, W.; Doroba, K.; Kalinowski, A.; Konecki, M.; Krolikowski, J.; Oklinski, W.; Pozniak, K.; Zabolotny, W.; Zych, P.] Univ Warsaw, Fac Phys, Inst Expt Phys, Warsaw, Poland; [Pozniak, K.; Zabolotny, W.; Kasprowicz, G.; Romaniuk, R.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Alemany-Fernandez, R.; Almeida, N.; Bargassa, P.; David, A.; Faccioli, P.; Ferreira Parracho, P. G.; Gallinaro, M.; Ribeiro, P. Q.; Seixas, J.; Silva, J.; Varela, J.; Vischia, P.] Lab Instrumentacao & Fis Expt Particulas, Lisbon, Portugal; [Tsamalaidze, Z.; Afanasiev, S.; Belotelov, I.; Bunin, P.; Ershov, Y.; Gavrilenko, M.; Golunov, A.; Golutvin, I.; Gorbounov, N.; Gorbunov, I.; Gramenitski, I.; Kalagin, V.; Kamenev, A.; Karjavin, V.; Konoplyanikov, V.; Korenkov, V.; Kozlov, G.; Kurenkov, A.; Lanev, A.; Makankin, A.; Malakhov, A.; Melnitchenko, I.; Mitsyn, V. V.; Moisenz, P.; Oleynik, D.; Orlov, A.; Palichik, V.; Perelygin, V.; Petrosyan, A.; Savina, M.; Semenov, R.; Shmatov, S.; Shulha, S.; Skachkova, A.; Skatchkov, N.; Smetannikov, V.; Smirnov, V.; Smolin, D.; Tikhonenko, E.; Vasil'ev, S.; Volodko, A.; Zarubin, A.; Zhiltsov, V.] Joint Inst Nucl Res, Dubna, Russia; [Evstyukhin, S.; Golovtsov, V.; Ivanov, Y.; Kim, V.; Levchenko, P.; Murzin, V.; Oreshkin, V.; Smirnov, I.; Sulimov, V.; Uvarov, L.; Vavilov, S.; Vorobyev, A.; Vorobyev, An.] Petersburg Nucl Phys Inst, Gatchina St Petersburg, Russia; HTTC RDIPE, Moscow, Russia; [Andreev, Yu.; Anisimov, A.; Dermenev, A.; Gninenko, S.; Golubev, N.; Gorbunov, D.; Karneyeu, A.; Kirsanov, M.; Krasnikov, N.; Matveev, V.; Pashenkov, A.; Pivovarov, G.; Postoev, V. E.; Rubakov, V.; Shirinyants, V.; Solovey, A.; Tlisov, D.; Toropin, A.; Troitsky, S.; Musienko, Y.] Inst Nucl Res, Moscow, Russia; [Epshteyn, V.; Erofeeva, M.; Gavrilov, V.; Kaftanov, V.; Kiselevich, I.; Kolosov, V.; Konoplyannikov, A.; Kossov, M.; Kozlov, Y.; Krokhotin, A.; Litvintsev, D.; Lychkovskaya, N.; Oulianov, A.; Popov, V.; Safronov, G.; Semenov, S.; Shreyber, I.; Stepanov, N.; Stolin, V.; Vlasov, E.; Zaytsev, V.; Zhokin, A.; Starodumov, A.; Nikitenko, A.] Inst Theoret & Expt Phys, Moscow, Russia; [Zhukov, V.; Katkov, I.; Belyaev, A.; Boos, E.; Bunichev, V.; Demiyanov, A.; Dubinin, M.; Dudko, L.; Ershov, A.; Gribushin, A.; Ilyin, V.; Kaminskiy, A.; Klyukhin, V.; Kodolova, O.; Korotkikh, V.; Kryukov, A.; Lokhtin, I.; Markina, A.; Obraztsov, S.; Perfilov, M.; Petrushanko, S.; Popov, A.; Proskuryakov, A.; Sarycheva, L.; Savrin, V.; Snigirev, A.; Vardanyan, I.] Moscow MV Lomonosov State Univ, Moscow, Russia; [Andreev, V.; Azarkin, M.; Dremin, I.; Kirakosyan, M.; Leonidov, A.; Mesyats, G.; Rusakov, S. V.; Vinogradov, A.] PN Lebedev Phys Inst, Moscow, Russia; [Azhgirey, I.; Bayshev, I.; Bitioukov, S.; Grishin, V.; Kachanov, V.; Kalinin, A.; Konstantinov, D.; Korablev, A.; Krychkine, V.; Levine, A.; Petrov, V.; Ryabov, A.; Ryutin, R.; Sobol, A.; Talov, V.; Tourtchanovitch, L.; Troshin, S.; Tyurin, N.; Uzunian, A.; Volkov, A.] Inst High Energy Phys, State Res Ctr Russian Federat, Protvino, Russia; [Adzic, P.; Krpic, D.; Milenovic, P.] Univ Belgrade, Fac Phys, Belgrade, Serbia; [Djordjevic, M.; Ekmedzic, M.; Milosevic, J.; Smiljkovic, N.; Zupan, M.; Milenovic, P.] Univ Belgrade, Vinca Inst Nucl Sci, Belgrade, Serbia; [Aguilar-Benitez, M.; Alcaraz Maestre, J.; Arce, P.; Battilana, C.; Calvo, E.; Cerrada, M.; Chamizo Llatas, M.; Colino, N.; De La Cruz, B.; Delgado Peris, A.; Dominguez Vazquez, D.; Fernandez Bedoya, C.; Fernandez Ramos, J. P.; Ferrando, A.; Flix, J.; Fouz, M. C.; Garcia-Abia, P.; Lopez, O. Gonzalez; Goy Lopez, S.; Hernandez, J. M.; Josa, M. I.; Merino, G.; Puerta Pelayo, J.; Quintario Olmeda, A.; Redondo, I.; Romero, L.; Santaolalla, J.; Soares, M. S.; Willmott, C.] CIEMAT, Madrid, Spain; [Albajar, C.; Codispoti, G.; de Troconiz, J. F.] Univ Autonoma Madrid, Madrid, Spain; [Brun, H.; Cuevas, J.; Fernandez Menendez, J.; Folgueras, S.; Gonzalez Caballero, I.; Lloret Iglesias, L.; Piedra Gomez, J.] Univ Oviedo, Oviedo, Spain; [Brochero Cifuentes, J. A.; Cabrillo, I. J.; Calderon, A.; Chuang, S. H.; Duarte Campderros, J.; Felcini, M.; Fernandez, M.; Gomez, G.; Gonzalez Sanchez, J.; Graziano, A.; Jorda, C.; Lopez Virto, A.; Marco, J.; Marco, R.; Martinez Rivero, C.; Matorras, F.; Munoz Sanchez, F. J.; Rodrigo, T.; Rodriguez-Marrero, A. Y.; Ruiz-Jimeno, A.; Scodellaro, L.; Sobron Sanudo, M.; Vila, I.; Vilar Cortabitarte, R.] CSIC Univ Cantabria, Inst Fis Cantabria IFCA, Santander, Spain; [Genchev, V.; Iaydjiev, P.; Puljak, I.; Chierici, R.; Lingemann, J.; Guthoff, M.; Hartmann, F.; Hauth, T.; Mohanty, A. K.; Calabria, C.; De Filippis, N.; Meneghelli, M.; Di Matteo, L.; Gennai, S.; De Cosa, A.; Paolucci, P.; Bacchetta, N.; Branca, A.; Lucaroni, A.; D'Agnolo, R. T.; Fiori, F.; Squillacioti, P.; Grassi, M.; Meridiani, P.; Mariotti, C.; Musich, M.; Marone, M.; Montanino, D.; Grishin, V.; Abbaneo, D.; Aspell, P.; Auffray, E.; Auzinger, G.; Bachtis, M.; Baechler, J.; Baillon, P.; Ball, A. H.; Barney, D.; Benitez, J. F.; Bernet, C.; Bialas, W.; Bianchi, G.; Bloch, P.; Bocci, A.; Bonato, A.; Botta, C.; Breuker, H.; Campi, D.; Camporesi, T.; Cano, E.; Cerminara, G.; Charkiewicz, A.; Christiansen, T.; Perez, J. A. Coarasa; Cure, B.; D'Enterria, D.; Dabrowski, A.; Daguin, J.; De Roeck, A.; Di Guida, S.; Dobson, M.; Dupont-Sagorin, N.; Elliott-Peisert, A.; Eppard, M.; Frisch, B.; Funk, W.; Gaddi, A.; Gastal, M.; Georgiou, G.; Gerwig, H.; Giffels, M.; Gigi, D.; Gill, K.; Giordano, D.; Girone, M.; Giunta, M.; Glege, F.; Garrido, R. Gomez-Reino; Goudard, R.; Govoni, P.; Gowdy, S.; Guida, R.; Gutleber, J.; Hammarstrom, R.; Hammer, J.; Hansen, M.; Harris, P.; Hartl, C.; Harvey, J.; Hegner, B.; Hinzmann, A.; Honma, A.; Innocente, V.; Janot, P.; Kaadze, K.; Karavakis, E.; Kloukinas, K.; Kousouris, K.; Lecoq, P.; Lee, Y. -J.; Lenzi, P.; Loos, R.; Lourenco, C.; Macpherson, A.; Magini, N.; Maeki, T.; Malberti, M.; Malgeri, L.; Mannelli, M.; Marchioro, A.; Noite, J. Marques Pinho; Masetti, L.; Meijers, F.; Mersi, S.; Meschi, E.; Moneta, L.; Mozer, M. U.; Mulders, M.; Musella, P.; Onnela, A.; Orsini, L.; Osborne, J. A.; Cortezon, E. Palencia; Perez, E.; Perrozzi, L.; Petagna, P.; Petrilli, A.; Petrucci, A.; Pfeiffer, A.; Pierini, M.; Pimiae, M.; Piparo, D.; Polese, G.; Postema, H.; Quertenmont, L.; Racz, A.; Reece, W.; Ricci, D.; Antunes, J. Rodrigues; Rolandi, G.; Rovelli, C.; Rovere, M.; Ryjov, V.; Sakulin, H.; Samyn, D.; Santanastasio, F.; Schaefer, C.; Schwick, C.; Sciaba, A.; Segoni, I.; Sekmen, S.; Sharma, A.; Siegrist, P.; Silva, P.; Simon, M.; Sphicas, P.; Spiga, D.; Taylor, B. G.; Teller, O.; Tropea, P.; Tropea, J.; Tsesmelis, E.; Tsirou, A.; Vasey, F.; Veillet, L.; Veres, G. I.; Vichoudis, P.; Vlimant, J. R.; Wertelaers, P.; Woehri, H. K.; Worm, S. D.; Zeuner, W. D.; Gao, Z.] European Org Nucl Res, CERN, Geneva, Switzerland; [Bertl, W.; Deiters, K.; Erdmann, W.; Feichtinger, D.; Gabathuler, K.; Horisberger, R.; Ingram, Q.; Kaestli, H. C.; Koenig, S.; Kotlinski, D.; Langenegger, U.; Meier, B.; Meier, F.; Renker, D.; Rohe, T.; Sakhelashvili, T.; Dambach, S.; Eggel, C.; Marchica, C.; Naegeli, C.; Trueb, P.] Paul Scherrer Inst, Villigen, Switzerland; [Baeni, L.; Behner, F.; Betev, B.; Blau, B.; Bortignon, P.; Buchmann, M. A.; Casal, B.; Chanon, N.; Chen, Z.; Di Calafiori, D. R. Da Silva; Dambach, S.; Davatz, G.; Deisher, A.; Deisher, G.; Dittmar, M.; Djambazov, L.; Donega, M.; Duenser, M.; Eggel, C.; Eugster, J.; Faber, G.; Freudenreich, K.; Grab, C.; Hintz, W.; Hits, D.; Hofer, H.; Holme, O.; Horvath, I.; Lecomte, P.; Lustermann, W.; Marchica, C.; Marini, A. C.; del Arbol, P. Martinez Ruiz; Mohr, N.; Moortgat, F.; Naegeli, C.; Nef, P.; Nessi-Tedaldi, F.; Pandolfi, F.; Pape, L.; Pauss, F.; Peruzzi, M.; Punz, T.; Ronga, F. J.; Roeser, U.; Rossini, M.; Sala, L.; Sanchez, A. K.; Sawley, M. -C.; Schinzel, D.; Starodumov, A.; Stieger, B.; Suter, H.; Takahashi, M.; Tauscher, L.; Thea, A.; Theofilatos, K.; Treille, D.; Trueb, P.; Udriot, S.; Urscheler, C.; Urscheler, G.; von Gunten, H. P.; Wallny, R.; Weber, H. A.; Wehrli, L.; Weng, J.; Zelepoukine, S.] Swiss Fed Inst Technol, Inst Particle Phys, Zurich, Switzerland; [Amsler, C.; Chiochia, V.; De Visscher, S.; Favaro, C.; Rikova, M. Ivova; Kilminster, B.; Mejias, B. Millan; Otiougova, P.; Robmann, P.; Snoek, H.; Tupputi, S.; Verzetti, M.] Univ Zurich, Zurich, Switzerland; [Chang, Y. H.; Chen, K. H.; Chen, W. T.; Ferro, C.; Go, A.; Kuo, C. M.; Li, S. W.; Lin, W.; Liu, M. H.; Liu, Z. K.; Lu, Y. J.; Singh, A. P.; Volpe, R.; Wu, J. H.; Yu, S. S.] Natl Cent Univ, Chungli, Taiwan; [Bartalini, P.; Chang, P.; Chang, Y. H.; Chang, Y. W.; Chao, Y.; Chen, K. F.; Dietz, C.; Gao, Z.; Grundler, U.; Hou, W. -S.; Hsiung, Y.; Kao, K. Y.; Lei, Y. J.; Liau, J. J.; Lin, S. W.; Lu, R. -S.; Majumder, D.; Petrakou, E.; Shi, X.; Shiu, J. G.; Tzeng, Y. M.; Ueno, K.; Velikzhanin, Y.; Wan, X.; Wang, C. C.; Wang, M.; Wei, J. T.; Yeh, P.] NTU, Taipei, Taiwan; [Asavapibhop, B.; Srimanobhas, N.] Chulalongkorn Univ, Bangkok, Thailand; [Adiguzel, A.; Bakirci, M. N.; Cerci, S.; Dozen, C.; Dumanoglu, I.; Eskut, E.; Girgis, S.; Gokbulut, G.; Gurpinar, E.; Hos, I.; Kangal, E. E.; Karaman, T.; Karapinar, G.; Topaksu, A. Kayis; Onengut, G.; Ozdemir, K.; Ozturk, S.; Polatoz, A.; Sogut, K.; Cerci, D. Sunar; Tali, B.; Topakli, H.; Vergili, L. N.; Vergili, M.] Cukurova Univ, Adana, Turkey; [Akin, I. V.; Aliev, T.; Bilin, B.; Deniz, M.; Gamsizkan, H.; Guler, A. M.; Ocalan, K.; Ozpineci, A.; Serin, M.; Sever, R.; Surat, U. E.; Zeyrek, M.] Middle E Tech Univ, Dept Phys, Ankara, Turkey; [Deliomeroglu, M.; Gulmez, E.; Isildak, B.; Kaya, M.; Kaya, O.; Ozkorucuklu, S.; Sonmez, N.] Bogazici Univ, Istanbul, Turkey; [Cankocak, K.] Istanbul Tech Univ, Istanbul, Turkey; [Grynyov, B.] Natl Acad Sci, Inst Single Crystals, Kharkov, Ukraine; [Levchuk, L.; Lukyanenko, S.; Soroka, D.; Sorokin, P.] Kharkov Inst Phys & Technol, Natl Sci Ctr, Kharkov, Ukraine; [Ahmad, M. K. H.; Branson, A.; McClatchey, R.; Odeh, M.; Shamdasani, J.; Soomro, K.] Univ W England, Ctr Complex Cooperat Syst, Bristol, Avon, England; [Barrass, T.; Bostock, F.; Brooke, J. J.; Clement, E.; Cussans, D.; Flacher, H.; Frazier, R.; Goldstein, J.; Grimes, M.; Heath, G. P.; Heath, H. F.; Kreczko, L.; Lacesso, W.; Metson, S.; Newbold, D. M.; Nirunpong, K.; Poll, A.; Senkin, S.; Smith, V. J.; Williams, T.] Univ Bristol, Bristol, Avon, England; [Worm, S. D.; Newbold, D. M.; Basso, L.; Bateman, E.; Bell, K. W.; Belyaev, A.; Brew, C.; Brown, R. M.; Camanzi, B.; Cockerill, D. J. A.; Connolly, J. F.; Coughlan, J. A.; Denton, L. G.; Flower, P. S.; French, M. J.; Greenhalgh, R. J. S.; Halsall, R. N. J.; Harder, K.; Harper, S.; Hill, J. A.; Jackson, J.; Kennedy, B. W.; Lintern, A. L.; Lodge, A. B.; Olaiya, E.; Pearson, M. R.; Petyt, D.; Radburn-Smith, B. C.; Shepherd-Themistocleous, C. H.; Smith, B. J.; Sproston, M.; Stephenson, R.; Tomalin, I. R.; Torbet, M. J.; Williams, J. H.; Womersley, W. J.] Rutherford Appleton Lab, Didcot, Oxon, England; [Bainbridge, R.; Ball, G.; Ballin, J.; Bauer, D.; Beuselinck, R.; Buchmuller, O.; Colling, D.; Cripps, N.; Cutajar, M.; Dauncey, P.; Davies, G.; Della Negra, M.; Ferguson, W.; Fulcher, J.; Futyan, D.; Gilbert, A.; Bryer, A. Guneratne; Hall, G.; Hatherell, Z.; Hays, J.; Iles, G.; Jarvis, M.; Jones, J.; Karapostoli, G.; Kenzie, M.; Leaver, J.; Lyons, L.; Magnan, A. -M.; Marrouche, J.; Mathias, B.; Miller, D. G.; Nandi, R.; Nash, J.; Nikitenko, A.; Noy, M.; Papageorgiou, A.; Pela, J.; Pesaresi, M.; Petridis, K.; Pioppi, M.; Rand, D.; Raymond, D. M.; Rogerson, S.; Rose, A.; Ryan, M. J.; Seez, C.; Sharp, P.; Sparrow, A.; Stoye, M.; Tapper, A.; Timlin, C.; Tourneur, S.; Acosta, M. Vazquez; Virdee, T.; Wakefield, S.; Wardle, N.; Whyntie, T.; Wingham, M.; Zorba, O.] Imperial Coll, London, England; [Chadwick, M.; Cole, J. E.; Hobson, P. R.; Khan, A.; Kyberd, P.; Leggat, D.; Leslie, D.; Martin, W.; Reid, I. D.; Symonds, P.; Teodorescu, L.; Turner, M.] Brunel Univ, Uxbridge, Middx, England; [Dittmann, J.; Hatakeyama, K.; Liu, H.; Scarborough, T.] Baylor Univ, Waco, TX USA; [Charaf, O.; Henderson, C.; Rumerio, P.] Univ Alabama, Tuscaloosa, AL USA; [Avetisyan, A.; Bose, T.; Jarrin, E. Carrera; Fantasia, C.; Hazen, E.; Heister, A.; St. John, J.; Lawson, P.; Lazic, D.; Rohlf, J.; Sperka, D.; Sulak, L.; Rodriguez, F. Varela; Wu, S.] Boston Univ, Boston, MA USA; [Alimena, J.; Bhattacharya, S.; Cutts, D.; Demiragli, Z.; Ferapontov, A.; Garabedian, A.; Heintz, U.; Hooper, R.; Jabeen, S.; Kukartsev, G.; Laird, E.; Landsberg, G.; Luk, M.; Narain, M.; Nguyen, D.; Segala, M.; Sinthuprasith, T.; Speer, T.; Tsang, K. V.; Unalan, Z.] Brown Univ, Providence, RI USA; [Breedon, R.; Breto, G.; Sanchez, M. Calderon De La Barca; Case, M.; Chauhan, S.; Chertok, M.; Conway, J.; Conway, R.; Cox, P. T.; Dolen, J.; Erbacher, R.; Gardner, M.; Grim, G.; Gunion, J.; Holbrook, B.; Ko, W.; Kopecky, A.; Lander, R.; Lin, F. C.; Miceli, T.; Murray, P.; Nikolic, M.; Pellett, D.; Ricci-Tam, F.; Rowe, J.; Rutherford, B.; Searle, M.; Smith, J.; Squires, M.; Tripathi, M.; Sierra, R. Vasquez; Yohay, R.] Univ Calif, Davis, CA USA; [Felcini, M.; Andreev, V.; Arisaka, K.; Cline, D.; Cousins, R.; Duris, J.; Erhan, S.; Everaerts, P.; Farrell, C.; Hauser, J.; Ignatenko, M.; Jarvis, C.; Kubic, J.; Otwinowski, S.; Plager, C.; Rakness, G.; Schlein, P.; Traczyk, P.; Valuev, V.; Weber, M.; Yang, X.; Zheng, Y.] Univ Calif Los Angeles, Los Angeles, CA USA; [Babb, J.; Clare, R.; Dinardo, M. E.; Ellison, J.; Gary, J. W.; Giordano, F.; Hanson, G.; Jeng, G. Y.; Layter, J. G.; Liu, H.; Long, O. R.; Luthra, A.; Nguyen, H.; Paramesvaran, S.; Shen, B. C.; Sturdy, J.; Sumowidagdo, S.; Wilken, R.; Wimpenny, S.] Univ Calif Riverside, Riverside, CA USA; [Andrews, W.; Branson, J. G.; Cerati, G. B.; Cinquilli, M.; Cittolin, S.; Evans, D.; Holzner, A.; Kelley, R.; Lebourgeois, M.; Letts, J.; Macneill, I.; Mangano, B.; Martin, T.; Mrak-Tadel, A.; Padhi, S.; Palmer, C.; Petrucciani, G.; Pieri, M.; Sani, M.; Sfiligoi, I.; Sharma, V.; Simon, S.; Sudano, E.; Tadel, M.; Tu, Y.; Vartak, A.; Wasserbaech, S.; Wuerthwein, F.; Yagil, A.; Yoo, J.] Univ Calif San Diego, La Jolla, CA USA; [Barge, D.; Bellan, R.; Campagnari, C.; D'Alfonso, M.; Danielson, T.; Flowers, K.; Geffert, P.; Golf, F.; Incandela, J.; Justus, C.; Kalavase, P.; Kovalskyi, D.; Krutelyov, V.; Kyre, S.; Lowette, S.; Magazzu, G.; Villalba, R. Magana; Mccoll, N.; Pavlunin, V.; Ribnik, J.; Richman, J.; Rossin, R.; Stuart, D.; To, W.; West, C.; White, D.] Univ Calif Santa Barbara, Santa Barbara, CA USA; [Dias, F. A.; Dubinin, M.; Adamczyk, D.; Apresyan, A.; Barczyk, A.; Bornheim, A.; Bunn, J.; Chen, Y.; Denis, G.; Di Marco, E.; Duarte, J.; Galvez, P.; Gataullin, M.; Kcira, D.; Lebeau, M.; Lebeau, I.; Litvine, V.; Ma, Y.; Maxa, Z.; Mott, A.; Mughal, A.; Nae, D.; Newman, H. B.; Ravot, S.; Rogan, C.; Rozsa, S. G.; Shevchenko, S.; Shin, K.; Spiropulu, M.; Steenberg, C.; Thomas, M.; Timciuc, V.; van Lingen, F.; Veverka, J.; Voicu, B. R.; Wilkinson, R.; Xie, S.; Yang, Y.; Zhang, L.; Zhu, K.; Zhu, R. Y.; Crotty, I.; Lusin, S.] CALTECH, Pasadena, CA USA; [Azzolini, V.; Calamba, A.; Carroll, R.; Ferguson, T.; Iiyama, Y.; Jang, D. W.; Jun, S. Y.; Liu, Y. F.; Paulini, M.; Russ, J.; Terentyev, N.; Vogel, H.; Vorobiev, I.] Carnegie Mellon Univ, Pittsburg, KS USA; [Cumalat, J. P.; Drell, B. R.; Ford, W. T.; Gaz, A.; Heyburn, B.; Johnson, D.; Lopez, E. L.; Nauenberg, U.; Smith, J. G.; Stenson, K.; Ulmer, K. A.; Wagner, S. R.; Zang, S. L.] Univ Colorado, Boulder, CO USA; [Agostino, L.; Alexander, J.; Chatterjee, A.; Eggert, N.; Gibbons, L. K.; Heltsley, B.; Khukhunaishvili, A.; Kreis, B.; Kuznetsov, V.; Mirman, N.; Kaufman, G. Nicolas; Patterson, J. R.; Riley, D.; Ryd, A.; Salvati, E.; Stroiney, S.; Sun, W.; Teo, W. D.; Thom, J.; Thompson, J.; Tucker, J.; Vaughan, J.; Weng, Y.; Winstrom, L.; Wittich, P.] Cornell Univ, Ithaca, NY USA; [Winn, D.] Fairfield Univ, Fairfield, CT USA; [Abdullin, S.; Albert, M.; Albrow, M.; Anderson, J.; Apollinari, G.; Atac, M.; Badgett, W.; Bailleux, D.; Bakken, J. A.; Baldin, B.; Banicz, K.; Bauerdick, L. A. T.; Beretvas, A.; Berryhill, J.; Bhat, P. C.; Binkley, M.; Borcherding, F.; Burkett, K.; Butler, J. N.; Chetluru, V.; Cheung, H. W. K.; Chlebana, F.; Cihangir, S.; Dagenhart, W.; Derylo, G.; Dumitrescu, C.; Dykstra, D.; Eartly, D. P.; Elias, J. E.; Elvira, V. D.; Eulisse, G.; Evans, D.; Fagan, D.; Fisk, I.; Foulkes, S.; Freeman, J.; Gaines, I.; Gao, Y.; Gartung, P.; Giacchetti, L.; Gottschalk, E.; Green, D.; Guo, Y.; Gutsche, O.; Hahn, A.; Hanlon, J.; Harris, R. M.; Hirschauer, J.; Holzman, B.; Hooberman, B.; Howell, J.; Huang, C. H.; Hufnagel, D.; Jindariani, S.; Johnson, M.; Jones, C. D.; Joshi, U.; Juska, E.; Klima, B.; Kunori, S.; Kwan, S.; Larson, K.; Leonidopoulos, C.; Linacre, J.; Lincoln, D.; Lipton, R.; Perez, J. A. Lopez; Los, S.; Lykken, J.; Maeshima, K.; Marraffino, J. M.; Maruyama, S.; Mason, D.; McBride, P.; McCauley, T.; Mishra, K.; Moccia, S.; Mommsen, R. K.; Mrenna, S.; Murray, S. J.; Musienko, Y.; Muzaffar, S.; Newman-Holmes, C.; O'Dell, V.; Osborne, I.; Pivarski, J.; Popescu, S.; Pordes, R.; Prokofyev, O.; Rapsevicius, V.; Ronzhin, A.; Rossman, P.; Ryu, S.; Sexton-Kennedy, E.; Sharma, S.; Shaw, T. M.; Smith, R. P.; Soha, A.; Spalding, W. J.; Spiegel, L.; Tanenbaum, W.; Taylor, L.; Thompson, R.; Tiradani, A.; Tkaczyk, S.; Tran, N. V.; Tuura, L.; Uplegger, L.; Vaandering, E. W.; Vidal, R.; Whitmore, J.; Wu, W.; Yang, F.; Yarba, J.; Yun, J. C.; Zimmerman, T.] Fermilab Natl Accelerator Lab, Batavia, IL USA; [Acosta, D.; Avery, P.; Barashko, V.; Bourilkov, D.; Chen, M.; Cheng, T.; Das, S.; De Gruttola, M.; Di Givanni, G. P.; Dobur, D.; Dolinsky, S.; Drozdetskiy, A.; Field, R. D.; Fisher, M.; Fu, Y.; Furic, I. K.; Gartner, J.; Gorn, L.; Holmes, D.; Hugon, J.; Kim, B.; Konigsberg, J.; Korytov, A.; Kropivnitskaya, A.; Kypreos, T.; Low, J. F.; Madorsky, A.; Matchev, K.; Milenovic, P.; Mitselmakher, G.; Muniz, L.; Park, M.; Remington, R.; Rinkevicius, A.; Scurlock, B.; Skhirtladze, N.; Snowball, M.; Stasko, J.; Yelton, J.; Zakaria, M.] Univ Florida, Gainesville, FL USA; [Gaultney, V.; Hewamanage, S.; Lebolo, L. M.; Linn, S.; Markowitz, P.; Martinez, G.; Rodriguez, J. L.] Florida Int Univ, Miami, FL USA; [Adams, T.; Askew, A.; Bertoldi, M.; Bochenek, J.; Chen, J.; Dharmaratna, W. G. D.; Diamond, B.; Gleyzer, S. V.; Haas, J.; Hagopian, S.; Hagopian, V.; Jenkins, M.; Johnson, K. F.; Prosper, H.; Tentindo, S.; Veeraraghavan, V.; Weinberg, M.] Florida State Univ, Tallahassee, FL USA; [Baarmand, M. M.; Dorney, B.; Hohlmann, M.; Kalakhety, H.; Ralich, R.; Vodopiyanov, I.; Yumiceva, F.] Florida Inst Technol, Melbourne, FL USA; [Adams, M. R.; Anghel, I. M.; Apanasevich, L.; Bai, Y.; Bazterra, V. E.; Betts, R. R.; Bucinskaite, I.; Callner, J.; Cavanaugh, R.; Chung, M. H.; Evdokimov, O.; Garcia-Solis, E. J.; Gauthier, L.; Gerber, C. E.; Hofman, D. J.; Hollis, R.; Iordanova, A.; Khalatyan, S.; Kunde, G. J.; Lacroix, F.; O'Brien, C.; Silkworth, C.; Silvestre, C.; Smoron, A.; Strom, D.; Turner, P.; Varelas, N.] Univ Illinois, Chicago, IL USA; [Ozturk, S.; Akgun, U.; Albayrak, E. A.; Ayan, A. S.; Bilki, B.; Clarida, W.; Debbins, P.; Duru, F.; Ingram, F. D.; McCliment, E.; Merlo, J. P.; Mermerkaya, H.; Mestvirishvili, A.; Miller, M. J.; Moeller, A.; Nachtman, J.; Newsom, C. R.; Norbeck, E.; Olson, J.; Onel, Y.; Ozok, F.; Schmidt, I.; Sen, S.; Tan, P.; Tiras, E.; Wetzel, J.; Yetkin, T.; Yi, K.] Univ Iowa, Iowa City, IA USA; [Barnett, B. A.; Blumenfeld, B.; Bolognesi, S.; Fehling, D.; Giurgiu, G.; Gritsan, A. V.; Guo, Z. J.; Hu, G.; Maksimovic, P.; Swartz, M.; Whitbeck, A.] Johns Hopkins Univ, Baltimore, MD USA; [Sibille, J.; Baringer, P.; Bean, A.; Benelli, G.; Coppage, D.; Grachov, O.; Iii, R. P. Kenny; Murray, M.; Noonan, D.; Radicci, V.; Sanders, S.; Stringer, R.; Tinti, G.; Wood, J. S.] Univ Kansas, Lawrence, KS USA; [Barfuss, A. F.; Bolton, T.; Chakaberia, I.; Ivanov, A.; Khalil, S.; Makouski, M.; Maravin, Y.; Shrestha, S.; Svintradze, I.] Kansas State Univ, Manhattan, KS USA; [Gronberg, J.; Lange, D.; Rebassoo, F.; Wright, D.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Baden, A.; Bard, R.; Boutemeur, M.; Calvert, B.; Eno, S. C.; Gomez, J. A.; Grassi, T.; Hadley, N. J.; Kellogg, R. G.; Kirn, M.; Kolberg, T.; Lu, Y.; Marionneau, M.; Mignerey, A. C.; Pedro, K.; Peterman, A.; Rossato, K.; Skuja, A.; Temple, J.; Tonjes, M. B.; Tonwar, S. C.; Toole, T.; Twedt, E.] Univ Maryland, College Pk, MD USA; [Apyan, A.; Bauer, G.; Bendavid, J.; Busza, W.; Butz, E.; Cali, I. A.; Chan, M.; Dutta, V.; Ceballos, G. Gomez; Goncharov, M.; Kim, Y.; Klute, M.; Krajczar, K.; Levin, A.; Luckey, P. D.; Ma, T.; Nahn, S.; Paus, C.; Ralph, D.; Roland, C.; Roland, G.; Rudolph, M.; Stephans, G. S. F.; Stoeckli, F.; Sumorok, K.; Sung, K.; Velicanu, D.; Wenger, E. A.; Wolf, R.; Wyslouch, B.; Yang, M.; Yilmaz, Y.; Yoon, A. S.; Zanetti, M.; Zhukova, V.] MIT, Cambridge, MA USA; [Cooper, S. I.; Cushman, P.; Dahmes, B.; De Benedetti, A.; Egeland, R.; Franzoni, G.; Gude, A.; Haupt, J.; Inyakin, A.; Kao, S. C.; Klapoetke, K.; Kubota, Y.; Mans, J.; Pastika, N.; Rusack, R.; Singovsky, A.; Tambe, N.; Turkewitz, J.] Univ Minnesota, Minneapolis, MN USA; [Cremaldi, L. M.; Kroeger, R.; Perera, L.; Rahmat, R.; Reidy, J.; Sanders, D. A.; Summers, D.] Univ Mississippi, Oxford, MS USA; [Attebury, G.; Avdeeva, E.; Bloom, K.; Bockelman, B.; Bose, S.; Claes, D. R.; Dominguez, A.; Eads, M.; Keller, J.; Kravchenko, I.; Lazo-Flores, J.; Lundstedt, C.; Malik, S.; Snihur, R.; Snow, G. R.; Swanson, D.] Univ Nebraska Lincoln, Lincoln, NE USA; [Baur, U.; Godshalk, A.; Iashvili, I.; Jain, S.; Kharchilava, A.; Kumar, A.; Rappoccio, S.; Shipkowski, S. P.; Smith, K.] SUNY Buffalo, Buffalo, NY USA; [Alverson, G.; Barberis, E.; Baumgartel, D.; Chasco, M.; Haley, J.; Moromisato, J.; Nash, D.; Orimoto, T.; Swain, J.; Trocino, D.; Von Goeler, E.; Wood, D.; Zhang, J.] Northeastern Univ, Boston, MA USA; [Anastassov, A.; Gobbi, B.; Hahn, K. A.; Kubik, A.; Lusito, L.; Odell, N.; Ofierzynski, R. A.; Pollack, B.; Pozdnyakov, A.; Schmitt, M.; Stoynev, S.; Velasco, M.; Won, S.] Northwestern Univ, Evanston, IL USA; [Antonelli, L.; Baumbaugh, B.; Berry, D.; Brinkerhoff, A.; Chan, K. M.; Heering, A. H.; Hildreth, M.; Jessop, C.; Karmgard, D. J.; Kellams, N.; Kolb, J.; Lannon, K.; Luo, W.; Lynch, S.; Marinelli, N.; Morse, D. M.; Pearson, T.; Planer, M.; Ruchti, R.; Slaunwhite, J.; Valls, N.; Wayne, M.; Wolf, M.; Woodard, A.] Univ Notre Dame, Notre Dame, IN USA; [Bylsma, B.; Durkin, L. S.; Hill, C.; Hughes, R.; Kotov, K.; Ling, T. Y.; Puigh, D.; Rodenburg, M.; Rush, C. J.; Sehgal, V.; Vuosalo, C.; Williams, G.; Winer, B. L.] Ohio State Univ, Columbus, OH USA; [Adam, N.; Berry, E.; Elmer, P.; Gerbaudo, D.; Halyo, V.; Hebda, P.; Hegeman, J.; Hunt, A.; Jindal, P.; Koay, S. A.; Pegna, D. Lopes; Lujan, P.; Marlow, D.; Medvedeva, T.; Mooney, M.; Olsen, J.; Piroue, P.; Quan, X.; Raval, A.; Saka, H.; Stickland, D.; Tully, C.; Werner, J. S.; Wildish, T.; Xie, Z.; Zenz, S. C.; Zuranski, A.] Princeton Univ, Princeton, NJ USA; [Acosta, J. G.; Del Alamo, M. Bonnett; Brownson, E.; Huang, X. T.; Lopez, A.; Mendez, H.; Oliveros, S.; Vargas, J. E. Ramirez; Zatserklyaniy, A.] Univ Puerto Rico, Mayaguez, PR USA; [Alagoz, E.; Arndt, K.; Barnes, V. E.; Benedetti, D.; Bolla, G.; Bortoletto, D.; Bujak, A.; De Mattia, M.; Everett, A.; Gutay, L.; Hu, Z.; Jones, M.; Koybasi, O.; Kress, M.; Laasanen, A. T.; Lee, J.; Leonardo, N.; Liu, C.; Maroussov, V.; Merkel, P.; Miller, D. H.; Miyamoto, J.; Neumeister, N.; Rott, C.; Roy, A.; Shipsey, I.; Silvers, D.; Svyatkovskiy, A.; Marono, M. Vidal; Yoo, H. D.; Zablocki, J.; Zheng, Y.] Purdue Univ, W Lafayette, IN USA; [Guragain, S.; Parashar, N.] Purdue Univ Calumet, Hammond, LA USA; [Adair, A.; Akgun, B.; Boulahouache, C.; Cuplov, V.; Ecklund, K. M.; Geurts, F. J. M.; Lee, S. J.; Li, W.; Liu, J. H.; Matveev, M.; Padley, B. P.; Redjimi, R.; Roberts, J.; Tumanov, A.; Yepes, P.; Zabel, J.] Rice Univ, Houston, TX USA; [Betchart, B.; Bodek, A.; Budd, H.; Chung, Y. S.; Covarelli, R.; de Barbaro, P.; Demina, R.; Eshaq, Y.; Ferbel, T.; Garcia-Bellido, A.; Ginther, G.; Goldenzweig, P.; Gotra, Y.; Han, J.; Harel, A.; Korjenevski, S.; Miner, D. C.; Orbaker, D.; Sakumoto, W.; Slattery, P.; Vishnevskiy, D.; Zielinski, M.] Univ Rochester, Rochester, NY USA; [Bhatti, A.; Ciesielski, R.; Demortier, L.; Goulianos, K.; Lungu, G.; Malik, S.; Mesropian, C.] Rockefeller Univ, New York, NY USA; [Arora, S.; Barker, A.; Chou, J. P.; Contreras-Campana, C.; Contreras-Campana, E.; Duggan, D.; Ferencek, D.; Gershtein, Y.; Gray, R.; Halkiadakis, E.; Hidas, D.; Lath, A.; Panwalkar, S.; Park, M.; Patel, R.; Rekovic, V.; Robles, J.; Rose, K.; Salur, S.; Schnetzer, S.; Seitz, C.; Somalwar, S.; Stone, R.; Thomas, S.] Rutgers State Univ, Piscataway, NJ USA; [Cerizza, G.; Hollingsworth, M.; Ragghianti, G.; Spanier, S.; Yang, Z. C.; York, A.] Univ Tennessee, Knoxville, TN USA; [Bouhali, O.; Eusebi, R.; Flanagan, W.; Gilmore, J.; Kamon, T.; Khotilovich, V.; Montalvo, R.; Nguyen, C. N.; Osipenkov, I.; Pakhotin, Y.; Perloff, A.; Roe, J.; Safonov, A.; Sakuma, T.; Sengupta, S.; Suarez, I.; Tatarinov, A.; Toback, D.] Texas A&M Univ, College Stn, TX USA; [Akchurin, N.; Damgov, J.; Dragoiu, C.; Dudero, P. R.; Jeong, C.; Kovitanggoon, K.; Lee, S. W.; Libeiro, T.; Sill, A.; Volobouev, I.; Wigmans, R.] Texas Tech Univ, Lubbock, TX USA; [Appelt, E.; Delannoy, A. G.; Engh, D.; Florez, C.; Gabella, W.; Greene, S.; Gurrola, A.; Johns, W.; Kurt, P.; Maguire, C.; Melo, A.; Sharma, M.; Sheldon, P.; Snook, B.; Tuo, S.; Velkovska, J.] Vanderbilt Univ, Nashville, TN USA; [Andelin, D.; Arenton, M. W.; Balazs, M.; Boutle, S.; Conetti, S.; Cox, B.; Francis, B.; Goodell, J.; Hirosky, R.; Ledovskoy, A.; Lin, C.; Neu, C.; Phillips, D., II; Wood, J.] Univ Virginia, Charlottesville, VA USA; [Gollapinni, S.; Harr, R.; Karchin, P. E.; Don, C. Kottachchi Kankanamge; Lamichhane, P.; Mattson, M.; Milstene, C.; Sakharov, A.] Wayne State Univ, Detroit, MI USA; [Zelepoukine, S.; Anderson, M.; Belknap, D.; Bellinger, J. N.; Borrello, L.; Bradley, D.; Carlsmith, D.; Cepeda, M.; Crotty, I.; Dasu, S.; Feyzi, F.; Friis, E.; Gorski, T.; Gray, L.; Grogg, K. S.; Grothe, M.; Hall-Wilton, R.; Herndon, M.; Herve, A.; Klabbers, P.; Klukas, J.; Lackey, J.; Lanaro, A.; Lazaridis, C.; Loveless, R.; Lusin, S.; de Abril, M. Magrans; Maier, W.; Mohapatra, A.; Ojalvo, I.; Palmonari, F.; Pierro, G. A.; Reeder, D.; Ross, I.; Savin, A.; Smith, W. H.; Swanson, J.; Wenman, D.] Univ Wisconsin, Madison, WI USA; [Fabjan, C.; Fruehwirth, R.; Jeitler, M.; Krammer, M.; Wulz, C. -E.] Vienna Univ Technol, Vienna, Austria; [Anjos, T. S.; Bernardes, C. A.; Gregores, E. M.; Mercadante, P. G.] Univ Fed ABC, Santo Andre, Brazil; [Assran, Y.] Suez Canal Univ, Suez, Egypt; [Elgammal, S.; Khalil, S.] Zewail City Sci & Technol, Zewail, Egypt; [Kamel, A. Ellithi] Cairo Univ, Cairo, Egypt; [Mahmoud, M. A.] Fayoum Univ, Al Fayyum, Egypt; [Radi, A.] British Univ, Cairo, Egypt; [Radi, A.] Ain Shams Univ, Cairo, Egypt; [Agram, J. -L.; Conte, E.; Drouhin, F.; Fontaine, J. -C.] Univ Haute Alsace, Mulhouse, France; [Bergholz, M.; Lohmann, W.; Schmidt, R.] Brandenburg Tech Univ Cottbus, Cottbus, Germany; [Vesztergombi, G.; Veres, G. I.] Eotvos Lorand Univ, Budapest, Hungary; [Gurtu, A.] King Abdulaziz Univ, Jeddah, Saudi Arabia; [Maity, M.] Univ Visva Bharati, Santini Ketan, W Bengal, India; [Arfaei, H.; Fahim, A.] Sharif Univ Technol, Tehran, Iran; [Etesami, S. M.] Isfahan Univ Technol, Esfahan, Iran; [Hashemi, M.] Shiraz Univ, Shiraz, Iran; [Safarzadeh, B.] Islamic Azad Univ, Sci & Res Branch, Plasma Phys Res Ctr, Tehran, Iran; [Saizu, M. A.; Popescu, S.] Horia Hulubei Natl Inst Phys & Nucl Engn IFIN HH, Bucharest, Romania; [Colafranceschi, S.] Univ Rome, Fac Ingn, Rome, Italy; [Cavallo, N.; Fabozzi, F.] Univ Basilicata, Potenza, Italy; [Meola, S.] Univ Guglielmo Marconi, Rome, Italy; [Biasotto, M.; Gulmini, M.; Maron, G.] Ist Nazl Fis Nucl, Lab Nazl Legnaro, Legnaro, Italy; [Martini, L.] Univ Siena, Siena, Italy; [Serban, A. T.] Univ Bucharest, Fac Phys, Bucharest, Romania; [Baccaro, S.] ENEA Casaccia Res Ctr, Santa Maria Di Galeria, Italy; [Rolandi, G.] Ist Nazl Fis Nucl, Scuola Normale, Pisa, Italy; [Amsler, C.] Albert Einstein Ctr Fundamental Phys, Bern, Switzerland; [Bakirci, M. N.; Topakli, H.] Gaziosmanpasa Univ, Tokat, Turkey; [Cerci, S.; Cerci, D. Sunar; Tali, B.] Adiyaman Univ, Adiyaman, Turkey; [Karapinar, G.] Izmir Inst Technol, Izmir, Turkey; [Sogut, K.] Mersin Univ, Mersin, Turkey; [Isildak, B.] Ozyegin Univ, Istanbul, Turkey; [Kaya, M.; Kaya, O.] Kafkas Univ, Kars, Turkey; [Ozkorucuklu, S.] Suleyman Demirel Univ, Isparta, Turkey; [Sonmez, N.] Ege Univ, Izmir, Turkey; [Basso, L.; Belyaev, A.] Univ Southampton, Sch Phys & Astron, Southampton, Hants, England; [Jeng, G. Y.] Univ Sydney, Sydney, NSW, Australia; [Wasserbaech, S.] Utah Valley Univ, Orem, UT USA; [Leonidopoulos, C.] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Kunde, G. J.] Los Alamos Natl Lab, Los Alamos, NM USA; [Bilki, B.] Argonne Natl Lab, Argonne, IL USA; [Mermerkaya, H.] Erzincan Univ, Erzincan, Turkey; [Ozok, F.] Mimar Sinan Univ, Istanbul, Turkey; [Bouhali, O.] Texas A&M Univ Qatar, Doha, Qatar; [Antunovic, Z.; Kovac, M.] Univ Split, Split, Croatia	Yerevan Physics Institute; Belarusian State University; National Center of Particles & High Energy Physics - Belarus; Belarusian State University; University of Antwerp; Vrije Universiteit Brussel; Ghent University; Universite Catholique Louvain; University of Mons; Centro Brasileiro de Pesquisas Fisicas; Universidade do Estado do Rio de Janeiro; Universidade Estadual Paulista; Bulgarian Academy of Sciences; Bulgarian Academy of Sciences; University of Sofia; Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Peking University; Universidad de los Andes (Colombia); University of Split; Rudjer Boskovic Institute; University of Cyprus; Charles University Prague; Egyptian Academy of Scientific Research & Technology (ASRT); Egyptian Knowledge Bank (EKB); Egyptian Network of High Energy Physics (ENHEP); National Institute of Chemical Physics & Biophysics (NICPB); University of Helsinki; Helsinki Institute of Physics; Lappeenranta University of Technology; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Haute-Alsace (UHA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; National Academy of Sciences of Georgia; Ivane Javakhishvili Tbilisi State University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Helmholtz Association; Karlsruhe Institute of Technology; National & Kapodistrian University of Athens; University of Ioannina; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; University of Debrecen; Panjab University; University of Delhi; Saha Institute of Nuclear Physics; Bhabha Atomic Research Center (BARC); Tata Institute of Fundamental Research (TIFR); Tata Institute of Fundamental Research (TIFR); Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Istituto Nazionale di Fisica Nucleare (INFN); University of Florence; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); University of Genoa; Istituto Nazionale di Fisica Nucleare (INFN); University of Milano-Bicocca; Istituto Nazionale di Fisica Nucleare (INFN); University of Naples Federico II; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University of Trento; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Istituto Nazionale di Fisica Nucleare (INFN); University of Pisa; Scuola Normale Superiore di Pisa; Istituto Nazionale di Fisica Nucleare (INFN); Sapienza University Rome; Istituto Nazionale di Fisica Nucleare (INFN); University of Turin; University of Eastern Piedmont Amedeo Avogadro; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Kangwon National University; Kyungpook National University; Chonnam National University; Korea University; University of Seoul; Sungkyunkwan University (SKKU); Vilnius University; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Iberoamericana Ciudad de Mexico; Benemerita Universidad Autonoma de Puebla; Universidad Autonoma de San Luis Potosi; University of Auckland; University of Canterbury; National Centre for Physics - Pakistan; Quaid I Azam University; National Centre for Nuclear Research; University of Warsaw; Warsaw University of Technology; Laboratorio de Instrumentacao e Fisica Experimental de Particulas; Joint Institute for Nuclear Research - Russia; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; Russian Academy of Sciences; Institute for Nuclear Research of the Russian Academy of Sciences; National Research Centre - Kurchatov Institute; Alikhanov Institute for Theoretical & Experimental Physics; Lomonosov Moscow State University; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; National Research Centre - Kurchatov Institute; Institute of High Energy Physics - IHEP; University of Belgrade; University of Belgrade; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Autonomous University of Madrid; University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA); European Organization for Nuclear Research (CERN); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; National Central University; National Taiwan University; Chulalongkorn University; Cukurova University; Middle East Technical University; Bogazici University; Istanbul Technical University; National Academy of Sciences Ukraine; Institute for Scintillation Materials of the National Academy of Sciences of Ukraine; Kharkov Institute of Physics & Technology; University of West England; University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Imperial College London; Brunel University; Baylor University; University of Alabama System; University of Alabama Tuscaloosa; Boston University; Brown University; University of California System; University of California Davis; University of California System; University of California Los Angeles; University of California System; University of California Riverside; University of California System; University of California San Diego; University of California System; University of California Santa Barbara; California Institute of Technology; Carnegie Mellon University; University of Colorado System; University of Colorado Boulder; Cornell University; Fairfield University; United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; State University System of Florida; University of Florida; State University System of Florida; Florida International University; State University System of Florida; Florida State University; Florida Institute of Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Iowa; Johns Hopkins University; University of Kansas; Kansas State University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University System of Maryland; University of Maryland College Park; Massachusetts Institute of Technology (MIT); University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Nebraska System; University of Nebraska Lincoln; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Northeastern University; Northwestern University; University of Notre Dame; University System of Ohio; Ohio State University; Princeton University; University of Puerto Rico; University of Puerto Rico Mayaguez; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Rice University; University of Rochester; Rockefeller University; Rutgers State University New Brunswick; University of Tennessee System; University of Tennessee Knoxville; Texas A&M University System; Texas A&M University College Station; Texas Tech University System; Texas Tech University; Vanderbilt University; University of Virginia; Wayne State University; University of Wisconsin System; University of Wisconsin Madison; Technische Universitat Wien; Universidade Federal do ABC (UFABC); Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Zewail City of Science & Technology; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Fayoum University; Egyptian Knowledge Bank (EKB); British University in Egypt; Egyptian Knowledge Bank (EKB); Ain Shams University; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA); Brandenburg University of Technology Cottbus; Eotvos Lorand University; King Abdulaziz University; Visva Bharati University; Sharif University of Technology; Isfahan University of Technology; Shiraz University; Islamic Azad University; Horia Hulubei National Institute of Physics & Nuclear Engineering; Sapienza University Rome; University of Basilicata; Guglielmo Marconi University; Istituto Nazionale di Fisica Nucleare (INFN); University of Siena; University of Bucharest; Italian National Agency New Technical Energy & Sustainable Economics Development; Istituto Nazionale di Fisica Nucleare (INFN); Scuola Normale Superiore di Pisa; University of Bern; Gaziosmanpasa University; Adiyaman University; Izmir Institute of Technology; Mersin University; Ozyegin University; Kafkas University; Suleyman Demirel University; Ege University; University of Southampton; University of Sydney; Utah System of Higher Education; Utah Valley University; University of Edinburgh; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Erzincan Binali Yildirim University; Mimar Sinan Guzel Sanatlar University; Qatar Foundation (QF); Texas A&M University Qatar; University of Split	Chatrchyan, S (corresponding author), Yerevan Phys Inst, Yerevan, Armenia.	cms-spokesperson@cern.ch	Sawley, Marie-christine/GWM-5211-2022; Fasanella, Daniele/ABD-9759-2020; Solin, Alexey/S-8006-2018; de Souza Sandro, Fonseca/ABB-8505-2020; Dhingra, Nitish/ABA-9507-2020; Dudko, Lev/D-7127-2012; Savina, Maria/HDO-6544-2022; Oguri, Vitor/B-5403-2013; García Abia, Pablo/K-3595-2017; Loukas, Dimitris/ABF-1478-2020; Titov, Maxim/AAM-2140-2020; Wulz, Claudia-Elisabeth E/H-5657-2011; Selvaggi, Michele/CAJ-2129-2022; Zhukov, Valery/K-3615-2013; CAKIR, Altan/ABD-4450-2020; Demianov, Andrei/E-4565-2012; Mundim, Luiz M/A-1291-2012; Puerta Pelayo, Jesus/L-1632-2014; LECOQ, Paul/S-7246-2019; Ocalan, Kadir/ABA-7004-2021; Strumia, Alessandro/ABB-3109-2020; Fiorendi, Sara/ABA-3311-2021; Traczyk, Piotr/ABA-8929-2020; Novaes, Sergio F./D-3532-2012; khurshid, taimoor/AAA-5677-2021; Janssen, Xavier/E-1915-2013; Faccioli, Pietro/AAF-1499-2019; MAESTRE, JUAN ALCARAZ/I-5763-2015; Duarte-Campderrós, Jordi/F-5025-2018; Korenkov, Vladimir V/H-7665-2017; Tytgat, Michael G./F-3732-2018; Ciulli, Vitaliano/ABC-5440-2020; Mesyats, Gennady A/L-3138-2015; Leonidov, Andrey V/P-3197-2014; Isildak, Bora/AAW-4994-2020; Cushman, Priscilla/ABD-2905-2020; Fedorov, Andrei/E-9455-2014; de gruttola, michele/AAN-7271-2020; Arcidiacono, Roberta/ABF-3918-2020; Ocalan, Kadir/AAX-5235-2021; Giammanco, Andrea/O-5017-2019; Piperov, Stefan/Q-1980-2017; De Guio, Federico/ABI-2018-2020; radi, amr/Y-1592-2019; 杨, 再宏/A-2494-2015; Kirakosyan, Martin R./N-2701-2015; Verwilligen, Piet Omer J/AAA-8819-2019; Hill, Christopher/B-5371-2012; Romero, Luciano/B-8917-2018; Wimpenny, Stephen J/K-8848-2013; Luukka, Panja-Riina/S-8956-2018; Safronov, Grigory/F-8494-2017; Singh, J B/ABF-5574-2021; BARRILLON, Stephanie/ABA-6873-2021; Malbouisson, H./N-6733-2015; Cerrada, Marcos/J-6934-2014; gunion, john/AAJ-9946-2021; Ramos, Juan Pablo Fernández/AAF-3114-2019; Özdemir, Kadri/P-8058-2014; Kenzie, Matthew/AAK-5674-2021; Puljak, Ivica/D-8917-2017; Bornheim, Adi/L-2750-2019; Tinoco Mendes, Andre David/D-4314-2011; Ferguson, Thomas A/O-3444-2014; Tomaszewska, Justyna/AAS-5761-2020; Petrushanko, Sergey/D-6880-2012; Azarkin, Maxim/N-2578-2015; Amapane, Nicola/HDN-9630-2022; Ozkorucuklu, Suat/AAE-7535-2020; Gamsızkan, Halil/AAF-5296-2019; Kozhuharov, Venelin/AAL-1658-2021; De Filippis, Nicola/AAD-6280-2019; Lazzizzera, Ignazio/E-9678-2015; Sanchez-Hernandez, Alberto/AAH-3473-2020; Heredia-De La Cruz, Ivan/L-2610-2018; Stahl, Achim/E-8846-2011; Romaniuk, Ryszard S/B-9140-2011; Civinini, Carlo/AAL-6403-2020; Lelas, Damir/H-2106-2017; d'Enterria, David/W-7763-2019; Alamillo, Enrique Calvo/L-1203-2014; Najafabadi, Mojtaba Mohammadi/AAF-7564-2019; Lutz, Benjamin/U-4283-2017; Demortier, Luc/AAE-6344-2020; Giacomelli, Paolo/B-8076-2009; Güler, Ali Murat/ABB-3382-2020; Casarsa, Massimo/L-3623-2018; Saoulidou, Niki/AAA-2891-2020; Dubinin, Mikhail N/I-3942-2016; Fabozzi, Francesco/T-6468-2019; GULER, E GURPINAR/AAH-4748-2019; Sznajder, Andre/L-1621-2016; korzhik, Mikhail V/E-9505-2014; Lokhtin, Igor/D-7004-2012; Servoli, Leonello/E-6766-2012; Peris, Antonio Delgado/AAA-5165-2019; M, F/HGF-3166-2022; Shmatov, Sergei/J-5621-2014; Ligabue, Franco/ABI-1681-2020; Yang, Fan/GYU-4249-2022; Paganoni, Marco/A-4235-2016; Bourilkov, Dimitri/AAO-4908-2020; Della Ricca, Giuseppe/B-6826-2013; Yazgan, Efe/C-4521-2014; Tiras, Emrah/ABG-2354-2020; Polatoz, Ayse/AAF-6722-2021; Iope, Rogério/F-2331-2014; TOPAKSU, Aysel KAYİS/B-8910-2018; Petrucci, Andrea/J-4207-2014; Lista, Luca/M-2912-2019; Lannon, Kevin/HGU-5755-2022; Ruiz, Alberto/E-4473-2011; Lopez, Oscar Gonzalez/AAH-3533-2019; Felcini, Marta A./S-2684-2019; Arce, Pedro/L-1268-2014; Perieanu, Adrian/D-3347-2018; Eskut, Eda/B-8905-2018; Grandi, Claudio/B-5654-2015; Frühwirth, Rudolf/H-2529-2012; Malvezzi, Sandra/B-8524-2009; Rolandi, Luigi/E-8563-2013; Josa, Isabel/K-5184-2014; Abdulsalam, Abdulla/B-3386-2019; Gorbunov, Dmitry S/F-5407-2017; Mousa, Jehad/I-8019-2019; Morovic, Srecko/T-9019-2019; Hernández, José M./H-9127-2015; Cortezon, Jose Enrique Palencia/F-1059-2017; Benussi, Luigi/O-9684-2014; Juodagalvis, Andrius/F-6952-2018; Gülmez, Erhan/P-9518-2015; Doğangün, Oktay/L-9252-2013; Krammer, Manfred/A-6508-2010; Liu, Sheng/K-2815-2013; Worm, Steven D/I-3575-2012; Goh, Junghwan/Q-3720-2016; Trocino, Daniele/AGI-2155-2022; Spagnolo, Paolo/G-3401-2017; Adiguzel, Aytul/AAC-9049-2020; yagil, avi/I-3278-2018; Tinti, Gemma/I-5886-2013; De La Cruz Burelo, Eduard/AAR-9103-2021; Vogel, Helmut/N-8882-2014; Zhu, Ren-Yuan/V-8966-2019; Rivero, Celso Martinez/V-6916-2017; Russ, James S/P-3092-2014; McClatchey, Richard H/M-4183-2015; Cepeda, Maria/AAF-4992-2019; Hektor, Andi/G-1804-2011; Ivanov, Andrew G/A-7982-2013; Waltenberger, Wolfgang/H-9330-2018; Ligabue, Franco/F-3432-2014; González Caballero, Isidro/E-7350-2010; Kryukov, Alexander/G-8076-2012; Tuominen, Eija M/A-5288-2017; Gribushin, Andrei M/J-4225-2012; Sanchez, Francisca J. Munoz/AAH-3909-2019; Fanò, Livio/K-2460-2015; Paktinat Mehdiabadi, Saeid/AAY-8501-2020; Rubakov, Valery A./B-1340-2014; Bunichev, Viacheslav E/E-2285-2012; kaya, mithat/D-8062-2011; Leonardo, Nuno T/M-6940-2016; Ragazzi, Stefano/D-2463-2009; Travaglini, Riccardo/AAR-1089-2021; Mekterović, Darko/S-7270-2018; Tsirou, Andromachi/HHC-6869-2022; Steggemann, Jan/AAL-5700-2020; Ferencek, Dinko/G-6411-2015; Fouz, Maria Cruz/AAF-1105-2019; B., Grynyov/D-1714-2010; Troitsky, Sergey V/C-1377-2014; Sanchez-Hernandez, Alberto/L-4955-2017; Chang, Yuan-Hann/AAP-4863-2021; Grachov, Oleg/J-1639-2016; Verwilligen, Piet/M-2968-2014; Kerzel, Ulrich/A-7275-2017; Tomei, Thiago R F P/E-7091-2012; Iorio, Alberto Orso Maria/GXA-0233-2022; Mahmoud, Mohammed Attia/AAD-1249-2019; Bortignon, Pierluigi/AAF-6561-2020; Tuo, Shengquan/ABA-9032-2021; Zeyrek, Mehmet/ABA-7235-2020; Pereira, Antonio Vilela/L-4142-2016; Grassi, Marco/U-1260-2017; Pfeiffer, Dorothea/AGS-6610-2022; Lychkovskaya, Natalia/F-8341-2017; Ulrich, Ralf/Q-3882-2019; Hall-Wilton, Richard/U-6918-2019; Cerizza, Giordano/AAO-5885-2020; de Paula Carvalho, Wagner/V-3343-2019; Vischia, Pietro/AAB-7811-2021; D'Alessandro, Raffaello/P-4138-2019; Majumder, Devdatta/X-2542-2019; My, Salvatore/I-5160-2015; TUVE', Cristina/P-3933-2015; Boimska, Bożena/Z-6088-2019; Obertino, Maria Margherita/ABH-1662-2020; Donvito, Giacinto/AAC-9872-2020; Gomez, Jaime Arturo/P-5242-2018; Sen, Sercan/C-6473-2014; Bedoya, Cristina F/K-8066-2014; Rott, Carsten/ABB-1304-2021; Seixas, Joao C/F-5441-2013; Rodrigo, Teresa/F-6183-2018; Ozturk, Sertac/AGO-2476-2022; polatoz, ayse/C-3463-2018; Rossin, Roberto/C-8376-2019; Hoorani, Hafeez R/D-1791-2013; Santoro, Alberto F.S./E-7932-2014; Leonidov, Andrey/M-4440-2013; Bernardes, Cesar Augusto/D-2408-2015; Yagil, Avi/GMX-0958-2022; Dallavalle, Gaetano Marco/AFW-4654-2022; Sill, Alan/AAC-4969-2019; cartiglia, nicolo/ABF-1008-2021; Farinon, Stefania/AAG-9056-2019; Paulini, Manfred/N-7794-2014; Bodek, Arie/AAD-2811-2019; Asavapibhop, Burin/X-1477-2019; KIM, Tae Jeong/P-7848-2015; Colafranceschi, Stefano/M-1807-2016; Matorras, Francisco/I-4983-2015; Sunar Cerci, Deniz/AHE-1706-2022; Klyukhin, Vyacheslav I/D-6850-2012; Trocsanyi, Zoltan/A-5598-2009; Krücker, Dirk/X-1844-2019; Govoni, Pietro/K-9619-2016; khurshid, taimoor/AAF-4900-2019; ozok, ferhat/A-6803-2018; Torassa, Ezio/I-1788-2012; MERCIER, Damien/C-4151-2017; dumanoglu, isa/C-3627-2018; gunion, john/L-3971-2019; Doğangün, Oktay/AAC-1579-2022; Cankocak, Kerem/A-1507-2018; Acosta, Monica Vazquez/AAB-2841-2019; Liu, Chang/B-7249-2009; Kannike, Kristjan/J-9797-2014; Petrosyan, Artem/N-3574-2019; Menichelli, Mauro/AAQ-4026-2020; Daskalakis, Georgios/M-4480-2013; Belyaev, Alexander/F-6637-2015; Zabołotny, Wojciech Marek/CAH-7647-2022; Leonidov, Andrey/ABI-6671-2020; Bagliesi, Giuseppe/C-2230-2013; Flix, Josep/G-5414-2012; Duarte, Javier Mauricio/AAA-5414-2020; Padula, Sandra S./AAE-4304-2020; Andreev, Vladimir F/M-8665-2015; Biino, Cristina/AAF-1585-2020; KUMAR, ASHOK/AAF-4055-2021; Widl, Edmund/AAF-2651-2019; Raidal, Martti/F-4436-2012; Pozniak, Krzysztof/AAO-7377-2020; Folgueras, Santiago/B-6549-2014; Cimmino, Anna/AAA-1673-2020; Sguazzoni, Giacomo/J-4620-2015; Yetkin, Taylan/ABH-2774-2021; Marlow, Daniel R/C-9132-2014; Hos, ilknur/T-1165-2019; Cortabitarte, Rocio Vilar/P-8480-2014; Aly, Ashraf A/M-9983-2014; Dorigo, Tommaso/AAY-6673-2020; Soares, Mara Senghi/GZM-6676-2022; Gokbulut, Gul/G-2141-2018; Blekman, Freya/ABD-7916-2020; Oehler, Andreas/GQH-8718-2022; Konecki, Marcin/G-4164-2015; Dahms, Torsten/A-8453-2015; Doroba, krzysztof/AAA-3419-2021; Yang, Yong/D-9724-2017; Marinho, Franciole/N-8101-2014; Ahmad, Wael Haj/E-6738-2016; Calderon, Alicia/K-3658-2014; De La Cruz Burelo, Eduard/Q-6021-2019; Ratnikov, Fedor/D-5137-2016; de la Cruz, Begona/K-7552-2014; Fanelli, Cristiano/AAS-1489-2020; Dremin, Igor/K-8053-2015; fahim, ali/C-2400-2016; Kim, Victor T/L-1648-2013; Xie, Si/O-6830-2016; liu, chang/HCI-5413-2022; D'Hondt, Jorgen/ABD-7930-2020; Battilana, Carlo/AAA-7345-2020; Markowitz, Pete/AAC-3382-2020; Khakzad, Mohsen/ABB-1945-2021; Smirnov, Vitaly A/B-5001-2017; CALZOLARI, FEDERICO/P-5543-2018; Markina, Anastasia/E-3390-2012; Rovelli, Tiziano/K-4432-2015; Pompili, Alexis/ABG-3556-2021; Petkov, Peicho Stoev/M-2080-2016; Scodellaro, Luca/K-9091-2014; Meridiani, Paolo/ABH-1655-2020; Mussgiller, Andreas/AAF-6933-2019; Venturi, Andrea/J-1877-2012; Oleynik, Danila/ABG-5349-2020; Amapane, Nicola/J-3683-2012; Ilyin, Viacheslav A./K-4641-2012; de Jesus Damiao, Dilson/G-6218-2012; Benaglia, Andrea/AGF-5495-2022; Palla, Fabrizio/F-4727-2012; Fernandez Menendez, Javier/B-6550-2014; Makarenko, Vladimir/G-2274-2017; Dharmaratna, Welathantri/F-6745-2018; Calligaris, Luigi/K-2018-2017; Lusito, Letizia/AAJ-7517-2020; Azzi, Patrizia/H-5404-2012; Luo, Wuming/J-4263-2018; Martinez-Ortega, Jorge/M-2556-2017; Redondo, Ignacio/K-8639-2014; Fiori, Francesco/H-1454-2018; Gomez, Gervasio/K-2860-2014; Akgun, Bora/AAM-8311-2021; Tabarelli de Fatis, Tommaso/A-7306-2010; Hobson, Peter/C-8919-2016; Malik, Sudhir/D-6621-2018; Popov, Andrey/E-1052-2012; Lloret Iglesias, Lara/A-6349-2018; Gonzalez Suarez, Rebeca/L-6128-2014; Menasce, Dario Livio/A-2168-2016; Marco de Lucas, Jesus/B-8735-2008; Bargassa, Pedrame/O-2417-2016; Lenzi, Piergiulio/I-9542-2016; Kyberd, Paul/P-1092-2014; Varela, Joao/K-4829-2016; Godinovic, Nikola/G-6124-2017; Andreev, Yuri/J-5779-2014; Pavlov, Borislav/O-8491-2018	Sawley, Marie-christine/0000-0003-0660-3489; Solin, Alexey/0000-0002-6277-3506; de Souza Sandro, Fonseca/0000-0001-7830-0837; Dudko, Lev/0000-0002-4462-3192; Savina, Maria/0000-0002-9020-7384; García Abia, Pablo/0000-0001-8809-8927; Loukas, Dimitris/0000-0002-7431-3857; Wulz, Claudia-Elisabeth E/0000-0001-9226-5812; CAKIR, Altan/0000-0002-8627-7689; Mundim, Luiz M/0000-0001-9964-7805; Puerta Pelayo, Jesus/0000-0001-7390-1457; Ocalan, Kadir/0000-0002-8419-1400; Fiorendi, Sara/0000-0003-3273-9419; Traczyk, Piotr/0000-0001-5422-4913; Novaes, Sergio F./0000-0003-0471-8549; Faccioli, Pietro/0000-0003-1849-6692; MAESTRE, JUAN ALCARAZ/0000-0003-0914-7474; Duarte-Campderrós, Jordi/0000-0003-0687-5214; Korenkov, Vladimir V/0000-0002-2342-7862; Tytgat, Michael G./0000-0002-3990-2074; Isildak, Bora/0000-0002-0283-5234; de gruttola, michele/0000-0003-4835-8688; Giammanco, Andrea/0000-0001-9640-8294; Piperov, Stefan/0000-0002-9266-7819; De Guio, Federico/0000-0001-5927-8865; Verwilligen, Piet Omer J/0000-0002-9285-8631; Hill, Christopher/0000-0003-0059-0779; Romero, Luciano/0000-0002-9055-0385; Wimpenny, Stephen J/0000-0003-0505-4908; Luukka, Panja-Riina/0000-0003-2340-4641; Singh, J B/0000-0001-9029-2462; BARRILLON, Stephanie/0000-0002-7075-1673; Cerrada, Marcos/0000-0003-0112-1691; Ramos, Juan Pablo Fernández/0000-0002-0122-313X; Özdemir, Kadri/0000-0002-0103-1488; Kenzie, Matthew/0000-0001-7910-4109; Puljak, Ivica/0000-0001-7387-3812; Tinoco Mendes, Andre David/0000-0001-5854-7699; Ferguson, Thomas A/0000-0001-5822-3731; Tomaszewska, Justyna/0000-0001-6883-7235; Azarkin, Maxim/0000-0002-7448-1447; Amapane, Nicola/0000-0001-9449-2509; Ozkorucuklu, Suat/0000-0001-5153-9266; Gamsızkan, Halil/0000-0002-2578-6295; Kozhuharov, Venelin/0000-0002-0669-7799; Lazzizzera, Ignazio/0000-0001-5092-7531; Sanchez-Hernandez, Alberto/0000-0001-9548-0358; Heredia-De La Cruz, Ivan/0000-0002-8133-6467; Stahl, Achim/0000-0002-8369-7506; Romaniuk, Ryszard S/0000-0002-5710-4041; Civinini, Carlo/0000-0002-4952-3799; Lelas, Damir/0000-0002-8269-5760; d'Enterria, David/0000-0002-5754-4303; Alamillo, Enrique Calvo/0000-0002-1100-2963; Najafabadi, Mojtaba Mohammadi/0000-0001-6131-5987; Lutz, Benjamin/0000-0003-3057-7831; Demortier, Luc/0000-0002-0499-4298; Giacomelli, Paolo/0000-0002-6368-7220; Casarsa, Massimo/0000-0002-1353-8964; Saoulidou, Niki/0000-0001-6958-4196; Dubinin, Mikhail N/0000-0002-7766-7175; Fabozzi, Francesco/0000-0001-9821-4151; GULER, E GURPINAR/0000-0002-6172-0285; Sznajder, Andre/0000-0001-6998-1108; Servoli, Leonello/0000-0003-1725-9185; Peris, Antonio Delgado/0000-0002-8511-7958; Shmatov, Sergei/0000-0001-5354-8350; Ligabue, Franco/0000-0002-1549-7107; Paganoni, Marco/0000-0003-2461-275X; Bourilkov, Dimitri/0000-0003-0260-4935; Della Ricca, Giuseppe/0000-0003-2831-6982; Yazgan, Efe/0000-0001-5732-7950; Tiras, Emrah/0000-0002-5628-7464; Polatoz, Ayse/0000-0001-9516-0821; TOPAKSU, Aysel KAYİS/0000-0001-5819-6913; Petrucci, Andrea/0000-0003-2524-8355; Lista, Luca/0000-0001-6471-5492; Lannon, Kevin/0000-0002-9706-0098; Ruiz, Alberto/0000-0002-3639-0368; Lopez, Oscar Gonzalez/0000-0002-4532-6464; Felcini, Marta A./0000-0002-2051-9331; Arce, Pedro/0000-0003-3009-0484; Grandi, Claudio/0000-0001-5998-3070; Malvezzi, Sandra/0000-0002-0218-4910; Rolandi, Luigi/0000-0002-0635-274X; Josa, Isabel/0000-0002-4985-6964; Abdulsalam, Abdulla/0000-0002-5424-7418; Gorbunov, Dmitry S/0000-0003-1424-683X; Mousa, Jehad/0000-0002-2978-2718; Hernández, José M./0000-0001-6436-7547; Cortezon, Jose Enrique Palencia/0000-0001-8264-0287; Benussi, Luigi/0000-0002-2363-8889; Juodagalvis, Andrius/0000-0002-1501-3328; Gülmez, Erhan/0000-0002-6353-518X; Doğangün, Oktay/0000-0002-1255-2211; Krammer, Manfred/0000-0003-2257-7751; Worm, Steven D/0000-0002-3865-4996; Goh, Junghwan/0000-0002-1129-2083; Trocino, Daniele/0000-0002-2830-5872; Spagnolo, Paolo/0000-0001-7962-5203; Adiguzel, Aytul/0000-0001-6644-0517; yagil, avi/0000-0002-6108-4004; Tinti, Gemma/0000-0003-1364-844X; De La Cruz Burelo, Eduard/0000-0002-7469-6974; Vogel, Helmut/0000-0002-6109-3023; Zhu, Ren-Yuan/0000-0003-3091-7461; Rivero, Celso Martinez/0000-0002-3224-956X; Russ, James S/0000-0001-9856-9155; McClatchey, Richard H/0000-0002-0042-5960; Cepeda, Maria/0000-0002-6076-4083; Hektor, Andi/0000-0001-7873-8118; Ivanov, Andrew G/0000-0002-9270-5643; Waltenberger, Wolfgang/0000-0002-6215-7228; Ligabue, Franco/0000-0002-1549-7107; González Caballero, Isidro/0000-0002-8087-3199; Kryukov, Alexander/0000-0002-1624-6131; Tuominen, Eija M/0000-0002-7073-7767; Sanchez, Francisca J. Munoz/0000-0002-6374-458X; Fanò, Livio/0000-0002-9007-629X; Paktinat Mehdiabadi, Saeid/0000-0001-7303-0217; Leonardo, Nuno T/0000-0002-9746-4594; Ragazzi, Stefano/0000-0001-8219-2074; Travaglini, Riccardo/0000-0002-5288-1407; Mekterović, Darko/0000-0001-6220-5958; Steggemann, Jan/0000-0003-4420-5510; Ferencek, Dinko/0000-0001-9116-1202; Fouz, Maria Cruz/0000-0003-2950-976X; Troitsky, Sergey V/0000-0001-6917-6600; Sanchez-Hernandez, Alberto/0000-0001-9548-0358; Chang, Yuan-Hann/0000-0002-2442-1403; Grachov, Oleg/0000-0002-4294-9025; Verwilligen, Piet/0000-0002-9285-8631; Kerzel, Ulrich/0000-0002-4939-6726; Tomei, Thiago R F P/0000-0002-1809-5226; Iorio, Alberto Orso Maria/0000-0002-3798-1135; Mahmoud, Mohammed Attia/0000-0001-8692-5458; Bortignon, Pierluigi/0000-0002-5360-1454; Zeyrek, Mehmet/0000-0002-9270-7403; Pereira, Antonio Vilela/0000-0003-3177-4626; Grassi, Marco/0000-0003-2422-6736; Ulrich, Ralf/0000-0002-2535-402X; Hall-Wilton, Richard/0000-0003-3221-2086; de Paula Carvalho, Wagner/0000-0003-0738-6615; Vischia, Pietro/0000-0002-7088-8557; D'Alessandro, Raffaello/0000-0001-7997-0306; Majumder, Devdatta/0000-0002-7578-0027; My, Salvatore/0000-0002-9938-2680; TUVE', Cristina/0000-0003-0739-3153; Boimska, Bożena/0000-0002-4200-1541; Obertino, Maria Margherita/0000-0002-8781-8192; Donvito, Giacinto/0000-0002-0628-1080; Gomez, Jaime Arturo/0000-0003-3958-9054; Sen, Sercan/0000-0001-7325-1087; Bedoya, Cristina F/0000-0001-8057-9152; Rott, Carsten/0000-0002-6958-6033; Seixas, Joao C/0000-0002-7531-0842; Ozturk, Sertac/0000-0001-6533-6144; Rossin, Roberto/0000-0003-3466-7500; Santoro, Alberto F.S./0000-0002-0568-665X; Bernardes, Cesar Augusto/0000-0001-5790-9563; Dallavalle, Gaetano Marco/0000-0002-8614-0420; Sill, Alan/0000-0003-2527-764X; Farinon, Stefania/0000-0002-6487-2137; Paulini, Manfred/0000-0002-6714-5787; Bodek, Arie/0000-0003-0409-0341; KIM, Tae Jeong/0000-0001-8336-2434; Colafranceschi, Stefano/0000-0002-7335-6417; Matorras, Francisco/0000-0003-4295-5668; Sunar Cerci, Deniz/0000-0002-5412-4688; Klyukhin, Vyacheslav I/0000-0002-8577-6531; Trocsanyi, Zoltan/0000-0002-2129-1279; Krücker, Dirk/0000-0003-1610-8844; Govoni, Pietro/0000-0002-0227-1301; khurshid, taimoor/0000-0001-9816-3630; ozok, ferhat/0000-0001-9630-7362; Torassa, Ezio/0000-0003-2321-0599; MERCIER, Damien/0000-0001-5063-7067; Doğangün, Oktay/0000-0002-1255-2211; Cankocak, Kerem/0000-0002-3829-3481; Acosta, Monica Vazquez/0000-0002-2409-9792; Petrosyan, Artem/0000-0003-2166-7894; Menichelli, Mauro/0000-0002-9004-735X; Daskalakis, Georgios/0000-0001-6070-7698; Belyaev, Alexander/0000-0002-1733-4408; Zabołotny, Wojciech Marek/0000-0002-6833-4846; Bagliesi, Giuseppe/0000-0003-4298-1620; Flix, Josep/0000-0003-2688-8047; Duarte, Javier Mauricio/0000-0002-5076-7096; Padula, Sandra S./0000-0003-3071-0559; Andreev, Vladimir F/0000-0002-5492-6920; KUMAR, ASHOK/0000-0002-9244-0622; Widl, Edmund/0000-0002-2834-306X; Raidal, Martti/0000-0001-7040-9491; Pozniak, Krzysztof/0000-0001-5426-1423; Folgueras, Santiago/0000-0001-7191-1125; Cimmino, Anna/0000-0001-7510-4996; Sguazzoni, Giacomo/0000-0002-0791-3350; Yetkin, Taylan/0000-0003-3277-5612; Hos, ilknur/0000-0002-7678-1101; Cortabitarte, Rocio Vilar/0000-0003-2045-8054; Soares, Mara Senghi/0000-0001-9676-6059; Gokbulut, Gul/0000-0002-0175-6454; Blekman, Freya/0000-0002-7366-7098; Oehler, Andreas/0000-0002-2858-3370; Konecki, Marcin/0000-0001-9482-4841; Dahms, Torsten/0000-0003-4274-5476; Doroba, krzysztof/0000-0002-7818-2364; Marinho, Franciole/0000-0002-7327-0349; Ahmad, Wael Haj/0000-0003-1491-0446; Calderon, Alicia/0000-0002-7205-2040; de la Cruz, Begona/0000-0001-9057-5614; fahim, ali/0000-0001-5736-6001; Kim, Victor T/0000-0001-7161-2133; Xie, Si/0000-0003-2509-5731; D'Hondt, Jorgen/0000-0002-9598-6241; Battilana, Carlo/0000-0002-3753-3068; Khakzad, Mohsen/0000-0002-2212-5715; CALZOLARI, FEDERICO/0000-0002-5510-3061; Rovelli, Tiziano/0000-0002-9746-4842; Petkov, Peicho Stoev/0000-0002-0420-9480; Scodellaro, Luca/0000-0002-4974-8330; Meridiani, Paolo/0000-0002-8480-2259; Mussgiller, Andreas/0000-0002-8331-8166; Oleynik, Danila/0000-0002-8862-770X; Amapane, Nicola/0000-0001-9449-2509; Ilyin, Viacheslav A./0000-0003-3243-3436; de Jesus Damiao, Dilson/0000-0002-3769-1680; Benaglia, Andrea/0000-0003-1124-8450; Tao, Junquan/0000-0003-2006-3490; Bartoloni, Alessandro/0000-0003-3938-5297; Gershtein, Yuri/0000-0002-4871-5449; Lukyanenko, Sergiy/0000-0003-0284-2351; Ptochos, Fotios/0000-0002-3432-3452; Palla, Fabrizio/0000-0002-6361-438X; Uliyanov, Alexey/0000-0001-6935-8949; Fernandez Menendez, Javier/0000-0002-5213-3708; Gallinaro, Michele/0000-0003-1261-2277; Kasemann, Matthias/0000-0002-0429-2448; Makarenko, Vladimir/0000-0002-8406-8605; Galli Mercadante, Pedro/0000-0001-8333-4302; Holzman, Burt/0000-0001-5235-6314; Safonov, Alexei/0000-0001-9497-5471; Ramirez, Juan Eduardo/0000-0002-4897-5857; Teller, Olivier/0000-0003-4650-8961; Ecklund, Karl/0000-0002-6976-4637; Pieri, Marco/0000-0003-3303-6301; Greco, Michela/0000-0002-7299-7829; Benitez, J.F./0000-0002-2633-6712; Bloom, Kenneth/0000-0002-4272-8900; Tropea, Paola/0000-0003-1899-2266; Grunewald, Martin/0000-0002-5754-0388; Branca, Antonio/0000-0001-8813-2128; Dharmaratna, Welathantri/0000-0002-6366-837X; Calligaris, Luigi/0000-0002-9951-9448; Rinkevicius, Aurelijus/0000-0002-7510-255X; Tricomi, Alessia Rita/0000-0002-5071-5501; Elgammal, Sherif/0000-0003-4280-0746; Evdokimov, Olga/0000-0002-1250-8931; cartiglia, nicolo/0000-0002-0548-9189; Cole, Joanne/0000-0001-5638-7599; Kasprowicz, Grzegorz/0000-0001-6128-0788; Martelli, Arabella/0000-0003-3530-2255; Lusito, Letizia/0000-0001-7569-0550; Azzi, Patrizia/0000-0002-3129-828X; Heracleous, Natalie/0000-0002-2744-7238; Feld, Lutz/0000-0001-9813-8646; Schroder, Matthias/0000-0001-8058-9828; Low, Jia Fu/0000-0003-4318-5968; Arcidiacono, Roberta/0000-0001-5904-142X; Mrenna, Stephen/0000-0001-8731-160X; Voutilainen, Mikko/0000-0002-5200-6477; Bluj, Michal/0000-0003-1229-1442; Brigljevic, Vuko/0000-0001-5847-0062; Wallny, Rainer/0000-0001-8038-1613; Ghezzi, Alessio/0000-0002-8184-7953; Beuselinck, Raymond/0000-0003-2613-7446; Merola, Mario/0000-0002-7082-8108; Massironi, Andrea/0000-0002-0782-0883; Rappoccio, Salvatore/0000-0002-5449-2560; Di Matteo, Leonardo/0000-0001-6698-1735; Lethuillier, Morgan/0000-0001-6185-2045; Bansal, Sunil/0000-0003-1992-0336; Lychkovskaya, Natalia/0000-0001-5084-9019; Luo, Wuming/0000-0003-0137-1797; Jung, Hannes/0000-0002-2964-9845; Farina, Fabio/0000-0001-7861-3673; Dominguez, Aaron/0000-0002-7420-5493; Rosowsky, Andre/0000-0001-7803-6650; Mitselmakher, Guenakh/0000-0001-5745-3658; Bernet, Colin/0000-0002-9923-8734; Martinez-Ortega, Jorge/0000-0001-8746-8359; Dominik, Wojciech/0000-0001-7444-9239; Baarmand, Marc/0000-0002-9792-8619; Erdmann, Martin/0000-0002-1653-1303; Smith, Wesley/0000-0003-3195-0909; Maity, Manas/0000-0002-3237-3608; Wendland, Lauri/0000-0003-4506-2486; Cavallari, Francesca/0000-0002-1061-3877; Szleper, Michal/0000-0002-1697-004X; Pfeiffer, Andreas/0000-0001-5328-448X; Tu, Yanjun/0000-0002-5865-183X; Redondo, Ignacio/0000-0003-3737-4121; Venturi, Andrea/0000-0002-0249-4142; Pedrini, Daniele/0000-0003-2414-4175; Ricci-Tam, Francesca/0000-0001-9750-7702; Ciulli, Vitaliano/0000-0003-1947-3396; CHANG, PAO-TI/0000-0003-4064-388X; Bansal, Monika/0000-0002-5413-8115; Kavka, Carlos/0000-0002-4837-4146; Pastrone, Nadia/0000-0001-7291-1979; Sordini, Viola/0000-0003-0885-824X; Bonnett Del Alamo, Miguel Reinaldo/0000-0002-1011-8411; Kreczko, Luke/0000-0003-2341-8330; Naimuddin, Md/0000-0003-4542-386X; Rahatlou, Shahram/0000-0001-9794-3360; Fiori, Francesco/0000-0001-8770-9343; Taylor, Lucas/0000-0002-6584-2538; Gomez, Gervasio/0000-0002-1077-6553; De Almeida Dias, Flavia/0000-0001-6882-5402; Akgun, Bora/0000-0001-8888-3562; Zuyeuski, Raman/0000-0002-1614-7926; Markowitz, Pete/0000-0002-5661-586X; Landsberg, Greg/0000-0002-4184-9380; Vieira de Castro Ferreira da Silva, Pedro Manuel/0000-0002-5725-041X; Tabarelli de Fatis, Tommaso/0000-0001-6262-4685; Pugliese, Gabriella/0000-0001-5460-2638; Diemoz, Marcella/0000-0002-3810-8530; Pierini, Maurizio/0000-0003-1939-4268; Alverson, George/0000-0001-6651-1178; Petrucciani, Giovanni/0000-0003-0889-4726; Dini, Paolo/0000-0001-7375-4899; Staiano, Amedeo/0000-0003-1803-624X; Chahal, Gurpreet Singh/0000-0003-0320-4407; Autermann, Christian/0000-0002-0057-0033; Levchuk, Leonid/0000-0001-5889-7410; Clarke, Jenny/0000-0003-0900-5169; Fehling, David/0000-0003-4520-7219; Hamel de Monchenault, Gautier/0000-0002-3872-3592; Soroka, Dmyro/0000-0002-9270-8262; Azzurri, Paolo/0000-0002-1717-5654; Rabbertz, Klaus/0000-0001-7040-9846; CONTE, Eric/0000-0003-3154-3123; Goldstein, Joel/0000-0003-1591-6014; Arndt, Kirk/0000-0002-6826-8340; Spiga, Daniele/0000-0002-2991-6384; Alves, Gilvan/0000-0002-8369-1446; Litov, Leandar/0000-0002-8511-6883; Tully, Christopher/0000-0001-6771-2174; Figueiredo, Diego/0000-0003-2514-6930; Hobson, Peter/0000-0002-5645-5253; Krolikowski, Jan/0000-0002-3055-0236; Mazzoni, Enrico/0000-0002-3885-3821; Leonidopoulos, Christos/0000-0002-7241-2114; Titov, Maxim/0000-0002-1119-6614; Malik, Sudhir/0000-0002-6356-2655; Vidal Marono, Miguel/0000-0002-2590-5987; /0000-0002-1985-1329; Costa, Salvatore/0000-0001-9919-0569; Giubilato, Piero/0000-0003-4358-5355; Gutsche, Oliver/0000-0002-8015-9622; Van Onsem, Gerrit/0000-0002-1664-2337; Adams, Todd/0000-0001-8049-5143; Lacroix, Florent/0000-0002-4304-8843; Cuevas Maestro, Francisco Javier/0000-0001-5080-0821; Demaria, Natale/0000-0003-0743-9465; Oguri, Vitor/0000-0002-5410-4863; Rizzi, Andrea/0000-0002-4543-2718; Poschlad, Angela/0000-0002-7661-0740; Ciesielski, Robert/0000-0001-9422-9129; Mooney, Michael/0000-0001-8348-4167; PERRIES, Stephane/0000-0003-2213-3579; Adler, Volker/0000-0002-4469-4468; Kratschmer, Ilse/0000-0002-5636-9259; Covarelli, Roberto/0000-0003-1216-5235; Theofilatos, Konstantinos/0000-0001-8448-883X; Popov, Andrey/0000-0002-1207-0984; Nash, Jordan/0000-0003-0607-6519; WANG, MIN-ZU/0000-0002-0979-8341; Kilminster, Benjamin/0000-0002-6657-0407; Golf, Frank/0000-0003-3567-9351; Dolinsky, Sergei/0000-0002-2789-453X; Roy, Ashim/0000-0002-5622-4260; Rodriguez, Jorge/0000-0001-6680-7761; Gallo, Elisabetta/0000-0001-7200-5175; Stober, Fred/0000-0003-2620-3159; Collard, Caroline/0000-0002-5230-8387; Bethani, Agni/0000-0002-8150-7043; Lloret Iglesias, Lara/0000-0002-0157-4765; Delaere, Christophe/0000-0001-8707-6021; Wildish, Anthony/0000-0003-4297-4738; Merino, Gonzalo/0000-0002-9540-5742; Gonzalez Suarez, Rebeca/0000-0002-6126-7230; Libeiro, Terence/0000-0003-0623-7909; Eskut, Eda/0000-0001-8328-3314; Silvestris, Lucia/0000-0002-8985-4891; Pozzobon, Nicola/0000-0002-9674-0809; Bunichev, Viacheslav/0000-0003-4418-2072; Zanetti, Marco/0000-0003-4281-4582; Zalewski, Piotr/0000-0003-4429-2888; Menasce, Dario Livio/0000-0002-9918-1686; McCauley, Thomas/0000-0001-6589-8286; Caudron, Julien/0000-0002-3530-6531; Noto, Francesco/0000-0003-2926-7342; Mondal, Naba/0000-0002-4098-8063; HSIUNG, YEE/0000-0003-4801-1238; Boccali, Tommaso/0000-0002-9930-9299; Marco de Lucas, Jesus/0000-0001-7914-8494; Carrera Jarrin, Edgar/0000-0002-0857-8507; Gorski, Maciej/0000-0003-2146-187X; Pansanel, Jerome/0000-0002-7067-5009; Shreyber, Irina/0000-0001-8654-5973; Srimanobhas, Norraphat/0000-0003-3563-2959; Vartak, Adish/0000-0003-1507-1365; Donega, Mauro/0000-0001-9830-0412; Lomidze, David/0000-0003-3936-6942; FORD, WILLIAM/0000-0001-8703-6943; Jafari, Abideh/0000-0001-7327-1870; Beaudette, Florian/0000-0002-1194-8556; Braibant-Giacomelli, Sylvie/0000-0003-2419-7971; Wang, Dayong/0000-0002-9013-1199; Bauer, Daniela/0000-0001-9412-4562; Kolberg, Ted/0000-0002-0211-6109; Toback, David/0000-0003-3457-4144; Ventura, Sandro/0000-0002-8938-2193; Passeri, Daniele/0000-0001-5322-2414; Robert, Schoefbeck/0000-0002-2332-8784; Martinez Ruiz del Arbol, Pablo/0000-0002-7737-5121; Bargassa, Pedrame/0000-0001-8612-3332; Arneodo, Michele/0000-0002-7790-7132; Tonelli, Guido Emilio/0000-0003-2606-9156; Bartalini, Paolo/0000-0002-0250-4507; Abbiendi, Giovanni/0000-0003-4499-7562; Kayis Topaksu, Aysel/0000-0002-3169-4573; Janssen, Tahys/0000-0002-3998-4081; Spandre, Gloria/0000-0003-0802-3453; Melo da Costa, Eliza/0000-0002-5016-6434; Zenz, Seth/0000-0002-9720-1794; Longo, Egidio/0000-0001-6238-6787; Raval, Amita/0000-0003-0164-4337; Botta, Cristina/0000-0002-8072-795X; Wardle, Nicholas/0000-0003-1344-3356; Dittmann, Jay R./0000-0002-1911-3158; Lenzi, Piergiulio/0000-0002-6927-8807; Lange, Joern/0000-0003-1307-1441; Kyberd, Paul/0000-0002-7353-7090; Wetzel, James/0000-0003-4687-7302; Everaerts, Pieter/0000-0003-3848-324X; Hooper, Ryan/0000-0003-1407-6578; Volpe, Roberta/0000-0003-1782-2978; Varela, Joao/0000-0003-2613-3146; Reis, Thomas/0000-0003-3703-6624; Gonzi, Sandro/0000-0003-4754-645X; Cousins, Robert/0000-0002-5963-0467; Tapper, Alexander/0000-0003-4543-864X; Lampen, Tapio/0000-0002-8398-4249; CHEN, KAI-FENG/0000-0003-1304-3782; Goy Lopez, Silvia/0000-0001-6508-5090; Gozzelino, Andrea/0000-0002-6284-1126; Godinovic, Nikola/0000-0002-4674-9450; Jun, Soon Yung/0000-0003-3370-6109; Heath, Helen/0000-0001-6576-9740; Meschi, Emilio/0000-0003-4502-6151; Gritsan, Andrei/0000-0002-3545-7970; Shopova, Mariana/0000-0001-6664-2493; Bockelman, Brian/0000-0003-2981-3809; Buchmueller, Oliver/0000-0002-3293-3759; Andreev, Yuri/0000-0002-7397-9665; Kumar, Arun/0000-0002-5180-6595; Milosevic, Jovan/0000-0001-8486-4604; Boutle, Sarah/0000-0002-8732-2963; Ratnikov, Fedor/0000-0003-0762-5583; Brinkerhoff, Andrew/0000-0002-4819-7995; Carrillo Montoya, Camilo/0000-0002-6245-6535; Dragicevic, Marko/0000-0003-1967-6783; Rodrigues Antunes, Joao/0000-0002-2911-6555; Meyer, Arnd/0000-0001-9598-6623; Nishu, Nishu/0000-0002-9048-1332; Pavlov, Borislav/0000-0003-3635-0646; Malgeri, Luca/0000-0002-0113-7389; Pagano, Davide/0000-0003-0333-448X; Gaz, Alessandro/0000-0001-6754-3315; Neumeister, Norbert/0000-0003-2356-1700; Piotrzkowski, Krzysztof/0000-0002-6226-957X; Bilki, Burak/0000-0001-9515-3306; Colaleo, Anna/0000-0002-0711-6319; Martinez, German Ruben/0000-0001-5443-9383; Belforte, Stefano/0000-0001-8443-4460; Senkin, Sergey/0000-0001-5848-005X; Kalinowski, Artur/0000-0002-1280-5493; Mahrous, Ayman/0000-0001-6853-8630; Kraan, Aafke/0000-0002-1417-8809; Deniz, Muhammed/0000-0002-9781-8241; Klanner, Robert/0000-0002-7004-9227; Kannike, Kristjan/0000-0003-3710-317X; Forthomme, Laurent/0000-0002-3302-336X; Chamont, David/0000-0003-2618-7355; Verdier, Patrice/0000-0003-3090-2948; Papadopoulos, Ioannis/0000-0002-9937-3063	Austrian Federal Ministry of Science and Research; Belgian Fonds de la Recherche Scientifique; Fonds voor Wetenschappelijk Onderzoek; Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (FAPESP); Bulgarian Ministry of Education, Youth, and Science; CERN; Chinese Academy of Sciences; Ministry of Science and Technology; National Natural Science Foundation of China; Colombian funding agency (COLCIENCIAS, Departamento Administrativo de Ciencia, Tecnologia, e Innovacion); Croatian Ministry of Science, Education, and Sport; Research Promotion Foundation, Cyprus; Ministry of Education and Research, Recurrent [SF0690030s09]; European Regional Development Fund, Estonia; Academy of Finland; Finnish Ministry of Education and Culture; Helsinki Institute of Physics; Institut National de Physique Nucleaire et de Physique des Particules-CNRS; Commissariat a l'Energie Atomique et aux Energies Alternatives-CEA, France; Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft; Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; General Secretariat for Research and Technology, Greece; National Scientific Research Foundation; National Office for Research and Technology, Hungary; Department of Atomic Energy and the Department of Science and Technology, India; Institute for Studies in Theoretical Physics and Mathematics, Iran; Science Foundation, Ireland; Istituto Nazionale di Fisica Nucleare, Italy; Korean Ministry of Education, Science and Technology; World Class University program of NRF, Republic of Korea; Lithuanian Academy of Sciences; Centro de Investigacion y Estudios Avanzados; CINVESTAV; Consejo Nacional de Ciencia y Technologia (CONACYT); Secretaria de Educacion P blica (SEP); Universidad Autonoma de San Luis Potosi Fondo de Apoyo a la Investigacion (UASLP-FAI); Ministry of Science and Innovation, New Zealand; Pakistan Atomic Energy Commission; Ministry of Science and Higher Education; National Science Centre, Poland; Fundacao para a Ciencia e a Tecnologia, Portugal; JINR (Joint Institute for Nuclear Research) (Armenia, Belarus, Georgia, Ukraine, Uzbekistan); Ministry of Education and Science of the Russian Federation; Federal Agency of Atomic Energy of the Russian Federation; Russian Academy of Sciences; Russian Foundation for Basic Research; Ministry of Science and Technological Development of Serbia; Secretaria de Estado de Investigacion, Desarrollo, e Innovacion and Programa Consolider-Ingenio, Spain; Eidgenossische Technische Hochschule (ETH) Board; ETH Zurich; Paul Scherrer Institut (PSI); Swiss National Science Foundation; Universitat Zurich; Canton Zurich; State Secretariat for Education and Research (SER); National Science Council, Taipei; Thailand Center of Excellence in Physics; Institute for the Promotion of Teaching Science and Technology of Thailand; National Science and Technology Development Agency of Thailand; Scientific and Technical Research Council of Turkey; Turkish Atomic Energy Authority; Science and Technology Facilities Council, UK; U.S. Department of Energy; NSF; STFC [PP/E002722/1, ST/K000616/1, ST/J004820/1, ST/J005614/1, ST/G502347/1, ST/J004901/1, ST/H00081X/2, ST/L001225/1, ST/I000410/1, ST/F007094/1, ST/G502412/1, ST/F006748/1, ST/I505572/1, ST/I002839/1, ST/I002200/1, ST/J005665/1, ST/I005912/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J004901/1, ST/F006748/1, ST/G502347/1, ST/K001604/1 GRIDPP, ST/I002839/1, PP/E002722/1, ST/I000410/1, ST/G502412/1, ST/I005912/1, ST/I505572/1, ST/K001604/1, ST/K000616/1, ST/I002200/1, ST/K001256/1, ST/J005665/1, ST/K001604/1 T2K, ST/F007094/1, ST/K001604/1 SuperNEMO, ST/K001604/1 LHCb, ST/K001604/1 CMS Upgrade, ST/K001604/1 LHCb Upgrades, ST/J004820/1, ST/J005614/1, ST/L001225/1, ST/K001604/1 DMUK, CMS, ST/K001604/1 MICE/UKNF, ST/I005912/1 GRIDPP, ST/H00081X/2] Funding Source: researchfish; Division Of Physics [1066578] Funding Source: National Science Foundation	Austrian Federal Ministry of Science and Research; Belgian Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Fonds voor Wetenschappelijk Onderzoek(FWO); Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Bulgarian Ministry of Education, Youth, and Science; CERN; Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Colombian funding agency (COLCIENCIAS, Departamento Administrativo de Ciencia, Tecnologia, e Innovacion); Croatian Ministry of Science, Education, and Sport(Ministry of Science, Education and Sports, Republic of Croatia); Research Promotion Foundation, Cyprus; Ministry of Education and Research, Recurrent; European Regional Development Fund, Estonia; Academy of Finland(Academy of Finland); Finnish Ministry of Education and Culture; Helsinki Institute of Physics; Institut National de Physique Nucleaire et de Physique des Particules-CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique et aux Energies Alternatives-CEA, France(French Atomic Energy Commission); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany(Helmholtz Association); General Secretariat for Research and Technology, Greece(Greek Ministry of Development-GSRT); National Scientific Research Foundation; National Office for Research and Technology, Hungary(National Office for Research and Technology); Department of Atomic Energy and the Department of Science and Technology, India; Institute for Studies in Theoretical Physics and Mathematics, Iran; Science Foundation, Ireland(Science Foundation IrelandEuropean Commission); Istituto Nazionale di Fisica Nucleare, Italy(Istituto Nazionale di Fisica Nucleare (INFN)); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University program of NRF, Republic of Korea; Lithuanian Academy of Sciences(Research Council of Lithuania (LMTLT)); Centro de Investigacion y Estudios Avanzados; CINVESTAV; Consejo Nacional de Ciencia y Technologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Secretaria de Educacion P blica (SEP); Universidad Autonoma de San Luis Potosi Fondo de Apoyo a la Investigacion (UASLP-FAI); Ministry of Science and Innovation, New Zealand; Pakistan Atomic Energy Commission; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre, Poland(National Science Centre, Poland); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); JINR (Joint Institute for Nuclear Research) (Armenia, Belarus, Georgia, Ukraine, Uzbekistan); Ministry of Education and Science of the Russian Federation(Ministry of Education and Science, Russian Federation); Federal Agency of Atomic Energy of the Russian Federation; Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia); Secretaria de Estado de Investigacion, Desarrollo, e Innovacion and Programa Consolider-Ingenio, Spain(Spanish Government); Eidgenossische Technische Hochschule (ETH) Board; ETH Zurich(ETH Zurich); Paul Scherrer Institut (PSI); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Universitat Zurich; Canton Zurich; State Secretariat for Education and Research (SER); National Science Council, Taipei(Ministry of Science and Technology, Taiwan); Thailand Center of Excellence in Physics; Institute for the Promotion of Teaching Science and Technology of Thailand; National Science and Technology Development Agency of Thailand; Scientific and Technical Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); Turkish Atomic Energy Authority(Ministry of Energy & Natural Resources - Turkey); Science and Technology Facilities Council, UK(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We congratulate our colleagues in the CERN accelerator departments for the excellent performance of the LHC machine. We thank the computing centers in the Worldwide LHC Computing Grid for the provisioning and excellent performance of computing infrastructure essential to our analyses and the administrative staff at CERN and the other CMS institutes.; r r We gratefully acknowledge the contributions of the technical staff at CERN and other CMS institutes and the support from all the funding agencies that contributed to the construction and the operation of the CMS detector: the Austrian Federal Ministry of Science and Research; the Belgian Fonds de la Recherche Scientifique, and Fonds voor Wetenschappelijk Onderzoek; the Brazilian funding agencies [Conselho Nacional de Desenvolvimento Cientifico e Technologico(CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and Fundacao de Amparo a Pesquisa do Estado do Sao Paulo (FAPESP)]; the Bulgarian Ministry of Education, Youth, and Science; CERN; the Chinese Academy of Sciences, Ministry of Science and Technology, and National Natural Science Foundation of China; the Colombian funding agency (COLCIENCIAS, Departamento Administrativo de Ciencia, Tecnologia, e Innovacion); the Croatian Ministry of Science, Education, and Sport; the Research Promotion Foundation, Cyprus; the Ministry of Education and Research, Recurrent financing contract SF0690030s09 and European Regional Development Fund, Estonia; the Academy of Finland, Finnish Ministry of Education and Culture, and Helsinki Institute of Physics; the Institut National de Physique Nucleaire et de Physique des Particules-CNRS, and Commissariat a l'Energie Atomique et aux Energies Alternatives-CEA, France; the Bundesministerium fur Bildung und Forschung, Deutsche Forschungsgemeinschaft, and Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany; the General Secretariat for Research and Technology, Greece; the National Scientific Research Foundation, and National Office for Research and Technology, Hungary; the Department of Atomic Energy and the Department of Science and Technology, India; the Institute for Studies in Theoretical Physics and Mathematics, Iran; the Science Foundation, Ireland; the Istituto Nazionale di Fisica Nucleare, Italy; the Korean Ministry of Education, Science and Technology and the World Class University program of NRF, Republic of Korea; the Lithuanian Academy of Sciences; the Mexican funding agencies [Centro de Investigacion y Estudios Avanzados, (CINVESTAV), Consejo Nacional de Ciencia y Technologia (CONACYT), Secretaria de Educacion P blica (SEP), and Universidad Autonoma de San Luis Potosi Fondo de Apoyo a la Investigacion (UASLP-FAI)]; the Ministry of Science and Innovation, New Zealand; the Pakistan Atomic Energy Commission; the Ministry of Science and Higher Education and the National Science Centre, Poland; the Fundacao para a Ciencia e a Tecnologia, Portugal; JINR (Joint Institute for Nuclear Research) (Armenia, Belarus, Georgia, Ukraine, Uzbekistan); the Ministry of Education and Science of the Russian Federation, the Federal Agency of Atomic Energy of the Russian Federation, Russian Academy of Sciences, and the Russian Foundation for Basic Research; the Ministry of Science and Technological Development of Serbia; the Secretaria de Estado de Investigacion, Desarrollo, e Innovacion and Programa Consolider-Ingenio 2010, Spain; the Swiss funding agencies [Eidgenossische Technische Hochschule (ETH) Board, ETH Zurich, Paul Scherrer Institut (PSI), Swiss National Science Foundation, Universitat Zurich, Canton Zurich, and State Secretariat for Education and Research (SER)]; the National Science Council, Taipei; the Thailand Center of Excellence in Physics, the Institute for the Promotion of Teaching Science and Technology of Thailand and the National Science and Technol; ogr yr Development Agency of Thailand; the Scientific and Technical Research Council of Turkey, and Turkish Atomic Energy Authority; the Science and Technology Facilities Council, UK; U.S. Department of Energy, and NSF.	Aad G, 2012, SCIENCE, V338, P1576, DOI 10.1126/science.1232005; Aad G, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.032003; Aaltonen T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.071804; Aaltonen T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.061802; Abbaneo D, 2003, PHYS LETT B, V565, P61, DOI 10.1016/S0370-2693(03)00614-2; Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Alioli S, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/04/002; Alwall J, 2007, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2007/09/028; ATLAS and CMS Collaborations, 2011, TECHNICAL REPORT ATL; Bhat PC, 2011, ANNU REV NUCL PART S, V61, P281, DOI [10.1146/annurev.nucl.012809.104427, 10.1146/annurev.nucl.012809.10442]; CDF Collaboration, 2012, COMBINED SEARCH FOR; Chatrchyan S, 2012, PHYS LETT B, V713, P68, DOI 10.1016/j.physletb.2012.05.028; Chatrchyan S, 2012, PHYS LETT B, V710, P91, DOI 10.1016/j.physletb.2012.02.076; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; Chatrchyan S, 2012, PHYS LETT B, V710, P284, DOI 10.1016/j.physletb.2012.02.085; Chatrchyan S, 2012, PHYS LETT B, V710, P403, DOI 10.1016/j.physletb.2012.03.003; Chatrchyan S, 2012, PHYS LETT B, V710, P26, DOI 10.1016/j.physletb.2012.02.064; Chatrchyan S, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.111804; Chatrchyan S, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2011)117; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; CMS Collaboration, 2012, JHEP, P036; CORNWALL JM, 1973, PHYS REV LETT, V30, P1268, DOI 10.1103/PhysRevLett.30.1268; CORNWALL JM, 1974, PHYS REV D, V10, P1145, DOI 10.1103/PhysRevD.10.1145; D0 Collaboration, 2012, COMBINED SEARCH FOR; ELLIS J, 1976, NUCL PHYS B, V106, P292, DOI 10.1016/0550-3213(76)90184-X; ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321; Evans L, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08001; GEORGI HM, 1978, PHYS REV LETT, V40, P692, DOI 10.1103/PhysRevLett.40.692; Gieseke S., 2006, HERWIG 20 RELEASE NO; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; GLASHOW SL, 1978, PHYS REV D, V18, P1724, DOI 10.1103/PhysRevD.18.1724; GURALNIK GS, 1964, PHYS REV LETT, V13, P585, DOI 10.1103/PhysRevLett.13.585; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; HIGGS PW, 1966, PHYS REV, V145, P1156, DOI 10.1103/PhysRev.145.1156; HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9; KIBBLE TWB, 1967, PHYS REV, V155, P1554, DOI 10.1103/PhysRev.155.1554; LANDAU LD, 1948, DOKL AKAD NAUK SSSR+, V60, P207; LEE BW, 1977, PHYS REV D, V16, P1519, DOI 10.1103/PhysRevD.16.1519; Nason P, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2010)037; Prosper H. B., 2008, PAPER PRESENTED AT X; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; Sjostrand T, 2006, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2006/05/026; Smith C. H. Llewellyn, 1973, PHYS LETT          B, V46, P233, DOI DOI 10.1016/0370-2693(73)90692-8; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264; YANG CN, 1950, PHYS REV, V77, P242, DOI 10.1103/PhysRev.77.242	46	66	66	2	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1569	1575		10.1126/science.1230816	http://dx.doi.org/10.1126/science.1230816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258887	Green Published, Green Submitted			2022-12-28	WOS:000312533100042
J	Della Negra, M; Jenni, P; Virdee, TS				Della Negra, M.; Jenni, P.; Virdee, T. S.			Journey in the Search for the Higgs Boson: The ATLAS and CMS Experiments at the Large Hadron Collider	SCIENCE			English	Article							BROKEN SYMMETRIES; GAUGE	The search for the standard model Higgs boson at the Large Hadron Collider (LHC) started more than two decades ago. Much innovation was required and diverse challenges had to be overcome during the conception and construction of the LHC and its experiments. The ATLAS and CMS Collaboration experiments at the LHC have discovered a heavy boson that could complete the standard model of particle physics.	[Della Negra, M.; Virdee, T. S.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Della Negra, M.; Virdee, T. S.] CMS, Geneva, Switzerland; [Jenni, P.] CERN, Geneva, Switzerland; [Jenni, P.] ATLAS, Geneva, Switzerland	Imperial College London; European Organization for Nuclear Research (CERN)	Virdee, TS (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	tejinder.virdee@cern.ch			Science and Technology Facilities Council [ST/K001604/1 T2K, ST/K001604/1 SuperNEMO, ST/K001604/1 LHCb Upgrades, ST/K001604/1 GRIDPP, ST/K001604/1 MICE/UKNF, ST/K001604/1 LHCb, ST/K001604/1, ST/K001604/1 CMS Upgrade, ST/K001604/1 DMUK] Funding Source: researchfish	Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))		Aad G, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.032003; Aad G, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1593-6; Aad G., 2008, JINST, V3, DOI DOI 10.1088/1748-0221/3/08/S08003; Aaltonen T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.071804; Aaltonen T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.061802; Abbaneo D, 2003, PHYS LETT B, V565, P61, DOI 10.1016/S0370-2693(03)00614-2; ATLAS Collaboration, 1992, CERN LHCC 92 004; ATLAS Collaboration, 1994, TECHNICAL PROPOSAL C; Chatrchyan S, 2012, PHYS LETT B, V711, P15, DOI 10.1016/j.physletb.2012.03.029; Chatrchyan S, 2012, PHYS LETT B, V710, P26, DOI 10.1016/j.physletb.2012.02.064; Chatrchyan S, 2010, J INSTRUM, V5, DOI 10.1088/1748-0221/5/03/T03001; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; CMS Collaboration, 2012, Physics Letters B, V716, P30, DOI 10.1016/j.physletb.2012.08.021; CMS Collaboration, 1992, CERN LHCC 92 003; CMS Collaboration, 1994, TECHNICAL PROPOSAL C; ELLIS N, 1994, ANNU REV NUCL PART S, V44, P609, DOI 10.1146/annurev.ns.44.120194.003141; ENGLERT F, 1964, PHYS REV LETT, V13, P321, DOI 10.1103/PhysRevLett.13.321; Evans L., 2009, THE LARGE HADRON COL; Evans L, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08001; Froidevaux D., 1990, P LARG HADR COLL WOR, P509; GLASHOW SL, 1961, NUCL PHYS, V22, P579, DOI 10.1016/0029-5582(61)90469-2; GURALNIK GS, 1964, PHYS REV LETT, V13, P585, DOI 10.1103/PhysRevLett.13.585; HIGGS PW, 1964, PHYS REV LETT, V13, P508, DOI 10.1103/PhysRevLett.13.508; HIGGS PW, 1966, PHYS REV, V145, P1156, DOI 10.1103/PhysRev.145.1156; HIGGS PW, 1964, PHYS LETT, V12, P132, DOI 10.1016/0031-9163(64)91136-9; KIBBLE TWB, 1967, PHYS REV, V155, P1554, DOI 10.1103/PhysRev.155.1554; LANDAU LD, 1948, DOKL AKAD NAUK SSSR+, V60, P207; LHC Computing Grid, 2005, TECHNICAL DESIGN REP; Salam A., 1968, Elementary particle theory, relativistic groups and analyticity, P367; Seez C., 1990, European Committee for Future Accelerators: Large Hadron Collider Workshop. Proceedings (CERN 90-10; ECFA 90-133), P474; WEINBERG S, 1967, PHYS REV LETT, V19, P1264, DOI 10.1103/PhysRevLett.19.1264; YANG CN, 1950, PHYS REV, V77, P242, DOI 10.1103/PhysRev.77.242	32	23	23	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1560	1568		10.1126/science.1230827	http://dx.doi.org/10.1126/science.1230827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258886				2022-12-28	WOS:000312533100041
J	Luga, V; Zhang, L; Viloria-Petit, AM; Ogunjimi, AA; Inanlou, MR; Chiu, E; Buchanan, M; Hosein, AN; Basik, M; Wrana, JL				Luga, Valbona; Zhang, Liang; Viloria-Petit, Alicia M.; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark; Wrana, Jeffrey L.			Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration	CELL			English	Article							TUMOR INVASION; POLARITY; METASTASIS; DEGRADATION; PROGRESSION; PLASTICITY; SECRETION; MOTILITY; RHOA	Stroma in the tumor microenvironment plays a critical role in cancer progression, but how it promotes metastasis is poorly understood. Exosomes are small vesicles secreted by many cell types and enable a potent mode of intercellular communication. Here, we report that fibroblast-secreted exosomes promote breast cancer cell (BCC) protrusive activity and motility via Wnt-planar cell polarity (PCP) signaling. We show that exosome-stimulated BCC protrusions display mutually exclusive localization of the core PCP complexes, Fzd-Dvl and Vangl-Pk. In orthotopic mouse models of breast cancer, coinjection of BCCs with fibroblasts dramatically enhances metastasis that is dependent on PCP signaling in BCCs and the exosome component, Cd81 in fibroblasts. Moreover, we demonstrate that trafficking in BCCs promotes tethering of autocrine Wnt11 to fibroblast-derived exosomes. This work reveals an intercellular communication pathway whereby fibroblast exosomes mobilize autocrine Wnt-PCP signaling to drive BCC invasive behavior.	[Luga, Valbona; Zhang, Liang; Ogunjimi, Abiodun A.; Inanlou, Mohammad R.; Chiu, Elaine; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Luga, Valbona; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Viloria-Petit, Alicia M.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Buchanan, Marguerite; Hosein, Abdel Nasser; Basik, Mark] Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3S 1Y7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Guelph; Lady Davis Institute; McGill University	Wrana, JL (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	wrana@lunenfeld.ca	Wrana, Jeffrey/F-8857-2013	Hosein, Abdel/0000-0003-1567-6700; ZHANG, Liang/0000-0003-3100-8593	CIHR [MOP14339]; Terry Fox Research Institute; Krembil Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute; Krembil Foundation	We thank Eduardo Aguiar for assistance with cloning, Katherine Huang and Payman Tehrani for help with data analysis, Douglas Holmyard for technical support with EM, Brett Larsen and Cunjie Zhang for assistance with proteomic studies, and members of the J.L.W. lab for discussion. We thank Drs. Liliana Attisano, Rod Bremner, and Helen McNeill for critical review of the manuscript. This work was supported by funds from CIHR (to J.L.W. grant MOP14339), a Terry Fox Research Institute group grant, and the Krembil Foundation. J.L.W. is the Mary Janigan Chair in Experimental Therapeutics.	Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Coudreuse D, 2007, DEVELOPMENT, V134, P3, DOI 10.1242/dev.02699; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Finak G, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1608; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Gray RS, 2011, DEV CELL, V21, P120, DOI 10.1016/j.devcel.2011.06.011; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Hosein AN, 2010, CANCER RES, V70, P5770, DOI 10.1158/0008-5472.CAN-10-0673; Jessen JR, 2009, ZEBRAFISH, V6, P21, DOI 10.1089/zeb.2008.0571; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Sahai E, 2007, J CELL BIOL, V176, P35, DOI 10.1083/jcb.200605135; SANFORD KK, 1956, CANCER RES, V16, P162; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Taylor DD, 2011, SEMIN IMMUNOPATHOL, V33, P441, DOI 10.1007/s00281-010-0234-8; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Zoller M, 2009, NAT REV CANCER, V9, P40, DOI 10.1038/nrc2543	30	907	945	12	271	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1542	1556		10.1016/j.cell.2012.11.024	http://dx.doi.org/10.1016/j.cell.2012.11.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260141	Bronze			2022-12-28	WOS:000312890300018
J	Qi, XL				Qi, Xiao-Liang			Symmetry Meets Topology	SCIENCE			English	Editorial Material							INSULATORS		Stanford Univ, Dept Phys, Stanford, CA 94305 USA	Stanford University	Qi, XL (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	xlqi@stanford.edu						Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; Fidkowski L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075103; Gu Z.-C., 2012, ARXIV12012648; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Moore JE, 2010, NATURE, V464, P194, DOI 10.1038/nature08916; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Turner AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075102	9	5	5	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1550	1551		10.1126/science.1232394	http://dx.doi.org/10.1126/science.1232394			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258881				2022-12-28	WOS:000312533100037
J	Boehncke, WH				Boehncke, Wolf-Henning			PERSPECTIVE Don't be superficial	NATURE			English	Editorial Material							PSORIASIS; RISK		Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland	University of Geneva	Boehncke, WH (corresponding author), Univ Hosp Geneva, Dept Dermatol, Geneva, Switzerland.	wolf-henning.boehncke@hcuge.ch						Coimbra S, 2010, J EUR ACAD DERMATOL, V24, P1386, DOI 10.1111/j.1468-3083.2010.03647.x; Gelfand JM, 2007, ARCH DERMATOL, V143, P1493, DOI 10.1001/archderm.143.12.1493; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Karadag AS, 2010, INT J DERMATOL, V49, P642, DOI 10.1111/j.1365-4632.2009.04358.x; Kimball AB, 2008, J AM ACAD DERMATOL, V58, P1031, DOI 10.1016/j.jaad.2008.01.006; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X	8	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					555	555		10.1038/492S55a	http://dx.doi.org/10.1038/492S55a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254972	Bronze, Green Published			2022-12-28	WOS:000312488200004
J	Garber, K				Garber, Ken			GENETICS Deep exploration	NATURE			English	Editorial Material							PSORIASIS											de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Jordan CT, 2012, AM J HUM GENET, V90, P784, DOI 10.1016/j.ajhg.2012.03.012; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467	4	16	17	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					556	557		10.1038/492S56a	http://dx.doi.org/10.1038/492S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23254973	Bronze			2022-12-28	WOS:000312488200005
J	Gregg, EW; Chen, HY; Wagenknecht, LE; Clark, JM; Delahanty, LM; Bantle, J; Pownall, HJ; Johnson, KC; Safford, MM; Kitabchi, AE; Pi-Sunyer, FX; Wing, RR; Bertoni, AG				Gregg, Edward W.; Chen, Haiying; Wagenknecht, Lynne E.; Clark, Jeanne M.; Delahanty, Linda M.; Bantle, John; Pownall, Henry J.; Johnson, Karen C.; Safford, Monika M.; Kitabchi, Abbas E.; Pi-Sunyer, F. Xavier; Wing, Rena R.; Bertoni, Alain G.		Look AHEAD Res Grp	Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BARIATRIC SURGERY; PREVENTION PROGRAM; MEDICAL THERAPY; OBESE-PATIENTS; REDUCTION; WEIGHT; INDIVIDUALS; MORTALITY; ORLISTAT; MELLITUS	Context The frequency of remission of type 2 diabetes achievable with lifestyle intervention is unclear. Objective To examine the association of a long-term intensive weight-loss intervention with the frequency of remission from type 2 diabetes to prediabetes or normoglycemia. Design, Setting, and Participants Ancillary observational analysis of a 4-year randomized controlled trial (baseline visit, August 2001-April 2004; last follow-up, April 2008) comparing an intensive lifestyle intervention (ILI) with a diabetes support and education control condition (DSE) among 4503 US adults with body mass index of 25 or higher and type 2 diabetes. Interventions Participants were randomly assigned to receive the ILI, which included weekly group and individual counseling in the first 6 months followed by 3 sessions per month for the second 6 months and twice-monthly contact and regular refresher group series and campaigns in years 2 to 4 (n=2241) or the DSE, which was an offer of 3 group sessions per year on diet, physical activity, and social support (n=2262). Main Outcome Measures Partial or complete remission of diabetes, defined as transition from meeting diabetes criteria to a prediabetes or nondiabetic level of glycemia (fasting plasma glucose <126 mg/dL and hemoglobin A(1c) <6.5% with no antihyperglycemic medication). Results Intensive lifestyle intervention participants lost significantly more weight than DSE participants at year 1 (net difference, -7.9%; 95% CI, -8.3% to -7.6%) and at year 4 (-3.9%; 95% CI, -4.4% to -3.5%) and had greater fitness increases at year 1 (net difference, 15.4%; 95% CI, 13.7%-17.0%) and at year 4 (6.4%; 95% CI, 4.7%-8.1%) (P<.001 for each). The ILI group was significantly more likely to experience any remission (partial or complete), with prevalences of 11.5% (95% CI, 10.1%-12.8%) during the first year and 7.3% (95% CI, 6.2%-8.4%) at year 4, compared with 2.0% for the DSE group at both time points (95% CIs, 1.4%-2.6% at year 1 and 1.5%-2.7% at year 4) (P<.001 for each). Among ILI participants, 9.2% (95% CI, 7.9%-10.4%), 6.4% (95% CI, 5.3%-7.4%), and 3.5% (95% CI, 2.7%-4.3%) had continuous, sustained remission for at least 2, at least 3, and 4 years, respectively, compared with less than 2% of DSE participants (1.7% [95% CI, 1.2%-2.3%] for at least 2 years; 1.3% [95% CI, 0.8%-1.7%] for at least 3 years; and 0.5% [95% CI, 0.2%-0.8%] for 4 years). Conclusions In these exploratory analyses of overweight adults, an intensive lifestyle intervention was associated with a greater likelihood of partial remission of type 2 diabetes compared with diabetes support and education. However, the absolute remission rates were modest.	[Gregg, Edward W.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30341 USA; [Chen, Haiying; Wagenknecht, Lynne E.; Bertoni, Alain G.] Wake Forest Sch Med, Winston Salem, NC USA; [Clark, Jeanne M.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Delahanty, Linda M.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Bantle, John] Univ Minnesota, Minneapolis, MN USA; [Pownall, Henry J.] Baylor Coll Med, Houston, TX 77030 USA; [Johnson, Karen C.; Kitabchi, Abbas E.] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; [Safford, Monika M.] Univ Alabama Birmingham, Birmingham, AL USA; [Pi-Sunyer, F. Xavier] Columbia Univ, St Lukes Roosevelt Hosp, New York, NY USA; [Wing, Rena R.] Miriam Hosp, Brown Med Sch, Providence, RI 02906 USA	Centers for Disease Control & Prevention - USA; Wake Forest University; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; Columbia University; Mount Sinai St. Luke's; Mount Sinai West; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Gregg, EW (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, 4770 Buford Hwy NE,MS K-10, Atlanta, GA 30341 USA.	edg7@cdc.gov	Albertin, Paloma C/X-1093-2018; Clark, Jeanne/AGG-8199-2022	Clark, Jeanne/0000-0003-1194-0092; Pownall, Henry/0000-0001-8412-506X; Gregg, Edward/0000-0003-2381-6822; Hill, James/0000-0003-4690-2264; Bertoni, Alain/0000-0002-7503-6273	US Department of Health and Human Services from the National Institutes of Health (NIH) [DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, DK56992]; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; NIH Office of Research on Women's Health; Centers for Disease Control and Prevention; Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (IHS); Johns Hopkins Medical Institutions Bayview General Clinical Research Center [M01RR02719]; Massachusetts General Hospital Mallinckrodt General Clinical Research Center; Massachusetts Institute of Technology General Clinical Research Center [M01RR01066]; University of Colorado Health Sciences Center General Clinical Research Center [M01RR00051]; Clinical Nutrition Research Unit [P30 DK48520]; University of Tennessee at Memphis General Clinical Research Center [M01RR0021140]; University of Pittsburgh General Clinical Research Center [M01RR000056]; Clinical Translational Research Center; Clinical and Translational Science Award [UL1 RR 024153]; NIH [DK 046204]; VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; Frederic C. Bartter General Clinical Research Center [M01RR01346]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056, M01RR001066, M01RR000051, UL1RR024153, M01RR001346, M01RR002719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK057078, P30DK046204, U01DK057154, U01DK057136, U01DK057182, U01DK056990, U01DK057149, U01DK057151, U01DK057135, U01DK057178, U01DK057002, R01DK083393, K24DK062222, U01DK057219, U01DK056992, R01DK060427, U01DK057131, U01DK057171, P30DK017047, R01DK048117, U01DK057008, P30DK048520, U01DK057177, R01DK089557] Funding Source: NIH RePORTER	US Department of Health and Human Services from the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (IHS); Johns Hopkins Medical Institutions Bayview General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Massachusetts General Hospital Mallinckrodt General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Massachusetts Institute of Technology General Clinical Research Center; University of Colorado Health Sciences Center General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Nutrition Research Unit; University of Tennessee at Memphis General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Pittsburgh General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Clinical Translational Research Center; Clinical and Translational Science Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; Frederic C. Bartter General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by the US Department of Health and Human Services through the following cooperative agreements from the National Institutes of Health (NIH): DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992. The following federal agencies have contributed support: National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Nursing Research; National Center on Minority Health and Health Disparities; NIH Office of Research on Women's Health; and the Centers for Disease Control and Prevention. This research was supported in part by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases. The Indian Health Service (IHS) provided personnel, medical oversight, and use of facilities. Additional support was received from The Johns Hopkins Medical Institutions Bayview General Clinical Research Center (M01RR02719); the Massachusetts General Hospital Mallinckrodt General Clinical Research Center and the Massachusetts Institute of Technology General Clinical Research Center (M01RR01066); the University of Colorado Health Sciences Center General Clinical Research Center (M01RR00051) and Clinical Nutrition Research Unit (P30 DK48520); the University of Tennessee at Memphis General Clinical Research Center (M01RR0021140); the University of Pittsburgh General Clinical Research Center (M01RR000056), the Clinical Translational Research Center funded by Clinical and Translational Science Award UL1 RR 024153 and NIH grant DK 046204; the VA Puget Sound Health Care System Medical Research Service, Department of Veterans Affairs; and the Frederic C. Bartter General Clinical Research Center (M01RR01346). The following organizations have committed to making major contributions to Look AHEAD: FedEx Corp; Health Management Resources; LifeScan Inc, a Johnson and Johnson Company; OPTIFAST of Nestle HealthCare Nutrition Inc; Hoffmann-La Roche Inc; Abbott Nutrition; and Slim-Fast Brand of Unilever North America.	Andrews RC, 2011, LANCET, V378, P129, DOI 10.1016/S0140-6736(11)60442-X; [Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc12-s011, 10.2337/dc35-S011, 10.2337/dc12-s004]; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bolen SD, 2012, OBES SURG, V22, P749, DOI 10.1007/s11695-012-0595-2; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Echouffo-Tcheugui JB, 2011, EPIDEMIOL REV, V33, P63, DOI 10.1093/epirev/mxq020; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Heymsfield SB, 2000, ARCH INTERN MED, V160, P1321, DOI 10.1001/archinte.160.9.1321; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelley DE, 2002, DIABETES CARE, V25, P1033, DOI 10.2337/diacare.25.6.1033; Kitabchi AE, 2005, DIABETES, V54, P2404, DOI 10.2337/diabetes.54.8.2404; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Li XM, 2006, STAT MED, V25, P2107, DOI 10.1002/sim.2343; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Perreault L, 2012, LANCET, V379, P2243, DOI 10.1016/S0140-6736(12)60525-X; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Sjostrom L, 2008, INT J OBESITY, V32, pS93, DOI 10.1038/ijo.2008.244; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Wadden TA, 2006, OBESITY, V14, P737; Wesche-Thobaben J, 2011, CLIN TRIALS, V8, P320, DOI 10.1177/1740774511405858; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	31	391	410	5	88	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 19	2012	308	23					2489	2496		10.1001/jama.2012.67929	http://dx.doi.org/10.1001/jama.2012.67929			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	055TU	23288372	Bronze, Green Accepted			2022-12-28	WOS:000312441400025
J	Parekh, AK; Galloway, JM; Hong, YL; Wright, JS				Parekh, Anand K.; Galloway, James M.; Hong, Yuling; Wright, Janet S.			Aspirin in the Secondary Prevention of Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Parekh, Anand K.] US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC USA; [Galloway, James M.] US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Chicago, IL USA; [Hong, Yuling; Wright, Janet S.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Wright, Janet S.] Ctr Medicare & Medicaid Innovat, Baltimore, MD USA	Centers for Disease Control & Prevention - USA	Parekh, AK (corresponding author), US Dept Hlth & Human Serv, Off Assistant Secretary Hlth, Washington, DC USA.							Ademi Z, 2011, CARDIOVASC THER; [Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P11; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046	5	16	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					204	205		10.1056/NEJMp1213380	http://dx.doi.org/10.1056/NEJMp1213380			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323896				2022-12-28	WOS:000313549900004
J	Santini, E; Huynh, TN; MacAskill, AF; Carter, AG; Pierre, P; Ruggero, D; Kaphzan, H; Klann, E				Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Pierre, Philippe; Ruggero, Davide; Kaphzan, Hanoch; Klann, Eric			Exaggerated translation causes synaptic and behavioural aberrations associated with autism	NATURE			English	Article							PROTEIN-SYNTHESIS; INHIBITION; MEMORY; MODEL; DYSFUNCTIONS	Autism spectrum disorders (ASDs) are an early onset, heterogeneous group of heritable neuropsychiatric disorders with symptoms that include deficits in social interaction skills, impaired communication abilities, and ritualistic-like repetitive behaviours(1,2). One of the hypotheses for a common molecular mechanism underlying ASDs is altered translational control resulting in exaggerated protein synthesis(3). Genetic variants in chromosome 4q, which contains theEIF4E locus, have been described in patients with autism(4,5). Importantly, a rare single nucleotide polymorphism has been identified in autism that is associated with increased promoter activity in the EIF4E gene(6). Here we show that genetically increasing the levels of eukaryotic translation initiation factor 4E (eIF4E) in mice(7) results in exaggerated cap-dependent translation and aberrant behaviours reminiscent of autism, including repetitive and perseverative behaviours and social interaction deficits. Moreover, these autistic-like behaviours are accompanied by synaptic pathophysiology in the medial prefrontal cortex, striatumand hippocampus. The autistic-like behaviours displayed by the eIF4E-transgenic mice are corrected by intracerebroventricular infusions of the cap-dependent translation inhibitor 4EGI-1. Our findings demonstrate a causal relationship between exaggerated cap-dependent translation, synaptic dysfunction and aberrant behaviours associated with autism.	[Santini, Emanuela; Huynh, Thu N.; MacAskill, Andrew F.; Carter, Adam G.; Kaphzan, Hanoch; Klann, Eric] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Pierre, Philippe] Aix Marseille Univ, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; [Pierre, Philippe] INSERM, U1104, F-13288 Marseille, France; [Pierre, Philippe] CNRS, URM 7280, F-13288 Marseille, France; [Ruggero, Davide] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Sch Med, Dept Urol, San Francisco, CA 94143 USA	New York University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu	Huynh, Thu/I-5864-2014; MacAskill, Andrew/AFO-2061-2022	Huynh, Thu/0000-0002-7625-5101; MacAskill, Andrew/0000-0002-0196-3779; pierre, philippe/0000-0003-0863-8255	National Institutes of Health (NIH) [NS034007, NS047384, NS078718]; Department of Defense CDMRP [W81XWH-11-1-0389]; NIH [CA154916]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA154916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS034007, R21NS078718, R01NS034007, R01NS047384] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense CDMRP(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank J. LeDoux and members of his laboratory for their technical support and suggestions. We would also like to thank D. St Clair and Z. Miedzybrodzka for their comments on the manuscript. This research was supported by National Institutes of Health (NIH) grants NS034007, NS047384 and NS078718, and Department of Defense CDMRP award W81XWH-11-1-0389 (E. K.), NIH grant CA154916 (D. R.) and the Wellcome Trust (A.F.M.).	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Borgkvist A, 2006, MOL CELL NEUROSCI, V31, P293, DOI 10.1016/j.mcn.2005.09.018; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Chalifoux JR, 2010, NEURON, V66, P101, DOI 10.1016/j.neuron.2010.03.012; Chevere-Torres I, 2012, NEUROBIOL DIS, V45, P156, DOI 10.1016/j.nbd.2011.07.018; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Dumitriu D, 2011, NAT PROTOC, V6, P1391, DOI 10.1038/nprot.2011.389; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Errico F, 2008, MOL CELL NEUROSCI, V37, P335, DOI 10.1016/j.mcn.2007.10.007; Fineberg NA, 2010, NEUROPSYCHOPHARMACOL, V35, P591, DOI 10.1038/npp.2009.185; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gingras AC, 2001, GENE DEV, V15, P2852; Hoeffer CA, 2011, P NATL ACAD SCI USA, V108, P3383, DOI 10.1073/pnas.1013063108; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Neves-Pereira M, 2009, J MED GENET, V46, P759, DOI 10.1136/jmg.2009.066852; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qiu AQ, 2010, J AM ACAD CHILD PSY, V49, P539, DOI 10.1016/j.jaac.2010.02.012; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Thomas A, 2009, PSYCHOPHARMACOLOGY, V204, P361, DOI 10.1007/s00213-009-1466-y; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	38	253	257	1	85	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					411	U158		10.1038/nature11782	http://dx.doi.org/10.1038/nature11782			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23263185	Green Accepted, Green Submitted			2022-12-28	WOS:000313615900053
J	Moist, L				Moist, Louise			Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Moist, Louise] Univ Western Ontario, London, ON, Canada; [Moist, Louise] London Hlth Sci Ctr, London, ON, Canada	Western University (University of Western Ontario); London Health Sciences Centre	Moist, L (corresponding author), Univ Western Ontario, London, ON, Canada.							Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC5	10.7326/0003-4819-158-2-201301150-02005	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318339				2022-12-28	WOS:000314029400004
J	Hatridge, M; Shankar, S; Mirrahimi, M; Schackert, F; Geerlings, K; Brecht, T; Sliwa, KM; Abdo, B; Frunzio, L; Girvin, SM; Schoelkopf, RJ; Devoret, MH				Hatridge, M.; Shankar, S.; Mirrahimi, M.; Schackert, F.; Geerlings, K.; Brecht, T.; Sliwa, K. M.; Abdo, B.; Frunzio, L.; Girvin, S. M.; Schoelkopf, R. J.; Devoret, M. H.			Quantum Back-Action of an Individual Variable-Strength Measurement	SCIENCE			English	Article							JOSEPHSON RING MODULATOR; SUPERCONDUCTING QUBIT; PHOTON; ELECTRODYNAMICS; COLLAPSE; LIMIT	Measuring a quantum system can randomly perturb its state. The strength and nature of this back-action depend on the quantity that is measured. In a partial measurement performed by an ideal apparatus, quantum physics predicts that the system remains in a pure state whose evolution can be tracked perfectly from the measurement record. We demonstrated this property using a superconducting qubit dispersively coupled to a cavity traversed by a microwave signal. The back-action on the qubit state of a single measurement of both signal quadratures was observed and shown to produce a stochastic operation whose action is determined by the measurement result. This accurate monitoring of a qubit state is an essential prerequisite for measurement-based feedback control of quantum systems.	[Hatridge, M.; Shankar, S.; Mirrahimi, M.; Schackert, F.; Geerlings, K.; Brecht, T.; Sliwa, K. M.; Abdo, B.; Frunzio, L.; Girvin, S. M.; Schoelkopf, R. J.; Devoret, M. H.] Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA; [Mirrahimi, M.] Inst Natl Rech Informat & Automat Paris Rocquenco, F-78153 Le Chesnay, France	Yale University	Hatridge, M (corresponding author), Yale Univ, Dept Phys & Appl Phys, New Haven, CT 06520 USA.	michael.hatridge@yale.edu	Frunzio, Luigi/O-1573-2019; Shankar, Shyam/K-5127-2013; Schoelkopf, Robert J/J-8178-2012	Frunzio, Luigi/0000-0002-0272-5481; Shankar, Shyam/0000-0002-1311-9508; Mirrahimi, Mazyar/0000-0001-9471-6031	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office [W911NF-09-1-0369]; U.S. Army Research Office [W911NF-09-1-0514]; Agence National de Recherche [ANR-09-JCJC-0070]; College de France; NSF DMR [1004406]	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; U.S. Army Research Office; Agence National de Recherche(French National Research Agency (ANR)); College de France; NSF DMR(National Science Foundation (NSF))	The authors thank A. Korotkov, B. Huard, M. Reed, A. Wallraff, and C. Eichler for helpful discussions. Facilities use was supported by the Yale Institute for Nanoscience and Quantum Engineering (YINQE) and the NSF MRSEC DMR 1119826. This research was supported in part by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office (W911NF-09-1-0369), and in part by the U.S. Army Research Office (W911NF-09-1-0514). All statements of fact, opinion, or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI, or the U. S. government. M. M. acknowledges partial support from the Agence National de Recherche under the project EPOQ2, ANR-09-JCJC-0070. M. H. D. acknowledges partial support from the College de France. S. M. G. acknowledges support from the NSF DMR 1004406.	Abdo B, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3653473; Bergeal N, 2010, NAT PHYS, V6, P296, DOI 10.1038/NPHYS1516; Bergeal N, 2010, NATURE, V465, P64, DOI 10.1038/nature09035; Blais A, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.062320; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Carmichael H, 1993, OPEN SYSTEMS APPROAC; CAVES CM, 1982, PHYS REV D, V26, P1817, DOI 10.1103/PhysRevD.26.1817; Corcoles AD, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658630; Gambetta J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012112; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haroche S., 2006, EXPLORING QUANTUM; Hoffman AJ, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.053602; Katz N, 2006, SCIENCE, V312, P1498, DOI 10.1126/science.1126475; Korotkov A. N., 2011, QUANTUM MACHINES MEA, P533; Mariantoni M, 2011, NAT PHYS, V7, P287, DOI [10.1038/nphys1885, 10.1038/NPHYS1885]; Palacios-Laloy A, 2010, NAT PHYS, V6, P442, DOI 10.1038/NPHYS1641; Riste D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.050507; Roch N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.147701; Schoelkopf RJ, 2008, NATURE, V451, P664, DOI 10.1038/451664a; Schreier JA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.180502; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Sears AP, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.180504; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Wiseman HM, 2009, QUANTUM MEASUREMENT	27	181	185	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					178	181		10.1126/science.1226897	http://dx.doi.org/10.1126/science.1226897			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307736	Green Submitted			2022-12-28	WOS:000313328200037
J	Ardaugh, BM; Graves, SE; Redberg, RF				Ardaugh, Brent M.; Graves, Stephen E.; Redberg, Rita F.			The 510(k) Ancestry of a Metal-on-Metal Hip Implant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ardaugh, Brent M.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Graves, Stephen E.] Australian Orthopaed Assoc, Natl Joint Replacement Registry, Adelaide, SA, Australia; [Graves, Stephen E.] Flinders Univ S Australia, Dept Surg, Adelaide, SA 5001, Australia; [Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA	Boston University; Framingham Heart Study; Flinders University South Australia; University of California System; University of California San Francisco	Ardaugh, BM (corresponding author), Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA.		Graves, Stephen E/A-9463-2016	Graves, Stephen E/0000-0002-1629-319X				Australian Orthopaedic Association National Joint Replacement Registry, 2012, REP INV PROSTH HIG S; Cabitza P, 1979, Arch Sci Med (Torino), V136, P45; Center for Devices and Radiological Health, CDRH 2012 STRAT PRIO; Institute of Medicine, 2011, MED DEV PUBL HLTH FD; RING PA, 1983, CLIN ORTHOP RELAT R, P115	5	71	71	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					97	100		10.1056/NEJMp1211581	http://dx.doi.org/10.1056/NEJMp1211581			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23301729	Bronze			2022-12-28	WOS:000313238100012
J	Webster, PJ				Webster, Peter J.			Improve weather forecasts for the developing world	NATURE			English	Editorial Material							BANGLADESH; FLOODS		Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Webster, PJ (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	pjw@eas.gatech.edu						Belanger JI, 2012, WEATHER FORECAST, V27, P757, DOI 10.1175/WAF-D-11-00083.1; Foresight, 2012, RED RISKS FUT DIS PR; Hopson TM, 2010, J HYDROMETEOROL, V11, P618, DOI 10.1175/2009JHM1006.1; Leutbecher M, 2008, J COMPUT PHYS, V227, P3515, DOI 10.1016/j.jcp.2007.02.014; Stephens GL, 2004, J CLIMATE, V17, P2213, DOI 10.1175/1520-0442(2004)017&lt;2213:OEFTMR&gt;2.0.CO;2; Teisberg T.J., 2009, BACKGROUND PAPER BEN; Webster PJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046346; Webster PJ, 2008, NAT GEOSCI, V1, P488, DOI 10.1038/ngeo257; Webster PJ, 2010, B AM METEOROL SOC, V91, P1493, DOI 10.1175/2010BAMS2911.1; Webster PJ, 2004, B AM METEOROL SOC, V85, P1745, DOI 10.1175/BAMS-85-11-1745	10	54	54	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 3	2013	493	7430					17	19		10.1038/493017a	http://dx.doi.org/10.1038/493017a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	062QC	23282347				2022-12-28	WOS:000312933800010
J	Carson, JL; Carless, PA; Hebert, PC				Carson, Jeffrey L.; Carless, Paul A.; Hebert, Paul C.			Outcomes Using Lower vs Higher Hemoglobin Thresholds for Red Blood Cell Transfusion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE		[Carson, Jeffrey L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Gen Internal Med, New Brunswick, NJ 08903 USA; [Carless, Paul A.] Univ Newcastle, Fac Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2300, Australia; [Hebert, Paul C.] Ottawa Hosp, Res Inst, Dept Med, Ottawa, ON, Canada	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Newcastle; University of Ottawa; Ottawa Hospital Research Institute	Carson, JL (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Gen Internal Med, 125 Paterson St, New Brunswick, NJ 08903 USA.	carson@umdnj.edu						Amer Soc Anesthesiologists Task Fo, 2006, ANESTHESIOLOGY, V105, P198; BERNSTEIN MJ, 1988, JAMA-J AM MED ASSOC, V260, P2700; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Carson JL, 2012, COCHRANE DB SYST REV, V18, P4, DOI DOI 10.1002/14651858.CD002042.PUB3; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Napolitano LM, 2009, CRIT CARE MED, V37, P3124, DOI 10.1097/CCM.0b013e3181b39f1b	7	89	90	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					83	84		10.1001/jama.2012.50429	http://dx.doi.org/10.1001/jama.2012.50429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280228				2022-12-28	WOS:000319113000030
J	Page, KA; Chan, O; Arora, J; Belfort-DeAguiar, R; Dzuira, J; Roehmholdt, B; Cline, GW; Naik, S; Sinha, R; Constable, RT; Sherwin, RS				Page, Kathleen A.; Chan, Owen; Arora, Jagriti; Belfort-DeAguiar, Renata; Dzuira, James; Roehmholdt, Brian; Cline, Gary W.; Naik, Sarita; Sinha, Rajita; Constable, R. Todd; Sherwin, Robert S.			Effects of Fructose vs Glucose on Regional Cerebral Blood Flow in Brain Regions Involved With Appetite and Reward Pathways	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOOD-INTAKE; SWEETENED BEVERAGES; INSULIN-RESISTANCE; DIETARY FRUCTOSE; FUNCTIONAL MRI; HUMANS; INCREASES; METABOLISM; SUCROSE; LEPTIN	Importance Increases in fructose consumption have paralleled the increasing prevalence of obesity, and high-fructose diets are thought to promote weight gain and insulin resistance. Fructose ingestion produces smaller increases in circulating satiety hormones compared with glucose ingestion, and central administration of fructose provokes feeding in rodents, whereas centrally administered glucose promotes satiety. Objective To study neurophysiological factors that might underlie associations between fructose consumption and weight gain. Design, Setting, and Participants Twenty healthy adult volunteers underwent 2 magnetic resonance imaging sessions at Yale University in conjunction with fructose or glucose drink ingestion in a blinded, random-order, crossover design. Main Outcome Measures Relative changes in hypothalamic regional cerebral blood flow (CBF) after glucose or fructose ingestion. Secondary outcomes included whole-brain analyses to explore regional CBF changes, functional connectivity analysis to investigate correlations between the hypothalamus and other brain region responses, and hormone responses to fructose and glucose ingestion. Results There was a significantly greater reduction in hypothalamic CBF after glucose vs fructose ingestion (-5.45 vs 2.84 mL/g per minute, respectively; mean difference, 8.3 mL/g per minute [95% CI of mean difference, 1.87-14.70]; P=.01). Glucose ingestion (compared with baseline) increased functional connectivity between the hypothalamus and the thalamus and striatum. Fructose increased connectivity between the hypothalamus and thalamus but not the striatum. Regional CBF within the hypothalamus, thalamus, insula, anterior cingulate, and striatum (appetite and reward regions) was reduced after glucose ingestion compared with baseline (P<.05 significance threshold, family-wise error [FWE] whole-brain corrected). In contrast, fructose reduced regional CBF in the thalamus, hippocampus, posterior cingulate cortex, fusiform, and visual cortex (P<.05 significance threshold, FWE whole-brain corrected). In whole-brain voxel-level analyses, there were no significant differences between direct comparisons of fructose vs glucose sessions following correction for multiple comparisons. Fructose vs glucose ingestion resulted in lower peak levels of serum glucose (mean difference, 41.0 mg/dL [95% CI, 27.7-54.5]; P<.001), insulin (mean difference, 49.6 mu U/mL [95% CI, 38.2-61.1]; P<.001), and glucagon-like polypeptide 1 (mean difference, 2.1 pmol/L [95% CI, 0.9-3.2]; P=.01). Conclusion and Relevance In a series of exploratory analyses, consumption of fructose compared with glucose resulted in a distinct pattern of regional CBF and a smaller increase in systemic glucose, insulin, and glucagon-like polypeptide 1 levels.	[Page, Kathleen A.; Chan, Owen; Belfort-DeAguiar, Renata; Dzuira, James; Roehmholdt, Brian; Cline, Gary W.; Naik, Sarita; Sherwin, Robert S.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Arora, Jagriti; Constable, R. Todd] Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06520 USA; [Sinha, Rajita] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Dzuira, James] Yale Ctr Clin Invest, New Haven, CT USA	Yale University; Yale University; Yale University	Sherwin, RS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Endocrinol Sect, S141,POB 208020, New Haven, CT 06520 USA.	robert.sherwin@yale.edu	Constable, R. Todd/ABE-8038-2021	Constable, R. Todd/0000-0001-5661-9521	National Institutes of Health [DK 20495, P30 DK 45735, T32 DK07058]; Yale Center for Clinical Investigation; Clinical Translational Science Award [UL1 RR024139]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R37DK020495, R01DK020495, T32DK007058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Clinical Investigation; Clinical Translational Science Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grants from the National Institutes of Health (DK 20495, P30 DK 45735, T32 DK07058) and the Yale Center for Clinical Investigation supported by the Clinical Translational Science Award (grant UL1 RR024139).	Bray GA, 2004, AM J CLIN NUTR, V79, P537; Cha SH, 2008, P NATL ACAD SCI USA, V105, P16871, DOI 10.1073/pnas.0809255105; Cha SH, 2009, BIOCHEM BIOPH RES CO, V386, P212, DOI 10.1016/j.bbrc.2009.06.017; CURRY DL, 1989, PANCREAS, V4, P2, DOI 10.1097/00006676-198902000-00002; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Figlewicz DP, 2008, AM J PHYSIOL-REG I, V295, pR388, DOI 10.1152/ajpregu.90334.2008; Figlewicz DP, 2009, AM J PHYSIOL-REG I, V296, pR9, DOI 10.1152/ajpregu.90725.2008; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Funari VA, 2005, MOL BRAIN RES, V142, P115, DOI 10.1016/j.molbrainres.2005.09.019; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; HANOVER LM, 1993, AM J CLIN NUTR, V58, P724, DOI 10.1093/ajcn/58.5.724S; Havel PJ, 1999, DIABETES, V48, P334, DOI 10.2337/diabetes.48.2.334; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Horne MR, 2010, BEHAV NEUROSCI, V124, P623, DOI 10.1037/a0020824; Jurgens H, 2005, OBES RES, V13, P1146, DOI 10.1038/oby.2005.136; Kong MF, 1999, PEPTIDES, V20, P545, DOI 10.1016/S0196-9781(99)00006-6; Lindqvist A, 2008, REGUL PEPTIDES, V150, P26, DOI 10.1016/j.regpep.2008.06.008; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; MACDONALD I, 1978, AM J CLIN NUTR, V31, P1305, DOI 10.1093/ajcn/31.8.1305; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Page KA, 2011, J CLIN INVEST, V121, P4161, DOI 10.1172/JCI57873; Page KA, 2009, DIABETES, V58, P448, DOI 10.2337/db08-1224; Papademetris X, 2004, LECT NOTES COMPUT SC, V3216, P763; Purnell JQ, 2011, DIABETES OBES METAB, V13, P229, DOI 10.1111/j.1463-1326.2010.01340.x; Shu HJ, 2006, NEUROSCIENCE, V140, P889, DOI 10.1016/j.neuroscience.2006.02.071; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smeets PAM, 2005, NEUROIMAGE, V24, P363, DOI 10.1016/j.neuroimage.2004.07.073; Smeets PAM, 2007, AM J PHYSIOL-ENDOC M, V293, pE754, DOI 10.1152/ajpendo.00231.2007; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tataranni PA, 1999, P NATL ACAD SCI USA, V96, P4569, DOI 10.1073/pnas.96.8.4569; Teff KL, 2009, J CLIN ENDOCR METAB, V94, P1562, DOI 10.1210/jc.2008-2192; Teff KL, 2004, J CLIN ENDOCR METAB, V89, P2963, DOI 10.1210/jc.2003-031855; THURSTON JH, 1972, J NEUROCHEM, V19, P1685, DOI 10.1111/j.1471-4159.1972.tb06213.x; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Volkow ND, 2011, TRENDS COGN SCI, V15, P37, DOI 10.1016/j.tics.2010.11.001; Woods SC, 1996, NEUROSCI BIOBEHAV R, V20, P139, DOI 10.1016/0149-7634(95)00044-F	37	245	252	1	80	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	2013	309	1					63	70		10.1001/jama.2012.116975	http://dx.doi.org/10.1001/jama.2012.116975			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	146TB	23280226	Green Accepted, Bronze			2022-12-28	WOS:000319113000028
J	Barbosa-Morais, NL; Irimia, M; Pan, Q; Xiong, HY; Gueroussov, S; Lee, LJ; Slobodeniuc, V; Kutter, C; Watt, S; Colak, R; Kim, T; Misquitta-Ali, CM; Wilson, MD; Kim, PM; Odom, DT; Frey, BJ; Blencowe, BJ				Barbosa-Morais, Nuno L.; Irimia, Manuel; Pan, Qun; Xiong, Hui Y.; Gueroussov, Serge; Lee, Leo J.; Slobodeniuc, Valentina; Kutter, Claudia; Watt, Stephen; Colak, Recep; Kim, TaeHyung; Misquitta-Ali, Christine M.; Wilson, Michael D.; Kim, Philip M.; Odom, Duncan T.; Frey, Brendan J.; Blencowe, Benjamin J.			The Evolutionary Landscape of Alternative Splicing in Vertebrate Species	SCIENCE			English	Article							GENE-EXPRESSION; EXON; GENOMES; EVENTS; MOUSE; BIRTH	How species with similar repertoires of protein-coding genes differ so markedly at the phenotypic level is poorly understood. By comparing organ transcriptomes from vertebrate species spanning similar to 350 million years of evolution, we observed significant differences in alternative splicing complexity between vertebrate lineages, with the highest complexity in primates. Within 6 million years, the splicing profiles of physiologically equivalent organs diverged such that they are more strongly related to the identity of a species than they are to organ type. Most vertebrate species-specific splicing patterns are cis-directed. However, a subset of pronounced splicing changes are predicted to remodel protein interactions involving trans-acting regulators. These events likely further contributed to the diversification of splicing and other transcriptomic changes that underlie phenotypic differences among vertebrate species.	[Barbosa-Morais, Nuno L.; Irimia, Manuel; Pan, Qun; Gueroussov, Serge; Slobodeniuc, Valentina; Colak, Recep; Kim, TaeHyung; Misquitta-Ali, Christine M.; Kim, Philip M.; Frey, Brendan J.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Barbosa-Morais, Nuno L.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Xiong, Hui Y.; Lee, Leo J.; Frey, Brendan J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Gueroussov, Serge; Wilson, Michael D.; Kim, Philip M.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Kutter, Claudia; Watt, Stephen; Wilson, Michael D.; Odom, Duncan T.] Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Colak, Recep; Kim, Philip M.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Kim, TaeHyung; Wilson, Michael D.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Odom, Duncan T.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Toronto; Universidade de Lisboa; University of Toronto; University of Toronto; CRUK Cambridge Institute; University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Wellcome Trust Sanger Institute	Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	Barbosa-Morais, Nuno L/I-2743-2013; Kutter, Claudia/HHD-1391-2022; Wilson, Michael D/K-6294-2014; Irimia, Manuel/E-3040-2010	Barbosa-Morais, Nuno L/0000-0002-1215-0538; Wilson, Michael D/0000-0002-4015-3066; Irimia, Manuel/0000-0002-2179-2567; Kutter, Claudia/0000-0002-8047-0058; Odom, Duncan/0000-0001-6201-5599	Canadian Institutes of Health Research; Canadian Cancer Society; Genome Canada (through the Ontario Genomics Institute); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada; EMBO YIP Grant; ERC starting Grant; CIHR postdoctoral fellowship; Marie Curie IOF fellowship; SNF postdoctoral fellowship; NSERC studentship; Human Frontiers Science Program Organization long-term fellowship; Cancer Research UK [15603] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Ontario Research Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); EMBO YIP Grant; ERC starting Grant(European Research Council (ERC)); CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); Marie Curie IOF fellowship(European Commission); SNF postdoctoral fellowship; NSERC studentship(Natural Sciences and Engineering Research Council of Canada (NSERC)); Human Frontiers Science Program Organization long-term fellowship(Human Frontier Science Program); Cancer Research UK(Cancer Research UK)	We thank H. Han, D. O'Hanlon, M. Lukk, and the Cambridge Research Institute Biorepository, Genomics, and Bioinformatics Units for expert assistance; V. Tybulewicz, E. Fisher, R. Cohen, J. Wade, D. Simpson, and J. Gurdon for tissues and mouse strains; and T. Hughes, C. Ouzounis, F. Roth, and past and present members of the Blencowe laboratory for helpful discussions and comments on the manuscript. Supported by grants from the Canadian Institutes of Health Research (B. J. B. and B. J. F.); Canadian Cancer Society (B. J. B.); Genome Canada (through the Ontario Genomics Institute) and the Ontario Research Fund (B. J. B., B. J. F. and others); Natural Sciences and Engineering Research Council of Canada (B. J. F.); EMBO YIP and ERC starting Grants (D.T.O.); CIHR postdoctoral and Marie Curie IOF fellowships (N.L.B.-M.); an SNF postdoctoral fellowship (C. K.); an NSERC studentship (S. G.); and a Human Frontiers Science Program Organization long-term fellowship (M. I.). RNA-Seq data sets analyzed in this study can be accessed through GEO (GSE41338, GSE30352) and ArrayExpress (E-MTAB-513).	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bellay J, 2012, MOL BIOSYST, V8, P185, DOI 10.1039/c1mb05235g; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Buljan M, 2012, MOL CELL, V46, P871, DOI 10.1016/j.molcel.2012.05.039; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; Corrionero A, 2009, MOL CELL, V36, P918, DOI 10.1016/j.molcel.2009.12.004; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; Gelfman S, 2012, GENOME RES, V22, P35, DOI 10.1101/gr.119834.110; Gracheva EO, 2011, NATURE, V476, P88, DOI 10.1038/nature10245; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Irimia M, 2012, CURR OPIN CELL BIOL, V24, P323, DOI 10.1016/j.ceb.2012.03.005; Irimia M, 2009, BIOESSAYS, V31, P40, DOI 10.1002/bies.080092; Jelen N, 2007, PLOS GENET, V3, P1838, DOI 10.1371/journal.pgen.0030173; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Lev-Maor G, 2003, SCIENCE, V300, P1288, DOI 10.1126/science.1082588; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Terai Y, 2003, P NATL ACAD SCI USA, V100, P12798, DOI 10.1073/pnas.2132833100; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wollerton MC, 2001, RNA, V7, P819, DOI 10.1017/S1355838201010214; Xiong HY, 2011, BIOINFORMATICS, V27, P2554, DOI 10.1093/bioinformatics/btr444; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang XHF, 2006, P NATL ACAD SCI USA, V103, P13427, DOI 10.1073/pnas.0603042103	34	613	630	5	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1587	1593		10.1126/science.1230612	http://dx.doi.org/10.1126/science.1230612			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258890				2022-12-28	WOS:000312533100045
J	Willyard, C				Willyard, Cassandra			DIAGNOSTICS Playing detective	NATURE			English	Editorial Material																		Damania D, 2012, CANCER RES, V72, P2720, DOI 10.1158/0008-5472.CAN-11-3807; Gaster RS, 2009, NAT MED, V15, P1327, DOI 10.1038/nm.2032; Nandakumar V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029230; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]	4	1	2	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S64	S65		10.1038/491S64a	http://dx.doi.org/10.1038/491S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320292				2022-12-28	WOS:000311339800009
J	Cong, L; Ran, FA; Cox, D; Lin, SL; Barretto, R; Habib, N; Hsu, PD; Wu, XB; Jiang, WY; Marraffini, LA; Zhang, F				Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Barretto, Robert; Habib, Naomi; Hsu, Patrick D.; Wu, Xuebing; Jiang, Wenyan; Marraffini, Luciano A.; Zhang, Feng			Multiplex Genome Engineering Using CRISPR/Cas Systems	SCIENCE			English	Article							STREPTOCOCCUS-THERMOPHILUS; IMMUNE-SYSTEM; TAL EFFECTORS; CAS SYSTEMS; SMALL RNAS; DNA; BACTERIA; ENDONUCLEASE; NUCLEASES; DEFENSE	Functional elucidation of causal genetic variants and elements requires precise genome editing technologies. The type II prokaryotic CRISPR (clustered regularly interspaced short palindromic repeats)/Cas adaptive immune system has been shown to facilitate RNA-guided site-specific DNA cleavage. We engineered two different type II CRISPR/Cas systems and demonstrate that Cas9 nucleases can be directed by short RNAs to induce precise cleavage at endogenous genomic loci in human and mouse cells. Cas9 can also be converted into a nicking enzyme to facilitate homology-directed repair with minimal mutagenic activity. Lastly, multiple guide sequences can be encoded into a single CRISPR array to enable simultaneous editing of several sites within the mammalian genome, demonstrating easy programmability and wide applicability of the RNA-guided nuclease technology.	[Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Cong, Le; Ran, F. Ann; Cox, David; Lin, Shuailiang; Habib, Naomi; Hsu, Patrick D.; Zhang, Feng] MIT, Dept Biol Engn, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Cong, Le] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Cox, David] Harvard Univ, Sch Med, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; [Ran, F. Ann; Hsu, Patrick D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Lin, Shuailiang] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Barretto, Robert] Columbia Univ, Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wu, Xuebing] MIT, Computat & Syst Biol Grad Program, Cambridge, MA 02139 USA; [Wu, Xuebing] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Jiang, Wenyan; Marraffini, Luciano A.] Rockefeller Univ, Bacteriol Lab, New York, NY 10065 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Tsinghua University; Columbia University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Rockefeller University	Zhang, F (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	zhang@broadinstitute.org	Habib, Naomi/AAA-8937-2020; Macrae, Rhiannon/AAX-1536-2020; Hsu, Patrick/ABD-5749-2021; Cong, Le/M-9981-2013; Wu, Xuebing/C-9152-2013; Lin, Shuailiang/O-3272-2016	Cong, Le/0000-0003-4725-8714; Wu, Xuebing/0000-0003-0369-5269; Hsu, Patrick/0000-0002-9380-2648	Zhang lab; Medical Scientist Training Program; NIH [R01-GM34277, R01-CA133404]; NIH Director's New Innovator Award [DP2AI104556]; NIH Director's Pioneer Award [DP1MH100706]; Keck foundation; McKnight foundation; Gates foundation; Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation; Simons foundation; NATIONAL CANCER INSTITUTE [R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP2AI104556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM034277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073124] Funding Source: NIH RePORTER	Zhang lab; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck foundation(W.M. Keck Foundation); McKnight foundation; Gates foundation(Bill & Melinda Gates Foundation); Damon Runyon foundation; Searle Scholars foundation; Klingenstein foundation(Klingenstein Philanthropies); Simons foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the entire Zhang lab for their support and advice; P. A. Sharp for generous help with Northern blot analysis; C. Jennings, R. Desimone, and M. Kowalczyk for helpful comments; and X. Ye for help with confocal imaging. L. C. and X. W. are Howard Hughes Medical Institute International Student Research Fellows. D. C. is supported by the Medical Scientist Training Program. P. D. H. is a James Mills Pierce Fellow. X. W. is supported by NIH grants R01-GM34277 and R01-CA133404 to P. A. Sharp, X.W.'s thesis adviser. L. A. M. is supported by Searle Scholars, R. Allen, an Irma T. Hirschl Award, and a NIH Director's New Innovator Award (DP2AI104556). F.Z. is supported by a NIH Director's Pioneer Award (DP1MH100706); the Keck, McKnight, Gates, Damon Runyon, Searle Scholars, Klingenstein, and Simons foundations; R. Metcalfe; M. Boylan; and J. Pauley. The authors have no conflicting financial interests. A patent application has been filed relating to this work, and the authors plan on making the reagents widely available to the academic community through Addgene and to provide software tools via the Zhang lab Web site (www.genome-engineering.org).	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Sander JD, 2011, NAT METHODS, V8, P67, DOI 10.1038/NMETH.1542; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Wood A. J., 2011, WOOD SCI, V333, P307; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	29	9235	10698	371	8187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					819	823		10.1126/science.1231143	http://dx.doi.org/10.1126/science.1231143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287718	Green Submitted, Green Accepted			2022-12-28	WOS:000314874400049
J	Gugliotta, JL; Goethert, HK; Berardi, VP; Telford, SR				Gugliotta, Joseph L.; Goethert, Heidi K.; Berardi, Victor P.; Telford, Sam R., III			Meningoencephalitis from Borrelia miyamotoi in an Immunocompromised Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FEVER GROUP SPIROCHETE; LYME-DISEASE; SENSU-LATO; TICK; BURGDORFERI; VECTOR; SERODIAGNOSIS	Ixodes ticks serve as vectors for Borrelia burgdorferi, the agent of Lyme disease. Globally, these ticks often concurrently harbor B. miyamotoi, a spirochete that is classified within the relapsing-fever group of spirochetes. Although humans presumably are exposed to B. miyamotoi, there are limited data suggesting disease attributable to it. We report a case of progressive mental deterioration in an older, immunocompromised patient, and even though Koch's postulates were not met, we posit B. miyamotoi as the cause, owing to its direct detection in cerebrospinal fluid (CSF) with the use of microscopy and a polymerase-chain-reaction (PCR) assay. It is likely that B. miyamotoi is an underrecognized cause of disease, especially in sites where Lyme disease is endemic.	[Gugliotta, Joseph L.] Hunterdon Med Ctr, Div Infect Dis, Dept Internal Med, Flemington, NJ USA; [Gugliotta, Joseph L.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Div Infect Dis Allergy & Immunol, New Brunswick, NJ USA; [Goethert, Heidi K.; Berardi, Victor P.] Imugen, Reference Diagnost Div, Norwood, MA USA; [Telford, Sam R., III] Tufts Univ, Cummings Sch Vet Med, Div Infect Dis, North Grafton, MA 01536 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Tufts University	Telford, SR (corresponding author), Tufts Univ, Cummings Sch Vet Med, Div Infect Dis, 200 Westboro Rd, North Grafton, MA 01536 USA.	sam.telford@tufts.edu		Goethert, Heidi/0000-0001-5145-9047	National Institutes of Health [R41 AI 078631, R21 AI 082436]; Evelyn Lilly Lutz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R41AI078631, R21AI082436] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Evelyn Lilly Lutz Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by grants from the National Institutes of Health (R41 AI 078631 and R21 AI 082436) and the Evelyn Lilly Lutz Foundation and by a gift from Gordon and Lulie Gund.	BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; BARBOUR AG, 1986, ZBL BAKT-INT J MED M, V263, P83; Barbour AG, 2009, AM J TROP MED HYG, V81, P1120, DOI 10.4269/ajtmh.2009.09-0208; BERARDI VP, 1988, J INFECT DIS, V158, P754, DOI 10.1093/infdis/158.4.754; CALLOW LL, 1967, BRIT VET J, V123, P492, DOI 10.1016/S0007-1935(17)39704-X; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Courtney JW, 2004, J CLIN MICROBIOL, V42, P3164, DOI 10.1128/JCM.42.7.3164-3168.2004; Feder HM, 2011, CLIN INFECT DIS, V53, pE142, DOI 10.1093/cid/cir553; Fraenkel CJ, 2002, J CLIN MICROBIOL, V40, P3308, DOI 10.1128/JCM.40.9.3308-3312.2002; FUKUNAGA M, 1995, INT J SYST BACTERIOL, V45, P804, DOI 10.1099/00207713-45-4-804; Krause PJ, 2013, NEW ENGL J MED, V368, P291, DOI 10.1056/NEJMc1215469; Lodes MJ, 2001, J CLIN MICROBIOL, V39, P2466, DOI 10.1128/JCM.39.7.2466-2476.2001; Molloy PJ, 2000, CLIN INFECT DIS, V31, P42, DOI 10.1086/313920; Mun J, 2006, J MED ENTOMOL, V43, P120, DOI 10.1603/0022-2585(2006)043[0120:DOABMS]2.0.CO;2; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; PERSING DH, 1990, J CLIN MICROBIOL, V28, P566, DOI 10.1128/JCM.28.3.566-572.1990; Platonov AE, 2011, EMERG INFECT DIS, V17, P1816, DOI 10.3201/eid1710.101474; Rich SM, 2001, J CLIN MICROBIOL, V39, P494, DOI 10.1128/JCM.39.2.494-497.2001; Richter D, 2003, EMERG INFECT DIS, V9, P697; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; SMITH RD, 1985, AM J VET RES, V46, P1396; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telford SR, 1998, EMERG INFECT DIS, V4, P132, DOI 10.3201/eid0401.980126; Ullmann AJ, 2005, J MED ENTOMOL, V42, P1057, DOI 10.1603/0022-2585(2005)042[1057:TMAFDO]2.0.CO;2; Young C, 2012, TRANSFUSION, V52, P1523, DOI 10.1111/j.1537-2995.2012.03612.x	27	188	195	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					240	245		10.1056/NEJMoa1209039	http://dx.doi.org/10.1056/NEJMoa1209039			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323900	Green Accepted			2022-12-28	WOS:000313549900008
J	Lin, CQ; Garruss, AS; Luo, ZJ; Guo, FL; Shilatifard, A				Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali			The RNA Pol II Elongation Factor EII3 Marks Enhancers in ES Cells and Primes Future Gene Activation	CELL			English	Article							EMBRYONIC STEM-CELLS; CIS-REGULATORY SIGNATURE; POLYMERASE-II; COMPLEX SEC; TRANSCRIPTION ELONGATION; CHROMATIN INTERACTIONS; GENOME; EXPRESSION; DROSOPHILA; COHESIN	Enhancers play a central role in precisely regulating the expression of developmentally regulated genes. However, the machineries required for enhancer-promoter communication have remained largely unknown. We have found that EII3, a member of the Ell (eleven-nineteen lysine-rich leukemia gene) family of RNA Pol II elongation factors, occupies enhancers in embryonic stem cells. EII3's association with enhancers is required for setting up proper Pol II occupancy at the promoter-proximal regions of developmentally regulated genes and for the recruitment of the super elongation complex ( SEC) to these loci following differentiation signals. Furthermore, EII3 binding to inactive or poised enhancers is essential for stem cell specification. We have also detected the presence of Pol II and EII3 in germ cell nuclei. These findings raise the possibility that transcription factors could prime gene expression by marking enhancers in ES cells or even as early as in the germ cell state.	[Lin, Chengqi; Garruss, Alexander S.; Luo, Zhuojuan; Guo, Fengli; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Shilatifard, A (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ash@stowers.org		Lin, Chengqi/0000-0002-2121-584X	Alex's Lemonade Stand Foundation; National Institute of Health [R01CA89455, R01CA150265]; NATIONAL CANCER INSTITUTE [R01CA089455, R01CA150265] Funding Source: NIH RePORTER	Alex's Lemonade Stand Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr. Edwin Smith for conversations and for critical reading of the manuscript. We also thank Boris Rubenstein for mathematical support and Michael Durnin, Stacy Marshall, and Ka Chun Lai for technical assistance. We are also thankful to Laura Shilatifard for editorial assistance. This work was performed to fulfill, in part, requirements for C.L.'s PhD. thesis research as a student registered with the Open University. Studies in this manuscript were supported, in part, by funds provided by the Alex's Lemonade Stand Foundation and from the National Institute of Health (R01CA89455 and R01CA150265 to A.S.).	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deng WL, 2010, CURR OPIN GENET DEV, V20, P548, DOI 10.1016/j.gde.2010.06.007; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorsett D, 2011, CURR OPIN GENET DEV, V21, P199, DOI 10.1016/j.gde.2011.01.018; Elmendorf BJ, 2001, J BIOL CHEM, V276, P23109, DOI 10.1074/jbc.M101445200; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khoueiry P, 2010, CURR BIOL, V20, P792, DOI 10.1016/j.cub.2010.03.063; Kvon EZ, 2012, GENE DEV, V26, P908, DOI 10.1101/gad.188052.112; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Markstein M, 2002, CURR OPIN GENET DEV, V12, P601, DOI 10.1016/S0959-437X(02)00345-3; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller T, 2000, J BIOL CHEM, V275, P32052, DOI 10.1074/jbc.M005175200; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Newman JJ, 2010, COLD SH Q B, V75, P227, DOI 10.1101/sqb.2010.75.016; Nien CY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002339; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Raschke EE, 1999, J IMMUNOL, V163, P4375; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Smith ER, 2011, MOL CELL, V44, P954, DOI 10.1016/j.molcel.2011.12.008; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	55	74	76	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					144	156		10.1016/j.cell.2012.12.015	http://dx.doi.org/10.1016/j.cell.2012.12.015			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23273992	Green Accepted, Bronze			2022-12-28	WOS:000313719800013
J	Belknap, SM				Belknap, Steven M.			NSAIDs were associated with increased risk for mortality, regardless of time since first MI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				Belknap Steven, 2002, ACP J Club, V136, P53; Rodriguez LAG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016780; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC10	10.7326/0003-4819-158-2-201301150-02010	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318332				2022-12-28	WOS:000314029400009
J	Kern, LM; Malhotra, S; Barron, Y; Quaresimo, J; Dhopeshwarkar, R; Pichardo, M; Edwards, AM; Kaushal, R				Kern, Lisa M.; Malhotra, Sameer; Barron, Yolanda; Quaresimo, Jill; Dhopeshwarkar, Rina; Pichardo, Michelle; Edwards, Alison M.; Kaushal, Rainu			Accuracy of Electronically Reported "Meaningful Use" Clinical Quality Measures	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-ARTERY-DISEASE; HEALTH RECORDS; PERFORMANCE-MEASURES; PRIMARY-CARE; OF-CARE; PHYSICIAN	Background: The federal Electronic Health Record Incentive Program requires electronic reporting of quality from electronic health records, beginning in 2014. Whether electronic reports of quality are accurate is unclear. Objective: To measure the accuracy of electronic reporting compared with manual review. Design: Cross-sectional study. Setting: A federally qualified health center with a commercially available electronic health record. Patients: All adult patients eligible in 2008 for 12 quality measures ( using 8 unique denominators) were identified electronically. One hundred fifty patients were randomly sampled per denominator, yielding 1154 unique patients. Measurements: Receipt of recommended care, assessed by both electronic reporting and manual review. Sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios, and absolute rates of recommended care were measured. Results: Sensitivity of electronic reporting ranged from 46% to 98% per measure. Specificity ranged from 62% to 97%, positive predictive value from 57% to 97%, and negative predictive value from 32% to 99%. Positive likelihood ratios ranged from 2.34 to 24.25 and negative likelihood ratios from 0.02 to 0.61. Differences between electronic reporting and manual review were statistically significant for 3 measures: Electronic reporting underestimated the absolute rate of recommended care for 2 measures ( appropriate asthma medication [ 38% vs. 77%; P < 0.001] and pneumococcal vaccination [27% vs. 48%; P < 0.001]) and overestimated care for 1 measure ( cholesterol control in patients with diabetes [ 57% vs. 37%; P = 0.001]). Limitation: This study addresses the accuracy of the measure numerator only. Conclusion: Wide measure-by-measure variation in accuracy threatens the validity of electronic reporting. If variation is not addressed, financial incentives intended to reward high quality may not be given to the highest-quality providers. Primary Funding Source: Agency for Healthcare Research and Quality.	[Kern, Lisa M.] Weill Cornell Med Coll, Dept Publ Hlth, Inst Family Hlth, Ctr Healthcare Informat & Policy, New York, NY USA; New York Presbyterian Hosp, New York, NY USA; Tacon Independent Practice Assoc, Fishkill, NY USA	Cornell University; NewYork-Presbyterian Hospital	Kern, LM (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, Inst Family Hlth, Ctr Healthcare Informat & Policy, 425 E 61st St,Suite 301, New York, NY USA.	lmk2003@med.cornell.edu	Kern, Lisa/AAI-9781-2021	Kern, Lisa/0000-0003-1191-8100	Agency for Healthcare Research and Quality [R18 HS 017067]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017067] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (grant R18 HS 017067).	[Anonymous], 2012, NAT QUAL FOR EL QUAL; [Anonymous], 2010, FED REG, V75, P44313; Baker DW, 2007, ANN INTERN MED, V146, P270, DOI 10.7326/0003-4819-146-4-200702200-00006; Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Bates DW, 2009, JT COMM J QUAL PATIE, V35, P358, DOI 10.1016/S1553-7250(09)35050-3; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Centers for Medicare and Medicaid Services (CMS) HHS, 2012, FED REG, V77, P53967; Centers for Medicare & Medicaid Services, 2012, QUAL MEAS; Chan Kitty S, 2010, Med Care Res Rev, V67, P503, DOI 10.1177/1077558709359007; Gordis L, 2008, EPIDEMIOLOGY, P85; Kern LM, 2009, JT COMM J QUAL PATIE, V35, P359, DOI 10.1016/S1553-7250(09)35051-5; Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555; Kmetik KS, 2011, ANN INTERN MED, V154, P227, DOI 10.7326/0003-4819-154-4-201102150-00003; Linder JA, 2012, J AM MED INFORM ASSN, V19, P1019, DOI [10.1136/amiajnl-2011-000788, 10.1136/amiajnl-2011-00078]; Linder JA, 2009, MED CARE, V47, P208, DOI 10.1097/MLR.0b013e318189375f; Mannion R, 2008, BMJ-BRIT MED J, V336, P306, DOI 10.1136/bmj.39463.454815.94; Murff HJ, 2011, JAMA-J AM MED ASSOC, V306, P848, DOI 10.1001/jama.2011.1204; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Ofri D, 2010, NEW ENGL J MED, V363, P606, DOI 10.1056/NEJMp1006298; Parsons A, 2012, J AM MED INFORM ASSN, V19, P604, DOI 10.1136/amiajnl-2011-000557; Pawlson LG, 2007, AM J MANAG CARE, V13, P594; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; Roth CP, 2009, AM J MED QUAL, V24, P385, DOI 10.1177/1062860609336627; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Tang PC, 2007, J AM MED INFORM ASSN, V14, P10, DOI 10.1197/jamia.M2198; Weiner JP, 2012, INT J QUAL HEALTH C, V24, P200, DOI 10.1093/intqhc/mzs011; Weiner M, 2005, QUAL SAF HEALTH CARE, V14, P99, DOI 10.1136/qshc.2004.011049	28	65	65	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2					77	+		10.7326/0003-4819-158-2-201301150-00001	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-00001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	077LO	23318309				2022-12-28	WOS:000314029400013
J	Sokol, DK				Sokol, Daniel K.			"The patient would have died anyway"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inner Temple, London, England		Sokol, DK (corresponding author), Inner Temple, London, England.	daniel.sokol@talk21.com						General Medical Council, DUT DOCT; Milberger S, 2006, TOB CONTROL, V15, P17; Sokol DK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7858; 2012, BRIT MED J, V345; 2012, BRIT MED J, V345	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2013	346								f285	10.1136/bmj.f285	http://dx.doi.org/10.1136/bmj.f285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	075ER	23321272				2022-12-28	WOS:000313867100018
J	Krumholz, HM				Krumholz, Harlan M.			Post-Hospital Syndrome - An Acquired, Transient Condition of Generalized Risk	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSION		[Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Yale University	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA.		, Harlan/AAI-2875-2020; Martin, Carmel Mary/B-6358-2011	Martin, Carmel Mary/0000-0001-8174-7859	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL105270] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Friedmann JM, 1997, AM J CLIN NUTR, V65, P1714, DOI 10.1093/ajcn/65.6.1714; Jencks SF, 2009, NEW ENGL J MED, V360, P1418; Kansagara D, 2011, JAMA-J AM MED ASSOC, V306, P1688, DOI 10.1001/jama.2011.1515	3	753	760	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					100	102		10.1056/NEJMp1212324	http://dx.doi.org/10.1056/NEJMp1212324			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	066RO	23301730	Green Accepted			2022-12-28	WOS:000313238100013
J	Yancey, AK; Sallis, RE; Bastani, R				Yancey, Antronette K.; Sallis, Robert E.; Bastani, Roshan			Changing Physical Activity Participation for the Medical Profession	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WALKING; TALK; CARE		[Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Canc Prevent & Control Res, Los Angeles, CA 90095 USA; [Yancey, Antronette K.; Bastani, Roshan] Univ Calif Los Angeles, Kaiser Permanente Ctr Hlth Equ, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Kaiser Permanente; University of California System; University of California Los Angeles	Yancey, AK (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, 650 Charles Young Dr,South Room 31-235 CHS, Los Angeles, CA 90095 USA.	ayancey@ucla.edu						Barr-Anderson DJ, 2011, AM J PREV MED, V40, P76, DOI 10.1016/j.amepre.2010.09.033; Bleich SN, 2012, OBESITY, V20, P999, DOI 10.1038/oby.2011.402; Boyle M, 2009, PEDIATRICS, V123, pS293, DOI 10.1542/peds.2008-2780H; Collins L, 2005, J NUTR EDUC BEHAV, V37, pS121, DOI 10.1016/S1499-4046(06)60212-1; Crawford PB, 2004, AM J PUBLIC HEALTH, V94, P1480, DOI 10.2105/AJPH.94.9.1480; Frank Erica, 2003, J Am Med Womens Assoc (1972), V58, P178; Frank E, 2009, CAN FAM PHYSICIAN, V55, P810; Lesser LI, 2012, JAMA-J AM MED ASSOC, V308, P983, DOI 10.1001/2012.jama.10427; Yancey AK, 2010, INSTANT RECESS BUILD	9	11	11	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2013	309	2					141	142		10.1001/jama.2012.127989	http://dx.doi.org/10.1001/jama.2012.127989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070NW	23299602				2022-12-28	WOS:000313517000019
J	Renata, H; Zhou, QH; Baran, PS				Renata, Hans; Zhou, Qianghui; Baran, Phil S.			Strategic Redox Relay Enables A Scalable Synthesis of Ouabagenin, A Bioactive Cardenolide	SCIENCE			English	Article							CROSS-COUPLING REACTIONS; STEROID GLYCOSIDES; NATURAL-PRODUCTS; BUFADIENOLIDES; OXIDATION; ALCOHOLS; OLEFINS; OUABAIN; OXYGEN	Here, we report on a scalable route to the polyhydroxylated steroid ouabagenin with an unusual take on the age-old practice of steroid semisynthesis. The incorporation of both redox and stereochemical relays during the design of this synthesis resulted in efficient access to more than 500 milligrams of a key precursor toward ouabagenin-and ultimately ouabagenin itself-and the discovery of innovative methods for carbon-hydrogen (C-H) and carbon-carbon activation and carbon-oxygen bond homolysis. Given the medicinal relevance of the cardenolides in the treatment of congestive heart failure, a variety of ouabagenin analogs could potentially be generated from the key intermediate as a means of addressing the narrow therapeutic index of these molecules. This synthesis also showcases an approach to bypass the historically challenging problem of selective C-H oxidation of saturated carbon centers in a controlled fashion.	[Renata, Hans; Zhou, Qianghui; Baran, Phil S.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Baran, PS (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pbaran@scripps.edu	Zhou, Qianghui/D-8258-2016; Zhou, Qianghui/U-8879-2019	Zhou, Qianghui/0000-0002-8125-0380; Zhou, Qianghui/0000-0002-8125-0380	LEO Pharma; TEVA; NIH/NCI [CA134785]; Bristol-Myers Squibb; Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE [R01CA134785] Funding Source: NIH RePORTER	LEO Pharma(LEO Pharma); TEVA(Teva Pharmaceutical Industries); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bristol-Myers Squibb(Bristol-Myers Squibb); Shanghai Institute of Organic Chemistry; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by LEO Pharma and an unrestricted grant from TEVA. Early studies were supported by the NIH/NCI (CA134785). Bristol-Myers Squibb supported a graduate fellowship to H. R., and the Shanghai Institute of Organic Chemistry supported a postdoctoral fellowship to Q.Z. We are grateful to A. Rheingold and C. E. Moore (University of California, San Diego) for x-ray crystallographic analysis and G. Siuzdak (the Scripps Research Institute) for mass spectrometry assistance. We thank J. Felding, H. Bladh, and R. Shenvi for valuable discussions. Metrical parameters for the structures of compounds 7 and 11' are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-909412 and 909413, respectively.	Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Baran PS, 2007, NATURE, V446, P404, DOI 10.1038/nature05569; Barker TJ, 2012, J AM CHEM SOC, V134, P13588, DOI 10.1021/ja3063716; Barluenga J, 2004, CHEM-EUR J, V10, P4206, DOI 10.1002/chem.200400136; BARTON DHR, 1962, J CHEM SOC, P470, DOI 10.1039/jr9620000470; BARTON DHR, 1982, J CHEM SOC PERK T 1, P2085, DOI 10.1039/p19820002085; CHUNG SK, 1979, J ORG CHEM, V44, P1014, DOI 10.1021/jo01320a033; Corey E. J., 1989, LOGIC CHEM SYNTHESIS, P17; COREY EJ, 1959, J AM CHEM SOC, V81, P5209, DOI 10.1021/ja01528a046; Egner U, 1999, TETRAHEDRON, V55, P11267, DOI 10.1016/S0040-4020(99)00638-9; ERHARDT PW, 1987, J MED CHEM, V30, P231, DOI 10.1021/jm00385a001; Fortner KC, 2010, J AM CHEM SOC, V132, P275, DOI 10.1021/ja906996c; Furstner A, 2008, CHEM COMMUN, P2873, DOI 10.1039/b805299a; Hanson JR, 2005, NAT PROD REP, V22, P104, DOI 10.1039/b415086b; Heasley B, 2012, CHEM-EUR J, V18, P3092, DOI 10.1002/chem.201103733; Hollingworth GJ, 1996, J CHEM SOC PERK T 1, P1913, DOI 10.1039/p19960001913; HRYCKO S, 1988, J ORG CHEM, V53, P1515, DOI 10.1021/jo00242a032; IMHOF R, 1972, HELV CHIM ACTA, V55, P1151, DOI 10.1002/hlca.19720550410; ISAYAMA S, 1989, CHEM LETT, P1071, DOI 10.1246/cl.1989.1071; Ishihara Y, 2010, SYNLETT, P1733, DOI 10.1055/s-0030-1258123; Jana CK, 2011, ANGEW CHEM INT EDIT, V50, P8407, DOI 10.1002/anie.201101869; Kamano Y, 1998, BIOORGAN MED CHEM, V6, P1103, DOI 10.1016/S0968-0896(98)00067-4; Kawamura A, 1999, P NATL ACAD SCI USA, V96, P6654, DOI 10.1073/pnas.96.12.6654; Larock R. C., 1989, COMPREHENSIVE ORGANI, P505; MCDONALD CE, 1990, TETRAHEDRON LETT, V31, P6283, DOI 10.1016/S0040-4039(00)97043-6; Narayan S, 2005, ANGEW CHEM INT EDIT, V44, P3275, DOI 10.1002/anie.200462883; Newhouse T, 2009, CHEM SOC REV, V38, P3010, DOI 10.1039/b821200g; Ng D, 2004, ORG LETT, V6, P645, DOI 10.1021/ol0499250; Rousseau G, 2011, ANGEW CHEM INT EDIT, V50, P2450, DOI 10.1002/anie.201006139; Samojlowicz C, 2008, CHEM COMMUN, P6282, DOI 10.1039/b816567j; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Shi J, 2011, J AM CHEM SOC, V133, P8014, DOI 10.1021/ja202103e; Szent-Gyorgyi A, 1953, CHEM PHYSL CONTRACTI, P86; TSCHESCHE R, 1972, PROC R SOC SER B-BIO, V180, P187, DOI 10.1098/rspb.1972.0014; VIJAYARAHAVAN B, 1990, TETRAHEDRON LETT, V31, P6223, DOI 10.1016/S0040-4039(00)97030-8; WEHRLI H, 1961, HELV CHIM ACTA, V44, P2162, DOI 10.1002/hlca.19610440745; WIESNER K, 1986, PURE APPL CHEM, V58, P799, DOI 10.1351/pac198658050799; Wietzerbin K, 2000, EUR J INORG CHEM, P1391; YEOM H, 1995, BIOCHEMISTRY-US, V34, P14733, DOI 10.1021/bi00045a014; YOSHII E, 1978, J ORG CHEM, V43, P3946, DOI 10.1021/jo00414a031; Zhang HX, 2008, ANGEW CHEM INT EDIT, V47, P1272, DOI 10.1002/anie.200704959	41	114	115	4	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					59	63		10.1126/science.1230631	http://dx.doi.org/10.1126/science.1230631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288535	Green Accepted			2022-12-28	WOS:000312985800050
J	Rolla, AR; Rodriguez-Gutierrez, R				Rolla, Arturo R.; Rodriguez-Gutierrez, Rene			Albright's Hereditary Osteodystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rolla, Arturo R.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Rodriguez-Gutierrez, Rene] Hosp Univ Dr Jose E Gonzalez, Monterrey, Mexico	Harvard University; Beth Israel Deaconess Medical Center; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon	Rolla, AR (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	arolla@caregroup.harvard.edu							0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 27	2012	367	26					2527	2527		10.1056/NEJMicm1208779	http://dx.doi.org/10.1056/NEJMicm1208779			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	059OG	23268667				2022-12-28	WOS:000312714200010
J	Srivastava, M; Nambiar, M; Sharma, S; Karki, SS; Goldsmith, G; Hegde, M; Kumar, S; Pandey, M; Singh, RK; Ray, P; Natarajan, R; Kelkar, M; De, A; Choudhary, B; Raghavan, SC				Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Karki, Subhas S.; Goldsmith, G.; Hegde, Mahesh; Kumar, Sujeet; Pandey, Monica; Singh, Ram K.; Ray, Pritha; Natarajan, Renuka; Kelkar, Madhura; De, Abhijit; Choudhary, Bibha; Raghavan, Sathees C.			An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression	CELL			English	Article							DNA-LIGASE IV; EMBRYONIC LETHALITY; XRCC4-LIGASE IV; UP-REGULATION; CELL-LINES; PROTEINS; GENES; P53	DNA Ligase IV is responsible for sealing of double-strand breaks (DSBs) during nonhomologous end-joining (NHEJ). Inhibiting Ligase IV could result in amassing of DSBs, thereby serving as a strategy toward treatment of cancer. Here, we identify a molecule, SCR7 that inhibits joining of DSBs in cell-free repair system. SCR7 blocks Ligase IV-mediated joining by interfering with its DNA binding but not that of T4 DNA Ligase or Ligase I. SCR7 inhibits NHEJ in a Ligase IV-dependent manner within cells, and activates the intrinsic apoptotic pathway. More importantly, SCR7 impedes tumor progression in mouse models and when coadministered with DSB-inducing therapeutic modalities enhances their sensitivity significantly. This inhibitor to target NHEJ offers a strategy toward the treatment of cancer and improvement of existing regimens.	[Srivastava, Mrinal; Nambiar, Mridula; Sharma, Sheetal; Hegde, Mahesh; Pandey, Monica; Choudhary, Bibha; Raghavan, Sathees C.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Karki, Subhas S.; Kumar, Sujeet] KLE Univ, Coll Pharm, Dept Pharmaceut Chem, Bangalore 560010, Karnataka, India; [Goldsmith, G.; Natarajan, Renuka; Choudhary, Bibha] Inst Bioinformat & Appl Biotechnol, Bangalore 560100, Karnataka, India; [Singh, Ram K.; Ray, Pritha; Kelkar, Madhura; De, Abhijit] Adv Ctr Treatment Res & Educ Canc, Navi Mumbai 410210, India	Indian Institute of Science (IISC) - Bangalore; K.L.E. Academy of Higher Education & Research; Tata Memorial Centre (TMC); Advance Centre for Treatment, Research & Education in Cancer (ACTREC)	Raghavan, SC (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	sathees@biochem.iisc.ernet.in	karki, subhas s/AAH-6451-2020; Srivastava, Mrinal/AAM-5013-2020; Hegde, MahesH/ABE-2057-2020; DE, ABHIJIT/AAR-5631-2021; KUMAR, SUJEET/AAD-5081-2019	karki, subhas s/0000-0002-5599-3594; Hegde, MahesH/0000-0002-7853-6281; DE, ABHIJIT/0000-0002-5818-0206; KUMAR, SUJEET/0000-0002-0833-158X; Singh, Ram Kumar/0000-0002-7654-1212	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR; IISc; DBT (India)	Indian Institute of Science, Bangalore; Leukemia Research Foundation, USA; CSIR(Council of Scientific & Industrial Research (CSIR) - India); IISc; DBT (India)(Department of Biotechnology (DBT) India)	We are thankful to Prof. N. Yathindra for modeling and docking studies. We also thank P. Ajitkumar and B. Tharakan for suggestions; P. Kuppusamy for help; K.K. Chiruvella for reagents; and S.R. Ranganatha, D. Iyer, S. Javadekar, and members of SCR laboratory for critical reading of the manuscript. We thank Strides ARCOLAB Bangalore for Doxorubicin. Ligase IV/XRCC4 plasmid was a gift from M. Modesti (France). pETDuet-1 was from B. Gopal (India); Ligase I and Ligase III alpha/XRCC1 plasmids were from A. Tomkinson (USA) and K.W. Caldecott (UK), respectively. pREP-hLIGIV was from C. Campbell (USA), I-SceI vector from R. Scully (USA), and pcDNA3.1 RFP from Arun Kumar (India); pJS296 was gifted by J. Stark (USA). We thank V. Hegde for NMR (IISc). Animal, NMR, confocal, microtome and FACS facilities of IISc, and FACS facilities of C-CAMP, NCBS, are also acknowledged. We thank R. Malhotra for mouse imaging (ACTREC). A start-up grant from the Indian Institute of Science, Bangalore, and financial assistance from Leukemia Research Foundation, USA, for S.C.R. are acknowledged. Financial support from R. Varadarajan is also acknowledged. M.S. and M.P. are supported by CSIR, M.N. by IISc Research Associate fellowship, and S.S. by DBT (India).	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Jayaram S, 2008, NUCLEIC ACIDS RES, V36, P5773, DOI 10.1093/nar/gkn552; Kumar TS, 2010, J BIOL CHEM, V285, P32657, DOI 10.1074/jbc.M110.140350; Kuschel B, 2002, HUM MOL GENET, V11, P1399, DOI 10.1093/hmg/11.12.1399; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; McElhinny SAN, 2000, MOL CELL BIOL, V20, P2996, DOI 10.1128/MCB.20.9.2996-3003.2000; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P5813, DOI 10.1093/nar/gkr223; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pucci S, 2001, ONCOGENE, V20, P739, DOI 10.1038/sj.onc.1204148; Riballo E, 1999, CURR BIOL, V9, P699, DOI 10.1016/S0960-9822(99)80311-X; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; Sharma S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/389129; Sharma S, 2011, CELL MOL LIFE SCI, V68, P661, DOI 10.1007/s00018-010-0472-x; Shintani S, 2003, CANCER SCI, V94, P894, DOI 10.1111/j.1349-7006.2003.tb01372.x; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Sirzen F, 1999, EUR J CANCER, V35, P111, DOI 10.1016/S0959-8049(98)00289-5; Zapata JM, 1998, BREAST CANCER RES TR, V47, P129, DOI 10.1023/A:1005940832123; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	33	261	271	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1474	1487		10.1016/j.cell.2012.11.054	http://dx.doi.org/10.1016/j.cell.2012.11.054			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260137	Bronze			2022-12-28	WOS:000312890300013
J	Vale, RD; DeRisi, J; Phillips, R; Mullins, RD; Waterman, C; Mitchison, TJ				Vale, Ronald D.; DeRisi, Joseph; Phillips, Rob; Mullins, R. Dyche; Waterman, Clare; Mitchison, Timothy J.			Interdisciplinary Graduate Training in Teaching Labs	SCIENCE			English	Editorial Material							SCIENCE-EDUCATION; BIOLOGY EDUCATION		[Vale, Ronald D.; Mullins, R. Dyche; Waterman, Clare; Mitchison, Timothy J.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Vale, Ronald D.; DeRisi, Joseph; Mullins, R. Dyche] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vale, Ronald D.; DeRisi, Joseph] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Phillips, Rob] CALTECH, Pasadena, CA 91106 USA; [Waterman, Clare] NHLBI, Bethesda, MD 20824 USA; [Mitchison, Timothy J.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Marine Biological Laboratory - Woods Hole; University of California System; University of California San Francisco; Howard Hughes Medical Institute; California Institute of Technology; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Harvard Medical School	Vale, RD (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.	vale@cmp.ucsf.edu		Waterman, Clare/0000-0001-6142-6775	NIH [GM085967, T32 EB009383]; Howard Hughes Medical Institute; Burroughs Wellcome Fund; National Institute of Biomedical Imaging and Bioengineering; Caltech Rosen Center for Bioengineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079556, R13GM085967, R01GM039565, R01GM061010] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Caltech Rosen Center for Bioengineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The MBL Physiology Course is supported by grants from the NIH (GM085967), the Howard Hughes Medical Institute, and the Burroughs Wellcome Fund. The UCSF iPQB courses are supported by a National Institute of Biomedical Imaging and Bioengineering, NIH, Interfaces grant (T32 EB009383), and the CalTech boot camp receives funding from the Caltech Rosen Center for Bioengineering.	Bednarski April E, 2005, Cell Biol Educ, V4, P207, DOI 10.1187/cbe.04070044; Bentley AM, 2008, CBE-LIFE SCI EDUC, V7, P175, DOI 10.1187/cbe.07-07-0049; Bialek W, 2004, SCIENCE, V303, P788, DOI 10.1126/science.1095480; Chen J, 2005, PLOS BIOL, V3, P207, DOI 10.1371/journal.pbio.0030059; Chiel HJ, 2010, CBE-LIFE SCI EDUC, V9, P248, DOI 10.1187/cbe.10-03-0022; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Labov JB, 2010, CBE-LIFE SCI EDUC, V9, P10, DOI 10.1187/cbe.09-12-0092; *NAT RES COUNC, 2003, BIOL 2010 TRANSF UND; Pevzner P, 2009, SCIENCE, V325, P541, DOI 10.1126/science.1173876; Smith MK, 2009, SCIENCE, V323, P122, DOI 10.1126/science.1165919	10	20	20	10	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1542	1543		10.1126/science.1216570	http://dx.doi.org/10.1126/science.1216570			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057AE	23258877	Green Accepted			2022-12-28	WOS:000312533100032
J	Goldston, D				Goldston, David			Time to stop relying on things past	NATURE			English	Editorial Material									Nat Resources Def Council, Washington, DC 20005 USA		Goldston, D (corresponding author), Nat Resources Def Council, Washington, DC 20005 USA.	partyofonecolumn@gmail.com							0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 20	2012	492	7429					313	313		10.1038/492313a	http://dx.doi.org/10.1038/492313a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	056KQ	23257843	Bronze			2022-12-28	WOS:000312488200013
J	Miossec, P				Miossec, Pierre			Rheumatoid arthritis: still a chronic disease	LANCET			English	Editorial Material							DOUBLE-BLIND; ETANERCEPT; METHOTREXATE; COMBINATION		Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, Immunogen & Inflammat Res Unit, F-69437 Lyon, France	CHU Lyon	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, Immunogen & Inflammat Res Unit, F-69437 Lyon, France.	miossec@univ-lyon1.fr						Bathon JM, 2000, NEW ENGL J MED, V343, P1586, DOI 10.1056/NEJM200011303432201; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Emery P, 2008, LANCET, V372, P375, DOI 10.1016/S0140-6736(08)61000-4; Emery P, 2012, ANN RHEUM DIS, V71, P989, DOI 10.1136/annrheumdis-2011-201066; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Miossec P, 2011, ANN RHEUM DIS, V70, P1713, DOI 10.1136/ard.2011.154252; Moreland LW, 2012, ARTHRITIS RHEUM-US, V64, P2824, DOI 10.1002/art.34498; Nielen MMJ, 2006, ANN RHEUM DIS, V65, P535, DOI 10.1136/ard.2005.040659; Smolen JS, 2013, LANCET; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Yamanishi Y, 2002, P NATL ACAD SCI USA, V99, P10025, DOI 10.1073/pnas.152333199	13	31	36	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 16	2013	381	9870					884	886		10.1016/S0140-6736(12)62192-8	http://dx.doi.org/10.1016/S0140-6736(12)62192-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105LB	23332235				2022-12-28	WOS:000316069700008
J	Markle, JGM; Frank, DN; Mortin-Toth, S; Robertson, CE; Feazel, LM; Rolle-Kampczyk, U; von Bergen, M; McCoy, KD; Macpherson, AJ; Danska, JS				Markle, Janet G. M.; Frank, Daniel N.; Mortin-Toth, Steven; Robertson, Charles E.; Feazel, Leah M.; Rolle-Kampczyk, Ulrike; von Bergen, Martin; McCoy, Kathy D.; Macpherson, Andrew J.; Danska, Jayne S.			Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity	SCIENCE			English	Article							DIABETES SUSCEPTIBILITY; NOD MOUSE; ASSOCIATION; PREVENTION; COOPERATE; TRENDS; MICE	Microbial exposures and sex hormones exert potent effects on autoimmune diseases, many of which are more prevalent in women. We demonstrate that early-life microbial exposures determine sex hormone levels and modify progression to autoimmunity in the nonobese diabetic (NOD) mouse model of type 1 diabetes (T1D). Colonization by commensal microbes elevated serum testosterone and protected NOD males from T1D. Transfer of gut microbiota from adult males to immature females altered the recipient's microbiota, resulting in elevated testosterone and metabolomic changes, reduced islet inflammation and autoantibody production, and robust T1D protection. These effects were dependent on androgen receptor activity. Thus, the commensal microbial community alters sex hormone levels and regulates autoimmune disease fate in individuals with high genetic risk.	[Markle, Janet G. M.; Mortin-Toth, Steven; Danska, Jayne S.] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Markle, Janet G. M.; Danska, Jayne S.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Frank, Daniel N.; Feazel, Leah M.] Univ Colorado, Div Infect Dis, Sch Med, Aurora, CO 80045 USA; [Robertson, Charles E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Rolle-Kampczyk, Ulrike; von Bergen, Martin] Helmholtz Ctr Environm Res, Dept Metab, D-04318 Leipzig, Germany; [von Bergen, Martin] Helmholtz Ctr Environm Res, Dept Prote, D-04318 Leipzig, Germany; [von Bergen, Martin] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [McCoy, Kathy D.; Macpherson, Andrew J.] Univ Bern, Maurice Muller Labs, Univ Klin Viszerale Chirurg & Med, CH-3008 Bern, Switzerland; [Danska, Jayne S.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Aalborg University; University of Bern; University Hospital of Bern; University of Toronto	Danska, JS (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genome Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jayne.danska@sickkids.ca	Markle, Janet/X-1975-2019; von Bergen, Martin/D-7960-2011; McCoy, Kathy/ABD-5814-2021; Rolle-Kampczyk, Ulrike E./D-4786-2015	von Bergen, Martin/0000-0003-2732-2977; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Markle, Janet/0000-0003-2189-4368; ROBERTSON, CHARLES/0000-0002-4136-4121	Canadian Institutes of Health Research (CIHR) [64216]; Juvenile Diabetes Research Foundation (JDRF) [17-2011-520]; Genome Canada; JDRF [36-2008-926]; Genaxen Foundation; CIHR Banting and Best fellowship; NIH [R21HG005964]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Genome Canada(Genome Canada); JDRF(Juvenile Diabetes Research Foundation); Genaxen Foundation; CIHR Banting and Best fellowship(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Bashir for assistance with metabolomic data analysis, C. Vogel Kotter for high-throughput sequencing, and E. Simpson and M. Palmert for helpful discussions. The 16S sequence data have been submitted to the National Center for Biotechnology Information short-read archive project, accession no. SRA064044. Flow cytometry was performed in the SickKids-University Health Network Flow Cytometry Facility with funds from the Ontario Institute for Cancer Research, McEwen Centre for Regenerative Medicine, Canada Foundation for Innovation, and SickKids Foundation. Roche 454 sequencing was performed at the Centre for Applied Genomics, Hospital for Sick Children. Illumina sequencing was performed at the University of Colorado School of Medicine. Supported by Canadian Institutes of Health Research (CIHR) grant 64216 and Juvenile Diabetes Research Foundation (JDRF) grant 17-2011-520 (J. S. D.), Genome Canada (administered by Ontario Genomics Institute) (J.S.D. and A. J. M.), JDRF grant 36-2008-926 and the Genaxen Foundation (A. J. M.), a CIHR Banting and Best fellowship (J. G. M. M.), and NIH grant R21HG005964 (D.N.F. and C. E. R.). J. G. M. M. and J. S. D. designed the study, analyzed data, and wrote the manuscript; J. G. M. M., D.N.F., S.M.-T., C. E. R., M. v. B., K. D. M., and A. J. M. performed experiments and analyzed data; L. M. F. and U.R.-K. performed experiments; and all authors contributed to manuscript editing.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chai JG, 2004, BLOOD, V103, P3951, DOI 10.1182/blood-2003-11-3763; Doran MF, 2002, ARTHRITIS RHEUM-US, V46, P625, DOI 10.1002/art.509; FOX HS, 1992, J EXP MED, V175, P1409, DOI 10.1084/jem.175.5.1409; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; HARADA M, 1990, DIABETES RES CLIN PR, V8, P85, DOI 10.1016/0168-8227(90)90017-N; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025792, 10.1371/journal.pone.0014764]; Ivakine EA, 2005, J IMMUNOL, V174, P7129, DOI 10.4049/jimmunol.174.11.7129; Ivakine EA, 2006, DIABETES, V55, P3611, DOI 10.2337/db06-0758; Koal T, 2010, CURR MOL MED, V10, P216, DOI 10.2174/156652410790963312; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Leiter E., 1998, NOD MICE RELATED STR, V2; Makino S, 1981, Jikken Dobutsu, V30, P137; Makino S, 1980, Jikken Dobutsu, V29, P1; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Mittelstrass K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002215; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; QIN HY, 1993, J IMMUNOL, V150, P2072; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Serreze DV, 2001, CURR DIRECT AUTOIMMU, V4, P31; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; WEINSHENKER BG, 1994, ANN NEUROL, V36, pS6, DOI 10.1002/ana.410360704; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	34	1144	1193	27	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 1	2013	339	6123					1084	1088		10.1126/science.1233521	http://dx.doi.org/10.1126/science.1233521			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	097CQ	23328391				2022-12-28	WOS:000315452000044
J	Zimmermann, M; Lottersberger, F; Buonomo, SB; Sfeir, A; de Lange, T				Zimmermann, Michal; Lottersberger, Francisca; Buonomo, Sara B.; Sfeir, Agnel; de lange, Titia			53BP1 Regulates DSB Repair Using Rif1 to Control 5 ' End Resection	SCIENCE			English	Article							PROTEIN 53BP1; DNA; RECOMBINATION; TELOMERES; DOMAINS; CELLS; CTIP	The choice between double-strand break (DSB) repair by either homology-directed repair (HDR) or nonhomologous end joining (NHEJ) is tightly regulated. Defects in this regulation can induce genome instability and cancer. 53BP1 is critical for the control of DSB repair, promoting NHEJ, and inhibiting the 5' end resection needed for HDR. Using dysfunctional telomeres and genome-wide DSBs, we identify Rif1 as the main factor used by 53BP1 to impair 5' end resection. Rif1 inhibits resection involving CtIP, BLM, and Exo1; limits accumulation of BRCA1/BARD1 complexes at sites of DNA damage; and defines one of the mechanisms by which 53BP1 causes chromosomal abnormalities in Brca1-deficient cells. These data establish Rif1 as an important contributor to the control of DSB repair by 53BP1.	[Zimmermann, Michal; Lottersberger, Francisca; Sfeir, Agnel; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA; [Zimmermann, Michal] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Zimmermann, Michal] Masaryk Univ, Fac Sci, CS-61137 Brno, Czech Republic; [Buonomo, Sara B.] European Mol Biol Lab, Mouse Biol Unit, Monterotondo, Italy	Rockefeller University; Masaryk University Brno; Masaryk University Brno; European Molecular Biology Laboratory (EMBL)	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X; Buonomo, Sara/0000-0002-0177-2884; Lottersberger, Francisca/0000-0002-0677-8986	Brno Ph.D. talent fellowship; Czech Science Foundation [P205/12/0550]; Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM049046] Funding Source: NIH RePORTER	Brno Ph.D. talent fellowship; Czech Science Foundation(Grant Agency of the Czech Republic); Breast Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. White for expert mouse husbandry and M. Nussenzweig for providing mutant 53BP1 constructs. M.Z. was supported by a Brno Ph.D. talent fellowship and by a grant from the Czech Science Foundation to Ctirad Hofr (P205/12/0550) (see supplementary materials for detailed acknowledgement). This work was supported by a grant from the Breast Cancer Research Foundation to T.d.L. T.d.L. is an American Cancer Society Research Professor.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Buonomo SBC, 2009, J CELL BIOL, V187, P385, DOI 10.1083/jcb.200902039; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Morales JC, 2003, J BIOL CHEM, V278, P14971, DOI 10.1074/jbc.M212484200; Noon AT, 2011, DNA REPAIR, V10, P1071, DOI 10.1016/j.dnarep.2011.07.012; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388	21	427	441	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 8	2013	339	6120					700	704		10.1126/science.1231573	http://dx.doi.org/10.1126/science.1231573			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	085BM	23306437	Green Accepted			2022-12-28	WOS:000314585600044
J	Frank, RG				Frank, Richard G.			Using Shared Savings to Foster Coordinated Care for Dual Eligibles	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Frank, RG (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.							Carlson BL, 2007, HEALTH SERV RES, V42, P467, DOI 10.1111/j.1475-6773.2006.00673.x; Dhar R, 2003, J MARKETING RES, V40, P146, DOI 10.1509/jmkr.40.2.146.19229; Goldstein DG, 2008, HARVARD BUS REV, V86, P99; Medicare Payment Advisory Commission, 2012, HLTH CAR SPEND MED P; Thorpe KE, 2011, ESTIMATED FEDERAL SA	5	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 31	2013	368	5					404	405		10.1056/NEJMp1214155	http://dx.doi.org/10.1056/NEJMp1214155			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	080BE	23281930				2022-12-28	WOS:000314215400004
J	Hansen, BB; Grotan, V; Aanes, R; Saether, BE; Stien, A; Fuglei, E; Ims, RA; Yoccoz, NG; Pedersen, AO				Hansen, Brage B.; Grotan, Vidar; Aanes, Ronny; Saether, Bernt-Erik; Stien, Audun; Fuglei, Eva; Ims, Rolf A.; Yoccoz, Nigel G.; Pedersen, Ashild O.			Climate Events Synchronize the Dynamics of a Resident Vertebrate Community in the High Arctic	SCIENCE			English	Article							POPULATION-DYNAMICS; SPATIAL SYNCHRONY; LEMMING CYCLES; SNOW EVENTS; REINDEER; SVALBARD; GREENLAND; RESPONSES; IMPACT; RAIN	Recently accumulated evidence has documented a climate impact on the demography and dynamics of single species, yet the impact at the community level is poorly understood. Here, we show that in Svalbard in the high Arctic, extreme weather events synchronize population fluctuations across an entire community of resident vertebrate herbivores and cause lagged correlations with the secondary consumer, the arctic fox. This synchronization is mainly driven by heavy rain on snow that encapsulates the vegetation in ice and blocks winter forage availability for herbivores. Thus, indirect and bottom-up climate forcing drives the population dynamics across all overwintering vertebrates. Icing is predicted to become more frequent in the circumpolar Arctic and may therefore strongly affect terrestrial ecosystem characteristics.	[Hansen, Brage B.; Grotan, Vidar; Aanes, Ronny; Saether, Bernt-Erik] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway; [Aanes, Ronny; Fuglei, Eva; Pedersen, Ashild O.] Norwegian Polar Res Inst, Fram Ctr, NO-9296 Tromso, Norway; [Stien, Audun] Norwegian Inst Nat Res, Fram Ctr, NO-9296 Tromso, Norway; [Ims, Rolf A.; Yoccoz, Nigel G.] Univ Tromso, Dept Arctic & Marine Biol, NO-9037 Tromso, Norway	Norwegian University of Science & Technology (NTNU); Norwegian Polar Institute; Norwegian Institute Nature Research; UiT The Arctic University of Tromso	Hansen, BB (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, NO-7491 Trondheim, Norway.	brage.b.hansen@ntnu.no	Grøtan, Vidar/A-4056-2008; Grøtan, Vidar/O-9453-2019; Yoccoz, Nigel/C-8561-2014; Hansen, Brage Bremset/B-9942-2008	Grøtan, Vidar/0000-0003-1222-0724; Grøtan, Vidar/0000-0003-1222-0724; Yoccoz, Nigel/0000-0003-2192-1039; Hansen, Brage Bremset/0000-0001-8763-4361; Stien, Audun/0000-0001-8046-7337	Norwegian Polar Institute; University of Tromso; Norwegian Institute for Nature Research (ALV); Norwegian Research Council; Governor of Svalbard; French Polar Institute; NORKLIMA [178561/S30, 216051]; European Research Council [ERC-2010-AdG 268562]; Centre for Conservation Biology (Norwegian University of Science and Technology); Nature Research, Norwegian Research Council (NORKLIMA)	Norwegian Polar Institute; University of Tromso; Norwegian Institute for Nature Research (ALV); Norwegian Research Council(Research Council of NorwayEuropean Commission); Governor of Svalbard; French Polar Institute; NORKLIMA; European Research Council(European Research Council (ERC)European Commission); Centre for Conservation Biology (Norwegian University of Science and Technology); Nature Research, Norwegian Research Council (NORKLIMA)	Data collection was financed by the Norwegian Polar Institute, University of Tromso, Norwegian Institute for Nature Research, Norwegian Research Council (ALV and NORKLIMA grants), Governor of Svalbard, and French Polar Institute. This study was financed by NORKLIMA (grants 178561/S30 and 216051), the European Research Council (ERC-2010-AdG 268562), and Centre for Conservation Biology (Norwegian University of Science and Technology). We thank the Norwegian Meteorological Institute (weather data), Governor of Svalbard (ptarmigan data), and Erik Ropstad (ptarmigan photo). Data are presented (table S8) in supplementary materials. Author contributions: A. S., R. A. I., N.G.Y., and E. F. collected vole data. R. A. collected reindeer data. E. F. collected fox data. E. F. and A.O.P. controlled ptarmigan data. R. A., B. B. H., and B. E. S. initiated the study. V. G. analyzed data and wrote Materials and Methods. B. B. H. wrote the manuscript. All authors contributed on later manuscript versions.	[Anonymous], 2011, SNOW WAT IC PERM ARC; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Eide NE, 2012, J ANIM ECOL, V81, P640, DOI 10.1111/j.1365-2656.2011.01936.x; Engen S, 2005, J ANIM ECOL, V74, P601, DOI 10.1111/j.1365-2656.2005.00942.x; FORCHHAMMER M, 1993, ECOGRAPHY, V16, P299, DOI 10.1111/j.1600-0587.1993.tb00219.x; Fuglei E, 2003, POLAR BIOL, V26, P93, DOI 10.1007/s00300-002-0458-8; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Hansen BB, 2011, ECOLOGY, V92, P1917, DOI 10.1890/11-0095.1; Heino M, 1997, P ROY SOC B-BIOL SCI, V264, P481, DOI 10.1098/rspb.1997.0069; Ims RA, 2000, NATURE, V408, P194, DOI 10.1038/35041562; Ims RA, 2005, BIOSCIENCE, V55, P311, DOI 10.1641/0006-3568(2005)055[0311:TICITE]2.0.CO;2; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Kausrud KL, 2008, NATURE, V456, P93, DOI 10.1038/nature07442; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Myers JH, 1998, ECOLOGY, V79, P1111, DOI 10.1890/0012-9658(1998)079[1111:SIOOFL]2.0.CO;2; Post E, 2004, P NATL ACAD SCI USA, V101, P9286, DOI 10.1073/pnas.0305029101; Post E, 2002, NATURE, V420, P168, DOI 10.1038/nature01064; Post E, 2009, SCIENCE, V325, P1355, DOI 10.1126/science.1173113; Putkonen J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016326; Rennert KJ, 2009, J CLIMATE, V22, P2302, DOI 10.1175/2008JCLI2117.1; Saether BE, 2000, ECOLOGY, V81, P642, DOI 10.2307/177366; Saether BE, 2007, J ANIM ECOL, V76, P315, DOI 10.1111/j.1365-2656.2006.01195.x; Schmidt NM, 2012, P ROY SOC B-BIOL SCI, V279, P4417, DOI 10.1098/rspb.2012.1490; Solberg EJ, 2001, ECOGRAPHY, V24, P441, DOI 10.1034/j.1600-0587.2001.d01-200.x; STEEN JB, 1985, ORNIS SCAND, V16, P191, DOI 10.2307/3676630; Stien A, 2012, BIOL LETTERS, V8, P1002, DOI 10.1098/rsbl.2012.0764; van der Wal R, 2009, PERSPECT PLANT ECOL, V11, P231, DOI 10.1016/j.ppees.2009.03.003; Vik JO, 2004, NATURE, V427, P697, DOI 10.1038/427697a; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Yoccoz Nigel G., 1999, Ecological Bulletins, V47, P137	31	172	172	5	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 18	2013	339	6117					313	315		10.1126/science.1226766	http://dx.doi.org/10.1126/science.1226766			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071UW	23329044	Green Submitted, Green Accepted			2022-12-28	WOS:000313622000042
J	Lee, AM; Kanter, BR; Wang, D; Lim, JP; Zou, ME; Qiu, CC; McMahon, T; Dadgar, J; Fischbach-Weiss, SC; Messing, RO				Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.			Prkcz null mice show normal learning and memory	NATURE			English	Article							KINASE M-ZETA; ANXIETY-LIKE BEHAVIOR; PKM-ZETA; DRUG REWARD; C-ZETA; MECHANISM; INHIBITION; PREFERENCE; 3-KINASE	Protein kinase M-zeta (PKM-zeta) is a constitutively active form of atypical protein kinase C that is exclusively expressed in the brain and implicated in the maintenance of long-term memory(1-9). Most studies that support a role for PKM-zeta in memory maintenance have used pharmacological PKM-zeta inhibitors such as the myristoylated zeta inhibitory peptide (ZIP) or chelerythrine. Here we use a genetic approach and target exon 9 of the Prkcz gene to generate mice that lack both protein kinase C-zeta (PKC-zeta) and PKM-zeta (Prkcz(-/-) mice). Prkcz(-/-) mice showed normal behaviour in a cage environment and in baseline tests of motor function and sensory perception, but displayed reduced anxiety-like behaviour. Notably, Prkcz(-/-) mice did not show deficits in learning or memory in tests of cued fear conditioning, novel object recognition, object location recognition, conditioned place preference for cocaine, or motor learning, when compared with wild-type littermates. ZIP injection into the nucleus accumbens reduced expression of cocaine-conditioned place preference in Prkcz(-/-) mice. In vitro, ZIP and scrambled ZIP inhibited PKM-zeta, PKC-iota and PKC-zeta with similar inhibition constant (K-i) values. Chelerythrine was a weak inhibitor of PKM-zeta (K-i = 76 mu M). Our findings show that absence of PKM-zeta does not impair learning and memory in mice, and that ZIP can erase reward memory even when PKM-zeta is not present.	[Lee, Anna M.; Kanter, Benjamin R.; Wang, Dan; Lim, Jana P.; Zou, Mimi E.; Qiu, Chichen; McMahon, Thomas; Dadgar, Jahan; Fischbach-Weiss, Sarah C.; Messing, Robert O.] Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Messing, RO (corresponding author), Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	romes@gallo.ucsf.edu	Kanter, Benjamin R./AAA-4781-2022; Messing, Robert/D-3642-2015; Lee, Anna/AAH-4598-2020	Messing, Robert/0000-0002-5345-4431; Lee, Anna/0000-0003-4551-0082; Kanter, Benjamin/0000-0003-4114-090X	National Institutes of Health [AA017072]; Canadian Institute of Health Research; State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA017072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); State of California for medical research on alcohol and drug abuse; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank V. N. Kharazia and A. J. Lean for assistance. This work was supported by National Institutes of Health grant AA017072 (R.O.M.), a Canadian Institute of Health Research Post-doctoral Fellowship (A. M. L.), and funds provided by the State of California for medical research on alcohol and drug abuse to UCSF.	Brabant C, 2005, PSYCHOPHARMACOLOGY, V180, P33, DOI 10.1007/s00213-004-2138-6; Chen J, 2007, GENES BRAIN BEHAV, V6, P776, DOI 10.1111/j.1601-183X.2007.00311.x; Choi DS, 2002, J NEUROSCI, V22, P9905; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Clarke JR, 2010, P NATL ACAD SCI USA, V107, P2652, DOI 10.1073/pnas.0915059107; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Hardt O, 2010, HIPPOCAMPUS, V20, P691, DOI 10.1002/hipo.20708; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Hodge CW, 2002, J CLIN INVEST, V110, P1003, DOI 10.1172/JCI200215903; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; Lisman J, 2012, HIPPOCAMPUS, V22, P648, DOI 10.1002/hipo.20980; Migues PV, 2010, NAT NEUROSCI, V13, P630, DOI 10.1038/nn.2531; Naik MU, 2000, J COMP NEUROL, V426, P243, DOI 10.1002/1096-9861(20001016)426:2<243::AID-CNE6>3.0.CO;2-8; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Parsons RG, 2011, NAT NEUROSCI, V14, P295, DOI 10.1038/nn.2745; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Shabashov D, 2012, J MOL NEUROSCI, V47, P546, DOI 10.1007/s12031-011-9671-7; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Wu-Zhang AX, 2012, J BIOL CHEM, V287, P12879, DOI 10.1074/jbc.M112.357244; Yao YD, 2013, NEUROPHARMACOLOGY, V64, P37, DOI 10.1016/j.neuropharm.2012.07.018	24	175	177	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					416	U163		10.1038/nature11803	http://dx.doi.org/10.1038/nature11803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23283171	Green Accepted			2022-12-28	WOS:000313615900054
J	Sasai, Y				Sasai, Yoshiki			Cytosystems dynamics in self-organization of tissue architecture	NATURE			English	Review							BRANCHING MORPHOGENESIS; PATTERN-FORMATION; CELL MORPHOLOGY; STEM-CELLS; IN-VITRO; GROWTH; REGENERATION; RECONSTRUCTION; EMBRYOS; MODEL	Our knowledge of the principles by which organ architecture develops through complex collective cell behaviours is still limited. Recent work has shown that the shape of such complex tissues as the optic cup forms by self-organization in vitro from a homogeneous population of stem cells. Multicellular self-organization involves three basic processes that are crucial for the emergence of latent intrinsic order. Based on lessons from recent studies, cytosystems dynamics is proposed as a strategy for understanding collective multicellular behaviours, incorporating four-dimensional measurement, theoretical modelling and experimental reconstitution.	RIKEN, Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Neurogenesis & Organogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp						Adler R, 2007, DEV BIOL, V305, P1, DOI 10.1016/j.ydbio.2007.01.045; Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Bonabeau E, 1999, ARTIF LIFE, V5, P95, DOI 10.1162/106454699568692; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; DANSOHKAWA M, 1986, J EMBRYOL EXP MORPH, V94, P47; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; Dobrescu R, 2011, J Med Life, V4, P82; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2012, BIOESSAYS, V34, P17, DOI 10.1002/bies.201100070; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Eliceiri KW, 2012, NAT METHODS, V9, P697, DOI [10.1038/nmeth.2084, 10.1038/NMETH.2084]; Ferrell JE, 2012, CURR BIOL, V22, pR458, DOI 10.1016/j.cub.2012.03.045; FORREST SB, 1992, SCIENCE, V255, P1240, DOI 10.1126/science.255.5049.1240; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Fuhrmann S, 2010, CURR TOP DEV BIOL, V93, P61, DOI [10.1016/B978-0-12-385044-7.00003-5, 10.1016/S0070-2153(10)93003-2]; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Gardner MK, 2008, CURR OPIN CELL BIOL, V20, P64, DOI 10.1016/j.ceb.2007.12.003; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; GREEN JBA, 1994, DEVELOPMENT, V120, P2271; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hamburger V, 1988, HERITAGE EXPT EMBRYO; Hannezo E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.078104; He L, 2010, NAT CELL BIOL, V12, P1133, DOI 10.1038/ncb2124; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kauffman S.A., 1993, ORIGINS ORDER; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Krzic U, 2012, NAT METHODS, V9, P730, DOI [10.1038/nmeth.2064, 10.1038/NMETH.2064]; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Li R., 2010, SYMMETRY BREAKING BI; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marikawa Y, 2009, GENESIS, V47, P93, DOI 10.1002/dvg.20473; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; Meinhardt H, 2000, BIOESSAYS, V22, P753, DOI 10.1002/1521-1878(200008)22:8<753::AID-BIES9>3.3.CO;2-Q; Meng FJ, 2012, J CELL SCI, V125, P743, DOI 10.1242/jcs.093104; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; MOORE SW, 1995, DEVELOPMENT, V121, P3131; Mori H, 2009, P NATL ACAD SCI USA, V106, P14890, DOI 10.1073/pnas.0901269106; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; NIEUWKOOP PD, 1985, J EMBRYOL EXP MORPH, V89, P333; Olivier N, 2010, SCIENCE, V329, P967, DOI 10.1126/science.1189428; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Rauzi M, 2010, NATURE, V468, P1110, DOI 10.1038/nature09566; Saetzler K, 2011, SEMIN CANCER BIOL, V21, P165, DOI 10.1016/j.semcancer.2011.04.004; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Savin T, 2011, NATURE, V476, P57, DOI 10.1038/nature10277; Sawai S, 2005, NATURE, V433, P323, DOI 10.1038/nature03228; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Spemann H, 1901, VERH ANAT GESELLSCH, V15, P61; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; Taniguchi K, 2011, SCIENCE, V333, P339, DOI 10.1126/science.1200940; Tanner K, 2012, P NATL ACAD SCI USA, V109, P1973, DOI 10.1073/pnas.1119578109; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Thorpe TA, 2007, MOL BIOTECHNOL, V37, P169, DOI 10.1007/s12033-007-0031-3; Togashi H, 2011, SCIENCE, V333, P1144, DOI 10.1126/science.1208467; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Toyoshima K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1784; Truong TV, 2011, NAT METHODS, V8, P757, DOI 10.1038/nmeth.1652; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VELARDE MG, 1980, SCI AM, V243, P92; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Weber GF, 2012, DEV CELL, V22, P104, DOI 10.1016/j.devcel.2011.10.013; Wei C, 2007, TISSUE ENG, V13, P721, DOI 10.1089/ten.2006.0123; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Whitesides GM, 2002, P NATL ACAD SCI USA, V99, P4769, DOI 10.1073/pnas.082065899; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; WINFREE AT, 1972, SCIENCE, V175, P634, DOI 10.1126/science.175.4022.634; Wu YI, 2009, NATURE, V461, P104, DOI 10.1038/nature08241; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yates E.F., 1987, SELF ORG SYSTEMS EME; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Zhao SL, 2001, DEVELOPMENT, V128, P5051; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Zhong Q, 2012, NAT METHODS, V9, P711, DOI [10.1038/NMETH.2046, 10.1038/nmeth.2046]	100	284	289	4	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	2013	493	7432					318	326		10.1038/nature11859	http://dx.doi.org/10.1038/nature11859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	071TA	23325214				2022-12-28	WOS:000313615900038
J	Schectman, JM				Schectman, Joel M.			Review: Interventions for patient transition from hospital to primary care may improve outcomes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Virginia Hlth Syst, Charlottesville, VA USA	University of Virginia	Schectman, JM (corresponding author), Univ Virginia Hlth Syst, Charlottesville, VA USA.								0	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC12	10.7326/0003-4819-158-2-201301150-02012	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318334				2022-12-28	WOS:000314029400011
J	Stockler, MR				Stockler, Martin R.			Intermittent and continuous androgen deprivation did not differ for mortality after radiotherapy for prostate CA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stockler, Martin R.] Univ Sydney, Sydney, NSW 2006, Australia; [Stockler, Martin R.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Stockler, Martin R.] Concord Hosp, Sydney, NSW, Australia	University of Sydney; University of Sydney; Concord Repatriation General Hospital	Stockler, MR (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.		Stockler, Martin R/N-3859-2016	Stockler, Martin R/0000-0003-3793-8724				Hussain M, 2012, J CLIN ONCOL, V30, DOI 10.1200/jco.2012.30.18_suppl.4	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	2013	158	2							JC9	10.7326/0003-4819-158-2-201301150-02009	http://dx.doi.org/10.7326/0003-4819-158-2-201301150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	077LO	23318343				2022-12-28	WOS:000314029400008
J	Spence, D				Spence, Des			Doctors no longer need medical secretaries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2013	346								f226	10.1136/bmj.f226	http://dx.doi.org/10.1136/bmj.f226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	070ZX	23315258				2022-12-28	WOS:000313555500007
J	Tabas, I; Glass, CK				Tabas, Ira; Glass, Christopher K.			Anti-Inflammatory Therapy in Chronic Disease: Challenges and Opportunities	SCIENCE			English	Review							REGULATORY T-CELLS; INSULIN-RESISTANCE; PPAR-GAMMA; INFLAMMATORY RESPONSE; ADENOSINE A(2A); GENE-EXPRESSION; RESOLVIN D2; ATHEROSCLEROSIS; INHIBITION; METHOTREXATE	A number of widespread and devastating chronic diseases, including atherosclerosis, type 2 diabetes, and Alzheimer's disease, have a pathophysiologically important inflammatory component. In these diseases, the precise identity of the inflammatory stimulus is often unknown and, if known, is difficult to remove. Thus, there is interest in therapeutically targeting the inflammatory response. Although there has been success with anti-inflammatory therapy in chronic diseases triggered by primary inflammation dysregulation or autoimmunity, there are considerable limitations. In particular, the inflammatory response is critical for survival. As a result, redundancy, compensatory pathways, and necessity narrow the risk: benefit ratio of anti-inflammatory drugs. However, new advances in understanding inflammatory signaling and its links to resolution pathways, together with new drug development, offer promise in this area of translational biomedical research.	[Tabas, Ira] Columbia Univ, Dept Med, Dept Anat & Cell Biol, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Columbia University; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego	Tabas, I (corresponding author), Columbia Univ, Dept Med, Dept Anat & Cell Biol, New York, NY 10032 USA.	iat1@columbia.edu; cglass@ucsd.edu	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	National Institutes of Health [P01-HL054591, R01-HL075662, R01-HL057560, DK074868, DK091183, HC088093]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075662, R01HL057560, R01HL106019, P01HL087123, R01HL107497, P01HL054591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK091183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Serhan, J. Bathon, R. Winchester, and G. Fredman for helpful discussions. This work was supported by National Institutes of Health grants P01-HL054591, R01-HL075662, and R01-HL057560 (to I.T.) and DK074868, DK091183, and HC088093 (to C.K.G.).	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Arnason Bgw, 2011, Int MS J, V17, P63; Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Brito V, 2012, ARTERIOSCL THROM VAS, V32, P2847, DOI 10.1161/ATVBAHA.112.300444; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Cui W, 2012, NEUROSCIENCE, V210, P200, DOI 10.1016/j.neuroscience.2012.02.047; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Feldmann M, 2010, ANN RHEUM DIS, V69, P97, DOI 10.1136/ard.2009.117143; Flogel U, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003717; Fox DA, 2012, NEW ENGL J MED, V367, P565, DOI 10.1056/NEJMe1206315; Genovese MC, 2009, ARTHRITIS RHEUM, V60, P317, DOI 10.1002/art.24264; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Juarez M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13529; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kox WJ, 2000, INTENS CARE MED, V26, pS124, DOI 10.1007/s001340051129; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Kubota T, 2010, MOD RHEUMATOL, V20, P213, DOI 10.1007/s10165-009-0271-0; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee SI, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3750; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578; Lobatto ME, 2010, MOL PHARMACEUT, V7, P2020, DOI 10.1021/mp100309y; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; McPherson R, 2012, CAN J CARDIOL, V28, P662, DOI 10.1016/j.cjca.2012.05.014; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Montaudie H, 2011, J EUR ACAD DERMATOL, V25, P12, DOI 10.1111/j.1468-3083.2011.03991.x; Montecucco F, 2009, SEMIN IMMUNOPATHOL, V31, P127, DOI 10.1007/s00281-009-0150-y; Montesinos MC, 2003, ARTHRITIS RHEUM-US, V48, P240, DOI 10.1002/art.10712; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Pan F, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003364; Polykratis A, 2012, CIRCULATION, V126, P1739, DOI 10.1161/CIRCULATIONAHA.112.100339; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Ridker PM, 2009, J THROMB HAEMOST, V7, P332, DOI 10.1111/j.1538-7836.2009.03404.x; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Scrivo R, 2011, AUTOIMMUN REV, V10, P369, DOI 10.1016/j.autrev.2010.12.006; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stamp L, 2006, BIOMED PHARMACOTHER, V60, P678, DOI 10.1016/j.biopha.2006.09.007; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Tabas I, 2012, NATURE, V487, P306, DOI 10.1038/487306a; Vucic E, 2012, JACC-CARDIOVASC IMAG, V5, P819, DOI 10.1016/j.jcmg.2011.11.025; Wang H, 2009, ARTERIOSCL THROM VAS, V29, P1046, DOI 10.1161/ATVBAHA.109.188839; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	70	741	786	18	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 11	2013	339	6116					166	172		10.1126/science.1230720	http://dx.doi.org/10.1126/science.1230720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307734	Green Accepted			2022-12-28	WOS:000313328200035
J	Hodder, SL; Justman, J; Hughes, JP; Wang, J; Haley, DF; Adimora, AA; Del Rio, C; Golin, CE; Kuo, I; Rompalo, A; Soto-Torres, L; Mannheimer, SB; Johnson-Lewis, L; Eshleman, SH; El-Sadr, WM				Hodder, Sally L.; Justman, Jessica; Hughes, James P.; Wang, Jing; Haley, Danielle F.; Adimora, Adaora A.; Del Rio, Carlos; Golin, Carol E.; Kuo, Irene; Rompalo, Anne; Soto-Torres, Lydia; Mannheimer, Sharon B.; Johnson-Lewis, LeTanya; Eshleman, Susan H.; El-Sadr, Wafaa M.		Womens HIV SeroIncidence Study	HIV Acquisition Among Women From Selected Areas of the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							BEHAVIORAL SURVEILLANCE; RISK; MEN; SEX; INFECTION; BIAS	Background: Women account for 23% of newly diagnosed HIV infections in the United States, but there are few recent, well-characterized cohorts of U. S. women in whom behavior characteristics and HIV acquisition have been well-described. Objective: To evaluate HIV incidence and describe behaviors among U. S. women residing in areas of high HIV prevalence. Design: Multisite, longitudinal cohort of women who had HIV rapid testing and audio computer-assisted self-interviews at baseline and every 6 months for up to 12 months. (ClinicalTrials.gov: NCT00995176) Setting: 10 urban and periurban communities with high HIV prevalence and poverty rates, located in the northeastern and southeastern United States. Patients: Venue-based sampling was used to recruit women aged 18 to 44 years who recently had unprotected sex and had 1 or more additional personal or partner risk factors and no self-reported previous HIV diagnosis. Measurements: HIV prevalence and incidence, frequency of HIV risk behaviors, and health status perceptions. Results: Among 2099 high-risk women (85.9% black and 11.7% of Hispanic ethnicity), 32 (1.5%) were diagnosed with HIV infection at enrollment. Annual HIV incidence was 0.32% (95% CI, 0.14% to 0.74%). Older age, substance use, and knowing a partner had HIV were associated with HIV prevalence. Ten women died during the study (0.61% per year). Limitations: Longitudinal assessment of risk behaviors was limited to a maximum of 12 months. There were few incident HIV infections, precluding identification of characteristics predictive of HIV acquisition. Conclusion: This study enrolled a cohort of women with HIV incidence substantially higher than the Centers for Disease Control and Prevention national estimate in the general population of U. S. black women. Concerted efforts to improve preventive health care strategies for HIV and overall health status are needed for similar populations. Primary Funding Source: National Institutes of Health. Ann Intern Med. 2013;158:10-18.	[Hodder, Sally L.] Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, Newark, NJ 07101 USA; Columbia Univ, Coll Phys & Surg, Int AIDS Care & Treatment Program, Joseph L Mailman Sch Publ Hlth, New York, NY USA; Columbia Univ Coll Phys & Surg, Harlem Hosp Ctr, New York, NY 10032 USA; Univ Washington, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; FHI 360, Durham, NC USA; Univ N Carolina, Sch Med, Chapel Hill, NC USA; Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Ctr AIDS Res, Atlanta, GA 30322 USA; George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC USA; Johns Hopkins Univ, Sch Med, Baltimore, MD USA; NIAID, NIH, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Columbia University; Columbia University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; FHI 360; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Emory University; Rollins School Public Health; Emory University; George Washington University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hodder, SL (corresponding author), Univ Med & Dent New Jersey, Dept Med, Div Infect Dis, 185 S Orange Ave,MSB I-506, Newark, NJ 07101 USA.	hoddersa@umdnj.edu	del Rio, Carlos/B-3763-2012; Justman, Jessica/AAA-3572-2020	del Rio, Carlos/0000-0002-0153-3517; 	National Institutes of Health; National Institute of Allergy and Infectious Diseases [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute on Drug Abuse [UM1 AI068619, U01-AI068613, UM1-AI068613]; National Institute of Mental Health [UM1 AI068619, U01-AI068613, UM1-AI068613]; Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University [5UM1A1069466]; University of North Carolina Clinical Trials Unit [AI069423]; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award [RR 025747]; University of North Carolina Center for AIDS Research [AI050410]; Emory University HIV/AIDS Clinical Trials Unit [5UO1AI069418]; Center for AIDS Research [P30 AI050409]; Clinical and Translational Science Award [UL1 RR025008, ULI RR025008]; Johns Hopkins Adult AIDS Clinical Trials Unit [AI069465]; Johns Hopkins Clinical and Translational Science Award [ULI RR025005]; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025008, UL1RR025747, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069466, U01AI069418, U01AI068613, P30AI050410, UM1AI068613, U01AI069423, UM1AI069465, P30AI050409, UM1AI069423, U01AI069484, U01AI069465, UM1AI068619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University; University of North Carolina Clinical Trials Unit; University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award; University of North Carolina Center for AIDS Research; Emory University HIV/AIDS Clinical Trials Unit; Center for AIDS Research; Clinical and Translational Science Award; Johns Hopkins Adult AIDS Clinical Trials Unit; Johns Hopkins Clinical and Translational Science Award; Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health.; Grant Support: By the National Institute of Allergy and Infectious Diseases, National Institute on Drug Abuse, and National Institute of Mental Health (cooperative agreement UM1 AI068619, U01-AI068613, and UM1-AI068613); Centers for Innovative Research to Control AIDS, Mailman School of Public Health, Columbia University (5UM1A1069466); University of North Carolina Clinical Trials Unit (AI069423); University of North Carolina Clinical Trials Research Center of the Clinical and Translational Science Award (RR 025747); University of North Carolina Center for AIDS Research (AI050410); Emory University HIV/AIDS Clinical Trials Unit (5UO1AI069418), Center for AIDS Research (P30 AI050409), and Clinical and Translational Science Award (UL1 RR025008); Johns Hopkins Adult AIDS Clinical Trials Unit (AI069465) and Clinical and Translational Science Award (ULI RR025008); Johns Hopkins Clinical and Translational Science Award (ULI RR025005); and The Terry Beirn Community Programs for Clinical Research on AIDS Clinical Trials Unit.	Allen DR, 2009, PUBLIC HEALTH REP, V124, P26, DOI 10.1177/003335490912400106; Brookmeyer R, 1997, J ROY STAT SOC A STA, V160, P127, DOI 10.1111/1467-985X.00049; Centers for Disease Control and Prevention, 2011, HIV WOM; Centers for Disease Control and Prevention, HIV SURV WOM; DeNavas-Walt C., 2009, CURRENT POPULATION R, P60; DiClemente RJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e85; Dr Hodder, 1985, DROP; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; Eshleman SH, 2013, J INFECT DI IN PRESS; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FISHER RJ, 1993, J CONSUM RES, V20, P303, DOI 10.1086/209351; Gallagher KM, 2007, PUBLIC HEALTH REP, V122, P32, DOI 10.1177/00333549071220S106; Haley D.F., ADM TECHNICAL LOGIST; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hodder L., OBTAINING FUNDING; Hodder S.L., PROVISION STUDY MAT; Hodder S.L., CRITICAL REVISION AR; Hodder S.L., DRAFTING ARTICLE; Hodder S.L., CONCEPTION DESIGN; Hodder S.L., ANAL INTERPRETATION; Hodder SL, 2010, JAIDS-J ACQ IMM DEF, V55, pS69, DOI 10.1097/QAI.0b013e3181fbbdf9; Laeyendecker O, 2013, J INFECT DI IN PRESS; LOCKE SE, 1992, JAMA-J AM MED ASSOC, V268, P1301, DOI 10.1001/jama.268.10.1301; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Masciotra S, 2010, 17 C RETR OPP INF SA; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Murphy SL, 2012, NATL VITAL STAT REPO, P60; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Turner CF, 1998, SCIENCE, V280, P867, DOI 10.1126/science.280.5365.867; UNAIDS, 2010, GLOB REP UNAIDS REP	34	73	74	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	2013	158	1					10	U53		10.7326/0003-4819-158-1-201301010-00004	http://dx.doi.org/10.7326/0003-4819-158-1-201301010-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	065AV	23277896	Green Accepted			2022-12-28	WOS:000313119900003
J	Alberts, B				Alberts, Bruce			The Breakthroughs of 2012	SCIENCE			English	Editorial Material																			0	5	12	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 21	2012	338	6114					1511	1511		10.1126/science.1234108	http://dx.doi.org/10.1126/science.1234108			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	057AE	23258851				2022-12-28	WOS:000312533100001
J	Jenniskens, P; Fries, MD; Yin, QZ; Zolensky, M; Krot, AN; Sandford, SA; Sears, D; Beauford, R; Ebel, DS; Friedrich, JM; Nagashima, K; Wimpenny, J; Yamakawa, A; Nishiizumi, K; Hamajima, Y; Caffee, MW; Welten, KC; Laubenstein, M; Davis, AM; Simon, SB; Heck, PR; Young, ED; Kohl, IE; Thiemens, MH; Nunn, MH; Mikouchi, T; Hagiya, K; Ohsumi, K; Cahill, TA; Lawton, JA; Barnes, D; Steele, A; Rochette, P; Verosub, KL; Gattacceca, J; Cooper, G; Glavin, DP; Burton, AS; Dworkin, JP; Elsila, JE; Pizzarello, S; Ogliore, R; Schmitt-Kopplin, P; Harir, M; Hertkorn, N; Verchovsky, A; Grady, M; Nagao, K; Okazaki, R; Takechi, H; Hiroi, T; Smith, K; Silber, EA; Brown, PG; Albers, J; Klotz, D; Hankey, M; Matson, R; Fries, JA; Walker, RJ; Puchtel, I; Lee, CTA; Erdman, ME; Eppich, GR; Roeske, S; Gabelica, Z; Lerche, M; Nuevo, M; Girten, B; Worden, SP				Jenniskens, Peter; Fries, Marc D.; Yin, Qing-Zhu; Zolensky, Michael; Krot, Alexander N.; Sandford, Scott A.; Sears, Derek; Beauford, Robert; Ebel, Denton S.; Friedrich, Jon M.; Nagashima, Kazuhide; Wimpenny, Josh; Yamakawa, Akane; Nishiizumi, Kunihiko; Hamajima, Yasunori; Caffee, Marc W.; Welten, Kees C.; Laubenstein, Matthias; Davis, Andrew M.; Simon, Steven B.; Heck, Philipp R.; Young, Edward D.; Kohl, Issaku E.; Thiemens, Mark H.; Nunn, Morgan H.; Mikouchi, Takashi; Hagiya, Kenji; Ohsumi, Kazumasa; Cahill, Thomas A.; Lawton, Jonathan A.; Barnes, David; Steele, Andrew; Rochette, Pierre; Verosub, Kenneth L.; Gattacceca, Jerome; Cooper, George; Glavin, Daniel P.; Burton, Aaron S.; Dworkin, Jason P.; Elsila, Jamie E.; Pizzarello, Sandra; Ogliore, Ryan; Schmitt-Kopplin, Phillipe; Harir, Mourad; Hertkorn, Norbert; Verchovsky, Alexander; Grady, Monica; Nagao, Keisuke; Okazaki, Ryuji; Takechi, Hiroyuki; Hiroi, Takahiro; Smith, Ken; Silber, Elizabeth A.; Brown, Peter G.; Albers, Jim; Klotz, Doug; Hankey, Mike; Matson, Robert; Fries, Jeffrey A.; Walker, Richard J.; Puchtel, Igor; Lee, Cin-Ty A.; Erdman, Monica E.; Eppich, Gary R.; Roeske, Sarah; Gabelica, Zelimir; Lerche, Michael; Nuevo, Michel; Girten, Beverly; Worden, Simon P.		Sutter's Mill Meteorite Consortium	Radar-Enabled Recovery of the Sutter's Mill Meteorite, a Carbonaceous Chondrite Regolith Breccia	SCIENCE			English	Article							OXYGEN ISOTOPIC COMPOSITIONS; TAGISH LAKE; METEOROIDS; ORIGIN; ACIDS; FALL	Doppler weather radar imaging enabled the rapid recovery of the Sutter's Mill meteorite after a rare 4-kiloton of TNT-equivalent asteroid impact over the foothills of the Sierra Nevada in northern California. The recovered meteorites survived a record high-speed entry of 28.6 kilometers per second from an orbit close to that of Jupiter-family comets (Tisserand's parameter = 2.8 +/- 0.3). Sutter's Mill is a regolith breccia composed of CM (Mighei)-type carbonaceous chondrite and highly reduced xenolithic materials. It exhibits considerable diversity of mineralogy, petrography, and isotope and organic chemistry, resulting from a complex formation history of the parent body surface. That diversity is quickly masked by alteration once in the terrestrial environment but will need to be considered when samples returned by missions to C-class asteroids are interpreted.	[Jenniskens, Peter; Hamajima, Yasunori; Nuevo, Michel] ISETI Inst, Mountain View, CA 94043 USA; [Jenniskens, Peter; Sandford, Scott A.; Sears, Derek; Cooper, George; Nuevo, Michel; Girten, Beverly; Worden, Simon P.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Fries, Marc D.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Yin, Qing-Zhu; Wimpenny, Josh; Yamakawa, Akane; Verosub, Kenneth L.; Roeske, Sarah] Univ Calif Davis, Dept Geol, Davis, CA 95616 USA; [Zolensky, Michael] NASA, Johnson Space Ctr, Houston, TX 77058 USA; [Krot, Alexander N.; Ogliore, Ryan] Univ Hawaii Manoa, Hawaii Inst Geophys, Honolulu, HI 96822 USA; [Krot, Alexander N.; Ogliore, Ryan] Univ Hawaii Manoa, Planetol & Astrobiol Inst, Honolulu, HI 96822 USA; [Beauford, Robert] Univ Arkansas, Arkansas Ctr Space & Planetary Sci, Fayetteville, AR 72701 USA; [Ebel, Denton S.; Friedrich, Jon M.] Amer Museum Nat Hist, Dept Earth & Planetary Sci, New York, NY 10024 USA; [Friedrich, Jon M.] Fordham Univ, Dept Chem, Bronx, NY 10458 USA; [Nishiizumi, Kunihiko; Welten, Kees C.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Hamajima, Yasunori] Kanazawa Univ, Low Level Radioact Lab, Nomi, Ishikawa 9231224, Japan; [Caffee, Marc W.] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Laubenstein, Matthias] Ist Nazl Fis Nucl, Lab Nazl Gran Sasso, I-67100 Assergi, Italy; [Davis, Andrew M.; Simon, Steven B.; Heck, Philipp R.] Univ Chicago, Chicago Ctr Cosmochem, Chicago, IL 60637 USA; [Davis, Andrew M.; Simon, Steven B.; Heck, Philipp R.] Univ Chicago, Dept Geophys Sci, Enrico Fermi Inst, Chicago, IL 60637 USA; [Davis, Andrew M.; Heck, Philipp R.] Field Museum Nat Hist, Robert Pritzker Ctr Meteorit & Polar Studies, Chicago, IL 60605 USA; [Young, Edward D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Kohl, Issaku E.; Nunn, Morgan H.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Thiemens, Mark H.; Nunn, Morgan H.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Mikouchi, Takashi] Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Hagiya, Kenji] Univ Hyogo, Grad Sch Life Sci, Hyogo 6781297, Japan; [Ohsumi, Kazumasa] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795189, Japan; [Cahill, Thomas A.; Lawton, Jonathan A.; Barnes, David] Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; [Steele, Andrew] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Rochette, Pierre; Gattacceca, Jerome] Aix Marseille Univ, CNRS, Ctr Europeen Rech & Enseignement, F-13545 Aix En Provence, France; [Glavin, Daniel P.; Burton, Aaron S.; Dworkin, Jason P.; Elsila, Jamie E.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Burton, Aaron S.] Oak Ridge Associated Univ, Greenbelt, MD 20771 USA; [Pizzarello, Sandra] Arizona State Univ, Tempe, AZ 85287 USA; [Schmitt-Kopplin, Phillipe; Harir, Mourad; Hertkorn, Norbert] Helmholtz Zentrum Munchen, D-85764 Munich, Germany; [Schmitt-Kopplin, Phillipe] Tech Univ Munich, Freising Weihenstephan, Germany; [Verchovsky, Alexander; Grady, Monica] Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England; [Nagao, Keisuke] Univ Tokyo, Geochem Res Ctr, Bunkyo Ku, Tokyo 1130033, Japan; [Okazaki, Ryuji; Takechi, Hiroyuki] Kyushu Univ, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; [Hiroi, Takahiro] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Smith, Ken] Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA; [Silber, Elizabeth A.; Brown, Peter G.] Univ Western Ontario, London, ON N6A 3K7, Canada; [Klotz, Doug] Space Sci Sch, Incline Village, NV 89451 USA; [Hankey, Mike] Amer Meteor Soc, Geneseo, NY 14454 USA; [Matson, Robert] Sci Applicat Int Corp, Seal Beach, CA 90740 USA; [Fries, Jeffrey A.] USAF, Weather Agcy, Weather Grp 1, Offutt Af Base, NE 68113 USA; [Walker, Richard J.; Puchtel, Igor] Univ Maryland, Dept Geol, College Pk, MD 20742 USA; [Lee, Cin-Ty A.; Erdman, Monica E.] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Eppich, Gary R.] Lawrence Livermore Natl Lab, Glenn Seaborg Inst, Livermore, CA 94550 USA; [Gabelica, Zelimir] Univ Haute Alsace, F-68093 Mulhouse, France; [Lerche, Michael] Univ Calif,Davis, McClellan Nucl Res Ctr, Mcclellan, CA 95652 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Davis; National Aeronautics & Space Administration (NASA); University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Arkansas System; University of Arkansas Fayetteville; American Museum of Natural History (AMNH); Fordham University; University of California System; University of California Berkeley; Kanazawa University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Gran Sasso Science Institute (GSSI); Istituto Nazionale di Fisica Nucleare (INFN); University of Chicago; University of Chicago; Field Museum of Natural History (Chicago); University of California System; University of California Los Angeles; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of California System; University of California San Diego; University of Tokyo; University of Hyogo; Japan Synchrotron Radiation Research Institute; University of California System; University of California Davis; Carnegie Institution for Science; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; United States Department of Energy (DOE); Oak Ridge National Laboratory; Arizona State University; Arizona State University-Tempe; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Open University - UK; University of Tokyo; Kyushu University; Brown University; Nevada System of Higher Education (NSHE); University of Nevada Reno; Western University (University of Western Ontario); Science Applications International Corporation (SAIC); United States Department of Defense; United States Air Force; University System of Maryland; University of Maryland College Park; Rice University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Universites de Strasbourg Etablissements Associes; Universite de Haute-Alsace (UHA)	Jenniskens, P (corresponding author), ISETI Inst, 189 Bernardo Ave, Mountain View, CA 94043 USA.	petrus.m.jenniskens@nasa.gov	Brown, Peter/C-8763-2018; Walker, Richard/K-6869-2016; Lee, Cin-Ty/AAV-8155-2021; Heck, Philipp R/AAU-1433-2021; Burton, Aaron/H-2212-2011; , Igor/ABA-2434-2020; Dworkin, Jason P./C-9417-2012; Elsila, Jamie/AAM-2654-2020; Rochette, Pierre/O-4612-2019; Lee, Cin-Ty/A-5469-2008; Mikouchi, Takashi/AAY-7355-2021; Steele, Andrew/A-3573-2013; HAMAJIMA, Yasunori/L-3802-2015; Hertkorn, Norbert/AAA-5990-2022; Laubenstein, Matthias/C-4851-2013; Gattacceca, Jerome/AAG-5651-2019; Yin, Qing-Zhu/B-8198-2009; Schmitt-Kopplin, Philippe/H-6271-2011; Glavin, Daniel P/D-6194-2012; Elsila, Jamie E/C-9952-2012	Walker, Richard/0000-0003-0348-2407; Lee, Cin-Ty/0000-0002-3586-0110; Heck, Philipp R/0000-0002-6319-2594; Burton, Aaron/0000-0002-1194-4336; Dworkin, Jason P./0000-0002-3961-8997; Rochette, Pierre/0000-0002-7362-0660; Steele, Andrew/0000-0001-9643-2841; HAMAJIMA, Yasunori/0000-0002-8485-4606; Laubenstein, Matthias/0000-0001-5390-4343; Gattacceca, Jerome/0000-0002-1639-7140; Yin, Qing-Zhu/0000-0002-4445-5096; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Glavin, Daniel P/0000-0001-7779-7765; Wimpenny, Josh/0000-0002-7637-0978; Grady, Monica/0000-0002-4055-533X; Welten, Kees/0000-0001-8577-6753; Erdman, Monica E./0000-0001-5115-6759; Nagashima, Kazuhide/0000-0002-9322-3187; Burton, Aaron/0000-0002-7137-1605; Elsila, Jamie/0000-0002-0008-2590; Eppich, Gary/0000-0003-2176-6673; Young, Edward/0000-0002-1299-0801; Davis, Andrew/0000-0001-7955-6236; Brown, Peter/0000-0001-6130-7039; Zolensky, Michael/0000-0002-3181-1303; Mikouchi, Takashi/0000-0002-9998-8754	NASA Cosmochemistry Program; NASA Lunar Science Institute; Near Earth Object Observation Program; Origins of Solar Systems; Planetary Major Equipment; Sample Return Laboratory Instruments; NASA Astrobiology Institute; SPring-8 Grant Program; Post Doctoral Programs; Tawani Foundation; Japan Society for the Promotion of Science; STFC [ST/I001964/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/I001964/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [22224010] Funding Source: KAKEN	NASA Cosmochemistry Program(National Aeronautics & Space Administration (NASA)); NASA Lunar Science Institute; Near Earth Object Observation Program; Origins of Solar Systems(National Aeronautics & Space Administration (NASA)); Planetary Major Equipment; Sample Return Laboratory Instruments; NASA Astrobiology Institute; SPring-8 Grant Program; Post Doctoral Programs; Tawani Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The rapid recovery of SM was made possible by the local communities of Lotus, Coloma, Pilot Hill, and Grass Valley, due in part to the support of property owners, community leaders, SETI Institute and University of Caifornia at Davis (UC Davis) student and volunteer searchers, and officials of the Marshall Gold Discovery State Historic Park and the State of California. We thank J. Howard, M. Carter, D. E. Macon, and L. Hofland of the NASA Ames Research Center; M. Hill of the American Museum of Natural History; and G. Baxter, N. Botto, D. Rowland, O. Kreylos, L. Kellogg, and D. Summer of UC Davis for assistance with reported measurements. The NASA Ames Research Center-coordinated search efforts were supported by the NASA Lunar Science Institute. E. D. Y., M. Z., A. M. D., D. S. E., J. E. E., K. N., K. C. W., M. H. T., M. W. C., Q.-Z. Y., and S. B. S. acknowledge the NASA Cosmochemistry Program for support of work reported here. In addition, the following NASA programs are sincerely acknowledged: Near Earth Object Observation Program (P. J.), Origins of Solar Systems (S. A. S.), Planetary Major Equipment (Q.-Z. Y.), Sample Return Laboratory Instruments and Data Analysis (M. W. C.), the NASA Astrobiology Institute (J. E. E., J. P. D., and D. P. G.), the SPring-8 Grant Program (M. Z.), and Post Doctoral Programs (A. S. B.). P. R. H. acknowledges support from the Tawani Foundation. R. O. acknowledges KAKENHI grants from the Japan Society for the Promotion of Science.	Benedix GK, 2003, GEOCHIM COSMOCHIM AC, V67, P1577, DOI 10.1016/S0016-7037(02)01078-5; Bischoff A., 2006, METEORITES EARLY SOL, P679; Britt D. T, 2012, PAPER PRESENTED AT T; Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; Christie DR, 2010, INFRASOUND MONITORING FOR ATMOSPHERIC STUDIES, P29, DOI 10.1007/978-1-4020-9508-5_2; CLAYTON RN, 1984, J GEOPHYS RES, V89, pC245, DOI 10.1029/JB089iS01p0C245; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; Clayton RN, 1999, GEOCHIM COSMOCHIM AC, V63, P2089, DOI 10.1016/S0016-7037(99)00090-3; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; COOPER GW, 1992, GEOCHIM COSMOCHIM AC, V56, P4109, DOI 10.1016/0016-7037(92)90023-C; CRONIN JR, 1990, GEOCHIM COSMOCHIM AC, V54, P2859, DOI 10.1016/0016-7037(90)90020-L; Ebel DS, 2007, METEORIT PLANET SCI, V42, P1627, DOI 10.1111/j.1945-5100.2007.tb00595.x; Ens TA, 2012, J ATMOS SOL-TERR PHY, V80, P208, DOI 10.1016/j.jastp.2012.01.018; Friedrich JM, 2002, METEORIT PLANET SCI, V37, P677, DOI 10.1111/j.1945-5100.2002.tb00847.x; Fries M, 2010, METEORIT PLANET SCI, V45, P1476, DOI 10.1111/j.1945-5100.2010.01115.x; Gattacceca J, 2004, EARTH PLANET SC LETT, V227, P377, DOI 10.1016/j.epsl.2004.09.013; Glavin DP, 2010, METEORIT PLANET SCI, V45, P1948, DOI 10.1111/j.1945-5100.2010.01132.x; Gounelle M., 2008, SOLAR SYSTEM NEPTUNE, P525; Grady MM, 2009, ASTRON GEOPHYS, V50, P21; Haack H, 2011, WORKSHOP ON THE FIRS, P9100; Haack H, 2012, METEORIT PLANET SCI, V47, P30, DOI 10.1111/j.1945-5100.2011.01311.x; HAQ M, 1989, GEOCHIM COSMOCHIM AC, V53, P1435, DOI 10.1016/0016-7037(89)90075-6; Heber VS, 2009, GEOCHIM COSMOCHIM AC, V73, P7414, DOI 10.1016/j.gca.2009.09.013; Jarosewich E, 1986, SMITHSONIAN CONTRIBU, V27, P1; Jenniskens P, 2012, METEORIT BULL, V46, P1; Leya I, 2000, METEORIT PLANET SCI, V35, P259, DOI 10.1111/j.1945-5100.2000.tb01775.x; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Macke RJ, 2011, METEORIT PLANET SCI, V46, P311, DOI 10.1111/j.1945-5100.2010.01155.x; MacPherson GJ, 2009, GEOCHIM COSMOCHIM AC, V73, P5493, DOI 10.1016/j.gca.2009.06.012; Monroe AA, 2011, GEOCHIM COSMOCHIM AC, V75, P7585, DOI 10.1016/j.gca.2011.09.041; Nesvorny D, 2010, ASTROPHYS J, V713, P816, DOI 10.1088/0004-637X/713/2/816; Nishiizumi K, 2009, METEORIT PLANET SCI, V44, pA158; Ott U, 2002, REV MINERAL GEOCHEM, V47, P71, DOI 10.2138/rmg.2002.47.3; Popova O, 2011, METEORIT PLANET SCI, V46, P1525, DOI 10.1111/j.1945-5100.2011.01247.x; Rochette P, 2008, METEORIT PLANET SCI, V43, P959, DOI 10.1111/j.1945-5100.2008.tb01092.x; Schmitt-Kopplin P, 2010, P NATL ACAD SCI USA, V107, P2763, DOI 10.1073/pnas.0912157107; Shaddad MH, 2010, METEORIT PLANET SCI, V45, P1557, DOI 10.1111/j.1945-5100.2010.01116.x; Silber EA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047633; Smith KD, 2004, SCIENCE, V305, P1277, DOI 10.1126/science.1101304; SPERGEL MS, 1986, J GEOPHYS RES-SOLID, V91, pD483, DOI 10.1029/JB091iB04p0D483; TONUI E, 2002, P NIPR S ANTARCTIC M, V15, P38; Tsuchiyama A, 2009, METEORIT PLANET SCI, V44, P5189; Walker RJ, 2002, GEOCHIM COSMOCHIM AC, V66, P4187, DOI 10.1016/S0016-7037(02)01003-7; Walsh K.J, 2012, PAPER PRESENTED AT T; Yin Q-Z, 2009, LUNAR PLANET SCI, VXL; Young ED, 1999, SCIENCE, V286, P1331, DOI 10.1126/science.286.5443.1331; Young ED, 1998, SCIENCE, V282, P452, DOI 10.1126/science.282.5388.452	47	173	173	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1583	1587		10.1126/science.1227163	http://dx.doi.org/10.1126/science.1227163			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258889	Green Submitted			2022-12-28	WOS:000312533100044
J	Li, ZY; Gadue, P; Chen, KF; Jiao, Y; Tuteja, G; Schug, J; Li, W; Kaestner, KH				Li, Zhaoyu; Gadue, Paul; Chen, Kaifu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Li, Wei; Kaestner, Klaus H.			Foxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation	CELL			English	Article							TRANSCRIPTION FACTORS; DNA METHYLATION; HIGH-RESOLUTION; GENOME; ENDODERM; PLURIPOTENT; ENHANCER; GENES; LIVER; MAPS	Nucleosome occupancy is fundamental for establishing chromatin architecture. However, little is known about the relationship between nucleosome dynamics and initial cell lineage specification. Here, we determine the mechanisms that control global nucleosome dynamics during embryonic stem (ES) cell differentiation into endoderm. Both nucleosome depletion and de novo occupation occur during the differentiation process, with higher overall nucleosome density after differentiation. The variant histone H2A.Z and the winged helix transcription factor Foxa2 both act to regulate nucleosome depletion and gene activation, thus promoting ES cell differentiation, whereas DNA methylation promotes nucleosome occupation and suppresses gene expression. Nucleosome depletion during ES cell differentiation is dependent on Nap1l1-coupled SWI/SNF and INO80 chromatin remodeling complexes. Thus, both epigenetic and genetic regulators cooperate to control nucleosome dynamics during ES cell fate decisions.	[Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Li, Zhaoyu; Jiao, Yang; Tuteja, Geetu; Schug, Jonathan; Kaestner, Klaus H.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Gadue, Paul] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Chen, Kaifu; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Div Biostat, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Baylor College of Medicine	Kaestner, KH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	kaestner@mail.med.upenn.edu		Li, Zhaoyu/0000-0002-1136-2758; Li, Wei/0000-0001-9931-5990	National Institute of Diabetes and Digestive and Kidney Diseases [P01-DK049210]; National Science and Engineering Research Council of Canada; Juvenile Diabetes Research Foundation; Cancer Prevention Research Institute of Texas [RP110471-C3]; NATIONAL CANCER INSTITUTE [R00CA168983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK049210, P30DK019525] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Shelley Berger for critical comments on the manuscript, and Alan Fox, Olga Smirnova, Matt Mansh, Aline Disimone, Karrie Brondell, Amber Riblett, and James LaRossa for excellent technical support. We thank Drs. Keji Zhao and Gangqing Hu (National Institutes of Health/National Heart, Lung, and Blood Institute) for helpful suggestions on computational analysis on our nucleosome data. We also thank Dr. Philip Streeter (Oregon) for kindly providing the ENDM1 (G10) antibody. This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (P01-DK049210 to K.H.K.). Z.L. was supported by National Science and Engineering Research Council of Canada and Juvenile Diabetes Research Foundation postdoctoral fellowship awards. This study was partially supported by the Cancer Prevention Research Institute of Texas (RP110471-C3 to W.L.). Z.L. and K.H.K. designed the experiments and wrote the manuscript. Z.L. performed the majority of experiments and computational analysis. P.G. and Y.J. did a part of the ES cell culture and sorting. K.C., W.L., G.T., and J.S. contributed to the computational analysis. K.H.K. directed the whole study.	Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kiefer JC, 2007, DEV DYNAM, V236, P1144, DOI 10.1002/dvdy.21094; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li ZY, 2011, NAT STRUCT MOL BIOL, V18, P742, DOI 10.1038/nsmb.2060; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MCPHERSON CE, 1993, CELL, V75, P387, DOI 10.1016/0092-8674(93)80079-T; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Morrison AJ, 2002, MOL CELL BIOL, V22, P856, DOI 10.1128/MCB.22.3.856-865.2002; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Shivaswamy S, 2008, PLOS BIOL, V6, P618, DOI 10.1371/journal.pbio.0060065; Tuteja G, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp536; Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108; Zaret K, 1999, DEV BIOL, V209, P1, DOI 10.1006/dbio.1999.9228	29	148	151	0	52	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1608	1616		10.1016/j.cell.2012.11.018	http://dx.doi.org/10.1016/j.cell.2012.11.018			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260146	Bronze, Green Accepted			2022-12-28	WOS:000312890300023
J	Tsai, BP; Hoverter, NP; Waterman, ML				Tsai, Becky P.; Hoverter, Nate P.; Waterman, Marian L.			Blending Hippo and WNT: Sharing Messengers and Regulation	CELL			English	Editorial Material							DOMAIN; TAZ	Two new studies reveal ways in which the Wnt pathway commandeers Hippo components for signaling. Azzolin et al. show how the Hippo transcription factor TAZ mediates Wnt signals, and Rosenbluh et al. show how beta-catenin and YAP1 form a kinase-regulated complex with transcription factor TBX5.	[Tsai, Becky P.; Hoverter, Nate P.; Waterman, Marian L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of California System; University of California Irvine	Waterman, ML (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	mlwaterm@uci.edu	Tsai, Becky/H-6568-2013	Tsai, Becky/0000-0002-1995-802X	NATIONAL CANCER INSTITUTE [R01CA096878, R21CA133275, R01CA108697, P30CA062203] Funding Source: NIH RePORTER; NCI NIH HHS [R21 CA133275, R01 CA108697, R01 CA096878, P30 CA062203] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azzolin L, 2012, CELL, V151, P1443, DOI 10.1016/j.cell.2012.11.027; Cheung HW, 2011, P NATL ACAD SCI USA, V108, P12372, DOI 10.1073/pnas.1109363108; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Imajo M, 2012, EMBO J, V31, P1109, DOI 10.1038/emboj.2011.487; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; SUDOL M, 1994, ONCOGENE, V9, P2145; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598	9	22	24	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1401	1403		10.1016/j.cell.2012.12.007	http://dx.doi.org/10.1016/j.cell.2012.12.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260132	Bronze			2022-12-28	WOS:000312890300006
J	Gravitz, L				Gravitz, Lauren			PHYSICAL SCIENTISTS TAKE ON CANCER	NATURE			English	Editorial Material																			0	7	7	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S49	S49		10.1038/491S49a	http://dx.doi.org/10.1038/491S49a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040RE	23320284	Bronze			2022-12-28	WOS:000311339800001
J	Mali, P; Yang, LH; Esvelt, KM; Aach, J; Guell, M; DiCarlo, JE; Norville, JE; Church, GM				Mali, Prashant; Yang, Luhan; Esvelt, Kevin M.; Aach, John; Guell, Marc; DiCarlo, James E.; Norville, Julie E.; Church, George M.			RNA-Guided Human Genome Engineering via Cas9	SCIENCE			English	Article							ZINC-FINGER NUCLEASES; SYNTHETIC BIOLOGY; MAMMALIAN-CELLS; GENE CORRECTION; IN-VIVO; SYSTEMS; CLEAVAGE; BACTERIA; IMMUNITY; SPECIFICITIES	Bacteria and archaea have evolved adaptive immune defenses, termed clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems, that use short RNA to direct degradation of foreign nucleic acids. Here, we engineer the type II bacterial CRISPR system to function with custom guide RNA (gRNA) in human cells. For the endogenous AAVS1 locus, we obtained targeting rates of 10 to 25% in 293T cells, 13 to 8% in K562 cells, and 2 to 4% in induced pluripotent stem cells. We show that this process relies on CRISPR components; is sequence-specific; and, upon simultaneous introduction of multiple gRNAs, can effect multiplex editing of target loci. We also compute a genome-wide resource of similar to 190 K unique gRNAs targeting similar to 40.5% of human exons. Our results establish an RNA-guided editing tool for facile, robust, and multiplexable human genome engineering.	[Mali, Prashant; Yang, Luhan; Aach, John; Guell, Marc; Norville, Julie E.; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esvelt, Kevin M.; Church, George M.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Cambridge, MA 02138 USA; [Yang, Luhan] Harvard Univ, Sch Med, Biol & Biomed Sci Program, Boston, MA 02115 USA; [DiCarlo, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Boston University	Church, GM (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	gchurch@genetics.med.harvard.edu	Güell, Marc/AAB-3054-2021; Güell, Marc/J-2970-2017; DiCarlo, James/AAJ-1579-2021; Wilson, Matthew H/K-3193-2013	Güell, Marc/0000-0003-4000-7912; Güell, Marc/0000-0003-4000-7912; DiCarlo, James/0000-0003-4728-3186; Norville, Julie/0000-0001-9205-8936; Esvelt, Kevin/0000-0001-8797-3945; church, george/0000-0001-6232-9969	NIH [P50 HG005550]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH grant P50 HG005550. We thank S. Kosuri for advice on the oligonucleotide pool designs and synthesis. G. M. C. and P. M. have filed a patent based on the findings of this study.	Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; King NMP, 2008, MOL THER, V16, P432, DOI 10.1038/mt.2008.13; Kosuri S, 2010, NAT BIOTECHNOL, V28, P1295, DOI 10.1038/nbt.1716; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Li HJ, 2011, NATURE, V475, P217, DOI 10.1038/nature10177; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; REBAR EJ, 1994, SCIENCE, V263, P671, DOI 10.1126/science.8303274; Sanjana NE, 2012, NAT PROTOC, V7, P171, DOI 10.1038/nprot.2011.431; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	28	5959	7005	118	3826	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					823	826		10.1126/science.1232033	http://dx.doi.org/10.1126/science.1232033			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23287722	Green Accepted			2022-12-28	WOS:000314874400050
J	Sun, LJ; Wu, JX; Du, FH; Chen, X; Chen, ZJJ				Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.			Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway	SCIENCE			English	Article							INTRACELLULAR DNA; INNATE; IDENTIFICATION; IMMUNITY; RANGE; GENE; RNA	The presence of DNA in the cytoplasm of mammalian cells is a danger signal that triggers host immune responses such as the production of type I interferons. Cytosolic DNA induces interferons through the production of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), which binds to and activates the adaptor protein STING. Through biochemical fractionation and quantitative mass spectrometry, we identified a cGAMP synthase (cGAS), which belongs to the nucleotidyltransferase family. Overexpression of cGAS activated the transcription factor IRF3 and induced interferon-beta in a STING-dependent manner. Knockdown of cGAS inhibited IRF3 activation and interferon-b induction by DNA transfection or DNA virus infection. cGAS bound to DNA in the cytoplasm and catalyzed cGAMP synthesis. These results indicate that cGAS is a cytosolic DNA sensor that induces interferons by producing the second messenger cGAMP.	[Sun, Lijun; Wu, Jiaxi; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Sun, Lijun; Du, Fenghe; Chen, Xiang; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Wu, Jiaxi/K-3322-2016; Chen, Zhijian/C-6039-2012	Wu, Jiaxi/0000-0002-6976-4784; Chen, Zhijian/0000-0002-8475-8251	NIH [AI-093967]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank W. Li for helpful discussion on bioinformatics analyses. The GenBank accession numbers for human and mouse cGAS sequences are KC294566 and KC294567, respectively. Supported by NIH grant AI-093967. Z.J.C. is an investigator of Howard Hughes Medical Institute.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Keating SE, 2011, TRENDS IMMUNOL, V32, P574, DOI 10.1016/j.it.2011.08.004; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; O'Neill LAJ, 2009, CELL, V138, P428, DOI 10.1016/j.cell.2009.07.021; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rigby RE, 2008, BIOESSAYS, V30, P833, DOI 10.1002/bies.20808; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yao YH, 2013, AUTOIMMUN REV, V12, P558, DOI 10.1016/j.autrev.2012.10.006; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	21	2353	2473	63	670	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 15	2013	339	6121					786	791		10.1126/science.1232458	http://dx.doi.org/10.1126/science.1232458			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	088YS	23258413	Green Accepted			2022-12-28	WOS:000314874400039
J	Kellermann, AL; Rivara, FP				Kellermann, Arthur L.; Rivara, Frederick P.			Silencing the Science on Gun Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOMICIDE; HOME		[Kellermann, Arthur L.] RAND, Washington, DC USA; [Rivara, Frederick P.] Univ Washington, Inst Child Hlth, Dept Pediat, Seattle, WA 98115 USA; [Rivara, Frederick P.] Seattle Childrens Hosp, Seattle, WA USA	RAND Corporation; University of Washington; University of Washington Seattle; Seattle Children's Hospital	Rivara, FP (corresponding author), Univ Washington, Inst Child Hlth, Dept Pediat, 6200 NE 74th St,Ste 120B, Seattle, WA 98115 USA.	fpr@uw.edu						Branas CC, 2009, AM J PUBLIC HEALTH, V99, P2034, DOI 10.2105/AJPH.2008.143099; Centers for Disease Control and Prevention, WEB BAS INJ STAT QUE; Congressional Research Service, AM WAR MIL OP CAS LI; Cummings P, 1997, AM J PUBLIC HEALTH, V87, P974, DOI 10.2105/AJPH.87.6.974; Farah MM, 1999, PEDIATRICS, V104, P1059, DOI 10.1542/peds.104.5.1059; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; Reimer DJ, WASHINGTON POST	7	128	128	0	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2013	309	6					549	550		10.1001/jama.2012.208207	http://dx.doi.org/10.1001/jama.2012.208207			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	087PH	23262635	Bronze			2022-12-28	WOS:000314773700023
J	Miossec, P				Miossec, Pierre			Kinase inhibition in rheumatoid arthritis: a big advance?	LANCET			English	Editorial Material							TOFACITINIB; PLACEBO		[Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, F-69437 Lyon, France; [Miossec, Pierre] Univ Lyon, Edouard Herriot Hosp, Immunogenom & Inflammat Res Unit, F-69437 Lyon, France	CHU Lyon; CHU Lyon	Miossec, P (corresponding author), Univ Lyon, Edouard Herriot Hosp, Dept Clin Immunol & Rheumatol, F-69437 Lyon, France.	miossec@univ-lyon1.fr						Burmester GR, 2013, LANCET; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Food and Drug Administration, 2012, FDA APPR XELJ RHEUM; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Maeshima K, 2012, ARTHRITIS RHEUM-US, V64, P1790, DOI 10.1002/art.34329; Maiga M, 2012, J INFECT DIS, V205, P1705, DOI 10.1093/infdis/jis269; Migita K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3333; Milici AJ, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2365; Miossec P, 2011, ANN RHEUM DIS, V70, P1713, DOI 10.1136/ard.2011.154252; Rosengren S, 2012, ANN RHEUM DIS, V71, P440, DOI 10.1136/ard.2011.150284; Sandborn WJ, 2012, NEW ENGL J MED, V367, P616, DOI 10.1056/NEJMoa1112168; van Vollenhoven RF, 2012, NEW ENGL J MED, V367, P508, DOI 10.1056/NEJMoa1112072	14	4	4	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 9	2013	381	9865					429	431		10.1016/S0140-6736(12)61722-X	http://dx.doi.org/10.1016/S0140-6736(12)61722-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	088CH	23294499				2022-12-28	WOS:000314810900008
J	Chan, AW; Tetzlaff, JM; Altman, DG; Laupacis, A; Gotzsche, PC; Krleza-Jeric, K; Hrobjartsson, A; Mann, H; Dickersin, K; Berlin, JA; Dore, CJ; Parulekar, WR; Summerskill, WSM; Groves, T; Schulz, KF; Sox, HC; Rockhold, FW; Rennie, D; Moher, D				Chan, An-Wen; Tetzlaff, Jennifer M.; Altman, Douglas G.; Laupacis, Andreas; Gotzsche, Peter C.; Krleza-Jeric, Karmela; Hrobjartsson, Asbjorn; Mann, Howard; Dickersin, Kay; Berlin, Jesse A.; Dore, Caroline J.; Parulekar, Wendy R.; Summerskill, William S. M.; Groves, Trish; Schulz, Kenneth F.; Sox, Harold C.; Rockhold, Frank W.; Rennie, Drummond; Moher, David			SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED-TRIALS; EMPIRICAL-EVIDENCE; REGISTRATION; PUBLICATIONS; GUIDELINE; DATABASE; ACCESS; BIAS	The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol. The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.	Univ Toronto, Womens Coll Res Inst, Womens Coll Hosp, St Michaels Hosp, Toronto, ON M5G 1N8, Canada; Univ Toronto, Keenan Res Ctr, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON M5G 1N8, Canada; Canadian Inst Hlth Res, Ottawa Methods Ctr, Ottawa Hosp Res Inst, Eth Off, Ottawa, ON K1H 8L6, Canada; Univ Ottawa, Ottawa, ON K1H 8M5, Canada; Univ Oxford, Ctr Stat Med, Oxford OX2 6UD, England; Rigshosp, Nord Cochrane Ctr, DK-2100 Copenhagen O, Denmark; Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Clin Trials, Baltimore, MD 21205 USA; Janssen Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Titusville, NJ 08560 USA; The Lancet, UK Med Res Council, Clin Trials Unit, London NW1 7BY, England; BMJ, London WC1H 9JP, England; Queens Univ, NCIC Clin Trials Grp, Canc Res Inst, Kingston, ON K7L 3N6, Canada; FHI 360, Quantitat Sci, Res Triangle Pk, NC 27713 USA; GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA; Univ Calif San Francisco, PR Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Womens College Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Institute for Work & Health; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Oxford; Rigshospitalet; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johnson & Johnson; Janssen Pharmaceuticals; Medical Research Council Clinical Trials Unit; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Queens University - Canada; Canadian Cancer Trials Group; FHI 360; GlaxoSmithKline; Dartmouth College; University of California System; University of California San Francisco	Chan, AW (corresponding author), Univ Toronto, Womens Coll Res Inst, Womens Coll Hosp, 790 Bay St, Toronto, ON M5G 1N8, Canada.	anwen.chan@utoronto.ca	Groves, Trish/A-9119-2009; Dore, Caroline J/J-4716-2012; Rockhold, Frank W./C-7078-2019; Campbell, John/A-5792-2011; Al-Boloushi, Zaid/D-3321-2016; Moher, David/I-3408-2019; Krleza-Jeric, Karmela/M-5253-2018	Groves, Trish/0000-0001-7915-6419; Dore, Caroline J/0000-0001-9796-4970; Rockhold, Frank W./0000-0003-3732-4765; Campbell, John/0000-0002-6752-3493; Al-Boloushi, Zaid/0000-0002-0842-1104; Moher, David/0000-0003-2434-4206; Krleza-Jeric, Karmela/0000-0001-9377-0917	Canadian Institutes of Health Research [DET-106068, MET-117434]; Canadian Cancer Society Research Institute; Canadian Agency for Drugs and Technologies in Health; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; MRC [MC_EX_G0800814] Funding Source: UKRI	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canadian Agency for Drugs and Technologies in Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support for the SPIRIT meetings was provided by the Canadian Institutes of Health Research (grant DET-106068), National Cancer Institute of Canada (now Canadian Cancer Society Research Institute), and Canadian Agency for Drugs and Technologies in Health. The Canadian Institutes of Health Research has also funded ongoing dissemination activities (grant MET-117434).	Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Altman DG, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-6; [Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; [Anonymous], 1998, ICH HARM TRIP GUID G; [Anonymous], 1997, ICH HARM TRIP GUID G; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Chan AW, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8013; Chan AW, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d80; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Coultas David, 2007, Proc Am Thorac Soc, V4, P194, DOI 10.1513/pats.200701-007GC; Dwan Kerry, 2011, Cochrane Database Syst Rev, pMR000031, DOI 10.1002/14651858.MR000031.pub2; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; European Commission, 2008, OFFICIAL J EUROPEAN, V51, P3; Getz KA, 2011, DRUG INF J, V45, P265, DOI 10.1177/009286151104500307; GlaxoSmithKline, 2011, GLOB PUBL POL ISS; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gotzsche PC, 2007, PLOS MED, V4, P47, DOI 10.1371/journal.pmed.0040019; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Groves T., 2009, BMJ GROUP BLOGS; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hopewell Sally, 2010, BMJ, V340, pc723, DOI 10.1136/bmj.c723; Hrobjartsson A, 2009, J CLIN EPIDEMIOL, V62, P967, DOI 10.1016/j.jclinepi.2009.04.003; International Conference on Harmonization, 1996, INT C HARM TECHN REQ; Jones G, 2004, BRIT MED J, V329, P1360, DOI 10.1136/bmj.329.7479.1360; Krleza-Jeric K, 2005, BMJ-BRIT MED J, V330, P956, DOI 10.1136/bmj.330.7497.956; Laine C, 2007, ANN INTERN MED, V147, P275, DOI 10.7326/0003-4819-147-4-200708210-00166; Lassere M, 2002, LANCET, V360, P1620, DOI 10.1016/S0140-6736(02)11652-7; Lundh A, 2011, LANCET, V378, P1995, DOI 10.1016/S0140-6736(11)61871-0; Mhaskar R, 2012, J CLIN EPIDEMIOL, V65, P602, DOI 10.1016/j.jclinepi.2011.10.016; Miller JD, 2010, JAMA-J AM MED ASSOC, V303, P773, DOI 10.1001/jama.2010.207; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Murray GD, 2001, BRIT MED J, V322, P1461; National Research Council, 2010, NAT CANC CLIN TRIALS; Pildal J, 2005, BMJ-BRIT MED J, V330, P1049, DOI 10.1136/bmj.38414.422650.8F; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Reveiz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012484; Scharf O, 2006, J CLIN ONCOL, V24, P3933, DOI 10.1200/JCO.2005.05.3959; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SIEGEL JP, 1990, NEW ENGL J MED, V323, P1355; Sim I, 2006, LANCET, V367, P1631, DOI 10.1016/S0140-6736(06)68708-4; Smyth RMD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7153; Summerskill W, 2009, LANCET, V373, P992, DOI 10.1016/S0140-6736(09)60590-0; Tetzlaff JM, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-43; Tetzlaff JM, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-176; Turner EH, 2004, PLOS MED, V1, P180, DOI 10.1371/journal.pmed.0010060; Turner Lucy, 2012, Syst Rev, V1, P60, DOI 10.1186/2046-4053-1-60; Wieseler B, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8141; World Medical Association, WMA DECL HELS ETH PR	49	2985	3036	13	127	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 5	2013	158	3					200	+		10.7326/0003-4819-158-3-201302050-00583	http://dx.doi.org/10.7326/0003-4819-158-3-201302050-00583			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	087JP	23295957	Green Accepted, Green Submitted			2022-12-28	WOS:000314757900007
J	Stankovic, KM; Eskandar, E; El Khoury, JB; Lev, MH; Sadow, PM				Stankovic, Konstantina M.; Eskandar, Emad; El Khoury, Joseph B.; Lev, Michael H.; Sadow, Peter M.			Case 2-2013: A 20-Year-Old Man with Recurrent Ear Pain, Fever, and Headache Cholesteatoma and cholesterol granuloma associated with chronic otitis media, with intracranial and extracranial complications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BACTERIOLOGY; ADULTS		[Stankovic, Konstantina M.; Sadow, Peter M.] Harvard Univ, Sch Med, Dept Otolaryngol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA; [Eskandar, Emad] Harvard Univ, Sch Med, Dept Neurosurg, Massachusetts Gen Hosp, Boston, MA 02115 USA; [El Khoury, Joseph B.] Harvard Univ, Sch Med, Dept Infect Dis, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Lev, Michael H.] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Eskandar, Emad] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [El Khoury, Joseph B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lev, Michael H.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sadow, Peter M.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Stankovic, Konstantina M.] Harvard Univ, Sch Med, Dept Otolaryngol, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital	Stankovic, KM (corresponding author), Harvard Univ, Sch Med, Dept Otolaryngol, Massachusetts Eye & Ear Infirm, Boston, MA 02115 USA.		Sadow, Peter/AAO-9878-2020; Sadow, Peter/E-7691-2015	Sadow, Peter/0000-0003-1036-6367; Sadow, Peter/0000-0003-1036-6367	Medtronic; GE Healthcare; Millennium Pharmaceuticals	Medtronic(Medtronic); GE Healthcare(General ElectricGE Healthcare); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd)	Dr. Eskandar reports receiving consulting fees from Medtronic; and Dr. Lev, research support from GE Healthcare and consulting fees from Millennium Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Albino AP, 1998, AM J OTOL, V19, P7; [Anonymous], 2007, N ENGL J MED, V357, P1957; Bernardini Gary L, 2004, Curr Neurol Neurosci Rep, V4, P448, DOI 10.1007/s11910-004-0067-8; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; BROOK I, 1979, JAMA-J AM MED ASSOC, V241, P487, DOI 10.1001/jama.241.5.487; CELIN SE, 1991, JAMA-J AM MED ASSOC, V266, P2249, DOI 10.1001/jama.266.16.2249; Desloge RB, 1997, AM J OTOL, V18, P155; Ghoshal UC, 2002, J GASTROEN HEPATOL, V17, P1331, DOI 10.1046/j.1440-1746.2002.02750.x; Harris JP, 2005, SURG EAR TEMPORAL BO, P219; Merchant SN, 2001, OTOL NEUROTOL, V22, P305, DOI 10.1097/00129492-200105000-00006; Penido Nde O, 2005, OTOLARYNGOL HEAD NEC, V132, P37; Rappaport JM, 1999, J INFECT DIS, V179, P264, DOI 10.1086/314531; RUPA V, 1991, ACTA OTO-LARYNGOL, V111, P530, DOI 10.3109/00016489109138379; Thornton M A, 2005, Ir Med J, V98, P206; Wenig BM, 2008, ATLAS HEAD NECK PATH, P732; Yeo SG, 2007, ACTA OTO-LARYNGOL, V127, P1062, DOI 10.1080/00016480601126978	16	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	2013	368	3					267	277		10.1056/NEJMcpc1200089	http://dx.doi.org/10.1056/NEJMcpc1200089			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070YG	23323904				2022-12-28	WOS:000313549900013
J	Chatterjee, S; Biondi-Zoccai, G; Abbate, A; D'Ascenzo, F; Castagno, D; Van Tassell, B; Mukherjee, D; Lichstein, E				Chatterjee, Saurav; Biondi-Zoccai, Giuseppe; Abbate, Antonio; D'Ascenzo, Fabrizio; Castagno, Davide; Van Tassell, Benjamin; Mukherjee, Debabrata; Lichstein, Edgar			Benefits of beta blockers in patients with heart failure and reduced ejection fraction: network meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED INTERVENTION TRIAL; LEFT-VENTRICULAR FUNCTION; METOPROLOL CR/XL; ELDERLY-PATIENTS; DOUBLE-BLIND; ADRENERGIC ANTAGONISTS; CLINICAL-OUTCOMES; TASK-FORCE; CARVEDILOL; MORTALITY	Objective To clarify whether any particular beta blocker is superior in patients with heart failure and reduced ejection fraction or whether the benefits of these agents are mainly due to a class effect. Design Systematic review and network meta-analysis of efficacy of different beta blockers in heart failure. Data sources CINAHL(1982-2011), Cochrane Collaboration Central Register of Controlled Trials (-2011), Embase (1980-2011), Medline/PubMed (1966-2011), and Web of Science (1965-2011). Study selection Randomized trials comparing beta blockers with other beta blockers or other treatments. Data extraction The primary endpoint was all cause death at the longest available follow-up, assessed with odds ratios and Bayesian random effect 95% credible intervals, with independent extraction by observers. Results 21 trials were included, focusing on atenolol, bisoprolol, bucindolol, carvedilol, metoprolol, and nebivolol. As expected, in the overall analysis, beta blockers provided credible mortality benefits in comparison with placebo or standard treatment after a median of 12 months (odds ratio 0.69, 0.56 to 0.80). However, no obvious differences were found when comparing the different beta blockers head to head for the risk of death, sudden cardiac death, death due to pump failure, or drug discontinuation. Accordingly, improvements in left ventricular ejection fraction were also similar irrespective of the individual study drug. Conclusion The benefits of beta blockers in patients with heart failure with reduced ejection fraction seem to be mainly due to a class effect, as no statistical evidence from current trials supports the superiority of any single agent over the others.	[Chatterjee, Saurav; Lichstein, Edgar] Maimonides Hosp, Div Internal Med, New York, NY USA; [Biondi-Zoccai, Giuseppe] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Abbate, Antonio; Van Tassell, Benjamin] VCU Pauley Heart Ctr, Richmond, VA USA; [D'Ascenzo, Fabrizio; Castagno, Davide] Univ Turin, Div Cardiol, Turin, Italy; [Mukherjee, Debabrata] Texas Tech Univ, Div Cardiol, El Paso, TX USA	Maimonides Medical Center; Sapienza University Rome; Virginia Commonwealth University; University of Turin; Texas Tech University System; Texas Tech University	Chatterjee, S (corresponding author), 40 Roger Williams Green Apt 40 RWG, Providence, RI 02904 USA.	sauravchatterjeemd@gmail.com	D'Ascenzo, Fabrizio/D-2447-2012; Abbate, Antonio/G-8805-2016; Abbate, Antonio/E-3405-2014; Mukherjee, Debabrata/AAG-1486-2019; Biondi-Zoccai, Giuseppe/C-9670-2012	D'Ascenzo, Fabrizio/0000-0002-6646-9317; Abbate, Antonio/0000-0002-1930-785X; Mukherjee, Debabrata/0000-0002-5131-3694; Biondi-Zoccai, Giuseppe/0000-0001-6103-8510; Castagno, Davide/0000-0001-8491-152X	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Biondi-Zoccai GGL, 2005, INT J EPIDEMIOL, V34, P224, DOI 10.1093/ije/dyh311; Bristow MR, 2011, CIRC RES, V109, P1176, DOI 10.1161/CIRCRESAHA.111.245092; Bristow MR, 1996, CIRCULATION, V94, P2807, DOI 10.1161/01.CIR.94.11.2807; BRISTOW MR, 1994, CIRCULATION, V89, P1632, DOI 10.1161/01.CIR.89.4.1632; BRODSKY MA, 1988, AM HEART J, V115, P799, DOI 10.1016/0002-8703(88)90882-4; Brophy JM, 2001, ANN INTERN MED, V134, P550, DOI 10.7326/0003-4819-134-7-200104030-00008; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Cirillo W, 2000, CIRCULATION, V101, P378, DOI 10.1161/01.CIR.101.4.378; Cleland JGF, 2003, LANCET, V362, P14, DOI 10.1016/S0140-6736(03)13801-9; Cohn J N, 1997, J Card Fail, V3, P173, DOI 10.1016/S1071-9164(97)90013-0; Colucci WS, 1996, CIRCULATION, V94, P2800, DOI 10.1161/01.CIR.94.11.2800; Deedwania PC, 2004, EUR HEART J, V25, P1300, DOI 10.1016/j.ehj.2004.05.022; Doughty RN, 1997, EUR HEART J, V18, P560; Edes I, 2005, EUR J HEART FAIL, V7, P631, DOI 10.1016/j.ejheart.2004.10.015; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011; Flather MD, 2005, EUR HEART J, V26, P215, DOI 10.1093/eurheartj/ehi118; Fonarow GC, 2008, J AM COLL CARDIOL, V52, P190, DOI 10.1016/j.jacc.2008.03.048; Fung JWH, 2002, EUR J HEART FAIL, V4, P489, DOI 10.1016/S1388-9842(02)00031-4; Go AS, 2007, AM J CARDIOL, V100, P690, DOI 10.1016/j.amjcard.2007.03.084; Go AS, 2008, ARCH INTERN MED, V168, P2415, DOI 10.1001/archinternmed.2008.506; Heidenreich PA, 1997, J AM COLL CARDIOL, V30, P27, DOI 10.1016/S0735-1097(97)00104-6; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Intengan HD, 2000, J CARDIOVASC PHARM, V35, P763, DOI 10.1097/00005344-200005000-00013; Jafri SM, 2004, HEART FAIL REV, V9, P115, DOI 10.1023/B:HREV.0000046366.31764.ca; Jessup M, 2009, J AM COLL CARDIOL, V53, P1343, DOI 10.1016/j.jacc.2008.11.009; Komajda M, 2004, EUR J HEART FAIL, V6, P467, DOI 10.1016/j.ejheart.2003.12.019; Lazarus DL, 2011, AM J CARDIOL, V107, P1196, DOI 10.1016/j.amjcard.2010.12.017; Lechat P, 1999, LANCET, V353, P9; LECHAT P, 1994, CIRCULATION, V90, P1765, DOI 10.1161/01.CIR.90.4.1765; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; MacGregor John F, 2009, Congest Heart Fail, V15, P5, DOI 10.1111/j.1751-7133.2008.00038.x; MacMahon S, 1997, LANCET, V349, P375; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Mochizuki M, 2007, J AM COLL CARDIOL, V49, P1722, DOI 10.1016/j.jacc.2007.01.064; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; O'Connor CM, 2011, J AM COLL CARDIOL, V58, P915, DOI 10.1016/j.jacc.2011.03.057; Packer M, 1996, CIRCULATION, V94, P2793, DOI 10.1161/01.CIR.94.11.2793; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Remme WJ, 2007, J AM COLL CARDIOL, V49, P963, DOI 10.1016/j.jacc.2006.10.059; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Sturm B, 2000, EUR J HEART FAIL, V2, P407, DOI 10.1016/S1388-9842(00)00120-3; Waagstein F, 2003, EUR J HEART FAIL, V5, P679, DOI 10.1016/S1388-9842(03)00105-3; WAAGSTEIN F, 1993, LANCET, V342, P1441, DOI 10.1016/0140-6736(93)92930-R; Wikstrand J, 2002, J AM COLL CARDIOL, V40, P491, DOI 10.1016/S0735-1097(02)01970-8; Willenheimer R, 2005, CIRCULATION, V112, P2426, DOI 10.1161/CIRCULATIONAHA.105.582320; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104	53	177	190	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2013	346								f55	10.1136/bmj.f55	http://dx.doi.org/10.1136/bmj.f55			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	075FI	23325883	Green Published, hybrid			2022-12-28	WOS:000313868800017
J	Prasad, V; Jena, AB				Prasad, Vinay; Jena, Anupam B.			Prespecified Falsification End Points Can They Validate True Observational Associations?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FRACTURES; RISK		[Prasad, Vinay] NCI, Med Oncol Branch, NIH, Bethesda, MD 20892 USA; [Jena, Anupam B.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Jena, Anupam B.] Natl Bur Econ Res, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Bureau of Economic Research	Jena, AB (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	jena@hcp.med.harvard.edu		Prasad, Vinayak/0000-0002-6110-8221				Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Ioannidis JPA, 2012, JAMA-J AM MED ASSOC, V308, P575, DOI 10.1001/jama.2012.8144; Jena AB, 2013, J GEN INTERN MED, V28, P223, DOI 10.1007/s11606-012-2211-5; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Park-Wyllie LY, 2011, JAMA-J AM MED ASSOC, V305, P783, DOI 10.1001/jama.2011.190; Thomas L, 2012, JAMA-J AM MED ASSOC, V308, P773, DOI 10.1001/jama.2012.9502	8	172	173	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2013	309	3					241	242		10.1001/jama.2012.96867	http://dx.doi.org/10.1001/jama.2012.96867			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	070XG	23321761				2022-12-28	WOS:000313546800021
J	Lewandowski, B; De Bo, G; Ward, JW; Papmeyer, M; Kuschel, S; Aldegunde, MJ; Gramlich, PME; Heckmann, D; Goldup, SM; D'Souza, DM; Fernandes, AE; Leigh, DA				Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.			Sequence-Specific Peptide Synthesis by an Artificial Small-Molecule Machine	SCIENCE			English	Article							MULTISTEP ORGANIC-SYNTHESIS; RIBOSOME NOBEL LECTURE; CHEMICAL LIGATION; ANTIBIOTICS; ROTAXANES; CATALYSTS	The ribosome builds proteins by joining together amino acids in an order determined by messenger RNA. Here, we report on the design, synthesis, and operation of an artificial small-molecule machine that travels along a molecular strand, picking up amino acids that block its path, to synthesize a peptide in a sequence-specific manner. The chemical structure is based on a rotaxane, a molecular ring threaded onto a molecular axle. The ring carries a thiolate group that iteratively removes amino acids in order from the strand and transfers them to a peptide-elongation site through native chemical ligation. The synthesis is demonstrated with similar to 10(18) molecular machines acting in parallel; this process generates milligram quantities of a peptide with a single sequence confirmed by tandem mass spectrometry.	[Lewandowski, Bartosz; De Bo, Guillaume; Ward, John W.; Papmeyer, Marcus; Kuschel, Sonja; Leigh, David A.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Aldegunde, Maria J.; Gramlich, Philipp M. E.; Heckmann, Dominik; Goldup, Stephen M.; D'Souza, Daniel M.; Fernandes, Antony E.; Leigh, David A.] Univ Edinburgh, Sch Chem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of Manchester; University of Edinburgh	Leigh, DA (corresponding author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	david.leigh@manchester.ac.uk	Ward, John/AAF-3691-2021; Goldup, Stephen M/M-3136-2014; Leigh, David/K-5965-2015; De Bo, Guillaume/C-5861-2013; Goldup, Stephen/F-1660-2011	Ward, John/0000-0001-7186-6416; Goldup, Stephen M/0000-0003-3781-0464; Leigh, David/0000-0002-1202-4507; De Bo, Guillaume/0000-0003-2670-6370; Goldup, Stephen/0000-0003-3781-0464; Fernandes, Antony/0000-0002-7993-2980; Lewandowski, Bartosz/0000-0002-0342-4701	Engineering and Physical Sciences Research Council (UK); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique; Wallonie-Bruxelles International; European Union; Deutscher Akademischer Austausch Dienst; Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council [EP/H021620/2, EP/H021620/1] Funding Source: researchfish; EPSRC [EP/H021620/1, EP/H021620/2] Funding Source: UKRI	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Fundacja na Rzecz Nauki Polskiej; Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Wallonie-Bruxelles International; European Union(European Commission); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Akademia der Naturforscher Leopoldina; Peter und Traudl Engelhorn-Stiftung; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank V. Aucagne for useful suggestions during early versions of the molecular machine design. This research was funded by the Engineering and Physical Sciences Research Council (UK). We are grateful to the following organizations for postdoctoral fellowships: Fundacja na Rzecz Nauki Polskiej (to B. L.), Fonds de la Recherche Scientifique and Wallonie-Bruxelles International (to G. D. B.), the European Union 7th Framework Marie Curie Intra European Fellowship Program (to M.J.A.), Deutscher Akademischer Austausch Dienst (to P. M. E. G. and D. H.), and Deutsche Akademia der Naturforscher Leopoldina and Peter und Traudl Engelhorn-Stiftung (to D.M.D.).	Aucagne V, 2006, J AM CHEM SOC, V128, P2186, DOI 10.1021/ja056903f; Badi N, 2009, CHEM SOC REV, V38, P3383, DOI 10.1039/b806413j; Berg JM, 2006, BIOCHEMISTRY; Berna J, 2005, NAT MATER, V4, P704, DOI 10.1038/nmat1455; Blanco V, 2012, ANGEW CHEM INT EDIT, V51, P5166, DOI 10.1002/anie.201201364; Collier CP, 1999, SCIENCE, V285, P391, DOI 10.1126/science.285.5426.391; Crowley JD, 2009, CHEM SOC REV, V38, P1530, DOI 10.1039/b804243h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Green JE, 2007, NATURE, V445, P414, DOI 10.1038/nature05462; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Hansen FK, 2011, ORG BIOMOL CHEM, V9, P7162, DOI 10.1039/c1ob05740e; He Y, 2011, J AM CHEM SOC, V133, P9972, DOI 10.1021/ja201361t; He Y, 2010, NAT NANOTECHNOL, V5, P778, DOI [10.1038/nnano.2010.190, 10.1038/NNANO.2010.190]; Juluri BK, 2009, ACS NANO, V3, P291, DOI 10.1021/nn8002373; Kay ER, 2007, ANGEW CHEM INT EDIT, V46, P72, DOI 10.1002/anie.200504313; McKee ML, 2012, J AM CHEM SOC, V134, P1446, DOI 10.1021/ja2101196; McKee ML, 2010, ANGEW CHEM INT EDIT, V49, P7948, DOI 10.1002/anie.201002721; Monnereau C, 2010, J AM CHEM SOC, V132, P1529, DOI 10.1021/ja908524x; Muraoka T, 2006, NATURE, V440, P512, DOI 10.1038/nature04635; Payne RJ, 2007, J AM CHEM SOC, V129, P13527, DOI 10.1021/ja073653p; Ramakrishnan V, 2010, ANGEW CHEM INT EDIT, V49, P4355, DOI 10.1002/anie.201001436; Schmittel M, 2012, ANGEW CHEM INT EDIT, V51, P3832, DOI 10.1002/anie.201108089; Sieber SA, 2005, CHEM REV, V105, P715, DOI 10.1021/cr0301191; Steitz TA, 2010, ANGEW CHEM INT EDIT, V49, P4381, DOI 10.1002/anie.201000708; Thordarson P, 2003, NATURE, V424, P915, DOI 10.1038/nature01925; Wang JB, 2011, SCIENCE, V331, P1429, DOI 10.1126/science.1199844; WURTHNER F, 1995, ANGEW CHEM INT EDIT, V34, P446, DOI 10.1002/anie.199504461; Yonath A, 2010, ANGEW CHEM INT EDIT, V49, P4340, DOI 10.1002/anie.201001297; Yoon HJ, 2010, SCIENCE, V330, P66, DOI 10.1126/science.1193928	30	520	527	12	582	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 11	2013	339	6116					189	193		10.1126/science.1229753	http://dx.doi.org/10.1126/science.1229753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	067XI	23307739	Green Submitted			2022-12-28	WOS:000313328200040
J	Kasting, JF				Kasting, James F.			How Was Early Earth Kept Warm?	SCIENCE			English	Editorial Material							GREENHOUSE; ATMOSPHERE; CLIMATE		Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kasting, JF (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	jfk4@psu.edu	Kasting, James/AAF-6851-2020					BORYSOW A, 1986, ASTROPHYS J, V303, P495, DOI 10.1086/164096; Dauphas N, 2011, NATURE, V474, pE2, DOI 10.1038/nature09960; Driese SG, 2011, PRECAMBRIAN RES, V189, P1, DOI 10.1016/j.precamres.2011.04.003; Goldblatt C, 2009, NAT GEOSCI, V2, P891, DOI 10.1038/NGEO692; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; KASTING JF, 1987, PRECAMBRIAN RES, V34, P205, DOI 10.1016/0301-9268(87)90001-5; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; MCKAY CP, 1991, SCIENCE, V253, P1118, DOI 10.1126/science.11538492; Pierrehumbert R, 2011, ASTROPHYS J LETT, V734, DOI 10.1088/2041-8205/734/1/L13; Rosing MT, 2010, NATURE, V464, P744, DOI 10.1038/nature08955; Sheldon ND, 2006, PRECAMBRIAN RES, V147, P148, DOI 10.1016/j.precamres.2006.02.004; Wordsworth R, 2013, SCIENCE, V339, P64, DOI 10.1126/science.1225759	13	12	12	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 4	2013	339	6115					44	45		10.1126/science.1232662	http://dx.doi.org/10.1126/science.1232662			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23288532				2022-12-28	WOS:000312985800045
J	van der Meer, AJ; Veldt, BJ; Feld, JJ; Wedemeyer, H; Dufour, JF; Lammert, F; Duarte-Rojo, A; Heathcote, EJ; Manns, MP; Kuske, L; Zeuzem, S; Hofmann, WP; de Knegt, RJ; Hansen, BE; Janssen, HLA				van der Meer, Adriaan J.; Veldt, Bart J.; Feld, Jordan J.; Wedemeyer, Heiner; Dufour, Jean-Francois; Lammert, Frank; Duarte-Rojo, Andres; Heathcote, E. Jenny; Manns, Michael P.; Kuske, Lorenz; Zeuzem, Stefan; Hofmann, W. Peter; de Knegt, Robert J.; Hansen, Bettina E.; Janssen, Harry L. A.			Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATOCELLULAR-CARCINOMA INCIDENCE; RECOMBINANT INTERFERON-ALPHA; HCV-RELATED CIRRHOSIS; PLUS RIBAVIRIN; PEGINTERFERON ALPHA-2A; THERAPY; TELAPREVIR; STEATOSIS; OUTCOMES; IMPACT	Context Chronic hepatitis C virus (HCV) infection outcomes include liver failure, hepatocellular carcinoma (HCC), and liver-related death. Objective To assess the association between sustained virological response (SVR) and all-cause mortality in patients with chronic HCV infection and advanced hepatic fibrosis. Design, Setting, and Patients An international, multicenter, long-term follow-up study from 5 large tertiary care hospitals in Europe and Canada of 530 patients with chronic HCV infection who started an interferon-based treatment regimen between 1990 and 2003, following histological proof of advanced hepatic fibrosis or cirrhosis (Ishak score 4-6). Complete follow-up ranged between January 2010 and October 2011. Main Outcome Measures All-cause mortality. Secondary outcomes were liver failure, HCC, and liver-related mortality or liver transplantation. Results The 530 study patients were followed up for a median (interquartile range [IQR]) of 8.4 (6.4-11.4) years. The baseline median (IQR) age was 48 (42-56) years and 369 patients (70%) were men. The Ishak fibrosis score was 4 in 143 patients (27%), Sin 101 patients (19%), and 6 in 286 patients (54%). There were 192 patients (36%) who achieved SVR; 13 patients with SVR and 100 without SVR died (10-year cumulative all-cause mortality rate, 8.9% [95% Cl, 3.3%-14.5%] with SVR and 26.0% [95% Cl, 20.2%-28.4%] without SVR; P<.001). In time-dependent multivariate Cox regression analysis, SVR was associated with reduced risk of all-cause mortality (hazard ratio [HR], 0.26; 95% Cl, 0.14-0.49; P<.001) and reduced risk of liver-related mortality or transplantation (HR, 0.06; 95% Cl, 0.02-0.19; P<.001), the latter occurring in 3 patients with SVR and 103 without SVR. The 10-year cumulative incidence rate of liver-related mortality or transplantation was 1.9% (95% Cl, 0.0%-4.1%) with SVR and 27.4% (95% Cl, 22.0%-32.8%) without SVR (P<.001). There were 7 patients with SVR and 76 without SVR who developed HCC (10-year cumulative incidence rate, 5.1%; 95% Cl, 1.3%-8.9%; vs 21.8%; 95% Cl, 16.6%-27.0%; P<.001), and 4 patients with SVR and 111 without SVR experienced liver failure (10-year cumulative incidence rate, 2.1%; 95% CI, 0.0%-4.5%; vs 29.9%; 95% Cl, 24.3%-35.5%; P<.001). Conclusion Among patients with chronic HCV infection and advanced hepatic fibrosis, sustained virological response to interferon-based treatment was associated with lower all-cause mortality. JAMA. 2012;308(24):2584-2593 www.jama.com	[van der Meer, Adriaan J.; Veldt, Bart J.; de Knegt, Robert J.; Hansen, Bettina E.; Janssen, Harry L. A.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-3015 CE Rotterdam, Netherlands; [Feld, Jordan J.; Duarte-Rojo, Andres; Heathcote, E. Jenny] Toronto Western Hosp, Ctr Liver, Univ Hlth Network, Toronto, ON M5T 2S8, Canada; [Wedemeyer, Heiner; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany; [Dufour, Jean-Francois; Kuske, Lorenz] Univ Bern, Dept Clin Res, Bern, Switzerland; [Lammert, Frank] Univ Saarland, Med Ctr, Dept Med, Homburg, Germany; [Zeuzem, Stefan; Hofmann, W. Peter] Klinikum Johann Wolfgang Goethe Univ, Med Klin 1, Frankfurt, Germany	Erasmus University Rotterdam; Erasmus MC; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Hannover Medical School; University of Bern; Saarland University; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Janssen, HLA (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, S Gravendijkwal 230,Room Ha 204, NL-3015 CE Rotterdam, Netherlands.	h.janssen@erasmusmc.nl	Dufour, Jean Francois Jacques/AAL-9866-2020; Zeuzem, Stefan/AAE-7435-2019; Feld, Jordan/AAH-5628-2020; De Knegt, Robert/X-4629-2019; Hansen, Bettina E/P-5468-2014	Dufour, Jean Francois Jacques/0000-0002-8062-1346; Feld, Jordan/0000-0003-2640-2211; De Knegt, Robert/0000-0003-0934-6975; Hansen, Bettina E/0000-0001-8307-3341	GlaxoSmithKline; Hoffmann-LaRoche; Merck; Gilead; Tibotec; Abbott; Vertex; Clinical Care Options; Roche; MSD; Novartis; Bristol Myers Squibb; Hoffman-LaRoche; Janssen; Boehringer Ingelheim	GlaxoSmithKline(GlaxoSmithKline); Hoffmann-LaRoche(Hoffmann-La Roche); Merck(Merck & Company); Gilead(Gilead Sciences); Tibotec; Abbott(Abbott Laboratories); Vertex(Vertex Pharmaceuticals); Clinical Care Options; Roche(Roche Holding); MSD; Novartis(Novartis); Bristol Myers Squibb(Bristol-Myers Squibb); Hoffman-LaRoche; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Boehringer Ingelheim(Boehringer Ingelheim)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Veldt reported receiving financial compensation for a board membership at GlaxoSmithKline. Dr Feld reported receiving financial compensation for consultancy, lecture, and development of educational presentation activities from Hoffmann-LaRoche, Merck, Gilead, Tibotec, Abbott, Vertex, and Clinical Care Options. Dr Wedemeyer reported receiving financial compensation for consultancy and/or lecture activities from Roche, MSD, Abbott, Novartis, Bristol Myers Squibb, and Gilead, and his institution received research grants from Roche, Merck Sharp & Dohme, Abbott, Novartis, Bristol Myers Squibb, and Gilead. Dr Duarte-Rojo reported receiving financial compensation for fees for participation in review activities from Gilead. Dr Heathcote reported that her institution received a research grant from Hoffman-LaRoche. Dr Manns reported receiving financial compensation for consultancy and/or lecture activities from Roche, Bristol Myers Squibb, Gilead, Boehringer Ingelheim, Novartis, Merck, Janssen, and GlaxoSmithKline, and research grants from Roche, Gilead, Novartis, Boehringer Ingelheim, Bristol Myers Squibb, Merck, and Janssen. Dr Zeuzem reported receiving financial compensation for consultancy and/or lecture activities from Abbott, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Gilead, Merck, Novartis, Roche, Santaris, Janssen, and Vertex. Dr Hofmann reported receiving financial compensation for lecture activities from Roche, Merck Sharp & Dohme, Bristol Myers Squibb, Gilead, and Janssen. Dr de Knegt reported that his institution received financial compensation for consultancy and/or lecture activities or patents from Merck, Janssen, Roche, Gilead, and Medtronic, and research grants from Merck and Roche. DrJanssen reported receiving financial compensation for consultancy activities and/or payment for lectures from Roche, Merck, Abbott, Santaris, Anadys, Medtronic, Tibotec, Bristol Myers Squibb, and Gilead, and that his institution received research grants from Roche, Merck, Abbott, Santaris, Anadys, Medtronic, and Tibotec. All financial activities were reported to fall outside of this study. No other authors disclosed any financial conflicts.	[Anonymous], 2002, AG TABL 1995 2000; Backus LI, 2011, CLIN GASTROENTEROL H, V9, P509, DOI 10.1016/j.cgh.2011.03.004; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Buti M, 2005, J HEPATOL, V42, P639, DOI 10.1016/j.jhep.2004.12.031; Cardoso AC, 2010, J HEPATOL, V52, P652, DOI 10.1016/j.jhep.2009.12.028; Centers for Disease Control and Prevention, 2012, HEP C PROP EXP TEST; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; DIBISCEGLIE AM, 1989, NEW ENGL J MED, V321, P1506, DOI 10.1056/NEJM198911303212204; Fernandez-Rodriguez CM, 2010, AM J GASTROENTEROL, V105, P2164, DOI 10.1038/ajg.2010.294; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gronbaek K, 2002, J VIRAL HEPATITIS, V9, P443, DOI 10.1046/j.1365-2893.2002.00389.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Little R. J. A., 1987, STAT ANAL MISSING DA; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Morgan TR, 2010, HEPATOLOGY, V52, P833, DOI 10.1002/hep.23744; Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x; Ohata K, 2003, CANCER-AM CANCER SOC, V97, P3036, DOI 10.1002/cncr.11427; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Probst A, 2011, J VIRAL HEPATITIS, V18, P745, DOI 10.1111/j.1365-2893.2011.01481.x; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Veldt BJ, 2005, J HEPATOL, V42, P225	30	1126	1151	1	61	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	2012	308	24					2584	2593		10.1001/jama.2012.144878	http://dx.doi.org/10.1001/jama.2012.144878			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	062JR	23268517	Bronze			2022-12-28	WOS:000312916600024
J	Chen, X; Gu, ZC; Liu, ZX; Wen, XG				Chen, Xie; Gu, Zheng-Cheng; Liu, Zheng-Xin; Wen, Xiao-Gang			Symmetry-Protected Topological Orders in Interacting Bosonic Systems	SCIENCE			English	Article								Symmetry-protected topological (SPT) phases are bulk-gapped quantum phases with symmetries, which have gapless or degenerate boundary states as long as the symmetries are not broken. The SPT phases in free fermion systems, such as topological insulators, can be classified; however, it is not known what SPT phases exist in general interacting systems. We present a systematic way to construct SPT phases in interacting bosonic systems. Just as group theory allows us to construct 230 crystal structures in three-dimensional space, we use group cohomology theory to systematically construct different interacting bosonic SPT phases in any dimension and with any symmetry, leading to the discovery of bosonic topological insulators and superconductors.	[Wen, Xiao-Gang] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Chen, Xie] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Chen, Xie; Liu, Zheng-Xin; Wen, Xiao-Gang] MIT, Dept Phys, Cambridge, MA 02139 USA; [Gu, Zheng-Cheng] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Liu, Zheng-Xin; Wen, Xiao-Gang] Tsinghua Univ, Inst Adv Study, Beijing 100084, Peoples R China	Perimeter Institute for Theoretical Physics; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; Tsinghua University	Wen, XG (corresponding author), Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada.	xwen@perimeterinstitute.ca	Gu, Zheng-Cheng/L-5415-2014; Liu, Zheng-Xin/B-9911-2015	Liu, Zheng-Xin/0000-0002-8594-6350; Wen, Xiao-Gang/0000-0002-5874-581X	NSF [DMR-1005541, PHY05-51164]; NSFC [11074140]	NSF(National Science Foundation (NSF)); NSFC(National Natural Science Foundation of China (NSFC))	This research is supported by NSF grant DMR-1005541 and NSFC 11074140. Z.-C.G. is supported by NSF grant PHY05-51164.	AFFLECK I, 1988, COMMUN MATH PHYS, V115, P477, DOI 10.1007/BF01218021; Bernevig BA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.106802; Chen X, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235141; Chen X, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.035107; Fidkowski L, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075103; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Gu ZC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155131; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.226801; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Kitaev A, 2009, AIP CONF PROC, V1134, P22, DOI 10.1063/1.3149495; Landau L. D., 1958, STAT PHYS COURSE THE, V5; Levin M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115109; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Ryu S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/6/065010; Schuch N, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165139; Turner AM, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.075102; Wen X. G., 1990, International Journal of Modern Physics B, V4, P239, DOI 10.1142/S0217979290000139; WESS J, 1971, PHYS LETT B, VB 37, P95, DOI 10.1016/0370-2693(71)90582-X; WITTEN E, 1983, NUCL PHYS B, V223, P422, DOI 10.1016/0550-3213(83)90063-9	23	418	421	5	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 21	2012	338	6114					1604	1606		10.1126/science.1227224	http://dx.doi.org/10.1126/science.1227224			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	057AE	23258892	Green Submitted			2022-12-28	WOS:000312533100048
J	Plotnikov, SV; Pasapera, AM; Sabass, B; Waterman, CM				Plotnikov, Sergey V.; Pasapera, Ana M.; Sabass, Benedikt; Waterman, Clare M.			Force Fluctuations within Focal Adhesions Mediate ECM-Rigidity Sensing to Guide Directed Cell Migration	CELL			English	Article							PAXILLIN PHOSPHORYLATION; VINCULIN RECRUITMENT; MATRIX; KINASE; GROWTH; LAMELLIPODIA; CHEMOTAXIS; PHENOTYPE; DYNAMICS; ARP2/3	Cell migration toward areas of higher extracellular matrix (ECM) rigidity via a process called "durotaxis" is thought to contribute to development, immune response, and cancer metastasis. To understand how cells sample ECM rigidity to guide durotaxis, we characterized cell-generated forces on the nanoscale within single mature integrin-based focal adhesions (FAs). We found that individual FAs act autonomously, exhibiting either stable or dynamically fluctuating ("tugging") traction. We show that a FAK/phosphopaxillin/vinculin pathway is essential for high FA traction and to enable tugging FA traction over a broad range of ECM rigidities. We show that tugging FA traction is dispensable for FA maturation, chemotaxis, and haptotaxis but is critical to direct cell migration toward rigid ECM. We conclude that individual FAs dynamically sample rigidity by applying fluctuating pulling forces to the ECM to act as sensors to guide durotaxis, and that FAK/phosphopaxillin/vinculin signaling defines the rigidity range over which this dynamic sensing process operates.	[Plotnikov, Sergey V.; Pasapera, Ana M.; Waterman, Clare M.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20892 USA; [Sabass, Benedikt] Univ Stuttgart, Inst Theoret Phys, D-70550 Stuttgart, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Stuttgart	Waterman, CM (corresponding author), NHLBI, Cell Biol & Physiol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	watermancm@nhlbi.nih.gov	Sabass, Benedikt/N-1431-2017	Sabass, Benedikt/0000-0002-7769-8043; Waterman, Clare/0000-0001-6142-6775; Plotnikov, Sergey/0000-0002-5561-8890	Division of Intramural Research, National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005104] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Mary Beckerle for mouse embryonic fibroblasts, Michael Davidson for mApple paxillin, William Shin for support of the Waterman Lab microscopes, Sharon Campbell and Robert Fischer for helpful suggestions, and the NHLBI flow cytometry core facility. This research was supported by the Division of Intramural Research, National Heart Lung and Blood Institute.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; de Rooij J, 2005, J CELL BIOL, V171, P153, DOI 10.1083/jcb.200506152; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Dumbauld DW, 2010, BIOL CELL, V102, P203, DOI 10.1042/BC20090104; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fabry B, 2011, BIOPHYS J, V101, P2131, DOI 10.1016/j.bpj.2011.09.043; Flanagan LA, 2002, NEUROREPORT, V13, P2411, DOI 10.1097/00001756-200212200-00007; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462; Koch D, 2012, BIOPHYS J, V102, P452, DOI 10.1016/j.bpj.2011.12.025; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Landau L.D., 1970, THEORY ELASTICITY; Mandeville JTH, 1997, J LEUKOCYTE BIOL, V61, P188, DOI 10.1002/jlb.61.2.188; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Nicolas A, 2004, P NATL ACAD SCI USA, V101, P12520, DOI 10.1073/pnas.0403539101; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Raz-Ben Aroush D, 2006, ADV MATER, V18, P1537, DOI 10.1002/adma.200600372; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sabass B, 2008, BIOPHYS J, V94, P207, DOI 10.1529/biophysj.107.113670; Schneider IC, 2009, MOL BIOL CELL, V20, P3155, DOI 10.1091/mbc.E09-03-0219; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Suraneni P, 2012, J CELL BIOL, V197, P239, DOI 10.1083/jcb.201112113; Ulrich TA, 2009, CANCER RES, V69, P4167, DOI 10.1158/0008-5472.CAN-08-4859; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wolfenson H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004304; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Wu CY, 2012, CELL, V148, P973, DOI 10.1016/j.cell.2011.12.034; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	552	560	17	249	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1513	1527		10.1016/j.cell.2012.11.034	http://dx.doi.org/10.1016/j.cell.2012.11.034			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260139	Green Accepted, Bronze			2022-12-28	WOS:000312890300016
J	Polo, JM; Anderssen, E; Walsh, RM; Schwarz, BA; Nefzger, CM; Lim, SM; Borkent, M; Apostolou, E; Alaei, S; Cloutier, J; Bar-Nur, O; Cheloufi, S; Stadtfeld, M; Figueroa, ME; Robinton, D; Natesan, S; Melnick, A; Zhu, JF; Ramaswamy, S; Hochedlinger, K				Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Nefzger, Christian M.; Lim, Sue Mei; Borkent, Marti; Apostolou, Effie; Alaei, Sara; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Figueroa, Maria Eugenia; Robinton, Daisy; Natesan, Sridaran; Melnick, Ari; Zhu, Jinfang; Ramaswamy, Sridhar; Hochedlinger, Konrad			A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells	CELL			English	Article							PLURIPOTENT STEM-CELLS; MOUSE; EXPRESSION; FIBROBLASTS; INDUCTION; DISCOVERY	Factor-induced reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) is inefficient, complicating mechanistic studies. Here, we examined defined intermediate cell populations poised to becoming iPSCs by genome-wide analyses. We show that induced pluripotency elicits two transcriptional waves, which are driven by c-Myc/Klf4 (first wave) and Oct4/Sox2/Klf4 (second wave). Cells that become refractory to reprogramming activate the first but fail to initiate the second transcriptional wave and can be rescued by elevated expression of all four factors. The establishment of bivalent domains occurs gradually after the first wave, whereas changes in DNA methylation take place after the second wave when cells acquire stable pluripotency. This integrative analysis allowed us to identify genes that act as roadblocks during reprogramming and surface markers that further enrich for cells prone to forming iPSCs. Collectively, our data offer new mechanistic insights into the nature and sequence of molecular events inherent to cellular reprogramming.	[Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Anderssen, Endre; Walsh, Ryan M.; Schwarz, Benjamin A.; Borkent, Marti; Apostolou, Effie; Cloutier, Jennifer; Bar-Nur, Ori; Cheloufi, Sihem; Stadtfeld, Matthias; Robinton, Daisy; Ramaswamy, Sridhar; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Polo, Jose M.; Nefzger, Christian M.; Lim, Sue Mei; Alaei, Sara] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic 3800, Australia; [Polo, Jose M.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Anderssen, Endre; Ramaswamy, Sridhar] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Borkent, Marti] Erasmus MC, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands; [Figueroa, Maria Eugenia; Melnick, Ari] Weill Cornell Med Coll, Dept Med, Div Hematol Oncol, New York, NY 10065 USA; [Natesan, Sridaran] Sanofi Aventis, Cambridge, MA 02139 USA; [Zhu, Jinfang] NIAID, NIH, Bethesda, MD 20892 USA; [Hochedlinger, Konrad] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Monash University; Australian Regenerative Medicine Institute; Monash University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Erasmus University Rotterdam; Erasmus MC; Cornell University; Sanofi-Aventis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Ramaswamy, S (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	sridhar@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu	Bar-Nur, Ori/GWQ-5917-2022; Zhu, Jinfang/B-7574-2012; Figueroa, Maria/AAE-8662-2019; Melnick, Ari/AAA-5763-2020; Apostolou, Effie/AAG-1559-2020	Zhu, Jinfang/0000-0002-0117-4745; Polo, Jose M/0000-0002-2531-778X; Lim, Sue Mei/0000-0001-8287-5756; Alaei, Sara/0000-0003-4897-6339; Cheloufi, Sihem/0000-0002-1726-4796; Nefzger, Christian/0000-0003-4631-5633; Cloutier, Jennifer/0000-0003-3462-0307; Figueroa, Maria Eugenia/0000-0003-4887-4981; Stadtfeld, Matthias/0000-0002-5852-9906	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH [DP2OD003266, R01HD058013]; HHMI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	ECOR postdoctoral fellowship; Monash Larkins Program; NHMRC CDF(National Health and Medical Research Council (NHMRC) of AustraliaUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Hochedlinger and Ramaswamy labs for helpful suggestions and critical reading of the manuscript. We thank Laura Prickett and Kat Folz-Donahue at the MGH/HSCI flow cytometry core and Flowcore Monash for expert cell sorting; Paul Lacaze, Danielle Evans, and Michelle Garred at Millenium Science for support with the Fluidigm experiments; and Lucy Dagostino from Lifetech Australia for help in miRNA assays. We are grateful to Ben Wittner for help with formatting and uploading genome-wide data. Support to J.M.P. was from an ECOR postdoctoral fellowship, Monash Larkins Program, and a NHMRC CDF. J.Z. was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, USA. K.H. was supported by the NIH (DP2OD003266 and R01HD058013). S.R. was supported by an HHMI Physican-Scientist Early Career Award.	Aranda-Orgilles B., 2012, CELL STEM CELL; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buganim Y, 2012, CELL, V150, P1209, DOI 10.1016/j.cell.2012.08.023; Carey BW, 2011, CELL STEM CELL, V9, P588, DOI 10.1016/j.stem.2011.11.003; Chang CQ, 2008, BIOINFORMATICS, V24, P1349, DOI 10.1093/bioinformatics/btn131; Chen JK, 2011, CELL RES, V21, P205, DOI 10.1038/cr.2010.172; Hansson J., 2012, CELL REP IN PRESS; Huo J.S., 2012, BIOCH BIOPHYS ACTA; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kudo T, 2004, MOL CELL BIOL, V24, P4221, DOI 10.1128/MCB.24.10.4221-4228.2004; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wu SM, 2011, NAT CELL BIOL, V13, P497, DOI 10.1038/ncb0511-497; Yang CS, 2011, STEM CELLS, V29, P1528, DOI 10.1002/stem.717	26	599	614	8	192	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 21	2012	151	7					1617	1632		10.1016/j.cell.2012.11.039	http://dx.doi.org/10.1016/j.cell.2012.11.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260147	Green Accepted, Bronze			2022-12-28	WOS:000312890300024
J	Gotzsche, PC				Gotzsche, Peter C.			Deficiencies in proposed new EU regulation of clinical trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS		Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen O, Denmark	Rigshospitalet	Gotzsche, PC (corresponding author), Rigshosp, Nord Cochrane Ctr, Dept 7811, DK-2100 Copenhagen O, Denmark.	pcg@cochrane.dk						Andrade M, 2009, BMJ-BRIT MED J, V339, P538; Angell M., 2004, TRUTH DRUG CO THEY D; BLUMENTHAL DS, 1974, ARCH GEN PSYCHIAT, V31, P214; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Caldwell B, 2006, J ROY SOC MED, V99, P132, DOI 10.1258/jrsm.99.3.132; Chan AW, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2299; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; European Medicines Agency, 2012, ACC CLIN TRIAL DAT T; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1645, DOI 10.1001/jama.295.14.1645; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Gotzsche PC, 2006, BMJ-BRIT MED J, V333, P231, DOI 10.1136/bmj.38895.410451.79; Gotzsche PC, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-249; Gotzsche PC, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2686; Healy D, 2004, THEM EAT PROZAC; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jureidini JN, 2001, ACCOUNT RES, V18, P45; Jureidini JN, 2008, INT J RISK SAF MED, V29, P73, DOI DOI 10.3233/JRS-2008-0426; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Nielsen M, 2012, ADDICTION, V107, P900, DOI 10.1111/j.1360-0443.2011.03686.x; Prayle AP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d7373; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233	22	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 20	2012	345								e8522	10.1136/bmj.e8522	http://dx.doi.org/10.1136/bmj.e8522			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	059JI	23258926				2022-12-28	WOS:000312700600011
J	Jonietz, E				Jonietz, Erika			MECHANICS The forces of cancer	NATURE			English	Editorial Material													Jain, Rakesh K/I-1384-2017; Munn, Lance L/L-3950-2016	Jain, Rakesh K/0000-0001-7571-3548; Munn, Lance L/0000-0003-0698-7232				Baker EL, 2009, BIOPHYS J, V97, P1013, DOI 10.1016/j.bpj.2009.05.054; Fallica B, 2011, INTEGR BIOL-UK, V3, P529, DOI 10.1039/c0ib00142b; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476	4	53	53	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 22	2012	491	7425					S56	S57		10.1038/491S56a	http://dx.doi.org/10.1038/491S56a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	040RE	23320288	Bronze			2022-12-28	WOS:000311339800005
J	Vesikari, T; Esposito, S; Prymula, R; Ypma, E; Kohl, I; Toneatto, D; Dull, P; Kimura, A				Vesikari, Timo; Esposito, Susanna; Prymula, Roman; Ypma, Ellen; Kohl, Igor; Toneatto, Daniela; Dull, Peter; Kimura, Alan		EU Meningococcal B Infant Vaccine	Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials	LANCET			English	Article							BINDING PROTEIN; CONVULSIONS; STRAINS; FEBRILE; FEVER; YOUNG	Background Meningococcal serogroup B disease disproportionately affects infants. We assessed lot-to-lot consistency, safety and immunogenicity, and the effect of concomitant vaccination on responses to routine vaccines of an investigational multicomponent vaccine (4CMenB) in this population. Methods We did primary and booster phase 3 studies between March 31, 2008, and Aug 16, 2010, in 70 sites in Europe. We used two series of sponsor-supplied, computer-generated randomisation envelopes to allocate healthy 2 month-old infants to receive routine vaccinations (diphtheria-tetanus-acellular pertussis, inactivated poliovirus, hepatitis B plus Haemophilus influenzae type b, and seven-valent pneumococcal vaccine) wat 2, 4, and 6 months of age alone, or concomitantly with 4CMenB or serogroup C conjugate vaccine (MenC) in: 1) an open-label, lot-to-lot immunogenicity and safety substudy of three 4CMenB lots compared with routine vaccines alone (1:1:1:1, block size eight); or 2) an observer-blind, lot-to-lot safety substudy of three 4CMenB lots compared with MenC (1:1:1:3, block size six). At 12 months, 4CMenB-primed children from either substudy were randomised (1:1, block size two) to receive 4CMenB booster, with or without measles-mumps-rubella-varicella (MMRV) vaccine. Immunogenicity was assessed by serum bactericidal assay with human complement (hSBA) against serogroup B test strains, and on randomly selected subsets of serum samples for routine vaccines; laboratory personnel were masked to assignment. The first coprimary outcome was lot-to-lot consistency (hSBA geometric mean ratio of all lots between 0.5 and 2.0), and the second was an immune response (hSBA titre >= 5) for each of the three strains. The primary outcome for the booster study was immune response to booster dose. Immunogenicity data for 4CMenB were for the modified intention-to-treat population, including all infants from the open-label substudy who provided serum samples. The safety population included all participants who contributed safety data after at least one dose of study vaccine. These trials are registered with ClinicalTrials.gov, numbers NCT00657709 and NCT00847145. Findings We enrolled 2627 infants in the open-label phase, 1003 in the observer-blind phase, and 1555 in the booster study. Lot-to-lot consistency was shown for the three 4CMenB lots, with the lowest 95% lower confidence limit being 0.74 and the highest upper limit being 1.33. Of 1181-1184 infants tested 1 month after three 4CMenB doses (all lots pooled), 100% (95% CI 99-100) had hSBA titres of 5 or more against strains selective for factor H binding protein and neisserial adhesin A, and 84% (82-86) for New Zealand outer-membrane vesicle. In a subset (n=100), 84% (75-91) of infants had hSBA titres of 5 or more against neisseria heparin binding antigen. At 12 months of age, waning titres were boosted by a fourth dose, such that 95-100% of children had hSBA titres of 5 or more for all antigens, with or without concomitant MMRV. Immune responses to routine vaccines were much the same with or without concomitant 4CMenB, but concomitant vaccination was associated with increased reactogenicity. 77% (1912 of 2478) of infants had fever of 38.5 degrees C or higher after any 4CMenB dose, compared with 45% (295 of 659) after routine vaccines alone and 47% (228 of 490) with MenC, but only two febrile seizures were deemed probably related to 4CMenB. Interpretation 4CMenB is immunogenic in infants and children aged 12 months with no clinically relevant interference with routine vaccines, but increases reactogenicity when administered concomitantly with routine vaccines. This breakthrough vaccine offers an innovative solution to the major remaining cause of bacterial meningitis in infant and toddlers.	[Vesikari, Timo] Univ Tampere, Sch Med, Tampere 33014, Finland; [Esposito, Susanna] Univ Milan, Pediat Clin, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Prymula, Roman] Univ Hosp Hradec Kralove, Hradec Kralove, Czech Republic; [Ypma, Ellen; Kohl, Igor; Toneatto, Daniela; Dull, Peter; Kimura, Alan] Novartis Vaccines & Diagnost, Cambridge, MA USA	Tampere University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University Hospital Hradec Kralove; Novartis	Vesikari, T (corresponding author), Univ Tampere, Sch Med, Vaccine Res Ctr, Tampere 33014, Finland.	timo.vesikari@uta.fi	Esposito, Susanna/K-3475-2016; Prymula, Roman/AEG-7401-2022	Esposito, Susanna/0000-0003-4103-2837; Prymula, Roman/0000-0003-1567-2259	Novartis Vaccines and Diagnostics	Novartis Vaccines and Diagnostics	Funding Novartis Vaccines and Diagnostics.	Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Dinleyici Ener Cagri, 2010, Expert Rev Vaccines, V9, P1017, DOI 10.1586/erv.10.86; Donnelly J, 2011, 11 EUR MEN DIS SOC E; Donnelly J, 2010, P NATL ACAD SCI USA, V107, P19490, DOI 10.1073/pnas.1013758107; Santolaya ME, 2012, LANCET, V379, P617, DOI 10.1016/S0140-6736(11)61713-3; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Fischer TK, 2007, PEDIATR INFECT DIS J, V26, P411, DOI 10.1097/01.inf.0000259964.47941.00; Frasch CE, 2009, VACCINE, V27, pB112, DOI 10.1016/j.vaccine.2009.04.065; Giuliani MM, 2006, P NATL ACAD SCI USA, V103, P10834, DOI 10.1073/pnas.0603940103; Giuliani MM, 2010, VACCINE, V28, P5023, DOI 10.1016/j.vaccine.2010.05.014; Gossger N, 2012, JAMA-J AM MED ASSOC, V307, P575; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Heuclin T, 2009, J PEDIATR-US, V155, P695, DOI 10.1016/j.jpeds.2009.04.058; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Knuf M, 2006, PEDIATR INFECT DIS J, V25, P12, DOI 10.1097/01.inf.0000195626.35239.58; Lucidarme J, 2011, CLIN VACCINE IMMUNOL, V18, P194, DOI 10.1128/CVI.00401-10; Marcy SM, 2004, VACCINE, V22, P551, DOI 10.1016/j.vaccine.2003.09.007; Marshall HS, 2012, PEDIATR INFECT DIS J, V31, P1061, DOI 10.1097/INF.0b013e31826327e4; McNicholas A, 2007, HUM VACCINES, V3, P196, DOI 10.4161/hv.3.5.4458; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Oster P, 2007, VACCINE, V25, P3075, DOI 10.1016/j.vaccine.2007.01.023; Sadarangani M, 2010, LANCET INFECT DIS, V10, P112, DOI 10.1016/S1473-3099(09)70324-X; Santos GF, 2009, CLIN VACCINE IMMUNOL, V16, P1693, DOI 10.1128/CVI.00125-09; Serruto D, 2010, P NATL ACAD SCI USA, V107, P3770, DOI 10.1073/pnas.0915162107; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Tan LKK, 2010, NEW ENGL J MED, V362, P1511, DOI 10.1056/NEJMra0906357; Tappero JW, 1999, JAMA-J AM MED ASSOC, V281, P1520, DOI 10.1001/jama.281.16.1520; VANDENBERG BJ, 1969, PEDIATR RES, V3, P298, DOI 10.1203/00006450-196907000-00005; VERITY CM, 1985, BRIT MED J, V290, P1307, DOI 10.1136/bmj.290.6478.1307	32	198	206	0	45	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 9	2013	381	9869					825	835		10.1016/S0140-6736(12)61961-8	http://dx.doi.org/10.1016/S0140-6736(12)61961-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	105IL	23324563				2022-12-28	WOS:000316060600032
J	Paull, D; Emmanuele, V; Weiss, KA; Treff, N; Stewart, L; Hua, HQ; Zimmer, M; Kahler, DJ; Goland, RS; Noggle, SA; Prosser, R; Hirano, M; Sauer, MV; Egli, D				Paull, Daniel; Emmanuele, Valentina; Weiss, Keren A.; Treff, Nathan; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Goland, Robin S.; Noggle, Scott A.; Prosser, Robert; Hirano, Michio; Sauer, Mark V.; Egli, Dieter			Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants	NATURE			English	Article							MEIOTIC SPINDLE; HUMAN EMBRYOS; CELL-LINES; STEM-CELLS; MOUSE; SEGREGATION; MTDNA; VITRIFICATION; MICROTUBULES; DEFICIENCY	Mitochondrial DNA mutations transmitted maternally within the oocyte cytoplasm often cause life-threatening disorders. Here we explore the use of nuclear genome transfer between unfertilized oocytes of two donors to prevent the transmission of mitochondrial mutations. Nuclear genome transfer did not reduce developmental efficiency to the blastocyst stage, and genome integrity was maintained provided that spontaneous oocyte activation was avoided through the transfer of incompletely assembled spindle-chromosome complexes. Mitochondrial DNA transferred with the nuclear genome was initially detected at levels below 1%, decreasing in blastocysts and stem-cell lines to undetectable levels, and remained undetectable after passaging for more than one year, clonal expansion, differentiation into neurons, cardiomyocytes or beta-cells, and after cellular reprogramming. Stem cells and differentiated cells had mitochondrial respiratory chain enzyme activities and oxygen consumption rates indistinguishable from controls. These results demonstrate the potential of nuclear genome transfer to prevent the transmission of mitochondrial disorders in humans.	[Paull, Daniel; Weiss, Keren A.; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Noggle, Scott A.; Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY 10032 USA; [Emmanuele, Valentina; Hirano, Michio] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Treff, Nathan] Reprod Med Associates New Jersey, Morristown, NJ 07960 USA; [Hua, Haiqing; Goland, Robin S.] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY 10032 USA; [Prosser, Robert; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY 10019 USA; [Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY 10032 USA	The New York Stem Cell Foundation; Columbia University; Reproductive Medicine Associates of New Jersey; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Lab, New York, NY 10032 USA.	mvs9@columbia.edu; d.egli@nyscf.org	Kahler, David J/I-9275-2019	Kahler, David J/0000-0002-7144-2215; Noggle, Scott/0000-0002-0374-2240	New York Stem Cell Foundation; New York State Stem Cell Science award [C026184]; Bernard and Anne Spitzer Fund	New York Stem Cell Foundation; New York State Stem Cell Science award; Bernard and Anne Spitzer Fund	We thank S. Chang and K. Eggan for discussions, Z. Hall for critical reading of the manuscript, and L. Yu and O. Nahum for SNP-array preparation. We thank anonymous oocyte donors for participating in research, and M. Spencer for a Lykos laser system. This work was supported by the New York Stem Cell Foundation, the New York State Stem Cell Science award C026184, and the Bernard and Anne Spitzer Fund.	ASRM, 2012, FERTIL STERIL; Bai RK, 2004, CLIN CHEM, V50, P996, DOI 10.1373/clinchem.2004.031153; Bianchi V, 2005, HUM REPROD, V20, P1078, DOI 10.1093/humrep/deh736; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; BRINKLEY BR, 1975, ANN NY ACAD SCI, V253, P428, DOI 10.1111/j.1749-6632.1975.tb19218.x; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Craven L, 2010, NATURE, V465, P82, DOI 10.1038/nature08958; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DIMAURO S, 1987, ANN NEUROL, V22, P498, DOI 10.1002/ana.410220409; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Forman EJ, 2012, FERTIL STERIL, V98, P644, DOI 10.1016/j.fertnstert.2012.04.028; Fujikura J, 2012, DIABETOLOGIA, V55, P1689, DOI 10.1007/s00125-012-2508-2; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; GOOK DA, 1994, HUM REPROD, V9, P684, DOI 10.1093/oxfordjournals.humrep.a138572; Hyun CS, 2007, HUM REPROD, V22, P1991, DOI 10.1093/humrep/dem124; INOUE S, 1975, BIOPHYS J, V15, P725, DOI 10.1016/S0006-3495(75)85850-4; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; Kim K, 2007, SCIENCE, V315, P482, DOI 10.1126/science.1133542; Larman MG, 2007, REPROD BIOMED ONLINE, V15, P692, DOI 10.1016/S1472-6483(10)60537-8; Lee HS, 2012, CELL REP, V1, P506, DOI 10.1016/j.celrep.2012.03.011; Lin DPC, 2004, FERTIL STERIL, V81, P73, DOI 10.1016/j.fertnstert.2003.05.005; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; Meirelles FV, 1998, GENETICS, V148, P877; Mimaki M, 2010, ANN NEUROL, V68, P845, DOI 10.1002/ana.22111; Noggle S, 2011, NATURE, V478, P70, DOI 10.1038/nature10397; Nuffield Council on Bioethics, 2012, NOV TECHN PREV MIT D; Rosenwaks Z, 2010, NAT MED, V16, P645, DOI 10.1038/nm0610-645; SATHANANTHAN AH, 1991, P NATL ACAD SCI USA, V88, P4806, DOI 10.1073/pnas.88.11.4806; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Sharpley MS, 2012, CELL, V151, P333, DOI 10.1016/j.cell.2012.09.004; Soc As Reprod Tech Amer Reprod Med, 2004, FERTIL STERIL, V81, P1207, DOI 10.1016/j.fertnstert.2004.01.017; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Tachibana M, 2010, NAT PROTOC, V5, P1138, DOI 10.1038/nprot.2010.75; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang Jing, 2011, Curr Protoc Hum Genet, VChapter 19, DOI 10.1002/0471142905.hg1906s68	47	173	186	1	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 31	2013	493	7434					632	+		10.1038/nature11800	http://dx.doi.org/10.1038/nature11800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	080CU	23254936	Green Accepted			2022-12-28	WOS:000314219600048
J	Bumbarger, DJ; Riebesell, M; Rodelsperger, C; Sommer, RJ				Bumbarger, Daniel J.; Riebesell, Metta; Roedelsperger, Christian; Sommer, Ralf J.			System-wide Rewiring Underlies Behavioral Differences in Predatory and Bacterial-Feeding Nematodes	CELL			English	Article							CAENORHABDITIS-ELEGANS; NERVOUS-SYSTEM; PRISTIONCHUS-PACIFICUS; NEURAL CIRCUIT; PHARYNX; RECONSTRUCTION; INTERNEURONS; SENSITIVITY; CENTRALITY; PHYSIOLOGY	The relationship between neural circuit function and patterns of synaptic connectivity is poorly understood, in part due to a lack of comparative data for larger complete systems. We compare system-wide maps of synaptic connectivity generated from serial transmission electron microscopy for the pharyngeal nervous systems of two nematodes with divergent feeding behavior: the microbivore Caenorhabditis elegans and the predatory nematode Pristionchus pacificus. We uncover a massive rewiring in a complex system of identified neurons, all of which are homologous based on neurite anatomy and cell body position. Comparative graph theoretical analysis reveals a striking pattern of neuronal wiring with increased connectional complexity in the anterior pharynx correlating with tooth-like denticles, a morphological feature in the mouth of P. pacificus. We apply focused centrality methods to identify neurons I1 and I2 as candidates for regulating predatory feeding and predict substantial divergence in the function of pharyngeal glands.	[Bumbarger, Daniel J.; Riebesell, Metta; Roedelsperger, Christian; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de			Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	This work was funded by the Max-Planck Society. We are grateful for the technical advice of H. Schwarz and M. Flotenmeyer on electron microscopy. D. Hall and S. Emmons provided valuable insight into C. elegans anatomy and synaptic connectivity. A. Cardona's support and response to feedback in developing TrakEM2 has been very important in accelerating our progress. Methodology benefited from discussions with K. Borgwardt and others. We thank T. Ott, B. Eberhart, J. Nordt, J. Neuner, D. Kazempour, and A. Seitz for assistance in 3D segmentation of the data.	ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; Altun ZF, 2009, DEV DYNAM, V238, P1936, DOI 10.1002/dvdy.22025; Anderson JR, 2011, J MICROSC-OXFORD, V241, P13, DOI 10.1111/j.1365-2818.20.10.03402.x; AVERY L, 1989, NEURON, V3, P473, DOI 10.1016/0896-6273(89)90206-7; Baldwin JG, 2004, NEMATOLOGY, V6, P623, DOI 10.1163/1568541042843559; Baltzley MJ, 2010, J COMP PHYSIOL A, V196, P181, DOI 10.1007/s00359-010-0503-y; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Bastian M, 2009, INT AAAI C WEBL SOC; Bento G, 2010, NATURE, V466, P494, DOI 10.1038/nature09164; Bock DD, 2011, NATURE, V471, P177, DOI 10.1038/nature09802; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Brownlee D, 2000, ADV PARASIT, V45, P109, DOI 10.1016/S0065-308X(00)45004-9; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; CHALFIE M, 1985, J NEUROSCI, V5, P956; Chiang JTA, 2006, J EXP BIOL, V209, P1859, DOI 10.1242/jeb.02165; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Costa LD, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00006; De Carlos JA, 2007, BRAIN RES REV, V55, P8, DOI 10.1016/j.brainresrev.2007.03.010; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Denk W, 2012, NAT REV NEUROSCI, V13, P351, DOI 10.1038/nrn3169; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Eisenberg E, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.138701; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Franks Christopher J., 2006, Invertebrate Neuroscience, V6, P105, DOI 10.1007/s10158-006-0023-1; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; HALL DH, 1991, J NEUROSCI, V11, P1; HALL DH, 1987, ANN NY ACAD SCI, V494, P215, DOI 10.1111/j.1749-6632.1987.tb29527.x; Harris G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021897; Hayworth K., 2006, MICROSCOPY MICROA S2, V12, P86, DOI [10.1017/s1431927606066268, DOI 10.1017/S1431927606066268]; Hendricks M, 2012, NATURE, V487, P99, DOI 10.1038/nature11081; Heymann JAW, 2006, J STRUCT BIOL, V155, P63, DOI 10.1016/j.jsb.2006.03.006; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jurrus E., 2012, NEUROINFORMATICS; Kanzaki N, 2012, ZOOL SCI, V29, P403, DOI 10.2108/zsj.29.403; Katsuki T, 2011, DEV NEUROBIOL, V71, P458, DOI 10.1002/dneu.20859; Keane J, 2003, GENETICS, V164, P153; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lichtman JW, 2011, SCIENCE, V334, P618, DOI 10.1126/science.1209168; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Lu J, 2009, PLOS BIOL, V7, P265, DOI 10.1371/journal.pbio.1000032; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newcomb JM, 2009, P R SOC B, V276, P99, DOI 10.1098/rspb.2008.0683; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Page L, 1999, PAGERANK CITATION RA, DOI DOI 10.1109/IISWC.2012.6402911; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Rae R, 2008, J EXP BIOL, V211, P1927, DOI 10.1242/jeb.014944; Rivard L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-22; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saideman SR, 2007, J NEUROSCI, V27, P6664, DOI 10.1523/JNEUROSCI.0315-07.2007; Sakurai A, 2011, CURR BIOL, V21, P1036, DOI 10.1016/j.cub.2011.04.040; Schlager B, 2009, GENESIS, V47, P300, DOI 10.1002/dvg.20499; Seung S., 2012, CONNECTOME BRAINS WI; SHAW SR, 1989, VISUAL NEUROSCI, V3, P405, DOI 10.1017/S0952523800005903; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sommer Ralf J, 2006, WormBook, P1; Sommer RJ, 2006, DEVELOPMENT, V133, P2451, DOI 10.1242/dev.02425; Sporns O., 2010, NETWORKS BRAIN; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suthram S, 2005, NATURE, V438, P108, DOI 10.1038/nature04135; Tahseen Q, 2004, NEMATOLOGY, V6, P49, DOI 10.1163/156854104323072919; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; von Lieven AF, 2003, ZOOLOGY, V106, P183, DOI 10.1078/0944-2006-00115; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	75	93	94	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 17	2013	152	1-2					109	119		10.1016/j.cell.2012.12.013	http://dx.doi.org/10.1016/j.cell.2012.12.013			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23332749	Bronze			2022-12-28	WOS:000313719800010
J	Stroud, H; Greenberg, MVC; Feng, SH; Bernatavichute, YV; Jacobsen, SE				Stroud, Hume; Greenberg, Maxim V. C.; Feng, Suhua; Bernatavichute, Yana V.; Jacobsen, Steven E.			Comprehensive Analysis of Silencing Mutants Reveals Complex Regulation of the Arabidopsis Methylome	CELL			English	Article							NOVO DNA METHYLATION; LOCUS-SPECIFIC CONTROL; RNA-POLYMERASES IV; TRANSPOSABLE ELEMENTS; THALIANA; GENES; CHROMATIN; GENOME; METHYLTRANSFERASE; HETEROCHROMATIN	Cytosine methylation is involved in various biological processes such as silencing of transposable elements (TEs) and imprinting. Multiple pathways regulate DNA methylation in different sequence contexts, but the factors that regulate DNA methylation at a given site in the genome largely remain unknown. Here we have surveyed the methylomes of a comprehensive list of 86 Arabidopsis gene silencing mutants by generating single-nucleotide resolution maps of DNA methylation. We find that DNA methylation is site specifically regulated by different factors. Furthermore, we have identified additional regulators of DNA methylation. These data and analyses will serve as a comprehensive community resource for further understanding the control of DNA methylation patterning.	[Stroud, Hume; Greenberg, Maxim V. C.; Feng, Suhua; Bernatavichute, Yana V.; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Stroud, Hume/ABF-1325-2021	Greenberg, Maxim/0000-0001-9935-8763	NIH [GM60398]; NSF [0701745, 1121245]; Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship; US Public Health Service National Research Service Award [GM07104]; UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship; US Public Health Service National Research Service Award(United States Department of Health & Human ServicesUnited States Public Health Service); UCLA Dissertation Year Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Akhavan for Illumina sequencing; S. Cokus, W. Yan, and M. Pellegrini for help with the UCSC browser; X. Zhang for MNase protocols; and H. Vaucheret, X. Chen, C. Dean, M. Matzke, R. Amasino, X. Zhong, and L. Johnson for seeds. Sequencing was performed at the UCLA BSCRC Bio-Sequencing Core Facility. This work was supported by NIH grant GM60398 and NSF grants 0701745 and 1121245. H.S. was supported by a Fred Eiserling and Judith Lengyel Graduate Doctorate Fellowship. M.V.C.G. was supported by US Public Health Service National Research Service Award GM07104 and a UCLA Dissertation Year Fellowship. S.F. is a Special Fellow of the Leukemia and Lymphoma Society. S.E.J. is an investigator of the Howard Hughes Medical Institute.	Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Baurle I, 2007, SCIENCE, V318, P109, DOI 10.1126/science.1146565; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Berr A, 2010, PLANT CELL, V22, P3232, DOI 10.1105/tpc.110.079962; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Earley KW, 2010, GENE DEV, V24, P1119, DOI 10.1101/gad.1914110; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Feng SH, 2011, METHODS MOL BIOL, V733, P223, DOI 10.1007/978-1-61779-089-8_16; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Greenberg MVC, 2011, EPIGENETICS-US, V6, P344, DOI 10.4161/epi.6.3.14242; Gu XF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002366; Guo L, 2010, P NATL ACAD SCI USA, V107, P18557, DOI 10.1073/pnas.1010478107; Haag JR, 2011, NAT REV MOL CELL BIO, V12, P483, DOI 10.1038/nrm3152; He XJ, 2009, GENE DEV, V23, P318, DOI 10.1101/gad.1765209; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu XC, 2012, PLANT PHYSIOL, V158, P119, DOI 10.1104/pp.111.184275; Lu FL, 2011, NAT GENET, V43, P715, DOI 10.1038/ng.854; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Miura A, 2009, EMBO J, V28, P1078, DOI 10.1038/emboj.2009.59; Onodera Y, 2008, GENETICS, V180, P207, DOI 10.1534/genetics.108.090621; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontvianne F, 2010, ADV BOT RES, V53, P1, DOI 10.1016/S0065-2296(10)53001-5; Roudier F, 2011, EMBO J, V30, P1928, DOI 10.1038/emboj.2011.103; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Schotta G, 2003, GENETICA, V117, P149, DOI 10.1023/A:1022923508198; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; Tariq M, 2003, P NATL ACAD SCI USA, V100, P8823, DOI 10.1073/pnas.1432939100; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; To TK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002055; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Voinnet O, 2008, TRENDS PLANT SCI, V13, P317, DOI 10.1016/j.tplants.2008.05.004; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Weinhofer I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001152; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zheng BL, 2009, GENE DEV, V23, P2850, DOI 10.1101/gad.1868009; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhong XH, 2012, NAT STRUCT MOL BIOL, V19, P870, DOI 10.1038/nsmb.2354	53	555	566	8	148	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 17	2013	152	1-2					352	364		10.1016/j.cell.2012.10.054	http://dx.doi.org/10.1016/j.cell.2012.10.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	073CA	23313553	Green Accepted, Bronze			2022-12-28	WOS:000313719800029
J	Menting, JG; Whittaker, J; Margetts, MB; Whittaker, LJ; Kong, GKW; Smith, BJ; Watson, CJ; Zakova, L; Kletvikova, E; Jiracek, J; Chan, SJ; Steiner, DF; Dodson, GG; Brzozowski, AM; Weiss, MA; Ward, CW; Lawrence, MC				Menting, John G.; Whittaker, Jonathan; Margetts, Mai B.; Whittaker, Linda J.; Kong, Geoffrey K. -W.; Smith, Brian J.; Watson, Christopher J.; Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri; Chan, Shu Jin; Steiner, Donald F.; Dodson, Guy G.; Brzozowski, Andrzej M.; Weiss, Michael A.; Ward, Colin W.; Lawrence, Michael C.			How insulin engages its primary binding site on the insulin receptor	NATURE			English	Article							1ST 3 DOMAINS; DIABETES-ASSOCIATED MUTATIONS; LIGAND-INDUCED ACTIVATION; MOLECULAR REPLACEMENT; PROTEIN; AFFINITY; MODEL; REFINEMENT; PEPTIDE; ELEMENT	Insulin receptor signalling has a central role in mammalian biology, regulating cellular metabolism, growth, division, differentiation and survival(1,2). Insulin resistance contributes to the pathogenesis of type 2 diabetes mellitus and the onset of Alzheimer's disease(3); aberrant signalling occurs in diverse cancers, exacerbated by crosstalk with the homologous type 1 insulin-like growth factor receptor (IGF1R)(4). Despite more than three decades of investigation, the three-dimensional structure of the insulin-insulin receptor complex has proved elusive, confounded by the complexity of producing the receptor protein. Here we present the first view, to our knowledge, of the interaction of insulin with its primary binding site on the insulin receptor, on the basis of four crystal structures of insulin bound to truncated insulin receptor constructs. The direct interaction of insulin with the first leucine-rich-repeat domain (L1) of insulin receptor is seen to be sparse, the hormone instead engaging the insulin receptor carboxy-terminal alpha-chain (alpha CT) segment, which is itself remodelled on the face of L1 upon insulin binding. Contact between insulin and L1 is restricted to insulin B-chain residues. The aCT segment displaces the B-chain C-terminal beta-strand away from the hormone core, revealing the mechanism of a long-proposed conformational switch in insulin upon receptor engagement. This mode of hormone-receptor recognition is novel within the broader family of receptor tyrosine kinases(5). We support these findings by photo-crosslinking data that place the suggested interactions into the context of the holoreceptor and by isothermal titration calorimetry data that dissect the hormone-insulin receptor interface. Together, our findings provide an explanation for a wealth of biochemical data from the insulin receptor and IGF1R systems relevant to the design of therapeutic insulin analogues.	[Menting, John G.; Margetts, Mai B.; Kong, Geoffrey K. -W.; Smith, Brian J.; Ward, Colin W.; Lawrence, Michael C.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Whittaker, Jonathan; Whittaker, Linda J.; Weiss, Michael A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem, Melbourne, Vic 3086, Australia; [Watson, Christopher J.; Dodson, Guy G.; Brzozowski, Andrzej M.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Zakova, Lenka; Kletvikova, Emilia; Jiracek, Jiri] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Vvi, CR-16610 Prague, Czech Republic; [Chan, Shu Jin; Steiner, Donald F.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Lawrence, Michael C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; Case Western Reserve University; La Trobe University; University of York - UK; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; University of Chicago; University of Melbourne	Lawrence, MC (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	michael.weiss@case.edu; lawrence@wehi.edu.au	Zakova, Lenka/A-7119-2008; Zakova, Lenka/Y-6234-2019; Smith, Brian J/F-8282-2011; Jiracek, Jiri/A-7124-2008; Lawrence, Michael C/A-5357-2009; Jiracek, Jiri/Y-6703-2019	Zakova, Lenka/0000-0001-6439-2574; Smith, Brian J/0000-0003-0498-1910; Jiracek, Jiri/0000-0003-3848-2773; Jiracek, Jiri/0000-0003-3848-2773; Menting, John/0000-0003-3638-3544; Lawrence, Michael/0000-0003-1999-0801	Australian National Health and Medical Research Council (NHMRC) [516729, 575539, 1005896]; Hazel and Pip Appel Fund; NHMRC [361646]; Victorian State Government; NIH [DK40949, DK13914, DK20595]; American Diabetes Association [1-11INI-31]; Grant Agency of the Czech Republic [P207/11/P430]; Research Project of the Academy of Sciences of the Czech Republic [RVO: 61388963]; BBSRC; UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020595, R01DK040949, R37DK013914, P60DK020595, R01DK013914] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Hazel and Pip Appel Fund; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Project of the Academy of Sciences of the Czech Republic(Czech Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UoY Research Priming Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This Letter is dedicated to our co-author, the late Guy Dodson, in recognition of his lifetime contribution to the study of the structure of insulin. This work was supported by Australian National Health and Medical Research Council (NHMRC) Project grants 516729, 575539 and 1005896 and the Hazel and Pip Appel Fund (to M. C. L.), NHMRC Independent Research Institutes Infrastructure Support Scheme Grant 361646 and Victorian State Government Operational Infrastructure Support Grant (to the Walter and Eliza Hall Institute of Medical Research), NIH grant no. DK40949(to M. A. W. and J.W.) and American Diabetes Association grant no. 1-11INI-31 (to J.W.), Grant Agency of the Czech Republic grant P207/11/P430 (to L.Z.), Research Project of the Academy of Sciences of the Czech Republic RVO: 61388963 (to the Institute of Organic Chemistry and Biochemistry), NIH grants DK13914 and DK20595 (to D. F. S.), a BBSRC PhD studentship (to C. J.W.) and the UoY Research Priming Fund(to the York Structural Biology Laboratory). Part of this research was undertaken on the MX2 beamline at the Australian Synchrotron (AS), Victoria, Australia. We thank the DLS for access to beamline I24 and the Australian International Synchrotron Access Program for travel funds. We thank P. Colman and J. Gulbis, our colleagues at CSIRO and the AS beam line staff for their support; J. Turkenburg for assistance in collecting data at DLS; K. Huang for assistance with midi-receptor photo-crosslinking; Q.-X. Hua and Y. Yang for discussion of NMR studies of insulin; S.-Q. Hu, S. H. Nakagawa, N. F. Phillips and S. Wang for assistance with insulin analogue synthesis; P. G. Katsoyannis for advice about the synthesis of photo-reactive insulin analogues and for providing an initial set of Pap analogues; K. Siddle for supplying the 83-7 and 83-14 hybridomas; L. Lu and the fermentation group CSIRO Materials Science and Engineering for large-scale cell culture.	ADAMS MJ, 1969, NATURE, V224, P491, DOI 10.1038/224491a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bricogne G., 2011, BUSTER VERSION 2 10; Brunger AT, 2009, ACTA CRYSTALLOGR D, V65, P128, DOI 10.1107/S0907444908043795; Cohen P, 2006, NAT REV MOL CELL BIO, V7, P867, DOI 10.1038/nrm2043; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; Denley A, 2004, MOL ENDOCRINOL, V18, P2502, DOI 10.1210/me.2004-0183; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Evans P, 2012, SCIENCE, V336, P986, DOI 10.1126/science.1222162; Garrett TPJ, 1998, NATURE, V394, P395, DOI 10.1038/28668; HOOGENBOOM HR, 1991, NUCLEIC ACIDS RES, V19, P4133, DOI 10.1093/nar/19.15.4133; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Jiracek J, 2010, P NATL ACAD SCI USA, V107, P1966, DOI 10.1073/pnas.0911785107; JONES TA, 1986, EMBO J, V5, P819, DOI 10.1002/j.1460-2075.1986.tb04287.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kiselyov VV, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.78; Kleywegt GJ, 1997, ACTA CRYSTALLOGR D, V53, P179, DOI 10.1107/S0907444996012279; Kristensen C, 1999, J BIOL CHEM, V274, P37351, DOI 10.1074/jbc.274.52.37351; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lou MZ, 2006, P NATL ACAD SCI USA, V103, P12429, DOI 10.1073/pnas.0605395103; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARKUSSEN J, 1991, J BIOL CHEM, V266, P18814; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Menting JG, 2009, BIOCHEMISTRY-US, V48, P5492, DOI 10.1021/bi900261q; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Smith BJ, 2010, P NATL ACAD SCI USA, V107, P6771, DOI 10.1073/pnas.1001813107; SOOS MA, 1986, BIOCHEM J, V235, P199, DOI 10.1042/bj2350199; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; STANLEY P, 1989, MOL CELL BIOL, V9, P377, DOI 10.1128/MCB.9.2.377; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Ward CW, 2012, CURR OPIN STRUC BIOL, V22, P360, DOI 10.1016/j.sbi.2012.03.014; Ward CW, 2009, BIOESSAYS, V31, P422, DOI 10.1002/bies.200800210; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Whittaker J, 2012, P NATL ACAD SCI USA, V109, P11166, DOI 10.1073/pnas.1205681109; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Zakova L, 2008, BIOCHEMISTRY-US, V47, P5858, DOI 10.1021/bi702086w	52	265	285	3	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					241	U276		10.1038/nature11781	http://dx.doi.org/10.1038/nature11781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302862	Green Accepted			2022-12-28	WOS:000313259600043
J	Sun, J; Timurdogan, E; Yaacobi, A; Hosseini, ES; Watts, MR				Sun, Jie; Timurdogan, Erman; Yaacobi, Ami; Hosseini, Ehsan Shah; Watts, Michael R.			Large-scale nanophotonic phased array	NATURE			English	Article							LIGHT; ANTENNA	Electromagnetic phased arrays at radio frequencies are well known and have enabled applications ranging from communications to radar, broadcasting and astronomy(1). The ability to generate arbitrary radiation patterns with large-scale phased arrays has long been pursued. Although it is extremely expensive and cumbersome to deploy large-scale radiofrequency phased arrays(2), optical phased arrays have a unique advantage in that the much shorter optical wavelength holds promise for large-scale integration(3). However, the short optical wavelength also imposes stringent requirements on fabrication. As a consequence, although optical phased arrays have been studied with various platforms(4-8) and recently with chip-scale nanophotonics(9-12), all of the demonstrations so far are restricted to one-dimensional or small-scale two-dimensional arrays. Here we report the demonstration of a large-scale two-dimensional nanophotonic phased array (NPA), in which 64 x 64 (4,096) optical nanoantennas are densely integrated on a silicon chip within a footprint of 576 mu m x 576 mu m with all of the nanoantennas precisely balanced in power and aligned in phase to generate a designed, sophisticated radiation pattern in the far field. We also show that active phase tunability can be realized in the proposed NPA by demonstrating dynamic beam steering and shaping with an 8 x 8 array. This work demonstrates that a robust design, together with state-of-the-art complementary metal-oxide-semiconductor technology, allows large-scale NPAs to be implemented on compact and inexpensive nanophotonic chips. In turn, this enables arbitrary radiation pattern generation using NPAs and therefore extends the functionalities of phased arrays beyond conventional beam focusing and steering, opening up possibilities for large-scale deployment in applications such as communication, laser detection and ranging, three-dimensional holography and biomedical sciences, to name just a few.	[Sun, Jie; Timurdogan, Erman; Yaacobi, Ami; Hosseini, Ehsan Shah; Watts, Michael R.] MIT, Elect Res Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Watts, MR (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.	mwatts@mit.edu	shah hosseini, ehsan/C-1584-2013; Sun, Jie/B-9394-2013; Timurdogan, Erman/H-8262-2013	shah hosseini, ehsan/0000-0003-2486-202X; Timurdogan, Erman/0000-0001-5893-5245	Defense Advanced Research Projects Agency (DARPA) of the United States [HR0011-12-2-0007]; DARPA POEM [HR0011-11-C-0100]	Defense Advanced Research Projects Agency (DARPA) of the United States(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); DARPA POEM	We thank K. Shtyrkova and J. S. Orcutt for help with the initial measurement setup, and also APIC Corporation. This work was supported by the Defense Advanced Research Projects Agency (DARPA) of the United States under the E-PHI and SWEEPER projects, grant no. HR0011-12-2-0007. J. S. acknowledges support from DARPA POEM award HR0011-11-C-0100.	ABELES JH, 1988, APPL PHYS LETT, V53, P1375, DOI 10.1063/1.99983; Alu A, 2008, NAT PHOTONICS, V2, P307, DOI 10.1038/nphoton.2008.53; CARLSON NW, 1988, APPL PHYS LETT, V53, P2275, DOI 10.1063/1.100252; Cherry M, 2011, NATURE, V480, P308, DOI 10.1038/480308a; DeRose CT, 2011, 2011 OPTICAL FIBER COMMUNICATION CONFERENCE AND EXPOSITION (OFC/NFOEC) AND THE NATIONAL FIBER OPTIC ENGINEERS CONFERENCE; Doylend JK, 2011, OPT EXPRESS, V19, P21595, DOI 10.1364/OE.19.021595; FIENUP JR, 1978, OPT LETT, V3, P27, DOI 10.1364/OL.3.000027; GERCHBERG RW, 1972, OPTIK, V35, P237; Hansen R. C., 1998, WILEY MICRO; Haupt R. L., 2010, ANTENNA ARRAYS COMPU, DOI 10.1002/9780470937464.ch1; Kosako T, 2010, NAT PHOTONICS, V4, P312, DOI 10.1038/NPHOTON.2010.34; Kwong D, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3619847; Le Thomas N, 2007, J OPT SOC AM B, V24, P2964, DOI 10.1364/JOSAB.24.002964; McManamon PF, 1996, P IEEE, V84, P268, DOI 10.1109/5.482231; MEYER RA, 1972, APPL OPTICS, V11, P613, DOI 10.1364/AO.11.000613; Muhlschlegel P, 2005, SCIENCE, V308, P1607, DOI 10.1126/science.1111886; NG W, 1991, J LIGHTWAVE TECHNOL, V9, P1124, DOI 10.1109/50.85809; Padgett M, 2004, PHYS TODAY, V57, P35, DOI 10.1063/1.1768672; Resler DP, 1996, OPT LETT, V21, P689, DOI 10.1364/OL.21.000689; Roelkens G, 2006, OPT EXPRESS, V14, P11622, DOI 10.1364/OE.14.011622; Schuck PJ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.017402; Taflove A., 2005, COMPUTATIONAL ELECTR; Tang L, 2008, NAT PHOTONICS, V2, P226, DOI 10.1038/nphoton.2008.30; Van Acoleyen K, 2010, OPT EXPRESS, V18, P13655, DOI 10.1364/OE.18.013655; Van Acoleyen K, 2009, OPT LETT, V34, P1477, DOI 10.1364/OL.34.001477; Watts M.R, OPT LETT UNPUB; Xia C, 2011, OPT EXPRESS, V19, P16653, DOI 10.1364/OE.19.016653; Yaacobi A, 2012, OPT LETT, V37, P1454, DOI 10.1364/OL.37.001454; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	29	771	839	52	583	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 10	2013	493	7431					195	199		10.1038/nature11727	http://dx.doi.org/10.1038/nature11727			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	066YY	23302859				2022-12-28	WOS:000313259600034
J	Holt, B; Lessard, JP; Borregaard, MK; Fritz, SA; Araujo, MB; Dimitrov, D; Fabre, PH; Graham, CH; Graves, GR; Jonsson, KA; Nogues-Bravo, D; Wang, ZH; Whittaker, RJ; Fjeldsa, J; Rahbek, C				Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Dimitrov, Dimitar; Fabre, Pierre-Henri; Graham, Catherine H.; Graves, Gary R.; Jonsson, Knud A.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Fjeldsa, Jon; Rahbek, Carsten			An Update of Wallace's Zoogeographic Regions of the World	SCIENCE			English	Article							GLOBAL PATTERNS; CLIMATE-CHANGE; DISTRIBUTIONS; CONSERVATION; DIVERSITY; VELOCITY; ENDEMISM	Modern attempts to produce biogeographic maps focus on the distribution of species, and the maps are typically drawn without phylogenetic considerations. Here, we generate a global map of zoogeographic regions by combining data on the distributions and phylogenetic relationships of 21,037 species of amphibians, birds, and mammals. We identify 20 distinct zoogeographic regions, which are grouped into 11 larger realms. We document the lack of support for several regions previously defined based on distributional data and show that spatial turnover in the phylogenetic composition of vertebrate assemblages is higher in the Southern than in the Northern Hemisphere. We further show that the integration of phylogenetic information provides valuable insight on historical relationships among regions, permitting the identification of evolutionarily unique regions of the world.	[Holt, Ben G.; Lessard, Jean-Philippe; Borregaard, Michael K.; Fritz, Susanne A.; Araujo, Miguel B.; Graves, Gary R.; Nogues-Bravo, David; Wang, Zhiheng; Whittaker, Robert J.; Rahbek, Carsten] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark; [Fritz, Susanne A.] Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fritz, Susanne A.] Senckenberg Gesell Nat Forsch, D-60325 Frankfurt, Germany; [Araujo, Miguel B.] CSIC, Dept Biogeog & Global Change, Natl Museum Nat Sci, Madrid 28006, Spain; [Araujo, Miguel B.] Univ Evora, Ctr Invest Biodiversidade & Recursos Genet, P-7000 Evora, Portugal; [Dimitrov, Dimitar; Fabre, Pierre-Henri; Jonsson, Knud A.; Fjeldsa, Jon] Univ Copenhagen, Ctr Macroecol Evolut & Climate, Nat Hist Museum Denmark, DK-2100 Copenhagen O, Denmark; [Graham, Catherine H.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Graves, Gary R.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, Washington, DC 20013 USA; [Whittaker, Robert J.] Univ Oxford, Biodivers Res Grp, Sch Geog & Environm, Ctr Environm, Oxford OX1 3QY, England	University of Copenhagen; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); University of Evora; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Oxford	Lessard, JP (corresponding author), Univ Copenhagen, Ctr Macroecol Evolut & Climate, Dept Biol, DK-2100 Copenhagen O, Denmark.	jplessard@bio.ku.dk	Graham, Catherine/AAN-1237-2020; Fjeldså, Jon/A-9699-2013; Whittaker, Robert J/H-1548-2015; Jonsson, Knud A/F-6902-2012; Fritz, Susanne/M-9872-2014; Graves, Gary R/P-1003-2017; Rahbek, Carsten/D-9372-2013; Graham, Catherine/A-9560-2011; Araújo, Miguel B/B-6117-2008; Wang, Zhiheng/G-1750-2010; Dimitrov, Dimitar/A-9563-2009; Rahbek, Carsten/L-1129-2013; Jønsson, Knud/GMW-5310-2022; Borregaard, Michael/B-8442-2008	Graham, Catherine/0000-0001-9267-7948; Fjeldså, Jon/0000-0003-0790-3600; Whittaker, Robert J/0000-0001-7775-3383; Fritz, Susanne/0000-0002-4085-636X; Graves, Gary R/0000-0003-1406-5246; Graham, Catherine/0000-0001-9267-7948; Araújo, Miguel B/0000-0002-5107-7265; Wang, Zhiheng/0000-0003-0808-7780; Dimitrov, Dimitar/0000-0001-5830-5702; Rahbek, Carsten/0000-0003-4585-0300; Jønsson, Knud/0000-0002-1875-9504; Borregaard, Michael/0000-0002-8146-8435; Pierre-Henri, Fabre/0000-0002-3414-5625; Holt, Ben G./0000-0003-0831-9684; Nogues-Bravo, David/0000-0002-4060-0153	Danish National Research Foundation; Marie Curie Actions under the Seventh Framework Programme [PIEF-GA-2009-252888]; Spanish Research Council (CSIC)	Danish National Research Foundation(Danmarks Grundforskningsfond); Marie Curie Actions under the Seventh Framework Programme; Spanish Research Council (CSIC)	We thank the Danish National Research Foundation for its support of the Center for Macroecology, Evolution, and Climate. B.G.H. also thanks the Marie Curie Actions under the Seventh Framework Programme (PIEF-GA-2009-252888). M.B.A. also thanks the Spanish Research Council (CSIC) for support, and S.A.F. thanks the Landes-Offensive zur Entwicklung Wissenschaftlich-Okonomischer Exzellenz program of Hesse's Ministry of Higher Education, Research, and the Arts. We thank L. Hansen for help with data and reference compilations. We thank the International Union for Conservation of Nature and Natural Resources for making the amphibian and mammal range data available. Data are archived at http://macroecology.ku.dk/resources/wallace.	Allen JRM, 2010, QUATERNARY SCI REV, V29, P2604, DOI 10.1016/j.quascirev.2010.05.031; Buckley LB, 2008, P NATL ACAD SCI USA, V105, P17836, DOI 10.1073/pnas.0803524105; Cracraft J, 2001, P ROY SOC B-BIOL SCI, V268, P459, DOI 10.1098/rspb.2000.1368; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Fjeldsa J, 1999, ECOGRAPHY, V22, P63, DOI 10.1111/j.1600-0587.1999.tb00455.x; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Ladle R. J., 2011, CONSERVATION BIOGEOG, DOI 10.1002/9781444390001; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; MANTEL N, 1967, CANCER RES, V27, P209; Mayr E, 1944, Q REV BIOL, V19, P1, DOI 10.1086/394684; Munguia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034420; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Proches S, 2012, BIOSCIENCE, V62, P260, DOI 10.1525/bio.2012.62.3.7; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Sandel B, 2011, SCIENCE, V334, P660, DOI 10.1126/science.1210173; Sclater P.L, 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI [10.1111/j.1096-3642.1858.tb02549.x, DOI 10.1111/J.1096-3642.1858.TB02549.X]; Udvardy MDF, 1975, 18 INT UN CONS NAT; Upchurch P, 2008, TRENDS ECOL EVOL, V23, P229, DOI 10.1016/j.tree.2007.11.006; Wallace A. R, 1894, GEOGRAPHICAL J; Weber M, 1902, INDOAUSTRALISCHE ARC; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366; [No title captured]	26	789	845	19	618	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 4	2013	339	6115					74	78		10.1126/science.1228282	http://dx.doi.org/10.1126/science.1228282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	063HC	23258408				2022-12-28	WOS:000312985800054
J	Boj, SF; van Es, JH; Huch, M; Li, VSW; Jose, A; Hatzis, P; Mokry, M; Haegebarth, A; van den Born, M; Chambon, P; Voshol, P; Dor, Y; Cuppen, E; Fillat, C; Clevers, H				Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Jose, Anabel; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Chambon, Pierre; Voshol, Peter; Dor, Yuval; Cuppen, Edwin; Fillat, Cristina; Clevers, Hans			Diabetes Risk Gene and Wnt Effector Tcf7l2/TCF4 Controls Hepatic Response to Perinatal and Adult Metabolic Demand	CELL			English	Article							BETA-CATENIN; LIVER; POLYMORPHISMS; EXPRESSION; GLUCOSE; CORRELATE; RECEPTOR	Most studies on TCF7L2 SNP variants in the pathogenesis of type 2 diabetes (T2D) focus on a role of the encoded transcription factor TCF4 in beta cells. Here, a mouse genetics approach shows that removal of TCF4 from beta cells does not affect their function, whereas manipulating TCF4 levels in the liver has major effects on metabolism. In Tcf7l2(-/-) mice, the immediate postnatal surge in liver metabolism does not occur. Consequently, pups die due to hypoglycemia. By combining chromatin immunoprecipitation with gene expression profiling, we identify a TCF4-controlled metabolic gene program that is acutely activated in the postnatal liver. In concordance, adult liver-specific Tcf7l2 knockout mice show reduced hepatic glucose production during fasting and display improved glucose homeostasis when maintained on high-fat diet. Furthermore, liver-specific TCF4 overexpression increases hepatic glucose production. These observations imply that TCF4 directly activates metabolic genes and that inhibition of Wnt signaling may be beneficial in metabolic disease.	[Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Boj, Sylvia F.; van Es, Johan H.; Huch, Meritxell; Li, Vivian S. W.; Hatzis, Pantelis; Mokry, Michal; Haegebarth, Andrea; van den Born, Maaike; Cuppen, Edwin; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Jose, Anabel; Fillat, Cristina] CIBERER, Barcelona 08036, Spain; [Jose, Anabel; Fillat, Cristina] IDIBAPS, Barcelona 08036, Spain; [Chambon, Pierre] Univ Strasbourg 1, IGBMC, F-67404 Illkirch Graffenstaden, France; [Voshol, Peter] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Hebrew University of Jerusalem	Clevers, H (corresponding author), KNAW, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Cuppen, Edwin/F-5696-2011; Mokry, Michal/AAN-3809-2021; Cuppen, Edwin/H-2389-2016; van+Es, Johan/ABD-5411-2021; Fillat, Cristina/ABH-1674-2020	Cuppen, Edwin/0000-0002-0400-9542; Mokry, Michal/0000-0002-5298-4852; Cuppen, Edwin/0000-0002-0400-9542; Fillat, Cristina/0000-0002-0801-3338; Li, Vivian/0000-0003-2041-0085	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO [ALT-835-2007]; KWF/PF HUBR [2007-3956]; CGCII; long-term Marie Curie fellowship; Ti Pharm [T3-106]; MINECO [BIO2011-30299-C02-02]; Instituto de Salud Carlos III [IIS10/00014];  [EU/232814-stemcellmark];  [EU/236954-ICSC LGR5]	Stichting Diabetes Onderzoek Nederland; Diabetes Fonds; EMBO(European Molecular Biology Organization (EMBO)); KWF/PF HUBR; CGCII; long-term Marie Curie fellowship; Ti Pharm; MINECO(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ; 	We thank H. Begthel, J. Korving, L. van Gurp, C. Kroon-Veenboer, and B. El Haddouti for technical assistance and T. Mahmoudi and J.D. Mul for their helpful discussions. This work was supported by Stichting Diabetes Onderzoek Nederland and the Diabetes Fonds. S.F.B. is supported by EMBO long-term fellowship (ALT-835-2007) and by EU/232814-stemcellmark; J.H.E. is supported by EU/232814-stemcellmark; V.S.W.L. is supported by KWF/PF HUBR 2007-3956; P.H. was supported by CGCII; A.H. was supported by KWF/PF HUBR 2007-3956; M.H. is supported by long-term Marie Curie fellowship and EU/236954-ICSC LGR5; M.B. is supported by Ti Pharm/T3-106; and A.J. and C.F. are supported by BIO2011-30299-C02-02 from MINECO and IIS10/00014 from Instituto de Salud Carlos III.	Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DASHTI N, 1979, BIOCHEM MED METAB B, V22, P365, DOI 10.1016/0006-2944(79)90024-3; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elbein SC, 2007, DIABETOLOGIA, V50, P1621, DOI 10.1007/s00125-007-0717-x; Fechner H, 1999, GENE THER, V6, P1520, DOI 10.1038/sj.gt.3301030; FERRE P, 1986, REPROD NUTR DEV, V26, P619, DOI 10.1051/rnd:19860413; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gregorieff A, 2004, EMBO J, V23, P1825, DOI 10.1038/sj.emboj.7600191; Gustafsson J, 2009, INDIAN J MED RES, V130, P618; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mokry M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015092; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Pilgaard K, 2009, DIABETOLOGIA, V52, P1298, DOI 10.1007/s00125-009-1307-x; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Sanderson LM, 2009, MOL CELL BIOL, V29, P6257, DOI 10.1128/MCB.00370-09; Savic D, 2011, GENOME RES, V21, P1417, DOI 10.1101/gr.123745.111; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schuler M, 2004, GENESIS, V39, P167, DOI 10.1002/gene.20039; Shu L, 2008, DIABETES, V57, P645, DOI 10.2337/db07-0847; Shu LA, 2009, HUM MOL GENET, V18, P2388, DOI 10.1093/hmg/ddp178; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Xavier GD, 2009, DIABETES, V58, P894, DOI 10.2337/db08-1187	38	166	173	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 21	2012	151	7					1595	1607		10.1016/j.cell.2012.10.053	http://dx.doi.org/10.1016/j.cell.2012.10.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	062AA	23260145	Bronze			2022-12-28	WOS:000312890300022
J	Stabler, SP				Stabler, Sally P.			Vitamin B-12 Deficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COBALAMIN DEFICIENCY; METHYLMALONIC ACID; PERNICIOUS-ANEMIA; TOTAL HOMOCYSTEINE; FOLIC-ACID; SERUM; HOLOTRANSCOBALAMIN; SUPPLEMENTATION; BIOMARKERS; THROMBOSIS	A 57-year-old woman reports increasing symptoms of painful paresthesias in both legs for the past 18 months. Physical examination reveals impaired position sense and vibration sense. The serum vitamin B-12 level is 205 pg per milliliter (151.2 pmol per liter), which is above the lower end of the laboratory reference range. The hemato-crit is 42%, with a mean corpuscular volume of 96 fl. The serum methylmalonic acid level is 3600 nmol per liter (normal level, <400), and the serum homocysteine level 49.1 mu mol per liter (normal level, <14). How should this patient be further evaluated and treated?	Univ Colorado, Div Hematol, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Stabler, SP (corresponding author), Univ Colorado, Div Hematol, Sch Med, Aurora, CO 80045 USA.	sally.stabler@ucdenver.edu						Andres E, 2006, CLIN LAB HAEMATOL, V28, P50, DOI 10.1111/j.1365-2257.2006.00755.x; BERLIN H, 1968, ACTA MED SCAND, V184, P247; Bolaman Z, 2003, CLIN THER, V25, P3124, DOI 10.1016/S0149-2918(03)90096-8; Bor MV, 2008, HAEMATOL-HEMATOL J, V93, P1755, DOI 10.3324/haematol.13122; Bor MV, 2010, AM J CLIN NUTR, V91, P571, DOI 10.3945/ajcn.2009.28082; Carmel R, 2000, CLIN CHEM, V46, P2017; Carmel R, 2012, NEW ENGL J MED, V367, P976; Carmel R, 2008, BLOOD, V112, P2214, DOI 10.1182/blood-2008-03-040253; Castelli MC, 2011, CLIN THER, V33, p358e2; Chan JCW, 2006, MEDICINE, V85, P129, DOI 10.1097/01.md.0000224710.47263.70; Dalsania CJ, 2008, AM J MED, V121, P107, DOI 10.1016/j.amjmed.2007.11.003; de Jager J, 2010, BMJ-BRIT MED J, V340, pc2181; Dror DK, 2008, NUTR REV, V66, P250, DOI 10.1111/j.1753-4887.2008.00031.x; England JD, 2009, PM&R, V1, P14, DOI 10.1016/j.pmrj.2008.11.011; Eussen SJPM, 2005, ARCH INTERN MED, V165, P1167, DOI 10.1001/archinte.165.10.1167; Food and Nutrition Board - Institute of Medicine, 1998, DIET REF INT THIAM R; Galloway M, 2007, BMJ-BRIT MED J, V335, P884, DOI 10.1136/bmj.39325.689641.471; Greibe E, 2011, CLIN CHEM LAB MED, V49, P1883, DOI 10.1515/CCLM.2011.754; HEALTON EB, 1991, MEDICINE, V70, P229, DOI 10.1097/00005792-199107000-00001; Heil SG, 2012, ANN CLIN BIOCHEM, V49, P184, DOI 10.1258/acb.2011.011039; Hershko C, 2006, BLOOD, V107, P1673, DOI 10.1182/blood-2005-09-3534; Hirota WK, 2006, GASTROINTEST ENDOSC, V63, P570, DOI 10.1016/j.gie.2006.02.004; Honzik T, 2010, EUR J PAEDIATR NEURO, V14, P488, DOI 10.1016/j.ejpn.2009.12.003; Kim HI, 2011, ANN SURG ONCOL, V18, P3711, DOI 10.1245/s10434-011-1764-6; Kuzminski AM, 1998, BLOOD, V92, P1191, DOI 10.1182/blood.V92.4.1191.416k15_1191_1198; Lewerin C, 2008, SCAND J GASTROENTERO, V43, P1050, DOI 10.1080/00365520802078341; Limal N, 2006, THROMB HAEMOSTASIS, V96, P233, DOI 10.1160/TH06-01-0059; LINDENBAUM J, 1988, NEW ENGL J MED, V318, P1720, DOI 10.1056/NEJM198806303182604; Mangels AR, 2003, J AM DIET ASSOC, V103, P748, DOI 10.1053/jada.2003.50142; Nachum-Biala Y, 2012, BIOFACTORS, V38, P145, DOI 10.1002/biof.1006; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Parmentier S, 2012, ANN HEMATOL, V91, P1979, DOI 10.1007/s00277-012-1488-0; PENNYPACKER LC, 1992, J AM GERIATR SOC, V40, P1197, DOI 10.1111/j.1532-5415.1992.tb03641.x; Pittock SJ, 2002, MAYO CLIN PROC, V77, P291, DOI 10.4065/77.3.291; Rajan S, 2002, J AM GERIATR SOC, V50, P1789, DOI 10.1046/j.1532-5415.2002.50506.x; RASMUSSEN K, 1990, CLIN CHEM, V36, P1523; Remacha AF, 2011, INT J HEMATOL, V93, P458, DOI 10.1007/s12185-011-0825-8; Sarafoglou K, 2011, JAMA-J AM MED ASSOC, V305, P1198, DOI 10.1001/jama.2011.310; SAVAGE DG, 1994, AM J MED, V96, P239, DOI 10.1016/0002-9343(94)90149-X; Schrempf W, 2011, J NEUROL, V258, P393, DOI 10.1007/s00415-010-5764-4; Singer MA, 2008, MUSCLE NERVE, V37, P125, DOI 10.1002/mus.20840; Stabler S. P., 2012, Present knowledge in nutrition, P343; Stabler SP, 2004, ANNU REV NUTR, V24, P299, DOI 10.1146/annurev.nutr.24.012003.132440; STABLER SP, 1988, J CLIN INVEST, V81, P466, DOI 10.1172/JCI113343; STABLER SP, 1990, BLOOD, V76, P871; STABLER SP, 1986, J CLIN INVEST, V77, P1606, DOI 10.1172/JCI112476; Stabler SP, 2006, CLIN HEMATOLOGY, P242; Tanner SM, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-56; Toh BH, 2012, CLIN REV ALLERG IMMU, V42, P269, DOI 10.1007/s12016-010-8218-y; Yang DT, 2012, NEW ENGL J MED, V366, P1742, DOI 10.1056/NEJMc1201655; Yang HT, 2012, EUR J INTERN MED, V23, P745, DOI 10.1016/j.ejim.2012.07.004	52	656	694	3	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	2013	368	2					149	160		10.1056/NEJMcp1113996	http://dx.doi.org/10.1056/NEJMcp1113996			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	066RO	23697528				2022-12-28	WOS:000313238100005
